PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Markey, KL; Abdo, DA; Evans, SN; Bosserelle, C				Markey, Kathryn L.; Abdo, Dave A.; Evans, Scott N.; Bosserelle, Cyprien			Keeping It Local: Dispersal Limitations of Coral Larvae to the High Latitude Coral Reefs of the Houtman Abrolhos Islands	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; COMPETENCE PERIODS; SURVIVAL DYNAMICS; GENETIC DIVERSITY; SETTLEMENT; REPRODUCTION; CONNECTIVITY; SURVIVORSHIP; RECRUITMENT	In 2011 the first recorded bleaching event for the high latitude Houtman Abrolhos Islands (HAI) coral communities was documented. This bleaching event highlighted the question of whether a supply of `heat tolerant' coral recruits from the tropical north would be sufficient to provide a level of resistance for these reefs to future warming events. Using Lagrangian modelling we showed that due to its regional isolation, large-scale larval input from potential tropical northern source populations to the HAI is unlikely, despite the southward flowing Leeuwin current. Successful recruitment to artificial substrates was recorded following the bleaching event. However, this was negligible (0.4 +/- 0.1 recruits per tile) compared to 2013 post impact recruitment (128.8 +/- 15.8 recruits per tile). Our data therefore provides preliminary evidence suggesting that the connectivity of the HAI with coral communities in the north is limited, and population maintenance and recovery is likely driven primarily by self-recruitment. Given the low thermal tolerance of the HAI coral communities, the dominance of Acropora, and the apparent reliance on self-recruitment, an increased frequency of thermally anomalous conditions at the HAI (such as experienced in 2011) has the potential to reduce the long-term stability of the HAI coral populations and species that depend upon them.	[Markey, Kathryn L.; Abdo, Dave A.; Evans, Scott N.] Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, POB 20, North Beach, WA 6920, Australia; [Bosserelle, Cyprien] Secretariat Pacific Commun, Geosci Div, Private Mail Bag, Suva, Fiji	Government of Western Australia	Abdo, DA (corresponding author), Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, POB 20, North Beach, WA 6920, Australia.	dave.abdo@fish.wa.gov.au		Markey, Kathryn/0000-0002-2556-3366	Department of Fisheries, Government of Western Australia	Department of Fisheries, Government of Western Australia	Funding was provided by the Department of Fisheries, Government of Western Australia. The authors would like to thank Tyrone Ridgway for helpful discussions and editing earlier versions of this manuscript and Joshua Dornan and Nick Konzewistch for field and laboratory assistance.; Funding for this study was provided by the Department of Fisheries, Government of Western Australia.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1984, CORAL REEFS, V2, P187; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2001, ECOLOGY CORAL LARVAE; Baird Andrew H., 2004, Journal and Proceedings of the Royal Society of New South Wales, V137, P43; Ben-David-Zaslow R, 1998, MAR ECOL PROG SER, V163, P235, DOI 10.3354/meps163235; Ben-David-Zaslow R., 1996, J EXP MAR BIOL ECOL, V206, P55, DOI DOI 10.1016/S0022-0981(96)02618-4; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; BLACK KP, 1990, CORAL REEFS, V9, P105, DOI 10.1007/BF00258221; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dahan M, 1998, INVERTEBR BIOL, V117, P271, DOI 10.2307/3227029; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Dullo WC, 2005, FACIES, V51, P33, DOI 10.1007/s10347-005-0060-y; English S., 1997, SURVEY MANUAL TROPIC; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Ho MJ, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-5; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Nozawa Y, 2000, P 9 INT COR REEF S B; Nozawa Y, 2008, MAR BIOL, V155, P347, DOI 10.1007/s00227-008-1034-8; Nozawa Y, 2011, BIOL BULL-US, V220, P15, DOI 10.1086/BBLv220n1p15; Oliver J. K., 2009, V205, P21; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2002, CORAL REEFS, V21, P13, DOI 10.1007/s00338-001-0204-7; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Rosser NL, 2008, CORAL REEFS, V27, P345, DOI 10.1007/s00338-007-0335-6; Rosser NL, 2013, CORAL REEFS, V32, P455, DOI 10.1007/s00338-012-0986-9; SAMMARCO PW, 1991, PALAEOGEOGR PALAEOCL, V88, P1, DOI 10.1016/0031-0182(91)90011-F; Shedrawi G, 2013, W AUSTR MARINE MONIT, P63; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; SMITH SV, 1981, LIMNOL OCEANOGR, V26, P612, DOI 10.4319/lo.1981.26.4.0612; Sudek M, 2012, CORAL REEFS, V31, P351, DOI 10.1007/s00338-011-0844-1; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tay YC, 2011, J EXP MAR BIOL ECOL, V409, P324, DOI 10.1016/j.jembe.2011.09.013; Thomas L, 2015, P ROY SOC B-BIOL SCI, V282, P50, DOI 10.1098/rspb.2015.1217; Underwood JN, 2013, J NAT CONSERV, V21, P163, DOI 10.1016/j.jnc.2012.12.001; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Veron JEN, 1988, RECORDS W AUSTR S29; Viikmae B, 2013, OCEAN DYNAM, V63, P589, DOI 10.1007/s10236-013-0615-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Watch NCR, 2014, NOAA COR REEF WATCH; Wells F, 1997, MARINE FLORA FAUNA H; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Wijeratne EMS, 2014, AUSTR COAST OC MOD O; Wijeratne EMS, 2012, MODELLING MESOSCALE; Wilson JR, 1998, MAR BIOL, V131, P339, DOI 10.1007/s002270050327; Woolsey ES, 2013, MAR ECOL PROG SER, V493, P179, DOI 10.3354/meps10499	75	14	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147628	10.1371/journal.pone.0147628	http://dx.doi.org/10.1371/journal.pone.0147628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812259	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000045
J	Streit, MR; Weiss, CS; Meyer, S; Ochs, MM; Hagenmueller, M; Riffel, JH; Buss, SJ; Heger, T; Katus, HA; Hardt, SE				Streit, Marcus R.; Weiss, Celine S.; Meyer, Soeren; Ochs, Marco M.; Hagenmueller, Marco; Riffel, Johannes H.; Buss, Sebastian J.; Heger, Thomas; Katus, Hugo A.; Hardt, Stefan E.			Cardiac Effects of Attenuating Gs alpha - Dependent Signaling	PLOS ONE			English	Article							HEART-FAILURE; PROTEIN; DISRUPTION; MICE; OVEREXPRESSION; CARDIOMYOPATHY; CARVEDILOL; MORTALITY; MYOCYTES	Aims Inhibition of beta-adrenergic signalling plays a key role in treatment of heart failure. Gs alpha is essential for beta-adrenergic signal transduction. In order to reduce side-effects of beta-adrenergic inhibition diminishing beta-adrenergic signalling in the heart at the level of Gsa is a promising option. Methods and Results We analyzed the influence of Gsa on regulation of myocardial function and development of cardiac hypertrophy, using a transgenic mouse model (C57BL6/J mice) overexpressing a dominant negative Gs alpha-mutant under control of the alpha-MHC-promotor. Cardiac phenotype was characterized in vivo and in vitro and under acute and chronic beta-adrenergic stimulation. At rest, Gs alpha-DN-mice showed bradycardia (602 +/- 13 vs. 660 +/- 17 bpm, p<0.05) and decreased dp/dt(max) (5037 +/- 546- vs. 6835 +/- 505 mmHg/s, p = 0.02). No significant differences were found regarding ejection fraction, heart weight and cardiomyocyte size. beta-blockade by propranolol revealed no baseline differences of hemodynamic parameters between wildtype and Gsa-DN-mice. Acute adrenergic stimulation resulted in decreased beta-adrenergic responsiveness in Gsa-DN-mice. Under chronic adrenergic stimulation, wildtype mice developed myocardial hypertrophy associated with increase of LV/BW-ratio by 23% (4.4 +/- 0.2 vs. 3.5 +/- 0.1 mg/g, p<0.01) and cardiac myocyte size by 24% (14927 +/- 442 px vs. 12013 +/- 583 px, p<0.001). In contrast, both parameters were unchanged in Gsa-DN-mice after chronic isoproterenol stimulation. Conclusion Overexpression of a dominant negative mutant of Gsa leads to decreased beta-adrenergic responsiveness and is protective against isoproterenol-induced hypertrophy. Thus, Gs alpha-DN-mice provide novel insights into beta-adrenergic signal transduction and its modulation in myocardial overload and failure.	[Streit, Marcus R.; Weiss, Celine S.; Meyer, Soeren; Ochs, Marco M.; Hagenmueller, Marco; Riffel, Johannes H.; Buss, Sebastian J.; Heger, Thomas; Katus, Hugo A.; Hardt, Stefan E.] Univ Heidelberg Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Streit, Marcus R.] Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany; [Hardt, Stefan E.] Ctr Cardiac & Circulatory Dis, Hoheneggerstr 9, D-76646 Bruchsal, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hardt, SE (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Hardt, SE (corresponding author), Ctr Cardiac & Circulatory Dis, Hoheneggerstr 9, D-76646 Bruchsal, Germany.	stefanhardt@outlook.com			Deutsche Forschungsgemeinschaft [HA 2959/2-2, HA 2959/3-1, DFG-Forschergruppe 1036]; Ernst-und-Berta-Grimmke foundation; Deutsche Herzstiftung e.V	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-und-Berta-Grimmke foundation; Deutsche Herzstiftung e.V	The work presented herein was in part supported by the Deutsche Forschungsgemeinschaft (HA 2959/2-2, and HA 2959/3-1 within the DFG-Forschergruppe 1036), by a research grant from the Ernst-und-Berta-Grimmke foundation (SEH), and by a research grant of the Deutsche Herzstiftung e.V (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Eschenhagen T, 2008, NAT MED, V14, P485, DOI 10.1038/nm0508-485; GAUDIN C, 1995, J CLIN INVEST, V95, P1676, DOI 10.1172/JCI117843; Geng YJ, 1999, CIRC RES, V84, P34; Hardt SE, 2002, CIRCULATION, V105, P614, DOI 10.1161/hc0502.103012; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Iwase M, 1997, AM J PHYSIOL-HEART C, V272, pH585, DOI 10.1152/ajpheart.1997.272.1.H585; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kim SJ, 1999, J CLIN INVEST, V103, P1089, DOI 10.1172/JCI4848; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Lechat P, 1999, LANCET, V353, P9; Lee S, 2008, PFLUG ARCH EUR J PHY, V455, P767, DOI 10.1007/s00424-007-0324-1; LONGABAUGH JP, 1988, J CLIN INVEST, V81, P420, DOI 10.1172/JCI113335; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146988	10.1371/journal.pone.0146988	http://dx.doi.org/10.1371/journal.pone.0146988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811901	gold, Green Published			2022-12-27	WOS:000369528000018
J	Tuong, ZK; Lau, P; Du, XM; Condon, ND; Goode, JM; Oh, TG; Yeo, JC; Muscat, GEO; Stow, JL				Tuong, Zewen Kelvin; Lau, Patrick; Du, Ximing; Condon, Nicholas D.; Goode, Joel M.; Oh, Tae Gyu; Yeo, Jeremy C.; Muscat, George E. O.; Stow, Jennifer L.			ROR alpha and 25-Hydroxycholesterol Crosstalk Regulates Lipid Droplet Homeostasis in Macrophages	PLOS ONE			English	Article							ORPHAN RECEPTOR-ALPHA; NUCLEAR RECEPTOR; ROR-ALPHA(SG/SG) MICE; VLDL RECEPTOR; CHOLESTEROL; EXPRESSION; PROTEIN; MOUSE; IDENTIFICATION; LOCALIZATION	Nuclear hormone receptors have important roles in the regulation of metabolic and inflammatory pathways. The retinoid-related orphan receptor alpha (Ror alpha)-deficient staggerer (sg/sg) mice display several phenotypes indicative of aberrant lipid metabolism, including dyslipidemia, and increased susceptibility to atherosclerosis. In this study we demonstrate that macrophages from sg/sg mice have increased ability to accumulate lipids and accordingly exhibit larger lipid droplets (LD). We have previously shown that BMMs from sg/sg mice have significantly decreased expression of cholesterol 25-hydroxylase (Ch25h) mRNA, the enzyme that produces the oxysterol, 25-hydroxycholesterol (25HC), and now confirm this at the protein level. 25HC functions as an inverse agonist for ROR alpha. siRNA knockdown of Ch25h in macrophages up-regulates Vldlr mRNA expression and causes increased accumulation of LDs. Treatment with physiological concentrations of 25HC in sg/sg macrophages restored lipid accumulation back to normal levels. Thus, 25HC and ROR alpha signify a new pathway involved in the regulation of lipid homeostasis in macrophages, potentially via increased uptake of lipid which is suggested by mRNA expression changes in Vldlr and other related genes.	[Tuong, Zewen Kelvin; Lau, Patrick; Condon, Nicholas D.; Goode, Joel M.; Oh, Tae Gyu; Yeo, Jeremy C.; Muscat, George E. O.; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Du, Ximing] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Queensland; University of New South Wales Sydney	Muscat, GEO; Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	g.muscat@imb.uq.edu; j.stow@imb.uq.edu.au	Tuong, Zewen Kelvin/E-4419-2017; Muscat, George/A-6401-2017; Stow, Jennifer/I-4723-2013	Tuong, Zewen Kelvin/0000-0002-6735-6808; Lau, Patrick/0000-0002-9693-390X; OH, TAE GYU/0000-0003-3971-6789; Muscat, George/0000-0002-5829-5695; Stow, Jennifer/0000-0002-5409-9101; Oh, Tae Gyu/0000-0002-2756-3546	Australian Research Council, Australia, Research Project [DP140101461]; National Health and Medical Research Council, Australia, Fellowships; Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia; UQ International RHD Scholarship	Australian Research Council, Australia, Research Project(Australian Research Council); National Health and Medical Research Council, Australia, Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia; UQ International RHD Scholarship	This work was supported by the Australian Research Council, Australia, Research Project Grant DP140101461 and National Health and Medical Research Council, Australia, Fellowships to J.L.S. and G.E.O.M. Imaging was performed in the Australian Cancer Research Foundation Cancer Biology Imaging Facility at Institute for Molecular Bioscience, UQ, Australia. Z.K. Tuong is a recipient of a UQ International RHD Scholarship.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Bjorkhem I, 2000, TRENDS ENDOCRIN MET, V11, P180, DOI 10.1016/S1043-2760(00)00255-1; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Fitzsimmons RL, 2012, J STEROID BIOCHEM, V130, P159, DOI 10.1016/j.jsbmb.2011.06.009; Fujimoto T, 2004, SEIKAGAKU, V76, P578; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; HUME DA, 1983, J CELL PHYSIOL, V117, P189, DOI 10.1002/jcp.1041170209; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Listenberger LL, 2007, CURR PROTOC CELL BIO; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Raichur S, 2010, NUCLEIC ACIDS RES, V38, P4296, DOI 10.1093/nar/gkq180; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Silva AR, 2009, BBA-MOL CELL BIOL L, V1791, P1066, DOI 10.1016/j.bbalip.2009.06.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tuong ZK, 2013, ENDOCRINOLOGY, V154, P140, DOI 10.1210/en.2012-1889; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012	35	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147179	10.1371/journal.pone.0147179	http://dx.doi.org/10.1371/journal.pone.0147179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812621	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528000024
J	DeSouza, O; Araujo, APA; Florencio, DF; Rosa, CS; Marins, A; Costa, DA; Rodrigues, VB; Cristaldo, PF				DeSouza, Og; Albano Araujo, Ana Paula; Florencio, Daniela Faria; Rosa, Cassiano Sousa; Marins, Alessandra; Costa, Diogo Andrade; Rodrigues, Vinicius Barros; Cristaldo, Paulo Fellipe			Allometric Scaling of Patrolling Rate and Nest Volume in Constrictotermes cyphergaster Termites: Hints on the Settlement of Inquilines	PLOS ONE			English	Article							COLONY SIZE; ANT; DEFENSE; ISOPTERA; CAATINGA; BEHAVIOR; INSECTS; ECOLOGY; GROWTH; STAGE	Structural and functional traits of organisms are known to be related to the size of individuals and to the size of their colonies when they belong to one. Among such traits, propensity to inquilinism in termites is known to relate positively to colony size. Larger termitaria hold larger diversity of facultative inquilines than smaller nests, whereas obligate inquilines seem unable to settle in nests smaller than a threshold volume. Respective underlying mechanisms, however, remain hypothetical. Here we test one of such hypotheses, namely, that nest defence correlates negatively to nest volume in Constrictotermes cyphergaster termites (Termitidae: Nasutitermitinae). As a surrogate to defence, we used 'patrolling rate', i.e., the number of termite individuals attending per unit time an experimentally damaged spot on the outer wall of their termitaria. We found that patrolling rate decayed allometrically with increasing nest size. Conspicuously higher patrolling rates occurred in smaller nests, while conspicuously lower rates occurred in larger nests presenting volumes in the vicinity of the threshold value for the establishment of inquilinism. This could be proven adaptive for the host and guest. At younger nest age, host colonies are smaller and presumably more vulnerable and unstable. Enhanced defence rates may, hence, prevent eventual risks to hosts from inquilinism at the same time that it prevents inquilines to settle in a still unstable nest. Conversely, when colonies grow and maturate enough to stand threats, they would invest in priorities other than active defence, opening an opportunity for inquilines to settle in nests which are more suitable or less risky. Under this two-fold process, cohabitation between host and inquiline could readily stabilize.	[DeSouza, Og; Marins, Alessandra; Costa, Diogo Andrade; Rodrigues, Vinicius Barros] Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil; [Albano Araujo, Ana Paula; Cristaldo, Paulo Fellipe] Univ Fed Sergipe, Dept Ecol, Lab Interacoes Ecol, Sao Cristovao, SE, Brazil; [Florencio, Daniela Faria] Univ Fed Rural Semi Arido, Dept Agrotecnol & Ciencias Sociais, Mossoro, RN, Brazil; [Rosa, Cassiano Sousa] Univ Fed Triangulo Mineiro, Iturama, MG, Brazil; [Costa, Diogo Andrade] Univ Estado Mato Grosso, Dept Ciencias Biol, Tangara Da Serra, MT, Brazil	Universidade Federal de Vicosa; Universidade Federal de Sergipe; Universidade Federal Rural do Semi-Arido (UFERSA); Universidade Federal do Triangulo Mineiro; Universidade do Estado de Mato Grosso	Cristaldo, PF (corresponding author), Univ Fed Sergipe, Dept Ecol, Lab Interacoes Ecol, Sao Cristovao, SE, Brazil.	pfellipec@gmail.com	DeSouza, Og/A-7140-2008; Cristaldo, Paulo/A-1247-2013; Rosa, Cassiano S/A-1780-2011; Rodrigues, Vinícius Barros/G-1317-2014	DeSouza, Og/0000-0002-7108-0242; Cristaldo, Paulo/0000-0003-4939-0487; Rosa, Cassiano S/0000-0003-3294-5677; Rodrigues, Vinícius Barros/0000-0003-4196-8088; Albano Araujo, Ana P./0000-0001-7853-8001	National Council for Scientific and Technological Development (CNPq-Brazil); Coordination for the Improvement of High Education Personnel (CAPES-Brazil) [PVE 0148/2012]; Minas Gerais Foundation for Research Support (FAPEMIG-Brazil) [APQ 01519-11, APQ 00811-15]; CNPq [PDJ 502940/2014-7, PQ 305736/2013-2]; CNPq/FAPITEC [DCR 302246/2014, DCR 303326/2014-0]; CAPES [142551/2008-2]	National Council for Scientific and Technological Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of High Education Personnel (CAPES-Brazil); Minas Gerais Foundation for Research Support (FAPEMIG-Brazil); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/FAPITEC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by the National Council for Scientific and Technological Development (CNPq-Brazil, http://www.cnpq.br), Coordination for the Improvement of High Education Personnel (CAPES-Brazil PVE 0148/2012, http://www.capes.gov.br) and Minas Gerais Foundation for Research Support (FAPEMIG-Brazil, APQ 01519-11 and APQ 00811-15, http://www.fapemig.br). Post-doctoral grants are held by AM (CNPq PDJ 502940/2014-7), PFC (CNPq/FAPITEC DCR 302246/2014), DFF (CNPq/FAPITEC DCR 303326/2014-0) and CSR (CAPES 142551/2008-2). A CAPES doctoral grant supports VBR. ODS holds a Research Fellowship from CNPq (PQ 305736/2013-2).	Agritempo, 2018, AGR; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; [Anonymous], 2014, R LANG ENV STAT COMP; Ballesteros FJ, 2014, ARXIV14073659; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; Cristaldo PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085315; da Cunha HF, 2003, SOCIOBIOLOGY, V42, P761; Dahlsjo CAL, 2015, ACTA OECOL, V63, P16, DOI 10.1016/j.actao.2015.01.003; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; Domingos, 1983, CIENC CULT, V35, P783; EMERSON ALFRED E., 1938, ECOL MONOGR, V8, P247, DOI 10.2307/1943251; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Evans TA, 2006, INSECT SOC, V53, P56, DOI 10.1007/s00040-005-0835-8; Florencio DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066535; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; INMET, 2015, BANC DAT MET ENS PES; JEANNE RL, 1986, BEHAV ECOL SOCIOBIOL, V19, P333, DOI 10.1007/BF00295706; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Lavine L, 2015, ANNU REV ENTOMOL, V60, P453, DOI 10.1146/annurev-ento-010814-021045; Pequeno PACL, 2013, ECOL ENTOMOL, V38, P515, DOI 10.1111/een.12044; London KB, 2003, BEHAV ECOL SOCIOBIOL, V54, P539, DOI 10.1007/s00265-003-0662-8; Mailleux AC, 2003, INSECT SOC, V50, P24, DOI 10.1007/s000400300004; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Moura FMS, 2006, INSECT SOC, V53, P472, DOI 10.1007/s00040-005-0899-0; Muradian R, 1999, PHYSIOL BEHAV, V66, P731, DOI 10.1016/S0031-9384(99)00011-6; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; Oster G.F., 1978, Monographs in Population Biology, pi; Pohl S, 2013, INSECT SOC, V60, P293, DOI 10.1007/s00040-013-0293-7; Porter EE, 2001, AM NAT, V157, P97, DOI 10.1086/317006; Riveros AJ, 2011, J INSECT PHYSIOL, V57, P688, DOI 10.1016/j.jinsphys.2011.01.011; Satoh T, 2005, ENTOMOL SCI, V8, P277, DOI 10.1111/j.1479-8298.2005.00126.x; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; STUART AM, 1967, SCIENCE, V156, P1123, DOI 10.1126/science.156.3778.1123; Szczuka A, 1997, ACTA NEUROBIOL EXP, V57, P135; Valverde S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066106; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wiernasz DC, 2014, INSECT SOC, V61, P273, DOI 10.1007/s00040-014-0352-8	46	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147594	10.1371/journal.pone.0147594	http://dx.doi.org/10.1371/journal.pone.0147594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808197	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800145
J	Gogoi, P; Sepehri, S; Zhou, Y; Gorin, MA; Paolillo, C; Capoluongo, E; Gleason, K; Payne, A; Boniface, B; Cristofanilli, M; Morgan, TM; Fortina, P; Pienta, KJ; Handique, K; Wang, YX				Gogoi, Priya; Sepehri, Saedeh; Zhou, Yi; Gorin, Michael A.; Paolillo, Carmela; Capoluongo, Ettore; Gleason, Kyle; Payne, Austin; Boniface, Brian; Cristofanilli, Massimo; Morgan, Todd M.; Fortina, Paolo; Pienta, Kenneth J.; Handique, Kalyan; Wang, Yixin			Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CANCER-PATIENTS; PROSTATE-CANCER; BREAST-CANCER; PROGRESSION; SURVIVAL	Current analysis of circulating tumor cells (CTCs) is hindered by sub-optimal sensitivity and specificity of devices or assays as well as lack of capability of characterization of CTCs with clinical biomarkers. Here, we validate a novel technology to enrich and characterize CTCs from blood samples of patients with metastatic breast, prostate and colorectal cancers using a microfluidic chip which is processed by using an automated staining and scanning system from sample preparation to image processing. The Celsee system allowed for the detection of CTCs with apparent high sensitivity and specificity (94% sensitivity and 100% specificity). Moreover, the system facilitated rapid capture of CTCs from blood samples and also allowed for downstream characterization of the captured cells by immunohistochemistry, DNA and mRNA fluorescence in-situ hybridization (FISH). In a subset of patients with prostate cancer we compared the technology with a FDA-approved CTC device, CellSearch and found a higher degree of sensitivity with the Celsee instrument. In conclusion, the integrated Celsee system represents a promising CTC technology for enumeration and molecular characterization.	[Gogoi, Priya; Sepehri, Saedeh; Zhou, Yi; Gleason, Kyle; Payne, Austin; Boniface, Brian; Handique, Kalyan; Wang, Yixin] Celsee Diagnost, 46701 Commerce Ctr Dr, Plymouth, MI USA; [Gorin, Michael A.; Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Gorin, Michael A.; Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Paolillo, Carmela; Fortina, Paolo] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Paolillo, Carmela; Capoluongo, Ettore] Univ Hosp A Gemelli, Dept Lab Med, Mol Biol Lab, Rome, Italy; [Cristofanilli, Massimo] Northwestern Univ, Robert Lurie Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Morgan, Todd M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Fortina, Paolo] Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Johns Hopkins University; Johns Hopkins University; Jefferson University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Michigan System; University of Michigan; Sapienza University Rome	Wang, YX (corresponding author), Celsee Diagnost, 46701 Commerce Ctr Dr, Plymouth, MI USA.	ywang@celsee.com	Paolillo, Carmela/AAK-2578-2020; Fortina, Paolo/ABE-8350-2020; Gorin, M.D., Michael A./GZM-6377-2022	Paolillo, Carmela/0000-0003-2677-5747; Gorin, M.D., Michael A./0000-0002-8315-6603; CAPOLUONGO, Ettore Domenico/0000-0003-4402-8403; Fortina, Paolo/0000-0002-5898-2081; Morgan, Todd/0000-0002-1140-0603	Celsee Diagnostics; NIH/NCI Cancer Center Core grant [P30 CA056036]; Department of Defense Physician Research Training Award [W81XWH-14-1-0287]; PCF Young Investigator Award; A. Alfred Taubman Medical Research Institute at the University of Michigan; NATIONAL CANCER INSTITUTE [P30CA056036, P30CA060553] Funding Source: NIH RePORTER	Celsee Diagnostics; NIH/NCI Cancer Center Core grant; Department of Defense Physician Research Training Award(United States Department of Defense); PCF Young Investigator Award; A. Alfred Taubman Medical Research Institute at the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was in part funded by Celsee Diagnostics and by NIH/NCI Cancer Center Core grant (P30 CA056036) to PF of Thomas Jefferson University, a Department of Defense Physician Research Training Award (W81XWH-14-1-0287) (TMM), PCF Young Investigator Award (TMM), and by the A. Alfred Taubman Medical Research Institute (TMM) at the University of Michigan. The funding provided support in the form of salaries for the authors PG, SS, YZ, KG, AP, BB, KH and YW, but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The roles of these authors are specifically articulated in the Author Contributions section.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; [Anonymous], [US Patent Application, Celsee Diagnostics], Patent No. [US 2013/ 0190212 A1, 20130190212]; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Li P, 2013, LAB CHIP, V13, P602, DOI 10.1039/c2lc90148j; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Majid EW, 2013, LAB CHIP; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Paris PL, 2009, CANCER LETT, V277, P164, DOI 10.1016/j.canlet.2008.12.007; Powell AA, 2012, PLOS ONE, V2012; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Riahi R, 2014, INT J ONCOL, V44, P1870, DOI 10.3892/ijo.2014.2353; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Saliba AE, 2010, P NATL ACAD SCI USA, V107, P14524, DOI 10.1073/pnas.1001515107; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Warkiani ME, 2014, LAB CHIP, V14, P128, DOI 10.1039/c3lc50617g; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	27	61	62	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147400	10.1371/journal.pone.0147400	http://dx.doi.org/10.1371/journal.pone.0147400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808060	Green Published, gold			2022-12-27	WOS:000369527800088
J	Greenwald, R; Hayat, MJ; Barton, J; Lopukhin, A				Greenwald, Roby; Hayat, Matthew J.; Barton, Jerusha; Lopukhin, Anastasia			A Novel Method for Quantifying the Inhaled Dose of Air Pollutants Based on Heart Rate, Breathing Rate and Forced Vital Capacity	PLOS ONE			English	Article							POLLUTION; EXPOSURE; ASSOCIATION; VENTILATION; PEDESTRIANS; EXERCISE	To better understand the interaction of physical activity and air pollution exposure, it is important to quantify the change in ventilation rate incurred by activity. In this paper, we describe a method for estimating ventilation using easily-measured variables such as heart rate (HR), breathing rate (f(B)), and forced vital capacity (FVC). We recruited healthy adolescents to use a treadmill while we continuously measured HR, fB, and the tidal volume (V-T) of each breath. Participants began at rest then walked and ran at increasing speed until HR was 160-180 beats per minute followed by a cool down period. The novel feature of this method is that minute ventilation ((V) over dot(E)) was normalized by FVC. We used general linear mixed models with a random effect for subject and identified nine potential predictor variables that influence either (V) over dot(E) or FVC. We assessed predictive performance with a five-fold cross-validation procedure. We used a brute force selection process to identify the best performing models based on cross-validation percent error, the Akaike Information Criterion and the p-value of parameter estimates. We found a two-predictor model including HR and fB to have the best predictive performance ((V) over dot(E)/FVC=-4.247+0.0595HR+0.226fB, mean percent error = 8.1 +/- 29%); however, given the ubiquity of HR measurements, a one-predictor model including HR may also be useful ((V) over dot(E)/FVC = -3.859+0.101HR, mean percent error = 11.3+/-36%).	[Greenwald, Roby] Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA; [Greenwald, Roby; Barton, Jerusha; Lopukhin, Anastasia] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Hayat, Matthew J.] Georgia State Univ, Div Epidemiol & Biostat, Sch Publ Hlth, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University	Greenwald, R (corresponding author), Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA.; Greenwald, R (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	rgreenwald@gsu.edu			NIEHS [K25ES020355]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K25ES020355] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this work came from NIEHS grant number K25ES020355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb TG, 2013, EXERC SPORT SCI REV, V41, P11, DOI 10.1097/JES.0b013e318267c0d2; Beals JAJ, 1996, ENVIRON HEALTH PERSP, V104, P974, DOI 10.2307/3433145; Bernmark E, 2006, ERGONOMICS, V49, P1486, DOI 10.1080/00140130600708206; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Cozza IC, 2015, SCI TOTAL ENVIRON, V520, P160, DOI 10.1016/j.scitotenv.2015.03.049; Luke C, 2006, ENVIRON INT, V32, P815, DOI 10.1016/j.envint.2006.03.012; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 2001, ENVIRON HEALTH PERSP, V109, P483, DOI 10.2307/3454657; Faria M, 2014, TRANSP RES PROC, V3, P780, DOI 10.1016/j.trpro.2014.10.057; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; Hyatt RE, 2014, INTERPRETATION PULMO; Jakes RW, 2002, AM J EPIDEMIOL, V156, P139, DOI 10.1093/aje/kwf021; Liu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134804; MacAuley D, 1999, IRISH J MED SCI, V168, P119, DOI 10.1007/BF02946480; MERMIER CM, 1993, ARCH ENVIRON HEALTH, V48, P263, DOI 10.1080/00039896.1993.9940371; Mirowsky J, 2015, J EXPO SCI ENV EPID, V25, P354, DOI 10.1038/jes.2014.93; Morton AR, 1999, PEDIAT RESP MED, P111; Nayor M, 2015, CURRENT OPINION CARD, V30; Peters A, 2001, CIRCULATION, V103, P2810; Ramos CA, 2015, SCI TOTAL ENVIRON, V527, P111, DOI 10.1016/j.scitotenv.2015.04.120; Samet JM, 1993, HLTH EFFECTS I, P59; Stewart RAH, 2015, CURR OPIN CARDIOL, V30, P551, DOI 10.1097/HCO.0000000000000207; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; VANWIJNEN JH, 1995, INT ARCH OCC ENV HEA, V67, P187, DOI 10.1007/BF00626351; Zuurbier M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-48	28	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147578	10.1371/journal.pone.0147578	http://dx.doi.org/10.1371/journal.pone.0147578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809066	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800139
J	Kuan, CS; Too, WCS; Few, LL				Kuan, Chee Sian; Too, Wei Cun See; Few, Ling Ling			Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; REAL-TIME PCR; REFERENCE GENES; ETHANOLAMINE; EXPRESSION; DNA; PHOSPHORYLATION; KINASE; CANCER; ALPHA	Background Ethanolamine kinase (EK) catalyzes the phosphorylation of ethanolamine, the first step in the CDP-ethanolamine pathway for the biosynthesis of phosphatidylethanolamine (PE). Human EK exists as EK1, EK2 alpha and EK2 beta isoforms, encoded by two separate genes, named ek1 and ek2. EK activity is stimulated by carcinogens and oncogenes, suggesting the involvement of EK in carcinogenesis. Currently, little is known about EK transcriptional regulation by endogenous or exogenous signals, and the ek gene promoter has never been studied. Methodology/Principal Findings In this report, we mapped the important regulatory regions in the human ek1 promoter. 5' deletion analysis and site-directed mutagenesis identified a Sp site at position (-40/-31) that was essential for the basal transcription of this gene. Treatment of HCT116 cells with trichostatin A (TSA), a histone deacetylase inhibitor, significantly upregulated the ek1 promoter activity through the Sp(-40/-31) site and increased the endogenous expression of ek1. Chromatin immunoprecipitation assay revealed that TSA increased the binding of Sp1, Sp3 and RNA polymerase II to the ek1 promoter in HCT116 cells. The effect of TSA on ek1 promoter activity was cell-line specific as TSA treatment did not affect ek1 promoter activity in HepG2 cells. Conclusion/Significance In conclusion, we showed that Sp1 and Sp3 are not only essential for the basal transcription of the ek1 gene, their accessibility to the target site on the ek1 promoter is regulated by histone protein modification in a cell line dependent manner.	[Kuan, Chee Sian; Too, Wei Cun See; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia	Universiti Sains Malaysia	Few, LL (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	fewling@usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Universiti Sains Malaysia Research University Grant [1001/PPSK/815101]; Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [203/PPSK/6171171]	Universiti Sains Malaysia Research University Grant(Universiti Sains Malaysia); Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	This work is supported by Universiti Sains Malaysia Research University Grant (1001/PPSK/815101) (http://www.research.usm.my/default.asp?tag=23) to WCST, and Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia (203/PPSK/6171171) (https://jpt.mohe.gov.my/menupenyelidik.php), to LLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MR, 2007, AM J PHYSIOL-GASTR L, V293, pG374, DOI 10.1152/ajpgi.00128.2007; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Block KL, 1996, BLOOD, V88, P2071, DOI 10.1182/blood.V88.6.2071.bloodjournal8862071; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chua SL, 2011, CYTOTECHNOLOGY, V63, P645, DOI 10.1007/s10616-011-9383-4; COLGAN J, 1995, P NATL ACAD SCI USA, V92, P1955, DOI 10.1073/pnas.92.6.1955; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fu J, 2009, ANAL SCI, V25, P675, DOI 10.2116/analsci.25.675; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Jung HH, 2005, FEBS LETT, V579, P3941, DOI 10.1016/j.febslet.2005.06.011; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Kiss Z, 1997, EUR J BIOCHEM, V250, P395, DOI 10.1111/j.1432-1033.1997.0395a.x; Kiss Z, 1999, CELL SIGNAL, V11, P149, DOI 10.1016/S0898-6568(98)00057-6; KISS Z, 1995, FEBS LETT, V357, P279, DOI 10.1016/0014-5793(94)01371-7; KISS Z, 1993, FEBS LETT, V336, P115, DOI 10.1016/0014-5793(93)81622-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Malewicz B, 1998, EUR J BIOCHEM, V253, P10, DOI 10.1046/j.1432-1327.1998.2530010.x; Mazzella N, 2004, J LIPID RES, V45, P1355, DOI 10.1194/jlr.D300040-JLR200; Ni PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050502; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Pan QH, 2010, BIOCHEM BIOPH RES CO, V401, P306, DOI 10.1016/j.bbrc.2010.09.058; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takai Daiya, 2003, In Silico Biology, V3, P235; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Ward CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062610; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147886	10.1371/journal.pone.0147886	http://dx.doi.org/10.1371/journal.pone.0147886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807725	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800239
J	Mercy, C; Ize, B; Salcedo, SP; de Bentzmann, S; Bigot, S				Mercy, Chryslene; Ize, Berengere; Salcedo, Suzana P.; de Bentzmann, Sophie; Bigot, Sarah			Functional Characterization of Pseudomonas Contact Dependent Growth Inhibition (CDI) Systems	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; ESCHERICHIA-COLI; AERUGINOSA; BACTERIA; SECRETION; VIRULENCE; PROTEINS; IMMUNITY; TOXIN; IDENTIFICATION	Contact-dependent inhibition (CDI) toxins, delivered into the cytoplasm of target bacterial cells, confer to host strain a significant competitive advantage. Upon cell contact, the toxic C-terminal region of surface-exposed CdiA protein (CdiA-CT) inhibits the growth of CDI- bacteria. CDI+ cells express a specific immunity protein, CdiI, which protects from autoinhibition by blocking the activity of cognate CdiA-CT. CdiA-CT are separated from the rest of the protein by conserved peptide motifs falling into two distinct classes, the "E. coli"- and "Burkholderia-type". CDI systems have been described in numerous species except in Pseudomonadaceae. In this study, we identified functional toxin/immunity genes linked to CDI systems in the Pseudomonas genus, which extend beyond the conventional CDI classes by the variability of the peptide motif that delimits the polymorphic CdiA-CT domain. Using P. aeruginosa PAO1 as a model, we identified the translational repressor RsmA as a negative regulator of CDI systems. Our data further suggest that under conditions of expression, P. aeruginosa CDI systems are implicated in adhesion and biofilm formation and provide an advantage in competition assays. All together our data imply that CDI systems could play an important role in niche adaptation of Pseudomonadaceae.	[Mercy, Chryslene; Ize, Berengere; de Bentzmann, Sophie; Bigot, Sarah] Univ Aix Marseille, CNRS, Lab Ingn Syst Macromol, UMR7255, Marseille, France; [Mercy, Chryslene; Salcedo, Suzana P.; Bigot, Sarah] Univ Lyon 1, CNRS, Bases Mol & Struct Syst Infect, UMR 5086,Inst Biol & Chim Prot, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bigot, S (corresponding author), Univ Aix Marseille, CNRS, Lab Ingn Syst Macromol, UMR7255, Marseille, France.; Bigot, S (corresponding author), Univ Lyon 1, CNRS, Bases Mol & Struct Syst Infect, UMR 5086,Inst Biol & Chim Prot, F-69365 Lyon, France.	sarah.bigot@ibcp.fr	Salcedo, Suzana P/C-2853-2014; salcedo, suzana/P-9830-2019; IZE, Bérengère/GLQ-7207-2022	Salcedo, Suzana P/0000-0001-5149-7756; salcedo, suzana/0000-0001-5149-7756; IZE, Bérengère/0000-0001-9106-9254	CNRS, Aix-Marseille University; French cystic fibrosis foundation [RF20120600719]; FINOVI grant	CNRS, Aix-Marseille University; French cystic fibrosis foundation; FINOVI grant	This work was supported by the CNRS, Aix-Marseille University, by a grant from the French cystic fibrosis foundation (http://www.vaincrelamuco.org/) -SB- grant number: RF20120600719 and a FINOVI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2003, MOL MICROBIOL, V47, P61, DOI 10.1046/j.1365-2958.2003.03283.x; Anderson MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004076; Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Faure LM, 2013, MICROBIOL-SGM, V159, P1315, DOI 10.1099/mic.0.067645-0; Garcia EC, 2013, MOL MICROBIOL, V89, P1213, DOI 10.1111/mmi.12339; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Jamet A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004592; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Koskiniemi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004255; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Li KW, 2013, MBIO, V4, DOI 10.1128/mBio.00419-13; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Ruhe ZC, 2015, MOL MICROBIOL, V98, P175, DOI 10.1111/mmi.13114; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036	38	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147435	10.1371/journal.pone.0147435	http://dx.doi.org/10.1371/journal.pone.0147435			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808644	Green Published, gold			2022-12-27	WOS:000369527800094
J	Miyauchi, A; Kawase, Y				Miyauchi, Atsushi; Kawase, Yasushi			Z-Score-Based Modularity for Community Detection in Networks	PLOS ONE			English	Article							IDENTIFYING COMMUNITIES	Identifying community structure in networks is an issue of particular interest in network science. The modularity introduced by Newman and Girvan is the most popular quality function for community detection in networks. In this study, we identify a problem in the concept of modularity and suggest a solution to overcome this problem. Specifically, we obtain a new quality function for community detection. We refer to the function as Z-modularity because it measures the Z-score of a given partition with respect to the fraction of the number of edges within communities. Our theoretical analysis shows that Z-modularity mitigates the resolution limit of the original modularity in certain cases. Computational experiments using both artificial networks and well-known real-world networks demonstrate the validity and reliability of the proposed quality function.	[Miyauchi, Atsushi; Kawase, Yasushi] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Ookayama 2-12-1, Tokyo 1528552, Japan	Tokyo Institute of Technology	Miyauchi, A (corresponding author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Ookayama 2-12-1, Tokyo 1528552, Japan.	miyauchi.a.aa@m.titech.ac.jp	Kawase, Yasushi/B-8894-2015	Kawase, Yasushi/0000-0001-5626-779X	JSPS [26-11908]; JST, ERATO, Kawarabayashi Large Graph Project;  [26887014]; Grants-in-Aid for Scientific Research [14J11908] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST, ERATO, Kawarabayashi Large Graph Project; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AM is supported by a Grant-in-Aid for JSPS Fellows (No. 26-11908). YK is supported by a Grant-in-Aid for Research Activity Start-up (No. 26887014). This work was partially supported by JST, ERATO, Kawarabayashi Large Graph Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; [Anonymous], 2009, P SIAM INT C DAT MIN, DOI 10.1137/1.9781611972795.84; Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Cafieri S, 2014, DISCRETE APPL MATH, V163, P65, DOI 10.1016/j.dam.2012.03.030; Cafieri S, 2014, ANN OPER RES, V222, P213, DOI 10.1007/s10479-012-1286-z; Cafieri S, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046113; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Condon A, 2001, RANDOM STRUCT ALGOR, V18, P116, DOI 10.1002/1098-2418(200103)18:2<116::AID-RSA1001>3.0.CO;2-2; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fred ALN, 2003, PROC CVPR IEEE, P128; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Knuth DE., 1993, STANFORD GRAPH BASE; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Massen CP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046101; Medus A, 2005, PHYSICA A, V358, P593, DOI 10.1016/j.physa.2005.04.022; Miyauchi A, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40006-7; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pons P, 2011, THEOR COMPUT SCI, V412, P892, DOI 10.1016/j.tcs.2010.11.041; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Richardson T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036111; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang SQ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052802; Zhang SQ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066114	44	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147805	10.1371/journal.pone.0147805	http://dx.doi.org/10.1371/journal.pone.0147805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808270	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800215
J	O'Hara, CB; Keyes, A; Renwick, B; Leyton, M; Campbell, IC; Schmidt, U				O'Hara, Caitlin B.; Keyes, Alexandra; Renwick, Bethany; Leyton, Marco; Campbell, Iain C.; Schmidt, Ulrike			The Effects of Acute Dopamine Precursor Depletion on the Reinforcing Value of Exercise in Anorexia Nervosa	PLOS ONE			English	Article							ACUTE PHENYLALANINE/TYROSINE DEPLETION; ALTERED INSULA RESPONSE; AMINO-ACID MIXTURE; TYROSINE DEPLETION; PHYSICAL-ACTIVITY; EATING-DISORDERS; RECEPTOR AGONIST; REWARD; WOMEN; RECOVERY	This study investigated whether dopaminergic systems are involved in the motivation to engage in behaviours associated with anorexia nervosa (AN), specifically, the drive to exercise. Women recovered from AN (AN REC, n = 17) and healthy controls (HC, n = 15) were recruited. The acute phenylalanine/tyrosine depletion (APTD) method was used to transiently decrease dopamine synthesis and transmission. The effect of dopamine precursor depletion on drive to exercise was measured using a progressive ratio (PR) exercise breakpoint task. Both groups worked for the opportunity to exercise, and, at baseline, PR breakpoint scores were higher in AN REC than HC. Compared to values on the experimental control session, APTD did not decrease PR breakpoint scores in AN REC, but significantly decreased scores in HC. These data show that women recovered from AN are more motivated to exercise than HC, although in both groups, activity is more reinforcing than inactivity. Importantly, decreasing dopamine does not reduce the motivation to exercise in people recovered from AN, but in contrast, does so in HC. It is proposed that in AN, drive to exercise develops into a behaviour that is largely independent of dopamine mediated reward processes and becomes dependent on cortico-striatal neurocircuitry that regulates automated, habit- or compulsive-like behaviours. These data strengthen the case for the involvement of reward, learning, habit, and dopaminergic systems in the aetiology of AN.	[O'Hara, Caitlin B.; Keyes, Alexandra; Renwick, Bethany; Campbell, Iain C.; Schmidt, Ulrike] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, Sect Eating Disorders, London WC2R 2LS, England; [Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	University of London; King's College London; McGill University	O'Hara, CB (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, Sect Eating Disorders, London WC2R 2LS, England.	caitlin.b.o'hara@kcl.ac.uk	Leyton, Marco/AAY-7557-2020	Leyton, Marco/0000-0002-1243-2252	Swiss Anorexia Foundation [10-11]; NIHR Biomedical Research Centre (BRC) for Mental Health at South London; BRC; King's College London [12421]; Maudsley NHS Foundation Trust	Swiss Anorexia Foundation; NIHR Biomedical Research Centre (BRC) for Mental Health at South London; BRC; King's College London; Maudsley NHS Foundation Trust	This study was supported by the Swiss Anorexia Foundation (project number 10-11) and by the NIHR Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London (grant number 12421). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Iain Campbell and Ulrike Schmidt receive salary support from the BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailer UF, 2013, PSYCHIAT RES-NEUROIM, V211, P160, DOI 10.1016/j.pscychresns.2012.06.010; Barrett SP, 2008, EUR NEUROPSYCHOPHARM, V18, P439, DOI 10.1016/j.euroneuro.2008.01.008; Bergen AW, 2005, NEUROPSYCHOPHARMACOL, V30, P1703, DOI 10.1038/sj.npp.1300719; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Broft A, 2015, PSYCHIAT RES-NEUROIM, V233, P380, DOI 10.1016/j.pscychresns.2015.06.013; Carr K, 2009, PSYCHOPHARMACOLOGY, V202, P731, DOI 10.1007/s00213-008-1355-9; Carter JC, 2004, PSYCHOL MED, V34, P671, DOI 10.1017/S0033291703001168; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cawley EI, 2013, J PSYCHIATR NEUROSCI, V38, P388, DOI 10.1503/jpn.120181; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Correa M, 2013, BEHAV PHARMACOL, V24, pE3, DOI 10.1097/01.fbp.0000434689.20001.e8; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Davis C, 1997, COMPR PSYCHIAT, V38, P321, DOI 10.1016/S0010-440X(97)90927-5; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; Everitt BJ, 2016, ANNU REV PSYCHOL, V67, P23, DOI 10.1146/annurev-psych-122414-033457; Everitt BJ, 2014, EUR J NEUROSCI, V40, P2163, DOI 10.1111/ejn.12644; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Frank Guido K W, 2014, Front Nutr, V1, P19, DOI 10.3389/fnut.2014.00019; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Frieling H, 2010, INT J EAT DISORDER, V43, P577, DOI 10.1002/eat.20745; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Giel KE, 2013, BIOL PSYCHOL, V94, P575, DOI 10.1016/j.biopsycho.2013.10.004; Graybiel AM, 2014, SCI AM, V310, P38, DOI 10.1038/scientificamerican0614-38; Harmer CJ, 2001, PSYCHOPHARMACOLOGY, V154, P105, DOI 10.1007/s002130000613; Holsen LM, 2012, J PSYCHIATR NEUROSCI, V37, P322, DOI 10.1503/jpn.110156; HUNDT AG, 1963, SCIENCE, V142, P1087, DOI 10.1126/science.142.3595.1087; KAYE WH, 1984, ARCH GEN PSYCHIAT, V41, P350; Keyes A, 2015, INT J EAT DISORDER, V48, P46, DOI 10.1002/eat.22354; Klein DA, 2010, INT J EAT DISORDER, V43, P611, DOI 10.1002/eat.20758; Kullmann S, 2014, SOC COGN AFFECT NEUR, V9, P917, DOI 10.1093/scan/nst070; Le Masurier M, 2004, PSYCHOPHARMACOLOGY, V171, P435, DOI 10.1007/s00213-003-1607-7; Le Masurier M, 2014, J PSYCHOPHARMACOL, V28, P561, DOI 10.1177/0269881113507642; Leyton M, 2004, NEUROPSYCHOPHARMACOL, V29, P427, DOI 10.1038/sj.npp.1300328; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Leyton M, 2007, J PSYCHIATR NEUROSCI, V32, P129; Lorr M, 1988, PROFILE MOOD STATES; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; McTavish SFB, 1999, PSYCHOPHARMACOLOGY, V141, P182, DOI 10.1007/s002130050823; Montgomery AJ, 2003, AM J PSYCHIAT, V160, P1887, DOI 10.1176/appi.ajp.160.10.1887; Moore TJ, 2014, JAMA INTERN MED, V174, P1930, DOI 10.1001/jamainternmed.2014.5262; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; O'Hara CB, 2015, NEUROSCI BIOBEHAV R, V52, P131, DOI 10.1016/j.neubiorev.2015.02.012; Oberndorfer TA, 2013, AM J PSYCHIAT, V170, P1143, DOI 10.1176/appi.ajp.2013.11111745; Palmour RM, 1998, PSYCHOPHARMACOLOGY, V136, P1, DOI 10.1007/s002130050532; Park RJ, 2014, BEHAV RES THER, V62, P47, DOI 10.1016/j.brat.2014.07.007; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Roiser JP, 2005, NEUROPSYCHOPHARMACOL, V30, P775, DOI 10.1038/sj.npp.1300659; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Sheehan BD, 1996, J PSYCHOPHARMACOL, V10, P231, DOI 10.1177/026988119601000309; SILBERSTEIN LR, 1988, SEX ROLES, V19, P219, DOI 10.1007/BF00290156; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Tomasi D, 2013, CRIT REV BIOCHEM MOL, V48, P1, DOI 10.3109/10409238.2012.735642; Venugopalan VV, 2011, NEUROPSYCHOPHARMACOL, V36, P2469, DOI 10.1038/npp.2011.135; Verhagen LAW, 2009, EUR NEUROPSYCHOPHARM, V19, P153, DOI 10.1016/j.euroneuro.2008.09.005; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Walsh BT, 2013, AM J PSYCHIAT, V170, P477, DOI 10.1176/appi.ajp.2012.12081074; Zipfel S, 2015, LANCET PSYCHIAT, V2, P1099, DOI 10.1016/S2215-0366(15)00356-9	64	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145894	10.1371/journal.pone.0145894	http://dx.doi.org/10.1371/journal.pone.0145894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808920	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800013
J	Rodriguez, M; Salmeron, MD; Martin-Malo, A; Barbieri, C; Mari, F; Molina, RI; Costa, P; Aljama, P				Rodriguez, Mariano; Dolores Salmeron, M.; Martin-Malo, Alejandro; Barbieri, Carlo; Mari, Flavio; Molina, Rafael I.; Costa, Pedro; Aljama, Pedro			A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; SURVIVAL PREDICTABILITY; PARATHYROID-HORMONE; CKD-MBD; METABOLISM; DISORDER; MORTALITY; PHOSPHATE; CALCIUM; RISK	Background In hemodialysis patients, deviations from KDIGO recommended values of individual parameters, phosphate, calcium or parathyroid hormone (PTH), are associated with increased mortality. However, it is widely accepted that these parameters are not regulated independently of each other and that therapy aimed to correct one parameter often modifies the others. The aim of the present study is to quantify the degree of association between parameters of chronic kidney disease and mineral bone disease (CKD-MBD). Methods Data was extracted from a cohort of 1758 adult HD patients between January 2000 and June 2013 obtaining a total of 46.141 records (10 year follow-up). We used an advanced data analysis system called Random Forest (RF) which is based on self-learning procedure with similar axioms to those utilized for the development of artificial intelligence. This new approach is particularly useful when the variables analyzed are closely dependent to each other. Results The analysis revealed a strong association between PTH and phosphate that was superior to that of PTH and Calcium. The classical linear regression analysis between PTH and phosphate shows a correlation coefficient is 0.27, p<0.001, the possibility to predict PTH changes from phosphate modification is marginal. Alternatively, RF assumes that changes in phosphate will cause modifications in other associated variables (calcium and others) that may also affect PTH values. Using RF the correlation coefficient between changes in serum PTH and phosphate is 0.77, p<0.001; thus, the power of prediction is markedly increased. The effect of therapy on biochemical variables was also analyzed using this RF. Conclusion Our results suggest that the analysis of the complex interactions between mineral metabolism parameters in CKD-MBD may demand a more advanced data analysis system such as RF.	[Rodriguez, Mariano; Dolores Salmeron, M.; Martin-Malo, Alejandro; Molina, Rafael I.; Aljama, Pedro] Univ Cordoba, IMIBIC, Hosp Reina Sofia, Serv Nephrol, Cordoba, Spain; [Barbieri, Carlo; Mari, Flavio] Fresenius Med Care, Bad Homburg, Germany; [Costa, Pedro] Fresenius Med Care, Madrid, Spain	Universidad de Cordoba	Martin-Malo, A (corresponding author), Univ Cordoba, IMIBIC, Hosp Reina Sofia, Serv Nephrol, Cordoba, Spain.	alejandro.martin.sspa@juntadeandalucia.es		Rodriguez, Mariano/0000-0002-9380-6614	Nephrologic Foundation of Cordoba (Junta de Andalucia) [PI-0311-2014]; Fresenius Medical Care	Nephrologic Foundation of Cordoba (Junta de Andalucia)(Junta de Andalucia); Fresenius Medical Care	This work was supported by a restricted grant from Nephrologic Foundation of Cordoba (PI-0311-2014 Junta de Andalucia). Fresenius Medical Care provided support in the form of salaries for authors [CB, FM and PC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al Aly Z, 2004, AM J NEPHROL, V24, P422, DOI 10.1159/000080087; Almaden Y, 1998, J AM SOC NEPHROL, V9, P1845; Berdud I, 1996, NEPHROL DIAL TRANSPL, V11, P1292; Bhan I, 2010, J GEN INTERN MED, V25, P710, DOI 10.1007/s11606-010-1316-y; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 2013, CLIN J AM SOC NEPHRO, V8, P2132, DOI 10.2215/CJN.04260413; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cleophas TJ, 2014, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-3-319-04181-0; Cozzolino M, 2014, NEPHROL DIAL TRANSPL, V29, P1815, DOI 10.1093/ndt/gft514; Danese MD, 2008, CLIN J AM SOC NEPHRO, V3, P1423, DOI 10.2215/CJN.01060308; Eknoyan G, 2003, AM J KIDNEY DIS, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Evenepoel P, 2014, SEMIN NEPHROL, V34, P151, DOI 10.1016/j.semnephrol.2014.02.007; Felsenfeld AJ, 1999, J AM SOC NEPHROL, V10, P878; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Ketteler M, 2015, KID INT; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lertdumrongluk P, 2013, NEPHROL DIAL TRANSPL, V28, P2535, DOI 10.1093/ndt/gft290; Leung RKK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-162; Lorenzo V, 2001, AM J KIDNEY DIS, V37, P1260, DOI 10.1053/ajkd.2001.24532; Mas VR, 2007, MOL MED, V13, P315, DOI 10.2119/2007-00017.Mas; Palmer SC, 2009, COCHRANE DATABASE SY; Palomares I, 2013, BLOOD PURIFICAT, V36, P122, DOI 10.1159/000353418; Savage N., 2012, COMMUN ACM, V55, P1719; Scian MJ, 2012, TRANSPLANTATION, V94, P851, DOI 10.1097/TP.0b013e318263702b; Tentori F, 2014, AM J KIDNEY DIS, V63, P851, DOI 10.1053/j.ajkd.2014.02.003; Torregrosa JV, 2011, NEFROLOGIA, V31, P3, DOI 10.3265/Nefrologia.pre2011.Jan.10816; Vervloet MG, 2014, LANCET DIABETES ENDO, V2, P427, DOI 10.1016/S2213-8587(14)70059-2; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	33	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146801	10.1371/journal.pone.0146801	http://dx.doi.org/10.1371/journal.pone.0146801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808154	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800033
J	Roy, MP; Mazumdar, D; Dutta, S; Saha, SP; Ghosh, S				Roy, Moushree Pal; Mazumdar, Deepika; Dutta, Subhabrata; Saha, Shyama Prasad; Ghosh, Shilpi			Cloning and Expression of Phytase appA Gene from Shigella sp CD2 in Pichia pastoris and Comparison of Properties with Recombinant Enzyme Expressed in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI	The phytase gene appA(S) was isolated from Shigella sp. CD2 genomic library. The 3.8 kb DNA fragment contained 1299 bp open reading frame encoding 432 amino acid protein (AppA(S)) with 22 amino acid signal peptide at N-terminal and three sites of N-glycosylation. AppA(S) contained the active site RHGXRXP and HDTN sequence motifs, which are conserved among histidine acid phosphatases. It showed maximum identity with phytase AppA of Escherichia coli and Citrobacter braakii. The appA(S) was expressed in Pichia pastoris and E. coli to produce recombinant phytase rAppA(P) and rAppA(E), respectively. Purified glycosylated rAppA(P) and nonglycosylated rAppA(E) had specific activity of 967 and 2982 U mg(-1), respectively. Both had pH optima of 5.5 and temperature optima of 60 degrees C. Compared with rAppA(E), rAppA(P) was 13 and 17% less active at pH 3.5 and 7.5 and 11 and 18% less active at temperature 37 and 50 degrees C, respectively; however, it was more active at higher incubation temperatures. Thermotolerance of rAppA(P) was 33% greater at 60 degrees C and 24% greater at 70 degrees C, when compared with rAppA(E). Both the recombinant enzymes showed high specificity to phytate and resistance to trypsin. To our knowledge, this is the first report on cloning and expression of phytase from Shigella sp.	[Roy, Moushree Pal; Mazumdar, Deepika; Dutta, Subhabrata; Saha, Shyama Prasad; Ghosh, Shilpi] Univ N Bengal, Dept Biotechnol, Siliguri, India	University of North Bengal	Ghosh, S (corresponding author), Univ N Bengal, Dept Biotechnol, Siliguri, India.	ghosshilpi@gmail.com		Ghosh, Shilpi/0000-0003-4868-2197; MAZUMDAR, DEEPIKA/0000-0002-6210-6762; Saha, Shyama Prasad/0000-0003-4528-7052	University Grant Commission, Govt. of India [41-547/2012, SR]	University Grant Commission, Govt. of India(University Grants Commission, India)	Financial support for SG from University Grant Commission, Govt. of India (F.No. 41-547/2012, SR) is gratefully acknowledged. DM acknowledges UGC for financial support as Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for SG from University Grant Commission, Govt. of India (F.No. 41-547/2012, SR) is gratefully acknowledged. DM acknowledges UGC for financial support as Research Fellow.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Fonseca-Maldonado R, 2014, PROTEIN EXPRES PURIF, V99, P43, DOI 10.1016/j.pep.2014.03.006; Guerrero-Olazaran M, 2010, APPL ENVIRON MICROB, V76, P5601, DOI 10.1128/AEM.00762-10; Guo MJ, 2008, ENZYME MICROB TECH, V42, P340, DOI 10.1016/j.enzmictec.2007.10.013; Hmida-Sayari A, 2014, MOL BIOTECHNOL, V56, P839, DOI 10.1007/s12033-014-9764-y; Huang HQ, 2006, BIOCHEM BIOPH RES CO, V350, P884, DOI 10.1016/j.bbrc.2006.09.118; Huang HQ, 2009, J MICROBIOL BIOTECHN, V19, P1085, DOI 10.4014/jmb.0901.039; Joshi S, 2014, J IND MICROBIOL BIOT, V41, P977, DOI 10.1007/s10295-014-1407-6; Kim YO, 2006, BIOTECHNOL LETT, V28, P33, DOI 10.1007/s10529-005-9684-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lei X.G., 2007, IND ENZYMES STRUCTUR, P505, DOI DOI 10.1007/1-4020-5377-0_; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Promdonkoy P, 2009, FEMS MICROBIOL LETT, V290, P18, DOI 10.1111/j.1574-6968.2008.01399.x; Rao DECS, 2008, J APPL MICROBIOL, V105, P1128, DOI 10.1111/j.1365-2672.2008.03833.x; Rodriguez E, 1999, BIOCHEM BIOPH RES CO, V257, P117, DOI 10.1006/bbrc.1999.0361; Roy MP, 2012, INDIAN J BIOCHEM BIO, V49, P266; Sajidan A, 2004, APPL MICROBIOL BIOT, V65, P110, DOI 10.1007/s00253-003-1530-1; Tai HM, 2013, J AGR FOOD CHEM, V61, P6007, DOI 10.1021/jf401853b; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viader-Salvado JM, 2010, APPL ENVIRON MICROB, V76, P6423, DOI 10.1128/AEM.00253-10; Xiong AS, 2006, APPL MICROBIOL BIOT, V72, P1039, DOI 10.1007/s00253-006-0384-8; Yao MZ, 2012, J APPL MICROBIOL, V112, P1, DOI 10.1111/j.1365-2672.2011.05181.x; Yao MZ, 2013, BIOTECHNOL LETT, V35, P1669, DOI 10.1007/s10529-013-1255-x; YATES JR, 1987, J BACTERIOL, V169, P1861, DOI 10.1128/jb.169.5.1861-1870.1987; Zinin NV, 2004, FEMS MICROBIOL LETT, V236, P283, DOI [10.1016/j.femsle.2004.05.051, 10.1111/j.1574-6968.2004.tb09659.x]	29	12	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145745	10.1371/journal.pone.0145745	http://dx.doi.org/10.1371/journal.pone.0145745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808559	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800010
J	Sina, M; Wood, RC; Saldarriaga, E; Lawler, J; Zunt, J; Garcia, P; Carcamo, C				Sina, Mariella; Wood, Rachel C.; Saldarriaga, Enrique; Lawler, Joshua; Zunt, Joseph; Garcia, Patricia; Carcamo, Cesar			Understanding Perceptions of Climate Change, Priorities, and Decision-Making among Municipalities in Lima, Peru to Better Inform Adaptation and Mitigation Planning	PLOS ONE			English	Article							EL-NINO; HEALTH; IMPACT; CHALLENGES; LEVEL	Climate change poses multiple risks to the population of Lima, the largest city and capital of Peru, located on the Pacific coast in a desert ecosystem. These risks include increased water scarcity, increased heat, and the introduction and emergence of vector-borne and other climate sensitive diseases. To respond to these threats, it is necessary for the government, at every level, to adopt more mitigation and adaptation strategies. Here, focus groups were conducted with representatives from five Lima municipalities to determine priorities, perception of climate change, and decision-making processes for implementing projects within each municipality. These factors can affect the ability and desire of a community to implement climate change adaptation and mitigation strategies. The results show that climate change and other environmental factors are of relatively low priority, whereas public safety and water and sanitation services are of highest concern. Perhaps most importantly, climate change is not well understood among the municipalities. Participants had trouble distinguishing climate change from other environmental issues and did not fully understand its causes and effects. Greater understanding of what climate change is and why it is important is necessary for it to become a priority for the municipalities. Different aspects of increased climate change awareness seem to be connected to having experienced extreme weather events, whether related or not to climate change, and to higher socioeconomic status.	[Sina, Mariella; Saldarriaga, Enrique; Garcia, Patricia; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Wood, Rachel C.; Zunt, Joseph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lawler, Joshua] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wood, RC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	woodr8@uw.edu	Zunt, Joseph/ABD-2886-2021	Saldarriaga, Enrique M/0000-0001-8879-6354; Sina, Mariella/0000-0001-9056-5969	National Institutes of Health Research Training Grant [5D43TW009375-02]; FOGARTY INTERNATIONAL CENTER [D43TW009375] Funding Source: NIH RePORTER	National Institutes of Health Research Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the National Institutes of Health Research Training Grant 5D43TW009375-02 awarded to Kuskaya: An Interdisciplinary Training Program for Innovation in Global Health from the Fogarty International Center, United States National Institutes of Health (http://www.fic.nih.gov/). The funders had no role in study design, data collection, and analysis, decision to publish, or preparing the manuscript.	APEIM. [Socioeconomic Levels in Lima and Callao], 2005, SOC LEV LIM CALL; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Bayer AM, 2014, DISASTERS, V38, P351, DOI 10.1111/disa.12046; Baylis M, 2013, ANIM HEALTH RES REV, V14, P143, DOI 10.1017/S1466252313000145; Begum RA, 2015, MITIG ADAPT STRAT GL, V20, P361, DOI 10.1007/s11027-013-9495-6; Bijma J, 2013, MAR POLLUT BULL, V74, P495, DOI 10.1016/j.marpolbul.2013.07.022; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cardwell FS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-208; Debela N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1012-9; Detchon R, 2014, NATURE, V508, P309, DOI 10.1038/508309a; Diaz H.F., 2000, EL NINO SO OSCILLATI; Doyle J., 2011, ENVIRON SOCIOL; Funari E, 2012, ANN I SUPER SANITA, V48, P473, DOI 10.4415/ANN_12_04_13; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grimm P., 2010, WILEY INT ENCY MARKE, DOI 10.1002/9781444316568.wiem02057; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Dang HL, 2014, ENVIRON MANAGE, V54, P331, DOI 10.1007/s00267-014-0299-6; INEI, 2012, PER EST PROYECC POBL; Ipsos APOYO, 2012, 211 IPS APOYO; Ipsos Peru, 2014, PERF ZON LIM METR 20; Laukkonen J, 2009, HABITAT INT, V33, P287, DOI 10.1016/j.habitatint.2008.10.003; Lennox E, 2014, ECOSYST SERV, V10, P155, DOI 10.1016/j.ecoser.2014.08.007; Lundgren K, 2013, IND HEALTH, V51, P3, DOI 10.2486/indhealth.2012-0089; Measham TG, 2011, MITIG ADAPT STRAT GL, V16, P889, DOI 10.1007/s11027-011-9301-2; MEF MINAM GIZ, 2013, MAP PEL ESC CLIM; Mimura N, 2013, P JPN ACAD B-PHYS, V89, P281, DOI 10.2183/pjab.89.281; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Nuttall N, 2014, LIMA CALL CLIMATE AC; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Raymond CM, 2013, J ENVIRON MANAGE, V115, P69, DOI 10.1016/j.jenvman.2012.11.003; Ripoll J, 2014, J EXP BOT, V65, P4097, DOI 10.1093/jxb/eru197; SENAMHI, 2009, ESC CLIM PER AN 2030; Takahashi Bruno, 2013, Public Underst Sci, V22, P427, DOI 10.1177/0963662511431204; Taylor A, 2014, RISK ANAL, V34, P1995, DOI 10.1111/risa.12234; Tirado MC, 2013, FOOD NUTR BULL, V34, P533, DOI 10.1177/156482651303400415; UCL, 2013, TRANSF PLANN ENV JUS; UNFCCC MINAM, LIM COP20 CMP 10; Villacorta S, 2015, EVALUACION GEOLOGICA; Wei JN, 2014, ENVIRON RES, V134, P301, DOI 10.1016/j.envres.2014.08.006; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235	42	5	5	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147201	10.1371/journal.pone.0147201	http://dx.doi.org/10.1371/journal.pone.0147201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808087	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800060
J	Xu, F; Wang, F; Wang, ZH; Lv, WS; Wang, W; Wang, YG				Xu, Feng; Wang, Fang; Wang, Zhenhong; Lv, Wenshan; Wang, Wei; Wang, Yangang			Glucose Uptake Activities of Bis (2, 3-Dibromo-4, 5-Dihydroxybenzyl) Ether, a Novel Marine Natural Product from Red Alga Odonthaliacorymbifera with Protein Tyrosine Phosphatase 1B Inhibition, In Vitro and In Vivo	PLOS ONE			English	Article							INSULIN SENSITIVITY; BROMOPHENOLS; RESISTANCE; PTP1B	Background and Aims Protein tyrosine phosphatase 1B (PTP1B) is a novel therapeutic target for type-2 diabetes, which negatively regulates the insulin signaling transduction. Bis (2, 3-dibromo-4, 5-dihydroxybenzyl) ether (BDDE), a novel bromophenol isolated from the Red Alga, is a novel PTP1B inhibitor. But the anti-diabetic effects are not clear. In the present study, we evaluated the in vitro and in vivo antidiabetic effects of BDDE. Methods The insulin-resistant HepG2 cells were used to evaluate the in vitro antidiabetic effects of BDDE. MTT assay was used to determine the safety concentrations in HepG2 cells. Glucose assay kit was used to check glucose uptake after treated with BDDE. Western blotting assay was used to explore the potent mechanisms. The db/db mice were used to evaluate the in vivo antidiabetic effects of BDDE. Body weight, blood glucose, Glycated hemoglobin (HbA1c), lipid profile, and insulin level were checked at the respective time points. Gastrocnemii were dissected and used to analyze the PTP1B and insulin receptor beta (IR beta) expression. Results BDDE increased the insulin-resisted glucose uptake in HepG2 cells. BDDE also decreased the expression of PTP1B and activated the substrates and downstream signals in insulin signal pathway, such as IR beta, insulin receptor substrate-1/2 (IRS1/2), phosphoinositide 3-kinase (PI3K), and protein kinase B (PKB/Akt). In the db/db mice model, BDDE significantly decreased the blood glucose, HbA1c and triglyceride (TG) levels. BDDE also decreased the expression of PTP1B and activated the phosphorylation of IR beta in gastrocnemii. Moreover, BDDE at high doses downregulated the body weight without affecting food and water intake. Conclusion Our results suggest that BDDE as a new PTP1B inhibitor improves glucose metabolism by stimulating the insulin signaling and could be used in the treatment of type-2 diabetes mellitus.	[Xu, Feng] Qingdao Univ, Affiliated Hosp, Res & Educ Dept, Qingdao 266071, Peoples R China; [Wang, Fang; Lv, Wenshan; Wang, Yangang] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China; [Wang, Zhenhong] Qingdao Univ, Affiliated Hosp, Dept Continued Educ, Qingdao 266071, Peoples R China; [Wang, Wei] Qingdao Univ, Affiliated Hosp, Dept Hematol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University	Wang, YG (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China.	wangyg1966@126.com			Natural Science Foundation of Shandong Province, China [2014ZRB01809]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work was financially supported by the Natural Science Foundation of Shandong Province, China (#2014ZRB01809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, HOME HEALTHCARE NOW, V33, P311; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fukuda S, 2010, DIABETES OBES METAB, V12, P299, DOI 10.1111/j.1463-1326.2009.01162.x; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Hu X, 2014, INT J MOL SCI, V15, P10446, DOI 10.3390/ijms150610446; Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1; Kim KY, 2008, PHYTOCHEMISTRY, V69, P2820, DOI 10.1016/j.phytochem.2008.09.007; Kim KY, 2010, J FOOD SCI, V75, pH145, DOI 10.1111/j.1750-3841.2010.01629.x; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kurihara H, 1999, J NAT PROD, V62, P882, DOI 10.1021/np980324p; Kurihara H, 1999, FISHERIES SCI, V65, P300, DOI 10.2331/fishsci.65.300; Nader NS, 2008, CURR DIABETES REP, V8, P383, DOI 10.1007/s11892-008-0066-2; Nagao M, 2015, ENDOCR J, V62, P561, DOI 10.1507/endocrj.EJ15-0055; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Shi DY, 2008, CHINESE SCI BULL, V53, P2476, DOI 10.1007/s11434-008-0353-y; Shi DY, 2013, MAR DRUGS, V11, P350, DOI 10.3390/md11020350; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	19	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147748	10.1371/journal.pone.0147748	http://dx.doi.org/10.1371/journal.pone.0147748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808535	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800204
J	Yang, JM; Sung, MS; Heo, H; Park, SW				Yang, Jee Myung; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo			The Effect of Laser Trabeculoplasty on Posture-Induced Intraocular Pressure Changes in Patients with Open Angle Glaucoma	PLOS ONE			English	Article							LATERAL DECUBITUS POSITION; NORMAL-TENSION GLAUCOMA; VISUAL-FIELD LOSS; GOLDMANN APPLANATION TONOMETER; EPISCLERAL VENOUS-PRESSURE; HEALTHY-YOUNG SUBJECTS; BODY POSITION; OCULAR HYPERTENSION; EYES; FLUCTUATION	Purpose To investigate the effect of argon laser trabeculoplasty (ALT) on posture-induced intraocular pressure (IOP) changes in patients with open angle glaucoma (OAG). Methods Thirty eyes of 30 consecutive patients with OAG who underwent ALT were prospectively analyzed. The IOP was measured using Icare PRO in the sitting position, supine position, and dependent lateral decubitus position (DLDP) before ALT and at 1 week, 1 month, 2 months, and 3 months after ALT. Results Compared to the baseline values, the IOP in each position was significantly decreased after ALT (all P < 0.001). During follow-up, the mean percentage of IOP reduction was similar in the sitting and supine positions, but was significantly lower in DLDP than in the sitting or supine positions (all P < 0.05). In terms of postural IOP changes, the IOP in the supine position and DLDP was significantly higher than that in the sitting position at the same time points during the follow-up period (all P < 0.001). The difference between the IOP in the supine position and DLDP during follow-up was significant (all P < 0.001). The extent of IOP differences between any positions did not show significant changes during the follow-up period (all P > 0.05). Conclusions ALT appears to be effective in lowering the IOP in various body positions, but the degree of this effect was significantly lower in DLDP. In addition, ALT seemed to have limited effects on posture-induced IOP changes.	[Yang, Jee Myung; Sung, Mi Sun; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwang Ju, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Sci, Gwang Ju, South Korea	Chonnam National University; Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwang Ju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Sci, Gwang Ju, South Korea.	exo70@naver.com		Yang, Jee Myung/0000-0001-5729-2233	Cheil-Nammyung Foundation Research Fund	Cheil-Nammyung Foundation Research Fund	This study was supported by the 2012 Cheil-Nammyung Foundation Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ED, 2011, CLIN OPHTHALMOL, V5, P933, DOI 10.2147/OPTH.S21759; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P603; BABIZHAYEV MA, 1990, GRAEF ARCH CLIN EXP, V228, P90, DOI 10.1007/BF02764299; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Buys YM, 2010, OPHTHALMOLOGY, V117, P1348, DOI 10.1016/j.ophtha.2009.11.015; BYLSMA SS, 1988, ARCH OPHTHALMOL-CHIC, V106, P544; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Caprioli J, 2007, ARCH OPHTHALMOL-CHIC, V125, P1124, DOI 10.1001/archopht.125.8.1124; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; GREENIDGE KC, 1983, OPHTHALMOLOGY, V90, P800; Guzey M, 1999, OPHTHALMOLOGICA, V213, P214, DOI 10.1159/000027424; Heijl A, 2011, AM J OPHTHALMOL, V152, P842, DOI 10.1016/j.ajo.2011.04.036; HETLANDE.J, 1966, ACTA OPHTHALMOL, V44, P515; Hirooka K, 2003, J GLAUCOMA, V12, P379, DOI 10.1097/00061198-200308000-00015; Hirooka K, 2009, J GLAUCOMA, V18, P689, DOI 10.1097/IJG.0b013e31819c49f4; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; Iliev ME, 2006, BRIT J OPHTHALMOL, V90, P833, DOI 10.1136/bjo.2005.089870; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim KN, 2014, AM J OPHTHALMOL, V157, P739, DOI 10.1016/j.ajo.2013.12.016; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Kita Y, 2011, JPN J OPHTHALMOL, V55, P228, DOI 10.1007/s10384-011-0017-3; Kiuchi T, 2007, AM J OPHTHALMOL, V143, P693, DOI 10.1016/j.ajo.2006.11.020; Kiuchi T, 2006, OPHTHALMOLOGY, V113, P2150, DOI 10.1016/j.ophtha.2006.06.014; KRIEGLSTEIN GK, 1975, OPHTHALMOLOGICA, V171, P132, DOI 10.1159/000307479; KRIEGLSTEIN GK, 1978, A GRAEF ARCH KLIN EX, V206, P99, DOI 10.1007/BF00414618; KRUG J, 1995, AM J OPHTHALMOL, V120, P718; Lee AC, 2007, OPHTHALMOLOGY, V114, P666, DOI 10.1016/j.ophtha.2006.07.058; Lee HS, 2005, J KOREAN OPHTHALMOL, V46, P2004; Lee JWY, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000238; Lee JY, 2013, AM J OPHTHALMOL, V155, P329, DOI 10.1016/j.ajo.2012.08.003; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Lee TE, 2013, OPHTHALMOLOGY, V120, P1565, DOI 10.1016/j.ophtha.2013.01.011; Lee TE, 2015, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2015.07.030, DOI 10.1016/J.AJ0.2015.07.030]; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Mizokami J, 2011, GRAEF ARCH CLIN EXP, V249, P879, DOI 10.1007/s00417-010-1565-9; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PARSLEY J, 1987, BRIT J OPHTHALMOL, V71, P494, DOI 10.1136/bjo.71.7.494; Sahin A, 2007, CLIN EXP OPHTHALMOL, V35, P335, DOI 10.1111/j.1442-9071.2007.01451.x; Sawada A, 2014, INVEST OPHTH VIS SCI, V55, P446, DOI 10.1167/iovs.13-13030; Sawada A, 2012, INVEST OPHTH VIS SCI, V53, P7631, DOI 10.1167/iovs.12-10454; Sawada A, 2012, GRAEF ARCH CLIN EXP, V250, P1361, DOI 10.1007/s00417-012-1942-7; SHINGLETON BJ, 1993, OPHTHALMOLOGY, V100, P1324; SINGH M, 1992, INT OPHTHALMOL, V16, P163, DOI 10.1007/BF00916436; SMITH TJ, 1985, AM J OPHTHALMOL, V99, P617, DOI 10.1016/S0002-9394(14)77989-9; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Sultan M, 2003, J GLAUCOMA, V12, P370, DOI 10.1097/00061198-200308000-00013; Sung MS, 2013, J GLAUCOMA; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389; VANBUSKIRK EM, 1984, OPHTHALMOLOGY, V91, P1005; WISE JB, 1979, ARCH OPHTHALMOL-CHIC, V97, P319, DOI 10.1001/archopht.1979.01020010165017; YAMABAYASHI S, 1991, BRIT J OPHTHALMOL, V75, P652, DOI 10.1136/bjo.75.11.652; Yang YX, 2014, J GLAUCOMA, V23, P19, DOI 10.1097/IJG.0b013e31825afc9d; 1996, OPHTHALMOLOGY, V103, P1706	56	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147963	10.1371/journal.pone.0147963	http://dx.doi.org/10.1371/journal.pone.0147963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807852	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800254
J	Zhuang, JG; Gao, P; Pollock, Z; Harrod, KS; Xu, FD				Zhuang, Jianguo; Gao, Peng; Pollock, Zemmie; Harrod, Kevin S.; Xu, Fadi			Depressed Hypoxic and Hypercapnic Ventilatory Responses at Early Stage of Lethal Avian Influenza A Virus Infection in Mice	PLOS ONE			English	Article							PULMONARY; INDONESIA; NEURONS; HUMANS; APNEA; VIRULENCE; INJECTION; PATHWAYS; FEATURES; LACKING	H5N1 virus infection results in similar to 60% mortality in patients primarily due to respiratory failure, but the underlying causes of mortality are unclear. The goal of this study is to reveal respiratory disorders occurring at the early stage of infection that may be responsible for subsequent respiratory failure and death. BALB/c mice were intranasally infected with one of two H5N1 virus strains: HK483 (lethal) or HK486 (non-lethal) virus. Pulmonary ventilation and the responses to hypoxia (HVR; 7% O-2 for 3 min) and hypercapnia (HCVR; 7% CO2 for 5 min) were measured daily at 2 days prior and 1, 2, and 3 days postinfection (dpi) and compared to mortality typically by 8 dpi. At 1, 2, and 3 dpi, immunoreactivities (IR) of substance P (SP-IR) in the nodose ganglion or tyrosine hydroxylase (TH-IR) in the carotid body coupled with the nucleoprotein of influenza A (NP-IR) was examined in some mice, while arterial blood was collected in others. Our results showed that at 2 and 3 dpi: 1) both viral infections failed to alter body temperature and weight, V (V) over dot (CO2), or induce viremia while producing similarly high lung viral titers; 2) HK483, but not HK486, virus induced tachypnea and depressed HVR and HCVR without changes in arterial blood pH and gases; and 3) only HK483 virus led to NP-IR in vagal SP-IR neurons, but not in the carotid body, and increased density of vagal SP-IR neurons. In addition, all HK483, rather than HK486, mice died at 6 to 8 dpi and the earlier death was correlated with more severe depression of HVR and HCVR. Our data suggest that tachypnea and depressed HVR/HCVR occur at the early stage of lethal H5N1 viral infection associated with viral replication and increased SP-IR density in vagal neurons, which may contribute to the respiratory failure and death.	[Zhuang, Jianguo; Gao, Peng; Pollock, Zemmie; Harrod, Kevin S.; Xu, Fadi] Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org		Harrod, Kevin/0000-0003-0780-9470	 [HL119683];  [HL 107462];  [AI111457]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119683, R01HL107462] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The studies were supported by HL119683 and HL 107462 (Fadi Xu) and AI111457 (Kevin Harrod). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bauman NM, 2000, ANN OTO RHINOL LARYN, V109, P1150, DOI 10.1177/000348940010901213; Boychuk CR, BEHAV BRAIN RES; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1245; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; COLERIDGE HM, 1994, ANNU REV PHYSIOL, V56, P69, DOI 10.1146/annurev.ph.56.030194.000441; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gozal D, 1996, AM J RESP CRIT CARE, V153, P761, DOI 10.1164/ajrccm.153.2.8564130; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Horie Y, 1999, AM J RESP CRIT CARE, V159, pA786; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kim HM, 2015, ARCH VIROL, V160, P305, DOI 10.1007/s00705-014-2284-z; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Moreira TS, 2007, J NEUROPHYSIOL, V98, P3627, DOI 10.1152/jn.00675.2007; Morishima Tsuneo, 2004, Rinsho Shinkeigaku, V44, P965; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Okumura A, 2013, J CLIN VIROL, V56, P25, DOI 10.1016/j.jcv.2012.10.007; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Paton JFR, 1997, J PHYSIOL-LONDON, V502, P623, DOI 10.1111/j.1469-7793.1997.623bj.x; Paton JFR, 1998, J NEUROPHYSIOL, V79, P2365, DOI 10.1152/jn.1998.79.5.2365; Paton JFR, 2001, NEUROSCIENCE, V105, P231, DOI 10.1016/S0306-4522(01)00106-3; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Robinson DM, 2002, J PHYSIOL-LONDON, V538, P957, DOI 10.1113/jphysiol.2001.012705; Sapru HN, 1996, ADV EXP MED BIOL, V410, P357; Schuen JN, 1997, RESP PHYSIOL, V109, P231, DOI 10.1016/S0034-5687(97)00052-2; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; SHEA SA, 1993, J PHYSIOL-LONDON, V468, P623, DOI 10.1113/jphysiol.1993.sp019792; Smart JA, 2000, BRIT J ANAESTH, V84, P735, DOI 10.1093/oxfordjournals.bja.a013584; Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644; Takakura ACT, 2006, J PHYSIOL-LONDON, V572, P503, DOI 10.1113/jphysiol.2005.103788; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Uchimura T, 2012, J INFECT CHEMOTHER, V18, P59, DOI 10.1007/s10156-011-0284-4; UGOLINI G, 1992, J COMP NEUROL, V326, P527, DOI 10.1002/cne.903260404; WHO, 2021, CUM NUMB CONF HUM CA; Xu F, 2007, RESP PHYSIOL NEUROBI, V158, P5, DOI 10.1016/j.resp.2007.04.004; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Xu FD, 2005, FASEB J, V19, pA656; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhuang J, 2008, FASEB J, V22, P1172; Zhuang J, 2014, PHYSL REP, V2, P1	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147522	10.1371/journal.pone.0147522	http://dx.doi.org/10.1371/journal.pone.0147522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808681	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800120
J	Hofstede, SN; Marang-van de Mheen, PJ; Vlieland, TPMV; van den Ende, CHM; Nelissen, RGHH; van Bodegom-Vos, L				Hofstede, Stefanie N.; Marang-van de Mheen, Perla J.; Vliet Vlieland, Thea P. M.; van den Ende, Cornelia H. M.; Nelissen, Rob G. H. H.; van Bodegom-Vos, Leti			Barriers and Facilitators Associated with Non Surgical Treatment Use for Osteoarthritis Patients in Orthopaedic Practice	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; HIP-REPLACEMENT; PRIMARY-CARE; MANAGEMENT; RECOMMENDATIONS; IMPLEMENTATION; GUIDELINES; CENTERS; ADULTS; PAIN	Introduction International evidence-based guidelines for the management of patients with hip and knee osteoarthritis (OA) recommend to start with (a combination of) non-surgical treatments, and using surgical intervention only if a patient does not respond sufficiently to non-surgical treatment options. Despite these recommendations, there are strong indications that nonsurgical treatments are not optimally used in orthopaedic practice. To improve the adoption of non-surgical treatments, more insight is needed into barriers and facilitators of these treatments. Therefore, this study assessed which barriers and facilitators are associated with the use and prescription of different non-surgical treatments before hip and knee OA in orthopaedic practice among patients and orthopaedic surgeons in the Netherlands. Materials and Methods We performed two internet-based surveys among 172 orthopaedic surgeons and 174 OA patients. Univariate association and multivariable regression techniques are used to identify barriers and facilitators associated with the use of non-surgical treatments. Results Most barriers and facilitators among patients were associated with the use of physical therapy, lifestyle advice and dietary therapy. Among orthopaedic surgeons, most were associated with prescription of acetaminophen, dietary therapy and physical therapy. Examples of barriers and facilitators among patients included "People in my environment had positive experiences with a surgery" (facilitator for education about OA), and "Advice of people in my environment to keep on moving" (facilitator for lifestyle and dietary advice). For orthopaedic surgeons, examples were "Lack of knowledge about guideline" (barrier for lifestyle advice), "Agreements/deliberations with primary care" and "Easy communication with a dietician" (facilitators for dietary therapy). Also the belief in the efficacy of these treatments was associated with increased prescription. Conclusions Strategies to improve non-surgical treatment use in orthopaedic practice should be targeted at changing the beliefs of orthopedic surgeons, communication with other OA care providers and involving patient's environment in OA treatment.	[Hofstede, Stefanie N.; Marang-van de Mheen, Perla J.; van Bodegom-Vos, Leti] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Vliet Vlieland, Thea P. M.; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands; [van den Ende, Cornelia H. M.] Sint Maartensklin Nijmegen, Dept Rheumatol, Hengstdal 3, Ubbergen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Sint Maartens Clinic	van Bodegom-Vos, L (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	l.vanbodegom-vos@lumc.nl	de Mheen, Perla J. Marang-van/I-2783-2015; Nelissen, Rob/AAD-8134-2020; van den Ende, Cornelia/G-9559-2011; van den Ende, Cornelia/ABG-7626-2020; van Bodegom-Vos, Leti/J-8087-2015; Vlieland, Thea Vliet/AAJ-8119-2020	de Mheen, Perla J. Marang-van/0000-0003-1439-0989; Nelissen, Rob/0000-0003-1228-4162; van den Ende, Cornelia/0000-0002-4352-2824; van Bodegom-Vos, Leti/0000-0002-8486-6404; Vlieland, Thea Vliet/0000-0001-6322-3859	Netherlands Organisation for Health Research and Development [837004002]; Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research project is supported by a grant from the Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/), grant number 837004002, LV. Funding was obtained from the Netherlands Organisation for Scientific Research (NWO) Incentive fund Open Access publications (http://www.nwo.nl/), LV.	Ackerman IN, 2009, ARTHRIT RHEUM-ARTHR, V61, P166, DOI 10.1002/art.24215; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Beckstead JW, 2012, INT J NURS STUD, V49, P635, DOI 10.1016/j.ijnurstu.2012.04.011; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Brand CA, 2014, ARTHRIT CARE RES, V66, P551, DOI 10.1002/acr.22197; Broadbent J, 2008, BRIT J GEN PRACT, V58, P839, DOI 10.3399/bjgp08X376177; Cavazos JM, 2008, ALIMENT PHARM THER, V28, P789, DOI 10.1111/j.1365-2036.2008.03791.x; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Cuperus N, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-181; Dieppe P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-19; Dutch Arthroplasty Register (LROI), 2012, MOR INS QUAL ORTH CA; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hofstede SN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009117; Hofstede SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094176; Holden MA, 2012, ARTHRIT CARE RES, V64, P1554, DOI 10.1002/acr.21700; Hoogeboom TJ, 2012, OSTEOARTHR CARTILAGE, V20, P525, DOI 10.1016/j.joca.2012.03.003; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Nelson AE, 2013, SEMIN ARTHRITIS RHEU; Netherlands Orthopaedic Association (NOV), 2007, GUID DIAGN TREATM HI; Obremskey W, 2014, J ORTHOP TRAUMA, V28, pE203, DOI 10.1097/BOT.0000000000000034; Otten Renee, 2010, Ned Tijdschr Geneeskd, V154, pA1534; Petursdottir U, 2010, PHYS THER, V90, P1014, DOI 10.2522/ptj.20090217; Poitras S, 2010, JOINT BONE SPINE, V77, P458, DOI 10.1016/j.jbspin.2010.08.001; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Sanders C, 2004, RHEUMATOLOGY, V43, P353, DOI 10.1093/rheumatology/keh044; Smink AJ, 2011, CLIN RHEUMATOL, V30, P1623, DOI 10.1007/s10067-011-1835-x; Smink AJ, 2013, ARTHRITIS CARE RES H, V65; Snijders GF, 2011, SCAND J RHEUMATOL, V40, P225, DOI 10.3109/03009742.2010.530611; Ursum J, 2013, COMMON IS OSTEOARTHR; van Beek ELK, 2010, REDUCEREN PRAKTIJKVA; van den Ende CM, 2010, NED TIJDSCHR GENEES, pA1574; Voorn VM, 2014, TRANSFUSION; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	38	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147406	10.1371/journal.pone.0147406	http://dx.doi.org/10.1371/journal.pone.0147406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799974	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300104
J	Pan, W; Yu, HZ; Huang, SJ; Zhu, PL				Pan, Wei; Yu, Huizhen; Huang, Shujie; Zhu, Pengli			Resveratrol Protects against TNF-alpha-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; KAPPA-B PATHWAY; OXIDATIVE STRESS; CHLAMYDOPHILA-PNEUMONIAE; SIRT1; CD40; EXPRESSION; ACTIVATION; APOPTOSIS; RELEASE	Inflammation and reactive oxygen species (ROS) play important roles in the pathogenesis of atherosclerosis. Resveratrol has been shown to possess anti-inflammatory and antioxidative stress activities, but the underlying mechanisms are not fully understood. In the present study, we investigated the molecular basis associated with the protective effects of resveratrol on tumor necrosis factor-alpha (TNF-alpha)-induced injury in human umbilical endothelial cells (HUVECs) using a variety of approaches including a cell viability assay, reverse transcription and quantitative polymerase chain reaction, western blot, and immunofluorescence staining. We showed that TNF-alpha induced CD40 expression and ROS production in cultured HUVECs, which were attenuated by resveratrol treatment. Also, resveratrol increased the expression of sirtuin 1 (SIRT1); and repression of SIRT1 by small-interfering RNA (siRNA) and the SIRT1 inhibitor Ex527 reduced the inhibitory effects of resveratrol on CD40 expression and ROS generation. In addition, resveratrol downregulated the levels of p65 and phospho-p38 MAPK, but this inhibitory effect was attenuated by the suppression of SIRT1 activity. Moreover, the p38 MAPK inhibitor SD203580 and the nuclear factor (NF)-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC) achieved similar repressive effects as resveratrol on TNF-alpha-induced ROS generation and CD40 expression. Thus, our study provides a mechanistic link between resveratrol and the activation of SIRT1, the latter of which is involved in resveratrol-mediated repression of the p38 MAPK/NF-kappa B pathway and ROS production in TNF-alpha-treated HUVECs.	[Pan, Wei; Yu, Huizhen; Zhu, Pengli] Fujian Med Univ, Prov Clin Med Coll, Fuzhou, Peoples R China; [Yu, Huizhen] Fujian Med Univ, Fujian Prov Hosp Key Lab Geriatr, Dept Geriatr, Fuzhou, Peoples R China; [Yu, Huizhen; Huang, Shujie; Zhu, Pengli] Fujian Inst Clin Geriatr, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Provincial Hospital	Zhu, PL (corresponding author), Fujian Med Univ, Prov Clin Med Coll, Fuzhou, Peoples R China.; Zhu, PL (corresponding author), Fujian Inst Clin Geriatr, Fuzhou, Peoples R China.	zpl7755@126.com			Natural Science Foundation of China [81373785]; Natural Science Foundation of Fujian Province [2011J01134, 2010J01127]; Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System [2013-ZQN-ZD-2]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System	This study was supported by grants from the Natural Science Foundation of China (grant no. 81373785), the Natural Science Foundation of Fujian Province (no. 2011J01134; no. 2010J01127), and the Projection of Excellent Young Doctor Training Plan in the Fujian Provincial Health System (no. 2013-ZQN-ZD-2).	Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barbe-Tuana F, 2015, J CELLULAR BIOCH; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bosutti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08093; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chong E, 2015, HEART RHYTHM, V12, P1046, DOI 10.1016/j.hrthm.2015.01.044; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Dong WW, 2015, FREE RADICAL BIOL ME; Dymicka-Piekarska V, 2014, INT J BIOL MARKER, V29, pE261, DOI 10.5301/jbm.5000083; Gao YL, 2016, CARDIOVASC TOXICOL, V16, P130, DOI 10.1007/s12012-015-9321-3; Ghisays F, 2015, CELL REPORTS; Gocmen AY, 2011, APPL PHYSIOL NUTR ME, V36, P323, DOI [10.1139/h11-022, 10.1139/H11-022]; Guo R, 2014, CELL PHYSIOL BIOCHEM, V34, P603, DOI 10.1159/000363026; Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holthoff JH, 2010, BIOCHEM PHARMACOL, V80, P1260, DOI 10.1016/j.bcp.2010.06.027; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Kutlesa Z, 2015, J BONE MINERAL METAB; Lee JH, 2015, ONCOLOGY REPORTS; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Lin QQ, 2012, CYTOKINE, V60, P447, DOI 10.1016/j.cyto.2012.05.025; Naylor AJD, 2009, LIFE SCI, V84, P637, DOI [10.1016/j.lfs.2009.02.011, 10.1016/j.lfs.2009.02.01]; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Sassi N, 2014, BBA-BIOENERGETICS, V1837, P1781, DOI 10.1016/j.bbabio.2014.06.010; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takizawa Y, 2013, BRIT J NUTR, V110, P2150, DOI 10.1017/S0007114513001670; Thiel G, 2014, MOL NUTR FOOD RES, V58, P1402, DOI 10.1002/mnfr.201300913; Tousoulis D, 2010, TRENDS CARDIOVAS MED, V20, P153, DOI 10.1016/j.tcm.2010.12.004; Tsuruoka S, 2012, KIDNEY INT, V82, P735, DOI 10.1038/ki.2012.182; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Volz MS, 2015, CLIN VACCINE IMMUNOL, pCVI; Wissel H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-51; Wissel H, 2005, BBA-MOL CELL RES, V1743, P37, DOI 10.1016/j.bbamcr.2004.08.009; Xu H, 2015, INFLAMMATION, V38, P327, DOI 10.1007/s10753-014-0036-6; Yang LN, 2012, CELL PHYSIOL BIOCHEM, V30, P1287, DOI 10.1159/000343318; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang J, 2013, CELL PHYSIOL BIOCHEM, V31, P230, DOI 10.1159/000343364; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	44	98	102	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147034	10.1371/journal.pone.0147034	http://dx.doi.org/10.1371/journal.pone.0147034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799794	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300055
J	Aymerich, IF; Oliva, M; Giralt, S; Martin-Herrero, J				Aymerich, Ismael F.; Oliva, Marc; Giralt, Santiago; Martin-Herrero, Julio			Detection of Tephra Layers in Antarctic Sediment Cores with Hyperspectral Imaging	PLOS ONE			English	Article							SOUTH-SHETLAND-ISLANDS; LIVINGSTON-ISLAND; ANISOTROPIC DIFFUSION; BYERS PENINSULA; LAKE; ICE; ERUPTION; ICELAND; QUALITY; RECORD	Tephrochronology uses recognizable volcanic ash layers (from airborne pyroclastic deposits, or tephras) in geological strata to set unique time references for paleoenvironmental events across wide geographic areas. This involves the detection of tephra layers which sometimes are not evident to the naked eye, including the so-called cryptotephras. Tests that are expensive, time-consuming, and/or destructive are often required. Destructive testing for tephra layers of cores from difficult regions, such as Antarctica, which are useful sources of other kinds of information beyond tephras, is always undesirable. Here we propose hyperspectral imaging of cores, Self-Organizing Map (SOM) clustering of the preprocessed spectral signatures, and spatial analysis of the classified images as a convenient, fast, non-destructive method for tephra detection. We test the method in five sediment cores from three Antarctic lakes, and show its potential for detection of tephras and cryptotephras.	[Aymerich, Ismael F.; Martin-Herrero, Julio] Univ Vigo, AtlantTIC, Vigo 36310, Spain; [Oliva, Marc] Univ Lisbon, Ctr Geog Studies IGOT, P-1699 Lisbon, Portugal; [Giralt, Santiago] Inst Earth Sci Jaume Almera CSIC, Barcelona, Spain	Universidade de Vigo; atlanTTic; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN)	Aymerich, IF (corresponding author), Univ Vigo, AtlantTIC, Vigo 36310, Spain.	ismael.aymerich@gmail.com	Giralt, Santiago/G-4823-2011; Martin-Herrero, Julio/D-3827-2009; Oliva, Marc/K-5423-2014; Giralt, Santiago/AAA-8585-2020	Giralt, Santiago/0000-0001-8570-7838; Oliva, Marc/0000-0001-6521-6388; Giralt, Santiago/0000-0001-8570-7838; Martin-Herrero, Julio/0000-0003-1109-6338	Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project; Portuguese Polar Program (PROPOLAR); AXA Research Fund	Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project; Portuguese Polar Program (PROPOLAR); AXA Research Fund(AXA Research Fund)	Core extraction and analyses were funded by the Portuguese Science Foundation through the HOLOANTAR (Holocene environmental change in the Maritime Antarctic: Interactions Between permafrost and the lacustrine environment) project and the Portuguese Polar Program (PROPOLAR). The AXA Research Fund sponsored M. Oliva's research activities in Antarctica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro P, 2010, J IBER GEOL, V36, P21; Andrews JT, 2006, HOLOCENE, V16, P1035, DOI 10.1177/0959683606069384; Aymerich IF, 2009, APPL SPECTROSC, V63, P716, DOI 10.1366/000370209788559683; Bartolini S, 2014, J VOLCANOL GEOTH RES, V285, P150, DOI 10.1016/j.jvolgeores.2014.08.009; BJORCK S, 1991, ANTARCT SCI, V3, P61, DOI 10.1017/S095410209100010X; Bjorck S, 1996, LIVINGSTON ISLAND BA, P49; Blockley SPE, 2005, QUATERNARY SCI REV, V24, P1952, DOI 10.1016/j.quascirev.2004.12.008; Calvino-Cancela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102381; Caseldine C, 1999, HOLOCENE, V9, P635, DOI 10.1191/095968399666026772; Chen QQ, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.19932; Cioni R, 2014, EARTH PLANET SC LETT, V394, P111, DOI 10.1016/j.epsl.2014.02.051; DEPERSIA AT, 1995, P SOC PHOTO-OPT INS, V2496, P159, DOI 10.1117/12.211312; Ferreiro-Arman M, 2006, LECT NOTES COMPUT SC, V4142, P730; Gehrels MJ, 2008, QUATERN INT, V178, P68, DOI 10.1016/j.quaint.2006.10.014; Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017; Grahn H. F., 2007, TECHNIQUES APPL HYPE; Grosjean M., 2014, Past Global Changes Magazine, V22, P10; Gudmundsdottir ER, 2011, J QUATERNARY SCI, V26, P589, DOI 10.1002/jqs.1474; Himberg J, 2001, PATTERN RECOGN, P38; Hodgson DA, 1998, ANTARCT SCI, V10, P13, DOI 10.1017/S0954102098000030; Huang H, 2014, SENSORS-BASEL, V14, P7248, DOI 10.3390/s140407248; Hunt JB, 2001, J QUATERNARY SCI, V16, P105, DOI 10.1002/jqs.571; Kim MS, 2001, T ASAE, V44, P721; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kohonen T., 1989, SELF ORG ASS MEMORY; Kohonen T, 1997, SELF ORGANIZING MAPS; Kruse FA, 1998, P 9 AUSTR REM SENS C; Kylander ME, 2012, HOLOCENE, V22, P371, DOI 10.1177/0959683611423688; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YI, 2007, QUATERNARY SCI REV, V26, P3167, DOI 10.1016/j.quascirev.2007.09.007; Levy J, 2014, ANTARCT SCI, V26, P565, DOI 10.1017/S0954102013000977; Liu EJ, 2015, SEDIMENTARY IN PRESS, DOI [10.1016/j.sedgeo.2015.08.002, DOI 10.1016/J.SEDGEO.2015.08.002]; Majewski W, 2012, MAR GEOL, V326, P67, DOI 10.1016/j.margeo.2012.08.009; MARTI J., 2013, B VOLCANOL, V75, P1; Martin-Herrero J, 2004, INT C PATT RECOG, P301, DOI 10.1109/ICPR.2004.1333763; Martin-Herrero J, 2004, LECT NOTES COMPUT SC, V3212, P323; Martin-Herrero J., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2820, DOI 10.1109/ICPR.2010.691; Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569; Mehl PM, 2004, J FOOD ENG, V61, P67, DOI 10.1016/S0260-8774(03)00188-2; Mendez-Rial R, 2012, IEEE T IMAGE PROCESS, V21, P2389, DOI 10.1109/TIP.2011.2179059; Narcisi B, 2005, EARTH PLANET SC LETT, V239, P253, DOI 10.1016/j.epsl.2005.09.005; Narcisi B, 2012, QUATERNARY SCI REV, V49, P52, DOI 10.1016/j.quascirev.2012.06.011; NICODEMU.FE, 1965, APPL OPTICS, V4, P767, DOI 10.1364/AO.4.000767; Oladottir BA, 2008, B VOLCANOL, V70, P475, DOI 10.1007/s00445-007-0150-5; Pallas R, 2001, HOLOCENE, V11, P149, DOI 10.1191/095968301669281809; Parton E, 2013, SPIE PROFESSIONAL, V8; Pedrazzi D, 2014, J GEOL SOC LONDON, V171, P765, DOI 10.1144/jgs2014-015; Ponomareva V, 2004, J VOLCANOL GEOTH RES, V136, P199, DOI 10.1016/j.jvolgeores.2004.05.013; Ponomareva V, 2013, INT J EARTH SCI, V102, P1673, DOI 10.1007/s00531-013-0898-0; Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938; SERRA J, 1986, COMPUT VISION GRAPH, V35, P283, DOI 10.1016/0734-189X(86)90002-2; Severi M, 2012, CLIM PAST, V8, P509, DOI 10.5194/cp-8-509-2012; Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497; Shippert P, 2004, PHOTOGRAMM ENG REM S, V70, P377; Smellie JL, 1999, GLOBAL PLANET CHANGE, V21, P51, DOI 10.1016/S0921-8181(99)00007-7; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Stokman H., 1999, BMVC99. Proceedings of the 10th British Machine Vision Conference, P643; Thorarinsson S, 1967, ERUPTIONS HEKLA HIST; THORNorarinsson S, 1939, GEOGR ANN, V21, P216; Toro M, 2013, ANTARCT SCI, V25, P198, DOI 10.1017/S0954102012000788; ULTSCH A, 1990, INTERNATIONAL NEURAL NETWORK CONFERENCE, VOLS 1 AND 2, P305; Winter EM, 2004, INT GEOSCI REMOTE SE, P1597	63	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146578	10.1371/journal.pone.0146578	http://dx.doi.org/10.1371/journal.pone.0146578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815202	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200017
J	Kelly, S; Martin, S; Kuhn, I; Cowan, A; Brayne, C; Lafortune, L				Kelly, Sarah; Martin, Steven; Kuhn, Isla; Cowan, Andy; Brayne, Carol; Lafortune, Louise			Barriers and Facilitators to the Uptake and Maintenance of Healthy Behaviours by People at Mid-Life: A Rapid Systematic Review	PLOS ONE			English	Review							PHYSICAL-ACTIVITY PARTICIPATION; LIFE-STYLE; SMOKING-CESSATION; ADULTS PARTICIPATION; PRIMARY-CARE; FOOD CHOICE; ALCOHOL-USE; RISK-FACTOR; MIDDLE; WOMEN	Background With an ageing population, there is an increasing societal impact of ill health in later life. People who adopt healthy behaviours are more likely to age successfully. To engage people in health promotion initiatives in mid-life, a good understanding is needed of why people do not undertake healthy behaviours or engage in unhealthy ones. Methods Searches were conducted to identify systematic reviews and qualitative or longitudinal cohort studies that reported mid-life barriers and facilitators to healthy behaviours. Mid-life ranged from 40 to 64 years, but younger adults in disadvantaged or minority groups were also eligible to reflect potential earlier disease onset. Two reviewers independently conducted reference screening and study inclusion. Included studies were assessed for quality. Barriers and facilitators were identified and synthesised into broader themes to allow comparisons across behavioural risks. Findings From 16,426 titles reviewed, 28 qualitative studies, 11 longitudinal cohort studies and 46 systematic reviews were included. Evidence was found relating to uptake and maintenance of physical activity, diet and eating behaviours, smoking, alcohol, eye care, and other health promoting behaviours and grouped into six themes: health and quality of life, sociocultural factors, the physical environment, access, psychological factors, evidence relating to health inequalities. Most of the available evidence was from developed countries. Barriers that recur across different health behaviours include lack of time (due to family, household and occupational responsibilities), access issues (to transport, facilities and resources), financial costs, entrenched attitudes and behaviours, restrictions in the physical environment, low socioeconomic status, lack of knowledge. Facilitators include a focus on enjoyment, health benefits including healthy ageing, social support, clear messages, and integration of behaviours into lifestyle. Specific issues relating to population and culture were identified relating to health inequalities. Conclusions The barriers and facilitators identified can inform the design of tailored interventions for people in mid-life.	[Kelly, Sarah; Martin, Steven; Cowan, Andy; Brayne, Carol; Lafortune, Louise] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Forvie Site,Box 113 Cambridge Biomed Campus, Cambridge CB2 0SR, England; [Kuhn, Isla] Univ Cambridge, Sch Clin Med, Med Lib, Box 113 Cambridge Biomed Campus, Cambridge CB2 0SR, England	University of Cambridge; University of Cambridge	Kelly, S (corresponding author), Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Forvie Site,Box 113 Cambridge Biomed Campus, Cambridge CB2 0SR, England.	sak65@medschl.cam.ac.uk	Lafortune, Louise/AAJ-9257-2020; Brayne, Carol/AAA-4285-2020; Kuhn, Isla L/J-6753-2012	Lafortune, Louise/0000-0002-9018-1217; Brayne, Carol/0000-0001-5307-663X; Kelly, Sarah/0000-0002-1114-2456; Kuhn, Isla/0000-0002-2879-4020; Cowan, Andy/0000-0002-8981-5673	National Institute for Health and Care Excellence (NICE) [DDER 42013]; National Institute for Health Research School for Public Health Research; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	National Institute for Health and Care Excellence (NICE); National Institute for Health Research School for Public Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health and Care Excellence (NICE), invitation to tender reference DDER 42013, and supported by the National Institute for Health Research School for Public Health Research. The scope of the work was defined by NICE and the protocol was agreed with NICE prior to the start of work. The funders had no role in data analysis, preparation of the manuscript or decision to publish.	Amireault S, 2013, HEALTH PSYCHOL REV, V7, P55, DOI 10.1080/17437199.2012.701060; Babakus WS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-150; Bader P, 2007, AM J PUBLIC HEALTH, V97, P1434, DOI 10.2105/AJPH.2006.100909; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Benzies KM, 2008, HEALTH CARE WOMEN IN, V29, P997, DOI 10.1080/07399330802269675; Berg Gregory D, 2002, Manag Care, V11, P45; Berg Judith A, 2002, Health Care Women Int, V23, P894, DOI 10.1080/07399330290112399; Bisogni CA, 2012, J NUTR EDUC BEHAV, V44, P282, DOI 10.1016/j.jneb.2011.11.009; Bock C, 2012, MED CARE RES REV, V69, P495, DOI 10.1177/1077558712441084; Brienza RS, 2002, J GEN INTERN MED, V17, P387, DOI 10.1046/j.1525-1497.2002.10617.x; Bryden A, 2013, HEALTH PLACE, V21, P70, DOI 10.1016/j.healthplace.2013.01.012; Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003; Buck D., 2012, IMPLICATIONS POLICY; Caldwell TM, 2008, DRUG ALCOHOL DEPEN, V95, P269, DOI 10.1016/j.drugalcdep.2008.01.014; Caperchione CM, 2012, AM J MENS HEALTH, V6, P453, DOI 10.1177/1557988312444718; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Department of Health Insight report, 2010, SUMM INS RES MIDDL A; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; Enjezab Behnaz, 2012, Iran J Nurs Midwifery Res, V17, P390; Eyler AE, 2002, J WOMEN HEALTH GEN-B, V11, P239, DOI 10.1089/152460902753668448; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Folta Sara C, 2008, Prev Chronic Dis, V5, pA06; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Gidlow C., 2005, Health Education Journal, V64, P168, DOI 10.1177/001789690506400208; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Giskes K, 2011, OBES REV, V12, pe95, DOI 10.1111/j.1467-789X.2010.00769.x; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Gower EW, 2013, J HEALTH CARE POOR U, V24, P1042, DOI 10.1353/hpu.2013.0134; Guillaumie L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-12; Hammond GK, 2011, J HUM NUTR DIET, V24, P61, DOI 10.1111/j.1365-277X.2010.01125.x; Hart Patricia L, 2005, J Cardiovasc Nurs, V20, P170; Honjo K, 2010, NICOTINE TOB RES, V12, P1050, DOI 10.1093/ntr/ntq143; Hooker SP, 2012, J MENS HEALTH, V9, P79, DOI 10.1016/j.jomh.2012.02.001; Hooker SP, 2011, ETHNIC DIS, V21, P261; Hooker SP, 2011, HEALTH EDUC RES, V26, P732, DOI 10.1093/her/cyr034; Im EO, 2013, J MIDWIFERY WOM HEAL, V58, P440, DOI 10.1111/j.1542-2011.2012.00259.x; Im EO, 2012, J TELEMED TELECARE, V18, P419, DOI 10.1258/jtt.2012.120514; Janen C, 2012, PSYCHOSOC MED, V9, DOI [10.3205/psm000085, DOI 10.3205/PSM000085]; Jilcott SB, 2009, WOMEN HEALTH, V49, P164, DOI 10.1080/03630240902915085; Kakde S, 2012, PUBLIC HEALTH, V126, P635, DOI 10.1016/j.puhe.2012.05.002; Kamphuis CBM, 2006, BRIT J NUTR, V96, P620, DOI 10.1079/BJN20061896; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; King DE, 2007, AM J MED, V120, P598, DOI 10.1016/j.amjmed.2006.09.020; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lafortune L, 2015, DISABILITY DEMENTIA; Lewis BA, 2002, AM J PREV MED, V23, P26, DOI 10.1016/S0749-3797(02)00471-3; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Meadows LM, 2001, QUAL HEALTH RES, V11, P450, DOI 10.1177/104973201129119244; Mejean C, 2011, BRIT J NUTR, V105, P776, DOI 10.1017/S0007114510004174; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Murray J, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-120; Myint PK, 2011, AGE AGEING, V40, P589, DOI 10.1093/ageing/afr058; National Institute for Clinical Excellence, 2012, METH DEV NICE PUBL H; Newman AB, 2011, AGING-US, V3, P63, DOI 10.18632/aging.100242; NICE, 2012, GUID MAN APP H METH; Niederdeppe J, 2008, SOC SCI MED, V67, P1343, DOI 10.1016/j.socscimed.2008.06.037; Pavey T, 2012, J EPIDEMIOL COMMUN H, V66, P737, DOI 10.1136/jech-2011-200354; Petersson U, 2008, SCAND J PUBLIC HEALT, V36, P389, DOI 10.1177/1403494808089561; Pettinato Maria, 2008, Issues Ment Health Nurs, V29, P619, DOI 10.1080/01612840802048865; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Ryan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-96; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Schunemann HJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-4; Segar M, 2006, SEX ROLES, V54, P175, DOI 10.1007/s11199-006-9336-5; Segar ML, 2008, WOMEN HEALTH ISS, V18, P281, DOI 10.1016/j.whi.2008.02.003; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shi HJ, 2004, PREV MED, V39, P1164, DOI 10.1016/j.ypmed.2004.04.030; Siddiqi Z, 2011, HEALTH EDUC RES, V26, P1010, DOI 10.1093/her/cyr068; Smith-DiJulio K, 2010, QUAL HEALTH RES, V20, P966, DOI 10.1177/1049732310362985; Sorensen L, 2005, OCCUP MED-OXFORD, V55, P136, DOI 10.1093/occmed/kqi036; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867; Vandelanotte C, 2013, J HEALTH COMMUN, V18, P1070, DOI 10.1080/10810730.2013.768731; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; Vaughn S, 2009, REHABIL NURS, V34, P17, DOI 10.1002/j.2048-7940.2009.tb00243.x; Vrazel J, 2008, AM J HEALTH PROMOT, V23, P2, DOI 10.4278/ajhp.06070999; Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440; Wurm S, 2010, PSYCHOL HEALTH, V25, P25, DOI 10.1080/08870440802311314; Yarwood Judy, 2005, Nurs Prax N Z, V21, P24; Yates BC, 2012, SOC SCI MED, V75, P659, DOI 10.1016/j.socscimed.2012.01.001	88	136	139	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145074	10.1371/journal.pone.0145074	http://dx.doi.org/10.1371/journal.pone.0145074			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815199	Green Published, gold			2022-12-27	WOS:000369528200003
J	Solomon, SS; Srikrishnan, AK; McFall, AM; Kumar, MS; Saravanan, S; Balakrishnan, P; Solomon, S; Thomas, DL; Sulkowski, MS; Mehta, SH				Solomon, Sunil S.; Srikrishnan, Aylur K.; McFall, Allison M.; Kumar, M. Suresh; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti; Thomas, David L.; Sulkowski, Mark S.; Mehta, Shruti H.			Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TRANSIENT ELASTOGRAPHY; NATURAL-HISTORY; RISK BEHAVIORS; INSULIN-RESISTANCE; B-VIRUS; INFECTION; FIBROSIS; PREVALENCE; USERS	Background and Objective We characterize the burden of liver disease in a cohort of PWID in Chennai, India, with a high prevalence of HCV. Materials and Methods 1,042 PWID were sampled through community outreach in Chennai. Participants underwent fasting blood draw, questionnaire and an examination that included liver stiffness assessment using transient elastography (Fibroscan) and assessment of steatosis via ultrasound. Results The median age was 39 years, all were male, 14.8% were HIV infected and 35.6% were HCV antibody positive, of whom 78.9% were chronically infected (HCV RNA positive). Median liver stiffness was 6.2 kPA; 72.9% had no evidence of or mild stiffness, 14.5% had moderate stiffness, and 12.6% had evidence of severe stiffness/cirrhosis. Prevalence of severe stiffness/cirrhosis was significantly higher among persons who were older, had a longer duration of injecting drugs, higher body mass index, higher prevalence of insulin resistance, higher prevalence of steatosis, higher HCV RNA levels and evidence of alcohol dependence. An estimated 42.1% of severe stiffness/cirrhosis in this sample was attributable to HCV. 529 (53.0%) had some evidence of steatosis. Prevalence of steatosis was higher among those who had larger waist circumference, insulin resistance, higher HDL cholesterol and a history of antiretroviral therapy. Conclusions We observed a high burden of liver disease in this relatively young cohort that was primarily driven by chronic HCV infection, metabolic factors (insulin resistance and steatosis) and heavy alcohol use. Interventions to improve access to HCV treatment and reduce alcohol use are needed to prevent further progression of liver disease.	[Solomon, Sunil S.; Thomas, David L.; Sulkowski, Mark S.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Solomon, Sunil S.; McFall, Allison M.; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Solomon, Sunil S.; Srikrishnan, Aylur K.; Kumar, M. Suresh; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mehta, SH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	smehta@jhu.edu	Balakrishnan, Pachamuthu/ABV-6282-2022; Saravanan, Shanmugam/GOG-9024-2022; Solomon, Sunil Suhas/P-6907-2019	Balakrishnan, Pachamuthu/0000-0002-1710-9155; Saravanan, Shanmugam/0000-0002-5991-8022; 	National Institute on Drug Abuse [R01 DA026727];  [P30 AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026727, K24DA034621] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by R01 DA026727 (http://www.drugabuse.gov/), National Institute on Drug Abuse (to SHM); and P30 AI094189 (http://hopkinscfar.org/funding-opportunities/faculty-development-awards/), Johns Hopkins Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057; BENVEGNU L, 1994, CANCER, V74, P2442, DOI 10.1002/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO;2-#; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Das K, 2012, HEPATOLOGY, V55, P584, DOI 10.1002/hep.24694; Goyal R, 2013, J GASTROEN HEPATOL, V28, P1738, DOI 10.1111/jgh.12318; Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Liu CJ, 2014, WORLD J GASTROENTERO, V20, P2955, DOI 10.3748/wjg.v20.i11.2955; Lucas GM, 2016, AIDS, V30, P619, DOI [10.1097/QAD.0000000000000949, 10.1097/QAD.0000000000000592]; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Panda S, 1997, DRUG ALCOHOL REV, V16, P17, DOI 10.1080/09595239700186291; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sagnelli E, 2002, HEPATOLOGY, V36, P1285, DOI 10.1053/jhep.2002.36509; Saludes V, 2014, WORLD J GASTROENTERO, V20, P3431, DOI 10.3748/wjg.v20.i13.3431; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SATO S, 1994, J HEPATOL, V21, P159, DOI 10.1016/S0168-8278(05)80389-7; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sharma P, 2014, INDIAN J GASTROENTER, V33, P445, DOI 10.1007/s12664-014-0491-x; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sirli R, 2009, J GASTROINTEST LIVER, V18, P57; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Solomon SS, 2010, SUBST USE MISUSE, V45, P354, DOI 10.3109/10826080903452447; Solomon SS, 2009, AIDS, V23, P997, DOI 10.1097/QAD.0b013e32832a594e; Solomon SS, 2015, LANCET INFECT DIS, V15, P36, DOI 10.1016/S1473-3099(14)71045-X; Solomon SS, 2014, CLIN INFECT DIS, V59, P589, DOI 10.1093/cid/ciu324; Solomon SS, 2010, AM J EPIDEMIOL, V172, P1259, DOI 10.1093/aje/kwq288; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; United Nations Office on Drugs and Crime, 2008 WORLD DRUG REP; WELTMAN MD, 1995, J VIRAL HEPATITIS, V2, P39, DOI 10.1111/j.1365-2893.1995.tb00070.x; Yu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139015; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0	47	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147879	10.1371/journal.pone.0147879	http://dx.doi.org/10.1371/journal.pone.0147879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812065	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000059
J	Lima, VBD; Dourado, LRB; Machado, LP; Biagiotti, D; de Lima, SBP; Ferreira, GJBD; Farias, LA; de Sousa, FA; Acacio, RM; Silva, DRSE				de Sousa Lima, Vania Batista; Barros Dourado, Leilane Rocha; Machado, Luciana Pereira; Biagiotti, Daniel; Pinheiro de Lima, Stelio Bezerra; Bolzani de Campos Ferreira, Guilherme Jose; Farias, Leonardo Atta; de Sousa, Francinete Alves; Acacio, Raian Malta; Silva e Silva, Danilo Rodrigo			Cottonseed Oil in Diets for Broilers in the Pre-Starter and Starter Phases	PLOS ONE			English	Article							LIPID SOURCES; PERFORMANCE; IRON; MEAL; YIELD	The objective of this study was to evaluate the effect of different levels of crude cottonseed oil in isoenergetic diets, with or without supplementation of ferrous sulfate, on performance variables, relative weight of organs, and blood parameters of broilers, and on the economic viability of diets in the periods from 1 to 7 and 1 to 21 days of age. A total of 600 male birds of the Ross line were distributed in a completely randomized design in a (4x2) factorial arrangement with eight treatments (0, 2, 4, and 6% cottonseed oil with and without ferrous sulfate), and five replicates. The following variables were studied: feed intake, weight gain, feed conversion, weight of organs, blood parameters, and yield of carcass and cuts at 21 days. No effects of the levels of cottonseed oil were found on the performance of animals aged 1 to 7 days, or on the relative weights of the organs. In this same period, the weight gain, and the relative weights of heart, liver, and intestine of the animals that received ferrous sulfate were decreased, and feed conversion was worsened. In the period from 1 to 21 days, weight gain increased linearly with the increase in the levels of cottonseed oil. Blood parameters were not influenced by the diets. Crude cottonseed oil can be utilized in diets for broilers in the periods from 1 to 7 and 1 to 21 days of age at up to 6% of inclusion, and supplementation with ferrous sulfate is unnecessary if the differences in metabolization of the cottonseed oil are considered, with and without, it during the diet formulation process.	[de Sousa Lima, Vania Batista] Univ Fed Piaui, Anim Nutr Lab, Teresina, Piaui, Brazil; [Barros Dourado, Leilane Rocha; Pinheiro de Lima, Stelio Bezerra; Farias, Leonardo Atta] Univ Fed Piaui, Dept Anim Sci, Bom Jesus, Piaui, Brazil; [Machado, Luciana Pereira] Fed Univ Fronteira Sul, Dept Vet Sci, Realeza, Parana, Brazil; [Biagiotti, Daniel] Univ Fed Piaui, Tech Coll, Bom Jesus, Piaui, Brazil; [Bolzani de Campos Ferreira, Guilherme Jose] Univ Fed Piaui, Dept Vet Sci, Bom Jesus, Piaui, Brazil; [de Sousa, Francinete Alves; Acacio, Raian Malta; Silva e Silva, Danilo Rodrigo] Univ Fed Piaui, Bom Jesus, Piaui, Brazil	Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade Federal da Fronteira Sul; Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade Federal do Piaui	Lima, VBD (corresponding author), Univ Fed Piaui, Anim Nutr Lab, Teresina, Piaui, Brazil.; Dourado, LRB (corresponding author), Univ Fed Piaui, Dept Anim Sci, Bom Jesus, Piaui, Brazil.	vania_vet06@hotmail.com; leilane@ufpi.edu.br		, Danilo/0000-0001-7929-7254				Adams N.R., 1989, TOXICANTS PLANT ORIG, V4, P25; Alexander J., 2008, EFSA J, V908, P1; Baião NC, 2005, Rev. Bras. Cienc. Avic., V7, P129, DOI 10.1590/S1516-635X2005000300001; BERTECHINI A.G., 2013, NUTR MONOGASTRICOS, V2; Collier HB, 1944, CAN MED ASS J, V50; Duarte FD, 2010, ARQ BRAS MED VET ZOO, V62, P439, DOI 10.1590/S0102-09352010000200025; FORBES GB, 1972, J NUTR, V102, P647, DOI 10.1093/jn/102.5.647; Freire RM, 2006, REV EMBRAPA ALGODAO; Gamboa DA, 2001, POULTRY SCI, V80, P789, DOI 10.1093/ps/80.6.789; GOLDENFARB PB, 1971, AM J CLIN PATHOL, V56, P35; Kakani R., 2010, OPEN TOXICOLOGY J, V4, P26; KLEBANOFF SJ, 1989, J BIOL CHEM, V264, P19765; Lara LJC, 2006, ARQ BRAS MED VET ZOO, V58, P108, DOI 10.1590/S0102-09352006000100016; Lara LJC, 2005, ARQ BRAS MED VET ZOO, V57, P792; Menten JFM, 2000, REV BRASILEIRA CIENC, V2, P219; Moreira I, 2006, REV BRAS ZOOTECN, P35; Murakami AE, 2009, REV BRAS ZOOTECN, V38, P1256, DOI 10.1590/S1516-35982009000700014; Nagalakshmi Devanaboyina, 2007, Journal of Poultry Science, V44, P119, DOI 10.2141/jpsa.44.119; NRC, 1994, NUTR REQ POULTR; OBrien RD, 2005, BAILEYS IND OIL FAT; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Porto Graça, 2012, J Port Gastrenterol., V19, P26; Ramadan N. A., 2010, International Journal of Poultry Science, V9, P842; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Sakomura NK, 2004, REV BRAS ZOOTECN, V33, P1758, DOI 10.1590/S1516-35982004000700014; Sakomura NK, 2016, METODOS PESQUISA ANI; Santos M. do S. V. dos, 2009, Revista Brasileira de Saude e Producao Animal, V10, P654; Siah Chiang W, 2006, Clin Biochem Rev, V27, P5; SKUTCHES CL, 1973, J NUTR, V103, P851, DOI 10.1093/jn/103.6.851; Soares KR, 2005, CIENC AGROTEC, V29, P238, DOI 10.1590/S1413-70542005000100030; VAHL HA, 1987, BRIT POULTRY SCI, V28, P567, DOI 10.1080/00071668708416992; VANDERKRAAIJ AMM, 1988, CIRCULATION, V78, P442, DOI 10.1161/01.CIR.78.2.442; Wintrobe M.M., 1934, FOLIA HAEMATOL, V51, P32, DOI DOI 10.1111/J.1365-2141.1991.TB08590.X; Yang XJ, 2011, J APPL POULTRY RES, V20, P263, DOI 10.3382/japr.2010-00204	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147695	10.1371/journal.pone.0147695	http://dx.doi.org/10.1371/journal.pone.0147695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807917	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800185
J	He, H; Cao, SL; Niu, TH; Zhou, Y; Zhang, L; Zeng, Y; Zhu, W; Wang, YP; Deng, HW				He, Hao; Cao, Shaolong; Niu, Tianhua; Zhou, Yu; Zhang, Lan; Zeng, Yong; Zhu, Wei; Wang, Yu-ping; Deng, Hong-wen			Network-Based Meta-Analyses of Associations of Multiple Gene Expression Profiles with Bone Mineral Density Variations in Women	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORK; TUMOR-NECROSIS-FACTOR; IN-VIVO; OSTEOCLAST DIFFERENTIATION; R-PACKAGE; B-CELLS; OSTEOPOROSIS; RECEPTOR; MICROARRAY; RISK	Background Existing microarray studies of bone mineral density (BMD) have been critical for understanding the pathophysiology of osteoporosis, and have identified a number of candidate genes. However, these studies were limited by their relatively small sample sizes and were usually analyzed individually. Here, we propose a novel network-based meta-analysis approach that combines data across six microarray studies to identify functional modules from human protein-protein interaction (PPI) data, and highlight several differentially expressed genes (DEGs) and a functional module that may play an important role in BMD regulation in women. Methods Expression profiling studies were identified by searching PubMed, Gene Expression Omnibus (GEO) and ArrayExpress. Two meta-analysis methods were applied across different gene expression profiling studies. The first, a nonparametric Fisher's method, combined p-values from individual experiments to identify genes with large effect sizes. The second method combined effect sizes from individual datasets into a meta-effect size to gain a higher precision of effect size estimation across all datasets. Genes with Q test's p-values <0.05 or I-2 values >50% were assessed by a random effects model and the remainder by a fixed effects model. Using Fisher's combined p-values, functional modules were identified through an integrated analysis of microarray data in the context of large protein-protein interaction (PPI) networks. Two previously published meta-analysis studies of genomewide association (GWA) datasets were used to determine whether these module genes were genetically associated with BMD. Pathway enrichment analysis was performed with a hypergeometric test. Results Six gene expression datasets were identified, which included a total of 249 (129 high BMD and 120 low BMD) female subjects. Using a network-based meta-analysis, a consensus module containing 58 genes (nodes) and 83 edges was detected. Pathway enrichment analysis of the 58 module genes revealed that these genes were enriched in several important KEGG pathways including Osteoclast differentiation, B cell receptor signaling pathway, MAPK signaling pathway, Chemokine signaling pathway and Insulin signaling pathway. The importance of module genes was replicated by demonstrating that most module genes were genetically associated with BMD in the GWAS data sets. Meta-analyses were performed at the individual gene level by combining p-values and effect sizes. Five candidate genes (ESR1, MAP3K3, PYGM, RAC1 and SYK) were identified based on gene expression meta-analysis, and their associations with BMD were also replicated by two BMD metaanalysis studies. Conclusions In summary, our network-based meta-analysis not only identified important differentially expressed genes but also discovered biologically meaningful functional modules for BMD determination. Our study may provide novel therapeutic targets for osteoporosis in women.	[He, Hao; Niu, Tianhua; Zhou, Yu; Zhang, Lan; Zeng, Yong; Zhu, Wei; Wang, Yu-ping; Deng, Hong-wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA; [Cao, Shaolong; Wang, Yu-ping] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Tulane University; Tulane University	Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA.	hdeng2@tulane.edu		Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Tulane University, University of Missouri Kansas City; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University, University of Missouri Kansas City; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by grants from the National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221], and startup funds from Tulane University, University of Missouri Kansas City.	[Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee NK, 2006, MOL CELL BIOCHEM, V281, P55, DOI 10.1007/s11010-006-0333-y; Lei SF, 2009, BONE, V44, P1010, DOI 10.1016/j.bone.2008.05.016; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Melton LJ, 2005, J BONE MINER RES, V20, P886, DOI 10.1359/jbmr.2005.20.5.886; Mistry M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-105; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Reppe S, 2010, BONE, V46, P604, DOI 10.1016/j.bone.2009.11.007; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Toraldo G, 2003, P NATL ACAD SCI USA, V100, P125, DOI 10.1073/pnas.0136772100; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Xiao P, 2008, J BONE MINER RES, V23, P644, DOI [10.1359/jbmr.080105, 10.1359/JBMR.080105]; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yang ZZ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-80; Yun TJ, 1998, J IMMUNOL, V161, P6113; Zhang L, 2014, HUM MOL GENET, V23, P1923, DOI 10.1093/hmg/ddt575; Zinman GE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1224	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147475	10.1371/journal.pone.0147475	http://dx.doi.org/10.1371/journal.pone.0147475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808152	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800102
J	He, WT; Zheng, XM; Zhang, YH; Gao, YG; Song, AX; van der Goot, FG; Hu, HY				He, Wen-Tian; Zheng, Xue-Ming; Zhang, Yu-Hang; Gao, Yong-Guang; Song, Ai-Xin; van der Goot, Francoise Gisou; Hu, Hong-Yu			Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone	PLOS ONE			English	Article							MOLECULAR CHAPERONES; DEUBIQUITINATING ENZYMES; TETRATRICOPEPTIDE REPEAT; QUALITY-CONTROL; PROTEINS; DISEASES; PROTEOSTASIS; DEGRADATION; CLEARANCE; SYSTEM	Ubiquitin-specific protease 19 (USP19) is one of the deubiquitinating enzymes (DUBs) involved in regulating the ubiquitination status of substrate proteins. There are two major isoforms of USP19 with distinct C-termini; the USP19_a isoform has a transmembrane domain for anchoring to the endoplasmic reticulum, while USP19_b contains an EEVD motif. Here, we report that the cytoplasmic isoform USP19_b up-regulates the protein levels of the polyglutamine (polyQ)-containing proteins, ataxin-3 (Atx3) and huntingtin (Htt), and thus promotes aggregation of their polyQ-expanded species in cell models. Our data demonstrate that USP19_b may orchestrate the stability, aggregation and degradation of the polyQ-expanded proteins through the heat shock protein 90 (HSP90) chaperone system. USP19_b directly interacts with HSP90 through its N-terminal CS (CHORD and SGT1)/P23 domains. In conjunction with HSP90, the cytoplasmic USP19 may play a key role in triage decision for the disease-related polyQ-expanded substrates, suggesting a function of USP19 in quality control of misfolded proteins by regulating their protein levels.	[He, Wen-Tian; Zheng, Xue-Ming; Zhang, Yu-Hang; Gao, Yong-Guang; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [van der Goot, Francoise Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Zheng, Xue-Ming] Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang 212013, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Jiangsu University	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Gao, Yongguang/B-8546-2012; van der Goot, Gisou/B-2279-2012	Gao, Yongguang/0000-0002-9359-4252; van der Goot, Gisou/0000-0002-8522-274X	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31270773, 31470758]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Basic Research Program of China (2012CB911003) and the National Natural Science Foundation of China (31270773, 31470758).	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Gao XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019763; Gao XC, 2008, ACTA BIOCH BIOPH SIN, V40, P612, DOI 10.1111/j.1745-7270.2008.00441.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Lee JG, 2014, J BIOL CHEM, V289, P3510, DOI 10.1074/jbc.M113.538934; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wiles B, 2015, MOL BIOL CELL, V26, P913, DOI 10.1091/mbc.E14-06-1129; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang Y, 2011, INT J EMERGING ELECT, V48, P1, DOI [10.1007/s13225-011-0117-x, DOI 10.1371/J0URNAL.P0NE.0029362]; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	41	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147515	10.1371/journal.pone.0147515	http://dx.doi.org/10.1371/journal.pone.0147515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808260	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800117
J	Horton, RE; Yadid, M; McCain, ML; Sheehy, SP; Pasqualini, FS; Park, SJ; Cho, A; Campbell, P; Parker, KK				Horton, Renita E.; Yadid, Moran; McCain, Megan L.; Sheehy, Sean P.; Pasqualini, Francesco S.; Park, Sung-Jin; Cho, Alexander; Campbell, Patrick; Parker, Kevin Kit			Angiotensin II Induced Cardiac Dysfunction on a Chip	PLOS ONE			English	Article							HEART-FAILURE; VENTRICULAR MYOCYTES; GENE-EXPRESSION; EARLY AFTERDEPOLARIZATIONS; IN-VIVO; TRANSCRIPTIONAL REGULATION; CA2+ CHANNELS; RAT HEARTS; HYPERTROPHY; MYOCARDIUM	In vitro disease models offer the ability to study specific systemic features in isolation to better understand underlying mechanisms that lead to dysfunction. Here, we present a cardiac dysfunction model using angiotensin II (ANG II) to elicit pathological responses in a hearton-a-chip platform that recapitulates native laminar cardiac tissue structure. Our platform, composed of arrays of muscular thin films (MTF), allows for functional comparisons of healthy and diseased tissues by tracking film deflections resulting from contracting tissues. To test our model, we measured gene expression profiles, morphological remodeling, calcium transients, and contractile stress generation in response to ANG II exposure and compared against previous experimental and clinical results. We found that ANG II induced pathological gene expression profiles including over-expression of natriuretic peptide B, Rho GTPase 1, and T-type calcium channels. ANG II exposure also increased proarrhythmic early after depolarization events and significantly reduced peak systolic stresses. Although ANG II has been shown to induce structural remodeling, we control tissue architecture via microcontact printing, and show pathological genetic profiles and functional impairment precede significant morphological changes. We assert that our in vitro model is a useful tool for evaluating tissue health and can serve as a platform for studying disease mechanisms and identifying novel therapeutics.	[Horton, Renita E.; Yadid, Moran; McCain, Megan L.; Sheehy, Sean P.; Pasqualini, Francesco S.; Park, Sung-Jin; Cho, Alexander; Campbell, Patrick; Parker, Kevin Kit] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA; [Horton, Renita E.] Mississippi State Univ, Coll Agr & Life Sci, James Worth Bagley Coll Engn, Dept Agr & Biol Engn, Starkville, MS USA; [McCain, Megan L.] Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA	Harvard University; Mississippi State University; University of Southern California	Parker, KK (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA.	kkparker@seas.harvard.edu	Pasqualini, Francesco/AAQ-5928-2021	Pasqualini, Francesco/0000-0001-7038-3121; Horton, Renita/0000-0001-7589-9485	National Institutes of Health [1 UH2TR000522-01, 4 UH3TR000522-03]; National Science Foundation Division of Materials Research [DMR-1420570]; Harvard School of Engineering and Applied Sciences; Harvard Materials Research Science and Engineering Center (MRSEC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000522, UH3TR000522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); Harvard School of Engineering and Applied Sciences; Harvard Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the National Institutes of Health (www.nih.gov) Grants 1 UH2 TR000522-01, 4 UH3TR000522-03, the Harvard Materials Research Science and Engineering Center (MRSEC) as supported by National Science Foundation (www.nsf.gov) Division of Materials Research Grant DMR-1420570, and the Harvard School of Engineering and Applied Sciences. The funding institutions had no role in the study design, data collection and analysis, manuscript preparation, or the decision to publish.	Adams WJ, 2007, J COMPUT-AIDED MATER, V14, P19, DOI 10.1007/s10820-006-9045-6; Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Aikawa R, 2000, MOL CELL BIOCHEM, V212, P177, DOI 10.1023/A:1007185711745; ALLEN IS, 1988, CIRC RES, V62, P524, DOI 10.1161/01.RES.62.3.524; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; BOULAY G, 1994, ENDOCRINOLOGY, V135, P2130, DOI 10.1210/en.135.5.2130; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; CAPASSO JM, 1993, AM J PHYSIOL, V264, pH2056, DOI 10.1152/ajpheart.1993.264.6.H2056; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; De Mello WC, 2000, HYPERTENSION, V35, P1183, DOI 10.1161/01.HYP.35.6.1183; DEFERRARI GM, 1995, CIRCULATION, V91, P2510, DOI 10.1161/01.CIR.91.10.2510; DZAU VJ, 1987, AM J CARDIOL, V59, pA59, DOI 10.1016/0002-9149(87)90178-0; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Foldes G, 2011, J MOL CELL CARDIOL, V50, P367, DOI 10.1016/j.yjmcc.2010.10.029; Gerdes AM, 2002, J CARD FAIL, V8, pS264, DOI 10.1054/jcaf.2002.129280; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Harada K, 1998, CIRCULATION, V97, P315; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Huffaker R, 2004, HEART RHYTHM, V1, P441, DOI 10.1016/j.hrthm.2004.06.005; Huggins CE, 2003, J RENIN-ANGIO-ALDO S, V4, P186, DOI 10.3317/jraas.2003.030; ISHIHATA A, 1993, BRIT J PHARMACOL, V108, P999, DOI 10.1111/j.1476-5381.1993.tb13497.x; Izumiya Y, 2012, INT J VASC MED, V2012, P9; Jane-Lise S, 2000, Heart Fail Rev, V5, P239; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lefroy DC, 1996, AM J PHYSIOL-HEART C, V270, pH2060, DOI 10.1152/ajpheart.1996.270.6.H2060; Liu Y, 1998, CIRC RES, V82, P1145, DOI 10.1161/01.RES.82.11.1145; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; McCain ML, 2014, AM J PHYSIOL-HEART C, V306, pH1525, DOI 10.1152/ajpheart.00799.2013; McCain ML, 2013, P NATL ACAD SCI USA, V110, P9770, DOI 10.1073/pnas.1304913110; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meissner A, 1998, J MOL CELL CARDIOL, V30, P2507, DOI 10.1006/jmcc.1998.0813; MORAVEC CS, 1990, CIRCULATION, V82, P1973, DOI 10.1161/01.CIR.82.6.1973; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Onodera T, 1998, HYPERTENSION, V32, P753, DOI 10.1161/01.HYP.32.4.753; Palomeque J, 2006, AM J PHYSIOL-HEART C, V290, pH96, DOI 10.1152/ajpheart.00324.2005; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Pasqualini FS, 2015, STEM CELL REP, V4, P340, DOI 10.1016/j.stemcr.2015.01.020; Petroff MGV, 2000, J PHYSIOL-LONDON, V529, P189, DOI 10.1111/j.1469-7793.2000.00189.x; Remme CA, 2013, J PHYSIOL-LONDON, V591, P4099, DOI 10.1113/jphysiol.2013.256461; ROGERS TB, 1986, J PHARMACOL EXP THER, V236, P438; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Sakurai K, 2002, LIFE SCI, V70, P1173, DOI 10.1016/S0024-3205(01)01497-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; SEN L, 1994, CIRC RES, V75, P149, DOI 10.1161/01.RES.75.1.149; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Sheehy SP, 2009, CIRC-CARDIOVASC GENE, V2, P116, DOI 10.1161/CIRCGENETICS.108.806935; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Tfelt-Hansen J, 2010, J CARDIOVASC ELECTR, V21, P107, DOI 10.1111/j.1540-8167.2009.01633.x; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; vanKesteren CAM, 1997, J MOL CELL CARDIOL, V29, P2147, DOI 10.1006/jmcc.1997.0448; von Lewinski D, 2008, EUR J HEART FAIL, V10, P1172, DOI 10.1016/j.ejheart.2008.09.014; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZH, 2011, J MOL CELL CARDIOL, V50, P128, DOI 10.1016/j.yjmcc.2010.11.001	75	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146415	10.1371/journal.pone.0146415	http://dx.doi.org/10.1371/journal.pone.0146415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808388	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800021
J	Lancaster, KE; Powers, KA; Lungu, T; Mmodzi, P; Hosseinipour, MC; Chadwick, K; Go, VF; Pence, BW; Hoffman, IF; Miller, WC				Lancaster, Kathryn Elizabeth; Powers, Kimberly A.; Lungu, Thandie; Mmodzi, Pearson; Hosseinipour, Mina C.; Chadwick, Katy; Go, Vivian F.; Pence, Brian W.; Hoffman, Irving F.; Miller, William C.			The HIV Care Continuum among Female Sex Workers: A Key Population in Lilongwe, Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DRIED BLOOD SPOTS; ANTIRETROVIRAL TREATMENT; RISK BEHAVIORS; RESPONDENT-DRIVEN; PREVENTION; TRANSMISSION; PREVALENCE; INFECTION; MEN	Objective The HIV care continuum among female sex workers (FSW), a key population, has not been well characterized, especially within the generalized epidemics of sub-Saharan Africa. This was the first study to characterize the HIV care continuum among FSW in Lilongwe, Malawi. Methods From July through September 2014, we used venue-based sampling to enroll 200 adult FSW in Lilongwe, Malawi into a cross-sectional evaluation assessing HIV care continuum outcomes. Seropositive FSW, identified using HIV rapid testing, received rapid CD4 counts in addition to viral loads using dried blood spots. We calculated proportions of HIV-infected FSW who had history of care, were on ART, and had suppressed viral load and we used Poisson regression to estimate the associations of demographic characteristics and transmission risk behaviors with each outcome. Results HIV seroprevalence was 69% (n = 138). Among all FSW the median age was 24 years (IQR: 22-28). Among the 20% who were newly diagnosed and reported previously testing negative, the median time since last HIV test was 11 months (interquartile range: 3-17). The majority (69%) of HIV-infected FSW had a history of HIV care, 52% reported current ART use, and 45% were virally suppressed. Of the FSW who reported current ART use, 86% were virally suppressed. Transmission risk behaviors were not associated with continuum outcomes. Conclusions FSW in Lilongwe were predominately young and have a high HIV prevalence. Only half of HIV-infected FSW reported current ART use, but the majority of those on ART were virally suppressed. To reduce ongoing transmission and improve health outcomes, increased HIV testing, care engagement, and ART coverage is urgently needed among FSW. Universal testing and treatment strategies for all FSWin Malawi must be strongly considered.	[Lancaster, Kathryn Elizabeth; Powers, Kimberly A.; Pence, Brian W.; Miller, William C.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Lungu, Thandie; Mmodzi, Pearson; Hosseinipour, Mina C.; Hoffman, Irving F.] Univ N Carolina, UNC Project Malawi, Lilongwe, Malawi; [Lancaster, Kathryn Elizabeth; Hosseinipour, Mina C.; Hoffman, Irving F.; Miller, William C.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Chadwick, Katy] Theatre Change, Lilongwe, Malawi; [Go, Vivian F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Lancaster, KE (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.; Lancaster, KE (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA.	klancaster@unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Lancaster, Kathryn/0000-0003-2389-6973	NIH - Fogarty International Center [R25 TW009340]; NIH Office of the Director Office of AIDS Research; ORWH; NCI; NHLBI; NIAID [T32 AI0700]; University of North Carolina Center for AIDS Research; NIH [P30 AI50410]; National Institutes of Health [KL2 TR001109]; FOGARTY INTERNATIONAL CENTER [R25TW009340] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000700, T32AI007001, P30AI050410] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Office of the Director Office of AIDS Research; ORWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH Research Training Grant [http://www.fic.nih.gov/] (grant number: R25 TW009340) funded by the Fogarty International Center, the NIH Office of the Director Office of AIDS Research, ORWH, NCI, and NHLBI, the NIAID T32 training grant (grant number: T32 AI0700 [KEL]), the University of North Carolina Center for AIDS Research, an NIH funded program [www.unccfar.org](grant number: P30 AI50410 [KEL]), and the National Institutes of Health (grant number: KL2 TR001109 [KAP]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115465; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Batona G, 2015, JAIDS-J ACQ IMM DEF, V68, pS206, DOI 10.1097/QAI.0000000000000452; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chimbwandria F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cowan FM, 2014, 20 INT AIDS C MELB A; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001258; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Donastorg Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088157; Family Planning Association of Malawi, 2011, COUNT UNC REP SIT AN; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Goldenberg SM, 2016, AIDS BEHAV, V20, P977, DOI 10.1007/s10461-015-1102-2; Greenberg AE, 2009, HEALTH AFFAIR, V28, P1677, DOI 10.1377/hlthaff.28.6.1677; Herce ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1065-y; Holland CE, 2015, JAIDS-J ACQ IMM DEF, V68, pS232, DOI 10.1097/QAI.0000000000000443; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Matovu JKB, 2012, INT J STD AIDS, V23, P267, DOI 10.1258/ijsa.2011.011313; McGrath N, 2013, AIDS, V27, P2461, DOI 10.1097/01.aids.0000432473.69250.19; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Organization. WH, 2012, PREV TREATM HIV OTH; Peitzmeier S, 2014, INT J STD AIDS, V25, P244, DOI 10.1177/0956462413498858; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Rottinghaus E, ANTIVIR THER, P15; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Schwartz S, 2015, 8 IAS C HIV PATH TRE; Schwartz S, 2014, 20 INT AIDS C MELB A; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Van Beckhoven D, 2014, J INT AIDS SOC, V17, P30, DOI 10.7448/IAS.17.4.19534; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Weir SS, 2012, SEX TRANSM INFECT, V88, pI95, DOI 10.1136/sextrans-2012-050638; WHO, 2012, CONS GUID US ANT DRU; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zachariah R, 2003, INT J STD AIDS, V14, P185, DOI 10.1258/095646203762869197; Zulliger R, 2015, JAIDS-J ACQ IMM DEF, V69, P216, DOI 10.1097/QAI.0000000000000590; Zulliger R, 2015, AIDS BEHAV, V19, P715, DOI 10.1007/s10461-014-0979-5	62	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147662	10.1371/journal.pone.0147662	http://dx.doi.org/10.1371/journal.pone.0147662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808043	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800172
J	Lu, W; Sun, JH; Yoon, JS; Zhang, Y; Zheng, LX; Murphy, E; Mattson, MP; Lenardo, MJ				Lu, Wei; Sun, Junhui; Yoon, Jeong Seon; Zhang, Yan; Zheng, Lixin; Murphy, Elizabeth; Mattson, Mark P.; Lenardo, Michael J.			Mitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; DEATH; PHOSPHATASE; RIP3; PHOSPHORYLATION; APOPTOSIS; TRIGGERS; DYNAMICS	Necroptosis as a molecular program, rather than simply incidental cell death, was established by elucidating the roles of receptor interacting protein (RIP) kinases 1 and 3, along with their downstream partner, mixed lineage kinase/like domain protein (MLKL). Previous studies suggested that phosphoglycerate mutase family member 5 (PGAM5), a mitochondrial protein that associates with RIP1/RIP3/MLKL complex, promotes necroptosis. We have generated mice deficient in the pgam5 gene and surprisingly found PGAM5-deficiency exacerbated rather than reduced necroptosis in response to multiple in vitro and in vivo necroptotic stimuli, including ischemic reperfusion injury (I/R) in the heart and brain. Electron microscopy, biochemical, and confocal analysis revealed that PGAM5 is indispensable for the process of PINK1 dependent mitophagy which antagonizes necroptosis. The loss of PGAM5/PINK1 mediated mitophagy causes the accumulation of abnormal mitochondria, leading to the overproduction of reactive oxygen species (ROS) that worsen necroptosis. Our results revise the former proposal that PGAM5 acts downstream of RIP1/RIP3 to mediate necroptosis. Instead, PGAM5 protects cells from necroptosis by independently promoting mitophagy. PGAM5 promotion of mitophagy may represent a therapeutic target for stroke, myocardial infarction and other diseases caused by oxidative damage and necroptosis.	[Lu, Wei; Zheng, Lixin; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sun, Junhui; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yoon, Jeong Seon; Mattson, Mark P.] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, NIH, Baltimore, MD 21224 USA; [Zhang, Yan] NCI, Mol Mech Apoptosis Sect, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov			Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute; National Institute on Aging, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566, ZIAAI000718] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Heart Lung and Blood Institute and the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2012, CELL, V148, P17, DOI 10.1016/j.cell.2011.12.020; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Perier C, 2012, ANTIOXID REDOX SIGN, V16, P883, DOI 10.1089/ars.2011.4074; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Sun JH, 2010, AM J PHYSIOL-HEART C, V299, pH1309, DOI 10.1152/ajpheart.00373.2010; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wu H, 2014, AUTOPHAGY, V10, P1712, DOI 10.4161/auto.29568; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2011, CELL RES, V21, P368, DOI 10.1038/cr.2011.3; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang WG, 1999, CANCER LETT, V138, P189, DOI 10.1016/S0304-3835(99)00013-0; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	46	87	93	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147792	10.1371/journal.pone.0147792	http://dx.doi.org/10.1371/journal.pone.0147792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807733	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800211
J	Maina, D; Omuse, G; Revathi, G; Adam, RD				Maina, Daniel; Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.			Spectrum of Microbial Diseases and Resistance Patterns at a Private Teaching Hospital in Kenya: Implications for Clinical Practice	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; EPIDEMIOLOGY; CRYPTOCOCCOSIS; SURVEILLANCE; DEFINITIONS; BACTEREMIA; AFRICA; BURDEN; CARE	Background Accurate local prevalence of microbial diseases and microbial resistance data are vital for optimal treatment of patients. However, there are few reports of these data from developing countries, especially from sub-Saharan Africa. The status of Aga Khan University Hospital Nairobi as an internationally accredited hospital and a laboratory with an electronic medical record system has made it possible to analyze local prevalence and antimicrobial susceptibility data and compare it with other published data. Methods We have analyzed the spectrum of microbial agents and resistance patterns seen at a 300 bed tertiary private teaching hospital in Kenya using microbial identity and susceptibility data captured in hospital and laboratory electronic records between 2010 and 2014. Results For blood isolates, we used culture collection within the first three days of hospitalization as a surrogate for community onset, and within that group, Escherichia coli was the most common, followed by Staphylococcus aureus. In contrast, Candida spp. and Klebsiella pneumoniae were the most common hospital onset causes of bloodstream infection. Antimicrobial resistance rates for the most commonly isolated Gram negative organisms was higher than many recent reports from Europe and North America. In contrast, Gram positive resistance rates were quite low, with 94% of S. aureus being susceptible to oxacillin and only rare isolates of vancomycin-resistant enterococci. Conclusions The current report demonstrates high rates of antimicrobial resistance in Gram negative organisms, even in outpatients with urinary tract infections. On the other hand, rates of resistance in Gram positive organisms, notably S. aureus, are remarkably low. A better understanding of the reasons for these trends may contribute to ongoing efforts to combat antimicrobial resistance globally.	[Maina, Daniel; Omuse, Geoffrey; Revathi, Gunturu; Adam, Rodney D.] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya; [Adam, Rodney D.] Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya		Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya.; Adam, RD (corresponding author), Aga Khan Univ Hosp, Dept Med, Nairobi, Kenya.	rodney.adam@aku.edu	OMUSE, GEOFFREY/EVF-7884-2022; Maina, Daniel/AAK-2944-2021	Maina, Daniel/0000-0002-6282-9311; OMUSE, GEOFFREY/0000-0002-3866-5118				Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Biondi E, 2013, PEDIATRICS, V132, P990, DOI 10.1542/peds.2013-1759; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goncalves-Pereira J, 2013, CLIN MICROBIOL INFEC, V19, P242, DOI 10.1111/j.1469-0691.2012.03776.x; Hampton T, 2015, JAMA-J AM MED ASSOC, V313, P2411, DOI 10.1001/jama.2015.4738; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoenigl M, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0104702; Kibet E, 2014, AM J CLIN PATHOL, V141, P188, DOI 10.1309/AJCPV8A9MRWHGXEF; Kohli R, 2010, East Afr Med J, V87, P74; Laupland Kevin B, 2015, BMC Res Notes, V8, P123, DOI 10.1186/s13104-015-1051-x; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leopold SJ, 2014, J ANTIMICROB CHEMOTH, V69, P2337, DOI 10.1093/jac/dku176; Lyytikainen O, 2002, CLIN INFECT DIS, V35, pE14, DOI 10.1086/340981; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Onyango D, 2008, J INFECT DEV COUNTR, V2, P106, DOI 10.3855/T2.2.106; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; System NINS, 1997, SURV HOSP ACQ BACT E	31	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147659	10.1371/journal.pone.0147659	http://dx.doi.org/10.1371/journal.pone.0147659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807811	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800170
J	Modesti, PA; Reboldi, G; Cappuccio, FP; Agyemang, C; Remuzzi, G; Rapi, S; Perruolo, E; Parati, G				Modesti, Pietro Amedeo; Reboldi, Gianpaolo; Cappuccio, Francesco P.; Agyemang, Charles; Remuzzi, Giuseppe; Rapi, Stefano; Perruolo, Eleonora; Parati, Gianfranco		ESH Working Grp CV Risk Low	Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR RISK; ETHNIC-DIFFERENCES; SOUTH-ASIANS; ORIGIN POPULATIONS; INSULIN-RESISTANCE; PUBLICATION BIAS; UK HIGHER	Background People of Sub Saharan Africa (SSA) and South Asians(SA) ethnic minorities living in Europe have higher risk of stroke than native Europeans(EU). Study objective is to provide an assessment of gender specific absolute differences in office systolic(SBP) and diastolic (DBP) blood pressure(BP) levels between SSA, SA, and EU. Methods and Findings We performed a systematic review and meta-analysis of observational studies conducted in Europe that examined BP in non-selected adult SSA, SA and EU subjects. Medline, PubMed, Embase, Web of Science, and Scopus were searched from their inception through January 31st 2015, for relevant articles. Outcome measures were mean SBP and DBP differences between minorities and EU, using a random effects model and tested for heterogeneity. Twenty-one studies involving 9,070 SSA, 18,421 SA, and 130,380 EU were included. Compared with EU, SSA had higher values of both SBP (3.38 mmHg, 95% CI 1.28 to 5.48 mmHg; and 6.00 mmHg, 95% CI 2.22 to 9.78 in men and women respectively) and DBP (3.29 mmHg, 95% CI 1.80 to 4.78; 5.35 mmHg, 95% CI 3.04 to 7.66). SA had lower SBP than EU(-4.57 mmHg, 95% CI -6.20 to -2.93; -2.97 mmHg, 95% CI -5.45 to -0.49) but similar DBP values. Meta-analysis by subgroup showed that SA originating from countries where Islam is the main religion had lower SBP and DBP values than EU. In multivariate meta-regression analyses, SBP difference between minorities and EU populations, was influenced by panethnicity and diabetes prevalence. Conclusions 1) The higher BP in SSA is maintained over decades, suggesting limited efficacy of prevention strategies in such group in Europe; 2) The lower BP in Muslim populations suggests that yet untapped lifestyle and behavioral habits may reveal advantages towards the development of hypertension; 3) The additive effect of diabetes, emphasizes the need of new strategies for the control of hypertension in groups at high prevalence of diabetes.	[Modesti, Pietro Amedeo; Rapi, Stefano; Perruolo, Eleonora] Univ Florence, Dept Med Sperimentale & Clin, Florence, Italy; [Reboldi, Gianpaolo] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Cappuccio, Francesco P.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, IRCCS Ist Ric Farmacol Mario Negri, Unit Nephrol Dialysis & Transplantat, Bergamo, Italy; [Parati, Gianfranco] Univ Milano Bicocca, S Luca Hosp, Dept Cardiol, IRCCS Ist Auxol,Dept Hlth Sci, Milan, Italy	University of Florence; University of Perugia; University of Warwick; University of Warwick; University of Amsterdam; ASST Papa Giovanni XXIII; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milano-Bicocca	Modesti, PA (corresponding author), Univ Florence, Dept Med Sperimentale & Clin, Florence, Italy.	pamodesti@unifi.it	Cífková, Renata/O-5731-2017; Del Prato, Stefano/K-3405-2016; Parati, Gianfranco/K-7151-2016; Massetti, Luciano/O-3360-2015; Gudina, Esayas Kebede/AAX-2374-2020; Modesti, Pietro Amedeo/B-2638-2012; Reboldi, Gianpaolo/A-3444-2009; Ceriello, Antonio/J-9575-2016; Bruno, Rosa Maria/C-3594-2015; Remuzzi, Giuseppe/V-9766-2017; Fadnes, Lars T/E-9086-2016; Rapi, Stefano/U-8841-2017; Perlini, Stefano/E-2670-2012	Cífková, Renata/0000-0003-2765-3821; Del Prato, Stefano/0000-0002-5388-0270; Parati, Gianfranco/0000-0001-9402-7439; Massetti, Luciano/0000-0002-0941-5347; Gudina, Esayas Kebede/0000-0002-6264-9695; Modesti, Pietro Amedeo/0000-0002-9511-2173; Reboldi, Gianpaolo/0000-0002-9877-0702; Stuckler, David/0000-0002-1288-8401; Bruno, Rosa Maria/0000-0002-6107-3356; Lalic, Nebojsa/0000-0002-8082-6560; Bennet, Louise/0000-0001-7101-1290; Remuzzi, Giuseppe/0000-0002-6194-3446; Fadnes, Lars T/0000-0001-8757-2092; Carlsson, Axel C/0000-0001-6113-0472; WATFA, GHASSAN/0000-0002-1559-6930; Rapi, Stefano/0000-0001-8564-518X; Ceriello, Antonio/0000-0001-8122-3203; Redon, Josep/0000-0001-8777-6773; Perlini, Stefano/0000-0002-0320-8574; DZUDIE, Anastase/0000-0003-4038-4128; Kalyesubula, Robert/0000-0003-3211-163X				Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; Agyemang C, 2014, HEART, V100, P239, DOI 10.1136/heartjnl-2013-304721; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Agyemang C, 2015, INT J CARDIOL, V183, P180, DOI 10.1016/j.ijcard.2015.01.061; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Becker E, 2006, HLTH SURVEY ENGLAND, P1; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bhopal RS, 2014, LANCET DIABETES ENDO, V2, P218, DOI 10.1016/S2213-8587(13)70204-3; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Cappuccio FP, 2002, BRIT MED J, V325, P1271, DOI 10.1136/bmj.325.7375.1271; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Cappuccio FP, 2003, BR J DIABETES VASC D, V3, P286, DOI DOI 10.1177/14746514030030041101; Chaturvedi N, 2004, J HYPERTENS, V22, P1731, DOI 10.1097/00004872-200409000-00017; CHATURVEDI N, 1993, HYPERTENSION, V22, P90, DOI 10.1161/01.HYP.22.1.90; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; CRUICKSHANK JK, 1991, LANCET, V338, P842, DOI 10.1016/0140-6736(91)91501-K; Dong YB, 1999, HYPERTENSION, V34, P1193, DOI 10.1161/01.HYP.34.6.1193; Dorairaj P, 2003, CIRCULATION, V108, P773; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Erlinger TP, 2003, PREV MED, V37, P327, DOI 10.1016/S0091-7435(03)00140-3; Flack JM, 2010, HYPERTENSION, V56, P780, DOI 10.1161/HYPERTENSIONAHA.110.152892; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; GALBRAITH RF, 1994, J AM STAT ASSOC, V89, P1232, DOI 10.2307/2290987; Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x; Glenday K, 2006, EUR J CARDIOV PREV R, V13, P348; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Greer SL, 2013, LANCET, V381, P1135, DOI 10.1016/S0140-6736(12)62083-2; Gualdi-Russo E, 2009, J TRAVEL MED, V16, P88, DOI 10.1111/j.1708-8305.2008.00280.x; Gunarathne A, 2009, STROKE, V40, pE415, DOI 10.1161/STROKEAHA.108.535724; Gupta M, 2006, CIRCULATION, V113, pE924, DOI 10.1161/CIRCULATIONAHA.105.583815; HAINES AP, 1987, J HUM HYPERTENS, V1, P39; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harding S, 2008, HEART, V94, P463, DOI 10.1136/hrt.2007.122044; Harding S, 2003, EPIDEMIOLOGY, V14, P287, DOI 10.1097/00001648-200305000-00007; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Jin ZC, 2015, STAT MED, V34, P343, DOI 10.1002/sim.6342; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Khan JM, 2005, HEART, V91, P1105, DOI 10.1136/hrt.2004.044560; Kim AH, 2010, AM J SOCIOL, V115, P1558, DOI 10.1086/651375; KNIGHT T, 1993, J EPIDEMIOL COMMUN H, V47, P89, DOI 10.1136/jech.47.2.89; KNIGHT TM, 1992, BRIT HEART J, V67, P343; Kumar BN, 2009, OSLO IMMIGRANT HLTH, P1503; Lambie M, 2008, NEPHROL DIAL TRANSPL, V23, P3983, DOI 10.1093/ndt/gfn366; Lane D, 2002, J HUM HYPERTENS, V16, P267, DOI 10.1038/sj.jhh.1001371; Lemic-Stojcevic N, 2001, ETHNIC HEALTH, V6, P87, DOI 10.1080/13557850120068414; Lyratzopoulos G, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-125; MCKEIGUE PM, 1988, BRIT HEART J, V60, P390; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MEADE TW, 1978, BRIT HEART J, V40, P789, DOI 10.1136/hrt.40.7.789; Miller MA, 2004, THROMB HAEMOSTASIS, V92, P1060, DOI 10.1160/TH04-04-0228; Millett C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029836; Modesti PA, 2014, J HYPERTENS, V32, P951, DOI 10.1097/HJH.0000000000000125; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nanchahal K, 2001, J PUBLIC HEALTH MED, V23, P278, DOI 10.1093/pubmed/23.4.278; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Palloni A, 2001, ANN NY ACAD SCI, V954, P140; Patel S, 1999, DIABETIC MED, V16, P853, DOI 10.1046/j.1464-5491.1999.00163.x; Primatesta P, 2000, J HUM HYPERTENS, V14, P143, DOI 10.1038/sj.jhh.1000960; Rabanal KS, 2013, EUR J PREV CARDIOL, V20, P1013, DOI 10.1177/2047487312450539; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Regidor E, 2009, EUR J EPIDEMIOL, V24, P503, DOI 10.1007/s10654-009-9363-6; Schwarzer G, 2014, METAMETAANALYSIS R R; SEVER PS, 1979, CLIN EXP HYPERTENS, V1, P733, DOI 10.3109/10641967909068636; SILMAN AJ, 1987, J EPIDEMIOL COMMUN H, V41, P152, DOI 10.1136/jech.41.2.152; SIMMONS D, 1993, DIABETIC MED, V10, P751, DOI 10.1111/j.1464-5491.1993.tb00159.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Valles SA, 2012, PREV MED, V55, P405, DOI 10.1016/j.ypmed.2012.08.022; Waterworth DM, 2001, DIABETOLOGIA, V44, P245, DOI 10.1007/s001250051607; Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1	78	606	610	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147601	10.1371/journal.pone.0147601	http://dx.doi.org/10.1371/journal.pone.0147601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808317	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800146
J	Munyua, PM; Murithi, RM; Ithondeka, P; Hightower, A; Thumbi, SM; Anyangu, SA; Kiplimo, J; Bett, B; Vrieling, A; Breiman, RF; Njenga, MK				Munyua, Peninah M.; Murithi, R. Mbabu; Ithondeka, Peter; Hightower, Allen; Thumbi, Samuel M.; Anyangu, Samuel A.; Kiplimo, Jusper; Bett, Bernard; Vrieling, Anton; Breiman, Robert F.; Njenga, M. Kariuki			Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya	PLOS ONE			English	Article							OUTBREAK; LIVESTOCK; TANZANIA; LINEAGES	Background To-date, Rift Valley fever (RVF) outbreaks have occurred in 38 of the 69 administrative districts in Kenya. Using surveillance records collected between 1951 and 2007, we determined the risk of exposure and outcome of an RVF outbreak, examined the ecological and climatic factors associated with the outbreaks, and used these data to develop an RVF risk map for Kenya. Methods Exposure to RVF was evaluated as the proportion of the total outbreak years that each district was involved in prior epizootics, whereas risk of outcome was assessed as severity of observed disease in humans and animals for each district. A probability-impact weighted score (1 to 9) of the combined exposure and outcome risks was used to classify a district as high (score >= 5) or medium (score >= 2 - <5) risk, a classification that was subsequently subjected to expert group analysis for final risk level determination at the division levels (total = 391 divisions). Divisions that never reported RVF disease (score <2) were classified as low risk. Using data from the 2006/07 RVF outbreak, the predictive risk factors for an RVF outbreak were identified. The predictive probabilities from the model were further used to develop an RVF risk map for Kenya. Results The final output was a RVF risk map that classified 101 of 391 divisions (26%) located in 21 districts as high risk, and 100 of 391 divisions (26%) located in 35 districts as medium risk and 190 divisions (48%) as low risk, including all 97 divisions in Nyanza and Western provinces. The risk of RVF was positively associated with Normalized Difference Vegetation Index (NDVI), low altitude below 1000m and high precipitation in areas with solonertz, luvisols and vertisols soil types (p <0.05). Conclusion RVF risk map serves as an important tool for developing and deploying prevention and control measures against the disease.	[Munyua, Peninah M.; Breiman, Robert F.; Njenga, M. Kariuki] US Ctr Dis Control & Prevent Kenya, Global Dis Detect Div, Nairobi, Kenya; [Murithi, R. Mbabu; Ithondeka, Peter] Minist Agr Livestock & Fisheries, Nairobi, Kenya; [Hightower, Allen] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Thumbi, Samuel M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Anyangu, Samuel A.] Minist Hlth, Nairobi, Kenya; [Kiplimo, Jusper; Bett, Bernard] Int Livestock Res Inst, Nairobi, Kenya; [Vrieling, Anton] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands; [Njenga, M. Kariuki] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Washington State University; CGIAR; International Livestock Research Institute (ILRI); University of Twente; Kenya Medical Research Institute	Njenga, MK (corresponding author), US Ctr Dis Control & Prevent Kenya, Global Dis Detect Div, Nairobi, Kenya.; Njenga, MK (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	Knjenga@kemri.org	Munyua, Peninah/AAA-5922-2021; Vrieling, Anton/B-2639-2012; Mwangi, Thumbi/L-2216-2019	Vrieling, Anton/0000-0002-7979-1540; Mwangi, Thumbi/0000-0002-5754-0556; Ronoh, Jusper/0000-0001-6575-0281	Biosecurity Engagement Program of United States Department of State; U.S. Centers for Disease Control and Prevention	Biosecurity Engagement Program of United States Department of State; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the Biosecurity Engagement Program of United States Department of State and the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the team of expert from the Kenya Ministry of Livestock Development and Kenya Ministry of Public Health and Sanitation for their valuable input, and Norah Nanjala and Triza Shigoli for administrative support. The Biosecurity Engagement Program of United States Department of State and the U.S. Centers for Disease Control and Prevention provided the financial support for this study. The findings and conclusions in this manuscript are by the authors and should not be construed to represent CDC's determination or policy	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671; Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266; Anyamba A, 2001, Cad Saude Publica, V17 Suppl, P133, DOI 10.1590/S0102-311X2001000700022; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Centre ECJR, 2003, GLOB LAND COV 2000 D; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Hightower A, 2012, AM J TROP MED HYG, V86, P373, DOI 10.4269/ajtmh.2012.11-0450; Jost CC, 2010, AM J TROP MED HYG, V83, P65, DOI 10.4269/ajtmh.2010.09-0290; Meegan J. M., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P100; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020; Nderitu L, 2011, J INFECT DIS, V203, P655, DOI 10.1093/infdis/jiq004; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; RVF Decision Support, 2010, AM J TROP MED HYG, V83, P75, DOI 10.4269/ajtmh.2010.83s2a03; SALUZZO JF, 1987, LANCET, V1, P504	20	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144570	10.1371/journal.pone.0144570	http://dx.doi.org/10.1371/journal.pone.0144570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808021	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800004
J	Sweet, DE; Altice, FL; Cohen, CJ; Vandewalle, B				Sweet, Donna E.; Altice, Frederick L.; Cohen, Calvin J.; Vandewalle, Bjoern			Cost-Effectiveness of Single-Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States	PLOS ONE			English	Article							EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; INITIAL TREATMENT; EXPERIENCED PATIENTS; DRUG-RESISTANCE; TENOFOVIR DF; EFFICACY; SAFETY; COMBINATION	Background The possibility of incorporating generics into combination antiretroviral therapy and breaking apart once-daily single-tablet regimens (STRs), may result in less efficacious medications and/or more complex regimens with the expectation of marked monetary savings. A modeling approach that assesses the merits of such policies in terms of lifelong costs and health outcomes using adherence and effectiveness data from real-world U.S. settings. Methods A comprehensive computer-based microsimulation model was developed to assess the lifetime health (life expectancy and quality adjusted life-years-QALYs) and economic outcomes in HIV-1 infected patients initiating STRs compared with multiple-table regimens including generic medications where possible (gMTRs). The STRs considered included tenofovir disoproxil fumarate/emtricitabine and efavirenz or rilpivirine or elvitegravir/cobicistat. gMTRs substitutions included each counterpart to STRs, including generic lamivudine for emtricitabine and generic versus branded efavirenz. Results Life expectancy is estimated to be 1.301 years higher (discounted 0.619 QALY gain) in HIV-1 patients initiating a single-tablet regimen in comparison to a generic-based multiple-table regimen. STRs were associated with an average increment of $26,547.43 per patient in medication and $1,824.09 in other medical costs due to longer survival which were partially offset by higher inpatients costs ($12,035.61) with gMTRs treatment. Overall, STRs presented incremental lifetime costs of $16,335.91 compared with gMTRs, resulting in an incremental cost-effectiveness ratio of $26,383.82 per QALY gained. Conclusions STRs continue to represent good value for money under contemporary cost-effectiveness thresholds despite substantial price reductions of generic medications in the U.S.	[Sweet, Donna E.] Univ Kansas, Sch Med, Internal Med, Wichita, KS 67214 USA; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT USA; [Cohen, Calvin J.] CRI New England, Boston, MA USA; [Vandewalle, Bjoern] Exigo Consultores, Lisbon, Portugal; [Cohen, Calvin J.] Gilead Sci, Foster City, CA USA	University of Kansas; University of Kansas Medical Center; Yale University; Gilead Sciences	Vandewalle, B (corresponding author), Exigo Consultores, Lisbon, Portugal.	bjorn.vandewalle@exigoconsultores.com		Altice, Frederick/0000-0002-7860-693X	Gilead Sciences, Foster City, CA	Gilead Sciences, Foster City, CA(Gilead Sciences)	This work was supported by Gilead Sciences, Foster City, CA. DES, FLA, CJC and BV (prior to January 2015) are employees of independent academic institutions, research organizations or consulting firms and maintained independent scientific control over the study, including data analysis and interpretation of final results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries (after January 2015) for CJC. Gilead contracted with Exigo Consultores for the development of the model. Exigo Consultores provided support in the form of salaries for BV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arasteh K, 2009, ANTIVIR THER, V14, P859, DOI 10.3851/IMP1301; Barnett PG, 2011, MED CARE, V49, P848, DOI 10.1097/MLR.0b013e31821b34c0; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; CDC, 2014, NATL VITAL STAT REPO, V63; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Colombo GL, 2014, THER CLIN RISK MANAG, V10, P9, DOI 10.2147/TCRM.S49428; Colombo GL, 2013, CLINICOECONOMIC OUTC, V5, P59, DOI 10.2147/CEOR.S38977; Colombo GL, 2011, CLINICOECONOMIC OUTC, V3, P197, DOI 10.2147/CEOR.S24130; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; DHHS, 2015, GUIDELINES USE ANTIR; FDA, 2011, EMTR RILP TEN DIS FU; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gardner EM, 2010, AIDS, V24, P395, DOI 10.1097/QAD.0b013e328335cd8a; Gazzard B, 2012, CLINICOECONOMIC OUTC, V4, P193, DOI 10.2147/CEOR.S12496; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gilead, 2013, MARKET SHARE DATA Q; Guria J, 2005, ENVIRON RESOUR ECON, V32, P113, DOI 10.1007/s10640-005-6030-6; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hill AM, 2011, AIDS REV, V13, P41; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Janssen, 2015, POWER 1 2 96 WEEK PO; Johnson M, 2006, AIDS, V20, P711, DOI 10.1097/01.aids.0000216371.76689.63; Johnson M, 2005, AIDS, V19, P153, DOI 10.1097/00002030-200501280-00007; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Lee FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097482; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Maggiolo F, 2015, PATIENT-RELAT OUTCOM, V6, P53, DOI 10.2147/PROM.S63586; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; O'Hagan A, 2006, RELIAB ENG SYST SAFE, V91, P1290, DOI 10.1016/j.ress.2005.11.025; Porter DP, 2014, JAIDS-J ACQ IMM DEF, V65, P318, DOI 10.1097/QAI.0000000000000017; Pozniak A, 2013, 20 C RETR OPP INF; Ramiro MA, 2014, ENFERM INFEC MICR CL, V32, P598, DOI 10.1016/j.eimc.2013.06.008; Rao G, 2013, IMPACT HAART REGIMEN; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sax PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113031; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Solem CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098152; Sweet D, 2014, 20 INT AIDS C MELB A; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trottier B, 2005, JAIDS-J ACQ IMM DEF, V40, P413, DOI 10.1097/01.qai.0000185313.48933.2c; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; WHO, 2012, PHARM EQ CLIN INT GE; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c	59	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147821	10.1371/journal.pone.0147821	http://dx.doi.org/10.1371/journal.pone.0147821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808503	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800217
J	Ullah, I; Javaid, A; Tahir, Z; Ullah, O; Shah, AA; Hasan, F; Ayub, N				Ullah, Irfan; Javaid, Arshad; Tahir, Zarfishan; Ullah, Obaid; Shah, Aamer Ali; Hasan, Fariha; Ayub, Najma			Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; NATIONAL-SURVEY; PREVALENCE; SURVEILLANCE	Background Drug resistant tuberculosis (DR-TB) is a major public health problem in developing countries such as Pakistan. Objective The current study was conducted to assess the frequency of drug resistant tuberculosis including multi drug resistance (MDR-TB) as well as risk factors for development of DR-TB, in Punjab, Pakistan. Methodology Drug susceptibility testing (DST) was performed, using proportion method, for 2367 culture positive Mycobacterium tuberculosis (MTB) cases that were enrolled from January 2012 to December 2013 in the province of Punjab, Pakistan, against first-line anti-tuberculosis drugs. The data was analyzed using statistical software; SPSS version 18. Results Out of 2367 isolates, 273 (11.5%) were resistant to at least one anti-TB drug, while 221 (9.3%) showed MDR-TB. Risk factors for development of MDR-TB were early age (ranges between 10-25 years) and previously treated TB patients. Conclusion DR-TB is a considerable problem in Pakistan. Major risk factors are previous history of TB treatment and younger age group. It emphasizes the need for effective TB control Program in the country.	[Ullah, Irfan; Shah, Aamer Ali; Hasan, Fariha; Ayub, Najma] Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan; [Ullah, Irfan; Javaid, Arshad] Lady Reading Hosp, Programmat Management Drug Resistant TB Pulmonol, Peshawar, Pakistan; [Tahir, Zarfishan; Ullah, Obaid] Inst Publ Hlth, Dept Bacteriol, Jail Rd Lahore, Lahore, Pakistan	Quaid I Azam University	Ullah, I (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Microbiol, Islamabad, Pakistan.; Ullah, I (corresponding author), Lady Reading Hosp, Programmat Management Drug Resistant TB Pulmonol, Peshawar, Pakistan.	irfan_btn@hotmail.com	Ullah, Irfan/L-5150-2017	Ullah, Irfan/0000-0001-6992-6723; Shah, Aamer/0000-0001-7454-4105				Abbas A, 2007, BASIC PATHOLOGY, V8th; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chacon L, 2009, INT J TUBERC LUNG D, V13, P62; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Micheletti VCD, 2014, J BRAS PNEUMOL, V40, P155, DOI 10.1590/S1806-37132014000200009; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Flora M S, 2013, Bangladesh Med Res Counc Bull, V39, P34; Gomes M., 2014, J TUBERCULOSIS RES, V2, P111, DOI DOI 10.4236/JTR.2014.23014; Hussain Rabia, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P257; India T, 2009, RNTCP STAT REP; Irfan Ullah, 2014, Global Veterinaria, V13, P1002; Javaid A, 2008, INT J TUBERC LUNG D, V12, P326; Javaid A, 2011, J POSTGRADUATE MED I, V24; Karamat K. A., 1999, JPMA (Journal of the Pakistan Medical Association), V49, P262; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Li X, 2012, INT J TUBERC LUNG D, V16, P612, DOI 10.5588/ijtld.11.0507; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Mor Z, 2014, INT J TUBERC LUNG D, V18, P1195, DOI 10.5588/ijtld.14.0192; Paramasivan CN, 2002, INT J TUBERC LUNG D, V6, P479; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Vincent V, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P573; WHO, 2014, GLOB TUB REP 2014 WH; World Health Organization, 2013, WHO GLOB TUB REP 201; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yang Y, 2014, INT J INFECT DIS, V22, P83, DOI 10.1016/j.ijid.2013.12.015; Yasmin M, 2014, INFECT GENET EVOL, V27, P6, DOI 10.1016/j.meegid.2014.06.017; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	30	43	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147529	10.1371/journal.pone.0147529	http://dx.doi.org/10.1371/journal.pone.0147529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809127	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800123
J	Wouters, H; Van Dijk, L; Geers, HCJ; Winters, NA; Van Geffen, ECG; Stiggelbout, AM; Bouvy, ML				Wouters, Hans; Van Dijk, Liset; Geers, Harm C. J.; Winters, Nina A.; Van Geffen, Erica C. G.; Stiggelbout, Anne M.; Bouvy, Marcel L.			Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; BREAST-CANCER; MEDICATION-ADHERENCE; SELF-EFFICACY; OLDER WOMEN; PREDICTORS; TAMOXIFEN; BELIEFS; DISCONTINUATION; ANTIDEPRESSANTS	Background Non-adherence to statins is substantial and is associated with numerous perceptions and experiences. However, time limits in clinical practice constrain in depth explorations of these perceptions and experiences. Objectives To propose and examine a strategy aimed at an efficient assessment of a wide array of perceptions and experiences regarding the efficacy, side effects, and practical problems of statins. Furthermore, to assess associations between this wide array of experiences and perceptions and non-adherence and to examine whether patients' 'perceived self-efficacy' moderated these associations. Methods Patients were recruited through community pharmacies. A wide array of specific patient perceptions and experiences was efficiently assessed using the electronic Tailored Medicine Inventory that allows people to skip irrelevant questions. Adherence was measured through self-report and pharmacy refill data. Results Of the two-hundred twenty-nine patients who participated (mean age 63.9, standard deviation 10.2), 40%-70% doubted the necessity of or lacked knowledge about the efficacy of statins, 20%-35% of the patients were worried about joint and muscle side effects or had experienced these, and 23% had encountered practical problems regarding information about statins, intake of tablets, the package, or the blister. Experiencing more practical problems was associated with increased unintentional non-adherence (Odds ratio 1.54, 95% CI: 1.13-2.10, P < 0.01), whereas worrying about side effects was associated with increased intentional non-adherence (Odds ratio 1.90, 95% CI: 1.17-3.08, P < 0.01). Higher perceived self-efficacy' did not moderate these associations. Conclusions Insight into patients' specific barriers with regard to appropriate statin use may reveal personal reasons for being non-adherent. The Tailored Medicine Inventory is a promising tool to devise individualized intervention strategies aimed at improving adherence by the clinician-patient alliance.	[Wouters, Hans] Univ Groningen, Fac Math & Nat Sci, Groningen Res Inst Pharm, Dept Pharm,Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands; [Van Dijk, Liset] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Geers, Harm C. J.; Winters, Nina A.; Van Geffen, Erica C. G.; Bouvy, Marcel L.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Stiggelbout, Anne M.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands	University of Groningen; Netherlands Institute for Health Services Research; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wouters, H (corresponding author), Univ Groningen, Fac Math & Nat Sci, Groningen Res Inst Pharm, Dept Pharm,Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands.	h.wouters@rug.nl	Stiggelbout, Anne M/D-2293-2018; Bouvy, Marcel/M-4233-2016	Stiggelbout, Anne M/0000-0002-6293-4509; Bouvy, Marcel/0000-0002-4596-0684	Netherlands Organisation for Health Research and Development (ZonMw) [152002028]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Funding was provided by the Netherlands Organisation for Health Research and Development (ZonMw), http://www.zonmw.nl/en/, grant number 152002028. ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROD SUMM CHAR; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Brook OH, 2006, J CLIN PSYCHOPHARM, V26, P643, DOI 10.1097/01.jcp.0000246217.34024.53; Cameron KA, 2010, PATIENT EDUC COUNS, V80, P372, DOI 10.1016/j.pec.2010.06.029; Carpenter DM, 2010, PATIENT EDUC COUNS, V81, P169, DOI 10.1016/j.pec.2009.11.006; Casebeer L, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-48; Chlebowski RT, 2006, ONCOLOGY-BASEL, V71, P1, DOI 10.1159/000100444; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Demissie S, 2001, J CLIN ONCOL, V19, P322, DOI 10.1200/JCO.2001.19.2.322; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Fink AK, 2004, J CLIN ONCOL, V22, P3309, DOI 10.1200/JCO.2004.11.064; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Grunfeld EA, 2005, PATIENT EDUC COUNS, V59, P97, DOI 10.1016/j.pec.2004.10.005; Guth U, 2008, BRIT J CANCER, V99, P428, DOI 10.1038/sj.bjc.6604525; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Khanderia U, 2008, ANN PHARMACOTHER, V42, P192, DOI 10.1345/aph.1K497; Maddox TM, 2009, CURR OPIN CARDIOL, V24, P468, DOI 10.1097/HCO.0b013e32832ed62d; Mann DM, 2007, CARDIOVASC DRUG THER, V21, P311, DOI 10.1007/s10557-007-6040-4; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Silliman RA, 2002, J CLIN ONCOL, V20, P2680, DOI 10.1200/JCO.2002.08.137; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Uher R, 2009, BRIT J PSYCHIAT, V195, P202, DOI 10.1192/bjp.bp.108.061960; van Geffen ECG, 2010, ANN PHARMACOTHER, V44, P1104, DOI 10.1345/aph.1P052; Villeneuve J, 2010, CAN MED ASSOC J, V182, P447, DOI 10.1503/cmaj.090533; Wouters H, 2014, CLIN BREAST CANCER, V14, P460, DOI 10.1016/j.clbc.2014.04.005; Wouters H, 2014, PATIENT PREFER ADHER, V8, P179, DOI 10.2147/PPA.S53748; Wu JR, 2008, HEART LUNG, V37, P334, DOI 10.1016/j.hrtlng.2007.10.001; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	30	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146272	10.1371/journal.pone.0146272	http://dx.doi.org/10.1371/journal.pone.0146272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808151	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800019
J	Wu, Q; Ren, JA; Wang, GF; Li, GW; Gu, GS; Wu, XW; Li, Y; Chen, J; Zhao, YZ; Li, JS				Wu, Qin; Ren, Jianan; Wang, Gefei; Li, Guanwei; Gu, Guosheng; Wu, Xiuwen; Li, Yuan; Chen, Jun; Zhao, Yunzhao; Li, Jieshou			The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PLATELET TRANSFUSION; CARE; THERAPY; COUNTS	Background Studies on the incidence and risk factors of thrombocytopenia among intra-abdominal infection patients remain absent, hindering efficacy assessments regarding thrombocytopenia prevention strategies. Methods We retrospectively studied 267 consecutively enrolled patients with intra-abdominal infections. Occurrence of thrombocytopenia was scanned for all patients. All-cause 28-day mortality was recorded. Variables from univariate analyses that were associated with occurrence of hospital-acquired thrombocytopenia were included in a multivariable logistic regression analysis to determine thrombocytopenia predictors. Results Median APACHE II score and SOFA score of the whole cohort was 12 and 3 respectively. The overall ICU mortality was 7.87% and the 28-day mortality was 8.98%. The incidence of thrombocytopenia among intra-abdominal infection patients was 21.73%. Regardless of preexisting or hospital-acquired one, thrombocytopenia is associated with an increased ICU mortality and 28-day mortality as well as length of ICU or hospital stay. A higher SOFA and ISTH score at admission were significant hospital-acquired thrombocytopenia risk factors. Conclusions This is the first study to identify a high incidence of thrombocytopenia in patients with intraabdominal infections. Our findings suggest that the inflammatory milieu of intra-abdominal infections may uniquely predispose those patients to thrombocytopenia. More effective thrombocytopenia prevention strategies are necessary in intra-abdominal infection patients.	[Wu, Qin; Ren, Jianan; Wang, Gefei; Li, Guanwei; Gu, Guosheng; Wu, Xiuwen; Li, Yuan; Chen, Jun; Zhao, Yunzhao; Li, Jieshou] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ren, JA (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	JiananR@gmail.com	ZHAO, YUAN/HCI-5831-2022; Wu, Qin/AFJ-8752-2022; 吴, 秀文/AEO-0814-2022; zhao, YZ/GXH-6401-2022; Wu, Qin/AAF-5707-2022; Li, jie/GXG-4583-2022	Wu, Qin/0000-0002-7470-8429; Wu, Qin/0000-0002-7470-8429; Wu, Xiuwen/0000-0002-3813-3867	National Natural Science Foundation of China [81270478]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Science Foundation of China (81270478) received by JR. The funder had a role in data collection and analysis.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Alonso S, 2015, EJSO-EUR J SURG ONC, V41, P208, DOI 10.1016/j.ejso.2014.10.052; Chaari A, 2011, TRENDS ANAESTH CRIT, V1, P199, DOI 10.1016/j.tacc.2011.05.003; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; Friedrich AKU, 2014, J INTENSIVE CARE MED, V29, P247, DOI 10.1177/0885066613476465; IBERTI TJ, 1986, ANN SURG, V204, P341, DOI 10.1097/00000658-198610000-00001; Lieberman L, 2014, BLOOD, V123, P280, DOI [10.1182/ blood- 2013- 02- 435693, DOI 10.1182/BL00D-2013-02-435693]; Lieberman L, 2014, BLOOD, V123, P1146, DOI 10.1182/blood-2013-02-435693; Lim SY, 2012, J KOREAN MED SCI, V27, P1418, DOI 10.3346/jkms.2012.27.11.1418; Radia D, 2013, THROMBOCYTOPENIA MED, V41, P225, DOI [10.1016/j.mpmed.2013.01.017, DOI 10.1016/J.MPMED.2013.01.017]; Riccio LM, 2014, SURG INFECT, V15, P417, DOI 10.1089/sur.2012.077; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; Stanworth SJ, 2013, TRANSFUSION, V53, P1050, DOI 10.1111/j.1537-2995.2012.03866.x; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121; Williamson DR, 2013, CAN J ANESTH, V60, P641, DOI 10.1007/s12630-013-9933-7; Wu Q, 2017, CLIN APPL THROMB-HEM, V23, P84, DOI 10.1177/1076029615588785; Wu Q, 2014, J CRIT CARE, V29, P362, DOI 10.1016/j.jcrc.2013.11.023	18	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147482	10.1371/journal.pone.0147482	http://dx.doi.org/10.1371/journal.pone.0147482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808492	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800105
J	Xiao, CW; Wood, CM; Swist, E; Nagasaka, R; Sarafin, K; Gagnon, C; Fernandez, L; Faucher, S; Wu, HX; Kenney, L; Ratnayake, WMN				Xiao, Chao-Wu; Wood, Carla M.; Swist, Eleonora; Nagasaka, Reiko; Sarafin, Kurtis; Gagnon, Claude; Fernandez, Lois; Faucher, Sylvie; Wu, Hong-Xing; Kenney, Laura; Ratnayake, Walisundera M. N.			Cardio-Metabolic Disease Risks and Their Associations with Circulating 25-Hydroxyvitamin D and Omega-3 Levels in South Asian and White Canadians	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MULTILAYER FILM ELEMENTS; GROWTH-FACTOR 23; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; ADHESION MOLECULES; INSULIN-RESISTANCE; CARDIOMETABOLIC DISEASE; CLINICAL ANALYSIS; E-SELECTIN	Objectives This study compared cardio-metabolic disease risk factors and their associations with serum vitamin D and omega-3 status in South Asian (SAC) and White Canadians (WC) living in Canada's capital region. Methods Fasting blood samples were taken from 235 SAC and 279 WC aged 20 to 79 years in Ottawa, and 22 risk factors were measured. Results SAC men and women had significantly higher fasting glucose, insulin, homeostasis model assessment for insulin resistance (HOMA-IR), apolipoprotein B (ApoB), ratios of total (TC) to HDL cholesterol (HDLC) and ApoB to ApoA1, leptin, E-selectin, P-selectin, ICAM-1 and omega-3 (p < 0.05), but lower HDLC, ApoA1, vitamin D levels than WC (p < 0.05). SAC women had higher CRP and VEGF than WC women. Adequate (50-74.9 nmol/L) or optimal (>= 75 nmol/L) levels of 25(OH) D were associated with lower BMI, glucose, insulin, HOMA-IR, TG, TC, low density lipoprotein cholesterol (LDLC), ApoB/ApoA1 ratio, CRP, leptin, and higher HDLC, ApoA1, omega-3 index, L-selectin levels in WC, but not in SAC. Intermediate (>4%-<8%) or high (>= 8%) levels of omega-3 indices were related to lower E-selectin, P-selectin, ICAM-1 and higher HDLC, 25(OH) D levels in WC, but not in SAC. The BMIs of <= 25 kg/m(2) were related to lower LDLC, ApoB, VEGF, creatinine and higher 25(OH) D in WC, but not in SAC. Conclusions The associations of vitamin D, omega-3 status, BMI and risk factors were more profound in the WC than SAC. Compared to WC, vitamin D status and omega-3 index may not be good predictive risk factors for the prevalence of CVD and diabetes in SAC.	[Xiao, Chao-Wu; Wood, Carla M.; Swist, Eleonora; Nagasaka, Reiko; Sarafin, Kurtis; Gagnon, Claude; Fernandez, Lois; Kenney, Laura; Ratnayake, Walisundera M. N.] Hlth Canada, Bur Nutr Sci, Nutr Res Div, Ottawa, ON K1A 0L2, Canada; [Nagasaka, Reiko] Grad Sch Marine Sci & Technol, Dept Food Sci & Technol, Food Chem & Funct Nutr, Minato Ku, 5-7 Konan 4, Tokyo, Japan; [Faucher, Sylvie] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Xiao, Chao-Wu] Carleton Univ, Dept Chem, Food & Nutr Sci Program, Ottawa, ON K1S 5B6, Canada; [Wu, Hong-Xing] Hlth Canada, Bur Food Surveillance & Sci Integrat, Biostat & Modelling Div, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada; Carleton University; Health Canada	Xiao, CW (corresponding author), Hlth Canada, Bur Nutr Sci, Nutr Res Div, Ottawa, ON K1A 0L2, Canada.; Xiao, CW (corresponding author), Carleton Univ, Dept Chem, Food & Nutr Sci Program, Ottawa, ON K1S 5B6, Canada.	Chaowu.xiao@hc-sc.gc.ca	NAGASAKA, Reiko/O-1985-2014	NAGASAKA, Reiko/0000-0001-6157-9384	Health Canada	Health Canada	This study was funded by Health Canada.	Adamska A, 2014, ENDOCRINE, V45, P422, DOI 10.1007/s12020-013-0025-9; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Anand S S, 2000, Indian Heart J, V52, pS35; Bharmal N, 2015, J IMMIGR MINOR HEALT, V17, P781, DOI 10.1007/s10903-013-9973-7; Blann AD, 1998, BLOOD COAGUL FIBRIN, V9, P297, DOI 10.1097/00001721-199806000-00001; Celis-Morales CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082568; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Cotran RS, 1998, PATHOL BIOL, V46, P164; CURME HG, 1978, CLIN CHEM, V24, P1335; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; FAO, 2010, FATS FATT AC HUM NUT; Garcia-Bailo B, 2013, J AM COLL NUTR, V32, P296, DOI 10.1080/07315724.2013.826112; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gupta M, 2006, CAN J CARDIOL, V22, P193, DOI 10.1016/S0828-282X(06)70895-9; Gupta M, 2002, CAN MED ASSOC J, V166, P717; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Harris WS, 2007, PHARMACOL RES, V55, P217, DOI 10.1016/j.phrs.2007.01.013; Harris WS, 2008, CURR ATHEROSCLER REP, V10, P503, DOI 10.1007/s11883-008-0078-z; Harris WS, 2008, PROSTAG LEUKOTR ESS, V79, P169, DOI 10.1016/j.plefa.2008.09.005; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hillis GS, 1998, HEART, V79, P429, DOI 10.1136/hrt.79.5.429; Hoffman M, 2004, ATHEROSCLEROSIS, V172, P1, DOI 10.1016/S0021-9150(03)00164-3; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kraushaar LE, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-64; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lear SA, 2012, OBESITY, V20, P1293, DOI 10.1038/oby.2011.395; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pottala JV, 2012, LIPIDS, V47, P835, DOI 10.1007/s11745-012-3693-y; Raiten DJ, 2004, AM J CLIN NUTR, V80, p1673S, DOI 10.1093/ajcn/80.6.1673S; Rambihar VS, 2010, AM HEART J, V159, P1, DOI 10.1016/j.ahj.2009.10.020; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; RUDENSKI AS, 1991, METABOLISM, V40, P908, DOI 10.1016/0026-0495(91)90065-5; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sokup Alina, 2005, Przegl Lek, V62, P234; SPAYD RW, 1978, CLIN CHEM, V24, P1343; Statistics Canada, 2012, CENS 2012; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147648	10.1371/journal.pone.0147648	http://dx.doi.org/10.1371/journal.pone.0147648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809065	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800167
J	Belondrade, M; Nicot, S; Beringue, V; Coste, J; Lehmann, S; Bougard, D				Belondrade, Maxime; Nicot, Simon; Beringue, Vincent; Coste, Joliette; Lehmann, Sylvain; Bougard, Daisy			Rapid and Highly Sensitive Detection of Variant Creutzfeldt - Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; IN-VITRO GENERATION; SCRAPIE PRIONS; INFECTIVITY; INACTIVATION; STRAIN; CJD; VCJD; CONFORMATION; BIOASSAY	The prevalence of variant Creutzfeldt-Jakob disease (vCJD) in the population remains uncertain, although it has been estimated that 1 in 2000 people in the United Kingdom are positive for abnormal prion protein (PrPTSE) by a recent survey of archived appendix tissues. The prominent lymphotropism of vCJD prions raises the possibility that some surgical procedures may be at risk of iatrogenic vCJD transmission in healthcare facilities. It is therefore vital that decontamination procedures applied to medical devices before their reprocessing are thoroughly validated. A current limitation is the lack of a rapid model permissive to human prions. Here, we developed a prion detection assay based on protein misfolding cyclic amplification (PMCA) technology combined with stainless-steel wire surfaces as carriers of prions (Surf-PMCA). This assay allowed the specific detection of minute quantities (10(-8) brain dilution) of either human vCJD or ovine scrapie PrPTSE adsorbed onto a single steel wire, within a two week timeframe. Using Surf-PMCA we evaluated the performance of several reference and commercially available prion-specific decontamination procedures. Surprisingly, we found the efficiency of several marketed reagents to remove human vCJD PrPTSE was lower than expected. Overall, our results demonstrate that Surf-PMCA can be used as a rapid and ultrasensitive assay for the detection of human vCJD PrPTSE adsorbed onto a metallic surface, therefore facilitating the development and validation of decontamination procedures against human prions.	[Belondrade, Maxime; Nicot, Simon; Coste, Joliette; Bougard, Daisy] Etab Francais Sang Pyrenees Mediterranee, UMR 1058, Lab TransDiag, Montpellier, France; [Beringue, Vincent] INRA, UR892, Virol Immunol Mol, Jouy En Josas, France; [Lehmann, Sylvain] CHRU Montpellier, Montpellier, France; [Lehmann, Sylvain] Univ Montpellier, IRMB, Lab Biochim Proteom Clin, INSERM,U1183, F-34059 Montpellier, France	Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bougard, D (corresponding author), Etab Francais Sang Pyrenees Mediterranee, UMR 1058, Lab TransDiag, Montpellier, France.	daisy.bougard@efs.sante.fr	Lehmann, Sylvain/P-1301-2017	Lehmann, Sylvain/0000-0001-6117-562X; BOUGARD, Daisy/0000-0002-8779-9251	Alliance Biosecure Foundation; Agence Nationale de Securite du Medicament et des produits de sante ANSM	Alliance Biosecure Foundation; Agence Nationale de Securite du Medicament et des produits de sante ANSM(French National Research Agency (ANR))	This work was supported by grants from the Alliance Biosecure Foundation (http://www.fondation-alliance-biosecure.org) (Surf-PMCA project) to SL VB DB and the Agence Nationale de Securite du Medicament et des produits de sante ANSM (http://ansm.sante.fr) (Prion MD Secure project) to DB SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Boerner S, 2013, LAB ANIM-UK, V47, P106, DOI 10.1177/0023677213476856; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1997, NATURE, V386, P564, DOI 10.1038/386564b0; Diack AB, 2014, PRION, V8, P286, DOI 10.4161/pri.29237; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Fernie K, 2012, J HOSP INFECT, V80, P46, DOI 10.1016/j.jhin.2011.09.004; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Halliez S, 2014, J VIROL, V88, P8678, DOI 10.1128/JVI.01118-14; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Lehmann S, 2009, J HOSP INFECT, V72, P342, DOI 10.1016/j.jhin.2009.03.024; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Matsuura Y, 2013, BIOCHEM BIOPH RES CO, V432, P86, DOI 10.1016/j.bbrc.2013.01.081; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Segarra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069632; Shi S, 2009, VIRUS RES, V141, P26, DOI 10.1016/j.virusres.2008.12.010; Shikiya RA, 2014, PRION, V8, P415, DOI 10.4161/19336896.2014.983759; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Suyama K, 2007, BIOSCI BIOTECH BIOCH, V71, P2069, DOI 10.1271/bbb.70085; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yoshioka M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-134; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	52	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146833	10.1371/journal.pone.0146833	http://dx.doi.org/10.1371/journal.pone.0146833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800081	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300041
J	Miller, AL; Borgida, E				Miller, Andrea L.; Borgida, Eugene			The Separate Spheres Model of Gendered Inequality	PLOS ONE			English	Article							SYSTEM JUSTIFICATION; FLEXIBILITY STIGMA; STATUS INCONGRUITY; BENEVOLENT SEXISM; IDEOLOGY; WOMEN; BACKLASH; CONSEQUENCES; STEREOTYPES; WORKPLACE	Research on role congruity theory and descriptive and prescriptive stereotypes has established that when men and women violate gender stereotypes by crossing spheres, with women pursuing career success and men contributing to domestic labor, they face backlash and economic penalties. Less is known, however, about the types of individuals who are most likely to engage in these forms of discrimination and the types of situations in which this is most likely to occur. We propose that psychological research will benefit from supplementing existing research approaches with an individual differences model of support for separate spheres for men and women. This model allows psychologists to examine individual differences in support for separate spheres as they interact with situational and contextual forces. The separate spheres ideology (SSI) has existed as a cultural idea for many years but has not been operationalized or modeled in social psychology. The Separate Spheres Model presents the SSI as a new psychological construct characterized by individual differences and a motivated system -justifying function, operationalizes the ideology with a new scale measure, and models the ideology as a predictor of some important gendered outcomes in society. As a first step toward developing the Separate Spheres Model, we develop a new measure of individuals' endorsement of the SSI and demonstrate its reliability, convergent validity, and incremental predictive validity. We provide support for the novel hypotheses that the SSI predicts attitudes regarding workplace flexibility accommodations, income distribution within families between male and female partners, distribution of labor between work and family spheres, and discriminatory workplace behaviors. Finally, we provide experimental support for the hypothesis that the SSI is a motivated, system -justifying ideology.	[Miller, Andrea L.; Borgida, Eugene] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Miller, Andrea L.] Amer Bar Fdn, Chicago, IL 60611 USA	University of Minnesota System; University of Minnesota Twin Cities	Miller, AL (corresponding author), Amer Bar Fdn, Chicago, IL 60611 USA.	amiller@abfn.org	Miller, Andrea L./L-1414-2019	Miller, Andrea L./0000-0003-1701-8058	Graduate School Fellowship; Eva O. Miller Fellowship at the University of Minnesota; Society for the Psychological Study of Social Issues; Center for the Study of Political Psychology at the University of Minnesota; College of Liberal Arts Research and Travel Award; University of Minnesota Department of Psychology	Graduate School Fellowship; Eva O. Miller Fellowship at the University of Minnesota; Society for the Psychological Study of Social Issues; Center for the Study of Political Psychology at the University of Minnesota; College of Liberal Arts Research and Travel Award; University of Minnesota Department of Psychology	This research was conducted while Andrea Miller was supported by the Graduate School Fellowship and the Eva O. Miller Fellowship at the University of Minnesota. The research was also supported by a Grant-in-aid from the Society for the Psychological Study of Social Issues (www.spssi.org) (ALM), a grant from the Center for the Study of Political Psychology at the University of Minnesota (www.polisci.umn.edu/politicalpsych/center.html) (ALM), a College of Liberal Arts Research and Travel Award (ALM), and funds from the University of Minnesota Department of Psychology (psych.umn.edu) (ALM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JL, 2013, J SOC ISSUES, V69, P341, DOI 10.1111/josi.12018; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Biernat M, 2010, PERS SOC PSYCHOL B, V36, P855, DOI 10.1177/0146167210369483; Bowles HR, 2007, ORGAN BEHAV HUM DEC, V103, P84, DOI 10.1016/j.obhdp.2006.09.001; Brescoll V, 2004, PSYCHOL SCI, V15, P515, DOI 10.1111/j.0956-7976.2004.00712.x; Brescoll VL, 2013, J PERS SOC PSYCHOL, V105, P891, DOI 10.1037/a0034701; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Coltrane S, 2013, J SOC ISSUES, V69, P279, DOI 10.1111/josi.12015; Coontz Stephanie, 2011, STRANGE STIRRING FEM; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; CROSBY F, 1991, JUGGLING UNEXPECTED; Cuddy AJC, 2004, J SOC ISSUES, V60, P701, DOI 10.1111/j.0022-4537.2004.00381.x; Davis SN, 2009, ANNU REV SOCIOL, V35, P87, DOI 10.1146/annurev-soc-070308-115920; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; EPSTEIN S, 1979, J PERS SOC PSYCHOL, V37, P1097, DOI 10.1037/0022-3514.37.7.1097; Feygina I, 2010, PERS SOC PSYCHOL B, V36, P326, DOI 10.1177/0146167209351435; Fuegen K, 2004, J SOC ISSUES, V60, P737, DOI 10.1111/j.0022-4537.2004.00383.x; Furr M., 2011, SCALE CONSTRUCTION P; Gerson Kathleen, 2010, UNFINISHED REVOLUTIO; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Glick P, 2001, AM PSYCHOL, V56, P109, DOI 10.1037//0003-066X.56.2.109; Greenstein TN, 1996, J MARRIAGE FAM, V58, P585, DOI 10.2307/353719; Heilman ME, 2008, J APPL PSYCHOL, V93, P189, DOI 10.1037/0021-9010.93.1.189; Heilman ME, 2004, J APPL PSYCHOL, V89, P416, DOI 10.1037/0021-9010.89.3.416; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hochschild A. R., 1989, 2 SHIFT WORKING PARE; Jost J, 2011, PSYCHOL JUSTICE LEGI, V11, P173; Jost JT, 2012, PERS SOC PSYCHOL B, V38, P197, DOI 10.1177/0146167211422544; Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kay AC, 2005, PSYCHOL SCI, V16, P240, DOI 10.1111/j.0956-7976.2005.00810.x; Kroska A, 2000, GENDER SOC, V14, P368, DOI 10.1177/089124300014003002; Kroska A, 2009, SEX ROLES, V60, P313, DOI 10.1007/s11199-008-9552-x; Kuperberg A, 2008, GENDER SOC, V22, P497, DOI 10.1177/0891243208319767; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MARTIN CL, 1995, PERS SOC PSYCHOL B, V21, P45, DOI 10.1177/0146167295211006; Miller A, 2015, W MITCHELL LAW REV, V41, P1032; Miller AL, 2014, MINN LAW REV, V99, P343; Minnotte KL, 2010, SEX ROLES, V63, P425, DOI 10.1007/s11199-010-9818-y; Moss-Racusin CA, 2010, PSYCHOL MEN MASCULIN, V11, P140, DOI 10.1037/a0018093; North A, 2013, BUZZFEED        0318; Paulhus DL, 2004, MULTIVAR BEHAV RES, V39, P303, DOI 10.1207/s15327906mbr3902_7; Pedulla DS, 2015, AM SOCIOL REV, V80, P116, DOI 10.1177/0003122414564008; Phelan JE, 2008, PSYCHOL WOMEN QUART, V32, P406, DOI 10.1111/j.1471-6402.2008.00454.x; Prentice DA, 2006, PSYCHOL SCI, V17, P129, DOI 10.1111/j.1467-9280.2006.01675.x; Rudman LA, 2001, J SOC ISSUES, V57, P743, DOI 10.1111/0022-4537.00239; Rudman LA, 2013, J SOC ISSUES, V69, P322, DOI 10.1111/josi.12017; Rudman LA, 2012, J EXP SOC PSYCHOL, V48, P165, DOI 10.1016/j.jesp.2011.10.008; Saad L, 2012, STAY AT HOME MOMS US; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SPENCE JT, 1973, B PSYCHONOMIC SOC, V2, P219; Stone P, 2013, J SOC ISSUES, V69, P235, DOI 10.1111/josi.12013; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Twenge JM, 1997, PSYCHOL WOMEN QUART, V21, P35, DOI 10.1111/j.1471-6402.1997.tb00099.x; Vandello JA, 2013, J SOC ISSUES, V69, P303, DOI 10.1111/josi.12016; Wakslak CJ, 2007, PSYCHOL SCI, V18, P267, DOI 10.1111/j.1467-9280.2007.01887.x; Wakslak CJ, 2011, SOC COGNITION, V29, P288, DOI 10.1521/soco.2011.29.3.288; Williams J.C., 2006, CTR WORKLIFE LAW; Williams JC, 2013, J SOC ISSUES, V69, P209, DOI 10.1111/josi.12012; Williams JC, 2008, HASTINGS LAW J, V59, P1311	61	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147315	10.1371/journal.pone.0147315	http://dx.doi.org/10.1371/journal.pone.0147315			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800454	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300093
J	Li, FR; Gao, B; Xu, W; Chen, L; Xiong, SD				Li, Furong; Gao, Bo; Xu, Wei; Chen, Ling; Xiong, Sidong			The Defect in Autophagy Induction by Clinical Isolates of Mycobacterium Tuberculosis Is Correlated with Poor Tuberculosis Outcomes	PLOS ONE			English	Article							GENETIC DIVERSITY; MACROPHAGES; SURVIVAL; DEFENSE; CELLS; FLUX	Background Tuberculosis (TB) represents a major global health problem. The prognosis of clinically active tuberculosis depends on the complex interactions between Mycobacterium tuberculosis (Mtb) and its host. In recent years, autophagy receives particular attention for its role in host defense against intracellular pathogens, including Mtb. In present study, we aim to investigate the relationship of autophagy induction by clinical isolates of Mtb with the clinical outcomes in patients with TB. Methodology/Principal Findings We collected 185 clinical isolates of Mtb, and determined the effect of these Mtb isolates on autophagy induction in macrophages. It was found that most of clinical isolates of Mtb were able to induce autophagosome formation in macrophages, however, the autophagy-inducing ability varied significantly among different isolates. Of importance, our results revealed that patients infected by Mtb with poor autophagy-inducing ability displayed more severe radiographic extent of disease (p<0.001), and were more likely to have unfavorable treatment outcomes (p<0.001). No significant association was observed between the extent of Mtb-induced autophagy with some socio-demographic characteristics (such as gender, age and tobacco consumption), and some laboratory tests (such as hemoglobin, leukocyte count and erythrocyte sedimentation rate). Furthermore, results from logistic regression analysis demonstrated that the defect in autophagy induction by clinical isolates of Mtb was an independent risk factor for far-advanced radiographic disease (aOR 4.710 [1.93-11.50]) and unfavorable treatment outcomes (aOR 8.309 [2.22-28.97]) in TB. Conclusion/Significance These data indicated that the defect in autophagy induction by Mtb isolates increased the risk of poor clinical outcomes in TB patients, and detection of clinical isolates-induced autophagosome formation might help evaluate the TB outcomes.	[Li, Furong; Gao, Bo; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China; [Chen, Ling] Zunyi Med Coll, Affiliated Hosp, Dept Resp Med, Zunyi 563000, Peoples R China	Fudan University; Soochow University - China; Soochow University - China; Zunyi Medical University	Gao, B; Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Med Sci, Suzhou 215006, Peoples R China.	gaobo@fudan.edu.cn; sdxiongfd@126.com			National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China [2013ZX10003007]; Major State Basic Research Development Program of China [2013CB530501, 2013CB531502]; National Natural Science Foundation of China [31470839, 81072428]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [PCSIRT-IRT1075]	National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China; Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Innovative Research Team; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China	This work was supported by grants from the National Science & Technology Key Projects during the Twelfth Five-Year Plan Period of China (2013ZX10003007), Major State Basic Research Development Program of China (2013CB530501, 2013CB531502), the National Natural Science Foundation of China (31470839, 81072428), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Provincial Innovative Research Team, and the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (PCSIRT-IRT1075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento CF, 2015, DNA CELL BIOL, V34, P228, DOI 10.1089/dna.2014.2745; Bruns H, 2014, FUTURE MICROBIOL, V9, P327, DOI 10.2217/fmb.13.164; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Chen L, 2012, J CLIN MICROBIOL, V50, P1043, DOI 10.1128/JCM.06095-11; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; FALK AJ, 1969, CLASSIFICATION PULMO; Gao B, 2013, J IMMUNOL, V191, P464, DOI 10.4049/jimmunol.1203533; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harding CV, 2003, CURR OPIN IMMUNOL, V15, P112, DOI 10.1016/S0952-7915(02)00008-0; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Krishnan N, 2013, TUBERCULOSIS, V93, P538, DOI 10.1016/j.tube.2013.05.002; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Romero Melissa R., 2012, Journal of Marine Biology, P1; Rubin EJ, 2014, NEW ENGL J MED, V370, P375, DOI 10.1056/NEJMe1312301; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Songane M, 2012, TUBERCULOSIS, V92, P388, DOI 10.1016/j.tube.2012.05.004; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P4267, DOI 10.1128/JCM.01467-14; Vrba-Pech A, 2014, TUBERCULOSIS, V94, P383, DOI 10.1016/j.tube.2014.04.003; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; WHO, 2014, GLOB TUB REP 2014; WHO, 2009, TREATM TUB GUID NAT; World Health Organisation, 2015, GUID MAN LAT TUB INF; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	31	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147810	10.1371/journal.pone.0147810	http://dx.doi.org/10.1371/journal.pone.0147810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815035	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200054
J	Tan, XY; Xu, XB; Zeisberg, M; Zeisberg, EM				Tan, Xiaoying; Xu, Xingbo; Zeisberg, Michael; Zeisberg, Elisabeth M.			DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIAC FIBROSIS; KLOTHO GENE; CELLS; TARGET; SNAIL; PROGRESSION; ACTIVATION; PHOSPHORUS; PRESSURE	While phosphorus in the form of inorganic or organic phosphate is critically involved in most cellular functions, high plasma levels of inorganic phosphate levels have emerged as independent risk factor for cardiac fibrosis, cardiovascular morbidity and decreased life-expectancy. While the link of high phosphate and cardiovascular disease is commonly explained by direct cellular effects of phospho-regulatory hormones, we here explored the possibility of inorganic phosphate directly eliciting biological responses in cells. We demonstrate that human coronary endothelial cells (HCAEC) undergo an endothelial-mesenchymal transition (EndMT) when exposed to high phosphate. We further demonstrate that such EndMT is initiated by recruitment of aberrantly phosphorylated DNMT1 to the RASAL1 CpG island promoter by HDAC2, causing aberrant promoter methylation and transcriptional suppression, ultimately leading to increased Ras-GTP activity and activation of common EndMT regulators Twist and Snail. Our studies provide a novel aspect for known adverse effects of high phosphate levels, as eukaryotic cells are commonly believed to have lost phosphate-sensing mechanisms of prokaryotes during evolution, rendering them insensitive to extracellular inorganic orthophosphate. In addition, our studies provide novel insights into the mechanisms underlying specific targeting of select genes in context of fibrogenesis.	[Tan, Xiaoying; Xu, Xingbo; Zeisberg, Elisabeth M.] Univ Gottingen, Gottingen Univ Med Ctr, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Tan, Xiaoying; Zeisberg, Michael] Univ Gottingen, Gottingen Univ Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany; [Zeisberg, Michael; Zeisberg, Elisabeth M.] German Ctr Cardiovasc Res DZHK, Gottingen, Germany	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research	Zeisberg, EM (corresponding author), Univ Gottingen, Gottingen Univ Med Ctr, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany.; Zeisberg, EM (corresponding author), German Ctr Cardiovasc Res DZHK, Gottingen, Germany.	elisabeth.zeisberg@med.uni-goettingen.de	Zeisberg, Elisabeth/ABG-4970-2021	Xu, Xingbo/0000-0002-8249-5507	DFG [SFB1002/C01, ZE523/4-1]; University of Gottingen Medical Center (UMG); "seed funding research program" of the Faculty of Medicine; Georg August University Gottingen	DFG(German Research Foundation (DFG)); University of Gottingen Medical Center (UMG); "seed funding research program" of the Faculty of Medicine; Georg August University Gottingen	This work was supported by DFG grants SFB1002/C01 (to EZ) and ZE523/4-1 (to MZ) and funds from the University of Gottingen Medical Center (UMG) to EZ and MZ. XX was supported by the "seed funding research program" of the Faculty of Medicine, Georg August University Gottingen.	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Charytan DM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0029-6; Charytan DM, 2014, INT J CARDIOL, V176, P99, DOI 10.1016/j.ijcard.2014.06.062; Chavkin NW, 2015, EXP CELL RES, V333, P39, DOI 10.1016/j.yexcr.2015.02.002; Chen PY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005504; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ghosh AK, 2012, CELL SIGNAL, V24, P1031, DOI 10.1016/j.cellsig.2011.12.024; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Kuro-O M, 2011, KIDNEY INT S, V3, P420, DOI DOI 10.1038/KISUP.2013.88; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavoie G, 2011, BIOCHEM BIOPH RES CO, V409, P187, DOI 10.1016/j.bbrc.2011.04.115; Lee SW, 2013, MOL THER, V21, P1767, DOI 10.1038/mt.2013.146; Liu Y, 2015, BBA-MOL BASIS DIS, V1852, P2456, DOI 10.1016/j.bbadis.2015.08.013; Ma KL, 2013, INT J MED SCI, V10, P420, DOI 10.7150/ijms.5723; Maeshima Y, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-13; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saito S, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0024-y; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shobeiri N, 2014, BRIT J CLIN PHARMACO, V77, P39, DOI 10.1111/bcp.12117; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Tampe B, 2015, EBIOMEDICINE, V2, P19, DOI 10.1016/j.ebiom.2014.11.005; Tang RN, 2013, INT J CARDIOL, V162, P92, DOI 10.1016/j.ijcard.2011.06.052; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Xu XB, 2015, CIRC RES, V116, P857, DOI 10.1161/CIRCRESAHA.116.305629; Xu XB, 2015, CARDIOVASC RES, V105, P279, DOI 10.1093/cvr/cvv015; Yu HY, 2009, ACTA DERM-VENEREOL, V89, P351, DOI 10.2340/00015555-0634; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeng LF, 2013, J BIOL CHEM, V288, P31853, DOI 10.1074/jbc.M113.463745	44	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147816	10.1371/journal.pone.0147816	http://dx.doi.org/10.1371/journal.pone.0147816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815200	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200055
J	Zhao, PS; Zhang, JW; Zhao, X; Chen, GX; Ma, XF				Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei			Different Sets of Post-Embryonic Development Genes Are Conserved or Lost in Two Caryophyllales Species (Reaumuria soongorica and Agriophyllum squarrosum)	PLOS ONE			English	Article							DESICCATION TOLERANCE; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; MOLECULAR EVOLUTION; LEAFY PETIOLE; RESPONSES; STRESS; DEHYDRATION; GENOME; IDENTIFICATION	Reaumuria soongorica and sand rice (Agriophyllum squarrosum) belong to the clade of Caryophyllales and are widely distributed in the desert regions of north China. Both plants have evolved many specific traits and adaptation strategies to cope with recurring environmental threats. However, the genetic basis that underpins their unique traits and adaptation remains unknown. In this study, the transcriptome data of R. soongorica and sand rice were compared with three other species with previously sequenced genomes (Arabidopsis thaliana, Oryza sativa, and Beta vulgaris). Four different gene sets were identified, namely, the genes conserved in both species, those lost in both species, those conserved in R. soongorica only, and those conserved in sand rice only. Gene ontology showed that post-embryonic development genes (PEDGs) were enriched in all gene sets, and different sets of PEDGs were conserved or lost in both the R. soongorica and sand rice genomes. Expression profiles of Arabidopsis orthologs further provided some clues to the function of the species-specific conserved PEDGs. Such orthologs included LEAFY PETIOLE, which could be a candidate gene involved in the development of branch priority in sand rice.	[Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China; [Zhao, Pengshan; Zhang, Jiwei; Zhao, Xin; Chen, Guoxiong; Ma, Xiao-Fei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Zhao, PS (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Lanzhou, Gansu, Peoples R China.; Zhao, PS (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China.	zhaopengshan@lzb.ac.cn	Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065; zhang, ji wei/0000-0001-7402-4089	National Basic Research Program of China [2013CB429904]; National Natural Science Foundation of China [41201048]; Innovation Research Group Fund of Gansu Province, China [1308RJIA002]; "One Hundred Talents" Project of the Chinese Academy of Sciences [29Y127E71]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Research Group Fund of Gansu Province, China; "One Hundred Talents" Project of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program, 2013CB429904), by National Natural Science Foundation of China (No. 41201048), by Innovation Research Group Fund (1308RJIA002) of Gansu Province, China, and by Grant 29Y127E71 from the "One Hundred Talents" Project of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Carretero-Paulet L, 2015, GENOME BIOL EVOL, V7, P444, DOI 10.1093/gbe/evu288; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Chen GX, 2014, GENET RESOUR CROP EV, V61, P669, DOI 10.1007/s10722-014-0083-8; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Dinakar C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00482; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gaff DF, 2013, FUNCT PLANT BIOL, V40, P315, DOI 10.1071/FP12321; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Golicz AA, 2015, J EXP BOT, V66, P1489, DOI 10.1093/jxb/eru510; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Harmon F, 2008, PLANT J, V55, P568, DOI 10.1111/j.1365-313X.2008.03527.x; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Liu YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094277; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maia J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029123; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; Oliver MJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-89; Parent JS, 2015, PLANT J, V81, P223, DOI 10.1111/tpj.12720; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vigeland MD, 2013, NEW PHYTOL, V199, P1060, DOI 10.1111/nph.12337; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Xiao LH, 2015, P NATL ACAD SCI USA, V112, P5833, DOI 10.1073/pnas.1505811112; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang Y, 2015, MOL BIOL EVOL, V32, P2001, DOI 10.1093/molbev/msv081; Yin HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep15823; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhao PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-872; Zhao Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0345-x	46	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148034	10.1371/journal.pone.0148034	http://dx.doi.org/10.1371/journal.pone.0148034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815143	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200068
J	Getino, M; Fernandez-Lopez, R; Palencia-Gandara, C; Campos-Gomez, J; Sanchez-Lopez, JM; Martinez, M; Fernandez, A; de la Cruz, F				Getino, Maria; Fernandez-Lopez, Raul; Palencia-Gandara, Carolina; Campos-Gomez, Javier; Sanchez-Lopez, Jose M.; Martinez, Marta; Fernandez, Antonio; de la Cruz, Fernando			Tanzawaic Acids, a Chemically Novel Set of Bacterial Conjugation Inhibitors	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; 2-ALKYNOIC FATTY-ACIDS; TUMOR-CELL-LINE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; PENICILLIUM-CITRINUM; PLASMIDS; GROWTH; RELAXASE; SURVIVAL	Bacterial conjugation is the main mechanism for the dissemination of multiple antibiotic resistance in human pathogens. This dissemination could be controlled by molecules that interfere with the conjugation process. A search for conjugation inhibitors among a collection of 1,632 natural compounds, identified tanzawaic acids A and B as best hits. They specially inhibited IncW and IncFII conjugative systems, including plasmids mobilized by them. Plasmids belonging to IncFI, IncI, IncL/M, IncX and IncH incompatibility groups were targeted to a lesser extent, whereas IncN and IncP plasmids were unaffected. Tanzawaic acids showed reduced toxicity in bacterial, fungal or human cells, when compared to synthetic conjugation inhibitors, opening the possibility of their deployment in complex environments, including natural settings relevant for antibiotic resistance dissemination.	[Getino, Maria; Fernandez-Lopez, Raul; Palencia-Gandara, Carolina; Campos-Gomez, Javier; de la Cruz, Fernando] Univ Cantabria Consejo Super Invest Cient, Inst Biomed & Biotecnol Cantabria, Santander, Cantabria, Spain; [Sanchez-Lopez, Jose M.; Martinez, Marta; Fernandez, Antonio] Biomar Microbial Technol, Leon, Spain; [Campos-Gomez, Javier] So Res Inst, Drug Discovery Div, Dept Mol Biol & Biochem, Birmingham, AL 35255 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	de la Cruz, F (corresponding author), Univ Cantabria Consejo Super Invest Cient, Inst Biomed & Biotecnol Cantabria, Santander, Cantabria, Spain.	delacruz@unican.es	Palencia-Gándara, Carolina/AAT-9910-2021; de la Cruz, Fernando/L-2812-2014; Fernandez-Lopez, Raul/AAB-5928-2019; Getino, Maria/L-8541-2019	de la Cruz, Fernando/0000-0003-4758-6857; Fernandez-Lopez, Raul/0000-0002-9624-9059; Getino, Maria/0000-0002-2937-3420; Palencia-Gandara, Carolina/0000-0002-1421-8698; Campos-Gomez, Javier/0000-0002-2693-0885	Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-1-P]; European Seventh Framework Programme [612146/FP7-ICT-2013-10, 282004/FP7-HEALTH-2011-2.3.1-2, 282004/FP7-HEALTH-2011-2.3.12]; University of Cantabria; European Molecular Biology Organization [402-2010]; Biomar Microbial Technologies	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Seventh Framework Programme(European Commission); University of Cantabria; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Biomar Microbial Technologies	Work in the FDLC group was supported by grants BFU2014-55534-C2-1-P from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es) and 612146/FP7-ICT-2013-10 and 282004/FP7-HEALTH-2011-2.3.1-2 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). MG was supported by a PhD fellowship from the University of Cantabria (http://www.unican.es). JCG was supported by a postdoctoral fellowship ASTF 402-2010 from the European Molecular Biology Organization (http://www.embo.org). Biomar Microbial Technologies was supported by grant 282004/FP7-HEALTH-2011-2.3.12 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). Biomar Microbial Technologies provided support in the form of salaries for authors JMSL, MM, and AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carballeira NM, 2006, LIPIDS, V41, P507, DOI 10.1007/s11745-006-5124-4; Carballeira NM, 2012, BIOORG MED CHEM LETT, V22, P6185, DOI 10.1016/j.bmcl.2012.08.019; Cardoso-Martinez F, 2015, ORG BIOMOL CHEM, V13, P7248, DOI 10.1039/c5ob00773a; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Di Vaio C, 2013, J SCI FOOD AGR, V93, P1134, DOI 10.1002/jsfa.5863; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Fernandez-Lopez R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004171; Garcillan-Barcia MP, 2007, MOL MICROBIOL, V63, P404, DOI 10.1111/j.1365-2958.2006.05523.x; GERSHON H, 1978, CAN J MICROBIOL, V24, P593, DOI 10.1139/m78-096; Getino M, 2015, MBIO, V6, DOI 10.1128/mBio.01032-15; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUSSONI M, 1994, MAGN RESON IMAGING, V12, P477, DOI 10.1016/0730-725X(94)92542-9; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; KONTHIKAMEE W, 1982, ANTIMICROB AGENTS CH, V22, P805, DOI 10.1128/AAC.22.5.805; Kuramoto M, 1997, CHEM LETT, P885, DOI 10.1246/cl.1997.885; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019991; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; Malmstrom J, 2000, PHYTOCHEMISTRY, V54, P301, DOI 10.1016/S0031-9422(00)00106-0; MILLER JH, 1970, J BACTERIOL, V104, P1273, DOI 10.1128/JB.104.3.1273-1279.1970; Morbidoni HR, 2006, CHEM BIOL, V13, P297, DOI 10.1016/j.chembiol.2006.01.005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nash RP, 2012, BIOCHEM BIOPH RES CO, V424, P697, DOI 10.1016/j.bbrc.2012.07.012; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; RESKEKUNZ AB, 1984, SCAND J IMMUNOL, V20, P97, DOI 10.1111/j.1365-3083.1984.tb00982.x; Sanabria-Rios DJ, 2014, CHEM PHYS LIPIDS, V178, P84, DOI 10.1016/j.chemphyslip.2013.12.006; Sandjo LP, 2014, BEILSTEIN J ORG CHEM, V10, P251, DOI 10.3762/bjoc.10.20; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tasdemir D, 2010, BIOORGAN MED CHEM, V18, P7475, DOI 10.1016/j.bmc.2010.08.055; Taylor DE, 2004, PLASMID BIOLOGY, P473; TAYLOR DE, 1980, J GEN MICROBIOL, V116, P475; Quang TH, 2014, BIOORG MED CHEM LETT, V24, P5787, DOI 10.1016/j.bmcl.2014.10.035; Verovski VN, 1996, BRIT J CANCER, V73, P596, DOI 10.1038/bjc.1996.103; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	43	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148098	10.1371/journal.pone.0148098	http://dx.doi.org/10.1371/journal.pone.0148098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812051	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000075
J	Leone, L; Mazzetta, F; Martinelli, D; Valente, S; Alimandi, M; Raffa, S; Santino, I				Leone, Laura; Mazzetta, Francesca; Martinelli, Daniela; Valente, Sabatino; Alimandi, Maurizio; Raffa, Salvatore; Santino, Iolanda			Klebsiella pneumoniae Is Able to Trigger Epithelial-Mesenchymal Transition Process in Cultured Airway Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; INDUCTION; INFECTION; HYPOXIA; RESVERATROL; ACTIVATION; DEATH; EMT	The ability of some bacterial pathogens to activate Epithelial-Mesenchymal Transition normally is a consequence of the persistence of a local chronic inflammatory response or depends on a direct interaction of the pathogens with the host epithelial cells. In this study we monitored the abilities of the K. pneumoniae to activate the expression of genes related to EMT-like processes and the occurrence of phenotypic changes in airway epithelial cells during the early steps of cell infection. We describe changes in the production of intracellular reactive oxygen species and increased HIF-1 alpha mRNA expression in cells exposed to K. pneumoniae infection. We also describe the upregulation of a set of transcription factors implicated in the EMT processes, such as Twist, Snail and ZEB, indicating that the morphological changes of epithelial cells already appreciable after few hours from the K. pneumoniae infection are tightly regulated by the activation of transcriptional pathways, driving epithelial cells to EMT. These effects appear to be effectively counteracted by resveratrol, an antioxidant that is able to exert a sustained scavenging of the intracellular ROS. This is the first report indicating that strains of K. pneumoniae may promote EMT-like programs through direct interaction with epithelial cells without the involvement of inflammatory cells.	[Leone, Laura; Mazzetta, Francesca; Valente, Sabatino; Alimandi, Maurizio; Raffa, Salvatore; Santino, Iolanda] Univ Roma La Sapienza, Dept Clin & Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Martinelli, Daniela; Santino, Iolanda] Azienda Osped St Andrea, Microbiol Unit, Rome, Italy; [Raffa, Salvatore] Azienda Osped St Andrea, Cellular Diagnost Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Santino, I (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Santino, I (corresponding author), Azienda Osped St Andrea, Microbiol Unit, Rome, Italy.	iolanda.santino@uniroma1.it	Raffa, Salvatore/GPX-5723-2022; Raffa, Salvatore/AAW-7060-2020; Alimandi, Maurizio/AAG-9246-2019; RAFFA, SALVATORE/AAL-5514-2020; Mazzetta, Francesca/AAU-7981-2020; Valente, Sabatino/D-9213-2017	Raffa, Salvatore/0000-0001-9501-7638; Alimandi, Maurizio/0000-0002-1409-6803; Valente, Sabatino/0000-0002-9614-3270				Barbara M, 2012, OTOL NEUROTOL, V33, P988, DOI 10.1097/MAO.0b013e318259b8a0; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Borthwick LA, 2011, EUR RESPIR J, V37, P1237, DOI 10.1183/09031936.00088410; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; Cane G, 2010, CELL MICROBIOL, V12, P640, DOI 10.1111/j.1462-5822.2009.01422.x; Cano V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-156; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Hofman P, 2012, GUT MICROBES, V3, P176, DOI 10.4161/gmic.20288; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kondo Y, 2012, AM J PHYSIOL-LUNG C, V303, pL1057, DOI 10.1152/ajplung.00096.2012; Kovacs D, 2009, J DERMATOL SCI, V54, P106, DOI 10.1016/j.jdermsci.2009.01.005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Leone L, 2015, FUTURE MICROBIOL, V10, P743, DOI [10.2217/fmb.14.145, 10.2217/FMB.14.145]; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Markogiannakis A, 2013, FUTURE MICROBIOL, V8, P1147, DOI 10.2217/fmb.13.71; Martinez J, 2000, BIOCHEM PHARMACOL, V59, P865, DOI 10.1016/S0006-2952(99)00380-9; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Passariello C, 2011, INT J MED MICROBIOL, V301, P97, DOI 10.1016/j.ijmm.2010.06.008; Pilpilidis I, 2011, J SURG RES, V166, P255, DOI 10.1016/j.jss.2010.02.012; Ranieri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057659; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Santino I, 2013, INT J IMMUNOPATH PH, V26, P785, DOI 10.1177/039463201302600325; Strickertsson JAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063147; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wright MS, 2015, ANTIMICROB AGENTS CH, V59, P536, DOI 10.1128/AAC.04037-14; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	39	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146365	10.1371/journal.pone.0146365	http://dx.doi.org/10.1371/journal.pone.0146365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812644	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000008
J	Radman, I; Wessner, B; Bachl, N; Ruzic, L; Hackl, M; Baca, A; Markovic, G				Radman, Ivan; Wessner, Barbara; Bachl, Norbert; Ruzic, Lana; Hackl, Markus; Baca, Arnold; Markovic, Goran			Reliability and Discriminative Ability of a New Method for Soccer Kicking Evaluation	PLOS ONE			English	Article							ACCURACY; TESTS; PERFORMANCE; VALIDITY	The study aimed to evaluate the test-retest reliability of a newly developed 356 Soccer Shooting Test (356-SST), and the discriminative ability of this test with respect to the soccer players' proficiency level and leg dominance. Sixty-six male soccer players, divided into three groups based on their proficiency level (amateur, n = 24; novice semi-professional, n = 18; and experienced semi-professional players, n = 24), performed 10 kicks following a two-step run up. Forty-eight of them repeated the test on a separate day. The following shooting variables were derived: ball velocity (BV; measured via radar gun), shooting accuracy (SA; average distance from the ball-entry point to the goal centre), and shooting quality (SQ; shooting accuracy divided by the time elapsed from hitting the ball to the point of entry). No systematic bias was evident in the selected shooting variables (SA: 1.98 +/- 0.65 vs. 2.00 +/- 0.63 m; BV: 24.6 +/- 2.3 vs. 24.5 +/- 1.9 m s(-1); SQ: 2.92 +/- 1.0 vs. 2.93 +/- 1.0 m s(-1); all p>0.05). The intra-class correlation coefficients were high (ICC = 0.70-0.88), and the coefficients of variation were low (CV = 5.3-5.4%). Finally, all three 356-SST variables identify, with adequate sensitivity, differences in soccer shooting ability with respect to the players' proficiency and leg dominance. The results suggest that the 356-SST is a reliable and sensitive test of specific shooting ability in men's soccer. Future studies should test the validity of these findings in a fatigued state, as well as in other populations.	[Radman, Ivan; Wessner, Barbara; Bachl, Norbert] Univ Vienna, Inst Sport Sci, Dept Exercise Physiol, Vienna, Austria; [Bachl, Norbert; Hackl, Markus] Austrian Inst Sports Med, Vienna, Austria; [Ruzic, Lana] Univ Zagreb, Sch Kinesiol, Dept Exercise Physiol, Zagreb 41000, Croatia; [Baca, Arnold] Univ Vienna, Inst Sport Sci, Dept Biomech, Vienna, Austria; [Markovic, Goran] Univ Zagreb, Sch Kinesiol, Motor Control & Human Performance Lab, Zagreb 41000, Croatia	University of Vienna; University of Zagreb; University of Zagreb, Faculty of Kinesiology; University of Vienna; University of Zagreb; University of Zagreb, Faculty of Kinesiology	Radman, I (corresponding author), Univ Vienna, Inst Sport Sci, Dept Exercise Physiol, Vienna, Austria.; Markovic, G (corresponding author), Univ Zagreb, Sch Kinesiol, Motor Control & Human Performance Lab, Zagreb 41000, Croatia.	i.radmann@gmail.com; gmarkov@kif.hr	Wessner, Barbara/J-8244-2012; Radman, Ivan/P-8130-2019; Radman, Ivan/J-6914-2016	Wessner, Barbara/0000-0002-9061-7914; Radman, Ivan/0000-0002-5358-3591; Radman, Ivan/0000-0002-5358-3591; Ruzic, Lana/0000-0001-7017-0089	OeAD - Austrian Agency for International Cooperation in Education & Research - Austrian Federal Ministry of Science and Research [ICM-2011-00143]; Austrian Institute of Sports Medicine; Open Access Publishing Fund of the University of Vienna	OeAD - Austrian Agency for International Cooperation in Education & Research - Austrian Federal Ministry of Science and Research; Austrian Institute of Sports Medicine; Open Access Publishing Fund of the University of Vienna	This work was supported by The OeAD - Austrian Agency for International Cooperation in Education & Research, financed by the Austrian Federal Ministry of Science and Research (ICM-2011-00143; URL: https://www.oead.at), and The Austrian Institute of Sports Medicine. This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x; Ali A, 2007, MED SCI SPORT EXER, V39, P1969, DOI 10.1249/mss.0b013e31814fb3e3; Ali A, 2007, J SPORT SCI, V25, P1461, DOI 10.1080/02640410601150470; Andersen TB, 2011, SCAND J MED SCI SPOR, V21, P79, DOI 10.1111/j.1600-0838.2009.01024.x; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bacvarevic BB, 2012, J STRENGTH COND RES, V26, P1945, DOI 10.1519/JSC.0b013e318237e79d; Silva MJCE, 2010, INT J SPORTS MED, V31, P790, DOI 10.1055/s-0030-1263139; Finnoff JT, 2002, J SCI MED SPORT, V5, P348, DOI 10.1016/S1440-2440(02)80023-8; Haaland E, 2003, SCAND J MED SCI SPOR, V13, P179, DOI 10.1034/j.1600-0838.2003.00296.x; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jinshan X., 1993, SCI FOOTBALL, P203; Markovic G, 2006, J SPORT MED PHYS FIT, V46, P215; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Reilly T, 1983, PHYS ED REV, V6, P64; Rosch D, 2000, AM J SPORT MED, V28, pS29, DOI 10.1177/28.suppl_5.s-29; Russell M, 2012, J SCI MED SPORT, V15, P348, DOI 10.1016/j.jsams.2011.12.006; Russell M, 2011, SPORTS MED, V41, P523, DOI 10.2165/11589130-000000000-00000; Russell M, 2010, J SPORT SCI, V28, P1399, DOI 10.1080/02640414.2010.511247; Scurr J, 2009, J SPORT SCI MED, V8, P230; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Vaeyens R, 2006, BRIT J SPORT MED, V40, P928, DOI 10.1136/bjsm.2006.029652; Wood G, 2011, COGN PROCESS, V12, P257, DOI 10.1007/s10339-011-0393-0; Wood G, 2010, J SPORT SCI, V28, P937, DOI 10.1080/02640414.2010.495995	23	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147998	10.1371/journal.pone.0147998	http://dx.doi.org/10.1371/journal.pone.0147998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812247	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000069
J	Wang, DP; Yu, JM; Dorosky, RJ; Pierson, LS; Pierson, EA				Wang, Dongping; Yu, Jun Myoung; Dorosky, Robert J.; Pierson, Leland S., III; Pierson, Elizabeth A.			The Phenazine 2-Hydroxy-Phenazine-1-Carboxylic Acid Promotes Extracellular DNA Release and Has Broad Transcriptomic Consequences in Pseudomonas chlororaphis 30-84	PLOS ONE			English	Article							AUREOFACIENS STRAIN 30-84; BIOFILM FORMATION; FLUORESCENT PSEUDOMONADS; ANTIBIOTIC BIOSYNTHESIS; BIOLOGICAL-CONTROL; AERUGINOSA; EXPRESSION; SYSTEM; PUTIDA; GENES	Enhanced production of 2-hydroxy-phenazine-1-carboxylic acid (2-OH-PCA) by the biological control strain Pseudomonas chlororaphis 30-84 derivative 30-84O* was shown previously to promote cell adhesion and alter the three-dimensional structure of surface-attached biofilms compared to the wild type. The current study demonstrates that production of 2-OH-PCA promotes the release of extracellular DNA, which is correlated with the production of structured biofilm matrix. Moreover, the essential role of the extracellular DNA in maintaining the mass and structure of the 30-84 biofilm matrix is demonstrated. To better understand the role of different phenazines in biofilm matrix production and gene expression, transcriptomic analyses were conducted comparing gene expression patterns of populations of wild type, 30-84O* and a derivative of 30-84 producing only PCA (30-84PCA) to a phenazine defective mutant (30-84ZN) when grown in static cultures. RNA-Seq analyses identified a group of 802 genes that were differentially expressed by the phenazine producing derivatives compared to 30-84ZN, including 240 genes shared by the two 2-OH-PCA producing derivatives, the wild type and 30-84O*. A gene cluster encoding a bacteriophage-derived pyocin and its lysis cassette was upregulated in 2-OH-PCA producing derivatives. A holin encoded in this gene cluster was found to contribute to the release of eDNA in 30-84 biofilm matrices, demonstrating that the influence of 2-OH-PCA on eDNA production is due in part to cell autolysis as a result of pyocin production and release. The results expand the current understanding of the functions different phenazines play in the survival of bacteria in biofilm-forming communities.	[Wang, Dongping] Los Alamos Natl Lab, Earth & Environm Sci, POB 1663, Los Alamos, NM 87544 USA; [Yu, Jun Myoung; Dorosky, Robert J.; Pierson, Leland S., III; Pierson, Elizabeth A.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Pierson, Elizabeth A.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pierson, EA (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.; Pierson, EA (corresponding author), Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA.	eapierson@tamu.edu		Pierson, Elizabeth/0000-0001-8867-0743; Yu, Jun Myoung/0000-0003-1654-3053	National Science Foundation [0545804]; USDA NIFA [2008-35319-04490]; Director's Postdoctoral Fellowship at Los Alamos National Laboratory	National Science Foundation(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); Director's Postdoctoral Fellowship at Los Alamos National Laboratory	This project was supported by the National Science Foundation, grant no. 0545804, and USDA NIFA award no. 2008-35319-04490. D. Wang was supported by a Director's Postdoctoral Fellowship at Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morales DK, 2010, MOL MICROBIOL, V78, P1379, DOI 10.1111/j.1365-2958.2010.07414.x; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pierson E. A., 2013, MICROBIAL PHENAZINES, P141, DOI [10.1007/978-3-642-40573-0_7, DOI 10.1007/978-3-642-40573-0_7]; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; PIERSON LS, 1994, J BACTERIOL, V176, P3966, DOI 10.1128/JB.176.13.3966-3974.1994; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Wang DP, 2015, APPL ENVIRON MICROB, V81, P890, DOI 10.1128/AEM.02617-14; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; Wang DP, 2013, MICROBIOLOGYOPEN, V2, P505, DOI 10.1002/mbo3.90; Wang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045038; Wang DP, 2012, MICROBIOL-SGM, V158, P1745, DOI 10.1099/mic.0.059352-0; Wang DP, 2012, MOL PLANT MICROBE IN, V25, P6, DOI 10.1094/MPMI-08-11-0207; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025293; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Wood DW, 1996, GENE, V168, P49, DOI 10.1016/0378-1119(95)00754-7; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148003	10.1371/journal.pone.0148003	http://dx.doi.org/10.1371/journal.pone.0148003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812402	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000070
J	Azizi, S; Nematollahi, MA; Amiri, BM; Velez, EJ; Lutfi, E; Navarro, I; Capilla, E; Gutierrez, J				Azizi, Sheida; Nematollahi, Mohammad Ali; Amiri, Bagher Mojazi; Velez, Emilio J.; Lutfi, Esmail; Navarro, Isabel; Capilla, Encarnacion; Gutierrez, Joaquim			Lysine and Leucine Deficiencies Affect Myocytes Development and IGF Signaling in Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; MYOGENIC REGULATORY FACTORS; HEPATIC GENE-EXPRESSION; IN-VITRO ASSESSMENT; RAINBOW-TROUT; SKELETAL-MUSCLE; GROWTH-PERFORMANCE; ATLANTIC SALMON; COMPENSATORY GROWTH; RECEPTOR EXPRESSION	Optimizing aquaculture production requires better knowledge of growth regulation and improvement in diet formulation. A great effort has been made to replace fish meal for plant protein sources in aquafeeds, making necessary the supplementation of such diets with crystalline amino acids (AA) to cover the nutritional requirements of each species. Lysine and Leucine are limiting essential AA in fish, and it has been demonstrated that supplementation with them improves growth in different species. However, the specific effects of AA deficiencies in myogenesis are completely unknown and have only been studied at the level of hepatic metabolism. It is well-known that the TOR pathway integrates the nutritional and hormonal signals to regulate protein synthesis and cell proliferation, to finally control muscle growth, a process also coordinated by the expression of myogenic regulatory factors (MRFs). This study aimed to provide new information on the impact of Lysine and Leucine deficiencies in gilthead sea bream cultured myocytes examining their development and the response of insulin-like growth factors (IGFs), MRFs, as well as key molecules involved in muscle growth regulation like TOR. Leucine deficiency did not cause significant differences in most of the molecules analyzed, whereas Lysine deficiency appeared crucial in IGFs regulation, decreasing significantly IGF-I, IGF-II and IGF-IRb mRNA levels. This treatment also down-regulated the gene expression of different MRFs, including Myf5, Myogenin and MyoD2. These changes were also corroborated by a significant decrease in proliferation and differentiation markers in the Lysine-deficient treatment. Moreover, both Lysine and Leucine limitation induced a significant down-regulation in FOXO3 gene expression, which deserves further investigation. We believe that these results will be relevant for the production of a species as appreciated for human consumption as it is gilthead sea bream and demonstrates the importance of an adequate level of Lysine in fishmeal diet formulation for optimum growth.	[Azizi, Sheida; Nematollahi, Mohammad Ali; Amiri, Bagher Mojazi] Univ Tehran, Fac Nat Resources, Dept Fisheries Sci, Karaj, Iran; [Azizi, Sheida; Velez, Emilio J.; Lutfi, Esmail; Navarro, Isabel; Capilla, Encarnacion; Gutierrez, Joaquim] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona 08028, Spain	University of Tehran; University of Barcelona	Nematollahi, MA (corresponding author), Univ Tehran, Fac Nat Resources, Dept Fisheries Sci, Karaj, Iran.; Gutierrez, J (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona 08028, Spain.	malahi@ut.ac.ir; jgutierrez@ub.edu	Lutfi, Esmail/J-3529-2017; Gutierrez, Joaquim/H-2836-2015; Vélez, Emilio J/M-7661-2015; Capilla, Encarnación/L-6143-2014; Amiri, Bagher Mojazi/AAP-3899-2021; Azizi, Sheida/F-2085-2017; NAVARRO ALVAREZ, ISABEL/L-9318-2014	Lutfi, Esmail/0000-0002-0208-9075; Gutierrez, Joaquim/0000-0002-3126-2236; Vélez, Emilio J/0000-0002-6363-0697; Capilla, Encarnación/0000-0002-0863-9728; Amiri, Bagher Mojazi/0000-0002-3862-3460; NAVARRO ALVAREZ, ISABEL/0000-0002-2641-0361	"Ministerio de Ciencia e Innovacion" (MICINN) [AGL2009-12427, AGL2012-39768]; "Xarxa de Referencia d'R+D+I en Aquicultura"; "Generalitat de Catalunya" [2009SGR-00402, 2014SGR-01371]	"Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Xarxa de Referencia d'R+D+I en Aquicultura"; "Generalitat de Catalunya"(Generalitat de Catalunya)	E.J.V. is supported by a predoctoral fellowship from the "Ministerio de Ciencia e Innovacion" (MICINN). This study was supported by the projects from the MICINN AGL2009-12427 and AGL2012-39768 to J.G., and the "Xarxa de Referencia d'R+D+I en Aquicultura" and the 2009SGR-00402 and 2014SGR-01371 from the "Generalitat de Catalunya". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Alami-Durante H, 2010, COMP BIOCHEM PHYS A, V156, P561, DOI 10.1016/j.cbpa.2010.04.015; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Averous J, 2012, EXP CELL RES, V318, P217, DOI 10.1016/j.yexcr.2011.10.015; Azizi S, 2016, GEN COMP ENDOCR, V232, P7, DOI 10.1016/j.ygcen.2015.11.011; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Belghit I, 2014, BRIT J NUTR, V112, P493, DOI 10.1017/S0007114514001226; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Benedito-Palos L, 2007, AQUACULTURE, V267, P199, DOI 10.1016/j.aquaculture.2007.01.011; Bower NI, 2012, J BIOL CHEM, V287, P43936, DOI 10.1074/jbc.M112.361311; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Castillo J, 2004, AM J PHYSIOL-REG I, V286, pR935, DOI 10.1152/ajpregu.00459.2003; Castillo J, 2002, AM J PHYSIOL-REG I, V283, pR647, DOI 10.1152/ajpregu.00121.2002; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; CHOO PS, 1991, J NUTR, V121, P1932, DOI 10.1093/jn/121.12.1932; Codina M, 2008, GEN COMP ENDOCR, V157, P116, DOI 10.1016/j.ygcen.2008.04.009; Davies SJ, 1997, AQUAC RES, V28, P65, DOI 10.1111/j.1365-2109.1997.tb01316.x; Davies SJ, 1997, AQUAC RES, V28, P317; de Celis SVR, 2004, COMP BIOCHEM PHYS A, V138, P533, DOI 10.1016/j.cbpb.2004.06.007; de la Serrana DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074295; Deng DF, 2010, AQUACULTURE, V308, P44, DOI 10.1016/j.aquaculture.2010.07.041; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Du M, 2007, J ANIM SCI, V85, P919, DOI 10.2527/jas.2006-342; Duan CM, 1997, AM ZOOL, V37, P491; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; DUGUAY SJ, 1994, J MOL ENDOCRINOL, V12, P25, DOI 10.1677/jme.0.0120025; Duguay SJ, 1996, J MOL ENDOCRINOL, V16, P123, DOI 10.1677/jme.0.0160123; Gabillard JC, 2003, GEN COMP ENDOCR, V133, P233, DOI 10.1016/S0016-6480(03)00167-9; de la Serrana DG, 2014, COMP BIOCHEM PHYS A, V167, P90, DOI 10.1016/j.cbpa.2013.10.020; Gaylord TG, 2009, AQUACULTURE, V287, P180, DOI 10.1016/j.aquaculture.2008.10.037; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Hevroy EM, 2008, COMP BIOCHEM PHYS A, V151, P621, DOI 10.1016/j.cbpa.2008.07.026; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; JAMES PL, 1993, J BIOL CHEM, V268, P22305; Jash S, 2014, MOL CELL BIOL, V34, P3594, DOI 10.1128/MCB.00742-14; Jimenez-Amilburu V, 2013, GEN COMP ENDOCR, V188, P151, DOI 10.1016/j.ygcen.2013.02.033; Jobling M., 2012, AQUACULT INT, V20, P601, DOI [DOI 10.1007/S10499-011-9480-6, 10.1007/s10499-011-9480-6]; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Kwasek K, 2012, REV FISH BIOL FISHER, V22, P797, DOI 10.1007/s11160-012-9266-6; Lansard M, 2010, AMINO ACIDS, V39, P801, DOI 10.1007/s00726-010-0533-3; Le Bail PY, 1998, ANN NY ACAD SCI, V839, P157; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Montserrat N, 2007, CELL TISSUE RES, V330, P503, DOI 10.1007/s00441-007-0507-2; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Montserrat Nuria, 2012, Front Endocrinol (Lausanne), V3, P55, DOI 10.3389/fendo.2012.00055; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; Planas JV, 2000, AM ZOOL, V40, P223, DOI 10.1668/0003-1569(2000)040[0223:FIIIAI]2.0.CO;2; Pozios KC, 2001, AM J PHYSIOL-REG I, V280, pR1230, DOI 10.1152/ajpregu.2001.280.4.R1230; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rius-Francino M, 2011, GEN COMP ENDOCR, V172, P44, DOI 10.1016/j.ygcen.2011.03.024; Rolland M, 2015, COMP BIOCHEM PHYS B, V181, P33, DOI 10.1016/j.cbpb.2014.11.009; ROSENTHAL SM, 1991, J CLIN INVEST, V87, P1212, DOI 10.1172/JCI115121; ROTWEIN P, 1995, MOL ENDOCRINOL, V9, P913, DOI 10.1210/me.9.7.913; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2012, AUTOPHAGY, V8, P364, DOI 10.4161/auto.18863; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Siwicki AK, 2003, J APPL ICHTHYOL, V19, P44, DOI 10.1046/j.1439-0426.2003.00348.x; Snyder GS, 2012, AQUACULTURE, V338, P72, DOI 10.1016/j.aquaculture.2011.12.042; Nguyen MV, 2014, AQUACULT NUTR, V20, P25, DOI 10.1111/anu.12043; Velez EJ, 2014, GEN COMP ENDOCR, V205, P296, DOI 10.1016/j.ygcen.2014.05.024; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Yabu T, 2012, MAR BIOTECHNOL, V14, P491, DOI 10.1007/s10126-012-9432-9; Yang SD, 2011, AQUACULTURE, V312, P102, DOI 10.1016/j.aquaculture.2010.12.011; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	76	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147618	10.1371/journal.pone.0147618	http://dx.doi.org/10.1371/journal.pone.0147618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808650	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800150
J	Chaudhari, MR; Fallavollita, JA; Farkas, GA				Chaudhari, Milind R.; Fallavollita, James A.; Farkas, Gaspar A.			The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CHRONIC INTERMITTENT HYPOXIA; OBESE ZUCKER RATS; VOLUNTARY EXERCISE; ANESTHETIZED MICE; DIAPHRAGM MUSCLE; OXIDATIVE STRESS; NOCTURNAL ANGINA; GENE-EXPRESSION; HEART-FAILURE	Duchenne muscular dystrophy (DMD) is a fatal disease where over 90% of patients succumb to respiratory or cardiac failure. Sleep apnea and sleep disordered breathing (SDB) are noted in a plurality of DMD patients, and the resulting nocturnal episodic hypoxia (EH) cannot be ruled out as a contributing factor to cardiac and respiratory dysfunction. In this study, we investigated the impact of long-term episodic hypoxia, which mimics the cyclic hypoxia seen in sleep apnea, on cardiac and respiratory function in a murine model of DMD (mdx mice). Since the severity and prevalence of sleep apnea in DMD increases with age, we studied the impact of EH on young (6-month) and on older (18-month) mdx mice. Mice were either exposed for 12 weeks to EH (8 hours/day, 5 days/week) or to room air. We noted a significant increase in left ventricular (LV) dilatation (transthoracic echocardiography) on EH exposure in both age groups, but reduced LV contractility was seen only in 6-month old mice. With EH exposure, an increased fibrosis (hydroxyproline) was noted in both cardiac and diaphragm muscle in 18-month but not 6-month old mice. No significant change in relative diaphragm strength (in-vitro) was noted on EH exposure in 18-month old mice. In contrast, EH exposed 6-month old mice showed a significant increase in relative diaphragm strength. EH exposure did not result in any significant change in ventilatory parameters (barometric plethysmography) in awake 6-month old mdx mice. In contrast, 18-month old mdx mice showed considerable ventilatory dysfunction, consistent with reduced ventilatory reserve. Our findings highlight that sleep apnea impacts respiratory and cardiac function in muscular dystrophy, and that EH can have divergent effects on both systems. To our knowledge, this is the first comprehensive study to investigate the impact of EH on cardiac and respiratory function in mdx mice.	[Chaudhari, Milind R.; Farkas, Gaspar A.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Chaudhari, Milind R.; Fallavollita, James A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Chaudhari, Milind R.] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA; [Fallavollita, James A.] SUNY Buffalo, Ctr Res Cardiovasc Med, Buffalo, NY 14260 USA; [Fallavollita, James A.] VA Western New York Healthcare Syst Buffalo, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Farkas, GA (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	farkas@buffalo.edu			National Institutes of Health [R21AR53901]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health R21AR53901 - (NIH.Gov) GAF.	AMBROSIO G, 1991, J CLIN INVEST, V87, P2056, DOI 10.1172/JCI115236; Ameen Venus, 2010, Open Cardiovasc Med J, V4, P265, DOI 10.2174/1874192401004010265; [Anonymous], 2004, REV MALADIES RESP 2, V21, p7S5; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; BARBE F, 1994, EUR RESPIR J, V7, P1403, DOI 10.1183/09031936.94.07081403; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Bradley TD, 2003, CIRCULATION, V107, P1671, DOI 10.1161/01.CIR.0000061757.12581.15; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; CHAN HS, 1991, CHEST, V99, P1023, DOI 10.1378/chest.99.4.1023; Chen L, 2008, J APPL PHYSIOL, V104, P218, DOI 10.1152/japplphysiol.00301.2007; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Dematteis M, 2008, AM J RESP CRIT CARE, V177, P227, DOI 10.1164/rccm.200702-238OC; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; FARKAS GA, 1994, J APPL PHYSIOL, V77, P2250, DOI 10.1152/jappl.1994.77.5.2250; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1; GOSSELIN LE, 1994, AM J RESP CRIT CARE, V150, P174, DOI 10.1164/ajrccm.150.1.8025746; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hayashi T, 2011, AM J PHYSIOL-HEART C, V301, pH1062, DOI 10.1152/ajpheart.00150.2011; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; Heslop L, 2000, J CELL SCI, V113, P2299; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; Joyeux-Faure M, 2005, J APPL PHYSIOL, V98, P1691, DOI 10.1152/japplphysiol.01146.2004; Labanowski M, 1996, NEUROLOGY, V47, P1173, DOI 10.1212/WNL.47.5.1173; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee SD, 2000, AM J RESP CRIT CARE, V162, P1009, DOI 10.1164/ajrccm.162.3.9909058; Lin M, 2007, AM J PHYSIOL-HEART C, V293, pH997, DOI 10.1152/ajpheart.01124.2006; Maddika S, 2009, CAN J PHYSIOL PHARM, V87, P120, DOI 10.1139/Y08-105; Markham LW, 2006, J AM SOC ECHOCARDIOG, V19, P865, DOI 10.1016/j.echo.2006.02.003; Matecki S, 2004, AM J PHYSIOL-REG I, V287, pR961, DOI 10.1152/ajpregu.00146.2004; Matsumoto C, 2009, HYPERTENSION, V54, P164, DOI 10.1161/HYPERTENSIONAHA.109.131391; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McGuire M, 1999, RESP PHYSIOL, V117, P53, DOI 10.1016/S0034-5687(99)00047-X; Mosqueira M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069567; MYERS ML, 1985, CIRCULATION, V72, P915, DOI 10.1161/01.CIR.72.4.915; Naghshin J, 2009, J APPL PHYSIOL, V107, P787, DOI 10.1152/japplphysiol.91256.2008; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Peled N, 1999, J AM COLL CARDIOL, V34, P1744, DOI 10.1016/S0735-1097(99)00407-6; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PROCKOP DJ, 1960, ANAL BIOCHEM, V1, P228, DOI 10.1016/0003-2697(60)90050-6; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Rosa CM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-152; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; SMITH PEM, 1988, AM REV RESPIR DIS, V137, P884, DOI 10.1164/ajrccm/137.4.884; Spencer MJ, 2000, NEUROMUSCULAR DISORD, V10, P612, DOI 10.1016/S0960-8966(00)00160-7; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Tan TP, 2003, J CARDIOVASC PHARM, V42, P182, DOI 10.1097/00005344-200308000-00005; TOLEP K, 1995, AM J RESP CRIT CARE, V152, P677, DOI 10.1164/ajrccm.152.2.7633725; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Vilquin JT, 1998, MUSCLE NERVE, V21, P567, DOI 10.1002/(SICI)1097-4598(199805)21:5<567::AID-MUS2>3.0.CO;2-6; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	76	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147640	10.1371/journal.pone.0147640	http://dx.doi.org/10.1371/journal.pone.0147640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808526	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800162
J	Dimitriev, DA; Saperova, EV; Dimitriev, AD				Dimitriev, Dimitriy A.; Saperova, Elena V.; Dimitriev, Aleksey D.			State Anxiety and Nonlinear Dynamics of Heart Rate Variability in Students	PLOS ONE			English	Article							COMPLEX CORRELATION MEASURE; FREQUENCY-DOMAIN MEASURES; TIME-SERIES ANALYSIS; POINCARE PLOT; PERIOD VARIABILITY; APPROXIMATE ENTROPY; BLOOD-PRESSURE; CARDIOVASCULAR VARIABILITY; NEUROVISCERAL INTEGRATION; AUTONOMIC BLOCKADE	Objectives Clinical and experimental research studies have demonstrated that the emotional experience of anxiety impairs heart rate variability (HRV) in humans. The present study investigated whether changes in state anxiety (SA) can also modulate nonlinear dynamics of heart rate. Methods A group of 96 students volunteered to participate in the study. For each student, two 5-minute recordings of beat intervals (RR) were performed: one during a rest period and one just before a university examination, which was assumed to be a real-life stressor. Nonlinear analysis of HRV was performed. The Spielberger's State-Trait Anxiety Inventory was used to assess the level of SA. Results Before adjusting for heart rate, a Wilcoxon matched pairs test showed significant decreases in Poincare plot measures, entropy, largest Lyapunov exponent (LLE), and pointwise correlation dimension (PD2), and an increase in the short-term fractal-like scaling exponent of detrended fluctuation analysis (alpha 1) during the exam session, compared with the rest period. A Pearson analysis indicated significant negative correlations between the dynamics of SA and Poincare plot axes ratio (SD1/SD2), and between changes in SA and changes in entropy measures. A strong negative correlation was found between the dynamics of SA and LLE. A significant positive correlation was found between the dynamics of SA and alpha 1. The decreases in Poincare plot measures (SD1, complex correlation measure), entropy measures, and LLE were still significant after adjusting for heart rate. Corrected alpha 1 was increased during the exam session. As before, the dynamics of adjusted LLE was significantly correlated with the dynamics of SA. Conclusions The qualitative increase in SA during academic examination was related to the decrease in the complexity and size of the Poincare plot through a reduction of both the interbeat interval and its variation.	[Dimitriev, Dimitriy A.; Saperova, Elena V.; Dimitriev, Aleksey D.] Chuvash State Pedag Univ, Dept Biol, Chuvash Republic, Russia	Chuvash State Pedagogical University	Dimitriev, DA (corresponding author), Chuvash State Pedag Univ, Dept Biol, Chuvash Republic, Russia.	rothman68@mail.ru	Dimitriev, Dimitri A/J-6589-2012; Saperova, Elena/AAY-1589-2020	Dimitriev, Dimitri A/0000-0002-8102-7074; Dimitriev, Aleksey/0000-0002-3793-2894; Dimitriev, Aleksey/0000-0003-2084-8255	Ministry of education and science of the Russian Federation [1404]	Ministry of education and science of the Russian Federation(Ministry of Education and Science, Russian Federation)	Funding was provided by the Ministry of education and science of the Russian Federation (project 1404, http://dusp.ru). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya RA, 2004, MED BIOL ENG COMPUT, V42, P288, DOI 10.1007/BF02344702; Alvares GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070468; Anishchenko VS, 2001, CRIT REV BIOMED ENG, V29, P462, DOI 10.1615/CritRevBiomedEng.v29.i3.100; [Anonymous], 2011, ACTA MED MARTINIANA, DOI 10.2478/v10201-011-0010-z; Aubert AE, 1999, COMPUT METH PROG BIO, V60, P197, DOI 10.1016/S0169-2607(99)00017-6; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Baumert M, 2009, AM J PHYSIOL-HEART C, V297, pH674, DOI 10.1152/ajpheart.00236.2009; Beckers F, 2006, CLIN EXP PHARMACOL P, V33, P431, DOI 10.1111/j.1440-1681.2006.04384.x; Beckers F, 2006, AM J PHYSIOL-HEART C, V290, pH2560, DOI 10.1152/ajpheart.00903.2005; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P44, DOI 10.1111/j.1469-8986.1994.tb01024.x; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bolis L, 2002, HDB AUTONOMIC NERVOU; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Carrasco S, 2001, J MED ENG TECHNOL, V25, P240, DOI 10.1080/03091900110086651; Cassady JC, 2015, LEARN INDIVID DIFFER, V41, P14, DOI 10.1016/j.lindif.2015.06.002; Chen Z, 2010, IEEE T BIO-MED ENG, V57, P1335, DOI 10.1109/TBME.2010.2041002; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; de Chazal P, 2003, IEEE T BIO-MED ENG, V50, P686, DOI 10.1109/TBME.2003.812203; De Vito G, 2002, CLIN PHYSIOL FUNCT I, V22, P32, DOI 10.1046/j.1365-2281.2002.00395.x; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; Diedrich A, 2013, J APPL PHYSIOL, V114, P203, DOI 10.1152/japplphysiol.00509.2011; Eck VG, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2711; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Elbert T, 1994, PHYSIOL REV, V74, P41; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fishman M, 2012, J APPL PHYSIOL, V113, P297, DOI 10.1152/japplphysiol.01377.2010; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; Hagerman I, 1996, CARDIOVASC RES, V31, P410; Hanin Y. L., 1976, QUICK GUIDE APPL SCA; Hayano J, 2003, CARDIOVASC RES, V58, P1, DOI 10.1016/S0008-6363(02)00851-9; HAYANO J, 1991, AM J CARDIOL, V67, P199, DOI 10.1016/0002-9149(91)90445-Q; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Ho KKL, 1997, CIRCULATION, V96, P842; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Huang WX, 2000, J PHYSIOL-LONDON, V523, P459, DOI 10.1111/j.1469-7793.2000.00459.x; Huikuri HV, 2013, PROG CARDIOVASC DIS, V56, P153, DOI 10.1016/j.pcad.2013.07.003; HUIKURI HV, 1993, CIRCULATION, V87, P1220, DOI 10.1161/01.CIR.87.4.1220; Ilyin EI, 2001, EMOTIONS FEELINGS; Jelinek HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00186; Jelinek HF, 2011, COMPUT CARDIOL CONF, V38, P809; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Karademas EC, 2004, PERS INDIV DIFFER, V37, P1033, DOI 10.1016/j.paid.2003.11.012; Karmakar C, 2010, COMPUT CARDIOL CONF, V37, P601; Karmakar CK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-17; Karmakar CK, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-17; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lucini D, 2002, HYPERTENSION, V39, P184, DOI 10.1161/hy0102.100784; Mainardi LT, 2005, COMPUT CARDIOL, V32, P627; Malliani A., 1997, CARD ELECTROPHYSIOL, V3, P343; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Manzano BM, 2011, ARQ BRAS CARDIOL, V96, P154, DOI 10.1590/S0066-782X2011005000013; Mateo M, 2012, EUR J APPL PHYSIOL, V112, P113, DOI 10.1007/s00421-011-1962-8; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Millar PJ, 2009, AUTON NEUROSCI-BASIC, V150, P116, DOI 10.1016/j.autneu.2009.03.012; Monfredi O, 2014, HYPERTENSION, V64, P1334, DOI 10.1161/HYPERTENSIONAHA.114.03782; Montano N, 1996, J AUTONOM NERV SYST, V57, P116, DOI 10.1016/0165-1838(95)00113-1; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Mourot L, 2004, CLIN PHYSIOL FUNCT I, V24, P10, DOI 10.1046/j.1475-0961.2003.00523.x; Mukherjee S, 2011, CLIN NEUROPHYSIOL, V122, P2059, DOI 10.1016/j.clinph.2011.02.032; Nahshoni E, 2004, PSYCHOSOMATICS, V45, P129, DOI 10.1176/appi.psy.45.2.129; Noteboom JT, 2001, J APPL PHYSIOL, V91, P2093, DOI 10.1152/jappl.2001.91.5.2093; Osaka Motohisa, 1993, Frontiers of Medical and Biological Engineering, V5, P289; Parlitz U, 1998, NONLINEAR MODELING, P209; Paterniti S, 1999, PSYCHOSOM MED, V61, P77, DOI 10.1097/00006842-199901000-00013; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perkiomaki JS, 2002, ANN NONINVAS ELECTRO, V7, P326, DOI 10.1111/j.1542-474X.2002.tb00181.x; Perlitz V, 2004, PFLUG ARCH EUR J PHY, V448, P579, DOI 10.1007/s00424-004-1291-4; PINCUS SM, 1992, OBSTET GYNECOL, V79, P249; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Piskorski J, 2007, PHYSIOL MEAS, V28, P287, DOI 10.1088/0967-3334/28/3/005; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Power M.J., 1997, COGNITION EMOTION OR; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Raffety BD, 1997, J PERS SOC PSYCHOL, V72, P892, DOI 10.1037/0022-3514.72.4.892; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ringwood JV, 2001, AM J PHYSIOL-REG I, V280, pR1105, DOI 10.1152/ajpregu.2001.280.4.R1105; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; SAUL JP, 1990, AM J PHYSIOL, V258, pH713, DOI 10.1152/ajpheart.1990.258.3.H713; Schubert C, 2009, BIOL PSYCHOL, V80, P325, DOI 10.1016/j.biopsycho.2008.11.005; Skinner JE, 2000, AM J PHYSIOL-HEART C, V279, pH1669, DOI 10.1152/ajpheart.2000.279.4.H1669; Skinner N, 2002, J PERS SOC PSYCHOL, V83, P678, DOI 10.1037//0022-3514.83.3.678; Stauss HM, 2003, AM J PHYSIOL-REG I, V285, pR927, DOI 10.1152/ajpregu.00452.2003; Tan CO, 2009, J PHYSIOL-LONDON, V587, P3929, DOI 10.1113/jphysiol.2009.169219; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Toichi M, 1997, J AUTONOM NERV SYST, V62, P79, DOI 10.1016/S0165-1838(96)00112-9; Tonhajzerova I, 2012, PROG NEURO-PSYCHOPH, V39, P212, DOI 10.1016/j.pnpbp.2012.06.023; Tulppo MP, 2001, AM J PHYSIOL-HEART C, V280, pH1081, DOI 10.1152/ajpheart.2001.280.3.H1081; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; Valenza Gaetano, 2012, Front Neuroeng, V5, P3, DOI 10.3389/fneng.2012.00003; van Straaten ECW, 2013, EUR NEUROPSYCHOPHARM, V23, P7, DOI 10.1016/j.euroneuro.2012.10.010; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Vuksanovic V, 2007, MED ENG PHYS, V29, P344, DOI 10.1016/j.medengphy.2006.05.011; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1015, DOI 10.2174/1871527313666140612103425; WEISS G, 1975, J APPL PROBAB, V12, P831, DOI 10.2307/3212735; West BJ, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00001; Williamon A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0719; WOO MA, 1994, J AM COLL CARDIOL, V23, P565, DOI 10.1016/0735-1097(94)90737-4; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323; Yeh RG, 2010, J MED BIOL ENG, V30, P277, DOI 10.5405/jmbe.30.5.02; Zhang ZH, 2011, CLIN EXP HYPERTENS, V33, P281, DOI 10.3109/10641963.2010.531850	115	54	56	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146131	10.1371/journal.pone.0146131	http://dx.doi.org/10.1371/journal.pone.0146131			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807793	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800016
J	Gil, DPI; Clayton, C				Gil, Diana P. Inchaustegui; Clayton, Christine			Purification of Messenger Ribonucleoprotein Particles via a Tagged Nascent Polypeptide	PLOS ONE			English	Article							RNA-BINDING PROTEINS; 3 UNTRANSLATED REGION; TRYPANOSOMA-BRUCEI; AFFINITY PURIFICATION; POLYPYRIMIDINE TRACT; IN-VIVO; EXPRESSION; POLYSOMES; IDENTIFICATION; COMPLEXES	The cytoplasmic fates of mRNAs are influenced by interactions between RNA-binding proteins and cis regulatory motifs. In the cytoplasm, mRNAs are present as messenger ribonucleoprotein particles, which include not only proteins that bind directly to the mRNA, but also additional proteins that are recruited via protein-protein interactions. Many labs have sought to purify such particles from cells, with limited success. We here describe a simple two-step procedure to purify actively translated mRNAs, with their associated proteins, from polysomes. We use a reporter mRNA that encodes a protein with three streptavidin binding peptides at the N-terminus. The polysomal reporter mRNA, with associated proteins, is purified via binding to a streptavidin matrix. The method takes four days, and can be applied in any cell that can be genetically manipulated. Using Trypanosoma brucei as a model system, we routinely purified 8% of the input reporter mRNA, with roughly 22-fold enrichment relative to un-tagged mRNAs, a final reporter-mRNA: total-mRNA ratio of about 1: 10, and a protein purification factor of slightly over 1000-fold. Although the overall reporter mRNP composition is masked by the presence of proteins that are associated with many polysomal mRNAs, our method can be used to detect association of an RNA-binding protein that binds to specifically to a reporter mRNA.	[Gil, Diana P. Inchaustegui; Clayton, Christine] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Gil, Diana P. Inchaustegui] Dieselstr 1A,Wohnung 10, D-63225 Langen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; CORDINGLEY JS, 1980, MOL BIOCHEM PARASIT, V1, P129, DOI 10.1016/0166-6851(80)90011-0; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; GELVIN S, 1977, P NATL ACAD SCI USA, V74, P3193, DOI 10.1073/pnas.74.8.3193; GRONER B, 1977, J BIOL CHEM, V252, P6666; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HEHL A, 1994, P NATL ACAD SCI USA, V91, P370, DOI 10.1073/pnas.91.1.370; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Klein C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135973; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; LHEUREUX M, 1979, NUCLEIC ACIDS RES, V7, P595, DOI 10.1093/nar/7.3.595; Li ZH, 2012, J BIOL CHEM; MACGILLIVRAY RTA, 1980, P NATL ACAD SCI-BIOL, V77, P5153, DOI 10.1073/pnas.77.9.5153; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; PALFI Z, 1991, P NATL ACAD SCI USA, V88, P9097, DOI 10.1073/pnas.88.20.9097; Pena AC, 2014, MOL MICROBIOL, V93, P645, DOI 10.1111/mmi.12677; SCHUTZ G, 1977, NUCLEIC ACIDS RES, V4, P71, DOI 10.1093/nar/4.1.71; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Walker Scott C., 2008, V488, P23, DOI 10.1007/978-1-60327-475-3_3; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148131	10.1371/journal.pone.0148131	http://dx.doi.org/10.1371/journal.pone.0148131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808308	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800272
J	Jalowiecki, L; Chojniak, JM; Dorgeloh, E; Hegedusova, B; Ejhed, H; Magner, J; Plaza, GA				Jalowiecki, Lukasz; Chojniak, Joanna Malgorzata; Dorgeloh, Elmar; Hegedusova, Berta; Ejhed, Helene; Magner, Jorgen; Plaza, Grazyna Anna			Microbial Community Profiles in Wastewaters from Onsite Wastewater Treatment Systems Technology	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; BIOLOGICAL CHARACTERISTICS; BACTERIAL COMMUNITIES; FUNCTIONAL DIVERSITY; PERFORMANCE; SITE; PLANT	The aim of the study was to determine the potential of community-level physiological profiles (CLPPs) methodology as an assay for characterization of the metabolic diversity of wastewater samples and to link the metabolic diversity patterns to efficiency of select onsite biological wastewater facilities. Metabolic fingerprints obtained from the selected samples were used to understand functional diversity implied by the carbon substrate shifts. Three different biological facilities of onsite wastewater treatment were evaluated: fixed bed reactor (technology A), trickling filter/biofilter system (technology B), and aerated filter system (the fluidized bed reactor, technology C). High similarities of the microbial community functional structures were found among the samples from the three onsite wastewater treatment plants (WWTPs), as shown by the diversity indices. Principal components analysis (PCA) showed that the diversity and CLPPs of microbial communities depended on the working efficiency of the wastewater treatment technologies. This study provided an overall picture of microbial community functional structures of investigated samples in WWTPs and discerned the linkages between microbial communities and technologies of onsite WWTPs used. The results obtained confirmed that metabolic profiles could be used to monitor treatment processes as valuable biological indicators of onsite wastewater treatment technologies efficiency. This is the first step toward understanding relations of technology types with microbial community patterns in raw and treated wastewaters.	[Jalowiecki, Lukasz; Chojniak, Joanna Malgorzata; Plaza, Grazyna Anna] Inst Ecol Ind Areas, Dept Environm Microbiol, Katowice, Poland; [Dorgeloh, Elmar; Hegedusova, Berta] Rhein Westfal TH Aachen, Dev & Assessment Inst Waste Water Technol, Aachen, Germany; [Ejhed, Helene; Magner, Jorgen] IVL Swedish Environm Res Inst, Nat Resources & Environm Effects, Stockholm, Sweden	Institute for Ecology of Industrial Areas; RWTH Aachen University; IVL Swedish Environmental Research Institute	Plaza, GA (corresponding author), Inst Ecol Ind Areas, Dept Environm Microbiol, Katowice, Poland.	pla@ietu.katowice.pl		Chojniak-Gronek, Joanna/0000-0002-9288-8953; Plaza, Grazyna/0000-0001-5862-0905; Jalowiecki, Lukasz/0000-0002-1468-6811	BONUS EEIG [2112932-1]	BONUS EEIG	Optimization of small wastewater treatment facilities (OPTITREAT)" no. 2112932-1 financed by BONUS EEIG.	Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bradley RL, 2006, SOIL BIOL BIOCHEM, V38, P629, DOI 10.1016/j.soilbio.2005.07.002; Cicek N, 2001, WATER SCI TECHNOL, V43, P43, DOI 10.2166/wst.2001.0665; EPA, 2002, 821R02012 EPA US; Garcia SN, 2013, CHEMOSPHERE, V92, P38, DOI 10.1016/j.chemosphere.2013.03.007; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gomez E, 2004, APPL SOIL ECOL, V26, P21, DOI 10.1016/j.apsoil.2003.10.007; Hench KR, 2004, WATER ENVIRON RES, V76, P468, DOI 10.2175/106143004X151554; Kapley A, 2007, RES MICROBIOL, V158, P494, DOI 10.1016/j.resmic.2007.04.004; Kapley A, 2007, BIORESOURCE TECHNOL, V98, P2479, DOI 10.1016/j.biortech.2006.09.012; Kenarova A, 2014, ECOTOX ENVIRON SAFE, V100, P226, DOI 10.1016/j.ecoenv.2013.11.012; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Li JM, 2010, CAN J MICROBIOL, V56, P352, DOI [10.1139/w10-009, 10.1139/W10-009]; Liu Y, 2005, BIORESOURCE TECHNOL, V96, P1205, DOI 10.1016/j.biortech.2004.11.003; Manefield M, 2005, ENVIRON MICROBIOL, V7, P715, DOI 10.1111/j.1462-2920.2004.00746.x; Massoud MA, 2009, J ENVIRON MANAGE, V90, P652, DOI 10.1016/j.jenvman.2008.07.001; Nakajima J, 1999, WATER SCI TECHNOL, V39, P85, DOI 10.1016/S0273-1223(99)00189-4; Osem Y, 2007, ECOL ENG, V29, P133, DOI 10.1016/j.ecoleng.2006.06.003; Paul D, 2006, FEMS MICROBIOL ECOL, V57, P116, DOI 10.1111/j.1574-6941.2006.00103.x; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Rani A, 2008, BIORESOURCE TECHNOL, V99, P7098, DOI 10.1016/j.biortech.2008.01.003; Stefanis C, 2013, FOLIA MICROBIOL, V58, P61, DOI 10.1007/s12223-012-0179-5; Tiquia SM, 2010, ENVIRON POLLUT, V158, P1435, DOI 10.1016/j.envpol.2009.12.035; US Environmental Protection Agency, 2002, EPA652R00008 OFF WAT; US Environmental Protection Agency, 2005, 832B05001 EPA OFF WA; van Heerden J, 2002, WATER SA, V28, P29; van Heerden J, 2001, WATER SCI TECHNOL, V43, P83, DOI 10.2166/wst.2001.0020; Victorio L, 1996, WATER RES, V30, P1077, DOI 10.1016/0043-1354(95)00269-3; Wang S, 2014, J ENVIRON MANAGE, V136, P68, DOI 10.1016/j.jenvman.2014.01.038; Weber KP, 2007, J MICROBIOL METH, V69, P461, DOI 10.1016/j.mimet.2007.02.013; Weber KP, 2009, J MICROBIOL METH, V79, P55, DOI 10.1016/j.mimet.2009.07.020; Widmer F, 2001, SOIL BIOL BIOCHEM, V33, P1029, DOI 10.1016/S0038-0717(01)00006-2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhang CB, 2010, ECOL ENG, V36, P62, DOI 10.1016/j.ecoleng.2009.09.010	35	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147725	10.1371/journal.pone.0147725	http://dx.doi.org/10.1371/journal.pone.0147725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807728	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800197
J	Negishi, K; Masui, S; Mimura, M; Fujita, Y; Tsubota, K				Negishi, Kazuno; Masui, Sachiko; Mimura, Masaru; Fujita, Yoshio; Tsubota, Kazuo			Relationship between Functional Visual Acuity and Useful Field of View in Elderly Drivers	PLOS ONE			English	Article							MOTOR-VEHICLE CRASH; DRY EYE PATIENTS; OLDER-ADULTS; IMPAIRMENT; CATARACT; RISK; AGE	Purpose To investigate the relationship between the functional visual acuity (FVA) and useful field of view (UFOV) in elderly drivers and assess the usefulness of the FVA test to screen driving aptitude in elderly drivers. Methods This study included 45 elderly drivers (31 men, 14 women; mean age, 68.1 years) and 30 younger drivers (26 men, 4 women; mean age, 34.2 years) who drive regularly. All participants underwent measurement of the binocular corrected distant visual acuity (CDVA), binocular corrected distant FVA (CDFVA), and Visual Field with Inhibitory Tasks Elderly Version (VFIT-EV) to measure UFOV. The tear function and cognitive status also were evaluated. Results The CDVA, the CDFVA, cognitive status, and the correct response rate (CAR) of the VFIT-EV were significantly worse in the elderly group than in the control group (P = 0.000 for all parameters). The cognitive status was correlated significantly with the CDVA (r = -0.301, P = 0.009), CDFVA (r = -0.402, P = 0.000), and the CAR of the VFIT-EV (r = 0.348, P = 0.002) in all subjects. The results of the tear function tests were not correlated with the CDVA, CDFVA, or VFIT-EV in any subjects. Stepwise regression analysis for all subjects in the elderly and control groups showed that the CDFVA predicted the CAR most significantly among the clinical factors evaluated. Conclusion The FVA test is a promising method to screen the driving aptitude, including both visual and cognitive functions, in a short time.	[Negishi, Kazuno; Masui, Sachiko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Fujita, Yoshio] Mejiro Univ, Fac Hlth Sci, Tokyo, Japan	Keio University; Keio University	Negishi, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	fwic7788@mb.infoweb.ne.jp	Negishi, Kazuno/AAG-3260-2021	Negishi, Kazuno/0000-0002-2892-9810	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24592645]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI, Grant-in-Aid for Scientific Research (C), Grant number 24592645.	Ball K, 1993, J Am Optom Assoc, V64, P71; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Cross JM, 2009, BRIT J OPHTHALMOL, V93, P400, DOI 10.1136/bjo.2008.144584; Desapriya E, 2008, INT J INJ CONTROL SA, V15, P124, DOI 10.1080/17457300802150926; Desapriya E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006252.pub4; Fujita Y., 2012, SAGYOU RYOUHOU, V31, P233; Goto E, 2003, AM J OPHTHALMOL, V135, P704, DOI 10.1016/S0002-9394(02)02147-5; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2011, JPN J OPHTHALMOL, V55, P451, DOI 10.1007/s10384-011-0049-8; Kaido M, 2011, JPN J OPHTHALMOL, V55, P183, DOI 10.1007/s10384-011-0026-2; Nishi Y, 2013, ACTA OPHTHALMOL, V91, pE353, DOI 10.1111/aos.12060; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Rosenbloom S, 2001, TRANSPORTATION, V28, P375, DOI 10.1023/A:1011802707259; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; SEKULER R, 1986, J OPT SOC AM A, V3, P864, DOI 10.1364/JOSAA.3.000864; Tafaj E., 2013, INT C HLTH INF HEALT; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y; Wakamatsu TH, 2011, J CATARACT REFR SURG, V37, P258, DOI 10.1016/j.jcrs.2010.08.048; Watanabe K, 2013, J REFRACT SURG, V29, P19, DOI 10.3928/1081597X-20121211-01; Yamaguchi T, 2011, CURR OPIN OPHTHALMOL, V22, P31, DOI 10.1097/ICU.0b013e3283414f36; Yamaguchi T, 2009, J REFRACT SURG, V25, P410, DOI 10.3928/1081597X-20090422-02	24	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147516	10.1371/journal.pone.0147516	http://dx.doi.org/10.1371/journal.pone.0147516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808364	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800118
J	Chiang, CE; Naditch-Brule, L; Brette, S; Silva-Cardoso, J; Gamra, H; Murin, J; Zharinov, OJ; Steg, PG				Chiang, Chern-En; Naditch-Brule, Lisa; Brette, Sandrinie; Silva-Cardoso, Jose; Gamra, Habib; Murin, Jan; Zharinov, Oleg J.; Steg, Philippe Gabriel			Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; BASE-LINE DATA; RHYTHM-CONTROL; SINUS RHYTHM; REGISTRY; RECORDAF; GUIDELINES; STROKE	Background Atrial fibrillation (AF) can be managed with rhythm-or rate-control strategies. There are few data from routine clinical practice on the frequency with which each strategy is used and their correlates in terms of patients' clinical characteristics, AF control, and symptom burden. Methods RealiseAF was an international, cross-sectional, observational survey of 11,198 patients with AF. The aim of this analysis was to describe patient profiles and symptoms according to the AF management strategy used. A multivariate logistic regression identified factors associated with AF management strategy at the end of the visit. Results Among 10,497 eligible patients, 53.7% used a rate-control strategy, compared with 34.5% who used a rhythm-control strategy. In 11.8% of patients, no clear strategy was stated. The proportion of patients with AF-related symptoms (EHRA Class > = II) was 78.1% (n = 4396/5630) for those using a rate-control strategy vs. 67.8% for those using a rhythm-control strategy (p<0.001). Multivariate logistic regression analysis revealed that age <75 years or the paroxysmal or persistent form of AF favored the choice of a rhythm-control strategy. A change in strategy was infrequent, even in patients with European Heart Rhythm Association (EHRA) Class > = II. Conclusions In the RealiseAF routine clinical practice survey, rate control was more commonly used than rhythm control, and a change in strategy was uncommon, even in symptomatic patients. In almost 12% of patients, no clear strategy was stated. Physician awareness regarding optimal management strategies for AF may be improved.	[Chiang, Chern-En] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Gen Clin Res Ctr, Taipei 112, Taiwan; [Chiang, Chern-En] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Cardiol, Taipei 112, Taiwan; [Naditch-Brule, Lisa] Sanofi, Paris, France; [Brette, Sandrinie] Lincoln, Boulogne, France; [Silva-Cardoso, Jose] Hosp Sao Joao, Porto Med Sch, Dept Cardiol, Oporto, Portugal; [Gamra, Habib] Univ Monastir, Monastir, Tunisia; [Gamra, Habib] FattoumaBourguiba Univ Hosp, Cardiol Dept A, Cardiothrombosis LR12SP16, Monastir, Tunisia; [Murin, Jan] Comenius Univ, Dept Internal Med & Cardiol, Bratislava, Slovakia; [Zharinov, Oleg J.] Natl Med Acad Postgrad Educ, Funct Diagnost Dept, Kiev, Ukraine; [Steg, Philippe Gabriel] INSERM, U1148, Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, DHU FIRE, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, ICMS, NHLI, London, England	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Sanofi-Aventis; Sanofi France; Sao Joao Hospital; Universidade do Porto; Universite de Monastir; Comenius University Bratislava; Shupyk National Healthcare University of Ukraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Imperial College London; Royal Brompton Hospital	Chiang, CE (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Gen Clin Res Ctr, Taipei 112, Taiwan.; Chiang, CE (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Cardiol, Taipei 112, Taiwan.	cechiang@vghtpe.gov.tw	Zharinov, Oleg J/U-8033-2018; Silva-Cardoso, Jose Carlos/L-8033-2013; STEG, Philippe Gabriel/Z-1567-2019	Silva-Cardoso, Jose Carlos/0000-0002-9774-9864; Zharinov, Oleg/0000-0002-4089-9757; STEG, Philippe Gabriel/0000-0001-6896-2941	Sanofi; Abbott; AstraZeneca Pharmaceuticals; Menarini; Merck; Merck Sharp Dohme; Novartis; Pfizer; Astra Zeneca; Boston Scientific; Boehringer-Ingelheim; AstraZeneca; Boehringer Ingelheim; Servier; Amgen; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo/Eli Lilly Alliance; GlaxoSmithKline; Medtronic; Merck Sharpe Dohme; Roche; Medicines Company; Vivus	Sanofi; Abbott(Abbott Laboratories); AstraZeneca Pharmaceuticals(AstraZeneca); Menarini(Menarini Group); Merck(Merck & Company); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Astra Zeneca(AstraZeneca); Boston Scientific(Boston Scientific); Boehringer-Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Servier(Servier); Amgen(Amgen); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo/Eli Lilly Alliance(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck Sharpe Dohme(Merck & Company); Roche(Roche Holding); Medicines Company; Vivus	The RealiseAF survey was sponsored by Sanofi, who provided assistance with data collection. The funder provided support in the form of salaries for authors [LNB, SB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The RealiseAF survey was sponsored by Sanofi, who provided assistance with data collection. The authors thank the RealiseAF investigators that participated in the survey; and also acknowledge the assistance of Leigh Prevost, BSc Hons (PPSI, UK, a PAREXEL company), for the editing of the manuscript, supported by Sanofi. Disclosures: CEC has received honoraria for lectures from AstraZeneca, Merck Sharp & Dohme, Novartis, Pfizer, Sanofi, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, Roche, Servier, Tanabe and Takeda. LNB is an employee of Sanofi and has shares. SB is an employee of Lincoln, under contract with Sanofi for statistical analyses. JSC has consulted and received speaker fees for Abbott, AstraZeneca Pharmaceuticals, Menarini, Merck, Merck Sharp & Dohme, Novartis, Pfizer and Sanofi. HG has received consultancy and lecturing fees/honoraria from Sanofi, Novartis, Astra Zeneca, Boston Scientific and Boehringer-Ingelheim. JM has received honoraria for lectures from Gedeon Richter, Novartis, Pfizer, Roche diagnostics, Servier and Takeda, and consultancy fees from AstraZeneca, Boehringer Ingelheim and Sanofi. OZ has received lecturing fees from Sanofi and Boehringer- Ingelheim. PGS has received research grants from Sanofi and Servier; consultancy fees/honoraria from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo/Eli Lilly Alliance, GlaxoSmithKline, Medtronic, Merck Sharpe & Dohme, Novartis, Pfizer, Roche, Sanofi, Servier, The Medicines Company and Vivus, and has equity ownership in Aterovax.	Amerena J, 2012, AM J CARDIOL, V109, P378, DOI 10.1016/j.amjcard.2011.08.046; Camm AJ, 2011, J AM COLL CARDIOL, V58, P493, DOI 10.1016/j.jacc.2011.03.034; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258; De Vos CB, 2012, AM HEART J, V163, P887, DOI 10.1016/j.ahj.2012.02.015; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Ionescu-Ittu R, 2012, ARCH INTERN MED, V172, P997, DOI 10.1001/archinternmed.2012.2266; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012; Lip GYH, 2015, EUROPACE, V17, P24, DOI 10.1093/europace/euu155; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Steg PG, 2012, HEART, V98, P195, DOI 10.1136/heartjnl-2011-300550; Testa L, 2005, EUR HEART J, V26, P2000, DOI 10.1093/eurheartj/ehi306; Tsadok MA, 2012, CIRCULATION, V126, P2680, DOI 10.1161/CIRCULATIONAHA.112.092494; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147536	10.1371/journal.pone.0147536	http://dx.doi.org/10.1371/journal.pone.0147536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800084	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300121
J	Wu, ZQ; Zhang, Y; Xie, EF; Song, WJ; Yang, RX; Yan, CJ; Zhang, BF; Xu, HG				Wu, Zhi-Qi; Zhang, Yan; Xie, Erfu; Song, Wei-Juan; Yang, Rui-Xia; Yan, Cheng-Jing; Zhang, Bing-Feng; Xu, Hua-Guo			High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; BONE TURNOVER MARKERS; PROSTATE-CANCER; POSTMENOPAUSAL WOMEN; PROGNOSTIC IMPLICATIONS; CLINICAL-SIGNIFICANCE; METABOLIC SYNDROME; CARCINOMA PATIENTS; NATURAL-HISTORY; ISOFORM 5B	Background Bone metastases often occur in the majority of patients with advanced cancer, such as prostate cancer, lung cancer and breast cancer. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b), a novel bone resorption marker, has been used gradually in the clinics as a specific and sensitive marker of bone resorption for the early diagnosis of cancer patients with bone metastasis. Here, we reported that high concentrations of uric acid (UA) lead to decrease of TRACP 5b levels and determined whether TRACP 5b level was associated with UA in interference experiment. Methods A total of 77 patients with high concentrations of UA and 77 healthy subjects were tested to evaluate the differences in their TRACP 5b levels. Serial dilutions of UA were respectively spiked with a known concentration of TRACP 5b standard sample, then Serum TRACP 5b was detected by using bone TRAP (R) Assay. A correction equation was set to eliminate UA-derived TRACP 5b false-decrease. The effect of this correction was evaluated in high-UA individuals. Results The average TRACP level of the high-UA individuals (1.47 +/- 0.62 U/L) was significantly lower than that of the healthy subjects (2.62 +/- 0.63 U/L) (t-test, p<0.0001). The UA correction equation derived: Delta TRACP 5b = -1.9751lg Delta UA + 3.7365 with an R-2 = 0.98899. Application of the UA correction equation resulted in a statistically non-significant difference in TRACP 5b values between the healthy subjects and high-UA individuals (p = 0.24). Conclusions High UA concentrations can falsely decrease TRACP 5b levels due to a method-related systematic error. To avoid misdiagnoses or inappropriate therapeutic decisions, increased attention should be paid to UA interference, when TRACP 5b is used for early diagnosis of cancer patients with bone metastasis, evaluation of the aggressiveness of osteosarcoma or prediction of survival in prostate cancer and breast cancer with bone metastases.	[Wu, Zhi-Qi; Zhang, Yan; Xie, Erfu; Song, Wei-Juan; Yang, Rui-Xia; Yan, Cheng-Jing; Zhang, Bing-Feng; Xu, Hua-Guo] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Xu, HG (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	huaguoxu@njmu.edu.cn			National Natural Science Foundation of China [81302531]; Natural Science Foundation of Jiangsu Province of China [BK20131018]; Key laboratory for Laboratory Medicine of Jiangsu Province [XK201114]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Key Clinical Department of Laboratory Medicine of China in Nanjing	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Key laboratory for Laboratory Medicine of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Key Clinical Department of Laboratory Medicine of China in Nanjing	This work was supported by the National Natural Science Foundation of China (81302531), Natural Science Foundation of Jiangsu Province of China (BK20131018), the National Key Clinical Department of Laboratory Medicine of China in Nanjing, Key laboratory for Laboratory Medicine of Jiangsu Province (XK201114) and by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2013, OSTEOPOROSIS INT, V24, P2961, DOI 10.1007/s00198-013-2377-7; Alatalo SL, 2003, J BONE MINER RES, V18, P134, DOI 10.1359/jbmr.2003.18.1.134; Avnet S, 2008, INT J ONCOL, V33, P1231, DOI 10.3892/ijo_00000113; Bonjour JP, 2012, J NUTR, V142, P698, DOI 10.3945/jn.111.153692; Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108; Chao TY, 2010, CLIN CHIM ACTA, V411, P1553, DOI 10.1016/j.cca.2010.06.027; Chao TY, 2005, CLIN CANCER RES, V11, P544; CHINH NH, 1974, CLIN CHEM, V20, P499; Chung YC, 2006, CANCER EPIDEM BIOMAR, V15, P424, DOI 10.1158/1055-9965.EPI-04-0842; Ebert W, 2004, ANTICANCER RES, V24, P3193; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Halleen JM, 2001, CLIN CHEM, V47, P597; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Hammarsten J, 2010, CANCER EPIDEMIOL, V34, P574, DOI 10.1016/j.canep.2010.06.014; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Jung K, 2004, INT J CANCER, V111, P783, DOI 10.1002/ijc.20314; Kamiya N, 2010, UROLOGY, V75, P1446, DOI 10.1016/j.urology.2009.11.049; Korpela J, 2006, ANTICANCER RES, V26, P3127; MCNEIL BJ, 1984, SEMIN NUCL MED, V14, P277, DOI 10.1016/S0001-2998(84)80003-3; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Salminen EK, 2006, ANTICANCER RES, V26, P4879; Sarvari BKD, 2015, INDIAN J CLIN BIOCHE, V30, P66, DOI 10.1007/s12291-013-0399-8; Savarino L, 2010, J ORTHOP RES, V28, P887, DOI 10.1002/jor.21082; Tang CH, 2013, CLIN CHIM ACTA, V426, P102, DOI 10.1016/j.cca.2013.09.011; Terpos E, 2003, INT J CANCER, V106, P455, DOI 10.1002/ijc.11247; Terpos E, 2009, ANTICANCER RES, V29, P1651; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-158; Zhang L, 2015, CHINESE MED J-PEKING, V128, P1232, DOI 10.4103/0366-6999.156139	32	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147554	10.1371/journal.pone.0147554	http://dx.doi.org/10.1371/journal.pone.0147554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800211	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300122
J	Zhang, SQ; Lindner, HA; Kabtni, S; van den Born, J; Bakker, S; Navis, G; Kramer, B; Yard, B; Hauske, S				Zhang, Shiqi; Lindner, Holger A.; Kabtni, Sarah; van den Born, Jaap; Bakker, Stephan; Navis, Gerjan; Kraemer, Bernard; Yard, Benito; Hauske, Sibylle			Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; LEUCINE REPEAT; GENE CNDP1; POLYMORPHISM; ZINC; SECRETION; PROTEIN; DISEASE	Background and Aims The proportion of serum carnosinase (CN-1) recognized by RYSK173 monoclonal antibody negatively correlates with CN-1 activity. We thus hypothesized that the epitope recognized by RYSK173 is accessible only in a catalytically incompetent conformation of the zinc dependent enzyme and we mapped its position in the CN-1 structure. Since patients with kidney failure are often deficient in zinc and other trace elements we also assessed the RYSK173 CN-1 proportion in serum of these patients and studied the influence of hemodialysis hereon in relation to Zn2+ and Cu2+ concentration during hemodialysis. Methods and Results Epitope mapping using myc-tagged CN-1 fragments and overlapping peptides revealed that the RYSK173 epitope directly contributes to the formation of the dinuclear Zn center in the catalytic domain of homodimeric CN-1. Binding of RYSK173 to CN-1 was however not influenced by addition of Zn2+ or Cu2+ to serum. In serum of healthy controls the proportion of CN-1 recognized by RYSK173 was significantly lower compared to end-stage renal disease (ESRD) patients (1.12 +/- 0.17 vs. 1.56 +/- 0.40% of total CN-1; p<0.001). During hemodialysis the relative proportion of RYSK173 CN-1 decreased in parallel with increased serum Zn2+ and Cu2+ concentrations after dialysis. Conclusions Our study clearly indicates that RYSK173 recognizes a sequence within the transition metal binding site of CN-1, thus supporting our hypothesis that metal binding to CN-1 masks the epitope. The CN-1 RYSK173 proportion appears overall increased in ESRD patients, yet it decreases during hemodialysis possibly as a consequence of a relative increase in transition metal bound enzyme.	[Zhang, Shiqi; Kabtni, Sarah; Kraemer, Bernard; Yard, Benito; Hauske, Sibylle] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Mannheim, Germany; [Zhang, Shiqi] Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Peoples R China; [Lindner, Holger A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anesthesiol & Surg Intens Care Med, Mannheim, Germany; [van den Born, Jaap; Bakker, Stephan; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Ruprecht Karls University Heidelberg; Anhui Medical University; Ruprecht Karls University Heidelberg; University of Groningen	Yard, B (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Mannheim, Germany.	benito.yard@medma.uni-heidelberg.de	Lindner, Holger A/C-5106-2014	Lindner, Holger A/0000-0002-6679-4355; Krieg, Sarah/0000-0003-0012-0304; Zhang, Shiqi/0000-0002-2120-1544	Deutsche Forschungsgemeinschaft (DFG) [SA 2143/1-1]; Graduiertenkolleg (GRK) [1874/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduiertenkolleg (GRK)(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (DFG, URL: http://www.dfg.de/) SA 2143/1-1 to S.H. This author read and revised this manuscript. It was also supported by Graduiertenkolleg (GRK, URL: http://www.umm.uni-heidelberg.de/ag/grk1874/) 1874/1 to B.Y. This author designed, prepared, and decided to publish this manuscript.	Adelmann K, 2012, AMINO ACIDS, V43, P143, DOI 10.1007/s00726-012-1244-8; Aoki A, 2012, MICROB PATHOGENESIS, V52, P17, DOI 10.1016/j.micpath.2011.09.003; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; David A, 1998, HDB PROTEOLYTIC ENZY; Everaert I, 2012, AM J PHYSIOL-RENAL, V302, pF1537, DOI 10.1152/ajprenal.00084.2012; Freedman BI, 2007, NEPHROL DIAL TRANSPL, V22, P1131, DOI 10.1093/ndt/gfl717; HOMSHER R, 1985, CLIN CHEM, V31, P1310; Hu WW, 2012, ACS CHEM NEUROSCI, V3, P238, DOI 10.1021/cn200126p; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; JOHNSEN O, 1987, INT J ANDROL, V10, P435, DOI 10.1111/j.1365-2605.1987.tb00216.x; Kilis-Pstrusinska K, 2010, ARCH MED RES, V41, P356, DOI 10.1016/j.arcmed.2010.07.006; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Peters V, 2011, CLIN CHIM ACTA, V412, P263, DOI 10.1016/j.cca.2010.10.016; Peters V, 2010, AMINO ACIDS, V38, P1607, DOI 10.1007/s00726-009-0367-z; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Riedl E, 2007, DIABETES, V56, P2410, DOI 10.2337/db07-0128; Riedl E, 2010, DIABETES, V59, P1984, DOI 10.2337/db09-0868; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tonelli M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-25; Wang TY, 2008, FEBS J, V275, P5007, DOI 10.1111/j.1742-4658.2008.06635.x; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x; Zhu JM, 2013, GENET TEST MOL BIOMA, V17, P289, DOI 10.1089/gtmb.2012.0341	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146831	10.1371/journal.pone.0146831	http://dx.doi.org/10.1371/journal.pone.0146831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799971	gold, Green Published			2022-12-27	WOS:000368655300040
J	Flegr, J				Flegr, Jaroslav			Heterozygote Advantage Probably Maintains Rhesus Factor Blood Group Polymorphism: Ecological Regression Study	PLOS ONE			English	Article							RHD MOLECULE; TOXOPLASMOSIS; PROTEINS; WOMEN	Rhesus factor polymorphism has been an evolutionary enigma since its discovery in 1939. Carriers of the rarer allele should be eliminated by selection against Rhesus positive children born to Rhesus negative mothers. Here I used an ecologic regression study to test the hypothesis that Rhesus factor polymorphism is stabilized by heterozygote advantage. The study was performed in 65 countries for which the frequencies of RhD phenotypes and specific disease burden data were available. I performed multiple multivariate covariance analysis with five potential confounding variables: GDP, latitude (distance from the equator), humidity, medical care expenditure per capita and frequencies of smokers. The results showed that the burden associated with many diseases correlated with the frequencies of particular Rhesus genotypes in a country and that the direction of the relation was nearly always the opposite for the frequency of Rhesus negative homozygotes and that of Rhesus positive heterozygotes. On the population level, a Rhesus-negativity-associated burden could be compensated for by the heterozygote advantage, but for Rhesus negative subjects this burden represents a serious problem.	[Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic	Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Czech Science Foundation [P303/11/1398]	Czech Science Foundation(Grant Agency of the Czech Republic)	Funded by Czech Science Foundation P303/11/1398.	ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; FELDMAN MW, 1969, AM J HUM GENET, V21, P171; Fisher RA, 1944, NATURE, V153, P106, DOI 10.1038/153106b0; Flegel WA, 2011, TRANSFUS APHER SCI, V44, P81, DOI 10.1016/j.transci.2010.12.013; FLEGR J, 2014, PLOS ONE, V0009; Flegr J, 2013, PLOS ONE, V8; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141362; Flegr J, 2014, FOLIA PARASIT, V61, P485, DOI 10.14411/fp.2014.061; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Guthrie KA, 2001, J ROY STAT SOC A STA, V164, P141, DOI 10.1111/1467-985X.00193; Haldane JBS, 1942, EUGENICS, V11, P333; Hogben L, 1943, NATURE, V152, P721, DOI 10.1038/152721c0; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; LI CC, 1953, AM NAT, V87, P257, DOI 10.1086/281782; MOURANT A. E, 1954, DISTRIBUTION HUMAN B; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Wagner FF, 2000, BLOOD, V95, P3662; Wakefield J, 2001, J R STAT SOC A STAT, V164, P119, DOI 10.1111/1467-985X.00191; World Health Organization, 2008, GLOB BURD DIS 2004 U	26	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147955	10.1371/journal.pone.0147955	http://dx.doi.org/10.1371/journal.pone.0147955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811928	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000066
J	AlHabib, KF; Sulaiman, K; Al Suwaidi, J; Almahmeed, W; Alsheikh-Ali, AA; Amin, H; Al Jarallah, M; Alfaleh, HF; Panduranga, P; Hersi, A; Kashour, T; Al Aseri, Z; Ullah, A; Altaradi, HB; Asfina, KN; Welsh, RC; Yusuf, S				AlHabib, Khalid F.; Sulaiman, Kadhim; Al Suwaidi, Jassim; Almahmeed, Wael; Alsheikh-Ali, Alawi A.; Amin, Haitham; Al Jarallah, Mohammed; Alfaleh, Hussam F.; Panduranga, Prashanth; Hersi, Ahmad; Kashour, Tarek; Al Aseri, Zohair; Ullah, Anhar; Altaradi, Hani B.; Asfina, Kazi Nur; Welsh, Robert C.; Yusuf, Salim			Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps)	PLOS ONE			English	Article							DOOR-TO-BALLOON; PRIMARY PERCUTANEOUS INTERVENTION; REPERFUSION THERAPY; TIMELY ACCESS; MANAGEMENT; ASSOCIATION; IMPLEMENTATION; THROMBOLYSIS; FIBRINOLYSIS; TIMELINESS	Background Little is known about Emergency Medical Services (EMS) use and pre-hospital triage of patients with acute ST-elevation myocardial infarction (STEMI) in Arabian Gulf countries. Methods Clinical arrival and acute care within 24 h of STEMI symptom onset were compared between patients transferred by EMS (Red Crescent and Inter-Hospital) and those transferred by non-EMS means. Data were retrieved from a prospective registry of 36 hospitals in 6 Arabian Gulf countries, from January 2014 to January 2015. Results We enrolled 2,928 patients; mean age, 52.7 (SD +/- 11.8) years; 90% men; and 61.7% non-Arabian Gulf citizens. Only 753 patients (25.7%) used EMS; which was mostly via InterHospital EMS (22%) rather than direct transfer from the scene to the hospital by the Red Crescent (3.7%). Compared to the non-EMS group, the EMS group was more likely to arrive initially at a primary or secondary health care facility; thus, they had longer median symptom- onset-to-emergency department arrival times (218 vs. 158 min; p (<) .001); they were more likely to receive primary percutaneous coronary interventions (62% vs. 40.5%, p = 0.02); they had shorter door-to-needle times (38 vs. 42 min; p =.04); and shorter door-to-balloon times (47 vs. 83 min; p (<) .001). High EMS use was independently predicted mostly by primary/secondary school educational levels and low or moderate socioeconomic status. Low EMS use was predicted by a history of angina and history of percutaneous coronary intervention. The groups had similar in-hospital deaths and outcomes. Conclusion Most acute STEMI patients in the Arabian Gulf region did not use EMS services. Improving Red Crescent infrastructure, establishing integrated STEMI networks, and launching educational public campaigns are top health care system priorities.	[AlHabib, Khalid F.; Alfaleh, Hussam F.; Hersi, Ahmad; Kashour, Tarek; Ullah, Anhar; Altaradi, Hani B.; Asfina, Kazi Nur] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh 11461, Saudi Arabia; [Sulaiman, Kadhim; Panduranga, Prashanth] Royal Hosp, Dept Cardiol, Muscat, Oman; [Al Suwaidi, Jassim] HMC, Dept Cardiol, Doha, Qatar; [Almahmeed, Wael] Cleveland Clin, Inst Heart & Vasc, Abu Dhabi, U Arab Emirates; [Alsheikh-Ali, Alawi A.] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates; [Alsheikh-Ali, Alawi A.] Inst Cardiac Sci, Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Alsheikh-Ali, Alawi A.] Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA USA; [Amin, Haitham] Mohammed Bin Khalifa Cardiac Ctr, Manama, Bahrain; [Al Jarallah, Mohammed] Sabah Al Ahmed Cardiac Ctr, Kuwait, Kuwait; [Al Aseri, Zohair] King Saud Univ, Coll Med, Emergency Dept, Riyadh 11461, Saudi Arabia; [Welsh, Robert C.] Univ Alberta, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada	King Saud University; The Royal Hospital, Sultanate of Oman; Hamad Medical Corporation; Cleveland Clinic Foundation; Tufts Medical Center; King Saud University; University of Alberta; McMaster University; Population Health Research Institute	AlHabib, KF (corresponding author), King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh 11461, Saudi Arabia.	khalidalhabib13@hotmail.com	Ullah, Anhar/CAJ-2116-2022; Al Aseri, Zohair/A-6098-2018; Hersi, Ahmad/ABC-9266-2020; Welsh, Robert/ABH-3526-2021	Al Aseri, Zohair/0000-0001-9869-7544; Ullah, Anhar/0000-0001-6768-2112; Panduranga, Prashanth/0000-0002-0603-117X; Yusuf, Salim/0000-0003-4776-5601; Welsh, Robert/0000-0003-2613-9142; Alhabib, Khalid/0000-0002-6692-3874	AstraZeneca; Saudi Heart Association; College of Medicine Research Centre at King Khalid University Hospital; Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [RG-1436-013]	AstraZeneca(AstraZeneca); Saudi Heart Association; College of Medicine Research Centre at King Khalid University Hospital(King Saud University); Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia	The study was mainly funded by AstraZeneca, and partially by the Saudi Heart Association, the College of Medicine Research Centre at King Khalid University Hospital, and the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG-1436-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlHabib KF, 2014, ANGIOLOGY, V65, P703, DOI 10.1177/0003319713502846; AlHabib KF, 2012, ANN SAUDI MED, V32, P9, DOI 10.5144/0256-4947.2012.9; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; Bosson N, 2015, PREHOSP EMERG CARE, V19, P496, DOI 10.3109/10903127.2015.1005260; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Dauerman HL, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002450; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Jollis JG, 2007, JAMA-J AM MED ASSOC, V298, P2371, DOI 10.1001/jama.298.20.joc70124; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Kristensen SD, 2014, EUR HEART J, V35, P1957, DOI 10.1093/eurheartj/eht529; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Ladwig KH, 2011, INT J CARDIOL, V152, P350, DOI 10.1016/j.ijcard.2010.08.003; McLean S, 2008, EMERG MED J, V25, P370, DOI 10.1136/emj.2007.052746; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Mumma BE, 2014, AM HEART J, V167, P915, DOI 10.1016/j.ahj.2014.03.014; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; Nallamothu BK, 2009, AM J CARDIOL, V103, P1051, DOI 10.1016/j.amjcard.2008.12.030; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Rasmussen MB, 2014, HEART, V100, P711, DOI 10.1136/heartjnl-2013-304576; Roswell RO, 2014, CLIN CARDIOL, V37, P389, DOI 10.1002/clc.22278; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thylen I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007059; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Welsh RC, 2014, AM J CARDIOL, V114, P811, DOI 10.1016/j.amjcard.2014.06.011; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	28	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147385	10.1371/journal.pone.0147385	http://dx.doi.org/10.1371/journal.pone.0147385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807577	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800084
J	Bucher, HC; Achermann, R; Stohler, N; Meier, CR				Bucher, Heiner C.; Achermann, Rita; Stohler, Nadja; Meier, Christoph R.			Surveillance of Physicians Causing Potential Drug-Drug Interactions in Ambulatory Care: A Pilot Study in Switzerland	PLOS ONE			English	Article							PATIENT SAFETY; HEALTH-CARE; PHARMACIES; SUPPORT; RATES	Objectives We analysed potential drug-drug interactions (DDI) in ambulatory care in Switzerland based on claims data from three large health insurers in 2010 to identify physicians with peculiar prescription behaviour differing from peers of the same specialty. Methods We analysed contraindicated or potentially contraindicated DDI from the national drug formulary and calculated for each physician the ratios of the number of patients with a potential DDI divided by the number of patients at risk and used a zero inflated binomial distribution to correct for the inflated number of observations with no DDI. We then calculated the probability that the number of caused potential DDI of physicians was unlikely (p-value < 0.05 and >= 0.01) and very unlikely (p-value <0.01) to be due to chance. Results Of 1'607'233 females and 1'525'307 males 1.3% and 1.2% were exposed to at least one potential DDI during 12 months. When analysing the 40 most common DDI, 598 and 416 of 18,297 physicians (3.3% and 2.3%) were causing potential DDI in a frequency unlikely (p<0.05 and p >= 0.01) and very unlikely (p<0.01) to be explained by chance. Patients cared by general practitioners and cardiologists had the lowest probability (0.20 and 0.26) for not being exposed to DDI. Conclusions Contraindicated or potentially contraindicated DDI are frequent in ambulatory care in Switzerland, with a small proportion of physicians causing potential DDI in a frequency that is very unlikely to be explained by chance when compared to peers of the same specialty.	[Bucher, Heiner C.; Achermann, Rita] Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Stohler, Nadja; Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Inst Clin Pharm & Epidemiol, Basel, Switzerland; [Stohler, Nadja; Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Bucher, HC (corresponding author), Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	heiner.bucher@usb.ch			Swiss Medical Association (FMH); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	Swiss Medical Association (FMH); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	This study was supported by a grant from the Swiss Medical Association (FMH) and Santesuisse. The Basel Institute for Clinical Epidemiology has been supported by unrestricted research grants by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Swiss Medical Association (FMH) and Santesuisse. The Basel Institute for Clinical Epidemiology has been supported by unrestricted research grants by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann R., 2006, ABRECHNUNGSEFFEKTE B; Becker ML, 2007, PHARMACOEPIDEM DR S, V16, P641, DOI 10.1002/pds.1351; Bjerrum L, 2003, SCAND J PRIM HEALTH, V21, P153, DOI 10.1080/02813430310001806; Hammerlein A, 2007, ANN PHARMACOTHER, V41, P1825, DOI 10.1345/aph.1K207; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Johnell K, 2008, SCAND J PRIM HEALTH, V26, P86, DOI 10.1080/02813430802022196; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Merlo J, 2001, BRIT MED J, V323, P427, DOI 10.1136/bmj.323.7310.427; Solberg LI, 2004, AM J MANAG CARE, V10, P753; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steele AW, 2005, PLOS MED, V2, P864, DOI 10.1371/journal.pmed.0020255; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; VGAM: Vector Generalized Linear and Additive Models, 2014, VGAM VECTOR GEN LINE; Vonbach P., 2007, THESIS U BASEL; Weingart SN, 2009, ARCH INTERN MED, V169, P1465, DOI 10.1001/archinternmed.2009.252; Wolfstadt JI, 2008, J GEN INTERN MED, V23, P451, DOI 10.1007/s11606-008-0504-5	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147606	10.1371/journal.pone.0147606	http://dx.doi.org/10.1371/journal.pone.0147606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808430	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800147
J	Chung, HK; Han, YK; Oh, S; Kim, SH				Chung, Ho Kyung; Han, Young Keun; Oh, Sohee; Kim, Seok Hwan			Comparison of Optical Coherence Tomography Measurement Reproducibility between Children and Adults	PLOS ONE			English	Article							NERVE-FIBER LAYER; THICKNESS	Purpose To compare the reproducibility of SD-OCT (spectral-domain optical coherence tomography) measurements of RNFL (retinal nerve fiber layer) and macular thickness between children and adults. Methods Seventy-one eyes of 71 children and 71 eyes of 71 adults were prospectively enrolled. RNFL and macular thicknesses were measured by one operator, with a brief rest between measurements. The two measurements were obtained using the eye tracking and retest function of Spectralis SD-OCT. Reproducibility was evaluated with reference to COVs (coefficients of variation) and ICCs (intraclass correlation coefficients). The ICC values of the RNFL and macular thicknesses were compared, respectively between the two groups, by Fisher's z-test. Results The RNFL and macular thicknesses did not differ between the two groups. The COVs of the RNFL measurements ranged from 0.945 to 4.531% in the children group and from 0.496 to 1.391% in the adults group. In most of the RNFL sectors, the ICCs of the children group (range: 0.731-0.987) were significantly lower than those of the adults group (range: 0.986-0.993). The COVs of themacular measurements ranged from 0.496 to 1.157% in the children group and from 0.275 to 0.656% in the adults group. The ICCs (range: 0.860-0.974) in the children group, significantly lower than for the adults (range: 0.989-0.995), in all of themacular sectors. Conclusions The reproducibility of SD-OCT RNFL and macular measurements for children was excellent, albeit statistically lower than that for adults.	[Chung, Ho Kyung; Han, Young Keun; Kim, Seok Hwan] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Chung, Ho Kyung; Han, Young Keun; Kim, Seok Hwan] Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea; [Oh, Sohee] Seoul Natl Univ, Boramae Hosp, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea.	xcski@hanmail.net	Kim, Seok-Hwan/AAV-3518-2021; Kim, Seok-Hwan/G-9981-2015	Kim, Seok-Hwan/0000-0003-0209-0444; Kim, Seok-Hwan/0000-0003-0209-0444	SK Telecom Research Fund [16-2013-6]	SK Telecom Research Fund	This work was supported by grant no. 16-2013-6 from the SK Telecom Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad CE, 2011, BRIT J OPHTHALMOL, V95, P1696, DOI 10.1136/bjo.2010.195081; Altemir I, 2013, AM J OPHTHALMOL, V155, P171, DOI 10.1016/j.ajo.2012.06.012; Baker PS, 2010, OPHTHAL SURG LAS IM, V41, P201, DOI 10.3928/15428877-20100303-08; Bambo MP, 2014, BRIT J OPHTHALMOL, V98, P52, DOI 10.1136/bjophthalmol-2013-303752; Chang L, 2010, J AAPOS, V14, P511, DOI 10.1016/j.jaapos.2010.08.014; Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; El-Dairi MA, 2009, BRIT J OPHTHALMOL, V93, P1325, DOI 10.1136/bjo.2008.142562; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Ghasia FF, 2015, J GLAUCOMA, V24, P55, DOI 10.1097/IJG.0b013e31829521db; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Hess DB, 2005, AM J OPHTHALMOL, V139, P509, DOI 10.1016/j.ajo.2004.10.047; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jeoung JW, 2014, J GLAUCOMA, V23, P299, DOI 10.1097/IJG.0b013e3182741cc4; Kumar Vinod, 2010, Ophthalmic Surg Lasers Imaging, V41 Online, pe1, DOI 10.3928/15428877-20101223-06; Lange Alex P, 2012, ISRN Ophthalmol, V2012, P860819, DOI 10.5402/2012/860819; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Liu H, 2010, J PEDIAT OPHTH STRAB, V47, P17, DOI [10.3928/01913913-20091019-06, 10.3928/01913913-20100101-16]; Pang Y, 2011, INVEST OPHTH VIS SCI, V52, P2444, DOI 10.1167/iovs.10-5550; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Sander B, 2005, BRIT J OPHTHALMOL, V89, P207, DOI 10.1136/bjo.2004.045989; Serbecic N, 2011, BRIT J OPHTHALMOL, V95, P804, DOI 10.1136/bjo.2010.186221; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Youm Dong Ju, 2012, Korean J Ophthalmol, V26, P104, DOI 10.3341/kjo.2012.26.2.104	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147448	10.1371/journal.pone.0147448	http://dx.doi.org/10.1371/journal.pone.0147448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808961	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800096
J	Cordier, R; Chen, YW; Speyer, R; Totino, R; Doma, K; Leicht, A; Brown, N; Cuomo, B				Cordier, Reinie; Chen, Yu-Wei; Speyer, Renee; Totino, Rebekah; Doma, Kenji; Leicht, Anthony; Brown, Nicole; Cuomo, Belinda			Child-Report Measures of Occupational Performance: A Systematic Review	PLOS ONE			English	Review							ACQUIRED BRAIN-INJURY; METHODOLOGICAL QUALITY; PARTICIPATION OUTCOMES; PERCEIVED EFFICACY; CEREBRAL-PALSY; VALIDITY; RELIABILITY; COSMIN; PEGS	Introduction Improving occupational performance is a key service of occupational therapists and client-centred approach to care is central to clinical practice. As such it is important to comprehensively evaluate the quality of psychometric properties reported across measures of occupational performance; in order to guide assessment and treatment planning. Objective To systematically review the literature on the psychometric properties of child-report measures of occupational performance for children ages 2-18 years. Methods A systematic search of the following six electronic databases was conducted: CINAHL; Psy-cINFO; EMBASE; PubMed; the Health and Psychosocial Instruments (HAPI) database; and Google Scholar. The quality of the studies was evaluated against the COSMIN taxonomy of measurement properties and the overall quality of psychometric properties was evaluated using pre-set psychometric criteria. Results Fifteen articles and one manual were reviewed to assess the psychometric properties of the six measures-the PEGS, MMD, CAPE, PAC, COSA, and OSA-which met the inclusion criteria. Most of the measures had conducted good quality studies to evaluate the psychometric properties of measures (PEGS, CAPE, PAC, OSA); however, the quality of the studies for two of these measures was relatively weak (MMD, COSA). When integrating the quality of the psychometric properties of the measures with the quality of the studies, the PAC stood out as having superior psychometric qualities. Conclusions The overall quality of the psychometric properties of most measures was limited. There is a need for continuing research into the psychometric properties of child-report measures of occupational performance, and to revise and improve the psychometric properties of existing measures.	[Cordier, Reinie; Totino, Rebekah; Cuomo, Belinda] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Chen, Yu-Wei] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Speyer, Renee; Doma, Kenji; Leicht, Anthony; Brown, Nicole] James Cook Univ, Coll Healthcare Sci, Townsville, Qld 4811, Australia	Curtin University; University of Sydney; James Cook University	Cordier, R (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	reinie.cordier@curtin.edu.au	Leicht, Anthony/C-7187-2009; Cuomo, Belinda/AAI-2876-2021; Chen, Yu-Wei Ryan/AFN-1975-2022; Cordier, Reinie/AAH-6290-2019	Leicht, Anthony/0000-0002-0537-5392; Chen, Yu-Wei Ryan/0000-0001-5965-1279; Cordier, Reinie/0000-0002-9906-5300; Speyer, Renee/0000-0003-2828-8897; Doma, Kenji/0000-0002-8903-0067; Cuomo, Belinda/0000-0003-2841-7484	James Cook University Internal Faculty Grant	James Cook University Internal Faculty Grant	Funded by James Cook University Internal Faculty Grant.	Alderson P, 2004, COCHRANE LIB; American Occupational Therapy Association, 2008, AM J OCCUP THER, V62, P625, DOI DOI 10.5014/AJOT.62.6.625; Asgari A, 2008, OCCUP THER HEALTH CA, V22, P187, DOI 10.1080/07380570801991826; Brown Ted, 2014, Am J Occup Ther, V68, pe154, DOI 10.5014/ajot.2014.012237; Canadian Association of Occupational Therapists, 1997, ENABLING OCCUPATION; Capio CM, 2010, DEV MED CHILD NEUROL, V52, P908, DOI 10.1111/j.1469-8749.2010.03737.x; Chien CW, 2014, CHILD CARE HLTH DEV, V40, P458, DOI 10.1111/cch.12037; Christiansen C., 1997, OCCUPATIONAL THERAPY, P46; Clarke M, 2001, ASSESSMENT STUDY QUA, V4.1.4; Colon Wanda I, 2008, Occup Ther Int, V15, P100, DOI 10.1002/oti.250; Cordier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132299; Coster W, 1998, AM J OCCUP THER, V52, P337, DOI 10.5014/ajot.52.5.337; Coster W, 1995, OCCUPATIONAL THERAPY, P255; Coster WJ, 2006, OTJR-OCCUP PART HEAL, V26, P131, DOI 10.1177/153944920602600402; Darrah J, 2012, CHILD CARE HLTH DEV, V38, P41, DOI 10.1111/j.1365-2214.2010.01160.x; Debuse D, 2011, PEDIATR PHYS THER, V23, P221, DOI 10.1097/PEP.0b013e318227bbc6; Dunford C, 2013, BRIT J OCCUP THER, V76, P67, DOI 10.4276/030802213X13603244419158; Dunn W., 2000, BEST PRACTICE OCCUPA; Engel-Yeger Batya, 2008, Can J Occup Ther, V75, P220; Fawcett AJL., 2007, PRINCIPLES ASSESSMEN; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Harvey A, 2008, DEV MED CHILD NEUROL, V50, P190, DOI 10.1111/j.1469-8749.2008.02027.x; Ireland P, 2012, PHYS OCCUP THER PEDI, V32, P80, DOI 10.3109/01942638.2011.593619; James S, 2014, DEV MED CHILD NEUROL, V56, P233, DOI 10.1111/dmcn.12226; Keller Jessica, 2005, Scand J Occup Ther, V12, P118, DOI 10.1080/11038120510031752; Keller Jessica, 2005, Scand J Occup Ther, V12, P147, DOI 10.1080/11038120510031761; Kielhofner G., 2002, MODEL HUMAN OCCUPATI, P63; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; King GA, 2004, CAPE PAC MANUAL CHIL; Kramer JM, 2010, AM J OCCUP THER, V64, P621, DOI 10.5014/ajot.2010.08142; Law M, 2005, CANADIAN OCCUPATIONA, V4th; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Longo E, 2014, CHILD CARE HLTH DEV, V40, P231, DOI 10.1111/cch.12012; Ayuso DMR, 2009, OCCUP THER MENT HEAL, V25, P101, DOI 10.1080/01642120902856432; Matheson L., 2001, MEASURING OCCUPATION; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Nordtorp HL, 2013, PHYS OCCUP THER PEDI, V33, P199, DOI 10.3109/01942638.2012.739269; Organization WH, 2007, INT CLASS FUNCT DIS; Parker DM., 2006, BRIT J OCCUPATIONAL, V69, P150, DOI [10.1177/030802260606900402, DOI 10.1177/030802260606900402]; Potvin MC, 2013, AM J OCCUP THER, V67, P209, DOI 10.5014/ajot.2013.006288; Ricon T, 2013, OCCUP THER INT, V20, P173, DOI 10.1002/oti.1350; Rodger S., 2006, OCCUPATIONAL THERAPY; Rosenbaum P., 1998, FAMILY CENTRED SERVI, V18, P1, DOI [10.1080/J006v18n01, DOI 10.1080/J006V18N01, DOI 10.1080/J006v18n01_01]; Schellingerhout JM, 2012, QUAL LIFE RES, V21, P659, DOI 10.1007/s11136-011-9965-9; Speyer R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/458678; Sumsion T, 2000, BRIT J OCCUPATIONAL, V63, P304, DOI DOI 10.1177/030802260006300702; Taylor Renee, 2011, Am J Occup Ther, V65, pe20, DOI 10.5014/ajot.2011.000778; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Ullenhag A, 2012, SCAND J OCCUP THER, V19, P428, DOI 10.3109/11038128.2011.631218; van Hartingsveldt MJ, 2011, DEV MED CHILD NEUROL, V53, P506, DOI 10.1111/j.1469-8749.2010.03895.x; Vroland-Nordstrand K, 2012, SCAND J OCCUP THER, V19, P497, DOI 10.3109/11038128.2012.684221; Vroland-Nordstrand K, 2012, SCAND J OCCUP THER, V19, P506, DOI 10.3109/11038128.2012.685759; Wagner LV, 2012, CLIN ORTHOP RELAT R, V470, P1257, DOI 10.1007/s11999-011-2065-x; World Health Organization, 2001, ICF INT CLASFUNCT; Ziviani J, 2010, BRAIN IMPAIR, V11, P93, DOI 10.1375/brim.11.2.93	57	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147751	10.1371/journal.pone.0147751	http://dx.doi.org/10.1371/journal.pone.0147751			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808674	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800205
J	Hane, FT; Hayes, R; Lee, BY; Leonenko, Z				Hane, Francis T.; Hayes, Reid; Lee, Brenda Y.; Leonenko, Zoya			Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer's Amyloid-beta Peptides	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; A-BETA; PROTEIN OLIGOMERS; OXIDATIVE STRESS; DISEASE; BINDING; AGGREGATION; TOXICITY; SPECTROSCOPY; KINETICS	The presence of trace concentrations of metallic ions, such as copper and zinc, has previously been shown to drastically increase the aggregation rate and neurotoxicity of amyloid-beta (A beta), the peptide implicated in Alzheimer's disease (AD). The mechanism of why copper and zinc accelerate A beta aggregation is poorly understood. In this work, we use single molecule force spectroscopy (SMFS) to probe the kinetic and thermodynamic parameters (dissociation constant, K-d, kinetic dissociation rate, k(off), and free energy, Delta G) of the dissociation of an A beta dimer, the amyloid species which initiates the amyloid cascade. Our results show that nanomolar concentrations of copper do not change the single molecule affinity of A beta to another A beta peptide in a statistically significant way, while nanomolar concentrations of zinc decrease the affinity of A beta-A beta by an order of magnitude. This suggests that the binding of zinc ion to A beta may interfere with the binding of A beta-A beta, leading to a lower self-affinity.	[Hane, Francis T.; Lee, Brenda Y.; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Hayes, Reid; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Leonenko, Z (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.; Leonenko, Z (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca		Lee, Brenda/0000-0003-4086-7082	Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); Natural Science and Engineering Research Council of Canada (NSERC); University of Waterloo	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo	This research was supported by Canadian Foundation for Innovation (CFI), Ontario Research Fund (ORF), Natural Science and Engineering Research Council of Canada (NSERC) and University of Waterloo.	Alies B, 2011, J BIOL INORG CHEM, V16, P333, DOI 10.1007/s00775-010-0729-8; AnnaRita B, 2012, DYNAMIC FORCE SPECTR, P247; Azimi Samira, 2011, Int J Alzheimers Dis, V2011, P539762, DOI 10.4061/2011/539762; Bin YN, 2013, J INORG BIOCHEM, V119, P21, DOI 10.1016/j.jinorgbio.2012.10.013; Bisswanger H., 2008, ENZYME KINETICS PRIN; Buell AK, 2012, ANGEW CHEM INT EDIT, V51, P5247, DOI 10.1002/anie.201108040; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Drolle E, 2014, DRUG METAB REV, V46, P207, DOI 10.3109/03602532.2014.882354; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Friddle RW, 2012, P NATL ACAD SCI USA, V109, P13573, DOI 10.1073/pnas.1202946109; Furlan S, 2010, J PHYS CHEM B, V114, P15119, DOI 10.1021/jp102928h; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Han DX, 2008, BIOMETALS, V21, P189, DOI 10.1007/s10534-007-9107-6; Hane F, 2013, SINGLE MOL FORCE SPE; Hane FT, 2014, SOFT MATTER, V10, P1924, DOI 10.1039/c3sm52257a; Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101; Hane F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059005; Hane FT, 2014, BIOSENS BIOELECTRON, V54, P492, DOI 10.1016/j.bios.2013.10.060; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Karacsony O, 2011, LANGMUIR, V27, P11287, DOI 10.1021/la202530j; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Rozga M, 2010, CHEM RES TOXICOL, V23, P336, DOI 10.1021/tx900344n; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Suwalsky M, 2009, J ALZHEIMERS DIS, V17, P81, DOI 10.3233/JAD-2009-1032; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Zhang Yong, 2012, Yaoxue Xuebao, V47, P399	46	27	27	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147488	10.1371/journal.pone.0147488	http://dx.doi.org/10.1371/journal.pone.0147488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808970	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800110
J	Hu, JG; Zhou, J; Zhou, GM; Luo, YQ; Xu, XJ; Li, PH; Liang, JY				Hu, Junguo; Zhou, Jian; Zhou, Guomo; Luo, Yiqi; Xu, Xiaojun; Li, Pingheng; Liang, Junyi			Improving Estimations of Spatial Distribution of Soil Respiration Using the Bayesian Maximum Entropy Algorithm and Soil Temperature as Auxiliary Data	PLOS ONE			English	Article							CO2 EFFLUX; PARTICULATE MATTER; INTERPOLATION; VARIABILITY; AREA; HETEROGENEITY; DEPENDENCE; EMISSION; CARBON; SPACE	Soil respiration inherently shows strong spatial variability. It is difficult to obtain an accurate characterization of soil respiration with an insufficient number of monitoring points. However, it is expensive and cumbersome to deploy many sensors. To solve this problem, we proposed employing the Bayesian Maximum Entropy (BME) algorithm, using soil temperature as auxiliary information, to study the spatial distribution of soil respiration. The BME algorithm used the soft data (auxiliary information) effectively to improve the estimation accuracy of the spatiotemporal distribution of soil respiration. Based on the functional relationship between soil temperature and soil respiration, the BME algorithm satisfactorily integrated soil temperature data into said spatial distribution. As a means of comparison, we also applied the Ordinary Kriging (OK) and Co-Kriging (Co-OK) methods. The results indicated that the root mean squared errors (RMSEs) and absolute values of bias for both Day 1 and Day 2 were the lowest for the BME method, thus demonstrating its higher estimation accuracy. Further, we compared the performance of the BME algorithm coupled with auxiliary information, namely soil temperature data, and the OK method without auxiliary information in the same study area for 9, 21, and 37 sampled points. The results showed that the RMSEs for the BME algorithm (0.972 and 1.193) were less than those for the OK method (1.146 and 1.539) when the number of sampled points was 9 and 37, respectively. This indicates that the former method using auxiliary information could reduce the required number of sampling points for studying spatial distribution of soil respiration. Thus, the BME algorithm, coupled with soil temperature data, can not only improve the accuracy of soil respiration spatial interpolation but can also reduce the number of sampling points.	[Hu, Junguo; Zhou, Jian; Zhou, Guomo] Zhejiang A&F Univ, Informat Engn Coll, Linan, Peoples R China; [Hu, Junguo; Xu, Xiaojun; Li, Pingheng] Zhejiang Prov Key Lab Forestry Intelligent Monito, Linan, Peoples R China; [Luo, Yiqi; Liang, Junyi] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Zhejiang A&F University; University of Oklahoma System; University of Oklahoma - Norman	Zhou, GM (corresponding author), Zhejiang A&F Univ, Informat Engn Coll, Linan, Peoples R China.	zhougm@zafu.edu.cn	Liang, Junyi/H-3203-2016	Liang, Junyi/0000-0001-8252-5502; Zhou, Jian/0000-0001-9276-6086	NSF China Programs [31300539, 31500527, 31570629]; Public Welfare Technology Application Research Program of Zhejiang province [2015C31004]	NSF China Programs; Public Welfare Technology Application Research Program of Zhejiang province	This work was supported by the NSF China Programs (Grant No. 31300539 and 31500527), http://www.nsfc.gov.cn/; it was also supported by the Public Welfare Technology Application Research Program of Zhejiang province (Grant No. 2015C31004), http://www.zjkjt.gov.cn/.; This study was supported by the NSF China Programs (Grant No. 31300539 and 31570629) and the Public Welfare Technology Application Research Program of Zhejiang province (Grant No. 2015C31004).	Akita Y, 2012, J EXPO SCI ENV EPID, V22, P496, DOI 10.1038/jes.2012.57; [Anonymous], 2011, STAT SPATIOTEMPORAL; Bayat B, 2013, THEOR APPL CLIMATOL, V113, P429, DOI 10.1007/s00704-012-0795-7; Bogaert P, 2002, SOIL SCI SOC AM J, V66, P1492, DOI 10.2136/sssaj2002.1492; Bonavito N. L., 1994, Telematics and Informatics, V11, P295, DOI 10.1016/0736-5853(94)90021-3; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boyer DG, 1996, SOIL SCI, V161, P278, DOI 10.1097/00010694-199605000-00003; Brus DJ, 2008, EUR J SOIL SCI, V59, P166, DOI 10.1111/j.1365-2389.2007.00981.x; Chen ST, 2015, APPL SOIL ECOL, V86, P148, DOI 10.1016/j.apsoil.2014.10.013; CHRISTAKOS G, 1990, MATH GEOL, V22, P763, DOI 10.1007/BF00890661; Christakos G, 2000, ATMOS ENVIRON, V34, P3393, DOI 10.1016/S1352-2310(00)00080-7; Christakos G, 1998, MATH GEOL, V30, P435, DOI 10.1023/A:1021748324917; Christakos G, 2001, J GEOPHYS RES-ATMOS, V106, P9717, DOI 10.1029/2000JD900780; Christakos G, 2002, TEMPORAL GIS CD ROM; Clayton V, 1998, TECHNOMETRICS; D'Or D, 2001, STOCH ENV RES RISK A, V15, P87, DOI 10.1007/s004770000057; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Douaik A, 2005, GEODERMA, V128, P234, DOI 10.1016/j.geoderma.2005.04.006; Douaik A, 2004, STOCH ENV RES RISK A, V18, P219, DOI 10.1007/s00477-004-0177-5; Elbasiouny H, 2014, CATENA, V113, P70, DOI 10.1016/j.catena.2013.09.008; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Friedel MJ, 2013, ENVIRON MODELL SOFTW, V43, P60, DOI 10.1016/j.envsoft.2013.01.009; Gamma Design Software, 2008, GS GEOST ENV SCI VER; Gao SG, 2014, INT J APPL EARTH OBS, V32, P54, DOI 10.1016/j.jag.2014.03.003; Gomez-Casanovas N, 2013, GLOBAL CHANGE BIOL, V19, P1941, DOI 10.1111/gcb.12127; Guo PT, 2015, GEODERMA, V237, P49, DOI 10.1016/j.geoderma.2014.08.009; Hengl T., 2007, PRACTICAL GUIDE GEOS; Hu JG, 2013, ECOL MODEL, V266, P86, DOI 10.1016/j.ecolmodel.2013.06.027; Huang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105150; Jordan A, 2009, BIOGEOSCI DISCUSS, V6, P9977; Jurasinski G, 2012, FOREST ECOL MANAG, V263, P101, DOI 10.1016/j.foreco.2011.09.025; Kumar S, 2012, GEODERMA, V189, P627, DOI 10.1016/j.geoderma.2012.05.022; Lee SJ, 2010, STOCH ENV RES RISK A, V24, P283, DOI 10.1007/s00477-009-0317-z; Li AH, 2013, REMOTE SENS ENVIRON, V135, P52, DOI 10.1016/j.rse.2013.03.021; Li AH, 2013, INT J REMOTE SENS, V34, P227, DOI 10.1080/01431161.2012.712234; Li J., 2008, REV SPATIAL INTERPOL; Li J, 2010, GEOSCIENCE; Li J, 2014, ENVIRON MODELL SOFTW, V53, P173, DOI 10.1016/j.envsoft.2013.12.008; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; Orton TG, 2009, STOCH ENV RES RISK A, V23, P319, DOI 10.1007/s00477-008-0217-7; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Puangthongthub S, 2007, ATMOS ENVIRON, V41, P7788, DOI 10.1016/j.atmosenv.2007.06.051; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Savelieva E, 2005, GEODERMA, V128, P312, DOI 10.1016/j.geoderma.2005.04.011; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Strebel K, 2013, ENVIRON MODELL SOFTW, V41, P151, DOI 10.1016/j.envsoft.2012.12.001; Teixeira DD, 2013, SCI AGR, V70, P195, DOI 10.1590/S0103-90162013000300008; Teixeira DD, 2011, PLANT SOIL, V345, P187, DOI 10.1007/s11104-011-0770-6; Wood TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080965; Xiao WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101890; [徐林 Xu Lin], 2013, [林业科学, Scientia Silvae Sinicae], V49, P122; Yari G, 2012, COMPUT IND ENG, V63, P338, DOI 10.1016/j.cie.2012.03.010; Younger M.S., 1985, 1 COURSE LINEAR REGR; Yu HL, 2013, ENVIRON SCI TECHNOL, V47, P1416, DOI 10.1021/es302539f; Yu HL, 2009, ENVIRON HEALTH PERSP, V117, P537, DOI 10.1289/ehp.0800089; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117490; Zhang Bei, 2011, Acta Pedologica Sinica, V48, P831; Zhang SW, 2013, J INTEGR AGR, V12, P1673, DOI 10.1016/S2095-3119(13)60395-0; Zhou WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092531	60	11	12	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146589	10.1371/journal.pone.0146589	http://dx.doi.org/10.1371/journal.pone.0146589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807579	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800028
J	Ferri, MJ; Saez, M; Figueras, J; Fort, E; Sabat, M; Lopez-Ben, S; de Llorens, R; Aleixandre, RN; Peracaula, R				Jose Ferri, Maria; Saez, Marc; Figueras, Joan; Fort, Esther; Sabat, Miriam; Lopez-Ben, Santiago; de Llorens, Rafael; Nuria Aleixandre, Rosa; Peracaula, Rosa			Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; GROWTH-FACTOR AXIS; FACTOR-I AXIS; IGF-I; DUCTAL ADENOCARCINOMA; CANCER DIAGNOSIS; PROGNOSTIC SCORE; BIOMARKER PANEL; SERUM-LEVELS; IGFBP-3	Background There is still no reliable biomarker for the diagnosis of pancreatic adenocarcinoma. Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker only recommended for pancreatic adenocarcinoma follow-up. One of the clinical problems lies in distinguishing between this cancer and other benign pancreatic diseases such as chronic pancreatitis. In this study we will assess the value of panels of serum molecules related to pancreatic cancer physiopathology to determine whether alone or in combination could help to discriminate between these two pathologies. Methods CA 19-9, carcinoembryonic antigen (CEA), C-reactive protein, albumin, insulin growth factor-1 (IGF-1) and IGF binding protein-3 were measured using routine clinical analyzers in a cohort of 47 pancreatic adenocarcinoma, 20 chronic pancreatitis and 15 healthy controls. Results The combination of CA 19-9, IGF-1 and albumin resulted in a combined area under the curve (AUC) of 0.959 with 93.6% sensitivity and 95% specificity, much higher than CA 19-9 alone. An algorithm was defined to classify the patients as chronic pancreatitis or pancreatic cancer with the above specificity and sensitivity. In an independent validation group of 20 pancreatic adenocarcinoma and 13 chronic pancreatitis patients, the combination of the four molecules classified correctly all pancreatic adenocarcinoma and 12 out of 13 chronic pancreatitis patients. Conclusions Although this panel of markers should be validated in larger cohorts, the high sensitivity and specificity values and the convenience to measure these parameters in clinical laboratories shows great promise for improving pancreatic adenocarcinoma diagnosis.	[Jose Ferri, Maria] Dr Josep Trueta Univ Hosp, Clin Lab, Girona, Spain; [Saez, Marc] Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain; [Saez, Marc] CIBER Epidemiol & Publ Hlth CIBERESP, Girona, Spain; [Figueras, Joan; Lopez-Ben, Santiago] Dr Josep Trueta Univ Hosp, Girona Biomed Res Inst IDIBGI, Hepatobiliary & Pancreat Surg Unit, Girona, Spain; [Fort, Esther] Dr Josep Trueta Univ Hosp, Gastroenterol Unit, Girona, Spain; [Sabat, Miriam] Hosp Santa Caterina, Gastroenterol Unit, Girona, Spain; [Jose Ferri, Maria; de Llorens, Rafael; Peracaula, Rosa] Univ Girona, Dept Biol, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona	Peracaula, R (corresponding author), Univ Girona, Dept Biol, Girona, Spain.	rosa.peracaula@udg.edu		Sabat Mir, Miriam/0000-0001-7008-7373; Peracaula, Rosa/0000-0003-3513-524X; FERRI, M JOSE/0000-0002-2885-7175; Fort, Esther/0000-0002-9584-1210	Spanish Ministry of Science and Innovation Instituto de Salud Carlos III, Spain (FIS) [BIO 2010-16922, PI08621]	Spanish Ministry of Science and Innovation Instituto de Salud Carlos III, Spain (FIS)	Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/) [grant BIO 2010-16922 to RP] Instituto de Salud Carlos III, Spain (http://www.isciii.es/) (FIS Grant No. PI08621 to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasenthil S, 2011, CANCER PREV RES, V4, P137, DOI 10.1158/1940-6207.CAPR-10-0025; Bing C, 2005, BRIT J NUTR, V93, P761, DOI 10.1079/BJN20051459; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Brand RE, 2011, CLIN CANCER RES, V17, P805, DOI 10.1158/1078-0432.CCR-10-0248; Cartensen B, 2013, EPI PACKAGE STAT ANA; Chung HW, 2011, CANCER SCI, V102, P1673, DOI 10.1111/j.1349-7006.2011.01989.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Douglas JB, 2010, CANCER EPIDEM BIOMAR, V19, P2298, DOI 10.1158/1055-9965.EPI-10-0400; El-Mesallamy HO, 2013, PANCREAS, V42, P149, DOI 10.1097/MPA.0b013e3182550d9d; Evans JD, 1997, INT J PANCREATOL, V22, P95; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Hills M, 2009, FOLLOW UP EPI PACKAG; Jenkinson C, 2015, EXPERT REV GASTROENT, V9, P305, DOI 10.1586/17474124.2015.965145; Karna E, 2002, INT J EXP PATHOL, V83, P239, DOI 10.1046/j.1365-2613.2002.00237.x; Kaur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055171; Kloppel G, 2009, ARCH PATHOL LAB MED, V133, P382, DOI 10.1043/1543-2165-133.3.382; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CANCER EPIDEM BIOMAR, V13, P487; Matsumoto I, 2013, CLIN GASTROENTEROL H, V11, P712, DOI 10.1016/j.cgh.2012.12.033; Meggiato T, 1999, TUMOR BIOL, V20, P65, DOI 10.1159/000030049; Miyake K, 2010, CYTOKINE, V49, P251, DOI 10.1016/j.cyto.2009.09.010; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Nie S, 2014, J PROTEOME RES, V13, P1873, DOI 10.1021/pr400967x; Okamoto I, 2010, JPN J CLIN ONCOL, V40, P222, DOI 10.1093/jjco/hyp155; Ozkan H, 2011, PANCREATOLOGY, V11, P295, DOI 10.1159/000328963; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pepe MS, 2009, STATA J, V9, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robin X, 2013, PACKAGE PROC; Rohrmann S, 2012, BRIT J CANCER, V106, P1004, DOI 10.1038/bjc.2012.19; Shimoda M, 2010, CHEMOTHERAPY, V56, P501, DOI 10.1159/000321014; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Stolzenberg-Solomon RZ, 2004, CANCER EPIDEM BIOMAR, V13, P438; Strobel O, 2013, NAT REV GASTRO HEPAT, V10, P203, DOI 10.1038/nrgastro.2013.42; Tonack S, 2013, BRIT J CANCER, V108, P1846, DOI 10.1038/bjc.2013.150; Wang W, 2011, PANCREATOLOGY, V11, P16, DOI 10.1159/000322982; Wolpin BM, 2007, BRIT J CANCER, V97, P98, DOI 10.1038/sj.bjc.6603826; Zeh H. J., 2005, Cancer Biomarkers, V1, P259; Zhang PJ, 2014, INT J CANCER, V134, P2646, DOI 10.1002/ijc.28584; Zhou W, 1998, CANCER EPIDEM BIOMAR, V7, P109	43	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147214	10.1371/journal.pone.0147214	http://dx.doi.org/10.1371/journal.pone.0147214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808421	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800063
J	Korsten, H; Ziel-van der Made, ACJ; Van Weerden, WM; van der Kwast, T; Trapman, J; Van Duijn, PW				Korsten, Hanneke; Ziel-van der Made, Angelique C. J.; van Weerden, Wytske M.; van der Kwast, Theo; Trapman, Jan; Van Duijn, Petra W.			Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice	PLOS ONE			English	Article							DEFICIENT MOUSE MODEL; INTRADUCTAL CARCINOMA; GENE-EXPRESSION; CANCER; LEADS; INFLAMMATION; INFILTRATION; PROGRESSION; ACTIVATION; SUBTYPES	Previously, we generated a preclinical mouse prostate tumor model based on PSA-Cre driven inactivation of Pten. In this model homogeneous hyperplastic prostates (4-5m) developed at older age (> 10m) into tumors. Here, we describe the molecular and histological characterization of the tumors in order to better understand the processes that are associated with prostate tumorigenesis in this targeted mouse Pten knockout model. The morphologies of the tumors that developed were very heterogeneous. Different histopathological growth patterns could be identified, including intraductal carcinoma (IDC), adenocarcinoma and undifferentiated carcinoma, all strongly positive for the epithelial cell marker Cytokeratin (CK), and carcinosarcomas, which were negative for CK. IDC pattern was already detected in prostates of 7-8 month old mice, indicating that it could be a precursor stage. At more than 10 months IDC and carcinosarcoma were most frequently observed. Gene expression profiling discriminated essentially two molecular subtypes, denoted tumor class 1 (TC1) and tumor class 2 (TC2). TC1 tumors were characterized by high expression of epithelial markers like Cytokeratin 8 and E-Cadherin whereas TC2 tumors showed high expression of mesenchyme/stroma markers such as Snail and Fibronectin. These molecular subtypes corresponded with histological growth patterns: where TC1 tumors mainly represented adenocarcinoma / intraductal carcinoma, in TC2 tumors carcinosarcoma was the dominant growth pattern. Further molecular characterization of the prostate tumors revealed an increased expression of genes associated with the inflammatory response. Moreover, functional markers for senescence, proliferation, angiogenesis and apoptosis were higher expressed in tumors compared to hyperplasia. The highest expression of proliferation and angiogenesis markers was detected in TC2 tumors. Our data clearly showed that in the genetically well-defined PSA-Cre; Pten-loxP/loxP prostate tumor model, histopathological, molecular and biological heterogeneity occurred during later stages of tumor development.	[Korsten, Hanneke; Ziel-van der Made, Angelique C. J.; van der Kwast, Theo; Trapman, Jan; Van Duijn, Petra W.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [van Weerden, Wytske M.; Van Duijn, Petra W.] Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands; [van der Kwast, Theo] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Van Duijn, PW (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.; Van Duijn, PW (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands.	p.vanduijn@erasmusmc.nl		Van der Kwast, Theodorus/0000-0001-8640-5786	Innovative Medicines Initiative Joint Undertaking [115188]; European Union; Dutch Cancer Society KWF [EMCR 2006-3592]	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Dutch Cancer Society KWF(KWF Kankerbestrijding)	The research leading to these results has received support from: The Innovative Medicines Initiative Joint Undertaking under grant agreement no 115188, resources of which are composed of financial contribution from the European Union's 7th Framework Programme (2007-2013) and EFPIA companies' in kind contribution. www.predect.eu. Dutch Cancer Society KWF (Grant number: EMCR 2006-3592, www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Bianchi-Frias D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r117; Boyd LK, 2012, NAT REV UROL, V9, P652, DOI 10.1038/nrurol.2012.185; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2015, PROSTATE, V75, P1247, DOI 10.1002/pros.23005; CHU CT, 1994, LAB INVEST, V71, P792; De Velasco MA, 2014, CARCINOGENESIS, V35, P2142, DOI 10.1093/carcin/bgu143; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fraser M., 2014, UROL ONCOL; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Fujii T, 2013, PATHOBIOLOGY, V80, P119, DOI 10.1159/000342396; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haverkamp J, 2008, J CELL BIOCHEM, V103, P1344, DOI 10.1002/jcb.21536; Henry PC, 2009, J CLIN PATHOL, V62, P579, DOI 10.1136/jcp.2009.065003; Jackerott M, 2006, ENDOCRINOLOGY, V147, P5752, DOI 10.1210/en.2006-0601; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kobayashi M, 2008, PROSTATE, V68, P1715, DOI 10.1002/pros.20832; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lindberg J, 2015, EUR UROL, V67, P819, DOI 10.1016/j.eururo.2014.09.006; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Lotan TL, 2013, MODERN PATHOL, V26, P587, DOI 10.1038/modpathol.2012.201; Luchman HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003940; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Morais CL, 2015, AM J SURG PATHOL, V39, P169, DOI 10.1097/PAS.0000000000000348; O'Brien C, 2010, AM J CLIN PATHOL, V133, P654, DOI 10.1309/AJCP8EL5FTZSOBIH; Orr B, 2011, PROSTATE, V71, P305, DOI 10.1002/pros.21244; Petronilho Fabricia, 2013, Inflammation & Allergy Drug Targets, V12, P172; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Robinson BD, 2010, J UROLOGY, V184, P1328, DOI 10.1016/j.juro.2010.06.017; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Siadat F, 2015, PROSTATE, V75, P1277, DOI 10.1002/pros.23009; Solan JL, 2012, J MEMBRANE BIOL, V245, P255, DOI 10.1007/s00232-012-9446-2; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Squire JA, 2011, ADV CANCER RES, V112, P183, DOI 10.1016/B978-0-12-387688-1.00007-7; Strasner A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00128; Svensson RU, 2011, AM J PATHOL, V179, P502, DOI 10.1016/j.ajpath.2011.03.014; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thielen JL, 2007, DIFFERENTIATION, V75, P49, DOI 10.1111/j.1432-0436.2006.00115.x; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsuzuki T, 2015, INT J UROL, V22, P140, DOI 10.1111/iju.12657; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wilcox G, 1998, HUM PATHOL, V29, P1119, DOI 10.1016/S0046-8177(98)90423-3; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003	57	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147500	10.1371/journal.pone.0147500	http://dx.doi.org/10.1371/journal.pone.0147500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807730	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800113
J	Magombedze, G; Eda, S; Koets, A				Magombedze, Gesham; Eda, Shigetoshi; Koets, Ad			Can Immune Response Mechanisms Explain the Fecal Shedding Patterns of Cattle Infected with Mycobacterium avium Subspecies paratuberculosis?	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; GAMMA-INTERFERON; JOHNES-DISEASE; MACROPHAGES; INTERLEUKIN-10; EXPRESSION; SURVIVAL; CULTURE; CALVES	Johne's disease (JD) is a chronic disease in ruminants and is caused by infection with Mycobacterium avium subspecies paratuberculosis (MAP). At late stages of the disease, MAP bacilli are shed via feces excretion and in turn create the potential for oral-fecal transmission. The role of the host immune response in MAP bacteria shedding patterns at different stages of JD is still unclear. We employed mathematical modeling to predict if the variation in MAP shedding could be correlated to the immune response in infected animals. We used a novel inverse modeling approach that assumed biological interactions among the antigen-specific lymphocyte proliferation response (cell-mediated response), antibody/humoral immune responses, and MAP bacteria. The modeling framework was used to predict and test possible biological interactions between the measured variables and returns only the essential interactions that are relevant in explaining the observed cattle MAP experimental infection data. Through confronting the models with data, we predicted observed effects (enhancement or suppression) and extents of interactions among the three variables. This analysis enabled classification of the infected cattle into three different groups that correspond to the unique predicted immune responses that are essential to explain the data from cattle within these groups. Our analysis highlights the strong and weak points of the modeling approach, as well as the key immune mechanisms predicted to be expressed in all animals and those that were different between animals, hence giving insight into how animals exhibit different disease dynamics and bacteria shedding patterns.	[Magombedze, Gesham] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA; [Magombedze, Gesham] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Eda, Shigetoshi] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Ctr Wildlife Hlth, Knoxville, TN USA; [Koets, Ad] Wageningen Univ & Res Ctr, Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Koets, Ad] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	University of Tennessee System; University of Tennessee Knoxville; Imperial College London; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Wageningen University & Research; Utrecht University	Magombedze, G (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA.; Magombedze, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	gmagombedze@nimbios.org		Magombedze, Gesham/0000-0003-2745-3475	National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville	National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville	The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank valuable comments on our models from members of NIMBioS working group, Within-host modeling of MAP infections.; The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the members of the NIMBioS working group for their valuable comments regarding our within-host modeling of MAP infections.	Bannantine JP, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-2; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Buza JJ, 2004, INFECT IMMUN, V72, P2425, DOI 10.1128/IAI.72.4.2425-2428.2004; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; de Silva K, 2013, PREV VET MED, V112, P203, DOI 10.1016/j.prevetmed.2013.08.006; de Silva K, 2011, VET IMMUNOL IMMUNOP, V139, P10, DOI 10.1016/j.vetimm.2010.07.022; GILMOUR NJL, 1965, J COMP PATHOL THERAP, V75, P281, DOI 10.1016/0021-9975(65)90033-2; Gollnick NS, 2007, VET IMMUNOL IMMUNOP, V120, P93, DOI 10.1016/j.vetimm.2007.07.017; JORGENSEN JB, 1982, ACTA VET SCAND, V23, P325; Koets AP, 1999, VET IMMUNOL IMMUNOP, V70, P105, DOI 10.1016/S0165-2427(99)00062-8; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Langelaar MFM, 2005, THESIS UTRECHT U; Magombedze G, 2013, FRONT PHYSIOL, P4; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Magombedze G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003414; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Salem M, 2013, TROP ANIM HEALTH PRO, V45, P351, DOI 10.1007/s11250-012-0274-2; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P393, DOI 10.1128/CVI.00359-10; Stabel JR, 1996, J VET DIAGN INVEST, V8, P345, DOI 10.1177/104063879600800311; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; VARY PH, 1990, J CLIN MICROBIOL, V28, P933, DOI 10.1128/JCM.28.5.933-937.1990; Verna AE, 2007, ZOONOSES PUBLIC HLTH, V54, P243, DOI 10.1111/j.1863-2378.2007.01058.x; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	31	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146844	10.1371/journal.pone.0146844	http://dx.doi.org/10.1371/journal.pone.0146844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808389	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800035
J	Nemescu, D; Ursu, RG; Nemescu, ER; Negura, L				Nemescu, Dragos; Ursu, Ramona Gabriela; Nemescu, Elena Roxana; Negura, Lucian			Heterogeneous Distribution of Fetal Microchimerism in Local Breast Cancer Environment	PLOS ONE			English	Article							CELLS; WOMEN; QUANTIFICATION; CHIMERISM; DNA	Fetal cells enter maternal circulation during pregnancy and persist in the woman's body for decades, achieving a form of physiological microchimerism. These cells were also evidenced in tumors. We investigated the frequency and concentration of fetal microchimerism in the local breast cancer environment. From 19 patients with confirmed breast neoplasia, after breast surgical resection, we collected three fresh specimens from the tumor core, breast tissue at tumor periphery, and adjacent normal breast tissue. The presence of male DNA was analyzed with a quantitative PCR assay for the sex determining region gene (SRY) gene. In the group of women who had given birth to at least one son, we detected fetal microchimerism in 100% of samples from tumors and their periphery and in 64% (9 of 14) of those from normal breast tissue. The tissues from the tumor and its periphery carry a significantly increased number of SRY copies compared to its neighboring common breast tissue (p = 0.005). The median of the normalized SRY-signal was about 77 (range, 3.2-21467) and 14-fold (range, 1.3-2690) greater in the tumor and respectively in the periphery than in the normal breast tissue. In addition, the relative expression of the SRY gene had a median 5.5 times larger in the tumor than in its periphery (range, 1.1-389.4). We found a heterogeneous distribution of fetal microchimerism in breast cancer environment. In women with sons, breast neoplasia harbors male cells at significantly higher levels than in peripheral and normal breast tissue.	[Nemescu, Dragos] Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania; [Nemescu, Dragos] Cuza Voda Obstet & Gynecol Hosp, Iasi, Romania; [Ursu, Ramona Gabriela] Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania; [Nemescu, Elena Roxana] Univ Med & Pharm Gr T Popa, Dept Infect Dis, Iasi, Romania; [Negura, Lucian] Univ Med & Pharm Gr T Popa, Dept Immunol & Oncogenet, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy	Ursu, RG (corresponding author), Univ Med & Pharm Gr T Popa, Dept Microbiol, Iasi, Romania.	ramonagabrielaursu@yahoo.com	Ursu, Ramona Gabriela/U-6053-2017; Nemescu, Dragos/AAC-7813-2019; Negura, Lucian/A-9652-2011	Nemescu, Dragos/0000-0003-2345-1077; Ursu, Ramona Gabriela/0000-0002-1811-7923	Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grantl [PN-II-RU-TE-2014-4-2257]; UEFISCDI Young Research Teams research grant [PN-II-RU-TE-2014-4-2257]	Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grantl(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); UEFISCDI Young Research Teams research grant(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was partially supported by Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii Young Research Teams research grant PN-II-RU-TE-2014-4-2257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported partially by UEFISCDI Young Research Teams research grant PN-II-RU-TE-2014-4-2257. We would like to thank Dr S. Musca, Dr D. Scripcaru and Dr C. Terinte of the pathology unit for their assistance in probe collection and pathological evaluation.	Barbisin M, 2011, J FORENSIC RES, V2, P2; Barbisin M, 2009, J FORENSIC SCI, V54, P305, DOI 10.1111/j.1556-4029.2008.00951.x; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Cha D, 2003, OBSTET GYNECOL, V102, P774, DOI 10.1016/S0029-7844(03)00615-X; Dhimolea E, 2013, INT J CANCER, V133, P835, DOI 10.1002/ijc.28077; Dubernard G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1860; Eun JK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02192; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Gadi VK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001706; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Gadi VK, 2010, BREAST CANCER RES TR, V121, P241, DOI 10.1007/s10549-009-0548-1; Gadi VK, 2009, CANCER LETT, V276, P8, DOI 10.1016/j.canlet.2008.07.025; Huu SN, 2007, P NATL ACAD SCI USA, V104, P1871, DOI 10.1073/pnas.0606490104; Kamper-Jorgensen M, 2014, INT J EPIDEMIOL, V43, P168, DOI 10.1093/ije/dyt230; Kamper-Jorgensen Mads, 2012, Chimerism, V3, P72, DOI 10.4161/chim.22770; Kamper-Jorgensen M, 2012, EUR J CANCER, V48, P2227, DOI 10.1016/j.ejca.2012.02.006; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Klonisch T, 2009, TRENDS MOL MED, V15, P510, DOI 10.1016/j.molmed.2009.09.002; Koopmans M, 2008, J REPROD IMMUNOL, V78, P68, DOI 10.1016/j.jri.2008.01.002; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Nemescu D, 2008, GINECO RO, V4, P212; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147675	10.1371/journal.pone.0147675	http://dx.doi.org/10.1371/journal.pone.0147675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808509	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800176
J	Sharma, M; Tuaine, J; McLaren, B; Waters, DL; Black, K; Jones, LM; McCormick, SPA				Sharma, Monika; Tuaine, Jo; McLaren, Blair; Waters, Debra L.; Black, Katherine; Jones, Lynnette M.; McCormick, Sally P. A.			Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; DOXORUBICIN; PACLITAXEL; CARDIOMYOPATHY; THERAPY	Cardiovascular complications have emerged as a major concern for cancer patients. Many chemotherapy agents are cardiotoxic and some appear to also alter lipid profiles, although the mechanism for this is unknown. We studied plasma lipid levels in 12 breast cancer patients throughout their chemotherapy. Patients received either four cycles of doxorubicin and cyclophosphamide followed by weekly paclitaxel or three cycles of epirubicin, cyclophosphamide and 5'-fluorouracil followed by three cycles of docetaxel. Patients demonstrated a significant reduction (0.32 mmol/L) in high density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (apoA1) levels (0.18 g/L) and an elevation in apolipoprotein B (apoB) levels (0.15 g/L) after treatment. Investigation of the individual chemotherapy agents for their effect on genes involved in lipoprotein metabolism in liver cells showed that doxorubicin decreased ATP binding cassette transporter A1 (ABCA1) via a downregulation of the peroxisomal proliferator activated receptor. (PPAR.) and liver X receptor a (LXRa) transcription factors. In contrast, ABCA1 levels were not affected by cyclophosphamide or paclitaxel. Likewise, apoA1 levels were reduced by doxorubicin and remained unaffected by cyclophosphamide and paclitaxel. Doxorubicin and paclitaxel both increased apoB protein levels and paclitaxel also decreased low density lipoprotein receptor (LDLR) protein levels. These findings correlate with the observed reduction in HDL-C and apoA1 and increase in apoB levels seen in these patients. The unfavourable lipid profiles produced by some chemotherapy agents may be detrimental in the longer term to cancer patients, especially those already at risk of cardiovascular disease (CVD). This knowledge may be useful in tailoring effective follow-up care plans for cancer survivors.	[Sharma, Monika; McCormick, Sally P. A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Tuaine, Jo; McLaren, Blair] Dunedin Publ Hosp, Southern Blood & Canc Serv, Dunedin, New Zealand; [Waters, Debra L.] Univ Otago, Dept Med, Dunedin, New Zealand; [Black, Katherine] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Jones, Lynnette M.] Univ Otago, Sch Phys Educ Sport & Exercise Sci, Dunedin, New Zealand	University of Otago; Dunedin Public Hospital; University of Otago; University of Otago; University of Otago	McCormick, SPA (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	sally.mccormick@otago.ac.nz	Sharma, Monika/W-1636-2019	McCormick, Sally/0000-0001-9857-0703	University of Otago; New Zealand Heart Foundation [NHF 1509]	University of Otago; New Zealand Heart Foundation	This work was supported by University of Otago to LJ & KB and a New Zealand Heart Foundation grant (NHF 1509) to SM and a University of Otago postgraduate scholarship to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; ALEXOPOULOS CG, 1992, CANCER CHEMOTH PHARM, V30, P412, DOI 10.1007/BF00689971; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Bell KE, 2014, CLIN NUTR, V33, P550, DOI 10.1016/j.clnu.2013.08.001; Brace RJ, 2010, J LIPID RES, V51, P3370, DOI 10.1194/jlr.D008300; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIANNI L, 1995, J CLIN ONCOL, V13, P2688, DOI 10.1200/JCO.1995.13.11.2688; Gollerkeri A, 2001, INT J CANCER, V93, P139, DOI 10.1002/ijc.1295; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; PEASE RJ, 1990, J BIOL CHEM, V265, P553; Pein F, 2004, BRIT J CANCER, V91, P37, DOI 10.1038/sj.bjc.6601904; RAGHAVAN D, 1992, J CLIN ONCOL, V10, P1386, DOI 10.1200/JCO.1992.10.9.1386; Rzymowska J, 1999, PATHOBIOLOGY, V67, P129, DOI 10.1159/000028062; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Schultz PN, 2003, INT J CANCER, V104, P488, DOI 10.1002/ijc.10981; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shenoy C, 2011, ONCOLOGIST, V16, P1138, DOI 10.1634/theoncologist.2010-0348; STEINHERZ LJ, 1981, MED PEDIATR ONCOL, V9, P417, DOI 10.1002/mpo.2950090502; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111	25	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148049	10.1371/journal.pone.0148049	http://dx.doi.org/10.1371/journal.pone.0148049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807857	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800268
J	Yu, G; Li, H; Yang, SH; Wen, JG; Niu, JQ; Zu, YL				Yu, Ge; Li, Huan; Yang, Shuanghui; Wen, Jianguo; Niu, Junqi; Zu, Youli			ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells	PLOS ONE			English	Article							DISCOVERY	Hepatocellular carcinoma (HCC) is the third leading cause of death due to cancer worldwide with over 500,000 people affected annually. Although chemotherapy has been widely used to treat patients with HCC, alternate modalities to specifically deliver therapeutic cargos to cancer cells have been sought in recent years due to the severe side effects of chemotherapy. In this respect, aptamer-based tumor targeted drug delivery has emerged as a promising approach to increase the efficacy of chemotherapy and reduce or eliminate drug toxicity. In this study, we developed a new HepG2-specific aptamer (HCA#3) by a procedure known as systematic evolution of ligands by exponential enrichment (SELEX) and exploited its role as a targeting ligand to deliver doxorubicin (Dox) to HepG2 cells in vitro. The selected 76-base nucleotide aptamer preferentially bound to HepG2 hepatocellular carcinoma cells but not to control cells. The aptamer HCA#3 was modified with paired CG repeats at the 5'-end to carry and deliver a high payload of intercalated Dox molecules at the CG sites. Four Dox molecules (mol/mol) were fully intercalated in each conjugate aptamer-Dox (ApDC) molecule. Biostability analysis showed that the ApDC molecules are stable in serum. Functional analysis showed that ApDC specifically targeted and released Dox within HepG2 cells but not in control cells, and treatment with HCA#3 ApDC induced HepG2 cell apoptosis but had minimal effect on control cells. Our study demonstrated that HCA#3 ApDC is a promising aptamer-targeted therapeutic that can specifically deliver and release a high doxorubicin payload in HCC cells.	[Yu, Ge; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China; [Yu, Ge; Li, Huan; Yang, Shuanghui; Wen, Jianguo; Zu, Youli] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA; [Li, Huan; Yang, Shuanghui] Cent South Univ, Xiangya Hosp, Changsha 410083, Hunan, Peoples R China	Jilin University; The Methodist Hospital System; The Methodist Hospital - Houston; Central South University	Niu, JQ (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China.; Wen, JG; Zu, YL (corresponding author), Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA.	jwen@HoustonMethodist.org; junqiniu@aliyun.com; yzu@HoustonMethodist.org			National Instiutes of Health [R01CA151955, R33CA173382]; Cancer Prevention Research Institute of Texas [RP140315]; National Science and Technology Major Project [2014ZX10002002, 2013ZX10002008]; National Natural Science Foundation of China [81373057]; NATIONAL CANCER INSTITUTE [R01CA151955, R33CA173382] Funding Source: NIH RePORTER	National Instiutes of Health; Cancer Prevention Research Institute of Texas; National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01CA151955, http://www.nih.gov/, National Instiutes of Health to YLZ; R33CA173382, http://www.nih.gov/, National Instiutes of Health to YLZ; RP140315, http://www.cprit.state.tx.us/, Cancer Prevention Research Institute of Texas to YLZ; 2014ZX10002002, http://www.most.gov.cn/eng/programmes1/200610/t20061008_36200.htm, National Science and Technology Major Project to JQN; 2013ZX10002008, http://www.most.gov.cn/eng/programmes1/200610/t20061008_36200.htm, National Science and Technology Major Project to JQN; and 81373057, http://www.nsfc.gov.cn/, National Natural Science Foundation of China to JQN.	Akitomi J, 2011, BIOINFORMATION, V7, P38; Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gish RG, 2012, EXPERT REV GASTROENT, V6, P173, DOI [10.1586/egh.11.105, 10.1586/EGH.11.105]; Gross S, 2006, CURR OPIN CHEM BIOL, V10, P334, DOI 10.1016/j.cbpa.2006.06.028; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Hong H, 2011, CURR MED CHEM, V18, P4195, DOI 10.2174/092986711797189691; Hu Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728342; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lencioni Riccardo, 2013, Recent Results Cancer Res, V190, P181, DOI 10.1007/978-3-642-16037-0_12; Lencioni R, 2012, SEMIN ONCOL, V39, P503, DOI 10.1053/j.seminoncol.2012.05.004; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet Josep M, 2004, Curr Treat Options Gastroenterol, V7, P431, DOI 10.1007/s11938-004-0002-8; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Meng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033434; Parekh P, 2013, BIOMATERIALS, V34, P8909, DOI 10.1016/j.biomaterials.2013.07.099; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Porciani D, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.9; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Soontornworajit B, 2011, ANAL BIOANAL CHEM, V399, P1591, DOI 10.1007/s00216-010-4559-x; Subramanian N, 2012, MOL VIS, V18, P2783; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wen J, 2015, LEUKEMIA; Xing H, 2013, J MATER CHEM B, V1, P5288, DOI 10.1039/c3tb20412j; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	9	9	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147674	10.1371/journal.pone.0147674	http://dx.doi.org/10.1371/journal.pone.0147674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808385	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800175
J	Chen, YG				Chen, Yanguang			Spatial Autocorrelation Approaches to Testing Residuals from Least Squares Regression	PLOS ONE			English	Article								In geo-statistics, the Durbin-Watson test is frequently employed to detect the presence of residual serial correlation from least squares regression analyses. However, the Durbin-Watson statistic is only suitable for ordered time or spatial series. If the variables comprise cross-sectional data coming from spatial random sampling, the test will be ineffectual because the value of Durbin-Watson's statistic depends on the sequence of data points. This paper develops two new statistics for testing serial correlation of residuals from least squares regression based on spatial samples. By analogy with the new form of Moran's index, an autocorrelation coefficient is defined with a standardized residual vector and a normalized spatial weight matrix. Then by analogy with the Durbin-Watson statistic, two types of new serial correlation indices are constructed. As a case study, the two newly presented statistics are applied to a spatial sample of 29 China's regions. These results show that the new spatial autocorrelation models can be used to test the serial correlation of residuals from regression analysis. In practice, the new statistics can make up for the deficiencies of the Durbin-Watson test.	[Chen, Yanguang] Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing 100871, Peoples R China	Peking University	Chen, YG (corresponding author), Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	chenyg@pku.edu.cn			National Natural Science Foundation of China [41171129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by the National Natural Science Foundation of China (Grant no. 41171129). The support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty M, 1991, FRACTALS CHAOS, P43; Bowerman B. L., 1993, FORECASTING TIME SER; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bulliet R, 2010, EARTH ITS PEOPLES GL, V1; Chen Y.G., 2011, MATH METHODS GEOGRAP; Chen YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126158; Chen YG, 2012, LETT SPAT RESOUR SCI, V5, P65, DOI 10.1007/s12076-011-0076-6; Chen YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068336; [陈彦光 Chen Yanguang], 2011, [地理科学, Scientia Geographica Sinica], V30, P1; Chen YG, 2008, DISCRETE DYN NAT SOC, V2008, DOI 10.1155/2008/728420; Cliff A, 1973, SPATIAL AUTOCORRELAT; COX DR, 1958, J R STAT SOC B, V20, P215; Cox DR., 1989, ANAL BINARY DATA; Cumming G., 2013, UNDERSTANDING NEW ST; Dillinger W, 1979, 795 WORLD BANK; DURBIN J, 1971, BIOMETRIKA, V58, P1; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Fotheringham A.S., 1989, SPATIAL INTERACTION; Geary R.C., 1954, INC STAT, V5, P115, DOI [DOI 10.2307/2986645, 10.2307/2986645]; Haggett P., 1977, LOCATIONAL ANAL HUMA; KAC M, 1969, SCIENCE, V166, P695, DOI 10.1126/science.166.3906.695; Longley P.A., 1999, APPL GEOGRAPHY PRINC, P605; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; RAO DN, 1989, ENVIRON PLANN B, V16, P289, DOI 10.1068/b160289; Rao DN, 1988, NAT WORKSH FUT TECHN; SARGAN JD, 1983, ECONOMETRICA, V51, P153, DOI 10.2307/1912252; Zhou Y.X., 1999, URBAN GEOGR; Zhou YX, 1989, CHINESE SOCIOLOGY AN, V21, P3	30	31	31	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146865	10.1371/journal.pone.0146865	http://dx.doi.org/10.1371/journal.pone.0146865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800271	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300043
J	Snodgrass, R; Gardner, A; Jiang, L; Fu, C; Cesarman, E; Erickson, D				Snodgrass, Ryan; Gardner, Andrea; Jiang, Li; Fu, Cheng; Cesarman, Ethel; Erickson, David			KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; HERPESVIRUS; LYMPHOMA; DNA; OUTCOMES; DISEASE; GENE	Resource-limited settings present unique engineering challenges for medical diagnostics. Diagnosis is often needed for those unable to reach central healthcare systems, making portability and independence from traditional energy infrastructure essential device parameters. In 2014, our group presented a microfluidic device that performed a solar-powered variant of the polymerase chain reaction, which we called solar thermal PCR. In this work, we expand on our previous effort by presenting an integrated, portable, solar thermal PCR system targeted towards the diagnosis of Kaposi's sarcoma. We call this system KS-Detect, and we now report the system's performance as a diagnostic tool using pseudo-biopsy samples made from varying concentrations of human lymphoma cell lines positive for the KS herpesvirus (KSHV). KS-Detect achieved 83% sensitivity and 70% specificity at high (>= 10%) KSHV+ cell concentrations when diagnosing pseudo-biopsy samples by smart-phone image. Using histology, we confirm that our prepared pseudo-biopsies contain similar KSHV+ cell concentrations as human biopsies positive for KS. Through our testing of samples derived from human cell lines, we validate KS-Detect as a viable, portable KS diagnostic tool, and we identify critical engineering considerations for future solar-thermal PCR devices.	[Snodgrass, Ryan; Jiang, Li; Fu, Cheng; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Gardner, Andrea; Cesarman, Ethel] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Gardner, Andrea] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Cesarman, E (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA.	ecesarm@med.cornell.edu; de54@cornell.edu	Erickson, David/A-3319-2009	Erickson, David/0000-0002-1624-9711; Snodgrass, Ryan/0000-0003-0938-0356	US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) [EB016803]; National Science Foundation [ECCS-15420819]; STC Program of the National Science Foundation [ECS-9876771]; NATIONAL CANCER INSTITUTE [UH3CA202723] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016803] Funding Source: NIH RePORTER	US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB); National Science Foundation(National Science Foundation (NSF)); STC Program of the National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) under award EB016803. This work was performed partly at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-15420819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the US National Institutes of Biomedical Imaging and Bioengineering (NIH-NIBIB) under award EB016803. This work was performed partly at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-15420819) and at the Nanobiotechnology Center (NBTC), a STC Program of the National Science Foundation under Agreement no. ECS-9876771.	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; Amerson E, 2012, INFECT AGENTS CANCER, V7, P6; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Campbell TB, 2003, CLIN INFECT DIS, V36, P1144, DOI 10.1086/374599; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chu KM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-23; Cox HS, 2015, OPEN FORUM INFECT DI, P2, DOI 10.1093/ofid/ofv014; Dupont C, 2000, AIDS, V14, P987, DOI 10.1097/00002030-200005260-00010; Erickson D, 2014, LAB CHIP, V14, P3159, DOI 10.1039/c4lc00142g; Fan W, 2005, J VIROL, V79, P1244, DOI 10.1128/JVI.79.2.1244-1251.2005; Gingues S, 2006, HIV MED, V7, P369, DOI 10.1111/j.1468-1293.2006.00395.x; Haq IU, 2016, HIV MED, V17, P56, DOI 10.1111/hiv.12273; He J, 1998, J INFECT DIS, V178, P1787, DOI 10.1086/314512; He ML, 2012, CANCER RES, V72, P3582, DOI 10.1158/0008-5472.CAN-11-2876; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Jiang L., 2014, SCI REP, P4, DOI DOI 10.1038/SREP04137; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Mancuso M, 2013, NANOSCALE, V5, P1678, DOI 10.1039/c3nr33492a; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mosam A, 2010, CURR OPIN INFECT DIS, V23, P119, DOI 10.1097/QCO.0b013e328335b01a; Nguyen HQ, 2008, AIDS, V22, P937, DOI 10.1097/QAD.0b013e3282ff6275; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Poddar SK, 2000, MOL CELL PROBE, V14, P25, DOI 10.1006/mcpr.1999.0278; Schulz TF, 2015, CURR OPIN VIROL, V14, P116, DOI 10.1016/j.coviro.2015.08.016; Tam HK, 2002, INT J CANCER, V98, P916, DOI 10.1002/ijc.10274; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; World Health Organization, 2013, XPERT MTB RIF FACT S; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Zhang YH, 2009, ANAL CHIM ACTA, V638, P115, DOI 10.1016/j.aca.2009.02.038	31	21	21	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147636	10.1371/journal.pone.0147636	http://dx.doi.org/10.1371/journal.pone.0147636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799834	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300135
J	Bienhold, C; Zinger, L; Boetius, A; Ramette, A				Bienhold, Christina; Zinger, Lucie; Boetius, Antje; Ramette, Alban			Diversity and Biogeography of Bathyal and Abyssal Seafloor Bacteria	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEEP-SEA; MICROBIAL ECOLOGY; BETA-DIVERSITY; PHYLOGENETIC DIVERSITY; SURFACE SEDIMENTS; PACIFIC-OCEAN; COMMUNITIES; ABUNDANCE; PATTERNS	The deep ocean floor covers more than 60% of the Earth's surface, and hosts diverse bacterial communities with important functions in carbon and nutrient cycles. The identification of key bacterial members remains a challenge and their patterns of distribution in seafloor sediment yet remain poorly described. Previous studies were either regionally restricted or included few deep-sea sediments, and did not specifically test biogeographic patterns across the vast oligotrophic bathyal and abyssal seafloor. Here we define the composition of this deep seafloor microbiome by describing those bacterial operational taxonomic units (OTU) that are specifically associated with deep-sea surface sediments at water depths ranging from 1000-5300 m. We show that the microbiome of the surface seafloor is distinct from the subsurface seafloor. The cosmopolitan bacterial OTU were affiliated with the clades JTB255 (class Gammaproteobacteria, order Xanthomonadales) and OM1 (Actinobacteria, order Acidimicrobiales), comprising 21% and 7% of their respective clades, and about 1% of all sequences in the study. Overall, few sequence-abundant bacterial types were globally dispersed and displayed positive range-abundance relationships. Most bacterial populations were rare and exhibited a high degree of endemism, explaining the substantial differences in community composition observed over large spatial scales. Despite the relative physicochemical uniformity of deep-sea sediments, we identified indicators of productivity regimes, especially sediment organic matter content, as factors significantly associated with changes in bacterial community structure across the globe.	[Bienhold, Christina] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Bienhold, Christina] Max Planck Inst Marine Microbiol, Bremen, Germany; [Zinger, Lucie] Univ Toulouse 3, CNRS, ENFA, UMR EDB 5174, Toulouse, France; [Ramette, Alban] Univ Bern, ISPM, Bern, Switzerland	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Bern	Bienhold, C (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.; Bienhold, C (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	cbienhol@mpi-bremen.de	Boetius, Antje/D-5459-2013; Zinger, Lucie/D-2527-2010; Ramette, Alban/E-9197-2016	Boetius, Antje/0000-0003-2117-4176; Zinger, Lucie/0000-0002-3400-5825; Ramette, Alban/0000-0002-3437-4639; Bienhold, Christina/0000-0003-2269-9468	European Research Council Advanced Investigator Grant [294757]; EU 7th FP HERMIONE project [226354]; Leibniz programme of the DFG; Census of Marine Life project International Census of Marine Microbes (ICoMM); Deep Carbon Observatory's Census of Deep Life; Helmholtz Association; Max Planck Society	European Research Council Advanced Investigator Grant(European Research Council (ERC)); EU 7th FP HERMIONE project; Leibniz programme of the DFG(German Research Foundation (DFG)); Census of Marine Life project International Census of Marine Microbes (ICoMM); Deep Carbon Observatory's Census of Deep Life; Helmholtz Association(Helmholtz Association); Max Planck Society(Max Planck Society)	This study contributes to the project ABYSS funded by the European Research Council Advanced Investigator Grant 294757 to AB. Additional resources for this study were provided by the EU 7th FP HERMIONE project (226354), the Leibniz programme of the DFG to AB, the Census of Marine Life project International Census of Marine Microbes (ICoMM) to AB and AR (Alfred P. Sloan Foundation); and the Deep Carbon Observatory's Census of Deep Life (Alfred P. Sloan Foundation) to AB and AR, the Helmholtz Association and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zetter LA, 2010, LIFE WORLDS OCEANS D; Amend AS, 2013, J BIOGEOGR, V40, P800, DOI 10.1111/jbi.12034; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Boetius A, 2015, NAT REV MICROBIOL, V13, P677, DOI 10.1038/nrmicro3522; Boetius A, 2013, NAT GEOSCI, V6, P725, DOI [10.1038/ngeo1926, 10.1038/NGEO1926]; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Dang HY, 2009, WORLD J MICROB BIOT, V25, P179, DOI 10.1007/s11274-008-9877-1; Dyksma S, 2015, ISME J; Ebbe Brigitte, 2010, P139, DOI 10.1002/9781444325508.ch8; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Heijs SK, 2008, FEMS MICROBIOL ECOL, V64, P362, DOI 10.1111/j.1574-6941.2008.00463.x; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jacob M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072779; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kimes NE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00050; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Kulakov LA, 2002, APPL ENVIRON MICROB, V68, P1548, DOI 10.1128/AEM.68.4.1548-1555.2002; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Legendre L., 1998, NUMERICAL ECOLOGY; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Magnusson A, 2010, GMT INTERFACE GMT MA; MANTEL N, 1967, CANCER RES, V27, P209; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mason OU, 2014, ISME J, V8, P1464, DOI 10.1038/ismej.2013.254; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; MEADOWS A, 1994, J GEOL SOC LONDON, V151, P361, DOI 10.1144/gsjgs.151.2.0361; Muller AL, 2014, ISME J, V8, P1153, DOI 10.1038/ismej.2013.225; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rex M.A., 2010, BIOSCIENCE; Ristova PP, 2015, ISME J, V9, P1306, DOI 10.1038/ismej.2014.217; Roesch LF, 2007, APPL ENVIRON MICROB, V75, P5111; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Salter S, 2014, REAGENT CONTAMINATIO; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; SMITH CR, 1992, NATO ADV SCI I C-MAT, V360, P375; Smith CR, 2003, ECOSYSTEMS WORLD, P28; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Tian F, 2009, POLAR BIOL, V32, P93, DOI 10.1007/s00300-008-0509-x; van Etten J., 2014, PACKAGE GDISTANCE VE; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Walsh EA, 2016, ISME J, V10, P979, DOI 10.1038/ismej.2015.175; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zinger L, 2014, MOL ECOL, V23, P954, DOI 10.1111/mec.12640; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	105	78	80	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148016	10.1371/journal.pone.0148016	http://dx.doi.org/10.1371/journal.pone.0148016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814838	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200066
J	Carlin, DA; Caster, RW; Wang, XK; Betzenderfer, SA; Chen, CX; Duong, VM; Ryklansky, CV; Alpekin, A; Beaumont, N; Kapoor, H; Kim, N; Mohabbot, H; Pang, BY; Teel, R; Whithaus, L; Tagkopoulos, I; Siegel, JB				Carlin, Dylan Alexander; Caster, Ryan W.; Wang, Xiaokang; Betzenderfer, Stephanie A.; Chen, Claire X.; Duong, Veasna M.; Ryklansky, Carolina V.; Alpekin, Alp; Beaumont, Nathan; Kapoor, Harshul; Kim, Nicole; Mohabbot, Hosna; Pang, Boyu; Teel, Rachel; Whithaus, Lillian; Tagkopoulos, Ilias; Siegel, Justin B.			Kinetic Characterization of 100 Glycoside Hydrolase Mutants Enables the Discovery of Structural Features Correlated with Kinetic Constants	PLOS ONE			English	Article							COMPUTATIONAL PROTEIN DESIGN; ENZYMES; HYDROLYSIS; MECHANISMS; COMPLEXES; PATHWAY	The use of computational modeling algorithms to guide the design of novel enzyme catalysts is a rapidly growing field. Force-field based methods have now been used to engineer both enzyme specificity and activity. However, the proportion of designed mutants with the intended function is often less than ten percent. One potential reason for this is that current force-field based approaches are trained on indirect measures of function rather than direct correlation to experimentally-determined functional effects of mutations. We hypothesize that this is partially due to the lack of data sets for which a large panel of enzyme variants has been produced, purified, and kinetically characterized. Here we report the k(cat) and K-M values of 100 purified mutants of a glycoside hydrolase enzyme. We demonstrate the utility of this data set by using machine learning to train a new algorithm that enables prediction of each kinetic parameter based on readily-modeled structural features. The generated dataset and analyses carried out in this study not only provide insight into how this enzyme functions, they also provide a clear path forward for the improvement of computational enzyme redesign algorithms.	[Carlin, Dylan Alexander] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Caster, Ryan W.; Betzenderfer, Stephanie A.; Chen, Claire X.; Duong, Veasna M.; Ryklansky, Carolina V.; Alpekin, Alp; Beaumont, Nathan; Kapoor, Harshul; Kim, Nicole; Mohabbot, Hosna; Pang, Boyu; Teel, Rachel; Whithaus, Lillian; Tagkopoulos, Ilias; Siegel, Justin B.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Wang, Xiaokang] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Tagkopoulos, Ilias] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Siegel, JB (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jbsiegel@ucdavis.edu		Kim, Nicole/0000-0002-4560-8808; Beaumont, Nathan/0000-0002-1135-5785	Army Research Office [201121557]; National Science Foundation [1254205]; Alfred P. Sloan Foundation [BR2014-012]; University of California Davis Startup Funds	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of California Davis Startup Funds	This work was supported by Army Research Office #201121557 and National Science Foundation #1254205 (IT) and Alfred P. Sloan Foundation #BR2014-012 and University of California Davis Startup Funds (JBS).	Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI 10.1016/j.cbpa.2013.12.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordon SR, 2012, J AM CHEM SOC, V134, P20513, DOI 10.1021/ja3094795; Govindarajan S, 2015, ACS SYNTH BIOL, V4, P221, DOI 10.1021/sb500242x; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Mak WS, 2014, CURR OPIN STRUC BIOL, V27, P87, DOI 10.1016/j.sbi.2014.05.010; Marcheschi RJ, 2012, ACS CHEM BIOL, V7, P689, DOI 10.1021/cb200313e; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Minshull J, 2005, CURR OPIN CHEM BIOL, V9, P202, DOI 10.1016/j.cbpa.2005.02.003; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2015, P NATL ACAD SCI; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Sunden F, 2015, ELIFE, V4; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Wu SJ, 2011, J BIOL CHEM, V286, P32586, DOI 10.1074/jbc.M111.251041	26	27	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147596	10.1371/journal.pone.0147596	http://dx.doi.org/10.1371/journal.pone.0147596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815142	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200041
J	McManus, C; Barcellos, JOJ; Formenton, BK; Hermuche, PM; Carvalho, OA; Guimaraes, R; Gianezini, M; Dias, EA; Lampert, VD; Zago, D; Neto, JB				McManus, Concepta; Jardim Barcellos, Julio Otavio; Formenton, Bruna Krummenauer; Hermuche, Potira Meirelles; de Carvalho, Osmar Abilio, Jr.; Guimaraes, RenatoFontes; Gianezini, Miguelangelo; Dias, Eduardo Antunes; Lampert, Vinicius do Nascimento; Zago, Daniele; Neto, Jose Braccini			Dynamics of Cattle Production in Brazil	PLOS ONE			English	Article							SHEEP PRODUCTION; BEEF	Movement of livestock production within a country or region has implications for genetics, adaptation, well-being, nutrition, and production logistics, particularly in continental-sized countries, such as Brazil. Cattle production in Brazil from 1977 to 2011 was spatialized, and the annual midpoint of production was calculated. Changes in the relative production and acceleration of production were calculated and spatialized using ARCGIS (R). Cluster and canonical discriminant analyses were performed to further highlight differences between regions in terms of cattle production. The mean production point has moved from the Center of Minas Gerais State (in the southeast region) to the North of Goias State (in the Midwest region). This reflects changes in environmental factors, such as pasture type, temperature and humidity. Acceleration in production in the northern region of Brazil has remained strong over the years. More recently, "traditional" cattle-rearing regions, such as the south and southeast, showed a reduction in growth rates as well as a reduction in herd size or internal migration over the period studied. These maps showed that this movement tends to be gradual, with few regions showing high acceleration or deceleration rates.	[McManus, Concepta] Univ Brasilia, INCT Pecuaria, Brasilia, DF, Brazil; [Jardim Barcellos, Julio Otavio; Formenton, Bruna Krummenauer; Gianezini, Miguelangelo; Dias, Eduardo Antunes; Zago, Daniele; Neto, Jose Braccini] Univ Fed Rio Grande UFRGS, Dept Zootecnia, NESPRO, Porto Alegre, RS, Brazil; [Hermuche, Potira Meirelles; de Carvalho, Osmar Abilio, Jr.; Guimaraes, RenatoFontes] Univ Brasilia, Brasilia, DF, Brazil; [Lampert, Vinicius do Nascimento] Empresa Brasileira Pesquisa Agropecuaria, Bage, RS, Brazil; [Lampert, Vinicius do Nascimento] EMBRAPA CPPSUL, Curitiba, Parana, Brazil	Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Barcellos, JOJ (corresponding author), Univ Fed Rio Grande UFRGS, Dept Zootecnia, NESPRO, Porto Alegre, RS, Brazil.	Julio.barcellos@ufrgs.br	McManus, Concepta M/I-4356-2012; Dias, Eduardo Antunes/AAY-5058-2020; McManus, Connie/GRS-6152-2022; Barcellos, Julio/A-9209-2013; McManus, Concepta/AAF-4679-2020; De+Carvalho+Júnior, Osmar/AAK-4880-2021; Neto, José Braccini/J-4369-2012; Guimaraes, Renato/C-4601-2013	McManus, Concepta M/0000-0002-1106-8962; Barcellos, Julio/0000-0001-9858-1728; De+Carvalho+Júnior, Osmar/0000-0002-0346-1684; Neto, José Braccini/0000-0003-2881-0235; Guimaraes, Renato/0000-0002-9555-043X; Zago, Daniele/0000-0003-3444-4323; Meirelles Hermuche, Potira/0000-0003-3059-5001				[Anonymous], AGR EC; ANUALPEC, 2013, ANUALPEC AN PEC BRAS; Barcellos J. O. J., 2011, REV BRAS ZOOTECN, V40, P189; Barcellos JOJ, 2013, P CD 8 JORN NESPRO 1; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; De Arruda ZJ, 1994, REGIONALIZACAO PECUA; Hermuche P, 2013, APPL GEOGR, V44, P172, DOI 10.1016/j.apgeog.2013.07.016; Hermuche PM, 2013, ISPRS INT J GEO-INF, V2, P665, DOI 10.3390/ijgi2030665; IBGE-Brazilian Institute of Geography and Statistics, 2011, 2006 AGR CENS; MAPA, 2011, AGR BRAS NUM PEC EV; Marques PR, 2011, AGR SYST, V104, P689, DOI 10.1016/j.agsy.2011.08.002; Martha GB, 2012, AGR SYST, V110, P173, DOI 10.1016/j.agsy.2012.03.001; McAlpine CA, 2009, GLOBAL ENVIRON CHANG, V19, P21, DOI 10.1016/j.gloenvcha.2008.10.008; McManus C.M., 2014, BRAZILIAN J SCI TECH, V1, P3, DOI [DOI 10.1093/BIOINFORMATICS/BTY633, 10.1186/2196-288X-1-3, DOI 10.1186/2196-288X-1-3]; Naas IA, 2010, SCI AGR, P67; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Procopio D. P., 2011, Revista de Politica Agricola, V20, P40; Rada N, 2013, FOOD POLICY, V38, P146, DOI 10.1016/j.foodpol.2012.11.002; Carvalho LFR, 2012, PREV VET MED, V103, P74, DOI 10.1016/j.prevetmed.2011.08.006; Ruviaro CF, 2014, LAND USE POLICY, V38, P104, DOI 10.1016/j.landusepol.2013.08.019; Sparovek G, 2009, MITIG ADAPT STRAT GL, V14, P285, DOI 10.1007/s11027-008-9164-3; Valentim J., 2009, AMAZONIA CI DESENV, V4, P9; Walker R, 2009, GEOPHYS MONOGR SER, V186, P61, DOI 10.1029/2008GM000735; Walker R, 2009, GEOFORUM, V40, P732, DOI 10.1016/j.geoforum.2008.10.009	24	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147138	10.1371/journal.pone.0147138	http://dx.doi.org/10.1371/journal.pone.0147138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814797	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200026
J	Kasang, C; Kalluvya, S; Majinge, C; Kongola, G; Mlewa, M; Massawe, I; Kabyemera, R; Magambo, K; Ulmer, A; Klinker, H; Gschmack, E; Horn, A; Koutsilieri, E; Preiser, W; Hofmann, D; Hain, J; Muller, A; Dolken, L; Weissbrich, B; Rethwilm, A; Stich, A; Scheller, C				Kasang, Christa; Kalluvya, Samuel; Majinge, Charles; Kongola, Gilbert; Mlewa, Mathias; Massawe, Irene; Kabyemera, Rogatus; Magambo, Kinanga; Ulmer, Albrecht; Klinker, Hartwig; Gschmack, Eva; Horn, Anne; Koutsilieri, Eleni; Preiser, Wolfgang; Hofmann, Daniela; Hain, Johannes; Mueller, Andreas; Doelken, Lars; Weissbrich, Benedikt; Rethwilm, Axel; Stich, August; Scheller, Carsten			Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial	PLOS ONE			English	Article							T-CELL-ACTIVATION; LOW-DOSE PREDNISOLONE; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; PREDICT MORTALITY; PLASMA-LEVELS; THERAPY; INFLAMMATION; AIDS; SURVIVAL	Background HIV-disease progression correlates with immune activation. Here we investigated whether corticosteroid treatment can attenuate HIV disease progression in antiretroviral-untreated patients. Methods Double-blind, placebo-controlled randomized clinical trial including 326 HIV-patients in a resource-limited setting in Tanzania (clinicaltrials.gov NCT01299948). Inclusion criteria were a CD4 count above 300 cells/mu l, the absence of AIDS-defining symptoms and an ART-naive therapy status. Study participants received 5 mg prednisolone per day or placebo for 2 years. Primary endpoint was time to progression to an AIDS-defining condition or to a CD4-count below 200 cells/mu l. Results No significant change in progression towards the primary endpoint was observed in the intent-to-treat (ITT) analysis (19 cases with prednisolone versus 28 cases with placebo, p = 0.1407). In a per-protocol (PP)-analysis, 13 versus 24 study participants progressed to the primary study endpoint (p = 0.0741). Secondary endpoints: Prednisolone-treatment decreased immune activation (sCD14, suPAR, CD38/HLA-DR/CD8+) and increased CD4-counts (+77.42 +/- 5.70 cells/mu l compared to -37.42 +/- 10.77 cells/mu l under placebo, p < 0.0001). Treatment with prednisolone was associated with a 3.2-fold increase in HIV viral load (p < 0.0001). In a post-hoc analysis stratifying for sex, females treated with prednisolone progressed significantly slower to the primary study endpoint than females treated with placebo (ITT-analysis: 11 versus 21 cases, p = 0.0567; PP-analysis: 5 versus 18 cases, p = 0.0051): No changes in disease progression were observed in men. Conclusions This study could not detect any significant effects of prednisolone on disease progression in antiretroviral-untreated HIV infection within the intent-to-treat population. However, significant effects were observed on CD4 counts, immune activation and HIV viral load. This study contributes to a better understanding of the role of immune activation in the pathogenesis of HIV infection.	[Kasang, Christa; Mlewa, Mathias; Gschmack, Eva; Horn, Anne; Koutsilieri, Eleni; Hofmann, Daniela; Doelken, Lars; Weissbrich, Benedikt; Rethwilm, Axel; Scheller, Carsten] Univ Wurzburg, Inst Virol & Immunbiol, Versbacher Str 7, D-97078 Wurzburg, Germany; [Kalluvya, Samuel; Majinge, Charles; Mlewa, Mathias; Massawe, Irene; Kabyemera, Rogatus; Magambo, Kinanga] Bugando Med Ctr, POB 1370, Mwanza, Tanzania; [Kalluvya, Samuel; Kongola, Gilbert] Catholic Univ Hlth & Allied Sci, POB 1464, Mwanza, Tanzania; [Kasang, Christa; Mueller, Andreas; Stich, August] Med Mission Inst, Salvatorstr 7, D-97067 Wurzburg, Germany; [Klinker, Hartwig] Univ Clin Wurzburg, Div Infect Dis, Dept Internal Med, Josef Schneider Str 2, D-97080 Wurzburg, Germany; [Ulmer, Albrecht] HIV Intens Care Unit, Schwabstr 26, D-70197 Stuttgart, Germany; [Preiser, Wolfgang] Univ Stellenbosch, Natl Hlth Lab Serv, Div Med Virol, ZA-7505 Tygerberg, South Africa; [Hain, Johannes] Univ Wurzburg, Inst Math & Informat, Chair Math Stat 8, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Stellenbosch University; University of Wurzburg	Scheller, C (corresponding author), Univ Wurzburg, Inst Virol & Immunbiol, Versbacher Str 7, D-97078 Wurzburg, Germany.	scheller@vim.uni-wuerzburg.de	Kasang, Christa/AAW-5048-2021; Preiser, Wolfgang/J-4875-2016; Müller, Andreas H./F-5101-2013; Klinker, Hartwig/AAC-1134-2021	Kasang, Christa/0000-0003-0241-0321; Preiser, Wolfgang/0000-0002-0254-7910; Müller, Andreas H./0000-0002-9820-5527; 	German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Georg Ludwig Rexroth Foundation; Deutscher Akademischer Austauschdienst (DAAD); Unibund Wurzburg	German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Georg Ludwig Rexroth Foundation; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Unibund Wurzburg	This work was supported by the German Leprosy and Tuberculosis Relief Association (http://www.dahw.de/home); Evangelisches Studienwerk e.V. Villigst (http://www.evstudienwerk.de/); Georg Ludwig Rexroth Foundation (http://www.rexroth-stiftung.de/); Deutscher Akademischer Austauschdienst (DAAD) (https://www.daad.de/de/index.html); and the Unibund Wurzburg (http://www.unibund.uni-wuerzburg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Aiuti F, 2006, AIDS REV, V8, P88; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Andrieu JM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-17; ANDRIEU JM, 1995, J INFECT DIS, V171, P523, DOI 10.1093/infdis/171.3.523; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Berkhout B, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0085-9; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2004, J CLIN INVEST, V113, P808, DOI 10.1172/JCI200421318; Elliott AM, 2004, J INFECT DIS, V190, P869, DOI 10.1086/422257; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; French MA, 2015, AIDS, V29, P847, DOI 10.1097/QAD.0000000000000618; Funderburg NT, 2015, JAIDS-J ACQ IMM DEF, V68, P396, DOI 10.1097/QAI.0000000000000478; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kvale D, 2006, AIDS, V20, P813, DOI 10.1097/01.aids.0000218544.54586.f1; Lyons JL, 2011, JAIDS-J ACQ IMM DEF, V57, P371, DOI 10.1097/QAI.0b013e3182237e54; Magee MH, 2001, J CLIN PHARMACOL, V41, P1180, DOI 10.1177/00912700122012733; Overton ET, 2014, AIDS, V28, P2627, DOI 10.1097/QAD.0000000000000475; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sidenius N, 2000, BLOOD, V96, P4091; Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254; Ulmer A, 2005, EUR J MED RES, V10, P227; Ulmer A, 2005, EUR J MED RES, V10, P105; Villar-Garcia J, 2015, JAIDS-J ACQ IMM DEF, V68, P256, DOI 10.1097/QAI.0000000000000468; Wallis RS, 2003, JAIDS-J ACQ IMM DEF, V32, P281, DOI 10.1097/00126334-200303010-00006; Williams Brian, 2011, J Int AIDS Soc, V14 Suppl 1, pS6, DOI 10.1186/1758-2652-14-S1-S6	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146678	10.1371/journal.pone.0146678	http://dx.doi.org/10.1371/journal.pone.0146678			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812052	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000011
J	Li, XY; Liu, Y; Jiang, WD; Jiang, J; Wu, P; Zhao, J; Kuang, SY; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ; Feng, L				Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu; Feng, Lin			Co- and Post-Treatment with Lysine Protects Primary Fish Enterocytes against Cu-Induced Oxidative Damage	PLOS ONE			English	Article							ANTIOXIDANT DEFENSES; GENE-EXPRESSION; GROWTH-PERFORMANCE; ATLANTIC SALMON; DIETARY LYSINE; RAINBOW-TROUT; JUVENILE JIAN; ASCORBIC-ACID; AMINO-ACIDS; VITAMIN-E	The aim of the work was primarily to explore the protective activity pathways of lysine against oxidative damage in fish in vivo and in enterocytes in vitro. First, grass carp were fed diets containing six graded levels of lysine (7.1-19.6 g kg(-1) diet) for 56 days. Second, the enterocytes were treated with different concentrations of lysine (0-300 mg/L in media) prior to (pre-treatment), along with (co-treatment) or following (post-treatment) with 6 mg/L of Cu for 24 h. The results indicated that lysine improved grass carp growth performance. Meanwhile, lysine ameliorated lipid and protein oxidation by elevating the gene expression and activity of antioxidant enzymes (superoxide dismutase (SOD), glutathioneperoxidase (GPx), glutathione-S-transferase (GST) and reductase (GR)), and nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA levels in fish intestine. The in vitro studies showed that co- and post-treatment with lysine conferred significant protection against Cu-induced oxidative damage in fish primary enterocytes as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) OD values, along with alkaline phosphatase (ALP) and lactate dehydrogenase activities, and the depletion of protein carbonyl (PC), malondialdehyde (MDA) and 8-hydroxydeoxyguanosine contents. Moreover, lysine co-treatment decreased the activities and mRNA level of cellular SOD, GPx, GST and GR compared with the Cu- only exposed group. Gene expression of the signalling molecule Nrf2 showed the same pattern as that of SOD activity, whereas Kelch-like ECH-associated protein 1b (Keap1b) followed the opposite trend, indicating that co-treatment with lysine induced antioxidant enzymes that protected against oxidative stress through Nrf2 pathway. In addition, posttreatment with lysine increased proteasomal activity and blocked the Cu-stimulated increase in mRNA levels of GST and associated catalase (CAT) and GST activities (P<0.01 and P<0.001). GR activity and gene expression, and glutathione (GSH) content followed an opposite trend to GST activity (P<0.05). Thus, post-treatment of lysine elevated protein and DNA repair abilities and ameliorated the cellular redox state of enterocytes. The overall results suggest that lysine plays a significant role in the protection of fish intestine in vivo and in vitro through the induction of key antioxidant protection.	[Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Li, Xue-Yin; Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Liu, Yang; Jiang, Wei-Dan; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Key Lab Anim Disease Resistance Nutr China, Minist Educ, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Sichuan, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Key Lab Anim Disease Resistance Nutr China, Minist Educ, Chengdu, Sichuan, Peoples R China.	zhouxq@sicau.edu.cn; fenglin@sicau.edu.cn	liu, yang/HHY-8583-2022; jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022	Zhang, Yong-An/0000-0002-9956-3879	National Basic Research Program of China [2014CB138600]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20135103110001]; Science and Technology Support Program of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China(National Basic Research Program of China); National Department Public Benefit Research Foundation (Agriculture) of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Support Program of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), National Department Public Benefit Research Foundation (Agriculture) of China (201003020), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20135103110001), Science and Technology Support Program of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007; 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007), and Sichuan Province Research Foundation for Basic Research (2013JY0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi T, 2006, AQUACULTURE, V261, P369, DOI 10.1016/j.aquaculture.2006.07.041; Aebi H, 1984, Methods Enzymol, V105, P121; Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Agnoletto MH, 2007, CLIN BIOCHEM, V40, P1252, DOI 10.1016/j.clinbiochem.2007.08.017; Akrami R, 2013, FISH SHELLFISH IMMUN, V35, P1235, DOI 10.1016/j.fsi.2013.07.039; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; Barrera D, 2003, LIFE SCI, V73, P3027, DOI 10.1016/j.lfs.2003.06.002; Ben Salah-Abbes J, 2008, J PHARM PHARMACOL, V60, P761, DOI 10.1211/jpp.60.6.0012; Bicudo AJA, 2009, AQUACULTURE, V297, P151, DOI 10.1016/j.aquaculture.2009.09.031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Chen DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037709; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Deng DF, 2010, AQUACULTURE, V308, P44, DOI 10.1016/j.aquaculture.2010.07.041; Deng YP, 2014, AQUACULTURE, V434, P66, DOI 10.1016/j.aquaculture.2014.07.026; Dinu D, 2010, ARCH ENVIRON CON TOX, V58, P757, DOI 10.1007/s00244-009-9401-0; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; FARLEY JR, 1983, SCIENCE, V222, P330; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115129; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Higgins AD, 2005, FISH PHYSIOL BIOCHEM, V31, P33, DOI 10.1007/s10695-005-4587-1; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang WD, 2013, AQUAT TOXICOL, V132, P100, DOI 10.1016/j.aquatox.2013.02.005; Jiang WD, 2011, AQUAT TOXICOL, V105, P543, DOI 10.1016/j.aquatox.2011.08.012; Katayama S, 2007, J AGR FOOD CHEM, V55, P8458, DOI 10.1021/jf070866p; Kim Go-Woon, 2010, Int J Cell Biol, V2010, P632739, DOI 10.1155/2010/632739; Lambertucci RH, 2007, MECH AGEING DEV, V128, P267, DOI 10.1016/j.mad.2006.12.006; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100685; Li XY, 2014, FISH PHYSIOL BIOCHEM, V40, P659, DOI 10.1007/s10695-013-9874-7; Lin YH, 2007, AQUACULTURE, V267, P38, DOI 10.1016/j.aquaculture.2006.12.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTONE DR, 1990, FUNCT ECOL, V4, P415, DOI 10.2307/2389604; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Morris JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095486; Nandi D, 2005, TOXICOLOGY, V211, P26, DOI 10.1016/j.tox.2005.02.013; NRC, 2011, NUTR REQ FISH SHRIMP, DOI DOI 10.17226/13039; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Rau MA, 2004, COMP BIOCHEM PHYS C, V137, P335, DOI 10.1016/j.cca.2004.03.001; SADLER PJ, 1994, EUR J BIOCHEM, V220, P193, DOI 10.1111/j.1432-1033.1994.tb18614.x; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Selvakannan PR, 2003, LANGMUIR, V19, P3545, DOI 10.1021/la026906v; Shpyleva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113712; Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6; Sies H., 1994, EJB REV 1993, V1993, P101; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095855; Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Tian LX, 2004, N AM J AQUACULT, V66, P141, DOI 10.1577/A03-040.1; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Vijayavel K, 2006, SCI TOTAL ENVIRON, V372, P157, DOI 10.1016/j.scitotenv.2006.09.027; Wang X, 2010, J ETHNOPHARMACOL, V127, P424, DOI 10.1016/j.jep.2009.10.022; Wang XJ, 2010, CHEM BIOL, V17, P75, DOI 10.1016/j.chembiol.2009.12.013; Wu P, 2014, FISH SHELLFISH IMMUN, V38, P374, DOI 10.1016/j.fsi.2014.03.032; Yang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107670; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	78	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147408	10.1371/journal.pone.0147408	http://dx.doi.org/10.1371/journal.pone.0147408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812682	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000033
J	Low, LL; Tong, SF; Low, WY				Low, Lee Lan; Tong, Seng Fah; Low, Wah Yun			Selection of Treatment Strategies among Patients with Type 2 Diabetes Mellitus in Malaysia: A Grounded Theory Approach	PLOS ONE			English	Article							SEEKING BEHAVIOR; HEALTH-CARE; ILLNESS; PEOPLE	Background Diabetes Mellitus is a multifaceted chronic illness and its life-long treatment process requires patients to continuously engage with the healthcare system. The understanding of how patients manoeuvre through the healthcare system for treatment is crucial in assisting them to optimise their disease management. This study aims to explore issues determining patients' treatment strategies and the process of patients manoeuvring through the current healthcare system in selecting their choice of treatment for T2DM. Methods The Grounded Theory methodology was used. Twelve patients with Type 2 Diabetes Mellitus, nine family members and five healthcare providers from the primary care clinics were interviewed using a semi-structured interview guide. Three focus group discussions were conducted among thirteen healthcare providers from public primary care clinics. Both purposive and theoretical samplings were used for data collection. The interviews were audio-taped and transcribed verbatim, followed by line-by-line coding and constant comparison to identify the categories and core category. Results The concept of "experimentation" was observed in patients' help-seeking behaviour. The "experimentation" process required triggers, followed by information seeking related to treatment characteristics from trusted family members, friends and healthcare providers to enable decisions to be made on the choice of treatment modalities. The whole process was dynamic and iterative through interaction with the healthcare system. The decision-making process in choosing the types of treatment was complex with an element of trial-and-error. The anchor of this process was the desire to fulfil the patient's expected outcome. Conclusion Patients with Type 2 Diabetes Mellitus continuously used "experimentation" in their treatment strategies and help-seeking process. The "experimentation" process was experiential, with continuous evaluation, information seeking and decision-making tinged with the element of trial-and-error. The theoretical model generated from this study is abstract, is believed to have a broad applicability to other diseases, may be applied at varying stages of disease development and is non-context specific.	[Low, Lee Lan] Univ Malaya, Fac Med, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia; [Low, Lee Lan] Minist Hlth Malaysia, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia; [Tong, Seng Fah] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia; [Low, Wah Yun] Univ Malaya, Fac Med, Res & Management Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Low, LL (corresponding author), Univ Malaya, Fac Med, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia.; Low, LL (corresponding author), Minist Hlth Malaysia, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia.	lowleelan@yahoo.com	Low, Wah-Yun/B-1775-2009	Low, Wah-Yun/0000-0003-4409-1509	University of Malaya research grant [PV108/2012A]; Fogarty International Centre, National Institutes of Health [D43TW008332]; FOGARTY INTERNATIONAL CENTER [D43TW008332] Funding Source: NIH RePORTER	University of Malaya research grant; Fogarty International Centre, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a University of Malaya research grant (grant number PV108/2012A). LLL is supported by the Fogarty International Centre, National Institutes of Health, under Award Number: D43TW008332 (ASCEND Research Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, 14 DCPP; Atwine F, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.76.5497; Bowen ME, 2010, J MULTIDISCIP HEALTH, V3, P113; Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz, 2007, SAGE HDB GROUNDED TH, P97; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740; Elliott Naomi, 2005, Aust J Adv Nurs, V22, P48; Hale NL, 2010, J COMMUN HEALTH, V35, P365, DOI 10.1007/s10900-010-9259-0; Hjelm K, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-11; Ibrahim W.N., 2010, MALAYSIAN J PUBLIC H, V10, P68; Institute for Public Health Malaysia, 2011, NAT HLTH MORB SURV 2, VII; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; Low Lee Lan, 2014, Coll Antropol, V38, P11; MacKian S, 2004, HEALTH POLICY PLANN, V19, P137, DOI 10.1093/heapol/czh017; MacKian S., 2003, REV HLTH SEEKING BEH; Mazura M, 2011, RES HIGHLIGHT MUCH D; Men CR, 2007, I WISH I HAD AIDS QU; Nguma LK, 2010, HLTH SEEKING HLTH RE; Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36; Purintrapiban J, 2008, NATURAL PRODUCT RES, V25, P1379; Raaijmakers LGM, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-114; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Shaw C, 2008, INT J NURS STUD, V45, P1516, DOI 10.1016/j.ijnurstu.2007.11.005; Shaw C, 2001, J CLIN NURS, V10, P15, DOI 10.1046/j.1365-2702.2001.00443.x; Sheleaswani Inche ZA, 2014, ADV EPIDEMIOLOGY; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Unger-Saldana K, 2011, SOC SCI MED, V72, P1096, DOI 10.1016/j.socscimed.2011.01.022; WHO, 2000, WORLD HLTH REP HLTH; Wilde MH, 2007, J ADV NURS, V57, P339, DOI 10.1111/j.1365-2648.2006.04089.x; World Health Organization, 2001, LEG STAT TRAD MED CO; Worswick J, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-26	36	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147127	10.1371/journal.pone.0147127	http://dx.doi.org/10.1371/journal.pone.0147127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812053	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000019
J	Fichter, AM; Ritschl, LM; Borgmann, A; Humbs, M; Luppa, PB; Wolff, KD; Muke, T				Fichter, Andreas M.; Ritschl, Lucas M.; Borgmann, Anna; Humbs, Martin; Luppa, Peter B.; Wolff, Klaus-Dietrich; Mueke, Thomas			Development of an Extracorporeal Perfusion Device for Small Animal Free Flaps	PLOS ONE			English	Article							VIVO NORMOTHERMIC PERFUSION; MICROSURGICAL FREE FLAPS; RENAL-TRANSPLANTATION; MUSCLE FLAPS; EPIGASTRIC FLAPS; VITAL STORAGE; PORCINE MODEL; RATS; ISCHEMIA; TISSUE	Background Extracorporeal perfusion (ECP) might prolong the vital storage capabilities of composite free flaps, potentially opening a wide range of clinical applications. Aim of the study was the development a validated low-cost extracorporeal perfusion model for further research in small animal free flaps. Methods After establishing optimal perfusion settings, a specially designed extracorporeal perfusion system was evaluated during 8-hour perfusion of rat epigastric flaps followed by microvascular free flap transfer. Controls comprised sham-operation, ischemia and in vivo perfusion. Flaps and perfusate (diluted blood) were closely monitored by blood gas analysis, combined laser Doppler flowmetry and remission spectroscopy and Indocyanine-Green angiography. Evaluations were complemented by assessment of necrotic area and light microscopy at day 7. Results ECP was established and maintained for 8 hours with constant potassium and pH levels. Subsequent flap transfer was successful. Notably, the rate of necrosis of extracorporeally perfused flaps (27%) was even lower than after in vivo perfusion (49%), although not statistically significant (P = 0,083). After sham-operation, only 6% of the total flap area became necrotic, while 8-hour ischemia led to total flap loss (98%). Angiographic and histological findings confirmed these observations. Conclusions Vital storage capabilities of microvascular flaps can be prolonged by temporary ECP. Our study provides important insights on the pathophysiological processes during extracorporeal tissue perfusion and provides a validated small animal perfusion model for further studies.	[Fichter, Andreas M.; Ritschl, Lucas M.; Borgmann, Anna; Humbs, Martin; Wolff, Klaus-Dietrich; Mueke, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany; [Luppa, Peter B.] Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich	Fichter, AM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany.	andreas.fichter@tum.de	Mücke, Thomas/K-7106-2015	Mücke, Thomas/0000-0003-3561-1277	Deutsche Forschungsgemeinschaft [WO 507/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (WO 507/4-1), http://www.dfg.de.	Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; CARREL ALEXIS, 1935, SCIENCE, V81-201, P621, DOI 10.1126/science.81.2112.621; Charles, 1984, BASELINE HEMATOLOGY; Constantinescu MA, 2011, J SURG RES, V171, P291, DOI 10.1016/j.jss.2010.01.040; COOLEY B C, 1990, Journal of Reconstructive Microsurgery, V6, P49, DOI 10.1055/s-2007-1006802; DOMINGOPECH J, 1991, INT ORTHOP, V15, P289; Dragu A, 2012, PLAST RECONSTR SURG, V130, p265E, DOI 10.1097/PRS.0b013e3182589c2d; Dragu A, 2012, ARCH ORTHOP TRAUM SU, V132, P655, DOI 10.1007/s00402-011-1458-3; Dragu A, 2011, ARCH ORTHOP TRAUM SU, V131, P849, DOI 10.1007/s00402-010-1251-8; Fichter AM, 2014, BRIT J ORAL MAX SURG, V52, P432, DOI 10.1016/j.bjoms.2014.02.013; Fowler JD, 1999, MICROSURG, V19, P135, DOI 10.1002/(SICI)1098-2752(1999)19:3<135::AID-MICR3>3.0.CO;2-Y; Greaney PJ, 2010, J RECONSTR MICROSURG, V26, P517, DOI 10.1055/s-0030-1262951; Hassanein WH, 1998, J THORAC CARDIOV SUR, V116, P821, DOI 10.1016/S0022-5223(98)00452-8; Holzle F, 2010, INT J ORAL MAX SURG, V39, P21, DOI 10.1016/j.ijom.2009.10.012; Holzle F, 2006, J CRANIO MAXILL SURG, V34, P25, DOI 10.1016/j.jcms.2005.07.010; Hosgood SA, 2014, AM J TRANSPLANT, V14, P1690, DOI 10.1111/ajt.12766; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; LI XL, 1993, J HAND SURG-AM, V18A, P629, DOI 10.1016/0363-5023(93)90306-N; MAEDA M, 1993, PLAST RECONSTR SURG, V91, P113, DOI 10.1097/00006534-199301000-00017; Maeda M, 1993, PLAST RECONSTR SURG, V91, P25; MAYER B, 1993, OTOLARYNG HEAD NECK, V109, P690, DOI 10.1177/019459989310900409; Mayer B, 1996, LARYNGO RHINO OTOL, V75, P175, DOI 10.1055/s-2007-997558; Mayer B, 2002, LARYNGO RHINO OTOL, V81, P640, DOI 10.1055/s-2002-34452; MAYER B, 1994, OTO RHINO LARYN NOVA, V4, P190; Mayer B, 1992, OTORHINOLARYNGOL NOV, V2, P212, DOI [10.1159/000312849, DOI 10.1159/000312849]; Mayer B, 1998, TIERSCHUTZBEAUFTRAGT, V1, P67; McBride C M, 1970, Arch Chir Neerl, V22, P91; Mucke T, 2013, BRIT J ORAL MAX SURG, V51, P555, DOI 10.1016/j.bjoms.2012.09.007; Mucke T, 2011, MICROSURG, V31, P472, DOI 10.1002/micr.20892; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; Nicholson ML, 2013, AM J TRANSPLANT, V13, P1246, DOI 10.1111/ajt.12179; Rasband WS, 1997, INVENTORIMAGEJ1997 2; Ritschl LM, 2015, J RECONSTR MICROSURG, V31, P343, DOI 10.1055/s-0035-1546291; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; STRAUCH B, 1967, PLAST RECONSTR SURG, V40, P325, DOI 10.1097/00006534-196710000-00002; Taeger CD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11956; Taeger CD, 2014, J CELL MOL MED, V18, P885, DOI 10.1111/jcmm.12238; Tee R, 2012, TISSUE ENG PT A, V18, P1992, DOI [10.1089/ten.tea.2012.0151, 10.1089/ten.TEA.2012.0151]; USUI M, 1985, J BONE JOINT SURG BR, V67, P473, DOI 10.1302/0301-620X.67B3.3997959; Van Ginkel R J, 1999, Sarcoma, V3, P89, DOI 10.1080/13577149977703; Wesibroth, 1979, LAB RAT BIOL DIS; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG; Wolff KD, 2014, J CRANIO MAXILL SURG, V42, P1423, DOI 10.1016/j.jcms.2014.04.004; Wolff KD, 2009, J SURG ONCOL, V99, P123, DOI 10.1002/jso.21205; Worner M, 2014, ARTIF ORGANS, V38, P352, DOI 10.1111/aor.12155; YABE Y, 1994, J RECONSTR MICROSURG, V10, P185, DOI 10.1055/s-2007-1006586	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147755	10.1371/journal.pone.0147755	http://dx.doi.org/10.1371/journal.pone.0147755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808996	Green Published, gold			2022-12-27	WOS:000369527800207
J	Johnston, JD; Tuttle, SC; Nelson, MC; Bradshaw, RK; Hoybjerg, TG; Johnson, JB; Kruman, BA; Orton, TS; Cook, RB; Eggett, DL; Weber, KS				Johnston, James D.; Tuttle, Steven C.; Nelson, Morgan C.; Bradshaw, Rebecca K.; Hoybjerg, Taylor G.; Johnson, Julene B.; Kruman, Bryce A.; Orton, Taylor S.; Cook, Ryan B.; Eggett, Dennis L.; Weber, K. Scott			Evaporative Cooler Use Influences Temporal Indoor Relative Humidity but Not Dust Mite Allergen Levels in Homes in a Semi-Arid Climate	PLOS ONE			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS; WATER-BALANCE; HOUSE; ASTHMA; EXPOSURE; PYROGLYPHIDAE; PREVALENCE; ACARI; SENSITIZATION; REQUIREMENTS	Concerns about energy consumption and climate change make residential evaporative coolers a popular alternative to central air conditioning in arid and semi-arid climates. However, evaporative coolers have been shown to significantly increase indoor relative humidity and dust mite allergen levels in some studies, while showing no association in other studies. Improved measurement of temporal fluctuations in indoor relative humidity may help identify factors that promote mite growth in homes in dry climates. Dust samples and continuous indoor relative humidity measurements were collected from homes with central air conditioning and homes with evaporative coolers in Utah. Samples were collected over two seasons, winter/spring (Jan-Apr) and summer (July-Sept), 2014. Dust samples were analyzed for Der p 1 and Der f 1 using a two-site monoclonal antibody-based enzyme-linked immuno-sorbent assay (ELISA) analysis. Housing characteristics including age of home, occupant density, and age of mattresses, furniture, and carpeting were also measured. Positive Der p 1 or Der f 1 samples were found in 25.0% of the homes and there was no difference in mean allergen levels by type of air conditioning. Indoor relative humidity was significantly higher in homes with evaporative coolers compared to those with central air conditioning during the summer. Homes with evaporative coolers also spent significantly more time during summer above 55.0% and 65.0% relative humidity compared to central air homes, but not above 75.0%. Findings from this study suggest that increased humidity from evaporative coolers may not be sufficient to exceed the critical equilibrium humidity or maintain humidity excursions for sufficient duration in relatively larger single-family homes in semi-arid climates to support mite growth and reproduction.	[Johnston, James D.; Tuttle, Steven C.; Bradshaw, Rebecca K.; Kruman, Bryce A.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Nelson, Morgan C.; Hoybjerg, Taylor G.; Johnson, Julene B.; Orton, Taylor S.; Cook, Ryan B.; Weber, K. Scott] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Eggett, Dennis L.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Johnston, JD (corresponding author), Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA.	scott_weber@byu.edu	Weber, Scott/O-1022-2014	Weber, Scott/0000-0003-3688-2191; Johnston, James/0000-0002-6009-7241				Arlian Larry G, 2002, Curr Allergy Asthma Rep, V2, P401, DOI 10.1007/s11882-002-0074-2; ARLIAN LG, 1992, EXP APPL ACAROL, V16, P15, DOI 10.1007/BF01201490; ARLIAN LG, 1992, J ALLERGY CLIN IMMUN, V90, P292, DOI 10.1016/S0091-6749(05)80006-5; Arlian LG, 1998, J MED ENTOMOL, V35, P46, DOI 10.1093/jmedent/35.1.46; ARLIAN LG, 1981, J MED ENTOMOL, V18, P351, DOI 10.1093/jmedent/18.4.351; Arlian LG, 2001, J ALLERGY CLIN IMMUN, V107, pS406, DOI 10.1067/mai.2001.113670; Committee on the Assessment of Asthma and Indoor Air-Institute of Medicine (US), 2000, CLEAR AIR ASTHM IND; Dai YJ, 2002, APPL THERM ENG, V22, P1417, DOI 10.1016/S1359-4311(02)00069-8; De Boer R, 1998, J MED ENTOMOL, V35, P905, DOI 10.1093/jmedent/35.6.905; ELLINGSON AR, 1995, J ALLERGY CLIN IMMUN, V96, P473, DOI 10.1016/S0091-6749(95)70289-X; Johnston JD, 2015, J OCCUP ENVIRON HYG, V12, P785, DOI 10.1080/15459624.2015.1047024; KUEHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44, DOI 10.1016/0091-6749(94)90070-1; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; MATHEWS EH, 1994, BUILD ENVIRON, V29, P197, DOI 10.1016/0360-1323(94)90070-1; MOYER DB, 1985, ANN ALLERGY, V55, P680; NELSON HS, 1995, ANN ALLERG ASTHMA IM, V75, P337; Pate AD, 2005, J ALLERGY CLIN IMMUN, V116, P844, DOI 10.1016/j.jaci.2005.06.016; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Portnoy J, 2013, ANN ALLERG ASTHMA IM, V111, P465, DOI 10.1016/j.anai.2013.09.018; Prasad C, 2009, ALLERGY ASTHMA PROC, V30, P624, DOI 10.2500/aap.2009.30.3290; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Teplitsky V, 2008, INT J DERMATOL, V47, P790, DOI 10.1111/j.1365-4632.2008.03657.x; Tovey E. R., 1997, Journal of Allergy and Clinical Immunology, V99, pS163; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499; Vanlaar CH, 2001, ALLERGY, V56, P1211, DOI 10.1034/j.1398-9995.2001.00085.x; Watt J., 2012, EVAPORATIVE AIR COND; Wu JM, 2009, APPL THERM ENG, V29, P980, DOI 10.1016/j.applthermaleng.2008.05.016	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147105	10.1371/journal.pone.0147105	http://dx.doi.org/10.1371/journal.pone.0147105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808528	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800050
J	Liao, JQ; Yu, SC; Yang, F; Yang, M; Hu, YH; Zhang, JY				Liao, Jiaqiang; Yu, Shicheng; Yang, Fang; Yang, Min; Hu, Yuehua; Zhang, Juying			Short-Term Effects of Climatic Variables on Hand, Foot, and Mouth Disease in Mainland China, 2008-2013: A Multilevel Spatial Poisson Regression Model Accounting for Overdispersion	PLOS ONE			English	Article							ENTEROVIRUS-71; TEMPERATURE; EPIDEMIC; OUTBREAK; LEVEL	Background Hand, Foot, and Mouth Disease (HFMD) is a worldwide infectious disease. In China, many provinces have reported HFMD cases, especially the south and southwest provinces. Many studies have found a strong association between the incidence of HFMD and climatic factors such as temperature, rainfall, and relative humidity. However, few studies have analyzed cluster effects between various geographical units. Methods The nonlinear relationships and lag effects between weekly HFMD cases and climatic variables were estimated for the period of 2008-2013 using a polynomial distributed lag model. The extra-Poisson multilevel spatial polynomial model was used to model the exact relationship between weekly HFMD incidence and climatic variables after considering cluster effects, provincial correlated structure of HFMD incidence and overdispersion. The smoothing spline methods were used to detect threshold effects between climatic factors and HFMD incidence. Results The HFMD incidence spatial heterogeneity distributed among provinces, and the scale measurement of overdispersion was 548.077. After controlling for long-term trends, spatial heterogeneity and overdispersion, temperature was highly associated with HFMD incidence. Weekly average temperature and weekly temperature difference approximate inverse "V" shape and "V" shape relationships associated with HFMD incidence. The lag effects for weekly average temperature and weekly temperature difference were 3 weeks and 2 weeks. High spatial correlated HFMD incidence were detected in northern, central and southern province. Temperature can be used to explain most of variation of HFMD incidence in southern and northeastern provinces. After adjustment for temperature, eastern and Northern provinces still had high variation HFMD incidence. Conclusion We found a relatively strong association between weekly HFMD incidence and weekly average temperature. The association between the HFMD incidence and climatic variables spatial heterogeneity distributed across provinces. Future research should explore the risk factors that cause spatial correlated structure or high variation of HFMD incidence which can be explained by temperature. When analyzing association between HFMD incidence and climatic variables, spatial heterogeneity among provinces should be evaluated. Moreover, the extra-Poisson multilevel model was capable of modeling the association between overdispersion of HFMD incidence and climatic variables.	[Liao, Jiaqiang; Yang, Fang; Yang, Min; Zhang, Juying] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China; [Yu, Shicheng; Hu, Yuehua] Chinese Ctr Dis Prevent & Control, Off Epidemiol, Beijing, Peoples R China	Sichuan University; Chinese Center for Disease Control & Prevention	Zhang, JY (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China.	Juying109@163.com	Hu, Yue/HGE-1673-2022; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	 [2012LCLB02]		Funding for HFMD cases diagnose and data analysis was supported by NO.2012LCLB02 (http://bjs.lclxbx.zdsys.zhaolizhi.cn/).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; [Anonymous], 2008, GUID PREP CONTR MEAS, P146; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan KP, 2003, EMERG INFECT DIS, V9, P78; COOPER JP, 1972, AM STAT, V26, P32, DOI 10.2307/2682864; COX DR, 1983, BIOMETRIKA, V70, P269, DOI 10.1093/biomet/70.1.269; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Li L, 2013, CHINESE GEN PRACTICE, V3, P326; Lianmei Y, 2003, ACTA GEOGRAPHICA SIN, V4, P012; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; Liu SL, 2015, REV MED VIROL, V25, P115, DOI 10.1002/rmv.1827; LIU Y, 2007, DIS SURVEILLANCE, P22; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; SALO RJ, 1976, ARCH VIROL, V52, P269, DOI 10.1007/BF01315616; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; Toida M, 2003, J CLIN LASER MED SUR, V21, P363, DOI 10.1089/104454703322650176; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu YiLing, 2010, Journal of Tropical Medicine (Guangzhou), V10, P1237; Yu SC, 2012, BIOMED ENVIRON SCI, V25, P645, DOI 10.3967/0895-3988.2012.06.006; Yu Shicheng, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P271; Zhang SY, 2015, EXP THER MED, V9, P811, DOI 10.3892/etm.2015.2207; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhengrong L, 2012, CHIN J INFECT DIS, P201; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	32	15	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147054	10.1371/journal.pone.0147054	http://dx.doi.org/10.1371/journal.pone.0147054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808311	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800048
J	Norazmi-Lokman, NH; Purser, GJ; Patil, JG				Norazmi-Lokman, Nor Hakim; Purser, G. J.; Patil, Jawahar G.			Gravid Spot Predicts Developmental Progress and Reproductive Output in a Livebearing Fish, Gambusia holbrooki	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; SOUTH-EASTERN AUSTRALIA; MEDAKA ORYZIAS LATIPES; NUPTIAL COLORATION; INTRODUCED MOSQUITOFISH; SEXUAL CHARACTERISTICS; METHYL TESTOSTERONE; PLAGUE MINNOW; AFFINIS; BIOLOGY	In most livebearing fish, the gravid spot is an excellent marker to identify brooding females, however its use to predict progress of embryonic development, brood size, timing of parturition and overall reproductive potential of populations remain unexplored. Therefore, to understand these relationships, this study quantified visual attributes (intensity and size) of the gravid spot in relation to key internal development in Gambusia holbrooki. Observations show that the colour of the gravid spot arises from progressive melanisation on the surface of the ovarian sac at its hind margin, rather than melanisation of the developing embryos or the skin of the brooding mother. More importantly, the gravid spot intensity and size were closely linked with both developmental stages and clutch size, suggesting their reliable use as external surrogates of key internal developmental in the species. Using predictive consistency of the gravid spot, we also determined the effect of rearing temperature (23 degrees C and 25 degrees C) on gestation period and parturition behaviour. The results show that gestation period was significantly reduced (F = 364.58; df = 1,48; P>0.05) at 25 degrees C. However there was no significant difference in average number of fry parturated in the two temperature groups (P<0.05), reaffirming that gravid spot intensity is a reliable predictor of reproductive output. The parturition in the species occurred predominantly in the morning and in contrast to earlier reports, tails of the fry emerged first with a few exceptions of head-first, twin and premature births. This study demonstrates utility of the gravid spot for downstream reproductive investigations in a live-bearing fish both in the field and laboratory. The reproducibility of the relationships (intensity with both developmental stage and clutch size), imply that they are also relevant to wild populations that experience varying temperature climes and stressors, significant deviations of which may serve as indicators of environmental health and climate variability.	[Norazmi-Lokman, Nor Hakim; Purser, G. J.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Launceston, Tas, Australia; [Patil, Jawahar G.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia; [Patil, Jawahar G.] Inland Fisheries Serv, New Norfolk, Tas, Australia; [Norazmi-Lokman, Nor Hakim] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu, Terengganu, Malaysia	University of Tasmania; University of Tasmania; Universiti Malaysia Terengganu	Patil, JG (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia.; Patil, JG (corresponding author), Inland Fisheries Serv, New Norfolk, Tas, Australia.	Jawahar.Patil@utas.edu.au	Norazmi, Lokman Nor Hakim/AAD-2229-2020; Patil, Jawahar G/B-9527-2012	Norazmi, Lokman Nor Hakim/0000-0002-1927-6846; Patil, Jawahar G/0000-0002-2154-4627	Australian Research Council; Inland Fisheries Service; Ministry of Higher Education, Malaysia	Australian Research Council(Australian Research Council); Inland Fisheries Service; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	The project was funded by the Australian Research Council and Inland Fisheries Service. NHNL received an academic staff training scholarship Ministry of Higher Education, Malaysia.	Agrillo C, 2008, ETHOLOGY, V114, P479, DOI 10.1111/j.1439-0310.2008.01493.x; Arthur J, 2013, PREGNANCY FEMALE LIV; Bone Q., 2007, BIOL FISHES; CHAMBOLLE P, 1970, Bulletin Biologique de la France et de la Belgique, V104, P443; Chandra G, 2008, INDIAN J MED RES, V127, P13; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Constantz G.D., 1989, P33; Deaton R, 2008, J FISH BIOL, V72, P1607, DOI 10.1111/j.1095-8649.2008.01827.x; Dzikowski R, 2001, AQUACULTURE, V199, P323, DOI 10.1016/S0044-8486(01)00561-0; Edwards TM, 2007, AQUAT TOXICOL, V85, P40, DOI 10.1016/j.aquatox.2007.07.014; Emmens CW, 2013, KEEPING BREEDING AQU; Rautenberg GE, 2015, ECOL INDIC, V48, P706, DOI 10.1016/j.ecolind.2014.09.025; Fujii Ryozo, 1993, P535; Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x; Greven H., 2005, VIVIPAROUS FISHES, P146; Hamer AJ, 2002, OECOLOGIA, V132, P445, DOI 10.1007/s00442-002-0968-7; Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199; HOWELL WM, 1980, COPEIA, P676; HUBBS C, 1959, EVOLUTION, V13, P236, DOI 10.1111/j.1558-5646.1959.tb03008.x; Ishii S, 1963, J FS U TOKYO SECT, V4, P181; Ivantsoff W, 1999, MAR FRESHWATER RES, V50, P467, DOI 10.1071/MF98106; Jobling M., 1995, ENVIRON BIOL FISH; Keane JP, 2004, NEW ZEAL J MAR FRESH, V38, P857, DOI 10.1080/00288330.2004.9517285; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Kouba A, 2013, J APPL ICHTHYOL, V29, P193, DOI 10.1111/jai.12010; Koya Y, 2000, FISHERIES SCI, V66, P63, DOI 10.1046/j.1444-2906.2000.00009.x; Kwan L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0267; Langerhans R. Brian, 2011, P228; Ling N, 2004, NEW ZEAL J MAR FRESH, V38, P473, DOI 10.1080/00288330.2004.9517254; Macdonald JI, 2012, MAR FRESHWATER RES, V63, P659, DOI 10.1071/MF12019; Morgan DL, 2004, NEW ZEAL J MAR FRESH, V38, P511, DOI 10.1080/00288330.2004.9517257; NIWA HS, 1965, EMBRYOLOGIA, V8, P299, DOI 10.1111/j.1440-169X.1965.tb00204.x; NIWA HS, 1965, EMBRYOLOGIA, V8, P289, DOI 10.1111/j.1440-169X.1965.tb00203.x; Nordeide JT, 2002, CAN J ZOOL, V80, P1344, DOI 10.1139/Z02-116; Patil J. G., 2012, ADAPTIVE MANAGEMENT; PEDEN AE, 1973, COPEIA, P250, DOI 10.2307/1442963; PEDEN AE, 1973, COPEIA, P210; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reznick D, 1996, AM ZOOL, V36, P147; Reznick D.N., 1989, ECOLOGY EVOLUTION LI, P373; Rombought P. J, 1997, GLOBAL WARMING IMPLI, P177, DOI DOI 10.1007/BF02523274; ROSEN DE, 1961, COPEIA, P201, DOI 10.2307/1439999; ROSENTHAL HAROLD L., 1955, COPEIA, V1955, P52, DOI 10.2307/1439454; ROSENTHAL HL, 1951, COPEIA, P304; Rowe DK, 2008, REV IMPACTS GAMBUSIA; Scrimshaw Nevin S., 1944, COPEIA, V1944, P180, DOI 10.2307/1437814; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Senior AM, 2013, INDIVIDUAL POPULATIO; Skold HN, 2008, HORM BEHAV, V54, P549, DOI 10.1016/j.yhbeh.2008.05.018; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Svensson PA, 2011, SKIN BIOPSY PERSPECT, P336; Thresher RE, 2013, ECOL APPL, V23, P801, DOI 10.1890/12-1324.1; Tiwari V, 2007, J ENV RES DEV, V1, P241; Toft G, 2003, ECOTOX ENVIRON SAFE, V56, P228, DOI 10.1016/S0147-6513(02)00138-0; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; Urban J, 2012, J APPL ICHTHYOL, P1; Yasir I, 2009, J WORLD AQUACULT SOC, V40, P337, DOI 10.1111/j.1749-7345.2009.00254.x	59	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147711	10.1371/journal.pone.0147711	http://dx.doi.org/10.1371/journal.pone.0147711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808521	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800190
J	Rasheed, H; McKinney, C; Stamp, LK; Dalbeth, N; Topless, RK; Day, R; Kannangara, D; Williams, K; Smith, M; Janssen, M; Jansen, TL; Joosten, LA; Radstake, TR; Riches, PL; Tausche, AK; Liote, F; Lu, L; Stahl, EA; Choi, HK; So, A; Merriman, TR				Rasheed, Humaira; McKinney, Cushla; Stamp, Lisa K.; Dalbeth, Nicola; Topless, Ruth K.; Day, Richard; Kannangara, Diluk; Williams, Kenneth; Smith, Malcolm; Janssen, Matthijs; Jansen, Tim L.; Joosten, Leo A.; Radstake, Timothy R.; Riches, Philip L.; Tausche, Anne-Kathrin; Liote, Frederic; Lu, Leo; Stahl, Eli A.; Choi, Hyon K.; So, Alexander; Merriman, Tony R.			The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets	PLOS ONE			English	Article							ASSOCIATION; DISEASE; SUSCEPTIBILITY; POLYMORPHISMS; ARTHRITIS; GENE	Deposition of crystallized monosodium urate (MSU) in joints as a result of hyperuricemia is a central risk factor for gout. However other factors must exist that control the progression from hyperuricaemia to gout. A previous genetic association study has implicated the toll-like receptor 4 (TLR4) which activates the NLRP3 inflammasome via the nuclear factor-kappa B signaling pathway upon stimulation by MSU crystals. The T-allele of single nucleotide polymorphism rs2149356 in TLR4 is a risk factor associated with gout in a Chinese study. Our aim was to replicate this observation in participants of European and New Zealand Polynesian (Maori and Pacific) ancestry. A total of 2250 clinically-ascertained prevalent gout cases and 13925 controls were used. Non-clinically-ascertained incident gout cases and controls from the Health Professional Follow-up (HPFS) and Nurses Health Studies (NHS) were also used. Genotypes were derived from genome-wide genotype data or directly obtained using Taqman. Logistic regression analysis was done including age, sex, diuretic exposure and ancestry as covariates as appropriate. The T-allele increased the risk of gout in the clinically-ascertained European samples (OR = 1.12, P = 0.012) and decreased the risk of gout in Polynesians (OR = 0.80, P = 0.011). There was no evidence for association in the HPFS or NHS sample sets. In conclusion TLR4 SNP rs2143956 associates with gout risk in prevalent clinically-ascertained gout in Europeans, in a direction consistent with previously published results in Han Chinese. However, with an opposite direction of association in Polynesians and no evidence for association in a non-clinically-ascertained incident gout cohort this variant should be analysed in other international gout genetic data sets to determine if there is genuine evidence for association.	[Rasheed, Humaira; McKinney, Cushla; Topless, Ruth K.; Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Rasheed, Humaira] Univ Engn & Technol, Lahore, Pakistan; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland 1, New Zealand; [Day, Richard; Kannangara, Diluk; Williams, Kenneth] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Day, Richard; Kannangara, Diluk; Williams, Kenneth] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia; [Smith, Malcolm] Flinders Med Ctr, Dept Med, Adelaide, SA, Australia; [Smith, Malcolm] Repatriat Gen Hosp, Adelaide, SA, Australia; [Janssen, Matthijs] Rijnstate Hosp, Dept Rheumatol, Arnhem, Netherlands; [Jansen, Tim L.] VieCuri Med Ctr, Dept IQ HealthCare, Venlo, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Radstake, Timothy R.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Riches, Philip L.] Univ Edinburgh, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland; [Tausche, Anne-Kathrin] Univ Clin Carl Gustav Carus, Dept Rheumatol, Dresden, Germany; [Liote, Frederic] Hosp Lariboisiere, INSERM, UMR S 1132, Paris, France; [Liote, Frederic] Univ Paris Diderot, Sorbonne Paris Cite, UFR Med, Paris, France; [Lu, Leo; Choi, Hyon K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Stahl, Eli A.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [So, Alexander] Univ Lausanne, Lab Rheumatol, Serv Rheumatol, DAL,CHUV, Lausanne, Switzerland	University of Otago; University of Engineering & Technology Lahore; University of Otago; University of Auckland; University of New South Wales Sydney; St Vincents Hospital Sydney; Flinders Medical Centre; Flinders University South Australia; Rijnstate Hospital; VieCuri Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Edinburgh; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Merriman, TR (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.		Liote, Frederic/AAD-6926-2020; Janssen, Matthijs/AAZ-2784-2020; Day, Richard/D-8699-2011; Jansen, Tim/ABE-8812-2020; McKinney, Cushla/A-7407-2012; Joosten, Leo AB/H-3138-2015	Day, Richard/0000-0002-6045-6937; McKinney, Cushla/0000-0002-7051-6876; Joosten, Leo AB/0000-0001-6166-9830; Liote, Frederic/0000-0003-4419-0726; Janssen, Matthijs/0000-0003-3752-7837	Health Research Council of New Zealand [11/1075, 14/527]; Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Arthritis Australia; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University;  [N01-HC-55015];  [N01-HC-55016];  [N01-HC-55018];  [N01-HC-55019];  [N01-HC55020];  [N01-HC-55021];  [N01-HC-55022];  [R01HL087641];  [R01HL59367];  [R01HL086694]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055019, N01HC055021, N01HC055020, N01HC055022, N01HC055018, N01HC055015] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065968] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Arthritis New Zealand; New Zealand Lottery Health; University of Otago and Arthritis Australia; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Health Research Council of New Zealand (11/1075, 14/527), Arthritis New Zealand, New Zealand Lottery Health, the University of Otago and Arthritis Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Atherosclerosis Risk in Communities study is supported by contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Framingham Heart Study and the Framingham SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University.	Bao Y, 2015, ANN RHEUM DIS, V74, P1394, DOI 10.1136/annrheumdis-2014-206534; Batt C, 2014, ANN RHEUM DIS, V73, P2101, DOI 10.1136/annrheumdis-2013-203600; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hamajima N, 2012, GENE, V503, P131, DOI 10.1016/j.gene.2012.04.064; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Liote F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4348; Liu-Bryan R., 2011, GOUT OTHER CRYST ART, V2011, P59; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Merriman TR, 2014, RHEUM DIS CLIN N AM, V40, P279, DOI 10.1016/j.rdc.2014.01.009; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Qing YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064845; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Rasheed H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4366; Urano W, 2013, J RHEUMATOL, V40, P1374, DOI 10.3899/jrheum.121244; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320	24	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147939	10.1371/journal.pone.0147939	http://dx.doi.org/10.1371/journal.pone.0147939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808548	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800247
J	Sae-Lee, C; Moolsuwan, K; Chan, L; Poungvarin, N				Sae-Lee, Chanachai; Moolsuwan, Kanya; Chan, Lawrence; Poungvarin, Naravat			ChREBP Regulates Itself and Metabolic Genes Implicated in Lipid Accumulation in beta-Cell Line	PLOS ONE			English	Article							CARBOHYDRATE RESPONSE ELEMENT; PYRUVATE-KINASE GENE; FATTY-ACID-SYNTHASE; THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION FACTOR; BINDING PROTEIN; GLUCOSE REGULATION; RAT HEPATOCYTES; S-14 GENE; EXPRESSION	Carbohydrate response element binding protein (ChREBP) is an important transcription factor that regulates a variety of glucose-responsive genes in hepatocytes. To date, only two natural isoforms, Chrebpa and Chrebp beta, have been identified. Although ChREBP is known to be expressed in pancreatic beta cells, most of the glucose-responsive genes have never been verified as ChREBP targets in this organ. We aimed to explore the impact of ChREBP expression on regulating genes linked to accumulation of lipid droplets, a typical feature of beta-cell glucotoxicity. We assessed gene expression in 832/13 cells overexpressing constitutively active ChREBP (caChREBP), truncated ChREBP with nearly identical amino acid sequence to Chrebp beta, or dominant negative ChREBP (dnChREBP). Among multiple ChREBP-controlled genes, ChREBP was sufficient and necessary for regulation of Eno1, Pklr, Mdh1, Me1, Pdha1, Acly, Acaca, Fasn, Elovl6, Gpd1, Cpt1a, Rgs16, Mid1ip1, Txnip, and Chrebp beta. Expression of Chrebpa and Srebp1c were not changed by caChREBP or dnChREBP. We identified functional ChREBP binding sequences that were located on the promoters of Chrebp beta and Rgs16. We also showed that Rgs16 overexpression lead to increased considerable amounts of lipids in 832/13 cells. This phenotype was accompanied by reduction of Cpt1a expression and slight induction of Fasn and Pklr gene in these cells. In summary, we conclude that Chrebp beta modulates its own expression, not that of Chrebpa; it also regulates the expression of several metabolic genes in beta-cells without affecting SREBP-1c dependent regulation. We also demonstrate that Rgs16 is one of the ChREBP-controlled genes that potentiate accumulation of lipid droplets in beta-cells.	[Sae-Lee, Chanachai; Moolsuwan, Kanya; Poungvarin, Naravat] Mahidol Univ, Fac Med, Siriraj Hosp, Clin Mol Pathol Lab,Dept Clin Pathol, Bangkok 10700, Thailand; [Moolsuwan, Kanya] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Program Mol Med, Bangkok 10400, Thailand; [Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Mahidol University; Mahidol University; Baylor College of Medicine	Poungvarin, N (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Clin Mol Pathol Lab,Dept Clin Pathol, Bangkok 10700, Thailand.	naravat@gmail.com		Sae-Lee, Chanachai/0000-0001-7758-7653	Siriraj research fund from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [R015433020]; National Science and Technology Development Agency (NSTDA), Thailand; National Institutes of Health [HL051586/DK105527, P30DK079638]; Rutherford Chair in Diabetes research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	Siriraj research fund from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; National Science and Technology Development Agency (NSTDA), Thailand; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutherford Chair in Diabetes research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Siriraj research fund (R015433020) from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand (NP) and Discovery-based Development Grant (DD Grant) from National Science and Technology Development Agency (NSTDA), Thailand (NP). It was supported in part by National Institutes of Health grants HL051586/DK105527 and P30DK079638 and the Rutherford Chair in Diabetes research to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aipoalani DL, 2010, ENDOCRINOLOGY, V151, P2071, DOI 10.1210/en.2009-1058; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; da Silva XG, 2006, J LIPID RES, V47, P2482, DOI DOI 10.1194/JLR.M600289-JLR200; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Hanke N, 2011, BBA-MOL CELL RES, V1813, P377, DOI 10.1016/j.bbamcr.2010.12.021; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2013, ENDOCR J, V60, P473; Iizuka K, 2011, BIOCHEM BIOPH RES CO, V412, P638, DOI 10.1016/j.bbrc.2011.08.016; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Iizuka K, 2009, BIOCHEM BIOPH RES CO, V379, P499, DOI 10.1016/j.bbrc.2008.12.100; Iizuka K, 2008, BIOCHEM BIOPH RES CO, V374, P95, DOI 10.1016/j.bbrc.2008.06.101; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mourrieras F, 1997, BIOCHEM J, V326, P345, DOI 10.1042/bj3260345; Myburgh R, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.58; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Pedersen KB, 2010, BIOCHEM J, V426, P159, DOI 10.1042/BJ20091266; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; PRIPBUUS C, 1995, EUR J BIOCHEM, V230, P309, DOI 10.1111/j.1432-1033.1995.tb20564.x; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Wutthisathapornchai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102730; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhang P, 2015, DIABETES	48	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147411	10.1371/journal.pone.0147411	http://dx.doi.org/10.1371/journal.pone.0147411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808438	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800091
J	Wang, DM; Meng, MC; Guo, Y				Wang, De-Ming; Meng, Mei-Cen; Guo, Yun			Pollen Organ Telangiopsis sp of Late Devonian Seed Plant and Associated Vegetative Frond	PLOS ONE			English	Article							SP NOV.; RECONSTRUCTION; PTERIDOSPERM; AFFINITIES; CUPULATE; GEN.	Pollen organ Telangiopsis sp., associated with but not attached to vegetative fronds, has been collected from the Upper Devonian (Famennian) Wutong Formation, Dongzhi County, Anhui Province, China. Fertile axes with terminal pollen organs are dichotomous for 2-4 times and may be proximally attached by fragmentary pinnules. Pollen organs are synangiate and borne on the top of a short stalk. Synangia are radial in symmetry and each consists of 4-8 elongate microsporangia fused at base. Microsporangia have a longitudinal dehiscence line and show a tapered apex. The associated stem is spiny and bears a vegetative frond which bifurcates once at the basalmost part. Frond rachises possess one order of pinna arranged alternately. Pinnules are borne alternately, planate, highly dissected, and equally dichotomous for 2-3 times. Comparisons among Late Devonian seed plants recognize several branching patterns in the fertile fronds/axes bearing terminal pollen organs. Telangiopsis sp. reinforces that the Late Devonian pollen organs are synangiate usually with basally fused microsporangia. It is suggested that the evolutionary divergence of radial and bilateral symmetries of pollen organs may have occurred in the Famennian, when the earliest seed plants evolved planate and sometimes laminate pinnules.	[Wang, De-Ming] Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China; [Meng, Mei-Cen] China Sci Publishing & Media Ltd, Sci Press, 16 Donghuangchenggen North St, Beijing 100717, Peoples R China; [Guo, Yun] Yunnan Univ, Dept Geol, Sch Resource Environm & Earth Sci, Kunming 650091, Yunnan Province, Peoples R China	Peking University; Yunnan University	Wang, DM (corresponding author), Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China.	dmwang@pku.edu.cn			National Basic Research Program of China of the Ministry of Science and Technology of China [2012CB821900]; National Natural Science Foundation of China [41402023, 41302014]	National Basic Research Program of China of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China of the Ministry of Science and Technology of China (http://www.973.gov.cn/Default_3.aspx, no. 2012CB821900), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, no. 41402023 and no. 41302014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ORIGIN EVOLUTION GYM; [Anonymous], [No title captured]; Cressler WL, 2010, INT J COAL GEOL, V83, P91, DOI 10.1016/j.coal.2009.10.002; EGGERT DA, 1971, BOT GAZ, V132, P30, DOI 10.1086/336559; Galtier J, 1998, T ROY SOC EDIN-EARTH, V88, P197; Guo Y, 2009, ACTA GEOL SIN-ENGL, V83, P479, DOI 10.1111/j.1755-6724.2009.00069.x; Hilton J, 1999, BOT J LINN SOC, V129, P1; Hilton J, 2006, REV PALAEOBOT PALYNO, V142, P137, DOI 10.1016/j.revpalbo.2006.03.022; JENNINGS JR, 1976, AM J BOT, V63, P1119, DOI 10.2307/2441657; Klavins SD, 1996, REV PALAEOBOT PALYNO, V93, P253, DOI 10.1016/0034-6667(95)00129-8; Li X.X., 1984, BULLETION CHINESE AC, P119; Matten Lawrence C., 1994, Palaeontographica Abteilung B Palaeophytologie, V232, P15; Meyer-Berthaud B., 1989, PALAEONTOGR ABT B, V211, P87; MEYERBERTHAUD B, 1986, REV PALAEOBOT PALYNO, V48, P181, DOI 10.1016/0034-6667(86)90058-8; MILLAY MA, 1979, BOT REV, V45, P301, DOI 10.1007/BF02860858; Orlova OA, 2009, PALEONTOL J+, V43, P1316, DOI 10.1134/S003103010910013X; Ouyang S., 2000, J STRATIGR, V3, P230; Prestianni C, 2013, INT J PLANT SCI, V174, P832, DOI 10.1086/670235; Rothwell G. W, 1988, ORIGIN EVOLUTION GYM, P85; ROWE NP, 1988, BOT J LINN SOC, V97, P125, DOI 10.1111/j.1095-8339.1988.tb02457.x; SERBET R, 1992, INT J PLANT SCI, V153, P602, DOI 10.1086/297083; Shadle Gary L, 1975, Am J Bot, V62, P67, DOI 10.1002/j.1537-2197.1975.tb12339.x; SKOG JE, 1980, AM J BOT, V67, P440, DOI 10.2307/2442283; Taylor T.N., 1988, ORIGIN EVOLUTION GYM, P177; TAYLOR TN, 1982, BIOSCIENCE, V32, P23, DOI 10.2307/1308750; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; TAYLOR TN, 1981, REV PALAEOBOT PALYNO, V32, P27, DOI 10.1016/0034-6667(81)90074-9; Wang DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1613; Wang DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10736; Wang DM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0292-6; Wang DM, 2014, NATURWISSENSCHAFTEN, V101, P615, DOI 10.1007/s00114-014-1187-x; Wang Y, 2000, ACTA PALAEONTOL SIN, V39, P42	32	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147984	10.1371/journal.pone.0147984	http://dx.doi.org/10.1371/journal.pone.0147984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808271	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800257
J	Yang, L; He, CQ; Pang, MYC				Yang, Lei; He, Chengqi; Pang, Marco Yiu Chung			Reliability and Validity of Dual-Task Mobility Assessments in People with Chronic Stroke	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; TEST-RETEST RELIABILITY; PREDICTING FALLS; OLDER-ADULTS; WALKING; GAIT; BALANCE; PERFORMANCE; INDIVIDUALS; IMPAIRMENT	Background The ability to perform a cognitive task while walking simultaneously (dual-tasking) is important in real life. However, the psychometric properties of dual-task walking tests have not been well established in stroke. Objective To assess the test-retest reliability, concurrent and known-groups validity of various dual-task walking tests in people with chronic stroke. Design Observational measurement study with a test-retest design. Methods Eighty-eight individuals with chronic stroke participated. The testing protocol involved four walking tasks (walking forward at self-selected and maximal speed, walking backward at self-selected speed, and crossing over obstacles) performed simultaneously with each of the three attention-demanding tasks (verbal fluency, serial 3 subtractions or carrying a cup of water). For each dual-task condition, the time taken to complete the walking task, the correct response rate (CRR) of the cognitive task, and the dual-task effect (DTE) for the walking time and CRR were calculated. Forty-six of the participants were tested twice within 3-4 days to establish test-retest reliability. Results The walking time in various dual-task assessments demonstrated good to excellent reliability [Intraclass correlation coefficient (ICC2,1) = 0.70-0.93; relative minimal detectable change at 95% confidence level (MDC95%) = 29%-45%]. The reliability of the CRR (ICC2,1 = 0.58-0.81) and the DTE in walking time (ICC2,1 = 0.11-0.80) was more varied. The reliability of the DTE in CRR (ICC2,1 = -0.31-0.40) was poor to fair. The walking time and CRR obtained in various dual-task walking tests were moderately to strongly correlated with those of the dual-task Timed-up-and-Go test, thus demonstrating good concurrent validity. None of the tests could discriminate fallers (those who had sustained at least one fall in the past year) from non-fallers. Limitation The results are generalizable to community-dwelling individuals with chronic stroke only. Conclusions The walking time derived from the various dual-task assessments generally demonstrated good to excellent reliability, making them potentially useful in clinical practice and future research endeavors. However, the usefulness of these measurements in predicting falls needs to be further explored. Relatively low reliability was shown in the cognitive outcomes and DTE, which may not be preferred measurements for assessing dual-task performance.	[Yang, Lei; He, Chengqi] Sichuan Univ, West China Hosp, Dept Rehabil Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Yang, Lei] Hong Kong Polytech Univ, Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Sichuan, Peoples R China; [Yang, Lei; Pang, Marco Yiu Chung] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China	Sichuan University; Hong Kong Polytechnic University; Sichuan University; Hong Kong Polytechnic University	Pang, MYC (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	Marco.Pang@polyu.edu.hk		Pang, Marco Yiu Chung/0000-0003-1652-8945	Institute of Disaster Management and Reconstruction, Sichuan University; Hong Kong Polytechnic University, Chengdu, Sichuan, China [RTHV]	Institute of Disaster Management and Reconstruction, Sichuan University; Hong Kong Polytechnic University, Chengdu, Sichuan, China	This work was funded by Institute of Disaster Management and Reconstruction, Sichuan University - The Hong Kong Polytechnic University, Chengdu, Sichuan, China (Grant number: RTHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Andersson AG, 2006, J REHABIL MED, V38, P186, DOI 10.1080/16501970500478023; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Beauchet O, 2007, AGE AGEING, V36, P418, DOI 10.1093/ageing/afm011; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; Cho KH, 2015, DISABIL REHABIL, V37, P512, DOI 10.3109/09638288.2014.932445; Divani AA, 2009, STROKE, V40, P3286, DOI 10.1161/STROKEAHA.109.559195; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FLEISS JL, 1981, APPL PSYCH MEAS, V5, P105, DOI 10.1177/014662168100500115; Fuller RL, 2013, PARKINSONISM RELAT D, V19, P325, DOI 10.1016/j.parkreldis.2012.11.011; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Harley C, 2006, J NEUROL NEUROSUR PS, V77, P674, DOI 10.1136/jnnp.2005.074138; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hars M, 2013, GAIT POSTURE, V38, P1010, DOI 10.1016/j.gaitpost.2013.05.015; Hofheinz M, 2010, CLIN REHABIL, V24, P831, DOI 10.1177/0269215510367993; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Hsu PC, 2006, DISABIL REHABIL, V28, P1287, DOI 10.1080/09638280600638414; Hyndman D, 2006, DISABIL REHABIL, V28, P849, DOI 10.1080/09638280500534994; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; Muhaidat J, 2014, ARCH PHYS MED REHAB, V95, P58, DOI 10.1016/j.apmr.2013.07.027; Muhaidat J, 2013, GAIT POSTURE, V38, P43, DOI 10.1016/j.gaitpost.2012.10.011; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Patel P, 2014, TOP STROKE REHABIL, V21, P347, DOI 10.1310/tsr2104-347; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Plummer-D'Amato P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-129; Remaud A, 2013, EXP BRAIN RES, V231, P219, DOI 10.1007/s00221-013-3684-0; Said CM, 2013, PHYS THER, V93, P334, DOI 10.2522/ptj.20120200; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Takatori Katsuhiko, 2012, Physiotherapy Theory and Practice, V28, P292, DOI 10.3109/09593985.2011.600424; Tang PF, 2015, GERIATR GERONTOL INT, V15, P204, DOI 10.1111/ggi.12258; Tsang CSL, 2013, PHYS THER, V93, P1102, DOI 10.2522/ptj.20120454; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong MTP, 2002, INT J GERIATR PSYCH, V17, P459, DOI 10.1002/gps.633; Yang L, 2015, MATURITAS, V80, P359, DOI 10.1016/j.maturitas.2015.01.001	44	74	79	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147833	10.1371/journal.pone.0147833	http://dx.doi.org/10.1371/journal.pone.0147833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808662	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800220
J	Lien, RY; Yu, MH; Hsu, KH; Liao, PJ; Chen, YP; Lai, CC; Wu, WC				Lien, Reyin; Yu, Mu-Hsien; Hsu, Kuang-Hung; Liao, Pei-Ju; Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi			Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; MACULAR EDEMA SECONDARY; RETINAL VEIN OCCLUSION; INTRAVITREAL BEVACIZUMAB; VITREOUS HEMORRHAGE; AVASTIN; INJECTION; THERAPY; TRIAL	Purpose The current study aims to investigate the neurodevelopment of premature infants after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of prematurity (ROP) up to the age of 2 years. Methods The study design was retrospective observational case series conducted at an institutional referral center. Infants with type 1 ROP were classified into 3 groups: laser only, IVB only, and a combination of IVB and laser treatment. Main Outcome Measures were neurodevelopmental outcomes of the patients after treatment were assessed by Bayley Scales for Infant Development. Results Sixty-one patients who finished the neurodevelopmental survey were included. No detrimental effects on neurodevelopment were found in IVB group compared with the patients who received laser treatment only. The patients in the IVB + laser group had a higher incidence of significant mental (p = 0.028) and psychomotor (p = 0.002) impairment at 24 months than the patients in the laser group. The odds ratio of having severe psychomotor defects in the IVB + laser group was 5.3 compared with the laser group (p = 0.041). The causal source for the differences that were detected remained unknown due to lack of randomization in the study and accompanying bias in patient selection. Conclusions Two years after laser and/or intravitreal injections of bevacizumab for infants with retinopathy of prematurity, no difference on neurodevelopment for those who received only bevacizumab versus only laser treatment were found. Those infants who required rescue therapy with laser or bevacizumab injection after initial, unsuccessful treatment showed some detrimental, neurodevelopmental effects.	[Lien, Reyin; Yu, Mu-Hsien] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol, Taoyuan, Taiwan; [Lien, Reyin; Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsu, Kuang-Hung; Liao, Pei-Ju] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan; [Liao, Pei-Ju] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan; [Liao, Pei-Ju] Natl Taiwan Univ, Dept Business Adm, Taipei 10764, Taiwan; [Chen, Yen-Po; Lai, Chi-Chun; Wu, Wei-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Asia Eastern University of Science & Technology; National Taiwan University; Chang Gung Memorial Hospital	Wu, WC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.	weichi666@gmail.com		Hsu, Kuang-Hung/0000-0003-2642-7689; Lai, Chi-Chun/0000-0001-9547-7212	Ministry of Science and Technology, Taipei, Taiwan [NSC101-2314-B-182A-055-MY3, MOST104-2314-B-182A-100-MY2]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3D0251, CMRPG3D0522]	Ministry of Science and Technology, Taipei, Taiwan; Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the Ministry of Science and Technology, Taipei, Taiwan (NSC101-2314-B-182A-055-MY3 and MOST104-2314-B-182A-100-MY2) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG3D0251 and CMRPG3D0522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Banach MJ, 2000, OPHTHALMOLOGY, V107, P324, DOI 10.1016/S0161-6420(99)00042-1; Bashshur ZF, 2009, AM J OPHTHALMOL, V148, P59, DOI 10.1016/j.ajo.2009.02.006; BREIER G, 1992, DEVELOPMENT, V114, P521; GLASCOE FP, 1993, CLIN PEDIATR, V32, P203; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iliev ME, 2006, AM J OPHTHALMOL, V142, P1054, DOI 10.1016/j.ajo.2006.06.066; Jaissle GB, 2009, GRAEF ARCH CLIN EXP, V247, P27, DOI 10.1007/s00417-008-0916-2; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jonas JB, 2008, ACTA OPHTHALMOL, V86, P585, DOI 10.1111/j.1600-0420.2007.01107.x; Kriechbaum K, 2008, BRIT J OPHTHALMOL, V92, P518, DOI 10.1136/bjo.2007.127282; Malik S, 2013, J NEUROSCI, V33, P411, DOI 10.1523/JNEUROSCI.4445-12.2013; Martinez-Castellanos MA, 2013, RETINA-J RET VIT DIS, V33, P329, DOI 10.1097/IAE.0b013e318275394a; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Provost Beth, 2004, Pediatr Phys Ther, V16, P149, DOI 10.1097/01.PEP.0000136005.41585.FE; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Ruiz-Moreno JM, 2008, ACTA OPHTHALMOL, V86, P231, DOI 10.1111/j.1600-0420.2007.01021.x; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Sato T, 2009, OPHTHALMOLOGY, V116, P2165, DOI 10.1016/j.ophtha.2009.04.026; Sato T, 2009, OPHTHALMOLOGY, V116, P1599, DOI 10.1016/j.ophtha.2008.12.023; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Wu WC, 2015, JAMA OPHTHALMOL, V133, P391, DOI 10.1001/jamaophthalmol.2014.5373; Wu WC, 2013, AM J OPHTHALMOL, V155, P150, DOI 10.1016/j.ajo.2012.06.010; Wu WC, 2011, OPHTHALMOLOGY, V118, P176, DOI 10.1016/j.ophtha.2010.04.018; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425	33	99	100	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148019	10.1371/journal.pone.0148019	http://dx.doi.org/10.1371/journal.pone.0148019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815000	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528200067
J	Lee, KM; Lee, EJ; Kim, TW; Kim, H				Lee, Kyoung Min; Lee, Eun Ji; Kim, Tae-Woo; Kim, Hyunjoong			Comparison of the Abilities of SD-OCT and SS-OCT in Evaluating the Thickness of the Macular Inner Retinal Layer for Glaucoma Diagnosis	PLOS ONE			English	Article							OPTICAL-COHERENCE-TOMOGRAPHY; NERVE-FIBER LAYER; FOURIER-DOMAIN OCT; SWEPT-SOURCE OCT; OPERATING CHARACTERISTIC CURVES; GANGLION-CELL COMPLEX; SPECTRAL-DOMAIN; CHOROIDAL THICKNESS; NORMAL EYES; HIGH MYOPIA	Purpose To compare the abilities of spectral-domain optical coherence tomography (OCT) (SD-OCT; Spectralis, Heidelberg Engineering) and swept-source OCT (SS-OCT; DRI-OCT1 Atlantis system, Topcon) for analyzing the macular inner retinal layers in diagnosing glaucoma. Methods The study included 60 patients with primary open-angle glaucoma (POAG) and 60 healthy control subjects. Macular cube area was scanned using SD-OCT and SS-OCT on the same day to assess the thicknesses of the macular retinal nerve fiber layer (mRNFL), ganglion cell layer plus inner plexiform layer (GCIPL), and total retinal layer in nine subfields defined by the Early Treatment Diabetic Retinopathy Study (ETDRS). The abilities of the parameters to discriminate between the POAG and control groups were assessed using areas under the receiver operating characteristic curves (AUCs). Results Glaucoma-associated mRNFL and GCIPL thinning was more common in the outer zones than inner zones for both SD-OCT and SS-OCT. The mRNFL and GCIPL measurements showed distinct pattern differences between SD-OCT and SS-OCT in each ETDRS subfield. Although the glaucoma-diagnosis ability was comparable between SD-OCT and SS-OCT for most of the parameters, AUC was significantly larger for SD-OCT measurements of the GCIPL thickness in the outer temporal zones (p = 0.003) and of the mRNFL thickness in the outer nasal zones (p = 0.001), with the former having the largest AUC for discriminating POAG from healthy eyes (AUC = 0.894). Conclusion Spectralis SD-OCT and DRI SS-OCT have similar glaucoma-diagnosis abilities based on macular inner layer thickness analysis. However, Spectralis SD-OCT was potentially superior to DRI SS-OCT in detecting GCIPL thinning in the outer temporal zone, where the glaucomatous damage predominantly occurs.	[Lee, Kyoung Min; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea; [Kim, Hyunjoong] Yonsei Univ, Dept Appl Stat, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Lee, EJ; Kim, TW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	opticdisc@gmail.com; twkim7@snu.ac.kr		Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This study was supported by a grant from the National Research Foundation of Korea funded by Korean Government (no. 2013R1A1A1A05004781). The funding organization had no role in the design or conduct of this research.	Adhi M, 2014, AM J OPHTHALMOL, V157, P1272, DOI 10.1016/j.ajo.2014.02.034; Adhi M, 2013, OSLI RETINA, V44, pS40, DOI 10.3928/23258160-20131101-08; Amini N, 2014, INVEST OPHTH VIS SCI, V55, P7332, DOI 10.1167/iovs.14-14962; Bagga H, 2005, J GLAUCOMA, V14, P358, DOI 10.1097/01.ijg.0000176930.21853.04; Buchser NM, 2012, INVEST OPHTH VIS SCI, V53, P3742, DOI 10.1167/iovs.11-8432; Chauhan BC, 2014, OPHTHALMOLOGY, V121, P2287, DOI 10.1016/j.ophtha.2014.06.023; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Curcio CA, 2011, INVEST OPHTH VIS SCI, V52, P3943, DOI 10.1167/iovs.10-6377; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Dodd LE, 2003, BIOMETRICS, V59, P614, DOI 10.1111/1541-0420.00071; Ferguson AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132365; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang JY, 2011, J GLAUCOMA, V20, P87, DOI 10.1097/IJG.0b013e3181d787b6; Hwang YH, 2014, OPHTHALMOLOGY, V121, P1508, DOI 10.1016/j.ophtha.2014.02.019; Kim NR, 2011, BRIT J OPHTHALMOL, V95, P1115, DOI 10.1136/bjo.2010.182493; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kimura Y, 2013, AM J OPHTHALMOL, V156, P907, DOI 10.1016/j.ajo.2013.06.029; Knighton RW, 2000, J GLAUCOMA, V9, P56; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Lederer DE, 2003, AM J OPHTHALMOL, V135, P838, DOI 10.1016/S0002-9394(02)02277-8; Lee K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1118, DOI 10.1001/archophthalmol.2012.669; Martinez-De-La-Casa JM, 2014, INVEST OPHTH VIS SCI, V55, P8343, DOI 10.1167/iovs.14-15501; Matsuo Y, 2013, INVEST OPHTH VIS SCI, V54, P7630, DOI 10.1167/iovs.13-13135; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P44, DOI 10.1016/j.ajo.2004.08.069; Medeiros FA, 2006, INVEST OPHTH VIS SCI, V47, P2520, DOI 10.1167/iovs.05-1441; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Shin HY, 2014, OPHTHALMOLOGY, V121, P93, DOI 10.1016/j.ophtha.2013.06.041; Sung KR, 2012, OPHTHALMOLOGY, V119, P308, DOI 10.1016/j.ophtha.2011.08.022; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wollstein G, 2004, AM J OPHTHALMOL, V138, P218, DOI 10.1016/j.ajo.2004.03.019; Yamada H, 2014, AM J OPHTHALMOL, V158, P1318, DOI 10.1016/j.ajo.2014.08.040; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125957; Yang ZY, 2015, AM J OPHTHALMOL, V159, P193, DOI 10.1016/j.ajo.2014.10.019	50	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147964	10.1371/journal.pone.0147964	http://dx.doi.org/10.1371/journal.pone.0147964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812064	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000067
J	Narres, M; Claessen, H; Droste, S; Kvitkina, T; Koch, M; Kuss, O; Icks, A				Narres, Maria; Claessen, Heiner; Droste, Sigrid; Kvitkina, Tatjana; Koch, Michael; Kuss, Oliver; Icks, Andrea			The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review	PLOS ONE			English	Review							REPLACEMENT THERAPY; RACIAL-DIFFERENCES; ALLEGHENY COUNTY; UNITED-STATES; MORTALITY; MELLITUS; TRENDS; FAILURE; EPIDEMIOLOGY; SURVIVAL	End-stage renal disease (ESRD) in diabetes is a life threatening complication resulting in a poor prognosis for patients as well as high medical costs. The aims of this systematic review were (1) to evaluate the incidence of ESRD due to all causes and due to diabetic nephropathy in the diabetic population and differences between incidences of ESRD with respect to sex, ethnicity, age and regions, (2) to compare incidence rates in the diabetic and non-diabetic population, and (3) to investigate time trends. The systematic review was conducted according to the PRISMA group guidelines by performing systematic literature searches in the biomedical databases until January 3rd 2015; thirty-two studies were included. Among patients with incident type 1 diabetes the 30-year cumulative incidence ranged from 3.3% to 7.8%. Among patients with prevalent diabetes, incidence rates of ESRD due to all causes ranged from 132.0 to 167.0 per 100,000 person-years, whereas incidence rates of ESRD due to diabetic nephropathy varied from 38.4 to 804.0 per 100,000 person-years. The incidence of ESRD in the diabetic population was higher compared to the non-diabetic population, and relative risks varied from 6.2 in the white population to 62.0 among Native Americans. The results regarding time trends were inconsistent. The review conducted demonstrates the considerable variation of incidences of ESRD among the diabetic population. Consistent findings included an excess risk when comparing the diabetic to the non-diabetic population and ethnic differences. We recommend that newly designed studies should use standardized methods for the determination of ESRD and population at risk.	[Narres, Maria; Claessen, Heiner; Kvitkina, Tatjana; Kuss, Oliver; Icks, Andrea] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Droste, Sigrid; Kvitkina, Tatjana; Icks, Andrea] Univ Dusseldorf, Dept Publ Hlth, Dusseldorf, Germany; [Koch, Michael] Ctr Nephrol, Mettmann, Germany; [Koch, Michael] Univ Dusseldorf, Clin Nephrol, Dusseldorf, Germany; [Kuss, Oliver; Icks, Andrea] German Ctr Diabet Res DZD, Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Narres, M (corresponding author), German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	Maria.Narres@ddz.uni-duesseldorf.de		Kuss, Oliver/0000-0003-3301-5869	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work is supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG) and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1990, Diabet Med, V7, P360; [Anonymous], 2012, INC PRED END STAG RE; Assogba FGA, 2014, DIABETOLOGIA, V57, P718, DOI 10.1007/s00125-014-3160-9; Bell S, 2015, QJM-INT J MED, V108, P127, DOI 10.1093/qjmed/hcu170; Bergrem H, 2001, ADV RENAL REPLACE TH, V8, P4, DOI 10.1053/jarr.2001.21711; Bruno G, 2003, DIABETES CARE, V26, P2353, DOI 10.2337/diacare.26.8.2353; BURDEN AC, 1992, DIABETIC MED, V9, P641, DOI 10.1111/j.1464-5491.1992.tb01860.x; Burrows N. R., 2010, Morbidity and Mortality Weekly Report, V59, P1361; Burrows NR, 2014, MMWR-MORBID MORTAL W, V63, P186; Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Burrows NR, 2005, DIABETES CARE, V28, P1041, DOI 10.2337/diacare.28.5.1041; CATALANO C, 1992, NEPHROL DIAL TRANSPL, V7, P181, DOI 10.1093/oxfordjournals.ndt.a092103; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P834; Chang YT, 2014, DIABETES CARE, V37, P277, DOI 10.2337/dc13-0781; Cochrane Consumers and Communication Review Group, 2011, GUID REV AUTH ASS ST; Comas J, 2013, NEPHROL DIAL TRANSPL, V28, P1191, DOI 10.1093/ndt/gfs507; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Dyck RF, 2014, CAN J DIABETES, V38, P237, DOI 10.1016/j.jcjd.2014.03.005; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Gerrits EG, 2015, JAMA INTERN MED, V175, P469, DOI 10.1001/jamainternmed.2014.7985; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Hendrie GA, 2015, AUST NZ J PUBL HEAL, V39, P536, DOI 10.1111/1753-6405.12442; Hill CJ, 2012, J RENAL CARE, V38, P12, DOI 10.1111/j.1755-6686.2012.00273.x; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Icks A, 2012, DIABETES CARE, V35, P1868, DOI 10.2337/dc11-2159; Icks A, 2011, NEPHROL DIAL TRANSPL, V26, P264, DOI 10.1093/ndt/gfq398; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; IDF, 2019, IDF DIABETES ATLAS; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; LeCaire TJ, 2014, DIABETES CARE, V37, P381, DOI 10.2337/dc13-1287; LEE ET, 1994, DIABETES, V43, P572, DOI 10.2337/diabetes.43.4.572; Lin WH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000274; Lok CE, 2004, NEPHROL DIAL TRANSPL, V19, P3098, DOI 10.1093/ndt/gfh540; LOPES AAS, 1995, AM J KIDNEY DIS, V25, P714, DOI 10.1016/0272-6386(95)90547-2; Lopes AA, 2009, ETHNIC DIS, V19, P47; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P2283, DOI 10.1093/ndt/gfp761; MATSUSHIMA M, 1995, DIABETOLOGIA, V38, P236, DOI 10.1007/BF00400100; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mollsten A, 2010, DIABETES, V59, P1803, DOI 10.2337/db09-1744; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; NELSON RG, 1988, DIABETOLOGIA, V31, P730, DOI 10.1007/BF00274774; NEWMAN JM, 1990, AM J PUBLIC HEALTH, V80, P318, DOI 10.2105/AJPH.80.3.318; Nishimura R, 2003, AM J KIDNEY DIS, V42, P117, DOI 10.1016/S0272-6386(03)00414-1; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Owen WF, 1996, BLOOD PURIFICAT, V14, P278; Prevention CfDCa, 1992, MMWR-MORBID MORTAL W, V41, P845; Prevention CfDCa, 1992, MMWR-MORBID MORTAL W, V41, P7; PUGH JA, 1995, DIABETES, V44, P1375, DOI 10.2337/diabetes.44.12.1375; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Rigobon AV, 2015, CAN J PUBLIC HEALTH, V106, pE283, DOI 10.17269/cjph.106.4508; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Sattar A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-130; SMITH SR, 1991, KIDNEY INT, V40, P815, DOI 10.1038/ki.1991.281; STEPHENS GW, 1990, AM J KIDNEY DIS, V15, P562, DOI 10.1016/S0272-6386(12)80527-0; Stewart JH, 2007, NEPHROLOGY, V12, P520, DOI 10.1111/j.1440-1797.2007.00830.x; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Tien KJ, 2013, DIABETES CARE, V36, P3027, DOI 10.2337/dc12-2148; Uchigata Y, 2004, J DIABETES COMPLICAT, V18, P155, DOI 10.1016/j.jdiacomp.2003.10.002; UNITED STATES RENAL DATA SYSTEM, 2013, ATL CKD ESRD; Villar E, 2007, DIABETES CARE, V30, P3070, DOI 10.2337/dc07-0895; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Villar E, 2010, DIABETES CARE, V33, pE69, DOI 10.2337/dc10-0074; Wang AYM, 2011, J DIABETES, V3, P119, DOI 10.1111/j.1753-0407.2011.00113.x	66	120	126	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147329	10.1371/journal.pone.0147329	http://dx.doi.org/10.1371/journal.pone.0147329			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812415	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000030
J	Zhang, Y; Wu, SJ; Luo, D; Zhou, JF; Li, DJ				Zhang, Ye; Wu, SiJing; Luo, Dan; Zhou, JianFeng; Li, DengJu			Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; REMISSION INDUCTION; PROGNOSTIC-FACTORS; RAR-ALPHA; THERAPY; COAGULOPATHY; PML; CHEMOTHERAPY; PATHOGENESIS; MULTICENTER	Aim All-trans retinoic acid combined to anthracycline-based chemotherapy is the standard regimen of acute promyelocytic leukemia. The advent of arsenic trioxide has contributed to improve the anti-leukemic efficacy in acute promyelocytic leukemia. The objectives of the current study were to evaluate if dual induction by all-trans retinoic acid and arsenic trioxide could accelerate the recovery of abnormality of coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Methods Retrospective analysis was performed in 103 newly-diagnosed patients with acute promyelocytic leukemia. Hemostatic variables and the consumption of component blood were comparably analyzed among patients treated by different induction regimen with or without arsenic trioxide. Results Compared to patients with other subtypes of de novo acute myeloid leukemia, patients with acute promyelocytic leukemia had lower platelet counts and fibrinogen levels, significantly prolonged prothrombin time and elevated D-dimers (P<0.001). Acute promyelocytic leukemia patients with high or intermediate risk prognostic stratification presented lower initial fibrinogen level than that of low-risk group (P<0.05). After induction treatment, abnormal coagulation and fibrinolysis of patients with acute promyelocytic leukemia was significantly improved before day 10. The recovery of abnormal hemostatic variables (platelet, prothrombin time, fibrinogen and D-dimer) was not significantly accelerated after adding arsenic trioxide in induction regimens; and the consumption of transfused component blood (platelet and plasma) did not dramatically change either. Acute promyelocytic leukemia patients with high or intermediate risk prognostic stratification had higher platelet transfusion demands than that of low-risk group (P<0.05). Conclusions Unexpectedly, adding arsenic trioxide could not accelerate the recovery of abnormality of coagulation and fibrinolysis in acute promyelocytic leukemia patients who received all-trans retinoic acid combining chemotherapy.	[Zhang, Ye; Wu, SiJing; Luo, Dan; Zhou, JianFeng; Li, DengJu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, DJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	lidengju@163.com			Natural Science Foundation of Hubei Province of China [2013CFB075]; National Natural Science Foundation of China [81200353]	Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Hubei Province of China (No. 2013CFB075) (http://www.hbstd.gov.cn/) and National Natural Science Foundation of China (No. 81200353). DJL received the funding.	Aribi A, 2007, CANCER, V109, P1355, DOI 10.1002/cncr.22524; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Bercovitz RS, 2012, HEMATOL-AM SOC HEMAT, P157, DOI 10.1182/asheducation-2012.1.157; BIONDI A, 1995, LEUKEMIA, V9, P1461; Breen KA, 2012, BRIT J HAEMATOL, V156, P24, DOI 10.1111/j.1365-2141.2011.08922.x; Candoni A, 2003, EUR J HAEMATOL, V71, P1, DOI 10.1034/j.1600-0609.2003.00084.x; Dally N, 2005, THROMB RES, V116, P109, DOI 10.1016/j.thromres.2004.11.001; de la Serna J, 2008, BLOOD, V111, P3395, DOI 10.1182/blood-2007-07-100669; DOMBRET H, 1993, LEUKEMIA, V7, P2; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Falanga A, 2003, BEST PRACT RES CL HA, V16, P463, DOI 10.1016/S1521-6926(03)00059-8; Federici AB, 1996, BRIT J HAEMATOL, V92, P733, DOI 10.1046/j.1365-2141.1996.401939.x; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; Kwaan HC, 2014, BEST PRACT RES CL HA, V27, P11, DOI 10.1016/j.beha.2014.04.005; Kwaan Hau C, 2014, Semin Thromb Hemost, V40, P332, DOI 10.1055/s-0034-1370792; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lehmann S, 2011, LEUKEMIA, V25, P1128, DOI 10.1038/leu.2011.78; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; ROVELLI A, 1992, J CLIN ONCOL, V10, P1413, DOI 10.1200/JCO.1992.10.9.1413; Sanz MA, 2004, BLOOD, V103, P1237, DOI 10.1182/blood-2003-07-2462; Sanz MA, 2014, BEST PRACT RES CL HA, V27, P33, DOI 10.1016/j.beha.2014.04.004; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Stein E, 2009, BEST PRACT RES CL HA, V22, P153, DOI 10.1016/j.beha.2008.12.007; TALLMAN MS, 1992, BLOOD, V79, P543; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147545	10.1371/journal.pone.0147545	http://dx.doi.org/10.1371/journal.pone.0147545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812490	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000039
J	Chung, J; An, SH; Kang, SW; Kwon, K				Chung, Jihwa; An, Shung Hyun; Kang, Sang Won; Kwon, Kihwan			Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; FACTOR-KAPPA-B; ADVANCED GLYCATION; OXIDATIVE STRESS; INDUCED APOPTOSIS; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; ER STRESS; ACTIVATION	A naturally occurring bile acid, ursodeoxycholic acid (UDCA), is known to alleviate endoplasmic reticulum (ER) stress at the cellular level. However, the detailed action mechanisms of UDCA in atherosclerosis are not fully understood. In this study, we demonstrated whether UDCA exerts anti-atherogenic activity in diabetic atherosclerosis by targeting ER stress and "receptor for advanced glycation endproduct" (RAGE) signaling. UDCA markedly reduced ER stress, RAGE expression, and pro-inflammatory responses [including NF-kappa B activation and reactive oxygen species (ROS) production] induced in endothelial cells (ECs) by high glucose (HG). In particular, UDCA inhibited HG-induced ROS production by increasing the Nrf2 level. In macrophages, UDCA also blocked HG-induced RAGE and pro-inflammatory cytokine expression and inhibited foam cell formation via upregulation of the ATP-binding cassette (ABC) transporters, ABCA1 and ABCG1. In the diabetic mouse model, UDCA inhibited atheromatous plaque formation by decreasing ER stress, and the levels of RAGE and adhesion molecules. In conclusion, UDCA exerts an anti-atherogenic activity in diabetic atherosclerosis by targeting both ER stress and RAGE signaling. Our work implicates UDCA as a potential therapeutic agent for prevention or treatment of diabetic atherosclerosis.	[Chung, Jihwa; An, Shung Hyun; Kwon, Kihwan] Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, GT5 Program, Seoul, South Korea; [Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul, South Korea; [Kang, Sang Won] Ewha Womans Univ, Div Mol Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea.; Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Kwon, K (corresponding author), Ewha Womans Univ, Sch Med, GT5 Program, Seoul, South Korea.	kankadin@ewha.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST) [NRF-2011-0019695]; Daewoong Pharmaceutical Co. Ltd	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST); Daewoong Pharmaceutical Co. Ltd	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (NRF-2011-0019695) and Daewoong Pharmaceutical Co. Ltd. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; CIRILLO NW, 1994, AM J GASTROENTEROL, V89, P1447; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Crampton Steve P, 2007, J Vis Exp, P183, DOI 10.3791/183; Daffu G, 2015, DIABETES, V64, P4046, DOI 10.2337/db15-0575; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH491, DOI 10.1152/ajpheart.00464.2008; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2013, INT J CARDIOL, V168, P4168, DOI 10.1016/j.ijcard.2013.07.112; Ha CH, 2013, INT J MOL MED, V32, P373, DOI 10.3892/ijmm.2013.1393; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Khan MI, 2009, ANTIOXID REDOX SIGN, V11, P2289, DOI [10.1089/ars.2009.2569, 10.1089/ARS.2009.2569]; Kim SY, 2011, CARDIOVASC RES, V92, P307, DOI 10.1093/cvr/cvr219; Kumar P, 2013, METABOLISM, V62, P1149, DOI 10.1016/j.metabol.2013.02.006; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lee DJ, 2013, CANCER RES, V73, P4744, DOI 10.1158/0008-5472.CAN-12-4226; Liu WL, 2000, AM J PHYSIOL-ENDOC M, V279, pE782, DOI 10.1152/ajpendo.2000.279.4.E782; Ma J, 2004, EUR J PHARMACOL, V505, P67, DOI 10.1016/j.ejphar.2004.10.042; Maiese K, 2007, CURR NEUROVASC RES, V4, P63, DOI 10.2174/156720207779940653; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; McGinn S, 2003, AM J PHYSIOL-ENDOC M, V285, pE708, DOI 10.1152/ajpendo.00572.2002; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Patel DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022142; Piperi C, 2012, J CLIN ENDOCR METAB, V97, P2231, DOI 10.1210/jc.2011-3408; Schiekofer S, 2003, DIABETES, V52, P621, DOI 10.2337/diabetes.52.3.621; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	48	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147839	10.1371/journal.pone.0147839	http://dx.doi.org/10.1371/journal.pone.0147839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807573	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800224
J	Das, M; Sha, J; Hidalgo, B; Aslibekyan, S; Do, AN; Zhi, DG; Sun, DJY; Zhang, T; Li, SX; Chen, W; Srinivasan, SR; Tiwari, HK; Absher, D; Ordovas, JM; Berenson, GS; Arnett, DK; Irvin, MR				Das, Mithun; Sha, Jin; Hidalgo, Bertha; Aslibekyan, Stella; Do, Anh N.; Zhi, Degui; Sun, Dianjianyi; Zhang, Tao; Li, Shengxu; Chen, Wei; Srinivasan, Sathanur R.; Tiwari, Hemant K.; Absher, Devin; Ordovas, Jose M.; Berenson, Gerald S.; Arnett, Donna K.; Irvin, Marguerite R.			Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; CARNITINE; EPIGENETICS; CHROMATIN; TRAITS; GENES; RISK	In this study, we conducted an epigenome-wide association study of metabolic syndrome (MetS) among 846 participants of European descent in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). DNA was isolated from CD4+ T cells and methylation at similar to 470,000 cytosine-phosphate-guanine dinucleotide (CpG) pairs was assayed using the Illumina Infinium HumanMethylation450 BeadChip. We modeled the percentage methylation at individual CpGs as a function of MetS using linear mixed models. A Bonferroni-corrected P-value of 1.1 x 10(-7) was considered significant. Methylation at two CpG sites in CPT1A on chromosome 11 was significantly associated with MetS (P for cg00574958 = 2.6x10(-14) and P for cg17058475 = 1.2x10(-9)). Significant associations were replicated in both European and African ancestry participants of the Bogalusa Heart Study. Our findings suggest that methylation in CPT1A is a promising epigenetic marker for MetS risk which could become useful as a treatment target in the future.	[Das, Mithun; Sha, Jin; Hidalgo, Bertha; Aslibekyan, Stella; Do, Anh N.; Irvin, Marguerite R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Zhi, Degui; Tiwari, Hemant K.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Sch Publ Hlth, Birmingham, AL 35294 USA; [Sun, Dianjianyi; Zhang, Tao; Li, Shengxu; Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] IMDEA Food, Madrid, Spain; [Arnett, Donna K.] Univ Kentucky, Deans Off, Coll Publ Hlth, Lexington, KY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Tulane University; HudsonAlpha Institute for Biotechnology; Tufts University; United States Department of Agriculture (USDA); University of Kentucky	Irvin, MR (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	irvinr@uab.edu	Zhang, Tao/K-3238-2019	Zhang, Tao/0000-0003-1048-4443; Sun, Dianjianyi/0000-0003-3651-6693	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institutes [R01HL104135, U01HL72524]; National Institute on Aging [R01AG016592]; National Institute of Environmental Health Science [R01ES021724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104135, U01HL072524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institutes; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The GOLDN study (DKA) was funded by the US National Institutes of Health (NIH)/National Heart, Lung and Blood Institutes (http://www.nhlbi.nih.gov) grants R01HL104135 and U01HL72524. The Bogalusa Heart Study (GSB) was supported by grants R01AG016592 from the National Institute on Aging (https://www.nia.nih.gov) and R01ES021724 from National Institute of Environmental Health Science (http://www.niehs.nih.gov). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Berenson GS, 2001, AM J MED SCI, V322, P267, DOI 10.1097/00000441-200111000-00007; Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938; Cahova M, 2015, APPL PHYSIOL NUTR ME, V40, P280, DOI [10.1139/apnm-2014-0163, 10.1139/apnm-2014-016]; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Derosa G, 2003, CLIN THER, V25, P1429, DOI 10.1016/S0149-2918(03)80130-3; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Frazier-Wood AC, 2014, J LIPID RES, V55, P1324, DOI 10.1194/jlr.M048504; Grundy Scott M, 2005, Clin Cornerstone, V7, P36, DOI 10.1016/S1098-3597(05)80066-3; Grundy Scott M., 2008, Metabolic Syndrome and Related Disorders, V6, P281, DOI 10.1089/met.2008.0026; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Huang JV, 2012, J LIPID RES, V53, P1738, DOI 10.1194/jlr.R024505; Irvin MR, 2014, CIRCULATION, V130, P565, DOI 10.1161/CIRCULATIONAHA.114.009158; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Karns R, 2013, OBESITY, V21, pE745, DOI 10.1002/oby.20445; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lee JC, 2006, CURR OPIN LIPIDOL, V17, P101, DOI 10.1097/01.mol.0000217890.54875.13; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Luttmer R, 2013, OBES RES CLIN PRACT, V7, pE106, DOI 10.1016/j.orcp.2012.06.001; Malaguarnera M, 2009, AM J CLIN NUTR, V89, P71, DOI 10.3945/ajcn.2008.26251; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Siggens L, 2014, J INTERN MED, V276, P201, DOI 10.1111/joim.12231; Warodomwichit D, 2009, OBESITY, V17, P510, DOI 10.1038/oby.2008.583; Zhi D, 2013, EPIGENETICS-US, V8, P802, DOI 10.4161/epi.25501	32	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145789	10.1371/journal.pone.0145789	http://dx.doi.org/10.1371/journal.pone.0145789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808626	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800011
J	Fei, XF; Lou, ZH; Christakos, G; Liu, QM; Ren, YJ; Wu, JP				Fei, Xufeng; Lou, Zhaohan; Christakos, George; Liu, Qingmin; Ren, Yanjun; Wu, Jiaping			A Geographic Analysis about the Spatiotemporal Pattern of Breast Cancer in Hangzhou from 2008 to 2012	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; WOMEN; RISK; MORTALITY; STAGE; DISPARITIES; DIAGNOSIS; DISEASE; CHINA; RACE	Background Breast cancer (BC) is the most common female malignant tumor. Previous studies have suggested a big incidence disparity among different cities in China. The present work selected a typical city, Hangzhou, to study BC incidence disparity within the city. Methods Totally, 8784 female breast cancer cases were obtained from the Hangzhou Center for Disease Control and Prevention during the period 2008-2012. Analysis of Variance and Poisson Regression were the statistical tools implemented to compare incidence disparity in the space-time domain (reference group: township residents during 2008, area: subdistrict, town, and township, time frame: 2008-2012), space-time scan statistics was employed to detect significant spatiotemporal clusters of BC compared to the null hypothesis that the probability of cases diagnosed at a particular location was equal to the probability of cases diagnosed in the whole study area. Geographical Information System (GIS) was used to generate BC spatial distribution and cluster maps at the township level. Results The subdistrict populations were found to have the highest and most stable BC incidence. Although town and township populations had a relatively low incidence, it displayed a significant increasing trend from 2008 to 2012. The BC incidence distribution was spatially heterogeneous and clustered with a trend-surface from the southwest low area to the northeast high area. High clusters were located in the northeastern Hangzhou area, whereas low clusters were observed in the southwestern area during the time considered. Conclusions Better healthcare service and lifestyle changes may be responsible for the increasing BC incidence observed in towns and townships. One high incidence cluster (Linping subdistrict) and two low incidence clusters (middle Hangzhou) were detected. The low clusters may be attributable mainly to developmental level disparity, whereas the high cluster could be associated with other risk factors, such as environmental pollution.	[Fei, Xufeng] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Zhaohan; Christakos, George; Wu, Jiaping] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China; [Liu, Qingmin; Ren, Yanjun] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022; 刘庆敏, Liu qingmin/AAQ-9255-2020		Department of Science and Technology, Zhejiang Province [2013C03045-2]; Commission of Science and Technology, Hangzhou City [20120533Q01]	Department of Science and Technology, Zhejiang Province(Department of Science & Technology (India)); Commission of Science and Technology, Hangzhou City	This work was supported partially by the Department of Science and Technology, Zhejiang Province (2013C03045-2) and by the Commission of Science and Technology, Hangzhou City (20120533Q01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; Bollaerts K, 2014, THYROID, V24, P906, DOI 10.1089/thy.2013.0227; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Chia KS, 2005, INT J CANCER, V113, P302, DOI 10.1002/ijc.20561; Christakos G, 1997, SOC SCI MED, V45, P1503, DOI 10.1016/S0277-9536(97)00080-4; Dalzell LP, 2015, CANCER CAUSE CONTROL, V26, P699, DOI 10.1007/s10552-015-0571-y; DAVIS DL, 1993, ENVIRON HEALTH PERSP, V101, P372, DOI 10.2307/3431889; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; ESRI E, 2008, ARCMAP 9 3, V9, P1999; Esteve J, 1994, STAT METHODS CANC RE, VIV; Fei XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117572; Fei XF, 2014, STOCH ENV RES RISK A, V28, P1075, DOI 10.1007/s00477-014-0876-5; Ferlay J., 2004, GLOBOCAN 2002 CANC I; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P1641, DOI 10.1001/jama.300.14.1641; Hao J, 2008, CHINESE CANC REGISTR; Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679; Hsieh JCF, 2016, STOCH ENV RES RISK A, V30, P155, DOI 10.1007/s00477-015-1050-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHN EM, 1993, EPIDEMIOL REV, V15, P157, DOI 10.1093/oxfordjournals.epirev.a036099; KEY T, 1994, BMJ-BRIT MED J, V308, P1520, DOI 10.1136/bmj.308.6943.1520; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lipkus IM, 1999, CANCER EPIDEM BIOMAR, V8, P533; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; O'Malley MS, 2001, AM J PUBLIC HEALTH, V91, P49; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; Pollan M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-78; Pudrovska T, 2012, J AGING HEALTH, V24, P323, DOI 10.1177/0898264311422744; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; VANLOON AJM, 1994, INT J EPIDEMIOL, V23, P899, DOI 10.1093/ije/23.5.899; Wang FH, 2012, APPL GEOGR, V35, P1, DOI 10.1016/j.apgeog.2012.04.005; Yang Richard C, 2006, Asian Pac J Cancer Prev, V7, P79; Zhang ZH, 2013, APPL GEOGR, V45, P193, DOI 10.1016/j.apgeog.2013.09.013	39	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147866	10.1371/journal.pone.0147866	http://dx.doi.org/10.1371/journal.pone.0147866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808895	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800235
J	Park, CH; Kim, EH; Kang, JH; Chung, H; Park, JC; Shin, SK; Lee, SK; Lee, YC				Park, Chan Hyuk; Kim, Eun Hye; Kang, Jung Hyun; Chung, Hyunsoo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan			Low Incidence of Synchronous or Metachronous Tumors after Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated Histology	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ATROPHIC GASTRITIS; CONFOCAL ENDOMICROSCOPY; RESECTION; OUTCOMES; SURVEILLANCE; NEOPLASIA; BIOPSIES; CRITERIA; STOMACH	Background Gastric cancer with undifferentiated histology has different clinicopathologic characteristics compared to differentiated type gastric cancer. We aimed to compare the risk of synchronous or metachronous tumors after curative resection of early gastric cancer (EGC) via endoscopic submucosal dissection (ESD), according to the histologic differentiation of the primary lesion. Methods Clinicopathological data of patients with initial-onset EGC curatively resected via ESD between January 2007 and November 2014 in a single institution were reviewed. We analyzed the incidence of synchronous or metachronous tumors after ESD with special reference to the differentiation status of the primary lesion. Results Of 1,560 patients with EGC who underwent curative resection via ESD, 1,447 had differentiated type cancers, and 113 had undifferentiated type cancers. The cumulative incidence of metachronous or synchronous tumor after ESD was higher in the differentiated cancer group than in the undifferentiated cancer group (P = 0.008). Incidence of metachronous or synchronous tumor was 4.8% and 1.2% per person-year in the differentiated and undifferentiated cancer groups, respectively. The Cox proportional hazard model revealed that undifferentiated cancers were associated with a low risk of synchronous or metachronous tumors after adjusting for confounding variables (hazard ratio [95% confidence interval] = 0.287 [0.090-0.918]). Conclusions The rate of synchronous or metachronous tumors after curative ESD was significantly lower for undifferentiated cancers compare to differentiated cancers. These findings suggest that ESD should be actively considered as a possible treatment for undifferentiated type EGCs.	[Park, Chan Hyuk] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea; [Kim, Eun Hye; Kang, Jung Hyun; Chung, Hyunsoo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan] Yonsei Univ, Coll Med, Inst Gastroenterol, Div Gastroenterol,Dept Internal,Med Severance Hos, Seoul, South Korea	Hanyang University; Yonsei University; Yonsei University Health System	Lee, YC (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Div Gastroenterol,Dept Internal,Med Severance Hos, Seoul, South Korea.	leeyc@yuhs.ac	Park, Jun Chul/H-7218-2019; Park, Chan Hyuk/I-1794-2016; Chung, Hyunsoo/AAD-3634-2020	Park, Jun Chul/0000-0001-8018-0010; Park, Chan Hyuk/0000-0003-3824-3481; Chung, Hyunsoo/0000-0001-5159-357X; Shin, Sung Kwan/0000-0001-5466-1400; Lee, Yong Chan/0000-0001-8800-6906; Lee, Sang Kil/0000-0002-0721-0364				Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; Bok GH, 2013, GASTROINTEST ENDOSC, V77, P899, DOI 10.1016/j.gie.2013.01.018; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; CORREA P, 1988, CANCER RES, V48, P3554; Eguchi T, 1999, J AM COLL SURGEONS, V188, P22, DOI 10.1016/S1072-7515(98)00268-3; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Iseki K, 1998, GUT, V42, P20, DOI 10.1136/gut.42.1.20; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jeon SR, 2011, GASTROINTEST ENDOSC, V74, P772, DOI 10.1016/j.gie.2011.05.005; Kim JH, 2014, SURG ENDOSC, V28, P2627, DOI 10.1007/s00464-014-3514-x; Lee H, 2011, SURG ENDOSC, V25, P1985, DOI 10.1007/s00464-010-1499-7; Liu Y, 2005, J GASTROENTEROL, V40, P123, DOI 10.1007/s00535-004-1511-x; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Nagahama T, 2011, GASTROINTEST ENDOSC, V74, P1259, DOI 10.1016/j.gie.2011.09.005; Nagata N, 2011, GASTROENTEROL RES, V4, P203, DOI 10.4021/gr357w; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Oka S, 2014, SURG ENDOSC, V28, P639, DOI 10.1007/s00464-013-3222-y; Park CH, 2014, GASTROINTEST ENDOSC, V80, P599, DOI 10.1016/j.gie.2014.04.042; Park CH, 2014, SURG ENDOSC, V28, P1307, DOI 10.1007/s00464-013-3327-3; Park CH, 2013, DIGEST LIVER DIS, V45, P651, DOI 10.1016/j.dld.2013.01.014; Rugge M, 2008, DIGEST LIVER DIS, V40, P650, DOI 10.1016/j.dld.2008.02.030; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Shim CN, 2014, WORLD J GASTROENTERO, V20, P3938, DOI 10.3748/wjg.v20.i14.3938; Takeda J, 1998, HEPATO-GASTROENTEROL, V45, P1907; Vieth M, 2006, WORLD J GASTROENTERO, V12, P6109, DOI 10.3748/wjg.v12.i38.6109; Yamaguchi N, 2009, DIGESTION, V80, P173, DOI 10.1159/000215388; Yamamoto Y., 2015, DIG ENDOSC	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147874	10.1371/journal.pone.0147874	http://dx.doi.org/10.1371/journal.pone.0147874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809013	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800236
J	Penedo, FJ; Yanez, B; Castaneda, SF; Gallo, L; Wortman, K; Gouskova, N; Simon, M; Arguelles, W; Llabre, M; Sanchez-Johnsen, L; Brintz, C; Gonzalez, P; Van Horn, L; Rademaker, AW; Ramirez, AG				Penedo, Frank J.; Yanez, Betina; Castaneda, Sheila F.; Gallo, Linda; Wortman, Katy; Gouskova, Natalia; Simon, Melissa; Arguelles, William; Llabre, Maria; Sanchez-Johnsen, Lisa; Brintz, Carrie; Gonzalez, Patricia; Van Horn, Linda; Rademaker, Alfred W.; Ramirez, Amelie G.			Self-Reported Cancer Prevalence among Hispanics in the US: Results from the Hispanic Community Health Study/Study of Latinos	PLOS ONE			English	Article							RISK-FACTORS; PUERTO-RICANS; STATISTICS; BREAST; PREDICTORS; MEXICANS; CUBANS	Cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S., yet data on cancer prevalence and risk factors in Hispanics in regard to ancestry remain scarce. This study sought to describe (a) the prevalence of cancer among Hispanics from four major U.S. metropolitan areas, (b) cancer prevalence across Hispanic ancestry, and (c) identify correlates of self-reported cancer prevalence. Participants were 16,415 individuals from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), who self-identified as Cuban, Dominican, Mexican, Puerto Rican, Central or South American. All data were collected at a single time point during the HCHS/SOL baseline clinic visit. The overall self-reported prevalence rate of cancer for the population was 4%. The rates varied by Hispanic ancestry group, with individuals of Cuban and Puerto Rican ancestry reporting the highest cancer prevalence. For the entire population, older age (OR = 1.47, p <.001, 95% CI, 1.26-1.71) and having health insurance (OR = 1.93, p <.001, 95% CI, 1.42-2.62) were all significantly associated with greater prevalence, whereas male sex was associated with lower prevalence (OR = 0.56, p <.01, 95% CI,.40-.79). Associations between study covariates and cancer prevalence also varied by Hispanic ancestry. Findings underscore the importance of sociodemographic factors and health insurance in relation to cancer prevalence for Hispanics and highlight variations in cancer prevalence across Hispanic ancestry groups. Characterizing differences in cancer prevalence rates and their correlates is critical to the development and implementation of effective prevention strategies across distinct Hispanic ancestry groups.	[Penedo, Frank J.; Yanez, Betina; Wortman, Katy] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Castaneda, Sheila F.; Gonzalez, Patricia] San Diego State Univ, Inst Behav & Community Hlth, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Gallo, Linda] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Gouskova, Natalia] Univ N Carolina, Dept Biostat, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Simon, Melissa] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA; [Arguelles, William; Llabre, Maria; Brintz, Carrie] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Sanchez-Johnsen, Lisa] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Van Horn, Linda; Rademaker, Alfred W.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ramirez, Amelie G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot, San Antonio, TX 78229 USA	Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University; California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health San Antonio	Penedo, FJ (corresponding author), Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA.	Fpenedo@northwestern.edu	Castaneda, Sheila F./AAK-3025-2020; Bedjeti, Katy/GZM-2902-2022; Castaneda, Sheila/I-4132-2014	Castaneda, Sheila/0000-0002-1975-0544; Gallo, Linda C./0000-0002-3678-5888	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01HC65236]; San Diego State University [N01HC65237]; National Center on Minority Health and Health Disparities; National Institute on Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; NIH/NHLBI [1 RC2 HL101649]; Redes En Accin; National Latino Cancer Research Network; National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant; University of Texas Health Science Center at San Antonio Health [U01 CA114657-05, U54 CA153511]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA202995, P30CA060553, U54CA153511, U01CA114657, U54CA202997] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101649] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Redes En Accin; National Latino Cancer Research Network; National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant; University of Texas Health Science Center at San Antonio Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01HC65236), and San Diego State University (N01HC65237). The following institutes, centers, or offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute on Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The authors thank the staff and participants of HCHS/SOL for their important contributions. A complete list of staff and investigators was published in Ann Epidemiol. 2010; 20:642-649 and is also available on the study website, http://www.cscc.unc.edu/hchs/. The HCHS/SOL Sociocultural Ancillary Study was supported by grant 1 RC2 HL101649 from the NIH/NHLBI (Gallo/Penedo MPIs). The authors thank the staff and participants of HCHS/SOL and the HCHS/SOL Sociocultural Ancillary Study for their important contributions. This research was also made possible by grants from Redes En Accion: The National Latino Cancer Research Network. This research was supported by a National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities grant awarded to the University of Texas Health Science Center at San Antonio Health (Ramirez, PI; Penedo Midwest Region Co-PI/Research Project PI; U01 CA114657-05 and U54 CA153511).	American Cancer Society, 2012, CANC FACTS FIG HISP; American Cancer Society, 2014, CANC FACTS FIG 2014; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; [Anonymous], 2014, THE BURDEN OF CANC; [Anonymous], 2011, PROFILE AM FACTS FEA; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Brown A., 2014, STAT PORTRAIT HISPAN; Chiuve SE, 2012, J NUTR; Cokkinides VE, 2012, CA-CANCER J CLIN, V62, P353, DOI 10.3322/caac.21155; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Diaz JA, 2008, CANCER EPIDEM BIOMAR, V17, P2169, DOI 10.1158/1055-9965.EPI-07-2692; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Johnson-Kozlow M, 2010, J IMMIGR MINOR HEALT, V12, P454, DOI 10.1007/s10903-009-9236-9; Kaplan RC, 2014, AM J PREV MED, V46, P496, DOI 10.1016/j.amepre.2014.01.014; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; Martinez-Tyson D, 2009, J IMMIGR MINOR HEALT, V11, P249, DOI 10.1007/s10903-008-9152-4; O'Brien K, 2003, CA-CANCER J CLIN, V53, P208, DOI 10.3322/canjclin.53.4.208; Pinheiro PS, 2009, CANCER EPIDEM BIOMAR, V18, P2162, DOI 10.1158/1055-9965.EPI-09-0329; Ramirez AG, 2000, AM J HEALTH PROMOT, V14, P292, DOI 10.4278/0890-1171-14.5.292; Ramirez AG, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-84; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Ward E, 2008, CA-CANCER J CLIN, V58, P9, DOI 10.3322/CA.2007.0011	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146268	10.1371/journal.pone.0146268	http://dx.doi.org/10.1371/journal.pone.0146268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808047	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800018
J	Ranco, G; Bordino, I; Bormetti, G; Caldarelli, G; Lillo, F; Treccani, M				Ranco, Gabriele; Bordino, Ilaria; Bormetti, Giacomo; Caldarelli, Guido; Lillo, Fabrizio; Treccani, Michele			Coupling News Sentiment with Web Browsing Data Improves Prediction of Intra-Day Price Dynamics	PLOS ONE			English	Article							INFORMATION; BEHAVIOR; SEARCH	The new digital revolution of big data is deeply changing our capability of understanding society and forecasting the outcome of many social and economic systems. Unfortunately, information can be very heterogeneous in the importance, relevance, and surprise it conveys, affecting severely the predictive power of semantic and statistical methods. Here we show that the aggregation of web users' behavior can be elicited to overcome this problem in a hard to predict complex system, namely the financial market. Specifically, our in-sample analysis shows that the combined use of sentiment analysis of news and browsing activity of users of Yahoo! Finance greatly helps forecasting intra-day and daily price changes of a set of 100 highly capitalized US stocks traded in the period 2012-2013. Sentiment analysis or browsing activity when taken alone have very small or no predictive power. Conversely, when considering a news signal where in a given time interval we compute the average sentiment of the clicked news, weighted by the number of clicks, we show that for nearly 50% of the companies such signal Granger-causes hourly price returns. Our result indicates a "wisdom- of-the-crowd" effect that allows to exploit users' activity to identify and weigh properly the relevant and surprising news, enhancing considerably the forecasting power of the news sentiment.	[Ranco, Gabriele; Caldarelli, Guido] IMT Inst Adv Studies, Piazza San Francesco 19, I-55100 Lucca, Italy; [Bordino, Ilaria] Yahoo Labs, Barcelona, Spain; [Bormetti, Giacomo; Lillo, Fabrizio] Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Bormetti, Giacomo; Lillo, Fabrizio; Treccani, Michele] QUANTLab, Via Pietrasantina 123, I-56122 Pisa, Italy; [Caldarelli, Guido] ISC CNR, Via Taurini 19, I-00185 Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, South St 35 Mayfair, London W1K 2XF, England; [Treccani, Michele] Mediobanca SpA, Piazzetta E Cuccia 1, I-20121 Milan, Italy	IMT School for Advanced Studies Lucca; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Ranco, G (corresponding author), IMT Inst Adv Studies, Piazza San Francesco 19, I-55100 Lucca, Italy.	gabriele.ranco@gmail.com	Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010	Bormetti, Giacomo/0000-0003-3542-2505; Caldarelli, Guido/0000-0001-9377-3616	EUROPEAN COMMISSION SIMPOL [610704]; EUROPEAN COMMISSION MULTIPLEX [317532]; U.S. Department of the Defense, Defense Threat Reduction Agency [HDTRA1-11-1-0048]; Progetto di Interesse CNR CrisisLab; EUROPEAN COMMISSION [CRISIS-ICT-2011-288501]	EUROPEAN COMMISSION SIMPOL(European Commission); EUROPEAN COMMISSION MULTIPLEX; U.S. Department of the Defense, Defense Threat Reduction Agency; Progetto di Interesse CNR CrisisLab; EUROPEAN COMMISSION(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EUROPEAN COMMISSION SIMPOL 610704; EUROPEAN COMMISSION MULTIPLEX 317532; U.S. Department of the Defense, Defense Threat Reduction Agency, grant HDTRA1-11-1-0048; Progetto di Interesse CNR CrisisLab; and EUROPEAN COMMISSION CRISIS-ICT-2011-288501. The authors declare that Michele Treccani is working for Mediobanca S.p.A. and Ilaria Bordino is working for Yahoo! Labs. The authors also declare that QUANTLab is not a commercial affiliation. Mediobanca S.p.A. and Yahoo! Labs provided support in the form of salaries for authors IB and MT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903; Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; [Anonymous], 2008, 19 ACM C HYPERTEXT H; Bank M, 2011, FINANC MARK PORTFOLI, V25, P239, DOI 10.1007/s11408-011-0165-y; Birz G, 2011, J BANK FINANC, V35, P2791, DOI 10.1016/j.jbankfin.2011.03.006; Bollen J., 2011, ICWSM, P450; Bonanno G, 2004, EUR PHYS J B, V38, P363, DOI 10.1140/epjb/e2004-00129-6; Bordino I, 2014, PROC INT CONF DATA, P1168, DOI 10.1109/ICDE.2014.6816733; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Bormetti G, 2015, QUANT FINANC, V15, P1137, DOI 10.1080/14697688.2014.996586; Calcagnile L. M., 2015, ARXIV150500704; Caldarelli G., 2007, SCALE FREE NETWORKS; Caldarelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095809; Chan WS, 2003, J FINANC ECON, V70, P223, DOI 10.1016/S0304-405X(03)00146-6; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Engelberg JE, 2012, J FINANC ECON, V105, P260, DOI 10.1016/j.jfineco.2012.03.001; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross-Klussmann A, 2011, J EMPIR FINANC, V18, P321, DOI 10.1016/j.jempfin.2010.11.009; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02713; Lillo F, 2015, QUANT FINANC, V15, P213, DOI 10.1080/14697688.2014.931593; Loughran T, 2011, J FINANC, V66, P35, DOI 10.1111/j.1540-6261.2010.01625.x; Mao Huina, 2011, PREDICTING FINANCIAL; Mao Y., 2012, P 1 ACM INT WORKSHOP, P69, DOI DOI 10.1145/2392622.2392634; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Reis  J., 2015, ICWSM 15; Ruiz E. J., 2012, P 5 ACM INT C WEB SE, P513, DOI DOI 10.1145/2124295.2124358; Ruiz-Martinez J.M., 2012, P 1 INT WORKSH FIN E; Schumaker RP, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1462198.1462204; Tetlock PC, 2008, J FINANC, V63, P1437, DOI 10.1111/j.1540-6261.2008.01362.x; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Vega C, 2006, J FINANC ECON, V82, P103, DOI 10.1016/j.jfineco.2005.07.011; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Vlastakis N, 2012, J BANK FINANC, V36, P1808, DOI 10.1016/j.jbankfin.2012.02.007; Wang Chuan-Ju, 2013, P 6 INT JOINT C NAT, P802; Zhang W, 2013, ECON MODEL, V33, P613, DOI 10.1016/j.econmod.2013.03.018; Zhang X, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.562; Zhang YJ, 2014, PHYSICA A, V399, P70, DOI 10.1016/j.physa.2013.12.034; Zheludev I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04213; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	18	19	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146576	10.1371/journal.pone.0146576	http://dx.doi.org/10.1371/journal.pone.0146576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808833	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000369527800026
J	Takeuchi, Y; Hori, M; Tada, S; Oda, Y				Takeuchi, Yuichi; Hori, Michio; Tada, Shinya; Oda, Yoichi			Acquisition of Lateralized Predation Behavior Associated with Development of Mouth Asymmetry in a Lake Tanganyika Scale-Eating Cichlid Fish	PLOS ONE			English	Article							PERISSODUS-MICROLEPIS; MORPHOLOGICAL ASYMMETRY; DISRUPTIVE SELECTION; INTRASPECIFIC COMPETITION; MUSCLE WEIGHT; PATTERNS; MAUTHNER; DIMORPHISM; HANDEDNESS; EVOLUTION	The scale-eating cichlid Perissodus microlepis with asymmetric mouth is an attractive model of behavioral laterality: each adult tears off scales from prey fishes' left or right flanks according to the direction in which its mouth is skewed. To investigate the development of behavioral laterality and mouth asymmetry, we analyzed stomach contents and lower jawbone asymmetry of various-sized P. microlepis (22 <= SL < 115mm) sampled in Lake Tanganyika. The shapes of the pored scales found in each specimen's stomach indicated its attack side preference. Early-juvenile specimens (SL< 45mm) feeding mainly on zooplankton exhibited slight but significant mouth asymmetry. As the fish acquired scale-eating (45mm <= SL), attack side preference was gradually strengthened, as was mouth asymmetry. Among size-matched individuals, those with more skewed mouths ate more scales. These findings show that behavioral laterality in scale-eating P. microlepis is established in association with development of mouth asymmetry which precedes the behavioral acquisition, and that this synergistic interaction between physical and behavioral literalities may contribute to efficient scale-eating.	[Takeuchi, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 930, Japan; [Takeuchi, Yuichi; Oda, Yoichi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Hori, Michio] Kyoto Univ, Dept Biol Sci, Kyoto, Japan; [Tada, Shinya] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 790, Japan	University of Toyama; Nagoya University; Kyoto University; Ehime University	Takeuchi, Y (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 930, Japan.; Takeuchi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan.	takeuchi@med.u-toyama.ac.jp	Takeuchi, Yuichi/G-6201-2013	Takeuchi, Yuichi/0000-0002-7096-3086	Japan Society for the Promotion of Science [22.7689]; JSPS KAKENHI [25890006, 26830009, 24405001]; Sumitomo Foundation [120890]; Brain Science Foundation; Narishige Zoological Science Award; Sasagawa Grants for Science Fellows [26-522]; Grant for the Biodiversity Research of the 21st Century COE [A14]; Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [15H05230] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Brain Science Foundation; Narishige Zoological Science Award; Sasagawa Grants for Science Fellows; Grant for the Biodiversity Research of the 21st Century COE; Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Research Fellowship of the Japan Society for the Promotion of Science (22.7689 to Y.T.), JSPS KAKENHI (25890006, 26830009 to Y.T., and 24405001 to Y.O.), a Grant for Basic Science Research Projects from The Sumitomo Foundation (120890 to Y.T.), the Brain Science Foundation (Y.T.), a Narishige Zoological Science Award (Y.T.), Sasagawa Grants for Science Fellows (26-522), a Grant for the Biodiversity Research of the 21st Century COE (A14), and the Global Centre of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem", from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	ALOIA JF, 1978, METABOLISM, V27, P1793, DOI 10.1016/0026-0495(78)90265-2; Andrew RJ, 2009, PHILOS T R SOC B, V364, P983, DOI 10.1098/rstb.2008.0241; ANNETT M, 1970, BRIT J PSYCHOL, V61, P545, DOI 10.1111/j.2044-8295.1970.tb01274.x; ANNETT M, 1967, Q J EXP PSYCHOL, V19, P327, DOI 10.1080/14640746708400109; BENKMAN CW, 1991, NATURE, V349, P519, DOI 10.1038/349519a0; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Brandler WM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003751; Budaev S, 2009, BEHAV BRAIN RES, V200, P91, DOI 10.1016/j.bbr.2008.12.030; CANFIELD JG, 1993, J COMP PHYSIOL A, V172, P611, DOI 10.1007/BF00213683; CHHIBBER SR, 1972, ACTA ANAT, V81, P462; CHHIBBER SR, 1970, J ANAT, V106, P553; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Farrell AP, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; FRYER G, 1972, CICHLID FISHES GREAT, P642; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Hata H, 2013, ECOL EVOL, V3, P4641, DOI 10.1002/ece3.849; Hendry AP, 2009, P ROY SOC B-BIOL SCI, V276, P753, DOI 10.1098/rspb.2008.1321; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hori M., 1991, INTECOL B, V19, P89; Hori M, 2007, ZOOL SCI, V24, P486, DOI 10.2108/zsj.24.486; HUDDLESTON AL, 1980, JAMA-J AM MED ASSOC, V244, P1107, DOI 10.1001/jama.244.10.1107; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Kusche H, 2012, P ROY SOC B-BIOL SCI, V279, P4715, DOI 10.1098/rspb.2012.2082; Lee HJ, 2010, J FISH BIOL, V76, P1940, DOI 10.1111/j.1095-8649.2010.02620.x; Lee HJ, 2015, ECOL EVOL, V5, P4277, DOI 10.1002/ece3.1691; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044670; LIEM K F, 1976, Bulletin of the Museum of Comparative Zoology, V147, P319; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; MARLER P, 1990, PHILOS T ROY SOC B, V329, P109, DOI 10.1098/rstb.1990.0155; McManus C, 1991, INHERITANCE LEFT HAN; MEYER A, 1987, EVOLUTION, V41, P1357, DOI 10.1111/j.1558-5646.1987.tb02473.x; Michel GF, 2002, DEV INFANT HANDEDNES, P165; Nakajima M, 2007, ZOOL SCI, P855; NILSSON BE, 1971, CLIN ORTHOP RELAT R, P179; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers LJ, 2002, COMP VERTEBRATE LATE; Roy EA, 2003, BRAIN COGNITION, V53, P315, DOI 10.1016/S0278-2626(03)00133-7; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Takeuchi Y, 2008, ANIM BEHAV, V75, P1359, DOI 10.1016/j.anbehav.2007.09.008; Takeuchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029272; Takeuchi Y, 2010, BEHAV BRAIN RES, V208, P106, DOI 10.1016/j.bbr.2009.11.021; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; WIMBERGER PH, 1991, EVOLUTION, V45, P1545, DOI 10.1111/j.1558-5646.1991.tb02662.x; Yasugi M, 2011, ZOOL SCI, V28, P869, DOI 10.2108/zsj.28.869; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	55	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147476	10.1371/journal.pone.0147476	http://dx.doi.org/10.1371/journal.pone.0147476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808293	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800103
J	Turkay, M; Saracoglu, O; Arslan, MC				Turkay, Metin; Saracoglu, Oztuztrk; Arslan, Mehmet Can			Sustainability in Supply Chain Management: Aggregate Planning from Sustainability Perspective	PLOS ONE			English	Article							OF-THE-ART; REVERSE LOGISTICS; MODELS	Supply chain management that considers the flow of raw materials, products and information has become a focal issue in modern manufacturing and service systems. Supply chain management requires effective use of assets and information that has far reaching implications beyond satisfaction of customer demand, flow of goods, services or capital. Aggregate planning, a fundamental decision model in supply chain management, refers to the determination of production, inventory, capacity and labor usage levels in the medium term. Traditionally standard mathematical programming formulation is used to devise the aggregate plan so as to minimize the total cost of operations. However, this formulation is purely an economic model that does not include sustainability considerations. In this study, we revise the standard aggregate planning formulation to account for additional environmental and social criteria to incorporate triple bottom line consideration of sustainability. We show how these additional criteria can be appended to traditional cost accounting in order to address sustainability in aggregate planning. We analyze the revised models and interpret the results on a case study from real life that would be insightful for decision makers.	[Turkay, Metin; Saracoglu, Oztuztrk; Arslan, Mehmet Can] Koc Univ, Dept Ind Engn, Istanbul, Turkey	Koc University	Turkay, M (corresponding author), Koc Univ, Dept Ind Engn, Istanbul, Turkey.	mturkay@ku.edu.tr	Turkay, Metin/F-9769-2011	Turkay, Metin/0000-0003-4769-6714	European Commission through Log4Green project [287091]; European Commission [287091]	European Commission through Log4Green project; European Commission(European CommissionEuropean Commission Joint Research Centre)	The financial support for this work from European Commission through Log4Green project (Grant No: 287091) is gratefully acknowledged.; Funded by European Commission, Log4Green project, Grant No: 287091, http://www.log4green.eu.	ADLER PS, 1991, MANAGE SCI, V37, P267, DOI 10.1287/mnsc.37.3.267; [Anonymous], 2004, J SUPPLY CHAIN MANAG, DOI DOI 10.1111/J.1745-493X.2004.TB00175.X; Arslan MC, 2013, FOUND COMPUT DECIS S, V38, P223, DOI 10.2478/fcds-2013-0011; Beamon B. M., 1999, LOGISTICS INFORM MAN, V12, P332, DOI [DOI 10.1108/09576059910284159, 10.1108/09576059910284159]; Bonney M, 2009, INT J PROD ECON, V133, P43; Boulanger PM, 2005, ECOL ECON, V55, P337, DOI 10.1016/j.ecolecon.2005.07.033; Cai YP, 2008, INT J ENERG RES, V32, P988, DOI 10.1002/er.1407; Carter CR, 2002, TRANSPORT RES E-LOG, V38, P37, DOI 10.1016/S1366-5545(01)00008-4; Clift R., 2003, CLEAN TECHNOL ENVIR, V5, P240, DOI [10.1007/s10098-003-0220-0, DOI 10.1007/S10098-003-0220-0]; Elkington J., 2002, CANNIBALS FORKS TRIP; Fleischmann M, 1997, EUR J OPER RES, V103, P1, DOI 10.1016/S0377-2217(97)00230-0; Handfield R, 2005, BUSINESS STRATEGY EN, V14, P1, DOI [10.1002/cb.210, DOI 10.1002/CB.210, DOI 10.1002/BSE.422]; Handfield R.B., 1999, INTRO SUPPLY CHAIN M; Jones W.B., 2000, TRANSP LJ, V27, P345; Kim K, 2006, COMPUT IND ENG, V51, P279, DOI 10.1016/j.cie.2006.02.008; Koplin J, 2007, J CLEAN PROD, V15, P1053, DOI 10.1016/j.jclepro.2006.05.024; Letmathe P, 2005, EUR J OPER RES, V167, P398, DOI 10.1016/j.ejor.2004.04.025; Linares P, 2000, J OPER RES SOC, V51, P736, DOI 10.1057/palgrave.jors.2600944; Macharis C, 2004, EUR J OPER RES, V153, P400, DOI 10.1016/S0377-2217(03)00161-9; Nahmias S, 2009, PRODUCTION OPERATION; Penkuhn T, 1997, EUR J OPER RES, V97, P327, DOI 10.1016/S0377-2217(96)00201-9; Sarkis J, 2003, J CLEAN PROD, V11, P397, DOI 10.1016/S0959-6526(02)00062-8; Sarkis J, 1998, EUR J OPER RES, V107, P159, DOI 10.1016/S0377-2217(97)00160-4; Sasikumar P, 2009, INT J SUSTAIN ENG, V2, P2, DOI 10.1080/19397030802673374; Srivastava SK, 2007, INT J MANAG REV, V9, P53, DOI 10.1111/j.1468-2370.2007.00202.x; Toptal A, 2014, INT J PROD RES, V52, P243, DOI 10.1080/00207543.2013.836615; Turkay M., 2008, PROCESS SYSTEMS ENG, P45, DOI DOI 10.1002/9783527631209.CH23; World Commission on Environment and Development (WCED), 1987, OUR COMMON FUTURE	28	27	27	12	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147502	10.1371/journal.pone.0147502	http://dx.doi.org/10.1371/journal.pone.0147502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807848	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800114
J	Boavida, J; Paulo, D; Aurelle, D; Arnaud-Haond, S; Marschal, C; Reed, J; Goncalves, JMS; Serrao, EA				Boavida, Joana; Paulo, Diogo; Aurelle, Didier; Arnaud-Haond, Sophie; Marschal, Christian; Reed, John; Goncalves, Jorge M. S.; Serrao, Ester A.			A Well-Kept Treasure at Depth: Precious Red Coral Rediscovered in Atlantic Deep Coral Gardens (SW Portugal) after 300 Years	PLOS ONE			English	Article							SHALLOW-WATER; POPULATION-STRUCTURE; RUBRUM POPULATIONS; SUBMARINE-CANYON; BASE-LINE; GROWTH; FAUNA; VARIABILITY; HABITAT; SEA	Background The highly valuable red coral Corallium rubrum is listed in several Mediterranean Conventions for species protection and management since the 1980s. Yet, the lack of data about its Atlantic distribution has hindered its protection there. This culminated in the recent discovery of poaching activities harvesting tens of kg of coral per day from deep rocky reefs off SW Portugal. Red coral was irregularly exploited in Portugal between the 1200s and 1700s, until the fishery collapsed. Its occurrence has not been reported for the last 300 years. Results Here we provide the first description of an Atlantic red coral assemblage, recently rediscovered dwelling at 60-100 m depth in southern Portugal. We report a very slow growth rate (0.23 mm year-1), comparable to Mediterranean specimens. In comparison with most of the Mediterranean reports, the population reaches much larger sizes, estimated to be over one century old, and has a more complex coral branch architecture that promotes a rich assemblage of associated species, with boreal and Mediterranean affinities. Atlantic red coral is genetically distinct, yet mitochondrial analyses suggest that red corals from the Atlantic may have introgressed the Mediterranean ones after migration via the Algeria current. Our underwater surveys, using advanced mixed-gas diving, retrieved lost fishing gear in all coral sites. Besides illegal harvesting, the use and loss of fishing gears, particularly nets, by local fisheries are likely sources of direct impacts on these benthic assemblages. Conclusions We extended the knowledge on the distribution of C. rubrum in the Atlantic, discovered its genetic distinctiveness, and reveal a rich deep-dwelling fauna associated to these coral assemblages. These findings support a barrier role of the Atlantic-Mediterranean transition zone, but reveal also hints of connectivity along its southern margin. The results highlight the genetic and demographic uniqueness of red coral populations from SW Iberia. However, we also report threats to these vulnerable populations by direct and indirect fishing activities and argue that its protection from any mechanically destructive activities is urgent as a precautionary approach. This study advances our understanding of phylogeographic barriers and range edge genetic diversity, and serves as a baseline against which to monitor future human and environmental disturbances to Atlantic C. rubrum.	[Boavida, Joana; Paulo, Diogo; Goncalves, Jorge M. S.; Serrao, Ester A.] Univ Algarve, Ctr Ciencias Mar, CCMAR, Campus Gambelas, P-8005139 Faro, Portugal; [Aurelle, Didier; Marschal, Christian] Avignon Univ, Aix Marseille Univ, CNRS, IRD,IMBE,UMR 7263, F-13007 Marseille, France; [Arnaud-Haond, Sophie] IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, Bd Jean Monnet,BP 171, F-34203 Sete, France; [Reed, John] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL USA	Universidade do Algarve; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Ifremer; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University	Boavida, J (corresponding author), Univ Algarve, Ctr Ciencias Mar, CCMAR, Campus Gambelas, P-8005139 Faro, Portugal.	joanarboavida@gmail.com	Arnaud-Haond, Sophie/B-2479-2008; Aurelle, Didier/F-2592-2010; Serrao, Ester A/C-6686-2012; Gonçalves, Jorge MS/G-5206-2011; Paulo, Diogo/M-7522-2013; boavida, joana/M-5744-2013	Arnaud-Haond, Sophie/0000-0001-5814-8452; Aurelle, Didier/0000-0002-3922-7291; Serrao, Ester A/0000-0003-1316-658X; Gonçalves, Jorge MS/0000-0001-7704-8190; Paulo, Diogo/0000-0001-9061-6850; boavida, joana/0000-0001-5265-2498	Inaqua Conservation Fund by Oceanario de Lisboa; National Geographic Channel through project Deep Reefs, a National Geographic/Waitt grant [W153-11]; MeshAtlantic project [AA ERDF 2009-1/110]; OCEANA (Expedition Portugal)	Inaqua Conservation Fund by Oceanario de Lisboa; National Geographic Channel through project Deep Reefs, a National Geographic/Waitt grant; MeshAtlantic project; OCEANA (Expedition Portugal)	This research was supported with funding from the Inaqua Conservation Fund by Oceanario de Lisboa and National Geographic Channel through project Deep Reefs (http://www.deepreefs.com), a National Geographic/Waitt grant (no. W153-11), MeshAtlantic project 2013 (AA ERDF 2009-1/110), OCEANA (Expedition Portugal 2011), additional support for field expenses by Project Baseline/Global Underwater Expedition 2014. The funders had no role in study design, collection, analysis, interpretation of data, writing and in the decision to publish.	Al-Abdulrazzak D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043386; Allen JT, 2001, J MARINE SYST, V30, P263, DOI 10.1016/S0924-7963(01)00062-8; Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452; Andrada e Silva JB, 1790, MEMORIAS EC ACAD REA, V2, P389; Angiolillo M, 2016, MAR ECOL-EVOL PERSP, V37, P294, DOI 10.1111/maec.12274; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Aurelle D, 2011, GENETICA, V139, P855, DOI 10.1007/s10709-011-9589-6; Baldaque da Silva AA, 1891, ESTADO ACTUAL PESCAS, P20; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bavestrello G, 2015, MAR ECOL-EVOL PERSP, V36, P1354, DOI 10.1111/maec.12235; Boavida J, 2016, HYDROBIOLOGIA, V766, P247, DOI 10.1007/s10750-015-2459-y; Borges TC, 2001, J APPL ICHTHYOL, V17, P104; Boury-Esnault P. N., 2001, B MUSEU MUNICIPAL FU, V6, P15; Bramanti L, 2014, MAR BIOL, V161, P1015, DOI 10.1007/s00227-013-2383-5; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; BRAZEAU DA, 1988, CORAL REEFS, V7, P139, DOI 10.1007/BF00300973; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bruckner AW, 2009, MAR ECOL PROG SER, V397, P319, DOI 10.3354/meps08110; Cardenas P, 2013, ZOOL J LINN SOC-LOND, V169, P251, DOI 10.1111/zoj.12056; Carpine C, 1975, B I OCEANOGRAPHIQUE, V71; CastricFey A, 1996, OCEANOL ACTA, V19, P665; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Costantini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061546; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; da Silva Lopes J, 1841, COROGRAFIA MEMORIA E; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; De Lobo CB L, 1812, MEMORIAS EC ACAD REA, VIV, P241; Doughty CL, 2014, DEEP-SEA RES PT II, V99, P71, DOI 10.1016/j.dsr2.2013.05.023; Drummond A, 2011, GENEIOUS V 8 1 4; Gallmetzer I, 2010, ESTUAR COAST SHELF S, V90, P1, DOI 10.1016/j.ecss.2010.04.018; GARCIA-RODRIGUEZ M, 1986, Boletin Instituto Espanol de Oceanografia, V3, P61; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; GFCM General Fisheries Commission for the Mediterranean, 2011, 2 TRANSV WORKSH RED; Goncalves JMS, 2008, FISHERIES MANAG ECOL, V15, P199, DOI 10.1111/j.1365-2400.2008.00607.x; Gori A, 2015, J EXP MAR BIOL ECOL, V466, P92, DOI 10.1016/j.jembe.2015.02.004; GOTELLI NJ, 1991, ECOLOGY, V72, P457, DOI 10.2307/2937187; GOTELLI NJ, 1988, ECOLOGY, V69, P157, DOI 10.2307/1943170; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; HAYNES R, 1993, J GEOPHYS RES-OCEANS, V98, P22681, DOI 10.1029/93JC02016; Henry LA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05589; Henry LA, 2014, ICES J MAR SCI, V71, P895, DOI 10.1093/icesjms/fst175; Costa BHE, 2014, MAR ECOL PROG SER, V504, P241, DOI 10.3354/meps10749; INRH, 2013, ET STOCKS PECH MAR 2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; LASKER HR, 1991, OECOLOGIA, V86, P503, DOI 10.1007/BF00318316; Lasker HR, 1998, MAR ECOL PROG SER, V162, P111, DOI 10.3354/meps162111; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Montero-Serra I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117250; Morais P, 2007, MAR ECOL-EVOL PERSP, V28, P112, DOI 10.1111/j.1439-0485.2007.00175.x; Movilla J, 2014, CORAL REEFS, V33, P675, DOI 10.1007/s00338-014-1159-9; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Oliveira F, 2015, MAR POLLUT BULL, V97, P401, DOI 10.1016/j.marpolbul.2015.05.060; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Priori C, 2013, ESTUAR COAST SHELF S, V118, P43, DOI 10.1016/j.ecss.2012.12.011; Rau V, 1972, TEMPO HIST, VV, P143; RAU Virginia, 1971, TEMPO HIST, V4, P97; Reed JK, 2006, B MAR SCI, V78, P343; Reed JK, 2007, B MAR SCI, V81, P481; Relvas P, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000456; Reverdin G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001020; Robert K, 2014, MAR ECOL PROG SER, V501, P67, DOI 10.3354/meps10677; Rossi S, 2008, MAR BIOL, V154, P533, DOI 10.1007/s00227-008-0947-6; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Santangelo G, 2015, HYDROBIOLOGIA, V759, P171, DOI 10.1007/s10750-015-2241-1; Santangelo G, 2003, MAR ECOL PROG SER, V248, P99, DOI 10.3354/meps248099; Santangelo G, 2010, MAR ECOL PROG SER, V418, P295, DOI 10.3354/meps08897; Sartoretto S, 2012, SCI MAR, V76, P349, DOI 10.3989/scimar.03262.16B; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Torrents O, 2005, BIOL CONSERV, V121, P391, DOI 10.1016/j.biocon.2004.05.010; Tozzeti AT, 1880, PESCA NEI MARI ITALI, pXV; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Tsounis G, 2006, MAR BIOL, V149, P1059, DOI 10.1007/s00227-006-0302-8; Tsounis G, 2013, MAR POLICY, V39, P361, DOI 10.1016/j.marpol.2012.12.010; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Vazquez-Rodriguez M, 2012, BIOGEOSCIENCES, V9, P5217, DOI 10.5194/bg-9-5217-2012; Vielzeuf D, 2008, AM MINERAL, V93, P1799, DOI 10.2138/am.2008.2923; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Zibrowius H, 2005, ERLANGEN EARTH C SER, P807, DOI 10.1007/3-540-27673-4_42; ZIBROWIUS H, 1984, Tethys, V11, P163	92	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147228	10.1371/journal.pone.0147228	http://dx.doi.org/10.1371/journal.pone.0147228			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800449	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300077
J	Wang, YL; Chen, Q; Zhao, HB; Ren, BZ				Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong			Identification and Comparison of Candidate Olfactory Genes in the Olfactory and Non-Olfactory Organs of Elm Pest Ambrostoma quadriimpressum (Coleoptera: Chrysomelidae) Based on Transcriptome Analysis	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; PHEROMONE-BINDING-PROTEIN; ODORANT RECEPTOR; ANTENNAL TRANSCRIPTOME; BEETLE; MOSQUITO; NEURONS; EXPRESSION; COMPONENTS; FAMILIES	The leaf beetle Ambrostoma quadriimpressum (Coleoptera: Chrysomelidae) is a predominant forest pest that causes substantial damage to the lumber industry and city management. However, no effective and environmentally friendly chemical method has been discovered to control this pest. Until recently, the molecular basis of the olfactory system in A. quadriimpressum was completely unknown. In this study, antennae and leg transcriptomes were analyzed and compared using deep sequencing data to identify the olfactory genes in A. quadriimpressum. Moreover, the expression profiles of both male and female candidate olfactory genes were analyzed and validated by bioinformatics, motif analysis, homology analysis, semi-quantitative RT-PCR and RT-qPCR experiments in antennal and non-olfactory organs to explore the candidate olfactory genes that might play key roles in the life cycle of A. quadriimpressum. As a result, approximately 102.9 million and 97.3 million clean reads were obtained from the libraries created from the antennas and legs, respectively. Annotation led to 34344 Unigenes, which were matched to known proteins. Annotation data revealed that the number of genes in antenna with binding functions and receptor activity was greater than that of legs. Furthermore, many pathway genes were differentially expressed in the two organs. Sixteen candidate odorant binding proteins (OBPs), 10 chemosensory proteins (CSPs), 34 odorant receptors (ORs), 20 inotropic receptors [ 1] and 2 sensory neuron membrane proteins (SNMPs) and their isoforms were identified. Additionally, 15 OBPs, 9 CSPs, 18 ORs, 6 IRs and 2 SNMPs were predicted to be complete ORFs. Using RT-PCR, RT-qPCR and homology analysis, AquaOBP1/2/4/7/C1/C6, AquaCSP3/9, AquaOR8/9/10/14/15/18/20/26/29/33, AquaIR8a/13/25a showed olfactory-specific expression, indicating that these genes might play a key role in olfaction-related behaviors in A. quadriimpressum such as foraging and seeking. AquaOBP4/C5, AquaOBP4/C5, AquaCSP7/9/10, AquaOR17/24/32 and AquaIR4 were highly expressed in the antenna of males, suggesting that these genes were related to sex-specific behaviors, and expression trends that were male specific were observed for most candidate olfactory genes, which supported the existence of a female-produced sex pheromone in A. quadriim-pressum. All of these results could provide valuable information and guidance for future functional studies on these genes and provide better molecular knowledge regarding the olfactory system in A. quadriimpressum.	[Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong] NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China; [Wang, Yinliang; Chen, Qi; Zhao, Hanbo; Ren, Bingzhong] NE Normal Univ, MOE, Key Lab Vegetat Ecol, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Ren, BZ (corresponding author), NE Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China.; Ren, BZ (corresponding author), NE Normal Univ, MOE, Key Lab Vegetat Ecol, Changchun, Peoples R China.	bzren@163.com	zhao, hanbo/AAO-9409-2020	wang, yinliang/0000-0003-2207-3027	Natural Science Foundation of China [31172133, 31501890]; Natural Science Foundation of Jilin province [2412015KJ017, 20150520072JH]; Fundamental Research Funds for the Central Universities [2412015KJ017]; China Postdoctoral Science Foundation [2015M581385]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by Natural Science Foundation of China (No. 31172133, BZR; 31501890, YLW), Natural Science Foundation of Jilin province (No. 2412015KJ017, BZR; 20150520072JH, YLW), Fundamental Research Funds for the Central Universities (No. 2412015KJ017, YLW), and China Postdoctoral Science Foundation (No. 2015M581385, YLW).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai MR, 2013, J NEUROSCI, V33, P10741, DOI 10.1523/JNEUROSCI.5419-12.2013; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Cheng B., 2010, THESIS NE FORESTRY U; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Diakite MM, 2015, CAN ENTOMOL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FURLONG MJ, 1995, B ENTOMOL RES, V85, P331, DOI 10.1017/S0007485300036051; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hu J., 2012, THESIS NE FORESTRY U; JERMY T, 1991, ENTOMOL EXP APPL, V59, P75, DOI 10.1007/BF00187968; Koh TW, 2014, NEURON, V83, P850, DOI 10.1016/j.neuron.2014.07.012; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li H, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.57; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121504; Liang CJ, 1990, PESITICIDES, V29, P52; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu Y, 2014, HEILONGJIANG AGR SCI, V4, P167; Liu Yang, 2015, Frontiers in Ecology and Evolution, V3, P60; Lodish HF, 2000, MOL CELL BIOL CITESE; Martini N, 2015, J SPECTROSC, V2015, P1, DOI 10.1155/2015/563763; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nikonov AA, 2002, CHEM SENSES, V27, P495, DOI 10.1093/chemse/27.6.495; Peng GH, 2001, J CHEM ECOL, V27, P2183, DOI 10.1023/A:1012270602288; Raguso RA, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P83, DOI 10.1017/CBO9780511542268.006; Soroka JJ, 2005, J CHEM ECOL, V31, P1829, DOI 10.1007/s10886-005-5929-2; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TODD JL, 1992, PHYSIOL ENTOMOL, V17, P183, DOI 10.1111/j.1365-3032.1992.tb01198.x; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111	46	20	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147144	10.1371/journal.pone.0147144	http://dx.doi.org/10.1371/journal.pone.0147144			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800515	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300062
J	Wu, GR; Peng, XW; Ying, SH; Wang, Q; Yap, PT; Shen, D; Shen, DG				Wu, Guorong; Peng, Xuewei; Ying, Shihui; Wang, Qian; Yap, Pew-Thian; Shen, Dan; Shen, Dinggang			eHUGS: Enhanced Hierarchical Unbiased Graph Shrinkage for Efficient Groupwise Registration	PLOS ONE			English	Article							DIFFEOMORPHIC IMAGE REGISTRATION; BRAIN; SEGMENTATION; ALGORITHM; ALIGNMENT; ANATOMY; MODEL	Effective and efficient spatial normalization of a large population of brain images is critical for many clinical and research studies, but it is technically very challenging. A commonly used approach is to choose a certain image as the template and then align all other images in the population to this template by applying pairwise registration. To avoid the potential bias induced by the inappropriate template selection, groupwise registration methods have been proposed to simultaneously register all images to a latent common space. However, current groupwise registration methods do not make full use of image distribution information for more accurate registration. In this paper, we present a novel groupwise registration method that harnesses the image distribution information by capturing the image distribution manifold using a hierarchical graph with its nodes representing the individual images. More specifically, a low-level graph describes the image distribution in each subgroup, and a high-level graph encodes the relationship between representative images of subgroups. Given the graph representation, we can register all images to the common space by dynamically shrinking the graph on the image manifold. The topology of the entire image distribution is always maintained during graph shrinkage. Evaluations on two datasets, one for 80 elderly individuals and one for 285 infants, indicate that our method can yield promising results.	[Wu, Guorong; Peng, Xuewei; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Wu, Guorong; Peng, Xuewei; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC 27599 USA; [Peng, Xuewei] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Ying, Shihui] Shanghai Univ, Sch Sci, Dept Math, Shanghai 200444, Peoples R China; [Wang, Qian] Shanghai Jiao Tong Univ, MedX Res Inst, Shanghai 200240, Peoples R China; [Shen, Dan] Univ S Florida, Dept Math & Stat, Tampa, FL 33620 USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Shanghai University; Shanghai Jiao Tong University; State University System of Florida; University of South Florida; Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, CB 7510, Chapel Hill, NC 27599 USA.	dgshen@med.unc.edu	shen, ying/HHS-5635-2022; Wang, Qian/AAY-9494-2020; Shen, Dinggang/ABF-6812-2020	Wang, Qian/0000-0002-3490-3836; Shen, Dinggang/0000-0002-7934-5698	National Institutes of Health (NIH) [HD081467, EB006733, EB008374, EB009634, MH100217, AG041721, AG049371, AG042599, CA140413]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081467] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049371, R01AG042599, U01AG024904, R01AG041721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants HD081467, EB006733, EB008374, EB009634, MH100217, AG041721, AG049371, AG042599, CA140413, (URL: http://www.nibib.nih.gov/). The funders support the data analysis and the preparation of the manuscript. The elder brain data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health grant U01 AG024904).	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Auzias G, 2011, IEEE T MED IMAGING, V30, P1214, DOI 10.1109/TMI.2011.2108665; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Cootes TF, 2010, IEEE T PATTERN ANAL, V32, P1994, DOI 10.1109/TPAMI.2009.193; Durrleman S, 2011, NEUROIMAGE, V55, P1073, DOI 10.1016/j.neuroimage.2010.11.056; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; HELGASON S., 2001, DIFFERENTIAL GEOMETR; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jia HJ, 2011, NEUROIMAGE, V54, P928, DOI 10.1016/j.neuroimage.2010.09.019; Jia HJ, 2010, NEUROIMAGE, V51, P1057, DOI 10.1016/j.neuroimage.2010.03.010; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Learned-Miller EG, 2006, IEEE T PATTERN ANAL, V28, P236, DOI 10.1109/TPAMI.2006.34; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Orchard J, 2010, IEEE T IMAGE PROCESS, V19, P1236, DOI 10.1109/TIP.2009.2039371; Park H, 2005, LECT NOTES COMPUT SC, V3750, P419, DOI 10.1007/11566489_52; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rohlfing T, 2012, IEEE T MED IMAGING, V31, P153, DOI 10.1109/TMI.2011.2163944; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shi F, 2011, HUM BRAIN MAPP, V32, P382, DOI 10.1002/hbm.21023; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spiclin Z, 2012, IEEE T IMAGE PROCESS, V21, P2546, DOI 10.1109/TIP.2012.2186145; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Toga AW, 2003, ANNU REV BIOMED ENG, V5, P119, DOI 10.1146/annurev.bioeng.5.040202.121611; Toga AW, 2001, IMAGE VISION COMPUT, V19, P3, DOI 10.1016/S0262-8856(00)00055-X; Vercauteren T, 2008, LECT NOTES COMPUT SC, V5241, P754, DOI 10.1007/978-3-540-85988-8_90; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wachinger C, 2013, IEEE T PATTERN ANAL, V35, P1221, DOI 10.1109/TPAMI.2012.196; Wang QA, 2010, HUM BRAIN MAPP, V31, P1128, DOI 10.1002/hbm.20923; Wu GR, 2012, HUM BRAIN MAPP, V33, P253, DOI 10.1002/hbm.21209; Wu GR, 2011, NEUROIMAGE, V56, P1968, DOI 10.1016/j.neuroimage.2011.03.050; Ying SH, 2014, NEUROIMAGE, V84, P626, DOI 10.1016/j.neuroimage.2013.09.023; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146870	10.1371/journal.pone.0146870	http://dx.doi.org/10.1371/journal.pone.0146870			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800361	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300044
J	Matza, D; Badou, A; Klemic, KG; Stein, J; Govindarajulu, U; Nadler, MJ; Kinet, JP; Peled, A; Shapira, OM; Kaczmarek, LK; Flavell, RA				Matza, Didi; Badou, Abdallah; Klemic, Kathryn G.; Stein, Judith; Govindarajulu, Usha; Nadler, Monica J.; Kinet, Jean-Pierre; Peled, Amnon; Shapira, Oz M.; Kaczmarek, Leonard K.; Flavell, Richard A.			T Cell Receptor Mediated Calcium Entry Requires Alternatively Spliced Ca(v)1.1 Channels	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INTRACELLULAR CALCIUM; MICE LACKING; CA2+; ACTIVATION; LYMPHOCYTES; MEMBRANE; PROTEIN; INFLUX; STIM1	The process of calcium entry in T cells is a multichannel and multi-step process. We have studied the requirement for L-type calcium channels (Ca(v)1.1) alpha 1S subunits during calcium entry after TCR stimulation. High expression levels of Ca(v)1.1 channels were detected in activated T cells. Sequencing and cloning of Ca(v)1.1 channel cDNA from T cells revealed that a single splice variant is expressed. This variant lacks exon 29, which encodes the linker region adjacent to the voltage sensor, but contains five new N-terminal exons that substitute for exons 1 and 2, which are found in the Ca(v)1.1 muscle counterpart. Overexpression studies using cloned T cell Ca(v)1.1 in 293HEK cells (that lack TCR) suggest that the gating of these channels was altered. Knockdown of Ca(v)1.1 channels in T cells abrogated calcium entry after TCR stimulation, suggesting that Ca(v)1.1 channels are controlled by TCR signaling.	[Matza, Didi] Open Univ Israel, Dept Nat Sci, 1 Univ Rd, IL-4353701 Raanana, Israel; [Badou, Abdallah] Hassan II Univ, Casablanca Sch Med & Pharm, Genet & Mol Pathol Lab, Casablanca, Morocco; [Klemic, Kathryn G.] Virginia Tech Appl Res Corp, 900 North Glebe Rd, Arlington, VA 22203 USA; [Stein, Judith; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA; [Stein, Judith; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Govindarajulu, Usha] Yale Univ, Sch Med, Yale Ctr Clin Invest, New Haven, CT 06520 USA; [Nadler, Monica J.; Kinet, Jean-Pierre] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Peled, Amnon] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Shapira, Oz M.] Hadassah Univ Hosp, Dept Cardiothorac Surg, IL-91120 Jerusalem, Israel; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Open University Israel; Hassan II University of Casablanca; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Yale University; Yale University	Matza, D (corresponding author), Open Univ Israel, Dept Nat Sci, 1 Univ Rd, IL-4353701 Raanana, Israel.	didima@openu.ac.il		Govindarajulu, Usha/0000-0001-5864-7403; Badou, Abdallah/0000-0003-4849-9085	FP7-PEOPLE-RG - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship [268263]; Arthritis National Research Foundation; Aaron Beare Foundation, South Africa;  [5R01AI075129]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075129] Funding Source: NIH RePORTER	FP7-PEOPLE-RG - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship; Arthritis National Research Foundation(National Research Foundation of Korea); Aaron Beare Foundation, South Africa; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by (D.M.) - FP7-PEOPLE-2010-RG Proposal No 268263 - Acronym:Cav in Immune System and Cancer Research Institute postdoctoral fellowship, (A.B.) - Arthritis National Research Foundation. J.P.K. and M.J.N. were supported by 5R01AI075129 grant. R.A.F. is an investigator of the Howard Hughes Medical Institute.; The authors thank F. Manzo for assistance with the manuscript preparation. Dr. R. Babai for helpful discussions. D. M. also thank Michal Gropp and Etti Ben Shushan for their technical support. A.B. was supported by the Arthritis National Research Foundation. D. M was consecutively supported by Cancer Research Institute postdoctoral fellowship then by the European Council Marie Curie FP-7-PEOPLE-2010-RG (proposal number 268263) and The Aaron Beare Foundation, South Africa. J.P.K. and M.J.N. were supported by 5R01AI075129 grant. R. A. F. is an investigator of the Howard Hughes Medical Institute.	Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Bertin S, 2014, NAT IMMUNOL, V15, P1055, DOI 10.1038/ni.3009; BILBREY GL, 1973, J CLIN INVEST, V52, P3011, DOI 10.1172/JCI107499; Cantrell DA, 1996, CANCER SURV, V27, P165; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GELFAND EW, 1986, EUR J IMMUNOL, V16, P907, DOI 10.1002/eji.1830160806; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Luo DL, 2000, GEN PHARMACOL-VASC S, V34, P211, DOI 10.1016/S0306-3623(00)00064-1; MASON MJ, 1993, AM J PHYSIOL, V264, pC654, DOI 10.1152/ajpcell.1993.264.3.C654; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Savignac M, 2004, J IMMUNOL, V172, P5206, DOI 10.4049/jimmunol.172.9.5206; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tuluc P, 2009, BIOPHYS J, V96, P35, DOI 10.1016/j.bpj.2008.09.027; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Wissenbach U, 2007, CELL CALCIUM, V42, P439, DOI 10.1016/j.ceca.2007.05.014; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	46	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147379	10.1371/journal.pone.0147379	http://dx.doi.org/10.1371/journal.pone.0147379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815481	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200031
J	Panek, J; Frac, M; Bilinska-Wielgus, N				Panek, Jacek; Frac, Magdalena; Bilinska-Wielgus, Nina			Comparison of Chemical Sensitivity of Fresh and Long-Stored Heat Resistant Neosartorya fischeri Environmental Isolates Using BIOLOG Phenotype MicroArray System	PLOS ONE			English	Article							CARBONIC-ANHYDRASE INHIBITORS; ANTIFUNGAL PROTEIN NFAP; BYSSOCHLAMYS-FULVA; ZARAGOZIC ACIDS; ISOZYME-II; DERIVATIVES; FUNGI; ASCOSPORES; SELENIUM; DNA	Spoilage of heat processed food and beverage by heat resistant fungi (HRF) is a major problem for food industry in many countries. Neosartorya fischeri is the leading source of spoilage in thermally processed products. Its resistance to heat processing and toxigenicity makes studies about Neosartorya fischeri metabolism and chemical sensitivity essential. In this study chemical sensitivity of two environmental Neosartorya fischeri isolates were compared. One was isolated from canned apples in 1923 (DSM3700), the other from thermal processed strawberry product in 2012 (KC179765), used as long-stored and fresh isolate, respectively. The study was conducted using Biolog Phenotype MicroArray platforms of chemical sensitivity panel and traditional hole-plate method. The study allowed for obtaining data about Neosartorya fischeri growth inhibitors. The fresh isolate appeared to be much more resistant to chemical agents than the long-stored isolate. Based on phenotype microarray assay nitrogen compounds, toxic cations and membrane function compounds were the most effective in growth inhibition of N. fischeri isolates. According to the study zaragozic acid A, thallium(I) acetate and sodium selenate were potent and promising N. fischeri oriented fungicides which was confirmed by both chemical sensitivity microplates panel and traditional hole-plate methods.	[Panek, Jacek; Frac, Magdalena; Bilinska-Wielgus, Nina] Polish Acad Sci, Dept Plant & Soil Syst, Lab Mol & Environm Microbiol, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Frac, M (corresponding author), Polish Acad Sci, Dept Plant & Soil Syst, Lab Mol & Environm Microbiol, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland.	m.frac@ipan.lublin.pl	Panek, Jacek/W-3379-2019	Panek, Jacek/0000-0002-9217-5902; Frac, Magdalena/0000-0001-9437-3139; Bilinska-Wielgus, Nina/0000-0002-6312-6167	National Science Centre (Poland) [DEC-2012/07/D/NZ9/03357]	National Science Centre (Poland)	This research was supported by National Science Centre (Poland), project No.: DEC-2012/07/D/NZ9/03357, https://www.ncn.gov.pl/?language=en. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mejdad N.M.J.A., 2013, EUR J EXP BIOL, V3, P535; Bartizal KF, 1991, Novel anti-fungal compounds, Patent No. [US5053425 A, 5053425]; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; Beuchat L. R., 2001, COMPENDIUM METHODS M, P217; BEUCHAT LR, 1986, J FOOD SCI, V51, P1506, DOI 10.1111/j.1365-2621.1986.tb13846.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BRENNAN MB, 1980, J MOL BIOL, V136, P333, DOI 10.1016/0022-2836(80)90377-0; Bromley MJ, 2014, J GLOB ANTIMICROB RE, V2, P276, DOI 10.1016/j.jgar.2014.05.004; Brzozowski Z, 2010, EUR J MED CHEM, V45, P2396, DOI 10.1016/j.ejmech.2010.02.020; Chipley Jr, 2005, FOOD SCI, V143, P11; Conerly O, 2009, 7440280 CAS US EPA; Dabrah TT, 1995, Inhibitor of squalene synthase, Patent No. [US 5430055 A, 5430055]; David ER, 1959, Thiourea fungicides, Patent No. [US3006808 A, 3006808]; Delgado DA, 2012, FOOD CONTROL, V23, P165, DOI 10.1016/j.foodcont.2011.07.004; dos Santos L, 2008, BIOORGAN MED CHEM, V16, P8526, DOI 10.1016/j.bmc.2008.08.019; Faidallah HM, 2011, J FLUORINE CHEM, V132, P870, DOI 10.1016/j.jfluchem.2011.06.014; Frac M, SEQUENCE HEAT RESIST; Frac M, 2015, ADV AGRON, V132, P161, DOI 10.1016/bs.agron.2015.02.003; Gabrielson J, 2002, J MICROBIOL METH, V50, P63, DOI 10.1016/S0167-7012(02)00011-8; Gadad AK, 2000, EUR J MED CHEM, V35, P853, DOI 10.1016/S0223-5234(00)00166-5; Galgoczy L, 2013, MICROBIOL-SGM, V159, P411, DOI 10.1099/mic.0.061119-0; Galli A, 1996, MUTAT RES-GENET TOX, V370, P209, DOI 10.1016/S0165-1218(96)00078-X; Garaj V, 2005, BIOORG MED CHEM LETT, V15, P3102, DOI 10.1016/j.bmcl.2005.04.056; Hambuckers A, 2010, COMMUN SOIL SCI PLAN, V41, P1283, DOI 10.1080/00103621003759296; Hardy WB, 1957, Fungicide, Patent No. [US2953491 A, 2953491]; HARTMANN M, 1985, POLYM BULL, V13, P195; Johnson G. F., 1935, AGR HIST, V9, P67; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; JUKES T. H., 1963, Economic Botany, V17, P238, DOI 10.1007/BF02859441; Kaifuchi S, 2015, J ANTIBIOT, V68, P403, DOI 10.1038/ja.2014.167; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Kotowicz N. K., 2014, Journal of Animal and Plant Sciences (JAPS), V21, P3326; Kotzekidou P, 1997, J FOOD SCI, V62, P410, DOI 10.1111/j.1365-2621.1997.tb04014.x; Kovacic P, 2011, MED HYPOTHESES, V76, P24, DOI 10.1016/j.mehy.2010.08.023; Kovacs L, 2011, PEPTIDES, V32, P1724, DOI 10.1016/j.peptides.2011.06.022; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Li SS, 2012, BIOORG MED CHEM LETT, V22, P3317, DOI 10.1016/j.bmcl.2012.03.006; Liebelt EL, 2007, BIRTH DEFECTS RES B, V80, P259, DOI 10.1002/bdrb.20123; Ostby DJ, 1991, Water soluble fungicide in matrix between two layers of hydrophilic paper; railroad ties, Patent No. [US5043225 A, 5043225]; Parry KE, 1958, ANN APPL BIOL, V46, P446, DOI 10.1111/j.1744-7348.1958.tb02225.x; Pieckova E, 1997, INT J FOOD MICROBIOL, V36, P227, DOI 10.1016/S0168-1605(97)01239-7; Rajashekhara E, 1998, J FOOD PROTECT, V61, P1358, DOI 10.4315/0362-028X-61.10.1358; Raper KB, 1965, GENUS ASPERGILLUS GE; Renzi G, 2000, BIOORG MED CHEM LETT, V10, P673, DOI 10.1016/S0960-894X(00)00075-5; Rodriguez-Mercado JJ, 2015, ENVIRON TOXICOL, V30, P572, DOI 10.1002/tox.21934; Saczewski F, 2008, BIOORGAN MED CHEM, V16, P3933, DOI 10.1016/j.bmc.2008.01.034; Salama SM, 2001, ANTIMICROB AGENTS CH, V45, P2420, DOI 10.1128/AAC.45.9.2420-2426.2001; Salomao BCM, 2007, LWT-FOOD SCI TECHNOL, V40, P676, DOI 10.1016/j.lwt.2006.03.008; SAMSON RA, 1990, NATO ADV SCI I A-LIF, V185, P455; Sant'Ana AS, 2009, J APPL MICROBIOL, V107, P197, DOI 10.1111/j.1365-2672.2009.04195.x; SCHIESTL RH, 1989, NATURE, V337, P285, DOI 10.1038/337285a0; Schrauzer GN, 2001, J AM COLL NUTR, V20, P1; Sharma BK, 2008, J ENZYM INHIB MED CH, V23, P168, DOI [10.1080/14756360701450301, 10.1080/14756360701450301 ]; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Suresha GP, 2011, EUR J MED CHEM, V46, P2530, DOI 10.1016/j.ejmech.2011.03.041; TRESHOW M, 1965, MYCOLOGIA, V57, P216, DOI 10.2307/3756824; Tripathi K, 2012, FRONT MICROBIOL, P3; Turkkan M, 2014, PLANT PROTECT SCI, V50, P19, DOI 10.17221/9/2013-PPS; Ueda M, 2003, FEMS MICROBIOL LETT, V219, P93, DOI 10.1016/S0378-1097(02)01201-6; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Venkatachalam TK, 2004, BIOORGAN MED CHEM, V12, P4275, DOI 10.1016/j.bmc.2004.04.050; Viragh M, 2014, PROTEIN EXPRES PURIF, V94, P79, DOI 10.1016/j.pep.2013.11.003; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; Wollinsky Beate, 2012, Methods Mol Biol, V944, P111, DOI 10.1007/978-1-62703-122-6_7; Xu W, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004427; Yavuz S, 2013, J CHEM, V2013, P1; Zani F, 1998, ARCH PHARM, V331, P219, DOI 10.1002/(SICI)1521-4184(199806)331:6&lt;219::AID-ARDP219&gt;3.0.CO;2-U; Ziegler-Skylakakis K, 2003, THIOUREA CONCISE INT	72	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147605	10.1371/journal.pone.0147605	http://dx.doi.org/10.1371/journal.pone.0147605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815302	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200042
J	Finke, A; Essig, K; Marchioro, G; Ritter, H				Finke, Andrea; Essig, Kai; Marchioro, Giuseppe; Ritter, Helge			Toward FRP-Based Brain-Machine Interfaces-Single-Trial Classification of Fixation-Related Potentials	PLOS ONE			English	Article							EYE-MOVEMENTS; SPAN; EEG	The co-registration of eye tracking and electroencephalography provides a holistic measure of ongoing cognitive processes. Recently, fixation-related potentials have been introduced to quantify the neural activity in such bi-modal recordings. Fixation-related potentials are time-locked to fixation onsets, just like event-related potentials are locked to stimulus onsets. Compared to existing electroencephalography-based brain-machine interfaces that depend on visual stimuli, fixation-related potentials have the advantages that they can be used in free, unconstrained viewing conditions and can also be classified on a single-trial level. Thus, fixation-related potentials have the potential to allow for conceptually different brain-machine interfaces that directly interpret cortical activity related to the visual processing of specific objects. However, existing research has investigated fixation-related potentials only with very restricted and highly unnatural stimuli in simple search tasks while participant's body movements were restricted. We present a study where we relieved many of these restrictions while retaining some control by using a gaze-contingent visual search task. In our study, participants had to find a target object out of 12 complex and everyday objects presented on a screen while the electrical activity of the brain and eye movements were recorded simultaneously. Our results show that our proposed method for the classification of fixation-related potentials can clearly discriminate between fixations on relevant, non-relevant and background areas. Furthermore, we show that our classification approach generalizes not only to different test sets from the same participant, but also across participants. These results promise to open novel avenues for exploiting fixation-related potentials in electroencephalography-based brain-machine interfaces and thus providing a novel means for intuitive human-machine interaction.	[Finke, Andrea; Essig, Kai; Ritter, Helge] Univ Bielefeld, Ctr Excellence Cognit Interact Technol CITEC, D-33615 Bielefeld, Germany; [Finke, Andrea; Marchioro, Giuseppe; Ritter, Helge] Univ Bielefeld, Tech Fac, Neuroinformat Grp, D-33615 Bielefeld, Germany; [Essig, Kai] Univ Bielefeld, Fac Psychol, Neurocognit & Act Grp, D-33615 Bielefeld, Germany; [Marchioro, Giuseppe] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Verona	Finke, A (corresponding author), Univ Bielefeld, Ctr Excellence Cognit Interact Technol CITEC, D-33615 Bielefeld, Germany.; Finke, A (corresponding author), Univ Bielefeld, Tech Fac, Neuroinformat Grp, D-33615 Bielefeld, Germany.	afinke@techfak.uni-bielefeld.de	Essig, Kai/AAR-6354-2021	Finke, Andrea/0000-0002-4325-9202	Federal Ministry of Education and Research (BMBF) [16SV7275K]; Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University [EXC 277]; German Research Foundation (DFG)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/en/), grant no. 16SV7275K (KE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Stefan Genster and Dennis Wobrock for their invaluable assistance with the experiments. This research/work was supported by the Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG).	Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Brouwer AM, 2013, J VISION, V13, DOI 10.1167/13.3.17; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Farrow D, 2005, MOTOR CONTROL, V9, P332; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Henderson JM, 2013, FRONTIERS SYSTEMS NE, V7, P1; Holmqvist K., 2011, EYE TRACKING COMPREH; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kaper M, 2006, P300 BASED BRAIN COM; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Lao J., 2013, CULTURE BRAIN, V1, P158, DOI [10.1007/s40167-013-0012-2, DOI 10.1007/S40167-013-0012-2]; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lenhardt A, 2008, IEEE T NEUR SYS REH, V16, P121, DOI 10.1109/TNSRE.2007.912816; Lesenfants D, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035002; Makeig S., 2012, ERP FEATURES EEG OXF, P51, DOI 10.1093/oxfordhb/9780195374148.013.0035; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Miellet S, 2009, PSYCHOL SCI, V20, P721, DOI 10.1111/j.1467-9280.2009.02364.x; Muller-Putz GR, 2005, J NEURAL ENG, V2, P123, DOI 10.1088/1741-2560/2/4/008; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pomplun M, 2001, COGNITION, V81, pB57, DOI 10.1016/S0010-0277(01)00123-8; Rayner K, 2004, J EXP PSYCHOL HUMAN, V30, P720, DOI 10.1037/0096-1523.30.4.720; RAYNER K, 1979, SCIENCE, V206, P468, DOI 10.1126/science.504987; Riechmann H, 2016, IEEE T NEUR SYS REH, V24, P692, DOI 10.1109/TNSRE.2015.2490621; SAIDA S, 1979, PERCEPT PSYCHOPHYS, V25, P119, DOI 10.3758/BF03198797; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Winkler I, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035013; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	36	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146848	10.1371/journal.pone.0146848	http://dx.doi.org/10.1371/journal.pone.0146848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812487	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000015
J	Boni, L; Ruhs, PA; Windhab, EJ; Fischer, P; Kuster, S				Boeni, Lukas; Ruehs, Patrick A.; Windhab, Erich J.; Fischer, Peter; Kuster, Simon			Gelation of Soy Milk with Hagfish Exudate Creates a Flocculated and Fibrous Emulsion- and Particle Gel	PLOS ONE			English	Article							SLIME GLAND; PROTEIN; FIBERS; BIOLOGY; SALIVA	Hagfish slime is an ultra dilute, elastic and cohesive hydrogel that deploys within milliseconds in cold seawater from a glandularly secreted exudate. The slime is made of long keratin-like fibers and mucin-like glycoproteins that span a network which entraps water and acts as a defense mechanism against predators. Unlike other hydrogels, the slime only confines water physically and is very susceptible to mechanical stress, which makes it unsuitable for many processing operations and potential applications. Despite its huge potential, little work has been done to improve and functionalize the properties of this hydrogel. To address this shortcoming, hagfish exudate was mixed with a soy protein isolate suspension (4% w/v) and with a soy emulsion (commercial soy milk) to form a more stable structure and combine the functionalities of a suspension and emulsion with those of the hydrogel. Hagfish exudate interacted strongly with the soy systems, showing a markedly increased visco-elasticity and water retention. Hagfish mucin was found to induce a depletion and bridging mechanism, which caused the emulsion and suspension to flocculate, making "soy slime", a cohesive and cold-set emulsion-and particle gel. The flocculation network increases viscoelasticity and substantially contributes to liquid retention by entrapping liquid in the additional confinements between aggregated particles and protein fibers. Because the mucin-induced flocculation resembles the salt- or acid-induced flocculation in tofu curd production, the soy slime was cooked for comparison. The cooked soy slime was similar to conventional cooked tofu, but possessed a long-range cohesiveness from the fibers. The fibrous, cold-set, and curd-like structure of the soy slime represents a novel way for a cold coagulation and fiber incorporation into a suspension or emulsion. This mechanism could be used to efficiently gel functionalized emulsions or produce novel tofu-like structured food products.	[Boeni, Lukas; Windhab, Erich J.; Fischer, Peter; Kuster, Simon] ETH, Inst Food Nutr & Hlth, Food Proc Engn Grp, CH-8092 Zurich, Switzerland; [Ruehs, Patrick A.] ETH, Dept Mat, Complex Mat Grp, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Boni, L (corresponding author), ETH, Inst Food Nutr & Hlth, Food Proc Engn Grp, CH-8092 Zurich, Switzerland.	lukas.boeni@hest.ethz.ch	Fischer, Peter/A-8740-2011; Kuster, Simon/B-6140-2014; Windhab, Erich J/C-3381-2016; Boni, Lukas/B-2690-2015	Fischer, Peter/0000-0002-2992-5037; Kuster, Simon/0000-0003-2771-9667; Boni, Lukas/0000-0003-4958-0037	Walter Hochstrasser Stiftung; ETH Research Grant [ETH-19 14-1]	Walter Hochstrasser Stiftung; ETH Research Grant	The study was funded by the ETH Research Grant ETH-19 14-1.; The authors thank the curator Rune Veiseth and the whole team of the Atlanterhavsparken Aquarium in angstrom lesund for kindly providing the hagfish. We also express our thanks to Moreforsking angstrom lesund for the opportunity to use their facilities and Snorre Bakke for supervising the sampling of the hagfish according to the ethical guidelines (FOTS ID 6912). We thank Stephane Isabettini for his help with the Zetasizer measurements and Ruben Zurfluh for his support with the mucin dry weight measurements. We also thank the Walter Hochstrasser Stiftung that kindly provided funding in the initial project phase. This work was supported by ETH Research Grant ETH-19 14-1.	[Anonymous], 2012, LECTINS PROPERTIES F; Bocker L, 2016, ACS BIOMATERIALS SCI; Dickinson E, 2013, ADV COLLOID INTERFAC, V199, P114, DOI 10.1016/j.cis.2013.07.002; Dickinson E, 2012, FOOD HYDROCOLLOID, V28, P224, DOI 10.1016/j.foodhyd.2011.12.017; DOWNING SW, 1981, SCIENCE, V214, P1143, DOI 10.1126/science.7302586; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Ellis JE, 2015, FISH RES, V161, P24, DOI 10.1016/j.fishres.2014.06.011; ETZLER ME, 1985, ANNU REV PLANT PHYS, V36, P209, DOI 10.1146/annurev.pp.36.060185.001233; Everett D. H., 1988, RSC PAPERBACKS; Ferry JD, 1941, J BIOL CHEM, V138, P263; Fu J, 2015, BIOMACROMOLECULES, V16, P2327, DOI 10.1021/acs.biomac.5b00552; Fudge DS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P504; Fudge DS, 2005, J EXP BIOL, V208, P4613, DOI 10.1242/jeb.01963; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; FUKUSHIMA D, 1981, J AM OIL CHEM SOC, V58, P346, DOI 10.1007/BF02582376; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; HEALY TW, 1964, J COLL SCI IMP U TOK, V19, P323, DOI 10.1016/0095-8522(64)90034-0; Herr JE, 2010, J EXP BIOL, V213, P1092, DOI 10.1242/jeb.038992; HISAYASU S, 1992, J NUTR, V122, P1190, DOI 10.1093/jn/122.5.1190; Hyun K, 2011, PROG POLYM SCI, V36, P1697, DOI 10.1016/j.progpolymsci.2011.02.002; KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Lim J, 2006, J EXP BIOL, V209, P702, DOI 10.1242/jeb.02067; LUSAS EW, 1995, J NUTR, V125, pS573, DOI 10.1093/jn/125.3_Suppl.573S; Malhotra A, 2004, FOOD HYDROCOLLOID, V18, P101, DOI 10.1016/S0268-005X(03)00047-X; Maltais A, 2008, FOOD HYDROCOLLOID, V22, P550, DOI 10.1016/j.foodhyd.2007.01.026; Maltais A, 2009, FOOD HYDROCOLLOID, V23, P1647, DOI 10.1016/j.foodhyd.2008.12.006; McGuckin MA, 2012, METHODS MOL BIOL, V842, P1, DOI 10.1007/978-1-61779-513-8; Miserez A, 2013, CHEM SOC REV, V42, P1973, DOI 10.1039/c2cs35294j; NAGANO T, 1994, BIOPOLYMERS, V34, P1303, DOI 10.1002/bip.360341003; Negishi A, 2012, BIOMACROMOLECULES, V13, P3475, DOI 10.1021/bm3011837; Nishinari K, 2014, FOOD HYDROCOLLOID, V39, P301, DOI 10.1016/j.foodhyd.2014.01.013; Pinto N, 2014, BIOMACROMOLECULES, V15, P574, DOI 10.1021/bm401600a; Radford SJ, 2004, COLLOID SURFACE A, V238, P71, DOI 10.1016/j.colsurfa.2004.02.020; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; SALO WL, 1983, PREP BIOCHEM, V13, P103, DOI 10.1080/00327488308068743; Schaffeld M, 2006, EXP CELL RES, V312, P1447, DOI 10.1016/j.yexcr.2006.01.005; Shurtleff W, 2000, TOFU SOYMILK PRODUCT; Silletti E, 2007, FOOD HYDROCOLLOID, V21, P596, DOI 10.1016/j.foodhyd.2006.07.004; Vingerhoeds MH, 2005, FOOD HYDROCOLLOID, V19, P915, DOI 10.1016/j.foodhyd.2004.12.005; Winegard TM, 2010, J EXP BIOL, V213, P1235, DOI 10.1242/jeb.038075	41	13	13	8	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147022	10.1371/journal.pone.0147022	http://dx.doi.org/10.1371/journal.pone.0147022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808048	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800046
J	Kempf, F; Slugocki, C; Blum, SE; Leitner, G; Germon, P				Kempf, Florent; Slugocki, Cindy; Blum, Shlomo E.; Leitner, Gabriel; Germon, Pierre			Genomic Comparative Study of Bovine Mastitis Escherichia coli	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; VIRULENCE FACTORS; CLINICAL MASTITIS; INNATE IMMUNITY; SEQUENCE; IDENTIFICATION; SEROTYPES; COMMENSAL; SUSCEPTIBILITY; ALGORITHM	Escherichia coli, one of the main causative agents of bovine mastitis, is responsible for significant losses on dairy farms. In order to better understand the pathogenicity of E. coli mastitis, an accurate characterization of E. coli strains isolated from mastitis cases is required. By using phylogenetic analyses and whole genome comparison of 5 currently available mastitis E. coli genome sequences, we searched for genotypic traits specific for mastitis isolates. Our data confirm that there is a bias in the distribution of mastitis isolates in the different phylogenetic groups of the E. coli species, with the majority of strains belonging to phylogenetic groups A and B1. An interesting feature is that clustering of strains based on their accessory genome is very similar to that obtained using the core genome. This finding illustrates the fact that phenotypic properties of strains from different phylogroups are likely to be different. As a consequence, it is possible that different strategies could be used by mastitis isolates of different phylogroups to trigger mastitis. Our results indicate that mastitis E. coli isolates analyzed in this study carry very few of the virulence genes described in other pathogenic E. coli strains. A more detailed analysis of the presence/absence of genes involved in LPS synthesis, iron acquisition and type 6 secretion systems did not uncover specific properties of mastitis isolates. Altogether, these results indicate that mastitis E. coli isolates are rather characterized by a lack of bona fide currently described virulence genes.	[Kempf, Florent; Slugocki, Cindy] INRA, UMR Infectiol & Sante Publ 1282, CIRM Bacteries Pathogenes, F-37380 Nouzilly, France; [Germon, Pierre] INRA, UMR Infectiol & Sante Publ 1282, Immunite & Infect Mammaires, F-37380 Nouzilly, France; [Kempf, Florent; Slugocki, Cindy; Germon, Pierre] Univ Tours, UMR Infectiol & Sante Publ 1282, F-37000 Tours, France; [Blum, Shlomo E.; Leitner, Gabriel] Kimron Vet Inst, Div Bacteriol, Natl Mastitis Ctr, POB 12, IL-50250 Bet Dagan, Israel	INRAE; INRAE; Universite de Tours; Kimron Veterinary Institute	Germon, P (corresponding author), INRA, UMR Infectiol & Sante Publ 1282, Immunite & Infect Mammaires, F-37380 Nouzilly, France.; Germon, P (corresponding author), Univ Tours, UMR Infectiol & Sante Publ 1282, F-37000 Tours, France.	pierre.germon@tours.inra.fr	GERMON, Pierre/M-5264-2019; GERMON, Pierre/AAC-9111-2019	GERMON, Pierre/0000-0003-3078-876X; 	French National Institute for Agricultural Research (INRA AIP "Bio-Ressources")	French National Institute for Agricultural Research (INRA AIP "Bio-Ressources")	This work was supported by the French National Institute for Agricultural Research (INRA AIP "Bio-Ressources"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum S, 2012, J BACTERIOL, V194, P3732, DOI 10.1128/JB.00535-12; Blum SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136387; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bojer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015467; Bouchard L, 1999, J DAIRY SCI, V82, P2574, DOI 10.3168/jds.S0022-0302(99)75512-8; Boulanger V, 2001, J DAIRY SCI, V84, P1430, DOI 10.3168/jds.S0022-0302(01)70175-0; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fernandes JBC, 2011, J VET DIAGN INVEST, V23, P1146, DOI 10.1177/1040638711425581; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Ghanbarpour R, 2010, RES VET SCI, V88, P6, DOI 10.1016/j.rvsc.2009.06.003; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; HOGAN JS, 1989, J DAIRY SCI, V72, P1893, DOI 10.3168/jds.S0022-0302(89)79308-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Kaipainen T, 2002, VET MICROBIOL, V85, P37, DOI 10.1016/S0378-1135(01)00483-7; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kempf F, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomeA.00259-15, DOI 10.1128/GEN0MEA.00259-15]; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Koli P, 2011, MBIO, V2, DOI [10.1128/mBio.00182-11, DOI 10.1128/MBI0.00182-11]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lehtolainen T, 2003, ACTA VET SCAND, V44, P203, DOI 10.1186/1751-0147-44-203; Li J, 2015, ENVIRON MICROBIOL, V17, P2196, DOI 10.1111/1462-2920.12794; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LINTON AH, 1979, J APPL BACTERIOL, V46, P585, DOI 10.1111/j.1365-2672.1979.tb00859.x; LIPMAN LJA, 1995, VET MICROBIOL, V47, P1, DOI 10.1016/0378-1135(95)00108-M; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Munson GP, 2013, IMMUNOL RES, V57, P229, DOI 10.1007/s12026-013-8453-4; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; PEAKER M, 1975, NATURE, V253, P464, DOI 10.1038/253464a0; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reiland HA, 2014, ADV MICROBIOL, V4, P390, DOI DOI 10.4236/aim.2014.47046; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SELANDER RK, 1987, ESCHERICHIA COLI SAL, P1625; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Suojala L, 2011, VET MICROBIOL; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Waage S, 1999, J DAIRY SCI, V82, P712, DOI 10.3168/jds.S0022-0302(99)75288-4; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhao HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065466	82	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147954	10.1371/journal.pone.0147954	http://dx.doi.org/10.1371/journal.pone.0147954			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809117	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800251
J	Leite, F; Lima, M; Marino, F; Cosentino, M; Ribeiro, L				Leite, Fernanda; Lima, Margarida; Marino, Franca; Cosentino, Marco; Ribeiro, Laura			Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity	PLOS ONE			English	Article							ENDOGENOUS CATECHOLAMINES; INTERFERON-BETA; MESSENGER-RNA; T-CELLS; LYMPHOCYTES; D2; INSULIN; POLYMORPHISMS; ADDICTION; WEIGHT	Background Dopamine (DA) may be involved in central obesity (CO), an inflammatory condition, through its role in the central nervous system and in periphery, where it may affect immune cell function through five different DA receptors (DR). Whether dopaminergic pathways in peripheral immune cells are implicated in the inflammatory condition linked to CO is however unknown. Methods In a cohort of blood donors with and without CO, categorized by waist circumference (WC) (CO: WC >= 0.80 m in women and >= 0.94 m in men), we studied the expression of DR and tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA, in peripheral blood mononuclear cells (PBMCs) and their relation with anthropometric and metabolic/endocrine and inflammatory parameters. DR D1-5 and TH expression was assessed by semi quantitative real-time PCR. As inflammatory markers we investigated the immunophenotype of monocyte subsets by flow cytometry, staining for CD14, CD16, CD11b and CD36. Results qCO individuals showed higher plasma levels of leptin and higher inflammatory pattern of monocytes compared with non-CO. PBMC expression of DR D2, DRD4 and DR D5 as well as of TH were lower in CO in comparison with non-CO. DR D2, and DR D5 expression correlated with lower WC and weight, and with lower inflammatory pattern of monocytes, and TH expression correlated with lower WC. DR D-4 expression correlated with lower plasma levels of glycosylated hemoglobin, and DR D-2 expression correlated with lower CO. Conclusions Results show that CO is associated with peripheral inflammation and downregulation of dopaminergic pathways in PBMCs, possibly suggesting DR expressed on immune cells as pharmacological targets in obesity for better metabolic outcome.	[Leite, Fernanda; Ribeiro, Laura] Univ Porto, Fac Med, Dept Biochem, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Leite, Fernanda; Lima, Margarida] Ctr Hosp Porto, Dept Clin Haematol, Oporto, Portugal; [Leite, Fernanda; Lima, Margarida] Univ Porto, UMIB, ICBAS, Unit Multidisciplinary Res Biomed,Abel Salazar In, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Marino, Franca; Cosentino, Marco] Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy; [Ribeiro, Laura] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Ribeiro, Laura] Univ Porto, Dept Med Educ & Simulat, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Insubria; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Ribeiro, L (corresponding author), Univ Porto, Fac Med, Dept Biochem, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Ribeiro, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Ribeiro, L (corresponding author), Univ Porto, Dept Med Educ & Simulat, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lribeiro@med.up.pt	Leite, Fernanda/AAY-7771-2021; Leite, Fernanda/K-1470-2015; Cosentino, Marco/A-3848-2010; Leite, Fernanda/N-6357-2019; Lima, Margarida/S-7466-2016	Leite, Fernanda/0000-0002-7930-6066; Cosentino, Marco/0000-0002-6978-7775; Leite, Fernanda/0000-0002-7930-6066; Lima, Margarida/0000-0001-9702-5260; Ribeiro, Laura/0000-0003-1181-9217; Reis, AlessanRSS/0000-0001-8486-7469	FCT [UID/BIM/04293/2013, Pest-OE/SAU/UI0215/2014]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT funding UID/BIM/04293/2013-Instituto de Investigacao e Inovacao em Saude (I3S), University of Porto, Porto, Portugal and Pest-OE/SAU/UI0215/2014-Unidade Multidisciplinar de Investigacao Biomedica-UMIB/ICBAS/UP.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Baik JH, 2013, BMB REP, V46, P519, DOI 10.5483/BMBRep.2013.46.11.207; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Blum K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00919; Carlin J, 2013, OBESITY, V21, P2513, DOI 10.1002/oby.20374; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cosentino M, 2014, J NEUROIMMUNOL, V277, P193, DOI 10.1016/j.jneuroim.2014.10.009; Cosentino M, 2013, J NEUROIMMUNE PHARM, V8, P163, DOI 10.1007/s11481-012-9410-z; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Giorelli M, 2005, J INTERF CYTOK RES, V25, P395, DOI 10.1089/jir.2005.25.395; Jafari M, 2013, IMMUNOBIOLOGY, V218, P979, DOI 10.1016/j.imbio.2012.11.002; Jiang XL, 2014, HYPERTENSION, V63, pE74, DOI 10.1161/HYPERTENSIONAHA.113.02569; Kaczmarczyk MM, 2013, PSYCHONEUROENDOCRINO, V38, P1553, DOI 10.1016/j.psyneuen.2013.01.004; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kenny PJ, 2013, CURR OPIN NEUROBIOL, V23, P535, DOI 10.1016/j.conb.2013.04.012; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Levite M, 2012, NERVE-DRIVEN IMMUNITY: NEUROTRANSMITTERS AND NEUROPEPTIDES IN THE IMMUNE SYSTEM, P1, DOI 10.1007/978-3-7091-0888-8_1; Lima M, 2004, AM J PATHOL, V165, P1117, DOI 10.1016/S0002-9440(10)63373-1; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; McMurray RW, 2001, SEMIN ARTHRITIS RHEU, V31, P21, DOI 10.1053/sarh.2001.25482; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Mobini M, 2011, IRAN RED CRESCENT ME, V13, P749; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Perez-Cornago A, 2014, PSYCHONEUROENDOCRINO, V47, P98, DOI 10.1016/j.psyneuen.2014.05.003; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vincent S, 2004, CIRCULATION, V109, P3202, DOI 10.1161/01.CIR.0000130847.18666.39; Visvikis-Siest S, 2007, CLIN CHEM LAB MED, V45, P1154, DOI 10.1515/CCLM.2007.255; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yu CQ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-97; Zaffaroni M, 2008, EXP NEUROL, V214, P315, DOI 10.1016/j.expneurol.2008.08.015	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147483	10.1371/journal.pone.0147483	http://dx.doi.org/10.1371/journal.pone.0147483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808524	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800106
J	Liu, SF; Zhao, T; Song, BB; Zhou, JH; Wang, TT				Liu, Shufeng; Zhao, Ting; Song, BenBen; Zhou, Jianhua; Wang, Tony T.			Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 4B; TRANSMEMBRANE DOMAIN; ENTRY; GLYCOPROTEIN; REPLICATION; BINDING; NS4B; GLYCANS; CD81	Hepatitis C virus (HCV) poses a global threat to public health. HCV envelop protein E2 is the major component on the virus envelope, which plays an important role in virus entry and morphogenesis. Here, for the first time, we affinity purified E2 complex formed in HCV-infected human hepatoma cells and conducted comparative mass spectrometric analyses. 85 cellular proteins and three viral proteins were successfully identified in three independent trials, among which alphafetoprotein (AFP), UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) and HCV NS4B were further validated as novel E2 binding partners. Subsequent functional characterization demonstrated that gene silencing of UGT1 in human hepatoma cell line Huh7.5.1 markedly decreased the production of infectious HCV, indicating a regulatory role of UGT1 in viral lifecycle. Domain mapping experiments showed that HCV E2-NS4B interaction requires the transmembrane domains of the two proteins. Altogether, our proteomics study has uncovered key viral and cellular factors that interact with E2 and provided new insights into our understanding of HCV infection.	[Liu, Shufeng; Wang, Tony T.] SRI Int, Ctr Immunol & Infect Dis, Biosci Div, Harrisonburg, VA 22802 USA; [Zhao, Ting] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA; [Song, BenBen] Pall Corp, SLS Global Tech Support, Port Washington, NY 11050 USA; [Zhou, Jianhua] Univ Pittsburgh, Sch Med, Dept Neurol, Med Ctr, Pittsburgh, PA 15261 USA	SRI International; University of Michigan System; University of Michigan; Pall Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, TT (corresponding author), SRI Int, Ctr Immunol & Infect Dis, Biosci Div, Harrisonburg, VA 22802 USA.	tony.wang@sri.com			National Institute of Diabetes and Digestive and Kidney Diseases [NIH R01DK088787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088787] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIH R01DK088787 grant to TW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Douam F, 2014, HEPATOLOGY, V59, P776, DOI 10.1002/hep.26733; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2004, J VIROL, V78, P11288, DOI 10.1128/JVI.78.20.11288-11295.2004; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gouttenoire J, 2010, REV MED VIROL, V20, P117, DOI 10.1002/rmv.640; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kontorinis Nickolas, 2004, Rev Gastroenterol Disord, V4 Suppl 1, pS39; Lin C, 1997, J VIROL, V71, P6465, DOI 10.1128/JVI.71.9.6465-6471.1997; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2015, EBIOMEDICINE, V2, P1600, DOI 10.1016/j.ebiom.2015.09.018; Liu SF, 2010, VIROLOGY, V407, P160, DOI 10.1016/j.virol.2010.08.009; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Paredes AM, 2008, J VIROL, V82, P10671, DOI 10.1128/JVI.00875-08; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welsch C, 2007, J MOL GRAPH MODEL, V26, P546, DOI 10.1016/j.jmgm.2007.03.012; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147991	10.1371/journal.pone.0147991	http://dx.doi.org/10.1371/journal.pone.0147991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808496	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000369527800259
J	Ma, B; Chen, ZM; Xu, JK; Wang, YN; Chen, KY; Ke, FY; Niu, JQ; Li, L; Huang, CB; Zheng, JX; Yang, JH; Zhu, QG; Wang, YP				Ma, Bin; Chen, Zhi-min; Xu, Jia-ke; Wang, Ya-nan; Chen, Kuang-yang; Ke, Fa-yong; Niu, Jun-qiang; Li, Li; Huang, Cheng-ben; Zheng, Jian-xun; Yang, Jia-hui; Zhu, Qian-ge; Wang, Ya-ping			Do the CONSORT and STRICTA Checklists Improve the Reporting Quality of Acupuncture and Moxibustion Randomized Controlled Trials Published in Chinese Journals? A Systematic Review and Analysis of Trends	PLOS ONE			English	Article							CLINICAL-TRIALS; STATEMENT; COMMITTEE	Background We investigated whether there had been an improvement in the quality of reporting for randomised controlled trials of acupuncture and moxibustion published in Chinese journals. We compared the compliance rate for the quality of reporting following the publication of both the STRICTA and CONSORT recommendations in China. Methods Four Chinese databases were searched for RCTs of acupuncture from January 1978 through to December 2012. The CONSORT and STRICTA checklists were used to assess the quality of reporting. Data were collected using a standardised form. All included RCTs were divided into three distinct time periods based on the time that CONSORT and STRICTA were introduced in China, respectively. Pearson's chi(2) test and/or Fisher's exact test were used to assess differences in reporting among three groups. Principal Findings A total of 1978 RCTs were identified. Although the percentage of all the items has increased over time with the introduction of CONSORT and STRICTA in China, the actual compliance in several important methodological components, including sample size calculation (0% vs. 0% vs. 1.2%, for pre-CONSORT and pre-STRICTA, post-CONSORT but pre-STRICTA, and post-CONSORT and post-STRICTA, respectively), randomisation sequence generation (1.4% vs. 15% vs. 26.3%) and implementation (0% vs. 0% vs. 1.3%), allocation concealment (0% vs. 1.4% vs. 4.9%), and blinding (0% vs. 5.7% vs. 9.1%), remains low. Moreover, no RCTs have reported the setting and context of treatment and no descriptions of the participating acupuncturists have been provided thus far. Conclusions Overall, the quality of the reporting of RCTs of acupuncture and moxibustion published in Chinese journals has improved since CONSORT and STRICTA were introduced in China, though the actual compliance rate of some important items were still low as of 2012. In the future, Chinese journals should enhance the adoption of the CONSORT and STRICTA statement to improve the reporting quality of the RCTs of acupuncture and moxibustion and to ensure the truth and reliability of the conclusions.	[Ma, Bin; Chen, Zhi-min; Xu, Jia-ke; Wang, Ya-nan; Chen, Kuang-yang; Ke, Fa-yong; Huang, Cheng-ben; Zheng, Jian-xun; Yang, Jia-hui; Zhu, Qian-ge; Wang, Ya-ping] Lanzhou Univ, Sch Basic Med Sci, Inst Tradit Chinese & Western Med, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China; [Niu, Jun-qiang] Lanzhou Univ, Hosp 1, Tradit Chinese Med Ache Dept, Lanzhou 730000, Gansu, Peoples R China; [Li, Li] Lanzhou Univ, Hosp 1, Intervent Latrol Dept, Lanzhou 730000, Gansu, Peoples R China; [Ma, Bin] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Ma, B (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Tradit Chinese & Western Med, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China.; Ma, B (corresponding author), Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Gansu, Peoples R China.	kitty_mab@163.com	Li, LILUNlilun871116@/R-8202-2019	Wang, Yanan/0000-0002-3089-9462	National Natural Science Foundation of China [81303147]; Fundamental Research Funds for the Central Universities [lzujbky-2014-138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (Grant No. 81303147), http://npd.nsfc.gov.cn/ fundingProjectSearchAction!search.action; and by the Fundamental Research Funds for the Central Universities (Number: lzujbky-2014-138), http://news.lzu.edu.cn/FHup/files/201404/04-17_170202-9.xls. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JOINT STATEMENT ESTA; Begg C, 1997, JAMA-J AM MED ASSOC, V16, P189; BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204; Claraco AE, 2003, J ALTERN COMPLEM MED, V9, P151, DOI 10.1089/107555303321223026; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Geng Ling-Ling, 2008, Zhongguo Zhen Jiu, V28, P439; Hiroshi Tsukayama, 2002, CLIN ACUPUNCT ORIENT, V3, P105; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030683; Liu Xue-mei, 2004, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V26, P192; [刘雪梅 Liu Xuemei], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P699; Ma B, 2012, CONTEMP CLIN TRIALS, V33, P889, DOI 10.1016/j.cct.2012.06.008; [毛兵 Mao Bing], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P297; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Prady SL, 2007, J ALTERN COMPLEM MED, V13, P939, DOI 10.1089/acm.2007.7186; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Qian Yi-sheng, 1987, SHANGHAI J ACUPUNCTU, V3, P27; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Xiao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016922; Yank V, 2002, JAMA-J AM MED ASSOC, V287, P2835, DOI 10.1001/jama.287.21.2835; Ye Cheng-gu, 1989, ZHEN JIU ZA ZHI, V4, P41; Zhu Huan, 2008, SHANGHAI ZHENJIU ZAZ, V27, P42	23	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147244	10.1371/journal.pone.0147244	http://dx.doi.org/10.1371/journal.pone.0147244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808550	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800066
J	Nash, EE; Peters, BM; Lilly, EA; Noverr, MC; Fidel, PL				Nash, Evelyn E.; Peters, Brian M.; Lilly, Elizabeth A.; Noverr, Mairi C.; Fidel, Paul L., Jr.			A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response	PLOS ONE			English	Article							VULVO-VAGINAL CANDIDIASIS; IN-VITRO; BIOFILM FORMATION; ALBICANS; COLONIZATION; EPIDEMIOLOGY; PATHOGENESIS; SUSCEPTIBILITY; INFECTIONS; EPITHELIUM	Candida glabrata is the second most common organism isolated from women with vulvovaginal candidiasis (VVC), particularly in women with uncontrolled diabetes mellitus. However, mechanisms involved in the pathogenesis of C. glabrata-associated VVC are unknown and have not been studied at any depth in animal models. The objective of this study was to evaluate host responses to infection following efforts to optimize a murine model of C. glabrata VVC. For this, various designs were evaluated for consistent experimental vaginal colonization (i.e., type 1 and type 2 diabetic mice, exogenous estrogen, varying inocula, and co-infection with C. albicans). Upon model optimization, vaginal fungal burden and polymorphonuclear neutrophil (PMN) recruitment were assessed longitudinally over 21 days post-inoculation, together with vaginal concentrations of IL-1 beta, S100A8 alarmin, lactate dehydrogenase (LDH), and in vivo biofilm formation. Consistent and sustained vaginal colonization with C. glabrata was achieved in estrogenized streptozotocin-induced type 1 diabetic mice. Vaginal PMN infiltration was consistently low, with IL-1 beta, S100A8, and LDH concentrations similar to uninoculated mice. Biofilm formation was not detected in vivo, and co-infection with C. albicans did not induce synergistic immunopathogenic effects. This data suggests that experimental vaginal colonization of C. glabrata is not associated with an inflammatory immunopathogenic response or biofilm formation.	[Nash, Evelyn E.; Noverr, Mairi C.; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, Sch Med, New Orleans, LA USA; [Peters, Brian M.; Lilly, Elizabeth A.; Noverr, Mairi C.; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, Sch Dent, New Orleans, LA USA; [Noverr, Mairi C.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Prosthodont, New Orleans, LA USA; [Nash, Evelyn E.] Ctr Dis Control, Div STD Prevent, Atlanta, GA 30333 USA; [Peters, Brian M.] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Centers for Disease Control & Prevention - USA; University of Tennessee System; University of Tennessee Health Science Center	Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, Sch Med, New Orleans, LA USA.; Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, Sch Dent, New Orleans, LA USA.	pfidel@lsuhsc.edu		Noverr, Mairi/0000-0002-8812-1450	Louisiana State University Health Sciences Center (LSUHSC) Foundation	Louisiana State University Health Sciences Center (LSUHSC) Foundation	This work was supported by the Louisiana State University Health Sciences Center (LSUHSC) Foundation (www.lsuhealthfoundation.org) (P.L.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CT, 2014, J INFECTION, V69, P396, DOI 10.1016/j.jinf.2014.06.002; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Black CA, 1999, LAB ANIM SCI, V49, P668; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Corsello S, 2003, EUR J OBSTET GYN R B, V110, P66, DOI 10.1016/S0301-2115(03)00096-4; de Leon EM, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-1; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; FIDEL PL, 1995, INFECT IMMUN, V63, P4191, DOI 10.1128/IAI.63.10.4191-4194.1995; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; Gonzalez GM, 2011, MYCOSES, V54, P119, DOI 10.1111/j.1439-0507.2009.01775.x; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Holland J, 2003, SEX TRANSM INFECT, V79, P249, DOI 10.1136/sti.79.3.249; Kasper L, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov042; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; LEVISON ME, 1987, J INFECT DIS, V155, P841, DOI 10.1093/infdis/155.5.841; LYNCH ME, 1994, J MED VET MYCOL, V32, P267; Mahmoudi Rad Mahnaz, 2012, Infect Dis Obstet Gynecol, V2012, P872169, DOI 10.1155/2012/872169; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nyirjesy P, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2650; Peters BM, 2014, INFECT IMMUN, V82, P532, DOI 10.1128/IAI.01417-13; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Richter SS, 2005, J CLIN MICROBIOL, V43, P2155, DOI 10.1128/JCM.43.5.2155-2162.2005; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Seneviratne CJ, 2009, ARCH ORAL BIOL, V54, P1052, DOI 10.1016/j.archoralbio.2009.08.002; Silva S, 2011, J ORAL PATHOL MED, V40, P421, DOI 10.1111/j.1600-0714.2010.00981.x; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924, DOI 10.1016/S0002-9378(85)80003-X; SOBEL JD, 1992, CLIN INFECT DIS, V14, pS148, DOI 10.1093/clinids/14.Supplement_1.S148; Sweet RL, 2009, INFECT DIS FEMALE GE, P199; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10	41	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147969	10.1371/journal.pone.0147969	http://dx.doi.org/10.1371/journal.pone.0147969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807975	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800255
J	Real, FG; Barrionuevo, LP; Franklin, K; Bertelsen, RJ; Benediktsdottir, B; Forsberg, B; Gislason, T; Jogi, R; Johannessen, A; Omenaas, E; Saure, E; Schlunssen, V; Skorge, TD; Toren, K; Saavedra, AP; Svanes, O; Astrom, AN; Janson, C; Svanes, C				Real, Francisco Gomez; Barrionuevo, Laura Perez; Franklin, Karl; Bertelsen, Randi Jacobsen; Benediktsdottir, Bryndis; Forsberg, Bertil; Gislason, Thorarinn; Jogi, Rain; Johannessen, Ane; Omenaas, Ernst; Saure, Eirunn; Schlunssen, Vivi; Skorge, Trude Duelien; Toren, Kjell; Perez Saavedra, Antonio; Svanes, Oistein; Astrom, Anne Nordrehaug; Janson, Christer; Svanes, Cecilie			The Association of Gum Bleeding with Respiratory Health in a Population Based Study from Northern Europe	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PERIODONTAL-DISEASE; ORAL-HEALTH; GASTROESOPHAGEAL-REFLUX; ALZHEIMERS-DISEASE; AIRWAY-OBSTRUCTION; SALIVARY FLOW; ASTHMA; PATHOGENS; CARIES	Background There is little knowledge about how oral and respiratory health is interrelated even though the mucosa of the oral cavity and airways constitutes a continuum and the exposures to these are partly similar. Aims To investigate whether gum bleeding is related to asthma, respiratory symptoms and self-reported COPD. Methods A postal questionnaire including questions about respiratory and oral health was sent to general population samples in seven Northern European centres. In 13,409 responders, gum bleeding when brushing teeth was reported always/often by 4% and sometimes by 20%. Logistic regressions accounted for age, smoking, educational level, centre and gender. Effects of BMI, cardio-metabolic diseases, early life factors, gastro-oesophageal reflux, dental hygiene, nasal congestion, and asthma medication were addressed. Results Gum bleeding always/often was significantly associated with >= 3 asthma symptoms (OR 2.58, 95% CI 2.10-3.18), asthma (1.62 [1.23-2.14]) and self-reported COPD (2.02 [1.283.18]). There was a dose-response relationship between respiratory outcomes and gum bleeding frequency (>= 3 symptoms: gum bleeding sometimes 1.42 [1.25-1.60], often/always 2.58 [2.10-3.18]), and there was no heterogeneity between centres (p(heterogeneity) = 0.49). None of the investigated risk factors explained the associations. The observed associations were significantly stronger among current smokers (p(interaction) = 0.004). Conclusions A consistent link between gum bleeding and obstructive airways disease was observed, not explained by common risk factors or metabolic factors. We speculate that oral pathogens might have unfavourable impact on the airways, and that the direct continuity of the mucosa of the oral cavity and the airways reflects a pathway that might provide novel opportunities for interventions.	[Real, Francisco Gomez; Barrionuevo, Laura Perez; Bertelsen, Randi Jacobsen; Johannessen, Ane; Saure, Eirunn; Skorge, Trude Duelien; Svanes, Oistein; Svanes, Cecilie] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Real, Francisco Gomez] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Franklin, Karl] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Bertelsen, Randi Jacobsen; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Benediktsdottir, Bryndis; Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jogi, Rain] Tartu Univ Clin, Lung Clin, Tartu, Estonia; [Johannessen, Ane; Omenaas, Ernst] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Perez Saavedra, Antonio] Clin Dent Perez Saveedra, Malaga, Spain; [Svanes, Oistein; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway; [Astrom, Anne Nordrehaug] Univ Bergen, Dept Clin Dent, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Umea University; University of Iceland; Umea University; University of Tartu; University of Bergen; Haukeland University Hospital; Aarhus University; Sahlgrenska University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Real, FG (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Real, FG (corresponding author), Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway.	francisco.real@uib.no	Bertelsen, Randi J/N-6917-2017; Svanes, Cecilie/N-7556-2017	Bertelsen, Randi J/0000-0001-5319-525X; Svanes, Cecilie/0000-0001-8512-5192; Johannessen, Ane/0000-0003-3269-8354; Franklin, Karl/0000-0002-5306-1697; Gomez Real, Francisco/0000-0001-5407-3270; Schlunssen, Vivi/0000-0003-4915-1734	Norwegian Research Council [214123]; Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities [911 892, 911 631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council, Landspitali University; Estonian Science Foundation [4350]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Bergen Medical Research Foundation; Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Faculty of Health of Aarhus University; Wood Dust Foundation; Danish Lung Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Swedish Asthma and Allergy Association; Icelandic Research Council, Landspitali University; Estonian Science Foundation	The RHINE III was supported financially by the Norwegian Research Council (Grant No. 214123), the Bergen Medical Research Foundation, the Western Norwegian Regional Health Authorities (Grant No. 911 892 and 911 631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Faculty of Health of Aarhus University, (Project No. 240008), The Wood Dust Foundation (Project No. 444508795), the Danish Lung Association, the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Swedish Asthma and Allergy Association, the Icelandic Research Council, Landspitali University Hospital Research Fund, and the Estonian Science Foundation (Grant No. 4350). None of the study sponsors/funders had any role on study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had full responsibility for the decision to submit for publication.	AINAMO J, 1982, INT DENT J, V32, P281; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bagaitkar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027386; Bagaitkar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009323; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; D'Aiuto F, 2005, Int J Immunopathol Pharmacol, V18, P1; Dasanayake Ananda P, 2009, J Evid Based Dent Pract, V9, P21, DOI 10.1016/j.jebdp.2008.12.010; Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ercan E, 2013, ACTA ODONTOL SCAND, V71, P553, DOI 10.3109/00016357.2012.697576; Ersin NK, 2006, PEDIATR INT, V48, P549, DOI 10.1111/j.1442-200X.2006.02281.x; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; GREENSTEIN G, 1984, J PERIODONTOL, V55, P684, DOI 10.1902/jop.1984.55.12.684; Gunnbjomsdottir MI, 2004, EUR RESPIR J, V24, P116, DOI 10.1183/09031936.04.00042603; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; HYYPPA T, 1984, J CLIN PERIODONTOL, V11, P132, DOI 10.1111/j.1600-051X.1984.tb00841.x; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Laurikainen K, 1998, ALLERGY, V53, P316, DOI 10.1111/j.1398-9995.1998.tb03894.x; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Lindenmeyer A, 2013, FAM PRACT, V30, P113, DOI 10.1093/fampra/cms034; Lintula T, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-155; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; Petersen PE, 2013, ORAL HLTH SURVEYS BA, V5th; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Rath SK, 2014, INDIAN J PATHOL MICR, V57, P259, DOI 10.4103/0377-4929.134704; Santos NC, 2012, ALLERGOL IMMUNOPATH, V40, P220, DOI 10.1016/j.aller.2011.04.005; Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50; Si Y, 2012, J PERIODONTOL, V83, P1288, DOI 10.1902/jop.2012.110472; Song JY, 2014, GUT LIVER, V8, P35, DOI 10.5009/gnl.2014.8.1.35; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Stensson M, 2010, CARIES RES, V44, P540, DOI 10.1159/000321566; Stensson M, 2011, ACTA ODONTOL SCAND, V69, P158, DOI 10.3109/00016357.2010.547516; Straka M, 2012, NEUROENDOCRINOL LETT, V33, P16; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; Uppoor AS, 2013, GERODONTOLOGY, V30, P239, DOI 10.1111/j.1741-2358.2012.00660.x; Vargas MH, 2015, J ASTHMA, V52, P376, DOI 10.3109/02770903.2014.974816; Warburton David, 2006, Proc Am Thorac Soc, V3, P668, DOI 10.1513/pats.200605-122SF; Zeller I, 2014, J PERIODONTOL, V85, P837, DOI 10.1902/jop.2013.130336; Zhang LL, 2014, WIEN KLIN WOCHENSCHR, V126, P515, DOI 10.1007/s00508-014-0568-7; Zhou X, 2014, J CLIN PERIODONTOL, V41, P564, DOI 10.1111/jcpe.12247	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147518	10.1371/journal.pone.0147518	http://dx.doi.org/10.1371/journal.pone.0147518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808490	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800119
J	Sun, SL; Fu, HN; Wang, ZY; Duan, CX; Zong, XX; Zhu, ZD				Sun, Suli; Fu, Haining; Wang, Zhongyi; Duan, Canxing; Zong, Xuxiao; Zhu, Zhendong			Discovery of a Novel er1 Allele Conferring Powdery Mildew Resistance in Chinese Pea (Pisum sativum L.) Landraces	PLOS ONE			English	Article							ERYSIPHE-PISI; SCAR MARKERS; GENE; IDENTIFICATION; POLYMORPHISM; RAPD; TRIFOLII; ER-1; MAP; DC	Pea powdery mildew, caused by Erysiphe pisi D.C., is an important disease worldwide. Deployment of resistant varieties is the main way to control this disease. This study aimed to screen Chinese pea (Pisum sativum L.) landraces resistant to E. pisi, and to characterize the resistance gene(s) at the er1 locus in the resistant landraces, and to develop functional marker(s) specific to the novel er1 allele. The 322 landraces showed different resistance levels. Among them, 12 (3.73%), 4 (1.24%) and 17 (5.28%) landraces showed immunity, high resistance and resistance to E. pisi, respectively. The other landraces appeared susceptible or highly susceptible to E. pisi. Most of the immune and highly resistant landraces were collected from Yunnan province. To characterize the resistance gene at the er1 locus, cDNA sequences of PsMLO1 gene were determined in 12 immune and four highly resistant accessions. The cDNAs of PsMLO1 from the immune landrace G0005576 produced three distinct transcripts, characterized by a 129-bp deletion, and 155-bp and 220-bp insertions, which were consistent with those of er1-2 allele. The PsMLO1 cDNAs in the other 15 resistant landraces produced identical transcripts, which had a new point mutation (T -> C) at position 1121 of PsMLO1, indicating a novel er1 allele, designated as er1-6. This mutation caused a leucine to proline change in the amino acid sequence. Subsequently, the resistance allele er1-6 in landrace G0001778 was confirmed by resistance inheritance analysis and genetic mapping on the region of the er1 locus using populations derived from G0001778 x Bawan 6. Finally, a functional marker specific to er1-6, SNP1121, was developed using the high-resolution melting technique, which could be used in pea breeding via marker-assisted selection. The results described here provide valuable genetic information for Chinese pea landraces and a powerful tool for pea breeders.	[Sun, Suli; Fu, Haining; Wang, Zhongyi; Duan, Canxing; Zong, Xuxiao; Zhu, Zhendong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhu, ZD (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	zhuzhendong@caas.cn			Modern Agro-industry Technology Research System (CARS-09); Crop Germplasm Conservation and Utilization Program from the Ministry of Agriculture of China [2014NWB030-14]; Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS); Public Welfare Special Fund from the Institute of Crop Science, CAAS [610092015002-01]	Modern Agro-industry Technology Research System (CARS-09); Crop Germplasm Conservation and Utilization Program from the Ministry of Agriculture of China; Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS); Public Welfare Special Fund from the Institute of Crop Science, CAAS	This research was supported by the Modern Agro-industry Technology Research System (CARS-09), the Crop Germplasm Conservation and Utilization Program (2014NWB030-14) from the Ministry of Agriculture of China, the Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS), and the Public Welfare Special Fund (1610092015002-01) from the Institute of Crop Science, CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Modern Agro-industry Technology Research System (CARS-09), the Crop Germplasm Conservation and Utilization Program (2014NWB030-14) from the Ministry of Agriculture of China, the Agricultural Science and Technology Program for Innovation Team from Chinese Academy of Agricultural Sciences (CAAS), and the Public Welfare Special Fund (1610092015002-01) from the Institute of Crop Science, CAAS.	Attanayake RN, 2010, PLANT PATHOL, V59, P712, DOI 10.1111/j.1365-3059.2010.02306.x; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; [程建刚 CHENG Jiangang], 2009, [地理科学进展, Progress in Geography], V28, P18; COUSIN R, 1965, ANN AMELIOR PLANT, V15, P93; DIRLEWANGER E, 1994, THEOR APPL GENET, V88, P17, DOI 10.1007/BF00222388; Ek M, 2005, HEREDITAS, V142, P86, DOI 10.1111/j.1601-5223.2005.01906.x; Fondevilla S, 2008, MOL BREEDING, V22, P193, DOI 10.1007/s11032-008-9166-6; Fondevilla S, 2007, PLANT BREEDING, V126, P113, DOI 10.1111/j.1439-0523.2006.01312.x; Fondevilla S, 2006, EUR J PLANT PATHOL, V115, P309, DOI 10.1007/s10658-006-9015-6; Fondevilla S, 2013, EUR J PLANT PATHOL, V136, P557, DOI 10.1007/s10658-013-0187-6; Fondevilla S, 2011, PLANT BREEDING, V130, P281, DOI 10.1111/j.1439-0523.2010.01769.x; Fondevilla S, 2007, BREEDING SCI, V57, P181, DOI 10.1270/jsbbs.57.181; Fondevilla S, 2012, AGRON SUSTAIN DEV, V32, P401, DOI 10.1007/s13593-011-0033-1; [付海宁 Fu Haining], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P1028; Ghafoor A, 2012, EUPHYTICA, V186, P593, DOI 10.1007/s10681-011-0596-6; GRITTON ET, 1975, J AM SOC HORTIC SCI, V100, P137; HARLAND SC, 1948, HEREDITY, V2, P263, DOI 10.1038/hdy.1948.15; HERINGA RJ, 1969, EUPHYTICA, V18, P163, DOI 10.1007/BF00035687; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Huo ZG, 2001, ACTA ECOLOGICA SINIC, V22, P1873; Janila P, 2004, PLANT BREEDING, V123, P271, DOI 10.1111/j.1439-0523.2004.00963.x; Katoch V, 2010, MOL BREEDING, V25, P229, DOI 10.1007/s11032-009-9322-7; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kristensen LS, 2008, CANCER EPIDEM BIOMAR, V17, P1240, DOI 10.1158/1055-9965.EPI-07-2531; LANDER ES, 1993, CONSTRUCTING GENETIC; Lang LJ, 1988, WORLD CROPS COOL SEA, P1135; Lehmensiek A, 2008, THEOR APPL GENET, V117, P721, DOI 10.1007/s00122-008-0813-4; Li L, 2013, GENET RESOUR CROP EV, V60, P1801, DOI 10.1007/s10722-013-9955-6; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SM, 2003, AUST J EXP AGR, V43, P373, DOI 10.1071/EA01142; Loridon K, 2005, THEOR APPL GENET, V111, P1022, DOI 10.1007/s00122-005-0014-3; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Munjal R.L., 1963, INDIAN PHYTOPATHO, V19, P260; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; Ondrej Michal, 2006, Plant Protection Science, V42, P95; Pavan S, 2013, MOL BREEDING, V31, P247, DOI 10.1007/s11032-012-9781-0; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Peng H.X., 1991, J SW AGR U, V13, P384; Pereira G, 2010, EUPHYTICA, V171, P327, DOI 10.1007/s10681-009-0003-8; Rana JC, 2013, EUPHYTICA, V189, P271, DOI 10.1007/s10681-012-0798-6; RUBIALES D, 1993, EUPHYTICA, V67, P215, DOI 10.1007/BF00040623; Santo T, 2013, MOL BREEDING, V32, P723, DOI 10.1007/s11032-013-9889-x; SARALA K., 1993, THESIS INDIAN AGR RE; Sharma B., 2003, Pisum Genetics, V35, P22; Sharma B., 2003, Pisum Genetics, V35, P30; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Smith PH, 1996, PLANT PATHOL, V45, P302, DOI 10.1046/j.1365-3059.1996.d01-111.x; Srivastava RK, 2012, EUPHYTICA, V186, P855, DOI 10.1007/s10681-012-0650-z; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; Sun S, 2015, CROP J, V3, P489, DOI 10.1016/j.cj.2015.07.006; TIMMERMAN GM, 1994, THEOR APPL GENET, V88, P1050, DOI 10.1007/BF00220815; Tiwari KR, 1997, CAN J PLANT SCI, V77, P307, DOI 10.4141/P96-157; Tiwari KR, 1998, GENOME, V41, P440, DOI 10.1139/gen-41-3-440; Tonguc M., 2010, J PLANT MOL BIOL BIO, V1, P1; Vaid A, 1997, EUPHYTICA, V96, P203, DOI 10.1023/A:1002953129003; Wang X., 2007, IDENTIFICATION CONTR; Wang ZhongYi, 2015, Acta Agronomica Sinica, V41, P515; Wang ZhongYi, 2013, Acta Agronomica Sinica, V39, P1030, DOI 10.3724/SP.J.1006.2013.01030; Warkentin TD, 1996, CAN J PLANT SCI, V76, P933, DOI 10.4141/cjps96-156; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8; Zeng L., 2012, GRASS TURF, V32, P35; Zong XuXiao, 2008, Acta Agronomica Sinica, V34, P1330, DOI 10.1016/S1875-2780(08)60045-0	62	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147624	10.1371/journal.pone.0147624	http://dx.doi.org/10.1371/journal.pone.0147624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809053	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800153
J	Zhao, Q; Wen, YJ; Jiang, Y; Zhang, C; Li, Y; Zhang, GY; Zhang, L; Qiu, MF				Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Chen; Li, Yang; Zhang, Guiyun; Zhang, Lei; Qiu, Maofeng			Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; RISK; UNIT; HIV	We investigated potential patient-to-patient transmission of hepatitis C virus (HCV) in two hemodialysis centers in Beijing, China. Approximately 8.25%(32/388) hemodialysis patients were HCV antibody positive, and 4.90% (19/388) were HCV RNA-positive, which consisted of 2a genotype (1/19) and 1b genotypes (18/19). Using next generation sequencing (NGS) approach, MiSeq platform, we sequenced HCV, targeting hypervariable region 1 (263 base-pairs) of genotype 1b specimens and obtained 18 to 243 unique HCV variants. Analysis of phylogenetic tree, viral epidemiology signature pattern (VESP) and Shannon entropy indicated no obvious HCV similarity for most HCV infections but limited HCV variants from Patient 31 (P31) were closer with respect to evolutionary relationship with Patient 24 (P24). However, it was unlikely that HCV was transmitted directly from P24 to P31 in the hemodialysis center. Otherwise, their genetic distance (3.92%-8.92%), would have been much less. Moreover, P31 was infected less than two years before specimen collection, and other external high risk factors existed for these two patients. Thus, our data indicated no evidence of patient-to-patient transmission of HCV in the two hemodialysis centers, suggesting that current HCV infection control measures are effective.	[Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Guiyun; Qiu, Maofeng] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl AIDS Reference Lab, Beijing, Peoples R China; [Zhang, Chen; Li, Yang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Lei] Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China; [Zhang, Lei] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Zhang, Lei] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tsinghua University; Monash University	Qiu, MF (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl AIDS Reference Lab, Beijing, Peoples R China.; Zhang, L (corresponding author), Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China.; Zhang, L (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Zhang, L (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	lzhang20@mail.tsinghua.edu.cn; qiumaofeng@hotmail.com	Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X; li, yang/0000-0001-8771-7044	National Funding for Hepatitis C Virus Control and Prevention	National Funding for Hepatitis C Virus Control and Prevention	This work was supported by the National Funding for Hepatitis C Virus Control and Prevention 2015.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P189; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Campo DS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S5-S4; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Escobar-Gutierrez A, 2012, J CLIN MICROBIOL, V50, P1461, DOI 10.1128/JCM.00005-12; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; Girou E, 2008, CLIN INFECT DIS, V47, P627, DOI 10.1086/590564; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Nan R, 2011, ZHONGGUO GAN RAN KON, V10, P412; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Ross RS, 2009, J MED VIROL, V81, P249, DOI 10.1002/jmv.21394; Saludes V, 2013, J CLIN VIROL, V57, P263, DOI 10.1016/j.jcv.2013.03.007; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Su YY, 2013, J MED VIROL, V85, P425, DOI 10.1002/jmv.23486; Toda T, 2009, J MED VIROL, V81, P1363, DOI 10.1002/jmv.21537	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147566	10.1371/journal.pone.0147566	http://dx.doi.org/10.1371/journal.pone.0147566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808659	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800136
J	Hosohama-Saito, K; Kokubu, E; Okamoto-Shibayama, K; Kita, D; Katakura, A; Ishihara, K				Hosohama-Saito, Kyoko; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Kita, Daichi; Katakura, Akira; Ishihara, Kazuyuki			Involvement of luxS in Biofilm Formation by Capnocytophaga ochracea	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; AGGRESSIVE PERIODONTITIS; VIBRIO-HARVEYI; BACTERIA; AUTOINDUCER-2; LUMINESCENCE; EXPRESSION; INDUCTION; PROTEIN; MATRIX	Capnocytophaga ochracea is present in the dental plaque biofilm of patients with periodontitis. Biofilm cells change their phenotype through quorum sensing in response to fluctuations in cell-population density. Quorum sensing is mediated by auto-inducers (AIs). AI-2 is involved in intercellular signaling, and production of its distant precursor is catalyzed by LuxS, an enzyme involved in the activated methyl cycle. Our aim was to clarify the role of LuxS in biofilm formation by C. ochracea. Two luxS-deficient mutants, TmAI2 and LKT7, were constructed from C. ochracea ATCC 27872 by homologous recombination. The mutants produced significantly less AI-2 than the wild type. The growth rates of these mutants were similar to that of the wild-type in both undiluted Tryptic soy broth and 0.5 x Tryptic soy broth. However, according to crystal violet staining, they produced significantly less biofilm than the wild type. Confocal laser scanning microscopy and scanning electron microscopy showed that the biofilm of the TmAI2 strain had a rougher structure than that of the wild type. Complementation of TmAI-2 with extrinsic AI-2 from the culture supernatant of wild-type strain did not restore biofilm formation by the TmAI2 strain, but complementation of LKT7 strain with luxS partially restored biofilm formation. These results indicate that LuxS is involved in biofilm formation by C. ochracea, and that the attenuation of biofilm formation by the mutants is likely caused by a defect in the activated methyl cycle rather than by a loss of AI-2.	[Hosohama-Saito, Kyoko; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, 5-11-13 Sugano, Chiba, Japan; [Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan; [Kita, Daichi] Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan; [Katakura, Akira] Tokyo Dent Coll, Dept Oral Pathobiol Sci & Surg, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Ishihara, K (corresponding author), Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo, Japan.	ishihara@tdc.ac.jp		Ishihara, Kazuyuki/0000-0002-6567-807X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24592778]; Tokyo Dental College; Grants-in-Aid for Scientific Research [15K11023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Dental College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant 24592778 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Kazuyuki Ishihara, and research funds from Tokyo Dental College.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Blehert DS, 2003, J BACTERIOL, V185, P4851, DOI 10.1128/JB.185.16.4851-4860.2003; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Ciantar M, 2005, J PERIODONTOL, V76, P194, DOI 10.1902/jop.2005.76.2.194; Desai Sima S, 2007, J Infect, V54, pe107, DOI 10.1016/j.jinf.2006.06.014; Dibart S, 1998, ORAL MICROBIOL IMMUN, V13, P30, DOI 10.1111/j.1399-302X.1998.tb00747.x; DYER JK, 1985, CAN J MICROBIOL, V31, P1, DOI 10.1139/m85-001; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Gajardo M, 2005, J PERIODONTOL, V76, P289, DOI 10.1902/jop.2005.76.2.289; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; HAAPASALO M, 1991, INFECT IMMUN, V59, P4230, DOI 10.1128/IAI.59.11.4230-4237.1991; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Holt SC, 2011, BERGYS MANUAL SYSTEM, P168; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Huyghe A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002453; Kikuchi Y, 2005, MICROBIOL-SGM, V151, P841, DOI 10.1099/mic.0.27589-0; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Okuda T, 2012, ANAEROBE, V18, P157, DOI 10.1016/j.anaerobe.2012.01.001; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Redanz S, 2012, J BIOL CHEM, V287, P36111, DOI 10.1074/jbc.M112.379230; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Cruz IS, 2013, J PERIODONTAL RES, V48, P443, DOI 10.1111/jre.12024; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Sztajer H, 2008, J BACTERIOL, V190, P401, DOI 10.1128/JB.01086-07; Takahashi N, 2007, J ANTIMICROB CHEMOTH, V59, P59, DOI 10.1093/jac/dkl452; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang HK, 2007, J CLIN MICROBIOL, V45, P645, DOI 10.1128/JCM.01815-06; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005	40	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147114	10.1371/journal.pone.0147114	http://dx.doi.org/10.1371/journal.pone.0147114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800339	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300060
J	Moreno-Sanchez, I; Font-Clos, F; Corral, A				Moreno-Sanchez, Isabel; Font-Clos, Francesc; Corral, Alvaro			Large-Scale Analysis of Zipf's Law in English Texts	PLOS ONE			English	Article							DISTRIBUTIONS; TESTS	Despite being a paradigm of quantitative linguistics, Zipf's law for words suffers from three main problems: its formulation is ambiguous, its validity has not been tested rigorously from a statistical point of view, and it has not been confronted to a representatively large number of texts. So, we can summarize the current support of Zipf's law in texts as anecdotic. We try to solve these issues by studying three different versions of Zipf's law and fitting them to all available English texts in the Project Gutenberg database (consisting of more than 30 000 texts). To do so we use state-of-the art tools in fitting and goodness-of-fit tests, carefully tailored to the peculiarities of text statistics. Remarkably, one of the three versions of Zipf's law, consisting of a pure power-law form in the complementary cumulative distribution function of word frequencies, is able to fit more than 40% of the texts in the database (at the 0.05 significance level), for the whole domain of frequencies (from 1 to the maximum value), and with only one free parameter (the exponent).	[Moreno-Sanchez, Isabel; Font-Clos, Francesc; Corral, Alvaro] Ctr Recerca Matemat, E-08193 Barcelona, Spain; [Moreno-Sanchez, Isabel; Font-Clos, Francesc; Corral, Alvaro] Univ Autonoma Barcelona, Fac Ciencias, Dept Matemat, E-08193 Barcelona, Spain	Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; University of Barcelona	Font-Clos, F (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, E-08193 Barcelona, Spain.	francesc.font@gmail.com	Corral, Alvaro/I-5590-2015	Corral, Alvaro/0000-0002-5280-2692; Font-Clos, Francesc/0000-0003-4938-2452	Ministerio de Economia y Competitividad (Gobierno de Espana) [FIS2012-31324]; Agencia de Gestio d'Ajust Universitaris i de Recerca (Generalitat de Catalunya) [2014SGR-1307]; Spanish MINECO [FIS2012-31324]; AGAUR [2014SGR-1307]	Ministerio de Economia y Competitividad (Gobierno de Espana)(Spanish Government); Agencia de Gestio d'Ajust Universitaris i de Recerca (Generalitat de Catalunya); Spanish MINECO(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by Ministerio de Economia y Competitividad (Gobierno de Espana) (http://www.mineco.gob.es/), grant number FIS2012-31324 (receiver: ACC) and Agencia de Gestio d'Ajust Universitaris i de Recerca (Generalitat de Catalunya) (http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp), grant number 2014SGR-1307 (receiver: ACC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Project Gutenberg initiative, and to those who help maintain it alive. S. Pueyo provided bibliographic wisdom for Zipf's law in ecology, I. Serra assistance for ML estimation, and J. Serra a critical reading of the manuscript. I.M.-S. enjoys a contract from the Collaborative Mathematics Project of La Caixa Foundation. Research projects in which this work is included are FIS2012-31324, from Spanish MINECO, and 2014SGR-1307, from AGAUR.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Abramowitz M., 1965, HANDBOOK OF MATHEMAT; Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; Altmann EG, 2015, ARXIV; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baayen Harald, 2001, WORD FREQUENCY DISTR; Baroni M, 2009, HANDB SPRACH KOMMUN, V29, P803; Bauke H, 2007, EUR PHYS J B, V58, P167, DOI 10.1140/epjb/e2007-00219-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128254; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Camacho J, 2001, EUROPHYS LETT, V55, P774, DOI 10.1209/epl/i2001-00347-0; Cancho RFI, 2005, EUR PHYS J B, V44, P249, DOI 10.1140/epjb/e2005-00121-8; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Cancho RFI., 2001, J QUANT LINGUIST, V8, P165, DOI [10.1076/jqul.8.3.165.4101, DOI 10.1076/JQUL.8.3.165.4101]; Casella G, 2002, STATISTICAL INFERENC; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corominas-Murtra B, 2015, P NATL ACAD SCI USA, V112, P5348, DOI 10.1073/pnas.1420946112; Corominas-Murtra B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036115; Corral A, 2012, ARXIV; Corral A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129031; Corral A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066103; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; DEVROYE L, 1986, NON UNIFORM RANDOM V; Dickman R, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/12/P12022; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Font-Clos F, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.238701; Font-Clos F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093033; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gerlach M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021006; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Haro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033993; Herrero Corral A.M, 2015, UNPUB; Kolmogorov AN., 1956, FOUNDATIONS OF THE T; Li W., 2002, GLOTTOMETRICS, V5, P14; Li WT, 2010, ENTROPY-SWITZ, V12, P1743, DOI 10.3390/e12071743; Malevergne Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036111; Mandelbrot B., 1961, STRUCTURE LANGUAGE I, V12, P190, DOI [DOI 10.1090/PSAPM/012/9970, 10.1090/psapm/012/9970]; MILLER GA, 1957, AM J PSYCHOL, V70, P311, DOI 10.2307/1419346; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pawitan Y., 2001, IN ALL LIKELIHOOD ST; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Peterson J, 2013, P NATL ACAD SCI USA, V110, P20380, DOI 10.1073/pnas.1320578110; Piantadosi ST, 2014, PSYCHON B REV, V21, P1112, DOI 10.3758/s13423-014-0585-6; Press W.H., 1992, NUMERICAL RECIPES, Vsecond; Prokopenko M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/11/P11025; Pueyo S, 2006, SCIENCE, V313, DOI 10.1126/science.1129595; Ross S. M., 2010, 1 COURSE PROBABILITY; Saichev A, 2009, LECTURE NOTES IN ECO; Serra J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00521; SIMON HA, 1955, BIOMETRIKA, V42, P425; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Williams JR, 2015, ARXIV; Zanette D., 2014, ARXIV; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293	58	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147073	10.1371/journal.pone.0147073	http://dx.doi.org/10.1371/journal.pone.0147073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800025	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300057
J	Asada, K; Tojo, Y; Osanai, H; Saito, A; Hasegawa, T; Kumagaya, S				Asada, Kosuke; Tojo, Yoshikuni; Osanai, Hiroo; Saito, Atsuko; Hasegawa, Toshikazu; Kumagaya, Shinichiro			Reduced Personal Space in Individuals with Autism Spectrum Disorder	PLOS ONE			English	Article							HUMAN AMYGDALA; EYE-CONTACT; IMPAIRED RECOGNITION; ASPERGER-SYNDROME; ADULTS; CHILDREN; GAZE; MIND; FACES; ADOLESCENTS	Maintaining an appropriate distance from others is important for establishing effective communication and good interpersonal relations. Autism spectrum disorder (ASD) is a developmental disorder associated with social difficulties, and it is thus worth examining whether individuals with ASD maintain typical or atypical degrees of social distance. Any atypicality of social distancing may impact daily social interactions. We measured the preferred distances when individuals with ASD and typically developing (TD) individuals approached other people (a male experimenter) and objects (a coat rack with clothes) or when other people approached them. Individuals with ASD showed reduced interpersonal distances compared to TD individuals. The same tendency was found when participants judged their preferred distance from objects. In addition, when being approached by other people, both individuals with ASD and TD individuals maintained larger interpersonal distances when there was eye contact, compared to no eye contact. These results suggest that individuals with ASD have a relatively small personal space, and that this atypicality exists not only for persons but also for objects.	[Asada, Kosuke; Kumagaya, Shinichiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Tojo, Yoshikuni] Ibaraki Univ, Coll Educ, Ibaraki, Japan; [Osanai, Hiroo] Musashino Higashi Gakuen, Musashino Higashi Ctr Educ & Res, Tokyo, Japan; [Saito, Atsuko; Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo 1538902, Japan; [Saito, Atsuko] Musashino Univ, Dept Childhood Educ, Tokyo, Japan	University of Tokyo; Ibaraki University; University of Tokyo	Asada, K (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.	asada.kosuke@gmail.com	Saito, Atsuko/AAM-7028-2021; Asada, Kosuke/N-2345-2019		Japan Society for the Promotion of Science (JSPS) [25885024]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24119006]; JSPS [24330207]; Grants-in-Aid for Scientific Research [26381311, 25118003] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp.english.index.html) Grant Number 25885024 (Grant-in-Aid for Research Activity Start-up to KA), the Ministry of Education, Culture, Sports, Science and Technology (MEXT: http://www.mext.go.jp.english/) Grant Number 24119006 (Grant-in-Aid for Scientific Research on Innovative Areas to SK), and JSPS Grant Number 24330207 (Grant-in-Aid for Scientific Research (B) to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; American Psychiatric Association, 2013, DIAGN STAT MAN MET D; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; BURGESS JW, 1981, J NONVERBAL BEHAV, V6, P89, DOI 10.1007/BF00987284; Castell R., 1970, BEHAVIOUR STUDIES PS, P91; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Funabiki Y, 2013, JAPANESE VERSION CHI; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; Hall Edward T, 1992, HIDDEN DIMENSION; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Japanese WISC-III Publication Committee, 1998, NIH WISC 3 CHIN KENS; Kaiser MD, 2010, AUTISM RES, V3, P191, DOI 10.1002/aur.137; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kennedy DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103369; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; LITTLE KB, 1965, J EXP SOC PSYCHOL, V1, P237, DOI 10.1016/0022-1031(65)90028-4; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Magnee MJCM, 2007, J CHILD PSYCHOL PSYC, V48, P1122, DOI 10.1111/j.1469-7610.2007.01779.x; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Oberman LM, 2009, DEVELOPMENTAL SCI, V12, P510, DOI 10.1111/j.1467-7687.2008.00796.x; PEDERSEN J, 1989, ACTA PSYCHIAT SCAND, V80, P346, DOI 10.1111/j.1600-0447.1989.tb02991.x; Pellicano E, 2009, PSYCHON B REV, V16, P1094, DOI 10.3758/PBR.16.6.1094; Perry A, 2015, SOC NEUROSCI-UK, V10, P354, DOI 10.1080/17470919.2015.1010740; Piven J, 1996, J AM ACAD CHILD PSY, V35, P523, DOI 10.1097/00004583-199604000-00019; Rutter M., 2003, SOCIAL COMMUNICATION; Sawada Y, 2003, JPN PSYCHOL RES, V45, P115, DOI 10.1111/1468-5884.t01-2-00039; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shattuck PT, 2007, J AUTISM DEV DISORD, V37, P1735, DOI 10.1007/s10803-006-0307-7; Shinagawa F, 1990, JAPANESE WECHSLER AD; Zaki SR, 2013, AUTISM RES, V6, P280, DOI 10.1002/aur.1292	40	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146306	10.1371/journal.pone.0146306	http://dx.doi.org/10.1371/journal.pone.0146306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26814479	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200012
J	Manifacier, I; Milan, JL; Jeanneau, C; Chmilewsky, F; Chabrand, P; About, I				Manifacier, Ian; Milan, Jean-Louis; Jeanneau, Charlotte; Chmilewsky, Fanny; Chabrand, Patrick; About, Imad			Computational Tension Mapping of Adherent Cells Based on Actin Imaging	PLOS ONE			English	Article							STRESS FIBERS; MODEL; ADHESION; MECHANICS; FORCE; MECHANOTRANSDUCTION; PRESTRESS; STIFFNESS	Forces transiting through the cytoskeleton are known to play a role in adherent cell activity. Up to now few approaches haves been able to determine theses intracellular forces. We thus developed a computational mechanical model based on a reconstruction of the cytoskeleton of an adherent cell from fluorescence staining of the actin network and focal adhesions ( FA). Our custom made algorithm converted the 2D image of an actin network into a map of contractile interactions inside a 2D node grid, each node representing a group of pixels. We assumed that actin filaments observed under fluorescence microscopy, appear brighter when thicker, we thus presumed that nodes corresponding to pixels with higher actin density were linked by stiffer interactions. This enabled us to create a system of heterogeneous interactions which represent the spatial organization of the contractile actin network. The contractility of this interaction system was then adapted to match the level of force the cell truly exerted on focal adhesions; forces on focal adhesions were estimated from their vinculin expressed size. This enabled the model to compute consistent mechanical forces transiting throughout the cell. After computation, we applied a graphical approach on the original actin image, which enabled us to calculate tension forces throughout the cell, or in a particular region or even in single stress fibers. It also enabled us to study different scenarios which may indicate the mechanical role of other cytoskeletal components such as microtubules. For instance, our results stated that the ratio between intra and extra cellular compression is inversely proportional to intracellular tension.	[Manifacier, Ian; Milan, Jean-Louis; Jeanneau, Charlotte; Chmilewsky, Fanny; Chabrand, Patrick; About, Imad] Aix Marseille Univ, ISM, CNRS, UMR 7287, Marseille, France; [Manifacier, Ian; Milan, Jean-Louis; Chabrand, Patrick] St Marguerite Hosp, Inst Locomot, APHM, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Manifacier, I (corresponding author), Aix Marseille Univ, ISM, CNRS, UMR 7287, Marseille, France.; Manifacier, I (corresponding author), St Marguerite Hosp, Inst Locomot, APHM, F-13009 Marseille, France.	ian.manifacier@univ-amu.fr	Milan, Jean-Louis/I-5067-2016	Milan, Jean-Louis/0000-0001-5191-3094	 [ANR_12_BSV5_0010_04]		This study was supported by ANR_12_BSV5_0010_04 issued on December 18th, 2012 (www.agence-nationale-recherche.fr).	Abdul-Kadir MR, 2008, J BIOMECH, V41, P587, DOI 10.1016/j.jbiomech.2007.10.009; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Chong DYR, 2011, J BIOMECH, V44, P948, DOI 10.1016/j.jbiomech.2010.11.026; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Colombelli J, 2009, J CELL SCI, V122, P1928, DOI 10.1242/jcs.054577; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; Han SJ, 2011, COMPUT METHOD BIOMEC, V14, P459, DOI 10.1080/10255842.2011.554412; Herrera A, 2012, WORLD J ORTHOP, V3, P25, DOI 10.5312/wjo.v3.i4.25; Hersen P, 2011, NATURE; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu SH, 2004, FRONT BIOSCI-LANDMRK, V9, P2177, DOI 10.2741/1352; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Ketene AN, 2012, INTEGR BIOL-UK, V4, P540, DOI 10.1039/c2ib00168c; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Milan JL, 2007, BIOMECH MODEL MECHAN, V6, P373, DOI 10.1007/s10237-006-0057-7; Milan JL, 2013, EUR CELLS MATER, V25, P97, DOI 10.22203/eCM.v025a07; Pathak A, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4006452; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Soine JRD, 2015, PLOS COMPUTATIONAL B, V11, DOI [10.1371/journal.pcbi.1004076, DOI 10.1371/J0URNAL.PCBI.1004076]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; van Hoorn H, 2014, NANO LETT, V14, P4257, DOI 10.1021/nl5008773; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]	38	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146863	10.1371/journal.pone.0146863	http://dx.doi.org/10.1371/journal.pone.0146863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812601	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000016
J	Montroy, J; Breau, RH; Cnossen, S; Witiuk, K; Binette, A; Ferrier, T; Lavallee, LT; Fergusson, DA; Schramm, D				Montroy, Joshua; Breau, Rodney H.; Cnossen, Sonya; Witiuk, Kelsey; Binette, Andrew; Ferrier, Taylor; Lavallee, Luke T.; Fergusson, Dean A.; Schramm, David			Change in Adverse Events After Enrollment in the National Surgical Quality Improvement Program: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SITE INFECTIONS; AMERICAN-COLLEGE; IMPLEMENTATION; OUTCOMES; TOOL	Background The American College of Surgeons' National Surgical Quality Improvement Program (NSQIP) is the first nationally validated, risk-adjusted, outcomes-based program to measure and compare the quality of surgical care across North America. Participation in this program may provide an opportunity to reduce the incidence of adverse events related to surgery. Study Design A systematic review of the literature was performed. MedLine, EMBASE and PubMed were searched for studies relevant to NSQIP. Patient characteristics, intervention, and primary outcome measures were abstracted. The intervention was participation in NSQIP and monitoring of Individual Site Summary Reports with or without implementation of a quality improvement program. The outcomes of interest were change in peri-operative adverse events and mortality represented by pooled risk ratios (pRR) and 95% confidence intervals (CI). Results Eleven articles reporting on 35 health care institutions were included. Nine (82%) of the eleven studies implemented a quality improvement program. Minimal improvements in superficial (pRR 0.81; 95% CI 0.72-0.91), deep (pRR 0.82; 95% CI0.64-1.05) and organ space (pRR 1.15; 95% CI 0.96-1.37) infections were observed at centers that did not institute a quality improvement program. However, centers that reported formal interventions for the prevention and treatment of infections observed substantial improvements (superficial pRR 0.55, 95% CI 0.39-0.77; deep pRR 0.61, 95% CI 0.50-0.75, and organ space pRR 0.60, 95% CI 0.50-0.71). Studies evaluating other adverse events noted decreased incidence following NSQIP participation and implementation of a formal quality improvement program. Conclusions These data suggest that NSQIP is effective in reducing surgical morbidity. Improvement in surgical quality appears to be more marked at centers that implemented a formal quality improvement program directed at the reduction of specific morbidities.	[Montroy, Joshua; Breau, Rodney H.; Cnossen, Sonya; Witiuk, Kelsey; Fergusson, Dean A.; Schramm, David] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Binette, Andrew; Ferrier, Taylor] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada; [Breau, Rodney H.; Fergusson, Dean A.; Schramm, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [Breau, Rodney H.; Lavallee, Luke T.] Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada; [Schramm, David] Ottawa Hosp, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Breau, RH (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; Breau, RH (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada.; Breau, RH (corresponding author), Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada.	rbreau@ottawahospital.on.ca		Fergusson, Dean/0000-0002-3389-2485; Breau, Rodney/0000-0003-2344-9022; Montroy, Joshua/0000-0002-6611-0056; Schramm, David/0000-0002-6875-3709				Agency for Healthcare Research and Quality, UNS COMPR UN BAS SAF; American College of Surgeons National Surgical Quality Improvement Program, US GUID PART US DAT; Berenguer CM, 2010, J AM COLL SURGEONS, V210, P737, DOI 10.1016/j.jamcollsurg.2010.01.029; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Ceppa EP, 2013, HPB, V15, P384, DOI 10.1111/j.1477-2574.2012.00604.x; Cima R, 2013, J AM COLL SURGEONS, V216, P23, DOI 10.1016/j.jamcollsurg.2012.09.009; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Compoginis JM, 2013, AM SURGEON, V79, P274; Fuchshuber Pascal R, 2012, Perm J, V16, P39; Guillamondegui OD, 2012, J AM COLL SURGEONS, V214, P709, DOI 10.1016/j.jamcollsurg.2011.12.012; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Henke PK, 2010, SURGERY, V148, P883, DOI 10.1016/j.surg.2010.07.009; Lutfiyya Waleed, 2012, Perm J, V16, P10; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; Stachler RJ, 2010, OTOLARYNG HEAD NECK, V143, P26, DOI 10.1016/j.otohns.2010.02.017; Strengthening the reporting of observational studies in epidemiology (STROBE) Statement, 2009, STROBE CHECKL COH CA; Wick EC, 2012, J AM COLL SURGEONS, V215, P193, DOI 10.1016/j.jamcollsurg.2012.03.017; Wren SM, 2010, J AM COLL SURGEONS, V210, P491, DOI 10.1016/j.jamcollsurg.2010.01.009	18	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146254	10.1371/journal.pone.0146254	http://dx.doi.org/10.1371/journal.pone.0146254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812596	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000007
J	Tsao, CC; Tsao, PN; Chen, YG; Chuang, YH				Tsao, Cheng-Chiu; Tsao, Po-Nien; Chen, Yi-Guang; Chuang, Ya-Hui			Repeated Activation of Lung Invariant NKT Cells Results in Chronic Obstructive Pulmonary Disease-Like Symptoms	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; INNATE IMMUNE-RESPONSE; KILLER T-CELLS; CIGARETTE-SMOKE; AIRWAY HYPERREACTIVITY; INDUCED SPUTUM; COPD; ASTHMA; GLYCOSPHINGOLIPIDS; PATHOGENESIS	Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation, mucus hypersecretion, and emphysema, which lead to reduced lung function and breathlessness. The pathologies of COPD are due to an abnormal immune response. Invariant natural killer T (iNKT) cells are an important population of innate lymphocytes and have been implicated in the regulation of immune responses associated with a broad range of diseases including COPD. We have here analyzed the role of iNKT cells in a model of COPD induced by repeated intranasal administration of iNKT cell agonist alpha-galactosylceramide (alpha-GalCer). Our results demonstrated that mice that received repeated intranasal administration of alpha-GalCer had molecular and inflammatory features of COPD including airway inflammation with significant increases in infiltration of macrophages and lymphocytes, CD8(+) T cells, as well as proinflammatory cytokines IL-6 and TNF-alpha. In particular, these mice also showed the presence of pulmonary emphysema, mucus production, and pulmonary fibrosis. Furthermore, neutralization of IL-4 reduced alpha-GalCer induced emphysema. This study indicates the importance of iNKT cells in the pathogenesis of COPD by an IL-4 dependent mechanism.	[Tsao, Cheng-Chiu; Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Yi-Guang] Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Chen, Yi-Guang] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA	National Taiwan University; National Taiwan University; National Taiwan University; Medical College of Wisconsin; Medical College of Wisconsin	Chuang, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	yahuichuang@ntu.edu.tw		TSAO, PO-NIEN/0000-0002-6114-1769; CHUANG, YA-HUI/0000-0003-0857-0035	Ministry of Science and Technology, Taiwan [NSC 97-2320-B-002-017-MY3, NSC 100-2320-B-002086]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan, NSC 97-2320-B-002-017-MY3 and NSC 100-2320-B-002086-(YHC).	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121320; Chuang YH, 2011, J IMMUNOL, V186, P4687, DOI 10.4049/jimmunol.1003659; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Jeffery PK, 1999, CLIN EXP ALLERGY, V29, P14, DOI 10.1046/j.1365-2222.1999.00004.x-i2; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lin PY, 2015, IMMUNOLOGY, V144, P668, DOI 10.1111/imm.12419; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pichavant M, 2014, MUCOSAL IMMUNOL, V7, P568, DOI 10.1038/mi.2013.75; Provinciali M, 2011, CURR OPIN PULM MED, V17, pS3, DOI 10.1097/01.mcp.0000410742.90463.1f; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Turato G, 2001, RESPIRATION, V68, P117, DOI 10.1159/000050478; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wu LH, 2000, BIOCHEM BIOPH RES CO, V269, P808, DOI 10.1006/bbrc.2000.2368; Xie SP, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-148; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC	35	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147710	10.1371/journal.pone.0147710	http://dx.doi.org/10.1371/journal.pone.0147710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811900	gold, Green Published			2022-12-27	WOS:000369528000050
J	Abusara, Z; Von Kossel, M; Herzog, W				Abusara, Ziad; Von Kossel, Markus; Herzog, Walter			In Vivo Dynamic Deformation of Articular Cartilage in Intact Joints Loaded by Controlled Muscular Contractions	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CHONDROCYTE; COMPRESSION; EXERCISE; CELL; INDENTATION; BEHAVIOR	When synovial joints are loaded, the articular cartilage and the cells residing in it deform. Cartilage deformation has been related to structural tissue damage, and cell deformation has been associated with cell signalling and corresponding anabolic and catabolic responses. Despite the acknowledged importance of cartilage and cell deformation, there are no dynamic data on these measures from joints of live animals using muscular load application. Research in this area has typically been done using confined and unconfined loading configurations and indentation testing. These loading conditions can be well controlled and allow for accurate measurements of cartilage and cell deformations, but they have little to do with the contact mechanics occurring in a joint where non-congruent cartilage surfaces with different material and functional properties are pressed against each other by muscular forces. The aim of this study was to measure in vivo, real time articular cartilage deformations for precisely controlled static and dynamic muscular loading conditions in the knees of mice. Fifty and 80% of the maximal knee extensor muscular force (equivalent to approximately 0.4N and 0.6N) produced average peak articular cartilage strains of 10.5+/-1.0% and 18.3+/-1.3% (Mean+/-SD), respectively, during 8s contractions. A sequence of 15 repeat, isometric muscular contractions (0.5s on, 3.5s off) of 50% and 80% of maximal muscular force produced cartilage strains of 3.0+/-1.1% and 9.6+/-1.5% (Mean +/- SD) on the femoral condyles of the mouse knee. Cartilage thickness recovery following mechanical compression was highly viscoelastic and took almost 50s following force removal in the static tests.	[Abusara, Ziad; Von Kossel, Markus; Herzog, Walter] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	University of Calgary	Abusara, Z (corresponding author), Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.	zabusara@ucalgary.ca	Herzog, Walter/AAG-7188-2020; Von Kossel, Markus/AFK-6691-2022	Herzog, Walter/0000-0002-5341-0033; 	Alberta Innovates-Health Solutions; Canadian Institutes of Health research; Alberta Innovates Health Solutions	Alberta Innovates-Health Solutions; Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	Alberta Innovates-Health Solutions Fellowship and Team Grant on Osteoarthritis. The Canada Research Chair Program, the Canadian Institutes of Health Research, the Killam Foundation; This work was supported by Canadian Institutes of Health research (WH), Alberta Innovates Health Solutions (ZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusara Z, 2013, J BIOMECH, V46, P1225, DOI 10.1016/j.jbiomech.2013.02.027; Abusara Z, 2011, J BIOMECH, V44, P930, DOI 10.1016/j.jbiomech.2010.11.031; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Buschmann MD, 1996, J CELL SCI, V109, P499; Choi JB, 2007, J BIOMECH, V40, P2596, DOI 10.1016/j.jbiomech.2007.01.009; Cotofana S, 2011, EUR RADIOL, V21, P1127, DOI 10.1007/s00330-011-2057-y; Eckstein F, 1999, ANAT EMBRYOL, V200, P419, DOI 10.1007/s004290050291; Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x; Eckstein F, 2005, ANN RHEUM DIS, V64, P291, DOI 10.1136/ard.2004.022400; Eckstein F, 2000, J BIOMECH, V33, P819, DOI 10.1016/S0021-9290(00)00034-8; Federico S, 2005, J BIOMECH, V38, P2008, DOI 10.1016/j.jbiomech.2004.09.020; GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Guilak F, 2000, BIORHEOLOGY, V37, P27; Han SK, 2012, J BIOMECH, V45, P2450, DOI 10.1016/j.jbiomech.2012.06.028; Han SK, 2012, J ORTHOP RES, V30, P475, DOI 10.1002/jor.21536; Han SK, 2009, MED ENG PHYS, V31, P1038, DOI 10.1016/j.medengphy.2009.05.013; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; Herzog W, 1997, J BIOMECH, V30, P865, DOI 10.1016/S0021-9290(97)00046-8; Hosseini A, 2010, OSTEOARTHR CARTILAGE, V18, P909, DOI 10.1016/j.joca.2010.04.011; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Knight MM, 1998, MED ENG PHYS, V20, P684, DOI 10.1016/S1350-4533(98)00080-0; Li G, 2008, J BIOMECH, V41, P128, DOI 10.1016/j.jbiomech.2007.07.006; Li LP, 2005, MED ENG PHYS, V27, P51, DOI 10.1016/j.medengphy.2004.08.009; Moo EK, 2013, J BIOMECH, V46, P2024, DOI 10.1016/j.jbiomech.2013.06.007; Moskowitz RW, 1984, OSTEOARTHRITIS DIAGN, P213; MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9; MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Neu CP, 2003, J BIOMECH ENG-T ASME, V125, P180, DOI 10.1115/1.1560141; SAH RLY, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P373; Shrive N. G., 1999, BIOMECHANICS MUSCULO, P86; Sibole SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037538; Sutter EG, 2015, AM J SPORT MED, V43, P370, DOI 10.1177/0363546514559821; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; Urban JPG, 2000, BIORHEOLOGY, V37, P185; Van Ginckel A, 2013, PHYS THER, V93, P1049, DOI 10.2522/ptj.20120491	39	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147547	10.1371/journal.pone.0147547	http://dx.doi.org/10.1371/journal.pone.0147547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807930	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800129
J	Bier, G; Bongers, MN; Ditt, H; Bender, B; Ernemann, U; Horger, M				Bier, Georg; Bongers, Malte N.; Ditt, Hendrik; Bender, Benjamin; Ernemann, Ulrike; Horger, Marius			Accuracy of Non-Enhanced CT in Detecting Early Ischemic Edema Using Frequency Selective Non-Linear Blending	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ALBERTA STROKE; HEMORRHAGIC TRANSFORMATION; THROMBECTOMY; REPERFUSION; OCCLUSION; SCORE; RECANALIZATION; INFARCTION; EVENTS	Purpose Ischemic brain edema is subtle and hard to detect by computed tomography within the first hours of stroke onset. We hypothesize that non-enhanced CT (NECT) post-processing with frequency-selective non-linear blending ("best contrast"/BC) increases its accuracy in detecting edema and irreversible tissue damage (infarction). Methods We retrospectively analyzed the NECT scans of 76 consecutive patients with ischemic stroke (exclusively middle cerebral artery territory-MCA) before and after post-processing with BC both at baseline before reperfusion therapy and at follow-up (5.73 +/- 12.74 days after stroke onset) using the Alberta Stroke Program Early CT Score (ASPECTS). We assessed the differences in ASPECTS between unprocessed and post-processed images and calculated sensitivity, specificity, and predictive values of baseline NECT using follow-up CT serving as reference standard for brain infarction. Results NECT detected brain tissue hypoattenuation in 35 of 76 patients (46.1%). This number increased to 71 patients (93.4%) after post-processing with BC. Follow-up NECT confirmed brain infarctions in 65 patients (85.5%; p = 0.012). Post-processing increased the sensitivity of NECT for brain infarction from 35/65 (54%) to 65/65 (100%), decreased its specificity from 11/11 (100%) to 7/11 (64%), its positive predictive value (PPV) from 35/35 (100%) to 65/69 (94%) and increased its accuracy 46/76 (61%) to 72/76 (95%). Conclusions This post-hoc analysis suggests that post-processing of NECT with BC may increase its sensitivity for ischemic brain damage significantly.	[Bier, Georg; Bongers, Malte N.; Horger, Marius] Univ Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany; [Ditt, Hendrik] Siemens AG Healthcare, Imaging & Therapy Syst Computed Tomog & Radiat On, Siemensstr 1, D-91301 Forchheim, Germany; [Bender, Benjamin; Ernemann, Ulrike] Univ Tubingen, Dept Neuroradiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Siemens AG; Eberhard Karls University of Tubingen	Bier, G (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany.	georghomann@web.de		Bender, Benjamin/0000-0002-3205-4631	Siemens AG	Siemens AG(Siemens AG)	One of the authors (H.D.) is employed by a commercial company (Siemens AG Healthcare Sector). Since the manuscript is based on the application of a new software, the co-author gave technical support, but he and his organization did not play a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Siemens AG gave financial support in the form of H.D.'s salaries only.	Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Demchuk AM, 2005, NEUROIMAG CLIN N AM, V15, P409, DOI 10.1016/j.nic.2005.06.008; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hesselmann V, 2012, AM J NEURORADIOL, V33, P336, DOI 10.3174/ajnr.A2746; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Hirano T, 2012, J STROKE CEREBROVASC, V21, P898, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.018; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Na DG, 1998, RADIOLOGY, V207, P113, DOI 10.1148/radiology.207.1.9530306; Nambiar V, 2014, AM J NEURORADIOL, V35, P884, DOI 10.3174/ajnr.A3817; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; PESSIN MS, 1991, AM J NEURORADIOL, V12, P1123; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Tan S, 2014, J NEUROL, V261, P905, DOI 10.1007/s00415-014-7297-8; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147378	10.1371/journal.pone.0147378	http://dx.doi.org/10.1371/journal.pone.0147378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809010	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800082
J	Campos, LC; Rocha, MVV; Willers, DMC; Silva, DR				Campos, Leandro Cruz; Vieira Rocha, Marcos Vinicius; Cunha Willers, Denise Maria; Silva, Denise Rossato			Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence	PLOS ONE			English	Article							DIAGNOSIS; TRANSMISSION; COHORT; AREA; MORTALITY; SETTINGS; PROGRAM; ADULTS	Introduction Smear-negative pulmonary TB (SNPT) represents 30-60% of all pulmonary TB cases. The mortality of these patients can reach 25% in populations with high prevalence of HIV infection, and 10-20% of TB transmission at the population level are attributable to SNPT cases. Methods We conducted a retrospective study to evaluate epidemiological, clinical, and radiological characteristics of patients with SNPT and to compare these with patients who were diagnosed as having smear-positive pulmonary TB (SPPT). All adult patients (>= 18 years old) with a positive culture for Mycobacterium tuberculosis, and a diagnosis of pulmonary TB were included in the study. Results 198 patients met the inclusion criteria (positive culture for Mycobacterium tuberculosis) and were included in the analysis. Of these patients, 69 (34.8%) were smear positive (SPPT) and 129 (65.2%) were smear negative (SNPT). In univariate analysis, cough, dyspnea, and hemoptysis were less frequent in SNPT patients in comparison with SPPT patients. In a multivariate model, having no cough and no radiographic pattern typical of TB were the characteristics independently associated with a diagnosis of SNPT. Conclusions We found a very high prevalence of SNPT among patients with TB in a setting with high TB and HIV prevalence. The absence of cough in the presence of other symptoms suggestive of TB, and having no radiographic pattern typical of TB where independent predictors of SNPT.	[Campos, Leandro Cruz; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil; [Vieira Rocha, Marcos Vinicius; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Cunha Willers, Denise Maria; Silva, Denise Rossato] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	denise.rossato@terra.com.br		Rossato Silva, Denise/0000-0003-0230-2734	FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre)	FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre)	This work was supported by FIPE-HCPA (Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre).	Affolabi D, 2011, INT J TUBERC LUNG D, V15, P67; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Harries AD, 1997, ANN TROP MED PARASIT, V91, P771, DOI 10.1080/00034989760527; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Loh L C, 2005, Med J Malaysia, V60, P62; LONG R, 1991, AM J PUBLIC HEALTH, V81, P1326, DOI 10.2105/AJPH.81.10.1326; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Ministerio da Saude, 2011, PROGR NAC CONTR TUB; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Secretaria de Vigilancia em Saude-Ministerio da Saude, 2015, MIN SAUD B EP; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Shah NS, 2012, INT J TUBERC LUNG D, V16, P1234, DOI 10.5588/ijtld.11.0794; Soto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018486; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Tozkoparan E, 2005, ARCH MED RES, V36, P166, DOI 10.1016/j.arcmed.2004.12.010; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 1998, GUID CONTR MON TOB E; World Health Organization, 2011, GLOB TUB CONTR WHO R	39	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147933	10.1371/journal.pone.0147933	http://dx.doi.org/10.1371/journal.pone.0147933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808299	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800244
J	Eckerdal, P; Kollia, N; Lofblad, J; Hellgren, C; Karlsson, L; Hogberg, U; Wikstrom, AK; Skalkidou, A				Eckerdal, Patricia; Kollia, Natasa; Lofblad, Johanna; Hellgren, Charlotte; Karlsson, Linnea; Hogberg, Ulf; Wikstrom, Anna-Karin; Skalkidou, Alkistis			Delineating the Association between Heavy Postpartum Haemorrhage and Postpartum Depression	PLOS ONE			English	Article							POSTNATAL-DEPRESSION; RISK-FACTORS; PREVALENCE; WOMEN; ANEMIA; PREGNANCY; DELIVERY; COHORT; VALIDATION; PREDICTORS	Objectives To explore the association between postpartum haemorrhage (PPH) and postpartum depression (PPD), taking into account the role of postpartum anaemia, delivery experience and psychiatric history. Methods A nested cohort study (n = 446), based on two population-based cohorts in Uppsala, Sweden. Exposed individuals were defined as having a bleeding of >= 1000ml (n = 196) at delivery, and non-exposed individuals as having bleeding of <650ml (n = 250). Logistic regression models with PPD symptoms (Edinburgh Postnatal Depression scale (EPDS) score >= 12) as the outcome variable and PPH, anaemia, experience of delivery, mood during pregnancy and other confounders as exposure variables were undertaken. Path analysis using Structural Equation Modeling was also conducted. Results There was no association between PPH and PPD symptoms. A positive association was shown between anaemia at discharge from the maternity ward and the development of PPD symptoms, even after controlling for plausible confounders (OR = 2.29, 95% CI = 1.15-4.58). Path analysis revealed significant roles for anaemia at discharge, negative self-reported delivery experience, depressed mood during pregnancy and postpartum stressors in increasing the risk for PPD. Conclusion This study proposes important roles for postpartum anaemia, negative experience of delivery and mood during pregnancy in explaining the development of depressive symptoms after PPH.	[Eckerdal, Patricia; Lofblad, Johanna; Hellgren, Charlotte; Hogberg, Ulf; Wikstrom, Anna-Karin; Skalkidou, Alkistis] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Kollia, Natasa] Harokopio Univ, Dept Biostat, Athens, Greece; [Karlsson, Linnea] Turku Univ Hosp, Dept Child Psychiat, FIN-20520 Turku, Finland; [Karlsson, Linnea] Univ Turku, Inst Clin Med, Turku Brain & Mind Ctr, Turku, Finland	Uppsala University; Harokopio University Athens; University of Turku; University of Turku	Eckerdal, P (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	patricia.eckerdal@kbh.uu.se	Skalkidou, Alkistis/C-1521-2015; Karlsson, Linnea/AAI-5959-2020	Skalkidou, Alkistis/0000-0002-4935-7532; Karlsson, Linnea/0000-0002-4725-0176	Gillbergska Foundation [464250651]; Marianne and Marcus Wallenberg Foundation [521-2013-2339]; Uppsala University Hospital [2012-Skalkidou]; Swedish Medical Society [SLS-250581]	Gillbergska Foundation; Marianne and Marcus Wallenberg Foundation; Uppsala University Hospital; Swedish Medical Society	This work was supported by the Gillbergska Foundation (grant number 464250651), the Marianne and Marcus Wallenberg Foundation (grant number: 521-2013-2339), the Uppsala University Hospital (grant number: 2012-Skalkidou), and the Swedish Medical Society (grant number SLS-250581). The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kadir R, 2014, TRANSFUSION, V54, P1756, DOI 10.1111/trf.12550; Adams SS, 2012, BJOG-INT J OBSTET GY, V119, P298, DOI 10.1111/j.1471-0528.2011.03188.x; Albacar G, 2011, J AFFECT DISORDERS, V131, P136, DOI 10.1016/j.jad.2010.11.006; Alharbi AA, 2014, NEUROPSYCH DIS TREAT, V10, P311, DOI 10.2147/NDT.S57556; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Andersen LB, 2012, ACTA OBSTET GYN SCAN, V91, P1261, DOI 10.1111/j.1600-0412.2012.01476.x; [Anonymous], 2008, WORLDW PREV AN 1993; Armony-Sivan R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/521431; Bansil P, 2010, J WOMENS HEALTH, V19, P329, DOI 10.1089/jwh.2009.1387; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Bergmann RL, 2010, EUR J OBSTET GYN R B, V150, P126, DOI 10.1016/j.ejogrb.2010.02.030; Bloch M, 2006, GEN HOSP PSYCHIAT, V28, P3, DOI 10.1016/j.genhosppsych.2005.08.006; Bodnar LM, 2001, AM J OBSTET GYNECOL, V185, P438, DOI 10.1067/mob.2001.115996; Corwin EJ, 2005, JOGNN-J OBST GYN NEO, V34, P577, DOI 10.1177/0884217505279997; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Corwin EJ, 2007, MCN-AM J MATERN-CHIL, V32, P215, DOI 10.1097/01.NMC.0000281959.71454.e5; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dahlke JD, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.023; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Ekselius L., 2012, DIAGNOSTIK UPPFOLJNI; Esscher A, 2014, SUICIDES PREGN UNPUB, P1980; Figueiredo B, 2013, J PEDIAT-BRAZIL, V89, P332, DOI 10.1016/j.jped.2012.12.002; Furuta M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-133; Gausia K, 2012, J HEALTH POPUL NUTR, V30, P172, DOI 10.3329/jhpn.v30i2.11310; Green L., 2015, BLOOD TRANSFUSION OB; Hofmeyr GJ, 2001, BEST PRACT RES CL OB, V15, P645, DOI 10.1053/beog.2001.0205; Iliadis SI, 2015, ARCH WOMEN MENT HLTH, V18, P539, DOI 10.1007/s00737-014-0478-8; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Kassebaum N.J, 2014, LANCET; Katon W, 2014, J WOMENS HEALTH, V23, P753, DOI 10.1089/jwh.2014.4824; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Kline R.B., 2011, PRINCIPLES PRACTICE; Likis FE, 2015, MANAGEMENT POSTPARTU; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Lukose A, 2014, MATERN CHILD HLTH J, V18, P161, DOI 10.1007/s10995-013-1249-2; Markova V, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010861.pub2; McLintock C, 2011, J THROMB HAEMOST, V9, P1441, DOI 10.1111/j.1538-7836.2011.04398.x; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Mohammad KI, 2011, MIDWIFERY, V27, pE238, DOI 10.1016/j.midw.2010.10.008; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Oberg AS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4984; Olde E, 2006, CLIN PSYCHOL REV, V26, P1, DOI 10.1016/j.cpr.2005.07.002; Park EM, 2013, ARCH WOMEN MENT HLTH, V16, P539, DOI 10.1007/s00737-013-0356-9; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Petersson K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-364; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Richard Berkowitz R, 2012, MAN OBST HEM AM C OB; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Sentilhes L, 2011, ACTA OBSTET GYN SCAN, V90, P615, DOI 10.1111/j.1600-0412.2011.01119.x; Sword W, 2011, BJOG-INT J OBSTET GY, V118, P966, DOI 10.1111/j.1471-0528.2011.02950.x; Sylven SM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.022; Sylven SM, 2011, ARCH WOMEN MENT HLTH, V14, P195, DOI 10.1007/s00737-011-0211-9; Thompson JF, 2011, AUST NZ J OBSTET GYN, V51, P365, DOI 10.1111/j.1479-828X.2011.01317.x; Tuohy Alan, 2008, Psychol Health Med, V13, P43, DOI 10.1080/13548500701294531; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; Weisman O, 2010, ARCH WOMEN MENT HLTH, V13, P505, DOI 10.1007/s00737-010-0169-z; Wickberg B, 1996, ACTA PSYCHIAT SCAND, V94, P181, DOI 10.1111/j.1600-0447.1996.tb09845.x; Wickberg B, 1996, J AFFECT DISORDERS, V39, P209, DOI 10.1016/0165-0327(96)00034-1; Wilkie GL, 2014, OBSTET GYNECOL, V123, p82S, DOI 10.1097/01.AOG.0000447410.24175.c4	61	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144274	10.1371/journal.pone.0144274	http://dx.doi.org/10.1371/journal.pone.0144274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807799	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800002
J	Hao, HJ; Liang, JR; Duan, R; Chen, YH; Liu, C; Xiao, YC; Li, X; Su, MM; Jing, HQ; Wang, X				Hao, Huijing; Liang, Junrong; Duan, Ran; Chen, Yuhuang; Liu, Chang; Xiao, Yuchun; Li, Xu; Su, Mingming; Jing, Huaiqi; Wang, Xin			Yersinia spp. Identification Using Copy Diversity in the Chromosomal 16S rRNA Gene Sequence	PLOS ONE			English	Article							PSEUDOTUBERCULOSIS COMPLEX; DISTINCT TYPES; SP-NOV; ENTEROCOLITICA; FREDERIKSENII; WAUTERSII; STRAINS; GENOMES; OPERON; PESTIS	API 20E strip test, the standard for Enterobacteriaceae identification, is not sufficient to discriminate some Yersinia species for some unstable biochemical reactions and the same biochemical profile presented in some species, e.g. Yersinia ferderiksenii and Yersinia intermedia, which need a variety of molecular biology methods as auxiliaries for identification. The 16S rRNA gene is considered a valuable tool for assigning bacterial strains to species. However, the resolution of the 16S rRNA gene may be insufficient for discrimination because of the high similarity of sequences between some species and heterogeneity within copies at the intra-genomic level. In this study, for each strain we randomly selected five 16S rRNA gene clones from 768 Yersinia strains, and collected 3,840 sequences of the 16S rRNA gene from 10 species, which were divided into 439 patterns. The similarity among the five clones of 16S rRNA gene is over 99% for most strains. Identical sequences were found in strains of different species. A phylogenetic tree was constructed using the five 16S rRNA gene sequences for each strain where the phylogenetic classifications are consistent with biochemical tests; and species that are difficult to identify by biochemical phenotype can be differentiated. Most Yersinia strains form distinct groups within each species. However Yersinia kristensenii, a heterogeneous species, clusters with some Yersinia enterocolitica and Yersinia ferderiksenii/intermedia strains, while not affecting the overall efficiency of this species classification. In conclusion, through analysis derived from integrated information from multiple 16S rRNA gene sequences, the discrimination ability of Yersinia species is improved using our method.	[Hao, Huijing; Liang, Junrong; Duan, Ran; Chen, Yuhuang; Liu, Chang; Xiao, Yuchun; Li, Xu; Jing, Huaiqi; Wang, Xin] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Liu, Chang] Jiangsu Univ, Sch Med Sci, Dept Pathogen Biol, Zhenjiang, Jiangsu, Peoples R China; [Su, Mingming] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Jiangsu University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	wangxin@icdc.cn			National Natural Science Foundation of China [81470092]; NationalSci-Tech Key Project [2012ZX10004201, 2013ZX10004203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NationalSci-Tech Key Project	The National Natural Science Foundation of China (General Project, no. 81470092); the NationalSci-Tech Key Project (2012ZX10004201, 2013ZX10004203-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Batzilla J, 2011, J BACTERIOL, V193, P2067, DOI 10.1128/JB.01484-10; BOTTONE EJ, 1977, CRC CR REV MICROBIOL, V5, P211, DOI 10.3109/10408417709102312; CLAYTON RA, 1995, INT J SYST BACTERIOL, V45, P595, DOI 10.1099/00207713-45-3-595; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Jan Ursing DJB, 1980, CURRENT MICROBIOLOGY, V4, P213; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Kim W, 2003, ANTON LEEUW INT J G, V83, P125, DOI 10.1023/A:1023301924932; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Liang JR, 2012, APPL ENVIRON MICROB, V78, P2949, DOI 10.1128/AEM.07893-11; Linde HJ, 1999, J CLIN MICROBIOL, V37, P211, DOI 10.1128/JCM.37.1.211-214.1999; Mittal S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-25; Moreno C, 2002, MICROBIOL-SGM, V148, P1233, DOI 10.1099/00221287-148-4-1233; Neubauer H, 2000, INT J MED MICROBIOL, V290, P61; Neubauer H, 1998, J CLIN MICROBIOL, V36, P3366, DOI 10.1128/JCM.36.11.3366-3368.1998; Neubauer H, 2015, INT J SYST EVOL MICR, V65, P732, DOI 10.1099/ijs.0.070383-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Savin C, 2014, INT J MED MICROBIOL, V304, P452, DOI 10.1016/j.ijmm.2014.02.002; Sihvonen LM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-208; Souza RA, 2013, INT J SYST EVOL MICR, V63, P3124, DOI 10.1099/ijs.0.047175-0; Sprague LD, 2005, INT J SYST EVOL MICR, V55, P831, DOI 10.1099/ijs.0.63220-0; Sprague LD, 2008, INT J SYST EVOL MICR, V58, P952, DOI 10.1099/ijs.0.65417-0; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	30	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147639	10.1371/journal.pone.0147639	http://dx.doi.org/10.1371/journal.pone.0147639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808495	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800161
J	Lithanatudom, P; Wipasa, J; Inti, P; Chawansuntati, K; Svasti, S; Fucharoen, S; Kangwanpong, D; Kampuansai, J				Lithanatudom, Pathrapol; Wipasa, Jiraprapa; Inti, Pitsinee; Chawansuntati, Kriangkrai; Svasti, Saovaros; Fucharoen, Suthat; Kangwanpong, Daoroong; Kampuansai, Jatupol			Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro	PLOS ONE			English	Article							E TRAIT; GENETIC-STRUCTURE; POPULATIONS; THALASSEMIA; HEMOZOIN; DNA	Hemoglobin E (HbE) is one of the most common hemoglobin variants caused by a mutation in the beta-globin gene, and found at high frequencies in various Southeast Asian groups. We surveyed HbE prevalence among 8 ethnic groups residing in 5 villages selected for their high period malaria endemicity, and 5 for low endemicity in northern Thailand, in order to uncover factors which may affect genetic persistence of HbE in these groups. We found the overall HbE prevalence 6.7%, with differing frequencies from 0% in the Pwo Karen, the Lawa, and the Skaw Karen to 24% in the Mon. All HbE genes were heterozygous (AE). Differences in HbE prevalence among the studied ethnic groups indirectly documents that ancestries and evolutionary forces, such as drift and admixture, are the important factors in the persistence of HbE distribution in northern Thailand. Furthermore, the presence of HbE in groups of northern Thailand had no effect on the in vitro infectivity and proliferation of Plasmodium falciparum, nor the production of hemozoin, a heme crystal produced by malaria parasites, when compared to normal red-blood-cell controls. Our data may contribute to a better understanding on the persistence of HbE among ethnic groups and its association with malaria.	[Lithanatudom, Pathrapol; Inti, Pitsinee; Kangwanpong, Daoroong; Kampuansai, Jatupol] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Wipasa, Jiraprapa; Chawansuntati, Kriangkrai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Svasti, Saovaros; Fucharoen, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom, Thailand	Chiang Mai University; Chiang Mai University; Mahidol University	Kampuansai, J (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	Jatupol.K@cmu.ac.th	Svasti, Saovaros/AAH-6111-2020; LITHANATUDOM, PATHRAPOL/AAQ-1131-2021		National Research Council of Thailand [83447]	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Research Council of Thailand (http://en.nrct.go.th) Grant no. 83447 to JK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN AE, 1990, EUR J HAEMATOL, V45, P120; Bureau of Epidemiology, 2007, EP SURV REP; Chong SS, 2000, BLOOD, V95, P360; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Coronado LM, 2014, BBA-GEN SUBJECTS, V1840, P2032, DOI 10.1016/j.bbagen.2014.02.009; Fabry M, 2009, DISORDERS HEMOGLOBIN; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Fucharoen S, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P417; Glushakova S, 2014, J INFECT DIS, V210, P1100, DOI 10.1093/infdis/jiu203; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Hutagalung R, 2000, J INFECT DIS, V181, P1513, DOI 10.1086/315373; Kampuansai Jatupol, 2007, ScienceAsia, V33, P443, DOI 10.2306/scienceasia1513-1874.2007.33.443; Kuesap J, 2015, KOREAN J PARASITOL, V53, P265, DOI 10.3347/kjp.2015.53.3.265; Kutanan W, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-56; Kutanan W, 2011, CHIANG MAI J SCI, V38, P295; Langlois S, 2008, J OBSTET GYNAECOL CA, V30, P950, DOI 10.1016/S1701-2163(16)32975-9; Martiney JA, 1996, MOL MED, V2, P236, DOI 10.1007/BF03401620; Naka I, 2008, BIOCHEM GENET, V46, P708, DOI 10.1007/s10528-008-9185-3; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Penth H, 2000, BRIEF HIST L N N CIV; Rangan A, 2009, INDIAN J PEDIATR, V76, P615, DOI 10.1007/s12098-009-0082-5; Schliesinger J, 2000, ETHNIC GROUPS THAILA; Schliesinger J, 2001, INTRO OVERVIEW TAI G; Shannon KL, 2015, AM J TROP MED HYG, V93, P281, DOI 10.4269/ajtmh.14-0623; TAN IK, 1969, CLIN CHEM, V15, P467; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Tienthavorn V., 2006, THAI HEMATOL TRANSF, V16, P307; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Tripathi AK, 2004, ANAL BIOCHEM, V325, P85, DOI 10.1016/j.ab.2003.10.016; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Win N, 2005, ACTA MED OKAYAMA, V59, P63; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148079	10.1371/journal.pone.0148079	http://dx.doi.org/10.1371/journal.pone.0148079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808200	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800271
J	Minakhina, S; Naryshkina, T; Changela, N; Tan, W; Steward, R				Minakhina, Svetlana; Naryshkina, Tatyana; Changela, Neha; Tan, William; Steward, Ruth			Zfrp8/PDCD2 Interacts with RpS2 Connecting Ribosome Maturation and Gene-Specific Translation	PLOS ONE			English	Article							STEM-CELLS; FLUORESCENT PROTEIN; SELF-RENEWAL; DROSOPHILA; PDCD2; INITIATION; SUBUNITS; HOMOLOG; REVEALS; ENCODES	Zfrp8/PDCD2 is a highly conserved protein essential for stem cell maintenance in both flies and mammals. It is also required in fast proliferating cells such as cancer cells. Our previous studies suggested that Zfrp8 functions in the formation of mRNP (mRNA ribonucleoprotein) complexes and also controls RNA of select Transposable Elements (TEs). Here we show that in Zfrp8/PDCD2 knock down (KD) ovaries, specific mRNAs and TE transcripts show increased nuclear accumulation. We also show that Zfrp8/PDCD2 interacts with the (40S) small ribosomal subunit through direct interaction with RpS2 (uS5). By studying the distribution of endogenous and transgenic fluorescently tagged ribosomal proteins we demonstrate that Zfrp8/PDCD2 regulates the cytoplasmic levels of components of the small (40S) ribosomal subunit, but does not control nuclear/nucleolar localization of ribosomal proteins. Our results suggest that Zfrp8/PDCD2 functions at late stages of ribosome assembly and may regulate the binding of specific mRNA-RNPs to the small ribosomal subunit ultimately controlling their cytoplasmic localization and translation.	[Minakhina, Svetlana; Naryshkina, Tatyana; Changela, Neha; Tan, William; Steward, Ruth] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA; [Minakhina, Svetlana] Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Minakhina, S; Steward, R (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ USA.; Minakhina, S (corresponding author), Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.	svetam@rutgers.edu; steward@waksman.rutgers.edu			National Insitutes of Health (NIH) [RO1GM089992]; W. Horace Goldsmith Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. Horace Goldsmith Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the National Insitutes of Health, (NIH RO1GM089992) and by the W. Horace Goldsmith Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; ALLROBYN JA, 1990, MOL CELL BIOL, V10, P6544, DOI 10.1128/MCB.10.12.6544; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Barboza N, 2013, CANCER BIOL THER, V14, P546, DOI 10.4161/cbt.24484; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burroughs AM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00424; Chan HYE, 2001, MOL BIOL CELL, V12, P1409, DOI 10.1091/mbc.12.5.1409; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; CRAMTON SE, 1994, GENETICS, V137, P1039; Daftuar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068667; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Granier CJ, 2014, BIOL OPEN, V3, P821, DOI 10.1242/bio.20148326; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Huttlin E, 2010, BIOGRID; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kramer J, 2013, STEM CELLS DEV, V22, P58, DOI 10.1089/scd.2012.0074; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lecuyer Eric, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5019; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McLeod T, 2014, BIOCHEM SOC T, V42, P1224, DOI 10.1042/BST20140062; Minakhina S, 2007, DEVELOPMENT, V134, P2387, DOI 10.1242/dev.003616; Minakhina S, 2014, DEVELOPMENT, V141, P259, DOI 10.1242/dev.101410; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mu W, 2010, DEV BIOL, V347, P279, DOI 10.1016/j.ydbio.2010.08.026; Munn K, 2000, GENETICS, V156, P245; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Pare C, 2000, J CELL SCI, V113, P2119; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2009, J BIOL CHEM, V284, P15026, DOI 10.1074/jbc.M109.004812; PHILLIPS WF, 1976, J BIOL CHEM, V251, P2876; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rugjee KN, 2013, PEERJ, V1, DOI 10.7717/peerj.15; Scarr RB, 2002, ONCOGENE, V21, P5245, DOI 10.1038/sj.onc.1205647; Shpiz S, 2007, MOL BIOL EVOL, V24, P2535, DOI 10.1093/molbev/msm205; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sugimura K, 2003, J NEUROSCI, V23, P3752; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Sytnikova YA, 2014, GENOME RES, V24, P1977, DOI 10.1101/gr.178129.114; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Tan W, 2015, ZFRP8 FORMS CO UNPUB; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wilk R, 2013, G3-GENES GENOM GENET, V3, P1177, DOI 10.1534/g3.113.006023; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010	70	9	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147631	10.1371/journal.pone.0147631	http://dx.doi.org/10.1371/journal.pone.0147631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807849	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800156
J	Seike, S; Miyamoto, K; Kobayashi, K; Takehara, M; Nagahama, M				Seike, Soshi; Miyamoto, Kazuaki; Kobayashi, Keiko; Takehara, Masaya; Nagahama, Masahiro			Clostridium perfringens Delta-Toxin Induces Rapid Cell Necrosis	PLOS ONE			English	Article							PORE-FORMING TOXINS; BIOLOGICAL-ACTIVITIES; ALPHA-TOXIN; MEMBRANE; MECHANISM; COMPLEX; IDENTIFICATION; BINDING	Clostridium perfringens delta-toxin is a beta-pore-forming toxin and a putative pathogenic agent of C. perfringens types B and C. However, the mechanism of cytotoxicity of delta-toxin remains unclear. Here, we investigated the mechanisms of cell death induced by delta-toxin in five cell lines (A549, A431, MDCK, Vero, and Caco-2). All cell lines were susceptible to delta-toxin. The toxin caused rapid ATP depletion and swelling of the cells. Delta-toxin bound and formed oligomers predominantly in plasma membrane lipid rafts. Destruction of the lipid rafts with methyl beta-cyclodextrin inhibited delta-toxin-induced cytotoxicity and ATP depletion. Delta-toxin caused the release of carboxyfluorescein from sphingomyelin-cholesterol liposomes and formed oligomers; toxin binding to the liposomes declined with decreasing cholesterol content in the liposomes. Flow cytometric assays with annexin V and propidium iodide revealed that delta-toxin treatment induced an elevation in the population of annexin V-negative and propidium iodide-positive cells. Delta-toxin did not cause the fragmentation of DNA or caspase-3 activation. Furthermore, delta-toxin caused damage to mitochondrial membrane permeability and cytochrome c release. In the present study, we demonstrate that delta-toxin produces cytotoxic activity through necrosis.	[Seike, Soshi; Miyamoto, Kazuaki; Kobayashi, Keiko; Takehara, Masaya; Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho, Tokushima 7708514, Japan	Tokushima Bunri University	Nagahama, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho, Tokushima 7708514, Japan.	nagahama@ph.bunri-u.ac.jp		Alsayeh, Abdulaziz/0000-0003-2677-8841; Seike, Soshi/0000-0001-9029-0715	KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [2546052]	KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grants-in-Aid for Scientific Research, KAKENHI, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (https://www.jsps.go.jp/english/index.html), 2015, Grant number: 2546052. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1996, GENE DEV, V17, P2481; Alonso A, 2000, BIOCHEMISTRY-US, V39, P14019, DOI 10.1021/bi001739o; ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Huyet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066673; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; Manich M, 2008, PLOS ONE, V3, pe3764, DOI [10.1371/journal.pone.0003764, DOI 10.1371/J0URNAL.P0NE.0003764]; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Nagahama M, 1996, BBA-BIOMEMBRANES, V1280, P120, DOI 10.1016/0005-2736(95)00288-X; Nagahama M, 2015, TOXINS, V7, P396, DOI 10.3390/toxins7020396; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; NIILO L, 1988, CAN VET J, V29, P658; NIILO L, 1987, CAN J VET RES, V51, P224; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; SAKURAI J, 1995, MICROBIOL IMMUNOL, V39, P249, DOI 10.1111/j.1348-0421.1995.tb02197.x; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; YAMAGISHI T, 1987, MICROBIOL IMMUNOL, V31, P859, DOI 10.1111/j.1348-0421.1987.tb03147.x; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13; Zeng R, 2012, ACTA PHARMACOL SIN, V33, P91, DOI 10.1038/aps.2011.143	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147957	10.1371/journal.pone.0147957	http://dx.doi.org/10.1371/journal.pone.0147957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807591	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800252
J	Shultz, DB; Pai, J; Chiu, W; Ng, K; Hellendag, MG; Heestand, G; Chang, DT; Tu, DS; Moore, MJ; Parulekar, WR; Koong, AC				Shultz, David B.; Pai, Jonathan; Chiu, Wayland; Ng, Kendall; Hellendag, Madeline G.; Heestand, Gregory; Chang, Daniel T.; Tu, Dongsheng; Moore, Malcolm J.; Parulekar, Wendy R.; Koong, Albert C.			A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3	PLOS ONE			English	Article							CARBOHYDRATE ANTIGEN 19-9; PHASE-III TRIAL; PROGNOSTIC-SIGNIFICANCE; PROXIMITY LIGATION; EXPRESSION; CHEMOTHERAPY; PREDICTOR; SURVIVAL; CA-19-9; HYPOXIA	Purpose NCIC Clinical Trials Group PA.3 was a randomized control trial that demonstrated improved overall survival (OS) in patients receiving erlotinib in addition to gemcitabine for locally advanced or metastatic pancreatic cancer. Prior to therapy, patients had plasma samples drawn for future study. We sought to identify biomarkers within these samples. Experimental Design Using the proximity ligation assay (PLA), a probe panel was built from commercially available antibodies for 35 key proteins selected from a global genetic analysis of pancreatic cancers, and used to quantify protein levels in 20 uL of patient plasma. To determine if any of these proteins levels independently associated with OS, univariate and mulitbaraible Cox models were used. In addition, we examined the associations between biomarker expression and disease stage at diagnosis using Fisher's exact test. The correlation between Erlotinib sensitivity and each biomarkers was assessed using a test of interaction between treatment and biomarker. Results and Conclusion Of the 569 eligible patients, 480 had samples available for study. Samples were randomly allocated into training (251) and validation sets (229). Among all patients, elevated levels of interleukin-8 (IL-8), carcinoembryonic antigen (CEA), hypoxia-inducible factor 1-alpha (HIF-1 alpha), and interleukin-6 were independently associated with lower OS, while IL-8, CEA, platelet-derived growth factor receptor alpha and mucin-1 were associated with metastatic disease. Patients with elevated levels of receptor tyrosine-protein kinase erbB-2 (HER2) expression had improved OS when treated with erlotinib compared to placebo. In conclusion, PLA is a powerful tool for identifying biomarkers from archived, small volume serum samples. These data may be useful to stratify patient outcomes regardless of therapeutic intervention.	[Shultz, David B.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pai, Jonathan] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Chiu, Wayland; Ng, Kendall; Chang, Daniel T.; Koong, Albert C.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Hellendag, Madeline G.] Kaiser Permanente Med Ctr, San Francisco, CA USA; [Heestand, Gregory] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tu, Dongsheng; Parulekar, Wendy R.] Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada; [Moore, Malcolm J.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California San Francisco; Stanford University; Kaiser Permanente; University of California System; University of California San Diego; Queens University - Canada; Canadian Cancer Trials Group; British Columbia Cancer Agency	Koong, AC (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	akoong@stanford.edu		Koong, Albert/0000-0001-9824-1643; Shultz, David/0000-0001-8242-6555; Chiu, Wayland/0000-0001-6992-3020; Chang, Daniel/0000-0003-2760-1554; Ng, Kendall/0000-0001-7040-9301	My Blue Dots; Sydney Ng Memorial Fund	My Blue Dots; Sydney Ng Memorial Fund	Funding for this study was provided by My Blue Dots and the Sydney Ng Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bauer TM, 2013, CANCER-AM CANCER SOC, V119, P285, DOI 10.1002/cncr.27734; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Chen Y, 2012, WORLD J GASTROENTERO, V18, P1123, DOI 10.3748/wjg.v18.i10.1123; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Colbert LE, 2015, INT J RADIAT ONCOL, V91, P631, DOI 10.1016/j.ijrobp.2014.11.004; Dumitra S, 2013, HPB, V15, P1002, DOI 10.1111/hpb.12085; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Haas M, 2013, J CANCER RES CLIN, V139, P681, DOI 10.1007/s00432-012-1371-3; Hammel P, 2013, COMP CHEMORADIOTHERA, V2013, P31; Harder J, 2012, BRIT J CANCER, V106, P1033, DOI 10.1038/bjc.2012.18; Harsha H.C., 2009, PLOS MED, DOI DOI 10.1371/J0URNAL.PMED.1000046; Holmer R, 2014, HEPATOB PANCREAT DIS, V13, P371, DOI 10.1016/S1499-3872(14)60259-9; Kitamoto S, 2013, ONCOGENE, V32, P4614, DOI 10.1038/onc.2012.478; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Koom WS, 2009, INT J RADIAT ONCOL, V73, P1148, DOI 10.1016/j.ijrobp.2008.06.1483; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Micke O, 2003, ANTICANCER RES, V23, P835; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Safran H, 2004, CANCER INVEST, V22, P706, DOI 10.1081/CNV-200032974; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Shi QA, 1999, J INTERF CYTOK RES, V19, P1363, DOI 10.1089/107999099312821; Shibaji T, 2003, ANTICANCER RES, V23, P4721; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Stock AM, 2014, EXP CELL RES, V326, P307, DOI 10.1016/j.yexcr.2014.04.022; Tas F, 2014, CANCER CHEMOTH PHARM, V73, P1163, DOI 10.1007/s00280-014-2450-8; Vainshtein JM, 2013, INT J RADIAT ONCOL, V86, P96, DOI 10.1016/j.ijrobp.2012.11.020; Varga Z, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-615; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147995	10.1371/journal.pone.0147995	http://dx.doi.org/10.1371/journal.pone.0147995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808546	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800261
J	Singh, D; Singh, CK; Tomar, RSS; Taunk, J; Singh, R; Maurya, S; Chaturvedi, AK; Pal, M; Singh, R; Dubey, SK				Singh, Dharmendra; Singh, Chandan Kumar; Tomar, Ram Sewak Singh; Taunk, Jyoti; Singh, Ranjeet; Maurya, Sadhana; Chaturvedi, Ashish Kumar; Pal, Madan; Singh, Rajendra; Dubey, Sarawan Kumar			Molecular Assortment of Lens Species with Different Adaptations to Drought Conditions Using SSR Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; CULINARIS MEDIK.; LENTIL; STRESS; CHLOROPHYLL; MICROSATELLITE; TOLERANCE; LEGUMES; YIELD; RESISTANCE	The success of drought tolerance breeding programs can be enhanced through molecular assortment of germplasm. This study was designed to characterize molecular diversity within and between Lens species with different adaptations to drought stress conditions using SSR markers. Drought stress was applied at seedling stage to study the effects on morpho-physiological traits under controlled condition, where tolerant cultivars and wilds showed 12.8-27.6% and 9.5-23.2% reduction in seed yield per plant respectively. When juxtaposed to field conditions, the tolerant cultivars (PDL-1 and PDL-2) and wild (ILWL-314 and ILWL-436) accessions showed 10.5-26.5% and 7.5%-15.6% reduction in seed yield per plant, respectively under rain-fed conditions. The reductions in seed yield in the two tolerant cultivars and wilds under severe drought condition were 48-49% and 30.5-45.3% respectively. A set of 258 alleles were identified among 278 genotypes using 35 SSR markers. Genetic diversity and polymorphism information contents varied between 0.321-0.854 and 0.299-0.836, with mean value of 0.682 and 0.643, respectively. All the genotypes were clustered into 11 groups based on SSR markers. Tolerant genotypes were grouped in cluster 6 while sensitive ones were mainly grouped into cluster 7. Wild accessions were separated from cultivars on the basis of both population structure and cluster analysis. Cluster analysis has further grouped the wild accessions on the basis of species and sub-species into 5 clusters. Physiological and morphological characters under drought stress were significantly (P = 0.05) different among microsatellite clusters. These findings suggest that drought adaptation is variable among wild and cultivated genotypes. Also, genotypes from contrasting clusters can be selected for hybridization which could help in evolution of better segregants for improving drought tolerance in lentil.	[Singh, Dharmendra; Singh, Chandan Kumar; Taunk, Jyoti; Singh, Ranjeet] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Tomar, Ram Sewak Singh] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Maurya, Sadhana; Chaturvedi, Ashish Kumar; Pal, Madan] Indian Agr Res Inst, Div Plant Physiol, New Delhi 110012, India; [Singh, Rajendra] Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi 110012, India; [Dubey, Sarawan Kumar] Cent Soil & Water Conservat Res & Training Inst, Reg Ctr, Agra 248195, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Soil & Water Conservation	Singh, D (corresponding author), Indian Agr Res Inst, Div Genet, New Delhi 110012, India.	dsingh_gen@iari.res.in	CHATURVEDI, ASHISH KUMAR/K-1320-2019; TOMAR, RAM SEWAK SINGH/AAF-5619-2021; PAL, MRINAL/ABG-9676-2020	CHATURVEDI, ASHISH KUMAR/0000-0001-9541-0931; TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; PAL, MRINAL/0000-0002-1032-272X	Department of Biotechnology, India [BT/PR3584/AGR/2/828/2011]; Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, India, Grant Number BT/PR3584/AGR/2/828/2011, URL http://www.dbtindia.nic.in/.; We are grateful to the Head, Division of Genetics and Incharge, National Phytotron Facility, Indian Agricultural Research Institute, New Delhi, for help in all our research activities. Authors are thankful to Department of Biotechnology, Ministry of Science and Technology, Government of India for providing financial assistance. Supply of lentil seeds from International Center for Agricultural Research in the Dry Areas (ICARDA), Aleppo, Syria and National Bureau of Plant Genetic Resources, New Delhi, India is gratefully acknowledged. We are also thankful to Dr. Shiv Kumar Agarwal for providing origin of wild accessions.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Banon S, 2006, ENVIRON EXP BOT, V56, P36, DOI 10.1016/j.envexpbot.2004.12.004; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Chatterjee SS, 2005, FUNCTIONAL PHYSL DRO, P149; Cornelious BK, 2002, CROP SCI, V42, P642, DOI 10.2135/cropsci2002.0642; Dhanda SS, 2004, J AGRON CROP SCI, V190, P6, DOI 10.1111/j.1439-037X.2004.00592.x; Dikshit HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138101; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Erskine W, 2011, FOOD SECUR, V3, P127, DOI 10.1007/s12571-011-0124-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FANI E, 2012, ADV STUD BIOL, V4, P545; Fratini R, 2006, PLANT BREEDING, V125, P501, DOI 10.1111/j.1439-0523.2006.01277.x; Fratini R, 2006, EUPHYTICA, V150, P271, DOI 10.1007/s10681-006-9118-3; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Homayoun H., 2011, Middle East Journal of Scientific Research, V9, P418; Hu YC, 2007, ENVIRON EXP BOT, V60, P268, DOI 10.1016/j.envexpbot.2006.11.003; Idrissi O, 2016, PLANT MOL BIOL REP, V34, P659, DOI 10.1007/s11105-015-0940-4; Idrissi O, 2015, EUPHYTICA, V204, P693, DOI 10.1007/s10681-015-1373-8; Idrissi O, 2015, PLANT BREEDING, V134, P322, DOI 10.1111/pbr.12261; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; JOHANSEN C, 1994, CURR PLANT SCI BIOT, V19, P175; Joshi M, 2013, BIOSCAN S, V8, P1529; Kaur S, 2014, THEOR APPL GENET, V127, P703, DOI 10.1007/s00122-013-2252-0; Khayatnezhad M, 2012, AFR J MICROBIOL RES, V6, P2844, DOI 10.5897/AJMR11.964; Kumar A, 1998, ANN BOT-LONDON, V81, P413, DOI 10.1006/anbo.1997.0573; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Kumar S, 2011, BIOLOGY AND BREEDING OF FOOD LEGUMES, P81, DOI 10.1079/9781845937669.0081; Kushwaha UKS, 2015, AGR BIOL SCI J, V1, P16; Kushwaha UKS, 2013, INT J APPL SCI BIOTE, V1, P132, DOI DOI 10.3126/ijasbt.v1i3.8608; Liu K, 2004, POWER MARKER NEW GEN; Lovisolo C, 1998, J EXP BOT, V49, P693, DOI 10.1093/jexbot/49.321.693; MacKinney G, 1941, J BIOL CHEM, V140, P315; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; Monti A, 2006, FIELD CROP RES, V98, P157, DOI 10.1016/j.fcr.2006.01.002; Moussa HR, 2008, AUST J CROP SCI, V1, P31; Muehlbauer FJ, 2006, EUPHYTICA, V147, P149, DOI 10.1007/s10681-006-7108-0; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Muscolo A, 2014, J PLANT INTERACT, V9, P354, DOI 10.1080/17429145.2013.835880; Nagarajan Shantha, 2000, Indian Journal of Plant Physiology, V5, P264; Nazari L., 2008, Biotechnology, V7, P745; Pritchard JK, 2000, GENETICS, V155, P945; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Rana MK, 2004, J PLANT BIOCHEM BIOT, V13, P19, DOI 10.1007/BF03263185; Reddy MRK, 2010, PLANT BREEDING, V129, P514, DOI 10.1111/j.1439-0523.2009.01723.x; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Shah ZH, 2009, CURR ISSUES MOL BIOL, V11, P101; Sharma S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00309; Shunmugiah VR, 2015, TRANSCRIPTOMICS, DOI [10.4172/2329-8936.1000105, DOI 10.4172/2329-8936.1000105]; Siddique KHM, 1999, AUST J AGR RES, V50, P375, DOI 10.1071/A98096; SIMON L, 1994, J PLANT NUTR, V17, P293, DOI 10.1080/01904169409364728; Singh D, 2013, PLANT BREEDING, V132, P185, DOI 10.1111/pbr.12033; Sonnante G, 2007, GENET RESOUR CROP EV, V54, P1023, DOI 10.1007/s10722-006-9153-x; Suvorova G, 2014, CZECH J GENET PLANT, V50, P130, DOI 10.17221/231/2013-CJGPB; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terzi R, 2010, TURK J BOT, V34, P1, DOI 10.3906/bot-0905-20; Thameur A, 2012, J ENVIRON MANAGE, V113, P495, DOI 10.1016/j.jenvman.2012.05.026; Tullu A., 2013, CAN J PLANT SCI, V93, P1; Turyagyenda LF, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt007; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Youssef MA., 2010, J AM SCI, V6, P355; Yuzbasioglu E, 2006, GENET RESOUR CROP EV, V53, P507, DOI 10.1007/s10722-004-2030-6	71	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147213	10.1371/journal.pone.0147213	http://dx.doi.org/10.1371/journal.pone.0147213			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808306	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800062
J	Meyer, CB; Meyer, JS; Francisco, AB; Holder, J; Verdonck, F				Meyer, Carolyn B.; Meyer, Joseph S.; Francisco, Alex B.; Holder, Jennifer; Verdonck, Frederik			Can Ingestion of Lead Shot and Poisons Change Population Trends of Three European Birds: Grey Partridge, Common Buzzard, and Red Kite?	PLOS ONE			English	Article							PERDIX-PERDIX; MILVUS-MILVUS; DENSITY-DEPENDENCE; BUTEO-BUTEO; SURVIVAL; RAPTOR; EXPOSURE; REPRODUCTION; DECLINE; KESTREL	Little is known about the magnitude of the effects of lead shot ingestion alone or combined with poisons (e.g., in bait or seeds/granules containing pesticides) on population size, growth, and extinction of non-waterbird avian species that ingest these substances. We used population models to create example scenarios demonstrating how changes in these parameters might affect three susceptible species: grey partridge (Perdix perdix), common buzzard (Buteo buteo), and red kite (Milvus milvus). We added or subtracted estimates of mortality due to lead shot ingestion (4-16% of mortality, depending on species) and poisons (4-46% of mortality) reported in the UK or France to observed mortality of studied populations after models were calibrated to observed population trends. Observed trends were decreasing for partridge (in continental Europe), stable for buzzard (in Germany), and increasing for red kite (in Wales). Although lead shot ingestion and poison at modeled levels did not change the trend direction for the three species, they reduced population size and slowed population growth. Lead shot ingestion at modeled rates reduced population size of partridges by 10%, and when combined with bait and pesticide poisons, by 18%. For buzzards, decrease in mean population size by lead shot and poisons combined was much smaller (<= 1%). The red kite population has been recovering; however, modeled lead shot ingestion reduced its annual growth rate from 6.5% to 4%, slowing recovery. If mortality from poisoned baits could be removed, the kite population could potentially increase at a rapid annual rate of 12%. The effects are somewhat higher if ingestion of these substances additionally causes sublethal reproductive impairment. These results have uncertainty but suggest that declining or recovering populations are most sensitive to lead shot or poison ingestion, and removal of poisoned baits can have a positive impact on recovering raptor populations that frequently feed on carrion.	[Meyer, Carolyn B.; Meyer, Joseph S.] Arcadis, Lakewood, CO USA; [Meyer, Joseph S.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Francisco, Alex B.] Arcadis, Walnut Creek, CA USA; [Holder, Jennifer] ERM, Carpinteria, CA USA; [Verdonck, Frederik] ARCHE, Ghent, Belgium	Colorado School of Mines	Meyer, CB (corresponding author), Arcadis, Lakewood, CO USA.	Carolyn.meyer@arcadis.com			"ARCADIS"; "ERM"; "ARCHE"; Association of European Manufacturers of Sporting Ammunition (AFEMS)	"ARCADIS"; "ERM"; "ARCHE"; Association of European Manufacturers of Sporting Ammunition (AFEMS)	"ARCADIS", "ERM" and "ARCHE" provided support in the form of salaries for authors CBM, JSM, ABF (ARCADIS), JH (ERM) & FV (ARCHE), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section. Support was also provided by Association of European Manufacturers of Sporting Ammunition (AFEMS at www.afems.org).	Akcakaya HR, 2005, RAMAS METAPOP VIABIL; BEISSINGER SR, 1995, ECOL APPL, V5, P618, DOI 10.2307/1941971; Bennett R, 2011, EPA600R11023; Berny P, 2008, J WILDLIFE DIS, V44, P417, DOI 10.7589/0090-3558-44.2.417; Bird Life International, 2015, RED LIST OF BRIDS; BirdLife International, 2015, SPEC FACT SHEET RED; BirdLife International, 2004, BIRDS EUR UN STAT AS; Boele A, 2011, 201301 SOV VOG; Bro E, 2001, IBIS, V143, P120, DOI 10.1111/j.1474-919X.2001.tb04176.x; Bro E, 2005, WILDLIFE BIOL, V11, P287; Bro E, 2012, BIRD STUDY, V59, P320, DOI 10.1080/00063657.2012.674099; Browne SJ, 2006, GAMEBIRD 2006 QUAIL, P380; BUERGER TT, 1986, J WILDLIFE MANAGE, V50, P1, DOI 10.2307/3801479; Butler DA, 2005, WILDLIFE SOC B, V33, P583, DOI 10.2193/0091-7648(2005)33[583:LEIRPO]2.0.CO;2; Caswell H, 1989, MATRIX POPULATION MO; Clausen B, 1979, COMMUNICATION; Cross T., THREATS TO KITES; DAVIS PE, 1981, J ANIM ECOL, V50, P759, DOI 10.2307/4135; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; Donazar JA, 2002, BIOL CONSERV, V107, P89, DOI 10.1016/S0006-3207(02)00049-6; Elliott KH, 2011, J WILDLIFE MANAGE, V75, P1688, DOI 10.1002/jwmg.233; Ewald J, 2006, GAMEBIRD 2006 QUAIL, P27; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; Garcia-Ferandez AJ, 2005, B ENVIRON CONTAM TOX, V74, P314, DOI 10.1007/s00128-004-0586-7; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Grell MD, 2007, BIRD CENSUS NEWS, p20/1; HEITMEYER ME, 1993, J WILDLIFE MANAGE, V57, P733, DOI 10.2307/3809073; HENNY CJ, 2003, HDB ECOTOXICOLOGY, P755; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; HIRAI M, 1991, BIOL TRACE ELEM RES, V30, P291, DOI 10.1007/BF02991424; Hood G. M., 2011, POPTOOLS VERSION 3 2; JORGENSEN SS, 1987, AMBIO, V16, P11; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; Kruger O, 2004, BIRD STUDY, V51, P125; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O., 2000, THESIS U BIELEFELD; Kuijper DPJ, 2009, EUR J WILDLIFE RES, V55, P455, DOI 10.1007/s10344-009-0311-2; Landis W.G., 2011, INTRO ENV TOXICOLOGY, V4th edn.; Lensick R., 1997, J ANIM ECOL, V66, P811; Lieske DJ, 2000, AUK, V117, P184, DOI 10.1642/0004-8038(2000)117[0184:EOPDOS]2.0.CO;2; Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Mallory M.L., 2014, COMMON BIRDS NUNAVUT; Mateo R, 2009, INGESTION LEAD SPENT, P1; Mcconnell CA, 1968, P ANN C SE ASS GAM F, V21, P208; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Morris W. F., 2002, QUANTITATIVE CONSERV; Murn C, 2012, ECOLOGY CONSERVATION, P351; Newman MC., 2013, QUANTITATIVE ECOTOXI; NEWTON I, 1994, P ROY SOC B-BIOL SCI, V257, P317, DOI 10.1098/rspb.1994.0132; Newton I., 1979, Raptor Research, V13, P65; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Pain DJ, 2007, SCI TOTAL ENVIRON, V376, P116, DOI 10.1016/j.scitotenv.2007.01.062; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1995, ENVIRON POLLUT, V87, P173, DOI 10.1016/0269-7491(94)P2604-8; Parish DMB, 2007, WILDLIFE BIOL, V13, P140, DOI 10.2981/0909-6396(2007)13[140:TFORCG]2.0.CO;2; Potts G.R., 2012, PARTRIDGES COUNTRYSI, P480; Potts GR, 2005, EUR J WILDLIFE RES, V51, P31, DOI 10.1007/s10344-004-0071-y; Potts GR, 1986, PARTRIDGE PESTICIDES; Reif V, 2004, ANN ZOOL FENN, V41, P599; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; Rooney CP, 2007, ENVIRON POLLUT, V149, P149, DOI 10.1016/j.envpol.2007.01.009; SAMUEL MD, 1992, T N AM WILDL NAT RES, P486; Sanderson GC, 1986, SPEC PUBL, V4; SCHMUTZ J K, 1989, Journal of Raptor Research, V23, P147; Schreiber A, 2001, J ORNITHOL, V142, P34, DOI 10.1007/BF01651737; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smart J, 2010, BIOL CONSERV, V143, P1278, DOI 10.1016/j.biocon.2010.03.002; Stephens RM, 2005, SECONDARY LEAD POI; Tannenbaum L, 2014, HUM ECOL RISK ASSESS, V20, P479, DOI 10.1080/10807039.2012.746143; Tavecchia G, 2001, J APPL ECOL, V38, P1197, DOI 10.1046/j.0021-8901.2001.00684.x; Tavecchia G, 2012, J APPL ECOL, V49, P297, DOI 10.1111/j.1365-2664.2011.02074.x; Tenan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049187; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Welsh Kite Trust Producer, RED KIT DAT; Wotton SR, 2002, BIRD STUDY, V49, P278	80	9	10	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147189	10.1371/journal.pone.0147189	http://dx.doi.org/10.1371/journal.pone.0147189			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799815	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300071
J	Last, M; Rabinowitz, N; Leonard, G				Last, Mark; Rabinowitz, Nitzan; Leonard, Gideon			Predicting the Maximum Earthquake Magnitude from Seismic Data in Israel and Its Neighboring Countries	PLOS ONE			English	Article							MODEL; HAZARD; FAULT	This paper explores several data mining and time series analysis methods for predicting the magnitude of the largest seismic event in the next year based on the previously recorded seismic events in the same region. The methods are evaluated on a catalog of 9,042 earthquake events, which took place between 01/01/1983 and 31/12/2010 in the area of Israel and its neighboring countries. The data was obtained from the Geophysical Institute of Israel. Each earthquake record in the catalog is associated with one of 33 seismic regions. The data was cleaned by removing foreshocks and aftershocks. In our study, we have focused on ten most active regions, which account for more than 80% of the total number of earthquakes in the area. The goal is to predict whether the maximum earthquake magnitude in the following year will exceed the median of maximum yearly magnitudes in the same region. Since the analyzed catalog includes only 28 years of complete data, the last five annual records of each region (referring to the years 2006-2010) are kept for testing while using the previous annual records for training. The predictive features are based on the Gutenberg-Richter Ratio as well as on some new seismic indicators based on the moving averages of the number of earthquakes in each area. The new predictive features prove to be much more useful than the indicators traditionally used in the earthquake prediction literature. The most accurate result (AUC = 0.698) is reached by the Multi-Objective Info-Fuzzy Network (M-IFN) algorithm, which takes into account the association between two target variables: the number of earthquakes and the maximum earthquake magnitude during the same year.	[Last, Mark] Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel; [Rabinowitz, Nitzan] Human Monitoring Ltd, Rehovot, Israel; [Leonard, Gideon] Israel Atom Energy Commiss, Tel Aviv, Israel	Ben Gurion University	Last, M (corresponding author), Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel.	mlast@bgu.ac.il	Last, Mark/AAF-8443-2020		Human Monitoring Ltd	Human Monitoring Ltd	One of the authors (NR) is employed by a commercial company - Human Monitoring Ltd. The funder (Human Monitoring Ltd) provided support in the form of salary for the author NR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1995, SEISMOL RES LETT, DOI DOI 10.1785/GSSRL.66.4.8; ARIEH E, 1989, TECTONOPHYSICS, V167, P223, DOI 10.1016/0040-1951(89)90073-5; Cristianini N., 2000, INTRO SUPPORT VECTOR, DOI [10.1017/CBO9780511801389, DOI 10.1017/CBO9780511801389]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hamiel Y, 2009, B SEISMOL SOC AM, V99, P2020, DOI 10.1785/0120080218; Kaufmann L, 2008, FINDING GROUPS DATA; KEILISBOROK VI, 1990, PHYS EARTH PLANET IN, V61, P73, DOI 10.1016/0031-9201(90)90096-G; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; Last M, 2004, LECT NOTES COMPUT SC, V3201, P239; Last M, 2004, IEEE T KNOWL DATA EN, V16, P203, DOI 10.1109/TKDE.2004.1269598; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Minium E. W., 1999, ELEMENTS STAT REASON; Mitchell T.M, 2003, MACH LEARN; Morales-Esteban A, 2010, EXPERT SYST APPL, V37, P8333, DOI 10.1016/j.eswa.2010.05.050; Murck BW, 1999, GEOLOGY TODAY UNDERS; Panakkat A, 2007, INT J NEURAL SYST, V17, P13, DOI 10.1142/S0129065707000890; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rhoades DA, 2007, SEISMOL RES LETT, V78, P110, DOI 10.1785/gssrl.78.1.110; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Stein S, 2011, SEISMOL RES LETT, V82, P623, DOI 10.1785/gssrl.82.5.623; The Geophysical Institute of Israel Seismology Division, 2010, GEOPH I ISR SEISM B; Tiampo KF, 2002, EUROPHYS LETT, V60, P481, DOI 10.1209/epl/i2002-00289-y; Tormann T, 2008, B SEISMOL SOC AM, V98, P2149, DOI 10.1785/0120060217; Werner MJ, 2011, B SEISMOL SOC AM, V101, P1630, DOI 10.1785/0120090340; Ziv A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027141	27	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146101	10.1371/journal.pone.0146101	http://dx.doi.org/10.1371/journal.pone.0146101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812351	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000005
J	Min, PK; Cho, M; Hong, SY; Kim, JY; Choi, EY; Yoon, YW; Lee, BK; Hong, BK; Rim, SJ; Kwon, HM				Min, Pil-Ki; Cho, Minhee; Hong, Sung-Yu; Kim, Jong-Youn; Choi, Eui-Young; Yoon, Young-Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon			Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; C-REACTIVE PROTEIN; ENDOTHELIAL MICROPARTICLES; BIOMARKERS; GRAYSCALE; CORRELATE; PECTORIS; BLOOD	High levels of microparticles (MPs) circulate in the blood of patients with atherosclerotic diseases where they can serve as potential biomarkers of vascular injury and cardiovascular outcome. We used virtual histology intravascular ultrasound (VH-IVUS) to evaluate the relationship between the levels of circulating MPs and the coronary plaque composition in patients with stable angina. We included 35 patients with stable angina (22 men, age 64 +/- 9 years) and a de novo target lesion. Preintervention gray-scale and VH-IVUS analysis was performed across the target lesion. Volumetric analysis was performed over a 10-mm-long segment centered at the minimum luminal site. Blood samples were obtained from the femoral artery before coronary angioplasty. MPs were measured using a solid-phase capture assay from a commercial kit. We divided participants into either a low MPs group or high MPs group based on the median value of MPs. There was no significant difference in baseline characteristics between the groups. The plaque burden and remodeling index were similar between the groups. The presence of VH-IVUS-derived thin-cap fibroatheroma was not different between the groups. The percentage of the necrotic core (NC) was significantly higher in the high MPs group than in the low MPs group, both in planar (17.0 +/- 8.8% vs. 24.1 +/- 6.9%, p = 0.012) and volumetric analyses (17.0 +/- 4.8% vs. 22.1 +/- 4.3%, p = 0.002). Circulating MPs were positively correlated with the percentage of the NC area at the minimal luminal site (r = 0.491, p = 0.003) and the percentage of the NC volume (r = 0.496, p = 0.002). Elevated levels of circulating MPs were associated with the amount of NC in the target lesion in those with stable angina, suggesting a potential role of circulating MPs as a biomarker for detecting unstable plaque in patients with stable angina.	[Min, Pil-Ki; Cho, Minhee; Kim, Jong-Youn; Choi, Eui-Young; Yoon, Young-Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, Seoul 120749, South Korea; [Min, Pil-Ki; Yoon, Young-Won] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea; [Hong, Sung-Yu] Yonsei Univ Hlth Syst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Min, PK (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, Seoul 120749, South Korea.; Min, PK (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea.	cardioblues@yuhs.ac		Rim, Se Joong/0000-0002-7631-5581; Hong, Bum Kee/0000-0002-6456-0184; Kim, Jong-Youn/0000-0001-7040-8771; Min, Pil-Ki/0000-0001-7033-7651; Lee, Byoung Kwon/0000-0001-9259-2776; Choi, Eui-Young/0000-0003-3732-0190; Kwon, Hyuck Moon/0000-0001-9901-5015	Korean Society of Lipidology and Atherosclerosis	Korean Society of Lipidology and Atherosclerosis	This study was supported by grants from the Korean Society of Lipidology and Atherosclerosis (Industrial-Educational Cooperation, 2010).	Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Bernal-Mizrachi L, 2004, INT J CARDIOL, V97, P439, DOI 10.1016/j.ijcard.2003.10.029; Bernard S, 2009, ATHEROSCLEROSIS, V203, P429, DOI 10.1016/j.atherosclerosis.2008.07.039; Biasucci LM, 2012, CIRC J, V76, P2174, DOI 10.1253/circj.CJ-12-0068; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Ko YG, 2012, YONSEI MED J, V53, P508, DOI 10.3349/ymj.2012.53.3.508; Kubo T, 2009, CORONARY ARTERY DIS, V20, P531, DOI 10.1097/MCA.0b013e328332a6b0; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Maehara A, 2012, JACC-CARDIOVASC IMAG, V5, pS1, DOI 10.1016/j.jcmg.2011.11.019; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Min PK, 2013, ATHEROSCLEROSIS, V227, P323, DOI 10.1016/j.atherosclerosis.2013.01.032; Morel O, 2013, SEMIN THROMB HEMOST, V39, P477, DOI 10.1055/s-0033-1343888; Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044; Park JP, 2010, CIRC J, V74, P332, DOI 10.1253/circj.CJ-09-0570; Puddu Paolo, 2010, Can J Cardiol, V26, P140; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Rodriguez-Granillo Gaston A, 2005, EuroIntervention, V1, P367; Sarlon-Bartoli G, 2013, J AM COLL CARDIOL, V62, P1436, DOI 10.1016/j.jacc.2013.03.078; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148128	10.1371/journal.pone.0148128	http://dx.doi.org/10.1371/journal.pone.0148128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812147	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000076
J	Charles, JJ; Paine, TD				Charles, Jennifer J.; Paine, Timothy D.			Fitness Effects of Food Resources on the Polyphagous Aphid Parasitoid, Aphidius colemani Viereck (Hymenoptera: Braconidae: Aphidiinae)	PLOS ONE			English	Article							GOSSYPII GLOVER HOMOPTERA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; SUGAR COMPOSITION; FLORAL RESOURCES; HONEYDEW; LONGEVITY; FECUNDITY; FLOWERS; NECTAR	Conservation biological control involving the polyphagous aphid parasitoid, Aphidius colemani Viereck, may include provisioning resources from a variety of plant sources. The fitness of adult A. colemani was enhanced with the provision of food resources such as floral nectar from a range of both native and introduced plant species and aphid honeydew under laboratory conditions. However, enhanced fitness appeared to be species specific rather than associated with the whether the plant was a native or an introduced species. Parasitoid survival and fecundity were enhanced significantly in response to the availability of floral nectar and honeydew compared to the response to available extrafloral nectar. These positive effects on the parasitoid's reproductive activity can improve the effectiveness of conservation biological control in nursery production systems because of the abundance and diversity of floral resources within typical production areas. Additionally, surrounding areas of invasive weeds and native vegetation could serve as both floral resources and honeydew food resources for A. colemani.	[Charles, Jennifer J.; Paine, Timothy D.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Paine, TD (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	timothy.paine@ucr.edu			California Association of Nurseries and Garden Centers; UC Riverside College of Natural and Agricultural Sciences Research Support Application Program; USDA NIFA Hatch program	California Association of Nurseries and Garden Centers; UC Riverside College of Natural and Agricultural Sciences Research Support Application Program; USDA NIFA Hatch program	Funding in support of the research was provided by the California Association of Nurseries and Garden Centers, the UC Riverside College of Natural and Agricultural Sciences Research Support Application Program, and the USDA NIFA Hatch program in support of the Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt LA, 2006, BIOL CONTROL, V37, P50, DOI 10.1016/j.biocontrol.2005.12.005; BUDENBERG WJ, 1992, ENTOMOL EXP APPL, V63, P259, DOI 10.1007/BF00192774; Chaney William E., 1998, P73; Doten SB, 1911, U NEV AGR EXP STAT B; Dreistadt SH, 2001, U CALIF DIV AGR NAT, V3402; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; ELLIOTT NC, 1987, J KANSAS ENTOMOL SOC, V60, P25; ELLIOTT NC, 1994, GREAT LAKES ENTOMOL, V27, P137; Fiedler AK, 2008, BIOL CONTROL, V45, P254, DOI 10.1016/j.biocontrol.2007.12.009; FURK C, 1990, ANN APPL BIOL, V116, P557, DOI 10.1111/j.1744-7348.1990.tb06638.x; FURK C, 1993, ANN APPL BIOL, V123, P9, DOI 10.1111/j.1744-7348.1993.tb04066.x; Giron D, 2002, FUNCT ECOL, V16, P750, DOI 10.1046/j.1365-2435.2002.00679.x; GRASSWITZ TR, 1993, J INSECT BEHAV, V6, P511, DOI 10.1007/BF01049529; Gurr G., 2004, ECOLOGICAL ENG PEST; Harizanova V, 1997, J ENTOMOL SCI, V32, P17, DOI 10.18474/0749-8004-32.1.17; Heimpel George E., 2005, P267, DOI 10.1017/CBO9780511542220.010; Herron GA, 2001, AUST J ENTOMOL, V40, P85, DOI 10.1046/j.1440-6055.2001.00200.x; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Irvin NA, 2007, BIOL CONTROL, V40, P69, DOI 10.1016/j.biocontrol.2006.09.005; Irvin NA, 2007, BIOL CONTROL, V40, P80, DOI 10.1016/j.biocontrol.2006.09.004; Jacobson RJ, 1998, BIOCONTROL SCI TECHN, V8, P377, DOI 10.1080/09583159830180; JERVIS MA, 1993, J NAT HIST, V27, P67, DOI 10.1080/00222939300770051; Johansen HN, 1996, J AGR FOOD CHEM, V44, P1470, DOI 10.1021/jf950482b; Jonsson M, 2008, BIOL CONTROL, V45, P172, DOI 10.1016/j.biocontrol.2008.01.006; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lee JC, 2006, ECOL ENTOMOL, V31, P470, DOI 10.1111/j.1365-2311.2006.00800.x; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; LEIUS K., 1960, CANADIAN ENT, V92, P369; LEIUS K, 1967, CAN ENTOMOL, V99, P444, DOI 10.4039/Ent99444-4; Matkin O., 1957, UC SYSTEM PRODUCING, P68; OLSON DL, 1995, ENVIRON ENTOMOL, V24, P454, DOI 10.1093/ee/24.2.454; OPP SB, 1986, ANN ENTOMOL SOC AM, V79, P700, DOI 10.1093/aesa/79.4.700; Patt JM, 1997, ENTOMOL EXP APPL, V83, P21, DOI 10.1023/A:1002936210051; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; Pickett CH, 1998, C P U CALIFORNIA, P81; POWELL W, 1983, PHYSIOL ENTOMOL, V8, P439, DOI 10.1111/j.1365-3032.1983.tb00378.x; Rose USR, 2006, FUNCT ECOL, V20, P67, DOI 10.1111/j.1365-2435.2006.01071.x; ROSENHEIM JA, 1991, J ANIM ECOL, V60, P873, DOI 10.2307/5419; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; SCOPES NEA, 1980, SCI HORTIC-ENGLAND, V31, P48; Sivarajan V. V., 1991, INTRO PRINCIPLES PLA; Sivinski J, 2006, ENTOMOL EXP APPL, V118, P193, DOI 10.1111/j.1570-7458.2006.00379.x; Slosser JE, 1986, SW ENTOMOL, V14, P302; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Sweetman H, 1958, PRINCIPLES BIOL CONT; SYME PD, 1977, CAN ENTOMOL, V109, P995, DOI 10.4039/Ent109995-7; SYME PD, 1975, ENVIRON ENTOMOL, V4, P337, DOI 10.1093/ee/4.2.337; Tena A, 2015, J APPL ECOL, V52, P795, DOI 10.1111/1365-2664.12426; Tena A, 2013, BIOL CONTROL, V67, P117, DOI 10.1016/j.biocontrol.2013.07.018; Tylianakis JM, 2004, ECOLOGY, V85, P658, DOI 10.1890/03-0222; vam Emden HF, 2007, APHIDS CROP PESTS; van den BOSCH R., 1964, P459; van Lenteren JC, 2000, CROP PROT, V19, P375, DOI 10.1016/S0261-2194(00)00038-7; VANSTEENIS MJ, 1995, BIOCONTROL SCI TECHN, V5, P339, DOI 10.1080/09583159550039783; VANSTEENIS MJ, 1993, J APPL ENTOMOL, V116, P192, DOI 10.1111/j.1439-0418.1993.tb01188.x; Vasquez GM, 2006, J ECON ENTOMOL, V99, P1104, DOI 10.1603/0022-0493-99.4.1104; Vehrs S. L., 1991, California Agriculture, V45, P28; WAAGE JK, 1984, J ANIM ECOL, V53, P401, DOI 10.2307/4524; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Walton NJ, 2011, ENVIRON ENTOMOL, V40, P1177, DOI 10.1603/EN10321; Wilen C, 2002, CROP PROFILE CALIFOR	64	16	16	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147551	10.1371/journal.pone.0147551	http://dx.doi.org/10.1371/journal.pone.0147551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808191	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800131
J	Herrando-Grabulosa, M; Mulet, R; Pujol, A; Mas, JM; Navarro, X; Aloy, P; Coma, M; Casas, C				Herrando-Grabulosa, Mireia; Mulet, Roger; Pujol, Albert; Manuel Mas, Jose; Navarro, Xavier; Aloy, Patrick; Coma, Mireia; Casas, Caty			Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems	PLOS ONE			English	Article							SPINAL-CORD MOTONEURONS; MICROGLIAL ACTIVATION; DROSOPHILA MODEL; MOUSE MODEL; DISEASE; ALS; RECEPTORS; INJURY; EXCITOTOXICITY; DEGENERATION	Amyotrophic Lateral Sclerosis is a fatal, progressive neurodegenerative disease characterized by loss of motor neuron function for which there is no effective treatment. One of the main difficulties in developing new therapies lies on the multiple events that contribute to motor neuron death in amyotrophic lateral sclerosis. Several pathological mechanisms have been identified as underlying events of the disease process, including excitotoxicity, mitochondrial dysfunction, oxidative stress, altered axonal transport, proteasome dysfunction, synaptic deficits, glial cell contribution, and disrupted clearance of misfolded proteins. Our approach in this study was based on a holistic vision of these mechanisms and the use of computational tools to identify polypharmacology for targeting multiple etiopathogenic pathways. By using a repositioning analysis based on systems biology approach (TPMS technology), we identified and validated the neuroprotective potential of two new drug combinations: Aliretinoin and Pranlukast, and Aliretinoin and Mefloquine. In addition, we estimated their molecular mechanisms of action in silico and validated some of these results in a well-established in vitro model of amyotrophic lateral sclerosis based on cultured spinal cord slices. The results verified that Aliretinoin and Pranlukast, and Aliretinoin and Mefloquine promote neuroprotection of motor neurons and reduce microgliosis.	[Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Univ Autonoma Barcelona, Inst Neurociencies, Grp Neuroplast & Regenerat, E-08193 Barcelona, Spain; [Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Herrando-Grabulosa, Mireia; Navarro, Xavier; Casas, Caty] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Pujol, Albert; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC CRG Program Computat Biol, Barcelona, Catalonia, Spain; [Mulet, Roger; Manuel Mas, Jose; Coma, Mireia] Anax Biotech SL, Barcelona, Catalonia, Spain; [Aloy, Patrick] ICREA, Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Casas, C (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Grp Neuroplast & Regenerat, E-08193 Barcelona, Spain.; Casas, C (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain.; Casas, C (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain.; Coma, M (corresponding author), Anax Biotech SL, Barcelona, Catalonia, Spain.	mcoma@anaxomics.com; Caty.Casas@uab.cat	Navarro, Xavier/C-9577-2011; casas, caty/E-2149-2011; Herrando-Grabulosa, Mireia/K-5364-2014; Aloy, Patrick/AAB-3538-2019	Navarro, Xavier/0000-0001-9849-902X; casas, caty/0000-0002-2273-6321; Herrando-Grabulosa, Mireia/0000-0002-6685-3220; 	Fundacio La marato-TV3 [110430]; European Union's Seventh Framework Programme for research, technological development and demonstration [306240]; Spanish Ministerio de Ciencia e Innovacion [BIO2013-48222]; European Commission [306240]; European Research Council [614944]; ICREA Funding Source: Custom	Fundacio La marato-TV3; European Union's Seventh Framework Programme for research, technological development and demonstration; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	MHG was recipient of a postdoctoral fellowship from Fundacio La marato-TV3 (#110430). This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No. 306240. PA acknowledges financial support from the Spanish Ministerio de Ciencia e Innovacion (BIO2013-48222), the European Commission (Agreement no: 306240) and the European Research Council (Agreements no: 614944). RM and MC are Anaxomics Biotech SL employees and JMM is founder and CEO of Anaxomics. RM and MC have no role in the development of Therapeutic Performance Mapping System ( TPMS) proprietary technology; however, JMM contributes in the design of TPMS. The role of Anaxomics' employees are as follows: RM carried out the ALS characterization used to construct ALS biological network, and performed the analysis of the drug candidates in the context of ALS. JMM designed and carried out the in-silico experiments. MC performed the final selection of drug candidates, designed the in-vitro experimental validation of drugs candidates and wrote the paper.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Casas C, 2014, BRAIN PLAST, P1; Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chautard E, 2011, NUCLEIC ACIDS RES, V39, pD235, DOI 10.1093/nar/gkq830; Cheng C, 2008, ALITRETINOIN COMPREH, P437; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Cozzolino M, 2013, MOL CELL NEUROSCI, V55, P44, DOI 10.1016/j.mcn.2012.06.001; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Deivasigamani S, 2014, BIOL OPEN, V3, P1127, DOI 10.1242/bio.201410066; Droppelmann CA, 2014, AMYOTROPH LATERAL SC, P1; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Guzman-Lenis MS, 2008, NEUROSCIENCE, V155, P104, DOI 10.1016/j.neuroscience.2008.04.078; Guzman-Lenis MS, 2009, RESTOR NEUROL NEUROS, V27, P335, DOI 10.3233/RNN-2009-0482; Herrando-Grabulosa M, 2013, J NEUROCHEM, V124, P36, DOI 10.1111/jnc.12062; Jaeger S, 2012, IUBMB LIFE, V64, P529, DOI 10.1002/iub.1040; Joardar A, 2015, HUM MOL GENET, V24, P1741, DOI 10.1093/hmg/ddu587; Jokic N, 2007, J NEUROCHEM, V103, P1821, DOI 10.1111/j.1471-4159.2007.04893.x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kerrien S, 2012, NUCL ACIDS RES, V40; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lee S, 2012, KOREAN J PHYSIOL PHA, V16, P43, DOI 10.4196/kjpp.2012.16.1.43; Lim E, 2011, EXP NEUROL, V230, P114, DOI 10.1016/j.expneurol.2011.04.003; Llado J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00181; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Malaspina A, 2007, BRAIN RES BULL, V71, P437, DOI 10.1016/j.brainresbull.2006.10.032; Mewes HW, 2011, NUCLEIC ACIDS RES, V39, P220; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Perera S., 2014, NUTRAfoods, V13, P61; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Poppe L, 2014, EXP NEUROL ELSEV JUL; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Soler-Lopez M, 2012, BIOESSAYS, V34, P532, DOI 10.1002/bies.201100193; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Theron AJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/608930; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Tomari S, 2003, CLIN EXP ALLERGY, V33, P795, DOI 10.1046/j.1365-2222.2003.01656.x; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Valls R, 2013, ANAXOMICS METHODOLOG; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001	63	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147626	10.1371/journal.pone.0147626	http://dx.doi.org/10.1371/journal.pone.0147626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807587	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800154
J	Kossatz, S; Weber, WA; Reiner, T				Kossatz, Susanne; Weber, Wolfgang A.; Reiner, Thomas			Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							PROTEIN EXPRESSION; BREAST-CANCER; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; OROPHARYNGEAL CARCINOMA; DNA-DAMAGE; THERAPY; RADIOTHERAPY; CHROMATIN; SURVIVAL	Targeting and inhibiting DNA repair pathways is a powerful strategy of controlling malignant growth. One such strategy includes the inhibition of PARP1, a central element in the intracellular DNA damage response. To determine and visualize the expression and intercellular distribution of PARP1 in vivo, and to monitor the pharmacokinetics of PARP1 targeted therapeutics, fluorescent small probes were developed. To date, however, it is unclear how these probes behave in a more realistic clinical setting, where DNA damage has been induced through one or more prior lines of therapy. Here, we use one such imaging agent, PARPi-FL, in tissues both with and without prior DNA damage, and investigate its value as a probe for PARP1 imaging. We show that PARP1 expression in oral cancer is high, and that the uptake of PARPi-FL is selective, irrespective of whether cells were exposed to irradiation or not. We also show that PARPi-FL uptake increases in response to DNA damage, and that this increase is reflected in higher enzyme expression. Our findings provide a framework for measuring exposure of cells to external beam radiation, and could help to elucidate the effects of such treatments non-invasively in mouse models of cancer.	[Kossatz, Susanne; Weber, Wolfgang A.; Reiner, Thomas] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Weber, Wolfgang A.; Reiner, Thomas] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Reiner, T (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA.; Reiner, T (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA.	reinert@mskcc.org	Kossatz, Susanne/Q-7453-2017	Kossatz, Susanne/0000-0002-1908-1782; Reiner, Thomas/0000-0002-7819-5480	NIH Cancer Center Support Grant [2 P30 CA008748-48]; Imaging and Radiation Sciences Program; NIH Mentored Quantitative Research Career Development [K25 EB016673]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [KO 4966/1-1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB016673] Funding Source: NIH RePORTER	NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging and Radiation Sciences Program; NIH Mentored Quantitative Research Career Development; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank the Flow Cytometry Core and the Molecular Cytology Core at MSK (P30 CA008748). Technical services provided by the MSK Small-Animal Imaging Core Facility were supported in part by NIH Cancer Center Support Grant No 2 P30 CA008748-48. This work was funded in part by the Imaging and Radiation Sciences Program and a NIH Mentored Quantitative Research Career Development (T.R., K25 EB016673, http://grantome.com/grant/NIH/K25-EB016673-01). Susanne Kossatz was funded by a scholarship from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, reference number KO 4966/1-1).	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Carlucci G, 2015, MOL IMAGING BIOL MIB; Carney B, 2015, MOL IMAGING BIOL MIB; Chow JPH, 2013, MOL CANCER THER, V12, P2517, DOI 10.1158/1535-7163.MCT-13-0010; de Arruda FF, 2005, J CLIN ONCOL, V23, p503S; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Deeks ED, 2015, DRUGS, V75, P231, DOI 10.1007/s40265-015-0345-6; DOLY J, 1966, CR ACAD SCI D NAT, V263, P1341; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Dziaman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115558; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galia A, 2012, EUR J HISTOCHEM, V56, P45, DOI 10.4081/ejh.2012.e9; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Green AR, 2015, BREAST CANCER RES TR, V149, P353, DOI 10.1007/s10549-014-3230-1; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Irwin CP, 2014, NEOPLASIA, V16, P432, DOI 10.1016/j.neo.2014.05.005; JUAREZSALINAS H, 1979, NATURE, V282, P740, DOI 10.1038/282740a0; Klein EE, 2005, J APPL CLIN MED PHYS, V6, P81, DOI 10.1120/jacmp.2025.25355; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Lauber K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00116; Lee N, 2003, INT J RADIAT ONCOL, V57, P49, DOI 10.1016/S0360-3016(03)00405-X; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; Lok BH, 2012, INT J RADIAT ONCOL, V82, P1851, DOI 10.1016/j.ijrobp.2011.03.029; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Menegakis A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149; Miah AB, 2012, INT J RADIAT ONCOL, V82, P539, DOI 10.1016/j.ijrobp.2010.09.055; Munshi A, 2005, METH MOLEC MED, V110, P21; Nosho K, 2006, EUR J CANCER, V42, P2374, DOI 10.1016/j.ejca.2006.01.061; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Reiner T, 2012, NEOPLASIA, V14, P169, DOI 10.1593/neo.12414; Ren Y, 2012, INVEST RADIOL, V47, P25, DOI 10.1097/RLI.0b013e31823a82f6; Rieckmann T, 2013, RADIOTHER ONCOL, V107, P242, DOI 10.1016/j.radonc.2013.03.013; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Russell JS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00157; Salemi M, 2013, EUR J HISTOCHEM, V57, P80, DOI 10.4081/ejh.2013.e13; Staibano S, 2005, HUM PATHOL, V36, P724, DOI 10.1016/j.humpath.2005.04.017; Sulzyc-Bielicka V, 2012, POL J PATHOL, V63, P87; Taylor A, 2004, Cancer Imaging, V4, P68, DOI 10.1102/1470-7330.2004.0003; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01	47	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147752	10.1371/journal.pone.0147752	http://dx.doi.org/10.1371/journal.pone.0147752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808835	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800206
J	Lai, AY; Mui, MW; Wan, A; Stewart, SM; Yew, C; Lam, TH; Chan, SS				Lai, Agnes Y.; Mui, Moses W.; Wan, Alice; Stewart, Sunita M.; Yew, Carol; Lam, Tai-hing; Chan, Sophia S.			Development and Two-Year Follow-Up Evaluation of a Training Workshop for the Large Preventive Positive Psychology Happy Family Kitchen Project in Hong Kong	PLOS ONE			English	Article							THE-TRAINERS PROGRAM; PSYCHOSOCIAL CARE; TSUNAMI DISASTER; MENTAL-HEALTH; EDUCATION; MODEL; IMPLEMENTATION; INTERVENTIONS; SURVIVORS	Evidence-based practice and capacity-building approaches are essential for large-scale health promotion interventions. However, there are few models in the literature to guide and evaluate training of social service workers in community settings. This paper presents the development and evaluation of the "train-the-trainer" workshop (TTT) for the first large scale, community-based, family intervention projects, entitled "Happy Family Kitchen Project" (HFK) under the FAMILY project, a Hong Kong Jockey Club Initiative for a Harmonious Society. The workshop aimed to enhance social workers' competence and performance in applying positive psychology constructs in their family interventions under HFK to improve family well-being of the community they served. The two-day TTT was developed and implemented by a multidisciplinary team in partnership with community agencies to 50 social workers (64% women). It focused on the enhancement of knowledge, attitude, and practice of five specific positive psychology themes, which were the basis for the subsequent development of the 23 family interventions for 1419 participants. Acceptability and applicability were enhanced by completing a needs assessment prior to the training. The TTT was evaluated by trainees' reactions to the training content and design, changes in learners (trainees) and benefits to the service organizations. Focus group interviews to evaluate the workshop at three months after the training, and questionnaire survey at pre-training, immediately after, six months, one year and two years after training were conducted. There were statistically significant increases with large to moderate effect size in perceived knowledge, self-efficacy and practice after training, which sustained to 2-year follow-up. Furthermore, there were statistically significant improvements in family communication and well-being of the participants in the HFK interventions they implemented after training. This paper offers a practical example of development, implementation and model-based evaluation of training programs, which may be helpful to others seeking to develop such programs in diverse communities.	[Lai, Agnes Y.; Wan, Alice; Lam, Tai-hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mui, Moses W.] Hong Kong Council Social Serv, Hong Kong, Hong Kong, Peoples R China; [Stewart, Sunita M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Yew, Carol] United Christian Nethersole Community Hlth Serv, United Ctr Emot Hlth & Posit Living, Hong Kong, Hong Kong, Peoples R China; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmlth@hk.hku	Lam, Tai Hing/C-4317-2009	Lam, Tai Hing/0000-0002-2033-9971; LAI, Agnes Yuen Kwan/0000-0002-7321-2632	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	LTH received funding from The Hong Kong Jockey Club Charities Trust for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, AIDS EDUC PREV, V12, P75; Alvarez K., 2004, HUM RESOUR DEV REV, V3, P385, DOI [10.1177/1534484304270820, DOI 10.1177/1534484304270820]; Barrtman LKJ, 2011, EUCATION RES REV, V2, P125; Becker SM, 2006, AM J PUBLIC HEALTH, V96, P1397, DOI 10.2105/AJPH.2005.064428; Becker SM, 2009, AM J PUBLIC HEALTH, V99, P654, DOI 10.2105/AJPH.2008.146571; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bryant F. B., 2007, SAVORING NEW MODEL P; Chan SSC, 2011, HEALTH EDUC RES, V26, P664, DOI 10.1093/her/cyr026; Chickering A.W., 1977, EXPERIENCE LEARNING; Connell CM, 2002, J APPL GERONTOL, V21, P294, DOI 10.1177/073346480202100302; Coogle CL, 2000, COMMUNITY MENT HLT J, V36, P137, DOI 10.1023/A:1001864926148; Csikszentmihalyi M., 1997, FINDING FLOW PSYCHOL; DEPOY E, 1992, RES SOCIAL WORK PRAC, V2, P39, DOI 10.1177/104973159200200104; Dulin MF, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-38; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Fabrizio CS, 2014, J FAM PSYCHOL, V28, P42, DOI 10.1037/a0035275; Finn J, 2009, J FAM VIOLENCE, V24, P53, DOI 10.1007/s10896-008-9207-2; Fitzgerald MA, 2009, GERONTOL GERIATR EDU, V30, P114, DOI 10.1080/02701960902911257; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jackiewicz S, 2004, EVALUATION FAMILY PA; James L. E., 2012, INT PERSPECTIVES PSY, V1, P110, DOI DOI 10.1037/A0028321; JOHN OP, 1994, J PERS SOC PSYCHOL, V66, P206, DOI 10.1037/0022-3514.66.1.206; Joseph S., 2015, POSITIVE PSYCHOL PRA; KOLB 8DAVID A., 2015, EXPERIENTIAL LEARNIN; Laborde DJ, 2013, DISASTER MED PUBLIC, V7, P302, DOI 10.1001/dmp.2012.18; Lam Ching Man, 2011, Int J Adolesc Med Health, V23, P305; Lam W, 2012, HLTH ED RES; Langer E., 2005, BECOMING ARTIST REIN; Ledbetter AM, 2014, J FAM COMMUN, V14, P230, DOI 10.1080/15267431.2014.908196; Loughran H, 2015, BR J SOC WORK, V45; Maxwell AE, 2011, PREV CHRONIC DIS, V8; Meissner HI, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-12; Morganson VJ, 2014, PSYCHOL-MANAG J, V17, P221, DOI 10.1037/mgr0000023; Morse J. M., 1995, QUALITATIVE RES METH; Nayar U, 2007, PSYCHOL STUDIES U CA, V52, P178; Orfaly RA, 2005, J PUBLIC HEALTH MAN, pS123; Palumbo M. V., 2005, APPL HUMAN RESOURCE, V10, P13; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; Pearce J, 2012, J TRAUMA STRESS, V25, P337, DOI 10.1002/jts.21705; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Pitts M.J., 2013, POSITIVE COMMUNICATI; Polivka BJ, 2006, CLIN TOXICOL, V44, P109, DOI 10.1080/15563650500514301; Rogers E.M., 1995, DIFFUSION INNOVATION; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; School of Public Health, 2014, FAMILY JOCK CLUB IN; Schwarzer R., 2003, BERLIN FREIE U, DOI [10.5167/uzh-102499, DOI 10.5167/UZH-102499]; Segre LS, 2011, MATERN CHILD HLTH J, V15, P814, DOI 10.1007/s10995-010-0644-1; Seligman M. E. P., 2002, AUTHENTIC HAPPINESS; Seligman M. P., 2004, RICERCHE PSICOLOGIA, V27, P63; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Smith IC, 2011, PSYCHOL PSYCHOTHER-T, V84, P335, DOI 10.1111/j.2044-8341.2010.02000.x; Soong C, 2015, JMIR RES PROTOC, V28, P4; Stange KC, 2003, AM J PREV MED, V25, P296, DOI 10.1016/S0749-3797(03)00219-8; Stewart SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-106; Thorning H, 2013, INT SOC WORK, V56, P534, DOI 10.1177/0020872812437064; Viswanathan M, 2004, Evid Rep Technol Assess (Summ), P1	59	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147712	10.1371/journal.pone.0147712	http://dx.doi.org/10.1371/journal.pone.0147712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808541	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800191
J	Maeda, Y; Migita, K; Higuchi, O; Mukaino, A; Furukawa, H; Komori, A; Nakamura, M; Hashimoto, S; Nagaoka, S; Abiru, S; Yatsuhashi, H; Matsuo, H; Kawakami, A; Yasunami, M; Nakane, S				Maeda, Yasuhiro; Migita, Kiyoshi; Higuchi, Osamu; Mukaino, Akihiro; Furukawa, Hiroshi; Komori, Atsumasa; Nakamura, Minoru; Hashimoto, Satoru; Nagaoka, Shinya; Abiru, Seigo; Yatsuhashi, Hiroshi; Matsuo, Hidenori; Kawakami, Atsushi; Yasunami, Michio; Nakane, Shunya			Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population	PLOS ONE			English	Article							AUTOIMMUNE AUTONOMIC GANGLIONOPATHY; 3RD HYPERVARIABLE REGION; RHEUMATOID-ARTHRITIS; HEPATITIS; AUTOANTIBODIES; SUSCEPTIBILITY; DISEASES; PREDISPOSITION; MOLECULES; PEPTIDES	Background/Aims Anti-ganglionic nicotinic acetylcholine receptor (gAChR) antibodies are observed in autoimmune diseases, as well as in patients with autoimmune autonomic ganglionopathy. However, the genetic background of anti-gAChR antibodies is unclear. Here, we investigated HLA alleles in autoimmune hepatitis (AIH) patients with or without anti-gAChR antibodies. Methodology/Principal Findings Genomic DNA from 260 patients with type-1 autoimmune hepatitis (AIH) were genotyped for HLA-A, B, DRB1, and DQB1 loci. Anti-gAChR antibodies in the sera form AIH patients were measured using the luciferase immunoprecipitation system, and examined allelic association in patients with or without anti-gAChR antibodies. Methodology/Methods We detected anti-alpha 3 or -beta 4 gAChR antibodies in 11.5% (30/260) of patients with AIH. Among AIH patients there was no significant association between HLA-A, B DQB1 alleles and the positivity for anti-gAChR antibodies. Whereas the HLA-DRB1*0403 allele showed a significantly increased frequency in AIH patients with anti-gAChR antibodies compared with those without anti-gAChR antibodies. Conclusions/Significance The frequency of the HLA-DRB1*0403 allele differed among Japanese patients with AIH according to the presence or absence of anti-gAChR antibodies. Our findings suggest that particular HLA class II molecules might control the development of anti-gAChR antibodies in the autoimmune response to gAChR.	[Maeda, Yasuhiro; Higuchi, Osamu; Mukaino, Akihiro; Matsuo, Hidenori] Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan; [Maeda, Yasuhiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuroimmunol, Nagasaki 852, Japan; [Migita, Kiyoshi; Komori, Atsumasa; Hashimoto, Satoru; Nagaoka, Shinya; Abiru, Seigo; Yatsuhashi, Hiroshi] NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki, Japan; [Furukawa, Hiroshi] Univ Tsukuba, Dept Mol & Genet Epidemiol, Tsukuba, Ibaraki, Japan; [Nakamura, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Nagasaki, Nagasaki 852, Japan; [Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 1, Nagasaki, Nagasaki 852, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Nagasaki 852, Japan; [Nakane, Shunya] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Kumamoto, Japan	Nagasaki University; University of Tsukuba; Nagasaki University; Nagasaki University; Nagasaki University; Kumamoto University	Migita, K (corresponding author), NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki, Japan.	migita@nagasaki-mc.com	Nakane, Shunya/AAF-3715-2022; Nakane, Shunya/AFB-9194-2022		National Hospital Organization	National Hospital Organization	This work was supported by a grant from the National Hospital Organization.; This work was supported by a grant from the National Hospital Organization.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906; Caillat-Zucman S, 2009, TISSUE ANTIGENS, V73, P1, DOI 10.1111/j.1399-0039.2008.01167.x; Czaja AJ, 1996, HEPATOLOGY, V24, P1068; Gonzalez-Gay MA, 2002, SEMIN ARTHRITIS RHEU, V31, P355, DOI 10.1053/sarh.2002.32552; Goronzy J J, 1993, Curr Opin Rheumatol, V5, P169; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Liao WWP, 2011, AUTOIMMUN REV, V10, P469, DOI 10.1016/j.autrev.2011.02.003; Lie BA, 2005, CURR OPIN IMMUNOL, V17, P526, DOI 10.1016/j.coi.2005.07.001; Rodriguez-Fernandez JL, 2013, CURR TOP MED CHEM, V13, P712, DOI 10.2174/1568026611313060004; MANNS MP, 1991, J CLIN INVEST, V88, P1370, DOI 10.1172/JCI115443; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Moraes ME, 1997, TISSUE ANTIGENS, V49, P35, DOI 10.1111/j.1399-0039.1997.tb02707.x; Nakane S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118312; Oliveira LC, 2011, AUTOIMMUN REV, V10, P189, DOI 10.1016/j.autrev.2010.09.024; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Strassburg CP, 2002, SEMIN LIVER DIS, V22, P339, DOI 10.1055/s-2002-35704; Umemura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100565; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Vernino S, 2008, ANN NY ACAD SCI, V1132, P124, DOI 10.1196/annals.1405.011; Wang Z, 2007, NEUROLOGY, V68, P1917, DOI 10.1212/01.wnl.0000263185.30294.61; Weyand C M, 1999, Int Rev Immunol, V18, P37, DOI 10.3109/08830189909043018; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Winston N, 2010, CURR OPIN NEUROL, V23, P514, DOI 10.1097/WCO.0b013e32833d4c7f; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; Zanelli E, 1996, P NATL ACAD SCI USA, V93, P1814, DOI 10.1073/pnas.93.5.1814	28	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146048	10.1371/journal.pone.0146048	http://dx.doi.org/10.1371/journal.pone.0146048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807576	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800014
J	Okada, S; Morimoto, T; Ogawa, H; Sakuma, M; Soejima, H; Nakayama, M; Jinnouchi, H; Waki, M; Akai, Y; Ishii, H; Saito, Y				Okada, Sadanori; Morimoto, Takeshi; Ogawa, Hisao; Sakuma, Mio; Soejima, Hirofumi; Nakayama, Masafumi; Jinnouchi, Hideaki; Waki, Masako; Akai, Yasuhiro; Ishii, Hitoshi; Saito, Yoshihiko		Investigators Japanese Primary	Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study	PLOS ONE			English	Article							ANALGESIC USE; KIDNEY-FUNCTION; ACETYLSALICYLIC-ACID; PRIMARY PREVENTION; NEPHROPATHY; ACETAMINOPHEN; PROGRESSION; EVENTS; IMPACT; RISK	Background Low-dose aspirin is widely recommended for patients at high risk for cardiovascular disease (CVD); however, it remains uncertain whether long-term treatment adversely affects renal function in patients with diabetes. We investigated whether long-term low-dose aspirin affects renal dysfunction in patients with diabetes. Methods We conducted a randomized controlled trial (RCT), the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial, to evaluate low-dose aspirin as primary prevention for CVD in patients with type 2 diabetes. We followed the patients with negative urine dipstick albumin of the JPAD trial in a cohort study after the RCT period was completed. Patients were randomly allocated to receive aspirin (81 mg or 100 mg daily, aspirin group) or no aspirin (no aspirin group). After the RCT, the treating physician decided whether to administer aspirin. We evaluated the incidence of positive urine dipstick albumin and annual changes in estimated glomerular filtration rate (eGFR). Results Positive urine dipstick albumin developed in 297 patients in the aspirin group (n = 1,075) and 270 patients in the no aspirin group (n = 1,098) during follow-up (median, 8.5 years). Intention-to-treat analysis showed low-dose aspirin did not increase the incidence of positive urine dipstick albumin (hazard ratio [HR], 1.17; 95% confidence interval [CI], 0.995-1.38). On-treatment analysis yielded similar results (HR, 1.08; 95% CI, 0.92-1.28). Multivariable analysis showed the incidence of positive urine dipstick albumin was higher among the elderly and those with elevated serum creatinine, high hemoglobin A1c, or high blood pressure; however, low-dose aspirin did not increase the risk of positive urine dipstick albumin. There were no significant differences in annual changes in eGFR between the groups (aspirin, -0.8 +/- 2.9; no aspirin, -0.9 +/- 2.5 ml/min/1.73m(2)/year). Conclusion Long-term low-dose aspirin does not affect eGFR and positive urine dipstick albumin in patients with type 2 diabetes.	[Okada, Sadanori; Akai, Yasuhiro; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 634, Japan; [Okada, Sadanori; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan; [Morimoto, Takeshi; Sakuma, Mio] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo 6638501, Japan; [Ogawa, Hisao; Soejima, Hirofumi; Nakayama, Masafumi] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Jinnouchi, Hideaki] Jinnouchi Hosp, Diabet Care Ctr, Kumamoto, Japan; [Waki, Masako] Shizuoka City Hosp, Dept Internal Med, Div Endocrinol & Metab, Shizuoka, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University; Hyogo College of Medicine; Kumamoto University; Nara Medical University	Saito, Y (corresponding author), Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan.; Saito, Y (corresponding author), Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 634, Japan.	yssaito@naramed-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Ministry of Health, Labour and Welfare of Japan (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Agodoa LY, 2008, AM J KIDNEY DIS, V51, P573, DOI 10.1053/j.ajkd.2007.12.014; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; EVANS M, 2009, OFFICIAL PUBLICATION, V24, P1908, DOI DOI 10.1093/NDT/GFN745; Fored CM, 2001, NEW ENGL J MED, V345, P1801, DOI 10.1056/NEJMoa010323; Gaede P, 2003, NEPHROL DIAL TRANSPL, V18, P539, DOI 10.1093/ndt/18.3.539; Gerstein HC, 2000, LANCET, V355, P253; Hansen HP, 2000, DIABETES CARE, V23, P1742, DOI 10.2337/diacare.23.12.1742; HOPPER AH, 1989, NEPHROL DIAL TRANSPL, V4, P140; Ibanez L, 2005, KIDNEY INT, V67, P2393, DOI 10.1111/j.1523-1755.2005.00346.x; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Kurth T, 2003, AM J KIDNEY DIS, V42, P234, DOI 10.1016/S0272-6386(03)00647-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Rexrode KM, 2001, JAMA-J AM MED ASSOC, V286, P315, DOI 10.1001/jama.286.3.315; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Suleyman H, 2007, PHARMACOL REP, V59, P247	25	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147635	10.1371/journal.pone.0147635	http://dx.doi.org/10.1371/journal.pone.0147635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808136	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800158
J	Ravinet, N; Chartier, C; Bareille, N; Lehebel, A; Ponnau, A; Brisseau, N; Chauvin, A				Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Ponnau, Adeline; Brisseau, Nadine; Chauvin, Alain			Unexpected Decrease in Milk Production after Fenbendazole Treatment of Dairy Cows during Early Grazing Season	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE INFECTIONS; OSTERTAGIA-OSTERTAGI ELISA; TARGETED SELECTIVE TREATMENTS; ADULT MERINO SHEEP; ANTHELMINTIC TREATMENT; EPRINOMECTIN TREATMENT; PRODUCTION RESPONSE; TRICHOSTRONGYLID LARVAE; STOCKING MANAGEMENT; WESTERN-EUROPE	Gastrointestinal nematodes (GIN) infection can impair milk production (MP) in dairy cows. To investigate whether MP would be optimized by spring targeted-selective anthelmintic treatment in grazing cows, we assessed (1) the effect on MP of an anthelmintic treatment applied 1.5 to 2 months after turn-out, and (2) herd and individual indicators associated with the post-treatment MP response. A randomized controlled clinical trial was conducted in 13 dairy farms (578 cows) in western France in spring 2012. In each herd, lactating cows of the treatment group received fenbendazole orally, control cows remained untreated. Daily cow MP was recorded from 2 weeks before until 15 weeks after treatment. Individual serum pepsinogen and anti-Ostertagia antibody levels (expressed as ODR), faecal egg count and bulk tank milk (BTM) Ostertagia ODR were measured at treatment time. Anthelmintic treatment applied during the previous housing period was recorded for each cow. In each herd, information regarding heifers' grazing and anthelmintic treatment history was collected to assess the Time of Effective Contact (TEC, in months) with GIN infective larvae before the first calving. The effect of treatment on weekly MP averages and its relationships with herd and individual indicators were studied using linear mixed models with two nested random effects (cow within herd). Unexpectedly, spring treatment had a significant detrimental effect on MP (-0.92 kg/cow/day on average). This negative MP response was particularly marked in high producing cows, in cows not treated during the previous housing period or with high pepsinogen levels, and in cows from herds with a high TEC or a high BTM ODR. This post-treatment decrease in MP may be associated with immuno-inflammatory mechanisms. Until further studies can assess whether this unexpected result can be generalized, nonpersistent treatment of immunized adult dairy cows against GIN should not be recommended in early grazing season.	[Ravinet, Nadine] UMT Cattle Herd Hlth Management, French Livestock Inst, IDELE, Nantes, France; [Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Ponnau, Adeline; Brisseau, Nadine; Chauvin, Alain] LUNAM Univ, Oniris, Nantes Atlantic Coll Vet Med & Food Sci & Engn, UMR BioEpAR, Nantes, France; [Ravinet, Nadine; Chartier, Christophe; Bareille, Nathalie; Lehebel, Anne; Brisseau, Nadine; Chauvin, Alain] INRA, UMR Biol 1300, Epidemiol & Risk Anal Anim Hlth, Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Ravinet, N (corresponding author), UMT Cattle Herd Hlth Management, French Livestock Inst, IDELE, Nantes, France.; Ravinet, N (corresponding author), LUNAM Univ, Oniris, Nantes Atlantic Coll Vet Med & Food Sci & Engn, UMR BioEpAR, Nantes, France.; Ravinet, N (corresponding author), INRA, UMR Biol 1300, Epidemiol & Risk Anal Anim Hlth, Nantes, France.	ravinet.nadine@wanadoo.fr	Chauvin, Alain/A-1811-2009	Chauvin, Alain/0000-0001-6942-9372	CASDAR (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret) [1127]	CASDAR (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	The study was funded by the CASDAR project No 1127 (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret). CASDAR: Compte d'Affectation Special Developpement Agricole et Rural. Authors who received the funding: NR, AC, CC, N. Bareille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agneessens J, 2000, VET PARASITOL, V90, P83, DOI 10.1016/S0304-4017(00)00232-6; ANDERSON N, 1965, VET REC, V77, P1196, DOI 10.1136/vr.77.41.1196; ANDERSON N, 1988, VET PARASITOL, V27, P13, DOI 10.1016/0304-4017(88)90057-X; ARMOUR J, 1979, VET REC, V105, P500, DOI 10.1136/vr.105.22.500; ARMOUR J, 1980, VET PARASITOL, V6, P7, DOI 10.1016/0304-4017(80)90037-0; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; BISSET SA, 1987, VET PARASITOL, V26, P107, DOI 10.1016/0304-4017(87)90081-1; Bliss D.H, 1997, COMPEND CONT ED PRAC, V4, P104; Borgsteede FHM, 2000, VET PARASITOL, V89, P287, DOI 10.1016/S0304-4017(00)00219-3; Charlier J, 2014, VET REC, V175, P250, DOI 10.1136/vr.102512; Charlier J, 2007, VET PARASITOL, V143, P322, DOI 10.1016/j.vetpar.2006.08.015; Charlier J, 2010, PREV VET MED, V93, P147, DOI 10.1016/j.prevetmed.2009.10.002; Charlier J, 2009, VET PARASITOL, V164, P70, DOI 10.1016/j.vetpar.2009.04.012; Chartier C, 2013, P WAAVP PERTH AUSTR, P540; Cramer LG, 2000, PARASITOL RES, V86, P944, DOI 10.1007/s436-000-8011-z; Demeler J, 2009, VET PARASITOL, V160, P109, DOI 10.1016/j.vetpar.2008.10.030; Eysker M, 2002, VET PARASITOL, V110, P93, DOI 10.1016/S0304-4017(02)00312-6; Forbes AB, 2004, VET PARASITOL, V125, P353, DOI 10.1016/j.vetpar.2004.07.025; FRECHETTE JL, 1981, CAN VET J, V22, P252; Gasbarre LC, 2014, VET PARASITOL, V204, P3, DOI 10.1016/j.vetpar.2014.03.017; Geurden T, 2013, P WAAVP PERTH AUSTR, P167; Gibb MJ, 2005, VET PARASITOL, V133, P79, DOI 10.1016/j.vetpar.2004.11.038; Gross SJ, 1999, VET REC, V144, P581, DOI 10.1136/vr.144.21.581; JARA W, 1984, VET REC, V115, P565, DOI 10.1136/vr.115.22.565; Kenyon F, 2012, VET PARASITOL, V186, P10, DOI 10.1016/j.vetpar.2011.11.041; Kenyon F, 2009, VET PARASITOL, V164, P3, DOI 10.1016/j.vetpar.2009.04.015; Kerboeuf D, 2002, REV MED VET-TOULOUSE, V153, P707; Kloosterman A, 1996, VET PARASITOL, V64, P197, DOI 10.1016/0304-4017(95)00919-1; Larsen JWA, 1999, INT J PARASITOL, V29, P893, DOI 10.1016/S0020-7519(99)00050-8; LARSEN JWA, 1994, AUST VET J, V71, P365, DOI 10.1111/j.1751-0813.1994.tb00930.x; Larsen JWA, 2000, AUST VET J, V78, P112, DOI 10.1111/j.1751-0813.2000.tb10537.x; Mason WA, 2012, VET PARASITOL, V189, P250, DOI 10.1016/j.vetpar.2012.05.003; MCBEATH DG, 1979, VET REC, V105, P507, DOI 10.1136/vr.105.22.507; McPherson WB, 2001, NEW ZEAL VET J, V49, P106, DOI 10.1080/00480169.2001.36212; MCQUEEN I P M, 1977, New Zealand Journal of Experimental Agriculture, V5, P115; Meeusen ENT, 1999, VET PARASITOL, V84, P259, DOI 10.1016/S0304-4017(99)00038-2; MICHEL JF, 1982, VET REC, V111, P546; MILLER HRP, 1983, RES VET SCI, V35, P357, DOI 10.1016/S0034-5288(18)32033-2; Nodtvedt A, 2002, VET PARASITOL, V105, P191, DOI 10.1016/S0304-4017(02)00024-9; O'Shaughnessy J, 2014, VET REC, V175, DOI 10.1136/vr.102556; OFARRELL KJ, 1986, IRISH VET J, V40, P116; PLOEGER HW, 1990, VET PARASITOL, V35, P103, DOI 10.1016/0304-4017(90)90120-Z; PLOEGER HW, 1989, VET PARASITOL, V34, P239, DOI 10.1016/0304-4017(89)90054-X; Ravinet N, 2014, VET PARASITOL, V201, P95, DOI 10.1016/j.vetpar.2013.12.031; RAYNAUD J-P, 1976, Annales de Recherches Veterinaires, V7, P253; Reist M, 2002, VET REC, V151, P377, DOI 10.1136/vr.151.13.377; Rose H, 2015, VET REC, V176, DOI 10.1136/vr.102982; Sanchez J, 2004, PREV VET MED, V63, P237, DOI 10.1016/j.prevetmed.2004.01.006; Sanchez J, 2005, VET PARASITOL, V130, P115, DOI 10.1016/j.vetpar.2005.03.013; Sanchez J, 2002, VET PARASITOL, V107, P209, DOI 10.1016/S0304-4017(02)00158-9; Shaw DJ, 1998, VET PARASITOL, V75, P115, DOI 10.1016/S0304-4017(97)00214-8; Shaw DJ, 1998, VET PARASITOL, V75, P133, DOI 10.1016/S0304-4017(97)00213-6; Sithole F, 2005, J DAIRY SCI, V88, P929, DOI 10.3168/jds.S0022-0302(05)72760-0; SLOCOMBE JO, 1974, CAN J COMP MED, V38, P18; SNIDER TG, 1985, VET REC, V116, P69, DOI 10.1136/vr.116.3.69; Steinbach T, 2006, VET PARASITOL, V139, P115, DOI 10.1016/j.vetpar.2006.03.028; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; THARALDSEN J, 1989, ACTA VET SCAND, V30, P247; Van Wyk JA, 2001, ONDERSTEPOORT J VET, V68, P55; Vanderstichel R, 2013, PREV VET MED, V111, P63, DOI 10.1016/j.prevetmed.2013.04.001; Vercruysse J, 1997, VET PARASITOL, V72, P309, DOI 10.1016/S0304-4017(97)00103-9; Verschave SH, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0264-x; Waghorn TS, 2006, NEW ZEAL VET J, V54, P278, DOI 10.1080/00480169.2006.36711	63	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147835	10.1371/journal.pone.0147835	http://dx.doi.org/10.1371/journal.pone.0147835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808824	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800221
J	Russell, S; Martin, F; Zalwango, F; Namukwaya, S; Nalugya, R; Muhumuza, R; Katongole, J; Seeley, J				Russell, Steve; Martin, Faith; Zalwango, Flavia; Namukwaya, Stella; Nalugya, Ruth; Muhumuza, Richard; Katongole, Joseph; Seeley, Janet			Finding Meaning: HIV Self-Management and Wellbeing among People Taking Antiretroviral Therapy in Uganda	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUB-SAHARAN AFRICA; POSTTRAUMATIC GROWTH; OLDER-PEOPLE; SOUTH-AFRICA; HEALTH; ADHERENCE; INTERVENTIONS; COUNTRIES; HIV/AIDS	The health of people living with HIV (PLWH) and the sustained success of antiretroviral therapy (ART) programmes depends on PLWH's motivation and ability to self-manage the condition over the long term, including adherence to drugs on a daily basis. PLWH's self-management of HIV and their wellbeing are likely to be interrelated. Successful self-management sustains wellbeing, and wellbeing is likely to motivate continued self-management. Detailed research is lacking on PLWH's self-management processes on ART in resource-limited settings. This paper presents findings from a study of PLWH's self-management and wellbeing in Wakiso District, Uganda. Thirty-eight PLWH (20 women, 18 men) were purposefully selected at ART facilities run by the government and by The AIDS Support Organisation in and around Entebbe. Two in-depth interviews were completed with each participant over three or four visits. Many were struggling economically, however the recovery of health and hope on ART had enhanced wellbeing and motivated self-management. The majority were managing their condition well across three broad domains of self-management. First, they had mobilised resources, notably through good relationships with health workers. Advice and counselling had helped them to reconceptualise their condition and situation more positively and see hope for the future, motivating their work to self-manage. Many had also developed a new network of support through contacts they had developed at the ART clinic. Second, they had acquired knowledge and skills to manage their health, a useful framework to manage their condition and to live their life. Third, participants were psychologically adjusting to their condition and their new 'self': they saw HIV as a normal disease, were coping with stigma and had regained self-esteem, and were finding meaning in life. Our study demonstrates the centrality of social relationships and other non-medical aspects of wellbeing for self-management which ART programmes might explore further and encourage.	[Russell, Steve] Univ E Anglia, Sch Int Dev, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Zalwango, Flavia; Namukwaya, Stella; Nalugya, Ruth; Muhumuza, Richard; Katongole, Joseph; Seeley, Janet] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Martin, Faith] Univ E Anglia, Sch Int Dev, External Res Associate, Norwich NR4 7TJ, Norfolk, England; [Seeley, Janet] London Sch Hyg & Trop Med, London WC1, England	University of East Anglia; Uganda Virus Research Institute; University of East Anglia; University of London; London School of Hygiene & Tropical Medicine	Russell, S (corresponding author), Univ E Anglia, Sch Int Dev, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.russell@uea.ac.uk		Martin, Faith/0000-0002-0141-1210; Seeley, Janet/0000-0002-0583-5272; Muhumuza, Richard/0000-0002-9931-7600	UK Economic and Social Research Council (ESRC) [RES-063-23-2663, ES/H043551/1]; Medical Research Council and Department for International Development; Economic and Social Research Council [ES/H043551/1] Funding Source: researchfish; Medical Research Council [MC_U950097150] Funding Source: researchfish; ESRC [ES/H043551/1] Funding Source: UKRI; MRC [MC_U950097150] Funding Source: UKRI	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council and Department for International Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the UK Economic and Social Research Council (ESRC) (project number: RES-063-23-2663; Research Fish Award No: ES/H043551/1), and Medical Research Council and Department for International Development.	Aantjes CJ, 2014, PATIENT EDUC COUNS, V95, P185, DOI 10.1016/j.pec.2014.01.007; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bajunirwe F, 2009, AIDS CARE, V21, P271, DOI 10.1080/09540120802241863; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Kuteesa MO, 2012, AJAR-AFR J AIDS RES, V11, P295, DOI 10.2989/16085906.2012.754829; Martin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105154; Martin F, 2013, AIDS PATIENT CARE ST, V27, P697, DOI 10.1089/apc.2013.0254; Mbonye M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-804; McGrath JW, 2014, MED ANTHROPOL, V33, P303, DOI 10.1080/01459740.2014.892483; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mutabazi-Mwesigire D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-343; Negin J, 2013, J CROSS-CULT GERONTO, V28, P491, DOI 10.1007/s10823-013-9215-4; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Russell S, 2015, QUALITATIVE IN PRESS; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; RUTA D, 2007, J SOCIOECONOMICS, V0036; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stangl A, 2009, AIDS CARE, V19, P626; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Trevino KM, 2010, AIDS BEHAV, V14, P379, DOI 10.1007/s10461-007-9332-6; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watkins-Hayes C, 2012, SOC SCI MED, V74, P2028, DOI 10.1016/j.socscimed.2012.02.001; White S, 2009, 0944 WED U BATH ESRC; Wouters E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-103; Wright S, 2012, J CROSS-CULT GERONTO, V27, P319, DOI 10.1007/s10823-012-9178-x; Yalom ID, 2005, THEORY PRACTICE GROU	36	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147896	10.1371/journal.pone.0147896	http://dx.doi.org/10.1371/journal.pone.0147896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807932	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000369527800241
J	Shen, YQ; Song, HM; Ma, WL; Gong, Z; Ni, Y; Zhang, XY; Xu, WJ; Jiang, JF; Che, L; Xu, JH; Yan, WW; Zhou, L; Li, GH; Zhang, QP; Wang, LM				Shen, Yuqin; Song, Haoming; Ma, Wenlin; Gong, Zhu; Ni, Yi; Zhang, Xiaoyu; Xu, Wenjun; Jiang, Jinfa; Che, Lin; Xu, Jiahong; Yan, Wenwen; Zhou, Lin; Li, Guanghe; Zhang, Qiping; Wang, Lemin			The Prognostic Value of Peak Cardiac Power Output in Chinese Patients with Chronic Heart Failure	PLOS ONE			English	Article							CARDIOGENIC-SHOCK; EXERCISE; MORTALITY	Background Cardiopulmonary exercise testing has been widely used to risk stratify patients with chronic heart failure (CHF). Peak oxygen consumption (peakVO(2)) was regarded as a powerful predictor of survival, as it is a surrogate for peak cardiac output (CO), which by most is considered the "true" measure of heart failure. Therefore, it is reasonable to hypothesize that CO is an even stronger predictor than peak VO2. The present study is aimed to investigate the prognostic value of peak cardiac power output (peak CPO) in comparison with peakVO(2) in Chinese patients with CHF. Methods Participants provided written informed consent to participate in this study. Totally 129 patients with CHF underwent symptom-limited cardiopulmonary exercise testing (CPET), with mean age 59.1 +/- 11.4 years, 87.6% male, 57.4% ischemic etiology, body mass index (BMI) 24.7 +/- 3.7 kg/m(2) and LVEF 38 +/- 9%. CO was measured using an inert gas rebreathing method. The primary endpoints are cardiac deaths. Results Over median 33.7-month follow-up, 19 cardiac deaths were reported. Among peak VO2, VE/VCO2 slope and Peak CPO, their area under ROC were 0.64, 0.67, 0.68, respectively (<0.05). The optimal thresholds for predicting cardiac deaths were peak VO2 <= 13.4 ml.kg(-1). min(-1), and VE/VCO2 slope >= 39.3 and peak CPO <= 1.1 respectively by ROC analysis. Finally, in patients with a peak VO2 <= 13.4 ml.kg(-1).min(-1) those with peak CPO>1.1 W had better survival than those with peak CPO <= 1.1W. However, by multivariate analysis adjusted for age, sex, BMI, resting heart rate, LVMI, LVEF, Peak CPO was not an independent predictor of cardiac deaths (P > 0.05). Conclusions Peak CPO was not a predictor of cardiac death in Chinese CHF patients.	[Shen, Yuqin; Song, Haoming; Ma, Wenlin; Gong, Zhu; Ni, Yi; Xu, Wenjun; Jiang, Jinfa; Che, Lin; Xu, Jiahong; Yan, Wenwen; Zhou, Lin; Li, Guanghe; Zhang, Qiping; Wang, Lemin] Tongji Univ, Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China; [Zhang, Xiaoyu] Tongji Univ, Tongji Hosp, Dept Rheumatol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, LM (corresponding author), Tongji Univ, Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China.	wanglemin2003@163.com	zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; Ni, Yicheng/O-5887-2017; zhang, xuan/AAN-9914-2020	Ni, Yicheng/0000-0002-8553-7565; zhang, xuan/0000-0001-8775-1699	United Brainstorm Project of Shanghai New Technology [SHDC12010117]; Shanghai Health and Family Planning Committee [WSJ1324, WSJ20114322]	United Brainstorm Project of Shanghai New Technology; Shanghai Health and Family Planning Committee	This project was supported by grants from the United Brainstorm Project of Shanghai New Technology among top hospitals (SHDC12010117), from Shanghai Health and Family Planning Committee (WSJ1324), and from Shanghai Health and Family Planning Committee (WSJ20114322).	Bard RL, 2006, J HEART LUNG TRANSPL, V25, P589, DOI 10.1016/j.healun.2005.11.448; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Chinese Society of Cardiology of Chinese Medical Association, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1076; Corra U, 2002, AM HEART J, V143, P418, DOI 10.1067/mhj.2002.120772; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Lang CC, 2007, J CARD FAIL, V13, P672, DOI 10.1016/j.cardfail.2007.05.004; Lang CC, 2007, AM J CARDIOL, V99, P404, DOI 10.1016/j.amjcard.2006.08.047; Lang CC, 2009, CIRC-HEART FAIL, V2, P33, DOI 10.1161/CIRCHEARTFAILURE.108.798611; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Rantner B, 2015, ATHEROSCLEROSIS, V239, P428, DOI 10.1016/j.atherosclerosis.2014.12.060; TAN LB, 1986, LANCET, V2, P1360; TAN LB, 1990, BRIT HEART J, V64, P121; Williams SG, 2001, EUR HEART J, V22, P1496, DOI 10.1053/euhj.2000.2547; Yeboah J, 2012, CIRCULATION, V126, P2713, DOI 10.1161/CIRCULATIONAHA.112.112201	17	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147423	10.1371/journal.pone.0147423	http://dx.doi.org/10.1371/journal.pone.0147423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808510	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800092
J	Stok, KS; Besler, BA; Steiner, TH; Escudero, AVV; Zulliger, MA; Wilke, M; Atal, K; Quintin, A; Koller, B; Muller, R; Nesic, D				Stok, Kathryn S.; Besler, Bryce A.; Steiner, Thomas H.; Escudero, Ana V. Villarreal; Zulliger, Martin A.; Wilke, Markus; Atal, Kailash; Quintin, Aurelie; Koller, Bruno; Mueller, Ralph; Nesic, Dobrila			Three-Dimensional Quantitative Morphometric Analysis (QMA) for In Situ Joint and Tissue Assessment of Osteoarthritis in a Preclinical Rabbit Disease Model	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; SUBCHONDRAL BONE CHANGES; MICRO-COMPUTED TOMOGRAPHY; HIGH-RESOLUTION MRI; GUINEA-PIG MODEL; ARTICULAR-CARTILAGE; TRANSECTION MODEL; CANINE MODELS; KNEE CARTILAGE; MU-CT	This work utilises advances in multi-tissue imaging, and incorporates new metrics which define in situ joint changes and individual tissue changes in osteoarthritis (OA). The aims are to (1) demonstrate a protocol for processing intact animal joints for microCT to visualise relevant joint, bone and cartilage structures for understanding OA in a preclinical rabbit model, and (2) introduce a comprehensive three-dimensional (3D) quantitative morphometric analysis (QMA), including an assessment of reproducibility. Sixteen rabbit joints with and without transection of the anterior cruciate ligament were scanned with microCT and contrast agents, and processed for histology. Semi-quantitative evaluation was performed on matching two-dimensional (2D) histology and microCT images. Subsequently, 3D QMA was performed; including measures of cartilage, subchondral cortical and epiphyseal bone, and novel tibio-femoral joint metrics. Reproducibility of the QMA was tested on seven additional joints. A significant correlation was observed in cartilage thickness from matching histology-microCT pairs. The lateral compartment of operated joints had larger joint space width, thicker femoral cartilage and reduced bone volume, while osteophytes could be detected quantitatively. Measures between the in situ tibia and femur indicated an altered loading scenario. High measurement reproducibility was observed for all new parameters; with ICC ranging from 0.754 to 0.998. In conclusion, this study provides a novel 3D QMA to quantify macro and micro tissue measures in the joint of a rabbit OA model. New metrics were established consisting of: an angle to quantitatively measure osteophytes (sigma), an angle to indicate erosion between the lateral and medial femoral condyles (rho), a vector defining altered angulation (lambda,alpha,beta,gamma) and a twist angle (tau) measuring instability and tissue degeneration between the femur and tibia, a length measure of joint space width (JSW), and a slope and intercept (m,X) of joint contact to demonstrate altered loading with disease progression, as well as traditional bone and cartilage and histo-morphometry measures. We demonstrate correlation of microCT and histology, sensitive discrimination of OA change and robust reproducibility.	[Stok, Kathryn S.; Besler, Bryce A.; Steiner, Thomas H.; Escudero, Ana V. Villarreal; Atal, Kailash; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Stok, Kathryn S.; Zulliger, Martin A.; Koller, Bruno] SCANCO Med AG, Bruttisellen, Switzerland; [Wilke, Markus; Quintin, Aurelie; Nesic, Dobrila] Univ Bern, Dept Clin Res, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Stok, KS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Stok, KS (corresponding author), SCANCO Med AG, Bruttisellen, Switzerland.	kas@ethz.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Besler, Bryce/AAH-6837-2020; Stok, Kathryn/AAA-2667-2021	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Besler, Bryce/0000-0002-2164-111X; Stok, Kathryn/0000-0002-0522-4180; Nesic, Dobrila/0000-0003-1609-9255	Swiss Commission for Technology and Innovation (CTI) [9853.1]	Swiss Commission for Technology and Innovation (CTI)	Support was provided by the Swiss Commission for Technology and Innovation (CTI), Grant No 9853.1 (RM, DN) [https://www.kti.admin.ch/kti/en/home.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal PN, 2011, J ORTHOP RES, V29, P704, DOI 10.1002/jor.21312; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P986, DOI 10.1016/j.joca.2004.08.010; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P614, DOI 10.1016/j.joca.2004.03.002; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; Bolbos R, 2008, NMR BIOMED, V21, P366, DOI 10.1002/nbm.1198; Borges PD, 2014, OSTEOARTHR CARTILAGE, V22, P1419, DOI 10.1016/j.joca.2014.07.014; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burstein D, 2001, MAGNET RESON MED, V45, P36, DOI 10.1002/1522-2594(200101)45:1<36::AID-MRM1006>3.0.CO;2-W; Calvo E, 2001, OSTEOARTHR CARTILAGE, V9, P463, DOI 10.1053/joca.2001.0413; Chang DG, 1997, OSTEOARTHR CARTILAGE, V5, P357, DOI 10.1016/S1063-4584(97)80039-8; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cockman MD, 2006, OSTEOARTHR CARTILAGE, V14, P210, DOI 10.1016/j.joca.2005.08.010; Eckstein F, 1998, CLIN ORTHOP RELAT R, P137; Freedman JD, 2014, ANGEW CHEM INT EDIT, V53, P8406, DOI 10.1002/anie.201404519; GILMORE RS, 1987, J ANAT, V155, P77; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Goebel JC, 2010, RHEUMATOLOGY, V49, P1654, DOI 10.1093/rheumatology/keq154; Goldberg VM, 2011, OSTEOARTHR CARTILAGE, V19, P509, DOI 10.1016/j.joca.2011.02.017; Gu XI, 2012, OSTEOARTHR CARTILAGE, V20, P1011, DOI 10.1016/j.joca.2012.05.004; Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Intema F, 2010, J BONE MINER RES, V25, P1650, DOI 10.1002/jbmr.39; Joshi NS, 2009, J AM CHEM SOC, V131, P13234, DOI 10.1021/ja9053306; Kim Y-J, 2000, HARVARD ORTHOPAEDIC; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Kuroki K, 2011, OSTEOARTHR CARTILAGE, V19, P1142, DOI 10.1016/j.joca.2011.06.007; Lane NE, 2011, OSTEOARTHR CARTILAGE, V19, P478, DOI 10.1016/j.joca.2010.09.013; Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029; Li G, 2005, CLIN BIOMECH, V20, P736, DOI 10.1016/j.clinbiomech.2005.04.001; Little CB, 2008, CURR RHEUMATOL REV, V4, P175, DOI 10.2174/157339708785133523; Liu F, 2010, J BIOMECH, V43, P658, DOI 10.1016/j.jbiomech.2009.10.028; Makela JTA, 2014, OSTEOARTHR CARTILAGE, V22, P869, DOI 10.1016/j.joca.2014.04.010; Marenzana M, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0127; Marenzana M, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8173; Matsui H, 1997, MICROSC RES TECHNIQ, V37, P333, DOI 10.1002/(SICI)1097-0029(19970515)37:4<333::AID-JEMT8>3.0.CO;2-L; McCauley T R, 2001, Semin Musculoskelet Radiol, V5, P293, DOI 10.1055/s-2001-19040; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; MOSKOWITZ RW, 1973, ARTHRITIS RHEUM-US, V16, P397, DOI 10.1002/art.1780160317; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pastoureau P, 2003, OSTEOARTHR CARTILAGE, V11, P412, DOI 10.1016/S1063-4584(03)00050-5; Piscaer TM, 2008, OSTEOARTHR CARTILAGE, V16, P1011, DOI 10.1016/j.joca.2008.01.012; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; Sah RL, 1997, J ORTHOP RES, V15, P197, DOI 10.1002/jor.1100150207; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sniekers YH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-20; Steiner TH, 2012, OSTEOARTHR CARTILAGE, V20, pS50, DOI 10.1016/j.joca.2012.02.599; Stok KS, 2009, MICROSC RES TECHNIQ, V72, P650, DOI 10.1002/jemt.20713; Stok KS, 2009, BONE, V45, P414, DOI 10.1016/j.bone.2009.05.017; Tao HY, 2015, SKELETAL RADIOL, V44, P393, DOI 10.1007/s00256-014-2062-8; Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709; Trussel A.J., 2012, J BIOMECH, V45, pS108; Van de Velde SK, 2009, ARTHRITIS RHEUM-US, V60, P3693, DOI 10.1002/art.24965; Wang SX, 2007, ARTHRITIS RHEUM-US, V56, P1537, DOI 10.1002/art.22574; Xie L, 2010, OSTEOARTHR CARTILAGE, V18, P65, DOI 10.1016/j.joca.2009.07.014; Xie L, 2009, OSTEOARTHR CARTILAGE, V17, P313, DOI 10.1016/j.joca.2008.07.015; Xie ZY, 2010, LECT NOTES COMPUT SC, V6363, P57	59	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147564	10.1371/journal.pone.0147564	http://dx.doi.org/10.1371/journal.pone.0147564			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808542	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800135
J	Wheeler, SS; Ball, CS; Langevin, SA; Fang, Y; Coffey, LL; Meagher, RJ				Wheeler, Sarah S.; Ball, Cameron S.; Langevin, Stanley A.; Fang, Ying; Coffey, Lark L.; Meagher, Robert J.			Surveillance for Western Equine Encephalitis, St. Louis Encephalitis, and West Nile Viruses Using Reverse Transcription Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							REAL-TIME DETECTION; RAPID DETECTION; ASSAY; DIFFERENTIATION; QUANTIFICATION; SEROTYPES; HIV-1	Collection of mosquitoes and testing for vector-borne viruses is a key surveillance activity that directly influences the vector control efforts of public health agencies, including determining when and where to apply insecticides. Vector control districts in California routinely monitor for three human pathogenic viruses including West Nile virus (WNV), Western equine encephalitis virus (WEEV), and St. Louis encephalitis virus (SLEV). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) offers highly sensitive and specific detection of these three viruses in a single multiplex reaction, but this technique requires costly, specialized equipment that is generally only available in centralized public health laboratories. We report the use of reverse transcription loop-mediated isothermal amplification (RT-LAMP) to detect WNV, WEEV, and SLEV RNA extracted from pooled mosquito samples collected in California, including novel primer sets for specific detection of WEEV and SLEV, targeting the nonstructural protein 4 (nsP4) gene of WEEV and the 3' untranslated region (3'-UTR) of SLEV. Our WEEV and SLEV RT-LAMP primers allowed detection of <0.1 PFU/reaction of their respective targets in <30 minutes, and exhibited high specificity without cross reactivity when tested against a panel of alphaviruses and flaviviruses. Furthermore, the SLEV primers do not cross-react with WNV, despite both viruses being closely related members of the Japanese encephalitis virus complex. The SLEV and WEEV primers can also be combined in a single RT-LAMP reaction, with discrimination between amplicons by melt curve analysis. Although RT-qPCR is approximately one order of magnitude more sensitive than RT-LAMP for all three targets, the RT-LAMP technique is less instrumentally intensive than RT-qPCR and provides a more cost-effective method of vector-borne virus surveillance.	[Wheeler, Sarah S.; Fang, Ying; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Ball, Cameron S.; Langevin, Stanley A.; Meagher, Robert J.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Wheeler, Sarah S.] Sacramento Yolo Mosquito & Vector Control Dist, Elk Grove, CA USA; [Langevin, Stanley A.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Sandia National Laboratories; University of Washington; University of Washington Seattle	Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA.	rmeaghe@sandia.gov		Meagher, Robert/0000-0002-6262-2126; Coffey, Lark/0000-0002-0718-5146	Defense Threat Reduction Agency (DTRA) [DTRA1002710697]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was supported by a grant from the Defense Threat Reduction Agency (DTRA), contract DTRA1002710697. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000.	Ahmad F, 2011, BIOMED MICRODEVICES, V13, P929, DOI 10.1007/s10544-011-9562-2; Bergren NA, 2014, J VIROL, V88, P9260, DOI 10.1128/JVI.01463-14; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Felices V, 2014, EMERG INFECT DIS, V20, P730, DOI 10.3201/eid2004.131735; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Fukuta S, 2003, ARCH VIROL, V148, P1713, DOI 10.1007/s00705-003-0134-5; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004; Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Liu H, 2012, VECTOR-BORNE ZOONOT, V12, P1042, DOI 10.1089/vbz.2012.0991; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nie K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052486; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; Parida MM, 2006, J CLIN MICROBIOL, V44, P4172, DOI 10.1128/JCM.01487-06; Peyrefitte CN, 2008, J CLIN MICROBIOL, V46, P3653, DOI 10.1128/JCM.01188-08; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Poon LLM, 2006, CLIN CHEM, V52, P303; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Sun B, 2013, ANAL CHEM, V85, P1540, DOI 10.1021/ac3037206; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Toriniwa H, 2006, MICROBIOL IMMUNOL, V50, P379, DOI 10.1111/j.1348-0421.2006.tb03804.x; Wang X, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-138	30	15	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147962	10.1371/journal.pone.0147962	http://dx.doi.org/10.1371/journal.pone.0147962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807734	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800253
J	Woo, JH; Grinspan, Z; Shapiro, J; Rhee, SY				Woo, Jung Hoon; Grinspan, Zachary; Shapiro, Jason; Rhee, Sang Youl			Frequent Users of Hospital Emergency Departments in Korea Characterized by Claims Data from the National Health Insurance: A Cross Sectional Study	PLOS ONE			English	Article							ED USERS; VISITS; CARE; URBAN; SERVICES; ALCOHOL	The Korean National Health Insurance, which provides universal coverage for the entire Korean population, is now facing financial instability. Frequent emergency department (ED) users may represent a medically vulnerable population who could benefit from interventions that both improve care and lower costs. To understand the nature of frequent ED users in Korea, we analyzed claims data from a population-based national representative sample. We performed both bivariate and multivariable analyses to investigate the association between patient characteristics and frequent ED use (4+ ED visits in a year) using claims data of a 1% random sample of the Korean population, collected in 2009. Among 156,246 total ED users, 4,835 (3.1%) were frequent ED users. These patients accounted for 14% of 209,326 total ED visits and 17.2% of $ 76,253,784 total medical expenses generated from all ED visits in the 1% data sample. Frequent ED users tended to be older, male, and of lower socio-economic status compared with occasional ED users (p < 0.001 for each). Moreover, frequent ED users had longer stays in the hospital when admitted, higher probability of undergoing an operative procedure, and increased mortality. Among 8,425 primary diagnoses, alcohol-related complaints and schizophrenia showed the strongest positive correlation with the number of ED visits. Among the frequent ED users, mortality and annual outpatient department visits were significantly lower in the alcohol-related patient subgroup compared with other frequent ED users; furthermore, the rate was even lower than that for non-frequent ED users. Our findings suggest that expanding mental health and alcohol treatment programs may be a reasonable strategy to decrease the dependence of these patients on the ED.	[Woo, Jung Hoon] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Grinspan, Zachary] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Shapiro, Jason] Mt Sinai Sch Med, Dept Emergency Med, New York, NY USA; [Rhee, Sang Youl] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Columbia University; Cornell University; Icahn School of Medicine at Mount Sinai; Kyung Hee University	Rhee, SY (corresponding author), Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	bard95@hanmail.net	Rhee, Sang Youl/P-1895-2018	Rhee, Sang Youl/0000-0003-0119-5818; Grinspan, Zachary/0000-0001-6705-0932	Korean Diabetes Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS066274] Funding Source: NIH RePORTER	Korean Diabetes Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a grant (SYR, 2014) from the Korean Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2011, J COMMUN HEALTH NURS, V28, P190, DOI 10.1080/07370016.2011.614837; Alghanim SA, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2521, DOI 10.1177/1010539511431603; ANDREN KG, 1987, SOC SCI MED, V25, P825, DOI 10.1016/0277-9536(87)90040-2; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; Bernstein SL, 2006, ANN EMERG MED, V48, P18, DOI 10.1016/j.annemergmed.2006.03.033; Billings J, 2013, HEALTH AFFAIR, V32, P2099, DOI 10.1377/hlthaff.2012.1276; Blank FSJ, 2005, J EMERG NURS, V31, P139, DOI 10.1016/j.jen.2005.02.008; Capp R, 2013, AM J EMERG MED, V31, P1333, DOI 10.1016/j.ajem.2013.05.050; Chaput YJA, 2007, PSYCHIAT SERV, V58, P335, DOI 10.1176/appi.ps.58.3.335; Cook LJ, 2004, ACAD EMERG MED, V11, P256, DOI 10.1197/j.aem.2003.10.023; Curran GM, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-17; Department of Health New York State, DEL SYST REF INC PAY; Everett W., 2008, EMERGENCY DEP OVERUS; Felland Laurie E, 2008, Issue Brief Cent Stud Health Syst Change, P1; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Honigman LS, 2013, WEST J EMERG MED, V14, P609, DOI 10.5811/westjem.2013.5.16112; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Kang MS, 2012, J KOREAN MED SCI, V27, pS21, DOI 10.3346/jkms.2012.27.S.S21; Kim JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119939; Kim YK, 2012, J KOREAN MED SCI, V27, pS25, DOI 10.3346/jkms.2012.27.S.S25; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; LaCalle EJ, 2013, J EMERG MED, V44, P1167, DOI 10.1016/j.jemermed.2012.11.042; Liu SW, 2013, AM J EMERG MED, V31, P1512, DOI 10.1016/j.ajem.2013.08.006; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Minassian A, 2013, J EMERG MED, V45, P520, DOI 10.1016/j.jemermed.2013.05.007; Murphy AW, 1999, J ACCID EMERG MED, V16, P425; R Development Core Team, LANG ENV STAT COMP 2; Rask KJ, 1998, J GEN INTERN MED, V13, P614, DOI 10.1046/j.1525-1497.1998.00184.x; Regenstein M, 2014, QUAL MANAG HEALTH CA, V23, P203, DOI 10.1097/QMH.0000000000000043; Ruger JP, 2004, ACAD EMERG MED, V11, P1311, DOI 10.1197/j.aem.2004.07.008	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147450	10.1371/journal.pone.0147450	http://dx.doi.org/10.1371/journal.pone.0147450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809051	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800097
J	Corona, A; Meleddu, R; Esposito, F; Distinto, S; Bianco, G; Masaoka, T; Maccioni, E; Menendez-Arias, L; Alcaro, S; Le Grice, SFJ; Tramontano, E				Corona, Angela; Meleddu, Rita; Esposito, Francesca; Distinto, Simona; Bianco, Giulia; Masaoka, Takashi; Maccioni, Elias; Menendez-Arias, Luis; Alcaro, Stefano; Le Grice, Stuart F. J.; Tramontano, Enzo			Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6	PLOS ONE			English	Article							HIGH-RESOLUTION STRUCTURES; RNASE-H ACTIVITIES; DNA-SYNTHESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FORCE-FIELD; PRIMER GRIP; RESISTANCE; MUTATIONS; SITE	The DNA polymerase and ribonuclease H (RNase H) activities of human immunodeficiency virus type 1 (HIV-1) are needed for the replication of the viral genome and are validated drug targets. However, there are no approved drugs inhibiting RNase H and the efficiency of DNA polymerase inhibitors can be diminished by the presence of drug resistance mutations. In this context, drugs inhibiting both activities could represent a significant advance towards better anti-HIV therapies. We report on the mechanisms of allosteric inhibition of a newly synthesized isatin-based compound designated as RMNC6 that showed IC50 values of 1.4 and 9.8 mu M on HIV-1 RT-associated RNase H and polymerase activities, respectively. Blind docking studies predict that RMNC6 could bind two different pockets in the RT: one in the DNA polymerase domain (partially overlapping the non-nucleoside RT inhibitor [NNRTI] binding pocket), and a second one close to the RNase H active site. Enzymatic studies showed that RMNC6 interferes with efavirenz (an approved NNRTI) in its binding to the RT polymerase domain, although NNRTI resistance-associated mutations such as K103N, Y181C and Y188L had a minor impact on RT susceptibility to RMNC6. In addition, despite being naturally resistant to NNRTIs, the polymerase activity of HIV-1 group O RT was efficiently inhibited by RMNC6. The compound was also an inhibitor of the RNase H activity of wild-type HIV-1 group O RT, although we observed a 6.5-fold increase in the IC50 in comparison with the prototypic HIV-1 group M subtype B enzyme. Mutagenesis studies showed that RT RNase H domain residues Asn474 and Tyr501, and in a lesser extent Ala502 and Ala508, are critical for RMNC6 inhibition of the endonuclease activity of the RT, without affecting its DNA polymerization activity. Our results show that RMNC6 acts as a dual inhibitor with allosteric sites in the DNA polymerase and the RNase H domains of HIV-1 RT.	[Corona, Angela; Meleddu, Rita; Esposito, Francesca; Distinto, Simona; Bianco, Giulia; Maccioni, Elias; Tramontano, Enzo] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Masaoka, Takashi; Le Grice, Stuart F. J.] NCI, Frederick, MD 21701 USA; [Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Menendez-Arias, Luis] Univ Autonoma Madrid, Madrid, Spain; [Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy; [Tramontano, Enzo] CNR, Ist Ric Genet & Biomed, Cagliari, Italy	University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Tramontano, E (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	tramon@unica.it	Corona, Angela/G-7327-2014; Esposito, Francesca/I-8879-2012; Tramontano, Enzo/B-4919-2012; Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Distinto, Simona/P-9803-2016	Corona, Angela/0000-0002-6630-8636; Esposito, Francesca/0000-0001-9725-7977; Tramontano, Enzo/0000-0002-4849-0980; Arias, Luis Menendez/0000-0002-1251-6640; Distinto, Simona/0000-0003-1620-6225; Meleddu, Rita/0000-0003-1629-7454; Maccioni, Elias/0000-0003-2175-2802; ALCARO, Stefano/0000-0002-0437-358X	RAS [LR 7/2007CRP-24915]; Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Spanish Ministry of Economy and Competitiveness [BIO2013-48788-C2-1-R]; Fundacion Ramon Areces	RAS(Russian Academy of SciencesRegione Sardegna); Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces	This work was supported by RAS grant LR 7/2007CRP-24915. T.M. and S.L.G. are supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Work in Madrid was supported by grant BIO2013-48788-C2-1-R (Spanish Ministry of Economy and Competitiveness) and an institutional grant of Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2013, NUCLEIC ACIDS RES, V41, P4601, DOI 10.1093/nar/gkt109; Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancor G, 2015, NUCLEIC ACIDS RES, V43, P2259, DOI 10.1093/nar/gkv077; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; BRODER S, 1984, NEW ENGL J MED, V311, P1292, DOI 10.1056/NEJM198411153112006; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Cho AE, 2005, J COMPUT CHEM, V26, P915, DOI 10.1002/jcc.20222; Christen MT, 2012, CHEM BIOL DRUG DES, V80, P706, DOI 10.1111/cbdd.12010; Chung SM, 2012, J BIOL CHEM, V287, P4066, DOI 10.1074/jbc.M111.314781; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P6101, DOI 10.1128/AAC.03605-14; Corona A, 2014, FUTURE VIROL, V9, P445, DOI 10.2217/fvl.14.24; Corona A, 2013, FUTURE MED CHEM, V5, P2127, DOI 10.4155/fmc.13.178; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; Distinto S, 2013, CURR PHARM DESIGN, V19, P1850, DOI 10.2174/1381612811319100009; Distinto S, 2012, EUR J MED CHEM, V50, P216, DOI 10.1016/j.ejmech.2012.01.056; Esposito Francesca, 2012, Mol Biol Int, V2012, P586401, DOI 10.1155/2012/586401; Esposito F, 2011, FEBS J, V278, P1444, DOI 10.1111/j.1742-4658.2011.08057.x; Felts AK, 2011, J CHEM INF MODEL, V51, P1986, DOI 10.1021/ci200194w; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Gong QG, 2011, CHEM BIOL DRUG DES, V77, P39, DOI 10.1111/j.1747-0285.2010.01052.x; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hasel W., 1988, TETRAHEDRON COMPUT M, V1, P103, DOI DOI 10.1016/0898-5529(88)90015-2; Herman BD, 2013, BIOCHEM J, V455, P179, DOI 10.1042/BJ20130850; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Masaoka T, 2013, J MED CHEM, V56, P5436, DOI 10.1021/jm400405z; Meleddu R, 2015, EUR J MED CHEM, V93, P452, DOI 10.1016/j.ejmech.2015.02.032; Meleddu R, 2014, CHEMMEDCHEM, V9, P1869, DOI 10.1002/cmdc.201402015; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Paris KA, 2009, J MED CHEM, V52, P6413, DOI 10.1021/jm900854h; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; QuinonesMateu ME, 1997, VIROLOGY, V236, P364, DOI 10.1006/viro.1997.8748; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Ren JS, 2000, J BIOL CHEM, V275, P14316, DOI 10.1074/jbc.275.19.14316; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V61, P973, DOI 10.1093/jac/dkn060; SCHATZ O, 1990, ADV AP BIOT, V7, P293; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tramontano E, 2005, ANTIVIR RES, V65, P117, DOI 10.1016/j.antiviral.2004.11.002; Vernekar SKV, 2015, J MED CHEM, V58, P651, DOI 10.1021/jm501132s; Xu L, 2015, J MICROBIOL; YONETANI T, 1982, METHOD ENZYMOL, V87, P500	56	38	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147225	10.1371/journal.pone.0147225	http://dx.doi.org/10.1371/journal.pone.0147225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800261	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300075
J	Lee, SA; Holly, KS; Voziyanov, V; Villalba, SL; Tong, R; Grigsby, HE; Glasscock, E; Szele, FG; Vlachos, I; Murray, TA				Lee, Seon A.; Holly, Kevin S.; Voziyanov, Vladislav; Villalba, Stephanie L.; Tong, Rudi; Grigsby, Holly E.; Glasscock, Edward; Szele, Francis G.; Vlachos, Ioannis; Murray, Teresa A.			Gradient Index Microlens Implanted in Prefrontal Cortex of Mouse Does Not Affect Behavioral Test Performance over Time	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; ACETYLCHOLINE-RECEPTORS; CELLULAR RESOLUTION; FLUORESCENT PROTEIN; MICE; ORGANIZATION; MODELS; EXPRESSION; SUBUNITS	Implanted gradient index lenses have extended the reach of standard multiphoton microscopy from the upper layers of the mouse cortex to the lower cortical layers and even subcortical regions. These lenses have the clarity to visualize dynamic activities, such as calcium transients, with subcellular and millisecond resolution and the stability to facilitate repeated imaging over weeks and months. In addition, behavioral tests can be used to correlate performance with observed changes in network function and structure that occur over time. Yet, this raises the questions, does an implanted microlens have an effect on behavioral tests, and if so, what is the extent of the effect? To answer these questions, we compared the performance of three groups of mice in three common behavioral tests. A gradient index lens was implanted in the prefrontal cortex of experimental mice. We compared their performance with mice that had either a cranial window or a sham surgery. Three presurgical and five postsurgical sets of behavioral tests were performed over seven weeks. Behavioral tests included rotarod, foot fault, and Morris water maze. No significant differences were found between the three groups, suggesting that microlens implantation did not affect performance. The results for the current study clear the way for combining behavioral studies with gradient index lens imaging in the prefrontal cortex, and potentially other regions of the mouse brain, to study structural, functional, and behavioral relationships in the brain.	[Lee, Seon A.; Holly, Kevin S.; Voziyanov, Vladislav; Grigsby, Holly E.; Vlachos, Ioannis; Murray, Teresa A.] Louisiana Tech Univ, Ctr Biomed Res & Rehabil Sci, Ruston, LA 71270 USA; [Villalba, Stephanie L.; Glasscock, Edward] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Tong, Rudi; Szele, Francis G.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Louisiana System; Louisiana Technical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Oxford	Murray, TA (corresponding author), Louisiana Tech Univ, Ctr Biomed Res & Rehabil Sci, Ruston, LA 71270 USA.	bioengineer1@hotmail.com	Murray, Teresa/AAG-3531-2019; Murray, Teresa/AAV-3011-2020	Murray, Teresa/0000-0002-8857-154X; Lee, Seona/0000-0002-0124-6964	National Institutes of Health [R21 HD075376]; Louisiana Board of Regents Research Competitiveness Subprogram grant [12-180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD075376] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL107641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents Research Competitiveness Subprogram grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by the National Institutes of Health grant R21 HD075376 (https://grants.nih.gov) to TM, and the Louisiana Board of Regents Research Competitiveness Subprogram grant 12-180 (https://web.laregents.org/programs/borsf-programs) to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Birngruber T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090221; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Dazai J, 2011, JOVE-J VIS EXP, DOI 10.3791/2497; Deacon RM, 2013, JOVE-J VIS EXP, DOI [10.3791/2609(75):e2609, DOI 10.3791/2609(75):E2609]; DECOSTER MA, 1992, NEUROREPORT, V3, P773, DOI 10.1097/00001756-199209000-00013; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Deng HX, 2000, ARCH NEUROL-CHICAGO, V57, P1695, DOI 10.1001/archneur.57.12.1695; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gonzalez-Islas C, 2001, J NEUROPHYSIOL, V86, P2911, DOI 10.1152/jn.2001.86.6.2911; Green ECJ, 2005, BIOINFORMATICS, V21, P2930, DOI 10.1093/bioinformatics/bti441; James R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00030; James RE, 2016, GLIA, V64, P105, DOI 10.1002/glia.22906; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Li T, 2008, NEUROSCI LETT, V448, P99, DOI 10.1016/j.neulet.2008.10.033; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Lu XH, 2009, INT REV NEUROBIOL, V89, P37, DOI 10.1016/S0074-7742(09)89002-8; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Magnusson KR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-43; Massot P, 2012, CONTRAST MEDIA MOL I, V7, P45, DOI 10.1002/cmmi.464; Muhammad A, 2013, NEUROSCIENCE, V252, P178, DOI 10.1016/j.neuroscience.2013.08.016; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Murray TA, 2009, ACTA PHARMACOL SIN, V30, P828, DOI 10.1038/aps.2009.78; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 2002, J NEUROSCI, V22, P3338; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song CZ, 2005, NEUROPHARMACOLOGY, V48, P869, DOI 10.1016/j.neuropharm.2005.01.003; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; SZELE FG, 1995, J NEUROSCI, V15, P4429; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Valentim AM, 2008, J AM ASSOC LAB ANIM, V47, P16; Valvassori SS, 2013, REV BRAS PSIQUIATR, V35, pS121, DOI 10.1590/1516-4446-2013-1168; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Young CC, 2014, NEUROBIOL DIS, V63, P155, DOI 10.1016/j.nbd.2013.11.003; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	59	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146533	10.1371/journal.pone.0146533	http://dx.doi.org/10.1371/journal.pone.0146533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799938	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300024
J	Higashide, T; Ohkubo, S; Hangai, M; Ito, Y; Shimada, N; Ohno-Matsui, K; Terasaki, H; Sugiyama, K; Chew, P; Li, KKW; Yoshimura, N				Higashide, Tomomi; Ohkubo, Shinji; Hangai, Masanori; Ito, Yasuki; Shimada, Noriaki; Ohno-Matsui, Kyoko; Terasaki, Hiroko; Sugiyama, Kazuhisa; Chew, Paul; Li, Kenneth K. W.; Yoshimura, Nagahisa			Influence of Clinical Factors and Magnification Correction on Normal Thickness Profiles of Macular Retinal Layers Using Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; HEALTHY-SUBJECTS; AXIAL LENGTH; MYOPIC EYES; AGE; GLAUCOMA; SEX; REPRODUCIBILITY; DETERMINANTS	Purpose To identify the factors which significantly contribute to the thickness variabilities in macular retinal layers measured by optical coherence tomography with or without magnification correction of analytical areas in normal subjects. Methods The thickness of retinal layers {retinal nerve fiber layer (RNFL), ganglion cell layer plus inner plexiform layer (GCLIPL), RNFL plus GCLIPL (ganglion cell complex, GCC), total retina, total retina minus GCC (outer retina)} were measured by macular scans (RS-3000, NIDEK) in 202 eyes of 202 normal Asian subjects aged 20 to 60 years. The analytical areas were defined by three concentric circles (1-, 3-and 6-mm nominal diameters) with or without magnification correction. For each layer thickness, a semipartial correlation (sr) was calculated for explanatory variables including age, gender, axial length, corneal curvature, and signal strength index. Results Outer retinal thickness was significantly thinner in females than in males (sr(2), 0.07 to 0.13) regardless of analytical areas or magnification correction. Without magnification correction, axial length had a significant positive sr with RNFL (sr(2), 0.12 to 0.33) and a negative sr with GCLIPL (sr(2), 0.22 to 0.31), GCC (sr(2), 0.03 to 0.17), total retina (sr(2), 0.07 to 0.17) and outer retina (sr(2), 0.16 to 0.29) in multiple analytical areas. The significant sr in RNFL, GCLIPL and GCC became mostly insignificant following magnification correction. Conclusions The strong correlation between the thickness of inner retinal layers and axial length appeared to result from magnification effects. Outer retinal thickness may differ by gender and axial length independently of magnification correction.	[Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa] Kanazawa Univ, Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Ito, Yasuki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Shimada, Noriaki; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Chew, Paul] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Ophthalmol, Singapore, Singapore; [Li, Kenneth K. W.] United Christian Hosp, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Li, Kenneth K. W.] Tseung Kwan O Hosp, Hong Kong, Hong Kong, Peoples R China; [Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kanazawa University; Saitama Medical University; Nagoya University; Tokyo Medical & Dental University (TMDU); National University of Singapore; United Christian Hospital; Kyoto University	Higashide, T (corresponding author), Kanazawa Univ, Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp	Ito, Yasuki/M-4876-2014; Li, Kenneth/M-4140-2017	Ito, Yasuki/0000-0001-9219-9261; Li, Kenneth/0000-0001-9440-8063	Japan Society for the Promotion of Science [26462632]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (26462632) from the Japan Society for the Promotion of Science (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037638; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; Choovuthayakorn J, 2012, JPN J OPHTHALMOL, V56, P569, DOI 10.1007/s10384-012-0192-x; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Gupta P, 2013, INVEST OPHTH VIS SCI, V54, P7968, DOI 10.1167/iovs.13-12436; Harb E, 2012, OPTOMETRY VISION SCI, V89, P620, DOI 10.1097/OPX.0b013e318251293a; Hirasawa H, 2013, INVEST OPHTH VIS SCI, V54, P2562, DOI 10.1167/iovs.12-10552; Hirasawa K, 2013, JPN J OPHTHALMOL, V57, P429, DOI 10.1007/s10384-013-0241-0; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2012, TRANSL VIS SCI TECHN, V1, DOI 10.1167/tvst.1.1.3; Hwang YH, 2012, CLIN EXP OPTOM, V95, P492, DOI 10.1111/j.1444-0938.2012.00749.x; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kim NR, 2011, INVEST OPHTH VIS SCI, V52, P3413, DOI 10.1167/iovs.10-6648; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Myers CE, 2015, AM J OPHTHALMOL, V159, P445, DOI 10.1016/j.ajo.2014.11.025; Nakanishi H, 2015, GRAEF ARCH CLIN EXP, V253, P1143, DOI 10.1007/s00417-015-3026-y; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; Nowroozizadeh S, 2014, INVEST OPHTH VIS SCI, V55, P3439, DOI 10.1167/iovs.14-13880; Odell D, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/692574; Ohkubo S, 2014, INVEST OPHTH VIS SCI, V55, P5269, DOI 10.1167/iovs.14-14153; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Oner V, 2013, BRIT J OPHTHALMOL, V97, P75, DOI 10.1136/bjophthalmol-2012-301865; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Savini G, 2012, BRIT J OPHTHALMOL, V96, P57, DOI 10.1136/bjo.2010.196782; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wu PC, 2008, EYE, V22, P551, DOI 10.1038/sj.eye.6702789; Zhao ZN, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0080-5; Zhao ZN, 2013, CLIN EXP OPHTHALMOL, V41, P561, DOI 10.1111/ceo.12045	43	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147782	10.1371/journal.pone.0147782	http://dx.doi.org/10.1371/journal.pone.0147782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814541	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528200051
J	Berlyand, Y; Weintraub, D; Xie, SX; Mellis, IA; Doshi, J; Rick, J; McBride, J; Davatzikos, C; Shaw, LM; Hurtig, H; Trojanowski, JQ; Chen-Plotkin, AS				Berlyand, Yosef; Weintraub, Daniel; Xie, Sharon X.; Mellis, Ian A.; Doshi, Jimit; Rick, Jacqueline; McBride, Jennifer; Davatzikos, Christos; Shaw, Leslie M.; Hurtig, Howard; Trojanowski, John Q.; Chen-Plotkin, Alice S.			An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia	PLOS ONE			English	Article							PREDICTS COGNITIVE DECLINE; ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; LEWY BODY; BRAIN PATHOLOGY; TAU-SYNUCLEIN; RISK-FACTORS; BETA; IMPACT; HUNTINGTONS	Biomarkers from multiple modalities have been shown to correlate with cognition in Parkinson's disease (PD) and in Alzheimer's disease (AD). However, the relationships of these markers with each other, and the use of multiple markers in concert to predict an outcome of interest, are areas that are much less explored. Our objectives in this study were (1) to evaluate relationships among 17 biomarkers previously reported to associate with cognition in PD or AD and (2) to test performance of a five-biomarker classifier trained to recognize AD in identifying PD with dementia (PDD). To do this, we evaluated a cross-sectional cohort of PD patients (n = 75) across a spectrum of cognitive abilities. All PD participants had 17 baseline biomarkers from clinical, genetic, biochemical, and imaging modalities measured, and correlations among biomarkers were assessed by Spearman's rho and by hierarchical clustering. We found that internal correlation among all 17 candidate biomarkers was modest, showing a maximum pairwise correlation coefficient of 0.51. However, a five-marker subset panel derived from AD (CSF total tau, CSF phosphorylated tau, CSF amyloid beta 42, APOE genotype, and SPARE-AD imaging score) discriminated cognitively normal PD patients vs. PDD patients with 80% accuracy, when employed in a classifier originally trained to recognize AD. Thus, an AD-derived biomarker signature may identify PDD patients with moderately high accuracy, suggesting mechanisms shared with AD in some PDD patients. Based on five measures readily obtained during life, this AD-derived signature may prove useful in identifying PDD patients most likely to respond to AD-based crossover therapies.	[Berlyand, Yosef; Mellis, Ian A.; Rick, Jacqueline; Hurtig, Howard; Chen-Plotkin, Alice S.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Xie, Sharon X.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Doshi, Jimit; Davatzikos, Christos] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [McBride, Jennifer; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [McBride, Jennifer; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chen-Plotkin, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	chenplot@mail.med.upenn.edu	Weintraub, Daniel/AAC-5232-2020; Davatzikos, Christos/ABE-2057-2021; Weintraub, Daniel/AAD-8309-2020	Weintraub, Daniel/0000-0003-0633-7168; Mellis, Ian/0000-0002-6239-4821; Berlyand, Yosef/0000-0003-2313-8507; Davatzikos, Christos/0000-0002-1025-8561	NIH [P50 NS053488, U01 NS082134]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS082134, P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014971, P30AG010124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funding for this actual study was from the NIH only (P50 NS053488, U01 NS082134).	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; AstraZeneca, AN EFFICACY AND SAFE; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brandt J, 2001, HOPKINS VERBAL LEARN; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Chahine LM, 2013, JAMA NEUROL, V70, P852, DOI 10.1001/jamaneurol.2013.1274; Chen-Plotkin AS, 2014, NEURON, V84, P594, DOI 10.1016/j.neuron.2014.10.031; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Eisai Inc, DOS FIND STUD EV SAF; Eli Lilly and Company, CLIN TRIAL SOL OLD I; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Hughes TA, 2000, NEUROLOGY, V54, P1596, DOI 10.1212/WNL.54.8.1596; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jellinger KA, 2002, J NEURAL TRANSM, V109, P329, DOI 10.1007/s007020200027; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Kalaitzakis ME, 2008, J NEUROPATH EXP NEUR, V67, P155, DOI 10.1097/NEN.0b013e31816362aa; Kramer JH, 1989, NEUROPSYCHOLOGY, V3, P111, DOI 10.1037//0894-4105.3.2.111; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P695, DOI 10.1001/archneur.1995.00540310069018; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Marek K, 2008, ANN NEUROL, V64, pS111, DOI 10.1002/ana.21602; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Mollenhauer B, 2014, MOVEMENT DISORD, V29, P622, DOI 10.1002/mds.25846; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Pellecchia MT, 2013, J NEUROL, V260, P438, DOI 10.1007/s00415-012-6648-6; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Pressley JC, 2003, NEUROLOGY, V60, P87, DOI 10.1212/WNL.60.1.87; Rosenthal E, 2010, MOVEMENT DISORD, V25, P1170, DOI 10.1002/mds.23073; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P295, DOI 10.1097/WAD.0b013e31819c5ef4; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sherer TB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002488; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Su YS, 2011, J STAT SOFTW, V45, P1; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491	65	24	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147319	10.1371/journal.pone.0147319	http://dx.doi.org/10.1371/journal.pone.0147319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812251	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000029
J	Ramsay, JE; Tong, EMW; Pang, JS; Chowdhury, A				Ramsay, Jonathan E.; Tong, Eddie M. W.; Pang, Joyce S.; Chowdhury, Avijit			A Puzzle Unsolved: Failure to Observe Different Effects of God and Religion Primes on Intergroup Attitudes	PLOS ONE			English	Article							GENDER-DIFFERENCES; PROSOCIAL BEHAVIOR; PREJUDICE; SELF; COGNITION; IMPLICIT; THINKING; MEN	Religious priming has been found to have both positive and negative consequences, and recent research suggests that the activation of God-related and community-related religious cognitions may cause outgroup prosociality and outgroup derogation respectively. The present research sought to examine whether reminders of God and religion have different effects on attitudes towards ingroup and outgroup members. Over two studies, little evidence was found for different effects of these two types of religious primes. In study 1, individuals primed with the words "religion", "God" and a neutral control word evaluated both ingroup and outgroup members similarly, although a marginal tendency towards more negative evaluations of outgroup members by females exposed to religion primes was observed. In study 2, no significant differences in attitudes towards an outgroup member were observed between the God, religion, and neutral priming conditions. Furthermore, the gender effect observed in study 1 did not replicate in this second study. Possible explanations for these null effects are discussed.	[Ramsay, Jonathan E.] SIM Univ, UniSIM Coll, Singapore, Singapore; [Tong, Eddie M. W.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Pang, Joyce S.] Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore; [Chowdhury, Avijit] SIM Univ, Ctr Appl Res, Singapore, Singapore	Singapore University of Social Sciences (SUSS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore University of Social Sciences (SUSS)	Ramsay, JE (corresponding author), SIM Univ, UniSIM Coll, Singapore, Singapore.	jonathanramsay@unisim.edu.sg	Pang, Joyce S/C-2411-2017	Pang, Joyce S/0000-0002-1105-3031; Ramsay, Jonathan/0000-0003-4634-9040				Ahmed AM, 2011, J SOCIO-ECON, V43, P242, DOI 10.1016/j.socec.2010.12.013; Amodio DM, 2006, J PERS SOC PSYCHOL, V91, P652, DOI 10.1037/0022-3514.91.4.652; Anderson LR, 2009, ECON LETT, V105, P58, DOI 10.1016/j.econlet.2009.05.016; [Anonymous], 2011, QUALTR COMP SOFTW; Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Aveyard ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099447; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Batson C D, 1993, RELIG INDIVIDUAL SOC; Batson CD, 1999, J SCI STUD RELIG, V38, P445, DOI 10.2307/1387605; Baumard N, 2013, TRENDS COGN SCI, V17, P272, DOI 10.1016/j.tics.2013.04.003; Bekkers R, 2011, VOLUNT SECT REV, V2, P337, DOI 10.1332/204080511X6087712; Blaine BE, 1998, PERS SOC PSYCHOL B, V24, P1040, DOI 10.1177/01461672982410002; BRECKLER SJ, 1984, J PERS SOC PSYCHOL, V47, P1191, DOI 10.1037/0022-3514.47.6.1191; Brooks Arthur C., 2006, WHO REALLY CARES AM; Campbell J, 2013, WHY TERRIFYING RELIG; Chan KQ, 2014, SOC PSYCHOL PERS SCI, V5, P901, DOI 10.1177/1948550614537309; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Chong T., 2012, C INT SING; CROSBY F, 1980, PSYCHOL BULL, V87, P546, DOI 10.1037/0033-2909.87.3.546; Dijksterhuis A, 2008, J EXP SOC PSYCHOL, V44, P2, DOI 10.1016/j.jesp.2007.01.003; Ditonto TM, 2013, POLIT PSYCHOL, V34, P487, DOI 10.1111/pops.12013; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Francis LJ, 1997, RELIGION, V27, P81, DOI 10.1006/reli.1996.0066; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gervais WM, 2012, J EXP SOC PSYCHOL, V48, P298, DOI 10.1016/j.jesp.2011.09.006; Gervais WM, 2013, SOCIAL PERSONALITY P, V7, P366; Gomes CM, 2015, J EXP PSYCHOL GEN, V144, pE94, DOI 10.1037/xge0000027; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Griffin D, 1999, PERS RELATIONSHIP, V6, P505, DOI 10.1111/j.1475-6811.1999.tb00206.x; Hall DL, 2010, PERS SOC PSYCHOL REV, V14, P126, DOI 10.1177/1088868309352179; Han K, 2013, PASTORS IGNITE DEBAT; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hoffman RL, 2011, NAT C UND RES NCUR I; Hone LS, 2014, EVOL HUM BEHAV, V36, P81; Johnson MK, 2012, PSYCHOL RELIG SPIRIT, V4, P154, DOI 10.1037/a0025107; Johnson MK, 2010, SOC PSYCHOL PERS SCI, V1, P119, DOI 10.1177/1948550609357246; Loewenthal KM, 2002, PERS INDIV DIFFER, V32, P133, DOI 10.1016/S0191-8869(01)00011-3; Maselko J, 2006, SOC SCI MED, V62, P2848, DOI 10.1016/j.socscimed.2005.11.008; McCullough ME, 2012, EVOL HUM BEHAV, V33, P562, DOI 10.1016/j.evolhumbehav.2012.02.004; McKay R, 2011, P ROY SOC B-BIOL SCI, V278, P1858, DOI 10.1098/rspb.2010.2125; Moreno K. N., 2001, GROUP PROCESS INTERG, V4, P21, DOI DOI 10.1177/1368430201041002; Nanyang Technological University Corporate Information, 2013, FACTS FIG; National University of Singapore Registrar's Office, 2013, SUMM UND STUD ENR; Pichon I, 2007, EUR J SOC PSYCHOL, V37, P1032, DOI 10.1002/ejsp.416; Pichon I, 2009, ARCH PSYCHOL RELIG, V31, P215, DOI 10.1163/157361209X424466; Preston JL, 2013, PERS SOC PSYCHOL B, V39, P1471, DOI 10.1177/0146167213499937; Preston JL, 2010, SOC PERSONAL PSYCHOL, V4, P574, DOI 10.1111/j.1751-9004.2010.00286.x; Raman S, 2005, RELIG ROW TSUNAMI RE; Ramsay J. E., POLITICAL P IN PRESS; Ramsay JE, 2014, INT J PSYCHOL RELIG, V24, P1, DOI 10.1080/10508619.2012.761525; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Rowatt WC, 2009, PSYCHOL RELIG SPIRIT, V1, P14, DOI 10.1037/a0014989; Ruiter S, 2006, AM SOCIOL REV, V71, P191, DOI 10.1177/000312240607100202; Saroglou V, 2005, J SCI STUD RELIG, V44, P323, DOI 10.1111/j.1468-5906.2005.00289.x; Saroglou V., 2013, APA HDB PSYCHOL RELI; Saroglou V, 2008, J SCI STUD RELIG, V47, P83, DOI 10.1111/j.1468-5906.2008.00393.x; Saroglou V, 2009, INT J PSYCHOL RELIG, V19, P143, DOI 10.1080/10508610902880063; Scheepers P, 2002, REV RELIG RES, V43, P242, DOI 10.2307/3512331; Shariff A. F., 2015, PERSONALITY SOCIAL P; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Sherman J.W., J EXPT SOCI IN PRESS; Singapore Ministry of Education, 2010, ED STAT DIG; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; THOMPSON EH, 1991, J SCI STUD RELIG, V30, P381, DOI 10.2307/1387275; Tisdall S, 2010, WAVE ANTICHRISTIAN V; Turner J.C., 1987, REDISCOVERING SOCIAL; Tzu Chi Foundation, 2014, OBJ VIS MISS; Van Cappellen P, 2011, INT J PSYCHOL RELIG, V21, P97, DOI 10.1080/10508619.2011.556995; van Elk M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01365, 10.3389/fpg.2015.01365]; Wellman JK, 2004, J SCI STUD RELIG, V43, P291, DOI 10.1111/j.1468-5906.2004.00234.x; Wilson D., 2002, DARWINS CATHEDRAL EV; Xygalatas D, 2013, RELIG BRAIN BEHAV, V3, P91, DOI 10.1080/2153599X.2012.724547	73	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147178	10.1371/journal.pone.0147178	http://dx.doi.org/10.1371/journal.pone.0147178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DC9GB	26812526	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000369528000023
J	Yang, CY; Liu, HM; Chen, SK; Chen, YF; Lee, CW; Yeh, LR				Yang, Chung-Yi; Liu, Hon-Man; Chen, Shan-Kai; Chen, Ya-Fang; Lee, Chung-Wei; Yeh, Lee-Ren			Reproducibility of Brain Morphometry from Short-Term Repeat Clinical MRI Examinations: A Retrospective Study	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; POWER CALCULATIONS; MULTIPLE-SCLEROSIS; RELIABILITY; SEGMENTATION; DISEASE	Purpose To assess the inter session reproducibility of automatic segmented MRI-derived measures by FreeSurfer in a group of subjects with normal-appearing MR images. Materials and Methods After retrospectively reviewing a brain MRI database from our institute consisting of 14,758 adults, those subjects who had repeat scans and had no history of neurodegenerative disorders were selected for morphometry analysis using FreeSurfer. A total of 34 subjects were grouped by MRI scanner model. After automatic segmentation using FreeSurfer, label-wise comparison (involving area, thickness, and volume) was performed on all segmented results. An intraclass correlation coefficient was used to estimate the agreement between sessions. Wilcoxon signed rank test was used to assess the population mean rank differences across sessions. Mean-difference analysis was used to evaluate the difference intervals across scanners. Absolute percent difference was used to estimate the reproducibility errors across the MRI models. Kruskal-Wallis test was used to determine the across-scanner effect. Results The agreement in segmentation results for area, volume, and thickness measurements of all segmented anatomical labels was generally higher in Signa Excite and Verio models when compared with Sonata and TrioTim models. There were significant rank differences found across sessions in some labels of different measures. Smaller difference intervals in global volume measurements were noted on images acquired by Signa Excite and Verio models. For some brain regions, significant MRI model effects were observed on certain segmentation results.	[Yang, Chung-Yi; Yeh, Lee-Ren] I Shou Univ, E Da Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Yang, Chung-Yi; Liu, Hon-Man; Chen, Ya-Fang; Lee, Chung-Wei] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi; Liu, Hon-Man; Chen, Ya-Fang; Lee, Chung-Wei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Shan-Kai] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Yeh, Lee-Ren] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Central University; I Shou University	Liu, HM (corresponding author), Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan.; Liu, HM (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	hmliu@ntu.edu.tw		LEE, CHUNG-WEI/0000-0002-3573-2506; Yang, Chung-Yi/0000-0003-1697-8823; CHEN, YA-FANG/0000-0003-2995-9189; LIU, HON-MAN/0000-0001-6715-6366	Ministry of Science and Technology, Taiwan [MOST 103-2911-I-008-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology, Taiwan (http://www.most.gov.tw) MOST 103-2911-I-008-001: HML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Durand-Dubief F, 2012, AM J NEURORADIOL, V33, P1918, DOI 10.3174/ajnr.A3107; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fennema-Notestine C, 2007, NEUROINFORMATICS, V5, P235, DOI 10.1007/s12021-007-9003-9; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Haubold A, 2012, J CHILD PSYCHOL PSYC, V53, P519, DOI 10.1111/j.1469-7610.2012.02539.x; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Prescott JW, 2013, J DIGIT IMAGING, V26, P97, DOI 10.1007/s10278-012-9465-7; R Core Team, 2021, R LANGUAGE ENV STAT; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rovaris M, 2001, BRAIN, V124, P1803, DOI 10.1093/brain/124.9.1803; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Scharinger C, 2010, NEUROIMAGE, V53, P810, DOI 10.1016/j.neuroimage.2010.02.019; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Suckling J, 2014, HUM BRAIN MAPP, V35, P3569, DOI 10.1002/hbm.22465; Suckling J, 2012, HUM BRAIN MAPP, V33, P373, DOI 10.1002/hbm.21210; Suckling J, 2010, HUM BRAIN MAPP, V31, P1183, DOI 10.1002/hbm.20927; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	39	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146913	10.1371/journal.pone.0146913	http://dx.doi.org/10.1371/journal.pone.0146913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812647	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000017
J	Ederer, AK; Didier, KD; Reiter, LK; Brown, M; Hardy, R; Caldwell, J; Black, CD; Larson, RD; Ade, CJ				Ederer, Austin K.; Didier, Kaylin D.; Reiter, Landon K.; Brown, Michael; Hardy, Rachel; Caldwell, Jacob; Black, Christopher D.; Larson, Rebecca D.; Ade, Carl J.			Influence of Adjuvant Therapy in Cancer Survivors on Endothelial Function and Skeletal Muscle Deoxygenation	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PULMONARY O-2 UPTAKE; SKIN BLOOD-FLOW; OXIDATIVE-METABOLISM; OXYGEN EXTRACTION; PHYSICAL-ACTIVITY; UPTAKE KINETICS; GAS-EXCHANGE; EXERCISE; IMPAIRMENT	The cardiotoxic effects of adjuvant cancer treatments (i.e., chemotherapy and radiation treatment) have been well documented, but the effects on peripheral cardiovascular function are still unclear. We hypothesized that cancer survivors i) would have decreased resting endothelial function; and ii) altered muscle deoxygenation response during moderate intensity cycling exercise compared to cancer-free controls. A total of 8 cancer survivors (similar to 70 months post-treatment) and 9 healthy controls completed a brachial artery FMD test, an index of endothelial-dependent dilation, followed by an incremental exercise test up to the ventilatory threshold (VT) on a cycle ergometer during which pulmonary (V) over dotO(2) and changes in near-infrared spectroscopy (NIRS)-derived microvascular tissue oxygenation (TOI), total hemoglobin concentration ([Hb](total)), and muscle deoxygenation ([HHb] approximate to fractional O-2 extraction) were measured. There were no significant differences in age, height, weight, and resting blood pressure between cancer survivors and control participants. Brachial artery FMD was similar between groups (P = 0.98). During exercise at the VT, TOI was similar between groups, but [Hb](total) and [HHb] were significantly decreased in cancer survivors compared to controls (P < 0.01) The rate of change for TOI (Delta TOI Delta/(V) over dotO(2) and [HHb] (Delta[HHb]/Delta(V) over dotO(2)) relative to Delta(V) over dotO(2) were decreased in cancer survivors compared to controls (P = 0.02 and P = 0.03 respectively). In cancer survivors, a decreased skeletal muscle microvascular function was observed during moderate intensity cycling exercise. These data suggest that adjuvant cancer therapies have an effect on the integrated relationship between O-2 extraction, (V) over dotO(2) and O-2 delivery during exercise.	[Ederer, Austin K.; Didier, Kaylin D.; Reiter, Landon K.; Brown, Michael; Hardy, Rachel; Caldwell, Jacob; Black, Christopher D.; Larson, Rebecca D.; Ade, Carl J.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Ade, CJ (corresponding author), Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.	cade@ou.edu		Didier, Kaylin/0000-0002-0281-8493; Black, Christopher/0000-0003-2662-8341; Ade, Carl/0000-0002-1837-2342				Ammar HI, 2011, AM J PHYSIOL-HEART C, V301, pH2413, DOI 10.1152/ajpheart.01096.2010; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beckman JA, 2001, J AM COLL CARDIOL, V37, P761, DOI 10.1016/S0735-1097(00)01190-6; Boone J, 2009, EUR J APPL PHYSIOL, V105, P851, DOI 10.1007/s00421-008-0969-2; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Boyle LJ, 2013, J APPL PHYSIOL, V115, P1519, DOI 10.1152/japplphysiol.00837.2013; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; Davis SL, 2006, J APPL PHYSIOL, V100, P221, DOI 10.1152/japplphysiol.00867.2005; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Dengel DR, 2008, J PEDIAT HEMATOL ONC, V30, P20, DOI 10.1097/MPH.0b013e318159a593; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Duquaine D, 2003, VASC MED, V8, P101, DOI 10.1191/1358863x03vm476oa; Ferreira LF, 2007, J APPL PHYSIOL, V103, P1999, DOI 10.1152/japplphysiol.01414.2006; Ferreira LF, 2005, J APPL PHYSIOL, V98, P1820, DOI 10.1152/japplphysiol.00907.2004; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Gibson NM, 2013, J CARDIOVASC PHARM, V62, P355, DOI 10.1097/FJC.0b013e31829c9993; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Ito M, 1997, J CARDIOVASC PHARM, V29, P232, DOI 10.1097/00005344-199702000-00012; Jones LW, 2007, CANCER EPIDEM BIOMAR, V16, P1026, DOI 10.1158/1055-9965.EPI-06-0870; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Kalliokoski KK, 2004, MICROVASC RES, V67, P125, DOI 10.1016/j.mvr.2003.11.004; Khouri MG, 2012, CIRCULATION, V126, P2749, DOI 10.1161/CIRCULATIONAHA.112.100560; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Koga S, 2015, EUR J APPL PHYSIOL, V115, P335, DOI 10.1007/s00421-014-3019-2; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; Kowalchuk JM, 2002, EXP PHYSIOL, V87, P601, DOI 10.1113/eph8702456; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Mulrooney DA, 2012, J CARDIOVASC TRANSL, V5, P287, DOI 10.1007/s12265-012-9358-7; Murias JM, 2013, AM J PHYSIOL-REG I, V304, pR720, DOI 10.1152/ajpregu.00016.2013; Newcomer SC, 2004, J PHYSIOL-LONDON, V556, P1001, DOI 10.1113/jphysiol.2003.059717; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; PIIPER J, 1981, RESP PHYSIOL, V46, P193, DOI 10.1016/0034-5687(81)90121-3; Poole DC, 2011, ACTA PHYSIOL, V202, P293, DOI 10.1111/j.1748-1716.2010.02246.x; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; Porcelli S, 2010, J APPL PHYSIOL, V109, P101, DOI 10.1152/japplphysiol.00782.2009; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; ROCA J, 1992, J APPL PHYSIOL, V73, P1067; Rossiter HB, 2011, COMPR PHYSIOL, V1, P203, DOI 10.1002/cphy.c090010; Salvadego D, 2011, J APPL PHYSIOL, V111, P1719, DOI 10.1152/japplphysiol.01380.2010; SEER Program (National Cancer Institute (U. S.)) National Center for Health Statistics (U. S.) National Cancer Institute (U. S.). Surveillance Program. National Cancer Institute (U. S.). Cancer Statistics Branch. National Cancer Institute (U. S.). Cancer Control Research Program, 1993, NIH PUBLICATION, pv; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; Sugihara T, 1999, CIRCULATION, V100, P635, DOI 10.1161/01.CIR.100.6.635; Takagi S, 2014, MED SCI SPORT EXER, V46, P2062, DOI 10.1249/MSS.0000000000000334; van der Veldt AAM, 2010, ANTI-CANCER DRUG, V21, P439, DOI 10.1097/CAD.0b013e3283359c79; Vincent WJ, 2012, STAT KINESIOLOGY, Vxiv; WAGNER PD, 1992, MED SCI SPORT EXER, V24, P54	51	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147691	10.1371/journal.pone.0147691	http://dx.doi.org/10.1371/journal.pone.0147691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807572	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800182
J	Hirata, H; Takahashi, A; Shimoda, Y; Koide, T				Hirata, Haruna; Takahashi, Aki; Shimoda, Yasushi; Koide, Tsuyoshi			Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task	PLOS ONE			English	Article							BASAL GANGLIA; NMDA RECEPTORS; NUCLEUS-ACCUMBENS; POSTNATAL-DEVELOPMENT; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; DORSAL STRIATUM; C-FOS; ORGANIZATION	Caspr3 (Contactin-associated protein-like 3, Cntnap3) is a neural cell adhesion molecule belonging to the Caspr family. We have recently shown that Caspr3 is expressed abundantly between the first and second postnatal weeks in the mouse basal ganglia, including the striatum, external segment of the globus pallidus, subthalamic nucleus, and substantia nigra. However, its physiological role remains largely unknown. In this study, we conducted a series of behavioral analyses on Capsr3-knockout (KO) mice and equivalent wild-type (WT) mice to investigate the role of Caspr3 in brain function. No significant differences were observed in most behavioral traits between Caspr3-KO and WT mice, but we found that Caspr3-KO mice performed poorly during the early phase of the accelerated rotarod task in which latency to falling off a rod rotating with increasing velocity was examined. In the late phase, the performance of the Caspr3-KO mice caught up to the level of WT mice, suggesting that the deletion of Caspr3 caused a delay in motor learning. We then examined changes in neural activity after training on the accelerated rotarod by conducting immunohistochemistry using antibody to c-Fos, an indirect marker for neuronal activity. Experience of the accelerated rotarod task caused increases in the number of c-Fos-positive cells in the dorsal striatum, cerebellum, and motor cortex in both Caspr3-KO and WT mice, but the number of c-Fos-positive cells was significantly lower in the dorsal striatum of Caspr3-KO mice than in that of WT mice. The expression of c-Fos in the ventral striatum of Caspr3-KO and WT mice was not altered by the training. Our findings suggest that reduced activation of neural cells in the dorsal striatum in Caspr3-KO mice leads to a decline in motor learning in the accelerated rotarod task.	[Hirata, Haruna; Shimoda, Yasushi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 4118540, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan; [Takahashi, Aki] Univ Tsukuba, Lab Behav Neuroendocrinol, Tsukuba, Ibaraki 3058577, Japan	Nagaoka University of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); University of Tsukuba	Shimoda, Y (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan.; Koide, T (corresponding author), Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 4118540, Japan.; Koide, T (corresponding author), Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan.; Koide, T (corresponding author), Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan.	shimo@vos.nagaokaut.ac.jp; tkoide@nig.ac.jp	Takahashi, Aki/AAC-9290-2021	Takahashi, Aki/0000-0001-8325-9744	KAKENHI [15H01298, 15H04289, 15H05724]; NIG Collaborative Research Program [2013-A45]; Grants-in-Aid for Scientific Research [15H04289] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIG Collaborative Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Grants-in-Aid for Scientific Research (KAKENHI) (https://www.jsps.go.jp/english/e-grants/) as follows: KAKENHI 15H01298 and 15H04289 (TK), and KAKENHI 15H05724 (AT and TK). This work was also supported by the NIG Collaborative Research Program (2013-A45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belleau ML, 2000, J NEUROPHYSIOL, V84, P2204, DOI 10.1152/jn.2000.84.5.2204; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bergeron Y, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00026; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bradley KC, 2001, J NEUROSCI, V21, P2123, DOI 10.1523/JNEUROSCI.21-06-02123.2001; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Bureau G, 2010, NEUROBIOL LEARN MEM, V94, P107, DOI 10.1016/j.nlm.2010.04.008; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 1997, J NEUROSCI, V17, P4536; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; CHRONISTER RB, 1976, BRAIN RES, V108, P37, DOI 10.1016/0006-8993(76)90162-1; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hirata H, 2016, J NEUROSCI RES, V94, P74, DOI 10.1002/jnr.23670; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanno K, 2014, J NEUROSCI RES, V92, P287, DOI 10.1002/jnr.23291; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kato S, 2014, HEREDITY, V113, P416, DOI 10.1038/hdy.2014.42; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; Kosinski CM, 1998, J COMP NEUROL, V390, P63; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; Lett BT, 2000, APPETITE, V34, P87, DOI 10.1006/appe.1999.0274; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; MISGELD U, 1986, DEV BRAIN RES, V27, P59, DOI 10.1016/0165-3806(86)90232-4; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Palencia CA, 2004, NEUROBIOL LEARN MEM, V82, P81, DOI 10.1016/j.nlm.2004.04.004; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; Takahashi A, 2008, GENES BRAIN BEHAV, V7, P849, DOI 10.1111/j.1601-183X.2008.00419.x; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Traut W, 2006, MAMM GENOME, V17, P723, DOI 10.1007/s00335-005-0157-1; Vargas-Perez H, 2003, NEUROSCI LETT, V352, P81, DOI 10.1016/j.neulet.2003.08.073; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Wachter T, 2009, J NEUROSCI, V29, P436, DOI 10.1523/JNEUROSCI.4132-08.2009; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Willuhn I, 2006, NEUROPSYCHOPHARMACOL, V31, P2669, DOI 10.1038/sj.npp.1300995; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049	67	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147887	10.1371/journal.pone.0147887	http://dx.doi.org/10.1371/journal.pone.0147887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807827	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800240
J	Jiang, MF; Lee, JN; Bionaz, M; Deng, XY; Wang, Y				Jiang, MingFeng; Lee, Jung Nam; Bionaz, Massimo; Deng, Xiao Yu; Wang, Yong			Evaluation of Suitable Internal Control Genes for RT-qPCR in Yak Mammary Tissue during the Lactation Cycle	PLOS ONE			English	Article							REAL-TIME PCR; REVERSE TRANSCRIPTION-PCR; EXPRESSION; IDENTIFICATION; NORMALIZATION; SELECTION; MODEL	The yak is primarily found throughout the Tibetan high plateau and the surrounding mountainous area of south central Asia; among its others attributes, its milk is very important for the local population. A key concern in the field of yak research is the better understanding of which genes control the production and composition of milk. The most accurate and sensitive method for gene expression analysis is quantitative reverse transcription polymerase chain reaction (RT-qPCR). It is essential for reliable RT-qPCR to be able to the normalize the data using internal control genes (ICGs). However, it is critical to assess the reliability of the normalization by testing multiple ICGs. Our objective was to uncover a reliable normalization for RT-qPCR data obtained from yak mammary tissue during the lactation cycle. We assessed the reliability of 10 ICGs (ACTB, EIF6, GAPDH, LRP10, MRPL39, MRPS15, MTG1, RPS8, RPS23, and UXT) using geNorm. The analysis revealed that all of the tested ICGs can be considered to be reliable, but the use of the 6 most stable ICGs should be applied to yield a reliable normalization factor (NF). We compared the results of 3 target genes (CSN1S1, ESR1, and MYC) normalized using 6, 3, or 1 of the best ICGs. We did not observe overall differences between the 3 normalization strategies with the exception of 1 time point in MYC. The use of only a single ICG is not recommended; thus, we concluded that the calculation of the NF using the 3 best ICGs, MRPS15, RPS23, and UXT, is a reliable normalization strategy for RT-qPCR data obtained from yak mammary tissue during pregnancy and lactation. A dilution effect of the ICGs due to a large increase in the mRNA of abundantly expressed genes in bovine and porcine mammary tissue during the lactation cycle was previously observed. To test for the presence of a dilution effect in our study, we evaluated the pattern of non-normalized RT-qPCR data of ICGs from pregnancy to lactation and compared them with the total RNA concentration, milk yield, and non-normalized RT-qPCR data of 3 target genes. With a few exceptions, the non-normalized RT-qPCR data for the tested ICGs was significantly increased by lactation and had a positive correlation with total RNA and the non-normalized RT-qPCR data of CSN1S1. These data clearly indicated the presence of a "concentration effect" of single mRNA that remains unexplained but needs to be accounted for during the normalization of RT-qPCR data. Based on our findings, we recommend that the NF of the MRPS15, RPS23, and UXT genes should be used in the normalization of RT-qPCR data obtained from mammary tissue of lactating yaks during pregnancy and lactation.	[Jiang, MingFeng; Lee, Jung Nam; Deng, Xiao Yu] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China; [Lee, Jung Nam] Natl Res Fdn Korea, Seoul, South Korea; [Bionaz, Massimo] Oregon State Univ, Coll Agr Sci, Corvallis, OR 97331 USA; [Wang, Yong] Southwest Univ Nationalities, Sichuan Key Lab Conservat & Utilizat Anim Genet R, Chengdu, Peoples R China	Southwest Minzu University; Oregon State University; Southwest Minzu University	Jiang, MF (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China.; Bionaz, M (corresponding author), Oregon State Univ, Coll Agr Sci, Corvallis, OR 97331 USA.	mingfengjiang@vip.sina.com; Massimo.Bionaz@oregonstate.edu	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892	National Natural Science Foundation of China [31172198]; Sichuan Youth Science and Technology Fund [09ZQ026-011]; Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities [2011XWD-S071007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Youth Science and Technology Fund; Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities	This work was supported by the National Natural Science Foundation of China (MFJ, http://www.nsfc.gov.cn/) Grant number: 31172198, The Sichuan Youth Science and Technology Fund (MFJ, http://www.qnjj.sc.cn/) Grant number: 09ZQ026-011 and the Construction Project of Postgraduate Academic Degree in Southwest University for Nationalities (MFJ, http://mzyjy.swun.edu.cn/) Grant number: 2011XWD-S071007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai WL, 2014, J DAIRY SCI, V97, P902, DOI 10.3168/jds.2012-6437; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaiyabutr N, 2012, INTECH, V1, P4; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Tramontana S, 2008, J DAIRY SCI, V91, P3057, DOI 10.3168/jds.2008-1164; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney N, 2012, J DAIRY SCI, V95, P2935, DOI 10.3168/jds.2011-4442; Wathes DC, 2011, REPRODUCTION, V141, P269, DOI 10.1530/REP-10-0177; Wiener G, 2006, THE YAK, P119; Wu, 1994, P 1 INT C YAK, P27; Zhong JC, 2004, P 4 INT C YAK, P32	20	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147705	10.1371/journal.pone.0147705	http://dx.doi.org/10.1371/journal.pone.0147705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808329	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800188
J	Kosior-Jarecka, E; Lukasik, U; Wrobel-Dudzinska, D; Kocki, J; Bartosinska, J; Witczak, A; Chodorowska, G; Mosiewicz, J; Zarnowski, T				Kosior-Jarecka, Ewa; Lukasik, Urszula; Wrobel-Dudzinska, Dominika; Kocki, Janusz; Bartosinska, Joanna; Witczak, Agnieszka; Chodorowska, Grazyna; Mosiewicz, Jerzy; Zarnowski, Tomasz			Risk Factors for Normal and High-Tension Glaucoma in Poland in Connection with Polymorphisms of the Endothelial Nitric Oxide Synthase Gene	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ASSOCIATION; ENOS; METAANALYSIS; PRESSURE; MUTATION; PATHWAY	Aim The purpose of this study was to evaluate the influence of polymorphisms of the eNOS gene on the clinical status of patients with normal and high tension glaucoma. Methods 266 Polish Caucasian patients with primary open angle glaucoma were studied. Of the 266, 156 had normal tension glaucoma (NTG) and 110 high tension glaucoma (HTG). DNA material was isolated from peripheral venous blood using commercial kits. Real-time PCR reaction was used to amplify the promoter site of the endothelial nitric oxide synthase (eNOS) gene, including the single nucleotide polymorphism (SNP) site T-786C and part of the 7th exon of eNOS, including G894T SNP. Genotypes were determined with TaqMan SNP Genotyping Assays. Results There were no significant differences in frequencies of the allelic variants of both polymorphisms. In G894T SNP, however, the wild GG form was more common in the HTG group. The SNP of the eNOS gene did not significantly influence the progression rate in either of the groups studied. There were no differences in variants of the eNOS gene regarding the necessity for and success of surgery and the progression of the disease. In the NTG group, no statistical correlation was observed between G894T, T786C polymorphism variants, and risk factors such as optic disc haemorrhages, optic disc notches, and peripapillary atrophy. Mean diastolic and systolic pressure during the day and night were lowest in NTG patients with the CC variant of the T786C polymorphism. No statistical correlation was observed between the G894T and T786C polymorphisms and capillaroscopic examination results. Conclusions Genotype frequencies are similar for both the eNOS G894T and T-786C polymorphisms in NTG and HTG patients. These polymorphisms do not correlate with risk factors and do not influence the state of the capillary system in NTG patients. Systolic blood pressure is lower in NTG patients with mutated alleles of both polymorphisms.	[Kosior-Jarecka, Ewa; Lukasik, Urszula; Wrobel-Dudzinska, Dominika; Zarnowski, Tomasz] Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland; [Kocki, Janusz] Med Univ Lublin, Dept Clin Genet, Lublin, Poland; [Bartosinska, Joanna; Chodorowska, Grazyna] Med Univ Lublin, Dept Dermatol Venerol & Paediat Dermatol, Lublin, Poland; [Witczak, Agnieszka; Mosiewicz, Jerzy] Med Univ Lublin, Dept Internal Dis, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Kosior-Jarecka, E (corresponding author), Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland.	ekosior@poczta.onet.pl	Zarnowski, Tomasz/AAM-6460-2020; Bartosińska, Joanna/GOG-8263-2022; Chodorowska, Grażyna/A-2415-2019	Chodorowska, Grażyna/0000-0002-8055-5764; Zarnowski, Tomasz/0000-0002-6978-7417; Bartosinska, Joanna/0000-0003-4106-3051; Mosiewicz, Jerzy/0000-0003-0320-1863; Wrobel-Dudzinska, Dominika/0000-0002-1325-6692				Ayub H, 2010, MOL VIS, V16, P18; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; da Silva TM, 2012, GENE, V502, P142, DOI 10.1016/j.gene.2012.04.047; Dellamea BS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-9; Flammer J, 1994, SURV OPHTHALMOL S, V38, pSS3; Ghilardi G, 2002, CLIN CHEM, V48, P989; Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS51, DOI 10.1016/S0039-6257(99)00026-0; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0; Huttunen R, 2009, SHOCK, V31, P448, DOI 10.1097/SHK.0b013e318188e58e; Kang JH, 2014, EYE, V28, P662, DOI 10.1038/eye.2014.42; Kang JH, 2010, INVEST OPHTH VIS SCI, V51, P971, DOI 10.1167/iovs.09-4266; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Liao QO, 2011, MOL VIS, V17, P153; Lin HJ, 2005, J CLIN LAB ANAL, V19, P87, DOI 10.1002/jcla.20057; Logan JFJ, 2005, INVEST OPHTH VIS SCI, V46, P3221, DOI 10.1167/iovs.05-0368; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Pereira TV, 2007, J HYPERTENS, V25, P1763, DOI 10.1097/HJH.0b013e3281de740d; QUIGLEY HA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1409, DOI 10.1001/archopht.1993.01090100117038; Sakai T, 2007, GRAEF ARCH CLIN EXP, V245, P288, DOI 10.1007/s00417-005-0245-7; Stamer WD, 2011, INVEST OPHTH VIS SCI, V52, P9438, DOI 10.1167/iovs.11-7839; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Tunny TJ, 1998, CLIN EXP PHARMACOL P, V25, P26, DOI 10.1111/j.1440-1681.1998.tb02138.x; Wattanapitayakul SK, 2001, TRENDS PHARMACOL SCI, V22, P361, DOI 10.1016/S0165-6147(00)01692-8; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weiss J, 2012, MOL VIS, V18, P2174; Werner E, 1996, J GLAUCOMA, V5, P422; Yao YS, 2013, GENE, V528, P84, DOI 10.1016/j.gene.2013.06.047; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785	30	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147540	10.1371/journal.pone.0147540	http://dx.doi.org/10.1371/journal.pone.0147540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807726	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800127
J	Xiao, M; Pang, L; Chen, SCA; Fan, X; Zhang, L; Li, HX; Hou, X; Cheng, JW; Kong, FR; Zhao, YP; Xu, YC				Xiao, Meng; Pang, Lu; Chen, Sharon C-A.; Fan, Xin; Zhang, Li; Li, Hai-Xia; Hou, Xin; Cheng, Jing-Wei; Kong, Fanrong; Zhao, Yu-Pei; Xu, Ying-Chun			Accurate Identification of Common Pathogenic Nocardia Species: Evaluation of a Multilocus Sequence Analysis Platform and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MOLECULAR-IDENTIFICATION; GENUS NOCARDIA; PHYLOGENY; TAXONOMY; SYSTEM; GENES; GYRB; PCR; DNA	Species identification of Nocardia is not straightforward due to rapidly evolving taxonomy, insufficient discriminatory power of conventional phenotypic methods and also of single gene locus analysis including 16S rRNA gene sequencing. Here we evaluated the ability of a 5-locus (16S rRNA, gyrB, secA1, hsp65 and rpoB) multilocus sequence analysis (MLSA) approach as well as that of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in comparison with sequencing of the 5'-end 606 bp partial 16S rRNA gene to provide identification of 25 clinical isolates of Nocardia. The 5'-end 606 bp 16S rRNA gene sequencing successfully assigned 24 of 25 (96%) clinical isolates to species level, namely Nocardia cyriacigeorgica (n = 12, 48%), N. farcinica (n = 9, 36%), N. abscessus (n = 2, 8%) and N. otitidiscaviarum (n = 1, 4%). MLSA showed concordance with 16S rRNA gene sequencing results for the same 24 isolates. However, MLSA was able to identify the remaining isolate as N. wallacei, and clustered N. cyriacigeorgica into three subgroups. None of the clinical isolates were correctly identified to the species level by MALDI-TOF MS analysis using the manufacturer-provided database. A small "in-house" spectral database was established incorporating spectra of five clinical isolates representing the five species identified in this study. After complementation with the "in-house" database, of the remaining 20 isolates, 19 (95%) were correctly identified to species level (score >= 2.00) and one (an N. abscessus strain) to genus level (score >= 1.70 and < 2.00). In summary, MLSA showed superior discriminatory power compared with the 5'-end 606 bp partial 16S rRNA gene sequencing for species identification of Nocardia. MALDI-TOF MS can provide rapid and accurate identification but is reliant on a robust mass spectra database.	[Xiao, Meng; Pang, Lu; Fan, Xin; Zhang, Li; Hou, Xin; Cheng, Jing-Wei; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Pang, Lu; Li, Hai-Xia] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100871, Peoples R China; [Chen, Sharon C-A.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis, Westmead, NSW 2145, Australia; [Chen, Sharon C-A.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [Zhao, Yu-Pei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; University of Sydney; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Research Special Fund for Public Welfare Industry of Health of China [201402001]; National High Technology Research and Development Program of China (the "863" Program) [2013AA020203]	National Research Special Fund for Public Welfare Industry of Health of China; National High Technology Research and Development Program of China (the "863" Program)	The study was supported by a National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001, http://www.nhfpc.gov.cn) and a National High Technology Research and Development Program of China (the "863" Program, grant number 2013AA020203, http://program.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Buckwalter SP, 2016, J CLIN MICROBIOL, V54, P376, DOI 10.1128/JCM.02128-15; Carrasco G, 2015, J CLIN MICROBIOL, V53, P997, DOI 10.1128/JCM.03072-14; Carrasco G, 2013, J CLIN MICROBIOL, V51, P3602, DOI 10.1128/JCM.00515-13; Clark NM, 2009, AM J TRANSPLANT, V9, pS70, DOI 10.1111/j.1600-6143.2009.02896.x; Conville PS, 2006, J CLIN MICROBIOL, V44, P2760, DOI 10.1128/JCM.00155-06; Conville PS, 2005, J CLIN MICROBIOL, V43, P2881, DOI 10.1128/JCM.43.6.2881-2885.2005; Dunne WM, 2014, J CLIN MICROBIOL, V52, P3654, DOI 10.1128/JCM.01728-14; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Hsueh PR, 2014, J CLIN MICROBIOL, V52, P2371, DOI 10.1128/JCM.00456-14; Khot PD, 2015, J CLIN MICROBIOL, V53, P3366, DOI 10.1128/JCM.00780-15; Kong FR, 2010, J CLIN MICROBIOL, V48, P3928, DOI 10.1128/JCM.01113-10; Kong Fanrong, 2009, Open Microbiol J, V3, P97, DOI 10.2174/1874285800903010097; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WL, 2011, EUR J CLIN MICROBIOL, V30, P1341, DOI 10.1007/s10096-011-1227-9; McTaggart LR, 2010, J CLIN MICROBIOL, V48, P4525, DOI 10.1128/JCM.00883-10; Baio PVP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002573; Rodriguez-Nava V, 2006, J CLIN MICROBIOL, V44, P536, DOI 10.1128/JCM.44.2.536-546.2006; Roth A, 2003, J CLIN MICROBIOL, V41, P851, DOI 10.1128/JCM.41.2.851-856.2003; Rudramurthy SM, 2015, J MED MICROBIOL, V64, P1216, DOI 10.1099/jmm.0.000143; Schlaberg R, 2008, J CLIN MICROBIOL, V46, P265, DOI 10.1128/JCM.00937-07; Segawa S, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9078-5; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Toyokawa Masahiro, 2013, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V24, P1; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Versalovic J, 2011, MANUAL CLIN MICROBIO; Wang HL, 2014, AM J CLIN PATHOL, V142, P513, DOI 10.1309/AJCPW84AFTUWMHYU; Xiao M, 2010, J CLIN MICROBIOL, V48, P503, DOI 10.1128/JCM.01761-09; Yin XT, 2007, AM J OPHTHALMOL, V144, P570, DOI 10.1016/j.ajo.2007.06.031; Zhou LT, 2014, EXP THER MED, V8, P1142, DOI 10.3892/etm.2014.1883	35	24	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147487	10.1371/journal.pone.0147487	http://dx.doi.org/10.1371/journal.pone.0147487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808813	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800109
J	Leu, ST; Bull, CM				Leu, Stephan T.; Bull, C. Michael			Artificial Water Point for Livestock Influences Spatial Ecology of a Native Lizard Species	PLOS ONE			English	Article							SLEEPY LIZARD; TILIQUA-RUGOSA; BEHAVIORAL THERMOREGULATION; BODY TEMPERATURES; AUSTRALIAN LIZARD; MICROHABITAT USE; SOCIAL NETWORK; GILA MONSTERS; PATTERNS; REFUGE	Pastoralism is a major agricultural activity in drier environments, and can directly and indirectly impact native species in those areas. We investigated how the supply of an artificial watering point to support grazing livestock affected movement and activity patterns of the Australian sleepy lizard (Tiliqua rugosa) during a drought year. We observed 23 adult lizards; six had access to a dam, whereas 17 lizards did not. Lizards with access to the dam had larger home ranges, were substantially active on more days (days with >100 steps), and moved more steps per day compared to lizards that did not have access to the dam, both during the early and late period of our observation. Furthermore, while the two groups of lizards had similar body condition early in the season, they differed later in the season. Lizards with dam access retained, whereas lizards without access lost body condition. Local heterogeneity in access to an artificial water resource resulted in spatially dependent behavioural variation among sleepy lizard individuals. This suggests that sleepy lizards have flexible responses to changing climatic conditions, depending on the availability of water. Furthermore, while reducing activity appears a suitable short term strategy, if harsh conditions persist, then access to dams could be of substantial benefit and could support sustained lizard activity and movement and allow maintenance of body condition. Hence, artificial watering points, such as the dams constructed by pastoralists, may provide local higher quality refugia for sleepy lizards and other species during drought conditions.	[Leu, Stephan T.; Bull, C. Michael] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Leu, ST (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	stephan.leu@flinders.edu.au		Leu, Stephan T./0000-0003-2547-5056; Bull, Michael/0000-0002-9350-5950	Australian Research Council	Australian Research Council(Australian Research Council)	This research was supported by a Discovery Grant to CMB from the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; [Australian Bureau of Meteorology CSIRO], 2007, CLIM CHANG AUSTR TEC; BENNETT AF, 1977, ECOLOGY, V58, P697, DOI 10.2307/1939022; Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bull CM, 1998, BEHAV ECOL SOCIOBIOL, V42, P357, DOI 10.1007/s002650050448; BULL CM, 1987, COPEIA, P749; Bull CM, 1999, AUST J ZOOL, V47, P125, DOI 10.1071/ZO99021; BULL CM, 1995, AUST J ECOL, V20, P393, DOI 10.1111/j.1442-9993.1995.tb00555.x; Christian K, 1999, AUST J ECOL, V24, P171, DOI 10.1046/j.1442-9993.1999.241960.x; Davis JR, 2010, J HERPETOL, V44, P83, DOI 10.1670/08-263.1; Dawson TJ, 2006, J COMP PHYSIOL B, V176, P45, DOI 10.1007/s00360-005-0030-2; DUBAS G, 1991, WILDLIFE RES, V18, P147, DOI 10.1071/WR9910147; Firth BT, 1998, PHYSIOL ZOOL, V71, P303, DOI 10.1086/515919; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gienger CM, 2014, COPEIA, P279, DOI 10.1643/CP-13-086; Godfrey SS, 2014, ANIM BEHAV, V97, P35, DOI 10.1016/j.anbehav.2014.08.019; Godfrey SS, 2013, ANIM BEHAV, V86, P763, DOI 10.1016/j.anbehav.2013.07.016; Gomez M, 2015, 2ND ACM INTERNATIONAL CONFERENCE ON MOBILE SOFTWARE ENGINEERING AND SYSTEMS MOBILESOFT 2015, P1, DOI 10.1109/MobileSoft.2015.8; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kenward R. E., 2008, RANGES 8 ANAL TRACKI; Kerr GD, 2006, J ZOOL, V269, P137, DOI 10.1111/j.1469-7998.2006.00091.x; Kerr GD, 2006, BEHAV ECOL, V17, P380, DOI 10.1093/beheco/arj041; Kerr GD, 2004, J HERPETOL, V38, P519, DOI 10.1670/13-04A; Kerr GD, 2004, J ZOOL, V264, P179, DOI 10.1017/S0952836904005734; Kerr GD, 2004, WILDLIFE RES, V31, P171, DOI 10.1071/WR03048; Kerr GD, 2003, AUSTRAL ECOL, V28, P152, DOI 10.1046/j.1442-9993.2003.01268.x; Kerr GD, 2008, J ZOOL; Kerr Gregory D., 2002, Herpetological Review, V33, P24; Letnic M, 2015, BIODIVERS CONSERV, V24, P1, DOI 10.1007/s10531-014-0770-y; Letnic M, 2014, J APPL ECOL, V51, P795, DOI 10.1111/1365-2664.12232; Leu ST, 2016, ANIM BEHAV, V111, P23, DOI 10.1016/j.anbehav.2015.10.001; Leu ST, 2015, ETHOLOGY, V121, P760, DOI 10.1111/eth.12390; Leu ST, 2011, BEHAV ECOL SOCIOBIOL, V65, P837, DOI 10.1007/s00265-010-1087-9; Leu ST, 2010, BEHAV ECOL SOCIOBIOL, V64, P1495, DOI 10.1007/s00265-010-0964-6; Leu ST, 2010, ANIM BEHAV, V79, P217, DOI 10.1016/j.anbehav.2009.11.002; Lillywhite HB, 2012, INTEGR COMP BIOL, V52, P227, DOI 10.1093/icb/ics039; Lorenzon P, 1999, OECOLOGIA, V118, P423, DOI 10.1007/s004420050744; Murray Kris, 2004, Acta Ethologica, V7, P19; Prowse Thomas A. A., 2011, Pacific Conservation Biology, V17, P168; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Wright CD, 2013, J EXP BIOL, V216, P1439, DOI 10.1242/jeb.080895	47	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147433	10.1371/journal.pone.0147433	http://dx.doi.org/10.1371/journal.pone.0147433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800274	Green Published, gold			2022-12-27	WOS:000368655300107
J	Francis, SC; Hou, Y; Baisley, K; van de Wijgert, J; Watson-Jones, D; Ao, TT; Herrera, C; Maganja, K; Andreasen, A; Kapiga, S; Coulton, GR; Hayes, RJ; Shattock, RJ				Francis, Suzanna C.; Hou, Yanwen; Baisley, Kathy; van de Wijgert, Janneke; Watson-Jones, Deborah; Ao, Trong T.; Herrera, Carolina; Maganja, Kaballa; Andreasen, Aura; Kapiga, Saidi; Coulton, Gary R.; Hayes, Richard J.; Shattock, Robin J.			Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; DOUBLE-BLIND; HORMONAL CONTRACEPTION; MENSTRUAL-CYCLE; BACTERIAL VAGINOSIS; MICROBICIDE SAFETY; REPRODUCTIVE-TRACT; VAGINAL FLUID; SEMINAL FLUID; TRIAL	Soluble cervicovaginal biomarkers of inflammation, immune activation and risk of HIV acquisition are needed to reliably assess the safety of new biomedical prevention strategies including vaccines and microbicides. However, a fuller understanding of expression profiles in women at high risk for HIV infection is crucial to the effective use of these potential biomarkers in Phase 3 trial settings. We have measured 45 soluble proteins and peptides in cervicovaginal lavage samples from 100 HIV negative women at high risk for HIV infection. Women were followed over one menstrual cycle to investigate modulation by hormonal contraception, menstrual cycle phase, recent sexual exposure and intravaginal practices. Women using injectable DMPA had increased concentration of several soluble proteins of the innate and adaptive immune system, including IL-1 alpha, IL-1 beta, IL-2, MIP-1 beta, IP-10, IL-8, TGF-beta, HBD4, IgA, IgG1, and IgG2. Women using combined oral contraceptives had a similar signature. There were differences in concentrations among samples from post-ovulation compared to pre-ovulation, notably increased immunoglobulins. Increased prostate-specific antigen, indicative of recent sexual exposure, was correlated with increased IL-6, MCP-1, and SLPI, and decreased GM-CSF and HBD3. The identified signature profiles may prove critical in evaluating the potential safety and impact on risk of HIV acquisition of different biomedical intervention strategies.	[Francis, Suzanna C.; Baisley, Kathy; Ao, Trong T.; Kapiga, Saidi; Hayes, Richard J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Francis, Suzanna C.; Watson-Jones, Deborah; Ao, Trong T.; Maganja, Kaballa; Andreasen, Aura; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania, Tanzania; [Hou, Yanwen; Coulton, Gary R.] Univ London, St Georges Med Sch, Div Basic Med Sci, London, England; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Herrera, Carolina; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Mucosal Infect & Immun Grp, London, England; [Watson-Jones, Deborah; Andreasen, Aura] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; St Georges University London; University of London; University of Liverpool; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Francis, SC (corresponding author), London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England.; Francis, SC (corresponding author), Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania, Tanzania.	suzanna.francis@lshtm.ac.uk		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Herrera, Carolina/0000-0003-3701-752X; Andreasen, Aura/0000-0003-0664-7342; Hayes, Richard/0000-0002-1729-9892; Kapiga, Saidi/0000-0003-1753-4060; Francis, Suzanna Carter/0000-0002-3724-4813	European and Developing Countries Clinical Trials Partnership [CT_ct_05_32070_002]; European Combined Highly Active Retroviral Microbicides (CHAARM-FP7) [242135]; International Partnership for Microbicides; Medical Research Council (MRC); Department for International Development (DFID) [G1002369]; MRC DFID [G0700837]; MRC [G0701039, G1002369, G0901756, G0700837] Funding Source: UKRI; Medical Research Council [MR/K012126/1, G0901756, G1002369, G0700837, G0701039] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; European Combined Highly Active Retroviral Microbicides (CHAARM-FP7); International Partnership for Microbicides; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for the Biomarkers Project was provided by the European and Developing Countries Clinical Trials Partnership (project code: CT_ct_05_32070_002), the European Combined Highly Active Retroviral Microbicides (CHAARM-FP7 - Grant agreement no 242135 -www.chaarm.eu), the International Partnership for Microbicides, the Medical Research Council (MRC) and Department for International Development (DFID) with S.C. Francis (G1002369), R.J. Hayes and K. Baisley (G0700837) receiving MRC & DFID support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Bollen LJM, 2008, JAIDS-J ACQ IMM DEF, V47, P253, DOI 10.1097/QAI.0b013e31815d2f12; Bright PL, 2011, CONTRACEPTION, V84, P512, DOI 10.1016/j.contraception.2011.02.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Deese J, 2015, AM J REPROD IMMUNOL, V74, P357, DOI 10.1111/aji.12415; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fichorova RN, 2011, CYTOKINE, V55, P134, DOI 10.1016/j.cyto.2011.03.016; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Francis SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059085; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hochmeister MN, 1999, J FORENSIC SCI, V44, P1057; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kassam A, 1996, ENVIRON HEALTH PERSP, V104, P408, DOI 10.2307/3432685; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Lu FX, 1999, INFECT IMMUN, V67, P6321; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Mauck Christine, 2004, MANUAL STANDARDIZATI; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Moscicki AB, 2012, JAIDS-J ACQ IMM DEF, V59, P134, DOI 10.1097/QAI.0b013e31823f2aeb; NORVELL MK, 1984, J REPROD MED, V29, P269; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Connor KA, 2006, HUM REPROD, V21, P1442, DOI 10.1093/humrep/dei497; Rebbapragada A, 2008, JAIDS-J ACQ IMM DEF, V49, P520, DOI 10.1097/QAI.0b013e318189a7ca; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UN Joint Programme on HIV/AIDS, 2012, GLOB EP UNAIDS REP G; United Nations, 2013, WORLD CONTR PATT 201, P11, DOI DOI 10.1016/S0140; USALA SJ, 1989, J REPROD MED, V34, P292; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P171, DOI 10.1111/aji.12235; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	59	42	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0143109	10.1371/journal.pone.0143109	http://dx.doi.org/10.1371/journal.pone.0143109			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814891	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369528200001
J	Lecarpentier, E; Bhatt, M; Bertin, GI; Deloison, B; Salomon, LJ; Deloron, P; Fournier, T; Barakat, AI; Tsatsaris, V				Lecarpentier, E.; Bhatt, M.; Bertin, G. I.; Deloison, B.; Salomon, L. J.; Deloron, P.; Fournier, T.; Barakat, A. I.; Tsatsaris, V.			Computational Fluid Dynamic Simulations of Maternal Circulation: Wall Shear Stress in the Human Placenta and Its Biological Implications	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; BLOOD-FLOW; CELL; MICROVILLI; PREGNANCY; PROTEINS; MECHANOTRANSDUCTION; DIFFERENTIATION; INVOLVEMENT	Introduction In the human placenta the maternal blood circulates in the intervillous space (IVS). The syncytiotrophoblast (STB) is in direct contact with maternal blood. The wall shear stress (WSS) exerted by the maternal blood flow on the STB has not been evaluated. Our objective was to determine the physiological WSS exerted on the surface of the STB during the third trimester of pregnancy. Material and Methods To gain insight into the shear stress levels that the STB is expected to experience in vivo, we have formulated three different computational models of varying levels of complexity that reflect different physical representations of the IVS. Computations of the flow fields in all models were performed using the CFD module of the finite element code COMSOL Multi-physics 4.4. The mean velocity of maternal blood in the IVS during the third trimester was measured in vivo with dynamic MRI (0.94 +/- 0.14 mm.s(-1)). To investigate if the in silico results are consistent with physiological observations, we studied the cytoadhesion of human parasitized (Plasmodium falciparum) erythrocytes to primary human STB cultures, in flow conditions with different WSS values. Results The WSS applied to the STB is highly heterogeneous in the IVS. The estimated average values are relatively low (0.5 +/- 0.2 to 2.3 +/- 1.1 dyn.cm(-2)). The increase of WSS from 0.15 to 5 dyn.cm(-2) was associated with a significant decrease of infected erythrocyte cytoadhesion. No cytoadhesion of infected erythrocytes was observed above 5 dyn.cm(-2) applied for one hour. Conclusion Our study provides for the first time a WSS estimation in the maternal placental circulation. In spite of high maternal blood flow rates, the average WSS applied at the surface of the chorionic villi is low (<5 dyn.cm(-2)). These results provide the basis for future physiologicallyrelevant in vitro studies of the biological effects of WSS on the STB.	[Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] INSERM, UMR S 1139, Paris, France; [Lecarpentier, E.; Deloison, B.; Salomon, L. J.; Fournier, T.; Tsatsaris, V.] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Lecarpentier, E.; Tsatsaris, V.] Grp Hosp Univ Ouest, AP HP, Port Royal Matern,Dept Gynecol Obstet 1, Ctr Hosp Univ Cochin Broca Hotel Dieu, Paris, France; [Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] DHU Risques & Grossesse, Paris, France; [Lecarpentier, E.; Fournier, T.; Tsatsaris, V.] PremUP Fdn, Paris, France; [Bertin, G. I.; Deloron, P.] IRD, MERIT UMR216, Paris, France; [Bhatt, M.; Barakat, A. I.] Ecole Polytechn, Lab Hydrodynam LadHyX, CNRS, F-91128 Palaiseau, France; [Deloison, B.; Salomon, L. J.] Paris Cardiovas Res Ctr PARCC, INSERM, U970, Paris, France; [Deloison, B.; Salomon, L. J.] EA FETUS 7328, Paris, France; [Deloison, B.; Salomon, L. J.] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Dept Obstet & Fetal Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecarpentier, E (corresponding author), INSERM, UMR S 1139, Paris, France.; Lecarpentier, E (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France.; Lecarpentier, E (corresponding author), Grp Hosp Univ Ouest, AP HP, Port Royal Matern,Dept Gynecol Obstet 1, Ctr Hosp Univ Cochin Broca Hotel Dieu, Paris, France.; Lecarpentier, E (corresponding author), DHU Risques & Grossesse, Paris, France.; Lecarpentier, E (corresponding author), PremUP Fdn, Paris, France.	edouard.lecarpentier@wanadoo.fr	Lecarpentier, Edouard/Q-4557-2018; Deloron, Philippe/G-6305-2010; Barakat, Abdul I/AAI-3117-2020; Fournier, Thierry C/E-5836-2016	Deloron, Philippe/0000-0003-4705-2484; Barakat, Abdul I/0000-0002-7551-3631; Bertin, Gwladys/0000-0002-2218-9591; Fournier, Thierry/0000-0002-7515-339X; Deloison, Benjamin/0000-0002-3608-0837; Bhatt, Mrugank/0000-0002-3364-473X	Institut National de la Sante et de la Recherche Medicale (France); PremUP Foundation; AXA Research Fund; Ecole Polytechnique	Institut National de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); PremUP Foundation; AXA Research Fund(AXA Research Fund); Ecole Polytechnique	EL received a grant from Institut National de la Sante et de la Recherche Medicale (France) to perform this work. This work was supported by the PremUP Foundation. This work was partially funded by a permanent endowment in Cardiovascular Cellular Engineering from the AXA Research Fund (to AIB). MB was supported by an international summer scholarship from Ecole Polytechnique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrakhteh M, 2013, REV BRAS GINECOL OBS, V35, P317, DOI 10.1590/S0100-72032013000700006; ALSAT E, 1993, J CELL PHYSIOL, V154, P122, DOI 10.1002/jcp.1041540115; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Chernyavsky IL, 2010, PLACENTA, V31, P44, DOI 10.1016/j.placenta.2009.11.003; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Choi HW, 2005, BIORHEOLOGY, V42, P493; Collins SL, 2012, ULTRASOUND OBST GYN, V40, P171, DOI 10.1002/uog.10149; ERIAN FF, 1977, J BIOMECH, V10, P807, DOI 10.1016/0021-9290(77)90095-1; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gysin J, 1999, INFECT IMMUN, V67, P6596; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kurjak A, 1997, J PERINAT MED, V25, P373, DOI 10.1515/jpme.1997.25.4.373; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Rainey A, 2010, PLACENTA, V31, P602, DOI 10.1016/j.placenta.2010.04.005; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schmid-Schonbein H., 1988, PLACENTAL VASCULARIZ, P17, DOI 10.1007/978-1-4615-8109-3_2; Stepp DW, 2001, AM J PHYSIOL-HEART C, V281, pH796, DOI 10.1152/ajpheart.2001.281.2.H796; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRUMAN P, 1986, PLACENTA, V7, P95, DOI 10.1016/S0143-4004(86)80001-7; TRUMAN P, 1986, PLACENTA, V7, P111, DOI 10.1016/S0143-4004(86)80002-9; VANDERPUYE OA, 1986, BIOCHEM J, V233, P351, DOI 10.1042/bj2330351; Weinbaum S, 2001, BIORHEOLOGY, V38, P119	27	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147262	10.1371/journal.pone.0147262	http://dx.doi.org/10.1371/journal.pone.0147262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815115	Green Published, gold			2022-12-27	WOS:000369528200028
J	Mancini, F; Monaci, E; Lofano, G; Torre, A; Bacconi, M; Tavarini, S; Sammicheli, C; Arcidiacono, L; Galletti, B; Laera, D; Pallaoro, M; Tuscano, G; Fontana, MR; Bensi, G; Grandi, G; Rossi-Paccani, S; Nuti, S; Rappuoli, R; De Gregorio, E; Bagnoli, F; Soldaini, E; Bertholet, S				Mancini, Francesca; Monaci, Elisabetta; Lofano, Giuseppe; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Grandi, Guido; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie			One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4(+) T Cells, and IL-17A	PLOS ONE			English	Article							ALPHA-TOXIN; MOUSE MODEL; ABSCESS FORMATION; CARDIAC-SURGERY; MURINE MODEL; RISK-FACTORS; INFECTION; IMMUNITY; FHUD2; INTERLEUKIN-17A	A rapidly acting, single dose vaccine against Staphylococcus aureus would be highly beneficial for patients scheduled for major surgeries or in intensive care units. Here we show that one immunization with a multicomponent S. aureus candidate vaccine, 4C-Staph, formulated with a novel TLR7-dependent adjuvant, T7-alum, readily protected mice from death and from bacterial dissemination, both in kidney abscess and peritonitis models, outperforming alum-formulated vaccine. This increased efficacy was paralleled by higher vaccine-specific and a-hemolysin-neutralizing antibody titers and Th1/Th17 cell responses. Antibodies played a crucial protective role, as shown by the lack of protection of 4C-Staph/T7-alum vaccine in B-cell-deficient mice and by serum transfer experiments. Depletion of effector CD4(+) T cells not only reduced survival but also increased S. aureus load in kidneys of mice immunized with 4C-Staph/T7-alum. The role of IL-17A in the control of bacterial dissemination in 4C-Staph/T7-alum vaccinated mice was indicated by in vivo neutralization experiments. We conclude that single dose 4C-Staph/T7-alum vaccine promptly and efficiently protected mice against S. aureus through the combined actions of antibodies, CD4(+) effector T cells, and IL-17A. These data suggest that inclusion of an adjuvant that induces not only fast antibody responses but also IL-17-producing cell-mediated effector responses could efficaciously protect patients scheduled for major surgeries or in intensive care units.	[Mancini, Francesca; Monaci, Elisabetta; Lofano, Giuseppe; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Grandi, Guido; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie] Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy; [Mancini, Francesca] Univ Padua, Dept Biomed Sci, Padua, Italy; [Lofano, Giuseppe] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Bacconi, Marta] Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy; [Mancini, Francesca; Monaci, Elisabetta; Torre, Antonina; Bacconi, Marta; Tavarini, Simona; Sammicheli, Chiara; Arcidiacono, Letizia; Galletti, Bruno; Laera, Donatello; Pallaoro, Michele; Tuscano, Giovanna; Fontana, Maria Rita; Bensi, Giuliano; Rossi-Paccani, Silvia; Nuti, Sandra; Rappuoli, Rino; De Gregorio, Ennio; Bagnoli, Fabio; Soldaini, Elisabetta; Bertholet, Sylvie] GlaxoSmithKline Vaccines Srl, Siena, Italy; [Lofano, Giuseppe] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Grandi, Guido] Univ Trent, Ctr Integrat Biol, Trento, Italy	Novartis; University of Padua; Sapienza University Rome; University of Siena; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Trento	Soldaini, E (corresponding author), Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy.; Soldaini, E (corresponding author), GlaxoSmithKline Vaccines Srl, Siena, Italy.	elisabetta.x.soldaini@gsk.com	Pallaoro, Michele/AAU-7429-2020	Mancini, Francesca/0000-0003-2122-9480	Novartis Vaccines and Diagnostics S.r.l.	Novartis Vaccines and Diagnostics S.r.l.	This work was supported by internal funding by Novartis Vaccines and Diagnostics S.r.l. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chen LF, 2012, AM J INFECT CONTROL, V40, P963, DOI 10.1016/j.ajic.2012.01.012; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Fattom A, 2015, HUM VACC IMMUNOTHER, V11, P632, DOI 10.4161/hv.34414; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kanafani ZA, 2009, INFECT CONT HOSP EP, V30, P242, DOI 10.1086/596015; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Korea CG, 2014, INFECT IMMUN, V82, P4144, DOI 10.1128/IAI.01576-14; Lanternier F, 2013, CURR OPIN PEDIATR, V25, P736, DOI 10.1097/MOP.0000000000000031; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Maher BM, 2013, INFECT IMMUN, V81, P4478, DOI 10.1128/IAI.01026-13; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Mariotti P, 2013, BIOCHEM J, V449, P683, DOI 10.1042/BJ20121426; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Mishra RPN, 2012, J INFECT DIS, V206, P1041, DOI 10.1093/infdis/jis463; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Pozzi C, 2015, FEMS MICROBIOL REV, V39, P750, DOI 10.1093/femsre/fuv024; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Schluepen C, 2013, BIOCHEM J, V455, P273, DOI 10.1042/BJ20130540; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang BZ, 2015, INFECT IMMUN, V83, P339, DOI 10.1128/IAI.02498-14	47	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147767	10.1371/journal.pone.0147767	http://dx.doi.org/10.1371/journal.pone.0147767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812180	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528000052
J	Angenieux, C; Maitre, B; Eckly, A; Lanza, F; Gachet, C; de la Salle, H				Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri			Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity	PLOS ONE			English	Article							RETICULATED PLATELETS; PROTEIN-SYNTHESIS; THIAZOLE-ORANGE; IN-VIVO; TURNOVER; MEGAKARYOCYTE; QUIESCENCE; HEMATOLOGY; GRANULES; DYNAMICS	Previous investigations have indicated that RNAs are mostly present in the minor population of the youngest platelets, whereas translation in platelets could be biologically important. To attempt to solve this paradox, we studied changes in the RNA content of reticulated platelets, i.e., young cells brightly stained by thiazole orange (TObright), a fluorescent probe for RNAs. We provoked in mice strong thrombocytopenia followed by dramatic thrombocytosis characterized by a short period with a vast majority of reticulated platelets. During thrombocytosis, the TObright platelet count rapidly reached a maximum, after which TOdim platelets accumulated, suggesting that most of the former were converted into the latter within 12 h. Experiments on platelets, freshly isolated or incubated ex vivo at 37 degrees C, indicated that their "RNA content", here corresponding to the amounts of extracted RNA, and the percentage of TObright platelets were positively correlated. The "RNA Content" normalized to the number of platelets could be 20 to 40 fold higher when 80-90% of the cells were reticulated (20-40 fg/platelet), than when only 5-10% of control cells were TObright (less than 1fg/platelet). TObright platelets, incubated ex vivo at 37 degrees C or transfused into mice, became TOdim within 24 h. Ex vivo at 37 degrees C, platelets lost about half of their ribosomal and beta actin RNAs within 6 hours, and more than 98% of them after 24 hours. Accordingly, fluorescence in situ hybridization techniques confirmed the presence of beta actin mRNAs in most reticulated-enriched platelets, but detected them in only a minor subset of control platelets. In vitro, constitutive translation decreased considerably within less than 6 hours, questioning how protein synthesis in platelets, especially in non-reticulated ones, could have a biological function in vivo. Nevertheless, constitutive transient translation in young platelets under pathological conditions characterized by a dramatic increase in circulating reticulated platelets could deserve to be investigated.	[Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] INSERM, UMR S949, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] EFS Alsace, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] FMTS, Strasbourg, France; [Angenieux, Catherine; Maitre, Blandine; Eckly, Anita; Lanza, Francois; Gachet, Christian; de la Salle, Henri] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de la Salle, H (corresponding author), INSERM, UMR S949, Strasbourg, France.; de la Salle, H (corresponding author), EFS Alsace, Strasbourg, France.; de la Salle, H (corresponding author), FMTS, Strasbourg, France.; de la Salle, H (corresponding author), Univ Strasbourg, Strasbourg, France.	henri.delasalle@efs.sante.fr	De La Salle, Henri/H-9353-2016; Lanza, Francois/H-9252-2016	De La Salle, Henri/0000-0001-5136-0776; Lanza, Francois/0000-0002-5802-4748; Eckly, Anita/0000-0001-9620-4961; maitre, blandine/0000-0002-3264-7330	Association de Recherche et Developpement en Medecine et Sante Publique [UMR-S949]	Association de Recherche et Developpement en Medecine et Sante Publique	Association de Recherche et Developpement en Medecine et Sante Publique supports laboratory UMR-S949. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; BOOYSE FM, 1971, THROMB DIATH HAEMOST, V26, P167; Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Briggs C, 2012, J CLIN PATHOL, V65, P1024, DOI 10.1136/jclinpath-2012-200930; BRUCE IJ, 1987, BIOCHEM PHARMACOL, V36, P1769, DOI 10.1016/0006-2952(87)90236-X; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buttarello M, 2008, AM J CLIN PATHOL, V130, P104, DOI 10.1309/EK3C7CTDKNVPXVTN; Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]; Cesari F, 2010, THROMB HAEMOSTASIS, V104, P804, DOI 10.1160/TH10-02-0124; Cremer M, 2010, THROMB HAEMOSTASIS, V103, P1016, DOI 10.1160/TH09-03-0148; DALE GL, 1995, BLOOD, V85, P1822, DOI 10.1182/blood.V85.7.1822.bloodjournal8571822; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Eckly A, 2012, METHODS MOL BIOL, V788, P175, DOI 10.1007/978-1-61779-307-3_13; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; GARDEN GA, 1995, MOL CELL NEUROSCI, V6, P293, DOI 10.1006/mcne.1995.1023; Gnatenko DV, 2005, THROMB HAEMOSTASIS, V94, P412, DOI 10.1160/TH05-01-0037; Hase K, 2015, NUCLEIC ACIDS RES, V43, P6439, DOI 10.1093/nar/gkv579; Herter JM, 2014, J THROMB HAEMOST, V12, P1764, DOI 10.1111/jth.12730; Hoffmann JJML, 2014, CLIN CHEM LAB MED, V52, P1107, DOI 10.1515/cclm-2014-0165; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; INGRAM M, 1969, BRIT J HAEMATOL, V17, P225, DOI 10.1111/j.1365-2141.1969.tb01366.x; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Kickler TS, 2006, AM J CLIN PATHOL, V125, P282, DOI 10.1309/50H8JYHN9JWCKAM7; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Lindemann S, 2001, J BIOL CHEM, V276, P33947, DOI 10.1074/jbc.M104281200; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Londin ER, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-3; Manning KL, 1997, EXP HEMATOL, V25, P1019; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Matic GB, 1998, CYTOMETRY, V34, P229, DOI 10.1002/(SICI)1097-0320(19981015)34:5<229::AID-CYTO4>3.0.CO;2-2; Meintker L, 2013, CLIN CHEM LAB MED, V51, P2125, DOI 10.1515/cclm-2013-0252; NIKOLOV EN, 1987, INT J BIOCHEM, V19, P159, DOI 10.1016/0020-711X(87)90326-0; NIKOLOV EN, 1983, INT J BIOCHEM, V15, P1255, DOI 10.1016/0020-711X(83)90215-X; Parco S, 2012, ONCOTARGETS THER, V5, DOI 10.2147/OTT.S27883; Pillitteri D, 2007, PLATELETS, V18, P119, DOI 10.1080/09537100600800792; Robinson M, 2000, BRIT J HAEMATOL, V108, P859, DOI 10.1046/j.1365-2141.2000.01939.x; Robinson MSC, 1998, BRIT J HAEMATOL, V100, P351; Rosenwald IB, 2001, THROMB HAEMOSTASIS, V85, P142; Rowley JW, 2012, CURR OPIN HEMATOL, V19, P385, DOI 10.1097/MOH.0b013e328357010e; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Dusse LMS, 2015, CLIN CHIM ACTA, V439, P143, DOI 10.1016/j.cca.2014.10.024; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shashkin PN, 2008, J IMMUNOL, V181, P3495, DOI 10.4049/jimmunol.181.5.3495; Strassel C, 2012, EXP CELL RES, V318, P25, DOI 10.1016/j.yexcr.2011.10.003; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wadhawan V, 2004, ARCH BIOCHEM BIOPHYS, V422, P183, DOI 10.1016/j.abb.2003.12.024; Weyrich AS, 2009, J THROMB HAEMOST, V7, P241, DOI 10.1111/j.1538-7836.2008.03211.x; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zucker-Franklin D, 2003, ATLAS BLOOD CELLS FU	57	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148064	10.1371/journal.pone.0148064	http://dx.doi.org/10.1371/journal.pone.0148064			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808079	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800270
J	Drago, M; Franco-Trecu, V; Cardona, L; Inchausti, P; Tapia, W; Paez-Rosas, D				Drago, Massimiliano; Franco-Trecu, Valentina; Cardona, Luis; Inchausti, Pablo; Tapia, Washington; Paez-Rosas, Diego			Stable Isotopes Reveal Long-Term Fidelity to Foraging Grounds in the Galapagos Sea Lion (Zalophus wollebaeki)	PLOS ONE			English	Article							ANTARCTIC FUR-SEAL; OTARIA-FLAVESCENS; LIPID EXTRACTION; MARINE PREDATOR; LIFE-HISTORY; STRATEGIES; BEHAVIOR; CARBON; PREY; EVOLUTION	Most otariids have colony-specific foraging areas during the breeding season, when they behave as central place foragers. However, they may disperse over broad areas after the breeding season and individuals from different colonies may share foraging grounds at that time. Here, stable isotope ratios in the skull bone of adult Galapagos sea lions (Zalophus wollebaeki) were used to assess the long-term fidelity of both sexes to foraging grounds across the different regions of the Galapagos archipelago. Results indicated that the stable isotope ratios (delta C-13 and delta N-15) of sea lion bone significantly differed among regions of the archipelago, without any significant difference between sexes and with a non significant interaction between sex and region. Moreover, standard ellipses, estimated by Bayesian inference and used as a measure of the isotopic resource use area at the population level, overlapped widely for the sea lions from the southern and central regions, whereas the overlap of the ellipses for sea lions from the central and western regions was small and non-existing for those from the western and southern regions. These results suggest that males and females from the same region within the archipelago use similar foraging grounds and have similar diets. Furthermore, they indicate that the exchange of adults between regions is limited, thus revealing a certain degree of foraging philopatry at a regional scale within the archipelago. The constraints imposed on males by an expanded reproductive season (similar to 6 months), resulting from the weak reproductive synchrony among females, and those imposed on females by a very long lactation period (at least one year but up to three years), may explain the limited mobility of adult Galapagos sea lions of both sexes across the archipelago.	[Drago, Massimiliano] Secretaria Educ Super Ciencia Tecnol & Innovac, Programa PROMETEO SENESCYT, Quito, Ecuador; [Drago, Massimiliano; Inchausti, Pablo] Univ Republ UdeLaR, Ctr Univ Reg Este CURE, Dept Ecol & Evolut, Maldonado, Uruguay; [Franco-Trecu, Valentina] Univ Republ UdeLaR, Fac Sci, Dept Ecol & Evolut, Montevideo, Uruguay; [Cardona, Luis] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Tapia, Washington] Galapagos Natl Pk Serv, Dept Appl Res, Puerto Ayora, Galapagos, Ecuador; [Tapia, Washington] Galapagos Conservancy, Santa Cruz, Galapagos, Ecuador; [Paez-Rosas, Diego] Univ San Francisco Quito, San Cristobal, Galapagos, Ecuador; [Paez-Rosas, Diego] Galapagos Sci Ctr, San Cristobal, Galapagos, Ecuador; [Paez-Rosas, Diego] Unidad Tecn Operat San Cristobal, Direcc Parque Nacl Galapagos, Galapagos, Ecuador	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Barcelona	Drago, M (corresponding author), Secretaria Educ Super Ciencia Tecnol & Innovac, Programa PROMETEO SENESCYT, Quito, Ecuador.; Drago, M (corresponding author), Univ Republ UdeLaR, Ctr Univ Reg Este CURE, Dept Ecol & Evolut, Maldonado, Uruguay.	m.drago@ub.edu	Cardona, Luis/L-1680-2014; Drago, Massimiliano/K-1863-2017; Franco-Trecu, Valentina/L-4649-2019; Páez-Rosas, Diego/X-3047-2019; Franco-Trecu, Valentina/N-5266-2019; Cardona, Luis/AAL-1354-2021	Cardona, Luis/0000-0002-7892-1323; Drago, Massimiliano/0000-0003-2764-9849; Franco-Trecu, Valentina/0000-0003-1791-010X; Páez-Rosas, Diego/0000-0002-2446-9888; Cardona, Luis/0000-0002-7892-1323; Tapia, Washington/0000-0002-5222-1804	Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	The research was totally funded by the Project "Becas PROMETEO" of the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador (http://prometeo.educacionsuperior.gob.ec/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; ANDERSSON M, 1981, ECOLOGY, V62, P538, DOI 10.2307/1937718; Arthur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120888; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonadonna F, 2001, MAR ECOL PROG SER, V223, P287, DOI 10.3354/meps223287; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Boness D.J., 1991, P1; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; COSTA DP, 1991, AM ZOOL, V31, P111; Crespo EA, 2015, MAR MAMMAL SCI, V31, P866, DOI 10.1111/mms.12199; Cullen JT, 2001, LIMNOL OCEANOGR, V46, P996; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Davies NB, 1978, BEHAV ECOLOGY EVOLUT, P149; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Drago M, 2015, MAR ECOL PROG SER, V525, P261, DOI 10.3354/meps11236; Drago M, 2009, J ZOOL, V279, P251, DOI 10.1111/j.1469-7998.2009.00613.x; Drago M, 2009, MAR ECOL PROG SER, V384, P273, DOI 10.3354/meps08017; Drago M, 2010, SCI MAR, V74, P589, DOI 10.3989/scimar.2010.74n3589; Edgar GJ, 2008, AQUAT CONSERV, V18, P955, DOI 10.1002/aqc.901; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Franco-Trecu V, 2014, MAR BIOL, V161, P609, DOI 10.1007/s00227-013-2363-9; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; HARRIS MP, 1969, J ZOOL, V159, P145; Heath CB, 2002, ENCY MARINE MAMMALS; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Houston AI, 1987, QUANTITATIVE ANAL BE; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jeglinski JWE, 2012, MAR ECOL PROG SER, V453, P279, DOI 10.3354/meps09649; Kernaleguen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133018; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kuhn CE, 2014, CAN J ZOOL, V92, P861, DOI 10.1139/cjz-2014-0087; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Mueller B, 2011, MAR MAMMAL SCI, V27, P350, DOI 10.1111/j.1748-7692.2010.00404.x; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Orians G.H., 1979, P155; Paez-Rosas D, 2008, THESIS I POLITECNICO; Paez-Rosas D., 2011, THESIS I POLITECNICO; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Palacios DM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016232; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; RAU GH, 1992, GEOCHIM COSMOCHIM AC, V56, P1413, DOI 10.1016/0016-7037(92)90073-R; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Reid K, 2005, CAN J ZOOL, V83, P604, DOI 10.1139/Z05-045; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Riofrio-Lazo M, 2013, RAPID COMMUN MASS SP, V27, P1076, DOI 10.1002/rcm.6556; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Ryan C, 2012, RAPID COMMUN MASS SP, V26, P2745, DOI 10.1002/rcm.6394; Salazar SK, 2005, THESIS I POLITECNICO; Schulz TM, 2005, ECOL MONOGR, V75, P159, DOI 10.1890/04-0319; Sivertsen E., 1954, Kongelige Norske Videnskabernes Selskabsforhandlinger, V26, P1; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Soto KH, 2006, MAR ECOL PROG SER, V312, P277, DOI 10.3354/meps312277; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; STAMPS J, 1995, AM NAT, V146, P41, DOI 10.1086/285786; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Trillmich F., 1991, Ecological Studies, V88, P247; Trillmich F., 1986, P196; Trillmich F., 2015, ZALOPHUS WOLLEBAEKI, DOI [10.2305/IUCN.UK.2015-2.RLTS.T41668A45230540.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T41668A45230540.EN]; Trillmich F, 2008, BEHAV ECOL SOCIOBIOL, V62, P363, DOI 10.1007/s00265-007-0423-1; Trillmich F, 2014, SOC ECOL INTERACT GA, P61, DOI 10.1007/978-3-319-02769-2_3; Vales DG, 2015, MAR ECOL PROG SER, V525, P245, DOI 10.3354/meps11214; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070748; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zenteno L, 2013, J ZOOL, V291, P119, DOI 10.1111/jzo.12051	91	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147857	10.1371/journal.pone.0147857	http://dx.doi.org/10.1371/journal.pone.0147857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808381	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800231
J	Ingraham, KA; Fey, NP; Simon, AM; Hargrove, LJ				Ingraham, Kimberly A.; Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.			Assessing the Relative Contributions of Active Ankle and Knee Assistance to the Walking Mechanics of Transfemoral Amputees Using a Powered Prosthesis	PLOS ONE			English	Article							FOOT PROSTHESIS; PUSH-OFF; SWING INITIATION; PROGRESSION; LEG; MUSCLE; LEVEL; GAIT; SUPPORT; SIMULATION	Powered knee-ankle prostheses are capable of providing net-positive mechanical energy to amputees. Yet, there are limitless ways to deliver this energy throughout the gait cycle. It remains largely unknown how different combinations of active knee and ankle assistance affect the walking mechanics of transfemoral amputees. This study assessed the relative contributions of stance phase knee swing initiation, increasing ankle stiffness and powered plantarflexion as three unilateral transfemoral amputees walked overground at their self-selected walking speed. Five combinations of knee and ankle conditions were evaluated regarding the kinematics and kinetics of the amputated and intact legs using repeated measures analyses of variance. We found eliminating active knee swing initiation or powered plantarflexion was linked to increased compensations of the ipsilateral hip joint during the subsequent swing phase. The elimination of knee swing initiation or powered plantarflexion also led to reduced braking ground reaction forces of the amputated and intact legs, and influenced both sagittal and frontal plane loading of the intact knee joint. Gradually increasing prosthetic ankle stiffness influenced the shape of the prosthetic ankle plantarflexion moment, more closely mirroring the intact ankle moment. Increasing ankle stiffness also corresponded to increased prosthetic ankle power generation (despite a similar maximum stiffness value across conditions) and increased braking ground reaction forces of the amputated leg. These findings further our understanding of how to deliver assistance with powered knee-ankle prostheses and the compensations that occur when specific aspects of assistance are added/removed.	[Ingraham, Kimberly A.; Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Fey, Nicholas P.; Simon, Ann M.; Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University	Fey, NP (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.; Fey, NP (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	nfey@ricres.org		Simon, Ann/0000-0002-6431-0329	US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program [81XWH-09-2-0020, W81XWH-14-C-0105]; U.S. Department of Education [H133F130034]	US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program; U.S. Department of Education(US Department of Education)	This study was supported by the US Army's Telemedicine and Advanced Technology Research Center Joint Warfighter Program grants 81XWH-09-2-0020 and W81XWH-14-C-0105 (PI: Hargrove), as well as U.S. Department of Education grant H133F130034 (PI: Fey).	Allen JL, 2012, J BIOMECH, V45, P2157, DOI 10.1016/j.jbiomech.2012.05.037; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Caputo JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07213; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fey NP, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2343228; Fey NP, 2013, J BIOMECH, V46, P637, DOI 10.1016/j.jbiomech.2012.11.051; Fey NP, 2011, CLIN BIOMECH, V26, P1025, DOI 10.1016/j.clinbiomech.2011.06.007; Grabowski AM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-49; Gregg RD, 2014, IEEE T ROBOT, V30, P1455, DOI 10.1109/TRO.2014.2361937; Hargrove LJ, 2015, JAMA-J AM MED ASSOC, V313, P2244, DOI 10.1001/jama.2015.4527; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kepple TM, 1997, GAIT POSTURE, V6, P1, DOI 10.1016/S0966-6362(96)01094-6; Lee H, 2013, IEEE MTT S INT MICR; Lenzi T., 2014, AAOP ANN M; Lenzi T, 2014, IEEE ROBOT AUTOM MAG, V21, P94, DOI 10.1109/MRA.2014.2360305; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mooney L. M., 2014, IEEE EMBC; Morgenroth DC, 2011, GAIT POSTURE, V34, P502, DOI 10.1016/j.gaitpost.2011.07.001; Neptune RR, 2004, GAIT POSTURE, V19, P194, DOI 10.1016/S0966-6362(03)00062-6; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Pfeifer S, 2015, IEEE-ASME T MECH, V20, P1384, DOI 10.1109/TMECH.2014.2337514; Pfeifer S, 2012, IEEE T BIO-MED ENG, V59, P2604, DOI 10.1109/TBME.2012.2207895; Rarick R., 2014, IEEE ACC; Rouse EJ, 2014, INT J ROBOT RES, V33, P1611, DOI 10.1177/0278364914545673; Rouse EJ, 2014, IEEE T NEUR SYS REH, V22, P870, DOI 10.1109/TNSRE.2014.2307256; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Segal AD, 2006, J REHABIL RES DEV, V43, P857, DOI 10.1682/JRRD.2005.09.0147; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Silverman AK, 2008, GAIT POSTURE, V28, P602, DOI 10.1016/j.gaitpost.2008.04.005; Silverman AK, 2012, J BIOMECH, V45, P2271, DOI 10.1016/j.jbiomech.2012.06.008; Simon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099387; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005; Zmitrewicz RJ, 2007, J BIOMECH, V40, P1824, DOI 10.1016/j.jbiomech.2006.07.009	41	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147661	10.1371/journal.pone.0147661	http://dx.doi.org/10.1371/journal.pone.0147661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807889	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800171
J	Leal, E; Granja, AG; Zarza, C; Tafalla, C				Leal, Esther; Granja, Aitor G.; Zarza, Carlos; Tafalla, Carolina			Distribution of T Cells in Rainbow Trout (Oncorhynchus mykiss) Skin and Responsiveness to Viral Infection	PLOS ONE			English	Article							CHANNEL CATFISH; IMMUNE-SYSTEM; TELEOST SKIN; B-CELLS; FISH; ANTIBODY; DISEASE; IDENTIFICATION; IMMUNOGLOBULIN; EXPRESSION	Although the skin constitutes the first line of defense against waterborne pathogens, there is a great lack of information regarding the skin associated lymphoid tissue (SALT) and whether immune components of the skin are homogeneously distributed through the surface of the fish is still unknown. In the current work, we have analyzed the transcription of several immune genes throughout different rainbow trout (Oncorhynchus mykiss) skin areas. We found that immunoglobulin and chemokine gene transcription levels were higher in a skin area close to the gills. Furthermore, this skin area as well as other anterior sections also transcribed significantly higher levels of many different immune genes related to T cell immunity such as T cell receptor alpha (TCR alpha), TCR gamma, CD3, CD4, CD8, perforin, GATA3, Tbet, FoxP3, interferon gamma (IFN gamma), CD40L and Eomes in comparison to posterior skin sections. In agreement with these results, immunohistochemical analysis revealed that anterior skin areas had a higher concentration of CD3(+) T cells and flow cytometry analysis confirmed that the percentage of CD8(+) T lymphocytes was also higher in anterior skin sections. These results demonstrate for the first time that T cells are not homogeneously distributed throughout the teleost skin. Additionally, we studied the transcriptional regulation of these and additional T cell markers in response to a bath infection with viral hemorrhagic septicemia virus (VHSV). We found that VHSV regulated the transcription of several of these T cell markers in both the skin and the spleen; with some differences between anterior and posterior skin sections. Altogether, our results point to skin T cells as major players of teleost skin immunity in response to waterborne viral infections.	[Leal, Esther; Granja, Aitor G.; Tafalla, Carolina] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Zarza, Carlos] Skretting Aquaculture Res Ctr, POB 48, N-4001 Stavanger, Norway		Tafalla, C (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	tafalla@inia.es	Leal, Esther/ABA-6058-2021; Granja, Aitor/K-8102-2014; Tafalla, Carolina/J-8074-2014	, Esther/0000-0003-2847-450X; Tafalla, Carolina/0000-0002-0860-2976	European Research Council (ERC) [2011 280469]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2014-53061-R]	European Research Council (ERC)(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness (MINECO)	This work was supported by the European Research Council (ERC Starting Grant 2011 280469) and project AGL2014-53061-R from the Spanish Ministry of Economy and Competitiveness (MINECO).	Boardman T, 2012, VET IMMUNOL IMMUNOP, V145, P511, DOI 10.1016/j.vetimm.2011.11.017; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Chettri JK, 2014, J FISH DIS, V37, P771, DOI 10.1111/jfd.12169; Edholm ES, 2010, J IMMUNOL, V185, P4082, DOI 10.4049/jimmunol.1000631; Elliott DG, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P471; Esteban M., 2015, MUCOSAL HLTH AQUACUL, P67, DOI [DOI 10.1016/B978-0-12-417186-2.00004-2, 10.1016/b978-0-12-417186-2.00004-2]; Glimcher LH, 2000, GENE DEV, V14, P1693; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Granja AG, 2015, J IMMUNOL, V195, P1825, DOI 10.4049/jimmunol.1500322; Jorgensen TR, 2009, FOLIA PARASIT, V56, P251, DOI 10.14411/fp.2009.029; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Laing KJ, 2011, DEV COMP IMMUNOL, V35, P1282, DOI 10.1016/j.dci.2011.03.004; Maddocks CE, 2015, J FISH DIS, V38, P653, DOI 10.1111/jfd.12306; Makesh M, 2015, FISH SHELLFISH IMMUN, V44, P156, DOI 10.1016/j.fsi.2015.02.003; Maki JL, 2003, CLIN DIAGN LAB IMMUN, V10, P876, DOI 10.1128/CDLI.10.5.876-881.2003; Maloy KJ, 2000, J EXP MED, V191, P2159, DOI 10.1084/jem.191.12.2159; Milstein O, 2011, BLOOD, V117, P1042, DOI 10.1182/blood-2010-05-283770; Montero J, 2011, MOL IMMUNOL, V48, P1102, DOI 10.1016/j.molimm.2011.02.005; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Oidtmann B, 2013, J FISH DIS, V36, P921, DOI 10.1111/jfd.12086; Peeler EJ, 2014, J FISH DIS, V37, P1021, DOI 10.1111/jfd.12241; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Takizawa F, 2014, FISH SHELLFISH IMMUN, V36, P215, DOI 10.1016/j.fsi.2013.11.004; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Xu Z, 2013, P NATL ACAD SCI USA, V110, P13097, DOI 10.1073/pnas.1304319110; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zhang LJ, 2007, J CELL PHYSIOL, V211, P590, DOI 10.1002/jcp.21001; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhao XG, 2008, DEV COMP IMMUNOL, V32, P500, DOI 10.1016/j.dci.2007.08.009; Zilberg D, 1997, VET IMMUNOL IMMUNOP, V58, P171, DOI 10.1016/S0165-2427(97)00033-0	38	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147477	10.1371/journal.pone.0147477	http://dx.doi.org/10.1371/journal.pone.0147477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808410	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800104
J	Lee, EJ; Cha, GW; Ju, YR; Han, MG; Lee, WJ; Jeong, YE				Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui			Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; INTRAVENOUS IMMUNOGLOBULIN; VACCINATION; EPIDEMIOLOGY; INFECTION; GENOTYPE; VACCINES; TAIWAN; WEST	After an extensive vaccination policy, Japanese encephalitis (JE) was nearly eliminated since the mid-1980s in South Korea. Vaccination in children shifted the affected age of JE patients from children to adults. However, an abrupt increase in JE cases occurred in 2010, and this trend has continued. The present study aimed to investigate the prevalence of neutralizing antibodies to the JE virus (JEV) among high-risk age groups (>= 40 years) in South Korea. A plaque reduction neutralization test was conducted to evaluate the prevalence of neutralizing antibodies to JEV in 945 subjects within four age groups (30-39, 40-49, 50-59, and 60-69 years) in 10 provinces. Of the 945 enrolled subjects, 927 (98.1%) exhibited antibodies against JEV. No significant differences were found in the prevalence of neutralizing antibodies according to sex, age, or occupation. However, there were significant differences in the plaque reduction rate according to age and occupation; oldest age group had a higher reduction rate, and subjects who were employed in agriculture or forestry also had a higher value than the other occupations. We also found that three provinces (Gangwon, Jeonnam, and Gyeongnam) had a relatively lower plaque reduction rate than the other locations. In addition, enzyme-linked immunosorbent assays were conducted to determine recent viral infections and 12 (2.2%) subjects were found to have been recently infected by the virus. In conclusion, the present study clearly indicated that the prevalence of neutralizing antibodies has been maintained at very high levels among adult age groups owing to vaccination or natural infections, or both. In the future, serosurveillance should be conducted periodically using more representative samples to better understand the population-level immunity to JE in South Korea.	[Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea; [Lee, Eun Ju; Cha, Go-Woon; Ju, Young Ran; Han, Myung Guk; Lee, Won-Ja; Jeong, Young Eui] WHO Western Pacific Reg, Japanese Encephalitis Reg Reference Lab, Cheongju, Chungcheongbuk, South Korea; [Jeong, Young Eui] Hallym Univ, Grad Sch, Dept Biomed Sci, Cheongju, Chungcheongbuk, South Korea; [Ju, Young Ran] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Med Entomol, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Hallym University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Jeong, YE (corresponding author), Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea.; Jeong, YE (corresponding author), WHO Western Pacific Reg, Japanese Encephalitis Reg Reference Lab, Cheongju, Chungcheongbuk, South Korea.; Jeong, YE (corresponding author), Hallym Univ, Grad Sch, Dept Biomed Sci, Cheongju, Chungcheongbuk, South Korea.	yougeui58@gmail.com	Hegde, Nagendra/J-5920-2014	Hegde, Nagendra/0000-0001-5260-2159	National Institute of Health, Korea Centers for Disease Control and Prevention [2011-N53002-00, 4835-300-210, 4835-301-210]	National Institute of Health, Korea Centers for Disease Control and Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was undertaken with a grant from the National Institute of Health, Korea Centers for Disease Control and Prevention (2011-N53002-00, 4835-300-210, and 4835-301-210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, VACCINE, V21, P1989, DOI 10.1016/S0264-410X(02)00772-7; Abraham S, 2011, FLAVIVIRUS ENCEPHALI, P349; Arai S, 2008, JPN J INFECT DIS, V61, P333; Baldovin T, 2012, J MED VIROL, V84, P1274, DOI 10.1002/jmv.23313; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Caramello P, 2006, CLIN INFECT DIS, V43, P1620, DOI 10.1086/509644; Cha Go Woon, 2014, Osong Public Health Res Perspect, V5, P286, DOI 10.1016/j.phrp.2014.08.003; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Hegde NR, 2009, IMMUNOTHERAPY-UK, V1, P691, DOI [10.2217/IMT.09.26, 10.2217/imt.09.26]; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Hsu LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003030; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Jacobson JA, 2007, AM J TROP MED HYG, V77, P164, DOI 10.4269/ajtmh.2007.77.164; Jeong Young Eui, 2011, Osong Public Health Res Perspect, V2, P34, DOI 10.1016/j.phrp.2011.04.002; KIM DH, 2013, KOREAN J PEDIAT INFE, V20, P131; Kim KH, 1968, ANN REP NATL I HLTH, V1, P31; Kim SY, 2009, MED VET ENTOMOL, V23, P15, DOI 10.1111/j.1365-2915.2008.00755.x; Konishi E, 2010, VACCINE, V28, P2664, DOI 10.1016/j.vaccine.2010.01.008; Korea Centers for Disease Control and Prevention, 2015, INF DIS SURV YB 2014, V8-GL2015001; Lee CH, 1980, KOREAN J VIROL, V10, P65; Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006; Lee YT, 1986, J KOREAN ACAD PERIOD, V15, P1; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Park B, 2011, J KOREAN MED SCI, V26, P711, DOI 10.3346/jkms.2011.26.6.711; Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608; Saxena SK, 2011, FLAVIVIRUS ENCEPHALI, P295, DOI DOI 10.5772/22145; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Srivastava R, 2015, J GEN VIROL, V96, P1347, DOI 10.1099/vir.0.000079; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tsai T., 1999, MANUAL CLIN MICROBIO, P1118; Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242; Wiwanitkit V, 2009, INT J GEN MED, V2, P195; Wu YC, 1999, AM J TROP MED HYG, V61, P78, DOI 10.4269/ajtmh.1999.61.78	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147841	10.1371/journal.pone.0147841	http://dx.doi.org/10.1371/journal.pone.0147841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807709	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800225
J	Yi, LC; Sartor, CD; Souza, FT; Sacco, ICN				Yi, Liu Chiao; Sartor, Cristina D.; Souza, Francis Trombini; Sacco, Isabel C. N.			Intralimb Coordination Patterns in Absent, Mild, and Severe Stages of Diabetic Neuropathy: Looking Beyond Kinematic Analysis of Gait Cycle	PLOS ONE			English	Article							PEAK PLANTAR PRESSURES; GROUND REACTION FORCES; FOOT ULCERATION; PERIPHERAL NEUROPATHY; MUSCLE ACTIVATION; INDIVIDUALS; WALKING; STIFFNESS; MOBILITY; PHASE	Aim Diabetes Mellitus progressively leads to impairments in stability and joint motion and might affect coordination patterns, mainly due to neuropathy. This study aims to describe changes in intralimb joint coordination in healthy individuals and patients with absent, mild and, severe stages of neuropathy. Methods Forty-seven diabetic patients were classified into three groups of neuropathic severity by a fuzzy model: 18 without neuropathy (DIAB), 7 with mild neuropathy (MILD), and 22 with moderate to severe neuropathy (SVRE). Thirteen healthy subjects were included as controls (CTRL). Continuous relative phase (CRP) was calculated at each instant of the gait cycle for each pair of lower limb joints. Analysis of Variance compared each frame of the CRP time series and its standard deviation among groups (alpha = 5%). Results For the ankle-hip CRP, the SVRE group presented increased variability at the propulsion phase and a distinct pattern at the propulsion and initial swing phases compared to the DIAB and CTRL groups. For the ankle-knee CRP, the 3 diabetic groups presented more anti-phase ratios than the CTRL group at the midstance, propulsion, and terminal swing phases, with decreased variability at the early stance phase. For the knee-hip CRP, the MILD group showed more in-phase ratio at the early stance and terminal swing phases and lower variability compared to all other groups. All diabetic groups were more in-phase at early the midstance phase (with lower variability) than the control group. Conclusion The low variability and coordination differences of the MILD group showed that gait coordination might be altered not only when frank evidence of neuropathy is present, but also when neuropathy is still incipient. The ankle-knee CRP at the initial swing phase showed distinct patterns for groups from all degrees of neuropathic severity and CTRLs. The anklehip CRP pattern distinguished the SVRE patients from other diabetic groups, particularly in the transitional phase from stance to swing.	[Yi, Liu Chiao; Sartor, Cristina D.] Univ Fed Sao Paulo, Santos, Brazil; [Sartor, Cristina D.; Sacco, Isabel C. N.] Univ Sao Paulo, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil; [Souza, Francis Trombini] Univ Pernambuco, Dept Phys Therapy, Petrolina, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Pernambuco (UPE)	Sacco, ICN (corresponding author), Univ Sao Paulo, Phys Therapy Speech & Occupat Therapy Dept, Sao Paulo, Brazil.	icnsacco@usp.br	Sacco, Isabel/T-2630-2019; Sacco, Isabel/D-7172-2011; Yi, Liu C/K-8705-2013; Trombini-Souza, Francis/T-7359-2017; Sartor, Cristina D/C-6806-2013	Sacco, Isabel/0000-0003-1254-0007; Sacco, Isabel/0000-0003-1254-0007; Yi, Liu C/0000-0003-0202-2337; Trombini-Souza, Francis/0000-0001-8862-4691; Sartor, Cristina D/0000-0002-8461-8048	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/04997-2, 2013/01941-3]; Conselho Nacional de desenvolvimento cientifico e tecnologico [500716/2013-7]; Sao Paulo Research Foundation (FAPESP) [LCY 2013/01941-3, FTS 2014/04997-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [500716/2013-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de desenvolvimento cientifico e tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/04997-2 (FTS); Conselho Nacional de desenvolvimento cientifico e tecnologico 500716/2013-7 (CDS); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2013/01941-3 (LCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Sao Paulo Research Foundation (FAPESP LCY 2013/01941-3, FAPESP FTS 2014/04997-2), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process number 500716/2013-7).	Abboud RJ, 2000, CLIN BIOMECH, V15, P37, DOI 10.1016/S0268-0033(99)00038-8; Akashi PMH, 2008, CLIN BIOMECH, V23, P584, DOI 10.1016/j.clinbiomech.2007.11.015; Allet L, 2008, DIABETES-METAB RES, V24, P173, DOI 10.1002/dmrr.809; Armstrong DG, 1998, J BONE JOINT SURG AM, V80A, P365, DOI 10.2106/00004623-199803000-00009; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Bennetts CJ, 2013, J BIOMECH, V46, P19, DOI 10.1016/j.jbiomech.2012.09.007; Brown SJ, 2014, J BIOMECH, V47, P3639, DOI 10.1016/j.jbiomech.2014.10.005; Campbell K., 1987, ASME INT COMP ENG C; Cavanagh PR, 1991, BIOMECHANICS DIABETI; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Esposito ER, 2014, GAIT POSTURE, V40, P640, DOI 10.1016/j.gaitpost.2014.07.019; FERNANDO DJS, 1991, DIABETES CARE, V14, P8, DOI 10.2337/diacare.14.1.8; Fernando M, 2013, CLIN BIOMECH BRISTOL; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Ghanavati T, 2014, J BIOMECH, V47, P2300, DOI 10.1016/j.jbiomech.2014.04.038; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Giacomozzi C, 2002, DIABETES CARE, V25, P1451, DOI 10.2337/diacare.25.8.1451; Glasoe WM, 2004, FOOT ANKLE INT, V25, P550, DOI 10.1177/107110070402500807; Gomes AA, 2011, MUSCLE NERVE, V44, P258, DOI 10.1002/mus.22051; Guiotto A, 2014, J BIOMECH, V47, P3064, DOI 10.1016/j.jbiomech.2014.06.029; Haddad JM, 2010, J APPL BIOMECH, V26, P109, DOI 10.1123/jab.26.1.109; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Kwon OY, 2003, GAIT POSTURE, V18, P105, DOI 10.1016/S0966-6362(02)00166-2; Lamb PF, 2014, CLIN BIOMECH, V29, P484, DOI 10.1016/j.clinbiomech.2014.03.008; Lamola G, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0093-6; Lavery LA, 2002, J AM PODIAT MED ASSN, V92, P479, DOI 10.7547/87507315-92-9-479; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Powers Christopher M, 2012, J Orthop Sports Phys Ther, V42, pA1, DOI 10.2519/jospt.2012.0301; Rao ST, 2007, CLIN BIOMECH, V22, P464, DOI 10.1016/j.clinbiomech.2006.11.013; Rao S, 2006, GAIT POSTURE, V24, P295, DOI 10.1016/j.gaitpost.2005.10.004; Rao S, 2010, GAIT POSTURE, V31, P251, DOI 10.1016/j.gaitpost.2009.10.016; Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Sacco IC, 2015, DIABETES TECHNOL THE; Sacco ICN, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-24; Savelberg HHCM, 2010, CLIN BIOMECH, V25, P468, DOI 10.1016/j.clinbiomech.2010.02.005; Sawacha Z, 2012, GAIT POSTURE, V35, P101, DOI 10.1016/j.gaitpost.2011.08.016; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; van Schie C H M, 2005, Int J Low Extrem Wounds, V4, P160; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Watari R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-11; Williams DSB, 2007, J APPL BIOMECH, V23, P251, DOI 10.1123/jab.23.4.251; Wu WH, 2014, HUM MOVEMENT SCI, V33, P194, DOI 10.1016/j.humov.2013.09.002; Yavuzer G, 2006, Eura Medicophys, V42, P127	48	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147300	10.1371/journal.pone.0147300	http://dx.doi.org/10.1371/journal.pone.0147300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807858	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800072
J	Dvortsin, E; Gout-Zwart, J; Eijssen, ELM; van Brussel, J; Postma, MJ				Dvortsin, Evgeni; Gout-Zwart, Judith; Eijssen, Ernst-Lodewijk Marie; van Brussel, Jan; Postma, Maarten J.			Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer	PLOS ONE			English	Article							NECK-CANCER; TRASTUZUMAB; CETUXIMAB; HEAD; CHEMOTHERAPY; RADIOTHERAPY; TRIAL	Background Many oncological drugs that are being used in the adjuvant setting were first submitted for reimbursement in the metastatic stage, with differences in incremental cost-effectiveness ratios (ICERs) in both settings having potential implications for reimbursement and pricing. The aim of this study is to identify a possible trend in the cost-effectiveness for the early/adjuvant and late/metastatic stages of oncological drugs through review and case study. Methods We reviewed pairs of cost-effectiveness analyses of the same oncological drug in different stages for Scotland and the Netherlands. The case study in this report was directed at trastuzumab in the Dutch situation. Using a simplified Markov model, the cost-effectiveness in early and late stage of breast cancer was calculated and compared to the findings from the review. Results Comparable studies were found for cetuximab, bortezomib and bosutinib. Treatments in the late stage were found to be more expensive per QALY by a factor ranging from 1.5 to 12. The case study provided a similar result; late stage treatment was more expensive by a factor 10. Using, for example, a threshold of (sic)80,000/QALY, the early stage of cetuximab, bosutinib and trastuzumab are deemed cost-effective, while their compared late stage is lifted over the threshold and potentially considered not cost-effective. Conclusion ICERs of oncological drugs used in different stages are more unfavourable in the late stage than in the early stage. Applying a reasonable threshold may result in early stage treatment being deemed cost-effective while late stage potentially not. Authorities should be aware of this when assessing oncological drugs and interpreting the corresponding ICERs, in the situation where oncological drugs are generally most submitted for reimbursement in the late stage initially.	[Dvortsin, Evgeni; Gout-Zwart, Judith; Eijssen, Ernst-Lodewijk Marie; van Brussel, Jan; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, Groningen, Netherlands	University of Groningen; University of Groningen	Dvortsin, E (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	jenjadvortsin@gmail.com	Gout, Judith/L-5201-2019	Gout, Judith/0000-0001-5876-8344; Postma, Maarten/0000-0002-6306-3653	F. Hofmann-La Roche AG	F. Hofmann-La Roche AG	This study was funded by F. Hofmann-La Roche AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STUKK KENN HERB DUID; Brown B, 2008, VALUE HEALTH, V11, P791, DOI 10.1111/j.1524-4733.2007.00302.x; Carlson JJ, 2010, HEALTH POLICY, V96, P179, DOI 10.1016/j.healthpol.2010.02.005; Curran D, 2007, J CLIN ONCOL, V25, P2191, DOI 10.1200/JCO.2006.08.8005; Hannouf MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038557; Inflation.eu, WORLDW INFL DAT CURR; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Norum J, 2005, ANN ONCOL, V16, P909, DOI 10.1093/annonc/mdi188; Parkinson B, 2014, EUR J HEALTH ECON, V15, P93, DOI 10.1007/s10198-013-0459-2; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Scottish Medicines Consortium, 2009, BORT 3 5MG POWD SOL, V302; Scottish Medicines Consortium, 2013, BOS 100MG 500MG FILM, V910; Scottish Medicines Consortium, 2013, BORT 3 5MG POWD SOL, V927; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Tolley K, 2006, ISPOR CONNECTIONS, V6, P3; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	16	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146551	10.1371/journal.pone.0146551	http://dx.doi.org/10.1371/journal.pone.0146551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800029	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300025
J	Adrian-Kalchhauser, I; Burkhardt-Holm, P				Adrian-Kalchhauser, Irene; Burkhardt-Holm, Patricia			An eDNA Assay to Monitor a Globally Invasive Fish Species from Flowing Freshwater	PLOS ONE			English	Article							GOBY NEOGOBIUS-MELANOSTOMUS; ENVIRONMENTAL DNA SAMPLES; ROUND GOBY; GREAT-LAKES; SURVEILLANCE; EXTRACTION; PROGRAM; RHINE; BASIN; BIODIVERSITY	Ponto-Caspian gobies are a flock of five invasive fish species that have colonized freshwaters and brackish waters in Europe and North America. One of them, the round goby Neogobius melanostomus, figures among the 100 worst invaders in Europe. Current methods to detect the presence of Ponto-Caspian gobies involve catching or sighting the fish. These approaches are labor intense and not very sensitive. Consequently, populations are usually detected only when they have reached high densities and when management or containment efforts are futile. To improve monitoring, we developed an assay based on the detection of DNA traces (environmental DNA, or eDNA) of Ponto-Caspian gobies in river water. The assay specifically detects invasive goby DNA and does not react to any native fish species. We apply the assay to environmental samples and demonstrate that parameters such as sampling depth, sampling location, extraction protocol, PCR protocol and PCR inhibition greatly impact detection. We further successfully outline the invasion front of Ponto-Caspian gobies in a large river, the High Rhine in Switzerland, and thus demonstrate the applicability of the assay to lotic environments. The eDNA assay requires less time, equipment, manpower, skills, and financial resources than the conventional monitoring methods such as electrofishing, angling or diving. Samples can be taken by untrained individuals, and the assay can be performed by any molecular biologist on a conventional PCR machine. Therefore, this assay enables environment managers to map invaded areas independently of fishermen's' reports and fish community monitorings.	[Adrian-Kalchhauser, Irene; Burkhardt-Holm, Patricia] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Alberta	Adrian-Kalchhauser, I (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	irene.adrian-kalchhauser@unibas.ch	Adrian-Kalchhauser, Irene/O-7338-2017	Adrian-Kalchhauser, Irene/0000-0002-7563-2577	Federal Office for the Environment; Canton Basel Stadt; Cantons Solothurn, Aargau and Basel Land	Federal Office for the Environment; Canton Basel Stadt; Cantons Solothurn, Aargau and Basel Land	This work was supported by funding from the Federal Office for the Environment (http://www.bafu.admin.ch/), from the Canton Basel Stadt (http://www.aue.bs.ch/), and the lottery funds of the Cantons Solothurn, Aargau and Basel Land. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Green HC, 2012, WATER RES, V46, P3251, DOI 10.1016/j.watres.2012.03.041; Hensler SR, 2007, J GREAT LAKES RES, V33, P295, DOI 10.3394/0380-1330(2007)33[295:DVMORG]2.0.CO;2; Hirsch PE, 2015, AMBIO; Janac M, 2013, ECOL FRESHW FISH, V22, P430, DOI 10.1111/eff.12037; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; Kalchhauser Irene, 2013, BioInvasions Records, V2, P79; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; LaRue EA, 2011, HYDROBIOLOGIA, V663, P71, DOI 10.1007/s10750-010-0555-6; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Manne S, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013069; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poulos HM, 2012, AQUAT INVASIONS, V7, P59, DOI 10.3391/ai.2012.7.1.007; Ray WJ, 2001, J GREAT LAKES RES, V27, P329, DOI 10.1016/S0380-1330(01)70648-X; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; TAKAHARA T, 2012, PLOS ONE, V7; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiesner C, 2005, J APPL ICHTHYOL, V21, P324, DOI 10.1111/j.1439-0426.2005.00681.x	50	34	36	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147558	10.1371/journal.pone.0147558	http://dx.doi.org/10.1371/journal.pone.0147558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814998	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200040
J	Trigoso, YD; Evans, RC; Karsten, WE; Chooback, L				Trigoso, Yvonne D.; Evans, Russell C.; Karsten, William E.; Chooback, Lilian			Cloning, Expression, and Purification of Histidine-Tagged Escherichia coli Dihydrodipicolinate Reductase	PLOS ONE			English	Article							LYSINE BIOSYNTHESIS	The enzyme dihydrodipicolinate reductase (DHDPR) is a component of the lysine biosynthetic pathway in bacteria and higher plants. DHDPR catalyzes the NAD(P) H dependent reduction of 2,3-dihydrodipicolinate to the cyclic imine L-2,3,4,5,-tetrahydropicolinic acid. The dapB gene that encodes dihydrodipicolinate reductase has previously been cloned, but the expression of the enzyme is low and the purification is time consuming. Therefore the E. coli dapB gene was cloned into the pET16b vector to improve the protein expression and simplify the purification. The dapB gene sequence was utilized to design forward and reverse oligonucleotide primers that were used to PCR the gene from Escherichia coli genomic DNA. The primers were designed with NdeI or BamHI restriction sites on the 5' and 3' terminus respectively. The PCR product was sequenced to confirm the identity of dapB. The gene was cloned into the expression vector pET16b through NdeI and BamHI restriction endonuclease sites. The resulting plasmid containing dapB was transformed into the bacterial strain BL21 (DE3). The transformed cells were utilized to grow and express the histidine-tagged reductase and the protein was purified using Ni-NTA affinity chromatography. SDS/PAGE gel analysis has shown that the protein was 95% pure and has approximate subunit molecular weight of 28 kDa. The protein purification is completed in one day and 3 liters of culture produced approximately 40-50 mgs of protein, an improvement on the previous protein expression and multistep purification.	[Trigoso, Yvonne D.; Evans, Russell C.; Chooback, Lilian] Univ Cent Oklahoma, Dept Chem, 100 N Univ Dr, Edmond, OK 73034 USA; [Karsten, William E.] Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA	University of Central Oklahoma; University of Oklahoma System; University of Oklahoma - Norman	Chooback, L (corresponding author), Univ Cent Oklahoma, Dept Chem, 100 N Univ Dr, Edmond, OK 73034 USA.	Lchooback@UCO.edu	Evans, Russell/L-9579-2019	Evans, Russell/0000-0002-2134-238X	Oklahoma State Regent Grant for Higher Education [021606]; National Center for Research Resources (NCRR) a component of National Institute of Health (NIH) [P20RR016478]; University of Central Oklahoma office of Research [011574]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	Oklahoma State Regent Grant for Higher Education; National Center for Research Resources (NCRR) a component of National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Central Oklahoma office of Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from an Oklahoma State Regent Grant for Higher Education (021606), P20RR016478 grant from the National Center for Research Resources (NCRR) a component of National Institute of Health (NIH), and a grant from University of Central Oklahoma office of Research (011574, www.uco.edu) and Grants to L.C.	BOUVIER J, 1984, J BIOL CHEM, V259, P4829; Cirilli M, 2003, BIOCHEMISTRY-US, V42, P10644, DOI 10.1021/bi030044v; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; FARKAS W, 1965, J BIOL CHEM, V240, P4717; Girish TS, 2011, FEBS LETT, V585, P2561, DOI 10.1016/j.febslet.2011.07.021; Gunji Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1449, DOI 10.1271/bbb.68.1449; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Karsten WE, 1977, BIOCHEMISTRY-US, V36, P1730; Kefala G, 2005, ACTA CRYSTALLOGR F, V61, P718, DOI 10.1107/S174430910501938X; KIMURA K, 1975, J BIOCHEM, V77, P405, DOI 10.1093/oxfordjournals.jbchem.a130739; KIMURA K, 1977, J BIOCHEM-TOKYO, V81, P1367; Marisch K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-58; Pearce FG, 2008, J BIOCHEM, V143, P617, DOI 10.1093/jb/mvn012; REDDY SG, 1995, BIOCHEMISTRY-US, V34, P3492, DOI 10.1021/bi00011a002	17	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146525	10.1371/journal.pone.0146525	http://dx.doi.org/10.1371/journal.pone.0146525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815040	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200016
J	Grimes, DR				Grimes, David Robert			On the Viability of Conspiratorial Beliefs	PLOS ONE			English	Article							CLIMATE-CHANGE; TUSKEGEE-SYPHILIS; UNITED-STATES; MOON LANDINGS; SCIENCE; IMPACT; SKEPTICISM; MOVEMENT; MEDICINE; COVERAGE	Conspiratorial ideation is the tendency of individuals to believe that events and power relations are secretly manipulated by certain clandestine groups and organisations. Many of these ostensibly explanatory conjectures are non-falsifiable, lacking in evidence or demonstrably false, yet public acceptance remains high. Efforts to convince the general public of the validity of medical and scientific findings can be hampered by such narratives, which can create the impression of doubt or disagreement in areas where the science is well established. Conversely, historical examples of exposed conspiracies do exist and it may be difficult for people to differentiate between reasonable and dubious assertions. In this work, we establish a simple mathematical model for conspiracies involving multiple actors with time, which yields failure probability for any given conspiracy. Parameters for the model are estimated from literature examples of known scandals, and the factors influencing conspiracy success and failure are explored. The model is also used to estimate the likelihood of claims from some commonly-held conspiratorial beliefs; these are namely that the moon-landings were faked, climate-change is a hoax, vaccination is dangerous and that a cure for cancer is being suppressed by vested interests. Simulations of these claims predict that intrinsic failure would be imminent even with the most generous estimates for the secret-keeping ability of active participants-the results of this model suggest that large conspiracies (>= 1000 agents) quickly become untenable and prone to failure. The theory presented here might be useful in counteracting the potentially deleterious consequences of bogus and anti-science narratives, and examining the hypothetical conditions under which sustainable conspiracy might be possible.	[Grimes, David Robert] Univ Oxford, Old Rd Campus Res Bldg,Off Roosevelt Dr, Oxford OX3 7DQ, England	University of Oxford	Grimes, DR (corresponding author), Univ Oxford, Old Rd Campus Res Bldg,Off Roosevelt Dr, Oxford OX3 7DQ, England.	davidrobert.grimes@wolfson.ox.ac.uk	Grimes, David Robert/J-7384-2013	Grimes, David Robert/0000-0003-3140-3278				[Anonymous], PEDIATRICS; Antilla L, 2005, GLOBAL ENVIRON CHANG, V15, P338, DOI 10.1016/j.gloenvcha.2005.08.003; Brawley OW, 1998, INT J RADIAT ONCOL, V40, P5, DOI 10.1016/S0360-3016(97)00835-3; Carvalho A, 2007, PUBLIC UNDERST SCI, V16, P223, DOI 10.1177/0963662506066775; CASSILETH BR, 1984, ANN INTERN MED, V101, P105, DOI 10.7326/0003-4819-101-1-105; Cassileth BR, 1999, CANCER, V86, P1900, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1900::AID-CNCR4>3.3.CO;2-U; Chigwedere P, 2010, AIDS BEHAV, V14, P237, DOI 10.1007/s10461-009-9654-7; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Corbie-Smith G, 1999, AM J MED SCI, V317, P5, DOI 10.1097/00000441-199901000-00002; Del Vicario M., 2016, P NATL ACAD SCI USA; Douglas KM, 2008, J SOC PSYCHOL, V148, P210, DOI 10.3200/SOCP.148.2.210-222; Freudenburg WR, 2008, SOCIOL INQ, V78, P2, DOI 10.1111/j.1475-682X.2008.00219.x; GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630; Goertzel T, 2010, EMBO REP, V11, P493, DOI 10.1038/embor.2010.84; Grimes DR, 2015, BIOMED PHYS ENG EXPR, V1, DOI 10.1088/2057-1976/1/4/045209; Grimes DR, 2015, J EPIDEMIOL COMMUN H, V69, P616, DOI 10.1136/jech-2015-205708; Grimes DR., 2012, FOCUS ALTERNATIVE CO, V17, P149, DOI [10.1111/j.2042-7166.2012.01162.x, DOI 10.1111/J.2042-7166.2012.01162.X]; Jacobson RA, 2007, VACCINE, V25, P3146, DOI 10.1016/j.vaccine.2007.01.046; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Landau S, 2014, IEEE SECUR PRIV, V12, P62, DOI 10.1109/MSP.2013.161; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Levy G, 2014, BIOSTATISTICS OF AGING: FROM GOMPERTZIAN MORTALITY AND TO AN INDEX OF AGING-RELATEDNESS, P1, DOI 10.1002/9781118645840; Lewandowsky S, 2013, PSYCHOL SCI; Lewandowsky S., 2015, J SOCIAL POLITICAL P, V3, P142, DOI [10.5964/jspp.v3i1.443, DOI 10.5964/JSPP.V3I1.443]; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2003, SOC PROBL, V50, P348, DOI 10.1525/sp.2003.50.3.348; MCNEIL DR, 1968, J APPL PROBAB, V5, P624, DOI 10.2307/3211926; Milgrom P, 2000, ANNU REV PUBL HEALTH, V21, P403, DOI 10.1146/annurev.publhealth.21.1.403; National Security Agency, 2012, 60 YEARS DEF OUR NAT; Natl Res Council, 2009, STRENGTHENING FORENSIC SCIENCE IN THE UNITED STATES: A PATH FORWARD, P1; Nattrass N, 2010, AIDS BEHAV, V14, P248, DOI 10.1007/s10461-009-9641-z; Nimmen JV, 1976, NASA HIST DAT 1958 1, VI; Office of the Inspector General, 2014, ASS 1996 DEP JUST TA; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Perlmutter DD, 2008, VISUAL COMMUN-US, V7, P229, DOI 10.1177/1470357208088760; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Public Policy Polling, 2013, DEM REP DIFF CONSP T; REGELSON W, 1980, JAMA-J AM MED ASSOC, V243, P337; Schmidt K, 2003, VACCINE, V21, P1044, DOI 10.1016/S0264-410X(02)00628-X; Shermer M., 2014, SCI AM, V311, P94, DOI [10.1038/scientificamerican0914-94, DOI 10.1038/SCIENTIFICAMERICAN0914-94]; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Swami V, 2013, APPL COGNITIVE PSYCH, V27, P71, DOI 10.1002/acp.2873; THOMAS SB, 1991, AM J PUBLIC HEALTH, V81, P1498, DOI 10.2105/AJPH.81.11.1498; Yang JJ, 2014, HEALTH RISK SOC, V16, P339, DOI 10.1080/13698575.2014.923092	51	33	33	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147905	10.1371/journal.pone.0147905	http://dx.doi.org/10.1371/journal.pone.0147905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812482	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000062
J	Lin, CW; Tang, W; Wen, F; Chen, JJ; Zeng, XL; Chen, ZG				Lin, Chun-wang; Tang, Wen; Wen, Fang; Chen, Jin-jin; Zeng, Xiang-lin; Chen, Zong-geng			Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in Patients Younger than 18 Years	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; B-TYPE; SEPTIC SHOCK; CHILDREN; BIOMARKERS; VALUES; RISK; MECHANISMS; PREDICTION; DISEASE	This clinical study investigated plasma NT-proBNP levels as a potential predictor of heart failure in pediatric patients with sepsis. Plasma NT-ProBNP levels of 211 pediatric patients with sepsis and 126 healthy children were measured. Patients were stratified as with heart failure (HF) or without heart failure (non-HF). Patients were graded as having sepsis, severe sepsis, or septic shock. The optimal cut-off values of plasma NT-ProBNP for heart failure were determined by analyzing the receiver operating characteristic (ROC). In the HF, non-HF and control groups, the median plasma NT-proBNP levels were 3640, 656, and 226 ng/L, respectively. For all patients with sepsis, the optimal diagnostic cut-off value was 1268 ng/L for differentiating heart failure. In the severe sepsis patients and septic shock patients, the optimal diagnostic cut-off values were 1368 ng/L and 1525 ng/L, respectively. This report is the first one to reveal that NT-proBNP may predict heart failure in children with sepsis. It provides an important clinical reference for the diagnosis of heart failure in pediatric patients with sepsis, and enables monitoring septic children for cardiac involvement.	[Lin, Chun-wang; Wen, Fang; Chen, Jin-jin; Zeng, Xiang-lin] Jinan Univ, Affiliated Shunde Women & Childrens Hosp, Shunde 528300, Guangdong, Peoples R China; [Tang, Wen; Chen, Zong-geng] Zhongshan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Sun Yat Sen University	Lin, CW (corresponding author), Jinan Univ, Affiliated Shunde Women & Childrens Hosp, Shunde 528300, Guangdong, Peoples R China.; Tang, W (corresponding author), Zhongshan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.	1933500933@qq.com; tangwenr@21cn.com			Department of Science and Technology of Guangdong Province in China [2011B031800134]; Bureau of Science and Technology of Foshan City in China [201008189]	Department of Science and Technology of Guangdong Province in China; Bureau of Science and Technology of Foshan City in China	This study was supported by the Department of Science and Technology of Guangdong Province in China (grant no. 2011B031800134) and the Bureau of Science and Technology of Foshan City in China (grant no. 201008189). These funders were not involved in the study design, or the collection, analysis, or interpretation of the data, in the writing of the report, or in the decision to submit the article for publication.	Caksen H, 2002, JPN HEART J, V43, P9, DOI 10.1536/jhj.43.9; deFilippi CR, 2012, J AM COLL CARDIOL, V60, P2539, DOI 10.1016/j.jacc.2012.08.1006; Moutinho MAE, 2008, ARQ BRAS CARDIOL, V90, P145, DOI 10.1590/S0066-782X2008000200011; Eurlings LW, 2014, J CARD FAIL, V20, P881, DOI 10.1016/j.cardfail.2014.08.014; Flynn A, 2010, HEART FAIL REV, V15, P605, DOI 10.1007/s10741-010-9176-4; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gruson D, 2012, CLIN BIOCHEM, V45, P171, DOI 10.1016/j.clinbiochem.2011.07.012; Guazzi M, 2012, J CARD FAIL, V18, P313, DOI 10.1016/j.cardfail.2012.01.006; Iqbal N, 2013, EXPERT REV CARDIOVAS, V11, P1155, DOI 10.1586/14779072.2013.832476; Johns MC, 2008, AM J CARDIOL, V101, p76A, DOI 10.1016/j.amjcard.2007.11.028; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Laer S, 2002, AM HEART J, V143, P916, DOI 10.1067/mhj.2002.121265; Lin CW, 2014, J CARD FAIL, V20, P168, DOI 10.1016/j.cardfail.2013.12.013; Madamanchi C, 2014, INT J CARDIOL, V176, P611, DOI 10.1016/j.ijcard.2014.08.007; McGrady M, 2013, INT J CARDIOL, V169, P133, DOI 10.1016/j.ijcard.2013.08.089; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Pellicori P, 2014, INT J CARDIOL, V170, P364, DOI 10.1016/j.ijcard.2013.11.015; Popelova J, 2012, CAN J CARDIOL, V28, P471, DOI 10.1016/j.cjca.2012.01.015; Ross RD, 2012, PEDIATR CARDIOL, V33, P1295, DOI 10.1007/s00246-012-0306-8; Samransamruajkit R, 2014, INDIAN J CRIT CARE M, V18, P70, DOI 10.4103/0972-5229.126075; Seronde MF, 2013, INT J CARDIOL, V168, P3404, DOI 10.1016/j.ijcard.2013.04.164; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Wang F, 2012, CRIT CARE, V16, DOI 10.1186/cc11331; Wong DTH, 2011, AM J CARDIOL, V107, P573, DOI 10.1016/j.amjcard.2010.10.015; Xue Yang, 2010, Congest Heart Fail, V16 Suppl 1, pS62, DOI 10.1111/j.1751-7133.2010.00169.x; Zhang XH, 2013, EUR REV MED PHARMACO, V17, P517	26	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147930	10.1371/journal.pone.0147930	http://dx.doi.org/10.1371/journal.pone.0147930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812689	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000065
J	Cerny, KL; Ribeiro, RAC; Jeoung, M; Ko, C; Bridges, PJ				Cerny, Katheryn L.; Ribeiro, Rosanne A. C.; Jeoung, Myoungkun; Ko, CheMyong; Bridges, Phillip J.			Estrogen Receptor Alpha (ESR1)-Dependent Regulation of the Mouse Oviductal Transcriptome	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; EPITHELIAL-CELLS; GENE-EXPRESSION; IN-VITRO; PROSTAGLANDIN E-2; TUBAL OCCLUSION; FALLOPIAN-TUBE; PROGESTERONE; SECRETION; LOCALIZATION	Estrogen receptor-alpha (ESR1) is an important transcriptional regulator in the mammalian oviduct, however ESR1-dependent regulation of the transcriptome of this organ is not well defined, especially at the genomic level. The objective of this study was therefore to investigate estradiol-and ESR1-dependent regulation of the transcriptome of the oviduct using transgenic mice, both with (ESR1KO) and without (wild-type, WT) a global deletion of ESR1. Oviducts were collected from ESR1KO and WT littermates at 23 days of age, or ESR1KO and WT mice were treated with 5 IU PMSG to stimulate follicular development and the production of ovarian estradiol, and the oviducts collected 48 h later. RNA extracted from whole oviducts was hybridized to Affymetrix Genechip Mouse Genome 430-2.0 arrays (n = 3 arrays per genotype and treatment) or reverse transcribed to cDNA for analysis of the expression of selected mRNAs by real-time PCR. Following microarray analysis, a statistical two-way ANOVA and pairwise comparison (LSD test) revealed 2428 differentially expressed transcripts (DEG's, P < 0.01). Genotype affected the expression of 2215 genes, treatment (PMSG) affected the expression of 465 genes, and genotype x treatment affected the expression of 438 genes. With the goal of determining estradiol/ESR1-regulated function, gene ontology (GO) and bioinformatic pathway analyses were performed on DEG's in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Significantly enriched GO molecular function categories included binding and catalytic activity. Significantly enriched GO cellular component categories indicated the extracellular region. Significantly enriched GO biological process categories involved a single organism, modulation of a measurable attribute and developmental processes. Bioinformatic analysis revealed ESR1-regulation of the immune response within the oviduct as the primary canonical pathway. In summary, a transcriptomal profile of estradiol-and ESR1-regulated gene expression and related bioinformatic analysis is presented to increase our understanding of how estradiol/ESR1 affects function of the oviduct, and to identify genes that may be proven as important regulators of fertility in the future.	[Cerny, Katheryn L.; Ribeiro, Rosanne A. C.; Bridges, Phillip J.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA; [Jeoung, Myoungkun; Bridges, Phillip J.] Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA; [Ko, CheMyong] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61802 USA	University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Bridges, PJ (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40546 USA.; Bridges, PJ (corresponding author), Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA.	phillip.bridges@uky.edu	Ko, CheMyong Jay/A-7475-2019	Ko, CheMyong Jay/0000-0002-0963-3731	National Institutes of Health [P20 RR15592, K12 DA014040, P01 HD071875]; University of Kentucky; Kentucky Agricultural Experiment Station [16-07-008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD071875] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA014040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky; Kentucky Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants P20 RR15592 (P.B., C.K.), K12 DA014040 (P.B.), and P01 HD071875 (P.B., C.K.), the University of Kentucky, and Kentucky Agricultural Experiment Station.; This work was supported by National Institutes of Health Grants P20 RR15592 (P.B., C.K.), K12 DA014040 (P.B.), and P01 HD071875 (P.B., C.K), the University of Kentucky, and Kentucky Agricultural Experiment Station. The information reported in this paper (publication no. 16-07-008) is part of a project of the Kentucky Agricultural Experiment Station and is published with approval of the Director.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Briceag I, 2015, J Med Life, V8, P129; Bridges PJ, 2012, ENDOCRINOLOGY, V153, P1925, DOI 10.1210/en.2011-1900; Bridges PJ, 2011, REPROD BIOMED ONLINE, V23, P234, DOI 10.1016/j.rbmo.2011.04.007; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Dixon D, 1997, TOXICOL PATHOL, V25, P518, DOI 10.1177/019262339702500516; Dong ZH, 2017, REPROD FERT DEVELOP, V29, P482, DOI 10.1071/RD15246; DONNEZ J, 1988, EUR J OBSTET GYN R B, V29, P33, DOI 10.1016/0028-2243(88)90162-1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Ulloa AC, 2005, MED HYPOTHESES, V65, P908, DOI 10.1016/j.mehy.2005.03.031; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; Hedl M, 2014, J IMMUNOL, V192, P5924, DOI 10.4049/jimmunol.1302727; Huang N, 2015, PROSTAG OTH LIPID M, V121, P170, DOI 10.1016/j.prostaglandins.2015.08.002; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Jeoung M, 2010, ENDOCRINOLOGY, V151, P2858, DOI 10.1210/en.2009-1155; Kowsar R, 2014, MOL REPROD DEV, V81, P861, DOI 10.1002/mrd.22355; Kowsar R, 2013, J REPROD DEVELOP, V59, P470, DOI 10.1262/jrd.2013-036; Koy M, 2013, VET IMMUNOL IMMUNOP, V155, P162, DOI 10.1016/j.vetimm.2013.07.002; Liu JH, 2014, J REPROD DEVELOP, V60, P342, DOI 10.1262/jrd.2014-049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maisey K, 2003, INFECT IMMUN, V71, P527, DOI 10.1128/IAI.71.1.527-532.2003; Marey MA, 2014, REPRODUCTION, V147, P211, DOI 10.1530/REP-13-0375; Martinez SP, 2006, PROSTAG OTH LIPID M, V80, P155, DOI 10.1016/j.prostaglandins.2006.06.002; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; Okada A, 2003, J MOL ENDOCRINOL, V30, P301, DOI 10.1677/jme.0.0300301; Orihuela PA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-139; Otsuki M, 2007, J REPROD DEVELOP, V53, P59, DOI 10.1262/jrd.18036; Partek D., 2009, PARTEK DOCUMENTATION; Perfettini JL, 2000, INFECT IMMUN, V68, P2237, DOI 10.1128/IAI.68.4.2237-2244.2000; Popli P, 2015, J STEROID BIOCHEM, V154, P130, DOI 10.1016/j.jsbmb.2015.07.019; Punnonen R, 1984, Acta Eur Fertil, V15, P39; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Shao R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1430, DOI 10.1152/ajpendo.00384.2007; Steffl M, 2008, ANN ANAT, V190, P46, DOI 10.1016/j.aanat.2007.04.003; Sweet Richard L, 2011, Infect Dis Obstet Gynecol, V2011, P561909, DOI 10.1155/2011/561909; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Ulbrich SE, 2003, J STEROID BIOCHEM, V84, P279, DOI 10.1016/S0960-0760(03)00039-6; Verhage HG, 1997, HUM REPROD UPDATE, V3, P541, DOI 10.1093/humupd/3.6.541; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wijayagunawardane MPB, 1999, ANIM REPROD SCI, V56, P11, DOI 10.1016/S0378-4320(99)00021-4	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147685	10.1371/journal.pone.0147685	http://dx.doi.org/10.1371/journal.pone.0147685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808832	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800179
J	Duda, JP; Van Kranendonk, MJ; Thiel, V; Ionescu, D; Strauss, H; Schafer, N; Reitner, J				Duda, Jan-Peter; Van Kranendonk, Martin J.; Thiel, Volker; Ionescu, Danny; Strauss, Harald; Schaefer, Nadine; Reitner, Joachim			A Rare Glimpse of Paleoarchean Life: Geobiology of an Exceptionally Preserved Microbial Mat Facies from the 3.4 Ga Strelley Pool Formation, Western Australia	PLOS ONE			English	Article							PILBARA CRATON; STROMATOLITE REEF; WARRAWOONA GROUP; NORTH-POLE; SULFUR; OLD; REDUCTION; CHERT; BIOGENICITY; ORIGIN	Paleoarchean rocks from the Pilbara Craton of Western Australia provide a variety of clues to the existence of early life on Earth, such as stromatolites, putative microfossils and geo-chemical signatures of microbial activity. However, some of these features have also been explained by non-biological processes. Further lines of evidence are therefore required to convincingly argue for the presence of microbial life. Here we describe a new type of microbial mat facies from the 3.4 Ga Strelley Pool Formation, which directly overlies well known stromatolitic carbonates from the same formation. This microbial mat facies consists of laminated, very fine-grained black cherts with discontinuous white quartz layers and lenses, and contains small domical stromatolites and wind-blown crescentic ripples. Light-and cathodoluminescence microscopy, Raman spectroscopy, and time of flight-secondary ion mass spectrometry (ToF-SIMS) reveal a spatial association of carbonates, organic material, and highly abundant framboidal pyrite within the black cherts. Nano secondary ion mass spectrometry (NanoSIMS) confirmed the presence of distinct spheroidal carbonate bodies up to several tens of mu m that are surrounded by organic material and pyrite. These aggregates are interpreted as biogenic. Comparison with Phanerozoic analogues indicates that the facies represents microbial mats formed in a shallow marine environment. Carbonate precipitation and silicification by hydrothermal fluids occurred during sedimentation and earliest diagenesis. The deciphered environment, as well as the delta C-13 signature of bulk organic matter (-35.3 parts per thousand), are in accord with the presence of photoautotrophs. At the same time, highly abundant framboidal pyrite exhibits a sulfur isotopic signature (delta S-34 = +3.05 parts per thousand;Delta S-33 = 0.268 parts per thousand; and Delta S-36 = -0.282 parts per thousand) that is consistent with microbial sulfate reduction. Taken together, our results strongly support a microbial mat origin of the black chert facies, thus providing another line of evidence for life in the 3.4 Ga Strelley Pool Formation.	[Duda, Jan-Peter; Thiel, Volker; Schaefer, Nadine; Reitner, Joachim] Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany; [Duda, Jan-Peter; Reitner, Joachim] Gottingen Acad Sci & Humanities, Origin Life Grp, Theaterstr 7, Gottingen, Germany; [Van Kranendonk, Martin J.] Univ New S Wales, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia; [Van Kranendonk, Martin J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Ionescu, Danny] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Expt Limnol, Alte Fischerhutte 2, D-16775 Stechlin, Germany; [Strauss, Harald] Univ Munster, Inst Geol & Palaontol, Corrensstr 24, D-48149 Munster, Germany	University of Gottingen; University of New South Wales Sydney; University of New South Wales Sydney; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Munster	Duda, JP (corresponding author), Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.; Duda, JP (corresponding author), Gottingen Acad Sci & Humanities, Origin Life Grp, Theaterstr 7, Gottingen, Germany.	jan-peter.duda@geo.uni-goettingen.de	Ionescu, Danny/P-3261-2017	Ionescu, Danny/0000-0002-4658-8597; Duda, Jan-Peter/0000-0002-8959-097X; Thiel, Volker/0000-0003-4758-2784; Van Kranendonk, Martin/0000-0002-0611-2703	Deutsche Forschungsgemeinschaft (DFG Priority Programme 1833, "Building a Habitable Earth") [DU 1450/3-1]; Courant Research Centre of the University Gottingen (DFG, German Excellence Program); Gottingen Academy of Sciences and Humanities; University of New South Wales; Sloan Foundation; National Institute for Mathematical and Biological Synthesis (NIMBioS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; University of Gottingen	Deutsche Forschungsgemeinschaft (DFG Priority Programme 1833, "Building a Habitable Earth")(German Research Foundation (DFG)); Courant Research Centre of the University Gottingen (DFG, German Excellence Program); Gottingen Academy of Sciences and Humanities; University of New South Wales; Sloan Foundation(Alfred P. Sloan Foundation); National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; University of Gottingen	Financial support was provided by Deutsche Forschungsgemeinschaft (grant DU 1450/3-1, DFG Priority Programme 1833, "Building a Habitable Earth"), Courant Research Centre of the University Gottingen (DFG, German Excellence Program), Gottingen Academy of Sciences and Humanities, University of New South Wales, and the Sloan Foundation. University of Gottingen provided financial support for open access (open Access Publication Funds).; The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award # EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the members of the NIMBioS working group for their valuable comments regarding our within-host modeling of MAP infections.	Allwood A.C., 2007, STRATIGRAPHY FACIES; Allwood AC, 2007, PRECAMBRIAN RES, V158, P198, DOI 10.1016/j.precamres.2007.04.013; Allwood AC, 2010, CHEM GEOL, V270, P148, DOI 10.1016/j.chemgeo.2009.11.013; Allwood AC, 2009, P NATL ACAD SCI USA, V106, P9548, DOI 10.1073/pnas.0903323106; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; Benzerara K, 2014, BIO WEB CONF, V2, DOI 10.1051/bioconf/20140202002; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; Brasier M, 2006, PHILOS T R SOC B, V361, P887, DOI 10.1098/rstb.2006.1835; Brasier MD, 2011, EARLIEST LIFE ON EARTH: HABITATS, ENVIORNMENTS AND METHODS OF DETECTION, P115, DOI 10.1007/978-90-481-8794-2_5; Brasier MD, 2005, PRECAMBRIAN RES, V140, P55, DOI 10.1016/j.precamres.2005.06.008; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; Buick R, 1985, THESIS U W AUSTR; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fischer A.G., 1964, KANS GEOL SURV BULL, V169, P107; Flugel E., 1991, CALCAREOUS ALGAE STR, P481; Flugel E., 1982, INTRO FACIES ANAL BT, P1, DOI [10.1007/978-3-642-68423-4_1, DOI 10.1007/978-3-642-68423-4_1]; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Habermann D, 2000, CATHODOLUMINESCENCE; Head IM, 2000, FEMS MICROBIOL ECOL, V33, P171; Hickman A.H, 2008, REGIONAL REV 3426 33; Hickman AH, 2012, 34 INT GEOL C IGC BR, P66; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kashefi K, 2000, APPL ENVIRON MICROB, V66, P1050, DOI 10.1128/AEM.66.3.1050-1056.2000; Kilburn M.R., 2014, PRINCIPLES PRACTICE; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; Lindsay JF, 2003, ASTROBIOLOGY, V3, P739, DOI 10.1089/153110703322736060; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; LOWE DR, 1983, PRECAMBRIAN RES, V19, P239, DOI 10.1016/0301-9268(83)90016-5; MacLean LCW, 2008, GEOBIOLOGY, V6, P471, DOI 10.1111/j.1472-4669.2008.00174.x; Marshall CP, 2007, PRECAMBRIAN RES, V155, P1, DOI 10.1016/j.precamres.2006.12.014; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Nelson D.R., COMPILATION GEOCHRON, P190; Oehler DZ, 2006, ASTROBIOLOGY, V6, P838, DOI 10.1089/ast.2006.6.838; Oehler DZ, 2010, ASTROBIOLOGY, V10, P413, DOI 10.1089/ast.2009.0426; Oehler DZ, 2009, PRECAMBRIAN RES, V173, P70, DOI 10.1016/j.precamres.2009.01.001; Ohfuji H, 2005, EARTH-SCI REV, V71, P147, DOI 10.1016/j.earscirev.2005.02.001; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Popa R, 2004, GEOMICROBIOL J, V21, P193, DOI 10.1080/01490450490275497; Powell CL, 2000, GEOL SOC SPEC PUBL, V180, P439, DOI 10.1144/GSL.SP.2000.180.01.23; RICHTER DK, 1981, GEOL RUNDSCH, V70, P1276, DOI 10.1007/BF01820192; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; Rust GW, 1935, J GEOL, V43, P398, DOI 10.1086/624318; Sandberg PA, 1985, CARBONATE CEMENTS SE, V36, P33; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; SHINN EA, 1983, J SEDIMENT PETROL, V53, P619; SHINN EA, 1968, J SEDIMENT PETROL, V38, P215, DOI 10.1306/74D7191F-2B21-11D7-8648000102C1865D; Sugitani K, 2015, GEOBIOLOGY, P1; Sugitani K, 2013, PRECAMBRIAN RES, V226, P59, DOI 10.1016/j.precamres.2012.11.005; Sugitani K, 2010, ASTROBIOLOGY, V10, P899, DOI 10.1089/ast.2010.0513; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Tice MM, 2006, EARTH-SCI REV, V76, P259, DOI 10.1016/j.earscirev.2006.03.003; Tice MM, 2009, ASTROBIOLOGY, V9, P989, DOI 10.1089/ast.2008.0330; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; TREWIN NH, 1994, T ROY SOC EDIN-EARTH, V84, P433; Trewin NH, 1996, EVOLUTION HYDROTHERM; Tucker M., 1990, CARBONATE SEDIMENTOL; Van Kranendonk M.J., 2011, ADV STROMATOLITE GEO; Van Kranendonk M.J., 2006, REVISED LITHOSTRATIG; Van Kranendonk MJ, 2003, GEOBIOLOGY, V1, P91, DOI 10.1046/j.1472-4669.2003.00014.x; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005; Van Kranendonk MJ, 2004, GEOCHEM-EXPLOR ENV A, V4, P253, DOI 10.1144/1467-7873/04-205; Van Kranendonk MJ, 2002, ECON GEOL BULL SOC, V97, P695; VanKranendonk MJ, 2007, DEV PREC G, V15, P1; Von Knorre H, 2000, MICROBIAL SEDIMENTS, P25; Wacey D, 2010, GEOL SURV WA RECORD; Wacey D, 2015, GEOLOGY, V43, P27, DOI 10.1130/G36048.1; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Wacey D, 2011, EARTH PLANET SC LETT, V301, P393, DOI 10.1016/j.epsl.2010.11.025; Wacey D, 2010, GEOLOGY, V38, P1115, DOI 10.1130/G31329.1; Wacey D, 2010, ASTROBIOLOGY, V10, P381, DOI 10.1089/ast.2009.0423; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; Williford KW, 2015, LPI CONTRIBUTION; Wright DT, 2005, GEOMICROBIOL J, V22, P27, DOI 10.1080/01490450590922532	88	29	30	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147629	10.1371/journal.pone.0147629	http://dx.doi.org/10.1371/journal.pone.0147629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807732	Green Published, gold			2022-12-27	WOS:000369527800155
J	Kang, H; Weiss, TM; Bang, I; Weis, WI; Choi, HJ				Kang, Hyunook; Weiss, Thomas M.; Bang, Injin; Weis, William I.; Choi, Hee-Jung			Structure of the Intermediate Filament-Binding Region of Desmoplakin	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY SOLUTION; PLAKIN DOMAIN; BIOLOGICAL MACROMOLECULES; PALMOPLANTAR KERATODERMA; HAPLOINSUFFICIENCY; CRYSTALLOGRAPHY; CARDIOMYOPATHY; PREDICTION; TERMINUS	Desmoplakin (DP) is a cytoskeletal linker protein that connects the desmosomal cadherin/plakoglobin/plakophilin complex to intermediate filaments (IFs). The C-terminal region of DP (DPCT) mediates IF binding, and contains three plakin repeat domains (PRDs), termed PRD-A, PRD-B and PRD-C. Previous crystal structures of PRDs B and C revealed that each is formed by 4.5 copies of a plakin repeat (PR) and has a conserved positively charged groove on its surface. Although PRDs A and B are linked by just four amino acids, B and C are separated by a 154 residue flexible linker, which has hindered crystallographic analysis of the full DPCT. Here we present the crystal structure of a DPCT fragment spanning PRDs A and B, and elucidate the overall architecture of DPCT by small angle X-ray scattering (SAXS) analysis. The structure of PRD-A is similar to that of PRD-B, and the two domains are arranged in a quasi-linear arrangement, and separated by a 4 amino acid linker. Analysis of the B-C linker region using secondary structure prediction and the crystal structure of a homologous linker from the cytolinker periplakin suggests that the N-terminal similar to 100 amino acids of the linker form two PR-like motifs. SAXS analysis of DPCT indicates an elongated but non-linear shape with R-g = 51.5 angstrom and D-max = 178 angstrom. These data provide the first structural insights into an IF binding protein containing multiple PRDs and provide a foundation for studying the molecular basis of DP-IF interactions.	[Kang, Hyunook; Bang, Injin; Choi, Hee-Jung] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Weiss, Thomas M.] SLAC Natl Lab, Menlo Pk, CA USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	Seoul National University (SNU); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA USA.; Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA.	bill.weis@stanford.edu; choihj@snu.ac.kr	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kang, Hyunook/0000-0002-7017-4597; Choi, Hee-Jung/0000-0002-1167-1526; Bang, Injin/0000-0003-0247-6056	Interdisciplinary Research Program from the Research Institute for Basic Sciences; Seoul National University Research Grant; Basic Research Laboratory through the National Research Foundation of Korea [NRF-2014R1A4A10052590]; U.S. National Institutes of Health [GM56169, GM09463]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Seoul National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, P41GM103393] Funding Source: NIH RePORTER	Interdisciplinary Research Program from the Research Institute for Basic Sciences; Seoul National University Research Grant; Basic Research Laboratory through the National Research Foundation of Korea(National Research Foundation of Korea); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Seoul National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Interdisciplinary Research Program from the Research Institute for Basic Sciences, Seoul National University, the Seoul National University Research Grant, and a grant from the Basic Research Laboratory (NRF-2014R1A4A10052590) through the National Research Foundation of Korea (HJC), and the U.S. National Institutes of Health (GM56169 and GM09463) (WIW). Portions of this work were performed at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ai-Jassar C, 2013, J MOL BIOL, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; Jonkman MF, 2005, AM J HUM GENET, V77, P653, DOI 10.1086/496901; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whittock NV, 1999, J INVEST DERMATOL, V113, P940, DOI 10.1046/j.1523-1747.1999.00783.x	38	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147641	10.1371/journal.pone.0147641	http://dx.doi.org/10.1371/journal.pone.0147641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808545	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800163
J	Maquart, M; Boyer, S; Rakotoharinome, VM; Ravaomanana, J; Tantely, ML; Heraud, JM; Cardinale, E				Maquart, Marianne; Boyer, Sebastien; Rakotoharinome, Vincent Michel; Ravaomanana, Julie; Tantely, Michael Luciano; Heraud, Jean-Michel; Cardinale, Eric			High Prevalence of West Nile Virus in Domestic Birds and Detection in 2 New Mosquito Species in Madagascar	PLOS ONE			English	Article							TRANSMISSION	West Nile virus is an arthropod-borne zoonosis transmitted by a large number of mosquito species, and birds play a key role as reservoir of the virus. Its distribution is largely widespread over Africa, Asia, the Americas and Europe. Since 1978, it has frequently been reported in Madagascar. Studies described a high seroprevalence level of the virus in humans in different areas of the island and a human fatal case of WNV infection was reported in 2011. Despite these reports, the epidemiology of WNV in Madagascar, in particular, viral circulation remains unclear. To explore the transmission of WNV in two rural human populations of Madagascar, we investigated local mosquitoes and poultry for evidence of current infections, and determined seroprevalence of candidate sentinel species among the local poultry. These 2 areas are close to lakes where domestic birds, migratory wild birds and humans coexist. Serological analysis revealed WNV antibodies in domestic birds (duck, chicken, goose, turkey and guinea fowl) sampled in both districts (Antsalova 29.4% and Mitsinjo 16.7%). West Nile virus nucleic acid was detected in one chicken and in 8 pools of mosquitoes including 2 mosquito species (Aedeomyia madagascarica and Anopheles pauliani) that have not been previously described as candidate vectors for WNV. Molecular analysis of WNV isolates showed that all viruses detected were part of the lineage 2 that is mainly distributed in Africa, and were most closely matched by the previous Malagasy strains isolated in 1988. Our study showed that WNV circulates in Madagascar amongst domestic birds and mosquitoes, and highlights the utility of poultry as a surveillance tool to detect WNV transmission in a peri-domestic setting.	[Maquart, Marianne; Heraud, Jean-Michel] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Boyer, Sebastien; Tantely, Michael Luciano] Inst Pasteur Madagascar, Unit Entomol Med, Antananarivo, Madagascar; [Rakotoharinome, Vincent Michel] Minist Elevage, Direct Serv Vet, Antananarivo, Madagascar; [Ravaomanana, Julie] Ctr Natl Rech Appl Dev Rural, Dept Rech Zootech & Vet, Antananarivo, Madagascar; [Maquart, Marianne; Cardinale, Eric] Ctr Cooperat Int Rech Agronom Dev, UMR CMAEE 15, St Clotilde, Reunion, France; [Cardinale, Eric] Inst Natl Rech Agronom, UMR CMAEE 1309, St Clotilde, Reunion, France; [Cardinale, Eric] Ctr Rech & Veille Malad Emergentes Ocean Indie, St Clotilde, Reunion, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; CIRAD; INRAE	Maquart, M (corresponding author), Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar.; Maquart, M (corresponding author), Ctr Cooperat Int Rech Agronom Dev, UMR CMAEE 15, St Clotilde, Reunion, France.	mariannemaquart@yahoo.fr	maquart, marianne/AAX-8356-2021; Heraud, Jean-Michel/O-1464-2013; Tantely, Luciano Michaël/J-1385-2019	Heraud, Jean-Michel/0000-0003-1107-0859; Tantely, Luciano Michaël/0000-0002-4658-6372; Boyer, Sebastien/0000-0002-2946-586X	FEDER POCT (European Union); FEDER POCT (Regional Council of Reunion); FEDER POCT (French government); French Embassy of Madagascar	FEDER POCT (European Union); FEDER POCT (Regional Council of Reunion); FEDER POCT (French government); French Embassy of Madagascar	This study was conducted in the framework of AnimalRisk-OI, a research program on emerging animal diseases in the Indian Ocean, funded by FEDER POCT (European Union, Regional Council of Reunion and the French government). The study was also partially funded by the French Embassy of Madagascar.	Aharonson-Raz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113149; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Boyer S. M., 2014, ARCH I PASTEUR MADAG, V71, P1; Cernescu C., 1997, Romanian Journal of Virology, V48, P13; Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FONTENILLE D, 1989, ANN SOC BELG MED TR, V69, P233; Garcia-Bocanegra I, 2011, VECTOR-BORNE ZOONOT, V11, P1107, DOI 10.1089/vbz.2009.0237; Gouagna LC, 2015, ACTA TROP, V143, P89, DOI 10.1016/j.actatropica.2014.12.011; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2001, ANN NY ACAD SCI, V951, P58; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Larrieu S, 2013, AM J TROP MED HYG, V89, P211, DOI 10.4269/ajtmh.12-0003; Lonchampt C., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P33; MATHIOT C, 1984, Archives de l'Institut Pasteur de Madagascar, V51, P113; MORVAN J, 1991, B SOC PATHOL EXOT, V84, P225; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; PEIRIS JSM, 1994, HDB ZOONOSES B, P139; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petrovic T, 2013, EUROSURVEILLANCE, V18; R Core Team R. C, 2013, R LANG ENV STAT COMP; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	24	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147589	10.1371/journal.pone.0147589	http://dx.doi.org/10.1371/journal.pone.0147589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807720	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800141
J	Moss, P; Knight, E; Wright, A				Moss, Penny; Knight, Emma; Wright, Anthony			Subjects with Knee Osteoarthritis Exhibit Widespread Hyperalgesia to Pressure and Cold	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOW-BACK-PAIN; THERMAL HYPERALGESIA; SENSITIZATION; WHIPLASH; SENSITIVITY; DISABILITY; SEVERITY; ABNORMALITIES; MANAGEMENT	Hyperalgesia to mechanical and thermal stimuli are characteristics of a range of disorders such as tennis elbow, whiplash and fibromyalgia. This study evaluated the presence of local and widespread mechanical and thermal hyperalgesia in individuals with knee osteoarthritis, compared to healthy control subjects. Twenty-three subjects with knee osteoarthritis and 23 healthy controls, matched for age, gender and body mass index, were recruited for the study. Volunteers with any additional chronic pain conditions were excluded. Pain thresholds to pressure, cold and heat were tested at the knee, ipsilateral heel and ipsilateral elbow, in randomized order, using standardised methodology. Significant between-groups differences for pressure pain and cold pain thresholds were found with osteoarthritic subjects demonstrating significantly increased sensitivity to both pressure (p =.018) and cold (p=.003) stimuli, compared with controls. A similar pattern of results extended to the pain-free ipsilateral ankle and elbow indicating widespread pressure and cold hyperalgesia. No significant differences were found between groups for heat pain threshold, although correlations showed that subjects with greater sensitivity to pressure pain were also likely to be more sensitive to both cold pain and heat pain. This study found widespread elevated pain thresholds in subjects with painful knee osteoarthritis, suggesting that altered nociceptive system processing may play a role in ongoing arthritic pain for some patients.	[Moss, Penny; Knight, Emma; Wright, Anthony] Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Curtin University	Moss, P (corresponding author), Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	p.moss@curtin.edu.au						Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bajaj P, 2001, PAIN, V93, P107, DOI 10.1016/S0304-3959(01)00300-1; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Coombes BK, 2012, CLIN J PAIN, V28, P595, DOI 10.1097/AJP.0b013e31823dd333; Creamer P, 1998, CLIN GERIATR MED, V14, P435; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Dodo N, 2015, INT J PSYCHOL BEHAV, V5, P179, DOI DOI 10.5923/J.IJPBS.20150505.01; Ferreira AH, 2015, REV BRAS REUMATOL, V55, P434, DOI 10.1016/j.rbr.2015.03.001; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; George SZ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-68; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Harden RN, 2013, J PAIN, V14, P281, DOI 10.1016/j.jpain.2012.11.009; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; Hubscher M, 2014, CLIN J PAIN, V30, P886, DOI 10.1097/AJP.0000000000000045; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Jorum ET, 2003, PAIN, V101, P9; King CD, 2013, OSTEOARTHR CARTILAGE, V21, P1243, DOI 10.1016/j.joca.2013.05.015; Kosek E, 2000, EUR J PAIN, V4, P229, DOI 10.1053/eujp.2000.0175; Lee YC, 2011, ARTHRIT CARE RES, V63, P320, DOI 10.1002/acr.20373; Moss P, 2007, MANUAL THER, V12, P109, DOI 10.1016/j.math.2006.02.009; Neogi T, 2015, ANN RHEUM DIS, V74, P682, DOI 10.1136/annrheumdis-2013-204191; O'Sullivan P, 2014, MANUAL THER, V19, P311, DOI 10.1016/j.math.2014.03.006; Riek S, 2000, J ELECTROMYOGR KINES, V10, P249, DOI 10.1016/S1050-6411(00)00017-1; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; Smith J, 1999, J MUSCULOSKELET PAIN, V7, P55, DOI 10.1300/J094v07n04_06; Spielberger SD, 1970, MANUAL STATE TRAIT A; Sterling M, 2006, J PSYCHOSOM RES, V60, P387, DOI 10.1016/j.jpsychores.2005.08.016; Sterling M, 2009, MANUAL THER, V14, P173, DOI 10.1016/j.math.2008.01.009; Sterling M, 2006, PAIN, V122, P102, DOI 10.1016/j.pain.2006.01.014; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wright A., 1992, Pain Clinic, V5, P221; Wright A, 1994, J MUSCULOSKELET PAIN, V2, P85; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343	40	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147526	10.1371/journal.pone.0147526	http://dx.doi.org/10.1371/journal.pone.0147526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809009	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800122
J	Reti, JS				Reti, Jay S.			Quantifying Oldowan Stone Tool Production at Olduvai Gorge, Tanzania	PLOS ONE			English	Article							HOMINID LAND-USE; BED-II; ARTIFACT ASSEMBLAGES; PERCUSSION MARKS; WEST TURKANA; BASIN; GONA; REDUCTION; BONES; INFERENCES	Recent research suggests that variation exists among and between Oldowan stone tool assemblages. Oldowan variation might represent differential constraints on raw materials used to produce these stone implements. Alternatively, variation among Oldowan assemblages could represent different methods that Oldowan producing hominins utilized to produce these lithic implements. Identifying differential patterns of stone tool production within the Oldowan has implications for assessing how stone tool technology evolved, how traditions of lithic production might have been culturally transmitted, and for defining the timing and scope of these evolutionary events. At present there is no null model to predict what morphological variation in the Oldowan should look like. Without such a model, quantifying whether Oldowan assemblages vary due to raw material constraints or whether they vary due to differences in production technique is not possible. This research establishes a null model for Oldowan lithic artifact morphological variation. To establish these expectations this research 1) models the expected range of variation through large scale reduction experiments, 2) develops an algorithm to categorize archaeological flakes based on how they are produced, and 3) statistically assesses the methods of production behavior used by Oldowan producing hominins at the site of DK from Olduvai Gorge, Tanzania via the experimental model. Results indicate that a subset of quartzite flakes deviate from the null expectations in a manner that demonstrates efficiency in flake manufacture, while some basalt flakes deviate from null expectations in a manner that demonstrates inefficiency in flake manufacture. The simultaneous presence of efficiency in stone tool production for one raw material (quartzite) and inefficiency in stone tool production for another raw material (basalt) suggests that Oldowan producing hominins at DK were able to mediate the economic costs associated with stone tool procurement by utilizing high-cost materials more efficiently than is expected and low-cost materials in an inefficient manner.	[Reti, Jay S.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Reti, JS (corresponding author), Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA.	jreti@ucsc.edu			National Science Foundation DDIG program [1035266]; Leakey Foundation [432231]	National Science Foundation DDIG program; Leakey Foundation	This research was funded by the National Science Foundation DDIG program (grant number 1035266) and The Leakey Foundation (grant number 432231). Both grants supported the research of JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahler S.A., 1989, ALTERNATIVE APPROACH, V1, P85; Ahler S.A., 1989, BRIT ARCHAEOLOGICAL, V528, P199; AIELLO LC, 1992, J HUM EVOL, V22, P127, DOI 10.1016/0047-2484(92)90034-7; Aldenderfer Mark S., 1987, QUANTITATIVE RES ARC, P89; Aldenderfer Mark S., 1987, QUANTITATIVE RES ARC, P9; Amick D.S., 1988, LITHIC TECHNOLOGY, V17, P26, DOI DOI 10.1080/01977261.1988.11754523; Austin RJ, 1986, LITHIC TECHNOLOGY, V15, P96; Binford SR, 1972, ORIGIN HOMO SAPIENS, P199; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; BLUMENSCHINE RJ, 1988, J ARCHAEOL SCI, V15, P483, DOI 10.1016/0305-4403(88)90078-7; Blumenschine RJ, 2008, J ARCHAEOL SCI, V35, P76, DOI 10.1016/j.jas.2007.02.009; Blumenschine RJ, 2012, J HUM EVOL, V63, P384, DOI 10.1016/j.jhevol.2011.05.003; Bradbury AP, 1999, J ARCHAEOL SCI, V26, P105, DOI 10.1006/jasc.1998.0309; Braun DR, 2008, J ARCHAEOL SCI, V35, P2153, DOI 10.1016/j.jas.2008.01.015; Braun DR, 2009, J ARCHAEOL SCI, V36, P1605, DOI 10.1016/j.jas.2009.03.025; Braun DR, 2006, THESIS RUTGERS U NEW; BUNN H, 1980, WORLD ARCHAEOL, V12, P109, DOI 10.1080/00438243.1980.9979787; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Chauhan P.R., 2009, CUTTING EDGE NEW APP, P33; CLARK JR, 1979, ECON GEOGR, V55, P1, DOI 10.2307/142729; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; CRABTREE DE, 1970, SCIENCE, V169, P146, DOI 10.1126/science.169.3941.146; Crabtree DE, 1972, OCCASIONAL PAPERS ID, P28; de la Torre I, 2003, J HUM EVOL, V44, P203, DOI 10.1016/S0047-2484(02)00206-3; de Lumley H., 2009, STONE AGE I PUBLICAT, V3, P55; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Diez-Martin F, 2011, AM ANTIQUITY, V76, P690, DOI 10.7183/0002-7316.76.4.690; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dunnell R.C., 1971, SYSTEMATICS PREHISTO; Eren MI, 2014, J ARCHAEOL SCI, V49, P472, DOI 10.1016/j.jas.2014.05.034; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Fajardo B, 2009, CUTTING EDGE NEW APP, P115; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Gowlett JAJ, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P295, DOI 10.1007/978-1-4419-6861-6_13; Gurtov AN, 2014, QUATERN INT, V322, P285, DOI 10.1016/j.quaint.2013.08.010; Gurtov AN, 2015, LITHIC TECHNOLOGY; Harris JWK, 1978, THESIS UC BERKELEY; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hayden B., 1989, BAR INT SERIES, V528, P235; Iovita R, 2009, J ARCHAEOL SCI, V36, P1447, DOI 10.1016/j.jas.2009.02.008; Isaac G.L., 1986, STONE AGE PREHISTORY, P221; Isaac GL., 1981, P UN INT CIENC PREH, P101; Isaac GLI., 1997, KOOBI FORA RES PROJE, P71; Jones P.R., 1994, OLDUVAI GORGE, P254; Kimura Y, 2002, J HUM EVOL, V43, P291, DOI 10.1006/jhev.2002.0576; Kimura Y, 1999, J HUM EVOL, V37, P807, DOI 10.1006/jhev.1999.0316; Kuijt I., 1995, LITHIC TECHNOL, V20, P116; Kuman K., 2009, CUTTING EDGE NEW APP, P151; Kyara O, 1999, THESIS RUTGERS U NEW; Leakey LS. B., 1935, STONE AGE RACES KENY; Leakey MD, 1971, OLDUVAI GORGE; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Magne M., 1981, LITHIC TECHNOLOGY, V6, P34, DOI DOI 10.1080/01977261.1981.11754484; MARTIN RD, 1993, THEROPITHECUS, P273, DOI 10.1017/CBO9780511565540.011; Mauldin R. P., 1989, BAR INT SERIES, V528, P67; Merritt SR, 2012, J ARCHAEOL SCI, V39, P2984, DOI 10.1016/j.jas.2012.04.036; Moore MW, 2011, WORLD ARCHAEOL, V43, P702, DOI 10.1080/00438243.2011.624778; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Pante M., 2010, THESIS RUTGERS U NEW; Patterson L.W., 1982, LITHIC TECHNOLOGY, V11, P50; Patterson LW, 1978, PLAINS ANTHROPOL, V23, P103, DOI DOI 10.1080/2052546.1978.11908884; Pelcin A, 1997, J ARCHAEOL SCI, V24, P613, DOI 10.1006/jasc.1996.0145; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roche H, 2000, ACTA ARCHAEOL SIN, V19, P98; Sahnouni M., 2009, CUTTING EDGE NEW APP, P179; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Tactikos J.C., 2005, THESIS RUTGERS U NEW; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; TOTH N, 1987, J HUM EVOL, V16, P763, DOI 10.1016/0047-2484(87)90023-6; Toth N, 1982, THESIS UC BERKELEY	85	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147352	10.1371/journal.pone.0147352	http://dx.doi.org/10.1371/journal.pone.0147352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DC9FZ	26808429	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800077
J	Valentim, AM; Felix, LM; Carvalho, L; Diniz, E; Antunes, LM				Valentim, Ana M.; Felix, Luis M.; Carvalho, Leonor; Diniz, Enoque; Antunes, Luis M.			A New Anaesthetic Protocol for Adult Zebrafish (Danio rerio): Propofol Combined with Lidocaine	PLOS ONE			English	Article							NEUROSCIENCE RESEARCH; CLOVE OIL; TRICAINE; FISH; LIGNOCAINE; EFFICACY; MODELS	Background The increasing use of zebrafish model has not been accompanied by the evolution of proper anaesthesia for this species in research. The most used anaesthetic in fishes, MS222, may induce aversion, reduction of heart rate, and consequently high mortality, especially during long exposures. Therefore, we aim to explore new anaesthetic protocols to be used in zebrafish by studying the quality of anaesthesia and recovery induced by different concentrations of propofol alone and in combination with different concentrations of lidocaine. Material and Methods In experiment A, eighty-three AB zebrafish were randomly assigned to 7 different groups: control, 2.5 (2.5P), 5 (5P) or 7.5 mu g/ml (7.5P) of propofol; and 2.5 mu g/ml of propofol combined with 50, (P/50L), 100 (P/100L) or 150 mu g/ml (P/150L) of lidocaine. Zebrafish were placed in an anaesthetic water bath and time to lose the equilibrium, reflex to touch, reflex to a tail pinch, and respiratory rate were measured. Time to gain equilibrium was also assessed in a clean tank. Five and 24 hours after anaesthesia recovery, zebrafish were evaluated concerning activity and reactivity. Afterwards, in a second phase of experiments (experiment B), the best protocol of the experiment A was compared with a new group of 8 fishes treated with 100 mg/L of MS222 (100M). Results In experiment A, only different concentrations of propofol/lidocaine combination induced full anaesthesia in all animals. Thus only these groups were compared with a standard dose of MS222 in experiment B. Propofol/lidocaine induced a quicker loss of equilibrium, and loss of response to light and painful stimuli compared with MS222. However zebrafish treated with MS222 recovered quickly than the ones treated with propofol/lidocaine. Conclusion In conclusion, propofol/lidocaine combination and MS222 have advantages in different situations. MS222 is ideal for minor procedures when a quick recovery is important, while propofol/lidocaine is best to induce a quick and complete anaesthesia.	[Valentim, Ana M.; Felix, Luis M.; Antunes, Luis M.] Univ Porto, Lab Anim Sci Grp, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Valentim, Ana M.; Felix, Luis M.; Antunes, Luis M.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Valentim, Ana M.; Felix, Luis M.; Carvalho, Leonor; Diniz, Enoque; Antunes, Luis M.] Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal; [Diniz, Enoque] UJES, DSA, FMV, Huambo, Angola	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Tras-os-Montes & Alto Douro	Valentim, AM (corresponding author), Univ Porto, Lab Anim Sci Grp, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Valentim, AM (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Valentim, AM (corresponding author), Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal.	amaria@ibmc.up.pt	Félix, Luis/G-5426-2011; Valentim, Ana/C-3389-2013	Félix, Luis/0000-0001-9870-6666; Valentim, Ana/0000-0003-1428-0691; Antunes, Luis/0000-0002-9757-6879; Carvalho, Ana Leonor/0000-0002-8881-3887	"Fundo Europeu de Desenvolvimento Regional" through Operational Competitiveness Programme; National Funds through "Fundacao para a Ciencia e a Tecnologia" [FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012)]	"Fundo Europeu de Desenvolvimento Regional" through Operational Competitiveness Programme; National Funds through "Fundacao para a Ciencia e a Tecnologia"	This work was funded by "Fundo Europeu de Desenvolvimento Regional" through the Operational Competitiveness Programme and by National Funds through "Fundacao para a Ciencia e a Tecnologia" under the project FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012) (https://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2013, TRENDS CELL BIOL, V23, P584, DOI 10.1016/j.tcb.2013.09.009; Alves HC, 2007, LAB ANIM-UK, V41, P329, DOI 10.1258/002367707781282767; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Eriksson M, 1997, BRIT J ANAESTH, V78, P502, DOI 10.1093/bja/78.5.502; Fleming GJ, 2003, J ZOO WILDLIFE MED, V34, P153, DOI 10.1638/1042-7260(2003)034[0153:EOPAMF]2.0.CO;2; Ghanawi J, 2013, AQUAC RES, V44, P359, DOI 10.1111/j.1365-2109.2011.03039.x; GholipourKanani H, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-76; Gibaldi M., 2007, GIBALDIS DRUG DELIVE; Gomulka P, 2015, POL J VET SCI, V18, P147, DOI 10.1515/pjvs-2015-0019; Gressler LT, 2015, FISH PHYSIOL BIOCHEM, V41, P463, DOI 10.1007/s10695-014-9997-5; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Lilley EMM, 1996, ANAESTHESIA, V51, P815, DOI 10.1111/j.1365-2044.1996.tb12607.x; Masaki Y, 2000, ANESTH ANALG, V90, P989, DOI 10.1213/00000539-200004000-00039; Muir WW., 2015, VET ANESTHESIA ANALG, V5th, P415; Oda A, 2014, JAVMA-J AM VET MED A, V245, P1286, DOI 10.2460/javma.245.11.1286; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Park JW, 2003, ANESTH ANALG, V97, P769, DOI 10.1213/01.ANE.0000074797.70349.CA; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Reed B., 2011, GUIDANCE HOUSING CAR; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Russell WMS, 1992, PRINCIPLES HUMANE EX; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Warren KS, 2001, AM J PHYSIOL-HEART C, V281, pH1711, DOI 10.1152/ajpheart.2001.281.4.H1711; Wong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088030; Yamakage M, 2005, ANESTH ANALG, V101, P385, DOI 10.1213/01.ANE.0000154191.86608.AC; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1	31	35	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147747	10.1371/journal.pone.0147747	http://dx.doi.org/10.1371/journal.pone.0147747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808508	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800203
J	Wood, FM; Phillips, M; Jovic, T; Cassidy, JT; Cameron, P; Edgar, DW				Wood, Fiona M.; Phillips, Michael; Jovic, Tom; Cassidy, John T.; Cameron, Peter; Edgar, Dale W.		Steering Comm Burn Registry Austra	Water First Aid Is Beneficial In Humans Post-Burn: Evidence from a Bi-National Cohort Study	PLOS ONE			English	Article							BURN VICTIMS; HYPOTHERMIA; KNOWLEDGE; MORTALITY; INTERNET; CARE	Introduction Reported first aid application, frequency and practices around the world vary greatly. Based primarily on animal and observational studies, first aid after a burn injury is considered to be integral in reducing scar and infection, and the need for surgery. The current recommendation for optimum first aid after burn is water cooling for 20 minutes within three hours. However, compliance with this guideline is reported as poor to moderate at best and evidence exists to suggest that overcooling can be detrimental. This prospective cohort study of a binational burn patient registry examined data collected between 2009 and 2012. The aim of the study was to quantify the magnitude of effects of water cooling first aid after burn on indicators of burn severity in a large human cohort. Method The data for the analysis was provided by the Burn Registry of Australia and New Zealand (BRANZ). The application of first aid cooling prior to admission to a dedicated burn service, was analysed for its influence on four outcomes related to injury severity. The patient related outcomes were whether graft surgery occurred, and death while the health system (cost) outcomes included total hospital length of stay and admission to ICU. Robust regression analysis using bootstrapped estimation adjusted using a propensity score was used to control for confounding and to estimate the strength of association with first aid. Dose-response relationships were examined to determine associations with duration of first aid. The influence of covariates on the impact of first aid was assessed. Results Cooling was provided before Burn Centre admission for 68% of patients, with at least twenty minutes duration for 46%. The results indicated a reduction in burn injury severity associated with first aid. Patients probability for graft surgery fell by 0.070 from 0.537 (13% reduction) (p = 0.014). The probability for ICU admission fell by 0.084 from 0.175 (48% reduction) (p < 0.001) and hospital length of stay (LOS) fell by 2.27 days from 12.9 days (18% reduction) (p = 0.001). All outcomes except death showed a dose-response relationship with the duration of first aid. The size of burn and age interacted with many of the relationships between first aid and outcome and these are described and discussed. Discussion & Conclusion This study suggests that there are significant patient and health system benefits from cooling water first aid, particularly if applied for up to 20 minutes. The results of this study estimate the effect size of post-burn first aid and confirm that efforts to promote first aid knowledge are not only warranted, but provide potential cost savings.	[Wood, Fiona M.; Edgar, Dale W.] Fiona Stanley Hosp, State Adult Burn Unit, Burn Serv Western Australia, Murdoch, WA, Australia; [Wood, Fiona M.] Univ Western Australia, Burn Injury Res Unit, Crawley, WA, Australia; [Wood, Fiona M.; Edgar, Dale W.] Fiona Wood Fdn, Murdoch, WA, Australia; [Phillips, Michael] Royal Perth Hosp, Perkins Inst Med Res, Perth, WA 6001, Australia; [Phillips, Michael] Univ Western Australia, Crawley, WA, Australia; [Jovic, Tom] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Jovic, Tom; Cassidy, John T.] Royal Perth Hosp, Burn Serv Western Australia, Burn Unit, Perth, WA 6001, Australia; [Cassidy, John T.] James Connolly Mem Hosp, Dublin, Ireland; [Cameron, Peter] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Edgar, Dale W.] Univ Notre Dame Australia, Burn Injury Res Node, Fremantle, WA, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Edinburgh; Royal Perth Hospital; Monash University; University of Notre Dame Australia	Wood, FM (corresponding author), Fiona Stanley Hosp, State Adult Burn Unit, Burn Serv Western Australia, Murdoch, WA, Australia.; Wood, FM (corresponding author), Univ Western Australia, Burn Injury Res Unit, Crawley, WA, Australia.; Wood, FM (corresponding author), Fiona Wood Fdn, Murdoch, WA, Australia.	Fiona.wood@health.wa.gov.au	Jovic, Thomas H/N-7155-2019; Edgar, Dale W/AAV-9394-2021; fiona, wood/F-4703-2013	Jovic, Thomas H/0000-0002-8325-0931; Edgar, Dale W/0000-0001-7336-9317; Wood, Fiona Melanie/0000-0002-3284-6540; Phillips, Michael/0000-0002-0252-9085; Cameron, Peter/0000-0002-1443-557X; fiona, wood/0000-0001-5427-6588	Australian Commission on Safety and Quality in Health Care; Helen Macpherson Smith Trust; Thyne Reid Foundation; Fiona Wood Foundation	Australian Commission on Safety and Quality in Health Care; Helen Macpherson Smith Trust; Thyne Reid Foundation; Fiona Wood Foundation	The study is unfunded and completed with support of the Fiona Wood Foundation http://www.fionawoodfoundation.com/ research team in their routine capacity. The Burn Registry of Australia and New Zealand is co-funded by ANZBA http://anzba.org.au/ and the Julian Burton Burns Trust http://www.burnstrust.com.au/ with additional funding received from the Australian Commission on Safety and Quality in Health Care (2008-2009) http://www.safetyandquality.gov.au/, Helen Macpherson Smith Trust (2010) http://hmstrust.org.au/ and the Thyne Reid Foundation (2011-2012). The BRANZ did not contribute funds to this project.	Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Cuttle L, 2009, J BURN CARE RES, V30, P1028, DOI 10.1097/BCR.0b013e3181bfb7d1; Cuttle L, 2009, BURNS, V35, P768, DOI 10.1016/j.burns.2008.10.011; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JACKSON DM, 1979, ANN ROY COLL SURG, V61, P335; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Maitz PM, 2014, EMERGENCY MANAGEMENT; Mlcak R, 1998, PEDIATR EMERG CARE, V14, P51, DOI 10.1097/00006565-199802000-00013; MUNSTER AM, 1994, BURNS, V20, P61, DOI 10.1016/0305-4179(94)90109-0; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rea S, 2005, BURNS, V31, P1029, DOI 10.1016/j.burns.2005.05.010; Singer AJ, 2010, ACAD EMERG MED, V17, P456, DOI 10.1111/j.1553-2712.2010.00702.x; Skinner A, 2002, NZ MED J, V115, P199; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tiller G, 2006, BURNS, V32, P897, DOI 10.1016/j.burns.2006.02.020; Tung KY, 2005, BURNS, V31, pS12, DOI 10.1016/j.burns.2004.10.006; Wallace HJ, 2013, BURNS, V39, P1162, DOI 10.1016/j.burns.2013.02.007; Watterson D, 2011, BURNS, V37, P1296, DOI 10.1016/j.burns.2011.08.007	18	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147259	10.1371/journal.pone.0147259	http://dx.doi.org/10.1371/journal.pone.0147259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808839	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800068
J	Wood, R; Morrow, C; Barry, CE; Bryden, WA; Call, CJ; Hickey, AJ; Rodes, CE; Scriba, TJ; Blackburn, J; Issarow, C; Mulder, N; Woodward, J; Moosa, A; Singh, V; Mizrahi, V; Warner, DF				Wood, Robin; Morrow, Carl; Barry, Clifton E., III; Bryden, Wayne A.; Call, Charles J.; Hickey, Anthony J.; Rodes, Charles E.; Scriba, Thomas J.; Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Woodward, Jeremy; Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.			Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)	PLOS ONE			English	Article							AIRBORNE MYCOBACTERIUM-TUBERCULOSIS; AIR; INFECTION; COMPLEX; CYCLE	Knowledge of the airborne nature of respiratory disease transmission owes much to the pioneering experiments of Wells and Riley over half a century ago. However, the mechanical, physiological, and immunopathological processes which drive the production of infectious aerosols by a diseased host remain poorly understood. Similarly, very little is known about the specific physiological, metabolic and morphological adaptations which enable pathogens such as Mycobacterium tuberculosis (Mtb) to exit the infected host, survive exposure to the external environment during airborne carriage, and adopt a form that is able to enter the respiratory tract of a new host, avoiding innate immune and physical defenses to establish a nascent infection. As a first step towards addressing these fundamental knowledge gaps which are central to any efforts to interrupt disease transmission, we developed and characterized a small personal clean room comprising an array of sampling devices which enable isolation and representative sampling of airborne particles and organic matter from tuberculosis (TB) patients. The complete unit, termed the Respiratory Aerosol Sampling Chamber (RASC), is instrumented to provide real-time information about the particulate output of a single patient, and to capture samples via a suite of particulate impingers, impactors and filters. Applying the RASC in a clinical setting, we demonstrate that a combination of molecular and microbiological assays, as well as imaging by fluorescence and scanning electron microscopy, can be applied to investigate the identity, viability, and morphology of isolated aerosolized particles. Importantly, from a preliminary panel of active TB patients, we observed the real-time production of large numbers of airborne particles including Mtb, as confirmed by microbiological culture and polymerase chain reaction (PCR) genotyping. Moreover, direct imaging of captured samples revealed the presence of multiple rod-like Mtb organisms whose physical dimensions suggested the capacity for travel deep into the alveolar spaces of the human lung.	[Wood, Robin; Morrow, Carl; Barry, Clifton E., III; Scriba, Thomas J.; Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Wood, Robin; Morrow, Carl] Univ Cape Town, IDM, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Barry, Clifton E., III] NIAID, Lab Clin Infect Dis, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bryden, Wayne A.; Call, Charles J.] Zeteo Tech LLC, Ellicott City, MD USA; [Hickey, Anthony J.] RTI Int, Res Triangle Pk, NC USA; [Rodes, Charles E.] Aerosol Exposure Dimens, Cary, NC USA; [Scriba, Thomas J.] Univ Cape Town, Dept Paediat & Child Hlth, South African TB Vaccine Initiat, Cape Town, South Africa; [Blackburn, Jonathan; Issarow, Chacha; Mulder, Nicola; Woodward, Jeremy] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Struct Biol Res Unit, ZA-7925 Cape Town, South Africa; [Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, MRC NHLS UCT Mol Mycobacteriol Res Unit, Cape Town, South Africa; [Moosa, Atica; Singh, Vinayak; Mizrahi, Valerie; Warner, Digby F.] Univ Cape Town, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Dept Pathol, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Research Triangle Institute; University of Cape Town; University of Cape Town; University of Cape Town; National Research Foundation - South Africa; University of Cape Town	Morrow, C (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa.; Morrow, C (corresponding author), Univ Cape Town, IDM, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	Carl.Morrow@hiv-research.org.za	Scriba, Thomas/GPX-2573-2022; Warner, Digby F/K-4355-2012; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Singh, Vinayak/O-5099-2019; Scriba, Thomas/AAH-9413-2020; SINGH, VINAYAK/L-8442-2016	Scriba, Thomas/0000-0002-0641-1359; Warner, Digby F/0000-0002-4146-0930; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Singh, Vinayak/0000-0001-9002-2489; SINGH, VINAYAK/0000-0001-9002-2489; Mulder, Nicola J/0000-0003-4905-0941; Woodward, Jeremy/0000-0002-7350-8302; Moosa, Atica/0000-0001-9012-3634	Bill & Melinda Gates Foundation [OPP1116641, 26123]; National Treasury under Economic Competitiveness and Support Package [MRC-RFA-UFSP-01-2013/CCAMP]; Intramural Research Program of the NIAID, NIH; South African Medical Research Council (MRC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Treasury under Economic Competitiveness and Support Package; Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by grants from the Bill & Melinda Gates Foundation (OPP1116641), and the South African Medical Research Council (MRC) with funds from National Treasury under the Economic Competitiveness and Support Package (MRC-RFA-UFSP-01-2013/CCAMP) (RW CM TJS JB CI NM JW AM VS VM DFW); the Intramural Research Program of the NIAID, NIH (CEB); and Bill & Melinda Gates Foundation Investment ID 26123 (WAB CJC AJH CER).; Academic and technical support was provided from The Tuberculosis Aerobiology Advisory Group (TAAG) funded by the Bill and Melinda Gates Foundation.	ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; Caceres N, 2013, TUBERCULOSIS, V93, P690, DOI 10.1016/j.tube.2013.08.003; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Chen PS, 2005, AEROSOL SCI TECH, V39, P371, DOI 10.1080/027868290945767; Crowder TM, 2002, PHARMACEUT RES, V19, P239, DOI 10.1023/A:1014426530935; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; GORDON RE, 1953, J BACTERIOL, V66, P41, DOI 10.1128/JB.66.1.41-48.1953; Issarow CM, 2015, J THEOR BIOL, V372, P100, DOI 10.1016/j.jtbi.2015.02.010; KOCH R, 1882, AETIOLOGY TUBERCULOS; Mastorides SM, 1999, CHEST, V115, P19, DOI 10.1378/chest.115.1.19; Matuka O, 2015, J HOSP INFECT, V89, P192, DOI 10.1016/j.jhin.2014.11.013; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Richardson ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096334; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Swift D, 2007, INHALATION AEROSOLS, P55; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; van Belkum A, 2012, J CLIN MICROBIOL, V50, P1513, DOI 10.1128/JCM.00420-12; Wan GH, 2004, AM J INFECT CONTROL, V32, P17, DOI 10.1016/S0196-6553(03)00090-7; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Wood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106622	29	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146658	10.1371/journal.pone.0146658	http://dx.doi.org/10.1371/journal.pone.0146658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807816	Green Published, gold			2022-12-27	WOS:000369527800030
J	Yang, T; Scholl, ES; Pan, N; Fritzsch, B; Haeseleer, F; Lee, A				Yang, Tian; Scholl, Elizabeth S.; Pan, Ning; Fritzsch, Bernd; Haeseleer, Francoise; Lee, Amy			Expression and Localization of CaBP Ca2+ Binding Proteins in the Mouse Cochlea	PLOS ONE			English	Article							AUDITORY HAIR-CELLS; CALCIUM-CHANNELS; DEPENDENT INACTIVATION; CA2+-BINDING PROTEINS; CA(V)1.3 CHANNELS; SCHWANN-CELLS; CALMODULIN; INNER; CALDENDRIN; BRAIN	CaBPs are a family of EF-hand Ca2+ binding proteins that are structurally similar to calmodulin. CaBPs can interact with, and yet differentially modulate, effectors that are regulated by calmodulin, such as Ca(v)1 voltage-gated Ca2+ channels. Immunolabeling studies suggest that multiple CaBP family members (CaBP1, 2, 4, and 5) are expressed in the cochlea. To gain insights into the respective auditory functions of these CaBPs, we characterized the expression and cellular localization of CaBPs in the mouse cochlea. By quantitative reverse transcription PCR, we show that CaBP1 and CaBP2 are the major CaBPs expressed in mouse cochlea both before and after hearing onset. Of the three alternatively spliced variants of CaBP1 (caldendrin, CaBP1-L, and CaBP1-S) and CaBP2 (CaBP2-alt, CaBP2-L, CaBP2-S), caldendrin and CaBP2-alt are the most abundant. By in situ hybridization, probes recognizing caldendrin strongly label the spiral ganglion, while probes designed to recognize all three isoforms of CaBP1 weakly label both the inner and outer hair cells as well as the spiral ganglion. Within the spiral ganglion, caldendrin/CaBP1 labeling is associated with cells resembling satellite glial cells. CaBP2-alt is strongly expressed in inner hair cells both before and after hearing onset. Probes designed to recognize all three variants of CaBP2 strongly label inner hair cells before hearing onset and outer hair cells after the onset of hearing. Thus, CaBP1 and CaBP2 may have overlapping roles in regulating Ca2+ signaling in the hair cells, and CaBP1 may have an additional function in the spiral ganglion. Our findings provide a framework for understanding the role of CaBP family members in the auditory periphery.	[Yang, Tian; Scholl, Elizabeth S.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Yang, Tian; Scholl, Elizabeth S.; Fritzsch, Bernd; Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA USA; [Yang, Tian; Scholl, Elizabeth S.; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Pan, Ning; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Lee, A (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA.; Lee, A (corresponding author), Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA USA.; Lee, A (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lee, Amy/0000-0001-8021-0443; Fritzsch, Bernd/0000-0002-4882-8398	NIH [NS084190, DC009433, DC010362, EY020850]; Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE [R01EY020850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was support by grants from the NIH (NS084190, DC009433, to A.L.; DC010362 (Iowa Center for Molecular Auditory Neuroscience); EY020850 to F.H.), and a Carver Research Program of Excellence Award to A.L.; This work was support by grants from the NIH (NS084190, DC009433, to A.L.; DC010362 (Iowa Center for Molecular Auditory Neuroscience); EY020850 to F.H.), and a Carver Research Program of Excellence Award to A.L.	Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Bhattacharya R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-50; Cheli VT, 2015, EXP NEUROL, V265, P69, DOI 10.1016/j.expneurol.2014.12.012; Chen WC, 2011, HEARING RES, V278, P52, DOI 10.1016/j.heares.2011.01.016; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Inagaki A, 2013, CHANNELS, V7, P171, DOI 10.4161/chan.24104; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P297; Kim KY, 2014, NEUROSCIENCE, V268, P33, DOI 10.1016/j.neuroscience.2014.02.052; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lee SW, 2007, J PHYSIOL-LONDON, V583, P909, DOI 10.1113/jphysiol.2007.135582; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Luo BE, 2014, J NEUROSCI RES, V92, P893, DOI 10.1002/jnr.23365; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Redecker P, 2003, J HISTOCHEM CYTOCHEM, V51, P809, DOI 10.1177/002215540305100612; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; Schrauwen I, 2012, AM J HUM GENET, V91, P636, DOI 10.1016/j.ajhg.2012.08.018; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487; Westenbroek RE, 2004, J NEUROSCI RES, V75, P371, DOI 10.1002/jnr.10863; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	37	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147495	10.1371/journal.pone.0147495	http://dx.doi.org/10.1371/journal.pone.0147495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809054	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800111
J	Zhang, C; Jia, XJ; Wang, K; Bao, JL; Li, P; Chen, MW; Wan, JB; Su, HX; Mei, ZN; He, CW				Zhang, Chao; Jia, Xuejing; Wang, Kai; Bao, Jiaolin; Li, Peng; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; Mei, Zhinan; He, Chengwei			Polyphyllin VII Induces an Autophagic Cell Death by Activation of the JNK Pathway and Inhibition of PI3K/AKT/mTOR Pathway in HepG2 Cells	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; PARIS SAPONIN VII; CANCER-CELLS; SIGNALING PATHWAY; APOPTOSIS; PHOSPHORYLATION; GROWTH; BCL-2; SURVIVAL; TARGET	Polyphyllin VII (PP7), a pennogenyl saponin isolated from Rhizoma Paridis, exhibited strong anticancer activities in various cancer types. Previous studies found that PP7 induced apoptotic cell death in human hepatoblastoma cancer (HepG2) cells. In the present study, we investigated whether PP7 could induce autophagy and its role in PP7-induced cell death, and elucidated its mechanisms. PP7 induced a robust autophagy in HepG2 cells as demonstrated by the conversion of LC3B-I to LC3B-II, degradation of P62, formation of punctate LC3-positive structures, and autophagic vacuoles tested by western blot analysis or InCell 2000 confocal microscope. Inhibition of autophagy by treating cells with autophagy inhibitor (chloroquine) abolished the cell death caused by PP7, indicating that PP7 induced an autophagic cell death in HepG2 cells. C-Jun N-terminal kinase (JNK) was activated after treatment with PP7 and pretreatment with SP600125, a JNK inhibitor, reversed PP7induced autophagy and cell death, suggesting that JNK plays a critical role in autophagy caused by PP7. Furthermore, our study demonstrated that PP7 increased the phosphorylation of AMPK and Bcl-2, and inhibited the phosphorylation of PI3K, AKT and mTOR, suggesting their roles in the PP7-induced autophagy. This is the first report that PP7 induces an autophagic cell death in HepG2 cells via inhibition of PI3K/AKT/mTOR, and activation of JNK pathway, which induces phosphorylation of Bcl-2 and dissociation of Beclin-1 from Beclin-1/Bcl-2 complex, leading to induction of autophagy.	[Zhang, Chao; Jia, Xuejing; Wang, Kai; Bao, Jiaolin; Li, Peng; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China; [Mei, Zhinan] South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China	University of Macau; South Central Minzu University	He, CW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China.; Mei, ZN (corresponding author), South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China.	meizhinan@163.com; chengweihe@umac.mo	Su, Huanxing/X-3954-2019; Bao, Jiaolin/GRJ-8416-2022; Su, Huanxing/X-3980-2019; Wang, Kai/AIE-2501-2022; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; Bao, Jiaolin/0000-0003-0630-071X; He, Chengwei/0000-0003-4701-2984; Wan, Jian-Bo/0000-0002-6750-2617	Macao Science and Technology Development Fund [074/2013/A]; University of Macau [MYRG107(Y1-L3)-ICMS13-HCW, MYRG2015-00081-ICMS-QRCM]; National Key Technology R&D Program in 12th Five Year Plan of China [2012BAI27B06]; Hubei Province Natural Science Foundation of China [2013CFA013]; College of Pharmacy at South Central University for Nationalities	Macao Science and Technology Development Fund; University of Macau; National Key Technology R&D Program in 12th Five Year Plan of China(National Key Technology R&D Program); Hubei Province Natural Science Foundation of China(Natural Science Foundation of Hubei Province); College of Pharmacy at South Central University for Nationalities	This study was supported by the Macao Science and Technology Development Fund (code: 074/2013/A to CH) (http://www.fdct.gov.mo/), the Research Fund of the University of Macau (code: MYRG107(Y1-L3)-ICMS13-HCW to CH and MYRG2015-00081-ICMS-QRCM to CH) (www.umac.mo), the National Key Technology R&D Program in 12th Five Year Plan of China (code: 2012BAI27B06 to ZM) (http://program.most.gov.cn/) and the Hubei Province Natural Science Foundation of China (code: 2013CFA013 to ZM) (http://dzzw.ynstc.gov.cn/eWAP/) in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Zhinan Mei is employed by College of Pharmacy at South Central University for Nationalities, which provided support in the form of salary for author ZM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Chen YS, 2014, STEROIDS, V83, P39, DOI 10.1016/j.steroids.2014.01.014; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Huang XX, 2011, LAT AM J PHARM, V30, P540; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim A, 2013, BMC COMPLEM ALTERN M, V13, P1; Kim AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.273; Kim A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098703; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li CM, 2010, INT J ONCOL, V37, P1023, DOI 10.3892/ijo_00000754; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li YH, 2014, J ETHNOPHARMACOL, V154, P728, DOI 10.1016/j.jep.2014.04.049; Li YH, 2014, BIOCHEM PHARMACOL, V88, P150, DOI 10.1016/j.bcp.2014.01.018; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2013, CHIN J CANCER, V32, P113, DOI 10.5732/cjc.012.10010; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Miller WH, 2002, CANCER RES, V62, P3893; Moretti L, 2007, DRUG RESIST UPDATE, V10, P135, DOI 10.1016/j.drup.2007.05.001; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Park KJ, 2009, BIOCHEM BIOPH RES CO, V382, P726, DOI 10.1016/j.bbrc.2009.03.095; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qin XJ, 2012, STEROIDS, V77, P1242, DOI 10.1016/j.steroids.2012.07.007; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sun T, 2011, J TRANSL MED, V9, P1; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang H, 2013, PHYTOMEDICINE, V20, P985, DOI 10.1016/j.phymed.2013.04.014; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Xu MY, 2013, FOOD CHEM TOXICOL, V59, P703, DOI 10.1016/j.fct.2013.06.059; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113479; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693; Zhang YB, 2014, J JINAN U NATURAL SC, V35, P67; Zhang YX, 2010, J CELL BIOCHEM, V109, P764, DOI 10.1002/jcb.22455; 王艳霞, 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P628	51	52	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147405	10.1371/journal.pone.0147405	http://dx.doi.org/10.1371/journal.pone.0147405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808193	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800089
J	Lezyk, M; Jers, C; Kjaerulff, L; Gotfredsen, CH; Mikkelsen, MD; Mikkelsen, JD				Lezyk, Mateusz; Jers, Carsten; Kjaerulff, Louise; Gotfredsen, Charlotte H.; Mikkelsen, Maria D.; Mikkelsen, Jorn D.			Novel alpha-L-Fucosidases from a Soil Metagenome for Production of Fucosylated Human Milk Oligosaccharides	PLOS ONE			English	Article							THERMOTOGA-MARITIMA; CATALYTIC NUCLEOPHILE; NMR-SPECTROSCOPY; IDENTIFICATION; FUCOSE	This paper describes the discovery of novel alpha-L-fucosidases and evaluation of their potential to catalyse the transglycosylation reaction leading to production of fucosylated human milk oligosaccharides. Seven novel alpha-L-fucosidase-encoding genes were identified by functional screening of a soil -derived metagenome library and expressed in E. coli as recombinant 6xHis-tagged proteins. All seven fucosidases belong to glycosyl hydrolase family 29 (GH 29). Six of the seven alpha-L-fucosidases were substrate -inhibited, moderately thermostable and most hydrolytically active in the pH range 6-7, when tested with para-nitrophenyl-aL-fucopyranoside (pNP-Fuc) as the substrate. In contrast, one fucosidase (Mfuc6) exhibited a high pH optimum and an unusual sigmoidal kinetics towards pNP-Fuc substrate. When tested for trans-fucosylation activity using pNP-Fuc as donor, most of the enzymes were able to transfer fucose to pNP-Fuc (self -condensation) or to lactose. With the alpha-L-fucosidase from Thermotoga maritima and the metagenome-derived Mfuc5, different fucosyllactose variants including the principal fucosylated HMO 2'-fucosyllactose were synthesised in yields of up to -6.4%. Mfuc5 was able to release fucose from xyloglucan and could also use it as a fucosyl-donor for synthesis of fucosyllactose. This is the first study describing the use of glycosyl hydrolases for the synthesis of genuine fucosylated human milk oligosaccharides.	[Lezyk, Mateusz; Jers, Carsten; Mikkelsen, Jorn D.] Tech Univ Denmark, Ctr BioProc Engn, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark; [Kjaerulff, Louise; Gotfredsen, Charlotte H.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Mikkelsen, Maria D.] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Jers, C (corresponding author), Tech Univ Denmark, Ctr BioProc Engn, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark.	cjer@dtu.dk	Gotfredsen, Charlotte Held/ABC-8211-2021; Łężyk, Mateusz/O-9639-2019; Łężyk, Mateusz/W-1015-2018; Mikkelsen, Maria Dalgaard/AAP-3139-2021; Mikkelsen, Maria/R-1243-2016	Łężyk, Mateusz/0000-0003-4130-3561; Łężyk, Mateusz/0000-0003-4130-3561; Mikkelsen, Maria Dalgaard/0000-0003-4297-6119; Gotfredsen, Charlotte Held/0000-0002-7386-119X; Kjaerulff, Louise/0000-0001-6274-4265	Hempel (Barcelona, Spain); National Science Foundations' Plant Genome Program [DBI-0421683]	Hempel (Barcelona, Spain); National Science Foundations' Plant Genome Program	This work was supported by the funding from Hempel (Barcelona, Spain). Generation of the CCRC-M1 monoclonal antibody used in this work was supported by a grant from the National Science Foundations' Plant Genome Program (DBI-0421683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Benesova E, 2013, GLYCOBIOLOGY, V23, P1052, DOI 10.1093/glycob/cwt041; Bienenstock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076236; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Cao HN, 2014, J BIOL CHEM, V289, P25624, DOI 10.1074/jbc.M114.583286; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gavlighi HA, 2013, J AGR FOOD CHEM, V61, P1272, DOI 10.1021/jf304795f; Han NS, 2012, BIOTECHNOL ADV, V30, P1268, DOI 10.1016/j.biotechadv.2011.11.003; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Ishimizu T, 2007, J BIOCHEM, V142, P721, DOI 10.1093/jb/mvm186; Lee Myung Hwan, 2013, Genomics & Informatics, V11, P114, DOI 10.5808/GI.2013.11.3.114; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Murata T, 1999, CARBOHYD RES, V320, P192, DOI 10.1016/S0008-6215(99)00156-1; Osanjo G, 2007, BIOCHEMISTRY-US, V46, P1022, DOI 10.1021/bi061444w; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pauly M, 2001, PLANTA, V214, P67, DOI 10.1007/s004250100585; Rodriguez-Diaz J, 2013, APPL ENVIRON MICROB, V79, P3847, DOI 10.1128/AEM.00229-13; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Schomburg I., 2000, GENE FUNCT DIS, V1, P109, DOI DOI 10.1002/1438-826X(200010)1:3/43.0.CO;2-O; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Tuffin Marla, 2009, Biotechnology Journal, V4, P1671, DOI 10.1002/biot.200900235; Vanhooren PT, 1999, J CHEM TECHNOL BIOT, V74, P479, DOI 10.1002/(SICI)1097-4660(199906)74:6<479::AID-JCTB76>3.0.CO;2-E; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zeuner B, 2014, J AGR FOOD CHEM, V62, P9615, DOI 10.1021/jf502619p	38	46	47	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147438	10.1371/journal.pone.0147438	http://dx.doi.org/10.1371/journal.pone.0147438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800369	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300108
J	Manaskova, SH; Nazmi, K; van't Hof, W; van Belkum, A; Martin, NI; Bikker, FJ; van Wamel, WJB; Veerman, ECI				Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; van Belkum, Alex; Martin, Nathaniel I.; Bikker, Floris J.; van Wamel, Willem J. B.; Veerman, Enno C. I.			Staphylococcus aureus Sortase A-Mediated Incorporation of Peptides: Effect of Peptide Modification on Incorporation	PLOS ONE			English	Article							SURFACE-PROTEINS; CELL-WALL; LIPID-II; ANCHOR; SUBSTRATE; SEQUENCE; GENE	The endogenous Staphylococcus aureus sortase A (SrtA) transpeptidase covalently anchors cell wall-anchored (CWA) proteins equipped with a specific recognition motif (LPXTG) into the peptidoglycan layer of the staphylococcal cell wall. Previous in situ experiments have shown that SrtA is also able to incorporate exogenous, fluorescently labelled, synthetic substrates equipped with the LPXTG motif (K(FITC)LPETG-amide) into the bacterial cell wall, albeit at high concentrations of 500 pM to 1 mM. In the present study, we have evaluated the effect of substrate modification on the incorporation efficiency. This revealed that (i) by elongation of LPETG-amide with a sequence of positively charged amino acids, derived from the C-terminal domain of physiological SrtA substrates, the incorporation efficiency was increased by 20-fold at 10 pM, 100 pM and 250 pM; (ii) Substituting aspartic acid (E) for methionine increased the incorporation of the resulting K(FITC)LPMTG-amide approximately three times at all concentrations tested; (iii) conjugation of the lipid II binding antibiotic vancomycin to K(FITC)LPMTG-amide resulted in the same incorporation levels as K(FITC)LPETG-amide, but much more efficient at an impressive 500-fold lower substrate concentration. These newly developed synthetic substrates can potentially find broad applications in for example the in situ imaging of bacteria; the incorporation of antibody recruiting moieties; the targeted delivery and covalent incorporation of antimicrobial compounds into the bacterial cell wall.	[Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; Bikker, Floris J.; Veerman, Enno C. I.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol & Oral Biochem, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; Nazmi, Kamran; van't Hof, Wim; Bikker, Floris J.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; van Belkum, Alex; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Martin, Nathaniel I.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, Utrecht, Netherlands; [van Belkum, Alex] BioMerieux, Microbiol Res & Dev Unit, La Balme Les Grottes, France	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; bioMerieux	Manaskova, SH (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol & Oral Biochem, Amsterdam, Netherlands.; Manaskova, SH (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.; Manaskova, SH (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.hansenovamanaskova@erasmusmc.nl	Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019	Bikker, Floris/0000-0002-9453-4630; van Wamel, Willem/0000-0001-9145-9121	ZonMW [50-51700-98-055]	ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by ZonMW; grant title: Exploiting Staphylococcus aureus sortase for anti-infective purposes with the project number: 50-51700-98-055. The funding organisation was involved in financial support for conducting the research only.	Arnusch CJ, 2008, BIOCHEMISTRY-US, V47, P12661, DOI 10.1021/bi801597b; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Fischetti V. A., 2006, Gram-positive pathogens; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manaskova SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089260; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Pera NP, 2010, ORG BIOMOL CHEM, V8, P2425, DOI 10.1039/c000819b; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Punna S, 2005, BIOCONJUGATE CHEM, V16, P1536, DOI 10.1021/bc0501496; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Zhang L, 2007, ANGEW CHEM INT EDIT, V46, P1798, DOI 10.1002/anie.200604222; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115	33	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147401	10.1371/journal.pone.0147401	http://dx.doi.org/10.1371/journal.pone.0147401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799839	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300103
J	Shinto, L; Marracci, G; Mohr, DC; Bumgarner, L; Murchison, C; Senders, A; Bourdette, D				Shinto, Lynne; Marracci, Gail; Mohr, David C.; Bumgarner, Lauren; Murchison, Charles; Senders, Angela; Bourdette, Dennis			Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study	PLOS ONE			English	Article							ETHYL-EICOSAPENTAENOATE; DOUBLE-BLIND; AUGMENTATION; THERAPY	Multiple sclerosis is the most common chronic disabling disease in the central nervous system in young to middle aged adults. Depression is common in multiple sclerosis (MS) affecting between 50-60% of patients. Pilot studies in unipolar depression report an improvement in depression when omega-3 fatty acids are given with antidepressants. The objective of this study was to investigate whether omega-3 fatty acid supplementation, as an augmentation therapy, improves treatment-resistant major depressive disorder (MDD) in people with MS. We performed a randomized, double-blind, placebo-controlled pilot study of omega-3 fatty acids at six grams per day over three months. The primary outcome was a 50% or greater improvement on the Montgomery-Asberg Depression Rating Scale (MADRS). Thirty-nine participants were randomized and thirty-one completed the 3-month intervention. Improvement on MADRS between groups was not significantly different at the 3-month end point with 47.4% in the omega-3 fatty acid group and 45.5% in the placebo group showing 50% or greater improvement (p = 0.30). Omega-3 fatty acids as an augmentation therapy for treatment-resistant depression in MS was not significantly different than placebo in this pilot trial. Omega-3 fatty acid supplementation at the dose given was well-tolerated over 3 months.	[Shinto, Lynne; Marracci, Gail; Bumgarner, Lauren; Murchison, Charles; Senders, Angela; Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Marracci, Gail; Bourdette, Dennis] Res Serv, Portland, OR USA; [Marracci, Gail; Bourdette, Dennis] VA Multiple Sclerosis Ctr Excellence West, Portland, OR USA; [Mohr, David C.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	Oregon Health & Science University; Northwestern University	Shinto, L (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	shintol@ohsu.edu		Mohr, David/0000-0002-5443-7596; Senders, Angela/0000-0003-2507-4818	National Institutes of Health/National Center for Complemenary and Alternative Medicine [K23AT002155]; National Institutes of Health/National Center for Advancing Translational Research [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002155] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Complemenary and Alternative Medicine; National Institutes of Health/National Center for Advancing Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Institutes of Health/National Center for Complemenary and Alternative Medicine K23AT002155, http://nccam.nih.gov/; National Institutes of Health/National Center for Advancing Translational Research UL1TR000128, http://www.ncats.nih.gov/.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; Feinstein A, 2002, NEUROLOGY, V59, P674, DOI 10.1212/WNL.59.5.674; First M. B., 1997, STRUCTURED CLIN INTE; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Hammond MF, 1998, INT J GERIATR PSYCH, V13, P257, DOI 10.1002/(SICI)1099-1166(199804)13:4<257::AID-GPS773>3.0.CO;2-U; Hirschfeld RMA, 2002, J CLIN PSYCHIAT, V63, P826, DOI 10.4088/JCP.v63n0913; Hogancamp WE, 1997, MAYO CLIN P, V87, P1; Honarmand K, 2011, NEUROLOGY, V76, P1153, DOI 10.1212/WNL.0b013e318212ab0c; Iovieno N, 2012, J CLIN PSYCHIAT, V73, P1300, DOI 10.4088/JCP.11r07485; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Marchesi C, 2013, NEUROPSYCH DIS TREAT, V9, P915, DOI 10.2147/NDT.S44519; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mischoulon D, 2009, J CLIN PSYCHIAT, V70, P1636, DOI 10.4088/JCP.08m04603; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Mohr DC, 2001, J CONSULT CLIN PSYCH, V69, P942, DOI 10.1037//0022-006X.69.6.942; Muller MJ, 2003, J AFFECT DISORDERS, V77, P255, DOI 10.1016/S0165-0327(02)00120-9; Nemets B, 2002, AM J PSYCHIAT, V159, P477, DOI 10.1176/appi.ajp.159.3.477; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; RUYLE M, 1990, P NATL ACAD SCI USA, V87, P7902, DOI 10.1073/pnas.87.20.7902; Sadovnick AD, 1996, NEUROLOGY, V46, P628, DOI 10.1212/WNL.46.3.628; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Ware JE, 2001, SF 36 PHYS MENTAL HL	27	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147195	10.1371/journal.pone.0147195	http://dx.doi.org/10.1371/journal.pone.0147195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799942	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300072
J	Kohlmann, R; Gatermann, SG				Kohlmann, Rebekka; Gatermann, Soeren G.			Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data - The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC SUSCEPTIBILITY; ESCHERICHIA-COLI; HOSPITAL-WIDE; 1ST ISOLATE; ANTIBIOGRAMS; PREVALENCE; SURVEILLANCE; ELIMINATION; DUPLICATE	Introduction Many clinical microbiology laboratories report on cumulative antimicrobial susceptibility testing (cAST) data on a regular basis. Criteria for generation of cAST reports, however, are often obscure and inconsistent. Whereas the CLSI has published a guideline for analysis and presentation of cAST data, national guidelines directed at clinical microbiology laboratories are not available in Europe. Thus, we sought to describe the influence of different parameters in the process of cAST data analysis in the setting of a German routine clinical microbiology laboratory during 2 consecutive years. Material and Methods We developed various program scripts to assess the consequences ensuing from different algorithms for calculation of cumulative antibiograms from the data collected in our clinical microbiology laboratory in 2013 and 2014. Results One of the most pronounced effects was caused by exclusion of screening cultures for multi-drug resistant organisms which decreased the MRSA rate in some cases to one third. Dependent on the handling of duplicate isolates, i.e. isolates of the same species recovered from successive cultures on the same patient during the time period analyzed, we recorded differences in resistance rates of up to 5 percentage points for S. aureus, E. coli and K. pneumoniae and up to 10 percentage points for P. aeruginosa. Stratification by site of care and specimen type, testing of antimicrobials selectively on resistant isolates, change of interpretation rules and analysis at genus level instead of species level resulted in further changes of calculated antimicrobial resistance rates. Conclusion The choice of parameters for cAST data analysis may have a substantial influence on calculated antimicrobial resistance rates. Consequently, comparability of cAST reports from different clinical microbiology laboratories may be limited. We suggest that laboratories communicate the strategy used for cAST data analysis as long as national guidelines for standardized cAST data analysis and reporting do not exist in Europe.	[Kohlmann, Rebekka; Gatermann, Soeren G.] Ruhr Univ Bochum, Dept Med Microbiol, Univ Str 150, Bochum, Germany; [Kohlmann, Rebekka; Gatermann, Soeren G.] Bochum GmbH, Inst Med Lab Diagnost IML, Bochum, Germany	Ruhr University Bochum	Kohlmann, R (corresponding author), Ruhr Univ Bochum, Dept Med Microbiol, Univ Str 150, Bochum, Germany.; Kohlmann, R (corresponding author), Bochum GmbH, Inst Med Lab Diagnost IML, Bochum, Germany.	rebekka.kohlmann@rub.de		Laufenberg, Rebekka/0000-0003-4317-1347				Alvarez-Paredes L, 2013, CHEMOTHERAPY, V59, P453, DOI 10.1159/000362785; Anderson DJ, 2012, INFECT CONT HOSP EP, V33, P589, DOI 10.1086/665721; Boggan JC, 2012, PEDIATRICS, V130, pE615, DOI 10.1542/peds.2012-0563; Bosso JA, 2006, ANN PHARMACOTHER, V40, P1946, DOI 10.1345/aph.1H377; Bosso John A, 2013, Hosp Pharm, V48, P295, DOI 10.1310/hpj4804-295.test; Cebrian L, 2005, INT J ANTIMICROB AG, V25, P173, DOI 10.1016/j.ijantimicag.2004.09.017; CLSI, 2009, M39A4 CLSI; Cornaglia G, 2004, CLIN MICROBIOL INFEC, V10, P349, DOI 10.1111/j.1198-743X.2004.00887.x; Daxboeck F, 2004, J ANTIMICROB CHEMOTH, V54, P163, DOI 10.1093/jac/dkh277; Fridkin SK, 2001, CLIN INFECT DIS, V33, P324, DOI 10.1086/321893; Heginbothom ML, 2004, J ANTIMICROB CHEMOTH, V53, P1010, DOI 10.1093/jac/dkh229; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Horvat RT, 2003, J CLIN MICROBIOL, V41, P4611, DOI 10.1128/JCM.41.10.4611-4616.2003; Kaufman D, 1998, ARCH SURG-CHICAGO, V133, P1041, DOI 10.1001/archsurg.133.10.1041; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Lamoth F, 2010, INFECTION, V38, P249, DOI 10.1007/s15010-010-0033-0; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lee SO, 2004, J CLIN MICROBIOL, V42, P4776, DOI 10.1128/JCM.42.10.4776-4779.2004; Li FF, 2005, EMERG INFECT DIS, V11, P1552, DOI 10.3201/eid1110.050162; Lubowski TJ, 2001, INFECT CONT HOSP EP, V22, P379, DOI 10.1086/501918; Magee JT, 2004, J ANTIMICROB CHEMOTH, V54, P155, DOI 10.1093/jac/dkh295; McGregor JC, 2013, DIAGN MICR INFEC DIS, V76, P73, DOI 10.1016/j.diagmicrobio.2013.01.026; Rabs N, 2014, AM J INFECT CONTROL, V42, P393, DOI 10.1016/j.ajic.2013.11.004; Rodriguez JC, 2003, J ANTIMICROB CHEMOTH, V52, P132, DOI 10.1093/jac/dkg298; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Shannon KP, 2002, J ANTIMICROB CHEMOTH, V50, P965, DOI 10.1093/jac/dkf225; Sundqvist M, 2007, J ANTIMICROB CHEMOTH, V59, P913, DOI 10.1093/jac/dkm040; Swami SK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-63; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Weber SG, 2009, J ANTIMICROB CHEMOTH, V64, P1291, DOI 10.1093/jac/dkp349; White RL, 2001, DIAGN MICR INFEC DIS, V39, P39, DOI 10.1016/S0732-8893(00)00219-4; Wolfensberger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079130; Xu R, 2012, AM J HEALTH-SYST PH, V69, P598, DOI 10.2146/ajhp110332	34	22	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147965	10.1371/journal.pone.0147965	http://dx.doi.org/10.1371/journal.pone.0147965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814675	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200065
J	Zhao, HJ; Leppert, JT; Peehl, DM				Zhao, Hongjuan; Leppert, John T.; Peehl, Donna M.			A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data	PLOS ONE			English	Article							BREAST-CANCER; CIRCADIAN REGULATION; GENE-EXPRESSION; KIDNEY; THERAPY; PATHWAY; PROTEIN; TUMORS	Androgen receptor (AR) is expressed in normal murine and human kidneys of both genders, but its physiologic role is uncertain. Several studies showed loss of AR in renal cell carcinoma (RCC) in conjunction with increasing clinical stage and pathological grade, but others found that higher AR expression correlated with worse outcomes. Limited functional studies with renal cell lines suggested tumor-promoting activity of AR. In this study, we queried transcriptomic, proteomic, epigenetic and survival data from The Cancer Genome Atlas (TCGA) to evaluate AR expression and its association with overall survival in three subtypes of RCC (clear cell [ccRCC], papillary [pRCC], and chromophobe [chRCC]). We found that although there was no significant difference in AR mRNA expression in ccRCC of males vs. females, AR protein expression in ccRCC was significantly higher in male compared to female patients. More importantly, higher expression of AR at both transcript and protein levels was associated with improved overall survival in both genders with ccRCC, but did not predict survival of either gender with pRCC or chRCC. Genes whose transcript levels were associated with AR mRNA levels significantly overlapped between ccRCC and pRCC, but not with chRCC, suggesting a similar transcriptional program mediated by AR in ccRCC and pRCC. Ingenuity pathway analysis also identified overlapping pathways and upstream regulators enriched in AR-associated genes in ccRCC and pRCC. Hypermethylation of CpG sites located in the promoter and first exon of AR was associated with loss of AR expression and poor overall survival. Our findings support a tumor suppressor role for AR in both genders that might be exploited to decrease the incidence or progression of ccRCC.	[Zhao, Hongjuan; Leppert, John T.; Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Leppert, John T.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Peehl, DM (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	dpeehl@stanford.edu		Leppert, John/0000-0001-9980-3863	Department of Urology at Stanford University	Department of Urology at Stanford University	The authors thank the Department of Urology at Stanford University for funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139267; Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Bonny O, 2013, CURR OPIN NEPHROL HY, V22, P439, DOI 10.1097/MNH.0b013e32836213b8; Brown DF, 1998, MODERN PATHOL, V11, P55; BULLOCK LP, 1974, ENDOCRINOLOGY, V94, P746, DOI 10.1210/endo-94-3-746; CATTERALL JF, 1986, RECENT PROG HORM RES, V42, P71; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Ha YS, 2015, J UROLOGY, V194, P1441, DOI 10.1016/j.juro.2015.03.078; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; He DL, 2014, CANCER RES, V74, P4420, DOI 10.1158/0008-5472.CAN-13-2681; Huang R, 2015, MOL CANCER THER, V14, P1066, DOI 10.1158/1535-7163.MCT-14-0620; King SC, 2014, J UROLOGY, V191, P1665, DOI 10.1016/j.juro.2013.12.046; Langner C, 2004, J UROLOGY, V171, P611, DOI 10.1097/01.ju.0000108040.14303.c2; Linehan WM, 2014, NAT REV UROL, V11, P614, DOI 10.1038/nrurol.2014.262; Liu Q, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0117-z; Mazzoccoli G, 2014, TUMOR BIOL, V35, P1, DOI 10.1007/s13277-013-1076-5; Naderi A, 2015, EXP CELL RES, V331, P239, DOI 10.1016/j.yexcr.2014.10.002; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Noh SJ, 2013, PATHOLOGY, V45, P574, DOI 10.1097/PAT.0b013e3283652c7a; Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241; PAPAC RJ, 1993, EUR J CANCER, V29A, P997, DOI 10.1016/S0959-8049(05)80209-6; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Stone L, 2014, NAT REV UROL, V11, P425, DOI 10.1038/nrurol.2014.159; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Thong AE, 2014, UROL ONCOL, V32, P43, DOI DOI 10.1016/J.UR0L0NC.2013.05.008; Tobert CM, 2013, UROL ONCOL-SEMIN ORI, V31, P1316, DOI 10.1016/j.urolonc.2011.12.014; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Williams EM, 2015, INT UROL NEPHROL, V47, P81, DOI 10.1007/s11255-014-0834-7; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Zhu G, 2014, UROLOGY, V83, P510	35	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146505	10.1371/journal.pone.0146505	http://dx.doi.org/10.1371/journal.pone.0146505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814892	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200015
J	Yuan, SQ; Qu, L; Shou, CC				Yuan, Shiqin; Qu, Like; Shou, Chengchao			N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells	PLOS ONE			English	Article							MACROLIDE RESISTANCE; CONTAMINATION; ELIMINATION; GENITALIUM; CULTURE; EXPRESSION; CARCINOMA; HOMINIS	Mycoplasma infection in human and its contamination in cell cultures are worldwide problems. The drugs currently available for preventing or treating mycoplasma infection suffer from low sensitivity, strong resistance and high toxicity. Our previous work showed that Mycoplasma hyorhinis (M. hyorhinis) infection was mediated by the interaction between p37 of M. hyorhinis and Annexin A2 (ANXA2) of host cells, however the translational value of this mechanism was unknown. Herein, we synthesized the N-terminal of ANXA2 polypeptide (A2PP) and found that A2PP could decrease the infection of M. hyorhinis to gastric cancer cells and block M. hyorhinis infection-induced cell migration. Furthermore, we found that A2PP could reduce M. hyorhinis contamination of passage cells. Moreover, compared with the commercial antibiotics commonly used in cell culture to prevent M. hyorhinis infection, A2PP demonstrated a more effectiveness but a low toxicity on cell growth. Thus, our study for the first time revealed A2PP's potential for the treatment and prevention of M. hyorhinis infection.	[Yuan, Shiqin; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Peking University	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	cshou@vip.sina.com			National Natural Science Foundation of China [81572532]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China (81572532). http://www.nsfc.gov.cn/publish/portal1/. SCC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Callaway E, 2014, NATURE, V511, P518, DOI 10.1038/511518a; Cazanave C, 2012, MED MALADIES INFECT, V42, P381, DOI 10.1016/j.medmal.2012.05.006; Chrisment D, 2012, J ANTIMICROB CHEMOTH, V67, P2598, DOI 10.1093/jac/dks263; Darin N, 2003, BMC BIOCH, V4, P4; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Duan HY, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0135-3; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Dziduszko A, 2013, J VIROL, V87, P7502, DOI 10.1128/JVI.00519-13; GURNEY T, 1981, IN VITRO CELL DEV B, V17, P993, DOI 10.1007/BF02618424; HAYFLICK L, 1960, ANN NY ACAD SCI, V79, P433, DOI 10.1111/j.1749-6632.1960.tb42709.x; HENDERSHOT L, 1985, INFECT IMMUN, V49, P36, DOI 10.1128/IAI.49.1.36-39.1985; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Krausse R, 2010, CLIN MICROBIOL INFEC, V16, P1649, DOI [10.1111/j.1469-0691.2009.03155.x, 10.1111/j.1469-0691.2010.03155.x]; Langdon WB, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-3; Lo SC, 2011, ONCOTARGET, V2, P352, DOI 10.18632/oncotarget.282; MANILOFF J, 1972, BACTERIOL REV, V36, P263, DOI 10.1128/MMBR.36.3.263-290.1972; MANILOFF J, 1969, J BACTERIOL, V100, P1402, DOI 10.1128/JB.100.3.1402-1408.1969; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Ning JY, 2003, WORLD J GASTROENTERO, V9, P2164; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; PATON GR, 1965, NATURE, V207, P43, DOI 10.1038/207043a0; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Roediger W E W, 2004, Novartis Found Symp, V263, P85; Rogers MB, 2011, ONCOTARGET, V2, P271; Rottem S, 2012, BIOMEDICAL TISSUE CU, V17, P35, DOI 10.5772/51518; SCHMITT K, 1988, J IMMUNOL METHODS, V109, P17, DOI 10.1016/0022-1759(88)90437-1; Shetty PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044299; Sun GP, 2008, INFECT IMMUN, V76, P4405, DOI 10.1128/IAI.00575-08; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Takei A, 2001, ATHEROSCLEROSIS, V154, P79, DOI 10.1016/S0021-9150(00)00465-2; TAYLOR G, 1974, ANN RHEUM DIS, V33, P376, DOI 10.1136/ard.33.4.376; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Tocqueville V, 2014, J CLIN MICROBIOL, V52, P1664, DOI 10.1128/JCM.03437-13; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Wang CY, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/308976; Whitson WJ, 2014, J NEUROSURG-PEDIATR, V14, P212, DOI 10.3171/2014.4.PEDS13547; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132	40	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147776	10.1371/journal.pone.0147776	http://dx.doi.org/10.1371/journal.pone.0147776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812398	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000054
J	Cottrell, RS; Black, KD; Hutchison, ZL; Last, KS				Cottrell, Richard S.; Black, Kenny D.; Hutchison, Zoe L.; Last, Kim S.			The Influence of Organic Material and Temperature on the Burial Tolerance of the Blue Mussel, Mytilus edulis: Considerations for the Management of Marine Aggregate Dredging	PLOS ONE			English	Article							EASTERN ENGLISH-CHANNEL; BENTHIC COMMUNITY STRUCTURE; ANOXIC SURVIVAL; SULFATE REDUCTION; ENVIRONMENTAL-STRESS; SEDIMENT COMPOSITION; MEDITERRANEAN SEA; HYDROGEN-SULFIDE; MACOMA-BALTHICA; UNITED-KINGDOM	Rationale and Experimental Approach Aggregate dredging is a growing source of anthropogenic disturbance in coastal UK waters and has the potential to impact marine systems through the smothering of benthic fauna with organically loaded screening discards. This study investigates the tolerance of the blue mussel, Mytilus edulis to such episodic smothering events using a multi-factorial design, including organic matter concentration, temperature, sediment fraction size and duration of burial as important predictor variables. Results and Discussion Mussel mortality was significantly higher in organically loaded burials when compared to control sediments after just 2 days. Particularly, M. edulis specimens under burial in fine sediment with high (1%) concentrations of organic matter experienced a significantly higher mortality rate (p< 0.01) than those under coarse control aggregates. Additionally, mussels exposed to the summer maximum temperature treatment (20 degrees C) exhibited significantly increased mortality (p< 0.01) compared to those in the ambient treatment group (15 degrees C). Total Oxygen Uptake rates of experimental aggregates were greatest (112.7 mmol m(-2) day(-1)) with 1% organic loadings in coarse sediment at 20 degrees C. Elevated oxygen flux rates in porous coarse sediments are likely to be a function of increased vertical migration of anaerobically liberated sulphides to the sediment-water interface. However, survival of M. edulis under bacterial mats of Beggia-toa spp. indicates the species' resilience to sulphides and so we propose that the presence of reactive organic matter within the burial medium may facilitate bacterial growth and increase mortality through pathogenic infection. This may be exacerbated under the stable interstitial conditions in fine sediment and increased bacterial metabolism under high temperatures. Furthermore, increased temperature may impose metabolic demands upon the mussel that cannot be met during burial-induced anaerobiosis. Summary Lack of consideration for the role of organic matter and temperature during sedimentation events may lead to an overestimation of the tolerance of benthic species to smothering from dredged material.	[Cottrell, Richard S.; Black, Kenny D.; Hutchison, Zoe L.; Last, Kim S.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Cottrell, Richard S.] Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland	UHI Millennium Institute; University of St Andrews	Last, KS (corresponding author), Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk	Black, Kenneth/GXV-2598-2022; Cottrell, Richard S./AAT-8401-2020; Black, Kenneth D/A-7089-2010	Cottrell, Richard S./0000-0002-6499-7503; Black, Kenneth D/0000-0002-7626-2926; Hutchison, Zoe/0000-0003-1866-7877				Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Aksnes A, 1997, AQUACULTURE, V153, P251, DOI [10.1016/S0044-8486(97)00046-X, 10.1016/S0044-8486(97)00025-2]; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Attard K., 2010, THESIS UHI; Attramadal KJK, 2012, AQUACULT ENG, V49, P23, DOI 10.1016/j.aquaeng.2012.02.003; Avnimelech Y, 2001, AQUACULT ENG, V25, P25, DOI 10.1016/S0144-8609(01)00068-1; Babarro JMF, 2002, J EXP MAR BIOL ECOL, V273, P33, DOI 10.1016/S0022-0981(02)00139-9; Babarro JMF, 2001, COMP BIOCHEM PHYS C, V128, P325, DOI 10.1016/S1532-0456(00)00207-6; Bauer LJ, 2010, ESTUAR COAST, V33, P668, DOI 10.1007/s12237-010-9277-2; Birchenough SNR, 2010, ESTUAR COAST SHELF S, V87, P420, DOI 10.1016/j.ecss.2010.01.005; Black K. D., 2008, SALMON AQUACULTURE D; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvert S.E., 1987, MAR PET SOURCE ROCKS, V26, P137, DOI [DOI 10.1144/GSL.SP.1987.026.01.08, 10.1144/gsl.sp.1987.026.01.08]; Ceia FR, 2013, OCEAN COAST MANAGE, V72, P80, DOI 10.1016/j.ocecoaman.2011.07.009; Cooper K, 2011, ESTUAR COAST SHELF S, V91, P121, DOI 10.1016/j.ecss.2010.10.011; Cooper KM, 2008, J EXP MAR BIOL ECOL, V366, P82, DOI 10.1016/j.jembe.2008.07.011; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; Dando PR, 2004, MAR ECOL PROG SER, V280, P181, DOI 10.3354/meps280181; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; Daviesl SL, 2006, INT STAT REV, V74, P161, DOI 10.1111/j.1751-5823.2006.tb00167.x; De Silva SS, 2012, BIODIVERS CONSERV, V21, P3187, DOI 10.1007/s10531-012-0360-9; de Zwaan A, 2002, COMP BIOCHEM PHYS A, V131, P615, DOI 10.1016/S1095-6433(01)00513-X; de Zwaan A, 2001, MAR BIOL, V138, P1021, DOI 10.1007/s002270000515; de Zwaan A, 2001, MAR ECOL PROG SER, V211, P169, DOI 10.3354/meps211169; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Desprez M, 2010, ICES J MAR SCI, V67, P270, DOI 10.1093/icesjms/fsp245; Desprez M, 2000, ICES J MAR SCI, V57, P1428, DOI 10.1006/jmsc.2000.0926; deZwaan A, 1996, COMP BIOCHEM PHYS C, V113, P299; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; Dijkstra P, 2011, SOIL BIOL BIOCHEM, V43, P2023, DOI 10.1016/j.soilbio.2011.05.018; EERTMAN RHM, 1993, J EXP MAR BIOL ECOL, V170, P179, DOI 10.1016/0022-0981(93)90151-D; Elsasser B, 2013, J SEA RES, V77, P11, DOI 10.1016/j.seares.2012.12.006; ELSGAARD L, 1994, GEOCHIM COSMOCHIM AC, V58, P3335, DOI 10.1016/0016-7037(94)90089-2; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Frojan CRSB, 2008, ESTUAR COAST SHELF S, V79, P204, DOI 10.1016/j.ecss.2008.03.023; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114, DOI 10.1128/AEM.32.1.114-120.1976; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hendrick V, PLOS ONE UNPUB; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Holmer M, 2002, MAR POLLUT BULL, V44, P685, DOI 10.1016/S0025-326X(02)00048-6; Howell JM, 1996, J ENVIRON QUAL, V25, P1216, DOI 10.2134/jeq1996.00472425002500060007x; Hutchison Z, PLOS ONE UNPUB; Jansen JM, 2007, OECOLOGIA, V154, P23, DOI 10.1007/s00442-007-0808-x; Jansen JM, 2009, COMP BIOCHEM PHYS A, V153, P399, DOI 10.1016/j.cbpa.2009.03.013; Janssen F, 2005, LIMNOL OCEANOGR, V50, P779, DOI 10.4319/lo.2005.50.3.0779; Jorgensen B, 1983, MAJOR BIOGEOCHEMICAL, V21, P477; Karakassis I, 1998, MAR ECOL PROG SER, V162, P243, DOI 10.3354/meps162243; Kenny AJ, 1996, MAR POLLUT BULL, V32, P615, DOI 10.1016/0025-326X(96)00024-0; Koivisto ME, 2010, MAR BIOL, V157, P1463, DOI 10.1007/s00227-010-1421-9; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kutti T, 2007, AQUACULTURE, V262, P355, DOI 10.1016/j.aquaculture.2006.10.008; Laudien J, 2002, J EXP MAR BIOL ECOL, V271, P9, DOI 10.1016/S0022-0981(02)00030-8; Le Bot S, 2010, ESTUAR COAST SHELF S, V89, P221, DOI 10.1016/j.ecss.2010.06.012; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; LIVINGSTONE DR, 1977, J COMP PHYSIOL, V114, P143, DOI 10.1007/BF00688965; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; Lozach S, 2012, J SEA RES, V71, P14, DOI 10.1016/j.seares.2012.03.007; Martinez-Garcia E, 2015, BIOGEOCHEMISTRY, V125, P133, DOI 10.1007/s10533-015-0119-y; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; Naglerkerke N., 1991, BIOMETRIKA, V78, P691; Natale F, 2013, MAR POLICY, V38, P205, DOI 10.1016/j.marpol.2012.05.037; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 2004, J COASTAL RES, V20, P115, DOI 10.2112/1551-5036(2004)20[115:IOMADO]2.0.CO;2; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nickell LA, 2003, J EXP MAR BIOL ECOL, V285, P221, DOI 10.1016/S0022-0981(02)00529-4; NILSSON HC, 1994, MAR ECOL PROG SER, V115, P209, DOI 10.3354/meps115209; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Papageorgiou N, 2010, MAR ENVIRON RES, V69, P326, DOI 10.1016/j.marenvres.2009.12.007; Porrello S, 2005, AQUACULTURE, V249, P145, DOI 10.1016/j.aquaculture.2005.02.042; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Robinson JE, 2005, MAR ENVIRON RES, V60, P51, DOI 10.1016/j.marenvres.2004.09.001; Seiderer LJ, 1999, ICES J MAR SCI, V56, P757, DOI 10.1006/jmsc.1999.0495; Smith SDA, 2001, MAR POLLUT BULL, V42, P1040, DOI 10.1016/S0025-326X(01)00059-5; SUCHANEK TH, 1978, J EXP MAR BIOL ECOL, V31, P105, DOI 10.1016/0022-0981(78)90139-9; Szymelfenig M, 2006, ESTUAR COAST SHELF S, V68, P489, DOI 10.1016/j.ecss.2006.02.018; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Tyler-Walters H., 2008, COMMON MUSSEL MARINE; WALLIS RL, 1975, MAR BIOL, V30, P183, DOI 10.1007/BF00390741; WANG WX, 1993, MAR ECOL PROG SER, V95, P205, DOI 10.3354/meps095205; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6; WESTRICH JT, 1988, GEOMICROBIOL J, V6, P99, DOI 10.1080/01490458809377828; WIDDOWS J, 1971, J MAR BIOL ASSOC UK, V51, P827, DOI 10.1017/S0025315400018002; Wilber DH, 2007, MAR POLLUT BULL, V54, P42, DOI 10.1016/j.marpolbul.2006.08.042; ZANDEE DI, 1986, NETH J ZOOL, V36, P322; Zippay ML, 2012, INTEGR ZOOL, V7, P312, DOI 10.1111/j.1749-4877.2012.00310.x	91	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147534	10.1371/journal.pone.0147534	http://dx.doi.org/10.1371/journal.pone.0147534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809153	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800125
J	Hallstrom, T; Singh, B; Kraiczy, P; Hammerschmidt, S; Skerka, C; Zipfel, PF; Riesbeck, K				Hallstroem, Teresia; Singh, Birendra; Kraiczy, Peter; Hammerschmidt, Sven; Skerka, Christine; Zipfel, Peter F.; Riesbeck, Kristian			Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; EXTRACELLULAR-MATRIX PROTEINS; CANDIDA-ALBICANS; FACTOR-H; SERUM RESISTANCE; EPITHELIAL-CELLS; SURFACE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE	Pathogenicity of many microbes relies on their capacity to resist innate immunity, and to survive and persist in an immunocompetent human host microbes have developed highly efficient and sophisticated complement evasion strategies. Here we show that different human pathogens including Gram-negative and Gram-positive bacteria, as well as the fungal pathogen Candida albicans, acquire the human terminal complement regulator vitronectin to their surface. By using truncated vitronectin fragments we found that all analyzed microbial pathogens (n = 13) bound human vitronectin via the same C-terminal heparin-binding domain (amino acids 352-374). This specific interaction leaves the terminal complement complex (TCC) regulatory region of vitronectin accessible, allowing inhibition of C5b-7 membrane insertion and C9 polymerization. Vitronectin complexed with the various microbes and corresponding proteins was thus functionally active and inhibited complement-mediated C5b-9 deposition. Taken together, diverse microbial pathogens expressing different structurally unrelated vitronectin-binding molecules interact with host vitronectin via the same conserved region to allow versatile control of the host innate immune response.	[Hallstroem, Teresia; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Dept Translat Med, Clin Microbiol, Malmo, Sweden; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfaculty Inst Genet & Funct Genom, Greifswald, Germany; [Zipfel, Peter F.] Univ Jena, Fac Biol, Jena, Germany	Hans Knoll Institute (HKI); Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ernst Moritz Arndt Universitat Greifswald; Friedrich Schiller University of Jena	Riesbeck, K (corresponding author), Lund Univ, Dept Translat Med, Clin Microbiol, Malmo, Sweden.	kristian.riesbeck@med.lu.se	Hammerschmidt, Sven/G-2598-2010; Singh, Birendra/H-3592-2011	Hammerschmidt, Sven/0000-0002-6382-6681; Singh, Birendra/0000-0002-7246-1442; Riesbeck, Kristian/0000-0001-6274-6965	Alfred Osterlund Foundation; Anna and Edwin Berger Foundation; Greta and Johan Kock Foundation; Swedish Medical Research Council [K2015-57X-03163-43-4]; Physiographical Society (NMT and Forssman's Foundation); Skane County Council's Research and Development Foundation	Alfred Osterlund Foundation; Anna and Edwin Berger Foundation; Greta and Johan Kock Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Physiographical Society (NMT and Forssman's Foundation); Skane County Council's Research and Development Foundation	This work was supported by grants from the Alfred Osterlund, the Anna and Edwin Berger, and the Greta and Johan Kock Foundations, the Swedish Medical Research Council (Grant K2015-57X-03163-43-4, http://www.vr.se), the Physiographical Society (NMT and Forssman's Foundation), and the Skane County Council's Research and Development Foundation.	Akiyama SK, 2013, CURR PROTOC CELL BIO, V60; Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; ARKO RJ, 1991, J CLIN MICROBIOL, V29, P70, DOI 10.1128/JCM.29.1.70-75.1991; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Buommino E, 2014, FRONT BIOSCI-LANDMRK, V19, P408, DOI 10.2741/4215; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; da Silva LB, 2015, INFECT IMMUN, V83, P888, DOI 10.1128/IAI.02844-14; Dehio C, 1998, EXP CELL RES, V242, P528, DOI 10.1006/excr.1998.4116; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; Duensing TD, 1998, BIOCHEM J, V334, P133, DOI 10.1042/bj3340133; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137630; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Hubert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045132; Jordan RPC, 2014, MED MYCOL, V52, P254, DOI 10.1093/mmy/myt032; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; KOSTRZYNSKA M, 1992, MICROBIOS, V71, P179; Leduc I, 2008, INFECT IMMUN, V76, P1608, DOI 10.1128/IAI.00994-07; Leduc I, 2009, INFECT IMMUN, V77, P657, DOI 10.1128/IAI.00819-08; Leroy-Dudal J, 2004, MICROBES INFECT, V6, P875, DOI 10.1016/j.micinf.2004.05.004; Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230; LIANG OD, 1995, BBA-PROTEIN STRUCT M, V1250, P110, DOI 10.1016/0167-4838(95)00076-7; Liang OD, 1997, BIOCHEM BIOPH RES CO, V234, P445, DOI 10.1006/bbrc.1997.6663; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Riley SP, 2014, CELL MICROBIOL, V16, P849, DOI 10.1111/cmi.12243; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Singh B, 2014, INFECT IMMUN, V82, P2378, DOI 10.1128/IAI.01636-13; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Styriak I, 2003, CURR MICROBIOL, V46, P435, DOI 10.1007/s00284-002-3879-2; Styriak I, 1999, VET MICROBIOL, V67, P99, DOI 10.1016/S0378-1135(99)00037-1; Su YC, 2013, MICROBES INFECT, V15, P375, DOI 10.1016/j.micinf.2013.02.004; Su YC, 2013, MOL MICROBIOL, V87, P1245, DOI 10.1111/mmi.12164; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; VAKEVA A, 1993, AM J PATHOL, V143, P65; Virkola R, 2000, INFECT IMMUN, V68, P5696, DOI 10.1128/IAI.68.10.5696-5701.2000; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zomer A, 2012, J BACTERIOL, V194, P6969, DOI 10.1128/JB.01833-12	70	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147709	10.1371/journal.pone.0147709	http://dx.doi.org/10.1371/journal.pone.0147709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808444	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800189
J	Kim, M; Or, D				Kim, Minsu; Or, Dani			Individual-Based Model of Microbial Life on Hydrated Rough Soil Surfaces	PLOS ONE			English	Article							POROUS-MEDIA; COMMUNITY STRUCTURE; BACTERIAL MOTILITY; FRACTURE SURFACES; HYDRAULIC CONDUCTIVITY; ESCHERICHIA-COLI; CLIMATE-CHANGE; DIVERSITY; WATER; PORE	Microbial life in soil is perceived as one of the most interesting ecological systems, with microbial communities exhibiting remarkable adaptability to vast dynamic environmental conditions. At the same time, it is a notoriously challenging system to understand due to its complexity including physical, chemical, and biological factors in synchrony. This study presents a spatially-resolved model of microbial dynamics on idealised rough soil surfaces represented as patches with different (roughness) properties that preserve the salient hydration physics of real surfaces. Cell level microbial interactions are considered within an individual-based formulation including dispersion and various forms of trophic dependencies (competition, mutualism). The model provides new insights into mechanisms affecting microbial community dynamics and gives rise to spontaneous formation of microbial community spatial patterns. The framework is capable of representing many interacting species and provides diversity metrics reflecting surface conditions and their evolution over time. A key feature of the model is its spatial scalability that permits representation of microbial processes from cell-level (micro-metric scales) to soil representative volumes at sub-metre scales. Several illustrative examples of microbial trophic interactions and population dynamics highlight the potential of the proposed modelling framework to quantitatively study soil microbial processes. The model is highly applicable in a wide range spanning from quantifying spatial organisation of multiple species under various hydration conditions to predicting microbial diversity residing in different soils.	[Kim, Minsu; Or, Dani] Swiss Fed Inst Technol, Dept Environm Syst Sci USYS, STEP, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kim, M (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci USYS, STEP, CH-8092 Zurich, Switzerland.	minsu.kim@usys.ethz.ch	Or, Dani/D-8768-2012	Or, Dani/0000-0002-3236-2933; Kim, Minsu/0000-0002-3942-3743	Swiss National Science Foundation [200020-132154/1]; European Research Council (ERC) [320499-SoilLife]; SystemsX.ch [2013-158: MicroScapesX]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); SystemsX.ch	This work was supported by the Swiss National Science Foundation (200020-132154/1) (http://www.snf.ch/en/Pages/default.aspx), the European Research Council (ERC) Advanced Grant (320499-SoilLife) (http://erc.europa.eu/), and by SystemsX.ch (2013-158: MicroScapesX project) (http://www.systemsx.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; BADER FG, 1978, BIOTECHNOL BIOENG, V20, P183, DOI 10.1002/bit.260200203; Bar M, 2002, P ROY SOC B-BIOL SCI, V269, P937, DOI 10.1098/rspb.2002.1958; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bhatnagar A, 2005, CURR SCI INDIA, V89, P91; Bird NRA, 2000, EUR J SOIL SCI, V51, P55, DOI 10.1046/j.1365-2389.2000.00278.x; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Christofi N, 2002, J APPL MICROBIOL, V93, P915, DOI 10.1046/j.1365-2672.2002.01774.x; Colwell R.K., 2009, PRINCET GUIDE ECOL P, V663, P257, DOI DOI 10.1515/9781400833023.257; CORAPCIOGLU MY, 1984, J HYDROL, V72, P149; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawford JW, 2012, J R SOC INTERFACE, V9, P1302, DOI 10.1098/rsif.2011.0679; CRAWFORD JW, 1993, GEODERMA, V56, P157, DOI 10.1016/0016-7061(93)90107-V; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Dai J, 2013, ANAL CHEM, V85, P5892, DOI 10.1021/ac400648z; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Dechesne A, 2008, APPL ENVIRON MICROB, V74, P5195, DOI 10.1128/AEM.00313-08; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Du C, 1996, AICHE J, V42, P2392, DOI 10.1002/aic.690420831; Duhour A, 2009, APPL SOIL ECOL, V43, P83, DOI 10.1016/j.apsoil.2009.06.004; Ebrahimi AN, 2014, WATER RESOUR RES, V50, P7406, DOI 10.1002/2014WR015897; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferrer J, 2008, J BIOL PHYS, V34, P19, DOI 10.1007/s10867-008-9082-3; FORD RM, 1991, BIOTECHNOL BIOENG, V37, P661, DOI 10.1002/bit.260370708; Ford RM, 2007, ADV WATER RESOUR, V30, P1608, DOI 10.1016/j.advwatres.2006.05.019; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbisu C, 2011, APPL SOIL ECOL, V49, P1, DOI 10.1016/j.apsoil.2011.04.018; Ghanbarian-Alavijeh B, 2011, CAN J SOIL SCI, V91, P1, DOI 10.4141/CJSS10008; Gimenez D, 1997, ENG GEOL, V48, P161, DOI 10.1016/S0013-7952(97)00038-0; Ginovart M, 2005, NONLINEAR ANAL-REAL, V6, P773, DOI 10.1016/j.nonrwa.2004.12.005; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grundmann GL, 2000, FEMS MICROBIOL ECOL, V34, P57, DOI 10.1111/j.1574-6941.2000.tb00754.x; Grundmann GL, 2001, SOIL SCI SOC AM J, V65, P1709, DOI 10.2136/sssaj2001.1709; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hellweger FL, 2009, ECOL MODEL, V220, P8, DOI 10.1016/j.ecolmodel.2008.09.004; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Holden PA, 2011, ARCHITECTURE AND BIOLOGY OF SOILS: LIFE IN INNER SPACE, P118, DOI 10.1079/9781845935320.0118; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Huang GH, 2005, GEODERMA, V127, P52, DOI 10.1016/j.geoderma.2004.11.016; ISICHENKO MB, 1992, REV MOD PHYS, V64, P961, DOI 10.1103/RevModPhys.64.961; Jeffery S., 2010, EUROPEAN ATLAS SOIL; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kampichler C, 1999, GEODERMA, V88, P283, DOI 10.1016/S0016-7061(98)00110-4; KAMPICHLER C, 1993, GEODERMA, V56, P223, DOI 10.1016/0016-7061(93)90112-X; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Kim M, 2013, J ARID ENVIRON, V89, P38, DOI 10.1016/j.jaridenv.2012.09.014; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; LEVINS RICHARD, 1968; Long T, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004781; Long T, 2009, MICROB ECOL, V58, P262, DOI 10.1007/s00248-009-9510-3; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Moldrup P, 2003, SOIL SCI, V168, P321, DOI 10.1097/00010694-200305000-00002; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Monod J., 1942, ACTUALITES SCI IND; Murphy EM, 2000, HYDROGEOL J, V8, P142, DOI 10.1007/s100409900043; O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Or D, 2000, WATER RESOUR RES, V36, P1165, DOI 10.1029/2000WR900020; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Paerl HW, 2000, ENVIRON MICROBIOL, V2, P11, DOI 10.1046/j.1462-2920.2000.00071.x; PFEIFER P, 1984, APPL SURF SCI, V18, P146, DOI 10.1016/0378-5963(84)90042-4; PRAKASH S, 1992, PHYS REV A, V46, pR1724, DOI 10.1103/PhysRevA.46.R1724; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Ranjard L, 2000, MICROBIAL ECOL, V39, P263; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Rockhold ML, 2002, ADV WATER RESOUR, V25, P477, DOI 10.1016/S0309-1708(02)00023-4; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sahimi M, 1998, PHYS REP, V306, P214; SCHMITTBUHL J, 1995, J GEOPHYS RES-SOL EA, V100, P5953, DOI 10.1029/94JB02885; SCHMITTBUHL J, 1993, J PHYS A-MATH GEN, V26, P6115, DOI 10.1088/0305-4470/26/22/014; SENN H, 1994, BBA-GEN SUBJECTS, V1201, P424, DOI 10.1016/0304-4165(94)90072-8; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Smith Val H., 1993, Advances in Microbial Ecology, V13, P1; Stal LJ, 2012, ECOLOGY CYANOBACTERI, P65, DOI [DOI 10.1007/978-94-007-3855-3_4, 10.1007/978-94-007-3855-3_4]; STARK JM, 1995, APPL ENVIRON MICROB, V61, P218, DOI 10.1128/AEM.61.1.218-221.1995; Stein ML, 2002, J COMPUT GRAPH STAT, V11, P587, DOI 10.1198/106186002466; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Thullner M, 2002, J CONTAM HYDROL, V58, P169, DOI 10.1016/S0169-7722(02)00033-5; Thullner Martin, 1999, BIOREMEDIAT J, P247, DOI DOI 10.1080/10889869991219352; Tiedje J. M., 2001, Sustainable management of soil organic matter, P393, DOI 10.1079/9780851994659.0393; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D., 1997, SPATIAL ECOLOGY ROLE, V30; Tokunaga TK, 1997, WATER RESOUR RES, V33, P1287, DOI 10.1029/97WR00473; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tufenkji N, 2007, ADV WATER RESOUR, V30, P1455, DOI 10.1016/j.advwatres.2006.05.014; Tuller M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004142; Tuller M, 1999, WATER RESOUR RES, V35, P1949, DOI 10.1029/1999WR900098; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vlachos C, 2004, COMP FUNCT GENOM, V5, P100, DOI 10.1002/cfg.368; Vogel J, 2003, APPL ENVIRON MICROB, V69, P1482, DOI 10.1128/AEM.69.3.1482-1487.2003; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wang G, 2014, SCI REPORTS, V4; Wang G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00881; Wang G, 2010, ENVIRON MICROBIOL, V12, P1363, DOI 10.1111/j.1462-2920.2010.02180.x; Wang K, 2005, SOIL SCI SOC AM J, V69, P776, DOI 10.2136/sssaj2004.0247; Warren-Rhodes KA, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000305; Weiss J, 2001, INT J FRACTURE, V109, P365, DOI 10.1023/A:1011078531887; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; YAO KM, 1971, ENVIRON SCI TECHNOL, V5, P1105, DOI 10.1021/es60058a005; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; Young IM, 1998, SOIL BIOL BIOCHEM, V30, P1229, DOI 10.1016/S0038-0717(97)00263-0; Zelenev VV, 2005, ECOL MODEL, V188, P404, DOI 10.1016/j.ecolmodel.2005.01.046; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	131	57	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147394	10.1371/journal.pone.0147394	http://dx.doi.org/10.1371/journal.pone.0147394			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807803	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800086
J	Ledesma-Escobar, CA; Priego-Capote, F; de Castro, MDL				Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.			Comparative Study of the Effect of Sample Pretreatment and Extraction on the Determination of Flavonoids from Lemon (Citrus limon)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; FRUITS; QUERCETIN; CULTIVARS; MICROWAVE; DAMAGE	Background Flavonoids have shown to exert multiple beneficial effects on human health, being also appreciated by both food and pharmaceutical industries. Citrus fruits are a key source of flavonoids, thus promoting studies to obtain them. Characteristics of these studies are the discrepancies among sample pretreatments and among extraction methods, and also the scant number of comparative studies developed so far. Objective Evaluate the effect of both the sample pretreatment and the extraction method on the profile of flavonoids isolated from lemon. Results Extracts from fresh, lyophilized and air-dried samples obtained by shaking extraction (SE), ultrasound-assisted extraction (USAE), microwave-assisted extraction (MAE) and superheated liquid extraction (SHLE) were analyzed by LC-QTOF MS/MS, and 32 flavonoids were tentatively identified using MS/MS information. ANOVA applied to the data from fresh and dehydrated samples and from extraction by the different methods revealed that 26 and 32 flavonoids, respectively, were significant (p <= 0.01). The pairwise comparison (Tukey HSD; p <= 0.01) showed that lyophilized samples are more different from fresh samples than from air-dried samples; also, principal component analysis (PCA) showed a clear discrimination among sample pretreatment strategies and suggested that such differences are mainly created by the abundance of major flavonoids. On the other hand, pairwise comparison of extraction methods revealed that USAE and MAE provided quite similar extracts, being SHLE extracts different from the other two. In this case, PCA showed a clear discrimination among extraction methods, and their position in the scores plot suggests a lower abundance of flavonoids in the extracts from SHLE. In the two PCA the loadings plots revealed a trend to forming groups according to flavonoid aglycones. Conclusions The present study shows clear discrimination caused by both sample pretreatments and extraction methods. Under the studied conditions, liophilization provides extracts with higher amounts of flavonoids, and USAE is the best method for isolation of these compounds, followed by MAE and SE. On the contrary, the SHLE method was the less favorable to extract flavonoids from citrus owing to degradation.	[Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba, Dept Analyt Chem, Annex C-3,Campus Rabanales, E-14071 Cordoba, Spain; [Ledesma-Escobar, Carlos A.; Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba Agroalimentary Excellence Campus, ceiA3, Campus Rabanales, E-14071 Cordoba, Spain; [Priego-Capote, Feliciano; Luque de Castro, Maria D.] Univ Cordoba, Reina Sofia Hosp, Inst Biomed Res Maimonides IMIBIC, E-14071 Cordoba, Spain; [Ledesma-Escobar, Carlos A.] Technol Inst Veracruz, Chem & Biochem Engn Dept, Ave Miguel Angel de Quevedo 2779, Veracruz 91897, Veracruz, Mexico	Universidad de Cordoba; Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba	Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba, Dept Analyt Chem, Annex C-3,Campus Rabanales, E-14071 Cordoba, Spain.; Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba Agroalimentary Excellence Campus, ceiA3, Campus Rabanales, E-14071 Cordoba, Spain.; Priego-Capote, F; de Castro, MDL (corresponding author), Univ Cordoba, Reina Sofia Hosp, Inst Biomed Res Maimonides IMIBIC, E-14071 Cordoba, Spain.	q72prcaf@uco.es; qa1lucam@uco.es	Priego-Capote, Feliciano/C-7977-2014; Ledesma Escobar, Carlos A./I-3885-2019; Ledesma-Escobar, Carlos A./H-6603-2016	Priego-Capote, Feliciano/0000-0003-0697-719X; Ledesma Escobar, Carlos A./0000-0002-4658-8212; Ledesma-Escobar, Carlos A./0000-0002-4658-8212	Spanish Ministerio de Economia y Competitividad (MINECO) [CTQ2012-37428]; FEDER [CTQ2012-37428]; Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract [RYC-2009-03921]; Mexican National Council for Science and Technology (CONACYT, Mexico) [224905]; Mexican National Council for Science and Technology (CONACYT)	Spanish Ministerio de Economia y Competitividad (MINECO); FEDER(European Commission); Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract; Mexican National Council for Science and Technology (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER program are thanked for financial support through Project CTQ2012-37428. FPC was sponsored by Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract (RYC-2009-03921). CALE was sponsored by Mexican National Council for Science and Technology (CONACYT No. 224905, Mexico).; The Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER program are thanked for financial support through Project CTQ2012-37428. F.P.C. is sponsored by Ministerio de Ciencia e Innovacion (MICINN) through a Ramon y Cajal Contract (RYC-2009-03921). C.A.L.E. also thanks the Mexican National Council for Science and Technology (CONACYT) for grants to support his research in both countries.	Abad-Garcia B, 2012, J AGR FOOD CHEM, V60, P3635, DOI 10.1021/jf300022u; Alam MM, 2014, LIFE SCI, V109, P8, DOI 10.1016/j.lfs.2014.06.005; Chen ML, 2011, INT J FOOD SCI TECH, V46, P1179, DOI 10.1111/j.1365-2621.2011.02605.x; Dahmoune F, 2013, IND CROP PROD, V50, P77, DOI 10.1016/j.indcrop.2013.07.013; DAVIS WB, 1947, ANAL CHEM, V19, P476, DOI 10.1021/ac60007a016; FAO, 2012, CITR FRUIT FRESH PRO; Garcia- Castello EM, LWT FOOD SCI TECHNOL; Gonzalez-Molina E, 2010, J PHARMACEUT BIOMED, V51, P327, DOI 10.1016/j.jpba.2009.07.027; Hayat K, 2010, FOOD CHEM, V123, P423, DOI 10.1016/j.foodchem.2010.04.060; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Herrmann K, 1976, INT J FOOD SCI TECH, V11, P433; Hu XT, 2015, EUR J PHARMACOL, V754, P133, DOI 10.1016/j.ejphar.2015.02.007; Ignat I, 2011, FOOD CHEM, V126, P1821, DOI 10.1016/j.foodchem.2010.12.026; Ledesma-Escobar C.A., 2015, GREEN EXTRACTION NAT, P265; Ledesma-Escobar CA, 2015, TALANTA, V144, P522, DOI 10.1016/j.talanta.2015.07.011; Ledesma-Escobar CA, 2014, TRENDS FOOD SCI TECH, V39, P63, DOI 10.1016/j.tifs.2014.07.002; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Materska M, 2015, FOOD CHEM, V168, P546, DOI 10.1016/j.foodchem.2014.07.023; Molina-Calle M, 2015, TALANTA, V144, P349, DOI 10.1016/j.talanta.2015.05.054; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Ortuno A, 1997, SCI HORTIC-AMSTERDAM, V68, P231, DOI 10.1016/S0304-4238(96)00988-0; Roohbakhsh A, 2015, LIFE SCI, V124, P64, DOI 10.1016/j.lfs.2014.12.030; Sdiri S, 2012, FOOD RES INT, V49, P462, DOI 10.1016/j.foodres.2012.07.040; Sun YJ, 2015, LWT-FOOD SCI TECHNOL, V60, P1269, DOI 10.1016/j.lwt.2014.09.001; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Ueyama Y, 2002, PLANT SCI, V163, P253, DOI 10.1016/S0168-9452(02)00098-5; Ye XQ, 2011, FOOD CHEM, V124, P1561, DOI 10.1016/j.foodchem.2010.08.013	27	25	26	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148056	10.1371/journal.pone.0148056	http://dx.doi.org/10.1371/journal.pone.0148056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807979	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800269
J	Yoon, SY; Bae, SH; Shin, YJ; Park, SG; Hwang, SH; Hyon, JY; Wee, WR				Yoon, Sam Young; Bae, Seok Hyun; Shin, Young Joo; Park, Shin Goo; Hwang, Sang-Hee; Hyon, Joon Young; Wee, Won Ryang			Low Serum 25-Hydroxyvitamin D Levels Are Associated with Dry Eye Syndrome	PLOS ONE			English	Article							KOREA NATIONAL-HEALTH; VITAMIN-D LEVELS; EXAMINATION SURVEY KNHANES; D-RECEPTOR KNOCKOUT; RISK-FACTORS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; SJOGRENS-SYNDROME; PREVALENCE; DISEASE; EXPOSURE	Background Dry eye syndrome (DES) is a common tear film and ocular surface disease that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Systemic diseases associated with DES include diabetes mellitus, rheumatoid arthritis, depression, anxiety, thyroid disease, allergic diseases, irritable bowel syndrome, chronic pain syndrome, and hyperlipidemia. Interestingly, it has been found that most of these are associated with low levels of serum 25-hydroxyvitamin D (25(OH) D) or inadequate sunlight exposure. Methods In this cross-sectional data analysis, noninstitutionalized adults aged >= 19 years (N = 17,542) who participated in Korean National Health and Nutrition Examination Survey 2010-2012 were included. Information regarding duration of sunlight exposure was collected from the survey participants. Serum 25(OH) D and zinc levels were measured. The confounding variables were age, gender, sunlight exposure time, region of residence, obesity, serum 25(OH) D level, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and walking exercise. Results Mean serum 25(OH) D levels of subjects with and without DES were 16.90 +/- 6.0 and 17.52 +/- 6.07 (p< 0.001). Inadequate sunlight exposure time (odds ratio [OR], 1.554; 95% confidence interval [CI], 1.307-1.848), urban residence (OR, 1.669; 95% CI, 1.456-1.913), indoor occupation (OR, 1.578; 95% CI, 1.389-1.814), and low serum 25(OH) D level (OR, 1.158; 95% CI, 1.026-1.308) were the risk factors for DES. After adjusting for age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and occupation, low serum 25(OH) D level (OR, 1.178; 95% CI, 1.010-1.372) and deficient sunlight exposure time (OR, 1.383; 95% CI, 1.094-1.749) were the risk factors for diagnosed DES. Conclusion Low serum 25(OH) D levels and inadequate sunlight exposure are associated with DES in Korean adults. These results suggest that sufficient sunlight exposure or vitamin D supplementation may be useful in DES treatment.	[Yoon, Sam Young; Bae, Seok Hyun; Shin, Young Joo] Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Shin Goo] Inha Univ, Sch Med, Dept Occupat & Environm Med, Inchon, South Korea; [Hwang, Sang-Hee] Keimyung Univ, Sch Med, Dept Dent, Daegu, South Korea; [Hyon, Joon Young; Wee, Won Ryang] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Hyon, Joon Young] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, Gyeonggi, South Korea	Hallym University; Inha University; Keimyung University; Seoul National University (SNU); Seoul National University (SNU)	Shin, YJ (corresponding author), Hallym Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	schinn@hanmail.net		Hyon, Joon Young/0000-0003-3620-1536	National Research Foundation (NRF) - Korean government [NRF-2015R1D1A1A09058505]	National Research Foundation (NRF) - Korean government(Korean Government)	This study was supported by the National Research Foundation (NRF) grant (NRF-2015R1D1A1A09058505) funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2014, AM J OPHTHALMOL, V158, P1205, DOI 10.1016/j.ajo.2014.08.021; Alsalem JA, 2014, INVEST OPHTH VIS SCI, V55, P2140, DOI 10.1167/iovs.13-13019; Axelsson Johann, 2004, Int J Circumpolar Health, V63, P267; Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Beaven CM, 2011, J STRENGTH COND RES, V25, P1072, DOI 10.1519/JSC.0b013e3181bf4414; Berridge MJ, 2015, BIOCHEM BIOPH RES CO, V460, P53, DOI 10.1016/j.bbrc.2015.01.008; Binkley N, 2007, J CLIN ENDOCR METAB, V92, P2130, DOI 10.1210/jc.2006-2250; Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Brown NAP, 1998, EYE, V12, P127, DOI 10.1038/eye.1998.21; Buchholz P, 2006, OCUL SURF, V4, P155, DOI 10.1016/S1542-0124(12)70043-5; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Cheng HM, 2014, J ALLERGY CLIN IMMUN, V133, P1048, DOI 10.1016/j.jaci.2013.10.055; Choi CJ, 2013, J CLIN ENDOCR METAB, V98, P1703, DOI 10.1210/jc.2012-3901; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Doganay Z, 2003, AM J EMERG MED, V21, P271, DOI 10.1016/S0735-6757(03)00039-1; Dolin P J, 1994, Ophthalmic Epidemiol, V1, P155, DOI 10.3109/09286589409047224; Elizondo RA, 2014, INVEST OPHTH VIS SCI, V55, P5245, DOI 10.1167/iovs.13-13553; Erten S, 2015, INT J RHEUM DIS, V18, P70, DOI 10.1111/1756-185X.12298; Fujita M, 2005, AM J OPHTHALMOL, V140, P808, DOI 10.1016/j.ajo.2005.05.025; Galor A, 2014, OPHTHALMOLOGY, V121, P972, DOI 10.1016/j.ophtha.2013.11.036; Galor A, 2014, CORNEA, V33, P437, DOI 10.1097/ICO.0000000000000089; Geldenhuys S, 2014, DIABETES, V63, P3759, DOI 10.2337/db13-1675; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Han SB, 2011, ARCH OPHTHALMOL-CHIC, V129, P633, DOI 10.1001/archophthalmol.2011.78; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine of the National Academies, 2010, DIETARY REFERENCE IN; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033148; Kramer C, 2009, J STEROID BIOCHEM, V113, P9, DOI 10.1016/j.jsbmb.2008.10.010; Kurtul BE, 2015, EYE, V29, P1081, DOI 10.1038/eye.2015.96; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lemp MA, 2007, OCUL SURF, V5, P75; LO CW, 1986, AM J CLIN NUTR, V44, P683, DOI 10.1093/ajcn/44.5.683; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Lu XW, 2014, INVEST OPHTH VIS SCI, V55, P2975, DOI 10.1167/iovs.13-13788; Lucas RM, 2006, PROG BIOPHYS MOL BIO, V92, P140, DOI 10.1016/j.pbiomolbio.2006.02.019; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; Nam GE, 2014, PUBLIC HEALTH NUTR, V17, P186, DOI 10.1017/S1368980012004855; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; onsiglio M, 2015, EXP DERMATOL; PETERFY C, 1988, J PHYSIOL-LONDON, V398, P1, DOI 10.1113/jphysiol.1988.sp017025; Rhee SY, 2012, DIABETIC MED, V29, P1003, DOI 10.1111/j.1464-5491.2012.03575.x; Routsias JG, 2004, J MED CHEM, V47, P4327, DOI 10.1021/jm049844+; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Selter JH, 2015, CLIN OPHTHALMOL, V9, P57, DOI 10.2147/OPTH.S76583; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Stumpf WE, 2007, EUR J DRUG METAB PH, V32, P123, DOI 10.1007/BF03190474; Suzuki T, 2000, CURR EYE RES, V20, P127, DOI 10.1076/0271-3683(200002)20:2;1-D;FT127; Suzuki T, 2000, INVEST OPHTH VIS SCI, V41, P154; Truong S, 2014, CLIN EXP OPTOM, V97, P324, DOI 10.1111/cxo.12147; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Vehof J, 2014, BRIT J OPHTHALMOL, V98, P1712, DOI 10.1136/bjophthalmol-2014-305201; Vyssoki B, 2014, JAMA PSYCHIAT, V71, P1231, DOI 10.1001/jamapsychiatry.2014.1198; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127863; WEBB AR, 1990, AM J CLIN NUTR, V51, P1075, DOI 10.1093/ajcn/51.6.1075; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; Wolkoff P, 2007, ENVIRON INT, V33, P850, DOI 10.1016/j.envint.2007.04.004; Wong J, 2011, OCUL SURF, V9, P212, DOI 10.1016/S1542-0124(11)70034-9; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605	62	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147847	10.1371/journal.pone.0147847	http://dx.doi.org/10.1371/journal.pone.0147847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807908	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800227
J	Dogba, MJ; Dahan-Oliel, N; Snider, L; Glorieux, FH; Durigova, M; Palomo, T; Cordey, M; Bedard, MH; Bedos, C; Rauch, F				Dogba, Maman Joyce; Dahan-Oliel, Noemi; Snider, Laurie; Glorieux, Francis H.; Durigova, Michaela; Palomo, Telma; Cordey, Michel; Bedard, Marie-Helene; Bedos, Christophe; Rauch, Frank			Involving Families with Osteogenesis Imperfecta in Health Service Research: Joint Development of the OI/ECE Questionnaire	PLOS ONE			English	Article							CHILDREN; IMPACT; DISEASE; EXPERIENCES; TRANSLATION; INSTRUMENT; QUALITY; SCALE; LIFE	Background Despite the growing interest in understanding the psycho-social impact of rare genetic diseases, few studies examine this concept and even fewer seek to obtain feedback from families who have lived the experience. The aim of this project was to involve families of children living with osteogenesis imperfecta (OI) in the development of a tool to assess the impact of OI on the lives of patients and their families. Methods This project used an integrated knowledge translation approach in which knowledge users (clinicians and people living with OI and their families) were consulted throughout the four steps of development, that is: content mapping, item generation, tool appraisal and pre-testing of the questionnaires. The International Classification of Functioning and Health was used as a framework for content mapping. Based on a scoping review we selected two validated tools to use as a basis for developing the questionnaire. The final parent self-report version measured six domains: experience of diagnosis; use of health services; use of social and psychological support services; expectations about tertiary specialized centers; and socio-demographic information. Results A total of 27 out of 40 families receiving care at the Shriners Hospital for Children-Canada and invited to participate in the pre-test returned the completed questionnaires. In more than two-thirds of families (69%; n = 18) OI was suspected either at or within the first 3 months after birth. Up to 46% of families consulted between 3 and 5 doctors (46%; n = 12) prior to final diagnosis. The use of services by families varied from 0 to 16 consultations, 0 to 9 exploratory examinations and 1 to 10 types of allied health services. In the 12 months prior to the study, fewer than a quarter of children had been admitted, for treatment, for hospital stays of longer than 8 hours or to an emergency department (24% and 9% respectively). Only 29% of parents received psychological support. Conclusion This joint development process generated a tool, with good psychometric properties, that provides unique insight into the experiences of patients and families with OI, the psychosocial impact of the illness, and their service needs and expectations.	[Dogba, Maman Joyce] Univ Laval, Fac Med, Dept Family & Emergency Med, Quebec City, PQ G1K 7P4, Canada; [Dahan-Oliel, Noemi] Shriners Hosp Children, Off Clin Res, Montreal, PQ, Canada; [Snider, Laurie] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Glorieux, Francis H.; Durigova, Michaela; Palomo, Telma; Cordey, Michel; Bedard, Marie-Helene; Rauch, Frank] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; [Bedos, Christophe] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Bedos, Christophe] Univ Montreal, Fac Med, Dept Social & Prevent Med, Montreal, PQ H3C 3J7, Canada	Laval University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal	Dogba, MJ (corresponding author), Univ Laval, Fac Med, Dept Family & Emergency Med, Quebec City, PQ G1K 7P4, Canada.	joyce-maman.dogba@fmed.ulaval.ca; mdurigova@shriners.mcgill.ca	Rauch, Frank/D-1554-2009	Bedos, Christophe/0000-0003-0141-0928; Palomo, Telma/0000-0002-1655-7319; Rauch, Frank/0000-0002-6261-0360	Richard and Edith Strauss Foundation in Rehabilitation Research	Richard and Edith Strauss Foundation in Rehabilitation Research	This work was supported by the Richard and Edith Strauss Foundation in Rehabilitation Research.	Anderson M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-22; Battista RN, 2012, PUBLIC HEALTH GENOM, V15, P34, DOI 10.1159/000328846; Boote J, 2010, HEALTH POLICY, V95, P10, DOI 10.1016/j.healthpol.2009.11.007; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; Cho TJ, 2007, J BONE JOINT SURG AM, V89A, P1028, DOI 10.2106/JBJS.F.00814; Claesson IB, 2002, CHILD CARE HLTH DEV, V28, P309, DOI 10.1046/j.1365-2214.2002.00282.x; Daykin N, 2007, EVID POLICY, V3, P47, DOI [10.1332/174426407779702201, DOI 10.1332/174426407779702201]; Dogba MJ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0151-y; Dogba MJ, 2014, DISABIL HEALTH J, V7, P343, DOI 10.1016/j.dhjo.2014.03.002; Dogba MJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-153; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Dye DE, 2011, PUBLIC HEALTH GENOM, V14, P153, DOI 10.1159/000321767; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hatzmann J, 2008, PEDIATRICS, V122, pE1030, DOI 10.1542/peds.2008-0582; Kole A, 2009, VOICE 12000 PATIENTS; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Menon D, 2015, PATIENT, V8, P29, DOI 10.1007/s40271-014-0106-8; Parry D SJ, 2009, CONNAISSANCES PRATIQ; Perneger TV, 1999, J CLIN EPIDEMIOL, V52, P1037, DOI 10.1016/S0895-4356(99)00088-8; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; van den Tweel XW, 2008, HAEMATOLOGICA, V93, P588, DOI 10.3324/haematol.11610; WHO, 2001, WHO INT CLASS FUNCT; Zeitlin L, 2003, J PEDIATR ORTHOP B, V12, P77, DOI 10.1097/01.bpb.0000049567.52224.fa	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147654	10.1371/journal.pone.0147654	http://dx.doi.org/10.1371/journal.pone.0147654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799959	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300136
J	Lazaro-Diez, M; Remuzgo-Martinez, S; Rodriguez-Mirones, C; Acosta, F; Icardo, JM; Martinez-Martinez, L; Ramos-Vivas, J				Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Acosta, Felix; Icardo, Jose M.; Martinez-Martinez, Luis; Ramos-Vivas, Jose			Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms	PLOS ONE			English	Article							IN-VITRO; ANTIBIOTIC CONCENTRATIONS; INHIBITORY CONCENTRATIONS; BACTERICIDAL ACTIVITY; CELL-WALL; EPIDERMIDIS; EXPRESSION; AGR; MECHANISMS; PENETRATION	Ceftaroline (CPT) is a novel cephalosporin with in vitro activity against Staphylococcus aureus. Ceftaroline exhibits a level of binding affinity for PBPs in S. aureus including PBP2a of methicillin-resistant S. aureus (MRSA). The aims of this study were to investigate the morphological, physiological and molecular responses of MRSA clinical strains and MRSA biofilms to sub-MICs (1/4 and 1/16 MIC) of ceftaroline by using transmission, scanning and confocal microscopy. We have also used quantitative Real-Time PCR to study the effect of sub-MICs of ceftaroline on the expression of the staphylococcal icaA, agrA, sarA and sasF genes in MRSA biofilms. In one set of experiments, ceftaroline was able to inhibit biofilm formation in all strains tested at MIC, however, a strain dependent behavior in presence of sub-MICs of ceftaroline was shown. In a second set of experiments, destruction of preformed biofilms by addition of ceftaroline was evaluated. Ceftaroline was able to inhibit biofilm formation at MIC in all strains tested but not at the sub-MICs. Destruction of preformed biofilms was strain dependent because the biofilm formed by a matrix-producing strain was resistant to a challenge with ceftaroline at MIC, whereas in other strains the biofilm was sensitive. At sub-MICs, the impact of ceftaroline on expression of virulence genes was strain-dependent at 1/4 MIC and no correlation between ceftaroline-enhanced biofilm formation and gene regulation was established at 1/16 MIC. Our findings suggest that sub-MICs of ceftaroline enhance bacterial attachment and biofilm formation by some, but not all, MRSA strains and, therefore, stress the importance of maintaining effective bactericidal concentrations of ceftaroline to fight biofilm-MRSA related infections.	[Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Hosp Univ Marques de Valdecilla, Serv Microbiol, Santander, Cantabria, Spain; [Lazaro-Diez, Maria; Remuzgo-Martinez, Sara; Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain; [Rodriguez-Mirones, Cristina; Martinez-Martinez, Luis; Ramos-Vivas, Jose] Inst Salud Carlos III, REIPI, Madrid, Spain; [Acosta, Felix] Univ Las Palmas Gran Canaria, Grp Invest Acuicultura, Arucas, Gran Canaria, Spain; [Icardo, Jose M.] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Cantabria, Spain; [Martinez-Martinez, Luis] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria; Universidad de Cantabria; Universidad de Cantabria	Ramos-Vivas, J (corresponding author), Hosp Univ Marques de Valdecilla, Serv Microbiol, Santander, Cantabria, Spain.; Ramos-Vivas, J (corresponding author), Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain.	jvivas@idival.org	Martínez, Luis Martínez/U-1801-2017; Lázaro-Díez, María/AAA-1529-2020; Icardo, Jose Manuel/ABH-5431-2020; Ramos-Vivas, J/G-3643-2016	Martínez, Luis Martínez/0000-0002-6091-4045; Lázaro-Díez, María/0000-0002-6098-8052; Icardo, Jose Manuel/0000-0001-9543-2444; Ramos-Vivas, J/0000-0001-8795-519X; ACOSTA ARBELO, FELIX ANTONIO/0000-0002-1098-7529	AstraZeneca [IDIVAL CSI 13/08]	AstraZeneca(AstraZeneca)	This study was supported by an unrestricted grant from AstraZeneca (IDIVAL CSI 13/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Barber KE, 2014, ANTIMICROB AGENTS CH, V58, P2989, DOI 10.1128/AAC.02764-13; Biek D, 2010, J ANTIMICROB CHEMOTH, V65, piv9, DOI 10.1093/jac/dkq251; Blickwede M, 2004, J VET MED B, V51, P293, DOI 10.1111/j.1439-0450.2004.00767.x; Braga PC, 1997, J ANTIMICROB CHEMOTH, V39, P79, DOI 10.1093/jac/39.1.79; Brooks JL, 2012, ADV APPL MICROBIOL, V81, P63, DOI 10.1016/B978-0-12-394382-8.00002-2; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Gomes DLR, 2013, J MED MICROBIOL, V62, P754, DOI 10.1099/jmm.0.052373-0; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Institute CaLS, 2012, M7A9 CLSI; Joo HS, 2010, ANTIMICROB AGENTS CH, V54, P4942, DOI 10.1128/AAC.00064-10; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; Khodaverdian V, 2013, ANTIMICROB AGENTS CH, V57, P3645, DOI 10.1128/AAC.00269-13; Landini G, 2015, INT J ANTIMICROB AG, V45, P551, DOI 10.1016/j.ijantimicag.2015.01.001; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Long SW, 2014, ANTIMICROB AGENTS CH, V58, P6668, DOI 10.1128/AAC.03622-14; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Odenholt I, 2001, INT J ANTIMICROB AG, V17, P1, DOI 10.1016/S0924-8579(00)00243-0; Pottinger PS, 2013, MED CLIN N AM, V97, P601, DOI 10.1016/j.mcna.2013.02.005; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Saravolatz L, 2010, ANTIMICROB AGENTS CH, V54, P3027, DOI 10.1128/AAC.01516-09; Saravolatz LD, 2011, CLIN INFECT DIS, V52, P1156, DOI 10.1093/cid/cir147; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Smith K, 2010, ANTIMICROB AGENTS CH, V54, P380, DOI 10.1128/AAC.00155-09; Stefani S, 2003, CLIN MICROBIOL INFEC, V9, P1179, DOI 10.1111/j.1469-0691.2003.00698.x; Subrt N, 2011, J ANTIMICROB CHEMOTH, V66, P979, DOI 10.1093/jac/dkr043; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; Villegas-Estrada A, 2008, J AM CHEM SOC, V130, P9212, DOI 10.1021/ja8029448; Werth BJ, 2014, ANTIMICROB AGENTS CH, V58, P3177, DOI 10.1128/AAC.00088-14; Zhou XX, 2015, SCIENCE, V348, P574, DOI 10.1126/science.aaa1511	44	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147569	10.1371/journal.pone.0147569	http://dx.doi.org/10.1371/journal.pone.0147569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800524	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300126
J	Wolf, K; Braun, A; Haining, EJ; Tseng, YL; Kraft, P; Schuhmann, MK; Gotru, SK; Chen, WC; Hermanns, HM; Stoll, G; Lesch, KP; Nieswandt, B				Wolf, Karen; Braun, Attila; Haining, Elizabeth J.; Tseng, Yu-Lun; Kraft, Peter; Schuhmann, Michael K.; Gotru, Sanjeev K.; Chen, Wenchun; Hermanns, Heike M.; Stoll, Guido; Lesch, Klaus-Peter; Nieswandt, Bernhard			Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice	PLOS ONE			English	Article							REUPTAKE INHIBITORS; ISCHEMIC-STROKE; THROMBO-INFLAMMATION; 5-HT TRANSPORT; 5-HYDROXYTRYPTAMINE; RISK; ACTIVATION; AGGREGATION; HEMOSTASIS; CITALOPRAM	Background Serotonin (5-hydroxytryptamin, 5-HT) is an indolamine platelet agonist, biochemically derived from tryptophan. 5-HT is secreted from the enterochromaffin cells into the gastrointestinal tract and blood. Blood 5-HT has been proposed to regulate hemostasis by acting as a vasoconstrictor and by triggering platelet signaling through 5-HT receptor 2A (5HTR2A). Although platelets do not synthetize 5-HT, they take 5-HT up from the blood and store it in their dense granules which are secreted upon platelet activation. Objective To identify the molecular composite of the 5-HT uptake system in platelets and elucidate the role of platelet released 5-HT in thrombosis and ischemic stroke. Methods: 5-HT transporter knockout mice (5Htt(-/-)) were analyzed in different in vitro and in vivo assays and in a model of ischemic stroke. Results In 5Htt(-/-) platelets, 5-HT uptake from the blood was completely abolished and agonist-induced Ca2+ influx through store operated Ca2+ entry (SOCE), integrin activation, degranulation and aggregation responses to glycoprotein VI (GPVI) and C-type lectin-like receptor 2 (CLEC-2) were reduced. These observed in vitro defects in 5Htt(-/-) platelets could be normalized by the addition of exogenous 5-HT. Moreover, reduced 5-HT levels in the plasma, an increased bleeding time and the formation of unstable thrombi were observed ex vivo under flow and in vivo in the abdominal aorta and carotid artery of 5Htt(-/-) mice. Surprisingly, in the transient middle cerebral artery occlusion (tMCAO) model of ischemic stroke 5Htt(-/-) mice showed nearly normal infarct volume and the neurological outcome was comparable to control mice. Conclusion Although secreted platelet 5-HT does not appear to play a crucial role in the development of reperfusion injury after stroke, it is essential to amplify the second phase of platelet activation through SOCE and plays an important role in thrombus stabilization.	[Wolf, Karen; Braun, Attila; Haining, Elizabeth J.; Gotru, Sanjeev K.; Chen, Wenchun; Nieswandt, Bernhard] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Tseng, Yu-Lun] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Psychiat, Taipei, Taiwan; [Kraft, Peter; Schuhmann, Michael K.; Stoll, Guido] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Lesch, Klaus-Peter] Univ Hosp Wurzburg, Dept Mol Psychiat, Wurzburg, Germany; [Hermanns, Heike M.] Univ Hosp Wurzburg, Dept Med Clin & Policlin 2, Hepatol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Braun, A; Nieswandt, B (corresponding author), Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany.; Nieswandt, B (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany.	attila.braun@virchow.uni-wuerzburg.de; bernhard.nieswandt@virchow.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Chen, Wenchun/C-8912-2017	Lesch, Klaus-Peter/0000-0001-8348-153X; Chen, Wenchun/0000-0002-7159-7161	Deutsche Forschungsgemeinschaft [SFB 688]; Deutsche Forschungsgemeinschaft (Ministry of Science and Technology (Taiwan) [NSC-101-2314-B-039-037]; University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Ministry of Science and Technology (Taiwan); University of Wuerzburg	Funded by Deutsche Forschungsgemeinschaft (SFB 688 to BN (TPA01), AB (TPA18) and GS (TPB01), Ministry of Science and Technology (Taiwan) to YT (NSC-101-2314-B-039-037), and University of Wuerzburg in the funding program Open Access Publishing (BN).	Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Alberio Lorenzo J, 2004, Curr Hematol Rep, V3, P338; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; BAUMGARTNER HR, 1968, NATURE, V218, P137, DOI 10.1038/218137a0; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bischoff SC, 2009, AM J PHYSIOL-GASTR L, V296, pG685, DOI 10.1152/ajpgi.90685.2008; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BORN GVR, 1959, J PHYSIOL-LONDON, V146, P472, DOI 10.1113/jphysiol.1959.sp006206; Braun A, 2011, FRONT BIOSCI-LANDMRK, V16, P2144, DOI 10.2741/3844; Canan F, 2011, THROMB RES, V127, P57, DOI 10.1016/j.thromres.2010.07.017; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Espinera AR, 2013, NEUROSCIENCE, V247, P1, DOI 10.1016/j.neuroscience.2013.04.011; Frankhauser P, 2006, NEUROSCI LETT, V399, P197, DOI 10.1016/j.neulet.2006.01.062; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Gobin V, 2014, INT IMMUNOPHARMACOL, V20, P148, DOI 10.1016/j.intimp.2014.02.030; GOLINO P, 1989, CIRCULATION, V79, P154, DOI 10.1161/01.CIR.79.1.154; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; Hallback I, 2012, PHARMACOL REP, V64, P979, DOI 10.1016/S1734-1140(12)70894-0; Hankey GJ, 2014, STROKE, V45, P1917, DOI 10.1161/STROKEAHA.114.005844; HYTTEL J, 1994, INT CLIN PSYCHOPHARM, V9, P19, DOI 10.1097/00004850-199403001-00004; Jiang HY, 2015, CLIN GASTROENTEROL H, V13, P42, DOI 10.1016/j.cgh.2014.06.021; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Mazepa M, 2013, ARTERIOSCL THROM VAS, V33, P1747, DOI 10.1161/ATVBAHA.113.301790; McCann SK, 2014, STROKE, V45, P3055, DOI 10.1161/STROKEAHA.114.006304; McFarlane A, 2001, AM HEART J, V142, P617, DOI 10.1067/mhj.2001.116766; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; NISHIO H, 1995, EUR J PHARM-MOLEC PH, V288, P149, DOI 10.1016/0922-4106(95)90189-2; Pavanetto M, 2011, CELL PHYSIOL BIOCHEM, V27, P139, DOI 10.1159/000325216; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Qi RM, 1996, THROMB RES, V81, P43, DOI 10.1016/0049-3848(95)00212-X; Sander K, 2014, EMJ NEUROL, V1, P53; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schmitt A, 2007, J NEURAL TRANSM, V114, P1107, DOI 10.1007/s00702-007-0724-6; Schuhmann MK, 2015, J CEREBR BLOOD F MET, V35, P6, DOI 10.1038/jcbfm.2014.175; Selim MH, 2012, STROKE, V43, P3154, DOI 10.1161/STROKEAHA.112.657635; Serebruany VL, 2006, AM J MED, V119, P113, DOI 10.1016/j.amjmed.2005.03.044; Stegner D, 2013, J THROMB HAEMOST, V11, P1430, DOI 10.1111/jth.12293; Szasz R, 2003, CURR OPIN HEMATOL, V10, P351, DOI 10.1097/00062752-200309000-00005; TRANZER JP, 1966, NATURE, V212, P1574, DOI 10.1038/2121574a0; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; TUOMISTO J, 1976, NATURE, V262, P596, DOI 10.1038/262596a0; Turetta L, 2002, CELL CALCIUM, V31, P235, DOI 10.1016/S0143-4160(02)00052-0; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Watts SW, 2002, HYPERTENSION, V39, P825, DOI 10.1161/hy0302.104668; WESTER P, 1992, STROKE, V23, P870, DOI 10.1161/01.STR.23.6.870; Zarpellon A, 2008, CELL PHYSIOL BIOCHEM, V21, P87, DOI 10.1159/000113750; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004; ZUCKER MB, 1955, J APPL PHYSIOL, V7, P432, DOI 10.1152/jappl.1955.7.4.432; ZUCKER MB, 1958, ANN NY ACAD SCI, V75, P203, DOI 10.1111/j.1749-6632.1958.tb36867.x	69	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147664	10.1371/journal.pone.0147664	http://dx.doi.org/10.1371/journal.pone.0147664			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800051	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300137
J	Stevenson, JW; Conaty, EA; Walsh, RB; Poidomani, PJ; Samoriski, CM; Scollins, BJ; DeGiorgis, JA				Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.			The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner	PLOS ONE			English	Article							SQUID GIANT-AXON; SYNAPTIC PLASTICITY; VESICLE TRANSPORT; FAMILY-MEMBERS; IN-VITRO; BETA; GENE; CELL; KINESIN; IDENTIFICATION	The amyloid precursor protein (APP) is a causal agent in the pathogenesis of Alzheimer's disease and is a transmembrane protein that associates with membrane-limited organelles. APP has been shown to co-purify through immunoprecipitation with a kinesin light chain suggesting that APP may act as a trailer hitch linking kinesin to its intercellular cargo, however this hypothesis has been challenged. Previously, we identified an mRNA transcript that encodes a squid homolog of human APP(770). The human and squid isoforms share 60% sequence identity and 76% sequence similarity within the cytoplasmic domain and share 15 of the final 19 amino acids at the C-terminus establishing this highly conserved domain as a functionally import segment of the APP molecule. Here, we study the distribution of squid APP in extruded axoplasm as well as in a well-characterized reconstituted organelle/microtubule preparation from the squid giant axon in which organelles bind microtubules and move towards the microtubule plus-ends. We find that APP associates with microtubules by confocal microscopy and co-purifies with KI-washed axoplasmic organelles by sucrose density gradient fractionation. By electron microscopy, APP clusters at a single focal point on the surfaces of organelles and localizes to the organelle/microtubule interface. In addition, the association of APP-organelles with microtubules is an ATP dependent process suggesting that the APP-organelles contain a microtubule-based motor protein. Although a direct kinesin/APP association remains controversial, the distribution of APP at the organelle/microtubule interface strongly suggests that APP-organelles have an orientation and that APP like the Alzheimer's protein tau has a microtubule-based function.	[Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Stevenson, James W.; Conaty, Eliza A.; Walsh, Rylie B.; Poidomani, Paul J.; Samoriski, Colin M.; Scollins, Brianne J.; DeGiorgis, Joseph A.] Marine Biol Lab, Bell Ctr, Woods Hole, MA 02543 USA	Providence College; Marine Biological Laboratory - Woods Hole	DeGiorgis, JA (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.; DeGiorgis, JA (corresponding author), Marine Biol Lab, Bell Ctr, Woods Hole, MA 02543 USA.	jdegiorg@providence.edu			Institutional Development Award (IDeA) National Institute of General Medical Sciences of the National Institutes of Health [P20GM103430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brunholz S, 2012, EXP BRAIN RES, V217, P353, DOI 10.1007/s00221-011-2870-1; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; CRAWFORD F, 1991, NEUROSCI LETT, V133, P1, DOI 10.1016/0304-3940(91)90042-R; DeGiorgis JA, 2008, TRAFFIC, V9, P1867, DOI 10.1111/j.1600-0854.2008.00809.x; DeGiorgis JA, 2011, CYTOSKELETON, V68, P566, DOI 10.1002/cm.20531; DeLuca JG, 2001, J BIOL CHEM, V276, P28014, DOI 10.1074/jbc.M102801200; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Heber S, 2000, J NEUROSCI, V20, P7951; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Karnovsky MJ, 1982, BIOCHEMISTRY-US, V94, P1; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kuznetsov SA, 2001, METH MOL B, V164, P1; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lichtenthaler SF, 2012, CURR ALZHEIMER RES, V9, P165; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mileusnic R, 2005, ANN NY ACAD SCI, V1048, P149, DOI 10.1196/annals.1342.014; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Owen DJ, 2010, CURR BIOL, V20, pR413, DOI 10.1016/j.cub.2010.03.017; PALACIOS G, 1995, EUR J NEUROSCI, V7, P501, DOI 10.1111/j.1460-9568.1995.tb00346.x; Paliga K, 1997, EUR J BIOCHEM, V250, P354, DOI 10.1111/j.1432-1033.1997.0354a.x; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; ROTH M, 1966, NATURE, V209, P109, DOI 10.1038/209109a0; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; Sigua R, 2014, J VIS EXP; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Tabb JS, 1998, J CELL SCI, V111, P3221; Thonberg Hakan, 2011, BMC Res Notes, V4, P476, DOI 10.1186/1756-0500-4-476; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; VEGA JA, 1995, NEUROSCI LETT, V192, P132, DOI 10.1016/0304-3940(95)11618-7; Villegas C, 2014, HUM MOL GENET, V23, P1631, DOI 10.1093/hmg/ddt555; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Yamazaki T, 1996, J CELL SCI, V109, P999; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147808	10.1371/journal.pone.0147808	http://dx.doi.org/10.1371/journal.pone.0147808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814888	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200053
J	Tulino, R; Benjamin, AC; Jolinon, N; Smith, DL; Chini, EN; Carnemolla, A; Bates, GP				Tulino, Raffaella; Benjamin, Agnesska C.; Jolinon, Nelly; Smith, Donna L.; Chini, Eduardo N.; Carnemolla, Alisia; Bates, Gillian P.			SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice	PLOS ONE			English	Article							IN MOUSE MODEL; ACTIVATED PROTEIN-KINASE; MOLECULAR CHAPERONES; P53 ACETYLATION; GENE-EXPRESSION; CELL-SURVIVAL; DEACETYLASE; EXON-1; NEURODEGENERATION; AGGREGATION	Huntington's disease (HD) is a neurodegenerative disorder for which there are no disease-modifying treatments. SIRT1 is a NAD(+) -dependent protein deacetylase that is implicated in maintaining neuronal health during development, differentiation and ageing. Previous studies suggested that the modulation of SIRT1 activity is neuroprotective in HD mouse models, however, the mechanisms controlling SIRT1 activity are unknown. We have identified a striatum- specific phosphorylation-dependent regulatory mechanism of SIRT1 induction under normal physiological conditions, which is impaired in HD. We demonstrate that SIRT1 activity is down-regulated in the brains of two complementary HD mouse models, which correlated with altered SIRT1 phosphorylation levels. This SIRT1 impairment could not be rescued by the ablation of DBC1, a negative regulator of SIRT1, but was linked to changes in the sub-cellular distribution of AMPK-alpha 1, a positive regulator of SIRT1 function. This work provides insights into the regulation of SIRT1 activity with the potential for the development of novel therapeutic strategies.	[Tulino, Raffaella; Benjamin, Agnesska C.; Jolinon, Nelly; Smith, Donna L.; Carnemolla, Alisia; Bates, Gillian P.] Univ London, Kings Coll London, Dept Med & Mol Genet, London SW3 6LX, England; [Chini, Eduardo N.] Mayo Clin, Coll Med, Rochester, MN USA	University of London; King's College London; Mayo Clinic	Carnemolla, A; Bates, GP (corresponding author), Univ London, Kings Coll London, Dept Med & Mol Genet, London SW3 6LX, England.	alisia.carnemolla@kcl.ac.uk; gillian.bates@kcl.ac.uk	Carnemolla, Alisia/AAV-2154-2021; Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305	European Community Program FP7 [264508]; CHDI Foundation; MRC [G0801314] Funding Source: UKRI; Medical Research Council [G0801314] Funding Source: researchfish	European Community Program FP7; CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RT was funded by a Marie Curie Training Network from the European Community Program FP7/2010 under grant agreement no. 264508 and this funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the CHDI Foundation, a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. Some of this research conducted at King's College London was performed in collaboration with and funded by the CHDI Foundation.	Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cha YI, 2013, BMB REP, V46, P429, DOI 10.5483/BMBRep.2013.46.9.180; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Douglas PM, 2009, PRION, V3, P51, DOI 10.4161/pri.3.2.8587; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; HDCRG, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2014, ANN CLIN TRANSL NEUR, V1, P1047, DOI 10.1002/acn3.135; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Jones L, 2014, HUNTINGTONS DIS, P410, DOI [10.1093/med/9780199929146.003.0016, DOI 10.1093/MED/9780199929146.003.0016]; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lau AW, 2014, AM J CANCER RES, V4, P245; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Smith MR, 2014, HUM MOL GENET, V23, P2995, DOI 10.1093/hmg/ddu010; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sussmuth SD, 2015, BRIT J CLIN PHARMACO, V79, P465, DOI 10.1111/bcp.12512; Waldvogel H. J, 2014, HUNTINGTONS DIS, P185; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145425	10.1371/journal.pone.0145425	http://dx.doi.org/10.1371/journal.pone.0145425			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815359	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200004
J	Benamar, T; Tajounte, L; Alla, A; Khebba, F; Ahmed, H; Mulders, MN; Filali-Maltouf, A; El Aouad, R				Benamar, Touria; Tajounte, Latifa; Alla, Amal; Khebba, Fatima; Ahmed, Hinda; Mulders, Mick N.; Filali-Maltouf, Abdelkarim; El Aouad, Rajae			Real-Time PCR for Measles Virus Detection on Clinical Specimens with Negative IgM Result in Morocco	PLOS ONE			English	Article							LABORATORY CONFIRMATION; MOLECULAR DIAGNOSIS; INFECTION; ELIMINATION; IDENTIFICATION; EXPERIENCE; GENOTYPES; SETTINGS; OUTBREAK; ASSAYS	Since the confirmation of measles cases represents an important indicator regarding the performance of the measles-elimination program, the aim of this study was to evaluate the effectiveness of the routine procedures followed in Morocco for the laboratory confirmation of measles cases. Suspected cases reported between January 2010 and December 2012 were assessed for the timeliness of the sample collection, occurrence of measles clinical symptoms, and the results of the laboratory diagnoses. For 88% of the 2,708 suspected cases, a clinical specimen was collected within 7d of rash onset, of which 50% were IgM-positive and 2.6% were equivocal. The measles symptoms were reported in 91.4% of the cases; the occurrence of symptoms showed a positive association with the serological results (odds ratio [OR] = 2.9883, 95% confidence interval [CI] 2.2238-4.0157). Of the negative samples, 52% (n = 116) tested positive by real-time polymerase chain reaction (PCR). These results are in favor of using molecular detection to complement serological diagnosis in the context of measles surveillance approach in Morocco. In addition, the introduction of additional laboratory methods for differential diagnosis is required for the final classification of suspected cases with maculopapular rash and fever in the context of the measles elimination program.	[Benamar, Touria; Tajounte, Latifa; Khebba, Fatima] Minist Hlth, Natl Inst Hyg, Rabat, Morocco; [Alla, Amal] Minist Hlth, Dept Epidemiol, Rabat, Morocco; [Ahmed, Hinda] WHO EMRO, Dept Communicable Dis Prevent & Control, Cairo, Egypt; [Mulders, Mick N.] WHO, Expanded Programme Immunizat, CH-1211 Geneva, Switzerland; [Filali-Maltouf, Abdelkarim] Univ Mohammed 5, Fac Sci, Microbiol & Mol Biol Lab, Rabat, Morocco; [El Aouad, Rajae] Univ Mohamed V Souissi, Sch Med & Pharm, Rabat, Morocco	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Mohammed V University in Rabat; Mohammed V University in Rabat	Benamar, T (corresponding author), Minist Hlth, Natl Inst Hyg, Rabat, Morocco.	t_benamar@yahoo.com	Filali-Maltouf, Abdelkarim/AAD-3681-2022	Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; EL AOUAD, Rajae/0000-0002-2686-6924; BENAMAR, Touria/0000-0002-8284-6821	CDC; WHO	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO(World Health Organization)	The authors would like to acknowledge all of the Ministry of Health teams for their efforts and cooperation in carrying out the measles-elimination program. The authors would also like to thank the CDC and WHO for their support for the program.	Akiyoshi K, 2010, JPN J INFECT DIS, V63, P225; Al-Ghamdi AMA, 2011, ANN EPIDEMIOL, V21, P262, DOI 10.1016/j.annepidem.2010.12.004; Alla A, 2002, J MED VIROL, V68, P441, DOI 10.1002/jmv.10223; Alla A, 2006, J MED VIROL, V78, P1465, DOI 10.1002/jmv.20720; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2003, J INFECT DIS S, V187, pS264; Benamar T, 2014, EUR SCI J, V10, P228; Sanz JC, 2010, APMIS, V118, P203, DOI 10.1111/j.1600-0463.2009.02581.x; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P657; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Featherstone DA, 2011, J INFECT DIS, V204, pS491, DOI 10.1093/infdis/jir107; Garcia, 2010, OPEN VACCINE J, V3, P65; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Hickman CJ, 2011, J INFECT DIS, V204, pS549, DOI 10.1093/infdis/jir106; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Hutse V, 2010, INT J INFECT DIS, V14, pE991, DOI 10.1016/j.ijid.2010.06.009; Hyde TB, 2009, B WORLD HEALTH ORGAN, V87, P93, DOI 10.2471/BLT.07.045484; Ito M, 2010, PEDIATR INT, V52, P611, DOI 10.1111/j.1442-200X.2010.03124.x; Jayamaha J, 2012, J CLIN VIROL, V54, P168, DOI 10.1016/j.jcv.2012.02.025; Michel Y, 2013, J MED VIROL, V85, P723, DOI 10.1002/jmv.23515; MoH-Morocco, 2009, SYST SURV ROUG PHAS; MoH-Morocco/ WHO, 2005, POL SANT ENF MAROC A; Mosquera MM, 2005, J CLIN MICROBIOL, V43, P5117, DOI 10.1128/JCM.43.10.5117-5121.2005; Ozoemena LC, 2004, J MED VIROL, V73, P79, DOI 10.1002/jmv.20050; Pull L, 2012, J TRAVEL MED, V19, P268, DOI 10.1111/j.1708-8305.2012.00628.x; Ratnam S, 2000, J CLIN MICROBIOL, V38, P99; Rota PA, 2011, J INFECT DIS, V204, pS506, DOI 10.1093/infdis/jir117; Saraswathy TS, 2009, SE ASIAN J TROP MED, V40, P742; Thomas B, 2007, J MED VIROL, V79, P1587, DOI 10.1002/jmv.20997; Tischer A, 2004, J CLIN VIROL, V31, P165, DOI 10.1016/j.jcv.2004.05.007; WHO/ Morocco, 2008, CAMP NAT VACC CONTR; WHO-EMRO, 2013, MEAL TOT SUSP CAS ME; WHO-EMRO, 2006, MEASL EL PREV CONG R; Woo GKS, 2010, J MED VIROL, V82, P1773, DOI 10.1002/jmv.21888; World Health Organization, 2015, IMMUNIZATION VACCINE; World Health Organization, IMMUNIZATION VACCINE	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147154	10.1371/journal.pone.0147154	http://dx.doi.org/10.1371/journal.pone.0147154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812434	Green Published, gold			2022-12-27	WOS:000369528000022
J	Lu, DY; Yang, AC; Cheng, HM; Lu, TM; Yu, WC; Chen, CH; Sung, SH				Lu, Dai-Yin; Yang, Albert C.; Cheng, Hao-Min; Lu, Tse-Min; Yu, Wen-Chung; Chen, Chen-Huan; Sung, Shih-Hsien			Heart Rate Variability Is Associated with Exercise Capacity in Patients with Cardiac Syndrome X	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; POWER SPECTRUM ANALYSIS; ANGINA-PECTORIS; RATE RECOVERY; MECHANISMS; DYSFUNCTION; PREDICTORS; MORTALITY; ENDURANCE	Heart rate variability (HRV) reflects the healthiness of autonomic nervous system, which is associated with exercise capacity. We therefore investigated whether HRV could predict the exercise capacity in the adults with cardiac syndrome X (CSX). A total of 238 subjects (57 +/- 12 years, 67.8% men), who were diagnosed as CSX by the positive exercise stress test and nearly normal coronary angiogram were enrolled. Power spectrum from the 24-hour recording of heart rate was analyzed in frequency domain using total power (TP) and spectral components of the very low frequency (VLF), low frequency (LF) and high frequency (HF) ranges. Among the study population, 129 subjects with impaired exercise capacity during the treadmill test had significantly lower HRV indices than those with preserved exercise capacity (>= 90% of the age predicted maximal heart rate). After accounting for age, sex, and baseline SBP and heart rate, VLF (odds ratio per 1SD and 95% CI: 2.02, 1.19-3.42), LF (1.67, 1.10-2.55), and TP (1.82, 1.17-2.83) remained significantly associated with preserved exercise capacity. In addition, increased HRV indices were also associated with increased exercise duration, rate-pressure product, and heart rate recovery, independent of age, body mass index, and baseline SBP and heart rate. In subgroup analysis, HRV indices demonstrated similar predictive values related to exercise capacity across various subpopulations, especially in the young. In patients with CSX, HRV was independently associated with exercise capacity, especially in young subjects. The healthiness of autonomic nervous system may have a role in modulating the exercise capacity in patients with CSX.	[Lu, Dai-Yin; Lu, Tse-Min; Yu, Wen-Chung; Sung, Shih-Hsien] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Cheng, Hao-Min; Chen, Chen-Huan] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan; [Lu, Dai-Yin; Yu, Wen-Chung] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lu, Dai-Yin; Yang, Albert C.; Cheng, Hao-Min; Lu, Tse-Min; Chen, Chen-Huan; Sung, Shih-Hsien] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Chen, Chen-Huan; Sung, Shih-Hsien] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University	Sung, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan.	mr.sungsh@gmail.com		Yang, Albert Chih-Chieh/0000-0003-2794-9649	Taipei Veterans General Hospital [V103B-017]; Ministry of Health and Welfare, Taiwan [MOHW-104-TDU-B-211-113003]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Health and Welfare, Taiwan	The study was supported by Taipei Veterans General Hospital (V103B-017), and Ministry of Health and Welfare, Taiwan (MOHW-104-TDU-B-211-113003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 1998, AM J CARDIOL, V82, P862, DOI 10.1016/S0002-9149(98)00493-7; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bosquet L, 2007, EUR J APPL PHYSIOL, V100, P363, DOI 10.1007/s00421-007-0438-3; Camm AJ, 1996, CIRCULATION, V93, P1043; CANNON RO, 1985, CIRCULATION, V71, P218, DOI 10.1161/01.CIR.71.2.218; EPSTEIN SE, 1986, J AM COLL CARDIOL, V8, P459, DOI 10.1016/S0735-1097(86)80067-5; Filipovic M, 2003, J AM COLL CARDIOL, V42, P1767, DOI 10.1016/j.jacc.2003.05.008; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gulli G, 2001, CARDIOVASC RES, V52, P208, DOI 10.1016/S0008-6363(01)00369-8; Iellamo F, 2001, AUTON NEUROSCI-BASIC, V90, P66, DOI 10.1016/S1566-0702(01)00269-7; KASKI JC, 1995, J AM COLL CARDIOL, V25, P807, DOI 10.1016/0735-1097(94)00507-M; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; KEMP HG, 1973, AM J CARDIOL, V32, P375, DOI 10.1016/S0002-9149(73)80150-X; KIILAVUORI K, 1995, EUR HEART J, V16, P490; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lanza G A, 2000, Ital Heart J, V1, P221; Lee WL, 1998, INT J CARDIOL, V66, P253; Levy WC, 1998, AM J CARDIOL, V82, P1236, DOI 10.1016/S0002-9149(98)00611-0; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Malfatto G, 1998, AM J CARDIOL, V81, P834, DOI 10.1016/S0002-9149(98)00021-6; MALLIANI A, 1994, BRIT HEART J, V71, P1; Meeder JG, 1995, EUR HEART J, V16, P1571, DOI 10.1093/oxfordjournals.eurheartj.a060780; Munk PS, 2010, INT J CARDIOL, V145, P312, DOI 10.1016/j.ijcard.2009.11.015; Murad Khalil, 2012, Congest Heart Fail, V18, P192, DOI 10.1111/j.1751-7133.2011.00282.x; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Piotrowicz E, 2009, PACING CLIN ELECT S1, V32, pS113, DOI [10.1111/j.1540-8159.2008.02266.x, DOI 10.1111/J.1540-8159.2008.02266.X]; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; ROSANO GMC, 1994, AM J CARDIOL, V73, P1174, DOI 10.1016/0002-9149(94)90177-5; Silvilairat S, 2011, PEDIATR CARDIOL, V32, P1158, DOI 10.1007/s00246-011-0040-7; Soares-Miranda L, 2014, CIRCULATION, V129, P2100, DOI 10.1161/CIRCULATIONAHA.113.005361; Stahle A, 1999, EUR HEART J, V20, P1638, DOI 10.1053/euhj.1999.1715; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Wennerblom B, 2000, HEART, V83, P290, DOI 10.1136/heart.83.3.290; Wu L, 2014, INT J CARDIOL, V174, P857, DOI 10.1016/j.ijcard.2014.04.176	35	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0144935	10.1371/journal.pone.0144935	http://dx.doi.org/10.1371/journal.pone.0144935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812652	Green Published, gold			2022-12-27	WOS:000369528000001
J	Nakazato, H; Takeshima, H; Kishino, T; Kubo, E; Hattori, N; Nakajima, T; Yamashita, S; Igaki, H; Tachimori, Y; Kuniyoshi, Y; Ushijima, T				Nakazato, Hidetsugu; Takeshima, Hideyuki; Kishino, Takayoshi; Kubo, Emi; Hattori, Naoko; Nakajima, Takeshi; Yamashita, Satoshi; Igaki, Hiroyasu; Tachimori, Yuji; Kuniyoshi, Yukio; Ushijima, Toshikazu			Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis	PLOS ONE			English	Article							IDENTIFIES FREQUENT MUTATION; EPIGENETIC FIELD DEFECT; HEPATOCELLULAR-CARCINOMA; HYPERCALCEMIC TYPE; SMARCA4 MUTATIONS; SOMATIC MUTATIONS; CANCER; GENE; METHYLATION; ARID1A	The SWI/SNF chromatin remodeling complex is frequently inactivated by somatic mutations of its various components in various types of cancers, and also by aberrant DNA methylation. However, its somatic mutations and aberrant methylation in esophageal squamous cell carcinomas (ESCCs) have not been fully analyzed. In this study, we aimed to clarify in ESCC, what components of the SWI/SNF complex have somatic mutations and aberrant methylation, and when somatic mutations of the SWI/SNF complex occur. Deep sequencing of components of the SWI/SNF complex using a bench-top next generation sequencer revealed that eight of 92 ESCCs (8.7%) had 11 somatic mutations of 7 genes, ARID1A, ARID2, ATRX, PBRM1, SMARCA4, SMARCAL1, and SMARCC1. The SMARCA4 mutations were located in the Forkhead (85Ser>Leu) and SNF2 family N-terminal (882Glu>Lys) domains. The PBRM1 mutations were located in a bromodomain (80Asn>Ser) and an HMG-box domain (1,377Glu>Lys). For most mutations, their mutant allele frequency was 31-77% (mean 61%) of the fraction of cancer cells in the same samples, indicating that most of the cancer cells in individual ESCC samples had the SWI/SNF mutations on one allele, when present. In addition, a BeadChip array analysis revealed that a component of the SWI/SNF complex, ACTL6B, had aberrant methylation at its promoter CpG island in 18 of 52 ESCCs (34.6%). These results showed that genetic and epigenetic alterations of the SWI/SNF complex are present in ESCCs, and suggested that genetic alterations are induced at an early stage of esophageal squamous cell carcinogenesis.	[Nakazato, Hidetsugu; Takeshima, Hideyuki; Kishino, Takayoshi; Kubo, Emi; Hattori, Naoko; Yamashita, Satoshi; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan; [Nakazato, Hidetsugu; Igaki, Hiroyasu; Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Tokyo, Japan; [Nakazato, Hidetsugu; Kuniyoshi, Yukio] Univ Ryukyus, Dept Thorac & Cardiovasc Surg, Grad Sch Med, Okinawa, Japan; [Nakajima, Takeshi] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of the Ryukyus; National Cancer Center - Japan	Ushijima, T (corresponding author), Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan.	tushijim@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021; NAKAJIMA, Takeshi/HCH-0703-2022	Ushijima, Toshikazu/0000-0003-3405-7817; NAKAJIMA, TAKESHI/0000-0002-6825-3165; Takeshima, Hideyuki/0000-0002-8552-2427; Kishino, Takayoshi/0000-0002-3137-8730; Hattori, Naoko/0000-0002-0901-4869; Yamashita, Satoshi/0000-0002-8609-5797	Project for Development of Innovative Research on Cancer Therapeutics [15cm0106040h0005]; Applied Research for Innovative Treatment of Cancer from the Japan Agency for Medical Research and Development (AMED) [15ck0106023h0002]; Japan Society for the Promotion of Science (JSPS) [15K18422]; Grants-in-Aid for Scientific Research [15K18422] Funding Source: KAKEN	Project for Development of Innovative Research on Cancer Therapeutics; Applied Research for Innovative Treatment of Cancer from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct, http://p-direct.mext.go.jp/) (15cm0106040h0005); Applied Research for Innovative Treatment of Cancer (15ck0106023h0002) from the Japan Agency for Medical Research and Development (AMED, http://www.amed.go.jp/en/); A Grant-in-Aid for Young Scientists (B) (15K18422) from the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Baba Y, 2015, ANN SURG ONCOL, V22, P3659, DOI 10.1245/s10434-015-4445-z; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Khursheed M, 2013, BRIT J CANCER, V108, P2056, DOI 10.1038/bjc.2013.200; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082302; Takeshima H, 2015, CANCER LETT, V357, P328, DOI 10.1016/j.canlet.2014.11.038; Takeshima H, 2011, GENOMICS, V98, P182, DOI 10.1016/j.ygeno.2011.06.003; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Yoda Y, 2015, GASTRIC CANCER, V18, P65, DOI 10.1007/s10120-014-0348-0; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147372	10.1371/journal.pone.0147372	http://dx.doi.org/10.1371/journal.pone.0147372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812616	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000032
J	Priyadarshani, N; Marsland, S; Castro, I; Punchihewa, A				Priyadarshani, Nirosha; Marsland, Stephen; Castro, Isabel; Punchihewa, Amal			Birdsong Denoising Using Wavelets	PLOS ONE			English	Article							COURTSHIP SONGS; SIGNAL; TERRITORIAL; SOUNDS	Automatic recording of birdsong is becoming the preferred way to monitor and quantify bird populations worldwide. Programmable recorders allow recordings to be obtained at all times of day and year for extended periods of time. Consequently, there is a critical need for robust automated birdsong recognition. One prominent obstacle to achieving this is low signal to noise ratio in unattended recordings. Field recordings are often very noisy: birdsong is only one component in a recording, which also includes noise from the environment (such as wind and rain), other animals (including insects), and human-related activities, as well as noise from the recorder itself. We describe a method of denoising using a combination of the wavelet packet decomposition and band-pass or low-pass filtering, and present experiments that demonstrate an order of magnitude improvement in noise reduction over natural noisy bird recordings.	[Priyadarshani, Nirosha; Marsland, Stephen] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Castro, Isabel] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand; [Punchihewa, Amal] Asia Pacific Broadcasting Union, Kuala Lumpur, Malaysia	Massey University; Massey University	Priyadarshani, N; Marsland, S (corresponding author), Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand.; Castro, I (corresponding author), Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand.	N.Priyadarshani@massey.ac.nz; S.R.Marsland@massey.ac.nz; I.C.Castro@massey.ac.nz	Priyardarshani, Nirosha/AAB-5268-2019; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Priyardarshani, Nirosha/0000-0002-4302-5262; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024	Higher Education for the Twenty First Century (HETC), Sri Lanka [KLN/O-Sci/N6]; School of Engineering and Advanced Technology, Massey University, New Zealand; RSNZ Marsden Fund [MAU0908]; Massey University Research Fund (Massey University) [RM1000015982 P-MURF]; University of Kelaniya, Sri Lanka; WWF Conservation Innovation Awards New Ideas for Nature (research innovation) [CIA 14/05]	Higher Education for the Twenty First Century (HETC), Sri Lanka; School of Engineering and Advanced Technology, Massey University, New Zealand; RSNZ Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Massey University Research Fund (Massey University); University of Kelaniya, Sri Lanka; WWF Conservation Innovation Awards New Ideas for Nature (research innovation)	NP received a PhD grant (KLN/O-Sci/N6) from Higher Education for the Twenty First Century (HETC, http://www.hetc.lk/), Sri Lanka, and a research fund from School of Engineering and Advanced Technology, Massey University, New Zealand, during this study. NP was awarded with the runner up prize (CIA 14/05) in WWF Conservation Innovation Awards 2014-New Ideas for Nature (research innovation). SM was supported by RSNZ Marsden Fund (MAU0908). Recordings by IC were made with funding from Massey University Research Fund, 2011 (RM1000015982 P-MURF, 7003-Massey University). NP is on study leave and is supported by University of Kelaniya, Sri Lanka.	Aboufadel E., 2011, DISCOVERING WAVELETS; Bee SS, REAL TIME SPEECH DEN; Burrus CS, 1997, INTRO WAVELETS WAVEL, P98; Buxton RT, 2012, J FIELD ORNITHOL, V83, P47, DOI 10.1111/j.1557-9263.2011.00355.x; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CATCHPOLE CK, 1983, ANIM BEHAV, V31, P1217, DOI 10.1016/S0003-3472(83)80028-1; Chih-Hsun Chou, 2009, 2009 Symposia and Workshops on Ubiquitous, Autonomic and Trusted Computing in conjunction with the UIC 2009 and ATC 2009 Conferences, P189, DOI 10.1109/UIC-ATC.2009.85; Cornec C, 2014, ETHOLOGY, V120, P726, DOI 10.1111/eth.12244; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Duan S, 2013, P 25 INN APPL ART IN; Farina A., 2014, SOUNDSCAPE ECOLOGY; GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960; Gur BM, 2007, J ACOUST SOC AM, V122, P188, DOI 10.1121/1.2735111; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Hore Alain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2366, DOI 10.1109/ICPR.2010.579; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Kroodsma DE., 1982, ACOUSTIC COMMUNICATI; Kroodsma Donald, 2005, SINGING LIFE BIRDS; LEIN MR, 1972, NATURE, V237, P48, DOI 10.1038/237048a0; Ma H., 2012, FUTURE CONTROL AUTOM, V173, P35, DOI [DOI 10.1007/978-3-642-31003-45, 10.1007/978-3-642-31003-45]; Ma X, 2002, IEEE ELECTR INSUL M, V18, P37, DOI 10.1109/57.995398; Marsland S., 2014, MACHINE LEARNING ALG; Mertins A., 2001, SIGNAL ANAL, P210, DOI [10.1002/0470841834.ch8., DOI 10.1002/0470841834.CH8]; MORLET J, 1982, GEOPHYSICS, V47, P203, DOI 10.1190/1.1441328; MORSE DH, 1970, NATURE, V226, P659, DOI 10.1038/226659a0; Najafipour A, 2013, IET SCI MEAS TECHNOL, V7, P112, DOI 10.1049/iet-smt.2012.0113; Patil S, 2014, INT J COMPUT SCI NET, V14, P56; Pedersen M., 2007, MULTICHANNEL SPEECH, P1065; Potamitis I, 2014, APPL ACOUST, V80, P1, DOI 10.1016/j.apacoust.2014.01.001; Priyadarshani PGN, 2012, MIDWEST SYMP CIRCUIT, P892, DOI 10.1109/MWSCAS.2012.6292164; Ren Y, 2008, J ACOUST SOC AM, V124, P316, DOI 10.1121/1.2932070; Selin A, 2007, EURASIP J APPL SIG P, V1, P141; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R., 2013, IEEE CIRC SYST MAG, V4, P459; Shim I, 2001, IEEE ELECTR INSUL M, V17, P6, DOI 10.1109/57.901611; Shufei Duan, 2011, Proceedings of the 2011 Seventh International Conference on Intelligent Sensors, Sensor Networks and Information Processing (ISSNIP), P514, DOI 10.1109/ISSNIP.2011.6146597; Somervuo P, 2006, IEEE T AUDIO SPEECH, V14, P2252, DOI 10.1109/TASL.2006.872624; Swiston KA, 2009, J FIELD ORNITHOL, V80, P42, DOI 10.1111/j.1557-9263.2009.00204.x; Tsai SJS, 2002, POWER TRANSFORMER PA; Turunen J, 2006, ADV BIOACOUSTICS; Vaisman S, 2012, COMPUT BIOL MED, V42, P171, DOI 10.1016/j.compbiomed.2011.11.005; Varady P, 2001, P ANN INT IEEE EMBS, V23, P1846, DOI 10.1109/IEMBS.2001.1020582; Vaseghi S.V., 2008, ADV DIGITAL SIGNAL P; Wang D, 2011, EXPERT SYST APPL, V38, P14314, DOI 10.1016/j.eswa.2011.05.096	44	31	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146790	10.1371/journal.pone.0146790	http://dx.doi.org/10.1371/journal.pone.0146790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812391	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000014
J	Wang, L; Shao, HL; Luo, XH; Wang, R; Li, YF; Li, YN; Luo, YP; Chen, ZX				Wang, Li; Shao, Huili; Luo, Xiaohu; Wang, Ren; Li, Yongfu; Li, Yanan; Luo, Yingpeng; Chen, Zhengxing			Effect of Ozone Treatment on Deoxynivalenol and Wheat Quality	PLOS ONE			English	Article							FUSARIUM MYCOTOXINS NIVALENOL; AFLATOXIN B-1; PHYSICOCHEMICAL PROPERTIES; TRICHOTHECENE MYCOTOXINS; OZONATED WATER; FUMONISIN B-1; HEAD BLIGHT; DEGRADATION; FLOUR; GRAIN	Deoxynivalenol (DON) is a secondary metabolite produced by Fusarium fungi, which is found in a wide range of agricultural products, especially in wheat, barley, oat and corn. In this study, the distribution of DON in the wheat kernel and the effect of exposure time to ozone on DON detoxification were investigated. A high concentration of toxin was found in the outer part of the kernel, and DON was injected from the outside to the inside. The degradation rates of DON were 26.40%, 39.16%, and 53.48% after the samples were exposed to 75 mg/L ozone for 30, 60, and 90 min, respectively. The effect of ozonation on wheat flour quality and nutrition was also evaluated. No significant differences (P > 0.05) were found in protein content, fatty acid value, amino acid content, starch content, carbonyl and carboxyl content, and swelling power of ozone-treated samples. Moreover, the ozone-treated samples exhibited higher tenacity and whiteness, as well as lower extensibility and yellowness. This finding indicated that ozone treatment can simultaneously reduce DON levels and improve flour quality.	[Wang, Li; Wang, Ren; Chen, Zhengxing] Jiangnan Univ, Collaborat Innovat Ctr Food Safety & Qual Control, State Key Lab Food Sci & Technol, Key Lab Carbohydrate Chem & Biotechnol,Minist Edu, Wuxi 214122, Jiangsu, Peoples R China; [Wang, Li; Shao, Huili; Luo, Xiaohu; Wang, Ren; Li, Yongfu; Li, Yanan; Luo, Yingpeng; Chen, Zhengxing] Jiangnan Univ, Sch Food Sci & Technol, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Wang, L; Chen, ZX (corresponding author), Jiangnan Univ, Collaborat Innovat Ctr Food Safety & Qual Control, State Key Lab Food Sci & Technol, Key Lab Carbohydrate Chem & Biotechnol,Minist Edu, Wuxi 214122, Jiangsu, Peoples R China.; Wang, L; Chen, ZX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Natl Engn Lab Cereal Fermentat Technol, Wuxi 214122, Jiangsu, Peoples R China.	legend0318@hotmail.com; zxchen_2008@126.com			Special Fund for Grain-Scientific Research in the Public Interest of China [201313005]; Special Fund for Agro-Scientific Research in the Public Interest of China [201203037]; National Natural Science Foundation of China [31371874, 31171785, 31201381, 31471616, 31501579]; Fundamental Research Funds for the Central Universities [JUSRP11510]; National Key Technology RD Program [2012BAD34B02]; Jiangsu Province science and technology support project [BE2012404, BE2012428]	Special Fund for Grain-Scientific Research in the Public Interest of China; Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Technology RD Program(National Key Technology R&D Program); Jiangsu Province science and technology support project	This research was financially supported by the Special Fund for Grain-Scientific Research in the Public Interest of China (201313005), Special Fund for Agro-Scientific Research in the Public Interest of China (201203037), National Natural Science Foundation of China (31371874, 31171785, 31201381, 31471616, 31501579), Fundamental Research Funds for the Central Universities (JUSRP11510), National Key Technology R&D Program (2012BAD34B02), Jiangsu Province science and technology support project (BE2012404 & BE2012428).	ABBAS HK, 1985, APPL ENVIRON MICROB, V50, P482, DOI 10.1128/AEM.50.2.482-486.1985; Akbas MY, 2006, J SCI FOOD AGR, V86, P2099, DOI 10.1002/jsfa.2579; American Association of Cereal Chemists, 2000, APPR METH AM ASS CER, V10th ed.; Bata A, 1999, TRENDS FOOD SCI TECH, V10, P223, DOI 10.1016/S0924-2244(99)00050-3; Blandino M, 2006, EUR J AGRON, V25, P193, DOI 10.1016/j.eja.2006.05.001; Brera C, 2004, J FOOD PROTECT, V67, P1261, DOI 10.4315/0362-028X-67.6.1261; Cabanas R, 2008, FOOD MICROBIOL, V25, P642, DOI 10.1016/j.fm.2008.04.003; CAULFIELD MJ, 1979, CANCER RES, V39, P2155; Chan HT, 2009, J AGR FOOD CHEM, V57, P5965, DOI 10.1021/jf9008789; Chattopadhyay S, 1997, CARBOHYD POLYM, V34, P203, DOI 10.1016/S0144-8617(97)87306-7; Chen R, 2014, FOOD CHEM, V146, P284, DOI 10.1016/j.foodchem.2013.09.059; Chittrakorn S, 2008, USE OZONE ALTERNATIV; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Cullen PJ, 2009, TRENDS FOOD SCI TECH, V20, P125, DOI 10.1016/j.tifs.2009.01.049; de Alencar ER, 2012, J SCI FOOD AGR, V92, P899, DOI 10.1002/jsfa.4668; Desvignes C, 2008, J CEREAL SCI, V47, P245, DOI 10.1016/j.jcs.2007.04.004; Dexter JE, 1996, CEREAL CHEM, V73, P695; Diao EJ, 2012, J AGR FOOD CHEM, V60, P9364, DOI 10.1021/jf302528e; Ding WP, 2015, INT J FOOD SCI TECH, V50, P744, DOI 10.1111/ijfs.12691; DWARAKANATH CT, 1968, J AM OIL CHEM SOC, V45, P93, DOI 10.1007/BF02890715; Food and Drug Administration, 2001, FED REGISTER, V66, P33829; GB/T, 2009, DET DEOX FOOD HIGH P; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; IARC, 1993, SOM NAT OCC SUBST FO, P397; Ibanoglu S, 2001, J FOOD ENG, V48, P345, DOI 10.1016/S0260-8774(00)00177-1; Inan F, 2007, J STORED PROD RES, V43, P425, DOI 10.1016/j.jspr.2006.11.004; Indrani D, 2007, J FOOD ENG, V78, P1202, DOI 10.1016/j.jfoodeng.2005.12.032; Jackson LS, 2012, WORLD MYCOTOXIN J, V5, P251, DOI 10.3920/WMJ2012.1431; Katta SK, 1997, CEREAL CHEM, V74, P858, DOI 10.1094/CCHEM.1997.74.6.858; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; Kuakpetoon D, 2001, STARCH-STARKE, V53, P211, DOI 10.1002/1521-379X(200105)53:5<211::AID-STAR211>3.0.CO;2-M; Lancova K, 2008, FOOD ADDIT CONTAM A, V25, P650, DOI 10.1080/02652030701660536; LEE US, 1987, J AGR FOOD CHEM, V35, P126, DOI 10.1021/jf00073a027; Li MM, 2015, FOOD ADDIT CONTAM A, V32, P544, DOI 10.1080/19440049.2014.976596; Li M, 2013, INNOV FOOD SCI EMERG, V20, P223, DOI 10.1016/j.ifset.2013.06.004; Luo XH, 2014, FOOD CONTROL, V37, P171, DOI 10.1016/j.foodcont.2013.09.043; Luo XH, 2013, FOOD CONTROL, V31, P331, DOI 10.1016/j.foodcont.2012.10.030; MCCORMICK KM, 1991, AUST J AGR RES, V42, P317, DOI 10.1071/AR9910317; McDonough MX, 2011, J STORED PROD RES, V47, P249, DOI 10.1016/j.jspr.2011.04.001; Mendez F, 2003, J STORED PROD RES, V39, P33, DOI 10.1016/S0022-474X(02)00015-2; Naito S, 1989, NIPPON SHOKHIN KOGYO, V36, P878; Nations. FaAOotU, 2004, 1 FAAOOTU; Park DL, 2002, ADV EXP MED BIOL, V504, P173; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Proctor AD, 2004, FOOD ADDIT CONTAM A, V21, P786, DOI 10.1080/02652030410001713898; Richard Y, 1984, HDB OZONE TECHNOLOGY; Rose DJ, 2008, CEREAL CHEM, V85, P218, DOI 10.1094/CCHEM-85-2-0218; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Rupollo G, 2011, CARBOHYD POLYM, V86, P1403, DOI 10.1016/j.carbpol.2011.06.055; Sandhu HPS, 2012, CARBOHYD POLYM, V87, P1261, DOI 10.1016/j.carbpol.2011.09.003; Sandhu HPS, 2011, J SCI FOOD AGR, V91, P1576, DOI 10.1002/jsfa.4350; Sangseethong K, 2010, CARBOHYD POLYM, V82, P446, DOI 10.1016/j.carbpol.2010.05.003; Savi GD, 2014, J STORED PROD RES, V59, P245, DOI 10.1016/j.jspr.2014.03.008; Scussel VM, 2011, INT J ANAL CHEM, P1687; Smith R.J., 1967, STARCH CHEM TECHNOLO, VII, P620; TANAKA T, 1988, J AGR FOOD CHEM, V36, P979, DOI 10.1021/jf00083a019; Tiwari BK, 2010, J CEREAL SCI, V51, P248, DOI 10.1016/j.jcs.2010.01.007; Vanier NL, 2012, FOOD CHEM, V131, P1255, DOI 10.1016/j.foodchem.2011.09.114; Violleau F, 2012, J CEREAL SCI, V55, P392, DOI 10.1016/j.jcs.2012.01.014; Visconti A, 2004, TOXICOL LETT, V153, P181, DOI 10.1016/j.toxlet.2004.04.032; Wang Y, 2008, J AGR FOOD CHEM, V56, P7942, DOI 10.1021/jf801562v; Wijnands L.M., 2000, 257852004 RIVM; Yeh AI, 1999, CEREAL CHEM, V76, P614, DOI 10.1094/CCHEM.1999.76.5.614; Young JC, 2006, FOOD CHEM TOXICOL, V44, P417, DOI 10.1016/j.fct.2005.08.015; YOUNG JC, 1984, J AGR FOOD CHEM, V32, P659, DOI 10.1021/jf00123a058; YOUNG JC, 1986, J AGR FOOD CHEM, V34, P461, DOI 10.1021/jf00069a021; Zhang HJ, 2014, FOOD CONTROL, V44, P86, DOI 10.1016/j.foodcont.2014.03.037; Zheng YZ, 2014, FOOD CONTROL, V40, P193, DOI 10.1016/j.foodcont.2013.11.043; Zhong YueTong, 2008, China Tropical Medicine, V8, P132; Zorlugenc B, 2008, FOOD CHEM TOXICOL, V46, P3593, DOI 10.1016/j.fct.2008.09.003	71	53	57	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147613	10.1371/journal.pone.0147613	http://dx.doi.org/10.1371/journal.pone.0147613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812055	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000043
J	Xie, DH; Yang, TB; Liu, ZY; Wang, H				Xie, Donghua; Yang, Tubao; Liu, Zhiyu; Wang, Hua			Epidemiology of Birth Defects Based on a Birth Defect Surveillance System from 2005 to 2014 in Hunan Province, China	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; METAANALYSIS; PREVENTION; PREVALENCE; DISEASE	Objective To describe the epidemiology of birth defects (BDs) in perinatal infants in Hunan Province, China, between 2005 and 2014. Methods The BD surveillance data of perinatal infants (for stillbirth, dead fetus or live birth between 28 weeks of gestation and 7 days after birth) were collected from 52 registered hospitals of Hunan between 2005 and 2014. The prevalence rates of BDs with 95% confidence interval (CI) and crude odds ratio (ORs) were calculated to examine the associations of infant gender, maternal age, and region (urban vs rural) with BDs. Results From 2005 to 2014, there were a total of 925413 perinatal infants of which 17753 had BDs, with the average prevalence of 191.84 per 10000 PIs (perinatal infants), showing a significant uptrend. The risks of BDs are higher in urban areas versus rural areas (OR = 1.20), in male infants versus female infants (OR = 1.19), and in mothers above age 35 versus those below age 35 (OR = 1.24). The main five types of BDs are Congenital heart defects (CHD), Other malformation of external ear (OMEE), Polydactyly, Congenital malformation of kidney (CMK), and Congenital talipes equinovarus (CTE). From 2005 to 2014, the prevalence rates (per 10000 PIs) of CHD and CMK increased significantly from 22.56 to 74 (OR = 3.29, 95% CI: 2.65-4.11) and from 7.61 to 14.62 (OR = 1.92, 95% CI: 1.30-2.84), respectively; the prevalence rates of congenital hydrocephalus and neural tube defects (NTDs) decreased significantly from 11.8 to 5.29 (OR = 0.45, 95% CI: 0.31-0.65) and from 7.87 to 1.74 (OR = 0.22, 95% CI: 0.13-0.38), respectively. Conclusions The prevalence rates of specific BDs in perinatal infants in Hunan have changed in the last decade. Urban pregnant women, male perinatal infants, and mothers above age 35 present different prevalence rates of BDs. Wider use of new diagnosis technology, improving the ability of monitoring, strengthening the publicity and education are important to reduce the prevalence of BDs.	[Xie, Donghua; Yang, Tubao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Xie, Donghua; Liu, Zhiyu; Wang, Hua] Maternal & Children Hosp Hunan Prov, Dept Informat Management, 58 Xiangchun Rd, Changsha 410078, Hunan, Peoples R China	Central South University	Xie, DH; Yang, TB (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.; Xie, DH (corresponding author), Maternal & Children Hosp Hunan Prov, Dept Informat Management, 58 Xiangchun Rd, Changsha 410078, Hunan, Peoples R China.	Yangtbcsu@163.com						Annas GJ, 1999, AM J PUBLIC HEALTH, V89, P98, DOI 10.2105/AJPH.89.1.98; [Anonymous], 1999, N Engl J Med, V341, P1864; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Carmona RH, 2005, LANCET, V366, P1142, DOI 10.1016/S0140-6736(05)67459-4; Czeizel Andrew E, 2005, Int J Med Sci, V2, P91; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Garne E, 2004, SCAND CARDIOVASC J, V38, P357, DOI 10.1080/14017430410024379; Garne E, 2010, BJOG-INT J OBSTET GY, V117, P660, DOI 10.1111/j.1471-0528.2010.02531.x; ICBDMS, 2007, INT CLEAR BIRTH DEF; International clearinghouse for birth defects monitoring systems, 1998, TERATOLOGY, V57, P30; Li C., 2012, MINISTRY HLTH PRC, V3, DOI [10.46234/ccdcw2021.191, DOI 10.46234/CCDCW2021.191]; Li S, 2003, PAEDIATR PERINAT EP, V17, P287, DOI 10.1046/j.1365-3016.2003.00478.x; Li Shu-ping, 2001, Chinese Journal of Luminescence, V22, P172; Li Ying, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P414; Luo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081369; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Sokal R, 2014, BIRTH DEFECTS RES A, V100, P79, DOI 10.1002/bdra.23218; The foundation of March of Dimes in American, 2006, GLOB REP BIRTH DEF; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wu JL, 2008, BIOMED ENVIRON SCI, V21, P432, DOI 10.1016/S0895-3988(08)60065-3; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131874; Xu Xiao-Yan, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P350; Yang M, 2015, J MATERN-FETAL NEO M, V28, P799, DOI 10.3109/14767058.2014.932767; Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123	27	39	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147280	10.1371/journal.pone.0147280	http://dx.doi.org/10.1371/journal.pone.0147280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812057	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000027
J	Fukumoto, J; Cox, R; Fukumoto, I; Cho, Y; Parthasarathy, PT; Galam, L; Lockey, RF; Kolliputi, N				Fukumoto, Jutaro; Cox, Ruan, Jr.; Fukumoto, Itsuko; Cho, Young; Parthasarathy, Prasanna Tamarapu; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah			Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury	PLOS ONE			English	Article							SIGNAL-REGULATING KINASE-1; II EPITHELIAL-CELLS; APOPTOSIS; MACROPHAGES; ACTIVATION; PATHWAYS; INFLAMMATION; RELEASE; DEATH; GENE	Apoptosis signal-regulating kinase 1 (ASK1), a member of the MAPK kinase kinase kinase (MAP3K) family, is activated by various stimuli, which include oxidative stress, endoplasmic reticulum (ER) stress, calcium influx, DNA damage-inducing agents and receptor-mediated signaling through tumor necrosis factor receptor (TNFR). Inspiration of a high concentration of oxygen is a palliative therapy which counteracts hypoxemia caused by acute lung injury (ALI)-induced pulmonary edema. However, animal experiments so far have shown that hyperoxia itself could exacerbate ALI through reactive oxygen species (ROS). Our previous data indicates that ASK1 plays a pivotal role in hyperoxia-induced acute lung injury (HALI). However, it is unclear whether or not deletion of ASK1 in vivo protects against HALI. In this study, we investigated whether ASK1 deletion would lead to attenuation of HALI. Our results show that ASK1 deletion in vivo significantly suppresses hyperoxia-induced elevation of inflammatory cytokines (i.e. IL-1 beta and TNF-alpha), cell apoptosis in the lung, and recruitment of immune cells. In summary, the results from the study suggest that deletion of ASK1 in mice significantly inhibits hyperoxic lung injury.	[Fukumoto, Jutaro; Cox, Ruan, Jr.; Fukumoto, Itsuko; Cho, Young; Parthasarathy, Prasanna Tamarapu; Galam, Lakshmi; Lockey, Richard F.; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; [Cox, Ruan, Jr.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kolliputi, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA.	nkollipu@health.usf.edu			National Institutes of Health [HL105932]; Joy McCann Culverhouse Endowment; American Heart Association [14POST18200004, 13PRE17070137]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joy McCann Culverhouse Endowment; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health R01 grant HL105932 (NK), Joy McCann Culverhouse Endowment (NK) (http://health.usf.edu/medicine/internalmedicine/allergy/overviewoftheairwaycenter), American Heart Association postdoctoral fellowship award 14POST18200004 (JF), and American Heart Association predoctoral fellowship award 13PRE17070137 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox RR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00445; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Galam L, 2015, FREE RADICAL BIO MED, V84, P196, DOI 10.1016/j.freeradbiomed.2015.03.036; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hayakawa R, 2012, P JPN ACAD B-PHYS, V88, P434, DOI 10.2183/pjab.88.434; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kolliputi N, 2009, AM J RESP CELL MOL, V40, P314, DOI 10.1165/rcmb.2007-0287OC; Lagishetty V, 2014, AM J PHYSIOL-CELL PH, V306, pC999, DOI 10.1152/ajpcell.00064.2013; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Makena PS, 2012, AM J RESP CELL MOL, V46, P461, DOI 10.1165/rcmb.2011-0234OC; Marques LJ, 1997, AM J RESP CRIT CARE, V156, P1700, DOI 10.1164/ajrccm.156.5.9611052; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mo JS, 2013, P NATL ACAD SCI USA, V110, P6865, DOI 10.1073/pnas.1209078110; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Noguchi T, 2008, J ORAL BIOSCI, V50, P107, DOI 10.2330/joralbiosci.50.107; Nyunoya T, 2005, J BIOL CHEM, V280, P26295, DOI 10.1074/jbc.M500185200; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Phillips O, 2015, AM J RESP CELL MOL B; Savill J, 1997, BRIT MED BULL, V53, P491; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Watanabe T, 2005, BIOCHEM BIOPH RES CO, V333, P562, DOI 10.1016/j.bbrc.2005.05.151; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Yamada T, 2007, PULM PHARMACOL THER, V20, P650, DOI 10.1016/j.pupt.2006.07.004; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021	32	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147652	10.1371/journal.pone.0147652	http://dx.doi.org/10.1371/journal.pone.0147652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807721	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800169
J	Jiao, Y; Ma, S; Wang, YR; Li, J; Shan, LQ; Liu, Q; Liu, Y; Song, Q; Yu, F; Yu, HH; Liu, H; Huang, L; Chen, JH				Jiao, Yang; Ma, Sai; Wang, Yirong; Li, Jing; Shan, Lequn; Liu, Qian; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Huang, Li; Chen, Jihua			N-Acetyl Cysteine Depletes Reactive Oxygen Species and Prevents Dental Monomer-Induced Intrinsic Mitochondrial Apoptosis In Vitro in Human Dental Pulp Cells	PLOS ONE			English	Article							METHACRYLATE-INDUCED APOPTOSIS; HUMAN GINGIVAL FIBROBLASTS; CYTOCHROME-C RELEASE; 2-HYDROXYETHYL METHACRYLATE; RESIN MONOMERS; PHOSPHOLIPID LIPOSOMES; SUPEROXIDE DISMUTASES; OXIDATIVE STRESS; REDOX REGULATION; ADDUCT FORMATION	Purpose To investigate the involvement of intrinsic mitochondrial apoptosis in dental monomer-induced cytotoxicity and the influences of N/acetyl cysteine (NAC) on this process. Methods Human dental pulp cells (hDPCs) were exposed to several dental monomers in the absence or presence of NAC, and cell viability, intracellular redox balance, morphology and function of mitochondria and key indicators of intrinsic mitochondrial apoptosis were evaluated using various commercial kits. Results Dental monomers exerted dose-dependent cytotoxic effects on hDPCs. Concomitant to the over-production of reactive oxygen species (ROS) and depletion of glutathione (GSH), differential changes in activities of superoxide dismutase, glutathione peroxidase, and catalase were detected. Apoptosis, as indicated by positive Annexin V/propidium iodide (PI) staining and activation of caspase-3, was observed after dental monomer treatment. Dental monomers impaired the morphology and function of mitochondria, and induced intrinsic mitochondrial apoptosis in hDPCs via up-regulation of p53, Bax and cleaved caspase-3, and down-regulation of Bcl-2. NAC restored cell viability, relieved oxidative stress and blocked the apoptotic effects of dental monomers. Conclusions Dental monomers induced oxidative stress and mitochondrial intrinsic apoptosis in hDPCs. NAC could reduce the oxidative stress and thus protect hDPCs against dental monomer-induced apoptosis.	[Jiao, Yang; Ma, Sai; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Chen, Jihua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Jiao, Yang; Ma, Sai; Wang, Yirong; Liu, Ying; Song, Qian; Yu, Fan; Yu, Haohan; Liu, Huan; Chen, Jihua] Shaanxi Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Wang, Yirong] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed Oncol, Xian 710032, Peoples R China; [Shan, Lequn] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China; [Liu, Qian] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.; Chen, JH (corresponding author), Shaanxi Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.	jhchen@fmmu.edu.cn	Yu, Fan/GXF-5805-2022; song, qian/HDL-9868-2022	Yu, Fan/0000-0002-9917-593X; Chen, Ji-hua/0000-0002-1151-0693	Natural Science Foundation of Shaanxi Province [2015JQ8301]; National Nature Science Foundation of China [81130078, 81300927, 81272072, 81200816]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT13051]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was financially supported by grant 2015JQ8301 (principal investigator SM) from the Natural Science Foundation of Shaanxi Province, grant 81130078 (principal investigator JC), grant 81300927 (principal investigator SM), grant 81272072 (principal investigator LS) and grant 81200816 (principal investigator LH) from the National Nature Science Foundation of China, and Program No. IRT13051 from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Demarco FF, 2012, DENT MATER, V28, P87, DOI 10.1016/j.dental.2011.09.003; Eckhardt A, 2010, DENT MATER, V26, P232, DOI 10.1016/j.dental.2009.10.005; Engelmann J, 2004, BIOMATERIALS, V25, P4573, DOI 10.1016/j.biomaterials.2003.11.048; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FUJISAWA S, 1988, J DENT RES, V67, P1438, DOI 10.1177/00220345880670111501; FUJISAWA S, 1984, J BIOMED MATER RES, V18, P1105, DOI 10.1002/jbm.820180912; Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x; Jiao Y, 2015, MED SCI MONITOR, V21, P3197, DOI 10.12659/MSM.895628; Jiao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135815; Jiao Y, 2015, PEERJ, V3, DOI 10.7717/peerj.868; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kim JH, 2010, FOOD CHEM TOXICOL, V48, P807, DOI 10.1016/j.fct.2009.12.012; Kim NR, 2011, J BIOMED MATER RES B, V98B, P300, DOI 10.1002/jbm.b.31852; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Krifka S, 2012, CLIN ORAL INVEST, V16, P215, DOI 10.1007/s00784-010-0508-5; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Paranjpe A, 2008, J ENDODONT, V34, P1191, DOI 10.1016/j.joen.2008.06.011; Ramp U, 2003, BRIT J CANCER, V88, P1800, DOI 10.1038/sj.bjc.6600984; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schweikl H, 2007, DENT MATER, V23, P688, DOI 10.1016/j.dental.2006.06.021; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2001, J DENT RES, V80, P1615, DOI 10.1177/00220345010800070401; Schweikl H, 2014, BIOMATERIALS, V35, P2890, DOI 10.1016/j.biomaterials.2013.12.044; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Song XD, 2011, BIOL PHARM BULL, V34, P839, DOI 10.1248/bpb.34.839; Spagnuolo G, 2013, DENT MATER, V29, pE153, DOI 10.1016/j.dental.2013.04.023; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Urcan E, 2010, BIOMATERIALS, V31, P2010, DOI 10.1016/j.biomaterials.2009.11.065; Volk J, 2006, DENT MATER, V22, P499, DOI 10.1016/j.dental.2005.06.002; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5	42	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147858	10.1371/journal.pone.0147858	http://dx.doi.org/10.1371/journal.pone.0147858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808507	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800232
J	Kretschmar, C; Oyarzun, C; Villablanca, C; Jaramillo, C; Alarcon, S; Perez, G; Diaz-Encarnacion, MM; Pastor-Anglada, M; Garrido, W; Quezada, C; Martin, RS				Kretschmar, Catalina; Oyarzun, Carlos; Villablanca, Cristopher; Jaramillo, Catherinne; Alarcon, Sebastian; Perez, Gustavo; Diaz-Encarnacion, Montserrat M.; Pastor-Anglada, Marcal; Garrido, Wallys; Quezada, Claudia; San Martin, Rody			Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; TO-MESENCHYMAL TRANSITION; EXPRESSION LEVEL; RECEPTORS; INSULIN; KIDNEY; MYOFIBROBLASTS; INTERVENTION; INFLAMMATION; INHIBITION	Altered nucleoside levels may be linked to pathogenic signaling through adenosine receptors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kidney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the equilibrative nucleoside transporter 1 (ENT1) in proximal tubule cells. In addition, a correlation between increased plasma content of adenosine and a marker of renal fibrosis in diabetic rats was evidenced. At the cellular level, exposure of HK2 cells to high glucose, TGF-beta and the general adenosine receptor agonist NECA, induced the expression of profibrotic cell activation markers alpha-SMA and fibronectin. These effects can be avoided by using a selective antagonist of the adenosine A(3) receptor subtype in vitro. Furthermore, induction of fibrosis marker alpha-SMA was prevented by the A(3) receptor antagonist in diabetic rat kidneys. In conclusion, we evidenced the contribution of purinergic signaling to renal fibrosis in experimental diabetic nephropathy.	[Kretschmar, Catalina; Oyarzun, Carlos; Villablanca, Cristopher; Jaramillo, Catherinne; Alarcon, Sebastian; Perez, Gustavo; Garrido, Wallys; Quezada, Claudia; San Martin, Rody] Univ Austral Chile, Fac Sci, Inst Microbiol & Biochem, Valdivia, Chile; [Diaz-Encarnacion, Montserrat M.] Biomed Res Inst St Pau IIB St Pau, Nephrol Serv Fdn Puigvert, Barcelona, Spain; [Pastor-Anglada, Marcal] Univ Barcelona, Dept Biochem & Mol Biol, Natl Biomed Res Inst Liver & Gastrointestinal Dis, Inst Biomed & Oncol Programme, Barcelona, Spain	Universidad Austral de Chile; Fundacio Puigvert; University of Barcelona	Martin, RS (corresponding author), Univ Austral Chile, Fac Sci, Inst Microbiol & Biochem, Valdivia, Chile.	rodysanmartin@uach.cl	Pastor-Anglada, Marçal/C-3730-2017	Pastor-Anglada, Marçal/0000-0003-3712-1773; Jaramillo, Catherinne/0000-0002-0538-2912; Alarcon, Sebastian/0000-0002-8413-8028	FONDECYT from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile) [1130414, 3150548, 1121121]; Universidad Austral de Chile [S-2013-15]; Ministerio de Economia de Espana [SAF2011-23660]; Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile)	FONDECYT from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile); Universidad Austral de Chile; Ministerio de Economia de Espana; Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile)	Funded by grants FONDECYT 1130414 to RSM, 3150548 to WG and 1121121 to CQ from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile), www.conicyt.cl. Funded by grant S-2013-15 to CO from Universidad Austral de Chile, www.uach.cl. Funded by grant SAF2011-23660 to MPA from Ministerio de Economia de Espana, www.mineco.gob.es. SA hold doctoral fellowship from Comision Nacional de Ciencia y Tecnologia-Chile (CONICYT-Chile), www.conicyt.cl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley MA, 2003, J PHYSIOL-LONDON, V548, P507, DOI 10.1113/jphysiol.2002.038091; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Farias M, 2006, J CELL PHYSIOL, V208, P451, DOI 10.1002/jcp.20680; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Guillen-Gomez E, 2012, J CELL PHYSIOL, V227, P1521, DOI 10.1002/jcp.22869; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Lee J, 2013, AM J PATHOL, V183, P1488, DOI 10.1016/j.ajpath.2013.07.010; Mubagwa K, 2001, CARDIOVASC RES, V52, P25, DOI 10.1016/S0008-6363(01)00358-3; Munoz G, 2006, J CELL PHYSIOL, V209, P826, DOI 10.1002/jcp.20769; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Pawelczyk T, 2003, MOL PHARMACOL, V63, P81, DOI 10.1124/mol.63.1.81; Pedagogos E, 1997, AM J KIDNEY DIS, V29, P912, DOI 10.1016/S0272-6386(97)90466-2; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Quezada C, 2013, CURR DRUG TARGETS, V14, P490; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Riksen NP, 2005, ARTERIOSCL THROM VAS, V25, P109, DOI 10.1161/01.ATV.0000150651.85907.69; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Sakowicz M, 2004, BIOCHEM PHARMACOL, V68, P1309, DOI 10.1016/j.bcp.2004.06.020; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Sonoki K, 2003, EUR J PHARMACOL, V475, P139, DOI 10.1016/S0014-2999(03)02109-5; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tak E, 2014, J AM SOC NEPHROL, V25, P547, DOI 10.1681/ASN.2012101014; Vallon V, 2009, NEPHRON PHYSIOL, V111, P30, DOI 10.1159/000208211; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Xia JF, 2010, CLIN BIOCHEM, V43, P957, DOI 10.1016/j.clinbiochem.2010.05.013; Xia JF, 2009, J CHROMATOGR B, V877, P1930, DOI 10.1016/j.jchromb.2009.05.047; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	50	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147430	10.1371/journal.pone.0147430	http://dx.doi.org/10.1371/journal.pone.0147430			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808537	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800093
J	Ng, JYS; Wong, ML				Ng, Junice Y. S.; Wong, Mee-Lian			Determinants of Heterosexual Adolescents Having Sex with Female Sex Workers in Singapore	PLOS ONE			English	Article							MALE CLIENTS; CONDOM USE; PROTECTIVE FACTORS; SELF-ESTEEM; RISK; BEHAVIORS; HIV; PREVALENCE; ATTITUDES	Objectives We assessed the proportion of and socio-ecological factors associated with ever having had sex with female sex workers (FSWs) among heterosexual adolescents. We also described the characteristics of the adolescents who reported inconsistent condom use with FSWs. Methods This is a cross-sectional study (response rate: 73%) of 300 heterosexually active male adolescents of 16 to 19 years attending a national STI clinic in Singapore between 2009 and 2014. We assessed the ecological factors (individual, parental, peer, school and medial influences) and sexual risk behaviors using a self-reported questionnaire. Poisson regression was used to obtain the adjusted prevalence ratios (aPR) and confidence intervals (CI). Results The proportion of heterosexual male adolescents who had ever had sex with FSWs was 39%. Multivariate analysis showed that significant factors associated with ever having had sex with FSWs were sex initiation before 16 years old (aPR 1.79 CI: 1.30-2.46), never had a sexually active girlfriend (aPR 1.75 CI 1.28-2.38), reported lower self-esteem score (aPR 0.96 CI: 0.93-0.98), higher rebelliousness score (aPR 1.03 CI: 1.00-1.07) and more frequent viewing of pornography (aPR 1.47 CI: 1.04-2.09). Lifetime inconsistent condom use with FSWs was 30%. Conclusions A significant proportion of heterosexual male adolescents attending the public STI clinic had ever had sex with FSWs. A targeted intervention that addresses different levels of influence to this behavior is needed. This is even more so because a considerable proportion of adolescents reported inconsistent condom use with FSWs, who may serve as a bridge of STI transmission to the community. National surveys on adolescent health should include the assessment of frequency of commercial sex visits and condom use with FSWs for long-term monitoring and surveillance.	[Ng, Junice Y. S.; Wong, Mee-Lian] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National University of Singapore	Wong, ML (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	mee_lian_wong@nuhs.edu.sg			National Medical Research Council (NMRC), Singapore	National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study is funded by National Medical Research Council (NMRC), Singapore. There is no conflict of interest. NMRC is NOT involved in 1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication.; We thank the management and staff of DSC clinic who facilitated the study. We also thank Dede Tham and Raymond Lim who assisted in the data collection. The study was part of a behavioral intervention study for adolescents funded by National Medical Research Council.	[Anonymous], 2015, ALL END ADOLESCENTS; [Anonymous], 2014, DSC CLIN 2013 ANN RE; Belza MJ, 2008, SEX TRANSM INFECT, V84, P207, DOI 10.1136/sti.2008.029827; Coughlan E, 2001, INT J STD AIDS, V12, P665, DOI 10.1258/0956462011923895; Decker MR, 2010, JAIDS-J ACQ IMM DEF, V53, P240, DOI 10.1097/QAI.0b013e3181c2fb2e; Goodson P, 2006, J ADOLESCENT HEALTH, V38, P310, DOI 10.1016/j.jadohealth.2005.05.026; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Jackson C, 1998, HEALTH EDUC BEHAV, V25, P319, DOI 10.1177/109019819802500307; Jackson CA, 2012, J PUBLIC HEALTH-UK, V34, pI31, DOI 10.1093/pubmed/fdr113; JESSOR R, 1995, DEV PSYCHOL, V31, P923, DOI 10.1037/0012-1649.31.6.923; Kaestle CE, 2012, PREV SCI, V13, P314, DOI 10.1007/s11121-011-0268-8; KROSNICK JA, 1989, J PERS SOC PSYCHOL, V57, P416, DOI 10.1037/0022-3514.57.3.416; Lavoie F, 2010, ARCH SEX BEHAV, V39, P1147, DOI 10.1007/s10508-010-9605-4; Mahapatra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113599; McLaughlin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071394; MCLAUGHLIN SD, 1983, J MARRIAGE FAM, V45, P47, DOI 10.2307/351294; MIRANDE AM, 1968, J MARRIAGE FAM, V30, P572, DOI 10.2307/349497; Nguyen TTT, 1999, AIDS, V13, P719, DOI 10.1097/00002030-199904160-00013; Robinson ML, 2007, J YOUTH ADOLESCENCE, V36, P453, DOI 10.1007/s10964-006-9116-8; Rosenberg M., 1965, SOC ADOLESCENT SELF, Vxi; Sargent JD, 2001, BRIT MED J, V323, P1394, DOI 10.1136/bmj.323.7326.1394; SMALL SA, 1994, J MARRIAGE FAM, V56, P181, DOI 10.2307/352712; Sok P, 2008, SEX HEALTH, V5, P353, DOI 10.1071/SH08001; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wong ML, 2013, J PEDIATR-US, V162, P574, DOI 10.1016/j.jpeds.2012.08.010; Wong ML, 2009, PEDIATRICS, V124, pE44, DOI 10.1542/peds.2008-2954; Wong ML, 2004, AIDS, V18, P1195, DOI 10.1097/00002030-200405210-00013; Xantidis L, 2000, ARCH SEX BEHAV, V29, P165, DOI 10.1023/A:1001907806062; Yang C, 2010, AIDS CARE, V22, P246, DOI 10.1080/09540120903111437	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147110	10.1371/journal.pone.0147110	http://dx.doi.org/10.1371/journal.pone.0147110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808561	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800051
J	Davis, KC; Allen, J; Duke, J; Nonnemaker, J; Bradfield, B; Farrelly, MC; Shafer, P; Novak, S				Davis, Kevin C.; Allen, Jane; Duke, Jennifer; Nonnemaker, James; Bradfield, Brian; Farrelly, Matthew C.; Shafer, Paul; Novak, Scott			Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington	PLOS ONE			English	Article							CANNABIS	Aims A potential unintended consequence of legalizing recreational marijuana is increased marijuana-related driving impairment. Some states where recreational marijuana is legal have begun implementing interventions to mitigate driving under the influence (DUI) of marijuana, including media campaigns to increase knowledge about DUI laws. However, little is known about the associations between knowledge of DUI laws and marijuana DUI behavior. In this study, we provide new data from a survey of marijuana users in Colorado and Washington to examine associations between marijuana drugged driving and two potential behavioral precursors of marijuana DUI. We also explore other factors that may influence marijuana DUI. Methods Data are from an online survey of marijuana users in Colorado and Washington. Respondents who reported any marijuana use in the past 30 days (n = 865) served as the analytic sample. We examined prevalence of two behavioral outcomes: (1) any driving of a motor vehicle while high in the past year and (2) driving a motor vehicle within 1 hour of using marijuana 5 or more times in the past month. Additional outcomes measuring willingness to drive while high were also assessed. Logistic regressions were used to estimate each outcome as a function of two multi-item scales measuring knowledge of the legal consequences of driving high and perceptions that driving while high is not safe. Additional covariates for potential confounders were included in each model. Results Prevalence of past-year driving while under the influence of marijuana was 43.6% among respondents. The prevalence of driving within 1 hour of using marijuana at least 5 times in the past month was 23.9%. Increased perception that driving high is unsafe was associated with lower odds of past-year marijuana DUI (OR = 0.31, P < 0.01) and lower past-month odds of driving 5 or more times within 1 hour of using marijuana (OR = 0.26, P < 0.01). Increased knowledge of marijuana DUI laws was also associated with lower odds of each of these outcomes (OR = 0.63, P < 0.01, OR = 0.69, P = 0.02, respectively). Post-estimation Wald tests confirmed the negative associations with marijuana DUI were greater in magnitude for safety perceptions than knowledge of DUI laws. Increased perceptions that driving while high is unsafe was associated with significantly lower willingness to drive after using marijuana while increased knowledge of marijuana DUI laws was not associated with these outcomes. Conclusions Despite recent interventions targeting public awareness of the legal consequences of marijuana DUI, our results suggest that knowledge of these laws is a weaker predictor of DUI behavior than perceptions that driving high is unsafe. In addition, safety perceptions predict decreased openness to driving high while knowledge of DUI laws was not associated with openness. These findings suggest that interventions for reducing the incidence of marijuana DUI are likely to be more successful by targeting safety perceptions related to marijuana DUI rather than knowledge of DUI laws. We caution that because these data are limited to an online convenience sample, results may not be generalizable beyond our sample.	[Davis, Kevin C.; Allen, Jane; Duke, Jennifer; Nonnemaker, James; Bradfield, Brian; Farrelly, Matthew C.; Shafer, Paul; Novak, Scott] RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Davis, KC (corresponding author), RTI Int, Res Triangle Pk, NC USA.	kcdavis@rti.org		Appleyard Allen, Jane/0000-0001-7914-1866; Bradfield, Brian/0000-0002-0593-3518; nonnemaker, james/0000-0003-1044-7482; Shafer, Paul/0000-0003-0654-5821; Farrelly, Matthew/0000-0002-6035-1596; Davis, Kevin/0000-0001-8517-1295; duke, jennifer/0000-0002-4643-2429	RTI International	RTI International	This study was funded and conducted independently by RTI International.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Berning A, 2015, J DRUG ADDICT ED ERA; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Colorado Department of Public Health and Environment, 2014, INFL FACT HLTH LIV S; Compton R.P., 2015, J DRUG ADDICTION ED, V11, P29; Couper FJ, 2014, J ANAL TOXICOL, V38, P569, DOI 10.1093/jat/bku090; Danton K., 2003, HEALTH EDUC J, V62, P50, DOI [10.1177/001789690306200106, DOI 10.1177/001789690306200106, DOI 10.1177/001789690306200106GREENE2018]; Ferner M, 2015, OBAMA PREDICTS BRIGH; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gurman S, 2014, COLORADO DEATHS STOK; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hughes T., 2014, MARIJUANA EDIBLES PA; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; MOSKOWITZ H, 1985, ACCIDENT ANAL PREV, V17, P323, DOI 10.1016/0001-4575(85)90034-X; OHanlon JF, 1993, 808078 DOT HS; Salomonsen-Sautel S, 2014, DRUG ALCOHOL DEPEN, V140, P137, DOI 10.1016/j.drugalcdep.2014.04.008; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Terry P, 2005, ADDICT BEHAV, V30, P619, DOI 10.1016/j.addbeh.2004.08.007	19	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146853	10.1371/journal.pone.0146853	http://dx.doi.org/10.1371/journal.pone.0146853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800209	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300042
J	Kersten, B; Rampant, PF; Mader, M; Le Paslier, MC; Bounon, R; Berard, A; Vettori, C; Schroeder, H; Leple, JC; Fladung, M				Kersten, Birgit; Rampant, Patricia Faivre; Mader, Malte; Le Paslier, Marie-Christine; Bounon, Remi; Berard, Aurelie; Vettori, Cristina; Schroeder, Hilke; Leple, Jean-Charles; Fladung, Matthias			Genome Sequences of Populus tremula Chloroplast and Mitochondrion: Implications for Holistic Poplar Breeding	PLOS ONE			English	Article							ORGANELLAR GENOMES; PLASTID GENOMES; SNP MARKERS; GENES; DNA; EXPRESSION; SUBSTITUTION; ANNOTATION; PROTEINS; NUCLEUS	Complete Populus genome sequences are available for the nucleus (P. trichocarpa; section Tacamahaca) and for chloroplasts (seven species), but not for mitochondria. Here, we provide the complete genome sequences of the chloroplast and the mitochondrion for the clones P. tremula W52 and P. tremula x P. alba 717-1B4 (section Populus). The organization of the chloroplast genomes of both Populus clones is described. A phylogenetic tree constructed from all available complete chloroplast DNA sequences of Populus was not congruent with the assignment of the related species to different Populus sections. In total, 3,024 variable nucleotide positions were identified among all compared Populus chloroplast DNA sequences. The 5-prime part of the LSC from trnH to atpA showed the highest frequency of variations. The variable positions included 163 positions with SNPs allowing for differentiating the two clones with P. tremula chloroplast genomes (W52, 717-1B4) from the other seven Populus individuals. These potential P. tremula-specific SNPs were displayed as a whole-plastome barcode on the P. tremula W52 chloroplast DNA sequence. Three of these SNPs and one InDel in the trnH-psbA linker were successfully validated by Sanger sequencing in an extended set of Populus individuals. The complete mitochondrial genome sequence of P. tremula is the first in the family of Salicaceae. The mitochondrial genomes of the two clones are 783,442 bp (W52) and 783,513 bp (717-1B4) in size, structurally very similar and organized as single circles. DNA sequence regions with high similarity to the W52 chloroplast sequence account for about 2% of the W52 mitochondrial genome. The mean SNP frequency was found to be nearly six fold higher in the chloroplast than in the mitochondrial genome when comparing 717-1B4 with W52. The availability of the genomic information of all three DNA-containing cell organelles will allow a holistic approach in poplar molecular breeding in the future.	[Kersten, Birgit; Schroeder, Hilke; Fladung, Matthias] Thunen Inst Forest Genet, Genome Res, Grosshansdorf, Germany; [Rampant, Patricia Faivre; Le Paslier, Marie-Christine; Bounon, Remi; Berard, Aurelie] INRA, URGV Plant Genom Res, Evry, France; [Mader, Malte; Schroeder, Hilke] Thunen Inst Forest Genet, Ecol Genet, Grosshansdorf, Germany; [Vettori, Cristina] CNR, Inst Biosci & Bioresources IBBR, Sesto Fiorentino, Italy; [Leple, Jean-Charles] INRA, Res Unit AGPF, Orleans, France	Johann Heinrich von Thunen Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Johann Heinrich von Thunen Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); INRAE	Kersten, B (corresponding author), Thunen Inst Forest Genet, Genome Res, Grosshansdorf, Germany.	birgit.kersten@ti.bund.de	LEPLE, Jean charles/L-9604-2014; LEPLE, Jean-Charles/AAT-7414-2021; Vettori, Cristina/L-4651-2013	LEPLE, Jean charles/0000-0003-4125-0738; LEPLE, Jean-Charles/0000-0003-4125-0738; Vettori, Cristina/0000-0003-2475-773X; Kersten, Birgit/0000-0001-9900-9133; Fladung, Matthias/0000-0001-9301-8581; Mader, Malte/0000-0002-4808-2717	Federal Ministry of Education and Research [0315914A]; Agence Nationale pour la Recherche [ANR-2010-KBBE-007-01]; Thuenen Institute; INRA; CNR	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Thuenen Institute; INRA; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by the Federal Ministry of Education and Research (http://www.bmbf.de/en/) [Grant 0315914A] and by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/en/) [ANR-2010-KBBE-007-01] in the scope of the project "Tree For Joules" within the program "Transnational Plant Alliance for Novel Technologies" (PLANT-KBBE). This work was further supported by the Thuenen Institute, INRA and CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Adams KL, 2001, GENETICS, V158, P1289; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARRETT JW, 1993, GENOME, V36, P87, DOI 10.1139/g93-012; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Chen Ke, 2011, Scientific Research and Essays, V6, P4048; Dereeper A, 2015, NUCLEIC ACIDS RES, V43, pW295, DOI 10.1093/nar/gkv351; Dickmann D, 1993, CULTURE POPLARS E N; Eckenwalder James E., 1996, P7; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; GALLO LA, 1985, SILVAE GENET, V34, P208; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; Hanner R., 2009, DATA STANDARDS BARCO; Heinze B., 1998, Forest Genetics, V5, P31; Huang DI, 2014, NEW PHYTOL, V204, P693, DOI 10.1111/nph.12956; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kersten B, 2015, TREES-STRUCT FUNCT, V29, P575, DOI 10.1007/s00468-014-1136-5; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; Lemoine M, 1973, THESIS U NANCY FRANC; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Licht LA, 2005, BIOMASS BIOENERG, V28, P203, DOI 10.1016/j.biombioe.2004.08.015; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; Okumura S, 2006, TRANSGENIC RES, V15, P637, DOI 10.1007/s11248-006-9009-3; PopGenIE, POP GEN INT EXPL V3; RAJORA OP, 1992, CURR GENET, V22, P141, DOI 10.1007/BF00351474; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Sabir JSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094158; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schroeder H, 2012, PLANT BIOLOGY, V14, P374, DOI 10.1111/j.1438-8677.2011.00502.x; Schroeder H, 2010, SILVAE GENET, V59, P257, DOI 10.1515/sg-2010-0036; SCHROEDER H, 2011, BMC P, V5, P56, DOI DOI 10.1186/1753-6561-5-S7-P56; Schroeder H, 2015, IFOREST, V8, P544, DOI 10.3832/ifor1326-007; Shearman JR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-45; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Skuza L, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P553, DOI 10.5772/52028; Slavov GT, 2010, PLANT GENET GENOMICS, V8, P15, DOI 10.1007/978-1-4419-1541-2_2; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Stanton BJ, 2010, GENETICS GENOMICS PO, P368; Stettler R.F., 1996, BIOL POPULUS ITS IMP; Stoppel R, 2013, PLANTA, V237, P441, DOI 10.1007/s00425-012-1782-z; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Walle IV, 2007, BIOMASS BIOENERG, V31, P276, DOI 10.1016/j.biombioe.2007.01.002; Walter C, 2010, NAT BIOTECHNOL, V28, P656, DOI 10.1038/nbt0710-656; Wang ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103645; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wullschleger SD, 2002, PLANT CELL, V14, P2651, DOI 10.1105/tpc.141120; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124083; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yu J, 2008, J INTEGR PLANT BIOL, V50, P929, DOI 10.1111/j.1744-7909.2008.00679.x; Zhang QJ, 2014, COMPLETE CHLOROPLAST; Zhu AD, 2014, MOL BIOL EVOL, V31, P1228, DOI 10.1093/molbev/msu079	68	40	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147209	10.1371/journal.pone.0147209	http://dx.doi.org/10.1371/journal.pone.0147209			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800039	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300073
J	Begun, A; Morbach, S; Rumenapf, G; Icks, A				Begun, Alexander; Morbach, Stephan; Ruemenapf, Gerhard; Icks, Andrea			Study of Disease Progression and Relevant Risk Factors in Diabetic Foot Patients Using a Multistate Continuous-Time Markov Chain Model	PLOS ONE			English	Article							AMPUTATION; MORTALITY; SURVIVAL; RATES; ULCERS; IMPACT	The diabetic foot is a lifelong disease. The longer patients with diabetes and foot ulcers are observed, the higher the likelihood that they will develop comorbidities that adversely influence ulcer recurrence, amputation and survival (for example peripheral arterial disease, renal failure or ischaemic heart disease). The purpose of our study was to quantify person and limb-related disease progression and the time-dependent influence of any associated factors (present at baseline or appearing during observation) based on which effective prevention and/or treatment strategies could be developed. Using a nine-state continuous-time Markov chain model with time-dependent risk factors, all living patients were divided into eight groups based on their ulceration (previous or current) and previous amputation (none, minor or major) status. State nine is an absorbing state (death). If all transitions are fully observable, this model can be decomposed into eight submodels, which can be analyzed using the methods of survival analysis for competing risks. The dependencies of the risk factors (covariates) were included in the submodels using Cox-like regression. The transition intensities and relative risks for covariates were calculated from long-term data of patients with diabetic foot ulcers collected in a single specialized center in North-Rhine Westphalia (Germany). The detected estimates were in line with previously published, but scarce, data. Together with the interesting new results obtained, this indicates that the proposed model may be useful for studying disease progression in larger samples of patients with diabetic foot ulcers.	[Begun, Alexander; Morbach, Stephan; Icks, Andrea] Univ Dusseldorf, German Diabet Ctr, Paul Langerhans Grp Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Morbach, Stephan] Dept Diabet & Angiol, Marienkrankenhaus, Soest, Germany; [Ruemenapf, Gerhard] Gefasszentrum Oberrhein, Dept Vasc Surg, Diakonissen Stiftungs Krankenhaus Speyer, Mannheim, Germany; [Icks, Andrea] Univ Dusseldorf, Ctr Hlth & Soc, Dept Publ Hlth, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; St. Marien Hospital; Heinrich Heine University Dusseldorf	Begun, A (corresponding author), Univ Dusseldorf, German Diabet Ctr, Paul Langerhans Grp Hlth Serv Res & Hlth Econ, Dusseldorf, Germany.	alexander.begun@ddz.uni-duesseldorf.de						APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong David G, 2007, Int Wound J, V4, P286; Armstrong DG, 2013, J AM PODIAT MED ASSN, V103, P161, DOI 10.7547/1030161; Begun A, 2013, MED DECIS MAKING, V33, P298, DOI 10.1177/0272989X12466731; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brownrigg JRW, 2014, J VASC SURG, V60, P982, DOI 10.1016/j.jvs.2014.04.052; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; Hoffmann F, 2013, J DIABETES COMPLICAT, V27, P467, DOI 10.1016/j.jdiacomp.2013.05.001; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Icks A, 2011, DIABETES CARE, V34, P1350, DOI 10.2337/dc10-2341; Izumi Y, 2009, DIABETES RES CLIN PR, V83, P126, DOI 10.1016/j.diabres.2008.09.005; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Morbach S, 2013, DIABETES CARE, V36, pE62, DOI 10.2337/dc12-2335; Morbach S, 2012, DIABETES CARE, V35, P2021, DOI 10.2337/dc12-0200; Oakes D, 1996, ANAL SURVIVAL DATA; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pound N, 2005, DIABETIC MED, V22, P1306, DOI 10.1111/j.1464-5491.2005.01640.x; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Tanudjaja T, 1995, P 2 INT S DIAB FOOT; Welton NJ, 2005, MED DECIS MAKING, V25, P633, DOI 10.1177/0272989X05282637	21	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147533	10.1371/journal.pone.0147533	http://dx.doi.org/10.1371/journal.pone.0147533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814723	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200039
J	Temeles, EJ; Newman, JT; Newman, JH; Cho, SY; Mazzotta, AR; Kress, WJ				Temeles, Ethan J.; Newman, Julia T.; Newman, Jennifer H.; Cho, Se Yeon; Mazzotta, Alexandra R.; Kress, W. John			Pollinator Competition as a Driver of Floral Divergence: An Experimental Test	PLOS ONE			English	Article							FLOWER COLOR POLYMORPHISM; PURPLE-THROATED CARIBS; RESOURCE COMPETITION; MEDIATED SELECTION; HUMMINGBIRD; POPULATIONS; EVOLUTION; FIDELITY; TERRITORIALITY; BUMBLEBEES	Optimal foraging models of floral divergence predict that competition between two different types of pollinators will result in partitioning, increased assortative mating, and divergence of two floral phenotypes. We tested these predictions in a tropical plant-pollinator system using sexes of purple-throated carib hummingbirds (Anthracothorax jugularis) as the pollinators, red and yellow inflorescence morphs of Heliconia caribaea as the plants, and fluorescent dyes as pollen analogs in an enclosed outdoor garden. When foraging alone, males exhibited a significant preference for the yellow morph of H. caribaea, whereas females exhibited no preference. In competition, males maintained their preference for the yellow morph and through aggression caused females to over-visit the red morph, resulting in resource partitioning. Competition significantly increased within-morph dye transfer (assortative mating) relative to non-competitive environments. Competition and partitioning of color morphs by sexes of purple-throated caribs also resulted in selection for floral divergence as measured by dye deposition on stigmas. Red and yellow morphs did not differ significantly in dye deposition in the competition trials, but differences in dye deposition and preferences for morphs when sexes of purple-throated caribs foraged alone implied fixation of one or the other color morph in the absence of competition. Competition also resulted in selection for divergence in corolla length, with the red morph experiencing directional selection for longer corollas and the yellow morph experiencing stabilizing selection on corolla length. Our results thus support predictions of foraging models of floral divergence and indicate that pollinator competition is a viable mechanism for divergence in floral traits of plants.	[Temeles, Ethan J.; Newman, Julia T.; Newman, Jennifer H.; Cho, Se Yeon; Mazzotta, Alexandra R.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20560 USA	Amherst College; Smithsonian Institution; Smithsonian National Museum of Natural History	Temeles, EJ (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	ejtemeles@amherst.edu	Temeles, Ethan J./AAD-7366-2021		Amherst College; Smithsonian Institution; National Science Foundation [DEB-614218, DEB-1353783]	Amherst College; Smithsonian Institution(Smithsonian Institution); National Science Foundation(National Science Foundation (NSF))	This research was supported by awards from Amherst College (www.amherst.edu), The Smithsonian Institution (www.si.edu), and the National Science Foundation (www.nsf.gov) grants DEB-614218 and DEB-1353783. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Berry F., 1991, HELICONIA IDENTIFICA; Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348; Darwin C, 1859, ORIGIN SPECIES MEANS; Endler J.A., 1986, Monographs in Population Biology, pviii; FAIRBAIRN DJ, 2001, EVOLUTIONARY ECOLOGY, P35; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; Gill SA, 2006, BEHAV ECOL SOCIOBIOL, V61, P245, DOI 10.1007/s00265-006-0255-4; GOLDSMITH TH, 1980, SCIENCE, V207, P786, DOI 10.1126/science.7352290; Gowda V, 2009, THESIS G WASHINGTON; Gowda V, 2013, BIOTROPICA, V45, P224, DOI 10.1111/j.1744-7429.2012.00915.x; Gowda V, 2012, WILSON J ORNITHOL, V124, P81, DOI 10.1676/11-061.1; Graham L, 1996, AM MIDL NAT, V136, P401, DOI 10.2307/2426743; Greenberg R, 1997, J AVIAN BIOL, V28, P103, DOI 10.2307/3677303; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; HEINRICH B, 1976, ECOLOGY, V57, P874, DOI 10.2307/1941054; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Jones KN, 2001, AM J BOT, V88, P447, DOI 10.2307/2657109; Kearns C. A., 1993, TECHNIQUES POLLINATI; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Law BS, 1996, OIKOS, V77, P447, DOI 10.2307/3545934; Maglianesi MA, 2015, J ANIM ECOL, V84, P655, DOI 10.1111/1365-2656.12319; McDonald J.H., 2009, HDB BIOL STAT; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nattero J, 2010, OIKOS, V119, P852, DOI 10.1111/j.1600-0706.2009.17766.x; Pfennig D. W., 2012, EVOLUTIONS WEDGE COM; POSSINGHAM HP, 1992, ECOLOGY, V73, P1903, DOI 10.2307/1940041; RANTA E, 1980, OIKOS, V35, P298, DOI 10.2307/3544643; Rathcke B., 1983, P305; Remsen JV, 2015, ZOOTAXA, V3957, P143, DOI 10.11646/zootaxa.3957.1.13; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez-Girones M. A., 2010, OPEN ECOLOGY J, V3, P1, DOI [DOI 10.2174/1874213001003040001, 10.2174/1874213001003040001]; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rodriguez-Girones MA, 2005, P ROY SOC B-BIOL SCI, V272, P187, DOI 10.1098/rspb.2005.2936; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Rodriguez-Girones MA, 2006, BEHAV ECOL, V17, P905, DOI 10.1093/beheco/arl024; Rodriguez-Girones MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002992; Sandlin EA, 2000, BEHAV ECOL, V11, P550, DOI 10.1093/beheco/11.5.550; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sobral M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132522; Temeles EJ, 2013, J EVOLUTION BIOL, V26, P347, DOI 10.1111/jeb.12053; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Temeles EJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P163, DOI 10.1007/s00265-006-0247-4; Temeles EJ, 2010, P ROY SOC B-BIOL SCI, V277, P1607, DOI 10.1098/rspb.2009.2188; Temeles EJ, 2009, ECOLOGY, V90, P1147, DOI 10.1890/08-0695.1; Whitfield M, 2014, BEHAV ECOL, V25, P328, DOI 10.1093/beheco/art115	53	14	15	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146431	10.1371/journal.pone.0146431	http://dx.doi.org/10.1371/journal.pone.0146431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814810	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528200014
J	Dong, JF; Song, YQ; Li, WL; Shi, J; Wang, ZY				Dong, Junfeng; Song, Yueqin; Li, Wenliang; Shi, Jie; Wang, Zhenying			Identification of Putative Chemosensory Receptor Genes from the Athetis dissimilis Antennal Transcriptome	PLOS ONE			English	Article							OLFACTORY RECEPTORS; CHEMORECEPTOR SUPERFAMILY; MEMBRANE TOPOLOGY; ODORANT RECEPTORS; EVOLUTION; MOTH; SPECIALIZATION; FAMILY; EXPANSION; LINEAGE	Olfaction plays a crucial role in insect population survival and reproduction. Identification of the genes associated with the olfactory system, without the doubt will promote studying the insect chemical communication system. In this study, RNA-seq technology was used to sequence the antennae transcriptome of Athetis dissimilis, an emerging crop pest in China with limited genomic information, with the purpose of identifying the gene set involved in olfactory recognition. Analysis of the transcriptome of female and male antennae generated 13.74 Gb clean reads in total from which 98,001 unigenes were assembled, and 25,930 unigenes were annotated. Total of 60 olfactory receptors (ORs), 18 gustatory receptors (GRs), and 12 ionotropic receptors (IRs) were identified by Blast and sequence similarity analyzes. One obligated olfactory receptor co-receptor (Orco) and four conserved sex pheromone receptors (PRs) were annotated in 60 ORs. Among the putative GRs, five genes (AdisGR1, 6, 7, 8 and 94) clustered in the sugar receptor family, and two genes (AdisGR3 and 93) involved in CO2 detection were identified. Finally, AdisIR8a.1 and AdisIR8a.2 co-receptors were identified in the group of candidate IRs. Furthermore, expression levels of these chemosensory receptor genes in female and male antennae were analyzed by mapping the Illumina reads.	[Dong, Junfeng; Song, Yueqin; Li, Wenliang] Henan Univ Sci & Technol, Coll Forestry, Luoyang 471003, Peoples R China; [Shi, Jie] Hebei Acad Agr & Forestry Sci, Inst Plant Protect, Baoding 071000, Peoples R China; [Wang, Zhenying] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Henan University of Science & Technology; Hebei Academy of Agricultural & Forestry Sciences; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, ZY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zywang@ippcaas.cn	Li, Wenliang/AAO-1408-2021		Special Fund for Agro-scientific Research in the Public Interest [201303026]; Youth Scientific Fund of Henan University of Science and Technology [2015QN029]	Special Fund for Agro-scientific Research in the Public Interest; Youth Scientific Fund of Henan University of Science and Technology	This research was supported by Special Fund for Agro-scientific Research in the Public Interest (201303026) grant and the Youth Scientific Fund of Henan University of Science and Technology (2015QN029).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; ANDO T, 1977, AGR BIOL CHEM TOKYO, V41, P1485, DOI 10.1080/00021369.1977.10862690; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Cho YH, 2010, J NATL PARK RES, V1, P108; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Han Hui-Lin, 2008, Acta Zootaxonomica Sinica, V33, P696; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Leitch O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1466-8; [李静雯 Li Jingwen], 2014, [植物保护, Plant Protection], V40, P193; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Takahashi M., 1975, Japanese J Sanit Zool, V26, P66; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Xu W, 2015, INSECT MOL BIOL, V24, P253, DOI 10.1111/imb.12153; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]	52	24	31	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147768	10.1371/journal.pone.0147768	http://dx.doi.org/10.1371/journal.pone.0147768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812239	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000053
J	Romero-Soriano, V; Guerreiro, MPG				Romero-Soriano, Valeria; Garcia Guerreiro, Maria Pilar			Expression of the Retrotransposon Helena Reveals a Complex Pattern of TE Deregulation in Drosophila Hybrids	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; RNA PATHWAY; DNA LOSS; GENOME; TRANSPOSITION; BUZZATII; HYBRIDIZATION; GERMLINE; MELANOGASTER; INSTABILITY	Transposable elements (TEs), repeated mobile sequences, are ubiquitous in the eukaryotic kingdom. Their mobilizing capacity confers on them a high mutagenic potential, which must be strongly regulated to guarantee genome stability. In the Drosophila germline, a small RNA-mediated silencing system, the piRNA (Piwi-interacting RNA) pathway, is the main responsible TE regulating mechanism, but some stressful conditions can destabilize it. For instance, during interspecific hybridization, genomic stress caused by the shock of two different genomes can lead, in both animals and plants, to higher transposition rates. A recent study in D. buzatii-D. koepferae hybrids detected mobilization of 28 TEs, yet little is known about the molecular mechanisms explaining this transposition release. We have characterized one of the mobilized TEs, the retrotransposon Helena, and used quantitative expression to assess whether its high transposition rates in hybrids are preceded by increased expression. We have also localized Helena expression in the gonads to see if cellular expression patterns have changed in the hybrids. To give more insight into changes in TE regulation in hybrids, we analysed Helena-specific piRNA populations of hybrids and parental species. Helena expression is not globally altered in somatic tissues, but male and female gonads have different patterns of deregulation. In testes, Helena is repressed in F1, increasing then its expression up to parental values. This is linked with a mislocation of Helena transcripts along with an increase of their specific piRNA levels. Ovaries have additive levels of Helena expression, but the ping-pong cycle efficiency seems to be reduced in F1 hybrids. This could be at the origin of new Helena insertions in hybrids, which would be transmitted to F1 hybrid female progeny.	[Romero-Soriano, Valeria; Garcia Guerreiro, Maria Pilar] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Genom Bioinformat & Biol Evolut, Edifici C, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Guerreiro, MPG (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Genom Bioinformat & Biol Evolut, Edifici C, E-08193 Barcelona, Spain.	mariapilar.garcia.guerreiro@uab.cat	Guerreiro, Maria Pilar Garcia/AAB-5507-2019	Guerreiro, Maria Pilar Garcia/0000-0001-9951-1879; Romero-Soriano, Valeria/0000-0003-1717-2928	Ministerio de Economia y Competitividad (Spain) [CGL2013-42432-P]; Generalitat de Catalunya [SGR 1346]; Universitat Autonoma de Barcelona (Spain)	Ministerio de Economia y Competitividad (Spain)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Universitat Autonoma de Barcelona (Spain)	This work was supported by research grant CGL2013-42432-P from the Ministerio de Economia y Competitividad (Spain) and grant 2014 SGR 1346 from Generalitat de Catalunya to the Grup de Genomica, Bioinformatica i Biologia Evolutiva (GGBE). VRS was supported by a PIF PhD fellowship from the Universitat Autonoma de Barcelona (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkouche A, 2013, EMBO REP, V14, P458, DOI 10.1038/embor.2013.38; Akkouche A, 2012, J VIROL, V86, P3675, DOI 10.1128/JVI.07146-11; Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12; Borie N, 2002, HEREDITY, V89, P247, DOI 10.1038/sj.hdy.6800135; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; EVGENEV MB, 1982, CHROMOSOMA, V85, P375, DOI 10.1007/BF00330360; Fablet M, 2014, GENE, V537, P149, DOI 10.1016/j.gene.2013.11.095; Filatov DA, 1998, MOL GEN GENET, V258, P646, DOI 10.1007/s004380050778; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Fontdevila A, 2005, CYTOGENET GENOME RES, V110, P49, DOI 10.1159/000084937; Franco FF, 2010, J ZOOL SYST EVOL RES, V48, P322, DOI 10.1111/j.1439-0469.2010.00564.x; Guerreiro MPG, 2015, MOL GENET GENOMICS, V290, P1471, DOI 10.1007/s00438-015-1012-z; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gomez GA, 2003, MOL BIOL EVOL, V20, P410, DOI 10.1093/molbev/msg051; Granzotto A, 2011, MOL GENET GENOMICS, V286, P57, DOI 10.1007/s00438-011-0629-9; Granzotto A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-174; Grentzinger T, 2014, METHODS, V67, P91, DOI 10.1016/j.ymeth.2013.05.011; Guillen Y, 2015, GENOME BIOL EVOL, V7, P349, DOI 10.1093/gbe/evu291; Hirst J, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-22; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelleher ES, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001428; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Labrador M, 1999, MOL BIOL EVOL, V16, P931, DOI 10.1093/oxfordjournals.molbev.a026182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine MT, 2011, CELL, V147, P1440, DOI 10.1016/j.cell.2011.12.001; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marin I, 1998, J HERED, V89, P336, DOI 10.1093/jhered/89.4.336; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metcalfe CJ, 2007, GENETICS, V177, P2507, DOI 10.1534/genetics.107.082313; Mirkovic-Hosle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084994; Modolo L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0546-8; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; Moran T, 2014, J HERED, V105, P381, DOI 10.1093/jhered/esu003; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Olovnikov IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P572, DOI 10.1134/S0006297913060035; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 1995, P NATL ACAD SCI US; Piccinali R, 2004, MOL BIOL EVOL, V21, P141, DOI [10.1093/molbev/msh006, 10.1093/molbev.msh006]; PINOL J, 1988, NUCLEIC ACIDS RES, V16, P2736, DOI 10.1093/nar/16.6.2736; Rebollo R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-149; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rozhkov NV, 2013, GENES DEV; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senerchia N, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2874; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Simkin A, 2013, EVOLUTION, V67, P1081, DOI 10.1111/evo.12011; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Theron E, 2014, MOBILE DNA-UK, V5, P1; Ungerer MC, 2006, CURR BIOL, V16, pR872, DOI 10.1016/j.cub.2006.09.020; Vela D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088992; Vela D, 2011, BIOTECHNIQUES, V50, P247, DOI 10.2144/000113655; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; Wicker T, 2007, NAT REV GENET, V10, P276; Xie WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072163	68	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147903	10.1371/journal.pone.0147903	http://dx.doi.org/10.1371/journal.pone.0147903			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812285	Green Published, gold			2022-12-27	WOS:000369528000061
J	Tebruegge, M; Pantazidou, A; MacGregor, D; Gonis, G; Leslie, D; Sedda, L; Ritz, N; Connell, T; Curtis, N				Tebruegge, Marc; Pantazidou, Anastasia; MacGregor, Duncan; Gonis, Gena; Leslie, David; Sedda, Luigi; Ritz, Nicole; Connell, Tom; Curtis, Nigel			Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center	PLOS ONE			English	Article							VITAMIN-D; CERVICOFACIAL LYMPHADENITIS; CERVICAL LYMPHADENITIS; TUBERCULOSIS; PREVALENCE; INFECTION; SURVEILLANCE; MULTICENTER; SEASONALITY; ASSAYS	Background There are limited data on the epidemiology, diagnosis and optimal management of nontuberculous mycobacterial (NTM) disease in children. Methods Retrospective cohort study of NTM cases over a 10-year-period at a tertiary referral hospital in Australia. Results A total of 140 children with NTM disease, including 107 with lymphadenitis and 25 with skin and soft tissue infections (SSTIs), were identified. The estimated incidence of NTM disease was 0.6-1.6 cases / 100,000 children / year; no increasing trend was observed over the study period. Temporal analyses revealed a seasonal incidence cycle around 12 months, with peaks in late winter/spring and troughs in autumn. Mycobacterium-avium-complex accounted for most cases (77.8%), followed by Mycobacterium ulcerans (14.4%) and Mycobacterium marinum (3.3%). Polymerase chain reaction testing had higher sensitivity than culture and microscopy for acid-fast bacilli (92.0%, 67.2% and 35.7%, respectively). The majority of lymphadenitis cases underwent surgical excision (97.2%); multiple recurrences in this group were less common in cases treated with clarithromycin and rifampicin compared with clarithromycin alone or no anti-mycobacterial drugs (0% versus 7.1%; OR: 0.73). SSTI recurrences were also less common in cases treated with two anti-mycobacterial drugs compared with one or none (10.5% versus 33.3%; OR: 0.23). Conclusions There was seasonal variation in the incidence of NTM disease, analogous to recently published observations in tuberculosis, which have been linked to seasonal variation in vitamin D. Our finding that anti-mycobacterial combination therapy was associated with a reduced risk of recurrences in patients with NTM lymphadenitis or SSTI requires further confirmation in prospective trials.	[Tebruegge, Marc; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Tebruegge, Marc; Pantazidou, Anastasia; Connell, Tom; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia; [Tebruegge, Marc; Connell, Tom; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tebruegge, Marc] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Southampton, Hants, England; [MacGregor, Duncan] Royal Childrens Hosp Melbourne, Dept Anat Pathol, Parkville, Vic, Australia; [Gonis, Gena] Royal Childrens Hosp Melbourne, Dept Microbiol, Parkville, Vic, Australia; [Leslie, David] Victorian Infect Dis Reference Lab, Mycobacterium Reference Lab, North Melbourne, Australia; [Sedda, Luigi] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Ritz, Nicole] Univ Childrens Hosp Basel, Infect Dis Unit, Basel, Switzerland	University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Victorian Infectious Diseases Reference Laboratory; University of Southampton; University of Basel	Tebruegge, M (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.; Tebruegge, M (corresponding author), Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia.; Tebruegge, M (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Tebruegge, M (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.; Tebruegge, M (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Southampton, Hants, England.	m.tebruegge@soton.ac.uk	Curtis, Nigel/B-3491-2012; Sedda, Luigi/ABD-8784-2020; Ritz, Nicole/L-1452-2019; Ritz, Nicole/G-2924-2015	Curtis, Nigel/0000-0003-3446-4594; Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Sedda, Luigi/0000-0002-9271-6596	UK National Institute for Health Research (NIHR); National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	MT was supported by a Clinical Lectureship provided by the UK National Institute for Health Research (NIHR).	[Anonymous], 2008, YB AUSTR; Blyth CC, 2009, PEDIATR INFECT DIS J, V28, P801, DOI 10.1097/INF.0b013e31819f7b3f; Boyages S, 2012, CLIN ENDOCRINOL, V77, P515, DOI 10.1111/j.1365-2265.2012.04398.x; Bureau of Meterology TAG, 2013, AV DAIL SUNSH HOURS; Cruz AT, 2010, PEDIATR INFECT DIS J, V29, P772, DOI 10.1097/INF.0b013e3181da5795; Fyfe JA, 2008, J CLIN MICROBIOL, V46, P618, DOI 10.1128/JCM.01186-07; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Gelder CM, 2000, J INFECT DIS, V181, P2099, DOI 10.1086/315489; GRANGE JM, 1995, ARCH DIS CHILD, V72, P516, DOI 10.1136/adc.72.6.516; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Haverkamp MH, 2004, CLIN INFECT DIS, V39, P450, DOI 10.1086/422319; HORSBURGH CR, 1989, AM REV RESPIR DIS, V139, P4, DOI 10.1164/ajrccm/139.1.4; Jeon K, 2013, RESPIROLOGY, V18, P983, DOI 10.1111/resp.12109; KUTH G, 1995, ORL J OTO-RHINO-LARY, V57, P36, DOI 10.1159/000276704; Lindeboom JA, 2007, CLIN INFECT DIS, V44, P1057, DOI 10.1086/512675; Lopez-Varela E, 2015, LANCET RESP MED, V3, P244, DOI 10.1016/S2213-2600(15)00062-4; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Maltezou HC, 1999, PEDIATR INFECT DIS J, V18, P968, DOI 10.1097/00006454-199911000-00006; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Nolt D, 2003, PEDIATRICS, V112, pE434, DOI 10.1542/peds.112.5.e434; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Pham-Huy A, 2010, PAED CHILD HEALT-CAN, V15, P276, DOI 10.1093/pch/15.5.276; Pierre-Audigier C, 2005, J CLIN MICROBIOL, V43, P3467, DOI 10.1128/JCM.43.7.3467-3470.2005; Pilkington EF, 2010, INT J PEDIATR OTORHI, V74, P343, DOI 10.1016/j.ijporl.2009.08.029; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Reuss AM, 2009, PEDIATR INFECT DIS J, V28, P642, DOI 10.1097/INF.0b013e3181978e8e; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; Schaaf HS, 1996, TUBERCLE LUNG DIS, V77, P43, DOI 10.1016/S0962-8479(96)90074-X; Tebruegge M, 2010, EUR RESPIR J, V36, P214, DOI 10.1183/09031936.00025510; Tebruegge M., 2012, PRINCIPLES PRACTICE, VVolume 4, P786; Tebruegge M, 2011, ADV EXP MED BIOL, V719, P201, DOI 10.1007/978-1-4614-0204-6_17; Tebruegge M, 2010, INT J INFECT DIS, V14, pE305, DOI 10.1016/j.ijid.2010.02.2246; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; WHITE MP, 1986, ARCH DIS CHILD, V61, P368, DOI 10.1136/adc.61.4.368; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107; Zimmermann P, 2015, J INFECTION, V71, P9, DOI 10.1016/j.jinf.2015.02.010	39	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147513	10.1371/journal.pone.0147513	http://dx.doi.org/10.1371/journal.pone.0147513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812154	Green Published, gold, Green Accepted			2022-12-27	WOS:000369528000036
J	Aslam, M; Aggarwal, S; Sharma, KK; Galav, V; Madhu, SV				Aslam, Mohammad; Aggarwal, Sarla; Sharma, Krishna Kumar; Galav, Vikas; Madhu, Sri Venkata			Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes	PLOS ONE			English	Article							METABOLIC SYNDROME; PIOGLITAZONE; ROSIGLITAZONE; LIPOPROTEINS; SENSITIVITY; MELLITUS; LIPEMIA; WISTAR; MODEL; DIET	Insulin resistance (IR) and type 2 diabetes mellitus (T2DM) have been found to be associated with postprandial hypertriglyceridemia (PPHTg). However, whether PPHTg can cause IR and diabetes is not clear. We therefore investigated the role of PPHTg in development of T2DM in rat model of T2DM. 96 male Wistar rats were randomized into four groups (24 rats each). Control Group A, high sucrose diet (HSD) Group B, HSD+Pioglitazone (10mg/kg/day) Group C and HSD+Atorvastatin (20mg/kg/day) Group D. Fat and glucose tolerance tests were done at regular intervals in all groups besides insulin and body weight measurement. At 26 weeks, low dose streptozotocin (15mg/kg,i.p.) was given to half of the rats. All rats were followed up till 48 weeks. PPHTg developed as early as week 2 in Group B and stabilized by week 14. Group B displayed highest PPHTg compared to other groups. Atorvastatin treatment (Group D) abolished PPHTg which became comparable to controls, pioglitazone treatment partially blunted PPHTg resulting in intermediate PPHTg. Group B with highest PPHTg showed highest subsequent IR, glucose intolerance (GI) and highest incidence of prediabetes at week 26 and diabetes at week 34 and 46 compared to other groups. Group D rats displayed lower IR, GI, low incidence of prediabetes and diabetes at these time points compared to Groups B and C. ROC analysis showed that triglyceride area under the curve of each time point significantly predicts the risk of diabetes. Present study provides the evidence that PPHTg predicts the development of IR, GI and T2DM in rat model of diet induced T2DM.	[Aslam, Mohammad; Madhu, Sri Venkata] Univ Delhi, Ctr Diabet Endocrinol & Metab, Dept Med, Univ Coll Med Sci, Delhi 110007, India; [Aslam, Mohammad; Aggarwal, Sarla; Sharma, Krishna Kumar; Galav, Vikas; Madhu, Sri Venkata] GTB Hosp, Delhi, India; [Aggarwal, Sarla] Univ Delhi, Dept Pathol, Univ Coll Med Sci, Delhi 110007, India; [Sharma, Krishna Kumar; Galav, Vikas] Univ Delhi, Dept Pharmacol, Univ Coll Med Sci, Delhi 110007, India	University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences	Madhu, SV (corresponding author), Univ Delhi, Ctr Diabet Endocrinol & Metab, Dept Med, Univ Coll Med Sci, Delhi 110007, India.; Madhu, SV (corresponding author), GTB Hosp, Delhi, India.	drsvmadhu@gmail.com	Madhu, S/AAH-7431-2019	Madhu, S/0000-0003-0018-5984; Galav, Vikas/0000-0002-9059-4302	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR14215/MED/30/403/2010/]	Department of Biotechnology, Ministry of Science and Technology, India	The work was supported by Department of Biotechnology, Ministry of Science and Technology, India, Grant ID: BT/PR14215/MED/30/403/2010/. Grant received by S.V.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh N, 2015, THER ADV ENDOCRINOL, V6, P56, DOI 10.1177/2042018815574229; Aoki T, 2002, EUR J PHARMACOL, V444, P107, DOI 10.1016/S0014-2999(02)01547-9; Axelsen M, 1999, ANN INTERN MED, V131, P27, DOI 10.7326/0003-4819-131-1-199907060-00006; Battula SB, 2000, METABOLISM, V49, P1049, DOI 10.1053/meta.2000.7744; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Burnett JR, 1998, ARTERIOSCL THROM VAS, V18, P1906, DOI 10.1161/01.ATV.18.12.1906; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Chappuis B, 2007, DIABETES-METAB RES, V23, P392, DOI 10.1002/dmrr.715; Del Zotto H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740225; Derosa G, 2006, CLIN THER, V28, P679, DOI 10.1016/j.clinthera.2006.05.012; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Funatsu T, 2003, METABOLISM, V52, P609, DOI 10.1053/meta.2003.50097; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Harris WS, 1997, AM J CLIN NUTR, V65, P5; Kamgang R, 2005, DIABETES RES CLIN PR, V69, P224, DOI 10.1016/j.diabres.2005.02.005; King Allen B, 2002, Diabetes Technol Ther, V4, P145, DOI 10.1089/15209150260007354; Leahy Jack L, 2005, JOSLINS DIABETES MEL, P454; Madhu SV, 2008, DIABETES RES CLIN PR, V80, P380, DOI 10.1016/j.diabres.2008.01.016; Mingrone G, 1999, DIABETES, V48, P1258, DOI 10.2337/diabetes.48.6.1258; Mori Y, 2005, NUTRITION, V21, P933, DOI 10.1016/j.nut.2005.01.009; Park S, 2001, J KOREAN MED SCI, V16, P386, DOI 10.3346/jkms.2001.16.4.386; Pedrini MT, 2006, DIABETOLOGIA, V49, P1612, DOI 10.1007/s00125-006-0262-z; Peng J, 2014, PPAR RES, V2014, DOI 10.1155/2014/538183; Rajendran A, J APPL SCI RES, V3, P1434; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; SANE T, 1993, DIABETES CARE, V16, P1494, DOI 10.2337/diacare.16.11.1494; Savage DB, 2003, DIABETES, V52, P910, DOI 10.2337/diabetes.52.4.910; Sinha B, 2008, THESIS U DELHI; Wang HJ, 2007, ASIA PAC J CLIN NUTR, V16, P412; Zhang N, 2010, ACTA PHARMACOL SIN, V31, P35, DOI 10.1038/aps.2009.176	32	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145730	10.1371/journal.pone.0145730	http://dx.doi.org/10.1371/journal.pone.0145730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808523	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800009
J	Kowalczyk-Pachel, D; Iciek, M; Wydra, K; Nowak, E; Gorny, M; Filip, M; Wlodek, L; Lorenc-Koci, E				Kowalczyk-Pachel, Danuta; Iciek, Malgorzata; Wydra, Karolina; Nowak, Ewa; Gorny, Magdalena; Filip, Malgorzata; Wlodek, Lidia; Lorenc-Koci, Elzbieta			Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment	PLOS ONE			English	Article							MITOCHONDRIAL BIOENERGETIC FUNCTION; HYDROGEN-SULFIDE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; SULFANE SULFUR; INORGANIC SULFATE; ELECTRON-TRANSFER; MAMMALIAN-CELLS; MALE-MICE; IN-VITRO; STRESS	The role of cocaine in modulating the metabolism of sulfur-containing compounds in the peripheral tissues is poorly understood. In the present study we addressed the question about the effects of acute and repeated (5 days) cocaine (10 mg/kg i.p.) administration on the total cysteine (Cys) metabolism and on the oxidative processes in the rat liver and kidney. The whole pool of sulfane sulfur, its bound fraction and hydrogen sulfide (H2S) were considered as markers of anaerobic Cys metabolism while the sulfate as a measure of its aerobic metabolism. The total-, non-protein- and protein- SH group levels were assayed as indicators of the redox status of thiols. Additionally, the activities of enzymes involved in H2S formation (cystathionine gamma-lyase, CSE; 3-mercaptopyruvate sulfurtransferase, 3-MST) and GSH metabolism (gamma-glutamyl transpeptidase,gamma-GT; glutathione S-transferase, GST) were determined. Finally, we assayed the concentrations of reactive oxygen species (ROS) and malondialdehyde (MDA) as markers of oxidative stress and lipid peroxidation, respectively. In the liver, acute cocaine treatment, did not change concentrations of the whole pool of sulfane sulfur, its bound fraction, H2S or sulfate but markedly decreased levels of nonprotein SH groups (NPSH), ROS and GST activity while gamma-GT was unaffected. In the kidney, acute cocaine significantly increased concentration of the whole pool of sulfane sulfur, reduced the content of its bound fraction but H2S, sulfate and NPSH levels were unchanged while ROS and activities of GST and gamma-GT were reduced. Acute cocaine enhanced activity of the CSE and 3-MST in the liver and kidney, respectively. Repeatedly administered cocaine enhanced the whole pool of sulfane sulfur and reduced H2S level simultaneously increasing sulfate content both in the liver and kidney. After repeated cocaine, a significant decrease in ROS was still observed in the liver while in the kidney, despite unchanged ROS content, a marked increase in MDA level was visible. The repeated cocaine decreased 3-MST and increased gamma-GT activities in both organs but reduced GST in the kidney. Our results show that cocaine administered at a relatively low dose shifts Cys metabolism towards the formation of sulfane sulfur compounds which possess antioxidant and redox regulatory properties and are a source of H2S which can support mitochondrial bioenergetics.	[Kowalczyk-Pachel, Danuta; Iciek, Malgorzata; Gorny, Magdalena; Wlodek, Lidia] Jagiellonian Univ, Coll Med, Chair Med Biochem, Krakow, Poland; [Wydra, Karolina; Nowak, Ewa; Filip, Malgorzata] Polish Acad Sci, Inst Pharmacol, Lab Drug Addict Pharmacol, Krakow, Poland; [Lorenc-Koci, Elzbieta] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Polish Academy of Sciences	Lorenc-Koci, E (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, Krakow, Poland.	lorenc@if-pan.krakow.pl	Iciek, Małgorzata/GNP-4844-2022	Gorny, Magdalena/0000-0002-6393-9977; Lorenc-Koci, Elzbieta/0000-0002-9970-8548; Iciek, Malgorzata/0000-0002-0422-0428; Filip, Malgorzata/0000-0002-4321-7942	Statuary Founds of Institute Pharmacology Polish Academy of Sciences; KNOW (Leading National Research Centre, Krakow, Poland)	Statuary Founds of Institute Pharmacology Polish Academy of Sciences; KNOW (Leading National Research Centre, Krakow, Poland)	This work was supported by Statuary Founds of Institute Pharmacology Polish Academy of Sciences. The cost of this publication was financed by KNOW (Leading National Research Centre, Krakow, Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; Bilska A, 2007, NEUROSCIENCE, V146, P1758, DOI 10.1016/j.neuroscience.2007.04.002; Bilska A, 2008, PHARMACOL REP, V60, P225; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; BONDY SC, 1994, EUR J PHARM-ENVIRON, V270, P349, DOI 10.1016/0926-6917(94)90011-6; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Brannan RG, 2010, J AGR FOOD CHEM, V58, P3767, DOI 10.1021/jf903587n; Cerretani D, 2012, CURR MED CHEM, V19, P5619, DOI 10.2174/092986712803988785; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cunha-Oliveira T, 2013, LIFE SCI, V92, P1157, DOI 10.1016/j.lfs.2013.04.016; Cunha-Oliveira T, 2013, TOXICOL LETT, V219, P298, DOI 10.1016/j.toxlet.2013.03.025; Devi BG, 1997, LIFE SCI, V60, P849, DOI 10.1016/S0024-3205(97)00013-1; Devi BG, 1999, J CARDIOVASC PHARM, V33, P1, DOI 10.1097/00005344-199901000-00001; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Giles GI, 2001, FREE RADICAL BIO MED, V31, P1279, DOI 10.1016/S0891-5849(01)00710-9; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Glauser J, 2007, J EMERG MED, V32, P181, DOI 10.1016/j.jemermed.2006.05.044; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hatfield MJ, 2010, BRIT J PHARMACOL, V160, P1916, DOI 10.1111/j.1476-5381.2010.00700.x; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heard Kennon, 2008, Open Pharmacol J, V2, P70, DOI 10.2174/1874143600802010070; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; HINCHMAN CA, 1990, BIOCHEM PHARMACOL, V40, P1131, DOI 10.1016/0006-2952(90)90503-D; Huang J, 1998, CHEM-BIOL INTERACT, V110, P189, DOI 10.1016/S0009-2797(98)00015-5; Huseby NE, 2003, BIOFACTORS, V17, P151, DOI 10.1002/biof.5520170115; Iciek M, 2001, POL J PHARMACOL, V53, P215; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Jacob C, 2011, BIOCHEM SOC T, V39, P1247, DOI 10.1042/BST0391247; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kamendulis LM, 1996, J PHARMACOL EXP THER, V279, P713; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; KLOSS MW, 1983, TOXICOL LETT, V15, P65, DOI 10.1016/0378-4274(83)90171-6; KOJ A, 1967, BIOCHEM J, V103, P791, DOI 10.1042/bj1030791; Kovacic P, 2005, MED HYPOTHESES, V64, P350, DOI 10.1016/j.mehy.2004.06.028; Kowalczyk-Pachel D, 2013, NEUROTOX RES, V24, P377, DOI 10.1007/s12640-013-9403-6; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Labib R, 2002, J TOXICOL ENV HEAL A, V65, P977, DOI 10.1080/00984100290071252; Labib R, 2001, TOXICOL LETT, V125, P29, DOI 10.1016/S0378-4274(01)00412-X; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CY, 2013, METHODS, V62, P177, DOI 10.1016/j.ymeth.2013.05.020; MATSUO Y, 1959, J BIOL CHEM, V234, P516; MEHANNY SZ, 1991, TOXICOL PATHOL, V19, P24, DOI 10.1177/019262339101900103; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Modis K, 2014, BRIT J PHARMACOL, V171, P2123, DOI 10.1111/bph.12368; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Ndikum-Moffor FM, 1998, J PHARMACOL EXP THER, V284, P413; OGASAWARA Y, 1994, BIOL PHARM BULL, V17, P1535; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Ranguelova K, 2012, FREE RADICAL BIO MED, V52, P1264, DOI 10.1016/j.freeradbiomed.2012.01.016; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SODA K, 1967, AGR BIOL CHEM TOKYO, V31, P1054, DOI 10.1080/00021369.1967.10858916; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; STEWART DJ, 1979, CLIN PHARMACOL THER, V25, P464; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; SZCZEPKOWSKI T, 1961, NATURE, V189, P1007, DOI 10.1038/1891007a0; Tamizhselvi R, 2007, J CELL MOL MED, V11, P315, DOI 10.1111/j.1582-4934.2007.00024.x; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Turhan H, 2007, INT J CARDIOL, V114, P106, DOI 10.1016/j.ijcard.2005.11.020; Valente MJ, 2012, CURR MED CHEM, V19, P5601, DOI 10.2174/092986712803988938; Valente MJ, 2012, ARCH TOXICOL, V86, P249, DOI 10.1007/s00204-011-0749-3; VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X; Visalli T, 2005, INT J TOXICOL, V24, P43, DOI 10.1080/10915810590918715; Visalli T, 2004, INT J TOXICOL, V23, P163, DOI 10.1080/10915810490471334; Vitcheva V, 2012, CURR MED CHEM, V19, P5677, DOI 10.2174/092986712803988929; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; WIENER HL, 1990, BIOCHEM PHARMACOL, V40, P1763, DOI 10.1016/0006-2952(90)90353-M; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; Yadav A, 2013, J MOL MODEL, V19, P767, DOI 10.1007/s00894-012-1601-2; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8	88	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147238	10.1371/journal.pone.0147238	http://dx.doi.org/10.1371/journal.pone.0147238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808533	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800065
J	Pincham, HL; Bryce, D; Kokorikou, D; Fonagy, P; Fearon, RMP				Pincham, Hannah L.; Bryce, Donna; Kokorikou, Danae; Fonagy, Peter; Fearon, R. M. Pasco			Psychosocial Intervention Is Associated with Altered Emotion Processing: An Event-Related Potential Study in At-Risk Adolescents	PLOS ONE			English	Article							AFFECTIVE PICTURE PERCEPTION; ONSET CONDUCT DISORDER; AFFECTIVE MODULATION; JUVENILE-OFFENDERS; BRAIN POTENTIALS; NEURAL RESPONSES; STARTLE REFLEX; VISUAL-CORTEX; P3 AMPLITUDE; ERP ANALYSIS	Emotion processing is vital for healthy adolescent development, and impaired emotional responses are associated with a number of psychiatric disorders. However, it is unclear whether observed differences between psychiatric populations and healthy controls reflect modifiable variations in functioning (and thus could be sensitive to changes resulting from intervention) or stable, non-modifiable, individual differences. The current study therefore investigated whether the Late Positive Potential (LPP; a neural index of emotion processing) can be used as a marker of therapeutic change following psycho-social intervention. At-risk male adolescents who had received less than four months intervention (minimalintervention, N = 32) or more than nine months intervention (extended-intervention, N = 32) passively viewed emotional images whilst neural activity was recorded using electroencephalography. Significant differences in emotion processing, indicated by the LPP, were found between the two groups: the LPP did not differ according to valence in the minimal-intervention group, whereas the extended-intervention participants showed emotion processing in line with low risk populations (enhanced LPP for unpleasant images versus other images). Further, an inverse relationship between emotional reactivity (measured via the LPP) and antisocial behaviour was observed in minimal-intervention participants only. The data therefore provide preliminary cross-sectional evidence that abnormal neural responses to emotional information may be normalised following psychosocial intervention. Importantly, this study uniquely suggests that, in future randomised control trials, the LPP may be a useful biomarker to measure development and therapeutic change.	[Pincham, Hannah L.; Kokorikou, Danae; Fonagy, Peter; Fearon, R. M. Pasco] Anna Freud Ctr, Dev Neurosci Unit, 12 Maresfield Gardens, London NW3 5SU, England; [Pincham, Hannah L.; Fonagy, Peter; Fearon, R. M. Pasco] UCL, Res Dept Clin Educ & Hlth Psychol, 1-19 Torrington Pl, London WC1E 7HB, England; [Bryce, Donna] Univ Tubingen, Dept Psychol, Schleichstr 4, D-72076 Tubingen, Germany	The Anna Freud Centre; University of London; University College London; Eberhard Karls University of Tubingen	Fearon, RMP (corresponding author), Anna Freud Ctr, Dev Neurosci Unit, 12 Maresfield Gardens, London NW3 5SU, England.; Fearon, RMP (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, 1-19 Torrington Pl, London WC1E 7HB, England.	p.fearon@ucl.ac.uk	Bryce, Donna/H-2031-2013	Kokorikou, Danae/0000-0002-6635-9206; Bryce, Donna/0000-0001-8311-4457; Fonagy, Peter/0000-0003-0229-0091; Fearon, Richard/0000-0003-1847-8443	Waterloo Foundation [564/709]; Kids Company; National Institute for Health Research [NF-SI-0514-10157] Funding Source: researchfish	Waterloo Foundation; Kids Company; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Waterloo Foundation (grant code 564/709; http://www.waterloofoundation.org.uk), which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kids Company (http://www.kidsco.org.uk) supported the recruitment of participants from their services, and provided lab space, equipment and top-up funding. Kids Company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Cecil CAM, 2014, J CHILD PSYCHOL PSYC; Cho HS, 2005, J ABNORM CHILD PSYCH, V33, P363, DOI 10.1007/s10802-005-3574-4; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; Fairchild G, 2010, BIOL PSYCHIAT, V68, P272, DOI 10.1016/j.biopsych.2010.02.019; Gaffrey MS, 2013, J AM ACAD CHILD PSY, V52, P737, DOI 10.1016/j.jaac.2013.04.009; Gainotti G, 1972, Cortex, V8, P41; Gao Y, 2013, J CLIN CHILD ADOLESC, V42, P120, DOI 10.1080/15374416.2012.719458; Gaskell C, 2008, KIDS CO HELPS WHOLE; Gollan JK, 2014, BIOL PSYCHOL, V99, P198, DOI 10.1016/j.biopsycho.2014.03.003; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hajcak G, 2009, BIOL PSYCHOL, V80, P333, DOI 10.1016/j.biopsycho.2008.11.006; Hicks BM, 2007, PSYCHOPHYSIOLOGY, V44, P98, DOI 10.1111/j.1469-8986.2006.00471.x; Iacono WG, 2002, ARCH GEN PSYCHIAT, V59, P750, DOI 10.1001/archpsyc.59.8.750; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Jovchelovitch S, 2013, KIDS CO DIAGNOSIS OR; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; KidsCompany, 2010, KEY WORK TOOL KIT; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lang PJ, 2008, INT AFFECTIVE PICTUR; LEVY J, 1983, BRAIN COGNITION, V2, P404, DOI 10.1016/0278-2626(83)90021-0; Lewis MD, 2008, DEV PSYCHOPATHOL, V20, P913, DOI 10.1017/S0954579408000448; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Mills RC, 1988, ADOLESCENCE; Murthy PJNV, 1997, BIOL PSYCHIAT, V42, P740; NAUMANN E, 1992, J PSYCHOPHYSIOL, V6, P285; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; OLWEUS D, 1989, NATO ADV SCI I D-BEH, V50, P187; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Pincham HL, 2015, DEVELOPMENTAL SCI, V18, P994, DOI 10.1111/desc.12262; Podorefsky DL, 2001, J AM ACAD CHILD PSY, V40, P879, DOI 10.1097/00004583-200108000-00008; Prete G, 2015, NEUROPSYCHOLOGIA, V68, P94, DOI 10.1016/j.neuropsychologia.2015.01.002; RAINE A, 1990, ARCH GEN PSYCHIAT, V47, P1003; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Shaw DS, 2014, ANNU REV CLIN PSYCHO, P10; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Syngelaki EM, 2013, SOC NEUROSCI-UK, V8, P112, DOI 10.1080/17470919.2012.712549; Syngelaki EM, 2013, DEVELOPMENTAL SCI, V16, P84, DOI 10.1111/j.1467-7687.2012.01191.x; van Goozen SHM, 2004, J CHILD PSYCHOL PSYC, V45, P884; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	56	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147357	10.1371/journal.pone.0147357	http://dx.doi.org/10.1371/journal.pone.0147357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808519	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800078
J	Sambola, A; Mutuberria, M; del Blanco, BG; Alonso, A; Barrabes, JA; Bueno, H; Alfonso, F; Cequier, A; Zueco, J; Rodriguez-Leor, O; Tornos, P; Garcia-Dorado, D				Sambola, Antonia; Mutuberria, Maria; Garcia del Blanco, Bruno; Alonso, Albert; Barrabes, Jose A.; Bueno, Hector; Alfonso, Fernando; Cequier, Angel; Zueco, Javier; Rodriguez-Leor, Oriol; Tornos, Pilar; Garcia-Dorado, David			Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; STROKE; RISK; WARFARIN; OUTCOMES; METAANALYSIS; CLOPIDOGREL	Background and Purpose Selecting an ideal antithrombotic therapy for elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) can be challenging since they have a higher thromboembolic and bleeding risk than younger patients. The current study aimed to assess the efficacy and safety of triple therapy (TT: oral anticoagulation plus dual antiplatelet therapy: aspirin plus clopidogrel) in patients >= 75 years of age with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). Methods A prospective multicenter study was conducted from 2003 to 2012 at 6 Spanish teaching hospitals. A cohort study of consecutive patients with AF undergoing PCI and treated with TT or dual antiplatelet therapy (DAPT) was analyzed. All outcomes were evaluated at 1year of follow-up. Results Five hundred and eighty-five patients, 289 (49%) of whom were >= 75 years of age (79.6 +/- 3.4 years; 33% women) were identified. TT was prescribed in 55.9% of patients at discharge who had a higher thromboembolic risk (CHA(2)DS(2)VASc score: 4.23 +/- 1.51 vs 3.76 +/- 1.40, p = 0.007 and a higher bleeding risk (HAS-BLED >= 3: 88.6% vs 79.2%, p = 0.02) than those on DAPT. Therefore, patients on TT had a lower rate of thromboembolism than those on DAPT (0.6% vs 6.9%, p = 0.004; HR 0.08, 95% CI: 0.01-0.70, p = 0.004). Major bleeding events occurred more frequently in patients on TT than in those on DAPT (11.7% vs 2.4%, p = 0.002; HR 5.2, 95% CI: 1.53-17.57, p = 0.008). The overall mortality rate was similar in both treatment groups (11.9% vs 13.9%, p = 0.38); however, after adjustment for confounding variables, TT was associated with a reduced mortality rate (HR 0.33, 95% CI: 0.12-0.86, p = 0.02). Conclusions In elderly patients with AF undergoing PCI, the use of TT compared to DAPT was associated with reduced thromboembolism and mortality rates, although a higher rate of major bleeding.	[Sambola, Antonia; Mutuberria, Maria; Garcia del Blanco, Bruno; Alonso, Albert; Barrabes, Jose A.; Tornos, Pilar; Garcia-Dorado, David] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Cardiol, E-08193 Barcelona, Spain; [Bueno, Hector] Univ Gregorio Maranon, Gen Hosp, Dept Cardiol, Madrid, Spain; [Alfonso, Fernando] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain; [Cequier, Angel] Hosp Univ Bellvitge, Hosp Llobregat, Dept Cardiol, Barcelona, Spain; [Zueco, Javier] Hosp Univ Marques Valdecilla, Dept Cardiol, Santander, Spain; [Rodriguez-Leor, Oriol] Hosp Badalona Germans Trias & Pujol, Dept Cardiol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; General University Gregorio Maranon Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Germans Trias i Pujol	Sambola, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Cardiol, E-08193 Barcelona, Spain.	asambola@vhebron.net	Bueno, Hector/I-3910-2015; Rodriguez-Leor, Oriol/AAW-7762-2021	Bueno, Hector/0000-0003-0277-7596; Rodriguez-Leor, Oriol/0000-0003-2657-5657; Barrabes, Jose A./0000-0001-7062-6277	Spanish Government (Fondo de Investigacion Sanitaria) [TRA-200, EC11-473]	Spanish Government (Fondo de Investigacion Sanitaria)	This study was supported by a research grant from the Spanish Government (Fondo de Investigacion Sanitaria; References TRA-200; EC11-473). No additional external funding was received for this study. AS was the author who received the Grant.	Annala AP, 2012, ANN MED, V44, P271, DOI 10.3109/07853890.2010.543919; Chan W, 2012, AM J CARDIOL, V109, P471, DOI 10.1016/j.amjcard.2011.10.004; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Denas G, 2013, J THROMB THROMBOLYS, V35, P178, DOI 10.1007/s11239-012-0790-y; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Fauchier L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125164; Faxon DP, 2011, CIRC-CARDIOVASC INTE, V4, P522, DOI 10.1161/CIRCINTERVENTIONS.111.965186; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Fosbol EL, 2013, AM HEART J, V166, P864, DOI 10.1016/j.ahj.2013.08.005; Fosbol EL, 2012, AM HEART J, V163, P720, DOI 10.1016/j.ahj.2012.01.017; Fox KAA, 2013, LANCET, V381, P1080, DOI 10.1016/S0140-6736(13)60054-9; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hess CN, 2015, J AM COLL CARDIOL, V66, P616, DOI 10.1016/j.jacc.2015.05.062; Ho KW, 2013, CAN J CARDIOL, V29, P213, DOI 10.1016/j.cjca.2012.08.008; Hobbs FDR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3653; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mennuni MG, 2015, AM J CARDIOL, V116, P37, DOI 10.1016/j.amjcard.2015.03.033; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Nguyen MC, 2007, EUR HEART J, V28, P1717, DOI 10.1093/eurheartj/ehm186; Nikolsky E, 2012, AM J CARDIOL, V109, P831, DOI 10.1016/j.amjcard.2011.10.046; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Sambola A, 2009, HEART, V95, P1483, DOI 10.1136/hrt.2009.167064; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Smith JG, 2012, EUROINTERVENTION, V8, P672, DOI 10.4244/EIJV8I6A105; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; van Walraven C, 2009, STROKE, V40, P1410, DOI 10.1161/STROKEAHA.108.526988; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Zhao HJ, 2011, CHEST, V139, P260, DOI 10.1378/chest.09-3083	33	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147245	10.1371/journal.pone.0147245	http://dx.doi.org/10.1371/journal.pone.0147245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808678	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800067
J	Schulz, JF; Thoni, C				Schulz, Jonathan F.; Thoeni, Christian			Overconfidence and Career Choice	PLOS ONE			English	Article							CEO OVERCONFIDENCE; EXCESS ENTRY; GENDER	People self-assess their relative ability when making career choices. Thus, confidence in their own abilities is likely an important factor for selection into various career paths. In a sample of 711 first-year students we examine whether there are systematic differences in confidence levels across fields of study. We find that our experimental confidence measures significantly vary between fields of study: While students in business related academic disciplines (Political Science, Law, Economics, and Business Administration) exhibit the highest confidence levels, students of Humanities range at the other end of the scale. This may have important implications for subsequent earnings and professions students select themselves in.	[Schulz, Jonathan F.] Yale Univ, Dept Psychol, New Haven, CT USA; [Thoeni, Christian] Univ Lausanne, Lausanne, Switzerland	Yale University; University of Lausanne	Schulz, JF (corresponding author), Yale Univ, Dept Psychol, New Haven, CT USA.	jonathan.schulz@yale.edu	Thöni, Christian/AAA-6537-2020; Thöni, Christian/G-5032-2012; Schulz, Jonathan/AAB-2734-2020	Thöni, Christian/0000-0003-1190-8471; Thöni, Christian/0000-0003-1190-8471; Schulz, Jonathan/0000-0001-5341-3819	Grundlagenforschungsfonds of University of St. Gallen; European Research Council [AdG 295707]	Grundlagenforschungsfonds of University of St. Gallen; European Research Council(European Research Council (ERC)European Commission)	Financial support from the Grundlagenforschungsfonds of the University of St. Gallen and the European Research Council (AdG 295707) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Simon Gachter for valuable comments. Financial support from the Grundlagenforschungsfonds of the University of St. Gallen and the European Research Council (AdG 295707) is gratefully acknowledged.	Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Benabou R, 2002, Q J ECON, V117, P871, DOI 10.1162/003355302760193913; Bertella MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083488; Bertrand M, 2011, HBK ECON, V4, P1543, DOI 10.1016/S0169-7218(11)02415-4; Bundesamt fur Statistik (BFS), 2013, SCHW ABS; Burks SV, 2013, REV ECON STUD, V80, P949, DOI 10.1093/restud/rds046; Buser T, 2014, Q J ECON, V129, P1409, DOI 10.1093/qje/qju009; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; Chevalier A, 2009, ECON EDUC REV, V28, P716, DOI 10.1016/j.econedurev.2009.06.007; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; Dreber A, 2014, EXP ECON, V17, P154, DOI 10.1007/s10683-013-9361-0; Dubra J, 2004, REV ECON DYNAM, V7, P198, DOI 10.1016/S1094-2025(03)00036-X; Ewers M, 2015, J EUR ECON ASSOC, V13, P363, DOI 10.1111/jeea.12128; Fischbacher U, 2008, J ECON BEHAV ORGAN, V67, P150, DOI 10.1016/j.jebo.2006.05.018; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gachter S, 2005, MANAGE SCI, V51, P249, DOI 10.1287/mnsc.1040.0311; Kamas L, 2012, J ECON BEHAV ORGAN, V83, P82, DOI 10.1016/j.jebo.2011.06.013; Lamba S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104562; Malmendier U, 2005, J FINANC, V60, P2661, DOI 10.1111/j.1540-6261.2005.00813.x; Malmendier U, 2008, J FINANC ECON, V89, P20, DOI 10.1016/j.jfineco.2007.07.002; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; PAGLIN M, 1990, J LABOR ECON, V8, P123, DOI 10.1086/298239; Reuben E, EC J; Scheinkman JA, 2003, J POLIT ECON, V111, P1183, DOI 10.1086/378531; Sutter M, 2015, MANAGE SCI, V61, P2339, DOI 10.1287/mnsc.2014.1981; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Trivers R, 2000, ANN NY ACAD SCI, V907, P114	29	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145126	10.1371/journal.pone.0145126	http://dx.doi.org/10.1371/journal.pone.0145126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808273	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800006
J	Swatton, JE; Davenport, PW; Maunders, EA; Griffin, JL; Lilley, KS; Welch, M				Swatton, J. E.; Davenport, P. W.; Maunders, E. A.; Griffin, J. L.; Lilley, K. S.; Welch, M.			Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CYSTIC-FIBROSIS; SUBINHIBITORY CONCENTRATIONS; MACROLIDE ANTIBIOTICS; VIRULENCE FACTORS; BIOFILM FORMATION; GROWTH-PHASE; INFECTION; GENES; PAO1	The macrolide antibiotic, azithromycin (AZM), has been reported to improve the clinical outcome of cystic fibrosis patients, many of whom are chronically-infected with Pseudomonas aeruginosa. However, the highest clinically-achievable concentrations of this drug are well-below the minimum inhibitory concentration for P. aeruginosa, raising the question of why AZM exhibits therapeutic activity. One possibility that has been raised by earlier studies is that AZM inhibits quorum sensing (QS) by P. aeruginosa. To explicitly test this hypothesis the changes brought about by AZM treatment need to be compared with those associated with specific QS mutants grown alongside in the same growth medium, but this has not been done. In this work, we used quantitative 2D-difference gel electrophoresis and H-1-NMR spectroscopy footprint analysis to examine whether a range of clinically-relevant AZM concentrations elicited proteomic and metabolomic changes in wild-type cultures that were similar to those seen in cultures of defined QS mutants. Consistent with earlier reports, over half of the AZM-induced spot changes on the 2D gels were found to affect QS-regulated proteins. However, AZM modulated very few protein spots overall (compared with QS) and collectively, these modulated proteins comprised only a small fraction (12-13%) of the global QS regulon. We conclude that AZM perturbs a sub-regulon of the QS system but does not block QS per se. Reinforcing this notion, we further show that AZM is capable of attenuating virulence factor production in another Gram-negative species that secretes copious quantities of exoenzymes (Serratia marcescens), even in the absence of a functional QS system.	[Swatton, J. E.; Davenport, P. W.; Maunders, E. A.; Griffin, J. L.; Welch, M.] Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Lilley, K. S.] Cambridge Ctr Prote, Tennis Court Rd, Cambridge CB2 1QW, England; [Swatton, J. E.] Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Davenport, P. W.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Griffin, J. L.] Elsie Widdowson Lab, MRC Human Nutr Res, 120 Fulbourn Rd, Cambridge CB1 9NL, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Welch, M (corresponding author), Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mw240@cam.ac.uk	Lilley, Kathryn/ABF-5787-2020; Maunders, Eve/GVU-3355-2022	Lilley, Kathryn/0000-0003-0594-6543; Maunders, Eve/0000-0003-2812-6943	Biotechnology and Biological Sciences Research Council [BB/C/500252/1, BB/M019411/1]; BBSRC (UK); Biotechnology and Biological Sciences Research Council [BB/C500252/1] Funding Source: researchfish; Medical Research Council [MR/P011705/1, MC_UP_A090_1006, 1509178] Funding Source: researchfish; MRC [MR/P011705/1, MC_UP_A090_1006] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants (BB/C/500252/1) and (BB/M019411/1) from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have no conflicting financial interests. This work was supported by the BBSRC (UK). Pfizer (UK) is thanked for generously supplying azithromycin.	Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Baumann Ulrich, 2004, Can Respir J, V11, P151; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; Glansdorp FG, 2008, ORG BIOMOL CHEM, V6, P4120, DOI 10.1039/b813157k; Godeke J, 2013, ANTIMICROB AGENTS CH, V57, P1617, DOI 10.1128/AAC.02582-12; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gross J, 2013, FUTURE MICROBIOL, V8, P697, DOI [10.2217/fmb.13.40, 10.2217/FMB.13.40]; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Howe RA, 1997, J ANTIMICROB CHEMOTH, V40, P153, DOI 10.1093/jac/40.2.153; Imperi F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00178; Kai T, 2009, PULM PHARMACOL THER, V22, P483, DOI 10.1016/j.pupt.2009.04.004; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kohler T, 2007, ANTIMICROB AGENTS CH, V51, P4243, DOI 10.1128/AAC.00613-07; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; MCDONALD PJ, 1991, EUR J CLIN MICROBIOL, V10, P828, DOI 10.1007/BF01975835; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; MOLINARI G, 1993, J ANTIMICROB CHEMOTH, V31, P681, DOI 10.1093/jac/31.5.681; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Passmore IJ, 2015, J BACTERIOL, V197, P762, DOI 10.1128/JB.02404-14; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Perez-Martinez I, 2011, ANTIMICROB AGENTS CH, V55, P3399, DOI 10.1128/AAC.01801-10; Phelan VV, 2015, J AM SOC MASS SPECTR, V26, P873, DOI 10.1007/s13361-015-1101-6; Plotnikova JM, 2000, PLANT PHYSIOL, V124, P1766, DOI 10.1104/pp.124.4.1766; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Retsema J, 2001, INT J ANTIMICROB AG, V18, pS3, DOI 10.1016/S0924-8579(01)00401-0; Robert-Genthon M, 2013, MBIO, V4, DOI 10.1128/mBio.00309-13; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sams T, 2016, ISR J CHEM, V56, P282, DOI 10.1002/ijch.201400128; Sana TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076030; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Sibley CD, 2010, FUTURE MICROBIOL, V5, P1315, DOI [10.2217/fmb.10.99, 10.2217/FMB.10.99]; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Skindersoe ME, 2008, ANTIMICROB AGENTS CH, V52, P3648, DOI 10.1128/AAC.01230-07; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Tsai WC, 2009, INFLAMM RES, V58, P491, DOI 10.1007/s00011-009-0015-9; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wozniak DJ, 2004, CHEST, V125, p62S, DOI 10.1378/chest.125.2_suppl.62S; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x	68	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147698	10.1371/journal.pone.0147698	http://dx.doi.org/10.1371/journal.pone.0147698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808156	Green Published, gold			2022-12-27	WOS:000369527800187
J	Vogelsang, M; Tomasello, M				Vogelsang, Martina; Tomasello, Michael			Giving Is Nicer than Taking: Preschoolers Reciprocate Based on the Social Intentions of the Distributor	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; COOPERATION; ONTOGENY	Recent research has found that even preschoolers give more resources to others who have previously given resources to them, but the psychological bases of this reciprocity are unknown. In our study, a puppet distributed resources between herself and a child by taking some from a pile in front of the child or else by giving some from a pile in front of herself. Although the resulting distributions were identical, three-and five-year-olds reciprocated less generously when the puppet had taken rather than given resources. This suggests that children's judgments about resource distribution are more about the social intentions of the distributor and the social framing of the distributional act than about the amount of resources obtained. In order to rule out that the differences in the children's reciprocal behavior were merely due to experiencing gains and losses, we conducted a follow-up study. Here, three-and-five year olds won or lost resources in a lottery draw and could then freely give or take resources to/from a puppet, respectively. In this study, they did not respond differently after winning vs. losing resources.	[Vogelsang, Martina] Univ Kassel, Dev Psychol Grp, Dept Psychol, D-34125 Kassel, Germany; [Tomasello, Michael] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany	Universitat Kassel; Max Planck Society	Vogelsang, M (corresponding author), Univ Kassel, Dev Psychol Grp, Dept Psychol, D-34125 Kassel, Germany.	martina.vogelsang@uni-kassel.de						Anderson Joel, 1995, STRUGGLE RECOGNITION; Dunfield KA, 2010, PSYCHOL SCI, V21, P523, DOI 10.1177/0956797610364119; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; House B, 2013, EVOL HUM BEHAV, V34, P86, DOI 10.1016/j.evolhumbehav.2012.10.001; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; House BR, 2012, EVOL HUM BEHAV, V33, P291, DOI 10.1016/j.evolhumbehav.2011.10.007; Ibbotson P, 2014, CURR ANTHROPOL, V55, P814, DOI 10.1086/679254; Kenward B, 2015, COGNITION, V136, P1, DOI 10.1016/j.cognition.2014.11.035; Keysar B, 2008, PSYCHOL SCI, V19, P1280, DOI 10.1111/j.1467-9280.2008.02223.x; KNETSCH JL, 1989, AM ECON REV, V79, P1277; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; Nowak M., 2011, SUPERCOOPERATORS MAT; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; PETERSON L, 1977, CHILD DEV, V48, P1331; Robbins E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00353; Shaw A, 2014, J EXP CHILD PSYCHOL, V119, P40, DOI 10.1016/j.jecp.2013.10.007; Sommerville JA, 2013, INFANCY, V18, P40, DOI 10.1111/j.1532-7078.2012.00129.x; STAUB E, 1970, CHILD DEV, V41, P243, DOI 10.1111/j.1467-8624.1970.tb00990.x; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tyler T. R., 2000, COOPERATION GROUPS P; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Warneken F, 2013, J EXP CHILD PSYCHOL, V116, P338, DOI 10.1016/j.jecp.2013.06.002	26	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147539	10.1371/journal.pone.0147539	http://dx.doi.org/10.1371/journal.pone.0147539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807582	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800126
J	Wan, CY; Xiang, JM; Li, YW; Guo, DZ				Wan, Chunyun; Xiang, Jinmei; Li, Youwen; Guo, Dingzong			Differential Gene Expression Patterns in Chicken Cardiomyocytes during Hydrogen Peroxide-Induced Apoptosis	PLOS ONE			English	Article							CELL-CYCLE; OXIDATIVE STRESS; ACTIVATION; ARREST; HEART; CDK4; MITOCHONDRIA; INHIBITION; RESISTANCE; PROFILES	Hydrogen peroxide (H2O2) is both an exogenous and endogenous cytotoxic agent that can reliably induce apoptosis in numerous cell types for studies on apoptosis signaling pathways. However, little is known of these apoptotic processes in myocardial cells of chicken, a species prone to progressive heart failure. Sequencing of mRNA transcripts (RNA-Seq) allows for the identification of differentially expressed genes under various physiological and pathological conditions to elucidate the molecular pathways involved, including cellular responses to exogenous and endogenous toxins. We used RNA-seq to examine genes differentially expressed during H2O2-induced apoptosis in primary cultures of embryonic chicken cardiomyocytes. Following control or H2O2 treatment, RNA was extracted and sequencing performed to identify novel transcripts up-or downregulated in the H2O2 treatment group and construct protein - protein interaction networks. Of the 19,268 known and 2,160 novel transcripts identified in both control and H2O2 treatment groups, 4,650 showed significant differential expression. Among them, 55.63% were upregulated and 44.37% downregulated. Initiation of apoptosis by H2O2 was associated with upregulation of caspase-8, caspase-9, and caspase-3, and downregulation of anti-apoptotic genes API5 and TRIA1. Many other differentially expressed genes were associated with metabolic pathways (including 'Fatty acid metabolism', 'Alanine, aspartate, and glutamate metabolism', and 'Biosynthesis of unsaturated fatty acids') and cell signaling pathways (including 'PPAR signaling pathway', 'Adipocytokine signaling pathway', 'TGF-beta signaling pathway', 'MAPK signaling pathway', and 'p53 signaling pathway'). In chicken cardiomyocytes, H2O2 alters the expression of numerous genes linked to cell signaling and metabolism as well as genes directly associated with apoptosis. In particular, H2O2 also affects the biosynthesis and processing of proteins and unsaturated fatty acids. These results highlight the value of RNAseq for revealing unexpected molecular contributors to oxidative stress responses, thereby identifying novel potential therapeutic targets.	[Wan, Chunyun; Xiang, Jinmei; Li, Youwen; Guo, Dingzong] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Wan, Chunyun] Yangtze Univ, Coll Anim Sci, Jingzhou, Hubei, Peoples R China; [Xiang, Jinmei] Hubei Vocat Coll Biotechnol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Yangtze University	Guo, DZ (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China.	hlgdz@163.com			Huazhong agricultural university [52209-814112]	Huazhong agricultural university	This work was supported by preliminary research project of Huazhong agricultural university (52209-814112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082322; Briede JJ, 2010, TOXICOL SCI, V114, P193, DOI 10.1093/toxsci/kfp309; Chang GC, 2004, BIOCHEM PHARMACOL, V68, P1453, DOI 10.1016/j.bcp.2004.06.006; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Choi CH, 2007, LEUKEMIA RES, V31, P1267, DOI 10.1016/j.leukres.2006.11.006; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Connell S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040409; DEHAAN RL, 1967, CIRCULATION, V35, P821, DOI 10.1161/01.CIR.35.5.821; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Fong CC, 2007, TOXICOLOGY, V236, P16, DOI 10.1016/j.tox.2007.03.024; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Fukuda K, 2005, FUTUR CARDIOL, V1, P167, DOI 10.1517/14796678.1.2.167; Furukawa Junya, 2011, Nihon Rinsho, V69 Suppl 5, P117; Gaballa MA, 2002, J CARD FAIL, V8, pS476, DOI 10.1054/jcaf.2002.129270; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gruss-Fischer T, 2002, BIOCHEM PHARMACOL, V63, P1325, DOI 10.1016/S0006-2952(02)00863-8; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller T, 2003, CANCER RES, V63, P513; Olkowski AA, 2007, POULTRY SCI, V86, P999, DOI 10.1093/ps/86.5.999; Park KJ, 2012, KOREAN CIRC J, V42, P23, DOI 10.4070/kcj.2012.42.1.23; Piccoli MT, 2015, J MOL CELL CARDIOL; Platel A, 2010, MUTAT RES-FUND MOL M, V689, P21, DOI 10.1016/j.mrfmmm.2010.04.004; Renfro DP, 2012, NUCLEIC ACIDS RES, V40, pD1262, DOI 10.1093/nar/gkr907; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Skomedal H, 1999, J PATHOL, V187, P556, DOI 10.1002/(SICI)1096-9896(199904)187:5<556::AID-PATH294>3.0.CO;2-Y; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V444, P248, DOI 10.1016/j.bbrc.2014.01.058; Takeuchi T, 2014, DEV GROWTH DIFFER, V56, P402, DOI 10.1111/dgd.12134; Tamim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085591; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wu J, 2006, CELL MOL LIFE SCI, V63, P2538, DOI 10.1007/s00018-006-6138-z; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang J, 2014, MOL MED REP, V9, P621, DOI 10.3892/mmr.2013.1848; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025284; Zhao WY, 2013, MOL CELL BIOCHEM, V379, P243, DOI 10.1007/s11010-013-1646-2	46	7	7	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147950	10.1371/journal.pone.0147950	http://dx.doi.org/10.1371/journal.pone.0147950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808997	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800250
J	Cunha, JPS; Choupina, HMP; Rocha, AP; Fernandes, JM; Achilles, F; Loesch, AM; Vollmar, C; Hartl, E; Noachtar, S				Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira; Rocha, Ana Patricia; Fernandes, Jose Maria; Achilles, Felix; Loesch, Anna Mira; Vollmar, Christian; Hartl, Elisabeth; Noachtar, Soheyl			NeuroKinect: A Novel Low-Cost 3Dvideo-EEG System for Epileptic Seizure Motion Quantification	PLOS ONE			English	Article							UPPER-LIMB AUTOMATISMS; TEMPORAL-LOBE; MOVEMENT QUANTIFICATION; ACCELEROMETRY; SEMIOLOGY	Epilepsy is a common neurological disorder which affects 0.5-1% of the world population. Its diagnosis relies both on Electroencephalogram (EEG) findings and characteristic seizure -induced body movements - called seizure semiology. Thus, synchronous EEG and (2D) video recording systems (known as Video-EEG) are the most accurate tools for epilepsy diagnosis. Despite the establishment of several quantitative methods for EEG analysis, seizure semiology is still analyzed by visual inspection, based on epileptologists' subjective interpretation of the movements of interest (MOIs) that occur during recorded seizures. In this contribution, we present NeuroKinect, a low-cost, easy to setup and operate solution for a novel 3Dvideo-EEG system. It is based on a RGB-D sensor (Microsoft Kinect camera) and performs 24/7 monitoring of an Epilepsy Monitoring Unit (EMU) bed. It does not require the attachment of any reflectors or sensors to the patient's body and has a very low maintenance load. To evaluate its performance and usability, we mounted a state-of-the-art 6-camera motion-capture system and our low-cost solution over the same EMU bed. A comparative study of seizure-simulated MOIs showed an average correlation of the resulting 3D motion trajectories of 84.2%. Then, we used our system on the routine of an EMU and collected 9 different seizures where we could perform 3D kinematic analysis of 42 MOIs arising from the temporal (TLE) (n = 19) and extratemporal (ETE) brain regions (n = 23). The obtained results showed that movement displacement and movement extent discriminated both seizure MOI groups with statistically significant levels (mean = 0.15 m vs. 0.44 m, p<0.001; mean = 0.068 m(3) vs. 0.14 m(3), p< 0.05, respectively). Furthermore, TLE MOIs were significantly shorter than ETE (mean = 23 seconds vs 35 seconds, p< 0.01) and presented higher jerking levels (mean = 345 ms(-3) vs 172 ms(-3), p< 0.05). Our newly implemented 3D approach is faster by 87.5% in extracting body motion trajectories when compared to a 2D frame by frame tracking procedure. We conclude that this new approach provides a more comfortable (both for patients and clinical professionals), simpler, faster and lower-cost procedure than previous approaches, therefore providing a reliable tool to quantitatively analyze MOI patterns of epileptic seizures in the routine of EMUs around the world. We hope this study encourages other EMUs to adopt similar approaches so that more quantitative information is used to improve epilepsy diagnosis.	[Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira] Univ Porto, Inst Syst Engn & Comp Technol & Sci INESC TEC, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cunha, Joao Paulo Silva; Choupina, Hugo Miguel Pereira] Univ Porto, Fac Engn FEUP, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rocha, Ana Patricia; Fernandes, Jose Maria] Univ Aveiro, Inst Elect & Informat Engn Aveiro IEETA, P-3800 Aveiro, Portugal; [Rocha, Ana Patricia; Fernandes, Jose Maria] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal; [Choupina, Hugo Miguel Pereira; Achilles, Felix; Loesch, Anna Mira; Vollmar, Christian; Hartl, Elisabeth; Noachtar, Soheyl] Univ Munich, Dept Neurol, Epilepsy Ctr, D-80539 Munich, Germany; [Achilles, Felix] Tech Univ Munich, Chair Comp Aided Med Proc, D-80290 Munich, Germany	INESC TEC; Universidade do Porto; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro; University of Munich; Technical University of Munich	Cunha, JPS (corresponding author), Univ Porto, Inst Syst Engn & Comp Technol & Sci INESC TEC, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Cunha, JPS (corresponding author), Univ Porto, Fac Engn FEUP, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jcunha@ieee.org	Rocha, Ana Patrícia/A-7991-2019; Cunha, João Paulo/AAL-1526-2021; Fernandes, Jose Maria/A-1331-2012; Cunha, Joao Paulo/F-9039-2010	Rocha, Ana Patrícia/0000-0002-4094-7982; Fernandes, Jose Maria/0000-0002-0681-9354; Choupina, Hugo/0000-0003-0864-3003; Vollmar, Christian/0000-0002-4630-7484; Cunha, Joao Paulo/0000-0003-4131-9045	ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness); Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) [EEI/UI0127/2014, UID/CEC/00127/2013, PTDC/SAUBEB/72305/2006, PTDC/NEU-SCC/0767/2012, UID/EEA/50014/2013]	ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness); Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology)	This work is partially funded by the ERDF (European Regional Development Fund) through the COMPETE Programme (operational programme for competitiveness) and by Portuguese Funds through the FCT Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) within the projects Incentivo EEI/UI0127/2014 and UID/CEC/00127/2013, MovEpil3D (PTDC/SAUBEB/72305/2006), MDAS (PTDC/NEU-SCC/0767/2012) and UID/EEA/50014/2013 granted to INESC TEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asus, 2014, ASUS XTION PRO LIVE; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Becq G, 2011, COMPUT BIOL MED, V41, P46, DOI 10.1016/j.compbiomed.2010.11.005; Bleasel A, 1997, EPILEPSIA, V38, P168, DOI 10.1111/j.1528-1157.1997.tb01093.x; Burrus N., 2014, KINECT CALIBRATION; Chen L, 2009, EPILEPSY BEHAV, V14, P344, DOI 10.1016/j.yebeh.2008.11.007; Cook JL, 2013, BRAIN, V136, P2816, DOI 10.1093/brain/awt208; Cunha J. P. Silva, 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P1435, DOI 10.1007/978-3-642-03882-2_380; Cunha JPS, 2003, P ANN INT IEEE EMBS, V25, P671, DOI 10.1109/IEMBS.2003.1279851; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gabel Moshe, 2012, Annu Int Conf IEEE Eng Med Biol Soc, V2012, P1964, DOI 10.1109/EMBC.2012.6346340; Galna B, 2014, GAIT POSTURE; GIBSON JJ, 1957, PSYCHOL REV, V64, P288, DOI 10.1037/h0044277; Han J, 2013, IEEE T CYBERNETICS; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; HORN BKP, 1981, P SOC PHOTO-OPT INST, V281, P319; Jarque CM, 2011, INT ENCY STAT SCI, P701, DOI [10.1007/978-3-642-04898-2_319, DOI 10.1007/978-3-642-04898-2_319]; Karayiannis NB, 2005, EPILEPSIA, V46, P901, DOI 10.1111/j.1528-1167.2005.56504.x; Karayiannis NB, 2003, P ANN INT IEEE EMBS, V25, P874, DOI 10.1109/IEMBS.2003.1279904; Li Z, 1999, P 11 INT C EMG CLIN, V110, P128; Li ZJ, 2002, IEEE T BIO-MED ENG, V49, P565, DOI 10.1109/TBME.2002.1001971; Luders H, 2000, ATLAS CLASSIFICATION; Medical Optima, 2014, XLTEK EEG; Microsoft, 2014, KIN WIND V2; Microsoft, 2014, KIN SDK 1 5; Microsoft, 2014, KIN WIND DEV PROGR P; Mirzadjanova Z, 2010, EPILEPSIA, V51, P2140, DOI 10.1111/j.1528-1167.2010.02599.x; Nijsen TME, 2007, IEEE T BIO-MED ENG, V54, P2073, DOI 10.1109/TBME.2007.895114; Nijsen TME, 2005, EPILEPSY BEHAV, V7, P74, DOI 10.1016/j.yebeh.2005.04.011; Noachtar S, 2009, EPILEPSY BEHAV, V15, P2, DOI 10.1016/j.yebeh.2009.02.029; O'Dwyer R, 2007, EPILEPSIA, V48, P524, DOI 10.1111/j.1528-1167.2006.00967.x; Patel K., 2009, P 3 INT C PERV COMP, P1, DOI DOI 10.4108/ICST.PERVASIVEHEALTH2009.6019; Remi J, 2011, EPILEPSIA, V52, P1447, DOI 10.1111/j.1528-1167.2011.03076.x; Remi J, 2011, EPILEPSY BEHAV, V20, P642, DOI 10.1016/j.yebeh.2011.01.020; Rocha AP, 2014, IEEE ENG MED BIO, P3126, DOI 10.1109/EMBC.2014.6944285; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Cunha JPS, 2013, EPILEPSY BEHAV, V27, P404, DOI 10.1016/j.yebeh.2013.02.026; Cunha JPS, 2012, MED ENG PHYS, V34, P938, DOI 10.1016/j.medengphy.2011.10.013; SoftKinetic, 2014, DS311; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Systems Innovation, 2014, MAXTRAQ; Tezer FI, 2013, EPILEPTIC DISORD, V15, P338, DOI 10.1684/epd.2013.0597; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	43	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145669	10.1371/journal.pone.0145669	http://dx.doi.org/10.1371/journal.pone.0145669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799795	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300007
J	Dupas, J; Goanvec, C; Feray, A; Guernec, A; Alain, C; Guerrero, F; Mansourati, J				Dupas, Julie; Goanvec, Christelle; Feray, Annie; Guernec, Anthony; Alain, Charlene; Guerrero, Francois; Mansourati, Jacques			Progressive Induction of Type 2 Diabetes: Effects of a Reality-Like Fructose Enriched Diet in Young Wistar Rats	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; FATTY-ACIDS; HOMA-IR; HYPERTENSION; NEPHROPATHY	Purpose The aim of this study was to characterize short and medium-lasting effects of fructose supplementation on young Wistar rats. The diet was similar to actual human consumption. Methods Three week old male rats were randomly divided into 2 groups: control (C; n = 16), fructose fed (FF; n = 16) with a fructose enriched drink for 6 or 12 weeks. Bodyweight, fasting glycemia and systolic blood pressure were monitored. Glucose tolerance was evaluated using an oral glucose tolerance test. Insulinemia was measured concomitantly and enable us to calculate insulin resistance markers (HOMA-IR, Insulin Sensitivity Index for glycemia: ISI-gly). Blood chemistry analyses were performed. Results After six weeks of fructose supplementation, rats were not overweight but presented increased fasting glycemia, reduced glucose tolerance, and lower insulin sensitivity compared to control group. Systolic blood pressure and heart weight were also increased without any change in renal function (theoretical creatinine clearance). After twelve weeks of fructose supplementation, FF rats had increased bodyweight and presented insulin resistance (higher HOMA-IR, lower ISI-gly). Rats also presented higher heart volume and lower ASAT/ALAT ratio (presumed liver lesion). Surprisingly, the Total Cholesterol/Triglycerides ratio was increased only after six weeks of fructose supplementation, predicting a higher LDL presence and thus a higher risk of developing cardiovascular disease. This risk was no longer present after twelve weeks of a fructose enriched diet. Conclusion On young Wistar rats, six weeks of fructose supplementation is sufficient to induce signs of metabolic syndrome. After twelve weeks of fructose enriched diet, rats are insulin resistant. This model enabled us to study longitudinally the early development of type 2 diabetes.	[Dupas, Julie; Goanvec, Christelle; Feray, Annie; Guernec, Anthony; Alain, Charlene; Guerrero, Francois; Mansourati, Jacques] Univ Bretagne Occidentale, Optimisat Regulat Physiol, Brest, France; [Goanvec, Christelle] Univ Bretagne Occidentale, UFR Sci & Tech, Brest, France; [Feray, Annie; Guernec, Anthony; Guerrero, Francois] Univ Bretagne Occidentale, UFR Sport & Educ Phys, Brest, France; [Mansourati, Jacques] CHU Brest, Dept Cardiol, F-29285 Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest	Dupas, J (corresponding author), Univ Bretagne Occidentale, Optimisat Regulat Physiol, Brest, France.	julie.dupas@univ-brest.fr		Guerrero, Francois/0000-0002-0283-3503				Amerand A, 2006, UNDERSEA HYPERBAR M, V33, P157; Aydin A, 2001, CLIN BIOCHEM, V34, P65, DOI 10.1016/S0009-9120(00)00199-5; Baker HJ, 1979, BIOL AND DIS; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belfiore F, 1998, MOL GENET METAB, V63, P134, DOI 10.1006/mgme.1997.2658; Bettaieb A, 2014, FREE RADICAL BIO MED, V72, P247, DOI 10.1016/j.freeradbiomed.2014.04.011; Bhatia S, 2003, CLIN BIOCHEM, V36, P557, DOI 10.1016/S0009-9120(03)00094-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; da Silva RJ, 2011, CLINICS, V66, P1793, DOI 10.1590/S1807-59322011001000019; de Moura RF, 2009, BRIT J NUTR, V101, P1178, DOI 10.1017/S0007114508066774; Dimo T, 2002, J ETHNOPHARMACOL, V83, P183, DOI 10.1016/S0378-8741(02)00162-9; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Egbuonu A. C. C., 2013, American Journal of Biochemistry and Molecular Biology, V3, P50, DOI 10.3923/ajbmb.2013.50.60; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Haeri MR, 2009, PHYTOTHER RES, V23, P61, DOI 10.1002/ptr.2557; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Lamarche B, 1999, DIABETES METAB, V25, P199; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Ndlovu T, 2007, AFR J BIOTECHNOL, P6; Patel J, 2009, INDIAN J BIOCHEM BIO, V46, P66; PICKART L, 1983, ATHEROSCLEROSIS, V46, P21, DOI 10.1016/0021-9150(83)90160-0; Pranprawit A, 2013, J SCI FOOD AGR, V93, P3191, DOI 10.1002/jsfa.6240; Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009; Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6; Ross SW, 2001, COMP BIOCHEM PHYS C, V130, P289, DOI 10.1016/S1532-0456(01)00243-5; Schianca GPC, 2006, DIABETES-METAB RES, V22, P111, DOI 10.1002/dmrr.560; Seghrouchni I, 2002, CLIN CHIM ACTA, V321, P89, DOI 10.1016/S0009-8981(02)00099-2; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Yoshida Akihiro, 2004, J Atheroscler Thromb, V11, P215; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zamami Y, 2008, BIOL PHARM BULL, V31, P2103, DOI 10.1248/bpb.31.2103	45	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146821	10.1371/journal.pone.0146821	http://dx.doi.org/10.1371/journal.pone.0146821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799836	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300039
J	Greene, E				Greene, Ernest			Recognizing Words and Reading Sentences with Microsecond Flash Displays	PLOS ONE			English	Article							LIGHT-ADAPTATION; GANGLION-CELLS; MODULATION SENSITIVITY; SPECTRAL SENSITIVITY; CONE PHOTORECEPTORS; LUMINOUS SENSATION; VISUAL RESPONSE; RECOGNITION; PERCEPTION; FREQUENCY	Strings of dots can be used to construct easily identifiable letters, and these in turn can be used to write words and sentences. Prior work found that respondents could identify individual letters when all the dots were simultaneously flashed for an ultra-brief duration. Four of the experiments reported here constructed five-letter words with these dot-letters and a fifth experiment used them to write complete sentences. Respondents were able to recognize individual words that were displayed with a single, simultaneous ultra-brief flash of all the letters. Further, sentences could be efficiently read with a sequence of simultaneous flashes at a frequency that produced perceptual fusion. One experiment determined the frequency range that would produce flicker-fusion. Two experiments established the relation of intensity to probability of recognition with single flashes and with fused-flicker frequencies. Another established the intensities at which flicker-fused and steady displays were judged to be equal in brightness. The final experiment used those flicker-fused and steady intensities to display sentences. The two display conditions were read with equal efficiency, even though the flicker-fused displays provided light stimulation only 0.003% of the time.	[Greene, Ernest] Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA	University of Southern California	Greene, E (corresponding author), Univ So Calif, Dept Psychol, Lab Neurometr Res, Los Angeles, CA 90089 USA.	egreene@usc.edu			Quest for Truth Foundation; Neuropsychology Foundation	Quest for Truth Foundation; Neuropsychology Foundation	Quest for Truth Foundation and Neuropsychology Foundation provided some funding. No grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA TS, 1964, VISION RES, V4, P391, DOI 10.1016/0042-6989(64)90011-2; ANDERSON DA, 1966, J OPT SOC AM, V56, P1607, DOI 10.1364/JOSA.56.001607; Arnold W, 1934, J GEN PHYSIOL, V18, P97, DOI 10.1085/jgp.18.1.97; Baddeley A. D, 1986, WORKING MEMORY; BATTERSBY WS, 1953, J EXP PSYCHOL, V46, P154, DOI 10.1037/h0062884; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BERMAN SM, 1979, BIOL CYBERN, V34, P171, DOI 10.1007/BF00336968; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; BLACKWELL HR, 1963, J OPT SOC AM, V53, P129, DOI 10.1364/JOSA.53.000129; BOUMAN MA, 1952, J OPT SOC AM, V42, P617, DOI 10.1364/JOSA.42.000617; Broca A, 1902, CR HEBD ACAD SCI, V134, P831; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; BURR DC, 1993, J OPT SOC AM A, V10, P1706, DOI 10.1364/JOSAA.10.001706; Cao LH, 2014, P NATL ACAD SCI USA, V111, P2752, DOI 10.1073/pnas.1400268111; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Corwin TR, 1974, VISION RES, V14, P1675; Crozier WJ, 1941, J GEN PHYSIOL, V24, P635, DOI 10.1085/jgp.24.5.635; Crozier WJ, 1941, J GEN PHYSIOL, V25, P89, DOI 10.1085/jgp.25.1.89; Crozier WJ, 1941, J GEN PHYSIOL, V24, P505, DOI 10.1085/jgp.24.4.505; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; ERIKSEN CW, 1967, J EXP PSYCHOL, V74, P476, DOI 10.1037/h0024765; ESTES WK, 1975, J EXP PSYCHOL GEN, V104, P122, DOI 10.1037/0096-3445.104.2.122; Fizeau H, 1851, COMPTE RENDUE SEANCE, V33, P349; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; FREDERIKSEN JR, 1976, J EXP PSYCHOL HUMAN, V2, P361, DOI 10.1037/0096-1523.2.3.361; Friedburg C, 2004, J PHYSIOL-LONDON, V556, P819, DOI 10.1113/jphysiol.2004.061523; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Grainger J, 2012, CUR ISS PSYCHOL LANG, P159; Granit R, 1931, AM J PHYSIOL, V98, P644, DOI 10.1152/ajplegacy.1931.98.4.644; Greene E, 2015, ATTEN PERCEPT PSYCHO, V77, P1955, DOI 10.3758/s13414-015-0913-6; Greene E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123458; Greene E, 2014, I-PERCEPTION, V5, P87, DOI 10.1068/i0639rep; HABER RN, 1969, Q J EXP PSYCHOL, V21, P43, DOI 10.1080/14640746908400193; HAMER RD, 1992, J OPT SOC AM A, V9, P1889, DOI 10.1364/JOSAA.9.001889; HAMER RD, 1992, INVEST OPHTH VIS SCI, V33, P704; Hancock PJB, 2008, J VISION, V8, DOI 10.1167/8.7.21; Hecht S, 1933, J GEN PHYSIOL, V17, P269, DOI 10.1085/jgp.17.2.269; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; HERRICK RM, 1972, J OPT SOC AM, V62, P104, DOI 10.1364/JOSA.62.000104; Houpt JW, 2014, ACTA PSYCHOL, V145, P118, DOI 10.1016/j.actpsy.2013.10.013; Houpt JW, 2012, J MATH PSYCHOL, V56, P341, DOI 10.1016/j.jmp.2012.05.004; HUDSON PTW, 1985, J MEM LANG, V24, P46, DOI 10.1016/0749-596X(85)90015-4; IKEDA M, 1965, J OPT SOC AM, V55, P1527, DOI 10.1364/JOSA.55.001527; James KH, 2005, COGN AFFECT BEHAV NE, V5, P451; Jensen RJ, 2007, J NEURAL ENG, V4, pS1, DOI 10.1088/1741-2560/4/1/S01; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; JOHNSTON JC, 1981, PERCEPTION PRINT REA, P65; Kleitman N, 1924, CR SOC BIOL, V91, P453; Kraft TW, 1998, VISION RES, V38, P3663, DOI 10.1016/S0042-6989(97)00371-4; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Lee BB, 2007, J VISION, V7, DOI 10.1167/7.14.1; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MASSARO DW, 1973, J EXP PSYCHOL, V100, P349, DOI 10.1037/h0035681; MASSARO DW, 1979, ACTA PSYCHOL, V43, P413, DOI 10.1016/0001-6918(79)90033-7; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MEIJER JG, 1978, VISION RES, V18, P1111, DOI 10.1016/0042-6989(78)90093-7; Miller GA, 1954, J GEN PSYCHOL, V50, P129, DOI 10.1080/00221309.1954.9710109; MILLER JL, 1993, VISUAL NEUROSCI, V10, P653, DOI 10.1017/S0952523800005356; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Neisser U., 1967, COGNITIVE PSYCHOL; NELSON TM, 1965, J PSYCHOL, V59, P185, DOI 10.1080/00223980.1965.9916792; NUNN BJ, 1984, NATURE, V309, P264, DOI 10.1038/309264a0; OSAKA N, 1977, PERCEPT PSYCHOPHYS, V22, P63, DOI 10.3758/BF03206081; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; PINNEO LR, 1967, J NEUROL SCI, V5, P303, DOI 10.1016/0022-510X(67)90138-4; Plateau J. A. F., 1830, ANN PHYS-LEIPZIG, P304; Pokorny J, 2001, COLOR RES APPL, V26, pS140, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL31>3.0.CO;2-N; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; RICHARDSON JTE, 1976, BRIT J PSYCHOL, V67, P315, DOI 10.1111/j.2044-8295.1976.tb01518.x; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Rood ON, 1871, AM J SCI ARTS, V2, P159; Sakurai Y, 2000, J NEUROL SCI, V178, P42, DOI 10.1016/S0022-510X(00)00363-4; SCHNAPF JL, 1980, NATURE, V287, P239, DOI 10.1038/287239a0; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Starrfelt R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00519; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Talbot H.F., 1834, LOND EDINB PHIL MAG, V29, P321, DOI DOI 10.1080/14786443408648474; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Townsend JT, 2004, PSYCHOL REV, V111, P1003, DOI 10.1037/0033-295x.111.4.1003; Townsend JT, 1995, J MATH PSYCHOL, V39, P321, DOI 10.1006/jmps.1995.1033; UCHIKAWA K, 1993, J OPT SOC AM A, V10, P1697, DOI 10.1364/JOSAA.10.001697; UETSUKI T, 1970, J OPT SOC AM, V60, P377, DOI 10.1364/JOSA.60.000377; van Hateren JH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-34; VANDENBRINK G, 1954, J OPT SOC AM, V44, P616, DOI 10.1364/JOSA.44.000616; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wheatstone Charles, 1834, PHILOS T ROY SOC LON, V124, P583, DOI [10.1098/rspl.180.0178, DOI 10.1098/RSPL.1830.0178]; WHEELER DD, 1970, COGNITIVE PSYCHOL, V1, P59, DOI 10.1016/0010-0285(70)90005-8	108	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145697	10.1371/journal.pone.0145697	http://dx.doi.org/10.1371/journal.pone.0145697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800027	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300009
J	Nicholson, BA; West, AC; Mangiamele, P; Barbieri, N; Wannemuehler, Y; Nolan, LK; Logue, CM; Li, GW				Nicholson, Bryon A.; West, Aaron C.; Mangiamele, Paul; Barbieri, Nicolle; Wannemuehler, Yvonne; Nolan, Lisa K.; Logue, Catherine M.; Li, Ganwu			Genetic Characterization of ExPEC-Like Virulence Plasmids among a Subset of NMEC	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; NEONATAL MENINGITIS; NUCLEOTIDE-SEQUENCE; STRAINS; RESISTANCE; PROTEIN; IDENTIFICATION; COMMENSAL; REPA; EPIDEMIOLOGY	Neonatal Meningitis Escherichia coli (NMEC) is one of the most common causes of neonatal bacterial meningitis in the US and elsewhere resulting in mortality or neurologic deficits in survivors. Large plasmids have been shown experimentally to increase the virulence of NMEC in the rat model of neonatal meningitis. Here, 9 ExPEC-like plasmids were isolated from NMEC and sequenced to identify the core and accessory plasmid genes of ExPEC-like virulence plasmids in NMEC and create an expanded plasmid phylogeny. Results showed sequenced virulence plasmids carry a strongly conserved core of genes with predicted functions in five distinct categories including: virulence, metabolism, plasmid stability, mobile elements, and unknown genes. The major functions of virulence-associated and plasmid core genes serve to increase in vivo fitness by adding multiple iron uptake systems to the genetic repertoire to facilitate NMEC's survival in the host's low iron environment, and systems to enhance bacterial resistance to host innate immunity. Phylogenetic analysis based on these core plasmid genes showed that at least two lineages of ExPEC-like plasmids could be discerned. Further, virulence plasmids from Avian Pathogenic E. coli and NMEC plasmids could not be differentiated based solely on the genes of the core plasmid genome.	[Nicholson, Bryon A.; Mangiamele, Paul; Barbieri, Nicolle; Wannemuehler, Yvonne; Nolan, Lisa K.; Logue, Catherine M.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [West, Aaron C.] Iowa State Univ, Dept Chem, Coll Liberal Arts & Sci, Ames, IA USA; [Li, Ganwu] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, 1802 Univ Blvd, Ames, IA 50011 USA; [Li, Ganwu] Nanjing Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Nanjing 210095, Jiangsu, Peoples R China	Iowa State University; Iowa State University; Iowa State University; Nanjing Agricultural University	Li, GW (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, 1802 Univ Blvd, Ames, IA 50011 USA.; Li, GW (corresponding author), Nanjing Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Nanjing 210095, Jiangsu, Peoples R China.	liganwu@iastate.edu	Barbieri, Nicolle Lima/L-6477-2013; Li, Ganwu/AAC-7423-2020; Barbieri, Nicolle/AAB-3223-2020	Barbieri, Nicolle Lima/0000-0002-8223-6580; Logue, Catherine/0000-0002-6098-2662	National Institute of Health [AI101517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101517] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institute of Health (www.nih.gov) grant AI101517. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur DC, 2003, EMBO J, V22, P6346, DOI 10.1093/emboj/cdg607; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BINNS MM, 1982, INFECT IMMUN, V35, P654, DOI 10.1128/IAI.35.2.654-659.1982; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cusumano CK, 2010, INFECT IMMUN, V78, P1457, DOI 10.1128/IAI.01260-09; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Ingmer H, 2001, MOL MICROBIOL, V42, P519, DOI 10.1046/j.1365-2958.2001.02661.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 1996, J INFECT DIS, V173, P920, DOI 10.1093/infdis/173.4.920; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P2360, DOI 10.1128/AEM.02634-07; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2012, J BACTERIOL, V194, P2846, DOI 10.1128/JB.06375-11; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Klein M, 1996, DNA SEQUENCE, V6, P351, DOI 10.3109/10425179609047574; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Lemaitre C, 2014, J BACTERIOL, V196, P1343, DOI 10.1128/JB.01153-13; Lemaitre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074423; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Lynne AM, 2007, AVIAN DIS, V51, P771, DOI 10.1637/0005-2086(2007)51[771:COASOT]2.0.CO;2; MANEN D, 1992, P NATL ACAD SCI USA, V89, P8923, DOI 10.1073/pnas.89.19.8923; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Ruiz-Perez F, 2011, P NATL ACAD SCI USA, V108, P12881, DOI 10.1073/pnas.1101006108; Salipante SJ, 2015, GENOME RES, V25, P119, DOI 10.1101/gr.180190.114; Sand O, 2003, MICROBIOL-SGM, V149, P2107, DOI 10.1099/mic.0.26363-0; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Tarjan R, 1972, SIAM J COMPUT, V1, P15; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tivendale KA, 2009, J CLIN MICROBIOL, V47, P2513, DOI 10.1128/JCM.00391-09; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Wijetunge DSS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0547-9; Wijetunge DSS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0203-9; Williams LE, 2006, APPL ENVIRON MICROB, V72, P4899, DOI 10.1128/AEM.00354-06; XIA GX, 1993, J BACTERIOL, V175, P4165, DOI 10.1128/JB.175.13.4165-4175.1993; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147757	10.1371/journal.pone.0147757	http://dx.doi.org/10.1371/journal.pone.0147757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800268	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300139
J	Yuan, P; Cao, JL; Abuduwufuer, A; Wang, LM; Yuan, XS; Lv, W; Hu, J				Yuan, Ping; Cao, Jin-lin; Abuduwufuer, Abudumailamu; Wang, Lu-Ming; Yuan, Xiao-Shuai; Lv, Wang; Hu, Jian			Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE PROMOTER; THYROID-CANCER; DISEASE RECURRENCE; SOMATIC MUTATIONS; HIGHLY RECURRENT; CELL CARCINOMAS; HIGH-FREQUENCY; BRAF V600E; TELOMERASE; ASSOCIATION	Background The prevalence of telomerase reverse transcriptase (TERT) promoter mutations (pTERTm) in non-small-cell lung cancer (NSCLC) have been investigated, but the results were inconsistent. In addition, several studies have analysed the role of pTERTm in the etiology of various types of cancers, however, the results also remain inconsistent. Methods The genomic DNA sequence of 103 NSCLC samples were analysed to investigate the frequency of pTERTm in these patients and to establish whether these mutations are associated with their clinical data. Furthermore, a meta-analysis based on previously published articles and our cohort study was performed to investigate the association of pTERTm with patient gender, age at diagnosis, metastasis status, tumour stage and cancer prognosis (5-year overall survival rate). Results In the cohort study, 4 patients had C228T and 2 had C250T, with a total mutation frequency up to 5.8%. Significant difference of clinical data between pTERTm carriers and noncarriers was only found in age at diagnosis. In the meta-analysis, We found that pTERTm carriers in cancer patients are older than noncarriers (Mean difference (MD) = 5.24; 95% confidence interval [CI], 2.00 to 8.48), male patients were more likely to harbour pTERTm (odds Ratios (OR) = 1.38; 95% CI, 1.22 to 1.58), and that pTERTm had a significant association with distant metastasis (OR = 3.78; 95% CI, 2.45 to 5.82), a higher tumour grade in patients with glioma (WHO grade III, IV vs. I, II: OR, 2.41; 95% CI, 1.88 to 3.08) and a higher tumour stage in other types of cancer (III, IV vs. I, II: OR, 2.48; 95% CI, 1.48 to 4.15). pTERTm was also significantly associated with a greater risk of death (hazard ratio = 1.71; 95% CI, 1.41 to 2.08). Conclusions pTERTm are a moderately prevalent genetic event in NSCLC. The current meta-analysis indicates that pTERTm is associated with patient age, gender and distant metastasis. It may serves as an adverse prognostic factor in individuals with cancers.	[Yuan, Ping; Cao, Jin-lin; Abuduwufuer, Abudumailamu; Wang, Lu-Ming; Yuan, Xiao-Shuai; Lv, Wang; Hu, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China.	hujian_med@163.com			National Natural Science Foundation of China [NSFC 31170720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 31170720). Web site: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chan AK, 2014, MOD PATHOL; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100297; Chen YL, 2014, INT J SURG, V12, P659, DOI 10.1016/j.ijsu.2014.05.066; Cheng K, 2014, LAB INVEST, V94, p475A; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Cukusic A, 2008, CYTOGENET GENOME RES, V122, P263, DOI 10.1159/000167812; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Egberts F, 2014, MELANOMA RES, V24, P131, DOI 10.1097/CMR.0000000000000048; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gandolfi G, 2015, EUR J ENDOCRINOL, V172, P403, DOI 10.1530/EJE-14-0837; Goutagny S, 2014, BRAIN PATHOL, V24, P184, DOI 10.1111/bpa.12110; Griewank KG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju246; Heidenreich B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4401; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hosen I, 2014, INT J CANC; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang HN, 2014, MOD PATHOL; Killela PJ, 2014, ONCOTARGET, V5, P1515, DOI 10.18632/oncotarget.1765; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Labussiere M, 2014, BR J CANC; Landa I, 2013, J CLIN ENDOCR METAB, V98, pE1562, DOI 10.1210/jc.2013-2383; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Liu T, 2014, ONCOGENE, V33, P4978, DOI 10.1038/onc.2013.446; Liu TT, 2014, ENDOCR-RELAT CANCER, V21, P427, DOI 10.1530/ERC-14-0016; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Ma X, 2014, LUNG CANCER, V86, P369, DOI 10.1016/j.lungcan.2014.10.009; MANTEL N, 1959, J NATL CANCER I, V22, P719; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Muzza M, 2015, MOL CELL ENDOCRINOL, V399, P288, DOI 10.1016/j.mce.2014.10.019; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Papathomas TG, 2014, ENDOCR-RELAT CANCER, V21, P653, DOI 10.1530/ERC-13-0429; Park CK, 2014, ONCOTARGET, V5, P3399, DOI 10.18632/oncotarget.1975; Populo H, 2014, J INVEST DERMATOL, V134, P2251, DOI 10.1038/jid.2014.163; Qu YP, 2014, INT J CANCER, V135, P1008, DOI 10.1002/ijc.28728; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Remke M, 2013, ACTA NEUROPATHOL, V126, P917, DOI 10.1007/s00401-013-1198-2; Saretzki G, 2003, DRUG TODAY, V39, P265, DOI 10.1358/dot.2003.39.4.799403; Simon M, 2014, NEUROONCOL; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Spiegl-Kreinecker S, 2015, NEUROONCOL; Tallet A, 2014, ONCOGENE, V33, P3748, DOI 10.1038/onc.2013.351; Tolleson WH, 2005, J ENVIRON SCI HEAL C, V23, P105, DOI 10.1080/10590500500234970; Wang K, 2014, ONCOTARGET, V5, P1829, DOI 10.18632/oncotarget.1829; Wang N, 2014, CANCER-AM CANCER SOC, V120, P2965, DOI 10.1002/cncr.28800; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Wu S, 2014, EUR UROL, V65, P274, DOI 10.1016/j.eururo.2013.10.038; Xie H, 2014, ONCOTARGET; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Zheng X, 2014, JOURNAL OF HEMATOLOG, P7	58	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146803	10.1371/journal.pone.0146803	http://dx.doi.org/10.1371/journal.pone.0146803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799744	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300038
J	Li, ZY; Ren, BB; Tan, HY; Liu, SR; Wang, W; Pang, Y; Lin, JZ; Zeng, C				Li, Zhangyong; Ren, Binbin; Tan, Haiyan; Liu, Shengrong; Wang, Wei; Pang, Yu; Lin, Jinzhao; Zeng, Chen			Capsule Design for Blue Light Therapy against Helicobacter pylori	PLOS ONE			English	Article							ENDOSCOPY; SYSTEMS; SENSOR; CORE	A photo-medical capsule that emits blue light for Helicobacter pylori treatment was described in this paper. The system consists of modules for pH sensing and measuring, light-emitting diode driver circuit, radio communication and microcontroller, and power management. The system can differentiate locations by monitoring the pH values of the gastrointestinal tract, and turn on and off the blue light according to the preset range of pH values. Our experimental tests show that the capsule can operate in the effective light therapy mode for more than 32 minutes and the wireless communication module can reliably transmit the measured pH value to a receiver located outside the body.	[Li, Zhangyong; Ren, Binbin; Tan, Haiyan; Liu, Shengrong; Wang, Wei; Pang, Yu; Lin, Jinzhao; Zeng, Chen] Chongqing Univ Posts & Telecommun, Biomed Engn Res Ctr, Chongqing, Peoples R China; [Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA	Chongqing University of Posts & Telecommunications; George Washington University	Li, ZY (corresponding author), Chongqing Univ Posts & Telecommun, Biomed Engn Res Ctr, Chongqing, Peoples R China.	lizy@cqupt.edu.cn			National Natural Science Foundation of China [60901045]; Science Fund of Chongqing China [cstc2012jjA10148, KJ1400427]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund of Chongqing China	This project is supported by the National Natural Science Foundation of China (No. 60901045), Science Fund of Chongqing China (No. cstc2012jjA10148 and No. KJ1400427). The author Zhangyong Li plays a role in charge for both the funders.	Banerjee SS, 2015, J MATER CHEM B, V3, P3931, DOI 10.1039/c5tb00534e; Chen WW, 2014, INT J MED ROBOT COMP, V10, P147, DOI 10.1002/rcs.1520; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; Ganz RA, 2015, LASER SURG MED, V36, P260; Halbritter H, 2014, IEEE PHOTONIC TECH L, V26, P1871, DOI 10.1109/LPT.2014.2336732; Hamblin MR, 2005, ANTIMICROB AGENTS CH, V49, P2822, DOI 10.1128/AAC.49.7.2822-2827.2005; Jia ZW, 2015, AIP ADV, V5, DOI 10.1063/1.4907170; Jia Zhiwei, 2014, Journal of Medical Engineering & Technology, V38, P351, DOI 10.3109/03091902.2014.937835; Khan TH, 2014, SENSORS-BASEL, V14, P20779, DOI 10.3390/s141120779; Kwak SS, 2014, INT J ELECTRON, V101, P1683, DOI 10.1080/00207217.2014.888780; Lembo AJ, 2009, LASER SURG MED, V41, P337, DOI 10.1002/lsm.20770; Li J, 2013, J NANOPART RES, V15, P1; Makobongo MO, 2014, J MICROBIOL, V52, P259, DOI 10.1007/s12275-014-3603-5; Nakamura T, 2008, J GASTROENTEROL, V43, P93, DOI 10.1007/s00535-007-2153-6; Oppong P., 2015, MEDICINE, V43, P215, DOI [10.1016/j.mpmed.2015.01.008, DOI 10.1016/J.MPMED.2015.01.008]; Pedersen PB, 2014, PHARM RES-DORDR, V31, P2044, DOI 10.1007/s11095-014-1306-6; Qi Shao, 2014, IEEE Sensors 2014. Proceedings, P339, DOI 10.1109/ICSENS.2014.6985003; Qin YX, 2010, IEEE T POWER ELECTR, V25, P507, DOI 10.1109/TPEL.2009.2026752; Sri LR, 2013, INT J ENG TECHNOLOGY, V1, P46; Taylor NAS, 2014, J THERM BIOL, V46, P72, DOI 10.1016/j.jtherbio.2014.10.006; Than TD, 2012, IEEE T BIO-MED ENG, V59, P2387, DOI 10.1109/TBME.2012.2201715; Woods SP, 2013, IEEE T BIO-MED ENG, V60, P945, DOI 10.1109/TBME.2012.2228647; Xu F, 2015, MEASUREMENT, V64, P49, DOI 10.1016/j.measurement.2014.12.044; Yamasue K, 2012, ADV BIOMED ENG, V1, P9, DOI 10.14326/abe.1.9; Yim S, 2014, INT J CONTROL AUTOM, V12, P383, DOI 10.1007/s12555-013-0078-9	25	7	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147531	10.1371/journal.pone.0147531	http://dx.doi.org/10.1371/journal.pone.0147531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814481	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200038
J	Meher, A; Randhir, K; Mehendale, S; Wagh, G; Joshi, S				Meher, Akshaya; Randhir, Karuna; Mehendale, Savita; Wagh, Girija; Joshi, Sadhana			Maternal Fatty Acids and Their Association with Birth Outcome: A Prospective Study	PLOS ONE			English	Article							GENETIC-VARIANTS; GESTATIONAL-AGE; PRETERM BIRTH; BREAST-MILK; PREGNANCY; WEIGHT; SUPPLEMENTATION; MOTHERS; PLASMA; OMEGA-3-FATTY-ACIDS	Maternal nutrition, especially LCPUFA, is an important factor in determining fetal growth and development. Our earlier cross sectional study reports lower docosahexanoic acid (DHA) levels at the time of delivery in mothers delivering low birth weight (LBW) babies. This study was undertaken to examine the role of the maternal omega-3 and omega-6 fatty acid profile across the gestation in fetal growth. This is a hospital based study where women were recruited in early gestation. Maternal blood was collected at 3 time points, i.e., T1 = 16th-20th week, T2 = 26th-30th week and T3 = at delivery. Cord blood was collected at delivery. At delivery, these women were divided into 2 groups: those delivering at term a baby weighing >2.5kg [Normal birth weight (NBW) group] and those delivering at term a baby weighing <2.5kg [LBW group]. The study reports data on 111 women recruited at T1, out of which 60 women delivered an NBW baby at term and 51 women delivered an LBW baby at term. Fatty acids were analysed using gas chromatography. At T1 of gestation, maternal erythrocyte DHA levels were positively (p<0.05) associated with baby weight. Maternal plasma and erythrocyte arachidonic acid and total erythrocyte omega-6 fatty acid levels at T2 were higher (p<0.05 for both) in the LBW group. Total erythrocyte omega-3 fatty acid levels were lower (p<0.05) while total erythrocyte omega-6 fatty acid levels were higher (p<0.05) in the LBW group at delivery. Our data demonstrates the possible role of LCPUFA in the etiology of LBW babies right from early pregnancy.	[Meher, Akshaya; Randhir, Karuna; Joshi, Sadhana] Bharati Vidyapeeth Univ, Dept Nutrit Med, Interact Res Sch Hlth Affairs, Pune 411043, Maharashtra, India; [Mehendale, Savita; Wagh, Girija] Bharati Vidyapeeth Univ, Bharati Med Coll & Hosp, Dept Obstet & Gynaecol, Pune 411043, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Joshi, S (corresponding author), Bharati Vidyapeeth Univ, Dept Nutrit Med, Interact Res Sch Hlth Affairs, Pune 411043, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	Department of Biotechnology [BT/PR-10593/MED/12/396/2008]; 'Department of Science and Technology', Government of India	Department of Biotechnology; 'Department of Science and Technology', Government of India(Department of Science & Technology (India))	This study was partially funded by the Department of Biotechnology (No BT/PR-10593/MED/12/396/2008). Author AM received the 'INSPIRE fellowship' from 'Department of Science and Technology', Government of India.	Alvino G, 2008, PEDIATR RES, V64, P615, DOI 10.1203/PDR.0b013e31818702a2; Bobinski R, 2013, J MATERN-FETAL NEO M, V26, P96, DOI 10.3109/14767058.2012.722717; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Cetin I, 2009, J PHYSIOL-LONDON, V587, P3441, DOI 10.1113/jphysiol.2009.173062; Dangat KD, 2010, NEONATOLOGY, V97, P190, DOI 10.1159/000252971; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Dirix CEH, 2009, BRIT J NUTR, V101, P399, DOI 10.1017/S0007114508006740; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Gopalan C., 2003, NFI Bulletin, V24, P1; Haggarty P, 2014, CURR OPIN CLIN NUTR, V17, P151, DOI 10.1097/MCO.0000000000000036; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Innis SM, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2011.00318.x; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilari A, 2011, AM J HUM BIOL, V23, P319, DOI 10.1002/ajhb.21129; Kilari AS, 2010, J PERINAT MED, V38, P659, DOI [10.1515/JPM.2010.112, 10.1515/jpm.2010.112]; Kilari AS, 2009, J PERINAT MED, V37, P513, DOI 10.1515/JPM.2009.096; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; MATORRAS R, 1994, EUR J OBSTET GYN R B, V57, P189, DOI 10.1016/0028-2243(94)90299-2; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Muthayya S, 2009, EUR J CLIN NUTR, V63, P340, DOI 10.1038/sj.ejcn.1602933; Muthayya S, 2009, INDIAN J MED RES, V130, P600; Olsen SF, 2007, EUR J CLIN NUTR, V61, P976, DOI 10.1038/sj.ejcn.1602609; Ortega-Senovilla H, 2010, CLIN SCI, V118, P351, DOI 10.1042/CS20090292; Ramakrishnan U, 2010, FOOD NUTR BULL, V31, pS108, DOI 10.1177/15648265100312S203; Reynolds LP, 2012, MOL CELL ENDOCRINOL, V354, P54, DOI 10.1016/j.mce.2011.11.013; Rump P, 2001, AM J CLIN NUTR, V73, P797; Saccone G, 2015, ULTRASOUND IN PRESS; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; Saccone G, 2015, OBSTET GYNECOL, V125, P663, DOI 10.1097/AOG.0000000000000668; Smits LJM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-23; Smuts CM, 2003, LIPIDS, V38, P407, DOI 10.1007/s11745-003-1076-y; Sukla KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071587; Sundrani D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054153; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887, DOI 10.1093/ajcn/87.4.887; VILBERGSSON G, 1991, INT J GYNECOL OBSTET, V36, P277, DOI 10.1016/0020-7292(91)90481-J; Wadhwani NS, 2013, MATERN CHIL IN PRESS; WHO, 2018, GUIDELINES OPTIMAL F; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	43	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147359	10.1371/journal.pone.0147359	http://dx.doi.org/10.1371/journal.pone.0147359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815428	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200030
J	Ng, KCG; Lamontagne, M; Labrosse, MR; Beaule, PE				Ng, K. C. Geoffrey; Lamontagne, Mario; Labrosse, Michel R.; Beaule, Paul E.			Hip Joint Stresses Due to Cam-Type Femoroacetabular Impingement: A Systematic Review of Finite Element Simulations	PLOS ONE			English	Article							FEMORAL-HEAD; ACETABULAR CARTILAGE; COMPUTED-TOMOGRAPHY; CONTACT FORCES; MUSCLE FORCES; ALPHA ANGLE; CT; WALKING; OSTEOARTHRITIS; GEOMETRY	Background The cam deformity causes the anterosuperior femoral head to obstruct with the acetabulum, resulting in femoroacetabular impingement (FAI) and elevated risks of early osteoarthritis. Several finite element models have simulated adverse loading conditions due to cam FAI, to better understand the relationship between mechanical stresses and cartilage degeneration. Our purpose was to conduct a systematic review and examine the previous finite element models and simulations that examined hip joint stresses due to cam FAI. Methods The systematic review was conducted to identify those finite element studies of cam-type FAI. The review conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and studies that reported hip joint contact pressures or stresses were included in the quantitative synthesis. Results Nine articles studied FAI morphologies using finite element methods and were included in the qualitative synthesis. Four articles specifically examined contact pressures and stresses due to cam FAI and were included in the quantitative synthesis. The studies demonstrated that cam FAI resulted in substantially elevated contact pressures (median = 10.4 MPa, range = 8.5-12.2 MPa) and von Mises stresses (median 15.5 MPa, range = 15.0-16.0 MPa) at the acetabular cartilage; and elevated maximum-shear stress on the bone (median = 15.2 MPa, range = 14.3-16.0 MPa), in comparison with control hips, during large amplitudes of hip motions. Many studies implemented or adapted idealized, ball-and-cup, parametric models to predict stresses, along with homogeneous bone material properties and in vivo instrumented prostheses loading data. Conclusion The formulation of a robust subject-specific FE model, to delineate the pathomechanisms of FAI, remains an ongoing challenge. The available literature provides clear insight into the estimated stresses due to the cam deformity and provides an assessment of its risks leading to early joint degeneration.	[Ng, K. C. Geoffrey; Lamontagne, Mario; Labrosse, Michel R.] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada; [Lamontagne, Mario] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Beaule, Paul E.] Univ Ottawa, Div Orthopaed Surg, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Lamontagne, M (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.; Lamontagne, M (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	mlamon@uottawa.ca	Ng, K.C. Geoffrey/AFN-7422-2022	Ng, K.C. Geoffrey/0000-0002-9413-9294	Canadian Institutes of Health Research [97778A]; Natural Sciences and Engineering Research Council of Canada [106769-2013]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	One or more of the authors received funding from the Canadian Institutes of Health Research (ML, PEB; Grant 97778A; URL: www.cihr-irsc.gc.ca) and from the Natural Sciences and Engineering Research Council of Canada (ML; Grant 106769-2013; URL: www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola R, 2014, AM J SPORT MED, V42, P798, DOI 10.1177/0363546514524364; Agricola R, 2013, ANN RHEUM DIS, V72, P918, DOI 10.1136/annrheumdis-2012-201643; Alonso-Rasgado T, 2012, J ORTHOP RES, V30, P1999, DOI 10.1002/jor.22164; Anderson AE, 2010, J BIOMECH, V43, P1351, DOI 10.1016/j.jbiomech.2010.01.010; Anderson AE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2953472; Arbabi E, 2010, J ORTHOP RES, V28, P880, DOI 10.1002/jor.21076; Bardakos NV, 2009, J BONE JOINT SURG BR, V91B, P162, DOI 10.1302/0301-620X.91B2.21137; Beaule PE, 2012, CLIN ORTHOP RELAT R, V470, P3361, DOI 10.1007/s11999-012-2601-3; Beaule PE, 2005, J ORTHOP RES, V23, P1286, DOI 10.1016/j.orthres.2005.03.011; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Behrens BA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-7; BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2010, BIO-MED MATER ENG, V20, P65, DOI 10.3233/BME-2010-0616; Brisson N, 2013, GAIT POSTURE, V37, P258, DOI 10.1016/j.gaitpost.2012.07.016; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Chegini S, 2009, J ORTHOP RES, V27, P195, DOI 10.1002/jor.20747; Clohisy JC, 2013, AM J SPORT MED, V41, P1348, DOI 10.1177/0363546513488861; DAVY DT, 1988, J BONE JOINT SURG AM, V70A, P45, DOI 10.2106/00004623-198870010-00008; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Ejnisman L, 2013, ORTHOPEDICS, V36, pE293, DOI 10.3928/01477447-20130222-17; Ergen FB, 2014, DIAGN INTERV RADIOL, V20, P271, DOI 10.5152/dir.2013.13374; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; Ferguson SJ, 2000, CLIN BIOMECH, V15, P463, DOI 10.1016/S0268-0033(99)00099-6; Fornaro J, 2010, LECT NOTES COMPUT SC, V5958, P82, DOI 10.1007/978-3-642-11615-5_9; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Genda E, 2001, J BIOMECH, V34, P895, DOI 10.1016/S0021-9290(01)00041-0; Gilles B, 2009, J BIOMECH, V42, P1201, DOI 10.1016/j.jbiomech.2009.03.033; Harris MD, 2013, J ORTHOP RES, V31, P1620, DOI 10.1002/jor.22389; Hartofilakidis G, 2011, J BONE JOINT SURG BR, V93B, P580, DOI 10.1302/0301-620X.93B5.25236; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Hellwig FL, 2016, COMPUT METHOD BIOMEC, V19, P41, DOI 10.1080/10255842.2014.983490; Hunt MA, 2013, CLIN BIOMECH, V28, P519, DOI 10.1016/j.clinbiomech.2013.05.002; Ito K, 2001, J BONE JOINT SURG BR, V83B, P171, DOI 10.1302/0301-620X.83B2.11092; Jaberi FM, 2007, J ARTHROPLASTY, V22, P37, DOI 10.1016/j.arth.2007.05.039; Jorge JP, 2014, COMPUT METHOD BIOMEC, V17, P1275, DOI 10.1080/10255842.2012.744398; Jung KA, 2011, J BONE JOINT SURG BR, V93B, P1303, DOI 10.1302/0301-620X.93B10.26433; Kang ACL, 2010, AM J SPORT MED, V38, P1160, DOI 10.1177/0363546509358320; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Kapron Ashley L, 2011, J Bone Joint Surg Am, V93, DOI 10.2106/JBJS.K.00544; Kassarjian A, 2007, EUR J RADIOL, V63, P29, DOI 10.1016/j.ejrad.2007.03.020; Kennedy MJ, 2009, GAIT POSTURE, V30, P41, DOI 10.1016/j.gaitpost.2009.02.008; Lamontagne M, 2011, J BONE JOINT SURG AM, V93A, P40, DOI 10.2106/JBJS.J.01809; Lamontagne M, 2009, CLIN ORTHOP RELAT R, V467, P645, DOI 10.1007/s11999-008-0620-x; Laude F, 2007, JOINT BONE SPINE, V74, P127, DOI 10.1016/j.jbspin.2007.01.001; Lavigne M, 2004, CLIN ORTHOP RELAT R, P61; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; Li X, 2008, MED PHYS, V35, P1507, DOI 10.1118/1.2889758; Liechti EF, 2015, J ORTHOP RES, V33, P106, DOI 10.1002/jor.22724; Liu H, 2014, BIO-MED MATER ENG, V24, P3159, DOI 10.3233/BME-141138; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Menschik F, 1997, J BIOMECH, V30, P971, DOI 10.1016/S0021-9290(97)00051-1; Myers SR, 1999, CLIN ORTHOP RELAT R, P93; Ng KCG, 2015, CLIN ORTHOP RELAT R, V473, P1289, DOI 10.1007/s11999-014-3797-1; Ng K C Geoffrey, 2012, HSS J, V8, P206, DOI 10.1007/s11420-012-9292-x; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Philippon M, 2007, KNEE SURG SPORT TR A, V15, P908, DOI 10.1007/s00167-007-0332-x; Pollard TCB, 2010, ACTA ORTHOP, V81, P134, DOI 10.3109/17453671003619011; Radcliffe IAJ, 2007, CLIN BIOMECH, V22, P422, DOI 10.1016/j.clinbiomech.2006.12.001; Ranawat Anil S, 2011, HSS J, V7, P115, DOI 10.1007/s11420-010-9192-x; Roels P, 2014, OSTEOARTHR CARTILAGE, V22, P2074, DOI 10.1016/j.joca.2014.09.011; Rothenfluh E, 2012, AM J SPORT MED, V40, P2002, DOI 10.1177/0363546512456011; Rudman KE, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-12; Russell Mary E, 2006, J Orthop Surg Res, V1, P6, DOI 10.1186/1749-799X-1-6; Rylander JH, 2011, AM J SPORT MED, V39, p36S, DOI 10.1177/0363546511413993; Sartori Massimo, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975441, DOI 10.1109/ICORR.2011.5975441; Siebenrock KA, 2004, CLIN ORTHOP RELAT R, P54; Speirs AD, 2013, OSTEOARTHR CARTILAGE, V21, P551, DOI 10.1016/j.joca.2013.01.012; Speirs AD, 2014, J BIOMECH, V47, P2348, DOI 10.1016/j.jbiomech.2014.04.031; Standaert CJ, 2008, ARCH PHYS MED REHAB, V89, P890, DOI 10.1016/j.apmr.2008.02.013; Sutter R, 2012, RADIOLOGY, V264, P514, DOI 10.1148/radiol.12112479; Sutter R, 2012, RADIOLOGY, V263, P475, DOI 10.1148/radiol.12111903; Taddei F, 2007, MED ENG PHYS, V29, P973, DOI 10.1016/j.medengphy.2006.10.014; Taddei F, 2006, IEEE T BIO-MED ENG, V53, P2194, DOI 10.1109/TBME.2006.879473; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Tomazevic D, 2003, IEEE T MED IMAGING, V22, P1407, DOI 10.1109/TMI.2003.819277; Viceconti M, 2005, CLIN BIOMECH, V20, P451, DOI 10.1016/j.clinbiomech.2005.01.010; Wei HJ, 2005, BIOMATERIALS, V26, P1905, DOI 10.1016/j.biomaterials.2004.06.014	79	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147813	10.1371/journal.pone.0147813	http://dx.doi.org/10.1371/journal.pone.0147813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812602	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000056
J	Some, D; Edwards, JK; Reid, T; Van den Bergh, R; Kosgei, RJ; Wilkinson, E; Baruani, B; Kizito, W; Khabala, K; Shah, S; Kibachio, J; Musembi, P				Some, David; Edwards, Jeffrey K.; Reid, Tony; Van den Bergh, Rafael; Kosgei, Rose J.; Wilkinson, Ewan; Baruani, Bienvenu; Kizito, Walter; Khabala, Kelly; Shah, Safieh; Kibachio, Joseph; Musembi, Phylles			Task Shifting the Management of Non-Communicable Diseases to Nurses in Kibera, Kenya: Does It Work?	PLOS ONE			English	Article							HEALTH-CARE; AFRICA; QUALITY	Background In sub-Saharan Africa there is an increasing need to leverage available health care workers to provide care for non-communicable diseases (NCDs). This study was conducted to evaluate adherence to Medecins Sans Frontieres clinical protocols when the care of five stable NCDs (hypertension, diabetes mellitus type 2, epilepsy, asthma, and sickle cell) was shifted from clinical officers to nurses. Methods Descriptive, retrospective review of routinely collected clinic data from two integrated primary health care facilities within an urban informal settlement, Kibera, Nairobi, Kenya (May to August 2014). Results There were 3,554 consultations (2025 patients); 733 (21%) were by nurses out of which 725 met the inclusion criteria among 616 patients. Hypertension (64%, 397/616) was the most frequent NCD followed by asthma (17%, 106/616) and diabetes mellitus (15%, 95/616). Adherence to screening questions ranged from 65% to 86%, with an average of 69%. Weight and blood pressure measurements were completed in 89% and 96% of those required. Laboratory results were reviewed in 91% of indicated visits. Laboratory testing per NCD protocols was higher in those with hypertension (88%) than diabetesmellitus (67%) upon review. Only 17 (2%) consultations were referred back to clinical officers. Conclusion Nurses are able to adhere to protocols for managing stable NCD patients based on clear and standardized protocols and guidelines, thus paving the way towards task shifting of NCD care to nurses to help relieve the significant healthcare gap in developing countries.	[Some, David; Edwards, Jeffrey K.; Baruani, Bienvenu; Kizito, Walter; Khabala, Kelly] Med Sans Frontieres, Nairobi, Kenya; [Edwards, Jeffrey K.; Reid, Tony; Van den Bergh, Rafael; Kizito, Walter; Shah, Safieh] Operat Res Unit, Med Sans Frontieres, Brussels, Belgium; [Kosgei, Rose J.] Univ Nairobi, Dept Obstet & Gynaecol, Coll Hlth Sci, Nairobi, Kenya; [Wilkinson, Ewan] Chester Univ, Chester, Cheshire, England; [Kibachio, Joseph] Non Communicable Dis Control Unit, Minist Hlth, Nairobi, Kenya; [Musembi, Phylles] Minist Hlth, Sub Cty Med Officer Hlth, Nairobi, Kenya	Doctors Without Borders; University of Nairobi; University of Chester	Some, D (corresponding author), Med Sans Frontieres, Nairobi, Kenya.	kdsome@yahoo.com	Shah, Safieh/Z-2078-2018; Shah, Safieh/AAK-3257-2020	Shah, Safieh/0000-0001-5358-9240; Shah, Safieh/0000-0001-5358-9240; Van den Bergh, Rafael/0000-0001-6277-8713	Union, MSF; Department for International Development (DFID); WHO	Union, MSF; Department for International Development (DFID); WHO(World Health Organization)	The programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Daniels ME, 2014, COUNCIL FOREIGN RELA; Gill GV, 2008, DIABETIC MED, V25, P606, DOI 10.1111/j.1464-5491.2008.02421.x; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kenya Ministry of Health, KEN HLTH POL 2012 20; Kenya Ministry of Health, KEN NAT DIAB STRAT 2; Kenya National Bureau of Statistics, 2009, KEN POP HOUS CENS; Khabala KB, 2015, TROP MED INT HEALTH, V20, P1265, DOI 10.1111/tmi.12539; Kirkman MS, 2002, DIABETES CARE, V25, P1946, DOI 10.2337/diacare.25.11.1946; Kosgei R, 2010, E AFR MED J, V87, P7; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; Medecins San Frontieres Belgium Kibera Project, 2009, MEDECINS SAN FRONTIE; Ogedegbe G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005983; Sobry A, 2013, TROP MED INT HEALTH, DOI [10.1111/tmi.1221, DOI 10.1111/TMI.1221]; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; WHO, 2007, TREAT TRAIN RETR TAS; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; World Medical Association, WORLD MED ASS RES TA; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	22	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0145634	10.1371/journal.pone.0145634	http://dx.doi.org/10.1371/journal.pone.0145634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812079	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000003
J	Venkatesan, N; Kanwar, J; Deepa, PR; Khetan, V; Crowley, TM; Raguraman, R; Sugneswari, G; Rishi, P; Natarajan, V; Biswas, J; Krishnakumar, S				Venkatesan, Nalini; Kanwar, Jagat; Deepa, Perinkulam Ravi; Khetan, Vikas; Crowley, Tamsyn M.; Raguraman, Rajeswari; Sugneswari, Ganesan; Rishi, Pukhraj; Natarajan, Viswanathan; Biswas, Jyotirmay; Krishnakumar, Subramanian			Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER-DIAGNOSIS; PROGNOSTIC TEST; OVARIAN-CANCER; METASTASIS; GENE; PROFILE; ACTIVATION; DEATH; PTEN	Purpose To correlate the differentially expressed miRNAs with clinico-pathological features in uveal melanoma (UM) tumors harbouring chromosomal 3 aberrations among South Asian Indian cohort. Methods Based on chromosomal 3 aberration, UM (n = 86) were grouped into monosomy 3 (M3; n = 51) and disomy 3 (D3; n = 35) by chromogenic in-situ hybridisation (CISH). The clinico-pathological features were recorded. miRNA profiling was performed in formalin fixed paraffin embedded (FFPE) UM samples (n = 6) using Agilent, Human miRNA microarray, 8x15KV3 arrays. The association between miRNAs and clinico-pathological features were studied using univariate and multivariate analysis. miRNA-gene targets were predicted using Target-scan and MiRanda database. Significantly dys-regulatedmiRNAs were validated in FFPE UM (n = 86) and mRNAs were validated in frozen UM(n = 10) by qRT-PCR. Metastasis free-survival and miRNA expressions were analysed by Kaplen-Meier analysis in UM tissues (n = 52). Results Unsupervised analysis revealed 585 differentially expressed miRNAs while supervised analysis demonstrated 82 miRNAs (FDR; Q = 0.0). Differential expression of 8 miRNAs: miR-214, miR-149*, miR-143, miR-146b, miR-199a, let7b, miR-1238 and miR-134 were studied. Gene target prediction revealed SMAD4, WISP1, HIPK1, HDAC8 and C-KIT as the post-transcriptional regulators of miR-146b, miR-199a, miR-1238 and miR-134. Five miRNAs (miR-214, miR146b, miR-143, miR-199a and miR-134) were found to be differentially expressed in M3/D3 UM tumors. In UM patients with liver metastasis, miR-149* and miR134 expressions were strongly correlated. Conclusion UM can be stratified using miRNAs from FFPE sections. miRNAs predicting liver metastasis and survival have been identified. Mechanistic linkage of de-regulated miRNA/mRNA expressions provide new insights on their role in UM progression and aggressiveness.	[Venkatesan, Nalini; Raguraman, Rajeswari; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, Larsen & Toubro Dept Ocular Pathol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India; [Kanwar, Jagat] Deakin Univ, Fac Hlth, Mol & Med Res MMR Strateg Res Ctr, NLIMBR,SoM, Pigdons Rd, Geelong, Vic 3217, Australia; [Venkatesan, Nalini; Deepa, Perinkulam Ravi] BITS, Dept Biol Sci, Pilani 333031, Rajasthan, India; [Khetan, Vikas; Sugneswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Dept Vitreoretinal & Ocular Oncol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India; [Crowley, Tamsyn M.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Crowley, Tamsyn M.] CSIRO, Australian Anim Hlth Labs, Clayton, Vic, Australia; [Natarajan, Viswanathan] Med Res Fdn, Dept Biostat, Sankara Nethralaya 41,Coll Rd, Madras 600006, Tamil Nadu, India	Deakin University; Birla Institute of Technology & Science Pilani (BITS Pilani); Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Krishnakumar, S (corresponding author), Vis Res Fdn, Larsen & Toubro Dept Ocular Pathol, Sankara Nethralaya 18-41,Coll Rd, Madras 600006, Tamil Nadu, India.	drkrishnakumar_2000@yahoo.com	Rishi, Pukhraj/AAZ-5296-2020	Crowley, Tamsyn/0000-0002-3698-8917; Khetan, Vikas/0000-0003-4396-9877	Department of Science and Technology (DST), Government of India [F.NO.SR/SO/HS30/2009]; Department of Biotechnology, Government of India [BT/01/CE1B/11/V/16]	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Science and Technology (DST), Government of India (Grant Identification Number: F.NO.SR/SO/HS30/2009) and in part by Department of Biotechnology, Government of India (Grant identification number BT/01/CE1B/11/V/16-programme support on Retinoblastoma).	Aalto Y, 2001, INVEST OPHTH VIS SCI, V42, P313; Biswas Jyotirmay, 2004, Indian Journal of Ophthalmology, V52, P41; Brantley MA, 2000, AM J PATHOL, V157, P1795, DOI 10.1016/S0002-9440(10)64817-1; Cheng GF, 2015, ADV DRUG DELIVER REV, V81, P75, DOI 10.1016/j.addr.2014.09.001; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Damato B, 2012, EYE, V26, P1157, DOI 10.1038/eye.2012.126; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Danda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083398; Dror R, 2010, INVEST OPHTH VIS SCI, V51, P1811, DOI 10.1167/iovs.09-3392; el Filali M, 2010, INVEST OPHTH VIS SCI, V51, P2329, DOI 10.1167/iovs.09-4739; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Field MG, 2014, CURR OPIN OPHTHALMOL, V25, P234, DOI 10.1097/ICU.0000000000000051; Harbour JW, 2014, METHODS MOL BIOL, V1102, P427, DOI 10.1007/978-1-62703-727-3_22; Harbour JW, 2013, PLOS CURR, P5; Herlihy N, 2015, INVEST OPHTH VIS SCI, V56, P1447, DOI 10.1167/iovs.14-15250; Jmor F, 2012, ACTA OPHTHALMOL, V90, P534, DOI 10.1111/j.1755-3768.2010.02038.x; Khetan V, 2014, INDIAN J OPHTHALMOL, V62, P158, DOI 10.4103/0301-4738.128618; Klufas MA, 2015, JAMA OPHTHALMOL, V133, P1073, DOI 10.1001/jamaophthalmol.2015.1790; Larsen AC, 2014, ACTA OPHTHALMOL, V92, P541, DOI 10.1111/aos.12322; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Madhunapantula SV, 2013, PIGM CELL MELANOMA R, V26, P886, DOI DOI 10.1111/PCMR.12156; Mensink HW, 2009, INVEST OPHTH VIS SCI, V50, P500, DOI 10.1167/iovs.08-2279; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Radhakrishnan A, 2009, MOL VIS, V15, P2146; Rey C, 2013, CELL CYCLE, V12, P1879, DOI 10.4161/cc.24927; SI ZY, 1993, INT J CANCER, V54, P37, DOI 10.1002/ijc.2910540107; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Ventura BV, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.410; Venza M, 2014, TUMORI J, V100, pE4, DOI 10.1700/1430.15828; Wang Chun-lei, 2006, Chinese Medical Sciences Journal, V21, P33; Willson JKV, 2001, ARCH OPHTHALMOL-CHIC, V119, P670; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yang CH, 2011, SCI CHINA LIFE SCI, V54, P351, DOI 10.1007/s11427-011-4149-y; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	44	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146128	10.1371/journal.pone.0146128	http://dx.doi.org/10.1371/journal.pone.0146128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812476	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528000006
J	Assareh, H; Achat, HM; Stubbs, JM; Guevarra, VM; Hill, K				Assareh, Hassan; Achat, Helen M.; Stubbs, Joanne M.; Guevarra, Veth M.; Hill, Kim			Incidence and Variation of Discrepancies in Recording Chronic Conditions in Australian Hospital Administrative Data	PLOS ONE			English	Article							COMORBIDITY INFORMATION; MEANINGFUL VARIATION; HEART-DISEASE; QUALITY; RISK; EXPERIENCE; CARE; DIAGNOSIS; IMPACT	Diagnostic data routinely collected for hospital admitted patients and used for case-mix adjustment in care provider comparisons and reimbursement are prone to biases. We aim to measure discrepancies, variations and associated factors in recorded chronic morbidities for hospital admitted patients in New South Wales (NSW), Australia. Of all admissions between July 2010 and June 2014 in all NSW public and private acute hospitals, admissions with over 24 hours stay and one or more of the chronic conditions of diabetes, smoking, hepatitis, HIV, and hypertension were included. The incidence of a non-recorded chronic condition in an admission occurring after the first admission with a recorded chronic condition (index admission) was considered as a discrepancy. Poisson models were employed to (i) derive adjusted discrepancy incidence rates (IR) and rate ratios (IRR) accounting for patient, admission, comorbidity and hospital characteristics and (ii) quantify variation in rates among hospitals. The discrepancy incidence rate was highest for hypertension (51% of 262,664 admissions), followed by hepatitis (37% of 12,107), smoking (33% of 548,965), HIV (27% of 1500) and diabetes (19% of 228,687). Adjusted rates for all conditions declined over the four-year period; with the sharpest drop of over 80% for diabetes (47.7% in 2010 vs. 7.3% in 2014), and 20% to 55% for the other conditions. Discrepancies were more common in private hospitals and smaller public hospitals. Inter-hospital differences were responsible for 1% (HIV) to 9.4% (smoking) of variation in adjusted discrepancy incidences, with an increasing trend for diabetes and HIV. Chronic conditions are recorded inconsistently in hospital administrative datasets, and hospitals contribute to the discrepancies. Adjustment for patterns and stratification in risk adjustments; and furthermore longitudinal accumulation of clinical data at patient level, refinement of clinical coding systems and standardisation of comorbidity recording across hospitals would enhance accuracy of datasets and validity of case-mix adjustment.	[Assareh, Hassan; Achat, Helen M.; Stubbs, Joanne M.; Guevarra, Veth M.] Western Sydney Local Hlth Dist, Epidemiol & Hlth Analyt, Sydney, NSW, Australia; [Hill, Kim] Western Sydney Local Hlth Dist, Execut Med Serv, Sydney, NSW, Australia		Assareh, H (corresponding author), Western Sydney Local Hlth Dist, Epidemiol & Hlth Analyt, Sydney, NSW, Australia.	Hassan.Assareh@health.nsw.gov.au	Stubbs, Joanne/GLT-4827-2022	Stubbs, Joanne/0000-0002-6846-0324				[Anonymous], 2004, INT STAT CLASS DIS R; Assareh H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005502; Assareh H, 2013, THER INNOV REGUL SCI, V47, P70, DOI 10.1177/2168479012469957; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Institute of Health and Welfare, 2010, COD WORKF SHORTF; Bottle A, 2011, HEALTH SERV RES, V46, P1741, DOI 10.1111/j.1475-6773.2011.01295.x; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng P, 2009, HEALTH INF MANAG J, V38, P35, DOI 10.1177/183335830903800105; Coory M, 2005, AUST NZ J PUBL HEAL, V29, P143, DOI 10.1111/j.1467-842X.2005.tb00064.x; Demand and Performance Evaluation, 2010, DEM PERF EV; Eagar K., 2011, ABF INFORM SERIES, V1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fung V, 2010, MED CARE, V48, P140, DOI 10.1097/MLR.0b013e3181bd4dc3; Hedin K, 2006, SCAND J PRIM HEALTH, V24, P44, DOI 10.1080/02813430500240744; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99; Knight L, 2011, IMPACT CHANGES DIABE; Kronick Richard, 2014, Medicare Medicaid Res Rev, V4, DOI 10.5600/mmrr2014-004-02-a06; Lorence DP, 2002, J HLTH CARE FINANCE, V29, P29; Lujic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005768; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; National Centre for Classification in Health, 2010, AUSTR COD STAND ICD; Nedkoff L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-121; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; O'Reilly J, 2012, HEALTH ECON POLICY L, V7, P73, DOI 10.1017/S1744133111000314; Ou LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096164; Paddison C, 2012, BMJ QUAL SAF, V21, P634, DOI 10.1136/bmjqs-2011-000737; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R Core Team, 2021, R LANGUAGE ENV STAT; Rangachari Pavani, 2007, Perspect Health Inf Manag, V4, P3; Rostami R, 2009, CLIN TRIALS, V6, P141, DOI 10.1177/1740774509102590; Santos S, 2008, HEALTH INF MANAG J, V37, P25, DOI 10.1177/183335830803700103; SAS Institute, 2013, SAS ENT GUID; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Seymour CW, 2012, HEALTH SERV RES, V47, P2060, DOI 10.1111/j.1475-6773.2012.01402.x; Simpson JM, 2003, QUAL SAF HEALTH CARE, V12, P257, DOI 10.1136/qhc.12.4.257; Soo Martin, 2014, BMC Res Notes, V7, P253, DOI 10.1186/1756-0500-7-253; Stavrou E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-331; Steinbusch PJM, 2007, HEALTH POLICY, V81, P289, DOI 10.1016/j.healthpol.2006.06.002; Stryhn H., 2006, P 11 INT S VET EP EC; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307	45	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147087	10.1371/journal.pone.0147087	http://dx.doi.org/10.1371/journal.pone.0147087			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808428	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800049
J	Breen, M; Nogales, A; Baker, SF; Perez, DR; Marinez-Sobrido, L				Breen, Michael; Nogales, Aitor; Baker, Steven F.; Perez, Daniel R.; Martinez-Sobrido, Luis			Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies	PLOS ONE			English	Article							INFECTION; TOOLS; PROTECTION; RESCUE; COLOR; GFP	Influenza A and B viruses (IAV and IBV, respectively) cause annual seasonal human respiratory disease epidemics. In addition, IAVs have been implicated in occasional pandemics with inordinate health and economic consequences. Studying influenza viruses in vitro or in vivo requires the use of laborious secondary methodologies to identify infected cells. To circumvent this requirement, replication-competent infectious influenza viruses expressing an easily traceable fluorescent reporter protein can be used. Timer is a fluorescent protein that undergoes a time-dependent color emission conversion from green to red. The rate of spectral change is independent of Timer protein concentration and can be used to chronologically measure the duration of its expression. Here, we describe the generation of replication-competent IAV and IBV where the viral non-structural protein 1 (NS1) was fused to the fluorescent dynamic Timer protein. Timer-expressing IAV and IBV displayed similar plaque phenotypes and growth kinetics to wild-type viruses in tissue culture. Within infected cells, Timer's spectral shift can be used to measure the rate and cell-to-cell spread of infection using fluorescent microscopy, plate readers, or flow cytometry. The progression of Timer-expressing IAV infection was also evaluated in a mouse model, demonstrating the feasibility to characterize IAV cell-to-cell infections in vivo. By providing the ability to chronologically track viral spread, Timer-expressing influenza viruses are an excellent option to evaluate the in vitro and in vivo dynamics of viral infection.	[Breen, Michael; Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Perez, Daniel R.] Univ Georgia, Dept Populat Hlth, 953 Coll Stn Rd, Athens, GA 30602 USA	University of Rochester; University System of Georgia; University of Georgia	Marinez-Sobrido, L (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	luis_martinez@urmc.rochester.edu	Martinez-Sobrido, Luis/ACJ-7853-2022; NOGALES, AITOR/AAY-1590-2020; NOGALES, AITOR/W-3948-2017; Perez, Daniel R./D-5044-2016	Martinez-Sobrido, Luis/0000-0001-7084-0804; NOGALES, AITOR/0000-0002-2424-7900; Perez, Daniel R./0000-0002-6569-5689; Baker, Steven/0000-0001-8379-283X	Rochester Academy of Science Student Grant; University of Rochester [T32 AI 007285-26]; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285] Funding Source: NIH RePORTER	Rochester Academy of Science Student Grant; University of Rochester; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.B. was supported by the Rochester Academy of Science Student Grant. S.F.B. was supported by the University of Rochester Immunology Training Grant T32 AI 007285-26. This research was funded by the 2014 University of Rochester Research Award to LM-S.	Avilov SV, 2012, J VIROL, V86, P1433, DOI 10.1128/JVI.05820-11; Baker SF, 2014, J VIROL, V88, P10778, DOI 10.1128/JVI.01440-14; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; CDC, 2013, DEATHS FIN DAT 2013; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Dauber B, 2004, J VIROL, V78, P1865, DOI 10.1128/JVI.78.4.1865-1872.2004; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Eckert N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097695; Fiege JK, 2015, J VIROL, V89, P6167, DOI 10.1128/JVI.00462-15; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fukuyama S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7600; Fulton BO, 2015, J VIROL, V89, P12226, DOI 10.1128/JVI.02164-15; Gabor KA, 2014, DIS MODEL MECH, V7, P1227, DOI 10.1242/dmm.014746; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Influenza-associated pediatric deaths, 2011, MMWR-MORBID MORTAL W, V60, P1233; Karlsson EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7378; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; KRUG RM, 1973, VIROLOGY, V56, P334, DOI 10.1016/0042-6822(73)90310-3; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Martinez-Sobrido Luis, 2010, J Vis Exp, DOI 10.3791/2057; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nogales A, 2015, VIROLOGY, V476, P206, DOI 10.1016/j.virol.2014.12.006; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ozawa M, 2011, VIRUS RES, V162, P8, DOI 10.1016/j.virusres.2011.09.035; Palese P, 2013, FIELDS VIROLOGY, VI; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Pena L, 2013, J VIROL, V87, P5118, DOI 10.1128/JVI.02490-12; Perez J. T, 2013, CURRENT PROTOCOLS MI; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; Roberts KL, 2015, J VIROL, V89, P1537, DOI 10.1128/JVI.03306-14; Sadler AJ, 2011, IMMUNITY, V35, P491, DOI 10.1016/j.immuni.2011.10.005; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Spronken MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133888; Subbarao K, 2004, CURR TOP MICROBIOL, V283, P313; Sutton TC, 2014, VIRUS RES, V189, P14, DOI 10.1016/j.virusres.2014.05.003; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Yan D, 2015, BIOCHEMISTRY-US, V54, P5589, DOI 10.1021/acs.biochem.5b00623; Zhao DM, 2015, J VIROL, V89, P11337, DOI 10.1128/JVI.01886-15; Zhao DM, 2012, PROTEOMICS, V12, P1970, DOI 10.1002/pmic.201100619	47	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147723	10.1371/journal.pone.0147723	http://dx.doi.org/10.1371/journal.pone.0147723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809059	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800195
J	Cheng, STW; Chen, LH; Li, SYT; Mayoux, E; Leung, PS				Cheng, Sam Tsz Wai; Chen, Lihua; Li, Stephen Yu Ting; Mayoux, Eric; Leung, Po Sing			The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic beta-Cell Mass and Glucose Homeostasis in Type 1 Diabetes	PLOS ONE			English	Article							IMPROVES GLYCEMIC CONTROL; MELLITUS; INSULIN; DAPAGLIFLOZIN; KIDNEY; POTENT; RATS; MICE	The novel sodium glucose co-transporter 2 (SGLT2) inhibitor empagliflozin has recently been reported to improve glycemic control in streptozotocin-induced type 1 diabetic rats in an insulin-independent manner, via an increase in urinary glucose output. We investigated the potential of empagliflozin to recover insulin pathways in type 1 diabetes by improving pancreatic beta-cell mass. Blood glucose homeostasis was assessed by an intraperitoneal glucose tolerance test. Serum insulin levels and insulin mRNA expression were determined using commercial insulin ELISA kits and real-time quantitative polymerase chain reaction, respectively. Immunohistochemistry was used to investigate beta-cell areas, beta-cell proliferation, apoptosis of pancreatic beta-cells, and reactive oxygen species production in the pancreatic beta-cells. Results showed that glucose tolerance was significantly improved in streptozotocin-induced type 1 diabetic mice treated with empagliflozin. Empagliflozin-treated mice also showed an increase in insulin mRNA expression. Higher serum insulin levels were detected in mice treated with empagliflozin compared with the vehicle group. Immunohistochemistry indicated that beta-cell area/total pancreatic area and the expression of cell proliferation marker Ki-67 (co-stained with insulin) were significantly enhanced by empagliflozin treatment. These effects were due, probably, to a reduction in apoptosis and reactive oxygen species in the pancreatic beta-cells. Taken together, the results of this study indicate that empagliflozin may have a beneficial effect on preserving beta-cell regeneration, thus improving blood glucose homeostasis in type 1 diabetes mellitus, probably via the protection of pancreatic beta-cell from glucotoxicity-induced oxidative stress.	[Cheng, Sam Tsz Wai; Chen, Lihua; Li, Stephen Yu Ting; Leung, Po Sing] Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China; [Mayoux, Eric] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Chinese University of Hong Kong; Boehringer Ingelheim	Leung, PS (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Sha Tin, Hong Kong, Peoples R China.	psleung@cuhk.edu.hk	Li, Stephen Yu Ting/L-7657-2017; Leung, Po Sing/P-5758-2014	Leung, Po Sing/0000-0001-8074-3178; Chen, Lihua/0000-0003-3369-1875	Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK) [TB127545]; Boehringer-Ingelheim Pharma GmbH Co KG	Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK); Boehringer-Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim)	This work was supported by Boehringer-Ingelheim Pharma GmbH & Co KG, Biberach, Germany (CUHK Ref. No.: TB127545). Boehringer-Ingelheim Pharma GmbH & Co KG provided support in the form of a salary for author EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fowler MJ., 2008, CLIN DIABETES, V26, P170, DOI DOI 10.2337/DIACLIN.26.4.170; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Lamos EM, 2014, EXPERT OPIN INV DRUG, V23, P875, DOI 10.1517/13543784.2014.909407; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P101, DOI 10.3109/00365517109090668; Mosley Juan F 2nd, 2015, P T, V40, P451; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Rosenthal N, 2015, ANN NY ACAD SCI, P1; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; SCHIFFRIN A, 1988, DIABETES, V37, P920, DOI 10.2337/diabetes.37.7.920; Thomas L, 2012, DIABETES OBES METAB, V14, P94, DOI 10.1111/j.1463-1326.2011.01518.x; Triplitt Curtis L, 2012, Am J Manag Care, V18, pS11; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vargas Roberto, 2010, Rev Obstet Gynecol, V3, P92; Washburn WN, 2013, EXPERT OPIN INV DRUG, V22, P463, DOI 10.1517/13543784.2013.774372; Yang T, 2015, EFFICACY TOLERABILIT; Zhang L, 2011, J DIABETES, V3, P48, DOI 10.1111/j.1753-0407.2010.00102.x	31	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147391	10.1371/journal.pone.0147391	http://dx.doi.org/10.1371/journal.pone.0147391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807719	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800085
J	Kovacevic, D; Baker, AR; Staugaitis, SM; Kim, MS; Ricchetti, ET; Derwin, KA				Kovacevic, David; Baker, Andrew R.; Staugaitis, Susan M.; Kim, Myung-Sun; Ricchetti, Eric T.; Derwin, Kathleen A.			Development of an Arthroscopic Joint Capsule Injury Model in the Canine Shoulder	PLOS ONE			English	Article							ROTATOR CUFF TEARS; FATTY INFILTRATION; ANIMAL-MODEL; ATROPHY; MUSCLE; TENDON; DEGENERATION; OUTCOMES; REPAIR; DOGS	Background The natural history of rotator cuff tears can be unfavorable as patients develop fatty infiltration and muscle atrophy that is often associated with a loss of muscle strength and shoulder function. To facilitate study of possible biologic mechanisms involved in early degenerative changes to rotator cuff muscle and tendon tissues, the objective of this study was to develop a joint capsule injury model in the canine shoulder using arthroscopy. Methods Arthroscopic surgical methods for performing a posterior joint capsulectomy in the canine shoulder were first defined in cadavers. Subsequently, one canine subject underwent bilateral shoulder joint capsulectomy using arthroscopy, arthroscopic surveillance at 2, 4 and 8 weeks, and gross and histologic examination of the joint at 10 weeks. Results The canine subject was weight-bearing within eight hours after index and follow-up surgeries and had no significant soft tissue swelling of the shoulder girdle or gross lameness. Chronic synovitis and macroscopic and microscopic evidence of pathologic changes to the rotator cuff bony insertions, tendons, myotendinous junctions and muscles were observed. Conclusions This study demonstrates feasibility and proof-of-concept for a joint capsule injury model in the canine shoulder. Future work is needed to define the observed pathologic changes and their role in the progression of rotator cuff disease. Ultimately, better understanding of the biologic mechanisms of early progression of rotator cuff disease may lead to clinical interventions to halt or slow this process and avoid the more advanced and often irreversible conditions of large tendon tears with muscle fatty atrophy.	[Kovacevic, David; Ricchetti, Eric T.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Baker, Andrew R.; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Baker, Andrew R.; Derwin, Kathleen A.] Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44106 USA; [Staugaitis, Susan M.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA; [Kim, Myung-Sun] Chonnam Natl Univ, Coll Med, Dept Orthopaed Surg, Gwangju, South Korea; [Kovacevic, David] Yale Univ, Dept Orthopaed Surg, New Haven, CT USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chonnam National University; Yale University	Derwin, KA (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.; Derwin, KA (corresponding author), Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44106 USA.	derwink@ccf.org		Kovacevic, David/0000-0002-1900-5181	Cleveland Clinic George W. Crile Research Fellowship; Cleveland Clinic Department of Orthopaedic Surgery; Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Cleveland Clinic George W. Crile Research Fellowship; Cleveland Clinic Department of Orthopaedic Surgery; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this work was provided by a Cleveland Clinic George W. Crile Research Fellowship (DK), the Cleveland Clinic Department of Orthopaedic Surgery (DK) and the Clinical and Translational Science Collaborative of Cleveland (UL1TR000439) (KAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin M, 2000, ARTHRITIS RHEUM-US, V43, P576, DOI 10.1002/1529-0131(200003)43:3<576::AID-ANR14>3.0.CO;2-A; Boyce MK, 2013, OSTEOARTHR CARTILAGE, V21, P746, DOI 10.1016/j.joca.2013.02.653; Cook JL, 2009, VET SURG, V38, P224, DOI 10.1111/j.1532-950X.2008.00490.x; Derwin KA, 2010, TISSUE ENG PART B-RE, V16, P21, DOI [10.1089/ten.teb.2009.0209, 10.1089/ten.TEB.2009.0209]; Devitt CM, 2007, VET SURG, V36, P661, DOI 10.1111/j.1532-950X.2007.00318.x; Frey E, 2009, J ORTHOP RES, V27, P504, DOI 10.1002/jor.20695; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Itoigawa Y, 2011, J ORTHOP RES, V29, P861, DOI 10.1002/jor.21317; Kim HM, 2012, J SHOULDER ELB SURG, V21, P847, DOI 10.1016/j.jse.2011.05.004; Lajtai G, 2009, AM J SPORT MED, V37, P1375, DOI 10.1177/0363546509333850; Liu Xuhui, 2012, J Bone Joint Surg Am, V94, pe41, DOI 10.2106/JBJS.K.00620; Liu XH, 2011, J ORTHOP RES, V29, P588, DOI 10.1002/jor.21266; Longo UG, 2008, AM J SPORT MED, V36, P533, DOI 10.1177/0363546507308549; Longo UG, 2011, SPORTS MED ARTHROSC, V19, P227, DOI 10.1097/JSA.0b013e318213bccb; Melis B, 2009, ORTHOP TRAUMATOL-SUR, V95, P319, DOI 10.1016/j.otsr.2009.05.001; Melis B, 2010, J SHOULDER ELB SURG, V19, P757, DOI 10.1016/j.jse.2009.12.002; Melis B, 2010, CLIN ORTHOP RELAT R, V468, P1498, DOI 10.1007/s11999-009-1207-x; Pullin JG, 1997, J SHOULDER ELB SURG, V6, P272, DOI 10.1016/S1058-2746(97)90016-1; Rowshan K, 2010, J BONE JOINT SURG AM, V92A, P2270, DOI 10.2106/JBJS.I.00812; Safran O, 2005, J BONE JOINT SURG AM, V87A, P2662, DOI 10.2106/JBJS.D.02421; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Tajana M S, 2009, Chir Organi Mov, V93 Suppl 1, pS41, DOI 10.1007/s12306-009-0004-8; Yoshihara Y, 2001, J ORTHOP RES, V19, P573, DOI 10.1016/S0736-0266(00)00063-2; Zingg PO, 2007, J BONE JOINT SURG AM, V89A, P1928, DOI 10.2106/JBJS.F.01073	26	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147949	10.1371/journal.pone.0147949	http://dx.doi.org/10.1371/journal.pone.0147949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808837	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800249
J	Likanonsakul, S; Suntisuklappon, B; Nitiyanontakij, R; Prasithsirikul, W; Nakayama, EE; Shioda, T; Sangsajja, C				Likanonsakul, Sirirat; Suntisuklappon, Bussakorn; Nitiyanontakij, Ravee; Prasithsirikul, Wisit; Nakayama, Emi E.; Shioda, Tatsuo; Sangsajja, Chariya			A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection	PLOS ONE			English	Article							KIDNEY TUBULAR DYSFUNCTION; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; PLASMA-CONCENTRATIONS; ANTIRETROVIRAL-NAIVE; DRUG; SAFETY; NEPHROTOXICITY; TRANSPORTERS; THERAPY	Background In Thailand, the combined generic anti-retroviral drug stavudine/lamivudine/nevirapine (d4T/3TC/NVP) has been used to treat human immunodeficiency virus (HIV)-infected individuals since 2001. Due to relatively frequent adverse effects, d4T gradually has been replaced with tenofovir disoproxil fumarate (TDF). Although the frequency of adverse drug effects with TDF is lower than that with d4T, TDF is known to induce kidney dysfunction, especially in the proximal tubules. It has been reported that renal tubular transporters, including members of the multi-drug resistant (MDR) protein family, are implicated in tenofovir extrusion and may, therefore, confer susceptibility to TDF-induced kidney tubular dysfunction (KTD). We have explored the association between KTD and polymorphisms in genes that encode adenosine triphosphate-binding cassette (ABC)-type MDRs. Methods HIV-infected patients receiving TDF-containing antiretroviral regimens for at least one year were enrolled in the study. The levels of beta2-microglobulin in urine and creatinine (Cr) were measured. Three single-nucleotide polymorphisms, ABCC2 C-24T (rs717620), ABCC2 G1429A (rs2273697), and ABCC4 T4976C (rs1059751), were analyzed using Taq-Man SNP genotyping assays. Results A total of 273 HIV-infected patients were recruited. The median number of years of TDF treatment was 5.04 with interquartile range (IQR) of 3.9-6.7. Despite the length of treatment with TDF, 98.5% patients maintained an estimated glomerular filtration rate (eGFR) of >60 mL/min as calculated by the CKD-EPI formula. Fifty-four patients (19.8%) showed beta2-microglobulinuria (median 2636 mu g/g Cr with IQR of 1519-13197 mu g/g Cr). The allele frequency of ABCC4 T4976C among those 54 patients was 0.602, compared to 0.475 among the 219 remaining patients (p = 0.018). Conclusions Approximately 20% of HIV-infected patients receiving TDF showed beta2-microglobulinuria. The C allele at position 4976 of the ABCC4 gene was associated with beta2-microglobulinuria in this population. This polymorphism may help to identify patients at greater risk for developing TDF-associated KTD.	[Likanonsakul, Sirirat; Suntisuklappon, Bussakorn; Nitiyanontakij, Ravee; Prasithsirikul, Wisit; Sangsajja, Chariya] Minist Publ Hlth, Dept Dis Control, Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan	Ministry of Public Health - Thailand; Osaka University	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp	Prasithsirikul, Wisit/AAH-6284-2020	ying mei, zhong shan/0000-0002-0477-0980	Ministry of Health, Labor, and Welfare in Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Initiative for Global Research Network on Infectious Diseases; Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand	Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand	This work was supported by the grant from the Ministry of Health, Labor, and Welfare in Japan, the Ministry of Education, Culture, Sports, Science, and Technology, Japan; the Japan Initiative for Global Research Network on Infectious Diseases, directed by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Bamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calcagno A, 2016, PHARMACOGENOMICS J, V16, P514, DOI 10.1038/tpj.2015.71; Calcagno A, 2013, ANTIMICROB AGENTS CH, V57, P1840, DOI 10.1128/AAC.02434-12; Charoenpak R, 2014, J BAMRASNARADURA INF, V8, P94; Cihlar T, 2001, NUCLEOS NUCLEOT NUCL, V20, P641, DOI 10.1081/NCN-100002341; Ezinga M, 2014, ANTIVIR THER, V19, P765, DOI 10.3851/IMP2761; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Izzedine H, 2004, AIDS, V18, P1074, DOI 10.1097/00002030-200404300-00019; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lubomirov R, 2011, J INFECT DIS, V203, P246, DOI 10.1093/infdis/jiq043; Manosuthi W, 2014, J ANTIMICROB CHEMOTH, V69, P2195, DOI 10.1093/jac/dku129; Moss DM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00248; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2012, CLIN INFECT DIS, V55, P1558, DOI 10.1093/cid/cis772; Perazella MA, 2010, KIDNEY INT, V78, P1060, DOI 10.1038/ki.2010.344; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, CURR OPIN HIV AIDS, V5, P524, DOI 10.1097/COH.0b013e32833f203e; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Robertson EE, 2006, PHARMACOL THERAPEUT, V109, P399, DOI 10.1016/j.pharmthera.2005.07.005; Rodriguez-Novoa S, 2010, AIDS, V24, P1064, DOI 10.1097/QAD.0b013e32833202e2; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	31	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147724	10.1371/journal.pone.0147724	http://dx.doi.org/10.1371/journal.pone.0147724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807589	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800196
J	Pane, K; Durante, L; Pizzo, E; Varcamonti, M; Zanfardino, A; Sgambati, V; Di Maro, A; Carpentieri, A; Izzo, V; Di Donato, A; Cafaro, V; Notomista, E				Pane, Katia; Durante, Lorenzo; Pizzo, Elio; Varcamonti, Mario; Zanfardino, Anna; Sgambati, Valeria; Di Maro, Antimo; Carpentieri, Andrea; Izzo, Viviana; Di Donato, Alberto; Cafaro, Valeria; Notomista, Eugenio			Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; FUSION EXPRESSION; INCLUSION-BODIES; HUMAN THROMBIN; PURIFICATION; CLEAVAGE; ONCONASE; SYSTEM; LL-37	Commercial uses of bioactive peptides require low cost, effective methods for their production. We developed a new carrier protein for high yield production of recombinant peptides in Escherichia coli very well suited for the production of toxic peptides like antimicrobial peptides. GKY20, a short antimicrobial peptide derived from the C-terminus of human thrombin, was fused to the C-terminus of Onconase, a small ribonuclease (104 amino acids), which efficiently drove the peptide into inclusion bodies with very high expression levels (about 200-250 mg/L). After purification of the fusion protein by immobilized metal ion affinity chromatography, peptide was obtained by chemical cleavage in diluted acetic acid of an acid labile Asp-Pro sequence with more than 95% efficiency. To improve peptide purification, Onconase was mutated to eliminate all acid labile sequences thus reducing the release of unwanted peptides during the acid cleavage. Mutations were chosen to preserve the differential solubility of Onconase as function of pH, which allows its selective precipitation at neutral pH after the cleavage. The improved carrier allowed the production of 15-18 mg of recombinant peptide per liter of culture with 96-98% purity without the need of further chromatographic steps after the acid cleavage. The antimicrobial activity of the recombinant peptide, with an additional proline at the N-terminus, was tested on Gram-negative and Gram-positive strains and was found to be identical to that measured for synthetic GKY20. This finding suggests that N-terminal proline residue does not change the antimicrobial properties of recombinant (P) GKY20. The improved carrier, which does not contain cysteine and methionine residues, Asp-Pro and Asn-Gly sequences, is well suited for the production of peptides using any of the most popular chemical cleavage methods.	[Pane, Katia; Durante, Lorenzo; Pizzo, Elio; Varcamonti, Mario; Zanfardino, Anna; Sgambati, Valeria; Di Donato, Alberto; Cafaro, Valeria; Notomista, Eugenio] Univ Naples Federico II, Dept Biol, Naples, Italy; [Di Maro, Antimo] Seconda Univ Napoli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Carpentieri, Andrea] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Izzo, Viviana] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Naples Federico II; University of Salerno	Notomista, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	notomist@unina.it	Pane, Katia/AAA-6429-2020; Cafaro, Valeria/GLV-3363-2022; Pizzo, Elio/Q-4722-2017; Izzo, Viviana/Q-2076-2015	Pane, Katia/0000-0002-7594-7931; Pizzo, Elio/0000-0002-3652-8865; Izzo, Viviana/0000-0001-6066-7569; Carpentieri, Andrea/0000-0002-1944-5355; NOTOMISTA, Eugenio/0000-0003-0097-6487	Italian Cystic Fibrosis Research Foundation [FFC 9/2012, FFC 11/2013, FFC 12/2014]; Programma F.A.R.O IV tornata [CUP: E68C12000260003]; Polo delle Scienze e Tecnologie, Universita di Napoli Federico II	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Programma F.A.R.O IV tornata; Polo delle Scienze e Tecnologie, Universita di Napoli Federico II	This work was supported by grants FFC#9/2012, FFC#11/2013, and FFC#12/2014 from "Italian Cystic Fibrosis Research Foundation" (http://www.fibrosicisticaricerca.it) and "Programma F.A.R.O IV tornata" (CUP: E68C12000260003) funded by Polo delle Scienze e Tecnologie, Universita di Napoli Federico II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2014, RSC ADV, V4, P31564, DOI 10.1039/c4ra04056b; Beaulieu L, 2007, CAN J MICROBIOL, V53, P1246, DOI 10.1139/W07-089; Bornstein P, 1977, Methods Enzymol, V47, P132; Crimmins Dan L, 2005, Curr Protoc Protein Sci, VChapter 11, DOI 10.1002/0471140864.ps1104s40; Feng X, 2006, PROTEIN EXPRES PURIF, V47, P110, DOI 10.1016/j.pep.2005.08.016; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs GM, 2004, APPL ENVIRON MICROB, V70, P3292, DOI 10.1128/AEM.70.6.3292-3297.2004; Green MR, 2012, MOL CLONING LAB MANU, V1; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Houen G, 1999, ACTA CHEM SCAND, V53, P1122, DOI 10.3891/acta.chem.scand.53-1122; Hwang PM, 2014, FEBS LETT, V588, P247, DOI 10.1016/j.febslet.2013.09.028; Ingham AB, 2007, BIOTECHNOL APPL BIOC, V47, P1, DOI 10.1043/BA20060207; Joshi AB, 2005, J PHARM SCI-US, V94, P1912, DOI 10.1002/jps.20405; Joshi AB, 2004, INT J PHARMACEUT, V273, P213, DOI 10.1016/j.ijpharm.2004.01.006; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Katoch J, 2012, NANO LETT, V12, P2342, DOI 10.1021/nl300286k; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; Lee J, 2010, METHODS MOL BIOL, V634, P137, DOI 10.1007/978-1-60761-652-8_10; Li N, 2009, J PHARMACEUT BIOMED, V50, P73, DOI 10.1016/j.jpba.2009.03.020; Li XJ, 2006, J PHYS CHEM B, V110, P12621, DOI 10.1021/jp061518d; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Li YF, 2009, BIOTECHNOL APPL BIOC, V54, P1, DOI 10.1042/BA20090087; Mant CT, 2009, BIOPOLYMERS, V92, P573, DOI 10.1002/bip.21316; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Merza M, 2014, AM J PHYSIOL-GASTR L, V307, pG914, DOI 10.1152/ajpgi.00237.2014; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Notomista E, 2000, BIOCHEMISTRY-US, V39, P8711, DOI 10.1021/bi000415x; Notomista E, 1999, FEBS LETT, V463, P211, DOI 10.1016/S0014-5793(99)01623-3; Pan SH, 2000, BIOTECHNIQUES, V29, P1234, DOI 10.2144/00296st03; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pizzo E, 2008, FEBS J, V275, P1283, DOI 10.1111/j.1742-4658.2008.06289.x; Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672; Rodriguez V, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-65; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; STECK G, 1980, ANAL BIOCHEM, V107, P21, DOI 10.1016/0003-2697(80)90486-8; Tian ZG, 2009, APPL MICROBIOL BIOT, V83, P143, DOI 10.1007/s00253-009-1893-z; Vidovic V, 2009, J PEPT SCI, V15, P278, DOI 10.1002/psc.1112; Wang J, 2015, PROCESS BIOCHEM, V50, P1767, DOI 10.1016/j.procbio.2015.08.005; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wu GQ, 2011, APPL MICROBIOL BIOT, V92, P85, DOI 10.1007/s00253-011-3379-z; Zhang C., 2014, PROC VLDB ENDOW, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103456; Zhang LC, 2015, J IND MICROBIOL BIOT, V42, P1369, DOI 10.1007/s10295-015-1673-y; Zhao CX, 2015, BIOTECHNOL BIOENG, V112, P957, DOI 10.1002/bit.25505; Zhou QF, 2007, CURR MICROBIOL, V54, P366, DOI 10.1007/s00284-006-0466-y; Zorko M, 2010, METHODS MOL BIOL, V618, P61, DOI 10.1007/978-1-60761-594-1_5; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015	56	34	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146552	10.1371/journal.pone.0146552	http://dx.doi.org/10.1371/journal.pone.0146552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808536	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800024
J	Rahman, MA; Tanaka, N; Usui, K; Kawahara, S				Rahman, Md Ashrafur; Tanaka, Norifumi; Usui, Koji; Kawahara, Shigenori			Role of Muscarinic Acetylcholine Receptors in Serial Feature-Positive Discrimination Task during Eyeblink Conditioning in Mice	PLOS ONE			English	Article							NICTITATING-MEMBRANE RESPONSE; DECEREBRATE GUINEA-PIGS; IBOTENATE LESIONS; HIPPOCAMPUS; RETENTION; RATS; SCOPOLAMINE; RABBITS; ACQUISITION; MEMORY	We investigated the role of muscarinic acetylcholine receptors (mAChRs) in eyeblink serial feature-positive discrimination learning in mice using the mAChR antagonist. A 2-s light cue was delivered 5 or 6 s before the presentation of a 350-ms tone paired with a 100-ms periorbital electrical shock (cued trial) but not before the tone-alone presentation (non-cued trial). Mice received 30 cued and 30 non-cued trials each day in a random order. We found that saline-injected control mice were successfully discriminating between cued and non-cued trials within a few days of conditioning. The mice responded more frequently to the tone in cued trials than in non-cued trials. Analysis of conditioned response (CR) dynamics revealed that the CR onset latency was shorter in cued trials than in non-cued trials, despite the CR peak amplitude not differing significantly between the two conditions. In contrast, scopolamine-injected mice developed an equal number of CRs with similar temporal patterns irrespective of the presence of the cue during the 7 days of conditioning, indicating in a failure to acquire conditional discrimination. In addition, the scopolamine administration to the control mice after they had successfully acquired discrimination did not impair the conditional discrimination and expression of pre-acquired CR. These results suggest that mAChRs may play a pivotal role in memory formation in the conditional brain state associated with the feature cue; however they are unlikely to be involved in the development of discrimination after conditional memory had formed in the serial feature-positive discrimination task during eyeblink conditioning.	[Rahman, Md Ashrafur; Tanaka, Norifumi; Usui, Koji; Kawahara, Shigenori] Toyama Univ, Grad Sch Innovat Life Sci, 3190 Gofuku, Toyama 9308555, Japan; [Usui, Koji; Kawahara, Shigenori] Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan	University of Toyama; University of Toyama	Kawahara, S (corresponding author), Toyama Univ, Grad Sch Innovat Life Sci, 3190 Gofuku, Toyama 9308555, Japan.; Kawahara, S (corresponding author), Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan.	kawahara@eng.u-toyama.ac.jp		rahman, Md ashrafur/0000-0003-0146-5312				Berry SD, 2011, NEUROBIOL LEARN MEM, V95, P185, DOI 10.1016/j.nlm.2010.11.014; Bouger PCM, 2005, EUR NEUROPSYCHOPHARM, V15, P331, DOI 10.1016/j.euroneuro.2004.11.006; BRANDON SE, 1991, J EXP PSYCHOL ANIM B, V17, P299, DOI 10.1037/0097-7403.17.3.299; Bushnell PJ, 1997, PSYCHOPHARMACOLOGY, V134, P230, DOI 10.1007/s002130050446; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; DAUM I, 1991, BEHAV NEUROSCI, V105, P396, DOI 10.1037/0735-7044.105.3.396; DAVIDSON TL, 1989, PSYCHOBIOLOGY, V17, P49; DUNNE MP, 1986, PSYCHOPHARMACOLOGY, V89, P94; Fortier CB, 2003, BEHAV NEUROSCI, V117, P1181, DOI 10.1037/0735-7044.117.6.1181; Green JT, 2000, PSYCHOL BULL, V126, P138, DOI 10.1037/0033-2909.126.1.138; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Jarrard L E, 1991, Hippocampus, V1, P107, DOI 10.1002/hipo.450010110; JARRARD LE, 1990, PSYCHOBIOLOGY, V18, P68; Kaneko T, 1997, PSYCHOPHARMACOLOGY, V131, P161, DOI 10.1007/s002130050279; KEHOE EJ, 1987, J EXP PSYCHOL ANIM B, V13, P17, DOI 10.1037/0097-7403.13.1.17; Kotani S, 2003, EUR J NEUROSCI, V17, P1445, DOI 10.1046/j.1460-9568.2003.02566.x; Kotani S, 2002, EUR J NEUROSCI, V15, P1267, DOI 10.1046/j.1460-9568.2002.01963.x; Kuc KA, 2006, GENES BRAIN BEHAV, V5, P355, DOI 10.1111/j.1601-183X.2005.00168.x; LOECHNER KJ, 1987, BEHAV BRAIN RES, V26, P63, DOI 10.1016/0166-4328(87)90017-9; MAUK MD, 1987, BRAIN RES, V403, P89, DOI 10.1016/0006-8993(87)90126-0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCKINNEY M, 1983, J COMP NEUROL, V217, P103, DOI 10.1002/cne.902170109; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; ROSS RT, 1981, ANIM LEARN BEHAV, V9, P293, DOI 10.3758/BF03197835; ROSS RT, 1984, BEHAV NEUROSCI, V98, P211, DOI 10.1037/0735-7044.98.2.211; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; SPENCER DG, 1986, BRAIN RES, V380, P59, DOI 10.1016/0006-8993(86)91429-0; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; STEVENS R, 1981, PHYSIOL BEHAV, V27, P385, DOI 10.1016/0031-9384(81)90285-7; Takatsuki K, 2003, J NEUROSCI, V23, P17; Takatsuki K, 2002, NEUROREPORT, V13, P159, DOI 10.1097/00001756-200201210-00036; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Takehara K, 2003, J NEUROSCI, V23, P9897; Tokuda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112927; WAGNER AR, 1975, ANIM LEARN BEHAV, V3, P370, DOI 10.3758/BF03213461; Weidemann G, 1997, Q J EXP PSYCHOL-B, V50, P295; Weiss C, 2011, BEHAV NEUROSCI, V125, P318, DOI 10.1037/a0023520	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147572	10.1371/journal.pone.0147572	http://dx.doi.org/10.1371/journal.pone.0147572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808980	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800138
J	Smith, MR; Micha, R; Golden, CD; Mozaffarian, D; Myers, SS				Smith, Matthew R.; Micha, Renata; Golden, Christopher D.; Mozaffarian, Dariush; Myers, Samuel S.			Global Expanded Nutrient Supply (GENuS) Model: A New Method for Estimating the Global Dietary Supply of Nutrients	PLOS ONE			English	Article							NUTRITION TRANSITION; PROTEIN CONSUMPTION; PROJECT; OBESITY; TRENDS	Insufficient data exist for accurate estimation of global nutrient supplies. Commonly used global datasets contain key weaknesses: 1) data with global coverage, such as the FAO food balance sheets, lack specific information about many individual foods and no information on micronutrient supplies nor heterogeneity among subnational populations, while 2) household surveys provide a closer approximation of consumption, but are often not nationally representative, do not commonly capture many foods consumed outside of the home, and only provide adequate information for a few select populations. Here, we attempt to improve upon these datasets by constructing a new model-the Global Expanded Nutrient Supply (GENuS) model-to estimate nutrient availabilities for 23 individual nutrients across 225 food categories for thirty-four age-sex groups in nearly all countries. Furthermore, the model provides historical trends in dietary nutritional supplies at the national level using data from 1961-2011. We determine supplies of edible food by expanding the food balance sheet data using FAO production and trade data to increase food supply estimates from 98 to 221 food groups, and then estimate the proportion of major cereals being processed to flours to increase to 225. Next, we estimate intake among twenty-six demographic groups (ages 20+, both sexes) in each country by using data taken from the Global Dietary Database, which uses nationally representative surveys to relate national averages of food consumption to individual age and sex-groups; for children and adolescents where GDD data does not yet exist, average calorie-adjusted amounts are assumed. Finally, we match food supplies with nutrient densities from regional food composition tables to estimate nutrient supplies, running Monte Carlo simulations to find the range of potential nutrient supplies provided by the diet. To validate our new method, we compare the GENuS estimates of nutrient supplies against independent estimates by the USDA for historical US nutrition and find very good agreement for 21 of 23 nutrients, though sodium and dietary fiber will require further improvement.	[Smith, Matthew R.; Myers, Samuel S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Micha, Renata] Agr Univ Athens, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece; [Golden, Christopher D.] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth & Global Environm, Boston, MA 02115 USA; [Myers, Samuel S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Tufts University; Agricultural University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Smith, MR (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	msmith@hsph.harvard.edu	Mozaffarian, Dariush/ABC-2822-2020	Smith, Matthew/0000-0001-5207-2370; Golden, Christopher/0000-0002-2258-7493	Bill and Melinda Gates Foundation [7944]; Winslow Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Winslow Foundation	This work was supported by the Bill and Melinda Gates Foundation (#7944), Winslow Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agricultural Research Service U.S. Department of Agriculture], 2014, USDA NAT NUTR DAT ST; Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Allen L., 2006, GUIDELINES FOOD FORT, DOI [10.1242/jeb.02490, DOI 10.1242/JEB.02490]; [Anonymous], 2006, USDA FOOD SUPPL DAT; [Anonymous], 2009, TABL COMP AL AM LAT; [Anonymous], 2011, CENSO AGRO PECUARIO; [Anonymous], 2015, CONC DEF CLASS FACT; [Anonymous], 2000, LAO AGR CENS 1998 99; [Anonymous], 2009, PROJET SISA GUINEE B; [Anonymous], 2012, NAT SAMPL CENS AGR 2, VII; Borresen EC, 2014, WHEAT AND RICE IN DISEASE PREVENTION AND HEALTH: BENEFITS, RISKS AND MECHANISMS OF WHOLE GRAINS IN HEALTH PROMOTION, P301, DOI 10.1016/B978-0-12-401716-0.00022-2; Central Bureau of Statistics, 2010, NEP VEG CROPS SURV 2; de Boer J, 2006, ECOL ECON, V59, P267, DOI 10.1016/j.ecolecon.2005.10.011; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012, VI; Dipti SS, 2012, RICE, V5, DOI 10.1186/1939-8433-5-16; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Economic Research Service, 1992, AGR HDB, V697; FAO, 2011, STAT WORLD FISH AQ O; FAO (Food and Agriculture Organization), 2015, PROD TRAD DAT; Food and Agriculture Organization (FAO), 2015, FBS DAT; Food and Nutrition Board Commission on Life Sciences National Research Council, 1989, REC DIET ALL; Food Fortification Initiative, 2015, COUNTR FORT PROF; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Gerrior S, 2004, 56 HOM EC RES US DEP; Global Nutrition and Policy Consortium, 2014, GLOB DIET DAT; Gopalan C, 1989, NUTR VALUE INDIAN FO; GRIGG D, 1995, GEOFORUM, V26, P1, DOI 10.1016/0016-7185(94)00020-8; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Institute of Nutrition-Mahidol University, 2014, ASEAN FOOD COMP DAT; Kim S, 2000, AM J CLIN NUTR, V71, P44; Leung W.-T. W., 1968, FOOD COMPOSITION TAB; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Micha R, BMJ OPEN IN PRESS; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Serra-Majem L, 2003, J EPIDEMIOL COMMUN H, V57, P74, DOI 10.1136/jech.57.1.74; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Smith L.C., 2014, 008 IHSN, P1; Smith M. R, 2011, NUTR TOTALS AGE SEX, DOI 10.7910/DVN/XIKNDC; Smith MR, 2011, NUTR SUPPLIES FOOD C, pV2; Smith MR, 2015, LANCET IN PRESS; Smith MR, 2016, TOTAL NUTR SUPPLIES; Smith MR, 2016, EDIBLE FOOD COUNTRY; Smith MR, 2011, EDIBLE FOOD AGE SEX, pV2; Smith MR, 2011, TOTAL NUTR SUPPLY IN, pV2; Stadlmayr B., 2012, W AFRICAN FOOD COMPO; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050565; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119	52	68	69	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146976	10.1371/journal.pone.0146976	http://dx.doi.org/10.1371/journal.pone.0146976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807571	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800042
J	Su, XM; Guo, L; Ding, LX; Qu, K; Shen, CF				Su, Xiaomei; Guo, Li; Ding, Linxian; Qu, Kun; Shen, Chaofeng			Induction of Viable but Nonculturable State in Rhodococcus and Transcriptome Analysis Using RNA-seq	PLOS ONE			English	Article							EXTRACELLULAR ORGANIC-MATTER; MICROCOCCUS-LUTEUS; GENE-EXPRESSION; BACTERIAL COMMUNITY; VIBRIO-VULNIFICUS; ESCHERICHIA-COLI; RESUSCITATION; BIPHENYL; STRESS; BIODEGRADATION	Viable but nonculturable (VBNC) bacteria, which maintain the viability with loss of culturability, universally exist in contaminated and noncontaminated environments. In this study, two strains, Rhodococcus sp. TG13 and TN3, which were isolated from PCB-contaminated sediment and noncontaminated sediment respectively, were investigated under low temperature and oligotrophic conditions. The results indicated that the two strains TG13 and TN3 could enter into the VBNC state with different incubation times, and could recover culturability by reversal of unfavourable factors and addition of resuscitation-promoting factor (Rpf), respectively. Furthermore, the gene expression variations in the VBNC response were clarified by Illumina high throughput RNA-sequencing. Genome-wide transcriptional analysis demonstrated that upregulated genes in the VBNC cells of the strain TG13 related to protein modification, ATP accumulation and RNA polymerase, while all differentially expressed genes (DEGs) in the VBNC cells of the strain TN3 were downregulated. However, the downregulated genes in both the two strains mainly encoded NADH dehydrogenase subunit, catalase, oxidoreductase, which further verified that cold-induced loss of ability to defend oxidative stress may play an important role in induction of the VBNC state. This study further verified that the molecular mechanisms underlying the VBNC state varied with various bacterial species. Study on the VBNC state of nonpathogenic bacteria will provide new insights into the limitation of environmental micro-bioremediation and the cultivation of unculturable species.	[Su, Xiaomei; Guo, Li; Shen, Chaofeng] Zhejiang Univ, Dept Environm Engn, Coll Environm & Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Su, Xiaomei; Guo, Li; Shen, Chaofeng] Key Lab Water Pollut Control & Environm Safety Zh, Hangzhou 310058, Zhejiang, Peoples R China; [Ding, Linxian] Zhejiang Normal Univ, Coll Geog & Environm Sci, Jinhua 321004, Peoples R China; [Qu, Kun] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Zhejiang University; Zhejiang Normal University; Stanford University	Shen, CF (corresponding author), Zhejiang Univ, Dept Environm Engn, Coll Environm & Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Shen, CF (corresponding author), Key Lab Water Pollut Control & Environm Safety Zh, Hangzhou 310058, Zhejiang, Peoples R China.	ysxzt@zju.edu.cn	Shen, Chaofeng/I-7138-2013	Shen, Chaofeng/0000-0002-6394-7416	Fundamental Research Funds for the Central Universities [2014QNA6012]; National Natural Science Foundation of China [41271334]; National High Technology Research and Development Program of China [2012AA06A203]; Zhejiang Provincial Natural Science Foundation of China [LR12D01001]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors gratefully acknowledge the financial support provided by the Fundamental Research Funds for the Central Universities (2014QNA6012), the National Natural Science Foundation of China (41271334), the National High Technology Research and Development Program of China (2012AA06A203), and Zhejiang Provincial Natural Science Foundation of China (LR12D01001).	Asakura H, 2007, ENVIRON MICROBIOL, V9, P869, DOI 10.1111/j.1462-2920.2006.01206.x; Bell KS, 1998, J APPL MICROBIOL, V85, P195; Benjamini Y, 2001, ANN STAT, V29, P1165; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; Brousseau L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-238; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Coutard F, 2007, APPL ENVIRON MICROB, V73, P5183, DOI 10.1128/AEM.02776-06; Epstein SS, 2013, CURR OPIN MICROBIOL, V16, P636, DOI 10.1016/j.mib.2013.08.003; Epstein SS, 2009, GEN MODEL MICROBIAL, P131; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KAPRELYANTS AS, 1993, APPL ENVIRON MICROB, V59, P3187, DOI 10.1128/AEM.59.10.3187-3196.1993; Kong HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109792; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Larkin MJ, 2006, ADV APPL MICROBIOL, V59, P1, DOI 10.1016/S0065-2164(06)59001-X; Li H, 13033997V2QBIOGN ARX; Li J, 2003, J APPL MICROBIOL, V94, P48, DOI 10.1046/j.1365-2672.2003.01795.x; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liang C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-146; Lindback T, 2010, VET RES, V41, DOI 10.1051/vetres/2009056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Martinkova L, 2009, ENVIRON INT, V35, P162, DOI 10.1016/j.envint.2008.07.018; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Nowakowska J, 2013, FEMS MICROBIOL ECOL, V84, P213, DOI 10.1111/1574-6941.12052; Nystrom T, 2003, MOL MICROBIOL, V48, P17, DOI 10.1046/j.1365-2958.2003.03385.x; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Pinto D, 2011, J APPL MICROBIOL, V110, P1601, DOI 10.1111/j.1365-2672.2011.05016.x; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Senoh M, 2010, MICROBIOL IMMUNOL, V54, P502, DOI 10.1111/j.1348-0421.2010.00245.x; Serpaggi V, 2012, FOOD MICROBIOL, V30, P438, DOI 10.1016/j.fm.2011.12.020; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Smith B, 2006, APPL ENVIRON MICROB, V72, P1445, DOI 10.1128/AEM.72.2.1445-1451.2006; Su XM, 2015, MICROB BIOTECHNOL, V8, P569, DOI 10.1111/1751-7915.12266; Su XM, 2015, APPL MICROBIOL BIOT, V99, P1989, DOI 10.1007/s00253-014-6108-6; Su XM, 2015, ANTON LEEUW INT J G, V107, P55, DOI 10.1007/s10482-014-0303-4; Su XM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-117; Su XM, 2013, WORLD J MICROB BIOT, V29, P2213, DOI 10.1007/s11274-013-1390-5; Su XM, 2013, BIORESOURCE TECHNOL, V146, P27, DOI 10.1016/j.biortech.2013.07.028; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x; Wang HW, 2013, APPL ENVIRON MICROB, V79, P3734, DOI 10.1128/AEM.00560-13; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeng B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/907170; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062388	46	23	24	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147593	10.1371/journal.pone.0147593	http://dx.doi.org/10.1371/journal.pone.0147593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808070	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800144
J	Thomas, BE; Shanmugam, P; Malaisamy, M; Ovung, S; Suresh, C; Subbaraman, R; Adinarayanan, S; Nagarajan, K				Thomas, Beena Elizabeth; Shanmugam, Poonguzhali; Malaisamy, Muniyandi; Ovung, Senthanro; Suresh, Chandra; Subbaraman, Ramnath; Adinarayanan, Srividya; Nagarajan, Karikalan			Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review	PLOS ONE			English	Review							COMMUNITY-BASED THERAPY; TREATMENT OUTCOMES; ALCOHOL-USE; MDR-TB; HIV; ASSOCIATION; DISORDERS; SUPPORT; RUSSIA; TOMSK	Background Limited treatment options, long duration of treatment and associated toxicity adversely impact the physical and mental well-being of multidrug-resistant tuberculosis (MDR-TB) patients. Despite research advances in the microbiological and clinical aspects of MDR-TB, research on the psychosocial context of MDR-TB is limited and less understood. Methodology We searched the databases of PubMed, MEDLINE, Embase and Google Scholar to retrieve all published articles. The final manuscripts included in the review were those with a primary focus on psychosocial issues of MDR-TB patients. These were assessed and the information was thematically extracted on the study objective, methodology used, key findings, and their implications. Intervention studies were evaluated using components of the methodological and quality rating scale. Due to the limited number of studies and the multiple methodologies employed in the observational studies, we summarized these studies using a narrative approach, rather than conducting a formal meta-analysis. We used 'thematic synthesis' method for extracting qualitative evidences and systematically organised to broader descriptive themes. Results A total of 282 published articles were retrieved, of which 15 articles were chosen for full text review based on the inclusion criteria. Six were qualitative studies; one was a mixed methods study; and eight were quantitative studies. The included studies were divided into the following issues affecting MDR-TB patients: a) psychological issues b) social issues and economic issues c) psychosocial interventions. It was found that all studies have documented range of psychosocial and economic challenges experienced by MDR-TB patients. Depression, stigma, discrimination, side effects of the drugs causing psychological distress, and the financial constraints due to MDR-TB were some of the common issues reported in the studies. There were few intervention studies which addressed these psychosocial issues most of which were small pilot studies. There is dearth of large scale randomized psychosocial intervention studies that can be scaled up to strengthen management of MDR-TB patients which is crucial for the TB control programme. Conclusion This review has captured the psychosocial and economic issues challenging MDR patients. However there is urgent need for feasible, innovative psychosocial and economic intervention studies that help to equip MDR-TB patients cope with their illness, improve treatment adherence, treatment outcomes and the overall quality of life of MDR-TB patients.	[Thomas, Beena Elizabeth; Shanmugam, Poonguzhali; Malaisamy, Muniyandi; Ovung, Senthanro; Suresh, Chandra; Nagarajan, Karikalan] ICMR, Natl Inst Res TB, Chennai, Tamil Nadu, India; [Subbaraman, Ramnath] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Adinarayanan, Srividya] ICMR, Vector Control Res Ctr, Pondicherry, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC)	Thomas, BE (corresponding author), ICMR, Natl Inst Res TB, Chennai, Tamil Nadu, India.	beenaelli09@gmail.com	Sankarasubbu, Kandasami/K-8191-2017	Subbaraman, Ramnath/0000-0002-2063-943X	FOGARTY INTERNATIONAL CENTER [R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007433] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acha J, 2007, INT J RES POLICY PRA, V2, P404, DOI DOI 10.1080/17441690701191610; Baghaei P, 2011, AM J THER, V18, pE29, DOI 10.1097/MJT.0b013e3181c0806d; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Cavanaugh JS, 2012, INT J TUBERC LUNG D, V16, P1069, DOI 10.5588/ijtld.11.0696; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Daftary A, 2014, GLOB PUBLIC HEALTH, V9, P1107, DOI 10.1080/17441692.2014.934266; Das M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24912; Davies PDO, 2001, J ROY SOC MED, V94, P261, DOI 10.1177/014107680109400601; Duraisamy Karthickeyan, 2014, Ann Am Thorac Soc, V11, P712, DOI 10.1513/AnnalsATS.201312-447OC; Emmanual L, 2012, AIDS RES THER, V9, pe1; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; HOLLISTER LE, 1986, MED TOXICOL ADV DRUG, V1, P428, DOI 10.1007/BF03259854; Horter S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-81; Institute of Medicine (US) Forum on Drug Discovery Development and Translation; Russian Academy of Medical Science, 2011, NEW PROF DRUG RES TU, P4; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kaliakbarova G, 2013, OPEN INFECT DIS S1M7, V7, P60; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kelly MP, 2006, DEV EVIDENCE BASE SO; Kendall EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083480; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; Mauch V, 2013, REV PANAM SALUD PUBL, V33, P332, DOI 10.1590/S1020-49892013000500004; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Morris MD, 2013, INT J TUBERC LUNG D, V17, P954, DOI 10.5588/ijtld.12.0480; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Page EB, 2009, METHODS SYNTHESIS QU; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Sharma Raman, 2014, Acta Med Iran, V52, P448; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Skrahina A, 2013, B WORLD HEALTH ORGAN, V91, P36, DOI 10.2471/BLT.12.104588; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Sweet M., 2007, IMPROVING POPULATION; TB Alliance, EC IMP TB TB ALL PUT; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; Wells K, 2009, RES SOCIAL WORK PRAC, V19, P52, DOI 10.1177/1049731508317278; World Health Organization, 2013, WHOHTMTB201311; Zai S, 2010, J BIOMED SCI RES, V2, P279; Zetola NM, 2012, INT J TUBERC LUNG D, V16, P1529, DOI 10.5588/ijtld.12.0026	48	74	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147397	10.1371/journal.pone.0147397	http://dx.doi.org/10.1371/journal.pone.0147397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807933	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000369527800087
J	Thorn, CJ; Bissinger, K; Thorn, S; Bogner, FX				Thorn, Christine Johanna; Bissinger, Kerstin; Thorn, Simon; Bogner, Franz Xaver			"Trees Live on Soil and Sunshine!"-Coexistence of Scientific and Alternative Conception of Tree Assimilation	PLOS ONE			English	Article							STUDENTS; MISCONCEPTIONS; KNOWLEDGE; AGREEMENT; BIOLOGY; SCIENCE	Successful learning is the integration of new knowledge into existing schemes, leading to an integrated and correct scientific conception. By contrast, the co-existence of scientific and alternative conceptions may indicate a fragmented knowledge profile. Every learner is unique and thus carries an individual set of preconceptions before classroom engagement due to prior experiences. Hence, instructors and teachers have to consider the heterogeneous knowledge profiles of their class when teaching. However, determinants of fragmented knowledge profiles are not well understood yet, which may hamper a development of adapted teaching schemes. We used a questionnaire-based approach to assess conceptual knowledge of tree assimilation and wood synthesis surveying 885 students of four educational levels: 6th graders, 10th graders, natural science freshmen and other academic studies freshmen. We analysed the influence of learner's characteristics such as educational level, age and sex on the coexistence of scientific and alternative conceptions. Within all subsamples well-known alternative conceptions regarding tree assimilation and wood synthesis coexisted with correct scientific ones. For example, students describe trees to be living on "soil and sunshine", representing scientific knowledge of photosynthesis mingled with an alternative conception of trees eating like animals. Fragmented knowledge profiles occurred in all subsamples, but our models showed that improved education and age foster knowledge integration. Sex had almost no influence on the existing scientific conceptions and evolution of knowledge integration. Consequently, complex biological issues such as tree assimilation and wood synthesis need specific support e.g. through repeated learning units in class-and seminar-rooms in order to help especially young students to handle and overcome common alternative conceptions and appropriately integrate scientific conceptions into their knowledge profile.	[Thorn, Christine Johanna; Bissinger, Kerstin; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Univ Str 30,NW II, D-95447 Bayreuth, Germany; [Thorn, Christine Johanna; Bissinger, Kerstin; Bogner, Franz Xaver] Univ Bayreuth, Ctr Math & Sci Educ Z MNU, Univ Str 30,NW II, D-95447 Bayreuth, Germany; [Thorn, Simon] Bavarian Forest Natl Pk, Natl Pk,Freyunger Str 2, D-94481 Grafenau, Germany	University of Bayreuth; University of Bayreuth	Thorn, CJ (corresponding author), Univ Bayreuth, Dept Biol Educ, Univ Str 30,NW II, D-95447 Bayreuth, Germany.; Thorn, CJ (corresponding author), Univ Bayreuth, Ctr Math & Sci Educ Z MNU, Univ Str 30,NW II, D-95447 Bayreuth, Germany.	Christine.Thorn@uni-bayreuth.de	Thorn, Simon/ABD-9917-2020	Thorn, Simon/0000-0002-3062-3060	Open Discovery Space Project - European Union CIP PSP [297229]; University of Bayreuth; German Research Foundation (DFG)	Open Discovery Space Project - European Union CIP PSP; University of Bayreuth; German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support was granted by the Open Discovery Space Project funded by European Union CIP PSP Grant Agreement No. 297229 and the University of Bayreuth to FXB (www.opendiscoveryspace.eu). Publishing fees for CJA and KB were funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JK, 2012, CBE-LIFE SCI EDUC, V11, P152, DOI 10.1187/cbe.11-08-0079; Agresti A., 2002, CATEGORICAL DATA; Anderberg M. R., 1973, CLUSTER ANAL APPL; Anderson DL, 2002, J RES SCI TEACH, V39, P952, DOI 10.1002/tea.10053; Andrews TM, 2012, CBE-LIFE SCI EDUC, V11, P248, DOI 10.1187/cbe.11-12-0107; Bahar M., 2003, EDUC SCI-THEOR PRACT, V3, P55; Bledsoe KE, 2013, ELECT J SCI ED, V17, P1; Bozniak E.C., 1994, PLANT SCI B, V40, P42; Braun T, 2012, RES BIOL ED 9 C EUR; Carlsson B, 2002, INT J SCI EDUC, V24, P681, DOI 10.1080/09500690110098868; Chu HE, 2014, J SCI EDUC TECHNOL, V23, P238, DOI 10.1007/s10956-013-9472-6; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DiSessa AA, 2004, COGNITIVE SCI, V28, P843, DOI 10.1016/j.cogsci.2004.05.003; Driver R., 1994, ED RES, V23, P5, DOI [DOI 10.3102/0013189X023007005, 10.3102/0013189X023007005]; Ekici F., 2007, INT J ENV SCI ED, V2, P111; Finley F. N., 1982, SCI EDUC, V66, P531, DOI [DOI 10.1002/SCE.3730660404, 10.1002/sce.3730660404]; FISHER KM, 1985, J RES SCI TEACH, V22, P53, DOI 10.1002/tea.3660220105; Hammer D, 1996, AM J PHYS, V64, P1316, DOI 10.1119/1.18376; HASLAM F, 1987, J BIOL EDUC, V21, P203, DOI 10.1080/00219266.1987.9654897; Hokayem H, 2008, J RES SCI TEACH, V45, P395, DOI 10.1002/tea.20233; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kalinowski ST, 2012, CBE-LIFE SCI EDUC, V11, P142, DOI 10.1187/cbe.11-09-0087; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu XF, 2006, J RES SCI TEACH, V43, P320, DOI 10.1002/tea.20114; Machery E, 2010, BEHAV BRAIN SCI, V33, P195, DOI 10.1017/S0140525X09991531; Maskiewicz AC, 2013, CBE-LIFE SCI EDUC, V12, P352, DOI 10.1187/cbe.13-01-0014; Masson S, 2014, MIND BRAIN EDUC, V8, P44, DOI 10.1111/mbe.12043; Mayring P, 2001, FORUM QUALITATIVE SO, V2; McCullagh P., 1989, GEN LINEAR MODELS; Nehm RH, 2008, J RES SCI TEACH, V45, P1131, DOI 10.1002/tea.20251; Norusis M.J., 1993, SPSS WINDOWS BASE SY; Piaget J, 1937, CONSTRUCTION REEL CH, V311; Schneider M, 2013, DEV PSYCHOL, V49, P1639, DOI 10.1037/a0030976; Schussler EE, 2008, J BIOL EDUC, V42, P112, DOI 10.1080/00219266.2008.9656123; Sellmann D, 2015, J EDUC RES, V108, P250, DOI 10.1080/00220671.2014.896315; Shtulman A, 2012, COGNITION, V124, P209, DOI 10.1016/j.cognition.2012.04.005; Sinatra GM, 2014, EDUC PSYCHOL-US, V49, P123, DOI 10.1080/00461520.2014.916216; Smith J.P., 1993, J LEARN SCI, V3, P115, DOI [https://doi.org/10.1207/s15327809jls0302_1, DOI 10.1207/S15327809JLS0302_1, 10.1207/s15327809jls0302_1]; STAVY R, 1987, INT J SCI EDUC, V9, P105, DOI 10.1080/0950069870090111; Straatemeier M, 2008, J EXP CHILD PSYCHOL, V100, P276, DOI 10.1016/j.jecp.2008.03.004; Strike K. A., 1985, COGNITIVE STRUCTURE, P189; Thaden-Koch TC, 2006, PHYS ED RES, V2, P1; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Tran US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110391; TULLBERG A, 1994, INT J SCI EDUC, V16, P145, DOI 10.1080/0950069940160204; VOSNIADOU S, 1989, SIMILARITY AND ANALOGICAL REASONING, P1, DOI 10.1017/CBO9780511529863.002; Vosniadou S, 2014, SCI EDUC-NETHERLANDS, V23, P1427, DOI 10.1007/s11191-013-9640-3	47	15	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147802	10.1371/journal.pone.0147802	http://dx.doi.org/10.1371/journal.pone.0147802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807974	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800213
J	Wanyenze, RK; Musinguzi, G; Matovu, JKB; Kiguli, J; Nuwaha, F; Mujisha, G; Musinguzi, J; Arinaitwe, J; Wagner, GJ				Wanyenze, Rhoda K.; Musinguzi, Geofrey; Matovu, Joseph K. B.; Kiguli, Juliet; Nuwaha, Fred; Mujisha, Geoffrey; Musinguzi, Joshua; Arinaitwe, Jim; Wagner, Glenn J.			"If You Tell People That You Had Sex with a Fellow Man, It Is Hard to Be Helped and Treated": Barriers and Opportunities for Increasing Access to HIV Services among Men Who Have Sex with Men in Uganda	PLOS ONE			English	Article							HEALTH-SERVICES; STIGMA; CARE	Background Despite the high HIV prevalence among men who have sex with men (MSM) in sub-Saharan Africa, little is known about their access to HIV services. This study assessed barriers and opportunities for expanding access to HIV services among MSM in Uganda. Methods In October-December 2013, a cross-sectional qualitative study was conducted in 12 districts of Uganda. Semi-structured in-depth interviews were conducted with 85 self-identified MSM by snowball sampling and 61 key informants including HIV service providers and policy makers. Data were analysed using manifest content analysis and Atlas.ti software. Results Three quarters of the MSM (n = 62, 72.9%) were not comfortable disclosing their sexual orientation to providers and 69 (81.1%) felt providers did not respect MSM. Half (n = 44, 51.8%) experienced difficulties in accessing health services. Nine major barriers to access were identified, including: (i) unwelcoming provider behaviours; (ii) limited provider skills and knowledge; (iii) negative community perceptions towards MSM; (iv) fear of being exposed as MSM; (v) limited access to MSM-specific services; (vi) high mobility of MSM, (vii) lack of guidelines on MSM health services; viii) a harsh legal environment; and ix) HIV related stigma. Two-thirds (n = 56, 66%) participated in MSM social networks and 86% of these (48) received support from the networks to overcome barriers to accessing services. Conclusions Negative perceptions among providers and the community present barriers to service access among MSM. Guidelines, provider skills building and use of social networks for mobilization and service delivery could expand access to HIV services among MSM in Uganda.	[Wanyenze, Rhoda K.; Musinguzi, Geofrey; Nuwaha, Fred] Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Matovu, Joseph K. B.; Kiguli, Juliet] Makerere Univ, Sch Publ Hlth, Dept Community Hlth, Kampala, Uganda; [Mujisha, Geoffrey] MARPS Network, Kampala, Uganda; [Musinguzi, Joshua; Arinaitwe, Jim] Minist Hlth, Kampala, Uganda; [Wagner, Glenn J.] RAND Corp, Santa Monica, CA USA	Makerere University; Makerere University; RAND Corporation	Wanyenze, RK (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rwanyenze@hotmail.com	Matovu, Joseph/AAO-5790-2020		Uganda Ministry of Health through a Grant from the Global Fund; RAND	Uganda Ministry of Health through a Grant from the Global Fund; RAND	This research was funded by the Uganda Ministry of Health through a Grant from the Global Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author GJW is employed by RAND. RAND provided support in the form of salaries for author GJW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Batist E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18754; Bowring A, 2019, 10 IAS C HIV SCI; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Dijkstra M, 2015, INT HEALTH, V7, P151, DOI 10.1093/inthealth/ihu101; Graneheim U. H., NURSE ED TODAY, V24, P105; Hakim AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125218; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Holland CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122881; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Lewis-Beck M. S., 2004, ENCY SOCIAL SCI RES, V1-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Health Uganda and OR Macro, 2012, UG AIDS IND SURV 201; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132297; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Ross MW, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26096; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Scott Geibel, 2010, HORIZONS SYNTHESIS B; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Taegtmeyer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064527; Uganda AIDS Commission, UG HIV AIDS COUNTR S; Uganda AIDS Commission, 2014, CAS MOR STRAT INCR I; UNAIDS, 2014 GLOB STAT; UNAIDS, 2014, 90 90 90 AMB TREAT T; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18741; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization, 2014, CONS GUID KAPS CONS	27	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147714	10.1371/journal.pone.0147714	http://dx.doi.org/10.1371/journal.pone.0147714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808653	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800192
J	Warlaumont, AS; Finnegan, MK				Warlaumont, Anne S.; Finnegan, Megan K.			Learning to Produce Syllabic Speech Sounds via Reward-Modulated Neural Plasticity	PLOS ONE			English	Article							SOCIAL FEEDBACK; MOTOR CORTEX; INFANTS; MODEL; EVOLUTION; DOPAMINE; HEARING; VOCALIZATION; ORGANIZATION; OSCILLATIONS	At around 7 months of age, human infants begin to reliably produce well-formed syllables containing both consonants and vowels, a behavior called canonical babbling. Over subsequent months, the frequency of canonical babbling continues to increase. How the infant's nervous system supports the acquisition of this ability is unknown. Here we present a computational model that combines a spiking neural network, reinforcement-modulated spike-timing-dependent plasticity, and a human-like vocal tract to simulate the acquisition of canonical babbling. Like human infants, the model's frequency of canonical babbling gradually increases. The model is rewarded when it produces a sound that is more auditorily salient than sounds it has previously produced. This is consistent with data from human infants indicating that contingent adult responses shape infant behavior and with data from deaf and tracheostomized infants indicating that hearing, including hearing one's own vocalizations, is critical for canonical babbling development. Reward receipt increases the level of dopamine in the neural network. The neural network contains a reservoir with recurrent connections and two motor neuron groups, one agonist and one antagonist, which control the masseter and orbicularis oris muscles, promoting or inhibiting mouth closure. The model learns to increase the number of salient, syllabic sounds it produces by adjusting the base level of muscle activation and increasing their range of activity. Our results support the possibility that through dopamine-modulated spike-timing-dependent plasticity, the motor cortex learns to harness its natural oscillations in activity in order to produce syllabic sounds. It thus suggests that learning to produce rhythmic mouth movements for speech production may be supported by general cortical learning mechanisms. The model makes several testable predictions and has implications for our understanding not only of how syllabic vocalizations develop in infancy but also for our understanding of how they may have evolved.	[Warlaumont, Anne S.] Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA; [Finnegan, Megan K.] Univ Illinois, Speech & Hearing Sci, Champaign, IL USA	University of California System; University of California Merced; University of Illinois System; University of Illinois Urbana-Champaign	Warlaumont, AS (corresponding author), Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA.	awarlaumont2@ucmerced.edu	Finnegan, Megan/GXA-0133-2022	Finnegan, Megan/0000-0003-4095-1225	Merced Undergraduate Research in Computational Biology Program; National Science Foundation [DBI-1040962]; University of California	Merced Undergraduate Research in Computational Biology Program; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System)	MKF's efforts were funded by the University of California, Merced Undergraduate Research in Computational Biology Program, sponsored by National Science Foundation Grant DBI-1040962 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1040962).; We thank Thomas Hannagan, Chris Kello, and members of the UC Merced Emergence of Communication Lab for helpful comments on an earlier draft of this paper. MKF's efforts were funded by the University of California, Merced Undergraduate Research in Computational Biology Program, sponsored by National Science Foundation Grant DBI-1040962.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Andrew RJ, 1998, BEHAV BRAIN SCI, V21, P513, DOI 10.1017/S0140525X98241264; Barlow SM, 2009, HDB MAMMALIAN VOCALI, P351; Beaumont S., 1993, FIRST LANG, V13, P235, DOI DOI 10.1177/014272379301303805; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLOOM K, 1993, INFANT BEHAV DEV, V16, P109, DOI 10.1016/0163-6383(93)80032-4; BLOOM K, 1988, J CHILD LANG, V15, P469, DOI 10.1017/S0305000900012502; Boersma P., 2015, PRAAT; Boersma Paul, 1998, FUNCTIONAL PHONOLOGY; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brickner RM, 1940, J NEUROPHYSIOL, V3, P128, DOI 10.1152/jn.1940.3.2.128; Chorley P, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00021; Coath M, 2007, P ACM INT MEAS C SAN, P1; Coath M, 2009, CONNECT SCI, V21, P193, DOI 10.1080/09540090902733905; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Darshan R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003377; Davis B, 2013, EMERGENCE APPROACH S; de Jong NH, 2008, PRAAT SCRIPT SYLLABL; de Jong NH, 2009, BEHAV RES METHODS, V41, P385, DOI 10.3758/BRM.41.2.385; Deacon T.W., 1989, Human Evolution, V4, P367, DOI 10.1007/BF02436435; DePaolis RA, 2011, INFANT BEHAV DEV, V34, P590, DOI 10.1016/j.infbeh.2011.06.005; Eckel HE, 1999, ANN OTO RHINOL LARYN, V108, P232, DOI 10.1177/000348949910800303; Ejiri K, 2001, DEVELOPMENTAL SCI, V4, P40, DOI 10.1111/1467-7687.00147; Endo N, 2014, IEEE-RAS INT C HUMAN, P1063, DOI 10.1109/HUMANOIDS.2014.7041496; Ertmer DJ, 2010, OXFORD U HDB DEAF ST, V2, P360; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Ghazanfar AA, 1998, BEHAV BRAIN SCI, V21, P516, DOI 10.1017/S0140525X9828126X; Ghazanfar AA, 2014, J COGNITIVE NEUROSCI, V26, P1196, DOI 10.1162/jocn_a_00575; Giulivi S, 2011, LANG LEARN DEV, V7, P202, DOI 10.1080/15475441.2011.564569; Goldstein MH, 1999, J COMP PSYCHOL, V113, P52, DOI 10.1037/0735-7036.113.1.52; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Goldstein MH, 2010, TRENDS COGN SCI, V14, P249, DOI 10.1016/j.tics.2010.02.004; Goldstein UG, 1980, THESIS MIT; Grillner S, 1982, SPEECH MOTOR CONTROL; Gros-Louis J, 2006, INT J BEHAV DEV, V30, P509, DOI 10.1177/0165025406071914; GUENTHER FH, 1994, BIOL CYBERN, V72, P43, DOI 10.1007/BF00206237; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Heintz I, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P684; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Howard IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110334; Howard IS, 2011, MOTOR CONTROL, V15, P85, DOI 10.1123/mcj.15.1.85; HUANG CS, 1989, J NEUROPHYSIOL, V61, P635, DOI 10.1152/jn.1989.61.3.635; Iverson JM, 2007, BRAIN LANG, V101, P198, DOI 10.1016/j.bandl.2006.11.004; Iyer SN, 2008, VOLTA REV, V108, P115; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; JONAS S, 1981, J COMMUN DISORD, V14, P349, DOI 10.1016/0021-9924(81)90019-8; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Jurgens U, 1974, BRAIN RES, V18; Kanda H, 2009, IEEE INT CONF ROBOT, P4036; Kello CT, 2013, PSYCHOL REV, V120, P230, DOI 10.1037/a0030970; Koopmans-van Beinum FJ., 1986, PRECURSORS EARLY SPE, P37, DOI DOI 10.1007/978-1-349-08023-6_4; Kozma R, 2015, CURR OPIN NEUROBIOL, V31, P181, DOI 10.1016/j.conb.2014.11.005; Kroger BJ, 2014, EPJ NONLINEAR BIOMED, V2, DOI 10.1140/epjnbp15; Kroger BJ, 2009, SPEECH COMMUN, V51, P793, DOI 10.1016/j.specom.2008.08.002; Locke JL, 1995, BRAIN LANG, V51, P498, DOI 10.1006/brln.1995.1073; LOCKE JL, 1990, J CHILD LANG, V17, P1, DOI 10.1017/S0305000900013076; Locke JL, 1989, FIRST LANG, V9, P191, DOI [10.1177/014272378900900606, DOI 10.1177/014272378900900606]; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; MacNeilage PF, 2000, CHILD DEV, V71, P153, DOI 10.1111/1467-8624.00129; MASATAKA N, 1994, INFANT BEHAV DEV, V17, P461, DOI 10.1016/0163-6383(94)90038-8; McCune L, 2001, J SPEECH LANG HEAR R, V44, P670, DOI 10.1044/1092-4388(2001/054); Meier RP, 1997, PHONETICA, V54, P153, DOI 10.1159/000262219; Menard L, 2004, J SPEECH LANG HEAR R, V47, P1059, DOI 10.1044/1092-4388(2004/079); Miura K, 2012, ADV ROBOTICS, V26, P23, DOI 10.1163/016918611X607347; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Morrill RJ, 2012, DEVELOPMENTAL SCI, V15, P557, DOI 10.1111/j.1467-7687.2012.01149.x; Moulin-Frier C, 2012, P 2012 IEEE INT C DE, P1; Moulin-Frier C, J PHON IN PRESS; Moulin-Frier C, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01006; Munhall KG, 1998, BEHAV BRAIN SCI, V21, P524, DOI 10.1017/S0140525X98391268; Murakami M, 2015, P 2015 IEEE INT C DE; Nam H, 2013, J PHONETICS, V41, P63, DOI 10.1016/j.wocn.2012.11.002; Ohala JJ, 1996, J ACOUST SOC AM, V99, P1718, DOI 10.1121/1.414696; Ohala JJ, 1998, BEHAV BRAIN SCI, V21, P525, DOI 10.1017/S0140525X98401262; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [10.1016/B978-0-12-770601-6.50011-5, DOI 10.1016/B978-0-12-770601-6.50011-5]; Oller D.K., 2000, EMERGENCE SPEECH CAP; Oller DK, 2001, DEVELOPMENTAL SCI, V4, P49, DOI 10.1111/1467-7687.00148; OLLER DK, 1988, CHILD DEV, V59, P441, DOI 10.1111/j.1467-8624.1988.tb01479.x; Oller DK, 1997, J CHILD LANG, V24, P407; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Philippsen AK, 2014, J IEEE I C DEVELOP L, P195, DOI 10.1109/DEVLRN.2014.6982981; Schauwers K, 2004, OTOL NEUROTOL, V25, P263, DOI 10.1097/00129492-200405000-00011; Schulz GM, 2005, CEREB CORTEX, V15, P1835, DOI 10.1093/cercor/bhi061; Stark R. E., 1980, CHILD PHONOLOGY, V1, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; STOELGAMMON C, 1986, J SPEECH HEAR DISORD, V51, P33, DOI 10.1044/jshd.5101.33; THELEN E, 1981, DEV PSYCHOL, V17, P237, DOI 10.1037/0012-1649.17.3.237; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Warlaumont Anne S., 2013, 2013 IEEE Third Joint International Conference on Development and Learning and Epigenetic Robotics (ICDL), DOI 10.1109/DevLrn.2013.6652547; Warlaumont AS, 2014, J IEEE I C DEVELOP L, P262, DOI 10.1109/DEVLRN.2014.6982991; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; Warlaumont AS, 2013, NEURAL NETWORKS, V38, P64, DOI 10.1016/j.neunet.2012.11.012; Warlaumont AS, 2011, AISB 2011 COMPUTATIO, P23; Warlaumont AS, J PHON IN PRESS; Warlaumont AS, 2014, COMPUTATIONAL MODELS, P113; Warlaumont AS, 2012, IEEE INT C DEV LEARN, P1; Westermann G, 2004, BRAIN LANG, V89, P393, DOI 10.1016/S0093-934X(03)00345-6	102	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145096	10.1371/journal.pone.0145096	http://dx.doi.org/10.1371/journal.pone.0145096			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DC9FZ	26808148	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800005
J	Leclair, N; Thormer, G; Sorge, I; Ritter, L; Schuster, V; Hirsch, FW				Leclair, Nadine; Thoermer, Gregor; Sorge, Ina; Ritter, Lutz; Schuster, Volker; Hirsch, Franz Wolfgang			Whole-Body Diffusion-Weighted Imaging in Chronic Recurrent Multifocal Osteomyelitis in Children	PLOS ONE			English	Article							CRMO	Objective Chronic recurrent multifocal osteomyelitis/ chronic non-bacterial osteomyelitis (CRMO/ CNO) is a rare auto-inflammatory disease and typically manifests in terms of musculoskeletal pain. Because of a high frequency of musculoskeletal disorders in children/adolescents, it can be quite challenging to distinguish CRMO/ CNO from nonspecific musculosketetal pain or from malignancies. The purpose of this study was to evaluate the visibility of CRMO lesions in a whole-body diffusion-weighted imaging (WB-DWI) technique and its potential clinical value to better characterize MR-visible lesions. Material and Methods Whole-body imaging at 3T was performed in 16 patients (average: 13 years) with confirmed CRMO. The protocol included 2D Short Tau Inversion Recovery (STIR) imaging in coronal and axial orientation as well as diffusion-weighted imaging in axial orientation. Visibility of lesions in DWI and STIR was evaluated by two readers in consensus. The apparent diffusion coefficient (ADC) was measured for every lesion and corresponding reference locations. Results A total of 33 lesions (on average 2 per patient) visible in STIR and DWI images (b = 800 s/ mm2 and ADC maps) were included, predominantly located in the long bones. With a mean value of 1283 mm(2)/s in lesions, the ADC was significantly higher than in corresponding reference regions (782 mm(2)/s). By calculating the ratio (lesion to reference), 82% of all lesions showed a relative signal increase of 10% or higher and 76% (25 lesions) showed a signal increase of more than 15%. The median relative signal increase was 69%. Conclusion This study shows that WB-DWI can be reliably performed in children at 3T and predominantly, the ADC values were substantially elevated in CRMO lesions. WB-DWI in conjunction with clinical data is seen as a promising technique to distinguish benign inflammatory processes (in terms of increased ADC values) from particular malignancies.	[Leclair, Nadine; Sorge, Ina; Ritter, Lutz; Hirsch, Franz Wolfgang] Leipzig Univ Hosp, Dept Paediat Radiol, Leipzig, Germany; [Thoermer, Gregor] Siemens Healthcare GmbH, Diagnost Imaging, Magnet Resonance Imaging, Erlangen, Germany; [Schuster, Volker] Leipzig Univ Hosp, Dept Paediat Rheumatol, Leipzig, Germany	Leipzig University; Siemens AG; Leipzig University	Leclair, N (corresponding author), Leipzig Univ Hosp, Dept Paediat Radiol, Leipzig, Germany.	nadine.leclair@medizin.uni-leipzig.de	Hirsch, Franz Wolfgang/AAF-4708-2020	Hirsch, Franz Wolfgang/0000-0003-0960-3740	Siemens Healthcare	Siemens Healthcare(Siemens AG)	The funder (Siemens Healthcare) provided support in the form of salaries for author G.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ai F, 2012, RHEUMATOL INT, V32, P4005, DOI 10.1007/s00296-011-2333-9; Beck C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2992; Biffar A, 2010, EUR J RADIOL, V76, P298, DOI 10.1016/j.ejrad.2010.05.020; Blackledge MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091779; Falip C, 2013, PEDIATR RADIOL, V43, P355, DOI 10.1007/s00247-012-2544-6; Fritz J, 2009, RADIOLOGY, V252, P842, DOI 10.1148/radiol.2523081335; Giedion A, ANN RADIOL, V197, P329; Girschick HJ, 2007, NAT CLIN PRACT RHEUM, V3, P733, DOI 10.1038/ncprheum0653; Guerin-Pfyffer S, 2012, JOINT BONE SPINE, V79, P616, DOI 10.1016/j.jbspin.2011.12.001; Hauer MP, 1998, PEDIATR RADIOL, V28, P846, DOI 10.1007/s002470050479; Hillengass J, 2011, BRIT J HAEMATOL, V153, P721, DOI 10.1111/j.1365-2141.2011.08658.x; Jansson AF, 2011, ACTA PAEDIATR, V100, P1150, DOI 10.1111/j.1651-2227.2011.02205.x; Krohmer S, 2010, EUR J RADIOL, V74, P256, DOI 10.1016/j.ejrad.2009.01.037; Lee SK, 2014, MAGN RESON MED, V71, P1813, DOI 10.1002/mrm.24824; Messiou C, 2011, EUR RADIOL, V21, P1713, DOI 10.1007/s00330-011-2116-4; Neubauer H, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-20; Nonomura Y, 2001, J MAGN RESON IMAGING, V13, P757, DOI 10.1002/jmri.1105; Padhani AR, 2011, RADIOLOGY, V261, P700, DOI 10.1148/radiol.11110474; Padhani AR, 2011, CANC IMAGING, V11, P129, DOI DOI 10.1102/1470-7330.2011.9034; Thormer G, 2012, EUR RADIOL, V22, P1820, DOI 10.1007/s00330-012-2432-3; von Kalle T, 2013, ROFO-FORTSCHR RONTG, V185, P655, DOI 10.1055/s-0033-1335283; Wipff J, 2011, JOINT BONE SPINE, V78, P555, DOI 10.1016/j.jbspin.2011.02.010	22	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147523	10.1371/journal.pone.0147523	http://dx.doi.org/10.1371/journal.pone.0147523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799970	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300120
J	Liu, B; Luo, J; Li, W; Long, XF; Zhang, YQ; Zeng, ZG; Tian, YQ				Liu, Bo; Luo, Jin; Li, Wei; Long, Xiu-Feng; Zhang, Yu-Qin; Zeng, Zhi-Gang; Tian, Yong-Qiang			Erwinia teleogrylli sp nov., a Bacterial Isolate Associated with a Chinese Cricket	PLOS ONE			English	Article							DNA HYBRIDIZATION; SEQUENCE-ANALYSIS; PANTOEA; PLANTS; TREES	A bacterial isolate (SCU-B244(T)) was obtained in China from crickets (Teleogryllus occipitalis) living in cropland deserted for approximately 10 years. The isolated bacteria were Gram-negative, facultatively anaerobic, oxidase-negative rods. A preliminary analysis of the 16S rRNA gene sequence indicated that the strain belongs to either the genus Erwinia or Pantoea. Analysis of multilocus sequence typing based on concatenated partial atpD, gyrB and infB gene sequences and physiological and biochemical characteristics indicated that the strain belonged to the genus Erwinia, as member of a new species as it was distinct from other known Erwinia species. Further analysis of the 16S rRNA gene showed SCU-B244(T) to have 94.71% identity to the closest species of that genus, Erwinia oleae (DSM 23398(T)), which is below the threshold of 97% used to discriminate bacterial species. DNA-DNA hybridization results (5.78 +/- 2.52%) between SCU-B244(T) and Erwinia oleae (DSM 23398(T)) confirmed that SCU-B244(T) and Erwinia oleae (DSM 23398(T)) represent different species combined with average nucleotide identity values which range from 72.42% to 74.41. The DNA G+C content of SCU-B244(T) was 55.32 mol%, which also differs from that of Erwinia oleae (54.7 to 54.9 mol%). The polyphasic taxonomic approach used here confirmed that the strain belongs to the Erwinia group and represents a novel species. The name Erwinia teleogrylli sp. nov. is proposed for this novel taxon, for which the type strain is SCU-B244(T) (= CGMCC 1.12772(T) = DSM 28222(T) = KCTC 42022(T)).	[Liu, Bo; Long, Xiu-Feng; Tian, Yong-Qiang] Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Sichuan, Peoples R China; [Liu, Bo; Luo, Jin; Li, Wei] Sichuan Univ, Coll Chem Engn, Dept Pharmaceut & Biol Engn, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Yu-Qin] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhang, Yu-Qin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zeng, Zhi-Gang] Chengdu Univ, Sichuan Ind Inst Antibiot, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chengdu University	Tian, YQ (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Sichuan, Peoples R China.	yqtian@scu.edu.cn	Liu, Bo/HCG-9782-2022; Zhang, Yu-Qin/AEH-7339-2022; LI, feng/HIR-1703-2022	Liu, Bo/0000-0003-1685-7968; Zhang, Yu-Qin/0000-0002-1739-6705; Luo, Jin/0000-0001-6126-9394				Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; Brady CL, 2011, INT J SYST EVOL MICR, V61, P932, DOI 10.1099/ijs.0.022921-0; Brady CL, 2010, INT J SYST EVOL MICR, V60, P2430, DOI 10.1099/ijs.0.017301-0; Brady CL, 2010, INT J SYST EVOL MICR, V60, P484, DOI 10.1099/ijs.0.012070-0; Brady CL, 2009, INT J SYST EVOL MICR, V59, P2339, DOI 10.1099/ijs.0.009241-0; DELEY J, 1970, EUR J BIOCHEM, V12, P133; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gerhardt P, 1981, MANUAL METHODS GEN B; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M, 1984, NEUTRAL THEORY MOL E; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Lopez MM, 2011, INT J SYST EVOL MICR, V61, P561, DOI 10.1099/ijs.0.020479-0; Mergaert J, 1999, INT J SYST BACTERIOL, V49, P377, DOI 10.1099/00207713-49-2-377; Moretti C, 2000, FUTURE ROLE PESTICID; Moretti C, 2011, INT J SYST EVOL MICR, V61, P2745, DOI 10.1099/ijs.0.026336-0; Popp A, 2010, INT J SYST EVOL MICR, V60, P2786, DOI 10.1099/ijs.0.019430-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Xiang WS, 2011, INT J SYST EVOL MICR, V61, P1165, DOI 10.1099/ijs.0.023283-0	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146596	10.1371/journal.pone.0146596	http://dx.doi.org/10.1371/journal.pone.0146596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800121	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300026
J	Mayhew, SH; Ploubidis, GB; Sloggett, A; Church, K; Obure, CD; Birdthistle, I; Sweeney, S; Warren, CE; Watts, C; Vassall, A				Mayhew, Susannah H.; Ploubidis, George B.; Sloggett, Andy; Church, Kathryn; Obure, Carol D.; Birdthistle, Isolde; Sweeney, Sedona; Warren, Charlotte E.; Watts, Charlotte; Vassall, Anna		Integra Initiative	Innovation in Evaluating the Impact of Integrated Service-Delivery: The Integra Indexes of HIV and Reproductive Health Integration	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; CLUSTER-RANDOMIZED-TRIAL; PUBLIC-HEALTH; SOUTH-AFRICA; INTERVENTIONS; CARE; KENYA; FRAMEWORK; SYSTEMS; COSTS	Background The body of knowledge on evaluating complex interventions for integrated healthcare lacks both common definitions of 'integrated service delivery' and standard measures of impact. Using multiple data sources in combination with statistical modelling the aim of this study is to develop a measure of HIV-reproductive health (HIV-RH) service integration that can be used to assess the degree of service integration, and the degree to which integration may have health benefits to clients, or reduce service costs. Methods and Findings Data were drawn from the Integra Initiative's client flow (8,263 clients in Swaziland and 25,539 in Kenya) and costing tools implemented between 2008-2012 in 40 clinics providing RH services in Kenya and Swaziland. We used latent variable measurement models to derive dimensions of HIV-RH integration using these data, which quantified the extent and type of integration between HIV and RH services in Kenya and Swaziland. The modelling produced two clear and uncorrelated dimensions of integration at facility level leading to the development of two sub-indexes: a Structural Integration Index (integrated physical and human resource infrastructure) and a Functional Integration Index (integrated delivery of services to clients). The findings highlight the importance of multi-dimensional assessments of integration, suggesting that structural integration is not sufficient to achieve the integrated delivery of care to clients-i.e. "functional integration". Conclusions These Indexes are an important methodological contribution for evaluating complex multi-service interventions. They help address the need to broaden traditional evaluations of integrated HIV-RH care through the incorporation of a functional integration measure, to avoid misleading conclusions on its 'impact' on health outcomes. This is particularly important for decision-makers seeking to promote integration in resource constrained environments.	[Mayhew, Susannah H.; Sweeney, Sedona; Watts, Charlotte; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London WC1H 9SH, England; [Ploubidis, George B.] UCL, UCL Inst Educ, Dept Social Sci, Ctr Longitudinal Studies, 55-59 Gordon Sq, London WC1H 0NU, England; [Sloggett, Andy; Church, Kathryn; Birdthistle, Isolde] London Sch Hyg & Trop Med, Dept Populat Hlth, Keppel St, London WC1E 7HT, England; [Obure, Carol D.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, POB 4002, Basel, Switzerland; [Warren, Charlotte E.] Populat Council, Reprod Hlth Serv & Res, Suite 280,4301 Connecticut Ave NW, Washington, DC 20008 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute; Population Council	Mayhew, SH (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London WC1H 9SH, England.	susannah.mayhew@lshtm.ac.uk	Ploubidis, George B/G-9531-2011	Ploubidis, George B/0000-0002-8198-5790; Birdthistle, Isolde/0000-0001-5742-6588; Mayhew, Susannah/0000-0002-2433-3809; Vassall, Anna/0000-0002-2911-1375	Bill & Melinda Gates Foundation [48733]; Ministry of Health in Kenya; Ministry of Health in Swaziland	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Health in Kenya; Ministry of Health in Swaziland	The study was funded by the Bill & Melinda Gates Foundation (grant number 48733). The research team is completely independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to thank: the fieldwork teams; the research participants who gave their time to be interviewed; the managers of the clinics who facilitated data collection; and the Ministries of Health in Kenya and Swaziland who supported the research and are key partners in the Integra Initiative. Finally, we would like to thank other colleagues who gave feedback on aspects of research design and/or analysis.	[Anonymous], 1997, STUDIES HLTH SERVICE; Askew I, 2007, INT C ACT STRENGTH L; Asparouhov T., 2010, TECHNICAL REPORT; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Birdthistle IJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003715; Bradley H, 2008, AIDS CARE, V20, P61, DOI 10.1080/09540120701449112; Brindis CD, 2005, J ADOLESCENT HEALTH, V37, P155, DOI 10.1016/j.jadohealth.2004.09.015; Church K, 2009, STUD FAMILY PLANN, V40, P171, DOI 10.1111/j.1728-4465.2009.00201.x; Cousens S, 2011, J EPIDEMIOL COMMUN H, V65, P576, DOI 10.1136/jech.2008.082610; Curry N, 2010, CLIN SERVICE INTEGRA; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Foreit K, 2002, INT FAMILY PLANNING, V28; Garner P., 2011, COCHRANE DB SYST REV, P7; Gorsuch R., 1983, FACTOR ANAL; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hoang T, 2009, MED CARE, V47, P560, DOI 10.1097/MLR.0b013e31819432a0; Kennedy CE, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-26; Maharaj P, 2005, HEALTH POLICY PLANN, V20, P310, DOI 10.1093/heapol/czi038; Mayhew S.H., 2016, HLTH POLI S IN PRESS; MISLEVY RJ, 1992, J EDUC STAT, V17, P131, DOI 10.3102/10769986017002131; Mitchell M., 2004, INTEGRATION REVISITE; Mutemwa R., 2016, HLTH POLI S IN PRESS; Muthen B., 2010, MPLUS USERS GUIDE; Obure CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124476; Okello DRO, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0007-5; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Rabe-Hesketh S, 2008, STAT METHODS MED RES, V17, P5, DOI 10.1177/0962280207081236; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; Sweeney S, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-42; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Turan JM, 2015, JAIDS-J ACQ IMM DEF, V69, pe172, DOI 10.1097/QAI.0000000000000678; Uebel KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054266; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Warren CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-973; World Health Organization,, 2020, UNDERSTANDING SEXUAL; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146694	10.1371/journal.pone.0146694	http://dx.doi.org/10.1371/journal.pone.0146694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800517	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000368655300030
J	Wang, HW; Su, SH; Wang, YL; Chang, ST; Liao, KH; Lo, HH; Chiu, YL; Hsieh, TH; Huang, TS; Lin, CS; Cheng, SM; Cheng, CC				Wang, Hsei-Wei; Su, Shu-Han; Wang, Yen-Li; Chang, Shih-Ting; Liao, Ko-Hsun; Lo, Hung-Hao; Chiu, Ya-Lin; Hsieh, Tsung-Han; Huang, Tse-Shun; Lin, Chin-Sheng; Cheng, Shu-Meng; Cheng, Cheng-Chung			MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation	PLOS ONE			English	Article							COLONY-FORMING CELLS; REPEATED THERMAL THERAPY; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE PRODUCTION; PROGENITOR CELLS; DIABETES-MELLITUS; BONE-MARROW; MYOCARDIAL-INFARCTION; PROMOTES ANGIOGENESIS; HEART-DISEASE	Diabetes mellitus (DM) is a metabolic disease that is increasing worldwide. Furthermore, it is associated with the deregulation of vascular-related functions, which can develop into major complications among DM patients. Endothelial colony forming cells (ECFCs) have the potential to bring about medical repairs because of their post-natal angiogenic activities; however, such activities are impaired by high glucose-(HG) and the DM-associated conditions. Far-infrared radiation (FIR) transfers energy as heat that is perceived by the thermoreceptors in human skin. Several studies have revealed that FIR improves vascular endothelial functioning and boost angiogenesis. FIR has been used as anti-inflammatory therapy and as a clinical treatment for peripheral circulation improvement. In addition to vascular repair, there is increasing evidence to show that FIR can be applied to a variety of diseases, including cardiovascular disorders, hypertension and arthritis. Yet mechanism of action of FIR and the biomarkers that indicate FIR effects remain unclear. MicroRNA-134 (miR-134-5p) was identified by small RNA sequencing as being increased in high glucose (HG) treated dfECFCs (HG-dfECFCs). Highly expressed miR-134 was also validated in dmECFCs by RT-qPCR and it is associated with impaired angiogenic activities of ECFCs. The functioning of ECFCs is improved by FIR treatment and this occurs via a reduction in the level of miR-134 and an increase in the NRIP1 transcript, a direct target of miR-134. Using a mouse ischemic hindlimb model, the recovery of impaired blood flow in the presence of HG-dfECFCs was improved by FIR pretreatment and this enhanced functionality was decreased when there was miR-134 overexpression in the FIR pretreated HG-dfECFCs. In conclusion, our results reveal that the deregulation of miR-134 is involved in angiogenic defects found in DMpatients. FIR treatment improves the angiogenic activity of HG-dfECFCs and dmECFCs and FIR has potential as a treatment for DM. Detection of miR-134 expression in FIR-treated ECFCs should help us to explore further the effectiveness of FIR therapy.	[Wang, Hsei-Wei; Su, Shu-Han; Wang, Yen-Li; Liao, Ko-Hsun; Lo, Hung-Hao; Chiu, Ya-Lin; Hsieh, Tsung-Han] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, VGH YM Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Su, Shu-Han] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Su, Shu-Han] Acad Sinica, Taipei 115, Taiwan; [Chang, Shih-Ting] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Tse-Shun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Lin, Chin-Sheng; Cheng, Shu-Meng; Cheng, Cheng-Chung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; University of California System; University of California San Diego; National Defense Medical Center; Tri-Service General Hospital	Cheng, CC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	chengcc@mail.ndmctsgh.edu.tw			Tri-Service General Hospital [TSGH-C103-023, TSGH c104-028]; Ministry of Science and Technology [MOST] [103-2321-B-010-026, 103-2911-I-010-506, 104-2911-I-010-506, 104-2321-B-010-027]; Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program; Tsou's Foundation [VGHUST103-G7-2-3]; National Health Research Institutes [NHRI-EX103-10254SI]; Taipei City Hospital [10401-62-014]; National Science Council [102-2911-I-010-503, 101-2320-B-010-059-MY3]; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]; UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan MOST I-RiCE Program [103-2911-I-009-101]	Tri-Service General Hospital; Ministry of Science and Technology [MOST](Ministry of Science and Technology, China); Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program; Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University [Ministry of Education, Aim for the Top University Plan](Ministry of Education, Taiwan); UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan MOST I-RiCE Program	Provide materials: Tri-Service General Hospital [TSGH-C103-023, TSGH c104-028] Cheng-Chung Cheng received these fundings. Provide regents, human resources: Ministry of Science and Technology [MOST; 103-2321-B-010-026, 103-2911-I-010-506, and 104-2911-I-010-506 and 104-2321-B-010-027], Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program, Tsou's Foundation [VGHUST103-G7-2-3], National Health Research Institutes [NHRI-EX103-10254SI], Taipei City Hospital [10401-62-014], National Science Council [102-2911-I-010-503, 101-2320-B-010-059-MY3] and National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]. This work was also supported in part by the UST-UCSD International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan MOST I-RiCE Program [103-2911-I-009-101]. Hsei-Wei Wang received these fundings.	Akasaki Y, 2006, CIRC J, V70, P463, DOI 10.1253/circj.70.463; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beever R, 2009, CAN FAM PHYSICIAN, V55, P691; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2013, JOINT BONE SPINE, V80, P70, DOI 10.1016/j.jbspin.2012.02.015; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Cheng CC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-447; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Chi WY, 2014, BRAIN RES, V1592, P22, DOI 10.1016/j.brainres.2014.09.072; Clore JN, 2002, METABOLISM, V51, P1471, DOI 10.1053/meta.2002.35202; Critser PJ, 2010, MICROVASC RES, V80, P23, DOI 10.1016/j.mvr.2010.03.001; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Eckel RH, 2002, CIRCULATION, V105, P2923, DOI 10.1161/01.CIR.0000017823.53114.4C; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Golden SH, 2011, AM J CARDIOL, V108, p59B, DOI 10.1016/j.amjcard.2011.03.017; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Gui J, 2015, PLACENTA, V36, P410, DOI 10.1016/j.placenta.2015.01.195; Guo WX, 2008, ARCH MED RES, V39, P434, DOI 10.1016/j.arcmed.2008.02.001; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; HONDA K, 1988, INT J BIOMETEOROL, V32, P92, DOI 10.1007/BF01044900; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Huang PH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-99; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Imamura M, 2001, J AM COLL CARDIOL, V38, P1083, DOI 10.1016/S0735-1097(01)01467-X; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jiang HL, 2010, ATHEROSCLEROSIS, V210, P71, DOI 10.1016/j.atherosclerosis.2009.10.032; Jiang QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101774; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kihara T, 2002, J AM COLL CARDIOL, V39, P754, DOI 10.1016/S0735-1097(01)01824-1; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kyrou I, 2009, CURR OPIN PHARMACOL, V9, P787, DOI 10.1016/j.coph.2009.08.007; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Liu YY, 2015, DNA CELL BIOL, V34, P429, DOI 10.1089/dna.2014.2629; Lloyd BJ, 2003, J MICROWAVE POWER EE, V38, P213; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nautiyal J, 2013, TRENDS ENDOCRIN MET, V24, P451, DOI 10.1016/j.tem.2013.05.001; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Rau CS, 2011, PHOTOCHEM PHOTOBIOL, V87, P441, DOI 10.1111/j.1751-1097.2010.00853.x; Salem KA, 2013, MOL CELL BIOCHEM, V380, P83, DOI 10.1007/s11010-013-1662-2; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Seya Y, 2006, EUR J PHARMACOL, V553, P54, DOI 10.1016/j.ejphar.2006.09.048; Shao Y, 2015, J MOL NEUROSCI, V56, P461, DOI 10.1007/s12031-015-0522-9; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Sobajima M, 2011, AM J PHYSIOL-HEART C, V301, pH548, DOI 10.1152/ajpheart.00103.2011; Sun HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079540; Tang YX, 2011, J MOL ENDOCRINOL, V47, P315, DOI 10.1530/JME-11-0082; Toyokawa H, 2003, EXP BIOL MED, V228, P724, DOI 10.1177/153537020322800612; Trombetta A, 2013, DIABETES, V62, P1245, DOI 10.2337/db12-0646; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xue J, 2013, EXP CLIN ENDOCR DIAB, V121, P37, DOI 10.1055/s-0032-1323683; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x; Zeng Z, 2015, AM J PHYSIOL-CELL PH, V308, pC308, DOI 10.1152/ajpcell.00275.2013; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183	86	20	20	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147067	10.1371/journal.pone.0147067	http://dx.doi.org/10.1371/journal.pone.0147067			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799933	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300056
J	Lu, T; Yu, S; Liu, Y; Yin, CC; Ye, JJ; Liu, Z; Ma, DX; Ji, CY				Lu, Ting; Yu, Shuang; Liu, Yan; Yin, Congcong; Ye, Jingjing; Liu, Zhi; Ma, Daoxin; Ji, Chunyan			Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							T-CELLS; ELEVATED TH22; EXPRESSION; IL-17; INTERLEUKIN-17; T(H)17; INFLAMMATION; PHENOTYPE; CYTOKINE; DISTINCT	Non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of neoplasm in which 90% are B-cell lymphomas and 10% T-cell lymphomas. Although T-helper 17 (Th17) cells have been implicated to be essential in the pathogenesis of autoimmune and inflammatory diseases, its role in B-cell non-Hodgkin's lymphoma (B-NHL) remains unknown. In this study, we observed a significantly decreased frequency of Th17 cells in peripheral blood from B-NHL patients compared with healthy individuals, accompanied with increased Th1 cells. IL-17AF plasma levels were remarkably decreased in B-NHL patients, accompanied with undetectable IL-17FF and unchangeable IL-17AA. Moreover, Th17 and Th1 cells became normalized after one or two cycles of chemotherapy. Interestingly, in B-NHL, circulating Th17 cells frequencies were significantly higher in relapsed patients than those in untreated patients or normal individuals. Meanwhile, there was no statistical difference regarding the frequencies of Th1 cells between relapsed and untreated patients. Taken these data together, circulating Th17 subset immune response may be associated with the response of patients to treatment and with different stages of disease.	[Lu, Ting; Yu, Shuang; Liu, Yan; Yin, Congcong; Ye, Jingjing; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Zhi] Shandong Univ, Coll Informat Sci & Engn, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ma, DX; Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@sdu.edu.cn; jichunyan@sdu.edu.cn			National Natural Science Foundation of China [81370662]; Major Research plan of the National Natural Science Foundation of China [91442126]; Fundamental Research Funds of Shandong University [2014JC026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of Shandong University	This work was supported by the National Natural Science Foundation of China (81370662) to CJ, by grants from the Major Research plan of the National Natural Science Foundation of China (91442126) to CJ, and from the Fundamental Research Funds of Shandong University (2014JC026) to JY. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alexandrakis MG, 2006, EUR J INTERN MED, V17, P412, DOI 10.1016/j.ejim.2006.02.012; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Chen P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/416123; Cire A, 2004, INT J CANCER, V112, P113, DOI 10.1002/ijc.20373; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ersvaer Elisabeth, 2010, BMC Immunol, V11, P38, DOI 10.1186/1471-2172-11-38; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krejsgaard T, 2013, BLOOD, V122, P943, DOI 10.1182/blood-2013-01-480889; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Maggio E, 2002, ANN ONCOL, V13, P52, DOI 10.1093/annonc/13.S1.52; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Sundrud MS, 2013, SEMIN IMMUNOL, V25, P263, DOI 10.1016/j.smim.2013.10.021; Tian T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/915873; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang M, 2015, ONCOTARGET, V6, P17958, DOI 10.18632/oncotarget.4641; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yin QS, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0085-9; Yu S, 2014, INT J MOL SCI, V15, P1927, DOI 10.3390/ijms15021927; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	36	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148044	10.1371/journal.pone.0148044	http://dx.doi.org/10.1371/journal.pone.0148044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812681	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000073
J	Gleason, JM; Zhou, YH; Hackett, JL; Harris, BR; Greenfield, MD				Gleason, Jennifer M.; Zhou, Yihong; Hackett, Jennifer L.; Harris, Bethany R.; Greenfield, Michael D.			Development of a Genomic Resource and Quantitative Trait Loci Mapping of Male Calling Traits in the Lesser Wax Moth, Achroia grisella	PLOS ONE			English	Article							X ENVIRONMENT INTERACTION; SEXUAL SELECTION; FEMALE CHOICE; GENETIC VARIANCE; ACOUSTIC MOTH; LEPIDOPTERA; SIGNAL; SONG; DISCRIMINATION; PHYLOGEOGRAPHY	In the study of sexual selection among insects, the Lesser Waxmoth, Achroia grisella (Lepidoptera: Pyralidae), has been one of the more intensively studied species over the past 20 years. Studies have focused on how the male calling song functions in pair formation and on the quantitative genetics of male song characters and female preference for the song. Recent QTL studies have attempted to elucidate the genetic architecture of male song and female preference traits using AFLP markers. We continued these QTL studies using SNP markers derived from an EST library that allowed us to measure both DNA sequence variation and map loci with respect to the lepidopteran genome. We report that the level of sequence variation within A. grisella is typical among other Lepidoptera that have been examined, and that comparison with the Bombyx mori genome shows that macrosynteny is conserved. Our QTL map shows that a QTL for a male song trait, pulse-pair rate, is situated on the Z chromosome, a prediction for sexually selected traits in Lepidoptera. Our findings will be useful for future studies of genetic architecture of this model species and may help identify the genetics associated with the evolution of its novel acoustic communication.	[Gleason, Jennifer M.; Zhou, Yihong; Harris, Bethany R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Hackett, Jennifer L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Greenfield, Michael D.] Univ Tours, IRBI, CNRS, UMR 7261, Tours, France; [Zhou, Yihong] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Hackett, Jennifer L.] Univ Kansas, Higuchi Biosci Ctr, Lawrence, KS 66045 USA; [Harris, Bethany R.] Univ Calif San Diego, UC San Diego Lib, La Jolla, CA 92093 USA	University of Kansas; University of Kansas; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; University System of Georgia; University of Georgia; University of Kansas; University of California System; University of California San Diego	Gleason, JM (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	jgleason@ku.edu	; Gleason, Jennifer/E-7089-2012	Greenfield, Michael D./0000-0003-1935-3423; Gleason, Jennifer/0000-0002-0544-3404	National Science Foundation [IOB-0516634]	National Science Foundation(National Science Foundation (NSF))	The work was supported by National Science Foundation grant IOB-0516634 to MDG, PI and JMG, co-PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem S, 2013, J EVOLUTION BIOL, V26, P2581, DOI 10.1111/jeb.12252; Allison J, PHEROMONE COMMUNICAT; Arias CF, 2014, MOL ECOL, V23, P4137, DOI 10.1111/mec.12844; Basten C.J., 1997, QTL CARTOGRAPHER REF; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Brandt LSE, 2005, ETHOLOGY, V111, P609, DOI 10.1111/j.1439-0310.2005.01085.x; Brandt LSE, 2004, J EVOLUTION BIOL, V17, P821, DOI 10.1111/j.1420-9101.2004.00716.x; Collins RD, 1999, HEREDITY, V83, P644, DOI 10.1038/sj.hdy.6885540; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; d'Alencon E, 2009, P NATL ACAD SCI USA, V197, P7680, DOI [10.1073/pnas.091041310, DOI 10.1073/PNAS.091041310]; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; Danielson-Francois AM, 2009, GENETICA, V136, P27, DOI 10.1007/s10709-008-9297-z; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.01; Espeland M, 2007, BIOL J LINN SOC, V92, P727, DOI 10.1111/j.1095-8312.2007.00873.x; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Gleason JM, 2005, BEHAV GENET, V35, P265, DOI 10.1007/s10519-005-3219-y; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Greenfield MD, 2012, J EVOLUTION BIOL, V25, P601, DOI 10.1111/j.1420-9101.2012.02450.x; GREENFIELD MD, 1981, FLA ENTOMOL, V64, P4, DOI 10.2307/3494597; GREENFIELD MD, 1983, BEHAVIOUR, V84, P287, DOI 10.1163/156853983X00534; Greenfield MD, 2000, ETHOL ECOL EVOL, V12, P259; Greenfield MD, INSECT HEARING ACOUS, V1, P81; Greenfield MD, 2014, INSECT HEARING ACOUS, P81; Greig EI, 2004, BEHAVIOUR, V141, P799, DOI 10.1163/1568539042265626; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Jia FY, 2001, J INSECT BEHAV, V14, P19, DOI 10.1023/A:1007893411662; Jia FY, 2000, EVOLUTION, V54, P953; Jia FY, 1997, P ROY SOC B-BIOL SCI, V264, P1057, DOI 10.1098/rspb.1997.0146; Kause A, 1999, J EVOLUTION BIOL, V12, P471, DOI 10.1046/j.1420-9101.1999.00045.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kunike G., 1930, Zeitschrift fuer Angewandte Entomologie, V16, P304; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; Limousin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044554; Milum VG, 1940, GLEANINGS BEE CULT, V68, P424; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Moehring AJ, 2011, EVOLUTION, V65, P2621, DOI 10.1111/j.1558-5646.2011.01325.x; Powell Jerry A., 2009, ENCY INSECTS, P557; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Roff Derek A., 1992; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Silberglied RE, 1977, ANIMALS COMMUNICATE, P362; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; Stearns S., 1992, EVOLUTION LIFE HIST; TRAUT W, 1977, GENETICA, V47, P135, DOI 10.1007/BF00120178; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Vedenina VY, 2007, J EVOLUTION BIOL, V20, P260, DOI 10.1111/j.1420-9101.2006.01204.x; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhou YH, 2008, EVOLUTION, V62, P1317, DOI 10.1111/j.1558-5646.2008.00371.x; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	64	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147014	10.1371/journal.pone.0147014	http://dx.doi.org/10.1371/journal.pone.0147014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807910	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800045
J	Hatanaka, M; Kaimori, JY; Yamamoto, S; Matsui, I; Hamano, T; Takabatake, Y; Ecelbarger, CM; Takahara, S; Isaka, Y; Rakugi, H				Hatanaka, Masaki; Kaimori, Jun-Ya; Yamamoto, Satoko; Matsui, Isao; Hamano, Takayuki; Takabatake, Yoshitsugu; Ecelbarger, Carolyn M.; Takahara, Shiro; Isaka, Yoshitaka; Rakugi, Hiromi			Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in Mice	PLOS ONE			English	Article							BLOOD-PRESSURE; ANGIOTENSIN-II; JAPANESE PATIENTS; SODIUM SENSITIVITY; HYPERTENSIVE-RATS; MORNING SURGE; RECEPTOR; CANDESARTAN; MORTALITY; NHE3	A potent angiotensin II type-1 receptor blocker, azilsartan, has been reported to reduce blood pressure more effectively than candesartan. Interestingly, azilsartan can also restore the circadian rhythm of blood pressure. We hypothesized that azilsartan could also improve salt sensitivity; thus, we examined the effect of azilsartan on sodium handling in renal tubules. Subtotal nephrectomized C57BL/6 mice received azilsartan (1.0 mg/kg/day), candesartan (0.3 mg/kg/day), or vehicle via the oral route in conjunction with a normal-(0.3%) or high-salt (8.0%) diet. Two weeks later, the azilsartan group showed significantly lower blood pressure during the light period than the candesartan and vehicle groups (azilsartan: 103.1 +/- 1.0; candesartan: 111.7 +/- 2.7; vehicle: 125.5 +/- 2.5 mmHg; P < 0.05; azilsartan or candesartan vs. vehicle). The azilsartan group also showed higher urinary fractional excretion of sodium during the dark period than the candesartan and vehicle groups (azilsartan: 21.37 +/- 3.69%; candesartan: 14.17 +/- 1.42%; vehicle: 13.85 +/- 5.30%; P < 0.05 azilsartan vs. candesartan or vehicle). A pressure-natriuresis curve demonstrated that azilsartan treatment restored salt sensitivity. Immunofluorescence and western blotting showed lower levels of Na+-H+ exchanger-3 (NHE3) protein (the major sodium transporter in renal proximal tubules) in the azilsartan group, but not in the candesartan or vehicle groups. However, azilsartan did not affect NHE3 transcription levels. Interestingly, we did not observe increased expression of downstream sodium transporters, which would have compensated for the increased flow of sodium and water due to non-absorption by NHE3. We also confirmed the mechanism stated above using cultured opossum kidney proximal tubular cells. Results revealed that a proteasomal inhibitor (but not a lysosomal inhibitor) blocked the azilsartan-induced decrease in NHE3 protein expression, suggesting that azilsartan increases NHE3 ubiquitination. In conclusion, azilsartan (but not candesartan) improved salt sensitivity possibly by decreasing NHE3 expression via ubiquitin-proteasomal degradation.	[Hatanaka, Masaki; Kaimori, Jun-Ya; Yamamoto, Satoko; Matsui, Isao; Hamano, Takayuki; Takabatake, Yoshitsugu; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Kaimori, Jun-Ya; Takahara, Shiro] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Suita, Osaka, Japan; [Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka, Japan; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC USA	Osaka University; Osaka University; Osaka University; Georgetown University	Kaimori, JY (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan.; Kaimori, JY (corresponding author), Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Suita, Osaka, Japan.	kaimori@kid.med.osaka-u.ac.jp	Hamano, TAKAYUKI/AAZ-4837-2021	Hamano, TAKAYUKI/0000-0002-2100-9106; Rakugi, Hiromi/0000-0001-6508-4338; Matsui, Isao/0000-0001-8378-6130	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science (http://www.jsps.go.jp/).	Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; [Anonymous], 2004, STAT ANAL EPIDEMIOLO; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Brooks HL, 2001, J PHYSIOL-LONDON, V530, P359, DOI 10.1111/j.1469-7793.2001.0359k.x; CANO A, 1994, AM J PHYSIOL, V266, pC1603, DOI 10.1152/ajpcell.1994.266.6.C1603; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Di Sole F, 2011, KIDNEY INT, V80, P822, DOI 10.1038/ki.2011.229; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Duncan JL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2958; Endo S, 2009, HYPERTENS RES, V32, P513, DOI 10.1038/hr.2009.40; Fang ZW, 1999, J HYPERTENS, V17, P983, DOI 10.1097/00004872-199917070-00015; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Herlitz Hans, 1998, Blood Pressure, V7, P47; Hu MC, 2013, AM J PHYSIOL-RENAL, V304, pF1169, DOI 10.1152/ajprenal.00630.2012; JOURDAIN M, 1992, AM J PHYSIOL, V263, pC1141, DOI 10.1152/ajpcell.1992.263.6.C1141; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; KIMURA G, 1988, AM J HYPERTENS, V1, P372, DOI 10.1093/ajh/1.4.372; Kren S, 1999, KIDNEY INT, V56, P333, DOI 10.1046/j.1523-1755.1999.00527.x; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Kurtz TW, 2012, VASC HEALTH RISK MAN, V8, P133, DOI 10.2147/VHRM.S22595; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; MORDUCHOWICZ GA, 1991, J MEMBRANE BIOL, V122, P43, DOI 10.1007/BF01872738; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Morimoto S, 2006, HYPERTENS RES, V29, P567, DOI 10.1291/hypres.29.567; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Oikawa R, 2010, CARDIOVASC RES, V87, P187, DOI 10.1093/cvr/cvq034; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Rakugi H, 2014, BLOOD PRESS MONIT, V19, P164, DOI 10.1097/MBP.0000000000000042; Rakugi H, 2013, BLOOD PRESSURE, V22, P22, DOI 10.3109/08037051.2013.818758; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Schulman IH, 2007, HYPERTENSION, V49, P270, DOI 10.1161/01.HYP.0000253966.21795.d3; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Seldin DW G G, 1985, KIDNEY PHYSL PATHOPH; Takagi H, 2014, HYPERTENS RES, V37, P432, DOI 10.1038/hr.2013.142; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Ushio-Yamana H, 2012, NEPHRON EXP NEPHROL, V122, P95, DOI 10.1159/000348660; Uzu T, 1997, CIRCULATION, V96, P1859, DOI 10.1161/01.CIR.96.6.1859; Uzu T, 1996, HYPERTENSION, V28, P139, DOI 10.1161/01.HYP.28.1.139; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Widdop RE, 2008, CLIN EXP PHARMACOL P, V35, P386, DOI 10.1111/j.1440-1681.2008.04883.x; Xu L, 1997, HYPERTENSION, V29, P450, DOI 10.1161/01.HYP.29.1.450; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E	54	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147786	10.1371/journal.pone.0147786	http://dx.doi.org/10.1371/journal.pone.0147786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807585	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800210
J	Mouser, EEIM; Pollakis, G; Yazdanbakhsh, M; Harnett, W; de Jong, EC; Paxton, WA				Mouser, Emily E. I. M.; Pollakis, Georgios; Yazdanbakhsh, Maria; Harnett, William; de Jong, Esther C.; Paxton, William A.			Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells	PLOS ONE			English	Article							NEMATODE-SECRETED PRODUCT; PHOSPHORYLCHOLINE-CONTAINING GLYCOPROTEIN; HUMAN DENDRITIC CELLS; FILARIAL NEMATODES; IN-VIVO; ACANTHOCHEILONEMA-VITEAE; ENVELOPE GLYCOPROTEIN; IMMUNE ACTIVATION; HELMINTH PRODUCT; SIGN	One of the hallmarks of HIV-1 disease is the association of heightened CD4(+) T-cell activation with HIV-1 replication. Parasitic helminths including filarial nematodes have evolved numerous and complex mechanisms to skew, dampen and evade human immune responses suggesting that HIV-1 infection may be modulated in co-infected individuals. Here we studied the effects of two filarial nematode products, adult worm antigen from Brugia malayi (BmA) and excretory-secretory product 62 (ES-62) from Acanthocheilonema viteae on HIV-1 infection in vitro. Neither BmA nor ES-62 influenced HIV-1 replication in CD4(+) enriched T-cells, with either a CCR5- or CXCR4- using virus. BmA, but not ES-62, had the capacity to bind the C-type lectin dendritic cell-specific intercellular adhesion molecule3-grabbing non-integrin (DC-SIGN) thereby inhibiting HIV-1 trans-infection of CD4(+) enriched T-cells. As for their effect on DCs, neither BmA nor ES-62 could enhance or inhibit DC maturation as determined by CD83, CD86 and HLA-DR expression, or the production of IL-6, IL-10, IL-12 and TNF-alpha. As expected, due to the unaltered DC phenotype, no differences were found in CD4(+) T helper (Th) cell phenotypes induced by DCs treated with either BmA or ES-62. Moreover, the HIV-1 susceptibility of the Th-cell populations induced by BmA or ES-62 exposed DCs was unaffected for both CCR5- and CXCR4- using HIV-1 viruses. In conclusion, although BmA has the potential capacity to interfere with HIV-1 transmission or initial viral dissemination through preventing the virus from interacting with DCs, no differences in the Th-cell polarizing capacity of DCs exposed to BmA or ES-62 were observed. Neither antigenic source demonstrated beneficial or detrimental effects on the HIV-1 susceptibility of CD4(+) Th-cells induced by exposed DCs.	[Mouser, Emily E. I. M.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Pollakis, Georgios; Paxton, William A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool L69 3BX, Merseyside, England; [Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [de Jong, Esther C.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Liverpool; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Strathclyde; University of Amsterdam	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Paxton, WA (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool L69 3BX, Merseyside, England.; de Jong, EC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.c.dejong@amc.uva.nl; w.a.paxton@liverpool.ac.uk	paxton, william/R-9747-2019; Yazdanbakhsh, Maria/AAI-3996-2020; Georgios, Pollakis/Y-2341-2019	Yazdanbakhsh, Maria/0000-0002-7666-1441; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461; Harnett, William/0000-0001-9545-9401; Paxton, William/0000-0002-2654-5186	European Community's Seventh Framework Programme [41642]	European Community's Seventh Framework Programme	This work was supported by European Community's Seventh Framework Programme Grant 41642 (IDEA).	Annunziato F, 2000, BLOOD, V95, P1167, DOI 10.1182/blood.V95.4.1167.004k11_1167_1174; Aprahamian TR, 2015, INT J PARASITOL, V45, P203, DOI 10.1016/j.ijpara.2014.12.006; Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975; Bashi T, 2015, J AUTOIMMUN, V59, P1, DOI 10.1016/j.jaut.2015.03.001; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Ceballos A, 2007, IMMUNOLOGY, V121, P328, DOI 10.1111/j.1365-2567.2007.02578.x; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Garg R, 2012, VIROLOGY, V432, P271, DOI 10.1016/j.virol.2012.05.032; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Goodridge HS, 2007, PARASITE IMMUNOL, V29, P127, DOI 10.1111/j.1365-3024.2006.00926.x; Goodridge HS, 2005, IMMUNOLOGY, V115, P296, DOI 10.1111/j.1365-2567.2005.02167.x; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Gopinath R, 2000, J INFECT DIS, V182, P1804, DOI 10.1086/317623; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Harnett MM, 1998, PARASITE IMMUNOL, V20, P551, DOI 10.1046/j.1365-3024.1998.00181.x; Harnett W, 1999, PARASITE IMMUNOL, V21, P601, DOI 10.1046/j.1365-3024.1999.00267.x; HARNETT W, 1993, EXP PARASITOL, V77, P498, DOI 10.1006/expr.1993.1113; Harnett W, 2005, PARASITOLOGY, V130, pS63, DOI 10.1017/S0031182005008164; Harnett W, 1999, IMMUNOL TODAY, V20, P125, DOI 10.1016/S0167-5699(98)01419-4; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Houston KM, 2000, INFECT IMMUN, V68, P5466, DOI 10.1128/IAI.68.9.5466-5468.2000; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; LAWRENCE RA, 1994, J IMMUNOL, V153, P1216; Loke P, 2000, EUR J IMMUNOL, V30, P2669, DOI 10.1002/1521-4141(200009)30:9&lt;2669::AID-IMMU2669&gt;3.0.CO;2-1; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Mariani SA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S8; Marshall FA, 2005, J IMMUNOL, V175, P5817, DOI 10.4049/jimmunol.175.9.5817; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Moonis M, 2001, AIDS, V15, P1941, DOI 10.1097/00002030-200110190-00005; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Nielsen NO, 2007, T ROY SOC TROP MED H, V101, P602, DOI 10.1016/j.trstmh.2007.02.009; Nowak RG, 2011, J INFECT DIS, V203, P1182, DOI 10.1093/infdis/jiq172; Paily K P, 2009, J Parasit Dis, V33, P3, DOI 10.1007/s12639-009-0005-4; Pineda MA, 2012, ARTHRITIS RHEUM-US, V64, P3168, DOI 10.1002/art.34581; Plier DA, 1997, CLIN IMMUNOL IMMUNOP, V82, P216, DOI 10.1006/clin.1996.4317; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Raposo RAS, 2014, J VIROL, V88, P11624, DOI 10.1128/JVI.01771-14; Rzepecka J, 2013, INT J PARASITOL, V43, P211, DOI 10.1016/j.ijpara.2012.12.001; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; Stepek G, 2002, PARASITOLOGY, V125, P155, DOI 10.1017/S0031182002001920; Talaat KR, 2008, AM J TROP MED HYG, V79, P558, DOI 10.4269/ajtmh.2008.79.558; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Wang CH, 2011, J INFECT DIS, V203, P479, DOI 10.1093/infdis/jiq083; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; WHO, 2014, LYMPH FIL; Wilson EH, 2003, IMMUNOLOGY, V109, P238, DOI 10.1046/j.1365-2567.2003.01661.x	68	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146527	10.1371/journal.pone.0146527	http://dx.doi.org/10.1371/journal.pone.0146527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808476	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369527800022
J	Nguyen, TMD; Combarnous, Y; Praud, C; Duittoz, A; Blesbois, E				Thi Mong Diep Nguyen; Combarnous, Yves; Praud, Christophe; Duittoz, Anne; Blesbois, Elisabeth			Ca2+/Calmodulin-Dependent Protein Kinase Kinases (CaMKKs) Effects on AMP-Activated Protein Kinase (AMPK) Regulation of Chicken Sperm Functions	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; ACROSOME REACTION; FOWL SPERMATOZOA; MAMMALIAN SPERMATOZOA; CALCIUM REGULATION; MOUSE SPERMATOZOA; MOLECULAR-CLONING; HAMSTER SPERM; DOMESTIC-FOWL; CALMODULIN	Sperm require high levels of energy to ensure motility and acrosome reaction (AR) accomplishment. The AMP-activated protein kinase (AMPK) has been demonstrated to be strongly involved in the control of these properties. We address here the question of the potential role of calcium mobilization on AMPK activation and function in chicken sperm through the Ca2+/calmodulin-dependent protein kinase kinases (CaMKKs) mediated pathway. The presence of CaMKKs and their substrates CaMKI and CaMKIV was evaluated by western-blotting and indirect immunofluorescence. Sperm were incubated in presence or absence of extracellular Ca2+, or of CaMKKs inhibitor (STO-609). Phosphorylations of AMPK, CaMKI, and CaMKIV, as well as sperm functions were evaluated. We demonstrate the presence of both CaMKKs (alpha and beta), CaMKI and CaMKIV in chicken sperm. CaMKK alpha and CaMKI were localized in the acrosome, themidpiece, and atmuch lower fluorescence in the flagellum, whereas CaMKK beta was mostly localized in the flagellum and much less in the midpiece and the acrosome. CaMKIV was only present in the flagellum. The presence of extracellular calcium induced an increase in kinases phosphorylation and sperm activity. STO-609 reduced AMPK phosphorylation in the presence of extracellular Ca2+ but not in its absence. STO-609 did not affect CaMKIV phosphorylation but decreased CaMKI phosphorylation and this inhibition was quicker in the presence of extracellular Ca2+ than in its absence. STO-609 efficiently inhibited sperm motility and AR, both in the presence and absence of extracellular Ca2+. Our results show for the first time the presence of CaMKKs (alpha and beta) and one of its substrate, CaMKI in different subcellular compartments in germ cells, as well as the changes in the AMPK regulation pathway, sperm motility and AR related to Ca2+ entry in sperm through the Ca2+/CaM/ CaMKKs/CaMKI pathway. The Ca2+/CaMKKs/AMPK pathway is activated only under conditions of extracellular Ca2+ entry in the cells.	[Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] CNRS, UMR7247, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] Univ Tours, F-37000 Tours, France; [Thi Mong Diep Nguyen; Combarnous, Yves; Duittoz, Anne; Blesbois, Elisabeth] IFCE, F-37380 Nouzilly, France; [Praud, Christophe] INRA, Unit Rech Avicoles, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE	Blesbois, E (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.; Blesbois, E (corresponding author), CNRS, UMR7247, F-37380 Nouzilly, France.; Blesbois, E (corresponding author), Univ Tours, F-37000 Tours, France.; Blesbois, E (corresponding author), IFCE, F-37380 Nouzilly, France.	Elisabeth.Blesbois@tours.inra.fr	Praud, Christophe/AAT-9553-2020; Combarnous, Yves/K-4161-2019; Nguyen, Thi Mong Diep/AAB-3939-2020	Combarnous, Yves/0000-0002-0574-2025; Nguyen, Thi Mong Diep/0000-0001-6534-9041	French Agence Nationale de la Recherche; INRA; French National Science Infrastructure CRB-Anim - "Investissements d'avenir" [ANR-11-INBS-0003]; Vietnam Education Ministry; French National Science Infrastructure CRB-Anim	French Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; French National Science Infrastructure CRB-Anim - "Investissements d'avenir"(French National Research Agency (ANR)); Vietnam Education Ministry; French National Science Infrastructure CRB-Anim	This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), INRA (http://www.inra.fr), and the French National Science Infrastructure CRB-Anim funded by "Investissements d'avenir", ANR-11-INBS-0003 (http://www.crb-anim.fr). Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). We also thank Isabelle Grasseau, Sabine Alves, Aurore Thelie (INRA) and Daniele Klett (CNRS) for help regarding the methodology and discussions, and the staff of the INRA experimental unit PEAT for the animal breeding and participation in semen collections.; This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) INRA (http://www.inra.fr), and the French National Science Infrastructure CRB-Anim. Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2012, MOL ENDOCRINOL, V26, P281, DOI 10.1210/me.2011-1299; ASHIZAWA K, 1990, COMP BIOCHEM PHYS A, V96, P297, DOI 10.1016/0300-9629(90)90696-P; Ashizawa K, 2006, REPRODUCTION, V131, P1017, DOI 10.1530/rep.1.01069; Ashizawa K, 2004, REPRODUCTION, V128, P783, DOI 10.1530/rep.1.00327; ASHIZAWA K, 1994, J REPROD FERTIL, V101, P265, DOI 10.1530/jrf.0.1010265; BABCOCK DF, 1976, J BIOL CHEM, V251, P3881; Bendahmane M, 2001, ARCH BIOCHEM BIOPHYS, V390, P1, DOI 10.1006/abbi.2001.2364; Blackmore PF, 1999, STEROIDS, V64, P149, DOI 10.1016/S0039-128X(98)00109-3; Blesbois E, 2007, ANIMAL, V1, P1472, DOI 10.1017/S175173110700081X; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E, 2012, J POULT SCI, V49, P141, DOI 10.2141/jpsa.011120; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Campbell AK, 1983, INTRACELLULAR CA2 IT; Chalah T, 1998, THERIOGENOLOGY, V50, P487, DOI 10.1016/S0093-691X(98)00155-1; DAVIS BK, 1978, P SOC EXP BIOL MED, V157, P54, DOI 10.3181/00379727-157-39989; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Ferey JLA, 2014, AM J PHYSIOL-ENDOC M, V307, pE686, DOI 10.1152/ajpendo.00322.2014; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GROSS MK, 1987, J BIOL CHEM, V262, P8672; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Horrocks AJ, 2000, BIOCHEM BIOPH RES CO, V278, P84, DOI 10.1006/bbrc.2000.3766; HOWARTH B, 1983, BIOL REPROD, V28, P586, DOI 10.1095/biolreprod28.3.586; Hurtado de Llera A, 2014, BIOL REPROD, V90, P29, DOI [10.1095/biolreprod.113.112797, DOI 10.1095/BI0LREPR0D.113.112797]; Ignotz GG, 2005, BIOL REPROD, V73, P519, DOI 10.1095/biolreprod.105.040733; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; LAKE PE, 1981, BRIT POULTRY SCI, V22, P71, DOI 10.1080/00071688108447865; Lemoine M, 2008, REPRODUCTION, V136, P391, DOI 10.1530/REP-08-0094; Lemoine M, 2009, BIOL REPROD, V81, P657, DOI 10.1095/biolreprod.108.072660; Liguori L, 2004, J HISTOCHEM CYTOCHEM, V52, P833, DOI 10.1369/jhc.3B6141.2004; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Marin-Briggiler CI, 2005, J CELL SCI, V118, P2013, DOI 10.1242/jcs.02326; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; MORTON B, 1974, BIOCHEM BIOPH RES CO, V56, P372, DOI 10.1016/0006-291X(74)90852-3; MORTON BE, 1978, FERTIL STERIL, V29, P695; Nguyen TMD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121855; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; OKAMURA F, 1978, CELL TISSUE RES, V188, P497; Ozawa E, 2011, P JPN ACAD B-PHYS, V87, P486, DOI 10.2183/pjab.87.486; Peron A, 2006, POULTRY SCI, V85, P462, DOI 10.1093/ps/85.3.462; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Si YM, 2000, BIOL REPROD, V62, P1231, DOI 10.1095/biolreprod62.5.1231; Smith EF, 2002, MOL BIOL CELL, V13, P3303, DOI 10.1091/mbc.E02-04-0185; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; TASH JS, 1987, METHOD ENZYMOL, V139, P808; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; YANAGIMACHI R, 1975, BIOL REPROD, V13, P519, DOI 10.1095/biolreprod13.5.519; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zeng HT, 2003, J CELL SCI, V116, P1981, DOI 10.1242/jcs.00396	61	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147559	10.1371/journal.pone.0147559	http://dx.doi.org/10.1371/journal.pone.0147559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808520	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800134
J	Vashi, P; Edwin, P; Popiel, B; Lammersfeld, C; Gupta, D				Vashi, Pankaj; Edwin, Persis; Popiel, Brenten; Lammersfeld, Carolyn; Gupta, Digant			Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY CIPN; COBALAMIN DEFICIENCY; FOLATE; HOLOTRANSCOBALAMIN; DIAGNOSIS; PLASMA	Background/Aims Normal or high serum vitamin B-12 levels can sometimes be seen in a B-12 deficient state, and can therefore be misleading. High levels of Methymalonic Acid (MMA) and Homocysteine (HC) have been identified as better indicators of B-12 deficiency than the actual serum B-12 level itself. We evaluated the prevalence of vitamin B-12 deficiency using appropriate cut-off levels of vitamin B-12, MMA and HC, and determined the relationship between serum levels of vitamin B-12, MMA and HC in cancer. Methods This is a cross-sectional study using a consecutive case series of 316 cancer patients first seen at Cancer Treatment Centers of America (R) (CTCA) at Midwestern Regional Medical Center between April 2014 and June 2014. All patients were evaluated at baseline for vitamin B-12 (pg/mL), MMA (nmol/L) and HC (mu mol/L) levels. In accordance with previously published research, the following cut-offs were used to define vitamin B-12 deficiency: <300 pg/mL for vitamin B-12, >260 nmol/L for MMA and >12 mu mol/L for HC. The relationship between B-12, MMA and HC was evaluated using Spearman's rho correlation coefficient and cross-tabulation analysis. Receiver Operating Characteristic (ROC) curves were estimated using the non-parametric method to further evaluate the diagnostic accuracy of vitamin B-12 using Fedosov quotient as the "gold standard". Results Mean age at presentation was 52.5 years. 134 (42.4%) patients were males while 182 (57.6%) were females. Median vitamin B-12, MMA and HC levels were 582.5 pg/mL, 146.5 nmol/L and 8.4 mu mol/L respectively. Of 316 patients, 28 (8.9%) were vitamin B-12 deficient based on vitamin B-12 (<300pg/mL), 34 (10.8%) were deficient based on MMA (>260 nmol/L) while 55 (17.4%) were deficient based on HC (>12 mu mol/L). Correlation analysis revealed a significant weak negative correlation between vitamin B-12 and MMA (rho = -0.22) as well as B-12 and HC (rho = -0.35). ROC curves suggested MMA to have the best discriminatory power in predicting B-12 deficiency. Conclusion Vitamin B-12 is poorly correlated with MMA and HC in cancer. Using serum vitamin B-12 alone to evaluate B-12 status in cancer may fail to identify those with functional deficiency. A thorough clinical assessment is important to identify patients that may have risk factors and/or symptoms suggestive of deficiency. These patients should have additional testing of MMA and HC regardless of their B-12 levels.	[Vashi, Pankaj; Edwin, Persis; Popiel, Brenten; Lammersfeld, Carolyn; Gupta, Digant] Midwestern Reg Med Ctr, CTCA, 2520 Elisha Ave, Zion, IL 60099 USA		Gupta, D (corresponding author), Midwestern Reg Med Ctr, CTCA, 2520 Elisha Ave, Zion, IL 60099 USA.	gupta.digant@gmail.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Andres E, 2013, QJM-INT J MED, V106, P505, DOI 10.1093/qjmed/hct051; Bailey RL, 2011, AM J CLIN NUTR, V94, P552, DOI 10.3945/ajcn.111.015222; Bolann BJ, 2000, CLIN CHEM, V46, P1744; Carmel R, 2012, CURR OPIN GASTROEN, V28, P151, DOI 10.1097/MOG.0b013e3283505852; Fedosov SN, 2015, CLIN CHEM LAB MED, V53, P1215, DOI 10.1515/cclm-2014-0818; Green R, 2011, AM J CLIN NUTR, V94, p666S, DOI 10.3945/ajcn.110.009613; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Herrmann W, 2000, EUR J CLIN INVEST, V30, P1083, DOI 10.1046/j.1365-2362.2000.00746.x; Herrmann W, 2003, CLIN CHEM LAB MED, V41, P1478, DOI 10.1515/CCLM.2003.227; Klee GG, 2000, CLIN CHEM, V46, P1277; Lee EY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/848963; McMullin MF, 2001, CLIN LAB HAEMATOL, V23, P161, DOI 10.1046/j.1365-2257.2001.00370.x; Obeid R, 2013, BIOCHIMIE, V95, P1056, DOI 10.1016/j.biochi.2012.10.028; Oh RC, 2003, AM FAM PHYSICIAN, V67, P979; Palacios G, 2013, NUTR HOSP, V28, P1447, DOI 10.3305/nh.2013.28.5.6821; Piccolo J, 2014, AM J HEALTH-SYST PH, V71, P19, DOI 10.2146/ajhp130126; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Risch M, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0060-x; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schloss JM, 2015, SUPPORT CARE CANCER, V23, P1843, DOI 10.1007/s00520-015-2725-6; Schloss JM, 2013, CLIN NUTR, V32, P888, DOI 10.1016/j.clnu.2013.04.007; SCHNEEDE J, 1994, PEDIATR RES, V36, P194, DOI 10.1203/00006450-199408000-00010; Schroder TH, 2014, J NUTR, V144, P1658, DOI 10.3945/jn.114.194829; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Solomon LR, 2011, DIABETES CARE, V34, P1077, DOI 10.2337/dc11-0009; Valente E, 2011, CLIN CHEM, V57, P856, DOI 10.1373/clinchem.2010.158154; Vincenzi B, 2013, SUPPORT CARE CANCER, V21, P1313, DOI 10.1007/s00520-012-1667-5; ZWEIG MH, 1993, CLIN CHEM, V39, P561	29	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147843	10.1371/journal.pone.0147843	http://dx.doi.org/10.1371/journal.pone.0147843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807790	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800226
J	Wei, XJ; Liu, CZ; Wang, HX; Wang, LS; Xiao, FJ; Guo, ZK; Zhang, HC				Wei, Xiaojuan; Liu, Chaozhong; Wang, Hengxiang; Wang, Lisheng; Xiao, Fengjun; Guo, Zikuan; Zhang, Hongchao			Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells	PLOS ONE			English	Article							APOPTOTIC CELLS; ANNEXIN-V; PROMOTE ANGIOGENESIS; EXTRACELLULAR VESICLES; STROMAL CELLS; IN-VITRO; EXOSOMES; RECEPTOR; CLEARANCE; THERAPY	Background Previous data have proven that microvesicles derived from hypoxia-induced mesenchymal stem cells (MSC-MVs) can be internalized into endothelial cells, enhancing their proliferation and vessel structure formation and promoting in vivo angiogenesis. However, there is a paucity of information about how the MSC-MVs are up-taken by endothelial cells. Methods MVs were prepared from the supernatants of human bone marrow MSCs that had been exposed to a hypoxic and/or serum-deprivation condition. The incorporation of hypoxia-induced MSC-MVs into human umbilical cord endothelial cells (HUVECs) was observed by flow cytometry and confocal microscopy in the presence or absence of recombinant human Annexin-V (Anx-V) and antibodies against human CD29 and CD44. Further, small interfering RNA (siRNA) targeted at Anx-V and PSR was delivered into HUVECs, or HUVECs were treated with a monoclonal antibody against phosphatidylserine receptor (PSR) and the cellular internalization of MVs was re-assessed. Results The addition of exogenous Anx-V could inhibit the uptake of MVs isolated from hypoxia-induced stem cells by HUVECs in a dose-and time-dependent manner, while the antiCD29 and CD44 antibodies had no effect on the internalization process. The suppression was neither observed in Anx-V siRNA-transfected HUVECs, however, addition of anti-PSR antibody and PSR siRNA-transfected HUVECs greatly blocked the incorporation of MVs isolated from hypoxia-induced stem cells into HUVECs. Conclusion PS on the MVs isolated from hypoxia-induced stem cells is the critical molecule in the uptake by HUVECs.	[Wei, Xiaojuan; Liu, Chaozhong; Zhang, Hongchao] Gen Hosp Air Force, Dept Cardiol Surg, Beijing, Peoples R China; [Wang, Hengxiang] Gen Hosp Air Force, Dept Hematol, Beijing, Peoples R China; [Wang, Lisheng; Xiao, Fengjun; Guo, Zikuan] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zhang, HC (corresponding author), Gen Hosp Air Force, Dept Cardiol Surg, Beijing, Peoples R China.	zhcxw2015@163.com			Chinese High-Tech "863" Program [2012AA020807, 2012AA02A211]; National Natural Science Foundation [81270219]	Chinese High-Tech "863" Program(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Chinese High-Tech "863" Program (No. 2012AA020807, 2012AA02A211) and National Natural Science Foundation (No. 81270219). The funders had great support in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Boya Penga, 2014, CLIN CHIM ACTA, V427, P42, DOI [10.1016/j.cca.2013.09.048, DOI 10.1016/J.CCA.2013.09.048]; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chai Lai Ruenn, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, DOI 10.2217/RME.13.4]; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Frey B, 2011, SEMIN IMMUNOPATHOL, V33, P497, DOI 10.1007/s00281-010-0228-6; Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Janko C, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065006; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Jin JD, 2008, BIOCHEM BIOPH RES CO, V376, P191, DOI 10.1016/j.bbrc.2008.08.131; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kolb S, 2007, J PATHOL, V212, P249, DOI 10.1002/path.2190; Lasala GP, 2010, ANGIOLOGY, V61, P551, DOI 10.1177/0003319710364213; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li JW, 2013, J MOL HISTOL, V44, P213, DOI 10.1007/s10735-012-9475-2; Lima LG, 2013, THROMB RES, V132, P450, DOI 10.1016/j.thromres.2013.07.026; Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143; Liu Y, 2014, ACTA PHARMACOL SIN, V35, P230, DOI 10.1038/aps.2013.141; Lopatina T, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-26; Minguell JJ, 2013, STEM CELLS DEV, V22, P193, DOI 10.1089/scd.2012.0417; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/rme.12.17, 10.2217/RME.12.17]; Qu JM, 2000, BBA-MOL BASIS DIS, V1501, P99, DOI 10.1016/S0925-4439(00)00022-3; RAVANAT C, 1992, BIOCHEM J, V282, P7, DOI 10.1042/bj2820007; Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Shang YJ, 2013, ONCOL LETT, V6, P490, DOI 10.3892/ol.2013.1410; Shen HH, 2013, BIOMATERIALS, V34, P8361, DOI 10.1016/j.biomaterials.2013.07.042; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Soleti R, 2012, FREE RADICAL BIO MED, V53, P2159, DOI 10.1016/j.freeradbiomed.2012.09.021; Svensson Katrin J, 2013, J BIOL CHEM, V288, P17713, DOI [10.1074/jbc.M112.445403, DOI 10.1074/JBC.M112.445403]; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; Wang X, 2001, PLACENTA, V22, P837, DOI 10.1053/plac.2001.0724; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Wehder L, 2009, CELL CYCLE, V8, P1552, DOI 10.4161/cc.8.10.8404; Xiong J, 2012, J CARDIOVASC PHARM, V59, P124, DOI 10.1097/FJC.0b013e31820c6254; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013; Zhang HC, 2012, STEM CELLS DEV, V21, P3289, DOI 10.1089/scd.2012.0095; Zhou Z, 2007, DEV CELL, V13, P759, DOI 10.1016/j.devcel.2007.11.009	53	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147360	10.1371/journal.pone.0147360	http://dx.doi.org/10.1371/journal.pone.0147360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808539	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800079
J	Kappen, C				Kappen, Claudia			Developmental Patterning as a Quantitative Trait: Genetic Modulation of the Hoxb6 Mutant Skeletal Phenotype	PLOS ONE			English	Article							VERTEBRAL COLUMN; HOMEOTIC TRANSFORMATIONS; PRESOMITIC MESODERM; SEGMENTATION CLOCK; RETINOIC ACID; PROXIMAL RIBS; MOUSE EMBRYO; MICE; EXPRESSION; ABNORMALITIES	The process of patterning along the anterior-posterior axis in vertebrates is highly conserved. The function of Hox genes in the axis patterning process is particularly well documented for bone development in the vertebral column and the limbs. We here show that Hoxb6, in skeletal elements at the cervico-thoracic junction, controls multiple independent aspects of skeletal pattern, implicating discrete developmental pathways as substrates for this transcription factor. In addition, we demonstrate that Hoxb6 function is subject to modulation by genetic factors. These results establish Hox-controlled skeletal pattern as a quantitative trait modulated by gene-gene interactions, and provide evidence that distinct modifiers influence the function of conserved developmental genes in fundamental patterning processes.	[Kappen, Claudia] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kappen, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	claudia.kappen@pbrc.edu			Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation; Mayo Foundation for Medical Education and Research; Nebraska Research Initiative; Munroe-Meyer Institute through the Center for Human Molecular Genetics; Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS R21-AR052731]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR052731] Funding Source: NIH RePORTER	Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation; Mayo Foundation for Medical Education and Research; Nebraska Research Initiative; Munroe-Meyer Institute through the Center for Human Molecular Genetics; Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in parts by a Basil O'Connor Starter Scholar Research Award from the March of Dimes Birth Defects Foundation, Mayo Foundation for Medical Education and Research, the Nebraska Research Initiative, Munroe-Meyer Institute through the Center for Human Molecular Genetics, and by the Peggy M. Pennington Cole Endowed Chair in Developmental Biology at Pennington Biomedical Research Center. Funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases was received through NIAMS R21-AR052731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Allan D, 2001, DEV BIOL, V240, P46, DOI 10.1006/dbio.2001.0455; Bardeen CR, 1904, ANAT ANZEIGER, V25, P497; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; Capecchi MR, 1996, ANN NY ACAD SCI, V785, P34, DOI 10.1111/j.1749-6632.1996.tb56241.x; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CHEN JM, 1953, J ANAT, V87, P130; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; DUBOULE D, 1994, DEVELOPMENT, P135; Dubrulle J, 2002, CURR OPIN GENET DEV, V12, P519, DOI 10.1016/S0959-437X(02)00335-0; Etter LE, 1944, AM J ROENTGENOL RADI, V51, P359; Freitas C, 2001, DEVELOPMENT, V128, P5139; Galis F, 1999, J EXP ZOOL, V285, P19, DOI 10.1002/(SICI)1097-010X(19990415)285:1<19::AID-JEZ3>3.0.CO;2-Z; GOLDSTEIN RS, 1992, DEVELOPMENT, V116, P441; Goodman FR, 2003, LANCET, V362, P651, DOI 10.1016/S0140-6736(03)14187-6; Green EL, 1941, GENETICS, V26, P192; GREEN EL, 1951, GENETICS, V36, P391; GREGG BC, 1983, J EMBRYOL EXP MORPH, V73, P135; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; GRUNEBERG H, 1950, J GENET, V50, P112, DOI 10.1007/BF02986799; Gruneberg H, 1952, GENETICS MOUSE, P353; Gruneberg H, 1963, PATHOLOGY DEV; Guttentag AR, 1999, RADIOGRAPHICS, V19, P1125, DOI 10.1148/radiographics.19.5.g99se011125; HALD HJ, 1995, ROFO FORTSCHR RONTG, V163, P4, DOI 10.1055/s-2007-1015936; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HART CP, 1988, GENETICS, V118, P319; Hide T, 2002, DEVELOPMENT, V129, P4347; Huang RJ, 2003, DEV BIOL, V255, P30, DOI 10.1016/S0012-1606(02)00051-9; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; JOHNSON DR, 1992, J ANAT, V180, P507; Kallapur S, 1999, MOL REPROD DEV, V52, P341, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;341::AID-MRD2&gt;3.0.CO;2-N; Kappen C, 2004, GENESIS, V39, P155, DOI 10.1002/gene.20036; Kappen C, 2000, AM J HEMATOL, V65, P111, DOI 10.1002/1096-8652(200010)65:2<111::AID-AJH4>3.0.CO;2-Z; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; Kuhne K, 1932, Z MORPHOL ANTHROPOL, V30, P1; Leitges M, 2000, DEVELOPMENT, V127, P2259; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; MURAKAMI U, 1963, J EMBRYOL EXP MORPH, V11, P107; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Parisi MA, 2003, GASTROENTEROLOGY, V125, P1428, DOI 10.1016/j.gastro.2003.08.021; Peters H, 1999, DEVELOPMENT, V126, P5399; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sadler T W, 2000, Chest Surg Clin N Am, V10, P237; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; SEARLE AG, 1954, J GENET, V52, P413, DOI 10.1007/BF02981534; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; SOFAER JA, 1985, J ANAT, V140, P131; Stieve H, 1921, Z ANAT ENTWGESCH, V60, P307; Sudo H, 2001, DEV BIOL, V232, P284, DOI 10.1006/dbio.2001.0198; THEILER K, 1988, ADV ANAT EMBRYOL CEL, V112, P1; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; WALLIN J, 1994, DEVELOPMENT, V120, P1109; WEBER W, 1950, J GENET, V50, P174, DOI 10.1007/BF02986801; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6	79	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146019	10.1371/journal.pone.0146019	http://dx.doi.org/10.1371/journal.pone.0146019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800342	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300012
J	Miyagi, T; Tanaka, S; Hide, I; Shirafuji, T; Sakai, N				Miyagi, Tatsuhiro; Tanaka, Shigeru; Hide, Izumi; Shirafuji, Toshihiko; Sakai, Norio			The Subcellular Dynamics of the Gs-Linked Receptor GPR3 Contribute to the Local Activation of PKA in Cerebellar Granular Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CONSTITUTIVE ACTIVITY; AXONAL-TRANSPORT; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; FRET-BIOSENSORS; ORPHAN RECEPTOR; ACTIN DYNAMICS; POLARIZATION; KINESIN	G-protein-coupled receptor (GPR) 3 is a member of the GPR family that constitutively activates adenylate cyclase. We have reported that the expression of GPR3 in cerebellar granular neurons (CGNs) contributes to neurite outgrowth and modulates neuronal proliferation and survival. To further identify its role, we have analyzed the precise distribution and local functions of GPR3 in neurons. The fluorescently tagged GPR3 protein was distributed in the plasma membrane, the Golgi body, and the endosomes. In addition, we have revealed that the plasma membrane expression of GPR3 functionally up-regulated the levels of PKA, as measured by a PKA FRET indicator. Next, we asked if the PKA activity was modulated by the expression of GPR3 in CGNs. PKA activity was highly modulated at the neurite tips compared to the soma. In addition, the PKA activity at the neurite tips was up-regulated when GPR3 was transfected into the cells. However, local PKA activity was decreased when endogenous GPR3 was suppressed by a GPR3 siRNA. Finally, we determined the local dynamics of GPR3 in CGNs using time-lapse analysis. Surprisingly, the fluorescent GPR3 puncta were transported along the neurite in both directions over time. In addition, the anterograde movements of the GPR3 puncta in the neurite were significantly inhibited by actin or microtubule polymerization inhibitors and were also disturbed by the Myosin II inhibitor blebbistatin. Moreover, the PKA activity at the tips of the neurites was decreased when blebbistatin was administered. These results suggested that GPR3 was transported along the neurite and contributed to the local activation of PKA in CGN development. The local dynamics of GPR3 in CGNs may affect local neuronal functions, including neuronal differentiation and maturation.	[Miyagi, Tatsuhiro; Tanaka, Shigeru; Hide, Izumi; Shirafuji, Toshihiko; Sakai, Norio] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan	Hiroshima University	Tanaka, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan.	tanakamd@hiroshima-u.ac.jp	Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761	JSPS KAKENHI [15K09317]; Ministry of Education, Science, Sports and Culture; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Japanese Smoking Research Foundation; Grants-in-Aid for Scientific Research [15K09317, 25293061] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K09317, the Ministry of Education, Science, Sports and Culture Grant-in-Aid for Scientific Research (to S.T.), and by grants from the Mitsubishi Pharma Research Foundation (to S.T.) and the Takeda Science Foundation (to S.T.). This work was also supported in part by the Japanese Smoking Research Foundation (to N.S. & S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; CACERES A, 1986, J NEUROSCI, V6, P714; Claeysen S, 1999, MOL PHARMACOL, V55, P910; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Funahashi Y, 2014, CURR OPIN NEUROBIOL, V27, P215, DOI 10.1016/j.conb.2014.04.009; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Lasek RJ, 1984, J CELL BIOL 2, V99, p212s; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lowther KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065365; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Ruiz-Medina J, 2011, NEUROPHARMACOLOGY, V61, P43, DOI 10.1016/j.neuropharm.2011.02.014; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Ruthel G, 1998, CELL MOTIL CYTOSKEL, V40, P160, DOI 10.1002/(SICI)1097-0169(1998)40:2<160::AID-CM5>3.0.CO;2-J; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Spiering D, 2013, METHOD CELL BIOL, V114, P593, DOI 10.1016/B978-0-12-407761-4.00025-7; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tanaka S, 2014, NEUROBIOL DIS, V68, P215, DOI 10.1016/j.nbd.2014.04.007; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005922; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Tourino C, 2012, BRIT J PHARMACOL, V167, P892, DOI 10.1111/j.1476-5381.2012.02043.x; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Valverde O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004704; Verveer PJ, 2006, CSH PROTOCOLS, V2006, DOI [10.1101/pdb.prot4598, DOI 10.1101/PDB.PR0T4598]; Wang D, 2012, P NATL ACAD SCI USA, V109, pE3558, DOI 10.1073/pnas.1219203110; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730	48	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147466	10.1371/journal.pone.0147466	http://dx.doi.org/10.1371/journal.pone.0147466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800526	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300110
J	Wakabayashi, I; Marumo, M; Nonaka, D; Shimomura, T; Eguchi, R; Lee, LJ; Tanaka, K; Hatake, K				Wakabayashi, Ichiro; Marumo, Mikio; Nonaka, Daisuke; Shimomura, Tomoko; Eguchi, Ryoji; Lee, Lyang-Ja; Tanaka, Kenji; Hatake, Katsuhiko			Potential Biomarker Peptides Associated with Acute Alcohol-Induced Reduction of Blood Pressure	PLOS ONE			English	Article							DIRECT TRANSFER TECHNOLOGY; CORONARY-HEART-DISEASE; ETHANOL; HYPERTENSION; METAANALYSIS; WEIGHT; SEARCH	The purpose of this study was to explore the peptides that are related to acute reduction of blood pressure after alcohol drinking. Venous blood was collected from male healthy volunteers before and after drinking white wine (3 ml/kg weight) containing 13% of ethanol. Peptidome analysis for serum samples was performed using a new target plate, BLOTCHIP (R). Alcohol caused significant decreases in systolic and diastolic blood pressure levels at 45 min. The peptidome analysis showed that the levels of three peptides of m/z 1467, 2380 and 2662 changed significantly after drinking. The m/z 1467 and 2662 peptides were identified to be fragments of fibrinogen alpha chain, and the m/z 2380 peptide was identified to be a fragment of complement C4. The intensities of the m/z 2380 and m/z 1467 peptides before drinking were associated with % decreases in systolic and diastolic blood pressure levels at 45 min after drinking compared with the levels before drinking, while there were no significant correlations between the intensity of the m/z 2662 peptide and % decreases in systolic and diastolic blood pressure levels after drinking. The m/z 1467 and 2380 peptides are suggested to be markers for acute reduction of blood pressure after drinking alcohol.	[Wakabayashi, Ichiro; Marumo, Mikio; Shimomura, Tomoko; Eguchi, Ryoji] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Nonaka, Daisuke; Lee, Lyang-Ja; Tanaka, Kenji] Protosera Inc, Membrane Prot & Ligand Anal Ctr, Amagasaki, Hyogo 6600083, Japan; [Hatake, Katsuhiko] Nara Med Univ, Dept Legal Med, Kashihara, Nara 6348521, Japan	Hyogo College of Medicine; Nara Medical University	Wakabayashi, I (corresponding author), Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp		Nonaka, Daisuke/0000-0002-3510-7559; Eguchi, Ryoji/0000-0002-2417-7578	Japan Society for the Promotion of Science [24659341]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (No. 24659341) from the Japan Society for the Promotion of Science.	Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; ALTURA BM, 1982, FED PROC, V41, P2447; An YM, 2010, DIS MARKERS, V29, P11, DOI [10.1155/2010/681876, 10.3233/DMA-2010-0721]; Araki Y, 2011, PROTEOMICS, V11, P2727, DOI 10.1002/pmic.201000753; BANNAN LT, 1984, CLIN SCI, V66, P659, DOI 10.1042/cs0660659; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; GUIVERNAU M, 1987, J PHARMACOL EXP THER, V240, P59; HATAKE K, 1990, PHARMACOL BIOCHEM BE, V35, P437; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; KAWANO Y, 1992, HYPERTENSION, V20, P219, DOI 10.1161/01.HYP.20.2.219; KING AC, 1991, ALCOHOL CLIN EXP RES, V15, P478, DOI 10.1111/j.1530-0277.1991.tb00546.x; Klatsky AL, 2003, J CARDIOVASC RISK, V10, P21, DOI 10.1097/00043798-200302000-00005; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; KUPARI M, 1983, BRIT HEART J, V49, P174, DOI 10.1136/hrt.49.2.174; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MIZOI Y, 1983, PHARMACOL BIOCHEM BE, V18, P127, DOI 10.1016/0091-3057(83)90159-4; MURAMATSU T, 1989, ALCOHOL CLIN EXP RES, V13, P229, DOI 10.1111/j.1530-0277.1989.tb00317.x; Potter J F, 1983, J Hypertens Suppl, V1, P97; Puddey IB, 2001, CLIN EXP PHARMACOL P, V28, P1020, DOI 10.1046/j.1440-1681.2001.03572.x; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; RUBIN R, 1994, ALCOHOL CLIN EXP RES, V18, P105, DOI 10.1111/j.1530-0277.1994.tb00888.x; Scheid S, 2004, IEEE ACM T COMPUT BI, V1, P98, DOI 10.1109/TCBB.2004.24; Sogawa K, 2009, PROTEOM CLIN APPL, V3, P821, DOI 10.1002/prca.200800174; SUDDENDORF RF, 1989, PUBLIC HEALTH REP, V104, P615; Takeshita T, 1998, ALCOHOL CLIN EXP RES, V22, P1409, DOI 10.1111/j.1530-0277.1998.tb03928.x; Tanaka K, 2009, BIOCHEM BIOPH RES CO, V379, P110, DOI 10.1016/j.bbrc.2008.12.016; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Uchiyama K, 2015, J PROTEOM BIOINFORM, DOI [10.4172/jpb.S5-005, DOI 10.4172/JPB.S5-005]	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147297	10.1371/journal.pone.0147297	http://dx.doi.org/10.1371/journal.pone.0147297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815288	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200029
J	Chen, G; Zhou, M; Chen, L; Meng, ZJ; Xiong, XZ; Liu, HJ; Xin, JB; Zhang, JC				Chen, Gang; Zhou, Mei; Chen, Long; Meng, Zhao-Ji; Xiong, Xian-Zhi; Liu, Hong-Ju; Xin, Jian-Bao; Zhang, Jian-Chu			Cigarette Smoke Disturbs the Survival of CD8(+) Tc/Tregs Partially through Muscarinic Receptors-Dependent Mechanisms in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							T-CELLS; PERIPHERAL-BLOOD; CYTOKINE PRODUCTION; INFLAMMATION; LYMPHOCYTES; EXPRESSION; APOPTOSIS; AIRWAYS; SYSTEM; LUNGS	Background CD8(+) T cells (Cytotoxic T cells, Tc) are known to play a critical role in the pathogenesis of smoking related airway inflammation including chronic obstructive pulmonary disease (COPD). However, how cigarette smoke directly impacts systematic CD8(+) T cell and regulatory T cell (Treg) subsets, especially by modulating muscarinic acetylcholine receptors (MRs), has yet to be well elucidated. Methods Circulating CD8(+) Tc/Tregs in healthy nonsmokers (n = 15), healthy smokers (n = 15) and COPD patients (n = 18) were evaluated by flow cytometry after incubating with anti-CD3, anti-CD8, anti-CD25, anti-Foxp3 antibodies. Peripheral blood T cells (PBT cells) from healthy nonsmokers were cultured in the presence of cigarette smoke extract (CSE) alone or combined with MRs agonist/antagonist for 5 days. Proliferation and apoptosis were evaluated by flow cytometry using Ki-67/Annexin-V antibodies to measure the effects of CSE on the survival of CD8(+) Tc/Tregs. Results While COPD patients have elevated circulating percentage of CD8(+) T cells, healthy smokers have higher frequency of CD8(+) Tregs. Elevated percentages of CD8(+) T cells correlated inversely with declined FEV1 in COPD. CSE promoted the proliferation and inhibited the apoptosis of CD8(+) T cells, while facilitated both the proliferation and apoptosis of CD8(+) Tregs. Notably, the effects of CSE on CD8(+) Tc/Tregs can be mostly simulated or attenuated by muscarine and atropine, the MR agonist and antagonist, respectively. However, neither muscarine nor atropine influenced the apoptosis of CD8(+) Tregs. Conclusion The results imply that cigarette smoking likely facilitates a proinflammatory state in smokers, which is partially mediated by MR dysfunction. The MR antagonist may be a beneficial drug candidate for cigarette smoke-induced chronic airway inflammation.	[Chen, Gang; Zhou, Mei; Chen, Long; Meng, Zhao-Ji; Xiong, Xian-Zhi; Liu, Hong-Ju; Xin, Jian-Bao; Zhang, Jian-Chu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Xiong, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Hubei, Peoples R China.	xxz0508@hust.edu.cn			National Natural Science Foundation of China [81370146, 81570032, 81500031]; Science and Technology Program of Wuhan, China [2013062301010804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Wuhan, China	This work was supported by National Natural Science Foundation of China (No. 81370146, No. 81570032 and No. 81500031; URL: http://www.nsfc.gov.cn/) and Science and Technology Program of Wuhan, China (No. 2013062301010804; URL: http://www.whst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Dinesh RK, 2010, AUTOIMMUN REV, V9, P560, DOI 10.1016/j.autrev.2010.03.006; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Garn H, 2015, AM J RESP CRIT CARE, V191; Glader P, 2006, RESP MED, V100, P818, DOI 10.1016/j.rmed.2005.09.008; GROSS NJ, 1984, NEW ENGL J MED, V311, P421, DOI 10.1056/NEJM198408163110701; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Kalathil SG, 2014, AM J RESP CRIT CARE, V190, P40, DOI 10.1164/rccm.201312-2293OC; Kheradmand F, 2012, EXPERT REV CLIN IMMU, V8, P285, DOI [10.1586/ECI.12.7, 10.1586/eci.12.7]; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; LAURELL CB, 1965, CLIN CHIM ACTA, V11, P395, DOI 10.1016/0009-8981(65)90184-1; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Majori M, 1999, J ALLERGY CLIN IMMUN, V103, P458, DOI 10.1016/S0091-6749(99)70471-9; Mikko M, 2013, IMMUNOBIOLOGY, V218, P225, DOI 10.1016/j.imbio.2012.04.012; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pons J, 2005, EUR RESPIR J, V25, P441, DOI 10.1183/09031936.05.00069304; Profita M, 2012, IMMUNOBIOLOGY, V217, P345, DOI 10.1016/j.imbio.2011.07.013; Profita M, 2009, J PHARMACOL EXP THER, V329, P753, DOI 10.1124/jpet.108.145888; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; Tayebati SK, 2002, J NEUROIMMUNOL, V132, P147, DOI 10.1016/S0165-5728(02)00325-9; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Xiong Xian-Zhi, 2008, Zhonghua Yi Xue Za Zhi, V88, P471; Zhang Jian-Chu, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P33; Zhang JC, 2011, J HUAZHONG U SCI-MED, V31, P463, DOI 10.1007/s11596-011-0474-4; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112350; Zhou HB, 2015, RESPIROLOGY, V20, P426, DOI 10.1111/resp.12486; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622; Zimring JC, 2005, J NEUROIMMUNOL, V164, P66, DOI 10.1016/j.jneuroim.2005.03.018	34	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147232	10.1371/journal.pone.0147232	http://dx.doi.org/10.1371/journal.pone.0147232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808506	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800064
J	Cui, H; Gong, TT; Liu, CX; Wu, QJ				Cui, Hong; Gong, Ting-Ting; Liu, Cai-Xia; Wu, Qi-Jun			Associations between Passive Maternal Smoking during Pregnancy and Preterm Birth: Evidence from a Meta-Analysis of Observational Studies	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ENDOMETRIAL CANCER-RISK; DOSE-RESPONSE METAANALYSIS; SECONDHAND SMOKE; SERUM COTININE; EXPOSURE; OUTCOMES; WEIGHT; WOMEN; SUSCEPTIBILITY	Previous studies investigating the relationship between passive maternal smoking and preterm birth reveal inconsistent results. We conducted the current meta-analysis of observational studies to evaluate the relationship between passive maternal smoking and preterm birth. We identified relevant studies by searching PubMed, EMBASE, and ISI Web of Science databases. We used random-effects models to estimate summary odds ratios (SORs) and 95% confidence intervals (CIs) for aforementioned association. For the analysis, we included 24 studies that involved a total of 5607 women who experienced preterm birth. Overall, the SORs of preterm birth for women who were ever exposed to passive smoking versus women who had never been exposed to passive smoking at any place and at home were 1.20 (95% CI = 1.07-1.34, I-2 = 36.1%) and 1.16 (95% CI = 1.04-1.30, I-2 = 4.4%), respectively. When we conducted a stratified analysis according to study design, the risk estimate was slightly weaker in cohort studies (SOR = 1.10, 95% CI = 1.00-1.21, n = 16) than in cross-sectional studies (SOR = 1.47, 95% CI = 1.23-1.74, n = 5). Additionally, the associations between passive maternal smoking and preterm birth were statistically significant for studies conducted in Asia (SOR = 1.26, 95% CI = 1.05-1.52), for studies including more than 100 cases of preterm birth (SOR = 1.22, 95% CI = 1.05-1.41), and for studies adjusted for maternal age (SOR = 1.27,95% CI = 1.09-1.47), socioeconomic status and/or education (SOR = 1.28, 95% CI = 1.10-1.49), body mass index (SOR = 1.33, 95% CI = 1.04-1.71), and parity (SOR = 1.27, 95% CI = 1.13-1.43). Our findings demonstrate that passive maternal smoking is associated with an increased risk of preterm birth. Future prospective cohort studies are warranted to provide more detailed results stratified by passive maternal smoking during different trimesters of pregnancy and by different types and causes of preterm birth.	[Cui, Hong; Gong, Ting-Ting; Liu, Cai-Xia] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang 110001, Peoples R China; [Wu, Qi-Jun] China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wu, QJ (corresponding author), China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, Shenyang 110001, Peoples R China.	wuqj@sj-hospital.org						AHLBORG G, 1991, AM J EPIDEMIOL, V133, P338, DOI 10.1093/oxfordjournals.aje.a115886; Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; Andriani H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0414-y; [Anonymous], BORN TOO SOON GLOB A; [Anonymous], TECHN ASS PROGR; Ashford KB, 2010, JOGNN-J OBST GYN NEO, V39, P525, DOI 10.1111/j.1552-6909.2010.01169.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Centers for Disease C Prevention National Center for Chronic Disease P Health P Office on S Health, 2010, CTR DIS C PREV PUBL; DeLorenze GN, 2002, ENVIRON RES, V90, P21, DOI 10.1006/enrs.2001.4380; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKWO EE, 1993, INT J EPIDEMIOL, V22, P495, DOI 10.1093/ije/22.3.495; Eliopoulos C, 1996, CLIN INVEST MED, V19, P231; ESKENAZI B, 1995, AM J PUBLIC HEALTH, V85, P395, DOI 10.2105/AJPH.85.3.395; Fantuzzi G, 2007, PAEDIATR PERINAT EP, V21, P194, DOI 10.1111/j.1365-3016.2007.00815.x; Goel P, 2004, J Postgrad Med, V50, P12; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14051; Gong TT, 2015, INT J CANCER, V137, P1967, DOI 10.1002/ijc.29561; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hanke W, 1999, HUM EXP TOXICOL, V18, P265, DOI 10.1191/096032799678840020; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jaakkola JJK, 2001, ENVIRON HEALTH PERSP, V109, P557, DOI 10.2307/3455027; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Khader YS, 2011, MATERN CHILD HLTH J, V15, P453, DOI 10.1007/s10995-010-0599-2; Kim YJ, 2005, GYNECOL OBSTET INVES, V60, P206, DOI 10.1159/000087207; LAZZARONI F, 1990, INT J EPIDEMIOL, V19, P960, DOI 10.1093/ije/19.4.960; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Luan NN, 2013, AM J CLIN NUTR, V98, P1020, DOI 10.3945/ajcn.113.062794; Luo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049155; MARTIN TR, 1986, AM J EPIDEMIOL, V124, P633, DOI 10.1093/oxfordjournals.aje.a114436; MATHAI M, 1992, BRIT J OBSTET GYNAEC, V99, P342, DOI 10.1111/j.1471-0528.1992.tb13736.x; Meeker JD, 2013, CURR WOMENS HEALTH R, V9, P41, DOI 10.2174/1573404811309010003; Miyake Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-157; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Office on S Health, 2010, OFF S HLTH PUBL REP; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Pichini S, 2000, ENVIRON HEALTH PERSP, V108, P1079, DOI 10.2307/3434962; Pickett KE, 2005, PAEDIATR PERINAT EP, V19, P368, DOI 10.1111/j.1365-3016.2005.00660.x; Qiu J, 2014, AM J EPIDEMIOL, V180, P94, DOI 10.1093/aje/kwu092; Sadler L, 1999, AM J EPIDEMIOL, V150, P695; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Tuormaa Tuula E., 1995, Nutrition and Health (Bicester), V10, P105; Wang CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10834; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Windham GC, 2000, EPIDEMIOLOGY, V11, P427, DOI 10.1097/00001648-200007000-00011; Wu FY, 2007, SCI TOTAL ENVIRON, V386, P124, DOI 10.1016/j.scitotenv.2007.06.003; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Wu QJ, 2015, ONCOTARGET, V6, P42988, DOI 10.18632/oncotarget.5557; Wu QJ, 2015, ONCOTARGET, V6, P36081, DOI 10.18632/oncotarget.5555; Wu QJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14243; Wu T, 2007, AM J EPIDEMIOL, V166, P313, DOI 10.1093/aje/kwm090; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122	59	43	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147848	10.1371/journal.pone.0147848	http://dx.doi.org/10.1371/journal.pone.0147848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808045	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800228
J	Graham, CF; Eberts, RL; Morgan, TD; Boreham, DR; Lance, SL; Manzon, RG; Martino, JA; Rogers, SM; Wilson, JY; Somers, CM				Graham, Carly F.; Eberts, Rebecca L.; Morgan, Thomas D.; Boreham, Douglas R.; Lance, Stacey L.; Manzon, Richard G.; Martino, Jessica A.; Rogers, Sean M.; Wilson, Joanna Y.; Somers, Christopher M.			Fine-Scale Ecological and Genetic Population Structure of Two Whitefish (Coregoninae) Species in the Vicinity of Industrial Thermal Emissions	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NUCLEAR-POWER-PLANT; TROPHIC NICHE WIDTH; LAKE WHITEFISH; ROUND WHITEFISH; ATLANTIC SALMON; INDIVIDUAL IDENTIFICATION; PROSOPIUM-CYLINDRACEUM; SOCKEYE-SALMON; LIFE-HISTORY	Thermal pollution from industrial processes can have negative impacts on the spawning and development of cold-water fish. Point sources of thermal effluent may need to be managed to avoid affecting discrete populations. Correspondingly, we examined fine-scale ecological and genetic population structure of two whitefish species (Coregonus clupeaformis and Prosopium cylindraceum) on Lake Huron, Canada, in the immediate vicinity of thermal effluent from nuclear power generation. Niche metrics using delta C-13 and delta N-15 stable isotopes showed high levels of overlap (48.6 to 94.5%) in resource use by adult fish captured in areas affected by thermal effluent compared to nearby reference locations. Isotopic niche size, a metric of resource use diversity, was 1.3- to 2.8-fold higher than reference values in some thermally affected areas, indicative of fish mixing. Microsatellite analyses of genetic population structure (F-st, STRUCTURE and DAPC) indicated that fish captured at all locations in the vicinity of the power plant were part of a larger population extending beyond the study area. In concert, ecological and genetic markers do not support the presence of an evolutionarily significant unit in the vicinity of the power plant. Thus, future research should focus on the potential impacts of thermal emissions on development and recruitment.	[Graham, Carly F.; Eberts, Rebecca L.; Morgan, Thomas D.; Manzon, Richard G.; Martino, Jessica A.; Somers, Christopher M.] Univ Regina, Dept Biol, Regina, SK, Canada; [Boreham, Douglas R.] Northern Ontario Sch Med, Med Sci, Greater Sudbury, ON, Canada; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Athens, GA 30602 USA; [Rogers, Sean M.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada; [Wilson, Joanna Y.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	University of Regina; Northern Ontario School of Medicine; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Calgary; McMaster University	Somers, CM (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.	chris.somers@uregina.ca	Morgan, Tom/AAM-2532-2021; Somers, Christopher/AAE-6390-2019; Lance, Stacey/K-9203-2013	Lance, Stacey/0000-0003-2686-1733	Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants [433617-12]; Bruce Power: matching industrial funds as part of above NSERC CRD application; Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded as part of Canada Research Chair support; McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant as part of Canada Research Chair; Natural Sciences and Engineering Research Council of Canada; Bruce Power; Canada Research Chairs Program; Canada Foundation for Innovation; McMaster University; Northern Ontario School of Medicine; University of Regina; University of Regina's Institute of Environmental Change and Society; U.S. Department of Energy [DE-FC09-07SR22506]	Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bruce Power: matching industrial funds as part of above NSERC CRD application; Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded as part of Canada Research Chair support; McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant as part of Canada Research Chair; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bruce Power; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); McMaster University; Northern Ontario School of Medicine; University of Regina; University of Regina's Institute of Environmental Change and Society; U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Natural Sciences and Engineering Research Council of Canada - Collaborative Research and Development Grants (award # 433617-12, http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP-PP/CRD-RDC_eng.asp); Bruce Power: matching industrial funds as part of above NSERC CRD application (http://www.brucepower.com/); Canada Research Chairs: chair awarded in Genes & Environment to CMS; University of Regina: funds awarded to CMS as part of Canada Research Chair support (technician salary); McMaster University: overhead funds reinvested in program; Northern Ontario School of Medicine: overhead funds reinvested in program; Canada Foundation for Innovation: infrastructure grant awarded to CMS as part of Canada Research Chair (http://www.innovation.ca/). The designation of the 8 geographic zones adjacent to the nuclear plant and the collection of fish as described in the manuscript were conducted by Bruce Power as part of their Environmental Impact Assessment Follow-up Monitoring Program (http://www.brucepower.com/environment/environmental-policy/). The funders had no other roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Natural Sciences and Engineering Research Council of Canada, Bruce Power, the Canada Research Chairs Program, the Canada Foundation for Innovation, McMaster University, the Northern Ontario School of Medicine, and the University of Regina. We are grateful for in-kind support from the University of Regina's Institute of Environmental Change and Society. We would like to thank J. Thompson, C.L. Fietsch, and M.E. Cybulski for coordinating sample collection. Preparation of this manuscript was partially supported by U.S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2010, CAN J FISH AQUAT SCI, V67, P1274, DOI 10.1139/F10-061; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Borodczak N, 1978, CANADIAN WATER RESOU, V3, P142; Bradbury IR, 2015, CAN J FISH AQUAT SCI, V72, P83, DOI 10.1139/cjfas-2014-0058; Bruce Power, 2009, BREP0053100035 BRUC; Bruce Power, 2010, BREP0053100040 BRUC; BRYAN JE, 1975, J FISH RES BOARD CAN, V32, P283, DOI 10.1139/f75-026; Bryce Effer, 1975, THERMAL DISCHARGE ST, P371; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Carl LM, 2006, ENVIRON BIOL FISH, V75, P315, DOI 10.1007/s10641-006-0030-4; Casselman JM, 1995, J GREAT LAKES RES, V21, P384, DOI 10.1016/S0380-1330(95)71112-1; CASSELMAN JM, 1981, CAN J FISH AQUAT SCI, V38, P1772, DOI 10.1139/f81-225; Clarke, 1973, EFFECTS THERMAL DISC; Cooke SJ, 2003, WATER AIR SOIL POLL, V142, P113, DOI 10.1023/A:1022082003932; COUTANT CC, 1977, J FISH RES BOARD CAN, V34, P739, DOI 10.1139/f77-115; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Ebener M. P., 2012, COMM SPEC PUB, V13-01, P29; Ebener M.P., 2008, INT GOVERNANCE FISHE, P99; Ebener MP, 2010, J GREAT LAKES RES, V36, P38, DOI 10.1016/j.jglr.2010.02.002; Ebener MP, 1997, FISHERIES, V22, P18; Eldridge WH, 2007, MOL ECOL, V16, P2407, DOI 10.1111/j.1365-294X.2007.03271.x; Eme J, 2015, COMP BIOCHEM PHYS A, V179, P71, DOI 10.1016/j.cbpa.2014.09.005; Encina L, 2008, J THERM BIOL, V33, P444, DOI 10.1016/j.jtherbio.2008.08.002; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fink P, 2012, OIKOS, V121, P1985, DOI 10.1111/j.1600-0706.2012.20185.x; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Gagnaire PA, 2013, MOL ECOL, V22, P3036, DOI 10.1111/mec.12127; Golder & Associates, 2005, BRUC REF LIF EXT CON, V1; Guzzo MM, 2015, J GREAT LAK IN PRESS; Hamidan N, 2016, ECOL FRESHW FISH, V25, P455, DOI 10.1111/eff.12226; Hart J.L., 1931, CONTRIB CAN BIOL FIS, V6, P165, DOI DOI 10.1139/F31-007; Harvey CJ, 2000, CAN J FISH AQUAT SCI, V57, P1395, DOI 10.1139/cjfas-57-7-1395; Hayes Hebert, 1972, 44 ANZAAS C S; Hobson KA, 2012, J GREAT LAKES RES, V38, P58, DOI 10.1016/j.jglr.2010.11.008; Hoyle JA, 2011, AQUAT ECOSYST HEALTH, V14, P66, DOI 10.1080/14634988.2011.548730; IHSSEN PE, 1981, CAN J FISH AQUAT SCI, V38, P1790, DOI 10.1139/f81-226; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Johnsen A, 2014, FISHERIES MANAG ECOL, V21, P32, DOI 10.1111/fme.12049; Jombart T, 2010, BMC GENET, P11, DOI [10.1186/1471-2156-11-11, DOI 10.1186/1471-2156-11-11]; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; KELSO JRM, 1974, J FISH RES BOARD CAN, V31, P1507, DOI 10.1139/f74-181; Lance SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081853; Lardicci C, 1999, MAR POLLUT BULL, V38, P296, DOI 10.1016/S0025-326X(98)00149-0; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Lindholm E, 2004, HUM HERED, V58, P164, DOI 10.1159/000083543; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; LUKSIENE D, 1994, J FISH BIOL, V45, P613, DOI 10.1111/j.1095-8649.1994.tb00928.x; Luksiene D, 2000, J FISH BIOL, V56, P37, DOI 10.1111/j.1095-8649.2000.tb02085.x; Macpherson A, 2010, CURR ZOOL, V56, P109, DOI 10.1093/czoolo/56.1.109; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCracken GR, 2014, CONSERV GENET RESOUR, V6, P1023, DOI 10.1007/s12686-014-0276-7; McNickle GG, 2006, J GREAT LAKES RES, V32, P180, DOI 10.3394/0380-1330(2006)32[180:CIBICO]2.0.CO;2; Mee JA, 2015, EVOL APPL, V8, P423, DOI 10.1111/eva.12247; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mohr Lloyd C., 2005, Great Lakes Fishery Commission Technical Report, V66, P105; Moore JS, 2014, MOL ECOL, V23, P5680, DOI 10.1111/mec.12972; Morin R, 1982, CANADIAN J FISHERIES, V39, P959; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mueller CA, 2015, J COMP PHYSIOL B, V185, P315, DOI 10.1007/s00360-015-0886-8; Munroe SEM, 2015, J FISH BIOL, V86, P1567, DOI 10.1111/jfb.12660; Nalepa TF, 2009, AQUAT ECOSYST HEALTH, V12, P2, DOI 10.1080/14634980802715175; Newman RA, 2001, MOL ECOL, V10, P1087, DOI 10.1046/j.1365-294X.2001.01255.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Bryhim J, 2013, CONSERV GENET RESOUR, V5, P89, DOI 10.1007/s12686-012-9740-4; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Patrick PH, 2013, N AM J FISH MANAGE, V33, P1091, DOI 10.1080/02755947.2013.824937; Patton JC, 1997, CAN J FISH AQUAT SCI, V54, P1548, DOI 10.1139/cjfas-54-7-1548; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Pigeon D, 1997, EVOLUTION, V51, P196, DOI [10.2307/2410973, 10.1111/j.1558-5646.1997.tb02401.x]; Pothoven SA, 2008, N AM J FISH MANAGE, V28, P308, DOI 10.1577/M07-022.1; Pothoven SA, 2006, J GREAT LAKES RES, V32, P489, DOI 10.3394/0380-1330(2006)32[489:FEOLWI]2.0.CO;2; Pothoven SA, 2013, N AM J FISH MANAGE, V33, P1194, DOI 10.1080/02755947.2013.839973; Pritchard JK, 2000, GENETICS, V155, P945; Prugh LR, 2005, MOL ECOL, V14, P1585, DOI 10.1111/j.1365-294X.2005.02533.x; R Development Core Team, 2014, R LANG ENV STAT COMP; RAWSON D. S., 1951, JOUR FISH RES BD CANADA, V8, P207; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rennie MD, 2009, OECOLOGIA, V159, P789, DOI 10.1007/s00442-008-1271-z; REUTTER J M, 1976, Ohio Journal of Science, V76, P39; Richoux NB, 2014, MARINE ECOLOGY; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Rogers SM, 2004, MOL ECOL NOTES, V4, P89, DOI 10.1046/j.1471-8286.2003.00578.x; ROSEMAN EF, 2007, J GREAT LAKES RES, V33, P397; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; ROSS MJ, 1982, CAN J FISH AQUAT SCI, V39, P346, DOI 10.1139/f82-047; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2000, ECOL APPL, V10, P1090, DOI 10.1890/1051-0761(2000)010[1090:MSAOAC]2.0.CO;2; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sandstrom O, 1997, J FISH BIOL, V51, P1015, DOI 10.1006/jfbi.1997.0506; SANDSTROM O, 1995, J FISH BIOL, V47, P652, DOI 10.1006/jfbi.1995.0169; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sierszen ME, 2006, CAN J FISH AQUAT SCI, V63, P1496, DOI 10.1139/F06-057; Smythe A.G., 2000, ENVIRON SCI POLICY, V3, P225; Spidle AP, 2001, CONSERV GENET, V2, P11, DOI 10.1023/A:1011580217381; Steinhart GB, 2007, T31 NYSDEC BUR WILDL; Stott W, 2004, ANN ZOOL FENN, V41, P51; Stott W, 2008, ADV LIMNOLOGY, V63, P241; Stott W, 2013, ADV LIMNOL, V64, P205, DOI 10.1127/1612-166X/2013/0064-0015; Stott W, 2010, J GREAT LAKES RES, V36, P59, DOI 10.1016/j.jglr.2010.01.004; SYLVESTER J R, 1972, Environmental Pollution, V3, P205, DOI 10.1016/0013-9327(72)90004-3; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Takai N, 1999, CAN J ZOOL, V77, P258, DOI 10.1139/cjz-77-2-258; Taylor EB, 2011, CAN J ZOOL, V89, P255, DOI 10.1139/Z10-114; Teixeira TP, 2012, HYDROBIOLOGIA, V684, P161, DOI 10.1007/s10750-011-0980-1; Teixeira TP, 2009, MAR ENVIRON RES, V68, P188, DOI 10.1016/j.marenvres.2009.06.004; Thome C, CANADIAN J FIS UNPUB; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandehey JA, 2009, CAN J FISH AQUAT SCI, V66, P382, DOI 10.1139/F08-213; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Verones F, 2010, ENVIRON SCI TECHNOL, V44, P9364, DOI 10.1021/es102260c; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Waples R.S., 1991, MAR FISH REV, V53, P11; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wismer DA, 1987, GREAT LAKES FISHERY, V87-3	122	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146656	10.1371/journal.pone.0146656	http://dx.doi.org/10.1371/journal.pone.0146656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807722	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800029
J	Koster-Rasmussen, R; Simonsen, MK; Siersma, V; Henriksen, JE; Heitmann, BL; Olivarius, ND				Koster-Rasmussen, Rasmus; Simonsen, Mette Kildevaeld; Siersma, Volkert; Henriksen, Jan Erik; Heitmann, Berit Lilienthal; Olivarius, Niels de Fine			Intentional Weight Loss and Longevity in Overweight Patients with Type 2 Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							STRUCTURED PERSONAL CARE; ALL-CAUSE MORTALITY; US ADULTS; FOLLOW-UP; PREVENTION; OBESITY; INDIVIDUALS; MORBIDITY; DIET	Objective This study examined the influence of weight loss on long-term morbidity and mortality in overweight (BMI >= 25kg/m(2)) patients with type 2 diabetes, and tested the hypothesis that therapeutic intentional weight loss supervised by a medical doctor prolongs life and reduces the risk for cardiovascular disease in these patients. Methods This is a 19 year cohort study of patients in the intervention arm of the randomized clinical trial Diabetes Care in General Practice. Weight and prospective intentions for weight loss were monitored every third month for six years in 761 consecutive patients (>= 40 years) newly diagnosed with diabetes in general practices throughout Denmark in 1989-92. Multivariable Cox regression was used to estimate the association between weight change during the monitoring period (year 0 to 6) and the outcomes during the succeeding 13 years (year 6 to 19) in 444 patients who were overweight at diagnosis and alive at the end of the monitoring period (year 6). The analysis was adjusted for age, sex, education, BMI at diagnosis, change in smoking, change in physical activity, change in medication, and the Charlson comorbidity 6-year score. Outcomes were from national registers. Results Overall, weight loss regardless of intention was an independent risk factor for increased all-cause mortality (P<0.01). The adjusted hazard ratio for all-cause mortality, cardiovascular mortality, and cardiovascular morbidity attributable to an intentional weight loss of 1 kg/year was 1.20 (95%CI 0.97-1.50, P = 0.10), 1.26 (0.93-1.72, P = 0.14), and 1.06 (0.79-1.42, P = 0.71), respectively. Limiting the analysis to include only those patients who survived the first 2 years after the monitoring period did not substantially change these estimates. A non-linear spline estimate indicated a V-like association between weight change and all-cause mortality, suggesting the best prognosis for those who maintained their weight. Conclusions In this population-based cohort of overweight patients with type 2 diabetes, successful therapeutic intentional weight loss, supervised by a doctor over six years, was not associated with reduced all-cause mortality or cardiovascular morbidity/mortality during the succeeding 13 years.	[Koster-Rasmussen, Rasmus; Siersma, Volkert; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Koster-Rasmussen, Rasmus; Siersma, Volkert; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Koster-Rasmussen, Rasmus; Henriksen, Jan Erik] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Simonsen, Mette Kildevaeld] Rigshosp, Finsen Ctr, DK-2100 Copenhagen, Denmark; [Henriksen, Jan Erik] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Heitmann, Berit Lilienthal] Bispebjerg Hosp, Res Unit Dietary Studies, Parker Inst, Frederiksberg, Denmark; [Heitmann, Berit Lilienthal] Bispebjerg Hosp, Inst Prevent Med, Capital Reg, Frederiksberg, Denmark; [Heitmann, Berit Lilienthal] Frederiksberg Univ Hosp, Res Unit Dietary Studies, Parker Inst, Frederiksberg, Denmark; [Heitmann, Berit Lilienthal] Frederiksberg Univ Hosp, Inst Prevent Med, Capital Reg, Frederiksberg, Denmark; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Heitmann, Berit Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Sydney; University of Southern Denmark	Koster-Rasmussen, R (corresponding author), Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark.; Koster-Rasmussen, R (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark.; Koster-Rasmussen, R (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	glr478@ku.dk	Siersma, Volkert D/G-6867-2016; de Fine Olivarius, Niels/K-6832-2015	Siersma, Volkert D/0000-0003-1941-2681; de Fine Olivarius, Niels/0000-0001-6465-3615; Koster-Rasmussen, Rasmus/0000-0002-6452-1839; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Henriksen, Jan Erik/0000-0002-1908-7017	Danish Medical Research Council; Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Novo Nordisk Farmaka Denmark Ltd.; Pharmacy Foundation; Foundation for General Practice in Copenhagen; Frederiksberg; Tarnby and Dragor; Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust; Danish Medical Association Research Fund; Velux Foundation; Rockwool Foundation; Novo Nordisk Ltd.; Danish Diabetes Association, Oda and Hans Svenningsen's Fund; A P Moller Foundation for the Advancement of Medical Science; Captain Axel Viggo Morch and his Wife's Trust; Danish Eye Health Society; Mogens and Jenny Vissing's Trust; Bernhard and Marie Klein's Trust	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Novo Nordisk Farmaka Denmark Ltd.(Novo Nordisk); Pharmacy Foundation; Foundation for General Practice in Copenhagen; Frederiksberg; Tarnby and Dragor; Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust; Danish Medical Association Research Fund; Velux Foundation(Velux Fonden); Rockwool Foundation; Novo Nordisk Ltd.(Novo Nordisk); Danish Diabetes Association, Oda and Hans Svenningsen's Fund; A P Moller Foundation for the Advancement of Medical Science; Captain Axel Viggo Morch and his Wife's Trust; Danish Eye Health Society; Mogens and Jenny Vissing's Trust; Bernhard and Marie Klein's Trust	The authors received no specific funding for this paper. The DCGP trial was supported by the Danish Medical Research Council, The Danish Research Foundation for General Practice, The Health Insurance Foundation, The Danish Ministry of Health, Novo Nordisk Farmaka Denmark Ltd., The Pharmacy Foundation, The Foundation for General Practice in Copenhagen, Frederiksberg, Tarnby and Dragor, The Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust, The Danish Medical Association Research Fund, The Velux Foundation, The Rockwool Foundation, Novo Nordisk Ltd., The Danish Diabetes Association, Oda and Hans Svenningsen's Fund, The A P Moller Foundation for the Advancement of Medical Science, Captain Axel Viggo Morch and his Wife's Trust, The Danish Eye Health Society, Mogens and Jenny Vissing's Trust, and Bernhard and Marie Klein's Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banack HR, 2014, PREV MED, V62, P96, DOI 10.1016/j.ypmed.2014.02.003; Bohm A, 2013, EUR J CLIN NUTR, V67, pS79, DOI 10.1038/ejcn.2012.168; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Fine Olivarius N, 2006, DIABETOLOGIA, V49, P2058, DOI 10.1007/s00125-006-0328-y; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; FRENCH SA, 1995, OBES RES, V3, P163, DOI 10.1002/j.1550-8528.1995.tb00132.x; Gregg EW, 2004, DIABETES CARE, V27, P657, DOI 10.2337/diacare.27.3.657; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Hansen LJ, 2013, DIABETOLOGIA, V56, P1243, DOI 10.1007/s00125-013-2893-1; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; LEAN MEJ, 1990, DIABETIC MED, V7, P228, DOI 10.1111/j.1464-5491.1990.tb01375.x; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maggio CA, 1997, DIABETES CARE, V20, P1744, DOI 10.2337/diacare.20.11.1744; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Olivarius ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122219; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pi-Sunyer FX, 2000, DIABETES CARE, V23, P1451, DOI 10.2337/diacare.23.10.1451; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Siebenhofer A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008274.pub2; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; Williamson DF, 1999, AM J EPIDEMIOL, V149, P491, DOI 10.1093/oxfordjournals.aje.a009843; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zethelius B, 2014, EUR J PREV CARDIOL, V21, P244, DOI 10.1177/2047487313510893	32	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146889	10.1371/journal.pone.0146889	http://dx.doi.org/10.1371/journal.pone.0146889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808532	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800037
J	Nam, W; Epureanu, BI				Nam, Woochul; Epureanu, Bogdan I.			Effects of Obstacles on the Dynamics of Kinesins, Including Velocity and Run Length, Predicted by a Model of Two Dimensional Motion	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; AXONAL-TRANSPORT; MOLECULAR MOTORS; ATP HYDROLYSIS; BINDING STATE; FORCE CLAMP; TAU; MICROTUBULES; CYCLE	Kinesins are molecular motors which walk along microtubules by moving their heads to different binding sites. The motion of kinesin is realized by a conformational change in the structure of the kinesin molecule and by a diffusion of one of its two heads. In this study, a novel model is developed to account for the 2D diffusion of kinesin heads to several neighboring binding sites (near the surface of microtubules). To determine the direction of the next step of a kinesin molecule, this model considers the extension in the neck linkers of kinesin and the dynamic behavior of the coiled-coil structure of the kinesin neck. Also, the mechanical interference between kinesins and obstacles anchored on the microtubules is characterized. The model predicts that both the kinesin velocity and run length (i.e., the walking distance before detaching from the microtubule) are reduced by static obstacles. The run length is decreased more significantly by static obstacles than the velocity. Moreover, our model is able to predict the motion of kinesin when other (several) motors also move along the same microtubule. Furthermore, it suggests that the effect of mechanical interaction/interference between motors is much weaker than the effect of static obstacles. Our newly developed model can be used to address unanswered questions regarding degraded transport caused by the presence of excessive tau proteins on microtubules.	[Nam, Woochul; Epureanu, Bogdan I.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Epureanu, BI (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	epureanu@umich.edu		Nam, Woochul/0000-0002-2747-4850	National Science Foundation [DMI-0800202]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation, DMI-0800202 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; Beeg J, 2008, BIOPHYS J, V94, P532, DOI 10.1529/biophysj.106.097881; Bier M, 2011, BIOSYSTEMS, V103, P355, DOI 10.1016/j.biosystems.2010.11.005; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; DAVIS C, 1983, J PARASITOL, V69, P1094, DOI 10.2307/3280872; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dreblow K, 2010, BIOCHEM BIOPH RES CO, V395, P490, DOI 10.1016/j.bbrc.2010.04.035; Dreblow Kerstin, 2009, Biophysical Reviews and Letters, V4, P139, DOI 10.1142/S1793048009000958; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Hendricks AG, 2008, NONLINEAR DYNAM, V53, P303, DOI 10.1007/s11071-007-9315-1; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Mandelkow E, 1998, TRENDS BIOCHEM SCI, V23, P429, DOI 10.1016/S0968-0004(98)01278-X; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Muresan V, 2009, FUTUR NEUROL, V4, P761, DOI 10.2217/FNL.09.54; MURMANIS L, 1971, NEW PHYTOL, V70, P1089, DOI 10.1111/j.1469-8137.1971.tb04591.x; Nam W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003981; Nam W, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/375103; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; SWANSON E, 1978, J CHEM PHYS, V68, P5097, DOI 10.1063/1.435628; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Trinczek B, 1999, J CELL SCI, V112, P2355; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Zhang ZC, 2012, STRUCTURE, V20, P628, DOI 10.1016/j.str.2012.02.013	55	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147676	10.1371/journal.pone.0147676	http://dx.doi.org/10.1371/journal.pone.0147676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808534	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800177
J	Santos, I; Ball, K; Crawford, D; Teixeira, PJ				Santos, Ines; Ball, Kylie; Crawford, David; Teixeira, Pedro J.			Motivation and Barriers for Leisure-Time Physical Activity in Socioeconomically Disadvantaged Women	PLOS ONE			English	Article							SINGLE-ITEM MEASURES; WEIGHT-LOSS; SELF-DETERMINATION; EXERCISE; OVERWEIGHT; DETERMINANTS; RESILIENCE; STRATEGIES; BEHAVIOR; OBESITY	Introduction The aim of this study was to examine cross-sectional and longitudinal associations between motivation and barriers for physical activity, and physical activity behavior in women living in socioeconomic disadvantage. This study also examined whether weight control intentions moderate those associations. Methods Data from 1664 women aged 18-46 years was collected at baseline and three-year follow-up as part of the Resilience for Eating and Activity Despite Inequality study. In mail-based surveys, women reported sociodemographic and neighborhood environmental characteristics, intrinsic motivation, goals and perceived family barriers to be active, weight control intentions and leisure-time physical activity (assessed through the IPAQ-L). Linear regression models assessed the association of intrinsic motivation, goals and barriers with physical activity at baseline and follow-up, adjusting for environmental characteristics and also physical activity at baseline (for longitudinal analyses), and the moderating effects of weight control intentions were examined. Results Intrinsic motivation and, to a lesser extent, appearance and relaxation goals for being physically active were consistently associated with leisure-time physical activity at baseline and follow-up. Perceived family barriers, health, fitness, weight and stress relief goals were associated with leisure-time physical activity only at baseline. Moderated regression analyses revealed that weight control intentions significantly moderated the association between weight goals and leisure-time physical activity at baseline (beta = 0.538, 99% CI = 0.057, 0.990) and between intrinsic motivation and leisure-time physical activity at follow-up (beta = 0.666, 99% CI = 0.188, 1.145). For women actively trying to control their weight, intrinsic motivation was significantly associated with leisure-time physical activity at follow-up (beta = 0.184, 99% CI = 0.097, 0.313). Conclusions Results suggest that, especially in women trying to control their weight, intrinsic motivation plays an important role in sustaining physical activity participation over time. Also, weight goals for being physically active seem to play a role regarding short-term physical activity participation in this particular population. Addressing these motivational features may be important when promoting physical activity participation in women living in socioeconomically disadvantaged neighborhoods.	[Santos, Ines; Teixeira, Pedro J.] Univ Lisbon, Interdisciplinary Ctr Study Human Performance, Fac Human Kinet, Lisbon, Portugal; [Ball, Kylie; Crawford, David] Deakin Univ, Ctr Phys Activ & Nutr Res, Fac Hlth, Melbourne, Vic, Australia	Universidade de Lisboa; Deakin University	Teixeira, PJ (corresponding author), Univ Lisbon, Interdisciplinary Ctr Study Human Performance, Fac Human Kinet, Lisbon, Portugal.	pteixeira@fmh.ulisboa.pt	Teixeira, Pedro/C-9817-2010; Teixeira, Pedro J./AAA-9438-2021; Ball, Kylie/B-5866-2015; Crawford, David A/K-6301-2015; Santos, Inês/N-1856-2016	Teixeira, Pedro/0000-0001-7202-0527; Teixeira, Pedro J./0000-0001-7202-0527; Ball, Kylie/0000-0003-2893-8415; Crawford, David A/0000-0002-2467-7556; Santos, Inês/0000-0002-1638-8551	Portuguese Science and Technology Foundation [SFRH/BD/80739/2011]; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]; Australian National Health & Medical Research Council Strategic Award [374241]	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Marie Curie Actions(European Commission); Australian National Health & Medical Research Council Strategic Award	This study was funded by the Portuguese Science and Technology Foundation (grant number SFRH/BD/80739/2011 attributed to Ines Santos). Analyses for the current paper were part of the MeMo International Exchange programme funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). The READI study was funded by an Australian National Health & Medical Research Council Strategic Award [Grant number 374241].	Andreyeva T, 2010, J AM DIET ASSOC, V110, P535, DOI 10.1016/j.jada.2009.12.029; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2013, INT J EPIDEMIOL, V42, P1629, DOI 10.1093/ije/dys165; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Bergkvist L, 2009, INT J ADVERT, V28, P607, DOI 10.2501/S0265048709200783; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duncan Mitch J, 2005, Int J Behav Nutr Phys Act, V2, P11, DOI 10.1186/1479-5868-2-11; El Ansari W, 2009, INT J ENV RES PUB HE, V6, P1443, DOI 10.3390/ijerph6041443; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Jackson SE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003693; Jeffery RW, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-52; Korkeila M, 1999, AM J CLIN NUTR, V70, P965; Linde JA, 2006, HEALTH PSYCHOL, V25, P282, DOI 10.1037/0278-6133.25.3.282; Markland D., 2007, INTRINSIC MOTIVATION, P23, DOI DOI 10.5040/9781718206632.CH-001; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Ryan RM., 1996, P7; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2000, PREV MED, V30, P191, DOI 10.1006/pmed.1999.0619; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Santos I, 2015, OBESITY, V23, P957, DOI 10.1002/oby.21082; Sebire SJ, 2009, J SPORT EXERCISE PSY, V31, P189, DOI 10.1123/jsep.31.2.189; Segar M, 2006, SEX ROLES, V54, P175, DOI 10.1007/s11199-006-9336-5; Silva M., 2012, ENCY EXERCISE MED HL, P727; Silva MN, 2011, MED SCI SPORT EXER, V43, P728, DOI 10.1249/MSS.0b013e3181f3818f; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Vansteenkiste M, 2004, J SPORT EXERCISE PSY, V26, P232, DOI 10.1123/jsep.26.2.232; VERHOEF MJ, 1992, WOMEN HEALTH, V19, P15, DOI 10.1300/J013v19n04_02; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229	38	14	15	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147735	10.1371/journal.pone.0147735	http://dx.doi.org/10.1371/journal.pone.0147735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808440	Green Published, gold			2022-12-27	WOS:000369527800202
J	Silva, PAGC; Guerreiro, A; Santos, JM; Braks, JAM; Janse, CJ; Mair, GR				Silva, Patricia A. G. C.; Guerreiro, Ana; Santos, Jorge M.; Braks, Joanna A. M.; Janse, Chris J.; Mair, Gunnar R.			Translational Control of UIS4 Protein of the Host-Parasite Interface Is Mediated by the RNA Binding Protein Puf2 in Plasmodium berghei Sporozoites	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFECTION; HUNCHBACK MESSENGER-RNA; MALARIA PARASITES; MEMBRANE-PROTEINS; CELL INTERFACE; PUMILIO; NANOS; IDENTIFICATION; INFECTIVITY; EXPRESSION	UIS4 is a key protein component of the host-parasite interface in the liver stage of the rodent malaria parasite Plasmodium berghei and required for parasite survival after invasion. In the infectious sporozoite, UIS4 protein has variably been shown to be translated but also been reported to be translationally repressed. Here we show that uis4 mRNA translation is regulated by the P. berghei RNA binding protein Pumilio-2 (PbPuf2 or Puf2 from here on forward) in infectious salivary gland sporozoites in the mosquito vector. Using RNA immunoprecipitation we show that uis4 mRNA is bound by Puf2 in salivary gland sporozoites. In the absence of Puf2, uis4 mRNA translation is de-regulated and UIS4 protein expression upregulated in salivary gland sporozoites. Here, using RNA immunoprecipitation, we reveal the first Puf2-regulated mRNA in this parasite.	[Silva, Patricia A. G. C.; Guerreiro, Ana; Santos, Jorge M.; Mair, Gunnar R.] Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal; [Braks, Joanna A. M.; Janse, Chris J.] Dept Parasitol, Leiden, Netherlands; [Mair, Gunnar R.] Heidelberg Univ, Sch Med, Dept Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Ruprecht Karls University Heidelberg	Mair, GR (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal.; Mair, GR (corresponding author), Heidelberg Univ, Sch Med, Dept Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	gunnarmair@yahoo.com	Santos, Jorge M./AAE-1904-2021	Santos, Jorge M./0000-0002-4940-5207; Janse, Chris J/0000-0002-6410-6205; Mair, Gunnar/0000-0002-5187-3691; Guerreiro, Ana/0000-0002-2173-6514	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MIC/122082/2010, PTDC/BIA-BCM/105610/2008, SFRH/BPD/72619/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grants PTDC/SAU-MIC/122082/2010 and PTDC/BIA-BCM/105610/2008 to GRM, and SFRH/BPD/72619/2010 to PAGCS.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Aly ASI, 2011, MOL MICROBIOL, V79, P929, DOI 10.1111/j.1365-2958.2010.07497.x; Andreadaki M, 2014, CELL MICROBIOL, V16, P751, DOI 10.1111/cmi.12274; Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Douglas RG, 2015, TRENDS PARASITOL, V31, P357, DOI 10.1016/j.pt.2015.04.010; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Ginter-Matuszewska B, 2011, HISTOCHEM CELL BIOL, V136, P279, DOI 10.1007/s00418-011-0842-y; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gomes-Santos CSS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002046; Guerreiro A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0493-0; Hanson KK, 2013, P NATL ACAD SCI USA, V110, pE2838, DOI 10.1073/pnas.1306097110; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lindner SE, 2013, CELL MICROBIOL, V15, P1266, DOI 10.1111/cmi.12116; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Luitjens C, 2000, GENE DEV, V14, P2596, DOI 10.1101/gad.831700; MacKellar DC, 2010, EUKARYOT CELL, V9, P784, DOI 10.1128/EC.00336-09; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Miao J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003268; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Muller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019860; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Santos JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16034; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Silvie O, 2014, MOL MICROBIOL, V91, P1200, DOI 10.1111/mmi.12528; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; van Schaijk BCL, 2014, ELIFE, V3, DOI 10.7554/eLife.03582; Vera IM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002197; Wharton Robin P, 2006, Sci STKE, V2006, ppe37, DOI 10.1126/stke.3542006pe37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	46	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147940	10.1371/journal.pone.0147940	http://dx.doi.org/10.1371/journal.pone.0147940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808677	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800248
J	Slivicki, RA; Ali, YO; Lu, HC; Hohmann, AG				Slivicki, Richard A.; Ali, Yousuf O.; Lu, Hui-Chen; Hohmann, Andrea G.			Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo	PLOS ONE			English	Article							AXONAL DEGENERATION; VINCRISTINE; EXPRESSION; CAPSAICIN; MODEL; PAIN; RAT; MAINTENANCE; ACTIVATION; NEURONS	Nicotinamide mononucleotide adenylyl transferases (NMNATs) are essential neuronal maintenance factors postulated to preserve neuronal function and protect against axonal degeneration in various neurodegenerative disease states. We used in vitro and in vivo approaches to assess the impact of NMNAT2 reduction on cellular and physiological functions induced by treatment with a vinca alkaloid (vincristine) and a taxane-based (paclitaxel) chemotherapeutic agent. NMNAT2 null (NMNAT2-/-) mutant mice die at birth and cannot be used to probe functions of NMNAT2 in adult animals. Nonetheless, primary cortical cultures derived from NMNAT2-/- embryos showed reduced cell viability in response to either vincristine or paclitaxel treatment whereas those derived from NMNAT2 heterozygous (NMNAT2+/-) mice were preferentially sensitive to vincristine-induced degeneration. Adult NMNAT2+/- mice, which survive to adulthood, exhibited a 50% reduction of NMNAT2 protein levels in dorsal root ganglia relative to wildtype (WT) mice with no change in levels of other NMNAT isoforms (NMNAT1 or NMNAT3), NMNAT enzyme activity (i.e. NAD/NADH levels) or microtubule associated protein-2 (MAP2) or neurofilament protein levels. We therefore compared the impact of NMNAT2 knockdown on the development and maintenance of chemotherapy-induced peripheral neuropathy induced by vincristine and paclitaxel treatment using NMNAT2+/- and WT mice. NMNAT2+/- did not differ from WT mice in either the development or maintenance of either mechanical or cold allodynia induced by either vincristine or paclitaxel treatment. Intradermal injection of capsaicin, the pungent ingredient in hot chili peppers, produced equivalent hypersensitivity in NMNAT2+/- and WT mice receiving vehicle in lieu of paclitaxel. Capsaicin-evoked hypersensitivity was enhanced by prior paclitaxel treatment but did not differ in either NMNAT2+/- or WT mice. Thus, capsaicin failed to unmask differences in nociceptive behaviors in either paclitaxel-treated or paclitaxel-untreated NMNAT2+/- and WT mice. Moreover, no differences in motor behavior were detected between genotypes in the rotarod test. Our studies do not preclude the possibility that complete knockout of NMNAT2 in a conditional knockout animal could unmask a role for NMNAT2 in protection against detrimental effects of chemotherapeutic treatment.	[Slivicki, Richard A.; Lu, Hui-Chen; Hohmann, Andrea G.] Indiana Univ, Program Neurosci, Bloomington, IN USA; [Slivicki, Richard A.; Ali, Yousuf O.; Lu, Hui-Chen; Hohmann, Andrea G.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Ali, Yousuf O.; Lu, Hui-Chen] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA; [Ali, Yousuf O.; Lu, Hui-Chen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; Baylor College of Medicine	Lu, HC; Hohmann, AG (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN USA.; Lu, HC; Hohmann, AG (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.; Lu, HC (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA.; Lu, HC (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	hclu@indiana.edu; hohmanna@indiana.edu			integrative predoctoral training in drug abuse research at Indiana University [T32DA024628]; Belfer Neurodegeneration Consortium; Lilly Presidential Life Science Professorship;  [DA037673]; NATIONAL CANCER INSTITUTE [R01CA200417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA037673, T32DA024628] Funding Source: NIH RePORTER	integrative predoctoral training in drug abuse research at Indiana University; Belfer Neurodegeneration Consortium; Lilly Presidential Life Science Professorship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RAS is a Harlan Research Scholar and is supported by T32DA024628 integrative predoctoral training in drug abuse research at Indiana University. HCL and YOA were supported by the Belfer Neurodegeneration Consortium created by the Robert A. and Renee E. Belfer Family Foundation. AGH is supported by a Lilly Presidential Life Science Professorship and DA037673. The authors also want to thank Dr. Paul Overbeek for providing NMNAT2-Blad mice.; RAS is a Harlan Research Scholar and is supported by T32DA024628 integrative predoctoral training in drug abuse research at Indiana University. HCL and YOA were supported by the Belfer Neurodegeneration Consortium created by the Robert A. and Renee E. Belfer Family Foundation. AGH is supported by a Lilly Presidential Life Science Professorship and DA037673. We also want to thank Dr. Paul Overbeek for providing NMNAT2-Blad mice.	Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; BELLAMY WT, 1992, DRUGS, V44, P690, DOI 10.2165/00003495-199244050-00002; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bourke JL, 2014, TISSUE ENG PT A, V20, P1089, DOI [10.1089/ten.tea.2013.0295, 10.1089/ten.TEA.2013.0295]; Brunden KR, 2014, BIOORGAN MED CHEM, V22, P5040, DOI 10.1016/j.bmc.2013.12.046; CAROZZI VA, 2014, NEUROSCI LETT; Cashman C. R., 2015, NEUROSCI LETT; Chiang H, 2015, ACTA NEUROPATHOL, V129, P81, DOI 10.1007/s00401-014-1354-3; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Crowe MS Leishman E Banks ML Gujjar R Mahadevan A, 2014, BR J PHARM; Deng LT, 2015, BIOL PSYCHIAT, V77, P475, DOI 10.1016/j.biopsych.2014.04.009; Deng LT, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-71; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Gilchrist HD, 1996, PAIN, V67, P179, DOI 10.1016/0304-3959(96)03104-1; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Horste GMZ, 2011, NEUROBIOL DIS, V42, P1, DOI 10.1016/j.nbd.2010.12.006; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; Milde Stefan, 2013, Bioarchitecture, V3, P133, DOI 10.4161/bioa.27049; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Rahn EJ, 2007, BRIT J PHARMACOL, V152, P765, DOI 10.1038/sj.bjp.0707333; Rahn EJ, 2011, PHARMACOL BIOCHEM BE, V98, P493, DOI 10.1016/j.pbb.2011.02.024; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Scuteri A, 2006, ANTICANCER RES, V26, P1065; Spradley JM, 2010, PHARMACOL RES, V62, P249, DOI 10.1016/j.phrs.2010.03.007; Tanner KD, 1998, J COMP NEUROL, V395, P481; Topp KS, 2000, J COMP NEUROL, V424, P563; Watanabe M, 2007, NEUROSCI LETT, V411, P228, DOI 10.1016/j.neulet.2006.09.068; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147620	10.1371/journal.pone.0147620	http://dx.doi.org/10.1371/journal.pone.0147620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808812	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800151
J	Woo, HW; Choi, BY; Kim, MK				Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung			Cross-Sectional and Longitudinal Associations between Egg Consumption and Metabolic Syndrome in Adults >= 40 Years Old: The Yangpyeong Cohort of the Korean Genome and Epidemiology Study (KoGES_Yangpyeong)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA HDL CHOLESTEROL; DIETARY-CHOLESTEROL; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; WHOLE-EGG; RISK; MORTALITY; MEN; LIPOPROTEINS	Since the 1970s, the public has been advised to limit egg consumption even though there is little evidence of any harmful effect of eggs on blood cholesterol. The purpose of this cross-sectional and prospective study was to evaluate the potential association between egg consumption and metabolic syndrome (MetS) and MetS components in adults >= 40 years in KoGES_Yangpyeong. Yangpyeong is a rural area in South Korea. A total of 2,887 subjects (men 1,115, women 1,772) were recruited from 2005 to 2009, based on a physical examination and questionnaires administered using standardized protocol. After excluding subjects who had MetS at baseline, 1,663 subjects (675 men, 958 women) were followed for 3.20 years (range: 0.34-8.70). During the follow-up period, MetS occurred in 289 subjects. More than 3 eggs per week was significantly associated with decreased risk of MetS in both men (RR = 0.46, 95% CI, 0.26-0.82, P for trend = 0.1093) and women (RR = 0.54, 95% CI, 0.31-0.93, P for trend 0.0325) compared to non-users. There was a cross-sectional inverse relationship between egg consumption and abdominal obesity in men and women. Also, prospectively, higher egg consumption in men was associated with a decreased risk of high fasting blood glucose (RR = 0.39, 95% CI, 0.22-0.67, P for trend = 0.0042) and high triglycerides (RR = 0.42, 95% CI, 0.22-0.80, P for trend = 0.1080). In conclusion, our findings suggest that higher egg consumption may reduce the risk of MetS both in men and women, and the risk of high fasting blood glucose and high triglycerides in men. Current guidelines regarding egg consumption may need to be re-visited for healthy middle-aged and elderly people.	[Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Woo, Hye Won; Choi, Bo Youl; Kim, Mi Kyung] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Woo, Hye Won/0000-0001-6072-6119	Research Program - Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00]	Research Program - Korea Centers for Disease Control and Prevention	This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Barbosa-Leiker C, 2011, ANN EPIDEMIOL, V21, P111, DOI 10.1016/j.annepidem.2010.10.001; Blesso CN, 2013, J CLIN LIPIDOL, V7, P463, DOI 10.1016/j.jacl.2013.03.008; Blesso CN, 2013, METABOLISM, V62, P400, DOI 10.1016/j.metabol.2012.08.014; Blesso CN, 2013, FOOD FUNCT, V4, P213, DOI 10.1039/c2fo30154g; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; British Heart Foundation, 2007, PREV HEART DIS CHOL; Callas PW, 1998, AM J IND MED, V33, P33; Chung HY, 2004, J NUTR, V134, P1887, DOI 10.1093/jn/134.8.1887; Djousse L, 2009, DIABETES CARE, V32, P295, DOI 10.2337/dc08-1271; Djousse L, 2008, AM J CLIN NUTR, V87, P964, DOI 10.1093/ajcn/87.4.964; Djousse L, 2010, AM J CLIN NUTR, V92, P422, DOI 10.3945/ajcn.2010.29406; Food and Agriculture Organization of the United Nations, 2009, STAT FOOD AGR; GUTHRIE HA, 1981, J AM DIET ASSOC, V78, P240; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kathiresan S, 2006, CIRCULATION, V113, P20, DOI 10.1161/CIRCULATIONAHA.105.567107; Korea Centers for Disease Control and Prevention & Korea Health Industry Development Institute, 2007, IN DEPTH AN 3 KOR HL; Krauss RM, 2000, CIRCULATION, V102, P2284; Kurotani K, 2014, BRIT J NUTR, V112, P1636, DOI 10.1017/S000711451400258X; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; MacMahon B, 1970, EPIDEMIOLOGY PRINCIP; McNamara DJ, 2000, J AM COLL NUTR, V19, p540S, DOI 10.1080/07315724.2000.10718978; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mutungi G, 2008, J NUTR, V138, P272, DOI 10.1093/jn/138.2.272; Nakamura Y, 2006, BRIT J NUTR, V96, P921, DOI 10.1017/BJN20061937; National Rural Living Science Institute, 2006, 7 REV FOOD COMP TABL; OH SY, 1991, AM J CLIN NUTR, V54, P689, DOI 10.1093/ajcn/54.4.689; Pearce KL, 2011, BRIT J NUTR, V105, P584, DOI 10.1017/S0007114510003983; Pelletier X, 1996, ANN NUTR METAB, V40, P109, DOI 10.1159/000177903; Rong Y, 2013, BMJ-BRIT MED J, P346; Scrafford CG, 2011, PUBLIC HEALTH NUTR, V14, P261, DOI 10.1017/S1368980010001874; Song WO, 2000, J AM COLL NUTR, V19, p556S, DOI 10.1080/07315724.2000.10718980; STAMLER J, 1988, ARCH PATHOL LAB MED, V112, P1032; The Korean Nutrition Society, 2009, FOOD VAL; Virtanen JK, 2015, AM J CLIN NUTR, V101, P1088, DOI 10.3945/ajcn.114.104109; WHO J Consultation FE, 2003, WHO TECH REP SER, P916; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147729	10.1371/journal.pone.0147729	http://dx.doi.org/10.1371/journal.pone.0147729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808174	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800200
J	Zhang, XR; Dong, JN; Liu, HL; Wang, J; Qi, YX; Liang, ZS				Zhang, Xiaoru; Dong, Juane; Liu, Hailong; Wang, Jiao; Qi, Yuexin; Liang, Zongsuo			Transcriptome Sequencing in Response to Salicylic Acid in Salvia miltiorrhiza	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PLANT DEFENSE RESPONSE; GOSSYPIUM-HIRSUTUM L.; RNA-SEQ DATA; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; OXIDATIVE STRESS; FUNCTIONAL-ANALYSIS; NEGATIVE REGULATION; SIGNALING PATHWAYS	Salvia miltiorrhiza is a traditional Chinese herbal medicine, whose quality and yield are often affected by diseases and environmental stresses during its growing season. Salicylic acid (SA) plays a significant role in plants responding to biotic and abiotic stresses, but the involved regulatory factors and their signaling mechanisms are largely unknown. In order to identify the genes involved in SA signaling, the RNA sequencing (RNA-seq) strategy was employed to evaluate the transcriptional profiles in S. miltiorrhiza cell cultures. A total of 50,778 unigenes were assembled, in which 5,316 unigenes were differentially expressed among 0-, 2-, and 8-h SA induction. The up-regulated genes were mainly involved in stimulus response and multi-organism process. A core set of candidate novel genes coding SA signaling component proteins was identified. Many transcription factors (e.g., WRKY, bHLH and GRAS) and genes involved in hormone signal transduction were differentially expressed in response to SA induction. Detailed analysis revealed that genes associated with defense signaling, such as antioxidant system genes, cytochrome P450s and ATP-binding cassette transporters, were significantly overexpressed, which can be used as genetic tools to investigate disease resistance. Our transcriptome analysis will help understand SA signaling and its mechanism of defense systems in S. miltiorrhiza.	[Zhang, Xiaoru; Dong, Juane; Liu, Hailong; Wang, Jiao; Qi, Yuexin] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Dong, JN (corresponding author), Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	dzsys@nwsuaf.edu.cn; liangzs@iswc.ms.ac.cn			National Natural Science Foundation of China [31170274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant No. 31170274, URL.www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, FEBS LETT, V579, P2307, DOI 10.1016/j.febslet.2005.03.025; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2012, NEURAL METABOLISM IN; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bolwell GP, 1999, FREE RADICAL RES, V31, pS137; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Chen CH, 2002, PLANT PHYSIOL, V129, P706, DOI 10.1104/pp.001057; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong CJ, 2014, PLANTA, V240, P687, DOI 10.1007/s00425-014-2115-1; Dong JA, 2010, J BIOTECHNOL, V148, P99, DOI 10.1016/j.jbiotec.2010.05.009; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Dubreuil-Maurizi C, 2011, PLANT PHYSIOL, V157, P2000, DOI 10.1104/pp.111.182667; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gao CY, 2015, INT J MOL SCI, V16, P2052, DOI 10.3390/ijms16012052; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gleason JE, 2014, J BIOL INORG CHEM, V19, P595, DOI 10.1007/s00775-013-1045-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Hayat S, 2014, Z NATURFORSCH C, V69, P452, DOI [10.5560/znc.2014-0036, 10.5560/ZNC.2014-0036]; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Irmisch S, 2014, PLANT J, V80, P1095, DOI 10.1111/tpj.12711; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kang DG, 2003, PHYTOTHER RES, V17, P917, DOI 10.1002/ptr.1250; KATAGIRI F, 1989, NATURE, V340, P727, DOI 10.1038/340727a0; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li JZ, 2015, J EXP BOT, V66, P2723, DOI 10.1093/jxb/erv076; Li TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109492; Li XM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1046; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu GS, 2005, PLANT J, V41, P304, DOI 10.1111/j.1365-313X.2004.02296.x; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorca CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00169; Luo HM, 2014, PHYSIOL PLANTARUM, V152, P241, DOI 10.1111/ppl.12193; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Manosalva PM, 2010, MOL PLANT MICROBE IN, V23, P1151, DOI 10.1094/MPMI-23-9-1151; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Melvin P, 2015, PLANT MOL BIOL, V87, P287, DOI 10.1007/s11103-014-0276-8; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Mutlu S, 2009, BIOL PLANTARUM, V53, P334, DOI 10.1007/s10535-009-0061-8; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nazar R, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1003751; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rao MV, 1997, PLANT PHYSIOL, V115, P137, DOI 10.1104/pp.115.1.137; RASKIN I, 1992, PLANT PHYSIOL, V99, P799, DOI 10.1104/pp.99.3.799; Remy E, 2013, PLANT CELL, V25, P901, DOI 10.1105/tpc.113.110353; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Shah J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00030; Shi GY, 2015, PLANT CELL REP, V34, P1005, DOI 10.1007/s00299-015-1761-5; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Sun LJ, 2015, INT J MOL SCI, V16, P4306, DOI 10.3390/ijms16024306; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Huylenbroeck JM, 2000, PLANT SCI, V155, P59, DOI 10.1016/S0168-9452(00)00201-6; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang MM, 2007, J BIOCHEM MOL BIOL, V40, P325; Wang XD, 2013, FUNCT INTEGR GENOMIC, V13, P155, DOI 10.1007/s10142-013-0309-4; Wong CE, 2002, MOL PLANT MICROBE IN, V15, P75, DOI 10.1094/MPMI.2002.15.1.75; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xing Y, 2015, J EXP BOT; Yang Huimin, 2006, J Tradit Chin Med, V26, P120; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang YX, 2015, CURR PROTEIN PEPT SC, V16, P450, DOI 10.2174/1389203716666150330141638; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhu SY, 2014, GENE, V552, P67, DOI 10.1016/j.gene.2014.09.014; Zwicker S, 2007, MOL PLANT PATHOL, V8, P385, DOI [10.1111/j.1364-3703.2007.00399.x, 10.1111/J.1364-3703.2007.00399.X]	114	28	29	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147849	10.1371/journal.pone.0147849	http://dx.doi.org/10.1371/journal.pone.0147849			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808150	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800229
J	Jiang, L; Wu, XH; He, F; Liu, Y; Hu, XQ; Takeda, S; Qing, Y				Jiang, Lei; Wu, Xiaohua; He, Fang; Liu, Ying; Hu, Xiaoqing; Takeda, Shunichi; Qing, Yong			Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog	PLOS ONE			English	Article							STRAND BREAK REPAIR; INDUCED DNA-DAMAGE; POSTREPLICATION REPAIR; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS; DT40 CELLS; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL BREAKS; RAD51 PARALOGS; POLYMERASE	Nucleoside analogues (NAs) have been the most frequently used treatment option for chronic hepatitis B patients. However, they may have genotoxic potentials due to their interference with nucleic acid metabolism. Entecavir, a deoxyguanosine analog, is one of the most widely used oral antiviral NAs against hepatitis B virus. It has reported that entecavir gave positive responses in both genotoxicity and carcinogenicity assays. However the genotoxic mechanism of entecavir remains elusive. To evaluate the genotoxic mechanisms, we analyzed the effect of entecavir on a panel of chicken DT40 B -lymphocyte isogenic mutant cell line deficient in DNA repair and damage tolerance pathways. Our results showed that Parp1(-/-) mutant cells defective in single -strand break (SSB) repair were the most sensitive to entecavir. Ubc13(-/-) and translesion-DNA-synthesis deficient cells including Radl 8(-/-) and Rev3(-/-) were hypersensitive to entecavir. XPA(-/-) mutant deficient in nucleotide excision repair was also slightly sensitive to entecavir. y-H2AX foci forming assay confirmed the existence of DNA damage by entecavir in Parpr'-, Radl 8(-/-) and Brcal(-/-) mutants. Karyotype assay further showed entecavir-induced chromosomal aberrations, especially the chromosome gaps in Parp1(-/-), Brcar'-, Radl 8(-/-) and Rev3(-/-) cells when compared with wild -type cells. These genetic comprehensive studies clearly identified the genotoxic potentials of entecavir and suggested that SSB and postreplication repair pathways may suppress entecavir-induced genotoxicity.	[Jiang, Lei; Liu, Ying; Hu, Xiaoqing; Qing, Yong] Sichuan Univ, West China Sch Pharm, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Wu, Xiaohua] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China; [He, Fang] Sichuan Univ, West China Hosp, Ctr Infect Dis, Div Mol Biol Infect Dis,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Takeda, Shunichi] Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Kyoto 6068501, Japan	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Kyoto University	Qing, Y (corresponding author), Sichuan Univ, West China Sch Pharm, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China.	qingyongxy@yahoo.co.jp		Takeda, Shunichi/0000-0002-7924-7991	Science and Technology Support Program of Sichuan Province, China [2012SZ0147]; Administration of Traditional Chinese Medicine of Sichuan Province, China [12-3-340]	Science and Technology Support Program of Sichuan Province, China; Administration of Traditional Chinese Medicine of Sichuan Province, China	This work was supported by Science and Technology Support Program of Sichuan Province, China (No.2012SZ0147) and the Administration of Traditional Chinese Medicine of Sichuan Province, China (No.12-3-340). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; [Anonymous], 1985, INT SYSTEM HUMAN CYT; Asaad AM, 2015, BRAZ J INFECT DIS, V19, P525, DOI 10.1016/j.bjid.2015.03.007; Brambilla G, 2012, MUTAGENESIS, V27, P387, DOI 10.1093/mutage/ger094; Bristol-Myers Squibb, BAR ENT US PRESCR IN; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Brown JA, 2012, CHEM RES TOXICOL, V25, P225, DOI 10.1021/tx200458s; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldecott KW, 2014, EXP CELL RES, V329, P2, DOI 10.1016/j.yexcr.2014.08.027; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Danoy P, 2007, BIOCHEM BIOPH RES CO, V352, P763, DOI 10.1016/j.bbrc.2006.11.083; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Fung J, 2014, J GASTROEN HEPATOL, V29, P428, DOI 10.1111/jgh.12499; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Hochegger H, 2004, BIOESSAYS, V26, P151, DOI 10.1002/bies.10403; Hsiang YH, 1985, J BIOL CHEM, V260, P8; Hu J, 2012, ENVIRON SCI TECHNOL, V46, P4607, DOI 10.1021/es300020e; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Martin P, 2015, CLIN GASTROENTEROL H, V13, P2071, DOI 10.1016/j.cgh.2015.07.007; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Mizutani A, 2004, CANCER RES, V64, P3144, DOI 10.1158/0008-5472.CAN-03-3489; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000828; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Santantonio TA, 2014, WORLD J HEPATOL, V6, P284, DOI 10.4254/wjh.v6.i5.284; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Talorete TPN, 2006, CYTOTECHNOLOGY, V52, P189, DOI 10.1007/s10616-007-9057-4; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tian F, 2013, P NATL ACAD SCI USA, V110, P13558, DOI 10.1073/pnas.1306534110; Wu XH, 2006, CANCER RES, V66, P748, DOI 10.1158/0008-5472.CAN-05-2884; Yamamoto KN, 2011, ENVIRON MOL MUTAGEN, V52, P547, DOI 10.1002/em.20656; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yang SW, 2015, J GASTROEN HEPATOL, V30, P1175, DOI 10.1111/jgh.12921; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	52	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147440	10.1371/journal.pone.0147440	http://dx.doi.org/10.1371/journal.pone.0147440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800464	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300109
J	Kinoshita, A; Locher, L; Tienken, R; Meyer, U; Danicke, S; Rehage, J; Huber, K				Kinoshita, Asako; Locher, Lena; Tienken, Reka; Meyer, Ulrich; Daenicke, Sven; Rehage, Juergen; Huber, Korinna			Associations between Forkhead Box O1 (FoxO1) Expression and Indicators of Hepatic Glucose Production in Transition Dairy Cows Supplemented with Dietary Nicotinic Acid	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ENERGY-DENSE DIET; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NIACIN SUPPLEMENTATION; INSULIN-RESISTANCE; SOMATOTROPIC AXIS; METABOLISM; LACTATION; NUTRIENT	Forkhead box protein O1 (FoxO1) is a transcription factor which promotes hepatic glucose production (HGP) by up-regulating the transcription of gluconeogenic enzymes in monogastric species. The activity of FoxO1 is inhibited by insulin-induced phosphorylation. The aims of the present study were to find associations between FoxO1 expression and variables associated with HGP as affected by feeding regimen in dairy cows during the transition period. Twenty one healthy German Holstein cows were allocated to four groups (LC-CON, HC-CON, LC-NA with 5 cows/group and HC-NA with 6 cows/group, respectively). Cows received 0 (LC-CON and HC-CON) or 24 (LC-NA and HC-NA) g/d nicotinic acid with high (HC) or low (LC) concentrate proportion from -42 days (-41.8 + 4.8; mean + standard deviation) relative to expected calving date (d-42) to d24. Liver biopsy was taken at d-42, 1, 21, and 100. The total protein expression of FoxO1 (tFoxO1) and the extent of phosphorylation of FoxO1 at serine 256 (pFoxO1) were analysed semiquantitatively by Western Blotting. The expression of hepatic mRNA of FoxO1 and seven genes associated with HGP was measured by real-time RT-PCR. Mixed model and Pearson's correlation were used for statistical evaluation with the level of significance at P<0.05. No dietary effect was observed either on feed intake, energy balance, or on the concentration of blood metabolites. Neither time nor diet affected the expression of FoxO1 total protein and mRNA. A NA x concentrate interaction was found in pFoxO1. However, no corresponding dietary effect was found in the mRNA expression of investigated genes. Different patterns of correlations between FoxO1-related variables and investigated indicators for HGP were found at d21 and 100. The results indicated that the regulation of HGP did not take place on the levels of mRNA and protein expression and the phosphorylation of FoxO1 in dairy cows in early lactation.	[Kinoshita, Asako; Huber, Korinna] Univ Vet Med Hannover, Dept Physiol, Hannover, Lower Saxony, Germany; [Locher, Lena] Univ Munich, Ctr Vet Clin Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Munich, Bavaria, Germany; [Tienken, Reka; Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Lower Saxony, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Munich; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Huber, K (corresponding author), Univ Vet Med Hannover, Dept Physiol, Hannover, Lower Saxony, Germany.	korinna.huber@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [DA 558/6-1, HU 838/12-1, RE 819/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) with grant numbers DA 558/6-1, HU 838/12-1, and RE 819/7-1. SD, KH, and JR received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation for this work.	Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Aschemann M, 2012, ARCH ANIM NUTR, V66, P303, DOI 10.1080/1745039X.2012.697353; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi S, 2011, METABOLISM, V60, P134, DOI 10.1016/j.metabol.2010.02.013; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Grala TM, 2013, PHYSIOL GENOMICS, V45, P1157, DOI 10.1152/physiolgenomics.00134.2013; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Gross J, 2011, J DAIRY SCI, V94, P3484, DOI 10.3168/jds.2011-4251; Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27; Hayirli A, 2006, VET RES COMMUN, V30, P749, DOI 10.1007/s11259-006-3320-6; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kang I, 2011, J CLIN ENDOCR METAB, V96, P3048, DOI 10.1210/jc.2011-1104; Kenez A, 2015, J ANIM SCI, V93, P4012, DOI 10.2527/jas.2014-8833; Kenez A, 2014, J DAIRY SCI, V97, P3626, DOI 10.3168/jds.2013-7662; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Littell RC, 1998, J ANIM SCI, V76, P1216; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mendonca LGD, 2013, J DAIRY SCI, V96, P3588, DOI 10.3168/jds.2012-5804; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Neuvians TP, 2003, ENDOCRINE, V22, P93, DOI 10.1385/ENDO:22:2:93; Niehoff ID, 2009, BRIT J NUTR, V101, P5, DOI 10.1017/S0007114508043377; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Pires JAA, 2007, J DAIRY SCI, V90, P4635, DOI 10.3168/jds.2007-0146; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Rozen S, 2000, Methods Mol Biol, V132, P365; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schulz K, 2014, J DAIRY RES, V81, P257, DOI 10.1017/S0022029914000107; Tienken R, 2015, ARCH ANIM NUTR, V69, P319, DOI 10.1080/1745039X.2015.1073002; Titgemeyer E. C., 2011, International Journal of Dairy Science, V6, P134, DOI 10.3923/ijds.2011.134.141; Titgemeyer EC, 2011, J DAIRY SCI, V94, P4962, DOI 10.3168/jds.2011-4193; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146670	10.1371/journal.pone.0146670	http://dx.doi.org/10.1371/journal.pone.0146670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800252	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300027
J	Li, RL; Chai, MW; Qiu, GY				Li, Ruili; Chai, Minwei; Qiu, Guo Yu			Distribution, Fraction, and Ecological Assessment of Heavy Metals in Sediment Plant System in Mangrove Forest, South China Sea	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; ACID-VOLATILE SULFIDE; SURFACE SEDIMENTS; RISK-ASSESSMENT; QUALITY GUIDELINES; COMPREHENSIVE ASSESSMENT; SPATIAL VARIATION; MARINE-SEDIMENTS; MIYUN RESERVOIR; SEWAGE-SLUDGE	Overlying water, sediment, rhizosphere sediment and mangrove seedlings in the Futian mangrove forest were analyzed for heavy metals. The results showed that mangrove plant acidified sediment and increased organic matter contents. Except for chromium (Cr), nickel (Ni) and copper (Cu) in Aegiceras corniculatum sediment, heavy metals in all sediments were higher than in overlying water, rhizosphere sediment and mangrove root. Heavy metals in Avicennia marina sediments were higher than other sediments. The lower heavy metal biological concentration factors (BCFs) and translocation factors (TFs) indicated that mangrove plant adopted exclusion strategy. The geo-accumulation index, potential ecological risk index and risk assessment code (RAC) demonstrated that heavy metals have posed a considerable ecological risk, especially for cadmium (Cd). Heavy metals (Cr, Ni, Cu and Cd) mainly existed in the reducible fractions. These findings provide actual heavy metal accumulations in sediment -plant ecosystems in mangrove forest, being important in designing the long-term management and conservation policies for managers of mangrove forest.	[Li, Ruili] Peking Univ, Sch Environm & Energy, Shenzhen Key Lab Heavy Met Pollut Control & Reuti, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China; [Chai, Minwei] PKU HKUST Shenzhen HongKong Inst, Shenzhen Key Lab Environm Simulat & Pollut Contro, Shenzhen 518057, Peoples R China; [Qiu, Guo Yu] Peking Univ, Shenzhen Grad Sch, Sch Environm & Energy, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen; Hong Kong University of Science & Technology; Peking University; Peking University; University Town of Shenzhen	Chai, MW (corresponding author), PKU HKUST Shenzhen HongKong Inst, Shenzhen Key Lab Environm Simulat & Pollut Contro, Shenzhen 518057, Peoples R China.; Qiu, GY (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Environm & Energy, Shenzhen 518055, Peoples R China.	chaimw@pkusz.edu.cn; qiugy@pkusz.edu.cn			Program of Science and Technology of Shenzhen [JCYJ20120829170028566, JCYJ20140903101847739, JCYJ20130402164725017]; National Natural Science Foundation of China [31400446]; Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay	Program of Science and Technology of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay	Funding provided by Program of Science and Technology of Shenzhen JCYJ20120829170028566, Ruili Li; Program of Science and Technology of ShenzhenJCYJ20140903101847739, Ruili Li; Program of Science and Technology of Shenzhen JCYJ20130402164725017, Ruili Li; and Program of National Natural Science Foundation of China (31400446), Ruili Li.; This work was financially supported by the Program of Science and Technology of Shenzhen (JCYJ20120829170028566, JCYJ20130402164725017, JCYJ20140903101847739), and the Program of National Natural Science Foundation of China (31400446), and the Program of Assessment and Restoration of Mangrove Geiwei of Shenzhen Bay. We thank Dr. Hualin Xu from the Neilingding-Futian National Nature Reserve of Guangdong, Futian National Nature Reserve for critically reading and revising the manuscript.	Abdel-Satar AM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4592-5; Chai MW, 2014, MAR POLLUT BULL, V84, P115, DOI 10.1016/j.marpolbul.2014.05.028; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Cui S, 2007, ENVIRON GEOL, V51, P1043, DOI 10.1007/s00254-006-0373-3; Cuong DT, 2006, APPL GEOCHEM, V21, P1335, DOI 10.1016/j.apgeochem.2006.05.001; Dahmani-Muller H, 2000, ENVIRON POLLUT, V109, P231, DOI 10.1016/S0269-7491(99)00262-6; De Jonge M, 2012, WATER RES, V46, P2205, DOI 10.1016/j.watres.2012.01.052; Fernandes LL, 2012, CHEM ECOL, V28, P435, DOI 10.1080/02757540.2012.666527; Fitz WJ, 2002, J BIOTECHNOL, V99, P259, DOI 10.1016/S0168-1656(02)00218-3; Gao XL, 2012, MAR POLLUT BULL, V64, P1529, DOI 10.1016/j.marpolbul.2012.04.026; Greger M, 2008, PLANT SOIL, V312, P195, DOI 10.1007/s11104-008-9725-y; Guo TZ, 1997, ENVIRON INT, V23, P305; Gupta S, 2008, ENVIRON GEOL, V55, P731, DOI 10.1007/s00254-007-1025-y; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; He B, 2014, ENVIRON GEOCHEM HLTH, V36, P467, DOI 10.1007/s10653-013-9574-3; Huang HJ, 2011, BIORESOURCE TECHNOL, V102, P10346, DOI 10.1016/j.biortech.2011.08.117; Huang XX, 2013, ENVIRON MONIT ASSESS, V185, P8525, DOI 10.1007/s10661-013-3193-4; Kumar A, 2012, ENVIRON MONIT ASSESS, V184, P3027, DOI 10.1007/s10661-011-2168-6; [李崇 Li Chong], 2008, [生态环境, Ecology and Environment], V17, P560; [李存焕 Li Cunhuan], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P53; Li GG, 2013, MAR POLLUT BULL, V76, P420, DOI 10.1016/j.marpolbul.2013.08.032; Li J, 1988, ENV BACKGROUND VALUE; Li LZ, 2014, ENVIRON POLLUT, V188, P144, DOI 10.1016/j.envpol.2014.02.003; Lian YW, 1999, J WOOD SCI, V45, P343, DOI 10.1007/BF00833501; Liu JC, 2010, MAR POLLUT BULL, V60, P1209, DOI 10.1016/j.marpolbul.2010.03.029; Long ER, 1998, ENVIRON TOXICOL CHEM, V17, P714, DOI 10.1002/etc.5620170428; Lu HL, 2007, ENVIRON EXP BOT, V61, P159, DOI 10.1016/j.envexpbot.2007.05.007; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; Man YB, 2010, ENVIRON INT, V36, P570, DOI 10.1016/j.envint.2010.04.014; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Mei XQ, 2014, WATER RES, V50, P147, DOI 10.1016/j.watres.2013.12.004; Morgan B, 2012, SCI TOTAL ENVIRON, V438, P463, DOI 10.1016/j.scitotenv.2012.08.088; MULLER G, 1981, CHEM ZTG, V105, P157; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Na GS, 2013, MAR POLLUT BULL, V69, P233, DOI 10.1016/j.marpolbul.2012.12.028; Nath B, 2013, SCI TOTAL ENVIRON, V463, P667, DOI 10.1016/j.scitotenv.2013.06.024; Panda UC, 2010, J COASTAL RES, V26, P860, DOI 10.2112/08-1077.1; Perin G, 1985, P INT C HEAV MET ENV, P454; Perry CT, 2009, ESTUAR COAST SHELF S, V81, P225, DOI 10.1016/j.ecss.2008.10.019; Poynton CY, 2004, PLANTA, V219, P1080, DOI 10.1007/s00425-004-1304-8; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Rathinasabapathi B, 2006, CAN J MICROBIOL, V52, P695, DOI 10.1139/W06-017; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Ribeiro AP, 2013, MAR POLLUT BULL, V68, P55, DOI 10.1016/j.marpolbul.2012.12.023; Sakan S, 2015, ENVIRON EARTH SCI, V73, P6625, DOI 10.1007/s12665-014-3886-1; Sekomo CB, 2011, WATER AIR SOIL POLL, V214, P321, DOI 10.1007/s11270-010-0426-9; SEPA (State Environmental Protection Administration of China), 2002, MAR SED QUAL 18668 2; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; TAM NFY, 1995, HYDROBIOLOGIA, V295, P149, DOI 10.1007/BF00029122; Tam NFY, 2000, ENVIRON POLLUT, V110, P195, DOI 10.1016/S0269-7491(99)00310-3; Taylor S.R., 1985, CONTINENTAL CRUST IT; THOMAS RP, 1994, ANAL CHIM ACTA, V286, P423, DOI 10.1016/0003-2670(94)85088-7; US-EPA, 1996, SW 846 TEST METHOD 3; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wu QH, 2014, ECOTOX ENVIRON SAFE, V104, P143, DOI 10.1016/j.ecoenv.2014.02.017; Xie HaiWei, 2010, Guangxi Zhiwu / Guihaia, V30, P64; Yang YQ, 2012, MAR POLLUT BULL, V64, P1947, DOI 10.1016/j.marpolbul.2012.04.024; Yohannes YB, 2013, ENVIRON SCI POLLUT R, V20, P8663, DOI 10.1007/s11356-013-1821-8; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Younis AM, 2014, ENVIRON MONIT ASSESS, V186, P3567, DOI 10.1007/s10661-014-3639-3; Yu RL, 2010, ENVIRON MONIT ASSESS, V163, P241, DOI 10.1007/s10661-009-0830-z; Yuan HZ, 2011, ENVIRON GEOCHEM HLTH, V33, P67, DOI 10.1007/s10653-010-9323-9; Zhai YB, 2014, BIORESOURCE TECHNOL, V159, P72, DOI 10.1016/j.biortech.2014.02.049; Zhang J, 2001, GUANGZHOU ENV SCI, V16, P36; Zhang RF, 2013, J COASTAL RES, V29, P1341, DOI 10.2112/JCOASTRES-D-11-00215.1; Zhou HX, 2008, PEDOSPHERE, V18, P77, DOI 10.1016/S1002-0160(07)60105-2; Zhou YW, 2010, MAR POLLUT BULL, V60, P1319, DOI 10.1016/j.marpolbul.2010.03.010; Zhu XF, 2013, ENVIRON MONIT ASSESS, V185, P6049, DOI 10.1007/s10661-012-3005-2; Zhuang W, 2014, MAR POLLUT BULL, V83, P352, DOI 10.1016/j.marpolbul.2014.03.039	72	82	84	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147308	10.1371/journal.pone.0147308	http://dx.doi.org/10.1371/journal.pone.0147308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800267	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300091
J	Wei, YC; Liu, QH; Dong, HY; Zhou, ZC; Hao, YP; Chen, XL; Xu, LY				Wei, Yongcheng; Liu, Qinghua; Dong, Hongyu; Zhou, Zhichun; Hao, Yanping; Chen, Xuelian; Xu, Liuyi			Selection of Reference Genes for Real-Time Quantitative PCR in Pinus massoniana Post Nematode Inoculation	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; HOUSEKEEPING GENES; RT-PCR; EXPRESSION; QUANTIFICATION; IDENTIFICATION; NORMALIZATION; VALIDATION; MODEL; WILT	Pinus massoniaia Lamb has gained more and more attention as the most important tree species for timber and forestation in South China. Gene expression studies are of great importance to identify new and elite cultivars. Real-time quantitative PCR, a highly sensitive and specific method, is commonly used in the analysis of gene expression. The appropriate reference genes must be employed to normalize the calculation program for ascertaining repeatable and significant results. Herein, eleven housekeeping genes were evaluated during different stages of P. massoniana post nematode inoculation in this study. Three statistical approaches such as geNorm, NormFinder and BestKeeper were selected to analyze the stability of candidate genes. The results indicated that U2af and beta-TUB were the most stable reference genes. These two genes could be used for the normalization in most of the experiments of P. massoniana, while Histone and AK were the least stable ones. In addition, EF expressed at the lowest average Ct value was the most abundant candidate gene. As an important gene associated with defense mechanisms, ABC transporter was analyzed by qRT-PCR, and the results were used to confirm the reliability of two genes. The selected reference genes in the present study will be conducive to future gene expression normalized by qRT-PCR in P. massoniana.	[Wei, Yongcheng; Liu, Qinghua; Dong, Hongyu; Zhou, Zhichun] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China; [Wei, Yongcheng] Zhejiang Prov Key Lab Tree Breeding, Fuyang 311400, Zhejiang, Peoples R China; [Liu, Qinghua] State Forestry Adm Engn Res Ctr Masson Pine, Fuyang 311400, Zhejiang, Peoples R China; [Hao, Yanping; Chen, Xuelian; Xu, Liuyi] Anhui Acad Forestry, Hefei 230000, Anhui, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Liu, QH (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang 311400, Zhejiang, Peoples R China.; Liu, QH (corresponding author), State Forestry Adm Engn Res Ctr Masson Pine, Fuyang 311400, Zhejiang, Peoples R China.	liuqinghua642@163.com	hao, yan/HGB-0465-2022		National Science & Technology Pillar Program of China [2012BAD01B02]; National Natural Science Foundation of China [31470670]; National High-tech R&D Program of China (863 Program) [2011AA10020302]	National Science & Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China)	The work was supported by the following: 1. National Science & Technology Pillar Program of China (No. 2012BAD01B02, http://kjzc.jhgl.org/), Principal Investigator: Zhichun Zhou; 2. National Natural Science Foundation of China (No. 31470670), Principal Investigator: Qinghua Liu; and 3. National High-tech R&D Program of China (863 Program) (No. 2011AA10020302), Principal Investigator: Yi Zhang.	Alonso P, 2007, TREE PHYSIOL, V27, P1721, DOI 10.1093/treephys/27.12.1721; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Dong LM, 2011, MOL BIOL REP, V38, P5017, DOI 10.1007/s11033-010-0648-3; DROPKIN VH, 1981, PLANT DIS, V65, P1022, DOI 10.1094/PD-65-1022; Forestry Agency Ministry of Agriculture Forestry and Fisheries of Japan, 2010, ANN REP TRENDS FOR F; Fukuda, 1997, J FORESTRY RES, V2, P171; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goncalves S, 2005, PLANTA, V222, P556, DOI 10.1007/s00425-005-1562-0; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; KURODA K, 1991, EUR J FOREST PATHOL, V21, P430; Kuroda K., 1992, Journal of the Japanese Forestry Society, V74, P383; Kusumoto D, 2014, J FOREST RES-JPN, V19, P285, DOI 10.1007/s10310-013-0417-y; KUSUNOKI M, 1987, Annals of the Phytopathological Society of Japan, V53, P622, DOI 10.3186/jjphytopath.53.622; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ODANI K, 1985, Journal of the Japanese Forestry Society, V67, P366; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnaparkhe SM, 2009, PLANTA, V230, P339, DOI 10.1007/s00425-009-0949-8; Sang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082927; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Tamura H., 1984, Journal of the Japanese Forestry Society, V66, P306; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Tokushige Y., 1969, Journal of the Japanese Forestry Society, V51, P193; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vasquez-Robinet C, 2010, PLANT PHYSIOL BIOCH, V48, P256, DOI 10.1016/j.plaphy.2009.12.005; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; [王晓锋 Wang Xiaofeng], 2013, [分子植物育种, Molecular Plant Breeding], V11, P385; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Xu L.-Y., 2012, CHINA SCI TECHNOL, V26, P27, DOI DOI 10.3969/J.ISSN.1000-8101.2012.04.007; Yamada Toshihiro, 1993, Annals of the Phytopathological Society of Japan, V59, P659, DOI 10.3186/jjphytopath.59.659; Yang B. J., 2003, PINE WOOD NEMATODE D, P6	47	14	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147224	10.1371/journal.pone.0147224	http://dx.doi.org/10.1371/journal.pone.0147224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800152	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300074
J	Gubrij, IB; Pangle, AK; Pang, L; Johnson, LG				Gubrij, Igor B.; Pangle, Amanda K.; Pang, Li; Johnson, Larry G.			Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; MOLECULAR PATHOGENESIS; CHRONIC HYPOXIA; DISEASE; PROLIFERATION; MONOCROTALINE; GENE; SURVIVAL; INHIBITION	Background Animals models have played an important role in enhancing our understanding of the pathogenesis of pulmonary arterial hypertension (PAH). Dysregulation of the profile of microRNAs (miRNAs) has been demonstrated in human tissues from PAH patients and in animal models. In this study, we measured miRNA levels in the monocrotaline (MCT) rat model of PAH and examined whether blocking a specific dysregulated miRNA not previously reported in this model, attenuated PAH. We also evaluated changes in miRNA expression in lung specimens from MCT PAH rats overexpressing human prostacyclin synthase, which has been shown to attenuate MCT PAH. Methods Expression levels of a panel of miRNAs were measured in MCT-PAH rats as compared to naive (saline) control rats. Subsequently, MCT PAH rats were injected with a specific inhibitor (antagomiR) for miR-223 (A223) or a nonspecific control oligonucleotide (A-control) 4 days after MCT administration, then weekly. Three weeks later, RV systolic pressure and RV mass were measured. Total RNA, isolated from the lungs, microdissected pulmonary arteries, and right ventricle, was reverse transcribed and real-time quantitative PCR was performed. MiRNA levels were also measured in RNA isolated from paraffin sections of MCT-PAH rats overexpressing prostacyclin synthase. Results MiRs 17, 21, and 223 were consistently upregulated, whereas miRs 126, 145, 150, 204, 424, and 503 were downregulated in MCT PAH as compared to vehicle control. A223 significantly reduced levels of miR-223 in PA and lungs of MCT PAH rats as compared to levels measured in A-control or control MCT PAH rats, but A223 did not attenuate MCT PAH. Right ventricular mass and right ventricular systolic pressure in rats treated with A223 were not different from values in A-control or MCT PAH rats. In contrast, analysis of total RNA from lung specimens of MCT PAH rats overexpressing human prostacyclin synthase (hPGIS) demonstrated reversal of MCT-induced upregulation of miRs 17, 21, and 223 and an increase in levels of miR-424 and miR-503. Reduction in bone morphogenetic receptor 2 (BMPR2) messenger (m) RNA expression was not altered by A223, whereas human prostacyclin synthase overexpression restored BMPR2 mRNA to levels in MCT PAH to levels measured in naive controls. Conclusions Inhibition of miR-223 did not attenuate MCT PAH, whereas human prostacyclin synthase overexpression restored miRNA levels in MCT PAH to levels detected in naive rats. These data may establish a paradigm linking attenuation of PAH to restoration of BMPR2 signaling.	[Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Gubrij, Igor B.; Pangle, Amanda K.; Johnson, Larry G.] Univ Arkansas Med Sci, Dept Internal Med, Div Pulm & Crit Med, Little Rock, AR 72205 USA; [Pang, Li] Univ Arkansas Med Sci, Dept Pharmacol, Little Rock, AR 72205 USA; [Pang, Li] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA)	Johnson, LG (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.; Johnson, LG (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Pulm & Crit Med, Little Rock, AR 72205 USA.	lgjohnson@uams.edu		Pang, Li/0000-0002-0212-2090	U.S. Dept. of Veterans Affairs; Arkansas Biosciences Institute; Canadian Heart Centre and Actelion Pharmaceuticals	U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); Arkansas Biosciences Institute; Canadian Heart Centre and Actelion Pharmaceuticals	This manuscript was supported by a VA Merit Grant (LGJ) from the U.S. Dept. of Veterans Affairs and a grant from the Arkansas Biosciences Institute (LGJ). LGJ is an investigator on the PAHQueri trial sponsored by the Canadian Heart Centre and Actelion Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chavali S, 2013, RNA, V19, P1552, DOI 10.1261/rna.038414.113; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Gubrij IB, 2014, HUM GENE THER, V25, P498, DOI 10.1089/hum.2013.187; Guo L, 2012, HYPERTENSION, V59, P1006, DOI 10.1161/HYPERTENSIONAHA.111.185413; Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585; Huang JB, 2013, LUNG, V191, P601, DOI 10.1007/s00408-013-9505-1; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287; Kim J, 2014, MOL CELLS, V37, P196, DOI 10.14348/molcells.2014.2308; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Kim JD, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.45; Kim S, 2014, J CELL BIOCHEM, V115, P889, DOI 10.1002/jcb.24730; Li SS, 2013, BIOCHEM J, V452, P281, DOI 10.1042/BJ20120680; Liu D, 2013, CURR HYPERTENS REP, V15, P632, DOI 10.1007/s11906-013-0393-9; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; McLaughlin VV, 2010, CIRCULATION, V122, P106, DOI 10.1161/CIRCULATIONAHA.110.963983; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Meloche J, 2013, CURRENT VASCULAR PHA; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; PAN LC, 1993, TOXICOLOGY, V79, P21, DOI 10.1016/0300-483X(93)90203-5; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Yang J, 2013, ARTERIOSCL THROM VAS, V33, P34, DOI 10.1161/ATVBAHA.112.300121; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Yu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078769; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	49	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147827	10.1371/journal.pone.0147827	http://dx.doi.org/10.1371/journal.pone.0147827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815432	Green Published, gold			2022-12-27	WOS:000369528200057
J	Liu, B; Gao, FQ; Guo, J; Wu, D; Hao, B; Li, YR; Zhao, CF				Liu, Bin; Gao, Fengqin; Guo, Jun; Wu, Dubala; Hao, Bayasihuliang; Li, Yurong; Zhao, Cunfa			A Microarray-Based Analysis Reveals that a Short Photoperiod Promotes Hair Growth in the Arbas Cashmere Goat	PLOS ONE			English	Article							COMPREHENSIVE GUIDE; FOLLICLE; EXPRESSION; SKIN; MELATONIN; ANAGEN; CLASSIFICATION; LOCALIZATION; CYTOSKELETON; RECEPTORS	Many animals exhibit different behaviors in different seasons. The photoperiod can have effects on migration, breeding, fur growth, and other processes. The cyclic growth of the fur and feathers of some species of mammals and birds, respectively, is stimulated by the photoperiod as a result of hormone-dependent regulation of the nervous system. To further examine this phenomenon, we evaluated the Arbas Cashmere goat (Capra hircus), a species that is often used in this type of research. The goats were exposed to an experimentally controlled short photoperiod to study the regulation of cyclic cashmere growth. Exposure to a short photoperiod extended the anagen phase of the Cashmere goat hair follicle to increase cashmere production. Assessments of tissue sections indicated that the short photoperiod significantly induced cashmere growth. This conclusion was supported by a comparison of the differences in gene expression between the short photoperiod and natural conditions using gene chip technology. Using the gene chip data, we identified genes that showed altered expression under the short photoperiod compared to natural conditions, and these genes were found to be involved in the biological processes of hair follicle growth, structural composition of the hair follicle, and the morphogenesis of the surrounding skin appendages. Knowledge about differences in the expression of these genes as well as their functions and periodic regulation patterns increases our understanding of Cashmere goat hair follicle growth. This study also provides preliminary data that may be useful for the development of an artificial method to improve cashmere production by controlling the light cycle, which has practical significance for livestock breeding.	[Liu, Bin; Wu, Dubala; Li, Yurong; Zhao, Cunfa] Acad Agr & Stockbreeding Sci, Inst Anim Husb, Hohhot, Inner Mongolia, Peoples R China; [Liu, Bin] Chinese Acad Sci, Kunming Inst Anim Sci, Yunna, Inner Mongolia, Peoples R China; [Gao, Fengqin] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Guo, Jun] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Inner Mongolia, Peoples R China; [Hao, Bayasihuliang] Etuokeqianqi Arctic God Res Inst Cashmere & Lives, Erdos, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia Agricultural University	Li, YR; Zhao, CF (corresponding author), Acad Agr & Stockbreeding Sci, Inst Anim Husb, Hohhot, Inner Mongolia, Peoples R China.	yurong622003@126.com; zhaocunfa@163.com			National Natural Science Foundation of China [31260545]; Special Fund for Agro-scientific Research in the Public Interest [201303059]; Natural Science Foundation Project of Inner Mongolia Autonomous Region [2014BS0333]; Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region [2013QNJJM05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation Project of Inner Mongolia Autonomous Region; Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region	This work was supported by the National Natural Science Foundation of China (31260545); Special Fund for Agro-scientific Research in the Public Interest (201303059); Natural Science Foundation Project of Inner Mongolia Autonomous Region (2014BS0333); and Young Scholars Innovative Foundation for Academy of Agriculture and Stockbreeding Sciences of Inner Mongolia Autonomous Region (2013QNJJM05).	Aoki N, 1997, J BIOL CHEM, V272, P30512, DOI 10.1074/jbc.272.48.30512; Bawden CS, 2001, J INVEST DERMATOL, V116, P157, DOI 10.1046/j.1523-1747.2001.00215.x; Breitkopf T, 2013, J INVEST DERMATOL, V133, P1722, DOI 10.1038/jid.2013.53; BURNS R. H., 1962, Journal of the Textile Institute, V53, pT45; Chang TH, 2014, BIOMATERIALS, V35, P3934, DOI 10.1016/j.biomaterials.2014.01.028; [崔志峰 CUI Zhifeng], 2008, [山东大学学报. 理学版, Journal of Shangdong University], V43, P1; Dicks P, 1996, J ENDOCRINOL, V151, P55, DOI 10.1677/joe.0.1510055; Dicks P, 1994, EUROPEAN FINE FIBRE, V2, P109; Ebling F, 1991, BIOCH PHYSL SKIN, V1, P522; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Hardman JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121878; IBRAHEEM M, 1994, J ANAT, V185, P135; Jin M, 2011, MOL BIOL REP, V38, P3023, DOI 10.1007/s11033-010-9968-6; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; [李长青 Li Changqing], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P674; Li SW, 2009, EXP DERMATOL, V18, P134, DOI 10.1111/j.1600-0625.2008.00774.x; Man XY, 2009, CLIN EXP DERMATOL, V34, P396, DOI 10.1111/j.1365-2230.2008.03104.x; McGregor BA, 1998, SMALL RUMINANT RES, V28, P199, DOI 10.1016/S0921-4488(97)00100-4; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nixon AJ, 2002, J ENDOCRINOL, V172, P605, DOI 10.1677/joe.0.1720605; Ozeki M, 2003, BIOMATERIALS, V24, P2387, DOI 10.1016/S0142-9612(03)00045-0; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Paus R, 2003, J INVEST DERM SYMP P, V8, P188, DOI 10.1046/j.1087-0024.2003.00807.x; Pearson AJ, 1996, J ENDOCRINOL, V148, P157, DOI 10.1677/joe.0.1480157; Plonka PM, 2008, J DERMATOL SCI, V49, P227, DOI 10.1016/j.jdermsci.2007.09.010; Rebora A, 2004, ARCH DERMATOL, V140, P619, DOI 10.1001/archderm.140.5.619; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Simonetti O, 2004, BRIT J DERMATOL, V150, P940, DOI 10.1111/j.1365-2133.2004.05881.x; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Stenn K, 2005, J AM ACAD DERMATOL, V52, P374, DOI 10.1016/j.jaad.2004.07.040; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Storbeck KH, 2009, MOL CELL ENDOCRINOL, V300, P121, DOI 10.1016/j.mce.2008.09.009; Todini L, 2005, ATTI SOC ITALIANA SC, V59, P39; Wang YL, 1991, CURR OPIN CELL BIOL, V3, P27, DOI 10.1016/0955-0674(91)90162-R; Wu JH, 2012, J INTEGR AGR, V11, P1159, DOI 10.1016/S2095-3119(12)60110-5; Wu XJ, 2014, J DERMATOL SCI, V73, P152, DOI 10.1016/j.jdermsci.2013.10.002; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zhang W, 2011, J INNER MONGOLIA AGR, V32, P199; Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282	52	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147124	10.1371/journal.pone.0147124	http://dx.doi.org/10.1371/journal.pone.0147124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814503	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200025
J	Agomo, CO; Oyibo, WA; Sutherland, C; Hallet, R; Oguike, M				Agomo, Chimere Obiora; Oyibo, Wellington Aghoghovwia; Sutherland, Colin; Hallet, Rachael; Oguike, Mary			Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE; CHLOROQUINE RESISTANCE; IN-VIVO; SULFADOXINE-PYRIMETHAMINE; DIHYDROPTEROATE SYNTHASE; TYROSINE-86 ALLELE; MALARIA; MUTATIONS; AMODIAQUINE; PREVALENCE	Background The use of antimalarial drugs for prevention and treatment is a major strategy in the prevention of malaria in pregnancy. Although sulphadoxine-pyrimethamine (SP) is currently recommended for intermittent preventive treatment of malaria during pregnancy in Nigeria, previously used drugs for prophylaxis such as chloroquine (CQ) and pyrimethamine are accessible as they are purchased over the counter. This study describes the markers of absence or presence of resistance to quinoline (Pfcrt and Pfmdr 1) and type 1 antifolate antimalarial medicines (Pfdhfr). Methods Plasmodium falciparum-positive dried blood spots from pregnant women attending antenatal clinics for the first time during current pregnancy were investigated for the presence of mutations at codons 72-76 of Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene by real time polymerase chain reaction (PCR) using haplotype-specific probes. PCR followed by sequence analysis was used to identify mutations at codons 86, 184, 1034, 1042 and 1246 of P. falciparum multi-drug resistance-1 (Pfmdr1) gene; and codons 16, 50, 51, 59, 108, 140 and 164 of Pfdhfr gene. Results Two haplotypes of Pfcrt (n = 54) were observed: CVMNK 13(24.2%) and CVIET 41 (75.9%) of the samples. The SVMNT haplotype was absent in this population. The Pfmdr1 (n = 28) haplotypes were NYSND 15(53.6%), YYSND 5(17.9%), NFSND 6(21.4%) and YFSND 2 (7.1%). The Pfdhfr (n = 15) were ACNCSVI 4(26.7%), and ACICNSVI 1(6.7%) and ACIRNVI 10 (66.7%). The rate of occurrence of Pfcrt 76T, Pfdhfr108N, Pfmdr186Yand184F were 75.9%, 73.3%, 25% and 28.1% respectively. The Pfmdr1 86Y was associated with low parasitaemia (median = 71 parasites/mu l, P = 0.024) while Pfcrt 76T was associated with young maternal age (mean 24.1 +/- 4.5 years; P = 0.006). The median parasitaemia were similar (P>0.05) in wild and mutant strains of Pfcrt 76, Pfmdr1 184 and Pfdhfr 108. There was no association between gravidity or gestational age of the women and presence of mutations in the Pfcrt, Pfmdr1 or Pfdhfr genes (P> 0.05). Conclusion Markers of resistance to chloroquine and pyrimethamine were high, whereas cycloguanil-resistance marker was not present in the studied population. The low level of mutations in the Pfmdr1gene indicates likely efficacy of amodiaquine against malaria in pregnancy.	[Agomo, Chimere Obiora] Nigerian Inst Med Res, Malaria Res Lab, Lagos, Nigeria; [Oyibo, Wellington Aghoghovwia] Univ Lagos, Coll Med, ANDI Ctr Excellence Malaria Diag, WHO,TDR,FIND Malaria Specimen Bank Site, Lagos, Nigeria; [Sutherland, Colin; Hallet, Rachael; Oguike, Mary] Univ London London Sch Hyg & Trop Med, Dept Immunol, Keppel St, London WC1E 7HT, England	University of Lagos; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Oyibo, WA (corresponding author), Univ Lagos, Coll Med, ANDI Ctr Excellence Malaria Diag, WHO,TDR,FIND Malaria Specimen Bank Site, Lagos, Nigeria.	wellao@yahoo.com	Agomo, Chimere/CAF-0649-2022; Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407; Agomo, Chimere/0000-0002-6248-2725; Oyibo, Wellington/0000-0002-5730-5396	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Agomo CO, 2009, KOREAN J PARASITOL, V47, P179, DOI 10.3347/kjp.2009.47.2.179; Agomo CO, 2011, MALAR RES TREAT, V2011, P6, DOI 10.4061/2011/932895; Aina Oluwagbemiga O, 2013, Malar Res Treat, V2013, P487250, DOI 10.1155/2013/487250; Bertin G, 2005, J ANTIMICROB CHEMOTH, V55, P788, DOI 10.1093/jac/dki097; Bloland PB., 2001, DRUG RESISTANCE MALA; Dlamini SV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-68; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Federal Ministry of Health, 2005, NAT GUID STRAT MAL P, P50; Gama BE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-156; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; HYDE JE, 1990, PHARMACOL THERAPEUT, V48, P45, DOI 10.1016/0163-7258(90)90017-V; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Lekana-Douki JB, 2011, INFECT GENET EVOL, V11, P512, DOI 10.1016/j.meegid.2011.01.003; Menegon M, 2009, TROP MED INT HEALTH, V14, P1251, DOI 10.1111/j.1365-3156.2009.02369.x; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mkulama MAP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-87; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Ojurongbe O, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-41; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Schwenke A, 2001, WIEN KLIN WOCHENSCHR, V113, P63; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; Sutherland CJ, 2009, ANTIMICROB AGENTS CH, V53, P3405, DOI 10.1128/AAC.00024-09; Tukwasibwe S, 2014, J INFECT DIS, V210, P154, DOI 10.1093/infdis/jiu044; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2003, MALARIA	35	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146908	10.1371/journal.pone.0146908	http://dx.doi.org/10.1371/journal.pone.0146908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808627	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800038
J	Hodac, L; Ulum, FB; Opfermann, N; Breidenbach, N; Hojsgaard, D; Tjitrosoedirdjo, SS; Vornam, B; Finkeldey, R; Horand, E				Hodac, Ladislav; Ulum, Fuad Bahrul; Opfermann, Nicole; Breidenbach, Natalie; Hojsgaard, Diego; Tjitrosoedirdjo, Sri Sudarmiyati; Vornam, Barbara; Finkeldey, Reiner; Hoerand, Elvira			Population Genetic Structure and Reproductive Strategy of the Introduced Grass Centotheca lappacea in Tropical Land-Use Systems in Sumatra	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; BREEDING SYSTEMS; ALIEN PLANTS; DIVERSITY; ASTERACEAE; PATTERNS; DOMINANT; APOMIXIS; LOCI; AFLP	Intensive transformation of lowland rainforest into oil palm and rubber monocultures is the most common land-use practice in Sumatra (Indonesia), accompanied by invasion of weeds. In the Jambi province, Centotheca lappacea is one of the most abundant alien grass species in plantations and in jungle rubber (an extensively used agroforest), but largely missing in natural rainforests. Here, we investigated putative genetic differentiation and signatures for adaptation in the introduced area. We studied reproductive mode and ploidy level as putative factors for invasiveness of the species. We sampled 19 populations in oil palm and rubber monocultures and in jungle rubber in two regions (Bukit Duabelas and Harapan). Amplified fragment length polymorphisms (AFLP) revealed a high diversity of individual genotypes and only a weak differentiation among populations (F-ST = 0.173) and between the two regions (F-ST = 0.065). There was no significant genetic differentiation between the three land-use systems. The metapopulation of C. lappacea consists of five genetic partitions with high levels of admixture; all partitions appeared in both regions, but with different proportions. Within the Bukit Duabelas region we observed significant isolation-by-distance. Nine AFLP loci (5.3% of all loci) were under natural diversifying selection. All studied populations of C. lappacea were diploid, outcrossing and self-incompatible, without any hints of apomixis. The estimated residence time of c. 100 years coincides with the onset of rubber and oil palm planting in Sumatra. In the colonization process, the species is already in a phase of establishment, which may be enhanced by efficient selection acting on a highly diverse gene pool. In the land-use systems, seed dispersalmight be enhanced by adhesive spikelets. At present, the abundance of established populations in intensively managed land-use systems might provide opportunities for rapid dispersal of C. lappacea across rural landscapes in Sumatra, while the invasion potential in rainforest ecosystems appears to bemoderate as long as they remain undisturbed.	[Hodac, Ladislav; Ulum, Fuad Bahrul; Opfermann, Nicole; Hojsgaard, Diego; Hoerand, Elvira] Univ Gottingen, Dept Systemat Biodivers & Evolut Plants Herbarium, D-37073 Gottingen, Germany; [Tjitrosoedirdjo, Sri Sudarmiyati] Bogor Agr Univ, Fac Math & Nat Sci, IPB, Dept Biol, Bogor, Indonesia; [Breidenbach, Natalie; Vornam, Barbara; Finkeldey, Reiner] Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, D-37073 Gottingen, Germany	University of Gottingen; Bogor Agricultural University; University of Gottingen	Hodac, L (corresponding author), Univ Gottingen, Dept Systemat Biodivers & Evolut Plants Herbarium, D-37073 Gottingen, Germany.	lhodac@uni-goettingen.de	Hojsgaard, Diego H/O-5969-2017; Hodac, Ladislav/AAP-7284-2021; Finkeldey, Reiner/ABD-4392-2021	Hojsgaard, Diego H/0000-0002-8709-4091; Hodac, Ladislav/0000-0002-6885-1317; Finkeldey, Reiner/0000-0003-3500-5656; bahrul ulum, fuad/0000-0002-1969-6322	Deutsche Forschungsgemeinschaft; Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) [CRC990]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), CRC990: Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia) project B12 (EH) and project B03 (RF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abywijaya IK, 2014, THESIS BOGOR AGR U, P63; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BIOTROP, 2014, DATABASE; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Coart E, 2005, CONSERV GENET, V6, P259, DOI 10.1007/s10592-004-7833-7; Cosendai AC, 2010, ANN BOT-LONDON, V105, P457, DOI 10.1093/aob/mcp304; Dellinger AS, 2016, NEW PHYTOL, V209, P1313, DOI 10.1111/nph.13694; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 2006, ARLEQUIN INTEGRATED; Fennell M, 2014, ECOL EVOL, V4, P1648, DOI 10.1002/ece3.1043; FOC, 2006, FLORA CHINA; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foxcroft LC, 2010, BIOL INVASIONS, V12, P3913, DOI 10.1007/s10530-010-9823-7; Guillaume T, 2015, GLOBAL CHANGE BIOL, V21, P3548, DOI 10.1111/gcb.12907; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao JH, 2011, BIOL INVASIONS, V13, P571, DOI 10.1007/s10530-010-9850-4; Hardesty BD, 2012, DIVERS DISTRIB, V18, P147, DOI 10.1111/j.1472-4642.2011.00832.x; Hazalin NAMN, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-46; Hojsgaard D, 2014, CRIT REV PLANT SCI, V33, P414, DOI 10.1080/07352689.2014.898488; Hojsgaard D, 2009, GENET RESOUR CROP EV, V56, P533, DOI 10.1007/s10722-008-9384-0; Hojsgaard DH, 2013, NEW PHYTOL, V197, P336, DOI 10.1111/j.1469-8137.2012.04381.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Jiwan N, 2013, PALM OIL CONTROVERSY, P48; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Ma JW, 2011, WEED RES, V51, P363, DOI 10.1111/j.1365-3180.2011.00856.x; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Mubarok H, 2010, THESIS BOGOR AGR U, P85; Novak SJ, 2000, CAN J BOT, V78, P1469, DOI 10.1139/cjb-78-11-1469; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohwi J., 1971, TONAN AJIA KENKYU, V9, P194; OLORODE O, 1975, BRITTONIA, V27, P63, DOI 10.2307/2805647; Ortiz JPA, 2013, ANN BOT-LONDON, V112, P767, DOI 10.1093/aob/mct152; Otto F, 1990, Methods Cell Biol, V33, P105; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Ramana MV, 2014, NORD J BOT, V32, P559, DOI 10.1111/j.1756-1051.2013.00302.x; Rambuda TD, 2004, DIVERS DISTRIB, V10, P409, DOI 10.1111/j.1366-9516.2004.00100.x; Renno JF, 1995, PLANT SYST EVOL, V198, P89, DOI 10.1007/BF00985108; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Soerjani M., 1987, WEEDS RICE INDONESIA; Subrata SA, 2007, J ILMU KEHUTANAN, V1, P39; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Tjitrosoedirdjo S, 1990, WEED INFO SHEET 3; Tjitrosoedirdjo SS, 1993, WEED INFO SHEET 19; Ulum FB, 2014, THESIS GEORG AUGUST, P58; USDA, 2015, GERMPLASM RESOURCES; Uthicke S, 2005, CORAL REEFS, V24, P103, DOI 10.1007/s00338-004-0441-7; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vu LV, 2009, J ZOOL, V277, P15, DOI 10.1111/j.1469-7998.2008.00498.x; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041310; Ye shu J, 1810, FLORA CHINA, V22, p[189, 445]; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Yu XQ, 2014, BIOL INVASIONS, V16, P2351, DOI 10.1007/s10530-014-0669-2; Zhao SY, 2015, WEED RES, V55, P163, DOI 10.1111/wre.12130	73	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147633	10.1371/journal.pone.0147633	http://dx.doi.org/10.1371/journal.pone.0147633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807958	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800157
J	Kazeroonian, A; Frohlich, F; Raue, A; Theis, FJ; Hasenauer, J				Kazeroonian, Atefeh; Froehlich, Fabian; Raue, Andreas; Theis, Fabian J.; Hasenauer, Jan			CERENA: ChEmical REaction Network Analyzer-A Toolbox for the Simulation and Analysis of Stochastic Chemical Kinetics	PLOS ONE			English	Article							MASTER EQUATION; DISTRIBUTIONS; INFERENCE; SYSTEMS	Gene expression, signal transduction and many other cellular processes are subject to stochastic fluctuations. The analysis of these stochastic chemical kinetics is important for understanding cell-to-cell variability and its functional implications, but it is also challenging. A multitude of exact and approximate descriptions of stochastic chemical kinetics have been developed, however, tools to automatically generate the descriptions and compare their accuracy and computational efficiency are missing. In this manuscript we introduced CERENA, a toolbox for the analysis of stochastic chemical kinetics using Approximations of the Chemical Master Equation solution statistics. CERENA implements stochastic simulation algorithms and the finite state projection for microscopic descriptions of processes, the system size expansion and moment equations for meso-and macroscopic descriptions, as well as the novel conditional moment equations for a hybrid description. This unique collection of descriptions in a single toolbox facilitates the selection of appropriate modeling approaches. Unlike other software packages, the implementation of CERENA is completely general and allows, e.g., for time-dependent propensities and non-mass action kinetics. By providing SBML import, symbolic model generation and simulation using MEX-files, CERENA is user-friendly and computationally efficient. The availability of forward and adjoint sensitivity analyses allows for further studies such as parameter estimation and uncertainty analysis.	[Kazeroonian, Atefeh; Froehlich, Fabian; Theis, Fabian J.; Hasenauer, Jan] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Kazeroonian, Atefeh; Froehlich, Fabian; Theis, Fabian J.; Hasenauer, Jan] Tech Univ Munich, Chair Math Modeling Biol Syst, Dept Math, Garching, Germany; [Raue, Andreas] Merrimack Pharmaceut Inc, Discovery Devis, Cambridge, MA 02139 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hasenauer, J (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany.; Hasenauer, J (corresponding author), Tech Univ Munich, Chair Math Modeling Biol Syst, Dept Math, Garching, Germany.	jan.hasenauer@helmholtz-muenchen.de	Fröhlich, Fabian/AAK-8724-2021; Theis, Fabian J/ABD-5212-2021; Hasenauer, Jan/B-8853-2013	Fröhlich, Fabian/0000-0002-5360-4292; Theis, Fabian J/0000-0002-2419-1943; Hasenauer, Jan/0000-0002-4935-3312	European Union within the ERC grant "Latent Causes"; German Research Foundation (DFG) through the Graduate School of Quantitative Biosciences Munich; Merrimack Pharmaceuticals Inc.; European Union within the ERC grant 'Latent Causes'	European Union within the ERC grant "Latent Causes"; German Research Foundation (DFG) through the Graduate School of Quantitative Biosciences Munich(German Research Foundation (DFG)); Merrimack Pharmaceuticals Inc.; European Union within the ERC grant 'Latent Causes'	This work was funded by the European Union within the ERC grant "Latent Causes" (AK, FJT), and the German Research Foundation (DFG) through the Graduate School of Quantitative Biosciences Munich (FF). Merrimack Pharmaceuticals Inc. provided support in the form of salaries for AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; This work was funded by the European Union within the ERC grant 'Latent Causes' (A.K., F.J.T.), and the German Research Foundation (DFG) through the Graduate School of Quantitative Biosciences Munich (F.F.). Merrimack Pharmaceuticals Inc. provided support in the form of salaries for A.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Andreychenko A, 2015, DISTRIBUTION A UNPUB; Andreychenko A, 2015, J COUPLED SYST MULTI, V3, P156, DOI 10.1166/jcsmd.2015.1073; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Engblom S, 2006, APPL MATH COMPUT, V180, P498, DOI 10.1016/j.amc.2005.12.032; Frohlich F, 2015, INFERENCE STOC UNPUB; Gillespie CS, 2009, IET SYST BIOL, V3, P52, DOI 10.1049/iet-syb:20070031; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042124; Hasenauer J, 2014, J MATH BIOL, V69, P687, DOI 10.1007/s00285-013-0711-5; Hasenauer J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003686; Hegland M., 2010, CMEPY DOCUMENTATION; Hespanha J., 2008, P INT S COMM CONTR S, P42, DOI DOI 10.1109/ISCCSP.2008.4537208; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jahnke T, 2007, J MATH BIOL, V54, P1, DOI 10.1007/s00285-006-0034-x; Kazeev V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003359; Kazeroonian A., 2014, P 19 IFAC WORLD C CA, V47, P1729; Lapin M, 2011, HSCC 11: PROCEEDINGS OF THE 14TH INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P311; Maarleveld TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079345; Mateescu M, 2010, IET SYST BIOL, V4, P441, DOI 10.1049/iet-syb.2010.0005; Milner P, 2013, STAT COMPUT, V23, P287, DOI 10.1007/s11222-011-9310-8; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Norris J. R., 1997, MARKOV CHAINS, P60; Ramaswamy R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1775; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2015, BIOINFORMATICS; Raue A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074335; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Schnoerr D, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4934990; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Singh A, 2011, IEEE T AUTOMAT CONTR, V56, P414, DOI 10.1109/TAC.2010.2088631; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Thomas P, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012120; Thomas P, 2014, P NATL ACAD SCI USA, V111, P6994, DOI 10.1073/pnas.1400049111; Thomas P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038518; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	41	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146732	10.1371/journal.pone.0146732	http://dx.doi.org/10.1371/journal.pone.0146732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807911	Green Published, gold			2022-12-27	WOS:000369527800031
J	Kim, YH; Kim, DH; Shin, EJ; Lee, HJ; Wee, WR; Jeon, S; Kim, MK				Kim, Yun Hee; Kim, Dong Hyun; Shin, Eun Jung; Lee, Hyun Ju; Wee, Won Ryang; Jeon, Saewha; Kim, Mee Kum			Comparative Analysis of Substrate-Free Cultured Oral Mucosal Epithelial Cell Sheets from Cells of Subjects with and without Stevens-Johnson Syndrome for Use in Ocular Surface Reconstruction	PLOS ONE			English	Article							CULTIVATED CORNEAL EPITHELIUM; EPIDERMAL-GROWTH-FACTOR; REGENERATIVE MEDICINE; TRANSPLANTATION; KERATINOCYTES; DEFICIENCY; EXPRESSION; MIGRATION; COLONIES; DISEASES	Purpose To compare the regenerative potential of cultured oral mucosal epithelial cells sheets (COMECs) from Stevens-Johnson syndrome (SJS) subjects with those from non-SJS subjects. Methods Human oral mucosal epithelial cells from SJS and non-SJS subjects were cultured, and colony-forming efficiency (CFE), proliferative and migration potential, expression of cytokines/growth factors and stem cells were compared. COMECs from SJS and non-SJS subjects were transplanted into 12 limbal stem cell-deficient rabbits, and their regenerative potential was analyzed at 1 week after transplantation. Results CFE (p>0.05, student's t test), cell proliferation potential (p> 0.05, two-way ANOVA) and expression of the cytokeratins (K3, K4, K13, K19) in the oral mucosal epithelial cells from SJS subjects were similar to those of the cells from non-SJS subjects. The initial migratory potential of SJS cells was delayed compared to that of non-SJS cells (p < 0.05, RM two-way ANOVA). The SJS cells expressed lower levels of EGF and higher levels of VEGF compared to that of non-SJS cells (p<0.05, one-way ANOVA). In vivo transplanted SJS-COMECs showed similar expression of K3, K4, and K13, proliferation markers (Ki-67; p> 0.05, Mann-Whitney U test), and stem cell markers (p63; p> 0.05, Mann-Whitney U test) compared to non-SJS COMECs. The initial epithelial defects in vivo were larger in the eyes treated with SJS-COMECs on day 3 (p<0.01, RM two-way ANOVA), but no differences were observed by day 7 between SJS- and non-SJS-COMECs. Conclusions These results suggest that, aside from differences in migratory potential, oral mucosal epithelial cells from SJS and non-SJS subjects are comparable in their regeneration potential in treating limbal stem cell deficiency.	[Kim, Yun Hee; Shin, Eun Jung; Jeon, Saewha] Tego Sci Inc, Cutigen Res Inst, Seoul, South Korea; [Kim, Dong Hyun; Wee, Won Ryang; Kim, Mee Kum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Dong Hyun; Lee, Hyun Ju; Wee, Won Ryang; Kim, Mee Kum] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Corneal Regenerat Med & Ocular Immunol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jeon, S (corresponding author), Tego Sci Inc, Cutigen Res Inst, Seoul, South Korea.; Kim, MK (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Kim, MK (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Corneal Regenerat Med & Ocular Immunol, Seoul 110744, South Korea.	sjeon@tegoscience.com; kmk9@snu.ac.kr			Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI14C1573]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Project No. HI14C1573). Authors that received funding: DHK, HJL, WRW, MKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tego Science Inc. provided support in the form of salaries for authors YHK, EJS and SJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad S, 2012, STEM CELL TRANSL MED, V1, P110, DOI 10.5966/sctm.2011-0037; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; Chen HCJ, 2012, INVEST OPHTH VIS SCI, V53, P5615, DOI 10.1167/iovs.11-9293; Ezhkova E, 2010, NATURE, V466, P567, DOI 10.1038/466567a; Hirayama M, 2012, INVEST OPHTH VIS SCI, V53, P1602, DOI 10.1167/iovs.11-7847; Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003; Kaido M, 2012, AM J OPHTHALMOL, V154, P499, DOI 10.1016/j.ajo.2012.03.044; Kim DH, 2015, OPHTHALMOLOGY, V122, P254, DOI 10.1016/j.ophtha.2014.08.013; Kim MK, 2008, J KOREAN MED SCI, V23, P864, DOI 10.3346/jkms.2008.23.5.864; Krishnan S, 2010, INDIAN J MED RES, V131, P422; Ma DHK, 2009, EYE, V23, P1442, DOI 10.1038/eye.2009.60; Makela M, 1999, EXP CELL RES, V251, P67, DOI 10.1006/excr.1999.4564; Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakamura T, 2007, OPHTHALMOLOGY, V114, P1080, DOI 10.1016/j.ophtha.2006.09.034; Nakamura T, 2011, CURR OPIN OPHTHALMOL, V22, P274, DOI 10.1097/ICU.0b013e3283477d4d; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Satake Y, 2011, OPHTHALMOLOGY, V118, P1524, DOI 10.1016/j.ophtha.2011.01.039; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Sotozono C, 2013, OPHTHALMOLOGY, V120, P193, DOI 10.1016/j.ophtha.2012.07.053; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Yamada K, 2014, BRIT J OPHTHALMOL, V98, P1116, DOI 10.1136/bjophthalmol-2013-304645	30	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147548	10.1371/journal.pone.0147548	http://dx.doi.org/10.1371/journal.pone.0147548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808056	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800130
J	Marland, JRK; Smillie, KJ; Cousin, MA				Marland, Jamie R. K.; Smillie, Karen J.; Cousin, Michael A.			Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							DEPENDENT BULK ENDOCYTOSIS; LONG-TERM POTENTIATION; SYNDROME CRITICAL REGION; ALZHEIMERS-DISEASE; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSES; NERVE-TERMINALS; CALCINEURIN; PHOSPHORYLATION; DEFICITS	Down syndrome (DS) is the most common genetic cause of intellectual disability, and arises from trisomy of human chromosome 21. Accumulating evidence from studies of both DS patient tissue and mouse models has suggested that synaptic dysfunction is a key factor in the disorder. The presence of several genes within the DS trisomy that are either directly or indirectly linked to synaptic vesicle (SV) endocytosis suggested that presynaptic dysfunction could underlie some of these synaptic defects. Therefore we determined whether SV recycling was altered in neurons from the Ts65Dn mouse, the best characterised model of DS to date. We found that SV exocytosis, the size of the SV recycling pool, clathrin-mediated endocytosis, activity-dependent bulk endocytosis and SV generation from bulk endosomes were all unaffected by the presence of the Ts65Dn trisomy. These results were obtained using battery of complementary assays employing genetically-encoded fluorescent reporters of SV cargo trafficking, and fluorescent and morphological assays of fluid-phase uptake in primary neuronal culture. The absence of presynaptic dysfunction in central nerve terminals of the Ts65Dn mouse suggests that future research should focus on the established alterations in excitatory / inhibitory balance as a potential route for future pharmacotherapy.	[Marland, Jamie R. K.; Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,15 George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,15 George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470; Marland, Jamie/0000-0001-6442-082X	UK Medical Research Council [G1002117]; MRC [G1002117] Funding Source: UKRI; Medical Research Council [G1002117] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a grant from the UK Medical Research Council http://www.mrc.ac.uk/ (Grant number: G1002117).	Adayev T, 2006, BIOCHEM BIOPH RES CO, V351, P1060, DOI 10.1016/j.bbrc.2006.10.169; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5246; Cheung G, 2013, J NEUROSCI, V33, P3370, DOI 10.1523/JNEUROSCI.4697-12.2013; Cheung G, 2012, J NEUROSCI, V32, P6014, DOI 10.1523/JNEUROSCI.6305-11.2012; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Cottrell JR, 2013, J NEUROSCI, V33, P10938, DOI 10.1523/JNEUROSCI.5362-12.2013; Cousin MA, 2014, NEUROSCIENTIST; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Evergren E, 2007, J NEUROSCI, V27, P379, DOI 10.1523/JNEUROSCI.4683-06.2007; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim Y, 2010, NEUROSIGNALS, V18, P164, DOI 10.1159/000321994; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kokotos AC, 2015, TRAFFIC, V16, P229, DOI 10.1111/tra.12235; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; Murakami N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034845; Nosheny RL, 2015, NEUROBIOL DIS, V77, P173, DOI 10.1016/j.nbd.2015.02.022; Pechstein A, 2010, P NATL ACAD SCI USA, V107, P4206, DOI 10.1073/pnas.0911073107; PETIT TL, 1984, EXP NEUROL, V83, P13, DOI 10.1016/0014-4886(84)90041-4; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; REYNOLDS GP, 1988, NEUROSCI LETT, V94, P224, DOI 10.1016/0304-3940(88)90299-6; Risser D, 1997, LIFE SCI, V60, P1231, DOI 10.1016/S0024-3205(97)00067-2; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rozas JL, 2010, BIOCHEM SOC T, V38, P488, DOI 10.1042/BST0380488; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Ruparelia A, 2012, CURR OPIN NEUROBIOL, V22, P880, DOI 10.1016/j.conb.2012.05.002; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sakaba T, 2013, P NATL ACAD SCI USA, V110, P8266, DOI 10.1073/pnas.1219234110; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Siarey RJ, 1999, NEUROPHARMACOLOGY, V38, P1917, DOI 10.1016/S0028-3908(99)00083-0; Smillie KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3394; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Wu XS, 2014, CELL REP, V7, P982, DOI 10.1016/j.celrep.2014.04.020; Xie W, 2012, BIOCHEMISTRY-US, V51, P6786, DOI 10.1021/bi2017798; Zanin MP, 2013, J NEUROCHEM, V124, P290, DOI 10.1111/jnc.12086; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	75	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147974	10.1371/journal.pone.0147974	http://dx.doi.org/10.1371/journal.pone.0147974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808141	Green Published, gold			2022-12-27	WOS:000369527800256
J	Schroeder, AM; Bin Wang, H; Park, S; Jordan, MC; Gao, FY; Coppola, G; Fishbein, MC; Roos, KP; Ghiani, CA; Colwell, CS				Schroeder, Analyne M.; Bin Wang, Huei; Park, Saemi; Jordan, Maria C.; Gao, Fuying; Coppola, Giovanni; Fishbein, Michael C.; Roos, Kenneth P.; Ghiani, Cristina A.; Colwell, Christopher S.			Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MYOCARDIAL FIBROSIS; NATRIURETIC PEPTIDE; MUTATION CARRIERS; DEATH; FIBROBLASTS; ACTIVATION; EXPRESSION; PROFILE	While Huntington's disease (HD) is classified as a neurological disorder, HD patients exhibit a high incidence of cardiovascular events leading to heart failure and death. In this study, we sought to better understand the cardiovascular phenotype of HD using the BACHD mouse model. The age- related decline in cardiovascular function was assessed by echocardiograms, electrocardiograms, histological and microarray analysis. We found that structural and functional differences between WT and BACHD hearts start at 3 months of age and continue throughout life. The aged BACHD mice develop cardiac fibrosis and ultimately apoptosis. The BACHD mice exhibited adaptive physiological changes to chronic isoproterenol treatment; however, the medication exacerbated fibrotic lesions in the heart. Gene expression analysis indicated a strong tilt toward apoptosis in the young mutant heart as well as changes in genes involved in cellular metabolism and proliferation. With age, the number of genes with altered expression increased with the large changes occurring in the cardiovascular disease, cellular metabolism, and cellular transport clusters. The BACHD model of HD exhibits a number of changes in cardiovascular function that start early in the disease progress and may provide an explanation for the higher cardiovascular risk in HD.	[Schroeder, Analyne M.; Bin Wang, Huei; Park, Saemi; Gao, Fuying; Coppola, Giovanni; Ghiani, Cristina A.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Jordan, Maria C.; Roos, Kenneth P.] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Fishbein, Michael C.; Ghiani, Cristina A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	ccolwell@mednet.ucla.edu	Jordan, Maria/HHN-5358-2022; Ghiani, Cristina/Q-9385-2019; Colwell, Chris/AAM-6111-2020	Ghiani, Cristina/0000-0002-9867-6185; Colwell, Christopher/0000-0002-1059-184X; Wang, Huei-Bin/0000-0002-7141-0950	CHDI Foundation [A4339]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER	CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by CHDI Foundation, A4339, CSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrich J, 2002, J NEUROL NEUROSUR PS, V72, P726, DOI 10.1136/jnnp.72.6.726; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Aziz NA, 2010, EUR J NEUROL, V17, P1068, DOI 10.1111/j.1468-1331.2010.02973.x; Bar KJ, 2008, EUR J NEUROL, V15, P869, DOI 10.1111/j.1468-1331.2008.02173.x; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Buonincontri G, 2014, J HUNTINGTONS DIS, V3, P25, DOI 10.3233/JHD-130083; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; CHIU E, 1982, MED J AUSTRALIA, V1, P153, DOI 10.5694/j.1326-5377.1982.tb132224.x; Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Henkel DM, 2012, AM J CARDIOL, V109, P390, DOI 10.1016/j.amjcard.2011.09.027; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Kobal J, 2004, EUR J NEUROL, V11, P842, DOI 10.1111/j.1468-1331.2004.00894.x; Kobal J, 2010, ACTA NEUROL SCAND, V121, P392, DOI 10.1111/j.1600-0404.2009.01251.x; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Kuljis Dika, 2012, Minerva Pneumol, V51, P93; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, ARCH NEUROL-CHICAGO, V45, P878, DOI 10.1001/archneur.1988.00520320068017; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Margolis RL, 2003, CLIN CHEM, V49, P1726, DOI 10.1373/49.10.1726; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Melkani GC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004024; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Rozen S, 2000, Methods Mol Biol, V132, P365; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Schroeder Analyne M, 2011, PLoS Curr, V3, pRRN1266, DOI 10.1371/currents.RRN1266; Sharma KR, 1999, ARCH NEUROL-CHICAGO, V56, P1248, DOI 10.1001/archneur.56.10.1248; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; Valor LM, 2014, MOL NEUROBIOL; Vondriska TM, 2008, CIRC RES, V103, P1194, DOI 10.1161/CIRCRESAHA.108.189118; Wood NI, 2012, J HUNTINGTONS DIS, V1, P57, DOI 10.3233/JHD-2012-120004; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]	46	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147269	10.1371/journal.pone.0147269	http://dx.doi.org/10.1371/journal.pone.0147269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807590	Green Published, gold			2022-12-27	WOS:000369527800070
J	Shuryak, I; Dadachova, E				Shuryak, Igor; Dadachova, Ekaterina			Quantitative Modeling of Microbial Population Responses to Chronic Irradiation Combined with Other Stressors	PLOS ONE			English	Article							IONIZING-RADIATION; CHRONIC EXPOSURE; GAMMA-RADIATION; DOSE-RATE; FUNGI; CHERNOBYL; GROWTH; RADIOSENSITIVITY; BIOREMEDIATION; INVERTEBRATES	Microbial population responses to combined effects of chronic irradiation and other stressors (chemical contaminants, other sub-optimal conditions) are important for ecosystem functioning and bioremediation in radionuclide-contaminated areas. Quantitative mathematical modeling can improve our understanding of these phenomena. To identify general patterns of microbial responses to multiple stressors in radioactive environments, we analyzed three data sets on: (1) bacteria isolated from soil contaminated by nuclear waste at the Hanford site (USA); (2) fungi isolated from the Chernobyl nuclear-power plant (Ukraine) buildings after the accident; (3) yeast subjected to continuous.-irradiation in the laboratory, where radiation dose rate and cell removal rate were independently varied. We applied generalized linear mixed-effects models to describe the first two data sets, whereas the third data set was amenable to mechanistic modeling using differential equations. Machine learning and information-theoretic approaches were used to select the best-supported formalism( s) among biologically-plausible alternatives. Our analysis suggests the following: (1) Both radionuclides and co-occurring chemical contaminants (e.g. NO2) are important for explaining microbial responses to radioactive contamination. (2) Radionuclides may produce non-monotonic dose responses: stimulation of microbial growth at low concentrations vs. inhibition at higher ones. (3) The extinction-defining critical radiation dose rate is dramatically lowered by additional stressors. (4) Reproduction suppression by radiation can be more important for determining the critical dose rate, than radiation-induced cell mortality. In conclusion, the modeling approaches used here on three diverse data sets provide insight into explaining and predicting multi-stressor effects on microbial communities: (1) the most severe effects (e.g. extinction) on microbial populations may occur when unfavorable environmental conditions (e.g. fluctuations of temperature and/or nutrient levels) coincide with radioactive contamination; (2) an organism's radioresistance and bioremediation efficiency in rich laboratory media may be insufficient to carry out radionuclide bioremediation in the field-robustness against multiple stressors is needed.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu	Dadachova, Ekaterina/I-7838-2013					Alonzo F, 2008, J ENVIRON RADIOACTIV, V99, P1464, DOI 10.1016/j.jenvrad.2007.11.021; Bezrukov V, 2015, ECOL INDIC, V52, P128, DOI 10.1016/j.ecolind.2014.11.014; Bolker B, 2008, ECOLOGICAL MODELS DA; BRENNER DJ, 1988, RADIAT ENVIRON BIOPH, V27, P189, DOI 10.1007/BF01210836; Browne E, 2007, NUCL DATA SHEETS, V108, P2173, DOI 10.1016/j.nds.2007.09.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen PQ, 2009, GENETICS, V183, P639, DOI 10.1534/genetics.109.106492; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Dallas LJ, 2012, RADIAT RES, V177, P693, DOI 10.1667/RR2687.1; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Gotelli Nicholas J., 2011, P39; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hendriks AJ, 2005, ENVIRON TOXICOL CHEM, V24, P2267, DOI 10.1897/05-122.1; Hilborn Ray, 1997, V28; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; KIEFER J, 1988, RADIAT RES, V113, P71, DOI 10.2307/3577181; KIEFER J, 1977, RADIAT RES, V69, P230, DOI 10.2307/3574431; Kohavi R., 1995, P 1995 INT JOINT C A; Kumar R, 2007, OMICS, V11, P295, DOI 10.1089/omi.2007.0013; Martins LR, 2015, J ENV ENG; Mitchel REJ, 2007, NATO SCI PEACE SECUR, P31, DOI 10.1007/978-1-4020-6335-0_3; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Mongodin EF, 2006, SECRETS SOIL SURVIVA; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Parisot F, 2015, AQUAT TOXICOL, V163, P27, DOI 10.1016/j.aquatox.2015.03.002; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Ruggiero CE, 2005, ENVIRON MICROBIOL, V7, P88, DOI 10.1111/j.1462-2920.2004.00666.x; Sachs RK, 1997, INT J RADIAT BIOL, V72, P351, DOI 10.1080/095530097143149; SALEH YG, 1988, APPL ENVIRON MICROB, V54, P2134, DOI 10.1128/AEM.54.8.2134-2135.1988; Sazykina TG, 2012, RADIAT ENVIRON BIOPH, V51, P215, DOI 10.1007/s00411-012-0404-2; Shuryak I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085561; Singal AG, 2013, AM J GASTROENTEROL, V108, P1723, DOI 10.1038/ajg.2013.332; Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-5; Springman R, 2010, GENETICS, V184, P221, DOI 10.1534/genetics.109.108803; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; Vanhoudt N, 2012, ENVIRON POLLUT, V168, P177, DOI 10.1016/j.envpol.2012.04.023; Batlle JVI, 2012, RADIAT ENVIRON BIOPH, V51, P399, DOI 10.1007/s00411-012-0430-0; WELCH GP, 1968, RADIAT RES, V36, P274, DOI 10.2307/3572652; YI PN, 1993, RADIAT RES, V133, P163, DOI 10.2307/3578352; ZAIDER M, 1993, RADIAT RES, V133, P20, DOI 10.2307/3578252; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	50	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147696	10.1371/journal.pone.0147696	http://dx.doi.org/10.1371/journal.pone.0147696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808049	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800186
J	Yamamoto, T; Suzuki, T; Ohashi, S; Miyazaki, A; Tsutsui, T				Yamamoto, Takehisa; Suzuki, Tohru; Ohashi, Seiichi; Miyazaki, Ayako; Tsutsui, Toshiyuki			Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014	PLOS ONE			English	Article							UNITED-STATES; SEQUENCE-ANALYSIS; VIRUS; EMERGENCE; OUTBREAK; KOREA; PEDV	Porcine epidemic diarrhea virus (PEDV) is a positive-sense RNA virus that causes infectious gastroenteritis in pigs. Following a PED outbreak that occurred in China in 2010, the disease was identified for the first time in the United States in April 2013, and was reported in many other countries worldwide from 2013 to 2014. As a novel approach to elucidate the epidemiological relationship between PEDV strains, we explored their genome sequences to identify the motifs that were shared within related strains. Of PED outbreaks reported in many countries during 2013-2014, 119 PEDV strains in Japan, USA, Canada, Mexico, Germany, and Korea were selected and used in this study. We developed a motif mining program, which aimed to identify a specific region of the genome that was exclusively shared by a group of PEDV strains. Eight motifs were identified (M1-M8) and they were observed in 41, 9, 18, 6, 10, 14, 2, and 2 strains, respectively. Motifs M1-M6 were shared by strains from more than two countries, and seemed to originate from one PEDV strain, Indiana12.83/USA/2013, among the 119 strains studied. BLAST search for motifs M1-M6 revealed that M3-M5 were almost identical to the strain ZMDZY identified in 2011 in China, while M1 and M2 were similar to other Chinese strains isolated in 2011-2012. Consequently, the PED outbreaks in these six countries may be closely related, and multiple transmissions of PEDV strains between these countries may have occurred during 2013-2014. Although tools such as phylogenetic tree analysis with whole genome sequences are increasingly applied to reveal the connection between isolates, its interpretation is sometimes inconclusive. Application of motifs as a tool to examine the whole genome sequences of causative agents will be more objective and will be an explicit indicator of their relationship.	[Yamamoto, Takehisa; Suzuki, Tohru; Ohashi, Seiichi; Miyazaki, Ayako; Tsutsui, Toshiyuki] Natl Agr & Res Org, Natl Inst Anim Hlth, Virol & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yamamoto, T (corresponding author), Natl Agr & Res Org, Natl Inst Anim Hlth, Virol & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan.	mtbook@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry	Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry and Fisheries, and Food Industry.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bridgen A, 1998, ADV EXP MED BIOL, V440, P781; Chen X, 2012, VIRUS GENES, V45, P499, DOI 10.1007/s11262-012-0794-x; Chiou HY, 2017, TRANSBOUND EMERG DIS, V64, P157, DOI 10.1111/tbed.12357; Chiou M, 2014, AUSTIN VIROL RETRO V, V1, P2; Choi JC, 2014, INFECT GENET EVOL, V26, P348, DOI 10.1016/j.meegid.2014.06.005; Vui DT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00753-14; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4; Grasland B, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00535-15; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kim SH, 2015, ARCH VIROL, V160, P1055, DOI 10.1007/s00705-015-2353-y; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01116-14; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Marthaler D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00555-13; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park SJ, 2008, VIRUS GENES, V36, P95, DOI 10.1007/s11262-007-0164-2; Park SJ, 2012, J VIROL, V86, P5964, DOI 10.1128/JVI.00557-12; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Sintchenko V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1314; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Song DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120310; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun M, 2015, J CLIN MICROBIOL, V53, P1484, DOI 10.1128/JCM.02898-14; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Suzuki T, 2015, INFECT GENET EVOL, V36, P363, DOI 10.1016/j.meegid.2015.10.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian PF, 2014, EMERG INFECT DIS, V20, P1735, DOI 10.3201/eid2010.140338; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; Yang DQ, 2014, ARCH VIROL, V159, P2777, DOI 10.1007/s00705-014-2102-7; Zhao PD, 2015, CAN J VET RES, V79, P8	45	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147994	10.1371/journal.pone.0147994	http://dx.doi.org/10.1371/journal.pone.0147994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808527	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800260
J	Janssens, X; Decuman, S; De Keyser, F				Janssens, Xavier; Decuman, Saskia; De Keyser, Filip		Belgian Rheumatoid Arthritis Disab	Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICF CORE SET; INTERNATIONAL-CLASSIFICATION; PSYCHOMETRIC PROPERTIES; GENERAL-POPULATION; DISEASE-ACTIVITY; VALIDATION; RESPONSIVENESS; RELIABILITY; BENEFITS	Objective Scores on the Health Assessment Questionnaire (HAQ) predict the need for support measures in patients with rheumatoid arthritis (RA). In this study we compare the performance of the HAQ in this context with that of the more disease-specific Belgian Rheumatoid Arthritis Disability Assessment (BRADA) questionnaire. Methods In this multicenter observational study, patients with RA and disease duration of at least one year who consulted their rheumatologist for a routine follow-up visit filled out the HAQ, and BRADA questionnaires. The performance of HAQ and BRADA to predict the need for support measures available to patients with RA was evaluated using Receiver Operator Characteristic (ROC) curves, with the expert opinion of the rheumatologist as a reference. Results The study analyzed data of 301 patients with RA (70.8% females) with mean age 59.8 +/- 12.8, disease duration 11.4 +/- 9.3 years, and DAS28 values of 2.84 +/- 1.18. HAQ scores averaged 0.97 +/- 0.73 and BRADA scores were 3.92 +/- 3.49 over the last week and 3.89 +/- 3.50 over the last 3 months. The area under the ROC curves for the BRADA scores for the support measures investigated ranged from 0.702 to 0.862 and did not differ significantly from those of the HAQ (range 0.725-0.860). Conclusion The disease-specific BRADA questionnaire is equivalent to the HAQ in predicting the need for support measures in patients with stable RA.	[Janssens, Xavier; Decuman, Saskia; De Keyser, Filip] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [Decuman, Saskia] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	Janssens, X (corresponding author), Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium.	janssens.reuma@skynet.be			Roche	Roche(Roche Holding)	This study received funding from Roche, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Boonen A, 2011, CLIN RHEUMATOL, V30, pS3, DOI 10.1007/s10067-010-1634-9; Bruce B, 2003, J RHEUMATOL, V30, P167; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20; Fruin C, 2008, MUSCULOSKELET CARE, V6, P211, DOI 10.1002/msc.133; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Geuskens GA, 2007, J RHEUMATOL, V34, P1248; Huscher D, 2006, ANN RHEUM DIS, V65, P1175, DOI 10.1136/ard.2005.046367; Janssens X, 2013, CLIN EXP RHEUMATOL, V31, P596; Janssens X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106749; Kirchberger I, 2007, PHYS THER, V87, P368, DOI 10.2522/ptj.20050237; Langley C, 2004, RHEUMATOLOGY, V43, P863, DOI 10.1093/rheumatology/keh184; Lillegraven S, 2007, BEST PRACT RES CL RH, V21, P827, DOI 10.1016/j.berh.2007.05.004; Linde L, 2008, J RHEUMATOL, V35, P1528; Matcham F, 2014, SEMIN ARTHRITIS RHEU, V44, P123, DOI 10.1016/j.semarthrit.2014.05.001; Memel DS, 2002, RHEUMATOLOGY, V41, P100, DOI 10.1093/rheumatology/41.1.100; Pincus T, 2006, J RHEUMATOL, V33, P834; Pincus T, 2015, CURR PHARM DESIGN, V21, P241; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sokka T, 2006, ARTHRITIS RHEUM-US, V54, P3113, DOI 10.1002/art.22130; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Uhlig T, 2009, ANN RHEUM DIS, V68, P879, DOI 10.1136/ard.2008.088708; Uhlig T, 2007, ANN RHEUM DIS, V66, P1078, DOI 10.1136/ard.2006.058693; Uhlig T, 2007, J RHEUMATOL, V34, P1241; Uhlig T, 2014, PHARMACOECONOMICS, V32, P841, DOI 10.1007/s40273-014-0174-6; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Yelin E, 1999, ARTHRITIS RHEUM, V42, P1209, DOI 10.1002/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146688	10.1371/journal.pone.0146688	http://dx.doi.org/10.1371/journal.pone.0146688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800345	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300028
J	Bush, M; Setiaputra, D; Yip, CK; Molday, RS				Bush, Martin; Setiaputra, Dheva; Yip, Calvin K.; Molday, Robert S.			Cog-Wheel Octameric Structure of RS1, the Discoidin Domain Containing Retinal Protein Associated with X-Linked Retinoschisis	PLOS ONE			English	Article							JUVENILE RETINOSCHISIS; ELECTRON-MICROSCOPY; MOUSE MODEL; GENE; VISUALIZATION; MECHANISMS; RESOLUTION; MUTATIONS	RS1, also known as retinoschisin, is a disulphide-linked, discoidin domain containing homo-oligomeric protein that plays a crucial role in maintaining the cellular and synaptic organization of the retina. This is highlighted by the finding that over 130 mutations in RS1 cause X-linked retinoschisis, a retinal degenerative disease characterized by the splitting of the retinal cell layers, disruption of the photoreceptor-bipolar synapses, degeneration of photoreceptors, and severe loss in central vision. In this study, we investigated the arrangement of the RS1 subunits within the oligomer complex using single particle electron microscopy. RS1 was seen as two stacked rings with each ring displaying a symmetrical cog wheel-like structure with eight teeth or projections corresponding to the RS1 subunits. Three dimensional reconstruction and molecular modelling indicated that the discoidin domain, the principal functional unit of RS1, projects outward, and the Rs1 domain and C-terminal segment containing intermolecular disulphide bonds are present in the inner ring to form the core octameric structure. These studies provide a basis for further understanding the role of the novel core RS1 octameric complex in retinal cell biology and X-linked retinoschisis.	[Bush, Martin; Setiaputra, Dheva; Yip, Calvin K.; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	molday@mail.ubc.ca		Setiaputra, Dheva/0000-0003-2956-6422; Yip, Calvin/0000-0003-1779-9501	National Institutes of Health [EY002422]; Macula Vision Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery [418157]; Canadian Institutes of Health Research operating [MOP-126126]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research operating(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health EY002422 (RSM), Macula Vision Research Foundation (RSM), Natural Sciences and Engineering Research Council of Canada Discovery Grant 418157 (CKY), and Canadian Institutes of Health Research operating grant (MOP-126126) (CKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; CONSORTIUM R, 1998, HUM MOL GENET, V7, P1185; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dyka FM, 2008, BIOCHEMISTRY-US, V47, P9098, DOI 10.1021/bi800938g; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fraternali F, 2003, FEBS LETT, V544, P21, DOI 10.1016/S0014-5793(03)00433-2; Friedrich U, 2011, HUM MOL GENET, V20, P1132, DOI 10.1093/hmg/ddq557; Genead MA, 2010, ARCH OPHTHALMOL-CHIC, V128, P190, DOI 10.1001/archophthalmol.2009.398; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLNER U, 1990, GRAEF ARCH CLIN EXP, V228, P432, DOI 10.1007/BF00927256; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kotova S, 2010, BIOCHEMISTRY-US, V49, P7023, DOI 10.1021/bi1007029; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday RS, 2012, PROG RETIN EYE RES, V31, P195, DOI 10.1016/j.preteyeres.2011.12.002; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ou JX, 2015, J CLIN INVEST, V125, P2891, DOI 10.1172/JCI81380; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sergeev YV, 2010, HUM MOL GENET, V19, P1302, DOI 10.1093/hmg/ddq006; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Sikkink SK, 2007, J MED GENET, V44, P225, DOI 10.1136/jmg.2006.047340; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Xu J, 2009, INVEST OPHTH VIS SCI, V50, P2989, DOI 10.1167/iovs.08-2542; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576; Zhang LJ, 2015, DOC OPHTHALMOL, V131, P63, DOI 10.1007/s10633-015-9496-8	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147653	10.1371/journal.pone.0147653	http://dx.doi.org/10.1371/journal.pone.0147653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812435	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000046
J	Hielscher, A; Ellis, K; Qiu, C; Porterfield, J; Gerecht, S				Hielscher, Abigail; Ellis, Kim; Qiu, Connie; Porterfield, Josh; Gerecht, Sharon			Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis	PLOS ONE			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; ENDOTHELIAL-CELL MIGRATION; ANGIOGENESIS IN-VITRO; TUMOR-GROWTH; INTEGRIN; EXPRESSION; RECEPTOR; PROMOTES; SURFACE; TUBE	The extracellular matrix (ECM) has been demonstrated to facilitate angiogenesis. In particular, fibronectin has been documented to activate endothelial cells, resulting in their transition from a quiescent state to an active state in which the cells exhibit enhanced migration and proliferation. The goal of this study is to examine the role of polymerized fibronectin during vascular tubulogenesis using a 3 dimensional (3D) cell-derived de-cellularized matrix. A fibronectin-rich 3D de-cellularized ECM was used as a scaffold to study vascular morphogenesis of endothelial cells (ECs). Confocal analyses of several matrix proteins reveal high intra-and extra-cellular deposition of fibronectin in formed vascular structures. Using a small peptide inhibitor of fibronectin polymerization, we demonstrate that inhibition of fibronectin fibrillogenesis in ECs cultured atop de-cellularized ECM resulted in decreased vascular morphogenesis. Further, immunofluorescence and ultrastructural analyses reveal decreased expression of stromal matrix proteins in the absence of polymerized fibronectin with high co-localization of matrix proteins found in association with polymerized fibronectin. Evaluating vascular kinetics, live cell imaging showed that migration, migration velocity, and mean square displacement, are disrupted in structures grown in the absence of polymerized fibronectin. Additionally, vascular organization failed to occur in the absence of a polymerized fibronectin matrix. Consistent with these observations, we tested vascular morphogenesis following the disruption of EC adhesion to polymerized fibronectin, demonstrating that block of integrins alpha(5)beta(1) and alpha(v)beta(3), abrogated vascular morphogenesis. Overall, fibronectin deposition in a 3D cell-derived de-cellularized ECM appears to be imperative for matrix assembly and vascular morphogenesis.	[Hielscher, Abigail; Ellis, Kim; Qiu, Connie; Porterfield, Josh; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Hielscher, Abigail; Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Hielscher, Abigail] Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gerecht, S (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.; Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA.; Gerecht, S (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/HCH-8629-2022; Porterfield, Joshua/HCH-8115-2022	Gerecht, Sharon/0000-0002-8542-4835; Qiu, Connie/0000-0002-1623-9871	National Cancer Institute [U54CA143868]; National Institutes of Health [R01HL107938]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107938] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute (U54CA143868, SG) and the National Institutes of Health (R01HL107938, SG).	Abaci HE, 2011, AM J PHYSIOL-CELL PH, V301, pC431, DOI 10.1152/ajpcell.00074.2011; Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Davis GE, 2001, J CELL SCI, V114, P917; Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; FRIDMAN R, 1995, CANCER RES, V55, P2548; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; Hielscher A, 2013, CARCINOGENESIS MUTAG, DOI [10.4172/2157-2518.S13-005, DOI 10.4172/2157-2518.S13-005]; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Hilario E, 1996, HISTOL HISTOPATHOL, V11, P915; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Kim MC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002926; Laura E, 2010, SOFT MATTER, V6, P5109; Malik G, 2010, CANCER RES, V70, P4327, DOI 10.1158/0008-5472.CAN-09-3312; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075; Pola C, 2013, CANCER RES, V73, P4571, DOI 10.1158/0008-5472.CAN-13-0218; Rajagopalan P, 2004, BIOPHYS J, V87, P2818, DOI 10.1529/biophysj.103.037218; Roy R, 2005, EXP CELL RES, V312, P14; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Stahl PJ, 2014, ADV FUNCT MATER, V24, P3213, DOI 10.1002/adfm.201303217; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Taverna D, 2001, CANCER RES, V61, P5255; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Wautier MP, 2007, BLOOD, V110, P894, DOI 10.1182/blood-2006-10-048298; WU CY, 1993, J BIOL CHEM, V268, P21883; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Ye Zhaohui, 2008, V430, P243, DOI 10.1007/978-1-59745-182-6_17; Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.TEA.2010.0481, 10.1089/ten.tea.2010.0481]; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	57	53	56	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147600	10.1371/journal.pone.0147600	http://dx.doi.org/10.1371/journal.pone.0147600			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811931	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000042
J	Mapder, T; Talukder, S; Chattopadhyay, S; Banik, SK				Mapder, Tarunendu; Talukder, Srijeeta; Chattopadhyay, Sudip; Banik, Suman K.			Deciphering Parameter Sensitivity in the BvgAS Signal Transduction	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEMS; VIRULENCE GENE-EXPRESSION; BORDETELLA-PERTUSSIS; POSITIVE FEEDBACK; DNA-BINDING; PHOSPHORELAY; OPTIMIZATION; PHOSPHORYLATION; AMPLIFICATION; ROBUSTNESS	To understand the switching of different phenotypic phases of Bordetella pertussis, we propose an optimized mathematical framework for signal transduction through BvgAS two-component system. The response of the network output to the sensory input has been demonstrated in steady state. An analysis in terms of local sensitivity amplification characterizes the nature of the molecular switch. The sensitivity analysis of the model parameters within the framework of various correlation coefficients helps to decipher the contribution of the modular structure in signal propagation. Once classified, the model parameters are tuned to generate the behavior of some novel strains using simulated annealing, a stochastic optimization technique.	[Mapder, Tarunendu; Chattopadhyay, Sudip] Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India; [Talukder, Srijeeta] Univ Calcutta, Dept Chem, 92 APC Rd, Kolkata 700009, W Bengal, India; [Banik, Suman K.] Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, W Bengal, India	Indian Institute of Engineering Science Technology Shibpur (IIEST); University of Calcutta; Department of Science & Technology (India); Bose Institute	Chattopadhyay, S (corresponding author), Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India.; Banik, SK (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, W Bengal, India.	sudip_chattopadhyay@rediffmail.com; skbanik@jcbose.ac.in	Chattopadhyay, Sudip/AAE-6820-2019; Mapder, Tarunendu/U-5406-2019	Chattopadhyay, Sudip/0000-0002-3477-6013; Mapder, Tarunendu/0000-0002-1630-0716	CSIR (Council of Scientific & Industrial Research), India [01(2771)/14/EMR-II]; Bose Institute, Kolkata, India for research fund	CSIR (Council of Scientific & Industrial Research), India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute, Kolkata, India for research fund	TM, SC, and SKB acknowledge financial support from CSIR (Council of Scientific & Industrial Research), India [01(2771)/14/EMR-II]. SKB is thankful to Bose Institute, Kolkata, India for research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Bandyopadhyay A, 2012, BIOSYSTEMS, V110, P107, DOI 10.1016/j.biosystems.2012.08.004; Banik SK, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046008; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Beier D, 2008, ADV EXP MED BIOL, V631, P149, DOI 10.1007/978-0-387-78885-2_10; Boucher PE, 1997, J BACTERIOL, V179, P1755, DOI 10.1128/jb.179.5.1755-1763.1997; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hot D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-207; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Miyashiro T, 2008, P NATL ACAD SCI USA, V105, P17457, DOI 10.1073/pnas.0807278105; Prajapat MK, 2013, MOL BIOSYST, V9, P2635, DOI 10.1039/c3mb70213h; ROY CR, 1990, P NATL ACAD SCI USA, V87, P3763, DOI 10.1073/pnas.87.10.3763; Salteli A, 2004, SENSITIVITY ANAL PRA; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SCARLATO V, 1991, EMBO J, V10, P3971, DOI 10.1002/j.1460-2075.1991.tb04967.x; SCARLATO V, 1990, P NATL ACAD SCI USA, V87, P10067; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Talukder S, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869112; Talukder S, 2013, J CHEM SCI, V125, P1619, DOI 10.1007/s12039-013-0502-y; Talukder S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3654958; Tiwari A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036005; Wei K, 2014, MOL BIOSYST, V10, P2338, DOI 10.1039/c4mb00264d	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147281	10.1371/journal.pone.0147281	http://dx.doi.org/10.1371/journal.pone.0147281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812153	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528000028
J	Adema, AY; van Ittersum, FJ; Hoenderop, JG; de Borst, MH; Nanayakkara, PW; Ter Wee, PM; Heijboer, AC; Vervloet, MG				Adema, Aaltje Y.; van Ittersum, Frans J.; Hoenderop, Joost G.; de Borst, Martin H.; Nanayakkara, Prabath W.; Ter Wee, Piet M.; Heijboer, Annemieke C.; Vervloet, Marc G.		NIGRAM Consortium	Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating alpha-Klotho Concentrations	PLOS ONE			English	Article							ANTIAGING GENE; ENDOTHELIAL FUNCTION; DOWN-REGULATION; VITAMIN-E; EXPRESSION; MOUSE; PRAVASTATIN; BLOCKADE; ENZYME; RATS	The CKD-associated decline in soluble alpha-Klotho levels is considered detrimental. Some in vitro and in vivo animal studies have shown that anti-oxidant therapy can upregulate the expression of alpha-Klotho in the kidney. We examined the effect of anti-oxidant therapy on alpha-Klotho concentrations in a clinical cohort with mild tot moderate chronic kidney disease (CKD). We performed a post-hoc analysis of a prospective randomized trial involving 62 patients with mild to moderate CKD (the ATIC study), all using an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) for 12 months. On top of that, the intervention group received anti-oxidative therapy consisting of the combination of pravastatin (40 mg/d) and vitamin E (alpha-tocopherol acetate, 300 mg/d) while the placebo was not treated with anti-oxidants. alpha-Klotho concentrations were measured at baseline and after 12 months of anti-oxidant therapy. Data were analysed using T-tests and Generalized Estimating Equations, adjusting for potential confounders such as vitamin D, parathyroid hormone, fibroblast-growth-factor 23 (FGF23) and eGFR. The cohort existed of 62 patients with an eGFR (MDRD) of 35 +/- 14 ml/min/1.72m(2), 34 were male and mean age was 53.0 +/- 12.5 years old. Anti-oxidative therapy did successfully reduce oxLDL and LDL concentrations (P <0.001). alpha-Klotho concentrations did not change in patients receiving either antioxidative therapy (476.9 +/- 124.3 to 492.7 +/- 126.3 pg/mL, P = 0.23) nor in those receiving placebo 483.2 +/- 142.5 to 489.6 +/- 120.3 pg/mL, P = 0.62). Changes in alpha-Klotho concentrations were not different between both groups (p = 0.62). No evidence was found that antioxidative therapy affected alpha-Klotho concentrations in patients with mild-moderate CKD.	[Adema, Aaltje Y.; van Ittersum, Frans J.; Ter Wee, Piet M.; Vervloet, Marc G.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [Hoenderop, Joost G.] Radford Univ, Med Ctr Nijmegen, Dept Physiol, Nijmegen, Netherlands; [de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Nanayakkara, Prabath W.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Heijboer, Annemieke C.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Vervloet, Marc G.] Inst Cardiovascular Res VU ICaR VU, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Vervloet, MG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands.; Vervloet, MG (corresponding author), Inst Cardiovascular Res VU ICaR VU, Amsterdam, Netherlands.	m.vervloet@vumc.nl	Hoenderop, Joost G.J./H-8047-2014	Hoenderop, Joost G.J./0000-0002-1816-8544; Vervloet, Marc/0000-0003-4607-9415; De Borst, Martin/0000-0002-4127-8733; Heijboer, Annemieke/0000-0002-6712-9955	Dutch Kidney Foundation (NIGRAM Consortium) [CP10.11]	Dutch Kidney Foundation (NIGRAM Consortium)	The NIGRAM consortium is fully supported by the Dutch Kidney Foundation (CP10.11).r This work is supported by a consortium grant from the Dutch Kidney Foundation (NIGRAM Consortium, Grant No. CP10.11).	Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Giray B, 2003, CLIN CHIM ACTA, V338, P91, DOI 10.1016/j.cccn.2003.07.020; Haussler MR, 2010, J STEROID BIOCHEM, V121, P88, DOI 10.1016/j.jsbmb.2010.03.019; Heijboer AC, 2013, NEPHROL DIAL TRANSPL, V28, P2283, DOI 10.1093/ndt/gft236; Heijboer AC, 2009, ANN CLIN BIOCHEM, V46, P338, DOI 10.1258/acb.2009.009066; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kuwahara N, 2008, INT J CARDIOL, V123, P84, DOI 10.1016/j.ijcard.2007.02.029; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Moon GJ, 2014, J CLIN NEUROL, V10, P140, DOI 10.3988/jcn.2014.10.2.140; Nagai Taku, 2003, FASEB Journal, V17, P50; Nanayakkara PWB, 2007, ARCH INTERN MED, V167, P1262, DOI 10.1001/archinte.167.12.1262; Narumiya H, 2004, CARDIOVASC RES, V64, P331, DOI 10.1016/j.cardiores.2004.07.011; Olauson H, 2014, SEMIN NEPHROL, V34, P586, DOI 10.1016/j.semnephrol.2014.09.005; Pedersen L, 2013, CLIN BIOCHEM, V46, P1079, DOI 10.1016/j.clinbiochem.2013.05.046; Saito K, 2003, FEBS LETT, V551, P58, DOI 10.1016/S0014-5793(03)00894-9; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Tamura A, 2003, CIRC J, V67, P816, DOI 10.1253/circj.67.816; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Yamagishi T, 2001, HYPERTENS RES, V24, P705, DOI 10.1291/hypres.24.705; Yang HC, 2009, J AM SOC NEPHROL, V20, P2380, DOI 10.1681/ASN.2008111138; Yoon HE, 2012, NEPHRON EXP NEPHROL, V120, pE123, DOI 10.1159/000342117; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Zhang H, 2008, KIDNEY INT, V74, P732, DOI 10.1038/ki.2008.244; Zhang RH, 2008, KIDNEY INT, V74, P702, DOI 10.1038/ki.2008.382	36	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144121	10.1371/journal.pone.0144121	http://dx.doi.org/10.1371/journal.pone.0144121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807718	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800001
J	Kilpatrick, S; Dreistadt, M; Frowde, P; Powell, R; Milne, E; Smith, S; Morrison, L; Gow, AG; Handel, I; Mellanby, RJ				Kilpatrick, Scott; Dreistadt, Margaret; Frowde, Polly; Powell, Roger; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.			Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; ALCOHOLIC HEPATITIS; CIRRHOTIC-PATIENTS; MORTALITY; HYPONATREMIA; RISK; DISEASE; IL-6; TRANSPLANTATION; INTERLEUKIN-6	Primary hepatopathies are a common cause of morbidity and mortality in dogs. The underlying aetiology of most cases of canine hepatitis is unknown. Consequently, treatments are typically palliative and it is difficult to provide accurate prognostic information to owners. In human hepatology there is accumulating data which indicates that the presence of systemic inflammatory response syndrome (SIRS) is a common and debilitating event in patients with liver diseases. For example, the presence of SIRS has been linked to the development of complications such as hepatic encephalopathy (HE) and is associated with a poor clinical outcome in humans with liver diseases. In contrast, the relationship between SIRS and clinical outcome in dogs with a primary hepatitis is unknown. Seventy dogs with histologically confirmed primary hepatitis were enrolled into the study. Additional clinical and clinicopathological information including respiratory rate, heart rate, temperature, white blood cell count, sodium, potassium, sex, presence of ascites, HE score, alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin and red blood cell concentration were available in all cases. The median survival of dogs with a SIRS score of 0 or 1 (SIRS low) was 231 days compared to a median survival of 7 days for dogs with a SIRS score of 2, 3 or 4 (SIRS high) (p<0.001). A Cox proportional hazard model, which included all other co-variables, revealed that a SIRS high score was an independent predictor of a poor clinical outcome. The effect of modulating inflammation on treatment outcomes in dogs with a primary hepatitis is deserving of further study.	[Kilpatrick, Scott; Dreistadt, Margaret; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Kilpatrick, Scott; Dreistadt, Margaret; Milne, Elspeth; Smith, Sionagh; Morrison, Linda; Gow, Adam G.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland; [Frowde, Polly] Davies Vet Specialists Ltd, Manor Farm Business Pk, Higham Gobion, Herts, England; [Powell, Roger] PTDS, Unit 2a, Manor Farm Business Pk, Higham Gobion, Herts, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.; Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Frowde, Polly/AAG-8430-2020; Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Kilpatrick, Scott/0000-0002-1469-757X; Mellanby, Richard John/0000-0002-3467-7007; Morrison, Linda/0000-0003-0495-4592; Frowde, Polly/0000-0002-7299-2761				Abdel-Khalek Ehab E, 2011, Arab J Gastroenterol, V12, P173, DOI 10.1016/j.ajg.2011.11.006; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Angeli P, 2006, HEPATOLOGY, V44, P1535, DOI 10.1002/hep.21412; BOLOGNESI M, 1994, HEPATOLOGY, V19, P628, DOI 10.1002/hep.1840190313; Borroni G, 2000, DIGEST LIVER DIS, V32, P605, DOI 10.1016/S1590-8658(00)80844-0; Carey RG, 2010, PEDIATR TRANSPLANT, V14, P115, DOI 10.1111/j.1399-3046.2009.01142.x; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cordoba J, 2013, J HEPATOL; Cullen JM, 2009, VET CLIN N AM-SMALL, V39, P395, DOI 10.1016/j.cvsm.2009.02.003; Favier RP, 2013, VET QUART, V33, P113, DOI 10.1080/01652176.2013.826881; Fuentealba C, 1997, CAN VET J, V38, P365; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Guevara M, 2009, AM J GASTROENTEROL, V104, P1382, DOI 10.1038/ajg.2009.293; Gupta RK, 2010, METAB BRAIN DIS, V25, P355, DOI 10.1007/s11011-010-9206-x; Hammad LN, 2013, J IMMUNOTOXICOL, V10, P380, DOI 10.3109/1547691X.2012.758198; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Jiang XF, 2013, MOL MED REP, V7, P73, DOI 10.3892/mmr.2012.1136; Kilpatrick S, 2014, VET J; Li C, 2012, ANN HEPATOL, V11, P471, DOI 10.1016/S1665-2681(19)31460-7; Martinez D, 2015, LIVER INT, V35, P463, DOI 10.1111/liv.12473; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Mehta G, 2015, LIVER INT, V35, P724, DOI 10.1111/liv.12559; Michelena J, 2015, HEPATOLOGY; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nystrom PO, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.suppl_1.1; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Puri K, 2013, J PEDIATR GASTR NUTR, V57, P114, DOI 10.1097/MPG.0b013e318291fefe; Rambaldi A, 2008, ALIMENT PHARM THER, V27, P1167, DOI 10.1111/j.1365-2036.2008.03685.x; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Salgado M, 2013, COMPENDIUM, V35, pE10; Salgado Melissa, 2013, Compend Contin Educ Vet, V35, pE1; Schuttler J, 2015, VET CLIN PATH, V44, P223, DOI 10.1111/vcp.12255; Selgas AG, 2014, J VET DIAGN INVEST, V26, P246, DOI 10.1177/1040638713520602; Shawcross DL, 2011, J HEPATOL, V54, P640, DOI 10.1016/j.jhep.2010.07.045; Shin HS, 2014, YONSEI MED J, V55, P953, DOI 10.3349/ymj.2014.55.4.953; Thabut D, 2007, HEPATOLOGY, V46, P1872, DOI 10.1002/hep.21920; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tivers MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082303; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Weingarten MA, 2015, J VET EMERG CRIT CAR, V25, P455, DOI 10.1111/vec.12304; Wu HL, 2014, J GASTROEN HEPATOL, V29, P1629, DOI 10.1111/jgh.12606; Xie XM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000577	44	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146560	10.1371/journal.pone.0146560	http://dx.doi.org/10.1371/journal.pone.0146560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808672	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800025
J	Ramalho, T; Meyer, A; Mucki, A; Kapsner, K; Gerland, U; Simmel, FC				Ramalho, Tiago; Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Gerland, Ulrich; Simmel, Friedrich C.			Single Cell Analysis of a Bacterial Sender-Receiver System	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; PROGRAMMED POPULATION-CONTROL; QUORUM; COMMUNICATION; DIFFUSION; BIOLOGY; DISTRIBUTIONS; PHENOTYPES; LOGARITHM; DYNAMICS	Monitoring gene expression dynamics on the single cell level provides important information on cellular heterogeneity and stochasticity, and potentially allows for more accurate quantitation of gene expression processes. We here study bacterial senders and receivers genetically engineered with components of the quorum sensing system derived from Aliivibrio fischeri on the single cell level using microfluidics-based bacterial chemostats and fluorescence video microscopy. We track large numbers of bacteria over extended periods of time, which allows us to determine bacterial lineages and filter out subpopulations within a heterogeneous population. We quantitatively determine the dynamic gene expression response of receiver bacteria to varying amounts of the quorum sensing inducer N-3-oxo-C6-homoserine lactone (AHL). From this we construct AHL response curves and characterize gene expression dynamics of whole bacterial populations by investigating the statistical distribution of gene expression activity over time. The bacteria are found to display heterogeneous induction behavior within the population. We therefore also characterize gene expression in a homogeneous bacterial subpopulation by focusing on single cell trajectories derived only from bacteria with similar induction behavior. The response at the single cell level is found to be more cooperative than that obtained for the heterogeneous total population. For the analysis of systems containing both AHL senders and receiver cells, we utilize the receiver cells as 'bacterial sensors' for AHL. Based on a simple gene expression model and the response curves obtained in receiver-only experiments, the effective AHL concentration established by the senders and their 'sending power' is determined.	[Ramalho, Tiago; Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Gerland, Ulrich; Simmel, Friedrich C.] TU Mnchen, Dept Phys, Garching, Germany; [Meyer, Andrea; Mueckl, Andrea; Kapsner, Korbinian; Simmel, Friedrich C.] TU Mnchen, ZNN WSI, Garching, Germany; [Gerland, Ulrich; Simmel, Friedrich C.] Nanosyst Initiat Munich, Munich, Germany		Gerland, U; Simmel, FC (corresponding author), TU Mnchen, Dept Phys, Garching, Germany.; Simmel, FC (corresponding author), TU Mnchen, ZNN WSI, Garching, Germany.; Gerland, U; Simmel, FC (corresponding author), Nanosyst Initiat Munich, Munich, Germany.	gerland@tum.de; simmel@tum.de	Gerland, Ulrich/I-9902-2016; Simmel, Friedrich/G-3281-2010	Gerland, Ulrich/0000-0002-0859-6422; Simmel, Friedrich/0000-0003-3829-3446	European Commission FP7 [248919-BACTOCOM]; Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM); DFG [SPP 1617]	European Commission FP7(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by European Commission FP7 (grant no. 248919 - BACTOCOM, http://ec.europa.eu/research/fp7/index_en.cfm) and Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich - NIM and DFG priority program SPP 1617, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial support by the European Commission FP7 (grant no. 248919-BACTOCOM) and the Deutsche Forschungsgemeinschaft (Cluster of Excellence Nanosystems Initiative Munich-NIM). UG acknowledges support by the DFG priority program SPP 1617.	Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Carbonell-Ballestero M, 2014, NUCLEIC ACIDS RES, V42, P14060, DOI 10.1093/nar/gku964; Choi WS, 2011, BIOMATERIALS, V32, P2500, DOI 10.1016/j.biomaterials.2010.12.014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox Chris D., 2003, OMICS A Journal of Integrative Biology, V7, P317, DOI 10.1089/153623103322452422; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Dilanji GE, 2012, J AM CHEM SOC, V134, P5618, DOI 10.1021/ja211593q; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hense BA, 2012, SENSORS-BASEL, V12, P4156, DOI 10.3390/s120404156; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KOCH AL, 1966, J THEOR BIOL, V12, P276, DOI 10.1016/0022-5193(66)90119-6; KOCH AL, 1969, J THEOR BIOL, V23, P251, DOI 10.1016/0022-5193(69)90040-X; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Wang YF, 2011, BIOPHYS J, V100, P3045, DOI 10.1016/j.bpj.2011.05.006; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weiss R, 2000, 6 INT M DNA BAS COMP, V2054, P1; Weitz M, 2014, J AM CHEM SOC, V136, P72, DOI 10.1021/ja411132w; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Yan L, 2007, J MICROBIOL METH, V68, P40, DOI 10.1016/j.mimet.2006.06.002; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	48	16	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145829	10.1371/journal.pone.0145829	http://dx.doi.org/10.1371/journal.pone.0145829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808777	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800012
J	Ranjbar, N; Mehrali, M; Behnia, A; Pordsari, AJ; Mehrali, M; Alengaram, UJ; Jumaat, MZ				Ranjbar, Navid; Mehrali, Mehdi; Behnia, Arash; Pordsari, Alireza Javadi; Mehrali, Mohammad; Alengaram, U. Johnson; Jumaat, Mohd Zamin			A Comprehensive Study of the Polypropylene Fiber Reinforced Fly Ash Based Geopolymer	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MICROSTRUCTURAL ANALYSIS; COMPRESSIVE STRENGTH; SHRINKAGE; COMPOSITES; BEHAVIOR	As a cementitious material, geopolymers show a high quasi-brittle behavior and a relatively low fracture energy. To overcome such a weakness, incorporation of fibers to a brittle matrix is a well-known technique to enhance the flexural properties. This study comprehensively evaluates the short and long term impacts of different volume percentages of polypropylene fiber (PPF) reinforcement on fly ash based geopolymer composites. Different characteristics of the composite were compared at fresh state by flow measurement and hardened state by variation of shrinkage over time to assess the response of composites under flexural and compressive load conditions. The fiber-matrix interface, fiber surface and toughening mechanisms were assessed using field emission scan electron microscopy (FESEM) and atomic force microscopy (AFM). The results show that incorporation of PPF up to 3 wt % into the geopolymer paste reduces the shrinkage and enhances the energy absorption of the composites. While, it might reduce the ultimate flexural and compressive strength of the material depending on fiber content.	[Ranjbar, Navid; Behnia, Arash; Pordsari, Alireza Javadi; Alengaram, U. Johnson; Jumaat, Mohd Zamin] Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia; [Mehrali, Mehdi] Tech Univ Denmark, Dept Micro & Nanotechnol, DTU Nanotech, DK-2800 Lyngby, Denmark; [Mehrali, Mohammad] Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia; [Mehrali, Mohammad] Univ Malaya, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Technical University of Denmark; Universiti Malaya; Universiti Malaya	Ranjbar, N (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia.	navidr@siswa.um.edu.my	JUMAAT, MOHD ZAMIN/B-9138-2010; Jumaat, Mohd Zamin/ABD-3988-2020; Pordesari, Alireza Javadi/AAJ-8046-2020; Alengaram, U. Johnson/B-9980-2010; Ranjbar, Navid/L-4274-2018; Alengaram, U. Johnson/B-1036-2011; Mehrali, Mehdi/G-6395-2011; mehrali, mohammad/A-7328-2018; Mehrali, Mohammad/ABE-7990-2020	JUMAAT, MOHD ZAMIN/0000-0002-8783-1274; Pordesari, Alireza Javadi/0000-0003-3496-322X; Alengaram, U. Johnson/0000-0001-6153-9999; Ranjbar, Navid/0000-0002-1485-3931; Mehrali, Mehdi/0000-0002-5084-1823; mehrali, mohammad/0000-0001-6667-9368; Mehrali, Mohammad/0000-0001-6667-9368; Alengaram, U.Johnson/0000-0001-9358-2975	University of Malaya under a High Impact Research Grant (HIRG) [UM.C/HIR/MOHE/ENG/36/ D0000036-16001]; High Impact Research Grant (HIRG) [UM.C/HIR/MOHE/ENG/36/ D0000036-16001]	University of Malaya under a High Impact Research Grant (HIRG); High Impact Research Grant (HIRG)	This research work was funded by the University of Malaya under a High Impact Research Grant (HIRG) No. UM.C/HIR/MOHE/ENG/36/ D0000036-16001 (Strengthening structural elements for load and fatigue).; The work was supported by High Impact Research Grant (HIRG) No. UM.C/HIR/MOHE/ENG/36/ D0000036-16001 (Strengthening structural elements for load and fatigue).	Alhozaimy AM, 1996, CEMENT CONCRETE COMP, V18, P85, DOI 10.1016/0958-9465(95)00003-8; Alomayri T, 2014, COMPOS PART B-ENG, V60, P36, DOI 10.1016/j.compositesb.2013.12.036; Alzeer M, 2012, J MATER SCI, V47, P6958, DOI 10.1007/s10853-012-6644-3; [Anonymous], 1997, STANDARD TEST METHOD, P544; [Anonymous], 2015, C2000 ASTM INT, P1; ASTM, 2013, C143713 ASTM, P1; ASTM, 2013, C19113 ASTM; Aulia T.B., 2002, EFFECTS POLYPROPYLEN; Bakharev T, 2005, CEMENT CONCRETE RES, V35, P1224, DOI 10.1016/j.cemconres.2004.06.031; BAZANT ZP, 1992, J ENG MECH-ASCE, V118, P540, DOI 10.1061/(ASCE)0733-9399(1992)118:3(540); Bernal S, 2010, CONSTR BUILD MATER, V24, P208, DOI 10.1016/j.conbuildmat.2007.10.027; BRE, 2000, DES BUILD; Carstens PAB, 2000, J FLUORINE CHEM, V104, P97, DOI 10.1016/S0022-1139(00)00232-3; DAVIDOVITS J, 1991, J THERM ANAL, V37, P1633, DOI 10.1007/BF01912193; Davidovits J., 2020, GEOPOLYMER CHEM APPL, V5th ed.; Dias DP, 2005, CEMENT CONCRETE COMP, V27, P49, DOI 10.1016/j.cemconcomp.2004.02.044; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; He PG, 2010, CERAM INT, V36, P1447, DOI 10.1016/j.ceramint.2010.02.012; Kuenzel C, 2012, J AM CERAM SOC, V95, P3270, DOI 10.1111/j.1551-2916.2012.05380.x; Lopez-Buendia AM, 2013, CEMENT CONCRETE RES, V54, P29, DOI 10.1016/j.cemconres.2013.08.004; MacKenzie KJD, 2014, WOODH PUB S COMPOS S, P445, DOI 10.1533/9780857098825.3.445; Morent R, 2008, SURF INTERFACE ANAL, V40, P597, DOI 10.1002/sia.2619; Pan Z, 2011, MAG CONCRETE RES, V63, P763, DOI 10.1680/macr.2011.63.10.763; Perera DS, 2007, J MATER SCI, V42, P3099, DOI 10.1007/s10853-006-0533-6; Puertas F, 2003, CEMENT CONCRETE RES, V33, P2031, DOI 10.1016/s0008-8846(03)00222-9; Ranjbar N, 2016, COMPOS SCI TECHNOL, V122, P73, DOI 10.1016/j.compscitech.2015.11.009; Ranjbar N, 2016, J CLEAN PROD, V112, P723, DOI 10.1016/j.jclepro.2015.07.033; Ranjbar N, 2015, CEMENT CONCRETE RES, V76, P222, DOI 10.1016/j.cemconres.2015.06.003; Ranjbar N, 2014, CONSTR BUILD MATER, V65, P114, DOI 10.1016/j.conbuildmat.2014.04.064; Ranjbar N, 2014, MATER DESIGN, V59, P532, DOI 10.1016/j.matdes.2014.03.037; Richardson AE, 2006, STRUCT SURV, V24, P138, DOI [DOI 10.1108/02630800610666673, 10.1108/02630800610666673]; Ridtirud C, 2011, INT J MIN MET MATER, V18, P100, DOI 10.1007/s12613-011-0407-z; Sakulich AR, 2011, SUSTAIN CITIES SOC, V1, P195, DOI 10.1016/j.scs.2011.07.009; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; Silva FD, 2010, CONSTR BUILD MATER, V24, P777, DOI 10.1016/j.conbuildmat.2009.10.030; Singh S, 2004, CEMENT CONCRETE RES, V34, P1919, DOI 10.1016/j.cemconres.2004.02.014; Stang H, 1996, ADV CEM BASED MATER, V4, P106, DOI 10.1016/S1065-7355(96)00075-2; Tchadjie LN, 2016, CERAM INT, V42, P3046, DOI 10.1016/j.ceramint.2015.10.091; Zhang YS, 2008, CONSTR BUILD MATER, V22, P370, DOI 10.1016/j.conbuildmat.2006.08.006; Zhang ZH, 2009, J CENT SOUTH UNIV T, V16, P49, DOI 10.1007/s11771-009-0008-4; Zuhua Z, 2009, APPL CLAY SCI, V43, P218, DOI 10.1016/j.clay.2008.09.003	41	79	78	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147546	10.1371/journal.pone.0147546	http://dx.doi.org/10.1371/journal.pone.0147546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807825	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800128
J	Yasumoto, Y; Miyazaki, H; Vaidyan, LK; Kagawa, Y; Ebrahimi, M; Yamamoto, Y; Ogata, M; Katsuyama, Y; Sadahiro, H; Suzuki, M; Owada, Y				Yasumoto, Yuki; Miyazaki, Hirofumi; Vaidyan, Linda Koshy; Kagawa, Yoshiteru; Ebrahimi, Majid; Yamamoto, Yui; Ogata, Masaki; Katsuyama, Yu; Sadahiro, Hirokazu; Suzuki, Michiyasu; Owada, Yuji			Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells	PLOS ONE			English	Article							PHARMACOLOGICAL INHIBITORS; BINDING PROTEIN-7; B-FABP; CANCER; OVEREXPRESSION; PROGRESSION; CULTURE; TARGET; EVENT	Cellular metabolic changes, especially to lipid metabolism, have recently been recognized as a hallmark of various cancer cells. However, little is known about the significance of cellular lipid metabolism in the regulation of biological activity of glioma stem cells (GSCs). In this study, we examined the expression and role of fatty acid synthase (FASN), a key lipogenic enzyme, in GSCs. In the de novo lipid synthesis assay, GSCs exhibited higher lipogenesis than differentiated non-GSCs. Western blot and immunocytochemical analyses revealed that FASN is strongly expressed in multiple lines of patient-derived GSCs (G144 and Y10), but its expression was markedly reduced upon differentiation. When GSCs were treated with 20 mu M cerulenin, a pharmacological inhibitor of FASN, their proliferation and migration were significantly suppressed and de novo lipogenesis decreased. Furthermore, following cerulenin treatment, expression of the GSC markers nestin, Sox2 and fatty acid binding protein (FABP7), markers of GCSs, decreased while that of glial fibrillary acidic protein (GFAP) expression increased. Taken together, our results indicate that FASN plays a pivotal role in the maintenance of GSC stemness, and FASN-mediated de novo lipid biosynthesis is closely associated with tumor growth and invasion in glioblastoma.	[Yasumoto, Yuki; Miyazaki, Hirofumi; Vaidyan, Linda Koshy; Kagawa, Yoshiteru; Ebrahimi, Majid; Yamamoto, Yui; Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan; [Sadahiro, Hirokazu; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 755, Japan; [Yasumoto, Yuki; Miyazaki, Hirofumi; Kagawa, Yoshiteru; Ebrahimi, Majid; Ogata, Masaki; Katsuyama, Yu; Owada, Yuji] Tohoku Univ, Grad Sch Med, Dept Organ Anat, Sendai, Miyagi 980, Japan	Yamaguchi University; Yamaguchi University; Tohoku University	Owada, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan.; Owada, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Organ Anat, Sendai, Miyagi 980, Japan.	owada@med.tohoku.ac.jp		Owada, Yuji/0000-0002-5109-0531; Yasumoto, Yuki/0000-0001-9882-4478; Kagawa, Yoshiteru/0000-0003-2963-7905				Berezovsky AD, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cabarcas SM, 2010, CURR MOL MED, V10, P741; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Grube S, 2014, J NEURO-ONCOL, V118, P277, DOI 10.1007/s11060-014-1452-z; Kagawa Y, 2015, GLIA, V63, P780, DOI 10.1002/glia.22784; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morihiro Y, 2013, PATHOL INT, V63, P546, DOI 10.1111/pin.12109; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rashid A, 1997, AM J PATHOL, V150, P201; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sadahiro H, 2014, BRAIN TUMOR PATHOL, V31, P77, DOI 10.1007/s10014-013-0149-x; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Tirinato L, 2015, STEM CELLS, V33, P35, DOI 10.1002/stem.1837; Vazquez-Martin A, 2013, CELL CYCLE, V12, P207, DOI 10.4161/cc.23352; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang Y, 2001, CANCER LETT, V167, P99, DOI 10.1016/S0304-3835(01)00464-5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Zhao W, 2006, BRIT J CANCER, V95, P869, DOI 10.1038/sj.bjc.6603350	41	82	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147717	10.1371/journal.pone.0147717	http://dx.doi.org/10.1371/journal.pone.0147717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808816	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800193
J	Zhao, TT; Sun, SF; Zhang, HJ; Huang, XR; Yan, MH; Dong, X; Wen, YM; Wang, H; Lan, HY; Li, P				Zhao, TingTing; Sun, SiFan; Zhang, HaoJun; Huang, XiaoRu; Yan, MeiHua; Dong, Xi; Wen, YuMin; Wang, Hua; Lan, Hui Yao; Li, Ping			Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; GROWTH-FACTOR-BETA; RENAL FIBROSIS; DIVERSE ROLES; MOUSE MODEL; INFLAMMATION; SMAD7; MECHANISMS; RECEPTOR; DEGRADATION	Objective Inflammation and fibrosis are essential promoters in the pathogenesis of diabetic nephropathy (DN) in type 2 diabetes. The present study examined the anti-inflammation and anti-fibrosis effect of Tangshen Formula (TSF), a traditional Chinese medicine, on DN. Research Design and Methods Protective role of TSF in DN was examined in a rat model of type 2 DN that was established by high-fat diet-fed and low-dose-streptozotocin injection. TSF was suspended in 0.5% CMC-Na solution and delivered by oral gavage at a dosage of 1.67g/Kg body weight/day. The therapeutic effects and mechanisms of TSF on diabetic kidney injury were examined. Results We found that TSF treatment for 20 weeks attenuated DN by significantly inhibiting urinary excretion of albumin and renal histological injuries. These beneficial effects were associated with an inactivation of NF-kappa B signaling, thereby blocking the upregulation of pro-inflammatory cytokines (IL-1 beta, TNF alpha), chemokine (MCP-1), and macrophage infiltration in the TSF-treated rats with type 2 DN. In addition, TSF treatment also inactivated TGF-beta/Smad3 signaling and therefore suppressed renal fibrosis including expressions of fibronectin, collagen I, and collagen IV. Further studies revealed that the inhibitory effect of TSF on TGF-beta/Smad3 and NF-kappa B signaling in DN was associated with inhibition of Smurf2-dependent ubiquitin degradation of Smad7. Conclusions The present study reveals that TSF has therapeutic potential for type 2 DN in rats. Blockade of NF-kappa B-driven renal inflammation and TGF-beta/Smad3-mediated renal fibrosis by preventing the Smurf2-mediated Smad7 degradation pathway may be mechanisms through which TSF inhibits type 2 DN.	[Zhao, TingTing; Sun, SiFan; Zhang, HaoJun; Yan, MeiHua; Dong, Xi; Wen, YuMin; Wang, Hua; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, XiaoRu; Lan, Hui Yao] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	China-Japan Friendship Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Lan, HY; Li, P (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.; Lan, HY (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	hylan@cuhk.edu.hk; lp8675@163.com	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755; Zhang, Haojun/0000-0002-5993-5260	National Natural Science Foundation of China [81173422, 81130066, 81473526, 81373795, 81302942]; Beijing Natural Science Foundation [7142143]; China-International S T Cooperation [2011DFA31860]; Major State Basic Research Development Program of China (973 program) [2012CB517705]; Research Grant Council of Hong Kong [CUHK3/CRF/12R]; Chinese University of Hong Kong; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2015-QNYC-B-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China-International S T Cooperation; Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This work was supported by grants from the National Natural Science Foundation of China (No: 81173422 and 81130066 to PL, No: 81473526 to TTZ, No: 81373795 to HJZ, No: 81302942 to MHY), http://www.nsfc.gov.cn/; Beijing Natural Science Foundation (No: 7142143 to TTZ), http://www.bjnsf.org/; the China-International S & T Cooperation (No: 2011DFA31860 to PL), the Major State Basic Research Development Program of China (973 program, 2012CB517705 to HYL), http://www.most.gov.cn/; the Research Grant Council of Hong Kong (CUHK3/CRF/12R to HYL), http://www.most.gov.cn/; The Focused Investment Scheme A from Chinese University of Hong Kong (HYL), http://www.cuhk.edu.hk/chinese/index.html, and the China-Japan Friendship Hospital Youth Science and Technology Excellence Project. Award Number: 2015-QNYC-B-09. Recipient: Ting Ting Zhao, Ph.D.	Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Committee NP, 2010, PHARMACOPOEIA PEOPLE; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; El Mesallamy HO, 2012, CLIN BIOCHEM, V45, P646, DOI 10.1016/j.clinbiochem.2012.02.021; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hong SW, 2001, AM J PATHOL, V158, P1653; Huang W, 2013, BIOCHEM BIOPH RES CO, V438, P568, DOI 10.1016/j.bbrc.2013.07.065; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126027; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Liu GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053573; Liu Z, 2012, LAB INVEST, V92, P650, DOI 10.1038/labinvest.2012.2; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Williams Michael D, 2007, Curr Diab Rep, V7, P242, DOI 10.1007/s11892-007-0038-y; Zhang HJ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/613737; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807; Zhu B, 2014, MOL CELL BIOCHEM, V393, P23, DOI 10.1007/s11010-014-2043-1	33	37	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147693	10.1371/journal.pone.0147693	http://dx.doi.org/10.1371/journal.pone.0147693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807792	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800184
J	Demchenko, NL; Chapman, JW; Durkina, VB; Fadeev, VI				Demchenko, Natalia L.; Chapman, John W.; Durkina, Valentina B.; Fadeev, Valeriy I.			Life History and Production of the Western Gray Whale's Prey, Ampelisca eschrichtii Kroyer, 1842 (Amphipoda, Ampeliscidae)	PLOS ONE			English	Article							NORTHERN BERING-SEA; SAKHALIN ISLAND; ROBUSTUS; SHELF; OKHOTSK; RUSSIA; POPULATION; COMMUNITY; ABUNDANCE; PATTERNS	Ampelisca eschrichtii are among the most important prey of the Western North Pacific gray whales, Eschrichtius robustus. The largest and densest known populations of this amphipod occur in the gray whale's Offshore feeding area on the Northeastern Sakhalin Island Shelf. The remote location, ice cover and stormy weather at the Offshore area have prevented winter sampling. The incomplete annual sampling has confounded efforts to resolve life history and production of A. eschrichtii. Expanded comparisons of population size structure and individual reproductive development between late spring and early fall over six sampling years between 2002 and 2013 however, reveal that A. eschrichtii are gonochoristic, iteroparous, mature at body lengths greater than 15 mm and have a two-year life span. The low frequencies of brooding females, the lack of early stage juveniles, the lack of individual or population growth or biomass increases over late spring and summer, all indicate that growth and reproduction occur primarily in winter, when sampling does not occur. Distinct juvenile and adult size cohorts additionally indicate growth and juvenile production occurs in winter through spring under ice cover. Winter growth thus requires that winter detritus or primary production are critical food sources for these ampeliscid populations and yet, the Offshore area and the Eastern Sakhalin Shelf ampeliscid communities may be the most abundant and productive amphipod population in the world. These A. eschrichtii populations are unlikely to be limited by western gray whale predation. Whether benthic community structure can limit access and foraging success of western gray whales is unclear.	[Demchenko, Natalia L.; Fadeev, Valeriy I.] Russian Acad Sci, Lab Ecol Shelf Communities, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia; [Chapman, John W.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, 2030 Marine Sci Dr, Newport, OR 97365 USA; [Durkina, Valentina B.] Russian Acad Sci, Lab Cytophysiol, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Oregon State University; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences	Demchenko, NL (corresponding author), Russian Acad Sci, Lab Ecol Shelf Communities, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia.	demnal@hotmail.com	Demchenko, Natalia L./G-8634-2012; Durkina, Valentina/AAH-3314-2022; Durkina, Valentina/CAA-3700-2022	Demchenko, Natalia L./0000-0003-0479-3370; Durkina, Valentina/0000-0003-2659-3847; Durkina, Valentina/0000-0003-2659-3847	Exxon Neftegas, Ltd. [A2308506]; Sakhalin Energy Investment Co; Far Eastern Branch of the Russian Academy of Sciences [13-III-B-06-057]	Exxon Neftegas, Ltd.; Sakhalin Energy Investment Co; Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	Support for sample collections and partial financial support of NLD for sample analyses were provided by Exxon Neftegas, Ltd. No A2308506, by Sakhalin Energy Investment Co and partly by a grant to NLD from the Far Eastern Branch of the Russian Academy of Sciences 13-III-B-06-057. JWC and VBD were not funded. VIF is deceased. The funders supported the collection of the samples. They did not collect the samples for the express purpose of this study and did not participate in or support the analyses, decision to publish or in the preparation of the manuscript. NLD did not receive other funding (whether external or internal to her organization) that was reported previously.	Bogoslovskaya LS, 1996, PRIRODA, V12, P42; Bosin AA, 2010, OCEANOLOGY+, V50, P175, DOI 10.1134/S0001437010020037; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Budnikova LL, 2012, RUSS J MAR BIOL+, V38, P149, DOI 10.1134/S1063074012020022; Budnikova L.L, 2003, IZVESTIA TINRO, V135, P197; Buyanovsky AI, 2011, PROBL FISH, V12, P274; Carretta JV, 2014, GRAY WHALE ESCHRICHT, P171; Chapman JW, 2014, J CRUSTACEAN BIOL, V34, P349, DOI 10.1163/1937240X-00002236; Clarke KR, 1994, CHANGE MARINE COMMUN; Coyle KO, 2007, DEEP-SEA RES PT II, V54, P2906, DOI 10.1016/j.dsr2.2007.08.026; COYLE KO, 1994, MAR ECOL PROG SER, V107, P233, DOI 10.3354/meps107233; Crisp D. J., 1984, METHODS STUDY MARINE, P284; Demchenko N., 2011, IZV TINRO, V166, P244; Demchenko N.L., 2010, Zoologica Baetica, V21, P143; Dulepova EP, 2008, IZV TINRO, V154, P90; Fadeev V. I., 2007, RESPONSE MARINE BIOT, P213; Fadeev VI, 2009, INT WHAL COMM 61 ANN, P1; Fadeev VI, 2011, BENTHOS STUDIES FEED, P4; Fadeev VI, 2011, INT WHAL COMM 63 ANN, P1; Gayanilo F.C., 2005, WORLDFISH CTR NO 7, P168; Gorley C.K., 2006, GETTING STARTED PRIM; HIGHSMITH RC, 1990, NATURE, V344, P862, DOI 10.1038/344862a0; HIGHSMITH RC, 1991, AM ZOOL, V31, P861; HIGHSMITH RC, 1992, MAR ECOL PROG SER, V83, P141, DOI 10.3354/meps083141; Hunt GL, 2002, PROG OCEANOGR, V55, P5, DOI 10.1016/S0079-6611(02)00067-8; Johnson SR, 2007, ENVIRON MONIT ASSESS, V134, P1, DOI 10.1007/s10661-007-9813-0; KANNEWORFF EBBE, 1965, OPHELIA, V2, P305; Kedra M, 2012, ESTUAR COAST SHELF S, V114, P183, DOI 10.1016/j.ecss.2012.08.015; KIM SL, 1989, CAN J ZOOL, V67, P1531, DOI 10.1139/z89-218; Koblikov V.N., 1982, Izvestiya Tikhookeanskogo Nauchno-Issledovatel'skogo Instituta Rybnogo Khozyaistva i Okeanografii, V106, P90; Kudrjaschov VA., 1968, SOSTAV ZAKONOMERNOST, P86; Laake Jeffrey L., 2012, Journal of Cetacean Research and Management, V12, P287; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Maminov M. K., 2002, MARINE MAMMALS HOLAR, P170; Markina NP, 1984, IZV TINRO, V109, P109; Meier SK, 2007, ENVIRON MONIT ASSESS, V134, P107, DOI 10.1007/s10661-007-9811-2; MILLS EL, 1967, J FISH RES BOARD CAN, V24, P305, DOI 10.1139/f67-030; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Nadtochiy V.A., 2004, IZV TIKHOOKEAN NAUCH, V139, P317; Nakatsuka T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014029; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; Nerini M., 1984, P423; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Pasternak F. A., 1957, Trud Okean, V23, P237; Punt Andre E., 2012, Journal of Cetacean Research and Management, V12, P15; Rigolet C, 2012, ESTUAR COAST SHELF S, V113, P259, DOI 10.1016/j.ecss.2012.08.014; Rodkina SA, 2008, 1 FAR E INT S LIF SC, P65; Rugh DJ, 2005, J CETACEAN RES MANAG, V7, P1; Rutenko AN, 2014, RUSS METEOROL HYDRO+, V39, P335, DOI 10.3103/S1068373914050070; Rutenko AN, 2009, RUSS METEOROL HYDROL, V34, P93, DOI 10.3103/S1068373909020058; Schumacher JD, 2003, CLIMATE CHANGE SE BE; Shevchenko GV, 2004, J PHYS OCEANOGR, V34, P2470, DOI 10.1175/JPO2632.1; Sobolevskii EI, 2000, RUSS J ECOL+, V31, P126, DOI 10.1007/BF02828368; Sorokin YI, 2002, J PLANKTON RES, V24, P453, DOI 10.1093/plankt/24.5.453; Sosnin V. A., 2007, Russian Meteorology and Hydrology, V32, P50, DOI 10.3103/S1068373907010074; Sumich J., 2014, E ROBUSTUS BIOL HUMA; Tyurneva OY, 2010, RUSS J MAR BIOL+, V36, P117, DOI 10.1134/S1063074010020069; Tyurneva OY, 2012, INT WHAL COMM 65 SCI, P1; Tzvetkova N, 1975, PRIBREZHNYE GAMMARID; Vladimirov VA, 2010, INT WHAL COMM 62 ANN, P1; Vladimirov VA, 2012, DISTRIBUTION ABUNDAN, P1; Weller DW, 1999, MAR MAMMAL SCI, V15, P1208, DOI 10.1111/j.1748-7692.1999.tb00886.x; Weslawski Jan Marcin, 2002, Polish Polar Research, V23, P253; WILDISH DJ, 1981, CAN J FISH AQUAT SCI, V38, P1019, DOI 10.1139/f81-140; Yablokov A.V., 1984, P465; Yakovlev YM, 2014, PHOTOIDENTIFICATION, P66; Zakharkov SP, 2007, OCEANOLOGY+, V47, P519, DOI 10.1134/S0001437007040091	67	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147304	10.1371/journal.pone.0147304	http://dx.doi.org/10.1371/journal.pone.0147304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800185	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300090
J	Downs, J; Stahlhut, M; Wong, K; Syhler, B; Bisgaard, AM; Jacoby, P; Leonard, H				Downs, Jenny; Stahlhut, Michelle; Wong, Kingsley; Syhler, Birgit; Bisgaard, Anne-Marie; Jacoby, Peter; Leonard, Helen			Validating the Rett Syndrome Gross Motor Scale	PLOS ONE			English	Article							MECP2; MUTATIONS; DIAGNOSIS; SEVERITY	Rett syndrome is a pervasive neurodevelopmental disorder associated with a pathogenic mutation on the MECP2 gene. Impaired movement is a fundamental component and the Rett Syndrome Gross Motor Scale was developed to measure gross motor abilities in this population. The current study investigated the validity and reliability of the Rett Syndrome Gross Motor Scale. Video data showing gross motor abilities supplemented with parent report data was collected for 255 girls and women registered with the Australian Rett Syndrome Database, and the factor structure and relationships between motor scores, age and genotype were investigated. Clinical assessment scores for 38 girls and women with Rett syndrome who attended the Danish Center for Rett Syndrome were used to assess consistency of measurement. Principal components analysis enabled the calculation of three factor scores: Sitting, Standing and Walking, and Challenge. Motor scores were poorer with increasing age and those with the p.Arg133Cys, p.Arg294* or p.Arg306Cys mutation achieved higher scores than those with a large deletion. The repeatability of clinical assessment was excellent (intraclass correlation coefficient for total score 0.99, 95% CI 0.93-0.98). The standard error of measurement for the total score was 2 points and we would be 95% confident that a change 4 points in the 45-point scale would be greater than within-subject measurement error. The Rett Syndrome Gross Motor Scale could be an appropriate measure of gross motor skills in clinical practice and clinical trials.	[Downs, Jenny; Wong, Kingsley; Jacoby, Peter; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Downs, Jenny] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Stahlhut, Michelle; Syhler, Birgit; Bisgaard, Anne-Marie] Rigshosp, Dept Clin Genet, Ctr Rett Syndrome, DK-2100 Copenhagen, Denmark	Telethon Kids Institute; University of Western Australia; Curtin University; Rigshospitalet; University of Copenhagen	Downs, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.; Downs, J (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia.	Jenny.Downs@telethonkids.org.au	Wong, Kingsley/I-6935-2013; Leonard, Helen/A-1010-2013; Downs, Jenny/R-9947-2017	Wong, Kingsley/0000-0001-5178-6080; Leonard, Helen/0000-0001-6405-5834; Downs, Jenny/0000-0001-7358-9037; Stahlhut, Michelle/0000-0002-4551-5265	National Health and Medical Research Council [303189, 1004384, 572742, 572568]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study has been received from the National Health and Medical Research Council project grant #303189 (HL) and #1004384 (HL, JD), program grant #572742 (HL), and a research fellowship #572568 (HL) (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-87; Avery LM, 2003, ARCH PHYS MED REHAB, V84, P697, DOI 10.1016/S0003-9993(03)04896-7; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Bebbington A, 2012, EUR J HUM GENET, V20, P921, DOI 10.1038/ejhg.2012.34; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; Downs J, 2013, LIFE QUALITY OUTCOME; Downs JA, 2008, NEUROPEDIATRICS, V39, P205, DOI 10.1055/s-0028-1104575; Fehr S, 2011, PEDIATR RES, V70, P313, DOI 10.1203/PDR.0b013e3182242461; Fehr S, 2011, J CHILD NEUROL, V26, P980, DOI 10.1177/0883073811401396; Foley KR, 2011, J CHILD NEUROL, V26, P1237, DOI 10.1177/0883073811402688; Fyfe S, 2007, J AUTISM DEV DISORD, V37, P1636, DOI 10.1007/s10803-006-0293-9; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Humphreys P, 2015, DEV MED CHILD NEUROL; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Van Ginkel JR, 2014, J STAT COMPUT SIM, V84, P2298, DOI 10.1080/00949655.2013.788654; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	20	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147555	10.1371/journal.pone.0147555	http://dx.doi.org/10.1371/journal.pone.0147555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800272	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300123
J	Dutov, P; Antipova, O; Varma, S; Orgel, JPRO; Schieber, JD				Dutov, Pavel; Antipova, Olga; Varma, Sameer; Orgel, Joseph P. R. O.; Schieber, Jay D.			Measurement of Elastic Modulus of Collagen Type I Single Fiber	PLOS ONE			English	Article							FIBRIL SIZE; TRACKING	Collagen fibers are the main components of the extra cellular matrix and the primary contributors to the mechanical properties of tissues. Here we report a novel approach to measure the longitudinal component of the elastic moduli of biological fibers under conditions close to those found in vivo and apply it to type I collagen from rat tail tendon. This approach combines optical tweezers, atomic force microscopy, and exploits Euler-Bernoulli elasticity theory for data analysis. This approach also avoids drying for measurements or visualization, since samples are freshly extracted. Importantly, strains are kept below 0.5%, which appear consistent with the linear elastic regime. We find, surprisingly, that the longitudinal elastic modulus of type I collagen cannot be represented by a single quantity but rather is a distribution that is broader than the uncertainty of our experimental technique. The longitudinal component of the single-fiber elastic modulus is between 100 MPa and 360 MPa for samples extracted from different rats and/or different parts of a single tail. Variations are also observed in the fibril-bundle / fibril diameter with an average of 325 +/- 40 nm. Since bending forces depend on the diameter to the fourth power, this variation in diameter is important for estimating the range of elastic moduli. The remaining variations in the modulus may be due to differences in composition of the fibril-bundles, or the extent of the proteoglycans constituting fibril-bundles, or that some single fibrils may be of fibril-bundle size.	[Dutov, Pavel; Antipova, Olga; Orgel, Joseph P. R. O.; Schieber, Jay D.] IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA; [Dutov, Pavel; Schieber, Jay D.] IIT, Chem & Biol Engn Dept, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] IIT, Dept Biol, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.; Schieber, Jay D.] IIT, Dept Phys, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Antipova, Olga; Orgel, Joseph P. R. O.] BioCAT, APS Argonne Natl Lab, Sect 18,9700 S Cass Ave, Argonne, IL USA; [Varma, Sameer] Univ S Florida, Dept Phys, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of South Florida	Schieber, JD (corresponding author), IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.; Schieber, JD (corresponding author), IIT, Chem & Biol Engn Dept, Chicago, IL 60616 USA.; Schieber, JD (corresponding author), IIT, Dept Phys, Chicago, IL 60616 USA.	schieber@iit.edu			DARPA [W911NF-09-1-0378]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors acknowledge financial support of DARPA grant W911NF-09-1-0378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; Dutov P, 2013, OPT LETT, V38, P4923, DOI 10.1364/OL.38.004923; Eulero L, 1744, METHODUS INVENIENDI; Farman GP, 2010, BIOPHYS J, V99, P2978, DOI 10.1016/j.bpj.2010.09.003; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; Gross J, 1948, J EXP MED; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Magnusson SP, 2002, MATRIX BIOL, V21, P369, DOI 10.1016/S0945-053X(02)00011-2; Masic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6942; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089519; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Press W., 1992, NUMERICAL RECIPES FO; Shayegan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070590; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sun YL, 2002, BIOCHEM BIOPH RES CO, V295, P382, DOI 10.1016/S0006-291X(02)00685-X; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Wozniak A, 2009, SINGLE MOL FORCE SPE, P467; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Zeltz C, 2014, BBA-GEN SUBJECTS, V1840, P2533, DOI 10.1016/j.bbagen.2013.12.022	33	59	59	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145711	10.1371/journal.pone.0145711	http://dx.doi.org/10.1371/journal.pone.0145711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800120	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300010
J	Raes, EJ; Bodrossy, L; de Kamp, JV; Holmes, B; Hardman-Mountford, N; Thompson, PA; McInnes, AS; Waite, AM				Raes, Eric J.; Bodrossy, Levente; de Kamp, Jodie Van; Holmes, Bronwyn; Hardman-Mountford, Nick; Thompson, Peter A.; McInnes, Allison S.; Waite, Anya M.			Reduction of the Powerful Greenhouse Gas N2O in the South-Eastern Indian Ocean	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTASE; DENITRIFYING BACTERIA; DENITRIFICATION RATES; NOSZ; NITRIFICATION; DIVERSITY; PACIFIC; NITRATE; SYSTEM; GENES	Nitrous oxide (N2O) is a powerful greenhouse gas and a key catalyst of stratospheric ozone depletion. Yet, little data exist about the sink and source terms of the production and reduction of N2O outside the well-known oxygen minimum zones (OMZ). Here we show the presence of functional marker genes for the reduction of N2O in the last step of the denitrification process (nitrous oxide reductase genes; nosZ) in oxygenated surface waters (180-250 O-2 mu mol.kg(-1)) in the south-eastern Indian Ocean. Overall copy numbers indicated that nosZ genes represented a significant proportion of the microbial community, which is unexpected in these oxygenated waters. Our data show strong temperature sensitivity for nosZ genes and reaction rates along a vast latitudinal gradient (32 degrees S-12 degrees S). These data suggest a large N2O sink in the warmer Tropical waters of the south-eastern Indian Ocean. Clone sequencing from PCR products revealed that most denitrification genes belonged to Rhodobacteraceae. Our work highlights the need to investigate the feedback and tight linkages between nitrification and denitrification (both sources of N2O, but the latter also a source of bioavailable N losses) in the understudied yet strategic Indian Ocean and other oligotrophic systems.	[Raes, Eric J.; Hardman-Mountford, Nick] Univ Western Australia, Oceans Inst, M047 35 Stirling Hwy, Crawley, WA 6009, Australia; [Bodrossy, Levente; de Kamp, Jodie Van; Holmes, Bronwyn; Thompson, Peter A.] CSIRO Oceans & Atmosphere Flagship, GPO Box 1538, Hobart, Tas 7001, Australia; [Raes, Eric J.; Hardman-Mountford, Nick] CSIRO Oceans & Atmosphere Flagship, Private Bag 5, Wembley, WA 6913, Australia; [McInnes, Allison S.] Univ Technol Sydney, Plant Funct Biol & Climate Change, City Campus 15 Broadway, Ultimo, NSW 2007, Australia; [Waite, Anya M.] Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Raes, EJ (corresponding author), Univ Western Australia, Oceans Inst, M047 35 Stirling Hwy, Crawley, WA 6009, Australia.; Raes, EJ (corresponding author), CSIRO Oceans & Atmosphere Flagship, Private Bag 5, Wembley, WA 6913, Australia.	eric.raes@research.uwa.edu.au	Waite, Anya M/A-5492-2015; van de Kamp, Jodie L/E-9423-2015; Bodrossy, Levente/B-8054-2009; Thompson, Peter/A-2361-2012; McInnes, Allison/H-5694-2016	Waite, Anya M/0000-0003-2965-0296; van de Kamp, Jodie L/0000-0003-2167-0938; Bodrossy, Levente/0000-0001-6940-452X; Raes, Eric/0000-0002-4131-9312; Thompson, Peter/0000-0002-9504-5433; McInnes, Allison/0000-0002-8340-3133	University of Western Australia; CSIRO Wealth from Oceans postgraduate top-up scholarship	University of Western Australia; CSIRO Wealth from Oceans postgraduate top-up scholarship	E. J. Raes received an Australian Postgraduate scholarship from the University of Western Australia and a CSIRO Wealth from Oceans postgraduate top-up scholarship.	Bouskill NJ, 2012, ENVIRON MICROBIOL, V14, P714, DOI 10.1111/j.1462-2920.2011.02623.x; BROECKER WS, 1974, EARTH PLANET SC LETT, V23, P100, DOI 10.1016/0012-821X(74)90036-3; BUTLER JH, 1989, J GEOPHYS RES-ATMOS, V94, P14865, DOI 10.1029/JD094iD12p14865; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Ducey TF, 2015, J ENVIRON QUAL, V44, P1011, DOI 10.2134/jeq2014.09.0403; Freing A, 2012, PHILOS T R SOC B, V367, P1245, DOI 10.1098/rstb.2011.0360; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Iribar A, 2015, ECOL ENG, V80, P191, DOI 10.1016/j.ecoleng.2015.02.002; Jayakumar A, 2009, GEOPHYS MONOGR SER, V185, P187, DOI 10.1029/2008GM000730; Klawonn I, 2015, ISME J; Kloos K, 2001, AUST J PLANT PHYSIOL, V28, P991; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Li YH, 2006, DEEP-SEA RES PT I, V53, P94, DOI 10.1016/j.dsr.2005.09.009; Montzka S.A., 2011, OZONE DEPLETING SUBS, P516; Naqvi S, 2003, BIOGEOCHEMISTRY; Naqvi SWA, 2010, BIOGEOSCIENCES, V7, P2159, DOI 10.5194/bg-7-2159-2010; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nogales B, 2002, APPL ENVIRON MICROB, V68, P5017, DOI 10.1128/AEM.68.10.5017-5025.2002; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Pearce A., 2011, MARINE HEAT WAVE W A; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Raes EJ, 2014, MAR ECOL PROG SER; Raes EJ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1283, DOI 10.1002/2015GB005194; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Sabaty M, 1999, J BACTERIOL, V181, P6028, DOI 10.1128/JB.181.19.6028-6032.1999; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Takeshita Y, 2013, J GEOPHYS RES-OCEANS, V118, P5640, DOI 10.1002/jgrc.20399; Thompson PA, 2011, PROG OCEANOGR, V91, P345, DOI 10.1016/j.pocean.2011.02.011; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Villanueva L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00031; Voss M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0121; Waite AM, 2013, BIOGEOSCIENCES, V10, P5691, DOI 10.5194/bg-10-5691-2013; Waite AM, 2015, LIMNOL OCEA IN PRESS; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Wernberg T, 2012, NATURE CLIMATE CHANG; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wyman M, 2013, APPL ENVIRON MICROB, V79, P2670, DOI 10.1128/AEM.03705-12; Wyrtki K., 1973, ECOL STUD, V3, P18, DOI [10.1007/978-3-642-65468-8_3, DOI 10.1007/978-3-642-65468-8_3]; Yool A, 2011, METHOD ENZYMOL, V486, P3, DOI [10.1016/S0076-6879(11)86001-5, 10.1016/B978-0-12-381294-0.00001-8]; YOSHINARI T, 1980, APPL ENVIRON MICROB, V39, P81, DOI 10.1128/AEM.39.1.81-84.1980; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	53	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145996	10.1371/journal.pone.0145996	http://dx.doi.org/10.1371/journal.pone.0145996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800249	Green Published, gold			2022-12-27	WOS:000368655300011
J	Wu, J; Cui, W; Cai, Q; Fei, J; Zhang, SD; Han, TQ; Hu, H; Jiang, ZY				Wu, Jian; Cui, Wei; Cai, Qu; Fei, Jian; Zhang, Sheng-Dao; Han, Tian-Quan; Hu, Hai; Jiang, Zhao-Yan			The NPC1L1 Polymorphism 1679C > G Is Associated with Gallstone Disease in Chinese Patients	PLOS ONE			English	Article							PICK C1-LIKE 1; CHOLESTEROL ABSORPTION; GENETIC-VARIATION; GALLBLADDER BILE; PLANT STEROLS; EZETIMIBE; HYPERCHOLESTEROLEMIA; RISK; POPULATION; SATURATION	Niemann Pick Type C1 Like 1 (NPC1L1) protein plays a key role in intestinal and hepatic cholesterol metabolism in humans. Genetic variation in NPC1L1 has been widely studied in recent years. We analyzed NPC1L1 single nucleotide polymorphisms in Chinese gallstone disease patients to investigate their association with gallstone disease. NPC1L1 mRNA expression was also measured in liver biopsies from patients with cholesterol gallstone disease and compared between genotypes. The G allele of the g1679C>G (rs2072183) polymorphism was significantly more prevalent in patients with gallstones compared with gallstone-free subjects. Moreover, patients carrying the G allele had lower hepatic NPC1L1 mRNA expression and higher biliary cholesterol (molar percentages) and cholesterol saturation index. Our study suggests that the G allele of the NPC1L1 polymorphism g1679C>G may be a positive marker of gallstone formation risk.	[Wu, Jian; Hu, Hai; Jiang, Zhao-Yan] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai 200092, Peoples R China; [Wu, Jian; Cai, Qu; Fei, Jian; Zhang, Sheng-Dao; Han, Tian-Quan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg,Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Cui, Wei] Yijishan Hosp, Wannan Med Coll, Dept Surg, Nanjing, Jiangsu, Peoples R China	Tongji University; Shanghai Jiao Tong University; Wannan Medical College	Hu, H; Jiang, ZY (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai 200092, Peoples R China.	huhailc@sina.com; zhaoyanjiang@gmail.com		hu, hai/0000-0001-7915-6873	National Natural Science Foundation of China [81270537, 81070367, 81170428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81270537, 81070367 and 81170428).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; CAREY MC, 1978, J LIPID RES, V19, P945; Chen CW, 2009, J HUM GENET, V54, P242, DOI 10.1038/jhg.2009.18; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cui W, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-17; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Ference BA, 2015, J AM COLL CARDIOL, V66, P1086, DOI 10.1016/j.jacc.2015.06.1311; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gustafsson U, 2000, EUR J CLIN INVEST, V30, P1099, DOI 10.1046/j.1365-2362.2000.00740.x; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Jungst D, 2004, J LAB CLIN MED, V144, P134, DOI 10.1016/j.lab.2004.04.012; Kashiwabara Y, 2014, J CLIN PHARM THER, V39, P551, DOI 10.1111/jcpt.12176; KESANIEMI YA, 1987, EUR J CLIN INVEST, V17, P391, DOI 10.1111/j.1365-2362.1987.tb01132.x; Lauridsen BK, 2015, EUR HEART J, V36, P1601, DOI 10.1093/eurheartj/ehv108; Lupattelli G, 2013, J CLIN LIPIDOL, V7, P147, DOI 10.1016/j.jacl.2012.12.003; Maeda T, 2010, J ATHEROSCLER THROMB, V17, P356, DOI 10.5551/jat.2451; Martin B, 2010, NUTR METAB CARDIOVAS, V20, P236, DOI 10.1016/j.numecd.2009.03.023; Miao L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-61; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Miquel JF, 1998, GASTROENTEROLOGY, V114, P1016, DOI 10.1016/S0016-5085(98)70322-1; Nissinen MJ, 2008, BRIT J NUTR, V99, P370, DOI 10.1017/S0007114507811998; Pisciotta L, 2007, ATHEROSCLEROSIS, V194, pE116, DOI 10.1016/j.atherosclerosis.2006.10.036; Pisciotta L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-123; Polisecki E, 2010, J LIPID RES, V51, P1201, DOI 10.1194/jlr.P001172; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Stein A, 2012, WORLD J GASTROENTERO, V18, P5789, DOI 10.3748/wjg.v18.i40.5789; Tang WQ, 2011, BBA-MOL CELL BIOL L, V1811, P549, DOI 10.1016/j.bbalip.2011.05.013; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang HH, 2008, GASTROENTEROLOGY, V134, P2101, DOI 10.1053/j.gastro.2008.03.011; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147562	10.1371/journal.pone.0147562	http://dx.doi.org/10.1371/journal.pone.0147562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800364	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300124
J	Di Giorgio, L; Flaxman, AD; Moses, MW; Fullman, N; Hanlon, M; Conner, RO; Wollum, A; Murray, CJL				Di Giorgio, Laura; Flaxman, Abraham D.; Moses, Mark W.; Fullman, Nancy; Hanlon, Michael; Conner, Ruben O.; Wollum, Alexandra; Murray, Christopher J. L.			Efficiency of Health Care Production in Low-Resource Settings: A Monte-Carlo Simulation to Compare the Performance of Data Envelopment Analysis, Stochastic Distance Functions, and an Ensemble Model	PLOS ONE			English	Article							TECHNICAL EFFICIENCY; FRONTIER; VARIABLES; DEA	Low-resource countries can greatly benefit from even small increases in efficiency of health service provision, supporting a strong case to measure and pursue efficiency improvement in low-and middle-income countries (LMICs). However, the knowledge base concerning efficiency measurement remains scarce for these contexts. This study shows that current estimation approaches may not be well suited to measure technical efficiency in LMICs and offers an alternative approach for efficiency measurement in these settings. We developed a simulation environment which reproduces the characteristics of health service production in LMICs, and evaluated the performance of Data Envelopment Analysis (DEA) and Stochastic Distance Function (SDF) for assessing efficiency. We found that an ensemble approach (ENS) combining efficiency estimates from a restricted version of DEA (rDEA) and restricted SDF (rSDF) is the preferable method across a range of scenarios. This is the first study to analyze efficiency measurement in a simulation setting for LMICs. Our findings aim to heighten the validity and reliability of efficiency analyses in LMICs, and thus inform policy dialogues about improving the efficiency of health service production in these settings.	[Di Giorgio, Laura; Flaxman, Abraham D.; Moses, Mark W.; Fullman, Nancy; Hanlon, Michael; Conner, Ruben O.; Wollum, Alexandra; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Flaxman, AD (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	abie@uw.edu		Wollum, Alexandra/0000-0002-5737-0112	Disease Control Priorities Network (DCPN) project; Bill & Melinda Gates Foundation	Disease Control Priorities Network (DCPN) project; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Disease Control Priorities Network (DCPN) project, a grant funded by the Bill & Melinda Gates Foundation. The funders had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Akazili J, 2008, Ghana Med J, V42, P149; Andor M., 2011, CAWM DISCUSSION PAPE, V51; Andor M, 2014, J PROD ANAL, V41, P85, DOI 10.1007/s11123-013-0354-y; Barnighausen T, 2010, B WORLD HEALTH ORGAN, V88, P951, DOI 10.2471/BLT.09.073890; Banker R. D., 1988, APPL MODERN PRODUCTI, P33, DOI DOI 10.1007/978-94-009-3253-1_2; BANKER RD, 1993, EUR J OPER RES, V67, P332, DOI 10.1016/0377-2217(93)90289-Y; Banker RD, 2004, EUR J OPER RES, V153, P624, DOI 10.1016/S0377-2217(02)00699-9; Bennett S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001001; Bifulco R, 2001, ECON EDUC REV, V20, P417, DOI 10.1016/S0272-7757(00)00025-X; Bocoum FY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-997; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Charnes A., 1995, DATA ENVELOPMENT ANA; Chen WC, 2010, COMPUT OPER RES, V37, P417, DOI 10.1016/j.cor.2009.06.010; Chisholm D, 2010, IMPROVING HLTH SYSTE, P10; Coelli T, 1999, EUR J OPER RES, V117, P326, DOI 10.1016/S0377-2217(98)00271-9; Coelli T, 2000, 2000042 CORE; Collier T, 2011, EUR J OPER RES, V208, P153, DOI 10.1016/j.ejor.2010.08.024; Cooper W., 2011, HDB DATA ENVELOPMENT; Dias CTD, 2008, ECOL MODEL, V215, P293, DOI 10.1016/j.ecolmodel.2008.03.020; Estelle SM, 2010, COMPUT OPER RES, V37, P1087, DOI 10.1016/j.cor.2009.09.015; Farsi M, 2006, J EC STAT, V142, P1; GREENE WH, 1990, J ECONOMETRICS, V46, P141, DOI 10.1016/0304-4076(90)90052-U; Griffin JE, 2007, J PROD ANAL, V27, P163, DOI 10.1007/s11123-007-0033-y; GROSSKOPF S, 1987, J HEALTH ECON, V6, P89, DOI 10.1016/0167-6296(87)90001-4; Hadad Y, 2013, CENT EUR J OPER RES, V21, P595, DOI 10.1007/s10100-012-0249-4; Henningsen G, 2015, J PROD ANAL, V44, P309, DOI 10.1007/s11123-014-0416-9; Hernandez AR, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23190; IHME, 2014, HLTH SERV PROV KEN A; IHME, 2014, HLTH SERVICE PROVISI; Institute for Health Metrics and Evaluation (IHME), 2015, ACC BOTTL COSTS EQ A; Institute for Health Metrics and Evaluation (IHME), 2014, HLTH SERV PROV ZAM A; Irz X, 2004, J AGR ECON, V55, P455, DOI 10.1111/j.1477-9552.2004.tb00110.x; Jacobs R, 2006, MEASURING EFFICIENCY; JONDROW J, 1982, J ECONOMETRICS, V19, P233, DOI 10.1016/0304-4076(82)90004-5; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kneip A, 2008, ECONOMET THEOR, V24, P1663, DOI 10.1017/S0266466608080651; Kneller R, 2003, ECON LETT, V81, P223, DOI 10.1016/S0165-1765(03)00173-3; Lovell C., 1994, MODELS MEASUREMENT W, P787; Marschall P, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-5; Mortimer D., 2002, COMPETING METHODS EF; NYMAN JA, 1989, REV ECON STAT, V71, P586, DOI 10.2307/1928100; Otto PB, 2015, BENCHMARK FRONTIER A; Perelman S, 2011, EDUC ECON, V19, P29, DOI 10.1080/09645290802470475; Resti A, 2000, EUR J OPER RES, V121, P559, DOI 10.1016/S0377-2217(99)00054-5; Ruggiero J., 2007, International Transactions in Operational Research, V14, P259, DOI 10.1111/j.1475-3995.2007.00585.x; Ruggiero J, 1999, EUR J OPER RES, V115, P555, DOI 10.1016/S0377-2217(98)00245-8; Ruggiero J, 1998, EUR J OPER RES, V111, P369, DOI 10.1016/S0377-2217(97)00351-2; Sarkis J., 2006, PRODUCTIVITY ANAL SE, V3rd ed., P115; Portela MCAS, 2006, ANN OPER RES, V145, P129, DOI 10.1007/s10479-006-0029-4; STEVENSON RE, 1980, J ECONOMETRICS, V13, P57, DOI 10.1016/0304-4076(80)90042-1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yawe B, 2010, ZAMB SOC SCI J, V1; Yip W., 2015, IMPROVING HLTH SYSTE; Yu CY, 1998, EUR J OPER RES, V105, P569, DOI 10.1016/S0377-2217(97)00076-3; Zere Eyob, 2006, Cost Eff Resour Alloc, V4, P5	55	6	6	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147261	10.1371/journal.pone.0147261	http://dx.doi.org/10.1371/journal.pone.0147261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812685	gold, Green Published			2022-12-27	WOS:000369528000025
J	Norden, PR; Kim, DJ; Barry, DM; Cleaver, OB; Davis, GE				Norden, Pieter R.; Kim, Dae Joong; Barry, David M.; Cleaver, Ondine B.; Davis, George E.			Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; VASCULAR LUMEN FORMATION; BLOOD-VESSEL FORMATION; MOLECULAR-MECHANISMS; IN-VITRO; CELL MORPHOGENESIS; ACTIVATING PROTEIN; CAPILLARY LUMEN; COLLAGEN MATRIX; ANGIOGENESIS	A critical and understudied property of endothelial cells is their ability to form lumens and tube networks. Although considerable information has been obtained concerning these issues, including the role of Cdc42 and Rac1 and their effectors such as Pak2, Pak4, Par6b, and co-regulators such as integrins, MT1-MMP and Par3; many key questions remain that are necessary to elucidate molecular and signaling requirements for this fundamental process. In this work, we identify new small GTPase regulators of EC tubulogenesis including k-Ras, Rac2 and Rap1b that act in conjunction with Cdc42 as well as the key downstream effectors, IQGAP1, MRCK beta, beta-Pix, GIT1, and Rasip1 (which can assemble into multiprotein complexes with key regulators including alpha 2 beta 1 integrin and MT1-MMP). In addition, we identify the negative regulators, Arhgap31 (by inactivating Cdc42 and Rac) and Rasa1 (by inactivating k-Ras) and the positive regulator, Arhgap29 (by inactivating RhoA) which play a major functional role during the EC tubulogenic process. Human EC siRNA suppression or mouse knockout of Rasip1 leads to identical phenotypes where ECs form extensive cord networks, but cannot generate lumens or tubes. Essential roles for these molecules during EC tubulogenesis include; i) establishment of asymmetric EC cytoskeletal polarization (subapical distribution of acetylated tubulin and basal membrane distribution of F-actin); and ii) directed membrane trafficking of pinocytic vacuoles or other intracellular vesicles along acetylated tubulin tracks to the developing apical membrane surface. Cdc42 co-localizes subapically with acetylated tubulin, while Rac1 and k-Ras strongly label vacuole/vesicle membranes which accumulate and fuse together in a polarized, perinuclear manner. We observe polarized apical membrane and subapical accumulation of key GTPases and effectors regulating EC lumen formation including Cdc42, Rac1, Rac2, k-Ras, Rap1b, activated c-Raf and Rasip1 to control EC tube network assembly. Overall, this work defines novel key regulators and their functional roles during human EC tubulogenesis.	[Norden, Pieter R.; Kim, Dae Joong; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Barry, David M.; Cleaver, Ondine B.] UT Southwesten Med Ctr, Dept Mol Biol, Dallas, TX USA	University of Missouri System; University of Missouri Columbia	Davis, GE (corresponding author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	davisgeo@health.missouri.edu		Cleaver, Ondine/0000-0003-2454-6641; Norden, Pieter/0000-0002-5960-5245	National Institutes of Health, National Heart Lung and Blood Institute [HL126518, HL128584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126518, R01HL128584] Funding Source: NIH RePORTER	National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health, National Heart Lung and Blood Institute, HL126518 (GD, OC) and HL128584 (GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bowers SLK, 2015, METHODS MOL BIOL, V1189, P171, DOI 10.1007/978-1-4939-1164-6_12; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2015, CONNECT TISSUE RES, V56, P392, DOI 10.3109/03008207.2015.1066781; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Giglione C, 2001, EUR J BIOCHEM, V268, P3275, DOI 10.1046/j.1432-1327.2001.02230.x; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoang MV, 2011, MICROVASC RES, V81, P34, DOI 10.1016/j.mvr.2010.09.001; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Matsunaga H, 2014, BIOCHEM BIOPH RES CO, V444, P360, DOI 10.1016/j.bbrc.2014.01.041; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Smith AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085147; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zhao Zhuoshen, 2015, Small GTPases, V6, P81, DOI 10.1080/21541248.2014.1000699; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	54	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147758	10.1371/journal.pone.0147758	http://dx.doi.org/10.1371/journal.pone.0147758			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812085	gold, Green Published			2022-12-27	WOS:000369528000051
J	Wang, XF; Wu, CY; Hirafuji, M				Wang, Xuefeng; Wu, Chunyan; Hirafuji, Masayuki			Visible Light Image-Based Method for Sugar Content Classification of Citrus	PLOS ONE			English	Article							FRUITS	Visible light imaging of citrus fruit from Mie Prefecture of Japan was performed to determine whether an algorithm could be developed to predict the sugar content. This nondestructive classification showed that the accurate segmentation of different images can be realized by a correlation analysis based on the threshold value of the coefficient of determination. There is an obvious correlation between the sugar content of citrus fruit and certain parameters of the color images. The selected image parameters were connected by addition algorithm. The sugar content of citrus fruit can be predicted by the dummy variable method. The results showed that the small but orange citrus fruits often have a high sugar content. The study shows that it is possible to predict the sugar content of citrus fruit and to perform a classification of the sugar content using light in the visible spectrum and without the need for an additional light source.	[Wang, Xuefeng; Wu, Chunyan] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing 100091, Peoples R China; [Hirafuji, Masayuki] Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820071, Japan	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF	Hirafuji, M (corresponding author), Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820071, Japan.	hirafuji@affrc.go.jp		Wang, xuefeng/0000-0002-2703-9293	Japan Society for the promotion of Science [JSPS07-09]; National Science and Technology Major Projects of China [21-Y30B05-9001-13/15]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science and Technology Major Projects of China	This project was supported by Japan Society for the promotion of Science (JSPS07-09) and National Science and Technology Major Projects of China (21-Y30B05-9001-13/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai Jianrong, 2007, Microcomputer Information, V23, P224; Cao Leping, 2009, Journal of Test and Measurement Technology, V23, P63; Jamshidi B, 2012, COMPUT ELECTRON AGR, V85, P64, DOI 10.1016/j.compag.2012.03.008; Liu MuHua, 2007, Acta Agriculturae Universitatis Jiangxiensis, V29, P443; Lleo L, 2009, J FOOD ENG, V93, P229, DOI 10.1016/j.jfoodeng.2009.01.028; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Omid M, 2010, J FOOD ENG, V100, P315, DOI 10.1016/j.jfoodeng.2010.04.015; Peng YK, 2008, POSTHARVEST BIOL TEC, V48, P52, DOI 10.1016/j.postharvbio.2007.09.019; Rajkumar P, 2012, J FOOD ENG, V108, P194, DOI 10.1016/j.jfoodeng.2011.05.002; Suphamitmongkol W, 2013, COMPUT ELECTRON AGR, V91, P87, DOI 10.1016/j.compag.2012.11.014; Wang J.H., 2009, OPT OPTOELECTRON TEC, V7, P62; Xu HuiRong, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P98; Zhou ZhiYu, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P21	13	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147419	10.1371/journal.pone.0147419	http://dx.doi.org/10.1371/journal.pone.0147419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811935	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000034
J	Yeadon, PJ; Bowring, FJ; Catcheside, DEA				Yeadon, Patricia Jane; Bowring, Frederick James; Catcheside, David E. A.			Meiotic Recombination in Neurospora crassa Proceeds by Two Pathways with Extensive Holliday Junction Migration	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; MISMATCH REPAIR; CROSSING-OVER; SORDARIA-FIMICOLA; INITIATION SITE; BUDDING YEAST; UNPAIRED DNA; G LOCUS	Analysis of thousands of Delta msh-2 octads using our fluorescent recombination system indicates that, as in other filamentous fungi, symmetric heteroduplex is common in the his-3 region of Neurospora crassa. Symmetric heteroduplex arises from Holliday junction migration, and we suggest this mechanism explains the high frequency of His(+) spores in heteroallelic crosses in which recombination is initiated cis to the his-3 allele further from the initiator, cog(+). In contrast, when recombination is initiated cis to the his-3 allele closer to cog(+), His(+) spores are mainly a result of synthesis-dependent strand annealing, yielding asymmetric heteroduplex. Loss of Msh-2 function increases measures of allelic recombination in both his-3 and the fluorescent marker gene, indicating that mismatches in asymmetric heteroduplex, as in Saccharomyces cerevisiae, tend to be repaired in the direction of restoration. Furthermore, the presence of substantial numbers of conversion octads in crosses lacking Msh-2 function suggests that the disjunction pathway described in S. cerevisiae is also active in Neurospora, adding to evidence for a universal model for meiotic recombination.	[Yeadon, Patricia Jane; Bowring, Frederick James; Catcheside, David E. A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Yeadon, PJ (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jane.yeadon@flinders.edu.au	Yeadon, Jane/D-4654-2013	Yeadon, Jane/0000-0002-0158-8227; Catcheside, David/0000-0002-7101-6849	National Institutes of Health [R01 GM088338-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health provided initial funding (R01 GM088338-01A1), although the authors received no specific funding for most of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1994, GENETICS, V137, P19; Angel T, 1970, AUST J BIOL SCI, V23, P229; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; Bowring FJ, 1996, GENETICS, V143, P129; Bowring FJ, 2012, FUNGAL GENET BIOL, V49, P619, DOI 10.1016/j.fgb.2012.05.012; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; CARPENTER AT, 1974, GENETICS, V76, P453; CATCHESIDE DG, 1974, AUST J BIOL SCI, V27, P219, DOI 10.1071/BI9740219; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; DETLOFF P, 1992, GENETICS, V132, P113; Dong Z, 2003, NUCLEIC ACIDS RES, V31, P2576, DOI 10.1093/nar/gkg352; Ebbole D, 1990, FUNGAL GENET NEWSLET, V37; Evans E, 2000, MOL CELL BIOL, V20, P7839, DOI 10.1128/MCB.20.21.7839-7844.2000; FOGEL S, 1979, COLD SPRING HARB SYM, V43, P1325, DOI 10.1101/SQB.1979.043.01.152; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Getz TJ, 2008, GENETICS, V178, P1251, DOI 10.1534/genetics.106.067603; HAMZA H, 1981, P NATL ACAD SCI-BIOL, V78, P7648, DOI 10.1073/pnas.78.12.7648; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; KITANI Y, 1974, GENET RES, V24, P229, DOI 10.1017/S0016672300015263; KITANI Y, 1967, GENETICS, V57, P767; KITANI Y, 1978, GENETICS, V89, P467; Knoll A, 2012, PLANT CELL, V24, P1448, DOI 10.1105/tpc.112.096644; Koh LY, 2007, FUNGAL GENET BIOL, V44, P575, DOI 10.1016/j.fgb.2007.02.008; Kohl KP, 2013, GENETICS, V194, P327, DOI 10.1534/genetics.113.150581; Kohl KP, 2012, SCIENCE, V338, P1363, DOI 10.1126/science.1228190; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamb BC, 1996, MYCOL RES, V100, P1025, DOI 10.1016/S0953-7562(96)80212-7; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; Mitchell MB, 1955, P NATL ACAD SCI USA, V41, P216; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; REENAN RAG, 1992, GENETICS, V132, P975; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; STADLER DR, 1970, GENETICS, V66, P429; Stahl FW, 2008, GENETICS, V178, P1141; Stahl FW, 2010, GENETICS, V186, P515, DOI 10.1534/genetics.110.121194; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Stahl FW, 2000, GENETICS, V154, P1913; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Yeadon PJ, 2010, FUNGAL GENET BIOL, V47, P847, DOI 10.1016/j.fgb.2010.07.003; Yeadon PJ, 2004, GENETICS, V167, P1143, DOI 10.1534/genetics.103.025080; Yeadon PJ, 2004, CURR GENET, V45, P289, DOI 10.1007/s00294-004-0491-y; Yeadon PJ, 2002, GENETICS, V162, P747; Yeadon PJ, 1999, CURR GENET, V35, P631, DOI 10.1007/s002940050462; Yeadon PJ, 1998, GENETICS, V148, P113; YEADON PJ, 1995, CURR GENET, V28, P155, DOI 10.1007/BF00315782; Yeadon PJ, 2001, GENETICS, V159, P571; Yeadon PJ, 2011, MOL GENET GENOMICS, V287, P255; Zalevsky J, 1999, GENETICS, V153, P1271	67	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147815	10.1371/journal.pone.0147815	http://dx.doi.org/10.1371/journal.pone.0147815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812651	Green Published, gold			2022-12-27	WOS:000369528000057
J	Bradley, A; Yao, J; Dewald, J; Richter, CP				Bradley, Allison; Yao, Jun; Dewald, Jules; Richter, Claus-Peter			Evaluation of Electroencephalography Source Localization Algorithms with Multiple Cortical Sources	PLOS ONE			English	Article							EEG SOURCE LOCALIZATION; ELECTROMAGNETIC TOMOGRAPHY LORETA; HEAD MODELS; BRAIN; RESOLUTION; SLORETA; EEG/MEG; HUMANS; NOISE; FMRI	Background Source localization algorithms often show multiple active cortical areas as the source of electroencephalography (EEG). Yet, there is little data quantifying the accuracy of these results. In this paper, the performance of current source density source localization algorithms for the detection of multiple cortical sources of EEG data has been characterized. Methods EEG data were generated by simulating multiple cortical sources (2-4) with the same strength or two sources with relative strength ratios of 1:1 to 4:1, and adding noise. These data were used to reconstruct the cortical sources using current source density (CSD) algorithms: sLORETA, MNLS, and LORETA using a p-norm with p equal to 1, 1.5 and 2. Precision (percentage of the reconstructed activity corresponding to simulated activity) and Recall (percentage of the simulated sources reconstructed) of each of the CSD algorithms were calculated. Results While sLORETA has the best performance when only one source is present, when two or more sources are present LORETA with p equal to 1.5 performs better. When the relative strength of one of the sources is decreased, all algorithms have more difficulty reconstructing that source. However, LORETA 1.5 continues to outperform other algorithms. If only the strongest source is of interest sLORETA is recommended, while LORETA with p equal to 1.5 is recommended if two or more of the cortical sources are of interest. These results provide guidance for choosing a CSD algorithm to locate multiple cortical sources of EEG and for interpreting the results of these algorithms.	[Bradley, Allison; Dewald, Jules; Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Bradley, Allison; Richter, Claus-Peter] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Yao, Jun; Dewald, Jules] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Dewald, Jules] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA; [Bradley, Allison] Cincinnati Childrens Hosp, Commun Sci Res Ctr, Cincinnati, OH USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Cincinnati Children's Hospital Medical Center	Bradley, A (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Bradley, A (corresponding author), Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA.; Bradley, A (corresponding author), Cincinnati Childrens Hosp, Commun Sci Res Ctr, Cincinnati, OH USA.	allison.bradley@cchmc.org	Yao, Jun/AAK-2006-2020		E.R. Capita Foundation	E.R. Capita Foundation	This study was funded by the E.R. Capita Foundation (http://www.capitafoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Baillet S, 2001, PHYS MED BIOL, V46, P77, DOI 10.1088/0031-9155/46/1/306; Becker H, 2014, NEUROIMAGE, V96, P143, DOI 10.1016/j.neuroimage.2014.03.043; Becker H, 2015, IEEE SIGNAL PROC MAG, V32, P100, DOI 10.1109/MSP.2015.2413711; Bradley A., 2014, EVALUATION EEG SOURC; Brookes MJ, 2008, NEUROIMAGE, V40, P1090, DOI 10.1016/j.neuroimage.2007.12.030; CUFFIN BN, 1986, IEEE T BIO-MED ENG, V33, P854, DOI 10.1109/TBME.1986.325779; Cuffin BN, 2001, CLIN NEUROPHYSIOL, V112, P2288, DOI 10.1016/S1388-2457(01)00669-1; Ding L, 2007, NEUROIMAGE, V34, P575, DOI 10.1016/j.neuroimage.2006.09.042; Fuchs M, 1998, IEEE T BIO-MED ENG, V45, P980, DOI 10.1109/10.704867; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Haufe S, 2011, NEUROIMAGE, V54, P851, DOI 10.1016/j.neuroimage.2010.09.003; Liu ZM, 2006, IEEE ENG MED BIOL, V25, P46, DOI 10.1109/MEMB.2006.1657787; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Miao LF, 2013, IEEE T SIGNAL PROCES, V61, DOI 10.1109/TSP.2012.2226172; Michel CM, 2004, J CLIN NEUROPHYSIOL, V21, P71, DOI 10.1097/00004691-200403000-00001; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mizuhara H, 2012, NEUROIMAGE, V62, P1884, DOI 10.1016/j.neuroimage.2012.05.072; Murzin V, 2011, EXP BRAIN RES, V214, P515, DOI 10.1007/s00221-011-2850-5; Ou WM, 2009, NEUROIMAGE, V44, P932, DOI 10.1016/j.neuroimage.2008.05.063; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Sasaoka T., 2013, J COGN NEUROSCI; Shahbazi Avarvand F., 2012, COMPUTATIONAL MATH M, V2012; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Vergallo P., 2014, MED MEAS APPL MEMEA, P1; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Wipf DP, 2010, NEUROIMAGE, V49, P641, DOI 10.1016/j.neuroimage.2009.06.083; Yao J, 2005, NEUROIMAGE, V25, P369, DOI 10.1016/j.neuroimage.2004.11.036; Zhang YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2398883	35	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147266	10.1371/journal.pone.0147266	http://dx.doi.org/10.1371/journal.pone.0147266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809000	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800069
J	Jensen, RK; Kjaer, P; Jensen, TS; Albert, H; Kent, P				Jensen, Rikke K.; Kjaer, Per; Jensen, Tue S.; Albert, Hanne; Kent, Peter			Degenerative Pathways of Lumbar Motion Segments - A Comparison in Two Samples of Patients with Persistent Low Back Pain	PLOS ONE			English	Article							RESONANCE-IMAGING CHANGES; SIGNAL MODIC CHANGES; DISC DEGENERATION; ASSOCIATION; PREVALENCE; PATTERNS; AGE; REPRODUCIBILITY; INTRAOBSERVER	Background Magnetic resonance imaging (MRI) is used to identify spinal pathoanatomy in people with persistent low back pain. However, the clinical relevance of spinal degenerative MRI findings remains uncertain. Although multiple MRI findings are almost always present at the same time, research into the association with clinical outcomes (such as pain) has predominantly focused on individual MRI findings. This study aimed to: (i) investigate how multiple MRI lumbar spine findings cluster together within two different samples of patients with low back pain, (ii) classify these clusters into hypothetical pathways of degeneration based on scientific knowledge of disco-vertebral degeneration, and (iii) compare these clusters and degenerative pathways between samples. Methods We performed a secondary cross-sectional analysis on two dissimilar MRI samples collected in a hospital department: (1) data from the spinal MRI reports of 4,162 low back pain patients and (2) data from an MRI research protocol of 631 low back pain patients. Latent Class Analysis was used in both samples to cluster MRI findings from lumbar motion segments. Using content analysis, each cluster was then categorised into hypothetical pathways of degeneration. Results Six clusters of MRI findings were identified in each of the two samples. The content of the clusters in the two samples displayed some differences but had the same overall pattern of MRI findings. Although the hypothetical degenerative pathways identified in the two samples were not identical, the overall pattern of increasing degeneration within the pathways was the same. Conclusions It was expected that different clusters could emerge from different samples, however, when organised into hypothetical pathways of degeneration, the overall pattern of increasing degeneration was similar and biologically plausible. This evidence of reproducibility suggests that Latent Class Analysis may provide a new approach to investigating the relationship between MRI findings and clinically important characteristics such as pain and activity limitation.	[Jensen, Rikke K.; Kjaer, Per; Jensen, Tue S.] Univ Southern Denmark, Inst Reg Hlth Res, Hosp Lillebaelt, Res Dept,Spine Ctr Southern Denmark, Middelfart, Denmark; [Kjaer, Per; Kent, Peter] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Albert, Hanne] Bartholomews Hosp, Dept Orthopaed, London, England	University of Southern Denmark; University of Southern Denmark; University of London; Queen Mary University London	Jensen, RK (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Hosp Lillebaelt, Res Dept,Spine Ctr Southern Denmark, Middelfart, Denmark.	rikke.kruger.jensen@rsyd.dk	albert, hanne/L-7201-2019; Jensen, Rikke Krüger/AAF-6196-2019; Kjaer, Per/C-1210-2009; Jensen, Tue Secher/P-7400-2019; Jensen, Tue S/P-6882-2017	Jensen, Rikke Krüger/0000-0001-7528-3234; Kjaer, Per/0000-0001-5340-8649; Jensen, Tue Secher/0000-0002-7456-4306; Jensen, Tue S/0000-0002-7456-4306; Kent, Peter/0000-0002-2429-9233	Danish Chiropractors' Foundation;  [09/74]	Danish Chiropractors' Foundation; 	Number 09/74. The authors are grateful to The Danish Chiropractors' Foundation for funding this project (RKJ, TSJ, PMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://regioner.dk/Sundhed/Fonde%20vejledninger%20og%20databaser/Forskningsfonde/Kiropraktorfonden.aspx	Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Albert HB, 2011, EUR SPINE J, V20, P1355, DOI 10.1007/s00586-011-1794-6; Arnbak B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-274; Beales DJ, 2012, J ADOLESCENT HEALTH, V50, P509, DOI 10.1016/j.jadohealth.2011.09.017; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Jensen RK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-198; Jensen RK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-22; Jensen TS, 2007, ACTA RADIOL, V48, P748, DOI 10.1080/02841850701422112; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Kanna RM, 2014, SPINE J, V14, P300, DOI 10.1016/j.spinee.2013.10.042; Kent P, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-20; Kent P, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-16; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Kovacs FM, 2014, NEURORADIOLOGY, V56, P25, DOI 10.1007/s00234-013-1294-y; Meyerding HW, 1941, J BONE JOINT SURG, V23, P461; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; Sorensen JS, 2006, ACTA RADIOL, V47, P947, DOI 10.1080/02841850600965062; Takatalo J, 2012, SPINE, V37, P1231, DOI 10.1097/BRS.0b013e3182443855; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Wang Y, 2012, SPINE J, V12, P411, DOI 10.1016/j.spinee.2012.03.026	23	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146998	10.1371/journal.pone.0146998	http://dx.doi.org/10.1371/journal.pone.0146998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807697	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800043
J	Koessler, J; Hermann, S; Weber, K; Koessler, A; Kuhn, S; Boeck, M; Kobsar, A				Koessler, Juergen; Hermann, Stephanie; Weber, Katja; Koessler, Angela; Kuhn, Sabine; Boeck, Markus; Kobsar, Anna			Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets	PLOS ONE			English	Article							VASP-PHOSPHORYLATION; MOLECULAR-BASIS; PROTEIN-KINASE; ADP; ACTIVATION; SURFACE; ASSAY; VI	Background Washing of platelets is an important procedure commonly used for experimental studies, e. g. in cardiovascular research. As a known phenomenon, responsiveness to adenosine diphosphate (ADP) is reduced in washed platelets, although underlying molecular mechanisms- potentially interfering with experimental results-have not been thoroughly studied. Objectives Since ADP mediates its effects via three purinergic receptors P2Y1, P2X1 and P2Y12, their surface expression and function were investigated in washed platelets and, for comparison, in platelet-rich-plasma (PRP) at different time points for up to 2 hours after preparation. Results In contrast to PRP, flow cytometric analysis of surface expression in washed platelets revealed an increase of all receptors during the first 60 minutes after preparation followed by a significant reduction, which points to an initial preactivation of platelets and consecutive degeneration. The activity of the P2X1 receptor (measured by selectively induced calcium flux) was substantially maintained in both PRP and washed platelets. P2Y12 function (determined by flow cytometry as platelet reactivity index) was partially reduced after platelet washing compared to PRP, but remained stable in course of ongoing storage. However, the function of the P2Y1 receptor (measured by selectively induced calcium flux) continuously declined after preparation of washed platelets. Conclusion In conclusion, decreasing ADP responsiveness in washed platelets is particularly caused by impaired activity of the P2Y1 receptor associated with disturbed calcium regulation, which has to be considered in the design of experimental studies addressing ADP mediated platelet function.	[Koessler, Juergen; Hermann, Stephanie; Weber, Katja; Koessler, Angela; Kuhn, Sabine; Boeck, Markus; Kobsar, Anna] Univ Wurzburg, Inst Transfus Med & Haemotherapy, D-97070 Wurzburg, Germany	University of Wurzburg	Koessler, J (corresponding author), Univ Wurzburg, Inst Transfus Med & Haemotherapy, D-97070 Wurzburg, Germany.	koessler_j@ukw.de			Open Access Publication Fund of the University of Wuerzburg	Open Access Publication Fund of the University of Wuerzburg	This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; Cabeza N, 2004, DIABETES, V53, P2117, DOI 10.2337/diabetes.53.8.2117; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Geiger J, 2005, CLIN CHEM, V51, P957, DOI 10.1373/clinchem.2004.047050; Geiger TL, 2007, TRANSFUS MED REV, V21, P1, DOI 10.1016/j.tmrv.2006.09.001; Gresele P, 2002, PLATELETS THROMBOTIC, P1124; HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Keuren JFW, 2006, TRANSFUSION, V46, P204, DOI 10.1111/j.1537-2995.2006.00702.x; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Kunapuli SP, 1998, PLATELETS, V9, P343, DOI 10.1080/09537109876401; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Liu ECK, 2006, ANAL BIOCHEM, V357, P216, DOI 10.1016/j.ab.2006.06.034; McCabe White M, 1999, PROPERTIES MAT, P116; Pampuch A, 2006, THROMB HAEMOSTASIS, V96, P767, DOI 10.1160/TH06-09-0491; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Shou LM, 2013, ONCOL REP, V30, P1059, DOI 10.3892/or.2013.2601; SILVER WP, 1993, J VASC SURG, V17, P726, DOI 10.1016/0741-5214(93)90117-5; van der Meer PF, 2007, TRANSFUS CLIN BIOL, V14, P522, DOI 10.1016/j.tracli.2008.03.004; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; WALSH PN, 1977, BRIT J HAEMATOL, V36, P281, DOI 10.1111/j.1365-2141.1977.tb00649.x; Wayne PA, 2008, PLATELET FUNCTION TE, pH58	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147370	10.1371/journal.pone.0147370	http://dx.doi.org/10.1371/journal.pone.0147370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808867	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800081
J	Li, ZY; Wang, H				Li, Zhongyi; Wang, Hao			Ocean Wave Simulation Based on Wind Field	PLOS ONE			English	Article								Ocean wave simulation has a wide range of applications in movies, video games and training systems. Wind force is the main energy resource for generating ocean waves, which are the result of the interaction between wind and the ocean surface. While numerous methods to handle simulating oceans and other fluid phenomena have undergone rapid development during the past years in the field of computer graphic, few of them consider to construct ocean surface height field from the perspective of wind force driving ocean waves. We introduce wind force to the construction of the ocean surface height field through applying wind field data and wind-driven wave particles. Continual and realistic ocean waves result from the overlap of wind-driven wave particles, and a strategy was proposed to control these discrete wave particles and simulate an endless ocean surface. The results showed that the new method is capable of obtaining a realistic ocean scene under the influence of wind fields at real time rates.	[Li, Zhongyi; Wang, Hao] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wang, H (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Hubei Province, Peoples R China.	wanghao4110@hust.edu.cn		Wang, Hao/0000-0001-9355-1319				Clavet S., 2005, P 2005 ACM SIGGRAPH, P219, DOI [DOI 10.1145/1073368.1073400, DOI 10.1145/1073368]; Fournier A., 1986, Computer Graphics, V20, P75, DOI 10.1145/15886.15894; GASCUEL Mathieu Desbrun Marie-Paule, 2012, COMPUTER ANIMATION S; Gerstner F., 1809, ANN PHYS, V2, P412, DOI DOI 10.1002/ANDP.18090320808; Hasselmann K., 1973, ERGAENZUNGSHEFT DTSC; Jos Stam, 1995, P 22 ANN C COMP GRAP, P129, DOI [10.1145/218380.218430, DOI 10.1145/218380.218430]; LeBlanc G., 2012, J GRAPH TOOL, V16, P57, DOI [10.1080/2165347X.2012.680854, DOI 10.1080/2165347X.2012.680854]; MASTIN GA, 1987, IEEE COMPUT GRAPH, V7, P16, DOI 10.1109/MCG.1987.276961; Max N. L., 1981, Computer Graphics, V15, P317, DOI 10.1145/965161.806820; Mitchell J.L., 2005, REAL TIME SYNTHESIS, P121; Muller M., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P154; Peachey D. R., 1986, Computer Graphics, V20, P65, DOI 10.1145/15886.15893; PHILLIPS OM, 1985, J FLUID MECH, V156, P505, DOI 10.1017/S0022112085002221; PIERSON WJ, 1964, J GEOPHYS RES, V69, P5181, DOI 10.1029/JZ069i024p05181; Premoze S, 2001, COMPUT GRAPH FORUM, V20, P189, DOI 10.1111/1467-8659.00548; REEVES WT, 1983, ACM T GRAPHIC, V2, P91, DOI 10.1145/964967.801167; SCHACHTER B, 1980, COMPUT VISION GRAPH, V12, P187, DOI 10.1016/0146-664X(80)90011-8; Tessendorf J., 2001, SIGGRAPH, V1, P5; Yuksel C, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239550	19	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147123	10.1371/journal.pone.0147123	http://dx.doi.org/10.1371/journal.pone.0147123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808718	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800053
J	Lu, SZ; Natarajan, SK; Mott, JL; Kharbanda, KK; Harrison-Findik, DD				Lu, Sizhao; Natarajan, Sathish Kumar; Mott, Justin L.; Kharbanda, Kusum K.; Harrison-Findik, Duygu Dee			Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; ANTIMICROBIAL PEPTIDE; INSULIN-RESISTANCE; IRON-METABOLISM; STEATOHEPATITIS; INFLAMMATION; ACTIVATION; EXPRESSION	Changes in lipid metabolism and iron content are observed in the livers of patients with fatty liver disease. The expression of hepcidin, an iron-regulatory and acute phase protein synthesized by the liver, is also modulated. The potential interaction of lipid and iron metabolism is largely unknown. We investigated the role of lipid intermediate, ceramide in the regulation of human hepcidin gene, HAMP. Human hepatoma HepG2 cells were treated with cell-permeable ceramide analogs. Ceramide induced significant up-regulation of HAMP mRNA expression in HepG2 cells. The effect of ceramide on HAMP expression was mediated through transcriptional mechanisms because it was completely blocked with actinomycin D treatment. Reporter assays also confirmed the activation of 0.6 kb HAMP promoter by ceramide. HepG2 cells treated with ceramide displayed increased phosphorylation of STAT3, JNK, and NF-kappa B proteins. However, ceramide induced the binding of STAT3, but not NF-kappa B or c-Jun, to HAMP promoter, as shown by the chromatin immunoprecipitation assays. The mutation of STAT3 response element within 0.6 kb HAMP promoter region significantly inhibited the stimulatory effect of ceramide on HAMP promoter activity. Similarly, the inhibition of STAT3 with a pan-JAK kinase inhibitor and STAT3 siRNA pool also diminished the induction of both HAMP promoter activity and mRNA expression by ceramide. In conclusion, we have shown a direct role for ceramide in the activation of hepatic HAMP transcription via STAT3. Our findings suggest a crosstalk between lipid and iron metabolism in the liver, which may contribute to the pathogenesis of obesity-related fatty liver disease.	[Lu, Sizhao; Natarajan, Sathish Kumar; Mott, Justin L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA; [Kharbanda, Kusum K.; Harrison-Findik, Duygu Dee] Univ Nebraska Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, 982000 Nebraska Med Ctr, Omaha, NE 68198 USA; [Lu, Sizhao] Univ Colorado Denver, Dept Renal Med & Hypertens, 12700 East 19th Ave, Aurora, CO 80045 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Harrison-Findik, DD (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, 982000 Nebraska Med Ctr, Omaha, NE 68198 USA.	dufindik@gmail.com		Lu, Sizhao/0000-0002-9892-8784	NIH [R01AA017738, P20GM104320]; University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017738] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001155] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grant R01AA017738 (to D. Harrison-Findik), NIH grant P20GM104320 (to J.L. Mott) and University of Nebraska Medical Center Graduate Assistantship/Fellowship (to S. Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Aigner E, 2015, WORLD J HEPATOL, V7, P177, DOI 10.4254/wjh.v7.i2.177; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Czaja MJ, 2010, TRENDS ENDOCRIN MET, V21, P707, DOI 10.1016/j.tem.2010.08.010; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fillet M, 2003, BIOCHEM PHARMACOL, V65, P1633, DOI 10.1016/S0006-2952(03)00125-4; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ganz T, 2015, CLIN CHEM, V61, P577, DOI 10.1373/clinchem.2014.229179; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gentil B, 2003, MOL CELL BIOCHEM, V254, P203, DOI 10.1023/A:1027359832177; Gerjevic LN, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/459278; Gill JMR, 2009, DIABETOLOGIA, V52, P2475, DOI 10.1007/s00125-009-1546-x; Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kreydiyyeh SI, 2014, INT J BIOCHEM CELL B, V53, P102, DOI 10.1016/j.biocel.2014.04.027; Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Maziere C, 2001, FEBS LETT, V507, P163, DOI 10.1016/S0014-5793(01)02977-5; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Nelson JE, 2012, HEPATOLOGY, V56, P1730, DOI 10.1002/hep.25856; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Promrat K, 2011, HEPATOL RES, V41, P754, DOI 10.1111/j.1872-034X.2011.00815.x; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Saslowsky DE, 2009, FASEB J, V23, P259, DOI 10.1096/fj.08-116467; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Truksa J, 2007, BLOOD CELL MOL DIS, V39, P255, DOI 10.1016/j.bcmd.2007.06.014; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	63	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147474	10.1371/journal.pone.0147474	http://dx.doi.org/10.1371/journal.pone.0147474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807955	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800101
J	Majtanova, Z; Choleva, L; Symonova, R; Rab, P; Kotusz, J; Pekarik, L; Janko, K				Majtanova, Zuzana; Choleva, Lukas; Symonova, Radka; Rab, Petr; Kotusz, Jan; Pekarik, Ladislav; Janko, Karel			Asexual Reproduction Does Not Apparently Increase the Rate of Chromosomal Evolution: Karyotype Stability in Diploid and Triploid Clonal Hybrid Fish (Cobitis, Cypriniformes, Teleostei)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FRESH-WATER FISH; UNISEXUAL SALAMANDERS; MOLECULAR EVOLUTION; LOACHES COBITIS; GENUS AMBYSTOMA; LIKELIHOOD; POLYPLOIDY; IDENTIFICATION; REARRANGEMENTS	Interspecific hybridization, polyploidization and transitions from sexuality to asexuality considerably affect organismal genomes. Especially the last mentioned process has been assumed to play a significant role in the initiation of chromosomal rearrangements, causing increased rates of karyotype evolution. We used cytogenetic analysis and molecular dating of cladogenetic events to compare the rate of changes of chromosome morphology and karyotype in asexually and sexually reproducing counterparts in European spined loach fish (Cobitis). We studied metaphases of three sexually reproducing species and their diploid and polyploid hybrid clones of different age of origin. The material includes artificial F1 hybrid strains, representatives of lineage originated in Holocene epoch, and also individuals of an oldest known age to date ( roughly 0.37 MYA). Thereafter we applied GISH technique as a marker to differentiate parental chromosomal sets in hybrids. Although the sexual species accumulated remarkable chromosomal rearrangements after their speciation, we observed no differences in chromosome numbers and/or morphology among karyotypes of asexual hybrids. These hybrids possess chromosome sets originating from respective parental species with no cytogenetically detectable recombinations, suggesting their integrity even in a long term. The switch to asexual reproduction thus did not provoke any significant acceleration of the rate of chromosomal evolution in Cobitis. Asexual animals described in other case studies reproduce ameiotically, while Cobitis hybrids described here produce eggs likely through modified meiosis. Therefore, our findings indicate that the effect of asexuality on the rate of chromosomal change may be context-dependent rather than universal and related to particular type of asexual reproduction.	[Majtanova, Zuzana; Choleva, Lukas; Symonova, Radka; Rab, Petr; Janko, Karel] CAS, Inst Anim Physiol & Genet, Lab Fish Genet, Vvi, Libechov, Czech Republic; [Majtanova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Choleva, Lukas; Janko, Karel] Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [Symonova, Radka] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Kotusz, Jan] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland; [Pekarik, Ladislav] SAS, Inst Bot, Bratislava, Slovakia; [Pekarik, Ladislav] Trnava Univ, Dept Biol, Fac Educ, Trnava, Slovakia	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague; University of Ostrava; University of Innsbruck; University of Wroclaw; SAS Institute Inc; Slovak Academy of Sciences; University of Trnava	Majtanova, Z (corresponding author), CAS, Inst Anim Physiol & Genet, Lab Fish Genet, Vvi, Libechov, Czech Republic.; Majtanova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	majtanova@iapg.cas.cz	Pekárik, Ladislav/E-6218-2011	Pekárik, Ladislav/0000-0002-7253-2837; Kotusz, Jan/0000-0001-6229-7610; Majtanova, Zuzana/0000-0002-7100-2922	Grant Agency of the Charles University in Prague [158110]; Czech Science Foundation [GAP506/10/1155, GPP506/12/P857, 14-02940S, GA13-12580S]; Academy of Sciences of the Czech Republic [RVO 67985904]; National Science Centre in Poland [DEC-2011/03/B/NZ8/02095]	Grant Agency of the Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); National Science Centre in Poland(National Science Centre, Poland)	This study was supported by the Grant Agency of the Charles University in Prague (www.cuni.cz; project number 158110), Czech Science Foundation (www.gacr.cz; project number GAP506/10/1155 to KJ, PR and LC; GPP506/12/P857 to LC; 14-02940S PR and RS; GA13-12580S to KJ and LC), by the Academy of Sciences of the Czech Republic (www.cas.cz; project number RVO 67985904) and by the National Science Centre in Poland (http://www. ncn.gov.pl; project number DEC-2011/03/B/NZ8/02095) to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Arai K, 1997, J EXP ZOOL, V278, P412, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;412::AID-JEZ9&gt;3.0.CO;2-R; Arai R., 2011, FISH KARYOTYPES CHEC, DOI [10.1007/978-4-431-53877-6, DOI 10.1007/978-4-431-53877-6]; Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; Bi K, 2006, CYTOGENET GENOME RES, V112, P307, DOI 10.1159/000089885; Bi K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-238; Blackman RL, 2000, HEREDITY, V84, P254, DOI 10.1046/j.1365-2540.2000.00667.x; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Boron A, 2003, GENETICA, V119, P51, DOI 10.1023/A:1024475823321; Choleva L, 2008, PHILOS T R SOC B, V363, P2911, DOI 10.1098/rstb.2008.0059; Choleva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080641; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; da Barbiano LA, 2013, P NATL ACAD SCI USA, V110, P13797, DOI 10.1073/pnas.1303730110; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; HICKEY DA, 1982, GENETICS, V101, P519; Itono M, 2006, J EXP ZOOL PART A, V305A, P513, DOI 10.1002/jez.a.283; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2005, MOL ECOL, V14, P2991, DOI 10.1111/j.1365-294X.2005.02583.x; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Juchno D, 2014, ACTA BIOL CRACOV BOT, P64; Knytl M, 2013, CYTOGENET GENOME RES, V139, P276, DOI 10.1159/000350689; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; Mank JE, 2006, GENETICA, V127, P321, DOI 10.1007/s10709-005-5248-0; Martens K, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P187, DOI 10.1007/978-90-481-2770-2_9; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Mikulicek P, 2014, J EVOLUTION BIOL, V27, P628, DOI 10.1111/jeb.12332; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Normark BB, 1999, EVOLUTION, V53, P1458, DOI [10.2307/2640892, 10.1111/j.1558-5646.1999.tb05410.x]; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2006, USE R, P8; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Pereira CSA, 2014, HEREDITY, V112, P343, DOI 10.1038/hdy.2013.110; Pereira CSA, 2013, CYTOGENET GENOME RES, V141, P143, DOI 10.1159/000354582; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Rab P, 1988, METHODS CHROMOSOME A, P115; Rab Petr, 2007, P215; Rabova M, 2007, ECI 12 EUR C ICHTH C, P59; Rampin M, 2012, COMP CYTOGENET, V6, P287, DOI 10.3897/CompCytogen.v6i3.3543; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Robertson AV, 2006, MOL ECOL, V15, P3339, DOI 10.1111/j.1365-294X.2006.03005.x; Saat TV, 1991, SOVIET J DEV BIOL, V22, P332; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; Schneider MC, 2010, J HERED, V101, P491, DOI 10.1093/jhered/esq004; Slechtova V, 2008, MOL PHYLOGENET EVOL, V47, P812, DOI 10.1016/j.ympev.2007.12.018; Snowdon RJ, 1997, THEOR APPL GENET, V95, P1320, DOI 10.1007/s001220050699; Spence JM, 2000, CHROMOSOMA, V109, P490, DOI 10.1007/s004120000100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Sunnucks P, 1996, GENETICS, V144, P747; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Symonova R, 2013, CYTOGENET GENOME RES, V141, P153, DOI 10.1159/000354882; Symonova R., 2015, FISH CYTOGENETIC TEC, P118; Tang QY, 2008, HYDROBIOLOGIA, V605, P17, DOI 10.1007/s10750-008-9296-1; TRIANTAPHYLLOU AC, 1981, J NEMATOL, V13, P95; UZZELL T, 1976, P ACAD NAT SCI PHILA, V128, P147; Valente GT, 2009, CHROMOSOME RES, V17, P791, DOI 10.1007/s10577-009-9067-5; Volker M, 2015, FISH CYTOGENETIC TEC, P37, DOI [10.1201/b18534-4, DOI 10.1201/B18534-4]; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Welch JLM, 2004, P NATL ACAD SCI USA, V101, P1618, DOI 10.1073/pnas.0307677100; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zalesna A, 2011, CYTOGENET GENOME RES, V134, P206, DOI 10.1159/000327716; Zhu HP, 2007, AQUACULTURE, V265, P109, DOI 10.1016/j.aquaculture.2006.10.026	73	25	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146872	10.1371/journal.pone.0146872	http://dx.doi.org/10.1371/journal.pone.0146872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808475	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800036
J	Reddy, RB; Bhat, AR; James, BL; Govindan, SV; Mathew, R; Ravindra, DR; Hedne, N; Illiayaraja, J; Kekatpure, V; Khora, SS; Hicks, W; Tata, P; Kuriakose, MA; Suresh, A				Reddy, Ram Bhupal; Bhat, Anupama Rajan; James, Bonney Lee; Govindan, Sindhu Valiyaveedan; Mathew, Rohit; Ravindra, D. R.; Hedne, Naveen; Illiayaraja, Jeyaram; Kekatpure, Vikram; Khora, Samanta S.; Hicks, Wesley; Tata, Pramila; Kuriakose, Moni A.; Suresh, Amritha			Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DEATH DOMAIN; EXPRESSION PROFILES; C-MYC; PROTEIN EXPRESSION; DISTANT METASTASIS; GENE; TMEM16A; TRANSCRIPTOME; AMPLIFICATION	The head and neck squamous cell carcinoma (HNSCC) transcriptome has been profiled extensively, nevertheless, identifying biomarkers that are clinically relevant and thereby with translational benefit, has been a major challenge. The objective of this study was to use a meta-analysis based approach to catalog candidate biomarkers with high potential for clinical application in HNSCC. Data from publically available microarray series (N = 20) profiled using Agilent (4X44K G4112F) and Affymetrix (HGU133A, U133A_2, U133Plus 2) platforms was downloaded and analyzed in a platform/chip-specific manner (GeneSpring software v12.5, Agilent, USA). Principal Component Analysis (PCA) and clustering analysis was carried out iteratively for segregating outliers; 140 normal and 277 tumor samples from 15 series were included in the final analysis. The analyses identified 181 differentially expressed, concordant and statistically significant genes; STRING analysis revealed interactions between 122 of them, with two major gene clusters connected by multiple nodes (MYC, FOS and HSPA4). Validation in the HNSCC-specific database (N = 528) in The Cancer Genome Atlas (TCGA) identified a panel (ECT2, ANO1, TP63, FADD, EXT1, NCBP2) that was altered in 30% of the samples. Validation in treatment naive (Group I; N = 12) and post treatment (Group II; N = 12) patients identified 8 genes significantly associated with the disease (Area under curve > 0.6). Correlation with recurrence/re-recurrence showed ANO1 had highest efficacy (sensitivity: 0.8, specificity: 0.6) to predict failure in Group I. UBE2V2, PLAC8, FADD and TTK showed high sensitivity (1.00) in Group I while UBE2V2 and CRYM were highly sensitive (>0.8) in predicting re-recurrence in Group II. Further, TCGA analysis showed that ANO1 and FADD, located at 11q13, were co-expressed at transcript level and significantly associated with overall and disease-free survival (p < 0.05). The meta-analysis approach adopted in this study has identified candidate markers correlated with disease outcome in HNSCC; further validation in a larger cohort of patients will establish their clinical relevance.	[Reddy, Ram Bhupal; James, Bonney Lee; Mathew, Rohit; Ravindra, D. R.; Kuriakose, Moni A.; Suresh, Amritha] Narayana Hlth, Mazumdar Shaw Med Ctr, Mazumdar Shaw Ctr Translat Res, Integrated Head & Neck Oncol Program, Bangalore, Karnataka, India; [Reddy, Ram Bhupal; James, Bonney Lee; Govindan, Sindhu Valiyaveedan; Ravindra, D. R.; Hedne, Naveen; Kekatpure, Vikram; Kuriakose, Moni A.; Suresh, Amritha] Narayana Hlth, Mazumdar Shaw Med Ctr, Head & Neck Oncol, Bangalore, Karnataka, India; [Reddy, Ram Bhupal; Khora, Samanta S.] Vellore Inst Technol Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore, Tamil Nadu, India; [Bhat, Anupama Rajan; Tata, Pramila] Kirloskar Business Pk, Strand Life Sci, Bangalore, Karnataka, India; [Illiayaraja, Jeyaram] Narayana Hlth, Mazumdar Shaw Med Ctr, Dept Clin Res, Bangalore, Karnataka, India; [Hicks, Wesley] Roswell Pk Canc Inst, Dept Head & Neck Plast & Reconstruct Surg, Buffalo, NY 14263 USA; [Hicks, Wesley; Kuriakose, Moni A.] Roswell Pk Canc Inst, Roswell Pk Collaborat Program, Mazumdar Shaw Med Ctr, Buffalo, NY 14263 USA	Vellore Institute of Technology; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Suresh, A (corresponding author), Narayana Hlth, Mazumdar Shaw Med Ctr, Mazumdar Shaw Ctr Translat Res, Integrated Head & Neck Oncol Program, Bangalore, Karnataka, India.; Suresh, A (corresponding author), Narayana Hlth, Mazumdar Shaw Med Ctr, Head & Neck Oncol, Bangalore, Karnataka, India.	amritha.suresh@ms-mf.org	Khora, Samanta/T-4530-2019	Hicks, Jr, Wesley/0000-0003-2916-5231; Kuriakose, Moni/0000-0003-4229-752X; Khora, Samanta/0000-0001-9913-9720	Indian Council of Medical Research, India [5/8/10-18 (Oto)/CFP/11-NCD-1]	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	The project was funded by Indian Council of Medical Research, India (No: 5/8/10-18 (Oto)/CFP/11-NCD-1). (http://www.icmr.nic.in/). AS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2011, BREAST CANCER RES TR, V126, P797, DOI 10.1007/s10549-010-1329-6; Akervall J, 2003, CLIN CANCER RES, V9, P1750; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Bhattacharya N, 2009, J ORAL PATHOL MED, V38, P759, DOI 10.1111/j.1600-0714.2009.00781.x; Capkova M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408683; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi EJ, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-137; Choi P, 2005, CANCER-AM CANCER SOC, V104, P1113, DOI 10.1002/cncr.21293; De Cecco L, 2014, ANN ONCOL, V25, P1628, DOI 10.1093/annonc/mdu173; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elango KJ, 2011, ASIAN PAC J CANCER P, V12, P889; Fan SQ, 2013, CANCER BIOL THER, V14, P365, DOI 10.4161/cbt.23636; Filippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; GAPANY M, 1994, ARCH OTOLARYNGOL, V120, P255; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Goonesekere NCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093046; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Jarmuz-Szymczak M, 2013, MOL BIOL REP, V40, P4161, DOI 10.1007/s11033-013-2496-4; Katoh M, 2003, INT J ONCOL, V22, P1375; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li YW, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/784107; Lunde MLS, 2010, ANTICANCER RES, V30, P1083; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mourtada-Maarabouni M, CURRENT CANC DRUG TA, V13, P80; Murata Y, 2014, CANCER SCI, V105, P490, DOI 10.1111/cas.12363; Pacheco MM, 2002, HEAD NECK-J SCI SPEC, V24, P24, DOI 10.1002/hed.10009; Pattje WJ, 2013, HISTOPATHOLOGY, V63, P263, DOI 10.1111/his.12174; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Sano M, 2006, ONCOL REP, V16, P1093; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Stiekema J, 2013, EJSO-EUR J SURG ONC, V39, P17, DOI 10.1016/j.ejso.2012.07.008; Suresh A, 2012, DIS MARKERS, V32, P51, DOI [10.1155/2012/926703, 10.3233/DMA-2012-0860]; Toner M, 2009, HEAD NECK PATHOL, V3, P249, DOI 10.1007/s12105-009-0137-y; Urgoiti GBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108790; Wang XY, ASIAN PAC J CANC PRE, V14, P457; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Xie Fuliang, 2012, Plant Mol Biol; Yang ZZ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-80; Yom SS, 2015, SEMIN CUTAN MED SURG, V34, P178, DOI 10.12788/j.sder.2015.0182; Yu L, 2012, ONCOL REP, V27, P416, DOI 10.3892/or.2011.1481; Yu YQ, 2003, ARCH OTOLARYNGOL, V129, P1322, DOI 10.1001/archotol.129.12.1322; Zhang Lei, 2014, Yichuan, V36, P346, DOI 10.3724/SP.J.1005.2014.0346; Ziober AF, 2010, BIOMARK MED, V4, P571, DOI 10.2217/BMM.10.71	61	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147409	10.1371/journal.pone.0147409	http://dx.doi.org/10.1371/journal.pone.0147409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808319	gold, Green Submitted, Green Published			2022-12-27	WOS:000369527800090
J	Saraswathy, S; Tan, JCH; Yu, F; Francis, BA; Hinton, DR; Weinreb, RN; Huang, AS				Saraswathy, Sindhu; Tan, James C. H.; Yu, Fei; Francis, Brian A.; Hinton, David R.; Weinreb, Robert N.; Huang, Alex S.			Aqueous Angiography: Real-Time and Physiologic Aqueous Humor Outflow Imaging	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; EPISCLERAL VENOUS-PRESSURE; TRABECULAR MESHWORK; INNER-WALL; CATIONIC FERRITIN; CATARACT-SURGERY; BOVINE EYES; FACILITY; CANALOPLASTY; ENDOTHELIUM	Purpose Trabecular meshwork (TM) bypass surgeries attempt to enhance aqueous humor outflow (AHO) to lower intraocular pressure (IOP). While TM bypass results are promising, inconsistent success is seen. One hypothesis for this variability rests upon segmental (non-360 degrees uniform) AHO. We describe aqueous angiography as a real-time and physiologic AHO imaging technique in model eyes as a way to simulate live AHO imaging. Methods Pig (n = 46) and human (n = 6) enucleated eyes were obtained, orientated based upon inferior oblique insertion, and pre-perfused with balanced salt solution via a Lewicky AC maintainer through a 1 mm side-port. Fluorescein (2.5%) was introduced intracamerally at 10 or 30 mm Hg. With an angiographer, infrared and fluorescent (486 nm) images were acquired. Image processing allowed for collection of pixel information based on intensity or location for statistical analyses. Concurrent OCT was performed, and fixable fluorescent dextrans were introduced into the eye for histological analysis of angiographically active areas. Results Aqueous angiography yielded high quality images with segmental patterns (p<0.0001; Kruskal-Wallis test). No single quadrant was consistently identified as the primary quadrant of angiographic signal (p = 0.06-0.86; Kruskal-Wallis test). Regions of high proximal signal did not necessarily correlate with regions of high distal signal. Angiographically positive but not negative areas demonstrated intrascleral lumens on OCT images. Aqueous angiography with fluorescent dextrans led to their trapping in AHO pathways. Conclusions Aqueous angiography is a real-time and physiologic AHO imaging technique in model eyes.	[Saraswathy, Sindhu; Tan, James C. H.; Francis, Brian A.; Huang, Alex S.] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA; [Tan, James C. H.; Francis, Brian A.; Huang, Alex S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Yu, Fei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Hinton, David R.] Univ So Calif, Dept Ophthalmol & Pathol, Los Angeles, CA USA; [Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California San Diego; University of California System; University of California San Diego	Huang, AS (corresponding author), Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.; Huang, AS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	Ahuang@Doheny.org			National Institutes of Health, Bethesda, MD [K08EY024674, P30EY03040]; American Glaucoma Society (AGS) Mentoring for Physician Scientists Award; AGS Young Clinician Scientist Award; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [K08EY024674, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Glaucoma Society (AGS) Mentoring for Physician Scientists Award; AGS Young Clinician Scientist Award; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work came from National Institutes of Health, Bethesda, MD (Grant Numbers K08EY024674 [ASH]; P30EY03040 [Doheny Cell and Tissue Imaging Core]); American Glaucoma Society (AGS) Mentoring for Physician Scientists Award 2013 [ASH] and 2014 [ASH]; AGS Young Clinician Scientist Award 2015 [ASH]; Research to Prevent Blindness, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hassan D.W., 2014, J OCUL BIOL, V2; Ahmed IIK, 2014, J CATARACT REFR SURG, V40, P1295, DOI 10.1016/j.jcrs.2014.07.004; Ahuja Y, 2013, AM J OPHTHALMOL, V156, P927, DOI 10.1016/j.ajo.2013.06.001; Aktas Z, 2014, J OCUL PHARMACOL TH, V30, P277, DOI 10.1089/jop.2013.0203; ASHTON N, 1951, BRIT J OPHTHALMOL, V35, P291, DOI 10.1136/bjo.35.5.291; Battista SA, 2008, INVEST OPHTH VIS SCI, V49, P5346, DOI 10.1167/iovs.08-1707; Braakman ST, 2015, EXP EYE RES, V130, P87, DOI 10.1016/j.exer.2014.11.008; Camras LJ, 2012, INVEST OPHTH VIS SCI, V53, P5242, DOI [10.1167/iovs.12-9825, 10.1167/iovs.12-9825a]; Chang JYH, 2014, J OCUL PHARMACOL TH, V30, P213, DOI 10.1089/jop.2013.0182; Cobb B, 1969, Trans Ophthalmol Soc U K, V88, P211; Craven ER, 2012, J CATARACT REFR SURG, V38, P1339, DOI 10.1016/j.jcrs.2012.03.025; Eagle R, 2001, EYE PATHOLOGY ATLAS; Ethier CR, 2001, INVEST OPHTH VIS SCI, V42, P1795; Fellman RL, 2014, J GLAUCOMA, V23, P347, DOI 10.1097/IJG.0b013e31827a06d8; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gong H, 2014, SURG INNOVATIONS GLA; Grieshaber MC, 2012, DEV OPHTHALMOL, V50, P109, DOI 10.1159/000334793; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Hann CR, 2005, INVEST OPHTH VIS SCI, V46, P1, DOI 10.1167/iovs.04-0800; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Jacobs DS, 2006, OPHTHALMOLOGY, V113, P707, DOI 10.1016/j.ophtha.2006.01.024; Johnson DH, 2002, ARCH OPHTHALMOL-CHIC, V120, P67; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Kagemann L, 2012, OPHTHALMOLOGY, V119, P1563, DOI 10.1016/j.ophtha.2012.02.032; Keller KE, 2011, INVEST OPHTH VIS SCI, V52, P5049, DOI 10.1167/iovs.10-6948; Lei YA, 2010, INVEST OPHTH VIS SCI, V51, P5744, DOI 10.1167/iovs.10-5703; Li P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046013; Li P, 2013, BIOMED OPT EXPRESS, V4, P2051, DOI 10.1364/BOE.4.002051; Lindsey JD, 2009, INVEST OPHTH VIS SCI, V50, P5754, DOI 10.1167/iovs.09-3398; Lindsey JD, 2002, INVEST OPHTH VIS SCI, V43, P2201; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P443, DOI 10.1016/0014-4835(86)90004-7; Marvasti AH, BMC OPHTHALMOL UNPUB; Minckler D, 2008, T AM OPHTHALMOL SOC, V106, P149; Minckler D., 2008, T AM OPHTHAL SOC, V106, P59; Overby DR, 2009, EXP EYE RES, V88, P656, DOI 10.1016/j.exer.2008.11.033; Radcliffe NM, 2013, GLAUCOMA TODAY; Sabanay I, 2000, ARCH OPHTHALMOL-CHIC, V118, P955; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Sit AJ, 2011, EXP EYE RES, V93, P291, DOI 10.1016/j.exer.2011.05.003; Sit AJ, 2011, EXP EYE RES, V92, P537, DOI 10.1016/j.exer.2011.03.018; Swaminathan SS, 2014, J CATARACT REFR SURG, V40, P1263, DOI 10.1016/j.jcrs.2014.06.020; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Vandewalle E, 2014, J GLAUCOMA, V23, P95, DOI 10.1097/IJG.0b013e318269806a; Vranka JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122483; Yang CYC, 2013, INVEST OPHTH VIS SCI, V54, P5859, DOI 10.1167/iovs.12-10930; Zeppa Lucio, 2014, JAMA Ophthalmol, V132, P1281, DOI 10.1001/jamaophthalmol.2014.567	47	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147176	10.1371/journal.pone.0147176	http://dx.doi.org/10.1371/journal.pone.0147176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807586	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800056
J	She, XD; Calderone, R; Kruppa, M; Lowman, D; Williams, D; Zhang, LL; Gao, Y; Khamooshi, K; Liu, WD; Li, DM				She, Xiaodong; Calderone, Richard; Kruppa, Michael; Lowman, Douglas; Williams, David; Zhang, Lili; Gao, Ying; Khamooshi, Kasra; Liu, Weida; Li, Dongmei			Cell Wall N-Linked Mannoprotein Biosynthesis Requires Goa1p, a Putative Regulator of Mitochondrial Complex I in Candida albicans	PLOS ONE			English	Article							RECOGNITION; MANNAN; HYPHAL; YEAST; VIRULENCE; KINASE; GROWTH; MUTANT; GENE; ARCHITECTURE	The Goa1p of Candida albicans regulates mitochondrial Complex I (CI) activities in its role as a putative CI accessory protein. Transcriptional profiling of goa1 Delta revealed a down regulation of genes encoding beta-oligomannosyl transferases. Herein, we present data on cell wall phenotypes of goa1 Delta (strain GOA31). We used transmission electron microscopy (TEM), GPC/MALLS, and NMR to compare GOA31 to a gene-reconstituted strain (GOA32) and parental cells. We note by TEM a reduction in outer wall fibrils, increased inner wall transparency, and the loss of a defined wall layer close to the plasma membrane. GPC-MALLS revealed a reduction in high and intermediate Mw mannan by 85% in GOA31. A reduction of beta-mannosyl but not a-mannosyl linkages was noted in GOA31 cells. beta-(1,6)-linked glucan side chains were branched about twice as often but were shorter in length for GOA31. We conclude that mitochondrial CI energy production is highly integrated with cell wall formation. Our data also suggest that not all cell wall biosynthetic processes are dependent upon Goa1p even though it provides high levels of ATP to cells. The availability of both broadly conserved and fungal-specific mutants lacking CI subunit proteins should be useful in assessing functions of fungal-specific functions subunit proteins.	[She, Xiaodong; Calderone, Richard; Khamooshi, Kasra; Li, Dongmei] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA; [She, Xiaodong; Zhang, Lili; Gao, Ying; Liu, Weida] Chinese Acad Med Sci, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Inst Dermatol, Nanjing 210029, Jiangsu, Peoples R China; [Kruppa, Michael; Lowman, Douglas; Williams, David] E Tennessee State Univ, Dept Surg, Dept Biomed Sci, Johnson City, TN 37614 USA; [Kruppa, Michael; Lowman, Douglas; Williams, David] E Tennessee State Univ, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA	Georgetown University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; East Tennessee State University; East Tennessee State University	Calderone, R (corresponding author), Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA.	calderor@georgetown.edu	Kruppa, Michael D/B-6052-2009	Kruppa, Michael D/0000-0002-1747-2333	Georgetown University Biomedical Research Organization (BGRO); National Natural Science Foundation of China [81401652]; National Natural Science Foundation of Jiangsu Province, China [BK20130063]; NIH-NIAID [AI090290]; NIH [CC06RR0306551];  [NIHGM53522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083016] Funding Source: NIH RePORTER	Georgetown University Biomedical Research Organization (BGRO); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the Georgetown University Biomedical Research Organization (BGRO) to DL. We also wish to thank the National Natural Science Foundation of China (81401652) and the National Natural Science Foundation of Jiangsu Province, China (BK20130063) to XS and the NIH-NIAID, AI090290 to RC. This research was also supported, in part, by NIHGM53522 to DW. DW and MK would like to acknowledge partial support of this project through NIH CC06RR0306551.; The authors acknowledge the support of the Georgetown University Biomedical Research Organization (BGRO) to DL. We also wish to thank the National Natural Science Foundation of China (81401652) and the National Natural Science Foundation of Jiangsu Province, China (BK20130063) to XS and the NIH-NIAID, AI090290 to RC. This research was also supported, in part, by NIHGM53522 to DW. DW and MK would like to acknowledge partial support of this project through NIH CC06RR0306551.	Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chen H, 2012, FUNGAL GENET BIOL, V49, P1023, DOI 10.1016/j.fgb.2012.09.007; Devillers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084771; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fabre E, 2014, BIOCHEM J, V457, P347, DOI 10.1042/BJ20131012; Galello F, 2014, J PROTEOMICS, V109, P261, DOI 10.1016/j.jprot.2014.07.008; GOPAL PK, 1984, J GEN MICROBIOL, V130, P3295; GOW NAR, 1994, P NATL ACAD SCI USA, V91, P6216, DOI 10.1073/pnas.91.13.6216; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Jimenez-Lopez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003741; Johnson MA, 2013, CHEM SOC REV, V42, P4327, DOI 10.1039/c2cs35382b; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 2001, GLYCOBIOLOGY, V11, P693, DOI 10.1093/glycob/11.8.693; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kruppa M, 2003, FEMS YEAST RES, V3, P289, DOI 10.1016/S1567-1356(02)00164-2; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; Li DM, 2009, FUNGAL GENET BIOL, V46, P731, DOI 10.1016/j.fgb.2009.06.008; Li DM, 2011, EUKARYOT CELL, V10, P672, DOI 10.1128/EC.00303-10; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Lowman DW, 2011, CARBOHYD RES, V346, P2752, DOI 10.1016/j.carres.2011.09.029; Lowman DW, 2003, CARBOHYD RES, V338, P1491, DOI 10.1016/S0008-6215(03)00169-1; Lung A, 1999, APPL ENVIRON MICROB, V65, P5398; Martinez JP, 1998, CLIN MICROBIOL REV, V11, P121, DOI 10.1128/CMR.11.1.121; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; REES DA, 1971, J CHEM SOC B, P469, DOI 10.1039/j29710000469; Riquelme M, 2014, CURR OPIN MICROBIOL, V20, P27, DOI 10.1016/j.mib.2014.04.003; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; She XD, 2015, CELL MICROBIOL, V17, P1350, DOI 10.1111/cmi.12438; She XD, 2013, CELL MICROBIOL, V15, P1572, DOI 10.1111/cmi.12135; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; West L, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478743; Wilson W, 2015, FISH SHELLFISH IMMUN, V43, P346, DOI 10.1016/j.fsi.2014.12.032; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Xin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035106; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	48	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147175	10.1371/journal.pone.0147175	http://dx.doi.org/10.1371/journal.pone.0147175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809064	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800055
J	Vera, B; Martinez-Velez, N; Xipell, E; de la Rocha, AA; Patino-Garcia, A; Saez-Castresana, J; Gonzalez-Huarriz, M; Cascallo, M; Alemany, R; Alonso, MM				Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Patino-Garcia, Ana; Saez-Castresana, Javier; Gonzalez-Huarriz, Marisol; Cascallo, Manel; Alemany, Ramon; Alonso, Marta M.			Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01	PLOS ONE			English	Article							MOUSE MACROPHAGES; HYALURONAN FRAGMENTS; GENE-EXPRESSION; BRAIN-TUMOR; TOXICITY; PROMOTER; SURVIVAL; GLIOMA; GLIOBLASTOMA; TEMOZOLOMIDE	Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with tumor-selective viruses is emerging as a treatment option for this devastating disease. In this study we characterize the anti-glioma effect of VCN-01, an improved hyaluronidase-armed pRB-pathway-selective oncolytic adenovirus that has proven safe and effective in the treatment of several solid tumors. VCN-01 displayed a significant cytotoxic effect on glioma cells in vitro. In vivo, in two different orthotopic glioma models, a single intra-tumoral administration of VCN-01 increased overall survival significantly and led to long-term survivors free of disease.	[Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Patino-Garcia, Ana; Saez-Castresana, Javier; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Vera, Beatriz; Martinez-Velez, Naiara; Xipell, Enric; Acanda de la Rocha, Arlet; Gonzalez-Huarriz, Marisol; Alonso, Marta M.] Univ Hosp Navarra, Dept Med Oncol, Pamplona 31008, Spain; [Patino-Garcia, Ana] Univ Hosp Navarra, Dept Pediat, Pamplona 31008, Spain; [Saez-Castresana, Javier] Univ Navarra, Sch Sci, Brain Tumor Biol Unit, Pamplona 31008, Spain; [Cascallo, Manel] VCN Biosci, Barcelona 08174, Spain; [Alemany, Ramon] Hosp Llobregat, IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona 08907, Spain	Servicio Navarro de Salud - Osasunbidea; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; University of Navarra; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Alonso, MM (corresponding author), Navarras Hlth Res Inst IDISNA, Pamplona, Spain.; Alonso, MM (corresponding author), Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain.; Alonso, MM (corresponding author), Univ Hosp Navarra, Dept Med Oncol, Pamplona 31008, Spain.	mmalonso@unav.es	Patiño-Garcia, Ana/I-4299-2012; Alonso, Marta M/AAI-9457-2020	Patiño-Garcia, Ana/0000-0002-4066-8203; Alonso, Marta M/0000-0002-7520-7351; Castresana, Javier S./0000-0002-2373-482X; gonzalez-huarriz, marisol/0000-0002-0438-0077; Martinez-Velez, Naiara/0000-0003-2248-7692	European Union (Marie Curie) [IRG270459]; Instituto de Salud Carlos III y los Fondos Feder Europeos [PI13/125]; Spanish Ministry of Science and Innovation [RYC-2009-05571]; L'OREAL-Unesco Foundation; Department of Health of the Government of Navarra; Basque Foundation for Health Research (BIOEF) [BIO13/CI/005]; Caja Navarra Foundation; Credit Andorra Foundation; University of Navarra; Spanish Ministry of Education and Science [BIO2011-30299-C02-01]; VCN bioscience	European Union (Marie Curie)(European Commission); Instituto de Salud Carlos III y los Fondos Feder Europeos; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); L'OREAL-Unesco Foundation(L'Oreal Group); Department of Health of the Government of Navarra; Basque Foundation for Health Research (BIOEF); Caja Navarra Foundation; Credit Andorra Foundation; University of Navarra; Spanish Ministry of Education and Science(Spanish Government); VCN bioscience	This work was supported by the European Union (Marie Curie IRG270459 to MMA), the Instituto de Salud Carlos III y los Fondos Feder Europeos (PI13/125 to MMA), the Spanish Ministry of Science and Innovation (Ramon y Cajal contract RYC-2009-05571 to MMA), The L'OREAL-Unesco Foundation (to MMA), The Department of Health of the Government of Navarra (to MMA), The Basque Foundation for Health Research (BIOEF, BIO13/CI/005) and the Caja Navarra Foundation (to MMA). EX is supported by a fellowship from the Credit Andorra Foundation. AAR is supported by a fellowship from Friends of the University of Navarra (ADA). RA is supported by BIO2011-30299-C02-01 from the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VCN bioscience provided support in the form of salaries or research support for authors MC and RA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the European Union (Marie Curie IRG270459 to MMA), the Instituto de Salud Carlos III y los Fondos Feder Europeos (PI13/125 to MMA), the Spanish Ministry of Science and Innovation (Ramon y Cajal contract RYC-2009-05571 to MMA), The L'OREAL-Unesco Foundation (to MMA), The Department of Health of the Government of Navarra (to MMA), The Basque Foundation for Health Research (BIOEF, BIO13/CI/005) and the Caja Navarra Foundation (to MMA). EX is supported by a fellowship from the Credit Andorra Foundation. AAR is supported by a fellowship from Friends of the University of Navarra (ADA). RA is supported by BIO2011-30299-C02-01 from the Spanish Ministry of Education and Science.	Alemany R, 2007, MOL ASPECTS MED, V28, P42, DOI 10.1016/j.mam.2006.12.002; Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Alonso MM, 2007, CANCER RES, V67, P8255, DOI 10.1158/0008-5472.CAN-06-4675; Alonso MM, 2005, JNCI-J NATL CANCER I, V97, P1589, DOI 10.1093/jnci/dji340; Baier C, 2007, MATRIX BIOL, V26, P348, DOI 10.1016/j.matbio.2007.02.002; Ballman KV, 2007, NEURO-ONCOLOGY, V9, P29, DOI 10.1215/15228517-2006-025; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Cascallo M, 2007, MOL THER, V15, P1607, DOI 10.1038/sj.mt.6300239; Cascallo M, 2006, HUM GENE THER, V17, P929, DOI 10.1089/hum.2006.17.929; Chiarella P, 2013, HUM GENE THER, V24, P406, DOI 10.1089/hum.2012.215; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Horton MR, 1999, J IMMUNOL, V162, P4171; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Horton MR, 1998, J IMMUNOL, V160, P3023; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Majem M, 2006, CANCER GENE THER, V13, P696, DOI 10.1038/sj.cgt.7700940; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Rodriguez-Garcia A, 2015, CLIN CANCER RES, V21, P1406, DOI 10.1158/1078-0432.CCR-14-2213; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Ulasov IV, 2009, INT J ONCOL, V34, P729, DOI 10.3892/ijo_00000199	26	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147211	10.1371/journal.pone.0147211	http://dx.doi.org/10.1371/journal.pone.0147211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808201	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800061
J	Wibroe, EA; Yri, HM; Jensen, RH; Wibroe, MA; Hamann, S				Wibroe, Elisabeth A.; Yri, Hanne M.; Jensen, Rigmor H.; Wibroe, Morten A.; Hamann, Steffen			Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH)	PLOS ONE			English	Article							PSEUDOTUMOR CEREBRI; DIAGNOSTIC-CRITERIA; OBESITY; SERUM	Introduction Idiopathic intracranial hypertension (IIH) is a disorder of increased intracranial fluid pressure (ICP) of unknown etiology. This study aims to investigate osmolality of cerebrospinal fluid (CSF) from patients with IIH. Methods We prospectively collected CSF from individuals referred on suspicion of IIH from 2011-2013. Subjects included as patients fulfilled Friedman and Jacobson's diagnostic criteria for IIH. Individuals in whom intracranial hypertension was refuted were included as controls. Lumbar puncture with ICP measurement was performed at inclusion and repeated for patients after three months of treatment. Osmolality was measured with a Vapor Pressure Osmometer. Results We collected 90 CSF samples from 38 newly diagnosed patients and 28 controls. At baseline 27 IIH-samples and at 3 months follow-up 35 IIH-samples were collected from patients. We found no significant differences in osmolality between 1) patients at baseline and controls (p = 0. 86), 2) patients at baseline and after 3 months treatment (p = 0.97), and 3) patients with normalized pressure after 3 months and their baseline values (p = 0.79). Osmolality in individuals with normal ICP from 6-25 cmH(2)O (n = 41) did not differ significantly from patients with moderately elevated ICP from 26-45 cmH(2)O (n = 21) (p = 0.86) and patients with high ICP from 46-70 cmH(2)O (n = 4) (p = 0.32), respectively. There was no correlation between osmolality and ICP, BMI, age and body height, respectively. Mean CSF osmolality was 270 mmol/kg (+/- 1 SE, 95% confidence interval 267-272) for both patients and controls. Conclusions CSF osmolality was normal in patients with IIH, and there was no relation to treatment, ICP, BMI, age and body height. Mean CSF osmolality was 270 mmol/kg and constitutes a reference for future studies. Changes in CSF osmolality are not responsible for development of IIH. Other underlying pathophysiological mechanisms must be searched.	[Wibroe, Elisabeth A.; Hamann, Steffen] Univ Copenhagen, Rigshosp, Dept Ophthalmol, Glostrup, Denmark; [Yri, Hanne M.; Jensen, Rigmor H.] Univ Copenhagen, Rigshosp, Dept Neurol, Danish Headache Ctr, Glostrup, Denmark; [Wibroe, Morten A.] Univ Copenhagen, Rigshosp, Dept Pediat & Adolescent Med, Glostrup, Denmark; [Wibroe, Morten A.] Univ Copenhagen, Rigshosp, Dept Neurosurg, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Wibroe, EA (corresponding author), Univ Copenhagen, Rigshosp, Dept Ophthalmol, Glostrup, Denmark.	elisabeth.arnberg@gmail.com	Wibroe, Elisabeth A./N-2701-2016; Hamann, Steffen/E-2090-2013	Hamann, Steffen/0000-0003-4318-2716	Region Hovedstadens Forskningsfond; A. P. Moller Fonden til Laegevidenskabens Fremme [12-375]	Region Hovedstadens Forskningsfond; A. P. Moller Fonden til Laegevidenskabens Fremme	This work was supported by Region Hovedstadens Forskningsfond and A. P. Moller Fonden til Laegevidenskabens Fremme, grant number 12-375 (https://www.regionh.dk/til-fagfolk/forskning-og-innovation/Finansiering/ansoegningsfrister/Loebende-ansoegningsfrister/ Sider/Region-Hovedstadens-Forskningsfond-til-Sundhedsforskning.aspx, http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx). HMY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews LE, 2014, HORM RES PAEDIAT; Ball AK, 2009, CLIN ENDOCRINOL, V70, P863, DOI 10.1111/j.1365-2265.2008.03401.x; Baykan B, 2015, AGRI, V27, P63, DOI 10.5505/agri.2015.22599; Daniels AB, 2007, AM J OPHTHALMOL, V143, P635, DOI 10.1016/j.ajo.2006.12.040; Dhungana S, 2009, HEADACHE, V49, P282, DOI 10.1111/j.1526-4610.2008.001329.x; Edwards LJ, 2013, AM J CLIN EXP IMMUNO, V2, P234; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239; GOLDBERG NB, 1965, ANESTHESIOLOGY, V26, P829, DOI 10.1097/00000542-196511000-00021; IRELAND B, 1990, ARCH NEUROL-CHICAGO, V47, P315, DOI 10.1001/archneur.1990.00530030091021; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Kosmorsky GS, 2014, HEADACHE, V54, P389, DOI 10.1111/head.12284; Lecube A, 2012, J NEUROENDOCRINOL, V24, P944, DOI 10.1111/j.1365-2826.2012.02288.x; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Marzoli SB, 2013, NEUROL SCI, V34, pS143, DOI 10.1007/s10072-013-1373-1; Ooi LY, 2008, BRIT J NEUROSURG, V22, P187, DOI 10.1080/02688690701827340; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Rowe FJ, 1999, INT J OBESITY, V23, P54, DOI 10.1038/sj.ijo.0800758; Salpietro V, 2014, J PEDIATR ENDOCR MET, V27, P107, DOI 10.1515/jpem-2013-0156; Salpietro V, 2013, J PEDIATR-US, V162, P1084, DOI 10.1016/j.jpeds.2013.01.048; Salpietro V, 2012, NEUROENDOCRINOL LETT, V33, P569; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stiebel-Kalish H, 2014, INT J OBESITY, V38, P1475, DOI 10.1038/ijo.2014.44; Thurtell MJ, 2013, CURR TREAT OPTION NE, V15, P1, DOI 10.1007/s11940-012-0207-4; Walker RWH, 2001, J NEUROL NEUROSUR PS, V71, P1, DOI 10.1136/jnnp.71.1.1; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Warner JEA, 2007, J NEURO-OPHTHALMOL, V27, P258, DOI 10.1097/WNO.0b013e31815b9af0; Yri Hanne M, 2012, Ugeskr Laeger, V174, P1737; Yri HM, 2012, J NEUROL, V259, P886, DOI 10.1007/s00415-011-6273-9; Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146793	10.1371/journal.pone.0146793	http://dx.doi.org/10.1371/journal.pone.0146793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808050	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800032
J	Kauppi, AM; Edin, A; Ziegler, I; Molling, P; Sjostedt, A; Gylfe, A; Stralin, K; Johansson, A				Kauppi, Anna M.; Edin, Alicia; Ziegler, Ingrid; Molling, Paula; Sjostedt, Anders; Gylfe, Asa; Stralin, Kristoffer; Johansson, Anders			Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; SEPTIC SHOCK; METABOLOMICS; SAMPLES; SPECTROSCOPY; ANTIBIOTICS; ENDOTOXEMIA; MORTALITY; SEVERITY; CULTURE	A metabolomics approach for prediction of bacteremic sepsis in patients in the emergency room (ER) was investigated. In a prospective study, whole blood samples from 65 patients with bacteremic sepsis and 49 ER controls were compared. The blood samples were analyzed using gas chromatography coupled to time-of-flight mass spectrometry. Multivariate and logistic regression modeling using metabolites identified by chromatography or using conventional laboratory parameters and clinical scores of infection were employed. A predictive model of bacteremic sepsis with 107 metabolites was developed and validated. The number of metabolites was reduced stepwise until identifying a set of 6 predictive metabolites. A 6-metabolite predictive logistic regression model showed a sensitivity of 0.91(95% CI 0.69-0.99) and a specificity 0.84 (95% CI 0.58-0.94) with an AUC of 0.93 (95% CI 0.89-1.01). Myristic acid was the single most predictive metabolite, with a sensitivity of 1.00 (95% CI 0.85-1.00) and specificity of 0.95 (95% CI 0.74-0.99), and performed better than various combinations of conventional laboratory and clinical parameters. We found that a metabolomics approach for analysis of acute blood samples was useful for identification of patients with bacteremic sepsis. Metabolomics should be further evaluated as a new tool for infection diagnostics.	[Kauppi, Anna M.; Edin, Alicia; Sjostedt, Anders; Gylfe, Asa; Johansson, Anders] Dept Clin Microbiol, Clin Bacteriol, Lab Mol Infect Med, Stockholm, Sweden; [Kauppi, Anna M.; Edin, Alicia; Sjostedt, Anders; Gylfe, Asa; Johansson, Anders] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Ziegler, Ingrid] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Molling, Paula] Univ Orebro, Fac Med & Hlth, Dept Lab Med, SE-70182 Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Umea University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital	Johansson, A (corresponding author), Dept Clin Microbiol, Clin Bacteriol, Lab Mol Infect Med, Stockholm, Sweden.	anders.f.johansson@umu.se	Johansson, Anders/D-2928-2012; Sjöstedt, Anders/AAC-6575-2020; Johansson, Anders/H-9362-2017	Johansson, Anders/0000-0003-0548-5943; Sjöstedt, Anders/0000-0002-0768-8405; Johansson, Anders/0000-0003-0548-5943; Edin, Alicia/0000-0003-0309-1852	Umea University; Vasterbotten County Council [VLL-151871, VLL-495291, VLL-495361]	Umea University; Vasterbotten County Council	This work was supported by grants from Umea University and Vasterbotten County Council (VLL-151871, VLL-495291 and VLL-495361 to A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2015, INTENS CARE MED, V41, P1739, DOI 10.1007/s00134-015-3978-8; Antti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056971; Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Howell L., 2013, GLOBAL RISKS 2013; Jiye A., 2005, ANAL CHEM, V77, P8086, DOI DOI 10.1021/AC051211V; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kamisoglu K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0783-2; Kamisoglu K, 2014, SHOCK, V42, P499, DOI 10.1097/SHK.0000000000000248; Laiakis EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012655; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; Oehler RL, 2010, CLIN INFECT DIS, V50, P1268, DOI 10.1086/651602; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Raymond DP, 2001, ANN SURG, V233, P549, DOI 10.1097/00000658-200104000-00011; Seymour CW, 2013, INTENS CARE MED, V39, P1423, DOI 10.1007/s00134-013-2935-7; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Sogaard M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-139; Stringer KA, 2015, SHOCK, V44, P200, DOI 10.1097/SHK.0000000000000406; Ziegler I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-155	30	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147670	10.1371/journal.pone.0147670	http://dx.doi.org/10.1371/journal.pone.0147670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800189	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300138
J	Lukkala, PS; Honkanen, RJ; Rauma, PH; Williams, LJ; Quirk, SE; Kroger, H; Koivumaa-Honkanen, H				Lukkala, Pyry S.; Honkanen, Risto J.; Rauma, Paivi H.; Williams, Lana J.; Quirk, Shae E.; Kroger, Heikki; Koivumaa-Honkanen, Heli			Life Satisfaction and Morbidity among Postmenopausal Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; 6-YEAR FOLLOW-UP; BLOOD-PRESSURE; DEPRESSION; HEALTH; DISABILITY; MORTALITY; DISSATISFACTION; DISORDERS; IMPACT	Objective To investigate associations between morbidity and global life satisfaction in postmenopausal women taking into account type and number of diseases. Materials and Methods A total of 11,084 women (age range 57-66 years) from a population -based cohort of Finnish women (OSTPRE Study) responded to a postal enquiry in 1999. Life satisfaction was measured with a 4 -item scale. Self -reported diseases diagnosed by a physician and categorized according to ICD-10 main classes were used as a measure of morbidity. Enquiry data on health and lifestyle were used as covariates in the multivariate logistic models. Results Morbidity was strongly associated with life dissatisfaction. Every additional disease increased the risk of life dissatisfaction by 21.1% (p <.001). The risk of dissatisfaction was strongest among women with mental disorders (OR = 5.26; 95%Cl 3.84-7.20) and neurological disorders (OR = 3.62; 95%Cl 2.60-5.02) compared to the healthy (each p <.001). Smoking, physical inactivity and marital status were also associated with life dissatisfaction (each p <.001) but their introduction to the multivariate model did not attenuate the pattern of associations. Conclusions Morbidity and life dissatisfaction have a disease -specific and dose -dependent relationship. Even if women with mental and neurological disorders have the highest risk for life dissatisfaction, monitoring life satisfaction among aging women regardless of disorders should be undertaken in order to intervene the joint adverse effects of poor health and poor well-being.	[Lukkala, Pyry S.] UEF, Sch Med, Fac Hlth Sci, Kuopio, Finland; [Lukkala, Pyry S.; Honkanen, Risto J.; Rauma, Paivi H.; Kroger, Heikki] UEF, Surg, Inst Clin Med, Bone & Cartilage Res Unit, Kuopio, Finland; [Rauma, Paivi H.] UEF, Social Pharm, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Williams, Lana J.; Quirk, Shae E.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia; [Kroger, Heikki] KUH, Dept Orthopaed Traumatol & Handsurg, Kuopio, Finland; [Koivumaa-Honkanen, Heli] UEF, Psychiat, Inst Clin Med, Kuopio, Finland; [Koivumaa-Honkanen, Heli] KUH, Dept Psychiat, Kuopio, Finland; [Koivumaa-Honkanen, Heli] South Savonia Hosp Dist, Mikkeli, Finland; [Koivumaa-Honkanen, Heli] North Karelia Cent Hosp, Joensuu, Finland; [Koivumaa-Honkanen, Heli] SOSTERI, Savonlinna, Finland; [Koivumaa-Honkanen, Heli] SOTE, Iisalmi, Finland; [Koivumaa-Honkanen, Heli] Lapland Hosp Dist, Rovaniemi, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Deakin University; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital	Lukkala, PS (corresponding author), UEF, Sch Med, Fac Hlth Sci, Kuopio, Finland.; Lukkala, PS (corresponding author), UEF, Surg, Inst Clin Med, Bone & Cartilage Res Unit, Kuopio, Finland.	pyryluk@student.uef.fi	Koivumaa-Honkanen, Heli TJ/L-1274-2015	Quirk, Shae/0000-0002-4370-4337; Williams, Lana/0000-0002-1377-1272	Academy of Finland; Strategic Funding of University of Eastern Finland [115969, 250707]	Academy of Finland(Academy of Finland); Strategic Funding of University of Eastern Finland	This research has been supported by The Academy of Finland and Strategic Funding of University of Eastern Finland, grants 115969 (http://webfocus.aka.fi/ibi_apps/WFServlet?|BIF_ex=xHakKuvaus&CLICKED_ON=&HAKNRO1=250707&UILANG=en) and 250707 (https://www.psshp.fi/documents/11427/47580/Tutkimushankkeet_VTR_euro_p%C3%A4%C3%A4t%C3%B6s_2015.pdf/c7457898-f58b-41d1-bfbd-38d25869d5c8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Binder M, 2013, SOC SCI MED, V87, P155, DOI 10.1016/j.socscimed.2013.03.025; Broe GA, 1998, INT J GERIATR PSYCH, V13, P667, DOI 10.1002/(SICI)1099-1166(1998100)13:10<667::AID-GPS839>3.0.CO;2-G; Crump C, 2013, AM J PSYCHIAT, V170, P324, DOI 10.1176/appi.ajp.2012.12050599; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Dural A, 2003, DISABIL REHABIL, V25, P318, DOI 10.1080/0963828021000043761; Graham C, 2011, HEALTH ECON, V20, P1431, DOI 10.1002/hec.1682; Harter M, 2007, PSYCHOTHER PSYCHOSOM, V76, P354, DOI 10.1159/000107563; ISHIHARA M, 1987, DIABETES CARE, V10, P20, DOI 10.2337/diacare.10.1.20; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; KNOWLER WC, 1980, NEW ENGL J MED, V302, P645, DOI 10.1056/NEJM198003203021201; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Koivumaa-Honkanen H, 2004, PSYCHOL MED, V34, P221, DOI 10.1017/S0033291703001089; Koivumaa-Honkanen H, 2002, ACTA PSYCHIAT SCAND, V105, P444, DOI 10.1034/j.1600-0447.2002.01287.x; Koivumaa-Honkanen H, 2001, ACTA PSYCHIAT SCAND, V103, P38, DOI 10.1034/j.1600-0447.2001.00046.x; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Koivumaa-Honkanen H, 2008, SOC PSYCH PSYCH EPID, V43, P688, DOI 10.1007/s00127-008-0353-x; Koivumaa-Honkanen HT, 1998, LIFE SATISFACTION HL; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Mantyniemi A, 2012, OCCUP ENVIRON MED, V69, P574, DOI 10.1136/oemed-2011-100411; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Nabi H, 2013, EUR HEART J, V34, P2697, DOI 10.1093/eurheartj/eht216; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Pinquart M, 2007, PSYCHOL AGING, V22, P442, DOI 10.1037/0882-7974.22.3.442; Rauma PH, 2014, PSYCHOSOM MED, V76, P709, DOI 10.1097/PSY.0000000000000114; Rissanen T, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-140; Saharinen T, 2013, J PSYCHIAT MENT HLTH; Sinikallio S, 2011, J HEALTH PSYCHOL, V16, P783, DOI 10.1177/1359105310390723; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Terauchi M, 2013, J OBSTET GYNAECOL RE, V39, P1007, DOI 10.1111/j.1447-0756.2012.02064.x; Vaillant GE, 2003, AM J PSYCHIAT, V160, P1373, DOI 10.1176/appi.ajp.160.8.1373; Vazquez C, 2013, NATL REPRESENTATIVE, P1; Veenhoven R, 1996, SOC INDIC RES, V37, P1, DOI 10.1007/BF00300268; Veenhoven R, 2010, SOC INDIC RES, V97, P105, DOI 10.1007/s11205-009-9556-0; Viinamaki H, 2009, ACTA PSYCHIAT SCAND, V120, P23, DOI 10.1111/j.1600-0447.2008.01333.x	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147521	10.1371/journal.pone.0147521	http://dx.doi.org/10.1371/journal.pone.0147521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799838	Green Published, gold			2022-12-27	WOS:000368655300119
J	Madlala, HP; Metzinger, T; van Heerden, FR; Musabayane, CT; Mubagwa, K; Dessy, C				Madlala, Hlengiwe P.; Metzinger, Thomas; van Heerden, Fanie R.; Musabayane, Cephas T.; Mubagwa, Kanigula; Dessy, Chantal			Vascular Endothelium-Dependent and Independent Actions of Oleanolic Acid and Its Synthetic Oleanane Derivatives as Possible Mechanisms for Hypotensive Effects	PLOS ONE			English	Article							ORUJO OLIVE OIL; URSOLIC ACIDS; TRITERPENOIDS; RELAXATION; RELEASE; DISEASE; LIVER; AORTA; RATS	Purpose Plant-derived oleanolic acid (OA) and its related synthetic derivatives (Br-OA and Me-OA) possess antihypertensive effects in experimental animals. The present study investigated possible underlying mechanisms in rat isolated single ventricular myocytes and in vascular smooth muscles superfused at 37 degrees C. Methods Cell shortening was assessed at 1 Hz using a video-based edge-detection system and the L-type Ca2+ current (Ica) was measured using the whole-cell patch-clamp technique in single ventricular myocytes. Isometric tension was measured using force transducer in isolated aortic rings and in mesenteric arteries. Vascular effects were measured in endothelium intact and denuded vessels in the presence of various enzyme or channel inhibitors. Results OA and its derivatives increased cell shortening in cardiomyocytes isolated from normotensive rats but had no effect in those isolated from hypertensive animals. These triterpenes also caused relaxation in aortic rings and in mesenteric arteries pre-contracted with either phenylephrine or KCI-enriched solution. The relaxation was only partially inhibited by endothelium denudation, and also partly inhibited by the cyclooxygenase (COX) inhibitor indomethacin, with no additional inhibitory effect of the NO synthase inhibitor, N-w-Nitro-Larginine. A combination of both ATP-dependent channel inhibition by glibenclaminde and voltage-dependent K+ channel inhibition by 4-aminopyridine was necessary to fully inhibit the relaxation. Conclusion These data indicate that the effects of OA and its derivatives are mediated via both endothelium-dependent and independent mechanisms suggesting the involvement of COX in the endothelium-dependent effects and of vascular muscle K+ channels in the endothelium independent effects. Finally, our results support the view that the antihypertensive action of OA and its derivatives is due to a decrease of vascular resistance with no negative inotropic effect on the heart.	[Madlala, Hlengiwe P.; Musabayane, Cephas T.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa; [Metzinger, Thomas; Dessy, Chantal] Catholic Univ Louvain, Inst Expt & Clin Res, Pole Pharmacol & Therapeut, B-1200 Brussels, Belgium; [van Heerden, Fanie R.] Univ KwaZulu Natal, Sch Chem & Phys, Coll Agr Engn & Sci, Pietermaritzburg, South Africa; [Mubagwa, Kanigula] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium	University of Kwazulu Natal; Universite Catholique Louvain; University of Kwazulu Natal; KU Leuven	Dessy, C (corresponding author), Catholic Univ Louvain, Inst Expt & Clin Res, Pole Pharmacol & Therapeut, B-1200 Brussels, Belgium.	chantal.dessy@uclouvain.be	Van Heerden, Fanie R/A-5685-2008	Van Heerden, Fanie R/0000-0002-5710-7525	University of Leuven; Fonds de la Recherche Scientifique (FNRS)	University of Leuven(KU Leuven); Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by University of Leuven (http://www.ema2sa.eu; HPM) and Fonds de la Recherche Scientifique (FNRS) (http://www.fnrs.be/; CD).	Dongmo AB, 2011, J ETHNOPHARMACOL, V133, P204, DOI 10.1016/j.jep.2010.09.033; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; Kamboj VP, 2000, CURR SCI INDIA, V78, P35; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; Madlala HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128192; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Martin R, 2012, BRIT J PHARMACOL, V166, P1708, DOI 10.1111/j.1476-5381.2012.01869.x; Martinez-Gonzalez J, 2008, J NUTR, V138, P443, DOI 10.1093/jn/138.3.443; Martinsen A, 2012, CELL CALCIUM, V52, P413, DOI 10.1016/j.ceca.2012.07.002; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Ozsoy-Sacan O, 2004, BIOSCI BIOTECH BIOCH, V68, P1640, DOI 10.1271/bbb.68.1640; Rodriguez-Rodriguez R, 2008, BRIT J PHARMACOL, V155, P535, DOI 10.1038/bjp.2008.289; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; Rodriguez-Rodriguezl R, 2004, BRIT J NUTR, V92, P635, DOI 10.1079/BJN20041231; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; VanderGraaf PH, 1995, BRIT J PHARMACOL, V116, P3237	22	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147395	10.1371/journal.pone.0147395	http://dx.doi.org/10.1371/journal.pone.0147395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799746	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300102
J	Gao, L; Hu, H; Zhao, FL; Li, SC				Gao, Lan; Hu, Hao; Zhao, Fei-Li; Li, Shu-Chuen			Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples	PLOS ONE			English	Article							HEALTH-CARE COSTS; ECONOMIC BURDEN; REFRACTORY EPILEPSY; CONTRIBUTING FACTORS; UNITED-STATES; HONG-KONG; MELLITUS; POPULATION; GERMANY; TRANSFERABILITY	Objectives To systematically review cost of illness studies for schizophrenia (SC), epilepsy (EP) and type 2 diabetes mellitus (T2DM) and explore the transferability of direct medical cost across countries. Methods A comprehensive literature search was performed to yield studies that estimated direct medical costs. A generalized linear model (GLM) with gamma distribution and log link was utilized to explore the variation in costs that accounted by the included factors. Both parametric (Random-effects model) and non-parametric (Boot-strapping) meta-analyses were performed to pool the converted raw cost data (expressed as percentage of GDP/capita of the country where the study was conducted). Results In total, 93 articles were included (40 studies were for T2DM, 34 studies for EP and 19 studies for SC). Significant variances were detected inter-and intra-disease classes for the direct medical costs. Multivariate analysis identified that GDP/capita (p<0.05) was a significant factor contributing to the large variance in the cost results. Bootstrapping meta-analysis generated more conservative estimations with slightly wider 95% confidence intervals (CI) than the parametric meta-analysis, yielding a mean (95%CI) of 16.43% (11.32, 21.54) for T2DM, 36.17% (22.34, 50.00) for SC and 10.49% (7.86, 13.41) for EP. Conclusions Converting the raw cost data into percentage of GDP/capita of individual country was demonstrated to be a feasible approach to transfer the direct medical cost across countries. The approach from our study to obtain an estimated direct cost value along with the size of specific disease population from each jurisdiction could be used for a quick check on the economic burden of particular disease for countries without such data.	[Gao, Lan; Hu, Hao; Li, Shu-Chuen] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Zhao, Fei-Li] Pfizer Australia, Access & Publ Affair, West Ryde, NSW, Australia; [Gao, Lan] Deakin Univ, Fac Hlth, Sch Hlth & Social Dev, Deakin Hlth Econ Populat Hlth Strateg Res Ctr, Burwood, Vic, Australia; [Zhao, Fei-Li] Univ Technol Sydney, CHERE, Haymarket, NSW, Australia	University of Newcastle; Pfizer; Deakin University; University of Technology Sydney	Li, SC (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	ShuChuen.Li@newcastle.edu.au	Gao, Lan/X-9888-2019	Gao, Lan/0000-0001-9734-1140				Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; Al-Zakwani I, 2003, SEIZURE-EUR J EPILEP, V12, P555, DOI 10.1016/S1059-1311(03)00068-2; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amoo G, 2005, Afr J Med Med Sci, V34, P15; Bahia LR, 2011, VALUE HEALTH, V14, pS137, DOI 10.1016/j.jval.2011.05.009; Barbieri M, 2010, VALUE HEALTH, V13, P1028, DOI 10.1111/j.1524-4733.2010.00771.x; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Becker C, 2014, EXPERT REV PHARM OUT, V14, P661, DOI 10.1586/14737167.2014.940904; Beghi E, 2004, EPILEPSIA, V45, P171, DOI 10.1111/j.0013-9580.2004.14103.x; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; BEGLEY CE, 1994, EPILEPSIA, V35, P1230, DOI 10.1111/j.1528-1157.1994.tb01794.x; Begley CE, 2001, EPILEPSY RES, V47, P205, DOI 10.1016/S0920-1211(01)00310-2; Berto P, 2000, PHARMACOECONOMICS, V17, P197, DOI 10.2165/00019053-200017020-00008; Bolin K, 2012, EUR J HEALTH ECON, V13, P819, DOI 10.1007/s10198-011-0361-8; Bracco A, 2013, EXPERT REV PHARM OUT, V13, P579, DOI 10.1586/14737167.2013.837766; Bruno G, 2012, NUTR METAB CARDIOVAS, V22, P684, DOI 10.1016/j.numecd.2011.04.007; Cai L, 2013, INT J CARDIOL, V165, P273, DOI 10.1016/j.ijcard.2011.08.039; Gonzalez JC, 2009, REV PANAM SALUD PUBL, V26, P55, DOI 10.1590/S1020-49892009000700009; Carr VJ, 2003, AUST NZ J PSYCHIAT, V37, P31, DOI 10.1046/j.1440-1614.2003.01092.x; Chan BSW, 2007, INT J CLIN PHARM TH, V45, P455; Chang SM, 2008, J KOREAN MED SCI, V23, P167, DOI 10.3346/jkms.2008.23.2.167; Chatterjee S, 2011, HEALTH SOC CARE COMM, V19, P289, DOI 10.1111/j.1365-2524.2010.00981.x; Chodick G, 2010, HEALTH POLICY, V95, P271, DOI 10.1016/j.healthpol.2009.12.007; COCKERELL OC, 1994, EPILEPSY RES, V18, P249, DOI 10.1016/0920-1211(94)90045-0; Coyle D, 2001, INT J TECHNOL ASSESS, V17, P155, DOI 10.1017/S0266462301105015; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Dawson KG, 2002, DIABETES CARE, V25, P1303, DOI 10.2337/diacare.25.8.1303; de Zelicourt M, 2000, SEIZURE-EUR J EPILEP, V9, P88, DOI 10.1053/seiz.1999.0364; Durden ED, 2009, J OCCUP ENVIRON MED, V51, P1460, DOI 10.1097/JOM.0b013e3181c2bb31; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Fitzgerald PB, 2007, AUST NZ J PSYCHIAT, V41, P819, DOI 10.1080/00048670701579025; Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128; Gandra SR, 2006, J MANAGE CARE PHARM, V12, P546, DOI 10.18553/jmcp.2006.12.7.546; Garattini L, 2001, Value Health, V4, P251, DOI 10.1046/j.1524-4733.2001.43022.x; Garattini LG, 2004, SCHIZOPHRENIA BULL, V30, P295, DOI 10.1093/oxfordjournals.schbul.a007079; Garcia-Contreras F, 2006, ARCH MED RES, V37, P376, DOI 10.1016/j.arcmed.2005.07.005; Goeree R, 1999, CAN J PSYCHIAT, V44, P464, DOI 10.1177/070674379904400506; Goeree R, 2005, CURR MED RES OPIN, V21, P2017, DOI 10.1185/030079905X75087; Goeree R, 2007, CURR MED RES OPIN, V23, P671, DOI 10.1185/030079906X167327; Goeree R, 2011, CLINICOECONOMIC OUTC, V3, P89, DOI 10.2147/CEOR.S14404; Griffiths RI, 1999, EPILEPSIA, V40, P351, DOI 10.1111/j.1528-1157.1999.tb00717.x; Grover S, 2005, ACTA PSYCHIAT SCAND, V112, P54, DOI 10.1111/j.1600-0447.2005.00512.x; Guest JF, 1999, PHARMACOECONOMICS, V15, P597, DOI 10.2165/00019053-199915060-00007; Halpern M, 2000, NEUROEPIDEMIOLOGY, V19, P87, DOI 10.1159/000026243; Hamer HM, 2006, EPILEPSIA, V47, P2165, DOI 10.1111/j.1528-1167.2006.00889.x; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Honeycutt AA, 2009, HEALTH SERV RES, V44, P303, DOI 10.1111/j.1475-6773.2008.00909.x; Hong Z, 2009, EPILEPSIA, V50, P2192, DOI 10.1111/j.1528-1167.2009.02185.x; Icks A, 2004, EXP CLIN ENDOCR DIAB, V112, P302, DOI 10.1055/s-2004-820909; Ivanova JI, 2010, PHARMACOECONOMICS, V28, P675, DOI 10.2165/11535570-000000000-00000; Jacoby A, 1998, EPILEPSIA, V39, P776, DOI 10.1111/j.1528-1157.1998.tb01164.x; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jennum P, 2011, EPILEPSIA, V52, P949, DOI 10.1111/j.1528-1167.2010.02946.x; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Khowaja LA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-189; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Ko SY, 2003, PSYCHIAT CLIN NEUROS, V57, P373, DOI 10.1046/j.1440-1819.2003.01134.x; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Koster I, 2011, EXP CLIN ENDOCR DIAB, V119, P377, DOI 10.1055/s-0030-1269847; Kotsopoulos IAW, 2003, EPILEPSY RES, V54, P131, DOI 10.1016/S0920-1211(03)00062-7; Krishnan A, 2004, EPILEPSIA, V45, P289, DOI 10.1111/j.0013-9580.2004.63102.x; Lang HC, 2004, PSYCHIAT SERV, V55, P928, DOI 10.1176/appi.ps.55.8.928; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lee IH, 2008, PSYCHIAT RES, V158, P306, DOI 10.1016/j.psychres.2006.10.004; Lee KW, 2011, DIABETES METAB J, V35, P567, DOI 10.4093/dmj.2011.35.6.567; Libby AM, 2012, MED CARE, V50, P928, DOI 10.1097/MLR.0b013e31826c8613; Lipsey MW, 2000, PRACTICAL METAANALYS; Liu JM, 2013, EPILEPSY RES, V103, P288, DOI 10.1016/j.eplepsyres.2012.07.015; Lucioni Carlo, 2003, Treat Endocrinol, V2, P121, DOI 10.2165/00024677-200302020-00005; Mak W, 1999, SEIZURE-EUR J EPILEP, V8, P456, DOI 10.1053/seiz.1999.0343; Mangalore R, 2007, J MENT HEALTH POLICY, V10, P23; Murray MI, 1996, EPILEPSY RES, V23, P139, DOI 10.1016/0920-1211(95)00090-9; Nicholl D, 2010, CURR MED RES OPIN, V26, P943, DOI 10.1185/03007991003658956; Nolan J J, 2006, Ir Med J, V99, P307; Norlund A, 2001, J INTERN MED, V250, P57, DOI 10.1046/j.1365-2796.2001.00852.x; Nsengiyumva G, 2004, EPILEPSIA, V45, P673, DOI 10.1111/j.0013-9580.2004.36303.x; Oliva J, 2004, DIABETES CARE, V27, P2616, DOI 10.2337/diacare.27.11.2616; Pato AP, 2011, NEUROLOGIA, V26, P32, DOI 10.1016/j.nrl.2010.10.002; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Petersen M, 2003, DIABETES CARE, V26, P917; Phanthunane P, 2012, J MENT HEALTH POLICY, V15, P25; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Riewpaiboon A, 2007, VALUE HEALTH, V10, P223, DOI 10.1111/j.1524-4733.2007.00172.x; Rouillon F, 1997, PHARMACOECONOMICS, V11, P578, DOI 10.2165/00019053-199711060-00006; Rutten-van Molken MPMH, 1998, PHARMACOECONOMICS, V14, P671, DOI 10.2165/00019053-199814060-00007; Sancho J, 2008, EPILEPSY RES, V81, P176, DOI 10.1016/j.eplepsyres.2008.05.008; Sanya EO, 2011, EPILEPSIA, V52, P24; Schmitt-Koopmann I, 2004, EUR J PUBLIC HEALTH, V14, P3, DOI 10.1093/eurpub/14.1.3; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Solli O, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-15; Sorensen S, 2000, VALUE HEALTH; Stock SAK, 2006, DIABETIC MED, V23, P299, DOI 10.1111/j.1464-5491.2005.01779.x; Strzelczyk A, 2012, EPILEPSY BEHAV, V23, P451, DOI 10.1016/j.yebeh.2012.01.021; Swingler R J, 1994, Seizure, V3, P115, DOI 10.1016/S1059-1311(05)80201-8; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Tarricone R, 2000, HEALTH POLICY, V51, P1, DOI 10.1016/S0168-8510(99)00078-0; Tetto A, 2002, EPILEPSY RES, V48, P207, DOI 10.1016/S0920-1211(02)00013-X; Tharkar S, 2010, DIABETES RES CLIN PR, V89, P334, DOI 10.1016/j.diabres.2010.05.009; Thomas SV, 2001, EPILEPSIA, V42, P1052, DOI 10.1046/j.1528-1157.2001.0420081052.x; vanHout B, 1997, EPILEPSIA, V38, P1221; Vazquez-Polo FJ, 2005, J MENT HEALTH POLICY, V8, P153; Wagenpfeil S, 2002, VALUE HEALTH, V5, P398; Wang WB, 2009, VALUE HEALTH, V12, P923, DOI 10.1111/j.1524-4733.2009.00561.x; Warner DC, 1996, DIABETES CARE, V19, P1416, DOI 10.2337/diacare.19.12.1416; Welte R, 2004, PHARMACOECONOMICS, V22, P857, DOI 10.2165/00019053-200422130-00004; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Yoon D, 2009, EPILEPSIA, V50, P2186, DOI 10.1111/j.1528-1167.2009.02159.x; Zhao FL, 2013, PHARMACOECONOMICS, V26, P26	110	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147169	10.1371/journal.pone.0147169	http://dx.doi.org/10.1371/journal.pone.0147169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26814959	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200027
J	Hsiao, CT; Tsai, PC; Lin, CC; Liu, YT; Huang, YH; Liao, YC; Huang, HW; Lin, KP; Soong, BW; Lee, YC				Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Lin, Chou-Ching; Liu, Yo-Tsen; Huang, Yen-Hua; Liao, Yi-Chu; Huang, Han-Wei; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung			Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; MOTOR NEUROPATHY; PROTEIN SEIPIN	Background A small group of patients with inherited neuropathy that has been shown to be caused by mutations in the BSCL2 gene. However, little information is available about the role of BSCL2 mutations in inherited neuropathies in Taiwan. Methodology and Principal Findings Utilizing targeted sequencing, 76 patients with molecularly unassigned Charcot-Marie-Tooth disease type 2 (CMT2) and 8 with distal hereditary motor neuropathy (dHMN), who were selected from 348 unrelated patients with inherited neuropathies, were screened for mutations in the coding regions of BSCL2. Two heterozygous BSCL2 mutations, p.S90L and p.R96H, were identified, of which the p.R96H mutation is novel. The p.S90L was identified in a pedigree with CMT2 while the p.R96H was identified in a patient with apparently sporadic dHMN. In vitro studies demonstrated that the p.R96H mutation results in a remarkably low seipin expression and reduced cell viability. Conclusion BSCL2 mutations account for a small number of patients with inherited neuropathies in Taiwan. The p.R96H mutation is associated with dHMN. This study expands the molecular spectrum of BSCL2 mutations and also emphasizes the pathogenic role of BSCL2 mutations in molecularly unassigned hereditary neuropathies.	[Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liu, Yo-Tsen; Liao, Yi-Chu; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liu, Yo-Tsen; Liao, Yi-Chu; Lin, Kon-Ping; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Tsai, Pei-Chien; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Lin, Chou-Ching; Huang, Han-Wei] Natl Cheng Kung Univ Hosp, Sch Med, Dept Neurol, Taipei, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Inst Biomed Informat, Sch Med, Taipei 112, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.; Lee, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan.; Lee, YC (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan.	ycli@vghtpe.gov.tw	Lin, Chou-Ching K/I-1451-2019; Lee, Yi-Chung/H-8813-2019; Lee, Yi-Chung/GZK-7162-2022	Lin, Chou-Ching K/0000-0002-3070-5787; Lee, Yi-Chung/0000-0003-0102-164X; Liao, Yi-Chu/0000-0002-9644-2086; Tsai, Pei-Chien/0000-0001-7303-0516	Ministry of Science and Technology, Taiwan [102-2628-B-075-006-MY3]; Taipei Veterans General Hospital [V104C-041]; High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan [NSC-101-2319-B-010-001]; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan [MOST104-2319-B-010-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan	This work was supported by the grants from Ministry of Science and Technology, Taiwan (102-2628-B-075-006-MY3) and Taipei Veterans General Hospital (V104C-041). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.; We would like to thank the patients who participated in this study. We thank the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology of Taiwan (NSC-101-2319-B-010-001) for the service of nucleotide sequencing. We also thank the High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, the Ministry of Science and Technology, Taiwan (MOST104-2319-B-010-001), for the bioinformatics support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Auer-Grumbach M, 2005, ANN NEUROL, V57, P415, DOI 10.1002/ana.20410; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Choi BO, 2013, NEUROGENETICS, V14, P35, DOI 10.1007/s10048-012-0346-5; Drew AP, 2015, MOL GENET GENOM MED, V3, P143, DOI 10.1002/mgg3.126; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826; Guillen-Navarro E, 2013, J MED GENET, V50, P401, DOI 10.1136/jmedgenet-2013-101525; Irobi J, 2004, BRAIN, V127, P2124, DOI 10.1093/brain/awh232; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Klein CJ, 2014, J NEUROL NEUROSUR PS, V85, P1265, DOI 10.1136/jnnp-2013-306740; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YC, 2010, J NEUROL, V257, P1661, DOI 10.1007/s00415-010-5590-8; Liao YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133423; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Murphy SM, 2015, J NEUROL NEUROSUR PS, V86, P873; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sim MFM, 2013, DIABETOLOGIA, V56, P2498, DOI 10.1007/s00125-013-3029-3; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tsai PC, 2014, NEUROLOGY, V83, P903, DOI 10.1212/WNL.0000000000000758; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Wei SH, 2014, J NEUROCHEM, V129, P328, DOI 10.1111/jnc.12638; Wei SH, 2013, J NEUROCHEM, V124, P478, DOI 10.1111/jnc.12099; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444; Yang WL, 2013, BIOCHEM J, V452, P37, DOI 10.1042/BJ20121870; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	31	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147677	10.1371/journal.pone.0147677	http://dx.doi.org/10.1371/journal.pone.0147677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815532	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200044
J	Cignini, P; Giorlandino, M; Brutti, P; Mangiafico, L; Aloisi, A; Giorlandino, C				Cignini, Pietro; Giorlandino, Maurizio; Brutti, Pierpaolo; Mangiafico, Lucia; Aloisi, Alessia; Giorlandino, Claudio			Reference Charts for Fetal Cerebellar Vermis Height: A Prospective Cross-Sectional Study of 10605 Fetuses	PLOS ONE			English	Article							DANDY-WALKER MALFORMATION; SONOGRAPHIC DIAGNOSIS; POSTERIOR-FOSSA; WORM PLOT; HYPOPLASIA; PITFALLS; ANATOMY; BRAIN; FIT	Objective To establish reference charts for fetal cerebellar vermis height in an unselected population. Methods A prospective cross-sectional study between September 2009 and December 2014 was carried out at ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy. Of 25203 fetal biometric measurements, 12167 (48%) measurements of the cerebellar vermis were available. After excluding 1562 (12.8%) measurements, a total of 10605 (87.2%) fetuses were considered and analyzed once only. Parametric and nonparametric quantile regression models were used for the statistical analysis. In order to evaluate the robustness of the proposed reference charts regarding various distributional assumptions on the ultrasound measurements at hand, we compared the gestational age-specific reference curves we produced through the statistical methods used. Normal mean height based on parametric and nonparametric methods were defined for each week of gestation and the regression equation expressing the height of the cerebellar vermis as a function of gestational age was calculated. Finally the correlation between dimension/gestation was measured. Results The mean height of the cerebellar vermis was 12.7mm (SD, 1.6mm; 95% confidence interval, 12.7-12.8mm). The regression equation expressing the height of the CV as a function of the gestational age was: height (mm) = -4.85+0.78x gestational age. The correlation between dimension/ gestation was expressed by the coefficient r = 0.87. Conclusion This is the first prospective cross-sectional study on fetal cerebellar vermis biometry with such a large sample size reported in literature. It is a detailed statistical survey and contains new centile-based reference charts for fetal height of cerebellar vermis measurements.	[Cignini, Pietro; Giorlandino, Maurizio; Mangiafico, Lucia; Giorlandino, Claudio] ALTAMEDICA Fetal Maternal Med Ctr, Dept Prenatal Diag, Rome, Italy; [Brutti, Pierpaolo] Univ Roma La Sapienza, Dept Stat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Aloisi, Alessia] Campus Biomedico Univ Rome, Dept Obstet & Gynecol, Rome, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Cignini, P (corresponding author), ALTAMEDICA Fetal Maternal Med Ctr, Dept Prenatal Diag, Rome, Italy.	info@pietrocignini.it	Aloisi, Alessia/AAM-7268-2020	aloisi, alessia/0000-0002-7008-097X				Achiron R, 2004, ULTRASOUND OBST GYN, V24, P506, DOI 10.1002/uog.1731; ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x; American Institute of Ultrasound in Medicine, 2010, J Ultrasound Med, V29, P157; [Anonymous], 2005, METROPOLITAN ATLANTA; Babcook CJ, 1996, AM J ROENTGENOL, V166, P427, DOI 10.2214/ajr.166.2.8553961; Barkovic, 2000, PEDIAT NEUROIMAGING, P337; Basson MA, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00029; Blazer S, 1997, PRENATAL DIAG, V17, P907, DOI 10.1002/(SICI)1097-0223(199710)17:10<907::AID-PD172>3.0.CO;2-Q; Boddaert N, 2003, NEURORADIOLOGY, V45, P320, DOI 10.1007/s00234-003-0980-6; Boltshauser E, 2004, AM J MED GENET A, V126A, P376, DOI 10.1002/ajmg.a.20662; BROMLEY B, 1994, RADIOLOGY, V193, P761, DOI 10.1148/radiology.193.3.7972820; CHANG MC, 1994, RADIOLOGY, V193, P765, DOI 10.1148/radiology.193.3.7972821; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Ecker JL, 2000, PRENATAL DIAG, V20, P328, DOI 10.1002/(SICI)1097-0223(200004)20:4<328::AID-PD806>3.0.CO;2-O; Forzano F, 2007, PRENATAL DIAG, V27, P495, DOI 10.1002/pd.1722; Ginath S, 2013, J MATERN-FETAL NEO M, V26, P757, DOI 10.3109/14767058.2012.755508; Has R, 2004, FETAL DIAGN THER, V19, P342, DOI 10.1159/000077963; HIRSCH JF, 1984, J NEUROSURG, V61, P515, DOI 10.3171/jns.1984.61.3.0515; Koenker R, 2005, ECONOMETRIC SOC MONO, P38; Koenker R., QUANTREG QUANTILE RE; Levine D, 2003, RADIOLOGY, V229, P51, DOI 10.1148/radiol.2291020770; Limperopoulos C, 2006, AM J OBSTET GYNECOL, V194, P1070, DOI 10.1016/j.ajog.2005.10.191; Malinger G, 2004, ULTRASOUND OBST GYN, V23, P333, DOI 10.1002/uog.1016; Malinger G, 2001, PRENATAL DIAG, V21, P687, DOI 10.1002/pd.137; Malinger G, 2009, PRENATAL DIAG, V29, P372, DOI 10.1002/pd.2196; Middleton FA, 2001, J NEUROSCI; Oh HS, 2011, J COMPUT GRAPH STAT, V20, P510, DOI 10.1198/jcgs.2010.10063; Paladini D, 2006, ULTRASOUND OBST GYN, V27, P482, DOI 10.1002/uog.2748; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Pilu G, 2000, ULTRASOUND OBST GYN, V16, P115, DOI 10.1046/j.1469-0705.2000.00197.x; Pilu G, 2007, ULTRASOUND OBST GYN, V30, P233, DOI 10.1002/uog.4072; PILU G, 1992, ULTRASOUND OBST GYN, V2, P151, DOI 10.1046/j.1469-0705.1992.02030151.x; Pilu G, 1999, DIAGNOSIS FETAL ABNO, P5; Pya N., SCAM SHAPE CONSTRAIN; R Development Core Team, 2012, R LANG ENV STAT COMP; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Robinson AJ, 2014, ULTRASOUND OBST GYN, V43, P123, DOI 10.1002/uog.13296; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Salomon LJ, 2005, ULTRASOUND OBST GYN, V25, P559, DOI 10.1002/uog.1901; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Shevell MI, 1996, PEDIATR NEUROL, V15, P224, DOI 10.1016/S0887-8994(96)00220-2; Steinlin M, 1999, NEUROLOGY, V53, P966, DOI 10.1212/WNL.53.5.966; Tilea B, 2009, ULTRASOUND OBST GYN, V33, P173, DOI 10.1002/uog.6276; TimorTritsch IE, 1996, ULTRASOUND OBST GYN, V8, P42, DOI 10.1046/j.1469-0705.1996.08010042.x; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Buuren S, 2007, STAT MODEL, V7, P363, DOI 10.1177/1471082X0700700406; Vinals F, 2005, ULTRASOUND OBST GYN, V26, P622, DOI 10.1002/uog.2606; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zalel Y, 2002, ULTRASOUND OBST GYN, V19, P136, DOI 10.1046/j.0960-7692.2001.00621.x; Zhao D, 2013, PRENATAL DIAG, V33, P153, DOI 10.1002/pd.4027	55	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147528	10.1371/journal.pone.0147528	http://dx.doi.org/10.1371/journal.pone.0147528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812238	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000037
J	Kelly, SG; Plankey, M; Post, WS; Li, XH; Stall, R; Jacobson, LP; Witt, MD; Kingsley, L; Cox, C; Budoff, M; Palella, FJ				Kelly, Sean G.; Plankey, Michael; Post, Wendy S.; Li, Xiuhong; Stall, Ronald; Jacobson, Lisa P.; Witt, Mallory D.; Kingsley, Lawrence; Cox, Christopher; Budoff, Matthew; Palella, Frank J., Jr.			Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; HEART-DISEASE; SUBSTANCE USE; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; COCAINE USERS; RISK; ATHEROSCLEROSIS	Background We characterized associations between smoking, alcohol, and recreational drug use and coronary plaque by HIV serostatus within the Multicenter AIDS Cohort Study (MACS). Methods MACS participants (N = 1005, 621 HIV+ and 384 HIV-) underwent non-contrast CT scanning to measure coronary artery calcium; 764 underwent coronary CT angiograms to evaluate plaque type and extent. Self-reported use of alcohol, tobacco, smoked/inhaled cocaine, methamphetamine, ecstasy, marijuana, inhaled nitrites, and erectile dysfunction drugs was obtained at semi-annual visits beginning 10 years prior to CT scanning. Multivariable logistic and linear regression models were performed, stratified by HIV serostatus. Results Among HIV+ men, current smoking, former smoking, and cumulative pack years of smoking were positively associated with multiple coronary plaque measures (coronary artery calcium presence and extent, total plaque presence and extent, calcified plaque presence, and stenosis >50%). Smoking was significantly associated with fewer plaque measures of comparable effect size among HIV-men; current smoking and calcified plaque extent was the only such association. Heavy alcohol use (>14 drinks/week) was associated with stenosis >50% among HIV+ men. Among HIV-men, low/moderate (1-14 drinks/week) and heavy alcohol use were inversely associated with coronary artery calcium and calcified plaque extent. Few significant associations between other recreational drug use and plaque measures were observed. Conclusion Smoking is strongly associated with coronary plaque among HIV+ men, underscoring the value of smoking cessation for HIV+ persons. Alcohol use may protect against coronary artery calcium and calcified plaque progression in HIV-(but not HIV+) men. Few positive associations were observed between recreational drug use and coronary plaque measures.	[Kelly, Sean G.; Palella, Frank J., Jr.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Plankey, Michael] Georgetown Univ, Washington, DC USA; [Post, Wendy S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Post, Wendy S.; Li, Xiuhong; Jacobson, Lisa P.; Cox, Christopher] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Stall, Ronald; Kingsley, Lawrence] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Witt, Mallory D.; Budoff, Matthew] Harbor UCLA Med Ctr, Torrance, CA 90509 USA	Northwestern University; Feinberg School of Medicine; Georgetown University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Kelly, SG (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	Sean-Kelly@northwestern.edu	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Kingsley, Lawrence/0000-0002-7000-8556; Jacobson, Lisa P./0000-0003-1722-6826	National heart, Lung and Blood Institute [RO1 HL095129]; National Institute of Allergy and Infectious Diseases; National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health; National Center for Advancing Translational Sciences [UO1-AI-35042, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, Hopkins CRU UL1 TR 001079,, Harbor-UCLA UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043, U01AI035041, U01AI035040, U01AI035039, U01AI035042] Funding Source: NIH RePORTER	National heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The National heart, Lung and Blood Institute (RO1 HL095129). The Multicenter AIDS Cohort Study is funded by The National Institute of Allergy and Infectious Diseases, with additional supplemental funding from The National Cancer Institute, The National Institute on Drug Abuse, The National Institute of Mental Health, and The National Center for Advancing Translational Sciences (UO1-AI-35042, UM1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, Hopkins CRU UL1 TR 001079, and Harbor-UCLA UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Austen W G, 1975, Circulation, V51, P5; Benzaquen BS, 2001, AM HEART J, V142, P402, DOI 10.1067/mhj.2001.117607; Bergersen BM, 2004, EUR J CLIN MICROBIOL, V23, P625, DOI 10.1007/s10096-004-1177-6; Brennan-Ing M, 2014, BEHAV MED, V40, P108, DOI 10.1080/08964289.2014.889069; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Chew D, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/237834; Cummins Denise, 2005, Nurs Stand, V20, P41; D'Abramo A, 2013, EARLY ATHEROSCLEROSI; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; Ebersberger U, 2013, ATHEROSCLEROSIS, V229, P443, DOI 10.1016/j.atherosclerosis.2013.05.032; Farrugia PM, 2009, CARDIOL REV, V17, P211, DOI 10.1097/CRD.0b013e3181b151a3; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Gonzalez-Reimers E, 2014, WORLD J GASTROENTERO, V20, P14660, DOI 10.3748/wjg.v20.i40.14660; Hacioglu Y, 2013, ANATOL J CARDIOL, V13, P207, DOI 10.5152/akd.2013.065; Hakeem A, 2010, CURR ATHEROSCLER REP, V12, P119, DOI 10.1007/s11883-010-0089-4; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Karch SB, 1999, J FORENSIC SCI, V44, P359; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Lai H, 2002, AM J CARDIOL, V90, P326, DOI 10.1016/S0002-9149(02)02475-X; Lai S, 2003, AIDS PATIENT CARE ST, V23, P815; Leone Aurelio, 2011, Recent Pat Cardiovasc Drug Discov, V6, P61, DOI 10.2174/157489011794578437; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lloyd-Richardson EE, 2009, ADDICTION, V104, P1891, DOI 10.1111/j.1360-0443.2009.02623.x; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Maggi P, 2009, AIDS PATIENT CARE ST, V23, P809, DOI 10.1089/apc.2009.0102; Matthews AK, 2013, AIDS PATIENT CARE ST, V27, P22, DOI 10.1089/apc.2012.0253; Meng QY, 2003, INT J CARDIOL, V88, P191, DOI 10.1016/S0167-5273(02)00394-7; Mittleman MA, 2001, CIRCULATION, V103, P2805; Moadel AB, 2012, JAIDS-J ACQ IMM DEF, V61, P208, DOI 10.1097/QAI.0b013e3182645679; Mosunjac MI, 2008, AM J FOREN MED PATH, V29, P9, DOI 10.1097/PAF.0b013e318165152f; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Mukamal KJ, 2004, ATHEROSCLEROSIS, V173, P79, DOI 10.1016/j.atherosclerosis.2003.10.011; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mukamal KJ, 1987, J AM COLL CARDIOL, V2010, P1328, DOI DOI 10.1016/J.JACC.2009.10.056; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pletcher MJ, 2005, AM J EPIDEMIOL, V161, P423, DOI 10.1093/aje/kwi062; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Robinson F Patrick, 2005, J Cardiovasc Nurs, V20, P149; Roussillon C, 2015, C RETR OPP INF FEBR; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Sullivan PS, 1998, J ACQ IMMUN DEF SYND, V19, P266, DOI 10.1097/00042560-199811010-00009; Tai H, 2012, INT J CARDIOL, V161, P83, DOI 10.1016/j.ijcard.2011.04.034; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Yankelevitz DF, 2013, JACC-CARDIOVASC IMAG, V6, P651, DOI 10.1016/j.jcmg.2013.02.004; Zanni MV, 2014, AIDS, V28, P2061, DOI 10.1097/QAD.0000000000000360	52	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147822	10.1371/journal.pone.0147822	http://dx.doi.org/10.1371/journal.pone.0147822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811937	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000058
J	Kemppainen, E; George, J; Garipler, G; Tuomela, T; Kiviranta, E; Soga, T; Dunn, CD; Jacobs, HT				Kemppainen, Esko; George, Jack; Garipler, Gorkem; Tuomela, Tea; Kiviranta, Essi; Soga, Tomoyoshi; Dunn, Cory D.; Jacobs, Howard T.			Mitochondrial Dysfunction Plus High-Sugar Diet Provokes a Metabolic Crisis That Inhibits Growth	PLOS ONE			English	Article							MITORIBOSOMAL PROTEIN S12; DROSOPHILA-MELANOGASTER; ALTERNATIVE OXIDASE; ESCHERICHIA-COLI; PYRUVATE THERAPY; KETOGENIC DIET; DISEASE; TRANSLATION; EXPRESSION; MUTATION	The Drosophila mutant tko(25t) exhibits a deficiency ofmitochondrial protein synthesis, leading to a global insufficiency of respiration and oxidative phosphorylation. This entrains an organismal phenotype of developmental delay and sensitivity to seizures induced bymechanical stress. We found that the mutant phenotype is exacerbated in a dose-dependent fashion by high dietary sugar levels. tko(25t) larvae were found to exhibit severe metabolic abnormalities that were further accentuated by high-sugar diet. These include elevated pyruvate and lactate, decreased ATP and NADPH. Dietary pyruvate or lactate supplementation phenocopied the effects of high sugar. Based on tissue-specific rescue, the crucial tissue in which this metabolic crisis initiates is the gut. It is accompanied by down-regulation of the apparatus of cytosolic protein synthesis and secretion at both the RNA and post-translational levels, including a novel regulation of S6 kinase at the protein level.	[Kemppainen, Esko; George, Jack; Garipler, Gorkem; Tuomela, Tea; Kiviranta, Essi; Jacobs, Howard T.] Univ Tampere, BioMediTech & Tampere Univ Hosp, FI-33014 Tampere, Finland; [Garipler, Gorkem] Koc Univ, Dept Mol Biol & Genet, TR-34450 Istanbul, Turkey; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan; [Jacobs, Howard T.] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Garipler, Gorkem] NYU, Dept Biol, New York, NY 10003 USA	Tampere University; Tampere University Hospital; Koc University; Keio University; University of Helsinki; New York University	Jacobs, HT (corresponding author), Univ Tampere, BioMediTech & Tampere Univ Hosp, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland.	howard.jacobs@helsinki.fi	Kemppainen, Esko/AAF-7618-2019	Jacobs, Howard/0000-0003-1895-6003; Morikka, Jack/0000-0002-0053-4171; Dunn, Cory/0000-0003-2393-5944	Academy of Finland [272376]; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by funding from the Academy of Finland (CoE award 272376 to HTJ); Tampere University Hospital Medical Research Fund to HTJ; the Sigrid Juselius Foundation to HTJ and EMBO (Installation Grant 2010 to CDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva M, 2013, MITOCHONDRION, V13, P615, DOI 10.1016/j.mito.2013.08.011; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Ahola-Erkkila S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076; Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Calidas D, 2014, RNA, V20, P321, DOI 10.1261/rna.042432.113; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; CAVENER DR, 1986, GENETICS, V114, P111; Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719; Clarke C, 2013, MOL GENET METAB, V110, P145, DOI 10.1016/j.ymgme.2013.07.011; Danhauser K, 2015, J INHERIT METAB DIS, V38, P467, DOI 10.1007/s10545-014-9796-2; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Ferri Stefano, 2011, J Diabetes Sci Technol, V5, P1068; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004; Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002; Kemppainen KK, 2014, G3-GENES GENOM GENET, V4, P2013, DOI 10.1534/g3.114.013946; Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601; Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Merritt TJS, 2009, GENETICS, V182, P565, DOI 10.1534/genetics.109.100677; Merritt TJS, 2005, GENETICS, V171, P1707, DOI 10.1534/genetics.105.048249; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Newsholme E, 2010, FUNCTIONAL BIOCH HLT; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Park SY, 2014, GENETICS, V196, P539, DOI 10.1534/genetics.113.157602; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Sun X, 2014, CELL REPORTS, V8, P1; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Terhzaz S, 2010, PHYSIOL GENOMICS, V579, P633; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Toivonen JM, 2001, GENETICS, V159, P241; Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527; Zhang YQ, 1999, GENETICS, V153, P891; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0145836	10.1371/journal.pone.0145836	http://dx.doi.org/10.1371/journal.pone.0145836			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812173	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000004
J	Seekhuntod, S; Thavarungkul, P; Chaichanawongsaroj, N				Seekhuntod, Sirirat; Thavarungkul, Paninee; Chaichanawongsaroj, Nuntaree			Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients	PLOS ONE			English	Article							DNA EXTRACTION; RAS MUTATIONS; PCR; CARCINOMA; THERAPY; SYSTEM; RISK; PERFORMANCE; POPULATION; CETUXIMAB	Background Patients with KRAS mutations do not respond to epidermal growth factor receptor (EGFR) inhibitors and fail to benefit from adjuvant chemotherapy. Mutation analysis of KRAS is needed before starting treatment with monoclonal anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). The objective of this study is to develop a multiplex allele-specific PCR (MAS-PCR) assay to detect KRAS mutations. Methods We developed a single-tube MAS-PCR assay for the detection of seven KRAS mutations (G12D, G12A, G12R, G12C, G12S, G12V, and G13D). We performed MAS-PCR assay analysis for KRAS on DNA isolated from 270 formalin-fixed paraffin-embedded (FFPE) colorectal cancer tissues. Sequences of all 270 samples were determined by pyrosequencing. Seven known point-mutation DNA samples diluted with wild-type DNA were assayed to determine the limitation of detection and reproducibility of the MAS-PCR assay. Results Overall, the results of MAS-PCR assay were in good concordance with pyrosequencing, and only seven discordant samples were found. The MAS-PCR assay reproducibly detected 1 to 2% mutant alleles. The most common mutations were G13D in codon 13 (49.17%), G12D (25.83%) and G12V (12.50%) in codon 12. Conclusion The MAS-PCR assay provides a rapid, cost-effective, and reliable diagnostic tool for accurate detection of KRAS mutations in routine FFPE colorectal cancer tissues.	[Seekhuntod, Sirirat; Chaichanawongsaroj, Nuntaree] Chulalongkorn Univ, Dept Transfus Med & Clin Microbiol, Fac Allied Hlth Sci, Bangkok, Thailand; [Thavarungkul, Paninee] Minist Publ Hlth, Inst Pathol, Dept Med Serv, Bangkok, Thailand	Chulalongkorn University; Ministry of Public Health - Thailand	Chaichanawongsaroj, N (corresponding author), Chulalongkorn Univ, Dept Transfus Med & Clin Microbiol, Fac Allied Hlth Sci, Bangkok, Thailand.	nuntaree@gmail.com			90th anniversary of Chulalongkorn University fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125572134]; Faculty of Allied Health Sciences Fund [AHS-CU 58004]	90th anniversary of Chulalongkorn University fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University); Faculty of Allied Health Sciences Fund	SS was supported by the 90th anniversary of Chulalongkorn University fund (Ratchadaphiseksomphot Endowment Fund, GCUGR1125572134), and NC was supported by the Faculty of Allied Health Sciences Fund 2014 (AHS-CU 58004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Bader T, 2014, ALEX J MED, V50, P203, DOI 10.1016/j.ajme.2014.01.003; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1995, EUR J CANCER, V31A, P1051, DOI 10.1016/0959-8049(95)00168-I; BOS JL, 1989, CANCER RES, V49, P4682; Bosman FT, 2014, POL J PATHOL, V65, P257, DOI 10.5114/PJP.2014.48094; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Chang YS, 2014, CLIN CHIM ACTA, V436, P169, DOI 10.1016/j.cca.2014.05.008; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; de Macedo MP, 2015, EXP MOL PATHOL, V98, P563, DOI 10.1016/j.yexmp.2015.03.038; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Dolatkhah R, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/643020; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Gao J, 2010, WORLD J GASTROENTERO, V16, P4858, DOI 10.3748/wjg.v16.i38.4858; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Herreros-Villanueva M, 2014, CLIN CHIM ACTA, V431, P211, DOI 10.1016/j.cca.2014.01.049; Janecka A, 2015, ANAL BIOCHEM, V476, P8, DOI 10.1016/j.ab.2015.01.019; Kamphee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137791; Karim B, 2010, CANCER BIOMARK, V8, P331, DOI 10.3233/CBM-2011-0222; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Licar A, 2010, INT J ONCOL, V36, P1137, DOI 10.3892/ijo_00000596; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Liou JM, 2011, INT J COLORECTAL DIS, V26, P1387, DOI 10.1007/s00384-011-1229-1; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Liu PJ, 2012, EXP THER MED, V4, P109, DOI 10.3892/etm.2012.566; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Miglio U, 2013, PATHOL RES PRACT, V209, P233, DOI 10.1016/j.prp.2013.02.006; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogasawara N, 2011, JPN J CLIN ONCOL, V41, P52, DOI 10.1093/jjco/hyq151; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Potluri K, 2015, ANAL BIOCHEM, V486, P17, DOI 10.1016/j.ab.2015.06.029; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Sakai K, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-7; Sangrajrang S, 2012, ASIAN PAC J CANCER P, V13, P5759, DOI 10.7314/APJCP.2012.13.11.5759; Shi XD, 2013, GENE, V530, P95, DOI 10.1016/j.gene.2013.07.060; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Span M, 1996, INT J CANCER, V69, P241, DOI 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.3.CO;2-D; Sriamporn S, 2007, ASIAN PAC J CANCER P, V8, P573; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Van Cutsem E, 2009, ANN ONCOL, V20, P61, DOI 10.1093/annonc/mdp130; Villa E, 1996, GASTROENTEROLOGY, V110, P1346, DOI 10.1053/gast.1996.v110.pm8613038; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062126	47	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147672	10.1371/journal.pone.0147672	http://dx.doi.org/10.1371/journal.pone.0147672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812617	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000048
J	Tomitaka, S; Kawasaki, Y; Ide, K; Yamada, H; Miyake, H; Furukaw, TA				Tomitaka, Shinichiro; Kawasaki, Yohei; Ide, Kazuki; Yamada, Hiroshi; Miyake, Hirotsugu; Furukaw, Toshiaki A.			Distribution of Total Depressive Symptoms Scores and Each Depressive Symptom Item in a Sample of Japanese Employees	PLOS ONE			English	Article							MAJOR DEPRESSION; PREVALENCE; ADULTS; POPULATION; HEALTH; AGE	Background In a previous study, we reported that the distribution of total depressive symptoms scores according to the Center for Epidemiologic Studies Depression Scale (CES-D) in a general population is stable throughout middle adulthood and follows an exponential pattern except for at the lowest end of the symptom score. Furthermore, the individual distributions of 16 negative symptom items of the CES-D exhibit a common mathematical pattern. To confirm the reproducibility of these findings, we investigated the distribution of total depressive symptoms scores and 16 negative symptom items in a sample of Japanese employees. Methods We analyzed 7624 employees aged 20-59 years who had participated in the Northern Japan Occupational Health Promotion Centers Collaboration Study for Mental Health. Depressive symptoms were assessed using the CES-D. The CES-D contains 20 items, each of which is scored in four grades: "rarely," "some," "much," and "most of the time." The descriptive statistics and frequency curves of the distributions were then compared according to age group. Results The distribution of total depressive symptoms scores appeared to be stable from 30-59 years. The right tail of the distribution for ages 30-59 years exhibited a linear pattern with a log-normal scale. The distributions of the 16 individual negative symptom items of the CES-D exhibited a common mathematical pattern which displayed different distributions with a boundary at "some." The distributions of the 16 negative symptom items from "some" to "most" followed a linear pattern with a log-normal scale. Conclusions The distributions of the total depressive symptoms scores and individual negative symptom items in a Japanese occupational setting show the same patterns as those observed in a general population. These results show that the specific mathematical patterns of the distributions of total depressive symptoms scores and individual negative symptom items can be reproduced in an occupational population.	[Tomitaka, Shinichiro; Furukaw, Toshiaki A.] Panason Hlth Ctr, Dept Mental Hlth, Tokyo, Japan; [Tomitaka, Shinichiro; Kawasaki, Yohei; Ide, Kazuki; Yamada, Hiroshi] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan; [Miyake, Hirotsugu] Hokkaido Occupat Hlth Promot Ctr, Labor Hlth & Welf, Sapporo, Hokkaido, Japan; [Furukaw, Toshiaki A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan	University of Shizuoka; Kyoto University	Tomitaka, S (corresponding author), Panason Hlth Ctr, Dept Mental Hlth, Tokyo, Japan.; Tomitaka, S (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan.	tomitaka.shinichiro@jp.panasonic.com	Ide, Kazuki/H-3154-2018	Ide, Kazuki/0000-0001-6377-1361; Kawasaki, Yohei/0000-0002-7474-7647; Tomitaka, Shinichiro/0000-0002-7161-6967				[Anonymous], 2011, REPORT NO JAPAN OCCU; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cho MJ, 1998, PSYCHIAT RES, V81, P341, DOI 10.1016/S0165-1781(98)00122-X; CUNNINGHAM JJ, 1980, AM J CLIN NUTR, V33, P2372, DOI 10.1093/ajcn/33.11.2372; Diener E, 1993, EXPERIENCE EMOTIONAL, P405; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Eaton WW, 1997, ARCH GEN PSYCHIAT, V54, P993; HAYNER NS, 1965, DIABETES, V14, P413, DOI 10.2337/diab.14.7.413; Iwata N, 1998, PSYCHOL MED, V28, P153, DOI 10.1017/S0033291797005898; IWATA N, 1989, AM J PUBLIC HEALTH, V79, P1486, DOI 10.2105/AJPH.79.11.1486; KESSLER RC, 1992, PSYCHOL AGING, V7, P119, DOI 10.1037/0882-7974.7.1.119; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Melzer D, 2002, PSYCHOL MED, V32, P1195, DOI 10.1017/S0033291702006049; MILLAR WJ, 1987, AM J PUBLIC HEALTH, V77, P38, DOI 10.2105/AJPH.77.1.38; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Sutin AR, 2013, JAMA PSYCHIAT, V70, P803, DOI 10.1001/jamapsychiatry.2013.193; Tomitaka S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008599; Tomitaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114624	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147577	10.1371/journal.pone.0147577	http://dx.doi.org/10.1371/journal.pone.0147577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812649	Green Published, gold			2022-12-27	WOS:000369528000041
J	Bush, CK; Kurimella, D; Cross, LJS; Conner, KR; Martin-Schild, S; He, J; Li, CW; Chen, J; Kelly, T				Bush, Chad K.; Kurimella, Dayaamayi; Cross, Lee J. S.; Conner, Katherine R.; Martin-Schild, Sheryl; He, Jiang; Li, Changwei; Chen, Jing; Kelly, Tanika			Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							THERAPY; BIAS; HETEROGENEITY; SCORE; TIME; CARE	Importance Acute ischemic stroke is a leading cause of death and disability worldwide. Several recent clinical trials have shown that endovascular treatment improves clinical outcomes among patients with acute ischemic stroke. Objective To provide an overall and precise estimate of the efficacy of endovascular treatment predominantly using second-generation mechanical thrombectomy devices (stent-retriever devices) compared to medical management on clinical and functional outcomes among patients with acute ischemic stroke. Data Sources MEDLINE, EMBASE, Cochrane Collaboration Central Register of Controlled Clinical Trials, Web of Science, and NIH ClinicalTrials. gov were searched through November 2015. Study Selection Searches returned 3,045 articles. After removal of duplicates, two authors independently screened titles and abstracts to assess eligibility of 2,495 potentially relevant publications. From these, 38 full-text publications were more closely assessed. Finally, 5 randomized controlled trials of endovascular treatment with predominant use of retrievable stents were selected. Data Extraction and Synthesis Three authors independently extracted information on participant and trial characteristics and clinical events using a standardized protocol. Random effects models were used to pool endovascular treatment effects across outcomes. Main Outcomes and Measures The primary outcome was better functional outcome as measured on the modified Rankin Scale at 90 days of follow-up. Secondary outcomes included all-cause mortality and symptomatic intra-cerebral hemorrhage. Results Five trials representing 1,287 patients were included. Overall, patients randomized to endovascular therapy experienced 2.22 times greater odds of better functional outcome compared to those randomized to medical management (95% CI, 1.66 to 2.98; P < 0.0001). Endovascular therapy was not associated with mortality [OR (95% CI), 0.78 (0.54, 1.12); P = 0.1056] or symptomatic intracerebral hemorrhage [OR (95% CI), 1.19 (0.69, 2.05); P = 0.5348]. Meta-regression analysis suggested that shorter times from stroke onset to groin puncture and from stroke onset to reperfusion result in better functional outcomes in ischemic stroke patients (P = 0.0077 and P = 0.0089). There were no significant differences in the beneficial effects of endovascular treatment on functional outcomes across categories of gender, age, stroke severity, ischemic changes on computed tomography, or intravenous tissue plasminogen activator administration. Conclusions and Relevance This meta-analysis demonstrated superior functional outcomes in subjects receiving endovascular treatment compared to medical management. Further, this analysis showed that acute ischemic stroke patients may receive enhanced functional benefit from earlier endovascular treatment.	[Bush, Chad K.; Kurimella, Dayaamayi; Cross, Lee J. S.; Conner, Katherine R.; He, Jiang; Li, Changwei; Chen, Jing; Kelly, Tanika] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Bush, Chad K.; Martin-Schild, Sheryl; He, Jiang; Chen, Jing] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Bush, Chad K.; Martin-Schild, Sheryl] Tulane Univ, Sch Med, Dept Neurol, 1430 Tulane Ave, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Bush, CK; Kelly, T (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.; Bush, CK (corresponding author), Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA.; Bush, CK (corresponding author), Tulane Univ, Sch Med, Dept Neurol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	cbush4@tulane.edu; tkelly@tulane.edu	He, Jiang/AAF-5303-2020; Li, Changwei/S-5615-2016	He, Jiang/0000-0002-8286-9652; Li, Changwei/0000-0002-9203-304X; Bush, Chad/0000-0003-2542-3969				Adeoye O, 2014, STROKE, V45, P3019, DOI 10.1161/STROKEAHA.114.006293; Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fransen P, 2015, INT STROK C 2015 FEB; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill MD, 2015, INT J STROKE, V10, P6; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Meyers PM, 2011, CIRCULATION, V123, P2591, DOI 10.1161/CIRCULATIONAHA.110.971564; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Pierot L, 2015, STROKE, V46, P909, DOI 10.1161/STROKEAHA.114.007935; Sardar P, 2015, EUR HEART J, V36, P2373, DOI 10.1093/eurheartj/ehv270; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Singh B, 2013, MAYO CLIN PROC, V88, P1056, DOI 10.1016/j.mayocp.2013.07.015; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	35	50	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147287	10.1371/journal.pone.0147287	http://dx.doi.org/10.1371/journal.pone.0147287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807742	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800071
J	Eppinga, RN; Hartman, MHT; van Veldhuisen, DJ; Lexis, CPH; Connelly, MA; Lipsic, E; van der Horst, ICC; van der Harst, P; Dullaart, RPF				Eppinga, Ruben N.; Hartman, Minke H. T.; van Veldhuisen, Dirk J.; Lexis, Chris P. H.; Connelly, Margery A.; Lipsic, Erik; van der Horst, Iwan C. C.; van der Harst, Pim; Dullaart, Robin P. F.			Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; ARTERY-DISEASE; CAROTID ATHEROSCLEROSIS; PARTICLE NUMBER; HEART-DISEASE; CHOLESTEROL; SIZE; EVENTS; RISK	Objective Metformin affects low density lipoprotein (LDL) and high density (HDL) subfractions in the context of impaired glucose tolerance, but its effects in the setting of acute myocardial infarction (MI) are unknown. We determined whether metformin administration affects lipoprotein subfractions 4 months after ST-segment elevation MI (STEMI). Second, we assessed associations of lipoprotein subfractions with left ventricular ejection fraction (LVEF) and infarct size 4 months after STEMI. Methods 371 participants without known diabetes participating in the GIPS-III trial, a placebo controlled, double-blind randomized trial studying the effect of metformin (500 mg bid) during 4 months after primary percutaneous coronary intervention for STEMI were included of whom 317 completed follow-up (clinicaltrial.gov Identifier: NCT01217307). Lipoprotein subfractions were measured using nuclear magnetic resonance spectroscopy at presentation, 24 hours and 4 months after STEMI. (Apo)lipoprotein measures were obtained during acute STEMI and 4 months post-STEMI. LVEF and infarct size were measured by cardiac magnetic resonance imaging. Results Metformin treatment slightly decreased LDL cholesterol levels (adjusted P = 0.01), whereas apoB remained unchanged. Large LDL particles and LDL size were also decreased after metformin treatment (adjusted P < 0.001). After adjustment for covariates, increased small HDL particles at 24 hours after STEMI predicted higher LVEF (P = 0.005). In addition, increased medium-sized VLDL particles at the same time point predicted a smaller infarct size (P < 0.001). Conclusion LDL cholesterol and large LDL particles were decreased during 4 months treatment with metformin started early after MI. Higher small HDL and medium VLDL particle concentrations are associated with favorable LVEF and infarct size.	[Eppinga, Ruben N.; Hartman, Minke H. T.; van Veldhuisen, Dirk J.; Lexis, Chris P. H.; Lipsic, Erik; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Connelly, Margery A.] LabCorp, Raleigh, NC USA; [van der Horst, Iwan C. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	P.van.der.harst@umcg.nl		Hartman, Minke H.T./0000-0002-6965-3259	ZonMw, The Netherlands Organization for Health Research and Development, Hague [95103007]	ZonMw, The Netherlands Organization for Health Research and Development, Hague	The GIPS-III trial was supported by Grant 95103007 from ZonMw, The Netherlands Organization for Health Research and Development, The Hague, The Netherlands for PH. MAC, PhD is an employee of LabCorp (Raleigh, North Carolina, USA). The other authors state no conflict of interest. The study was investigator driven. The funder provided support in the form of performing the lipoprotein subfraction measurements at no cost and provided intellectual input as an coauthor on the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The GIPS-III trial was supported by Grant 95103007 from ZonMw, The Netherlands Organization for Health Research and Development, The Hague, The Netherlands.	Arsenault BJ, 2010, EUR J CLIN INVEST, V40, P1081, DOI 10.1111/j.1365-2362.2010.02357.x; AVOGARO P, 1978, EUR J CLIN INVEST, V8, P121, DOI 10.1111/j.1365-2362.1978.tb00824.x; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bouma Margriet, 2013, Ned Tijdschr Geneeskd, V157, pA6006; Brunner MP, 2011, CIRC-CARDIOVASC GENE, V4, P695, DOI 10.1161/CIRCGENETICS.111.960575; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dullaart RPF, 2014, CLIN CHIM ACTA, V433, P34, DOI 10.1016/j.cca.2014.02.026; Dullaart RPF, 2014, ATHEROSCLEROSIS, V234, P185, DOI 10.1016/j.atherosclerosis.2014.02.026; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Fujino M, 2014, AM J CARDIOL, V114, P1789, DOI 10.1016/j.amjcard.2014.09.015; Germano G, 2012, EUR HEART J, V33, P137; Goldberg R, 2013, J CLIN ENDOCR METAB, V98, P3989, DOI 10.1210/jc.2013-1452; Gordts SC, 2013, GENE THER, V20, P1053, DOI 10.1038/gt.2013.30; Joshi PH, 2016, EUR J PREV CARDIOL, V23, P41, DOI 10.1177/2047487314543890; KEMPEN HJ, 1987, J LAB CLIN MED, V109, P19; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lexis CPH, 2012, CARDIOVASC DRUG THER, V26, P417, DOI 10.1007/s10557-012-6413-1; Lexis CP, 2014, JAMA-J AM MED ASSOC, V311, P1526, DOI DOI 10.1001/JAMA.2014.3315; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Oksala N, 2013, ANN MED, V45, P141, DOI 10.3109/07853890.2012.679962; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Preiss D, 2014, LANCET DIABETES ENDO, V2, P116, DOI 10.1016/S2213-8587(13)70152-9; Riemens SC, 2001, SCAND J CLIN LAB INV, V61, P1; Rosenson RS, 2014, CIRC RES, V114, P1880, DOI 10.1161/CIRCRESAHA.114.302805; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Sanjuan R, 2014, INT J CARDIOL, V172, pE269, DOI 10.1016/j.ijcard.2013.12.207; Tardif JC, 2014, EUR HEART J, V35, P3277, DOI 10.1093/eurheartj/ehu171; Toth PP, 2014, ATHEROSCLEROSIS, V235, P585, DOI 10.1016/j.atherosclerosis.2014.05.914; Trifunovic D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-73; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Velagaleti RS, 2009, CIRCULATION, V120, P2345, DOI 10.1161/CIRCULATIONAHA.109.830984; Williams PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056782; Wong DTL, 2012, EUR RADIOL, V22, P1757, DOI 10.1007/s00330-012-2420-7; Xu RX, 2015, J CLIN LIPIDOL, V9, P26, DOI 10.1016/j.jacl.2014.11.003; Yang N, 2014, EUR REV MED PHARMACO, V18, P3761	47	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145719	10.1371/journal.pone.0145719	http://dx.doi.org/10.1371/journal.pone.0145719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808474	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800008
J	Komuro, H; Sato, N; Sasaki, A; Suzuki, N; Kano, M; Tanaka, Y; Yamaguchi-Kabata, Y; Kanazawa, M; Warita, H; Aoki, M; Fukudo, S				Komuro, Hazuki; Sato, Naoko; Sasaki, Ayaka; Suzuki, Naoki; Kano, Michiko; Tanaka, Yukari; Yamaguchi-Kabata, Yumi; Kanazawa, Motoyori; Warita, Hitoshi; Aoki, Masashi; Fukudo, Shin			Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; MAJOR DEPRESSIVE DISORDER; ADULT DEPRESSION; CHILDHOOD MALTREATMENT; RECTAL DISTENSION; PANIC DISORDER; MOTOR FUNCTION; STRESS; ASSOCIATION; EXPRESSION	Background Corticotropin-releasing hormone (CRH) plays an important role in the pathophysiology of irritable bowel syndrome (IBS) and regulates the stress response through two CRH receptors (R1 and R2). Previously, we reported that a CRHR1 gene polymorphism (rs110402, rs242924, and rs7209436) and haplotypes were associated with IBS. However, the association between the CRHR2 gene and IBS was not investigated. We tested the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are associated with IBS pathophysiology and negative emotion in IBS patients. Methods A total of 142 IBS patients and 142 healthy controls participated in this study. Seven single nucleotide polymorphisms (SNPs) of the CRHR2 gene (rs4722999, rs3779250, rs2240403, rs2267710, rs2190242, rs2284217, and rs2284220) were genotyped. Subjects' psychological states were evaluated using the Perceived-Stress Scale, the State-Trait Anxiety Inventory, and the Self-Rating Depression Scale. Results We found that rs4722999 and rs3779250, located in intronic region, were associated with IBS in terms of genotype frequency (rs4722999: P = 0.037; rs3779250: P = 0.017) and that the distribution of the major allele was significantly different between patients and controls. There was a significant group effect (controls vs. IBS), and a CRHR2 genotype effect was observed for three psychological scores, but the interaction was not significant. We found a haplotype of four SNPs (rs4722999, rs3779250, rs2240403, and rs2267710) and two SNPs (rs2284217 and rs2284220) in strong linkage disequilibrium (D' > 0.90). We also found that haplotypes of the CRHR2 gene were significantly different between IBS patients and controls and that they were associated with negative emotion. Conclusion Our findings support the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are related to IBS. In addition, we found associations between CRHR2 genotypes and haplotypes and negative emotion in IBS patients and controls. Further studies on IBS and the CRH system are warranted.	[Komuro, Hazuki; Sato, Naoko; Sasaki, Ayaka; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Kano, Michiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Tanaka, Yukari; Yamaguchi-Kabata, Yumi] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 980, Japan; [Yamaguchi-Kabata, Yumi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fukudo, Shin] Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.; Fukudo, S (corresponding author), Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan.	sfukudo@med.tohoku.ac.jp	Warita, Hitoshi/T-1970-2019; Suzuki, Naoki/J-6331-2019; Fukudo, Shin/J-4813-2014	Warita, Hitoshi/0000-0001-7934-3863; Suzuki, Naoki/0000-0001-8880-8554; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Science, and Culture of Japan [15H04799, 15H15267]; Ministry of Health, Welfare, and Labor of Japan [26-4]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, No. 15H04799, 15H15267 (http://www.mext.go.jp/english/), and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan (26-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2007, DEPRESS ANXIETY, V24, P66, DOI 10.1002/da.20220; Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; Akiba Y, 2015, DIGEST DIS SCI, V60, P858, DOI 10.1007/s10620-015-3579-y; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; DeYoung CG, 2011, J CHILD PSYCHOL PSYC, V52, P898, DOI 10.1111/j.1469-7610.2011.02404.x; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grammatopoulos D, 1998, J CLIN ENDOCR METAB, V83, P2539, DOI 10.1210/jc.83.7.2539; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guillaume S, 2013, J PSYCHIATR RES, V47, P259, DOI 10.1016/j.jpsychires.2012.10.014; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Ishitobi Y, 2012, AM J MED GENET B, V159B, P429, DOI 10.1002/ajmg.b.32046; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Kostich WA, 1998, MOL ENDOCRINOL, V12, P1077, DOI 10.1210/me.12.8.1077; Liu ZC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01548; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Mahajan S, 2014, PEPTIDES, V54, P58, DOI 10.1016/j.peptides.2014.01.007; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; NAPPI RE, 1995, BIOL REPROD, V53, P1417, DOI 10.1095/biolreprod53.6.1417; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Poon AH, 2008, PHARMACOGENET GENOM, V18, P373, DOI 10.1097/FPC.0b013e3282fa760a; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042450; Smith R, 1998, J CLIN ENDOCR METAB, V83, P2916, DOI 10.1210/jc.83.8.2916; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sumner JA, 2014, PSYCHONEUROENDOCRINO, V43, P71, DOI 10.1016/j.psyneuen.2014.02.002; TACHE Y, 1993, ANN NY ACAD SCI, V697, P233, DOI 10.1111/j.1749-6632.1993.tb49936.x; Valdenaire O, 1997, BBA-GENE STRUCT EXPR, V1352, P129, DOI 10.1016/S0167-4781(97)00047-X; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Villafuerte SM, 2002, AM J MED GENET, V114, P222, DOI 10.1002/ajmg.10179; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Wang YZ, 2014, MED SCI MONITOR, V20, P1246, DOI 10.12659/MSM.890315; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Wolf EJ, 2013, DEPRESS ANXIETY, V30, P1161, DOI 10.1002/da.22176; Yu F, 2014, GENET MOL RES, V13, P10285, DOI 10.4238/2014.December.4.23; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	59	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147817	10.1371/journal.pone.0147817	http://dx.doi.org/10.1371/journal.pone.0147817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808377	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800216
J	Kumar, S; Wang, J; Rani, R; Gandhi, CR				Kumar, Sudhir; Wang, Jiang; Rani, Richa; Gandhi, Chandrashekhar R.			Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice	PLOS ONE			English	Article							SULFUR CLUSTER BIOGENESIS; FAT-STORING CELLS; IRON OVERLOAD; SULFHYDRYL OXIDASE; HEREDITARY HEMOCHROMATOSIS; LIPID-PEROXIDATION; FRIEDREICHS-ATAXIA; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS	Why only a subpopulation (about 15%) of humans develops liver cirrhosis due to alcohol is a critical as yet unanswered question. Liver-specific depletion of augmenter of liver regeneration (ALR) protein in mice causes robust steatosis and hepatocyte apoptosis by 2 weeks; these pathologies regress subsequently with return of ALR expression even at lower than control levels, but the mice develop modest steatohepatitis by 8 weeks. We aimed to investigate whether chronic alcohol ingestion promotes excessive hepatic fibrosis in these ALR-deficient mice. Liver-specific ALR-deficient and wild type (WT) female mice (8-10 weeks old) were placed on 4% alcohol-supplemented or isocaloric diet for 4 weeks. Liver sections were examined for histopathology, and parameters of steatosis and fibrosis were quantified. The mRNA expression of alcohol dehydrogenase-1, acetaldehyde dehydrogenase-1 and cytochrome P450-2E1 increased in WT mice but decreased in ALR-deficient mice upon alcohol ingestion. While alcohol induced steatosis and mild inflammation in WT mice, ALR-deficient mice showed minimal steatosis, strong hepatocellular injury and inflammation, prominent ductular proliferation, and robust fibrosis. Compared to the WT mice, alcohol feeding of ALR-deficient mice resulted in significantly greater increase in hepatic TNF alpha and TGF beta, and oxidative stress; there was also hepatic iron accumulation, robust lipid peroxidation and mitochondrial DNA damage. Importantly, similar to ALR-deficient mice, lower hepatic ALR levels in human alcoholic liver cirrhosis were associated with increased iron content, reduced expression of alcohol dehydrogenase and acetaldehyde dehydrogenase, and elevated fibrogenic markers. We conclude that ALR deficiency or anomaly can play a critical role in alcohol-induced hepatic fibrosis/cirrhosis, mechanisms of which may involve dysregulation of alcohol metabolism and iron homeostasis, mitochondrial damage and oxidative injury.	[Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Wang, Jiang] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Gandhi, CR (corresponding author), Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA.	gandhicr@ucmail.uc.edu	Kumar, Sudhir/J-3844-2019		National Institutes of Health; US Department of Veterans Affairs; US Department of Defence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); US Department of Defence(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (CRG), US Department of Veterans Affairs (CRG), and US Department of Defence (CRG).	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babady NE, 2007, MOL GENET METAB, V92, P23, DOI 10.1016/j.ymgme.2007.05.009; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Bridle KR, 2006, ALCOHOL CLIN EXP RES, V30, P106, DOI 10.1111/j.1530-0277.2006.00002.x; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; CASTILLO T, 1992, HEPATOLOGY, V16, P992, DOI 10.1002/hep.1840160423; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1539, DOI 10.1016/S0891-5849(01)00743-2; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; CUNNINGHAM CC, 1986, BIOCHIM BIOPHYS ACTA, V885, P12, DOI 10.1016/0167-4889(86)90033-9; Deaciuc IV, 2005, HEPATOL RES, V31, P187, DOI 10.1016/j.hepres.2005.02.004; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Francavilla A, 1997, HEPATOLOGY, V25, P411; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-10; Gandhi CR, 2010, J CELL PHYSIOL, V222, P365, DOI 10.1002/jcp.21957; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GORWITZ K, 1970, Q J STUD ALCOHOL, V31, P423; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hasegawa D, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P41, DOI 10.1016/B978-0-12-800134-9.00004-X; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Kohgo Y, 2007, WORLD J GASTROENTERO, V13, P4699, DOI 10.3748/wjg.v13.i35.4699; Koyama Y, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P87, DOI 10.1016/B978-0-12-800134-9.00006-3; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Le Guenno G, 2007, DIABETES RES CLIN PR, V77, P363, DOI 10.1016/j.diabres.2007.02.004; LELBACH WK, 1975, ALCOHOLIC LIVER PATH, P1; LIEBER CS, 1988, J PHARMACOL EXP THER, V247, P791; Lin RC, 1991, DRUG ALCOHOL ABUSE R, V2, P221; LUMENG L, 1992, MEASURING ALCOHOL CONSUMPTION, P161; MATTHEWSON K, 1986, GUT, V27, P756, DOI 10.1136/gut.27.7.756; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niemela O, 1999, J LAB CLIN MED, V133, P451, DOI 10.1016/S0022-2143(99)90022-7; NUUTINEN H, 1983, ALCOHOL CLIN EXP RES, V7, P163, DOI 10.1111/j.1530-0277.1983.tb05432.x; Pietrangelo Antonello, 1998, Journal of Hepatology, V28, P8, DOI 10.1016/S0168-8278(98)80368-1; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; RAY MB, 1993, LIVER, V13, P36; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; SORRELL MF, 1987, ANN NY ACAD SCI, V492, P50, DOI 10.1111/j.1749-6632.1987.tb48652.x; TAKAHASHI T, 1993, HEPATOLOGY, V17, P236, DOI 10.1016/0270-9139(93)90083-Y; TAKASE S, 1989, HEPATOLOGY, V9, P704, DOI 10.1002/hep.1840090508; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2004, GUT, V53, P1010, DOI 10.1136/gut.2003.026534; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Tsuchiya H, 2013, METABOLISM, V62, P62, DOI 10.1016/j.metabol.2012.06.008; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Tury A, 2005, BRAIN RES, V1048, P87, DOI 10.1016/j.brainres.2005.04.050; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Wu DF, 2004, MOL PHARMACOL, V66, P749, DOI 10.1124/mol.104.002048; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	68	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147864	10.1371/journal.pone.0147864	http://dx.doi.org/10.1371/journal.pone.0147864			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808690	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800234
J	Pang, JJ; Fuller, ND; Hu, N; Barton, LA; Henion, JM; Guo, R; Chen, YG; Ren, J				Pang, Jiaojiao; Fuller, Nathan D.; Hu, Nan; Barton, Linzi A.; Henion, Jeremy M.; Guo, Rui; Chen, Yuguo; Ren, Jun			Alcohol Dehydrogenase Protects against Endoplasmic Reticulum Stress-Induced Myocardial Contractile Dysfunction via Attenuation of Oxidative Stress and Autophagy: Role of PTEN-Akt-mTOR Signaling	PLOS ONE			English	Article							ER STRESS; CARDIAC OVEREXPRESSION; INSULIN-RESISTANCE; ALDEHYDE; DEFICIENCY; HYPERTROPHY; ALDH2; SURVIVAL; CANCER; LIVER	Background The endoplasmic reticulum (ER) plays an essential role in ensuring proper folding of the newly synthesized proteins. Aberrant ER homeostasis triggers ER stress and development of cardiovascular diseases. ADH is involved in catalyzing ethanol to acetaldehyde although its role in cardiovascular diseases other than ethanol metabolism still remains elusive. This study was designed to examine the impact of ADH on ER stress-induced cardiac anomalies and underlying mechanisms involved using cardiac-specific overexpression of alcohol dehydrogenase (ADH). Methods ADH and wild-type FVB mice were subjected to the ER stress inducer tunicamycin (1 mg/kg, i.p., for 48 hrs). Myocardial mechanical and intracellular Ca2+ properties, ER stress, autophagy and associated cell signaling molecules were evaluated. Results ER stress compromised cardiac contractile function (evidenced as reduced fractional shortening, peak shortening, maximal velocity of shortening/relengthening, prolonged relengthening duration and impaired intracellular Ca2+ homeostasis), oxidative stress and upregulated autophagy (increased LC3B, Atg5, Atg7 and p62), along with dephosphorylation of PTEN, Akt and mTOR, all of which were attenuated by ADH. In vitro study revealed that ER stress-induced cardiomyocyte anomaly was abrogated by ADH overexpression or autophagy inhibition using 3-MA. Interestingly, the beneficial effect of ADH was obliterated by autophagy induction, inhibition of Akt and mTOR. ER stress also promoted phosphorylation of the stress signaling ERK and JNK, the effect of which was unaffected by ADH transgene. Conclusions Taken together, these findings suggested that ADH protects against ER stress-induced cardiac anomalies possibly via attenuation of oxidative stress and PTEN/Akt/mTOR pathway-regulated autophagy.	[Pang, Jiaojiao; Chen, Yuguo] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Pang, Jiaojiao; Fuller, Nathan D.; Hu, Nan; Barton, Linzi A.; Henion, Jeremy M.; Guo, Rui; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA; [Ren, Jun] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shandong University; University of Wyoming; Fudan University	Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China.; Ren, J (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.; Ren, J (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China.	chen919085@126.com; jren@uwyo.edu	Ren, Jun/ACG-5366-2022; Guo, Rui/ACH-5568-2022	Ren, Jun/0000-0002-0275-0783; 	National Natural Science Foundation of China [81570401]; Taishan Scholar Program of Shandong Province [ts20130911]; Fundamental Research Funds of Shandong University [2014QLKY04]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong Province; Fundamental Research Funds of Shandong University; China Scholarship Council(China Scholarship Council)	The work was funded in part by grants from the National Natural Science Foundation of China (81570401), Taishan Scholar Program of Shandong Province (ts20130911), the Fundamental Research Funds of Shandong University (2014QLKY04) and China Scholarship Council.	Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Fang CX, 2005, DIABETOLOGIA, V48, P2412, DOI 10.1007/s00125-005-1940-y; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Goto M, 2015, GENES CELLS, V20, P464, DOI 10.1111/gtc.12237; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guerrero-Hernandez A, 2014, CELL CALCIUM, V56, P311, DOI 10.1016/j.ceca.2014.08.006; Guo KK, 2006, AGING CELL, V5, P259, DOI 10.1111/j.1474-9726.2006.00215.x; Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; Hsu HC, 2016, EUR J NUTR, V55, P2031, DOI 10.1007/s00394-015-1017-8; Hu N, 2015, PHARMACOL RES, V100, P175, DOI 10.1016/j.phrs.2015.08.005; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liu GY, 2015, ACTA PHARMACOL SIN, V36, P1473, DOI 10.1038/aps.2015.101; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Svensson S, 1996, FEBS LETT, V394, P217, DOI 10.1016/0014-5793(96)00954-4; Turdi S, 2010, AGING CELL, V9, P592, DOI 10.1111/j.1474-9726.2010.00586.x; Winnier DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119941; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Xu XH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000439; Yang LF, 2014, TOXICOL LETT, V225, P333, DOI 10.1016/j.toxlet.2013.12.024; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zhang BF, 2013, BBA-MOL BASIS DIS, V1832, P574, DOI 10.1016/j.bbadis.2013.01.013; Zhang N, 2015, J PHYSIOL BIOCHEM, V71, P319, DOI 10.1007/s13105-015-0384-1; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005; Zhang YM, 2011, ANTIOXID REDOX SIGN, V15, P2407, DOI 10.1089/ars.2010.3751; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	50	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147322	10.1371/journal.pone.0147322	http://dx.doi.org/10.1371/journal.pone.0147322			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807981	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800073
J	Petrova, A; Moffett, DF				Petrova, Adelina; Moffett, David Franklin			Comprehensive Immunolocalization Studies of a Putative Serotonin Receptor from the Alimentary Canal of Aedes aegypti Larvae Suggest Its Diverse Roles in Digestion and Homeostasis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MALPIGHIAN TUBULES; NUCLEAR-LOCALIZATION; DIURETIC HORMONE; ION-TRANSPORT; MIDGUT; MECHANISMS; EXPRESSION; ANTERIOR; RHODNIUS	Serotonin regulates key processes including digestion and homeostasis in insects. Serotonin effects are mediated by serotonin receptors that transduce information through initiation of second messenger signaling pathways. Lack of information on serotonin receptors associated with the alimentary canal impedes the understanding of the serotonergic role in insect physiology. To address this void, the present study has cloned and identified a putative serotonin receptor (hereafter AaSeR-1) from the alimentary canal of Aedes aegypti (yellow fever mosquito) larvae. In addition to in-silico analyses of AaSeR-1 primary sequence, immunohistochemical investigations were carried out to elucidate receptor expression patterns. Specific AaSeR-1 immunofluorescence was detected in the caeca, the mid- and hind-gut, including the Malpighian tubules. These findings point out not only receptor ubiquitous nature but also its involvement in regulation of different stages of nutrient processing and homeostasis. Furthermore, AaSeR-1 may mediate an array of effects through its differential expression at various cell compartments. While AaSeR-1 specific immunofluorescence was depicted in the nucleus and nucleolus of principal cells of the anterior midgut, in the posterior, analyses suggest receptor association with the plasma membrane of both principal and regenerative cells. In addition, AaSeR-1 immunofluorescence was also found in some enteroendocrine cells and in both circular and longitudinal muscles that innervate the alimentary canal. Overall, immunohistochemical analyses of AaSeR-1 expression indicate that this receptor exercises multiple roles in digestion-and homeostasis-related mechanisms.	[Petrova, Adelina; Moffett, David Franklin] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Washington State University	Petrova, A (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	adelina.petrova@wsu.edu			National Institutes of Health [1R01AI063463-01A2]; College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been funded by National Institutes of Health grant (1R01AI063463-01A2), College of Arts and Sciences, Office of Commercialization at the WSU, Pullman, WA and financial assistance from Prof Len Kirschner, Prof David Moffett and Dr. Petrova.	ALI DW, 1994, BIOGENIC AMINES, V10, P195; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; AUDSLEY N, 1993, J EXP BIOL, V178, P231; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Blundell JE, 1995, OBES RES, V3, pS471, DOI 10.1002/j.1550-8528.1995.tb00214.x; Boivin B, 2005, J MOL CELL CARDIOL, V38, P665, DOI 10.1016/j.yjmcc.2005.02.011; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chapman R. F, 1998, INSECTS STRUCTURE FU, P38; Clark TM, 1999, J EXP BIOL, V202, P247; Clark TM, 1996, J INSECT PHYSIOL, V42, P593, DOI 10.1016/0022-1910(95)00124-7; Clements A.N., 1992, BIOL MOSQUITOES, V1, P231; Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Doufexis M, 2007, FASEB J, V21, P4095, DOI 10.1096/fj.06-7927com; Frazer A., 1999, BASIC NEUROCHEMISTRY; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jagadeshwaran U, 2010, J EXP BIOL, V213, P295, DOI 10.1242/jeb.037549; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koladich PM, 2002, J EXP BIOL, V205, P3123; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; MADDRELL SH, 1971, J EXP BIOL, V54, P779; MADDRELL SHP, 1991, J EXP BIOL, V156, P557; MADDRELL SHP, 1993, J EXP BIOL, V177, P273; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; Meethal SV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-103; Moffett SB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.20; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; OMARY MB, 1987, SCIENCE, V238, P1578, DOI 10.1126/science.2825352; Onken H, 2004, J EXP BIOL, V207, P3731, DOI 10.1242/jeb.01208; Onken H, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4601; Onken H, 2009, J EXP BIOL, V212, P2571, DOI 10.1242/jeb.030221; Pietrantonio PV, 2001, INSECT MOL BIOL, V10, P357, DOI 10.1046/j.0962-1075.2001.00274.x; Portas CM, 2000, PROG NEUROBIOL, V60, P13, DOI 10.1016/S0301-0082(98)00097-5; Re M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011489; Re R, 1999, HYPERTENSION, V34, P534, DOI 10.1161/01.HYP.34.4.534; Rhee MH, 2000, FEBS LETT, V466, P300, DOI 10.1016/S0014-5793(00)01094-2; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; Roser C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049459; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Sehnal F., 1996, P55; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Terra W. R., 1996, P206; Thamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082407; Vleugels R, 2014, INSECT MOL BIOL, V23, P230, DOI 10.1111/imb.12076; Vleugels R., 2015, NEUROTRANSMITTER, V2, P314, DOI 10.14800/nt.314; VOLKMANN A, 1989, TISSUE CELL, V21, P243, DOI 10.1016/0040-8166(89)90069-4; Watson PH, 2000, J BONE MINER RES, V15, P1033, DOI 10.1359/jbmr.2000.15.6.1033; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Wright Geraldine A, 2011, Commun Integr Biol, V4, P318, DOI 10.4161/cib.4.3.14840; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zornik E, 1999, PEPTIDES, V20, P45, DOI 10.1016/S0196-9781(98)00151-X	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146587	10.1371/journal.pone.0146587	http://dx.doi.org/10.1371/journal.pone.0146587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808995	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800027
J	Santos-Lopez, JA; Garcimartin, A; Merino, P; Lopez-Oliva, ME; Bastida, S; Benedi, J; Sanchez-Muniz, FJ				Santos-Lopez, Jorge A.; Garcimartin, Alba; Merino, Pinar; Elvira Lopez-Oliva, M.; Bastida, Sara; Benedi, Juana; Sanchez-Muniz, Francisco J.			Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets	PLOS ONE			English	Article							GENE-EXPRESSION; MEAT; GLUTATHIONE; NRF2; METABOLISM; STRESS; RICH; OIL; ACTIVATION; PROFILE	Background Pork is an essential component of the diet that has been linked with major degenerative diseases and development of non-alcoholic steatohepatitis (NASH). Previous studies have. Previous studies have demonstrated the in vitro antioxidant activity of silicon (Si). Furthermore, when Si is added to restructured pork (RP) strongly counterbalances the negative effect of high-cholesterol-ingestion, acting as an active hypocholesterolemic and hypolipemic dietary ingredient in aged rats. Objective This study was designed to evaluate the effects of Si vs hydroxytyrosol (HxT) RP on liver antioxidant defense in aged rats fed cholesterol-enriched high saturated/high cholesterol diets as a NASH model. Methods Four diets were prepared: Control RP diet (C) with non-added cholesterol; Cholesterol-enriched high-saturated/high-cholesterol control RP diet (CHOL-C) with added cholesterol and cholic acid; Si-or HxT-RP cholesterol-enriched high-saturated/high-cholesterol diets (CHOL-Si and CHOL-HxT). Groups of six male Wistar rats (1-yr old) were fed these modified diets for eight weeks. Total cholesterol, hepatosomatic index, liver Nrf2 and antioxidant (CAT, SOD, GSH, GSSG, GR, GPx) markers were determined. Results Both CHOL-Si and CHOL-HxT diets enhanced the liver antioxidant status, reduced hepatosomatic index and increased SOD actvity. Hydrogen peroxide removal seemed to be involved, explaining that the value of redox index was even lower than C without changing the CAT activity. CHOL-Si results were quite better than CHOL-HxT in most measured parameters. Conclusions Our study suggests that Si incorporated into RP matrix was able to counterbalance, more efficiently than HxT, the deleterious effect of consuming a high-saturated/high-cholesterol diet, by improving the liver antioxidant defenses in the context of NASH.	[Santos-Lopez, Jorge A.; Garcimartin, Alba; Benedi, Juana] Univ Complutense Madrid, Sch Pharm, Dept Pharmacol, Madrid, Spain; [Garcimartin, Alba; Bastida, Sara; Sanchez-Muniz, Francisco J.] Univ Complutense Madrid, Sch Pharm, Dept Nutr & Food Sci, Madrid, Spain; [Merino, Pinar] Univ Alcala de Henares, Sch Pharm, Teaching Unit Toxicol, Dept Biomed Sci, Madrid, Spain; [Elvira Lopez-Oliva, M.] Univ Complutense Madrid, Sch Pharm, Dept Physiol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Universidad de Alcala; Complutense University of Madrid	Sanchez-Muniz, FJ (corresponding author), Univ Complutense Madrid, Sch Pharm, Dept Nutr & Food Sci, Madrid, Spain.	frasan@ucm.es	Santos-López, Jorge Arturo/H-3046-2017; López-Oliva, Elvira ELO/L-1660-2014; Santos-López, Jorge Arturo/L-5371-2019; Bastida, Sara/L-1619-2014	Santos-López, Jorge Arturo/0000-0003-4924-0809; López-Oliva, Elvira ELO/0000-0002-0615-9149; Santos-López, Jorge Arturo/0000-0003-4924-0809; Bastida, Sara/0000-0002-2188-5966	CONACYT-Mexico;  [AGL 2011-29644-C02-02];  [BES-2012-054752]	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ; 	Supported by AGL 2011-29644-C02-02. J. A. S.-L. received the foreign PhD studies fellowship from CONACYT-Mexico, and A. G. received a predoctoral fellowship (grant BES-2012-054752) (FPI).	Aebi H, 1984, Methods Enzymol, V105, P121; Angulo P, 2001, GASTROENTEROLOGY, V120, P1281, DOI 10.1053/gast.2001.23591; Arihara K, 2006, MEAT SCI, V74, P219, DOI 10.1016/j.meatsci.2006.04.028; Babio N, 2012, NUTR METAB CARDIOVAS, V22, P200, DOI 10.1016/j.numecd.2010.06.011; BEYNEN AC, 1984, J NUTR, V114, P1640, DOI 10.1093/jn/114.9.1640; Bocanegra A, 2006, BRIT J NUTR, V95, P696, DOI 10.1079/BJN20051682; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlisle E M, 1987, Alzheimer Dis Assoc Disord, V1, P83, DOI 10.1097/00002093-198701020-00003; CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619; Chambel SS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/597134; Chapman IM, 2007, CLIN GERIATR MED, V23, P735, DOI 10.1016/j.cger.2007.06.001; Christian MS, 2004, DRUG CHEM TOXICOL, V27, P309, DOI 10.1081/DCT-200039714; CHRISTON R, 1995, J NUTR, V125, P3062; Cofrades S, 2008, MEAT SCI, V79, P767, DOI 10.1016/j.meatsci.2007.11.010; Cofrades S, 2014, LWT-FOOD SCI TECHNOL, V59, P941, DOI 10.1016/j.lwt.2014.06.051; Cofrades S, 2011, FOOD CHEM, V129, P429, DOI 10.1016/j.foodchem.2011.04.095; DAQUINO M, 1991, FREE RADICAL RES COM, V12-3, P147, DOI 10.3109/10715769109145779; Fki I, 2007, J AGR FOOD CHEM, V55, P624, DOI 10.1021/jf0623586; Garcimartin A, 2015, J NUTR, V145, P2039, DOI 10.3945/jn.115.213934; Garcimartin A, 2015, CHEMOSPHERE, V135, P217, DOI 10.1016/j.chemosphere.2015.04.060; Garcimartin A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-384; Gonzalez-Munoz MJ, 2008, FOOD CHEM TOXICOL, V46, P1111, DOI 10.1016/j.fct.2007.11.006; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; IANTOMASI T, 1993, MECH AGEING DEV, V70, P65, DOI 10.1016/0047-6374(93)90060-5; Jimenez-Colmenero F, 2001, MEAT SCI, V59, P5, DOI 10.1016/S0309-1740(01)00053-5; Jimenez-Colmenero F, 2010, FOOD CHEM, V123, P959, DOI 10.1016/j.foodchem.2010.05.104; Liu J, 2010, Patent Application, Patent No. [13/ 500,740, 13500740]; Liu ZB, 2007, J NEUROCHEM, V103, P2690, DOI 10.1111/j.1471-4159.2007.04954.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEPER J, 1979, ATHEROSCLEROSIS, V33, P397, DOI 10.1016/0021-9150(79)90032-7; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Manna C, 1999, J NUTR BIOCHEM, V10, P159, DOI 10.1016/S0955-2863(98)00085-0; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Neha J., 2011, INT J RES PHARMA BIO, V2, P624; Nesic DM, 2013, EUR J PHARMACOL, V710, P85, DOI 10.1016/j.ejphar.2013.03.052; Okada K, 2012, J GASTROENTEROL, V47, P924, DOI 10.1007/s00535-012-0552-9; Pan M, 2006, J PINEAL RES, V41, P79, DOI 10.1111/j.1600-079X.2006.00346.x; Pazos M, 2008, J AGR FOOD CHEM, V56, P3334, DOI 10.1021/jf073403s; PELUSO MR, 1994, J NUTR, V124, P853, DOI 10.1093/jn/124.6.853; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Moreira AS, 2010, PLANT FOOD HUM NUTR, V65, P290, DOI 10.1007/s11130-010-0179-z; SCHWARZ K, 1977, LANCET, V1, P454; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tomobe K, 2012, ARCH GERONTOL GERIAT, V54, pE1, DOI 10.1016/j.archger.2011.06.006; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092; Vazquez-Velasco M, 2014, FOOD CHEM, V159, P215, DOI 10.1016/j.foodchem.2014.03.015; Vazquez-Velasco M, 2011, BRIT J NUTR, V105, P1448, DOI 10.1017/S0007114510005015; Vide J, 2015, NUTRITION, V31, P1148, DOI 10.1016/j.nut.2015.03.014; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100	50	19	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147469	10.1371/journal.pone.0147469	http://dx.doi.org/10.1371/journal.pone.0147469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807847	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800100
J	Skerry, C; Klinkenberg, LG; Page, KR; Karakousis, PC				Skerry, Ciaran; Klinkenberg, Lee G.; Page, Kathleen R.; Karakousis, Petros C.			TLR2-Modulating Lipoproteins of the Mycobacterium tuberculosis Complex Enhance the HIV Infectivity of CD4+T Cells	PLOS ONE			English	Article							SUSCEPTIBILITY; EXPRESSION; PREVENTION; VIRULENCE; RAKAI	Co-infection with Mycobacterium tuberculosis accelerates progression from HIV to AIDS. Our previous studies showed that M. tuberculosis complex, unlike M. smegmatis, enhances TLR2-dependent susceptibility of CD4+ T cells to HIV. The M. tuberculosis complex produces multiple TLR2-stimulating lipoproteins, which are absent in M. smegmatis. M. tuberculosis production of mature lipoproteins and TLR2 stimulation is dependent on cleavage by lipoprotein signal peptidase A (LspA). In order to determine the role of potential TLR2-stimulating lipoproteins on mycobacterial-mediated HIV infectivity of CD4+ T cells, we generated M. smegmatis recombinant strains overexpressing genes encoding various M. bovis BCG lipoproteins, as well as a Mycobacterium bovis BCG strain deficient in LspA (Delta/spA). Exposure of human peripheral blood mononuclear cells (PBMC) to M. smegmatis strains overexpressing the BCG lipoproteins, LprF (p<0.01), LprH (p<0.05), LprI (p<0.05), LprP (p<0.001), LprQ (p<0.005), MPT83 (p<0.005), or PhoS1 (p<0.05), resulted in increased HIV infectivity of CD4+ T cells isolated from these PBMC. Conversely, infection of PBMC with Delta/spA reduced HIV infectivity of CD4+ T cells by 40% relative to BCG-infected cells (p<0.05). These results may have important implications for TB vaccination programs in areas with high mother-to-child HIV transmission.	[Skerry, Ciaran; Klinkenberg, Lee G.; Page, Kathleen R.; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Karakousis, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Karakousis, PC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	petros@jhmi.edu	Skerry, Ciaran/AAX-8291-2020; Karakousis, Petros Constantine/AAR-7899-2020		Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program [P30AI094189]; National Institutes of Health [K23HD056957]; NIH [K23HD056957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD056957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported in part by a developmental grant from the Johns Hopkins University Center for AIDS Research, a National Institutes of Health-funded program (P30AI094189) to LGK, and the National Institutes of Health under award number K23HD056957 to KRP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding sources had no role in the study design, data collection, data analysis, data interpretation, decision to publish, or writing of the manuscript.; Financial support: Research reported in this publication was supported in part by a developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH-funded program (P30AI094189) to LGK, and the NIH under award number K23HD056957 to KRP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banaiee N, 2007, J ANTIMICROB CHEMOTH, V60, P414, DOI 10.1093/jac/dkm223; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gordhan B G, 2001, Methods Mol Med, V54, P77, DOI 10.1385/1-59259-147-7:077; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Kalinkovich A, 2001, CLIN IMMUNOL, V100, P107, DOI 10.1006/clim.2001.5040; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KREMER L, 1995, MOL MICROBIOL, V17, P913, DOI 10.1111/j.1365-2958.1995.mmi_17050913.x; Krishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028476; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Mak TK, 2008, LANCET, V372, P786, DOI 10.1016/S0140-6736(08)61318-5; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rodriguez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080938; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Thayil SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041093; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; UNAIDS, 2014 GLOB STAT; WHO, 2011, TB DAT 2011; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	30	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147192	10.1371/journal.pone.0147192	http://dx.doi.org/10.1371/journal.pone.0147192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807859	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800058
J	Wang, C; Li, X; Zhang, YJ; Xu, Q; Huang, FF; Cao, K; Tao, LX; Guo, J; Gao, Q; Wang, W; Fang, LQ; Guo, XH				Wang, Chao; Li, Xia; Zhang, Yingjie; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Fang, Liqun; Guo, Xiuhua			Spatiotemporal Cluster Patterns of Hand, Foot, and Mouth Disease at the County Level in Mainland China, 2008-2012	PLOS ONE			English	Article							ASSOCIATION	Background Hand, foot, and mouth disease (HFMD) is known to be a highly contagious childhood illness. In recent years, the number of reported cases of HFMD has significantly increased in mainland China. This study aims at the epidemiological features, spatiotemporal patterns of HMFD at the county/district level in mainland China. Methods Data on reported HFMD cases for each county from 1 January 2008 to 31 December 2012 were obtained from the Chinese Center for Disease Control and Prevention. Cluster analysis, spatial autocorrelation, and retrospective scan methods were used to explore the spatiotemporal patterns of the disease. Results The annual incidences varied greatly among the counties, ranging from 0 to 74.31% with the median of 5.42%(interquartile range: 1.54%-13.55%) during 2008-2012 in mainland China. Counties close to provincial capital cities generally had higher incidences than rural counties. A seasonal distribution was observed between the northern and southern China, of which dual epidemic were shown in southern China and usually only one in northern China. Based on the global and local spatial autocorrelation analysis, we found that the spatial distribution of HFMD was presented a significant clustering pattern for each year (P<0.001), and hotspots of the disease were mostly distributed in coastal provinces of China. The retrospective scan statistic further identified the dynamics of spatiotemporal clustering areas of the disease, which were mainly distributed in the counties of eastern and southern China, as well as provincial capitals and their surrounding counties. Conclusions The spatiotemporal clustering areas of the disease identified in this way were relatively stable, and imminent public health planning and resource allocation should be focused within those areas.	[Wang, Chao; Li, Xia; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wang, Chao; Li, Xia; Xu, Qin; Huang, Fangfang; Cao, Kai; Tao, Lixin; Guo, Jin; Gao, Qi; Wang, Wei; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Zhang, Yingjie] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth, Surveillance & Informat Serv, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Fang, Liqun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Capital Medical University; University of Limerick; Chinese Center for Disease Control & Prevention; Edith Cowan University; Beijing Institute of Microbiology & Epidemiology	Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; Guo, XH (corresponding author), Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.; Fang, LQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fang_lq@163.com; guoxiuh@ccmu.edu.cn	Zhang, Yingjie/HHM-3016-2022; Gao, Qi/N-8721-2019; Ibrahim, Essam Hassan/G-1960-2018; Fang, Li-Qun/GWD-0296-2022; TAO, Li/HIR-4254-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Wang, Chao/0000-0002-7172-8256; Gao, Qi/0000-0002-5370-5536	National Science and Technology Major Project [2012ZX10005009-003, 2014ZX10004005-001]; National 973 Project [2011CB505404]; National Natural Science Foundation of China [81302516]	National Science and Technology Major Project; National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	XG is supported by National Science and Technology Major Project (2012ZX10005009-003 and 2014ZX10004005-001, URL: http://www.nmp.gov.cn/) and National 973 Project(Serial Number: 2011CB505404, URL: http://www.973.gov.cn/). XL is supported by National Natural Science Foundation of China (serial no.: 81302516 URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Cao HaiLan, 2012, Modern Preventive Medicine, V39, P148; Chan Ta-Chien, 2010, INFECT DIS INFORM BI, P208; Chen YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126158; Chen YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068336; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Hu YueHua, 2014, Disease Surveillance, V29, P827; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; Liu S, 2011, DIS SURVEILLANCE, V26, P499; Liu WD, 2012, ZHONGHUA LIU XING BI, V33, P813; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2012, IASR, V33, P55; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; [唐咸艳 Tang Xianyan], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P274; The Ministry of Health of the People's Republic of China, 2008, CAP J PUBLIC HLTH, P146; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang H, 2015, INT J INFECT DIS, V34, P66, DOI 10.1016/j.ijid.2015.03.007; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	39	20	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147532	10.1371/journal.pone.0147532	http://dx.doi.org/10.1371/journal.pone.0147532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809151	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800124
J	Kwon, MJ; O'Loughlin, EJ; Boyanov, MI; Brulc, JM; Johnston, ER; Kemner, KM; Antonopoulos, DA				Kwon, Man Jae; O'Loughlin, Edward J.; Boyanov, Maxim I.; Brulc, Jennifer M.; Johnston, Eric R.; Kemner, Kenneth M.; Antonopoulos, Dionysios A.			Impact of Organic Carbon Electron Donors on Microbial Community Development under Iron- and Sulfate-Reducing Conditions	PLOS ONE			English	Article							URANIUM-CONTAMINATED AQUIFER; LEPIDOCROCITE GAMMA-FEOOH; SUBSURFACE SEDIMENTS; SP-NOV; FERRIC IRON; DISSIMILATORY REDUCTION; METHANE PRODUCTION; FE(III) REDUCTION; GEN-NOV; GROUNDWATER	Although iron- and sulfate-reducing bacteria in subsurface environments have crucial roles in biogeochemical cycling of C, Fe, and S, how specific electron donors impact the compositional structure and activity of native iron-and/or sulfate-reducing communities is largely unknown. To understand this better, we created bicarbonate-buffered batch systems in duplicate with three different electron donors (acetate, lactate, or glucose) paired with ferrihydrite and sulfate as the electron acceptors and inoculated them with subsurface sediment as the microbial inoculum. Sulfate and ferrihydrite reduction occurred simultaneously and were faster with lactate than with acetate. 16S rRNA-based sequence analysis of the communities over time revealed that Desulfotomaculum was the major driver for sulfate reduction coupled with propionate oxidation in lactate-amended incubations. The reduction of sulfate resulted in sulfide production and subsequent abiotic reduction of ferrihydrite. In contrast, glucose promoted faster reduction of ferrihydrite, but without reduction of sulfate. Interestingly, the glucose-amended incubations led to two different biogeochemical trajectories among replicate bottles that resulted in distinct coloration (white and brown). The two outcomes in geochemical evolution might be due to the stochastic evolution of the microbial communities or subtle differences in the initial composition of the fermenting microbial community and its development via the use of different glucose fermentation pathways available within the community. Synchrotron-based x-ray analysis indicated that siderite and amorphous Fe(II) were formed in the replicate bottles with glucose, while ferrous sulfide and vivianite were formed with lactate or acetate. These data sets reveal that use of different C utilization pathways projects significant changes in microbial community composition over time that uniquely impact both the geochemistry and mineralogy of subsurface environments.	[Kwon, Man Jae; O'Loughlin, Edward J.; Boyanov, Maxim I.; Kemner, Kenneth M.; Antonopoulos, Dionysios A.] Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Kwon, Man Jae] Korea Inst Sci & Technol, Gangneung Inst, Kangnung 210340, South Korea; [Brulc, Jennifer M.; Johnston, Eric R.; Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; Korea Institute of Science & Technology (KIST); United States Department of Energy (DOE); Argonne National Laboratory	Antonopoulos, DA (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.; Antonopoulos, DA (corresponding author), Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA.	dion@anl.gov	Antonopoulos, Dionysios/ABE-6212-2020; Johnston, Eric R/J-1051-2019; BM, MRCAT/G-7576-2011; O'Loughlin, Edward/C-9565-2013	Antonopoulos, Dionysios/0000-0002-2238-5031; Johnston, Eric R/0000-0002-3217-7711; O'Loughlin, Edward/0000-0003-1607-9529	Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE) [DE-AC02-06CH11357]; Argonne Director's Postdoctoral Fellowship Program; KIST - Gangneung Institute [2Z04221]; Korea Ministry of Environment [2013000540005]	Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Argonne Director's Postdoctoral Fellowship Program; KIST - Gangneung Institute; Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research is part of the Subsurface Science Scientific Focus Area at Argonne National Laboratory, supported by the Subsurface Biogeochemical Research Program, Office of Biological and Environmental Research, Office of Science, U.S. Department of Energy (DOE), under contract DE-AC02-06CH11357. MRCAT/EnviroCAT operations are supported by DOE and the MRCAT/EnviroCAT member institutions. MJK was supported by the Argonne Director's Postdoctoral Fellowship Program, and part of this work was also supported by KIST - Gangneung Institute (Grant no. 2Z04221) and Korea Ministry of Environment as The GAIA Project-2013000540005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO MD, 1992, LANGMUIR, V8, P1671; Ahmed B, 2012, APPL ENVIRON MICROB, V78, P8001, DOI 10.1128/AEM.01844-12; Akob DM, 2008, APPL ENVIRON MICROB, V74, P3159, DOI 10.1128/AEM.02881-07; Anandkumar B, 2009, MATER CORROS, V60, P730, DOI 10.1002/maco.200805177; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Barlett M, 2012, BIODEGRADATION, V23, P535, DOI 10.1007/s10532-011-9531-8; Barton LL, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P1, DOI 10.1017/CBO9780511541490; Benning LG, 1999, GEOCHEMISTRY OF THE EARTH'S SURFACE, P429; Bethke CM, 2008, GEOLOGY, V36, P739, DOI 10.1130/G24859A.1; Borch T, 2007, ENVIRON SCI TECHNOL, V41, P166, DOI 10.1021/es060695p; Boyanov MI, 2007, GEOCHIM COSMOCHIM AC, V71, P1898, DOI 10.1016/j.gca.2007.01.025; Burkhardt EM, 2011, APPL ENVIRON MICROB, V77, P3132, DOI 10.1128/AEM.02085-10; Burkhardt EM, 2010, ENVIRON SCI TECHNOL, V44, P177, DOI 10.1021/es902038e; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAUMAS S, 1988, A VAN LEEUW J MICROB, V54, P165, DOI 10.1007/BF00419203; [Department of Energy US DOE US], 1999, FIN SIT OBS WORK PLA; Donald R, 1999, GEOCHIM COSMOCHIM AC, V63, P2019, DOI 10.1016/S0016-7037(99)00140-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards L, 2007, GEOCHIM COSMOCHIM AC, V71, P643, DOI 10.1016/j.gca.2006.09.017; FRANCIS AJ, 1988, APPL ENVIRON MICROB, V54, P1009, DOI 10.1128/AEM.54.4.1009-1014.1988; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; Garcia-Balboa C, 2010, WATER AIR SOIL POLL, V207, P213, DOI 10.1007/s11270-009-0130-9; Geets J, 2005, J SOIL SEDIMENT, V5, P149, DOI 10.1065/jss2004.12.125; Goorissen HP, 2003, INT J SYST EVOL MICR, V53, P1223, DOI 10.1099/ijs.0.02476-0; Handley KM, 2015, ENVIRON MICROBIOL, V17, P622, DOI 10.1111/1462-2920.12467; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; He Q, 2003, APPL ENVIRON MICROB, V69, P2712, DOI 10.1128/AEM.69.5.2712-2718.2003; Herbert RB, 1998, CHEM GEOL, V144, P87, DOI 10.1016/S0009-2541(97)00122-8; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Jorand F, 2011, SCI TOTAL ENVIRON, V409, P2586, DOI 10.1016/j.scitotenv.2011.03.030; Jorand FPA, 2013, GEOMICROBIOL J, V30, P600, DOI 10.1080/01490451.2012.746403; Kemner KM, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P1183; Kemner KM, 2005, ELEMENTS, V1, P217, DOI 10.2113/gselements.1.4.217; Kirk MF, 2004, GEOLOGY, V32, P953, DOI 10.1130/G20842.1; Komlos J, 2008, J ENVIRON QUAL, V37, P2058, DOI 10.2134/jeq2007.0665; Komlos J, 2007, WATER RES, V41, P2996, DOI 10.1016/j.watres.2007.03.019; Kropf AJ, 2010, AIP CONF PROC, V1234, P299, DOI 10.1063/1.3463194; Kwon Man Jae, 2014, [The Journal of Korean Society of Soil and Groundwater Environment, 지하수토양환경], V19, P54; Kwon MJ, 2014, GEOCHIM COSMOCHIM AC, V129, P177, DOI 10.1016/j.gca.2013.09.037; LAANBROEK HJ, 1981, ARCH MICROBIOL, V128, P330, DOI 10.1007/BF00422540; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P3721, DOI 10.1021/es204528m; Lentini CJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00404; Lovley D.R., 2000, ENV MICROBE METAL IN; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P3234, DOI 10.1128/AEM.55.12.3234-3236.1989; LOVLEY DR, 1987, GEOMICROBIOL J, V5, P375, DOI 10.1080/01490458709385975; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P2636, DOI 10.1128/AEM.53.11.2636-2641.1987; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Madigan M.T., 2006, BROCK BIOL MICROORGA; MIN H, 1990, ARCH MICROBIOL, V153, P399, DOI 10.1007/BF00249012; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; Neal AL, 2001, GEOCHIM COSMOCHIM AC, V65, P223, DOI 10.1016/S0016-7037(00)00537-8; Nevin KP, 2000, ENVIRON SCI TECHNOL, V34, P2472, DOI 10.1021/es991181b; Nevin KP, 2003, APPL ENVIRON MICROB, V69, P3672, DOI 10.1128/AEM.69.6.3672-3675.2003; Newville M, 1995, PROGRAM AUTOBK VERSI; O'Loughlin EJ, 2013, ENVIRON SCI TECHNOL, V47, P9157, DOI 10.1021/es400627j; O'Loughlin EJ, 2011, ACS SYM SER, V1071, P477; O'Loughlin EJ, 2010, ENVIRON SCI TECHNOL, V44, P4570, DOI 10.1021/es100294w; Oyekola OO, 2009, WATER RES, V43, P3345, DOI 10.1016/j.watres.2008.11.044; Petrie L, 2003, APPL ENVIRON MICROB, V69, P7467, DOI 10.1128/AEM.69.12.7467-7479.2003; PFENNIG N, 1976, ARCH MICROBIOL, V110, P3, DOI 10.1007/BF00416962; Plugge CM, 2002, INT J SYST EVOL MICR, V52, P391, DOI 10.1099/00207713-52-2-391; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Raza W, 2010, CURR MICROBIOL, V61, P390, DOI 10.1007/s00284-010-9624-3; Rickard D., 1969, STOCKHOLM CONTRIBUTI, V20, P49; Roden EE, 2003, ENVIRON SCI TECHNOL, V37, P1319, DOI 10.1021/es026038o; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; Seeliger S, 2002, FEMS MICROBIOL LETT, V211, P65, DOI 10.1111/j.1574-6968.2002.tb11204.x; Sergent AS, 2011, CHEM GEOL, V289, P86, DOI 10.1016/j.chemgeo.2011.07.016; SORENSEN J, 1982, APPL ENVIRON MICROB, V43, P319; SPORMANN AM, 1988, ARCH MICROBIOL, V150, P374, DOI 10.1007/BF00408310; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Thamdrup B, 2000, METHODS IN ECOSYSTEM SCIENCE, P86; VAUGHAN DJ, 1991, SCI PROG, V75, P371; WIDDEL F, 1977, ARCH MICROBIOL, V112, P119, DOI 10.1007/BF00446665; Wilkins MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057819; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Yao H, 1999, BIOGEOCHEMISTRY, V47, P269, DOI 10.1007/BF00992910; Yelton AP, 2013, ENVIRON SCI TECHNOL, V47, P6500, DOI 10.1021/es4006674	86	30	30	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146689	10.1371/journal.pone.0146689	http://dx.doi.org/10.1371/journal.pone.0146689			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800443	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300029
J	Shinn-Thomas, JH; del Campo, JJ; Wang, JJ; Mohler, WA				Shinn-Thomas, Jessica H.; del Campo, Jacob J.; Wang, Jianjun; Mohler, William A.			The EFF-1A Cytoplasmic Domain Influences Hypodermal Cell Fusions in C-elegans But Is Not Dependent on 14-3-3 Proteins	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; FUSOGEN EFF-1; ENTRY INHIBITORS; MEMBRANE-FUSION; MINIMOTIF MINER; SOMATIC-CELLS; VIRUS; PHOSPHORYLATION; MECHANISMS; TAIL	Background Regulatory and biophysical mechanisms of cell-cell fusion are largely unknown despite the fundamental requirement for fused cells in eukaryotic development. Only two cellular fusogens that are not of clear recent viral origin have been identified to date, both in nematodes. One of these, EFF-1, is necessary for most cell fusions in Caenorhabditis elegans. Unregulated EFF-1 expression causes lethality due to ectopic fusion between cells not developmentally programmed to fuse, highlighting the necessity of tight fusogen regulation for proper development. Identifying factors that regulate EFF-1 and its paralog AFF-1 could lead to discovery of molecular mechanisms that control cell fusion upstream of the action of a membrane fusogen. Bioinformatic analysis of the EFF-1A isoform's predicted cytoplasmic domain (endodomain) previously revealed two motifs that have high probabilities of interacting with 14-3-3 proteins when phosphorylated. Mutation of predicted phosphorylation sites within these motifs caused measurable loss of eff-1 gene function in cell fusion in vivo. Moreover, a human 14-3-3 isoform bound to EFF-1::GFP in vitro. We hypothesized that the two 14-3-3 proteins in C. elegans, PAR-5 and FTT-2, may regulate either localization or fusion-inducing activity of EFF-1. Methodology/Principal Findings Timing of fusion events was slightly but significantly delayed in animals unable to produce full-length EFF-1A. Yet, mutagenesis and live imaging showed that phosphoserines in putative 14-3-3 binding sites are not essential for EFF-1:: GFP accumulation at the membrane contact between fusion partner cells. Moreover, although the EFF-1A endodomain was required for normal rates of eff-1-dependent epidermal cell fusions, reduced levels of FTT-2 and PAR-5 did not visibly affect the function of wild-type EFF-1 in the hypodermis. Conclusions/Significance Deletion of the EFF-1A endodomain noticeably affects the timing of hypodermal cell fusions in vivo. However, prohibiting phosphorylation of candidate 14-3-3-binding sites does not impact localization of the fusogen. Hypodermal membrane fusion activity persists when 14-3-3 expression levels are reduced.	[Shinn-Thomas, Jessica H.; del Campo, Jacob J.; Wang, Jianjun; Mohler, William A.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Shinn-Thomas, Jessica H.] Utica Coll, Dept Biol, Utica, NY 13502 USA; [del Campo, Jacob J.] PepsiCo R&D, New Haven, CT 06511 USA; [Wang, Jianjun] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Connecticut; PepsiCo; Jefferson University	Mohler, WA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, MC-6403,263 Farmington Ave, Farmington, CT 06030 USA.	jhthomas@utica.edu; mohler.william@gmail.com			National Institutes of Health [HD043156, RR022232]; NIH Office of Research Infrastructure Programs [P40 OD010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043156] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by HD043156, [http://www.nih.gov/], National Institutes of Health, to WAM; and RR022232, [http://www.nih.gov/], National Institutes of Health, to WAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Morgan Tucker, Min Han, Jeffrey Simske, David Pilgram, H. Robert Horvitz, Craig Hunter, and Sieu Sylvia Lee for generously supplying us with reagents and strains used in this study; John O'Donnell for assistance with EFF-1 localization studies; Ala Berdichevsky for communications regarding MT14355 genotype and phenotype; Diane Morton for discussing KK299 strain maintenance and par-5 loss-of-function phenotypes; and Monica Palacios-Boyce, Patrick Spica, and Emra Klempic for proofreading. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRENNER S, 1974, GENETICS, V77, P71; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; COHEN DI, 1992, SCIENCE, V256, P542, DOI 10.1126/science.1570514; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Dutch RE, 2001, J VIROL, V75, P5363, DOI 10.1128/JVI.75.11.5363-5369.2001; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gattegno T, 2007, MOL BIOL CELL, V18, P1153, DOI 10.1091/mbc.E06-09-0855; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Golinowski W, 1997, DEV PLANT PATHOL, V10, P80; Harkness Ty, 2013, Critical Reviews in Oncogenesis, V18, P19; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Keay S, 1996, J GEN VIROL, V77, P2597, DOI 10.1099/0022-1317-77-10-2597; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Lluis F, 2010, J CELL PHYSIOL, V223, P6, DOI 10.1002/jcp.22003; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McKinnell JA, 2009, CURR OPIN HIV AIDS, V4, P513, DOI 10.1097/COH.0b013e328331d3d0; Melby Tom, 2009, V189, P177, DOI 10.1007/978-3-540-79086-0_7; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Mohler WA, 2006, EUREKAH BIOSCIENCE, V2, P12; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nguyen CQ, 1999, DEV BIOL, V207, P86, DOI 10.1006/dbio.1998.9173; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Oren-Suissa M, 2010, DEV DYNAM, V239, P1515, DOI 10.1002/dvdy.22284; Palma-Guerrero J, 2014, MOL MICROBIOL, V92, P164, DOI 10.1111/mmi.12545; Parris George E., 2013, Critical Reviews in Oncogenesis, V18, P1; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rasband W., 2006, IMAGEJ; Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Sanges D, 2011, ADV EXP MED BIOL, V713, P137, DOI 10.1007/978-94-007-0763-4_9; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Schiller M. R., 2007, CURR PROTOC PROTEIN; SERGEL T, 1995, VIROLOGY, V210, P264, DOI 10.1006/viro.1995.1343; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Shinn-Thomas JH, 2011, INT REV CEL MOL BIO, V289, P149, DOI 10.1016/B978-0-12-386039-2.00005-5; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sumer H, 2010, STEM CELLS DEV, V19, P239, DOI 10.1089/scd.2009.0142; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang WF, 1996, J MOL EVOL, V43, P384; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; YAO QH, 1995, J VIROL, V69, P7045, DOI 10.1128/JVI.69.11.7045-7053.1995; Yochem J, 1998, GENETICS, V149, P1323; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912	89	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146874	10.1371/journal.pone.0146874	http://dx.doi.org/10.1371/journal.pone.0146874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800457	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300045
J	Chau, TT; Wang, KY				Chau, Tang-Tat; Wang, Kuo-Ying			Association between Daily Hospital Outpatient Visits for Accidents and Daily Ambient Air Temperatures in an Industrial City	PLOS ONE			English	Article							AGGRESSION; HEAT	An accident is an unwanted hazard to a person. However, accidents occur. In this work, we search for correlations between daily accident rates and environmental factors. To study daily hospital outpatients who were admitted for accidents during a 5-year period, 20072011, we analyzed data regarding 168,366 outpatients using univariate regression models; we also used multivariable regression models to account for confounding factors. Our analysis indicates that the number of male outpatients admitted for accidents was approximately 1.31 to 1.47 times the number of female outpatients (P < 0.0001). Of the 12 parameters (regarding air pollution and meteorology) considered, only daily temperature exhibited consistent and significant correlations with the daily number of hospital outpatient visits for accidents throughout the 5-year analysis period. The univariate regression models indicate that older people (greater than 66 years old) had the fewest accidents per 1-degree increase in temperature, followed by young people (0-15 years old). Middle-aged people (16-65 years old) were the group of outpatients that were more prone to accidents, with an increase in accident rates of 0.8-1.2 accidents per degree increase in temperature. The multivariable regression models also reveal that the temperature variation was the dominant factor in determining the daily number of outpatient visits for accidents. Our further multivariable model analysis of temperature with respect to air pollution variables show that, through the increases in emissions and concentrations of CO, photochemical O3 production and NO2 loss in the ambient air, increases in vehicular emissions are associated with increases in temperatures. As such, increases in hospital visits for accidents are related to vehicular emissions and usage. This finding is consistent with clinical experience which shows about 60% to 80% of accidents are related to traffic, followed by accidents occurred in work place.	[Chau, Tang-Tat] Taiwan Landseed Hosp, Dept Family Med, Taoyuan, Taiwan; [Wang, Kuo-Ying] Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan	National Central University	Wang, KY (corresponding author), Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan.	kuoying@mail.atm.ncu.edu.tw			National Central University (NCU)-Landseed Hospital [(LSH)-100-A-004, (LSH)-101-A-006]	National Central University (NCU)-Landseed Hospital	This work was supported by National Central University (NCU)-Landseed Hospital (LSH)-100-A-004 and National Central University (NCU)-Landseed Hospital (LSH)-101-A-006.	af Wahlberg AE, 2008, SAFETY SCI, V46, P66, DOI 10.1016/j.ssci.2007.02.003; ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; ARBOUS AG, 1951, BIOMETRICS, V7, P340, DOI 10.2307/3001656; Barker M, 1996, ARCH DIS CHILD, V75, P156, DOI 10.1136/adc.75.2.156; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; KENRICK DT, 1986, ENVIRON BEHAV, V18, P179, DOI 10.1177/0013916586182002; KING KN, 1991, SOFTWARE PRACT EXPER, V21, P685, DOI 10.1002/spe.4380210704; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Lund M, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-1; Marill Jennifer L., 2009, D-Lib Magazine, V15, DOI 10.1045/may2009-marill; MCKEE CM, 1990, BRIT J GEN PRACT, V40, P150; Mirza S, 1999, ACCIDENT ANAL PREV, V31, P329, DOI 10.1016/S0001-4575(98)00025-6; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; Press W., 1992, NUMERICAL RECIPES FO; REIFMAN AS, 1991, PERS SOC PSYCHOL B, V17, P580, DOI 10.1177/0146167291175013; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; Taiwan Landseed Hospital, 2011, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2009, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2008, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2010, STAT ANN REP MED SER; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; Wang KY, 2004, WATER AIR SOIL POLL, V156, P29, DOI 10.1023/B:WATE.0000036788.41409.5b; Wang KY, 2002, ENVIRON MODELL SOFTW, V17, P731, DOI 10.1016/S1364-8152(02)00032-4	23	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145003	10.1371/journal.pone.0145003	http://dx.doi.org/10.1371/journal.pone.0145003			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815039	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200002
J	Mutumi, GL; Jacobs, DS; Winker, H				Mutumi, Gregory L.; Jacobs, David S.; Winker, Henning			Sensory Drive Mediated by Climatic Gradients Partially Explains Divergence in Acoustic Signals in Two Horseshoe Bat Species, Rhinolophus swinnyi and Rhinolophus simulator	PLOS ONE			English	Article							ECHOLOCATION CALLS; GEOGRAPHIC-VARIATION; FREQUENCY; EVOLUTION; BIRDS; SEX	Geographic variation can be an indicator of still poorly understood evolutionary processes such as adaptation and drift. Sensory systems used in communication play a key role in mate choice and species recognition. Habitat-mediated (i.e. adaptive) differences in communication signals may therefore lead to diversification. We investigated geographic variation in echolocation calls of African horseshoe bats, Rhinolophus simulator and R. swinnyi in the context of two adaptive hypotheses: 1) James' Rule and 2) the Sensory Drive Hypothesis. According to James' Rule body-size should vary in response to relative humidity and temperature so that divergence in call frequency may therefore be the result of climate-mediated variation in body size because of the correlation between body size and call frequency. The Sensory Drive Hypothesis proposes that call frequency is a response to climate-induced differences in atmospheric attenuation and predicts that increases in atmospheric attenuation selects for calls of lower frequency. We measured the morphology and resting call frequency (RF) of 111 R. simulator and 126 R. swinnyi individuals across their distributional range to test the above hypotheses. Contrary to the prediction of James' Rule, divergence in body size could not explain the variation in RF. Instead, acoustic divergence in RF was best predicted by latitude, geography and climate-induced differences in atmospheric attenuation, as predicted by the Sensory Drive Hypothesis. Although variation in RF was strongly influenced by temperature and humidity, other climatic variables (associated with latitude and altitude) as well as drift (as suggested by a positive correlation between call variation and geographic distance, especially in R. simulator) may also play an important role.	[Mutumi, Gregory L.; Jacobs, David S.] Univ Cape Town, Dept Biol Sci, Anim Evolut & Systemat Grp AES, ZA-7701 Cape Town, South Africa; [Winker, Henning] SANBI, Ctr Stat Ecol Environm & Conservat SEEC, Cape Town, South Africa	University of Cape Town; South African National Biodiversity Institute	Mutumi, GL; Jacobs, DS (corresponding author), Univ Cape Town, Dept Biol Sci, Anim Evolut & Systemat Grp AES, ZA-7701 Cape Town, South Africa.	mtmgre001@myuct.ac.za; david.jacobs@uct.ac.za	Mutumi, Gregory/AAH-8447-2021; mutumi, gregory/GYD-4103-2022; Jacobs, David Steve/L-9118-2013	mutumi, gregory/0000-0003-1911-2232; Jacobs, David Steve/0000-0002-3243-8571	University of Cape Town; South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation [GUN 64798]; University of Cape Town's Postgraduate Centre and Funding Office	University of Cape Town; South African Research Chair Initiative of the Department of Science and Technology; National Research Foundation; University of Cape Town's Postgraduate Centre and Funding Office	This research was supported by grants to DSJ from the University of Cape Town (www.uct.ac.za) and the South African Research Chair Initiative of the Department of Science and Technology (http://www.dst.gov.za), administered by the National Research Foundation (http://www.nrf.ac.za), grant number-GUN 64798. GLM also received funding (Research Associateship award) from the University of Cape Town's Postgraduate Centre and Funding Office (www.uct.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter J, 2005, EXTENT FREQUENCY EUR; Andersson Malte, 1994; Anthony E.L.P., 1988, P47; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Barnard G., 1963, J R STAT SOC B, V25, P294; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Bastian A, 2015, ANIM BEHAV, V101, P141, DOI 10.1016/j.anbehav.2014.12.010; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; CLIFF AD, 1970, ECON GEOGR, V46, P269, DOI 10.2307/143144; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gillam EH, 2009, BEHAV ECOL SOCIOBIOL, V64, P69, DOI 10.1007/s00265-009-0819-1; Gubitz T, 2005, P ROY SOC B-BIOL SCI, V272, P751, DOI 10.1098/rspb.2004.3018; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jiang TL, 2015, INTEGR ZOOL, V10, P241, DOI 10.1111/1749-4877.12129; Jiang TL, 2010, J ACOUST SOC AM, V128, P2204, DOI 10.1121/1.3478855; Jiang TL, 2010, ETHOLOGY, V116, P691, DOI 10.1111/j.1439-0310.2010.01785.x; Jones G, 1999, J EXP BIOL, V202, P3359; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Kormann U, 2015, DIVERS DISTRIB, P1; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; Lomolino MV, 2006, J BIOGEOGR, V33, P1503, DOI 10.1111/j.1365-2699.2006.01593.x; Luo JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0961; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; Morrone JJ, 2009, EVOLUTIONARY BIOL IN; Odendaal LJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-60; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; Schnitzler HU, 1987, RECENT ADV STUDY BAT; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Snell-Rood EC, 2012, J ACOUST SOC AM, V131, P1650, DOI 10.1121/1.3672695; Sternheim MM, 1986, GENERAL PHYSICS; Stilz WP, 2012, J ACOUST SOC AM, V132, P1765, DOI 10.1121/1.4733537; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Zuckerwar A. J., 2002, HDB SPEED SOUND REAL; Zuur Alain F., 2009, P1	55	23	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148053	10.1371/journal.pone.0148053	http://dx.doi.org/10.1371/journal.pone.0148053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815436	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528200070
J	Prado, JHF; Mattos, PH; Silva, KG; Secchi, ER				Prado, Jonatas H. F.; Mattos, Paulo H.; Silva, Kleber G.; Secchi, Eduardo R.			Long-Term Seasonal and Interannual Patterns of Marine Mammal Strandings in Subtropical Western South Atlantic	PLOS ONE			English	Article							AMERICAN SEA LION; WHALES MEGAPTERA-NOVAEANGLIAE; DOLPHIN PONTOPORIA-BLAINVILLEI; ANTARCTIC FUR-SEAL; GRANDE-DO-SUL; CETACEAN STRANDINGS; OTARIA-FLAVESCENS; GILLNET FISHERIES; BYCATCH; COAST	Understanding temporal patterns of marine mammal occurrence is useful for establishing conservation strategies. We used a 38 yr-long dataset spanning 1976 to 2013 to describe temporal patterns and trends in marine mammal strandings along a subtropical stretch of the east coast of South America. This region is influenced by a transitional zone between tropical and temperate waters and is considered an important fishing ground off Brazil. Generalized Additive Models were used to evaluate the temporal stranding patterns of the most frequently stranded species. Forty species were documented in 12,540 stranding events. Franciscana (n = 4,574), South American fur seal, (n = 3,419), South American sea lion (n = 2,049), bottlenose dolphins (n = 293) and subantarctic fur seal (n = 219) were the most frequently stranded marine mammals. The seasonality of strandings of franciscana and bottlenose dolphin coincided with periods of higher fishing effort and strandings of South American and subantarctic fur seals with post-reproductive dispersal. For South American sea lion the seasonality of strandings is associated with both fishing effort and post-reproductive dispersal. Some clear seasonal patterns were associated with occurrence of cold( e.g. subantarctic fur seal) and warm-water (e.g. rough-toothed dolphin) species in winter and summer, respectively. Inter-annual increases in stranding rate were observed for franciscana and South American fur seal and these are likely related to increased fishing effort and population growth, respectively. For subantarctic fur seal the stranding rate showed a slight decline while for bottlenose dolphin it remained steady. No significant year to year variation in stranding rate was observed for South American sea lion. The slight decrease in frequency of temperate/polar marine mammals and the increased occurrence of subtropical/tropical species since the late 1990s might be associated with environmental changes linked to climate change. This long-term study indicates that temporal stranding patterns of marine mammals might be explained by either fishing-related or environmental factors.	[Prado, Jonatas H. F.; Secchi, Eduardo R.] Univ Fed Rio Grande, Lab Ecol & Conservacao Megafauna Marinha, Inst Oceanog, Rio Grande, Brazil; [Mattos, Paulo H.] Univ Fed Rio Grande, Inst Oceanog, Lab Gerenciamento Costeiro, Rio Grande, Brazil; [Silva, Kleber G.] Nucl Educ & Monitoramento Ambiental, Rio Grande, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	Prado, JHF (corresponding author), Univ Fed Rio Grande, Lab Ecol & Conservacao Megafauna Marinha, Inst Oceanog, Rio Grande, Brazil.	jonatashenriquef@gmail.com	Secchi, Eduardo R./ABF-1191-2020	Secchi, Eduardo R./0000-0001-9087-9909	Yaqu Pacha; Cetacean Society International; Fundacao O Boticario de Protecao a Natureza; Petrobras; Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq; CNPq [140638/2012-1, PQ 307843/2014-0]; Yaqu Pacha (Germany); Fundacao O Boticario de Protecao a Natureza (Brazil); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil); Cetacean Society International (USA)	Yaqu Pacha; Cetacean Society International; Fundacao O Boticario de Protecao a Natureza; Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Yaqu Pacha (Germany); Fundacao O Boticario de Protecao a Natureza (Brazil); Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil); Cetacean Society International (USA)	ES received support from Yaqu Pacha (http://www.yaqupacha.org/) and the Cetacean Society International (http://csiwhalesalive.org/). ES and KS received support from Fundacao O Boticario de Protecao a Natureza (http://www.fundacaogrupoboticario.org.br/pt/Pages/default.aspx). KS received support from Petrobras (http://sites.petrobras.com.br/ppa2010/home/). JP and ES received funding from Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (http://www.cnpq.br/). JP received a scholarship from CNPq (Process 140638/2012-1). CNPq also provided a Research Fellowship to ES(PQ 307843/2014-0). The funders had role in data collection providing financial support to carried out survey beach.; We are grateful to Dr. Maria Cristina Pinedo and Lic. Hugo P. Castello who initially implemented the Stranding Network in southern Brazil and to all researchers, students and volunteers from Laboratorio de Ecologia e Conservacao da Megafauna Marinha/EcoMega-FURG, Museu Oceanografico Prof. Eliezer C. Rios-FURG and Nucleo de Educacao e Monitoramento Ambiental/NEMA who participated in data collection over these 38 years. Financial support was provided by Yaqu Pacha (Germany), Fundacao O Boticario de Protecao a Natureza (Brazil), Conselho Nacional para Desenvolvimento Cientifico e Tecnologico/CNPq (Brazilian Government), Petrobras (Brazil) and Cetacean Society International (USA). Logistical support was provided by Universidade Federal de Rio Grande (FURG) and NEMA.). We also thank Luciano Dalla Rosa and Randall Reeves for kindly reviewing the manuscript. We are also grateful to Matthieu Authier and three anonymous referees provided useful suggestions to improved the manuscript. This study was part of the Prado's PhD thesis under the supervision of Secchi. Prado received a scholarship from CNPq (Process 140638/2012-1). CNPq also provided a Research Fellowship to E.R.Secchi (PQ 307843/2014-0). This is a contribution of the Research Group 'Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq'.	[Anonymous], SCI REP WHALE RES I; Artico LO, 2010, BRAZ J MED BIOL RES, V43, P816, DOI 10.1590/S0100-879X2010007500074; Authier M, 2014, BIODIVERS CONSERV, V23, P2591, DOI 10.1007/s10531-014-0741-3; Bannister JL, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P80; Bastida R, 2007, MAMIFEROS ACUATICOS; Botta S, 2012, J MAR BIOL ASSOC UK, V92, P1689, DOI 10.1017/S0025315411000610; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Calliari L. J, 1998, ECOSISTEMAS COSTEIRO, P189; Castello H.P., 1977, Natureza em Revista, P40; Castello H.P., 1980, Boletim do Instituto Oceanografico, V29, P91; CASTELLO HP, 1979, J MAMMAL, V60, P429, DOI 10.2307/1379823; Castello HP, 1974, PHYSIS, V86, P371; Castello J.P., 1990, PUB ACIESP, V1-1, P112; Castello J. P, 1998, ECOSSISTEMAS COSTEIR, P189; CEPERG, DES PESC RIO GRAND 1; CIOTTI AM, 1995, CONT SHELF RES, V15, P1737, DOI 10.1016/0278-4343(94)00091-Z; Crespo E.A., 2012, CURRENT STATUS S AM; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; David JHM, 2003, AFR J MAR SCI, V25, P403, DOI 10.2989/18142320309504029; de Moura Jailson Fulgencio, 2012, Marine Biodiversity Records, V5, P1; de Souza RB, 2004, CONT SHELF RES, V24, P241, DOI 10.1016/j.csr.2003.10.001; Di Tullio JC, 2015, ENDANGER SPECIES RES, V29, P35, DOI 10.3354/esr00698; dos Santos RA, 2002, B MAR SCI, V71, P753; dos Santos RA, 2001, FISH RES, V52, P99; Epperly SP, 1996, B MAR SCI, V59, P289; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; FERREIRA EC, 2010, ATLANTICA, V32, P183, DOI DOI 10.5088/atl.2010.32.2.183; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Fire SE, 2011, HARMFUL ALGAE, V10, P330, DOI 10.1016/j.hal.2010.12.001; Fliedler PC, 2002, MAR ECOL PROG SER, V244, P265; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P316; Fruet PF, 2012, J MAR BIOL ASSOC UK, V92, P1865, DOI 10.1017/S0025315410001888; Garrigue C, 1996, MAR MAMMAL SCI, V12, P624; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gianuca N.M., 1976, Scientific Rep Whales Res Inst Tokyo, VNo. 28, P119; GORDON AL, 1989, DEEP-SEA RES, V36, P359, DOI 10.1016/0198-0149(89)90042-3; Greig Antonio B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P157; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Groch Karina R., 2005, Latin American Journal of Aquatic Mammals, V4, P41; HAIMOVICI M, 1994, MAR ECOL PROG SER, V108, P59, DOI 10.3354/meps108059; Haimovici M, 1998, ECOSISTEMAS COSTEIRO, P205; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Harwood J, 1998, NATURE, V393, P17, DOI 10.1038/29877; Hassel Lucas B., 2003, Latin American Journal of Aquatic Mammals, V2, P47; Hofmeyr GJG, 2010, AFR ZOOL, V45, P144, DOI 10.3377/004.045.0112; KAWAMURA A, 1980, SCI REP WHALES RES, V32, P155; Kinas Paul G., 2005, Latin American Journal of Aquatic Mammals, V4, P7; Kinas PG, 2002, B MAR SCI, V70, P409; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Lima ID, 1996, CONT SHELF RES, V16, P1307, DOI 10.1016/0278-4343(95)00066-6; Lodi Liliane, 1998, Bioikos, V12, P29; Lumpkin R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006285; Machado Rodrigo, 2015, Neotropical Biology and Conservation, V10, P43, DOI 10.4013/nbc.2015.101.06; MacLeod Colin D., 2004, Journal of Cetacean Research and Management, V6, P79; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; Moura J.F., 2007, LATIN AM J AQUATIC M, V6, p103 , DOI DOI 10.5597/LAJAM00114; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Oliveira L.R., 2004, THESIS U SAO PAULO; Oliveira LR, 1999, THESIS PONTIFICIA U; Paez E., 2006, BASES CONSERVACION M, P577; Paez E, 2013, EVALUACION RECURSOS, P65; Passadore C, 2015, ICES J MAR SCI, V72, P1637, DOI 10.1093/icesjms/fsu250; Passadore C, 2015, ICES J MAR SCI, V72, P1653, DOI 10.1093/icesjms/fsu251; Pavanato H, 2014, BRAZ J BIOL, V73, P855, DOI 10.1590/S1519-698420130004000023; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Petry Maria V., 2002, Ornitologia Neotropical, V13, P137; Pinedo M. C., 2002, Journal of Cetacean Research and Management, V4, P323; Pinedo M. C., 1999, Journal of Cetacean Research and Management, V1, P179; Pinedo M. C., 1989, ATLANTICA, V11, P85; Pinedo MC, 1990, G ORLA SER ZOOL, V15, P37; Pinedo MC., 2001, ATLANTICA, V23, P67; PINEDO MC, 1987, SCI REP WHALE RES I, V38, P171; PINEDO MC, 1989, ATLANTICA, V11, P77; Piola AR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021638; Piola AR, 2000, J GEOPHYS RES-OCEANS, V105, P6565, DOI 10.1029/1999JC000300; Prado JHF, 2013, ECOL INDIC, V32, P35, DOI 10.1016/j.ecolind.2013.03.005; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; R Core Team, 2018, R LANG ENV STAT COMP; Reeves R. R., 2013, ENDANGER SPECIES RES, V20, P71; Reeves RR, 2008, IUCN 2015 IUCN RED L; Rosa FCW, 1989, ATLANTICA, V11, P109; ROSAS FCW, 1994, MAMMALIA, V58, P51, DOI 10.1515/mamm.1994.58.1.51; Secchi E. R., 2004, LAT AM J AQUAT MAMM, V3, P61, DOI DOI 10.5597/LAJAM00049; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi ER, 2004, SC56SM20 INT WHAL CO; Seyboth E, 2015, MAR MAMMAL SCI, V31, P1521, DOI 10.1111/mms.12241; Sousa L, 2004, SERIE DOCUMENTOS REV; Szephegyi MN, 2010, 14 REUN TRAB EXP MAM; Toledo GAC, 2015, MAR BIODIVERS REC, V8, P1; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Tunez JI, 2008, HYDROBIOLOGIA, V598, P191, DOI 10.1007/s10750-007-9150-x; VOOREN CM, 1998, ECOSSISTEMAS COSTEIR, P157; Ward Eric, 2011, Journal of Cetacean Research and Management, P145; Wojtek B, 2010, SMITHSONIAN, V1000, P13; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113; Zerbini Alexandre N., 1998, Report of the International Whaling Commission, V48, P519; Zerbini NA, 2004, SERIE DOCUMENTOS REV; Zuur A. F., 2014, BEGINNERS GUIDE GEN	108	44	45	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146339	10.1371/journal.pone.0146339	http://dx.doi.org/10.1371/journal.pone.0146339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814667	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200013
J	Gao, Y; Lu, YM; Yi, JM; Li, ZH; Gao, DW; Yu, ZL; Wu, TN; Zhang, CG				Gao, Yan; Lu, Yiming; Yi, Jianming; Li, Zhihui; Gao, Dawen; Yu, Zhoulong; Wu, Tongning; Zhang, Chenggang			A Genome-Wide mRNA Expression Profile in Caenorhabditis elegans under Prolonged Exposure to 1750MHz Radiofrequency Fields	PLOS ONE			English	Article							SHOCK GENE-EXPRESSION; LETHAL HEAT-STRESS; WAVES RF-EMW; ELECTROMAGNETIC-FIELDS; TRANSGENIC NEMATODES; SEMEN PARAMETERS; CELLULAR PHONES; MOBILE PHONE; IN-VITRO; CELLS	Objective C. elegans has been used as a biomonitor for microwave-induced stress. However, the RF (radiofrequency) fields that have been used in previous studies were weak (<= 1.8W/kg), and the bio-effects on C. elegans were mostly negative or ambiguous. Therefore, this study used more intense RF fields (SAR = 3W/kg) and longer time course of exposure (60h at 25 degrees C, L1 stage through adult stage) to investigate the biological consequences of 1750 MHz RF fields in wild-type worms. Methods The growth rates and lifespans of RF-exposure group and the control group were carefully recorded. RNA samples were collected at L4 (35h) and gravid adult (50h) stages for further high-throughput sequencing, focusing on differences between the RF-exposure and the sham control groups. Results The RF-exposed and sham control groups developed at almost the same rate and had similar longevity curves. In L4 stage worms, 94 up-regulated and 17 down-regulated genes were identified, while 186 up-regulated and 3 down-regulated genes were identified in adult stage worms. GO analysis showed that the differentially expressed genes at 35h were associated with growth, body morphogenesis and collagen and cuticle-based development. Genes that were linked to growth rate and reproductive development were differentially expressed at 50h. Some embryonic and larval development genes in the offspring were also differentially expressed at 50h. Ten genes were differentially expressed at both 35h and 50h, most of which were involved in both embryonic and larval developmental processes. Although prolonged RF fields did not induce significant temperature increase in RF exposure groups, the temperature inside worms during exposure was unknown. Conclusions No harmful effects were observed in prolonged exposure to 1750 MHz RF fields at SAR of 3W/kg on development and longevity of C. elegans. Although some differentially expressed genes were found after prolonged RF exposure, these differences were ascribed to oscillating gene expression patterns in L4 and gravid adult worms. It was also difficult to rule out a weak thermal effect caused by prolonged RF exposure inside the worms.	[Gao, Yan; Lu, Yiming; Yi, Jianming; Li, Zhihui; Gao, Dawen; Yu, Zhoulong; Zhang, Chenggang] Beijing Inst Radiat Med, Cognit & Mental Hlth Res Ctr, State Key Lab Prote, State Key Lab Millimeter Wave, Beijing 100850, Peoples R China; [Wu, Tongning] China Acad Telecommun Res, Minist Ind & Informat Technol, 52 Huayuanbei Rd, Beijing 100191, Peoples R China	Academy of Military Medical Sciences - China	Zhang, CG (corresponding author), Beijing Inst Radiat Med, Cognit & Mental Hlth Res Ctr, State Key Lab Prote, State Key Lab Millimeter Wave, Beijing 100850, Peoples R China.; Wu, TN (corresponding author), China Acad Telecommun Res, Minist Ind & Informat Technol, 52 Huayuanbei Rd, Beijing 100191, Peoples R China.	toniwoo@gmail.com; zhangcg@bmi.ac.cn	Wu, Tongning/J-7308-2019; Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	General Program of the Natural Science Foundation of China [31101049, 31401141, 31300703, 81170558, 81573251]; Special Key Program for Science and Technology of China [2012ZX09102301-016, 2012ZX09J12107-03C, 2012AA022402]; General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology [LMB111001]; Program of the State Key Laboratory of Proteomics [SKLP-O201207-WTN, SKLP-Y201303-YML]	General Program of the Natural Science Foundation of China; Special Key Program for Science and Technology of China; General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology; Program of the State Key Laboratory of Proteomics	This work was supported by: 31101049 (YG), 31401141 (YML), 31300703 (YHW), 81170558 (HLL), 81573251 (CSC), the General Program of the Natural Science Foundation of China, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html; 2012ZX09102301-016 (CGZ), 2012ZX09J12107-03C (ZWX), 2012AA022402 (CGZ), the Special Key Program for Science and Technology of China, http://www.most.gov.cn/; LMB111001 (CGZ), the General Program of the Key Laboratory of Tropical Marine Bio-resources and Ecology, http://www.scsio.cas.cn/jgsz/; SKLP-O201207-WTN, SKLP-Y201303-YML, the Program of the State Key Laboratory of Proteomics, http://bprc.biomart.cn/.	Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022; Ahlbom A, 2001, ENVIRON HEALTH PERSP, V109, P911, DOI 10.2307/3454653; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERKS M, 1995, GENOME RES, V5, P99, DOI 10.1101/gr.5.2.99; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cleary SF, 1997, BIOELECTROMAGNETICS, V18, P499, DOI 10.1002/(SICI)1521-186X(1997)18:7<499::AID-BEM5>3.0.CO;2-Y; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Daniells C, 1998, MUTAT RES-FUND MOL M, V399, P55, DOI 10.1016/S0027-5107(97)00266-2; David HE, 2003, ENVIRON TOXICOL CHEM, V22, P111, DOI [10.1897/1551-5028(2003)022&lt;0111:CAEOAT&gt;2.0.CO;2, 10.1002/etc.5620220114]; Dawe AS, 2008, BIOELECTROMAGNETICS, V29, P92, DOI 10.1002/bem.20366; Dawe AS, 2009, BIOELECTROMAGNETICS, V30, P602, DOI 10.1002/bem.20515; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; Eichholz GG, 2002, HEALTH PHYS, V83, P920, DOI 10.1097/00004032-200212000-00021; Feijo C, 2011, HUM REPROD, V26, pI139; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gurisik E, 2006, CELL BIOL INT, V30, P793, DOI 10.1016/j.cellbi.2006.06.001; Gutschi T, 2011, ANDROLOGIA, V43, P312, DOI 10.1111/j.1439-0272.2011.01075.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humans IWGotEoCRt, 2013, IARC MONOGR EVAL CAR, V102, P1; Imai N, 2011, SYST BIOL REPROD MED, V57, P204, DOI 10.3109/19396368.2010.544839; JAUCHEM JR, 1994, J APPL PHYSIOL, V77, P434, DOI 10.1152/jappl.1994.77.1.434; Jauchem JR, 1997, J AUTON PHARMACOL, V17, P165, DOI 10.1046/j.1365-2680.1997.00453.x; Junkersdorf B, 2000, BIOELECTROMAGNETICS, V21, P100, DOI 10.1002/(SICI)1521-186X(200002)21:2<100::AID-BEM4>3.0.CO;2-U; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Laszlo A, 2005, RADIAT RES, V164, P163, DOI 10.1667/RR3406; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Leszczynski D, 2012, PROTEOMICS, V12, P2493, DOI 10.1002/pmic.201200122; Lim HB, 2005, RADIAT RES, V163, P45, DOI 10.1667/RR3264; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margaritis LH, 2014, ELECTROMAGN BIOL MED, V33, P165, DOI 10.3109/15368378.2013.800102; Miyakoshi J, 2005, BIOELECTROMAGNETICS, V26, P251, DOI 10.1002/bem.20077; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Power RS, 1998, J BIOSCIENCES, V23, P513, DOI 10.1007/BF02936145; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tas M, 2014, ELECTROMAGN BIOL MED, V33, P216, DOI 10.3109/15368378.2013.801850; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	44	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147273	10.1371/journal.pone.0147273	http://dx.doi.org/10.1371/journal.pone.0147273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811916	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000026
J	Laghari, S; Niazi, MA				Laghari, Samreen; Niazi, Muaz A.			Modeling the Internet of Things, Self-Organizing and Other Complex Adaptive Communication Networks: A Cognitive Agent-Based Computing Approach	PLOS ONE			English	Article							MULTIAGENT SYSTEMS	Background Computer Networks have a tendency to grow at an unprecedented scale. Modern networks involve not only computers but also a wide variety of other interconnected devices ranging from mobile phones to other household items fitted with sensors. This vision of the "Internet of Things" (IoT) implies an inherent difficulty in modeling problems. Purpose It is practically impossible to implement and test all scenarios for large-scale and complex adaptive communication networks as part of Complex Adaptive Communication Networks and Environments (CACOONS). The goal of this study is to explore the use of Agent-based Modeling as part of the Cognitive Agent-based Computing (CABC) framework to model a Complex communication network problem. Method We use Exploratory Agent-based Modeling (EABM), as part of the CABC framework, to develop an autonomous multi-agent architecture for managing carbon footprint in a corporate network. To evaluate the application of complexity in practical scenarios, we have also introduced a company-defined computer usage policy. Results The conducted experiments demonstrated two important results: Primarily CABC-based modeling approach such as using Agent-based Modeling can be an effective approach to modeling complex problems in the domain of IoT. Secondly, the specific problem of managing the Carbon footprint can be solved using a multi-agent system approach.	[Laghari, Samreen] Islamabad Model Coll Girls, Dept Comp Sci, St 25,F-6-2, Islamabad, Pakistan; [Niazi, Muaz A.] COMSATS Inst IT, Dept Comp Sci, Pk Rd, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Niazi, MA (corresponding author), COMSATS Inst IT, Dept Comp Sci, Pk Rd, Islamabad, Pakistan.	muaz.niazi@ieee.org	Niazi, Muaz/B-7567-2009	Niazi, Muaz/0000-0002-2259-6824				Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], IDC LAUNCH GREEN IT; Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672; Ashton K., 2009, RFID J, V22, P97; Bellifemine F, 1999, P PAAM; Bellifemine F, 1999, JADE A FIPA COMPLIAN; Berriman GB, 2010, E SCI WORKSH 2010 6; Campbell P, 2008, ACS NEWS; Fortino G, 2004, LECT NOTES COMPUT SC, V3187, P213; Friedman-Hill EJ, 1997, DISTRIBUTED COMPUTIN; Gilbert N., 2005, SIMULATION SOCIAL SC; Habib SJ, 2012, INF NETW ICOIN 2012; Habiba U, 2014, COMPLEX ADAPT SYST M, V2, DOI 10.1186/s40294-014-0005-9; Holland J.H., 2012, SIGNALS BOUNDARIES B; Hosseingholizadeh A, 2009, P 2009 SPRING SIM MU; Hui Cindy, 2010, International Journal of Agent Technologies & Systems, V2, P31, DOI 10.4018/jats.2010070103; Hussain A, 2014, COGN COMPUT, V6, P113, DOI 10.1007/s12559-013-9219-y; Huynh N, 2010, P 2010 SPRING SIM MU, P1; Ilarri S, 2009, J NETW COMPUT APPL, V32, P846, DOI 10.1016/j.jnca.2009.01.003; Johnson BJ, 1992, P 1992 ACEEE SUMM ST; Kiparsky M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084946; Laghari S, 2013, CARBON HOT SPOT MANA; Laghari S, 2016, DATA MODELING INTERN; Laghari S, 2015, FRONTIERS INFORM TEC; Lim SR, 2011, ENERGY POLICY; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Mingay S., 2007, G00154085; Moore S., 2010, GARTNER SAYS ENV SUT; Munzi A., 2011, COMPUTERS TURN THEM; Murugesan San, 2008, IT Professional, V10, P24, DOI 10.1109/MITP.2008.10; Niazi Muaz A., 2013, Multiagent System Technologies. 11th German Conference, MATES 2013. Proceedings: LNCS 8076, P361, DOI 10.1007/978-3-642-40776-5_30; Niazi M. A. K, 2011, NOVEL UNIFIED FRAMEW; Niazi MA, 2012, COMP INT MOD SIM CIS; Niazi MA, 2013, COGNITIVE AGENT BASE; Niazi M, 2011, SCIENTOMETRICS, V89, P479, DOI 10.1007/s11192-011-0468-9; Niazi MA, 2015, I SYMP CONSUM ELECTR, P437, DOI 10.1109/ICCE.2015.7066477; Niazi MA, 2013, SIMUL-T SOC MOD SIM, V89, P787, DOI 10.1177/0037549713497714; Niazi MA, 2013, SIMUL-T SOC MOD SIM, V89, P559, DOI 10.1177/0037549713492122; Niazi MA, 2011, IEEE INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS (ICCE 2011), P219, DOI 10.1109/ICCE.2011.5722549; North M.J., 2007, MANAGING BUSINESS CO; Panait L, 2005, AUTON AGENT MULTI-AG, V11, P387, DOI 10.1007/s10458-005-2631-2; Railsback S.F., 2011, AGENT BASED INDIVIDU; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Russell S.J., 2016, ARTIF INTELL; Russell SP, 2010, ARTIFICIAL INTELLIGE; Swartz J., 2009, US TODAY; USGov, 2011, TURN OFF COMP; Vidal, 2006, BOTNICA ORGANOGRAFIA; Vidal JM, 2004, AAMAS WORKSH TEACH M; Weber CL, 2008, ECOL ECON, V66, P379, DOI 10.1016/j.ecolecon.2007.09.021; Wiedmann T, 2007, ISA RESEARCH REPORT, P1; Wilensky U, 2007, NETLOGO 4 0 2 USER M	52	39	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146760	10.1371/journal.pone.0146760	http://dx.doi.org/10.1371/journal.pone.0146760			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812235	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000013
J	White, J; Rehkopf, D; Mortensen, LH				White, James; Rehkopf, David; Mortensen, Laust Hvas			Trends in Socioeconomic Inequalities in Body Mass Index, Underweight and Obesity among English Children, 2007-2008 to 2011-2012	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; CHILDHOOD OBESITY; CARDIOVASCULAR-DISEASE; OVERWEIGHT PREVALENCE; ADOLESCENT HEALTH; RISK-FACTORS; MORTALITY; ADULTHOOD; COUNTRIES; THINNESS	Background Socioeconomic inequalities in childhood obesity have been reported in most developed countries, with obesity more common in deprived groups. Whether inequalities are found in the prevalence of underweight, the rest of the body mass index (BMI) distribution, or have changed across time is not clear. Methods and Findings The sample comprised 5,027,128 children on entry (4 to 5 years old) and leaving (10 to 11 years) state primary (elementary) school who participated in the National Child Measurement Programme (England, United Kingdom). We used area-level deprivation (Indices of Multiple Deprivation at the lower super output area) as a measure of socioeconomic deprivation. From 2007-2008 to 2011-2012 inequalities in obesity between the most compared to least deprived group increased (from 7.21% to 8.30%; p<0.001), whereas inequalities in the prevalence of underweight (1.50% to 1.21%; p = 0.15) were stable during this period. There were no differences by age group or by sex, but a three-way interaction suggested inequalities in obesity had increased at a faster rate for 10 to 11 year old girls, than 4 to 5 year old boys, (2.03% vs 0.07%; p<0.001 for interaction). Investigating inequalities across the distribution of zBMI showed increases in mean zBMI (0.18 to 0.23, p<0.001) could be attributed to increases in inequalities between the 50th and 75th centiles of BMI. Using the 2011 to 2012 population attributable risk estimates, if inequalities were halved, 14.04% (95% CI 14.00% to 14.07%) of childhood obesity could be avoided. Conclusions Socioeconomic inequalities in childhood obesity and zBMI increased in England between 2007-2008 and 2011-2012. Inequalities in the prevalence of underweight did not change. Traditional methods of examining inequalities only at the clinical thresholds of overweight and obesity may have led the magnitude of inequalities in childhood BMI to be underestimated.	[White, James] Cardiff Univ, SEWTU, Cardiff CF10 3AX, S Glam, Wales; [White, James] Cardiff Univ, Ctr Dev & Evaluat Complex Intervent Publ Hlth Imp, Cardiff CF10 3AX, S Glam, Wales; [Rehkopf, David] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mortensen, Laust Hvas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Cardiff University; Cardiff University; Stanford University; University of Copenhagen	White, J (corresponding author), Cardiff Univ, SEWTU, Cardiff CF10 3AX, S Glam, Wales.; White, J (corresponding author), Cardiff Univ, Ctr Dev & Evaluat Complex Intervent Publ Hlth Imp, Cardiff CF10 3AX, S Glam, Wales.	whitej11@cf.ac.uk		White, James/0000-0001-8371-8453; Rehkopf, David/0000-0002-7597-6513	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council [MR/KO232331/1]; Welsh Government; Wellcome Trust; NATIONAL INSTITUTE ON AGING [K01AG047280] Funding Source: NIH RePORTER; Medical Research Council [MR/K023233/1] Funding Source: researchfish; MRC [MR/K023233/1] Funding Source: UKRI	Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a United Kingdom Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambra CL, 2015, NIHR J LIB; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bjornelv S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-279; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; CHARNEY E, 1976, NEW ENGL J MED, V295, P6, DOI 10.1056/NEJM197607012950102; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dinsdale H, 2014504 PUBL HLTH EN; Dinsdale H, 2010, NATL CHILD MEASUREME; El-Sayed AM, 2012, OBESITY FACTS, V5, P671, DOI 10.1159/000343611; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Elgar FJ, 2015, LANCET, V385, P2088, DOI 10.1016/S0140-6736(14)61460-4; Ells LJ, 2015, ARCH DIS CHILD, V100, P631, DOI 10.1136/archdischild-2014-307036; Eriksson M, 2005, ACTA PAEDIATR, V94, P1558, DOI 10.1080/08035250500274926; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Herouvi D, 2013, EUR J PEDIATR, V172, P721, DOI 10.1007/s00431-013-1932-8; Ice CL, 2011, INT J PEDIATR OBES, V6, P113, DOI 10.3109/17477161003792556; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jantti M., 2006, AM EXCEPTIONALISM NE; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kautiainen S, 2009, INT J PEDIATR OBES, V4, P360, DOI 10.3109/17477160902811173; Keane E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-974; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marmot M, 2010, FAIR SOC HLTH LIVES; MARMOT MG, 1986, LANCET, V2, P274; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; NHS Information Centre, 2009, NAT CHILD MEAS PROGR; O'Dea JA, 2010, INT J PUBLIC HEALTH, V55, P185, DOI 10.1007/s00038-009-0079-x; Program Operational Manual (POM), 2014, ON WASH NATL PROGR; Ridler C, 2009, NATL CHILD MEASUREME; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Salanave B, 2009, INT J PEDIATR OBES, V4, P66, DOI 10.1080/17477160902811207; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Sjoberg A, 2008, ACTA PAEDIATR, V97, P118, DOI 10.1111/j.1651-2227.2007.00613.x; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; STUNKARD A, 1972, J AMER MED ASSOC, V221, P579, DOI 10.1001/jama.221.6.579; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; The NHS Information Centre, 2011, NAT CHILD MEAS PROGR; The NHS Information Centre, 2012, NAT CHILD MEAS PROGR; The NHS Information Centre, 2010, NAT CHILD MEAS PROGR; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; World Health Organization (WHO), CRIT LINK INT PHYS G; Yang SM, 2008, AM J PUBLIC HEALTH, V98, P468, DOI 10.2105/AJPH.2007.111609	49	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147614	10.1371/journal.pone.0147614	http://dx.doi.org/10.1371/journal.pone.0147614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812152	Green Published, Green Accepted, gold			2022-12-27	WOS:000369528000044
J	Cobo, T; Viloria, CG; Solares, L; Fontanil, T; Gonzalez-Chamorro, E; De Carlos, F; Cobo, J; Cal, S; Obaya, AJ				Cobo, Teresa; Viloria, Cristina G.; Solares, Laura; Fontanil, Tania; Gonzalez-Chamorro, Elena; De Carlos, Felix; Cobo, Juan; Cal, Santiago; Obaya, Alvaro J.			Role of Periostin in Adhesion and Migration of Bone Remodeling Cells	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT; OSTEOCLAST DIFFERENTIATION; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; MC3T3-E1 CELLS; CANCER CELLS; EXPRESSION; PROLIFERATION; OSTEOBLAST; BREAST	Periostin is an extracellular matrix protein highly expressed in collagen-rich tissues subjected to continuous mechanical stress. Functionally, periostin is involved in tissue remodeling and its altered function is associated to numerous pathological processes. In orthodontics, periostin plays key roles in the maintenance of dental tissues and it is mainly expressed in those areas where tension or pressing forces are taking place. In this regard, high expression of periostin is essential to promote migration and proliferation of periodontal ligament fibroblasts. However little is known about the participation of periostin in migration and adhesion processes of bone remodeling cells. In this work we employ the mouse pre-osteoblastic MC3T3-E1 and the macrophage-like RAW 264.7 cell lines to overexpress periostin and perform different cell-based assays to study changes in cell behavior. Our data indicate that periostin overexpression not only increases adhesion capacity of MC3T3-E1 cells to different matrix proteins but also hampers their migratory capacity. Changes on RNA expression profile of MC3T3-E1 cells upon periostin overexpression have been also analyzed, highlighting the alteration of genes implicated in processes such as cell migration, adhesion or bone metabolism but not in bone differentiation. Overall, our work provides new evidence on the impact of periostin in osteoblasts physiology.	[Cobo, Teresa; Gonzalez-Chamorro, Elena; De Carlos, Felix; Cobo, Juan] Univ Oviedo, Fac Med, Dept Cirugia & Especialidades Med Quirurg, Asturias, Spain; [Viloria, Cristina G.; Solares, Laura; Obaya, Alvaro J.] Univ Oviedo, Fac Med, Dept Biol Func, Asturias, Spain; [Fontanil, Tania; Cal, Santiago] Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Asturias, Spain; [Cal, Santiago; Obaya, Alvaro J.] Univ Oviedo, Fac Med, Inst Univ Oncol IUOPA, Asturias, Spain	University of Oviedo; University of Oviedo; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Obaya, AJ (corresponding author), Univ Oviedo, Fac Med, Dept Biol Func, Asturias, Spain.; Obaya, AJ (corresponding author), Univ Oviedo, Fac Med, Inst Univ Oncol IUOPA, Asturias, Spain.	ajobaya@uniovi.es	COBO DIAZ, TERESA/GZG-8852-2022; Obaya, Alvaro J./AAQ-6115-2021; López, tania Fontanil/AAM-6512-2020	Obaya, Alvaro J./0000-0002-4163-2173; Fontanil, Tania/0000-0003-2261-7661	Fundacion Universidad de Oviedo; Instituto Asturiano de Odontologia; Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain; Instituto de Salud Carlos III (Spain) [FISS PI11/00371]; Fondos FEDER; Obra Social Cajastur	Fundacion Universidad de Oviedo; Instituto Asturiano de Odontologia; Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Fondos FEDER(European Commission); Obra Social Cajastur	This work was supported by Fundacion Universidad de Oviedo and Instituto Asturiano de Odontologia. C.G.V. was financed by Fundacion Universidad de Oviedo and L.S. was a recipient of Beca de Colaboracion from Ministerio de Educacion, Cultura y Deporte of Spain. This work was also partially supported by a grant from the Instituto de Salud Carlos III (Spain) (FISS PI11/00371) and Fondos FEDER. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur.	Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104016; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Dorval-Coiffec I, 2005, BIOL REPROD, V72, P602, DOI 10.1095/biolreprod.104.034892; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Freitas F, 2002, BONE, V30, P99, DOI 10.1016/S8756-3282(01)00625-1; Gillan L, 2002, CANCER RES, V62, P5358; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Gotz W, 2006, EUR J ORAL SCI, V114, P318; Hadjicharalambous C, 2015, J BIOMED MATER RES A, V103, P3834, DOI 10.1002/jbm.a.35527; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Henriquez M, 2011, J CELL SCI, V124, P1581, DOI 10.1242/jcs.073171; Hong LZ, 2010, MOL BIOL REP, V37, P2285, DOI 10.1007/s11033-009-9721-1; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hu LF, 2015, CELL BIOL INT, V39, P364, DOI 10.1002/cbin.10391; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim CJ, 2011, INT J ONCOL, V38, P1759, DOI 10.3892/ijo.2011.997; Ko CH, 2015, CALCIFIED TISSUE INT, V96, P389, DOI 10.1007/s00223-015-9966-8; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Lin W, 2015, J CELL BIOCHEM, DOI [10.1002/jcb.25310, DOI 10.1002/JCB]; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lu SH, 2015, J NAT PROD, V78, P61, DOI 10.1021/np500663y; Lv SY, 2014, J MOL HISTOL, V45, P303, DOI 10.1007/s10735-013-9548-x; Ma DD, 2011, J BIOL CHEM, V286, P4302, DOI 10.1074/jbc.M110.140202; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Moura AP, 2014, BONE, V69, P133, DOI 10.1016/j.bone.2014.09.019; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Padial-Molina M, 2014, J PERIODONTAL RES, V49, P405, DOI 10.1111/jre.12120; Perrier A, 2010, BONE, V47, P23, DOI 10.1016/j.bone.2010.03.010; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sanuki R, 2010, CONNECT TISSUE RES, V51, P150, DOI 10.3109/03008200903168484; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Shen YF, 2010, CELL MOL NEUROBIOL, V30, P909, DOI 10.1007/s10571-010-9520-1; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566; Suzuki H, 2004, ANAT REC PART A, V281A, P1264, DOI 10.1002/ar.a.20080; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Ventura RD, 2015, TISSUE ENG PT A, V21, P2649, DOI [10.1089/ten.TEA.2015.0024, 10.1089/ten.tea.2015.0024]; WARE CB, 1995, DEVELOPMENT, V121, P1283; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Windischhofer W, 2012, BIOCHIMIE, V94, P1997, DOI 10.1016/j.biochi.2012.05.023; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	76	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147837	10.1371/journal.pone.0147837	http://dx.doi.org/10.1371/journal.pone.0147837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809067	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800223
J	Doi, AM; Pignatari, ACC; Edmond, MB; Marra, AR; Camargo, LFA; Siqueira, RA; da Mota, VP; Colombo, AL				Doi, Andre Mario; Campos Pignatari, Antonio Carlos; Edmond, Michael B.; Marra, Alexandre Rodrigues; Aranha Camargo, Luis Fernando; Siqueira, Ricardo Andreotti; da Mota, Vivian Pereira; Colombo, Arnaldo Lopes			Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HISTORICAL TRENDS; PARAPSILOSIS; MULTICENTER; FLUCONAZOLE; CANDIDIASIS; RESISTANCE; HOSPITALS; GLABRATA; YEAST	Candidemia is a growing problem in hospitals all over the world. Despite advances in the medical support of critically ill patients, candidiasis leads to prolonged hospitalization, and has a crude mortality rate around 50%. We conducted a multicenter surveillance study in 16 hospitals distributed across five regions of Brazil to assess the incidence, species distribution, antifungal susceptibility, and risk factors for bloodstream infections due to Candida species. From June 2007 to March 2010, we studied a total of 2,563 nosocomial bloodstream infection (nBSI) episodes. Candida spp. was the 7th most prevalent agent. Most of the patients were male, with a median age of 56 years. A total of 64 patients (46.7%) were in the ICU when candidemia occurred. Malignancies were the most common underlying condition (32%). The crude mortality rate of candidemia during the hospital admission was 72.2%. Non-albicans species of Candida accounted for 65.7% of the 137 yeast isolates. C. albicans (34.3%), Candida parapsilosis (24.1%), Candida tropicalis (15.3%) and Candida glabrata (10.2%) were the most prevalent species. Only 47 out of 137 Candida isolates were sent to the reference laboratory for antifungal susceptibility testing. All C. albicans, C. tropicalis and C. parapsilosis isolates were susceptible to the 5 antifungal drugs tested. Among 11 C. glabrata isolates, 36% were resistant to fluconazole, and 64% SDD. All of them were susceptible to anidulafungin and amphotericin B. We observed that C. glabrata is emerging as a major player among non-albicans Candida spp. and fluconazole resistance was primarily confined to C. glabrata and C. krusei strains. Candida resistance to echinocandins and amphotericin B remains rare in Brazil. Mortality rates remain increasingly higher than that observed in the Northern Hemisphere countries, emphasizing the need for improving local practices of clinical management of candidemia, including early diagnosis, source control and precise antifungal therapy.	[Doi, Andre Mario; Campos Pignatari, Antonio Carlos; Siqueira, Ricardo Andreotti; Colombo, Arnaldo Lopes] Univ Fed Sao Paulo, Dept Med, Div Infect Dis, Sao Paulo, SP, Brazil; [Marra, Alexandre Rodrigues] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, SP, Brazil; [Aranha Camargo, Luis Fernando] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, SP, Brazil; [Edmond, Michael B.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [da Mota, Vivian Pereira] Hosp Sao Paulo, Lab Cent, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; University of Iowa	Colombo, AL (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Infect Dis, Sao Paulo, SP, Brazil.	colomboal@terra.com.br	Colombo, Arnaldo Lopes/H-4397-2012; Colombo, Arnaldo Lopes/V-4417-2019; Pignatari, Antonio CC/C-8427-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Edmond, Michael/0000-0002-4144-8974; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; Pignatari, Antonio/0000-0002-2146-8476	Pfizer, Inc.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/13533-9]	Pfizer, Inc.(Pfizer); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was funded in part by an independent medical grant provided by Pfizer, Inc. Great part was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2010/13533-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ahmed A, 2014, INDIAN J CRIT CARE M, V18, P682, DOI 10.4103/0972-5229.142178; Arendrup MC, 2014, CURR OPIN INFECT DIS, V27, P484, DOI 10.1097/QCO.0000000000000111; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bizerra FC, 2014, ANTIMICROB AGENTS CH, V58, P2438, DOI 10.1128/AAC.02189-13; Brito LR, 2006, MED MYCOL, V44, P261, DOI 10.1080/13693780500421476; Castanheira M, 2014, INT J ANTIMICROB AG, V44, P320, DOI 10.1016/j.ijantimicag.2014.06.007; Chen PY, 2014, J MICROBIOL IMMUNOL, V47, P95, DOI 10.1016/j.jmii.2012.08.025; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, VM27-S4; CLSI, 1908, M27A3 CLSI; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Colombo AL, 2013, MED MYCOL, V51, P38, DOI 10.3109/13693786.2012.698024; Cuenca-Estrella M, 2009, ANTIMICROB AGENTS CH, V53, P2192, DOI 10.1128/AAC.01543-08; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Nucci M, 2013, REV IBEROAM MICOL, V30, P179, DOI [10.1016/j.riam.2013.05.007, 10.1016/j.riam.2013.06.001]; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Pfaller MA, 2010, DIAGN MICROBIOL INFE, V68, P278, DOI DOI 10.1016/J.DIAGMICR0BI0.2010.06.015; Pfaller MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101510; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10; Souza ACR, 2015, ANTIMICROB AGENTS CH, V59, P6581, DOI 10.1128/AAC.01177-15; Wille MP, 2013, MEM I OSWALDO CRUZ, V108, P288, DOI 10.1590/S0074-02762013000300005; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005	31	114	121	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146909	10.1371/journal.pone.0146909	http://dx.doi.org/10.1371/journal.pone.0146909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808778	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800039
J	Hoeksema, L; Los, LI				Hoeksema, Lisette; Los, Leonoor I.			Vision-Related Quality of Life in Patients with Inactive HLA-B27-Associated-Spectrum Anterior Uveitis	PLOS ONE			English	Article							VISUAL FUNCTION QUESTIONNAIRE; STEROID TREATMENT TRIAL; ANKYLOSING-SPONDYLITIS; PSYCHOMETRIC EVALUATION; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; DEPRESSION	We investigated the vision-related quality of life (VR-QOL) in patients with HLA-B27 associated anterior uveitis (AU). The study was conducted in 2012 at the ophthalmology department of the University Medical Center of Groningen. We included AU patients who were HLA-B27 positive and/or were diagnosed by a rheumatologist with an HLA-B27 associated systemic disease. Sixty-one of 123 (50%) adult patients participated. All patients filled-out the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Beck Depression Inventory (BDI-II), social support lists and an additional questionnaire for gathering general information. Medical records were reviewed for clinical characteristics. Analyses were conducted on various patient and ocular characteristics. We compared our NEI VFQ-25 scores with those previously found in the literature. Our main outcome measures were VR-QOL scores and their associations with various general patient and ocular characteristics. We found that the NEI VFQ-25 mean overall composite score was 88.9 +/- 8.8, which is relatively high, but lower than that found in a normal working population. The mean general health score was 47.4 +/- 20.8, which is lower than in patients with other ocular diseases. Patients with a systemic disease scored significantly lower on general health and VR-QOL, compared to patients without a systemic disease. Patients with a depression (6/59 (10%)) frequently had ankylosing spondylitis (5/6 patients) and they scored significantly worse on VR-QOL. We concluded that patients with HLA-B27 associated AU have a relatively high VR-QOL. However, the presence of a systemic disease is associated with lower VR-QOL and general health scores. In addition, depression is associated with a lower VR-QOL.	[Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.; Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands.	l.hoeksema@umcg.nl			Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp	Stichting Nederlands Oogheelkundig Onderzoek; Stichting Blindenhulp	This work was supported by Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Cahill MT, 2005, OPHTHALMOLOGY, V112, P152, DOI 10.1016/j.ophtha.2004.06.036; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Dagfinrud H, 2004, ANN RHEUM DIS, V63, P1605, DOI 10.1136/ard.2003.019224; Davis JC, 2005, ARTHRIT RHEUM-ARTHR, V53, P494, DOI 10.1002/art.21330; Frick KD, 2012, INVEST OPHTH VIS SCI, V53, P1169, DOI 10.1167/iovs.11-8259; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Hoeksema L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085224; Hyphantis T, 2013, CLIN RHEUMATOL, V32, P635, DOI 10.1007/s10067-012-2162-6; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102; Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019; Kuiper JJW, 2013, ACTA OPHTHALMOL, V91, pE329, DOI 10.1111/aos.12054; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Maca SM, 2011, BRIT J OPHTHALMOL, V95, P699, DOI 10.1136/bjo.2009.174839; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2000, NEI VFQ SCORING ALGO; Naik RK, 2013, QUAL LIFE RES, V22, P2801, DOI 10.1007/s11136-013-0412-y; Ovayolu N, 2011, CLIN RHEUMATOL, V30, P655, DOI 10.1007/s10067-010-1604-2; Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Schiffman RM, 2001, ARCH OPHTHALMOL-CHIC, V119, P841	23	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146956	10.1371/journal.pone.0146956	http://dx.doi.org/10.1371/journal.pone.0146956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808922	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800040
J	Johnson, EJ; Zemanick, ET; Accurso, FJ; Wagner, BD; Robertson, CE; Harris, JK				Johnson, Emily J.; Zemanick, Edith T.; Accurso, Frank J.; Wagner, Brandie D.; Robertson, Charles E.; Harris, J. Kirk			Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis	PLOS ONE			English	Article							METHICILLIN-RESISTANT; GENE; FEMA; SENSITIVITY; MANAGEMENT; ALIGNMENT; SPUTUM; SILVA; MECA	Background Staphylococcus aureus is a common and significant pathogen in cystic fibrosis. We sought to determine if quantitative PCR (qPCR) and 16S rRNA gene sequencing could provide a rapid, culture-independent approach to the identification of S. aureus airway infections. Methods We examined the sensitivity and specificity of two qPCR assays, targeting the femA and 16S rRNA gene, using culture as the gold standard. In addition, 16S rRNA gene sequencing to identify S. aureus directly from airway samples was evaluated. DNA extraction was performed with and without prior enzymatic digestion. Results 87 samples [42 oropharyngeal (OP) and 45 expectorated sputum (ES)] were analyzed. 59 samples (68%) cultured positive for S. aureus. Using standard extraction techniques, sequencing had the highest sensitivity for S. aureus detection (85%), followed by FemA qPCR (52%) and 16SrRNA qPCR (34%). For all assays, sensitivity was higher from ES samples compared to OP swabs. Specificity of the qPCR assays was 100%, but 21.4% for sequencing due to detection of S. aureus in low relative abundance from culture negative samples. Enzymatic digestion increased the sensitivity of qPCR assays, particularly for OP swabs. Conclusion Sequencing had a high sensitivity for S. aureus, but low specificity. While femA qPCR had higher sensitivity than 16S qPCR for detection of S. aureus, neither assay was as sensitive as sequencing. The significance of S. aureus detection with low relative abundance by sequencing in culture-negative specimens is not clear.	[Johnson, Emily J.] Univ Colorado, Sch Med, Aurora, CO USA; [Zemanick, Edith T.; Accurso, Frank J.; Wagner, Brandie D.; Harris, J. Kirk] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Harris, JK (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	jonathan.harris@ucdenver.edu	Zemanick, Edith/D-5260-2017	Zemanick, Edith/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121	Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114883] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Cystic Fibrosis Foundation Therapeutics, Inc.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Caverly LJ, 2015, PEDIATR PULM, V50, pS31, DOI 10.1002/ppul.23243; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Deschaght P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; JOHNSON S, 1995, FEMS MICROBIOL LETT, V132, P221, DOI 10.1111/j.1574-6968.1995.tb07837.x; KOBAYASHI N, 1994, EPIDEMIOL INFECT, V113, P259, DOI 10.1017/S0950268800051682; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Mahboubi MA, 2016, J CLIN MICROBIOL, V54, P613, DOI 10.1128/JCM.02299-15; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; van Griethuysen A, 2005, J CLIN MICROBIOL, V43, P1361, DOI 10.1128/JCM.43.3.1361-1365.2005; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	30	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147643	10.1371/journal.pone.0147643	http://dx.doi.org/10.1371/journal.pone.0147643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808658	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800164
J	Kabore, J; Metzger, M; Helmer, C; Berr, C; Tzourio, C; Massy, ZA; Stengel, B				Kabore, Jean; Metzger, Marie; Helmer, Catherine; Berr, Claudine; Tzourio, Christophe; Massy, Ziad A.; Stengel, Benedicte			Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; BLOOD-PRESSURE CONTROL; CLINICAL CHARACTERISTICS; RENAL-DISEASE; PREVALENCE; RISK; POPULATION; EQUATIONS; COMMITTEE; AWARENESS	Background Cross-sectional studies show a strong association between chronic kidney disease and apparent treatment-resistant hypertension, but the longitudinal association of the rate of kidney function decline with the risk of resistant hypertension is unknown. Methods The population-based Three-City included 8,695 participants older than 65 years, 4265 of them treated for hypertension. We estimated the odds ratios (OR) of new-onset apparent treatment-resistant hypertension, defined as blood pressure >= 140/90 mmHg despite use of 3 antihypertensive drug classes or >= 4 classes regardless of blood pressure, associated with the mean estimated glomerular filtration rate (eGFR) level and its rate of decline over 4 years, compared with both controlled hypertension and uncontrolled nonresistant hypertension with <= 2 drugs. GFR was estimated with three different equations. Results Baseline prevalence of apparent treatment-resistant hypertension and of controlled and uncontrolled nonresistant hypertension, were 6.5%, 62.3% and 31.2%, respectively. During follow-up, 162 participants developed apparent treatment-resistant hypertension. Mean eGFR decline with the MDRD equation was 1.5 +/- 2.9 mL/min/1.73m(2) per year: 27.7% of the participants had an eGFR >= 3 and 10.1% >= 5 mL/min/1.73m(2) per year. After adjusting for age, sex, obesity, diabetes, and cardiovascular history, the ORs for new-onset apparent treatment-resistant hypertension associated with a mean eGFR level, per 15 mL/min/1.73m(2) drop, were 1.23 [95% confidence interval 0.91-1.64] compared to controlled hypertension and 1.10 [0.83-1.45] compared to uncontrolled nonresistant hypertension; ORs associated with a decline rate >= 3 mL/min/1.73m(2) per year were 1.89 [1.09-3.29] and 1.99 [1.19-3.35], respectively. Similar results were obtained when we estimated GFR with the CKDEPI and the BIS1 equations. ORs tended to be higher for an eGFR decline rate >= 5 mL/min/1.73m(2) per year. Conclusion The speed of kidney function decline is associated more strongly than kidney function itself with the risk of apparent treatment-resistant hypertension in the elderly.	[Kabore, Jean; Metzger, Marie; Massy, Ziad A.; Stengel, Benedicte] INSERM, U1018, CESP, Villejuif, France; [Kabore, Jean; Metzger, Marie; Stengel, Benedicte] Univ Paris Saclay, Univ Paris Sud, Villejuif, France; [Kabore, Jean] IRSS Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Helmer, Catherine; Tzourio, Christophe] INSERM, Epidemiol Biostat U897, Bordeaux, France; [Helmer, Catherine; Tzourio, Christophe] Univ Bordeaux, Bordeaux, France; [Helmer, Catherine] Clin Invest Ctr Clin Epidemiol, Bordeaux, France; [Berr, Claudine] INSERM, U1061, Montpellier, France; [Berr, Claudine] Univ Montpellier I, Montpellier, France; [Massy, Ziad A.] Ambroise Pare Univ Hosp, Div Nephrol, Boulogne Billancourt, France; [Massy, Ziad A.] Univ Paris Ouest UVSQ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre Muraz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Kabore, J (corresponding author), INSERM, U1018, CESP, Villejuif, France.; Kabore, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Villejuif, France.; Kabore, J (corresponding author), IRSS Ctr Muraz, Bobo Dioulasso, Burkina Faso.	jean.kabore@inserm.fr	berr, Claudine/D-5238-2014; Tzourio, christophe/B-4015-2009; Tzourio, christophe/L-6344-2019; HELMER, Catherine/AAG-5126-2021; HELMER, Catherine/I-6581-2015; Stengel, Benedicte/G-5730-2015; Metzger, Marie/K-9772-2018	berr, Claudine/0000-0001-5254-7655; Tzourio, christophe/0000-0002-6517-2984; Tzourio, christophe/0000-0002-6517-2984; HELMER, Catherine/0000-0002-5169-7421; Stengel, Benedicte/0000-0001-9469-0804; Metzger, Marie/0000-0003-3597-5409; Kabore, Jean/0000-0002-4038-813X	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Agence Nationale de la Recherche (ANR); French-speaking Society of Nephrology; French Ministry of Research	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French-speaking Society of Nephrology; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The Three-City Study was conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Fondation Plan Alzheimer partly funded the follow-up of the study. The 3C Study was also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques". The study also received a grant from the Agence Nationale de la Recherche (ANR). The CKD ancillary study at the 4-year follow-up was granted by the French-speaking Society of Nephrology. Jean Kabore was supported by a research grant from the French Ministry of Research. No donors played a role in the design and the conduct of the study.; The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Fondation Plan Alzheimer partly funded the follow-up of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques". The study also received a grant from the Agence Nationale de la Recherche (ANR). The CKD ancillary study at the 4-year follow-up was funded by the French-speaking Society of Nephrology. No donors played a role in the design and the conduct of the study. Jean Kabore is supported by a research grant from the French Ministry of Research. We thank Jo-Ann Cahn for editing the English version.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Brambilla G, 2013, J HYPERTENS, V31, P2018, DOI 10.1097/HJH.0b013e328363823f; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; Brindel P, 2006, J HYPERTENS, V24, P51, DOI 10.1097/01.hjh.0000198028.84353.86; Cai GY, 2013, J AM GERIATR SOC, V61, P2160, DOI 10.1111/jgs.12551; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi SW, 2014, J HUM HYPERTENS, V28, P201, DOI 10.1038/jhh.2013.76; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Galton F., 1886, J ANTHR I, V15, P246, DOI 10.2307%2F2841583; Gijon-Conde T, 2014, REV ESP CARDIOL, V67, P270, DOI 10.1016/j.rec.2013.09.027; Iyer AS, 2010, J AM SOC HYPERTENS, V4, P22, DOI 10.1016/j.jash.2010.02.002; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kestenbaum B, 2008, ANN INTERN MED, V148, P501, DOI 10.7326/0003-4819-148-7-200804010-00006; Koppe L, 2013, J NEPHROL, V26, P716, DOI 10.5301/jn.5000297; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; Muntner P, 2014, HYPERTENSION, V64, P1012, DOI 10.1161/HYPERTENSIONAHA.114.03850; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Roy L, 2013, KIDNEY INT, V84, P570, DOI 10.1038/ki.2013.103; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Sim JJ, 2013, MAYO CLIN PROC, V88, P1099, DOI 10.1016/j.mayocp.2013.06.017; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Tanner RM, 2013, CLIN J AM SOC NEPHRO, V8, P1583, DOI 10.2215/CJN.00550113; Tonelli M, 2002, NEPHROL DIAL TRANSPL, V17, P1426, DOI 10.1093/ndt/17.8.1426; Viazzi F, 2014, NEPHROL DIAL TRANSPL, P1; Vidal-Petiot E, 2014, AM J KIDNEY DIS, V63, P865, DOI 10.1053/j.ajkd.2014.01.421; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Xu H, 2014, NEPHROL DIAL TRANSPL, V29, P1538, DOI 10.1093/ndt/gfu057	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146056	10.1371/journal.pone.0146056	http://dx.doi.org/10.1371/journal.pone.0146056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807712	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800015
J	Morganti, JM; Riparip, LK; Rosi, S				Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna			Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MACROPHAGE ACTIVATION; ALTERNATIVE ACTIVATION; CEREBRAL-CORTEX; WHITE-MATTER; SPINAL-CORD; MOUSE MODEL; IN-VIVO; INFLAMMATION; PARADIGM	Following the primary mechanical impact, traumatic brain injury (TBI) induces the simultaneous production of a variety of pro-and anti-inflammatory molecular mediators. Given the variety of cell types and their requisite expression of cognate receptors this creates a highly complex inflammatory milieu. Increasingly in neurotrauma research there has been an effort to define injury-induced inflammatory responses within the context of in vitro defined macrophage polarization phenotypes, known as "M1" and "M2". Herein, we expand upon our previous work in a rodent model of TBI to show that the categorization of inflammatory response cannot be so easily delineated using this nomenclature. Specifically, we show that TBI elicited a wide spectrum of concurrent expression responses within both pro-and anti-inflammatory arms. Moreover, we show that the cells principally responsible for the production of these inflammatory mediators, microglia/macrophages, simultaneously express both "M1" and "M2" phenotypic markers. Overall, these data align with recent reports suggesting thatmicroglia/macrophages cannot adequately switch to a polarized "M1-only" or "M2-only" phenotype, but display a mixed phenotype due to the complex signaling events surrounding them.	[Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA.	susanna.rosi@ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	National Institute Of Neurological Disorders And Stroke; National Institute on Aging of the National Institutes of Health [F32NS090805, R21NS087458, R21AG042016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087458, F32NS090805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042016] Funding Source: NIH RePORTER	National Institute Of Neurological Disorders And Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers F32NS090805 (J.M.M.), R21NS087458 (S.R.); R21AG042016 (S.R.).	Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	44	142	145	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148001	10.1371/journal.pone.0148001	http://dx.doi.org/10.1371/journal.pone.0148001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808663	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800262
J	Munoz-Gutierrez, JF; Pierle, SA; Schneider, DA; Baszler, TV; Stanton, JB				Munoz-Gutierrez, Juan F.; Pierle, Sebastian Aguilar; Schneider, David A.; Baszler, Timothy V.; Stanton, James B.			Transcriptomic Determinants of Scrapie Prion Propagation in Cultured Ovine Microglia	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; NATURAL SCRAPIE; DENDRITIC CELLS; SELENOPROTEIN P; LYMPHOID-TISSUE; NEURONAL CELLS; MESSENGER-RNA; MOUSE MODELS; EXPRESSION; PROTEIN	Susceptibility to infection by prions is highly dependent on the amino acid sequence and host expression of the cellular prion protein (PrPC); however, cellular expression of a genetically susceptible PrPC is insufficient. As an example, it has been shown in cultured cells that permissive and resistant sublines derived from the same parental population often have similar expression levels of PrPC. Thus, additional cellular factors must influence susceptibility to prion infection. The aim of this study was to elucidate the factors associated with relative permissiveness and resistance to scrapie prions in cultured cells derived from a naturally affected species. Two closely related ovine microglia clones with different prion susceptibility, but no detectable differences in PrPC expression levels, were inoculated with either scrapie-positive or scrapie-negative sheep brainstem homogenates. Five passages post-inoculation, the transcriptional profiles of mock and infected clones were sequenced using Illumina technology. Comparative transcriptional analyses identified twenty-two differentially transcribed genes, most of which were upregulated in poorly permissive microglia. This included genes encoding for selenoprotein P, endolysosomal proteases, and proteins involved in extracellular matrix remodeling. Furthermore, in highly permissive microglia, transforming growth factor beta-induced, retinoic acid receptor response 1, and phosphoserine aminotranspherase 1 gene transcripts were upregulated. Gene Set Enrichment Analysis identified proteolysis, translation, and mitosis as the most affected pathways and supported the upregulation trend of several genes encoding for intracellular proteases and ribosomal proteins in poorly permissive microglia. This study identifies new genes potentially involved in scrapie prion propagation, corroborates results from other studies, and extends those results into another cell culture model.	[Munoz-Gutierrez, Juan F.; Pierle, Sebastian Aguilar; Schneider, David A.; Baszler, Timothy V.] Washington State Univ, Coll Vet Med, Dept Pathol & Microbiol, Pullman, WA 99164 USA; [Schneider, David A.] USDA, Agr Res Serv, Pullman, WA USA; [Stanton, James B.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Munoz-Gutierrez, Juan F.] Univ Wyoming, Dept Vet Sci, Laramie, WY USA; [Pierle, Sebastian Aguilar] Inst Pasteur, Unite Plasticite Genome Bacterien, Dept Genomes & Genet, Paris, France	Washington State University; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University of Wyoming; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Stanton, JB (corresponding author), Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA.; Munoz-Gutierrez, JF (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY USA.	juan.munoz@uwyo.edu; jbs@uga.edu	Stanton, James/A-5277-2011; Gutiérrez, Juan Muñoz/F-6626-2019; Schneider, David/A-2833-2010	Stanton, James/0000-0002-7661-2631; Schneider, David/0000-0001-9659-6731	United States Department of Agriculture, Agricultural Research Service [5348-32000-030-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, Agricultural Research Service (5348-32000-030-00D).	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bellinger FP, 2008, J ALZHEIMERS DIS, V15, P465; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Brown CA, 2014, HUM MOL GENET, V23, P5102, DOI 10.1093/hmg/ddu233; Budhia S, 2006, J IMMUNOL METHODS, V309, P160, DOI 10.1016/j.jim.2005.12.006; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Carroll JA, 2015, J VIROL, V89, P2388, DOI 10.1128/JVI.02952-14; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Du XB, 2014, INORG CHEM, V53, P11221, DOI 10.1021/ic501788v; El Kochairi I, 2006, MOL VIS, V12, P461; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Filali H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-59; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Goold R, 2013, J CELL SCI, V126, P3552, DOI 10.1242/jcs.120477; Gossner A, 2011, VET MICROBIOL, V153, P218, DOI 10.1016/j.vetmic.2011.05.036; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Huzarewich RLCH, 2011, J TOXICOL ENV HEAL A, V74, P1504, DOI 10.1080/15287394.2011.618979; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Marbiah MM, 2014, EMBO J, V33, P1527, DOI 10.15252/embj.201387150; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Munoz-Gutierrez JF, 2015, VIRUS RES, V198, P35, DOI 10.1016/j.virusres.2014.10.028; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Parakalan R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-64; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierle SA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-669; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Stanton JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051173; Stanton JB, 2009, BIOCHEM BIOPH RES CO, V386, P345, DOI 10.1016/j.bbrc.2009.06.030; Tanaka H, 2012, SCI REP, P2; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yam GHF, 2012, INVEST OPHTH VIS SCI, V53, P5890, DOI 10.1167/iovs.11-9068; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147727	10.1371/journal.pone.0147727	http://dx.doi.org/10.1371/journal.pone.0147727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807844	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800198
J	Pirhonen, J; Arola, J; Sadevirta, S; Luukkonen, P; Karppinen, SM; Pihlajaniemi, T; Isomaki, A; Hukkanen, M; Yki-Jarvinen, H; Ikonen, E				Pirhonen, Juho; Arola, Johanna; Sadevirta, Sanja; Luukkonen, Panu; Karppinen, Sanna-Maria; Pihlajaniemi, Taina; Isomaki, Antti; Hukkanen, Mika; Yki-Jarvinen, Hannele; Ikonen, Elina			Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MICROSCOPY; SYSTEMS	Background and Aims Early detection of fibrosis is important in identifying individuals at risk for advanced liver disease in non-alcoholic fatty liver disease (NAFLD). We tested whether second-harmonic generation (SHG) and coherent anti-Stokes Raman scattering (CARS) microscopy, detecting fibrillar collagen and fat in a label-free manner, might allow automated and sensitive quantification of early fibrosis in NAFLD. Methods We analyzed 32 surgical biopsies from patients covering histological fibrosis stages 0-4, using multimodal label-free microscopy. Native samples were visualized by SHG and CARS imaging for detecting fibrillar collagen and fat. Furthermore, we developed a method for quantitative assessment of early fibrosis using automated analysis of SHG signals. Results We found that the SHG mean signal intensity correlated well with fibrosis stage and the mean CARS signal intensity with liver fat. Little overlap in SHG signal intensities between fibrosis stages 0 and 1 was observed. A specific fibrillar SHG signal was detected in the liver parenchyma outside portal areas in all samples histologically classified as having no fibrosis. This signal correlated with immunohistochemical location of fibrillar collagens I and III. Conclusions This study demonstrates that label-free SHG imaging detects fibrillar collagen deposition in NAFLD more sensitively than routine histological staging and enables observer-independent quantification of early fibrosis in NAFLD with continuous grading.	[Pirhonen, Juho; Isomaki, Antti; Hukkanen, Mika; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Arola, Johanna] Univ Helsinki, Dept Pathol, Fac Med, Helsinki, Finland; [Sadevirta, Sanja; Luukkonen, Panu; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Fac Med, Helsinki, Finland; [Arola, Johanna] HUSLAB, Dept Pathol, Helsinki, Finland; [Pirhonen, Juho; Sadevirta, Sanja; Luukkonen, Panu; Yki-Jarvinen, Hannele; Ikonen, Elina] Minerva Fdn, Helsinki, Finland; [Karppinen, Sanna-Maria; Pihlajaniemi, Taina] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu	Pirhonen, J (corresponding author), Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.; Pirhonen, J (corresponding author), Minerva Fdn, Helsinki, Finland.	juho.pirhonen@helsinki.fi		Ikonen, Elina/0000-0001-8382-1135; Karppinen, Sanna/0000-0001-6233-9075; Pihlajaniemi, Taina/0000-0002-1664-9045; Luukkonen, Panu/0000-0003-2085-679X; Isomaki, Antti/0000-0001-8059-0714	Academy of Finland [131489, 263841, 272130, 251314, 259872]; European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF) [115372]; Sigrid Juselius; Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant); Novo Nordisk Foundation	Academy of Finland(Academy of Finland); European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF); Sigrid Juselius(Sigrid Juselius Foundation); Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was financially supported by the Academy of Finland (EI grants 131489, 263841, 272130; TP grant 251314; S-MK grant 259872, HYJ), European Union/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Joint Undertaking (European Medical Information Framework EMIF grant no. 115372, HYJ), the Sigrid Juselius (EI, TP, HYJ), Special governmental subsidy for health sciences research (EVO, Helsinki University Central Hospital grant, HYJ) and the Novo Nordisk Foundation (HYJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulanandan Ahilan, 2015, Curr Hepatol Rep, V14, P109; Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; DOYLE W, 1962, J ACM, V9, P259, DOI 10.1145/321119.321123; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gailhouste L, 2010, J HEPATOL, V52, P398, DOI 10.1016/j.jhep.2009.12.009; Galli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110295; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Nakano M, 2005, HEPATOL RES, V33, P110, DOI 10.1016/j.hepres.2005.09.016; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Wells RG., 2007, TXB HEPATOLOGY, P264; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Xu SY, 2014, J HEPATOL, V61, P260, DOI 10.1016/j.jhep.2014.02.015; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Zumbusch A, 2013, PROG LIPID RES, V52, P615, DOI 10.1016/j.plipres.2013.07.003	25	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147804	10.1371/journal.pone.0147804	http://dx.doi.org/10.1371/journal.pone.0147804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808140	gold, Green Published			2022-12-27	WOS:000369527800214
J	Rong, YJ; Lu, XJ; Chen, J				Rong, Ye-Jing; Lu, Xin-Jiang; Chen, Jiong			Molecular Characterization of E-Type Prostanoid Receptor 4 (EP4) from Ayu (Plecoglossus altivelis) and Its Functional Analysis in the Monocytes/Macrophages	PLOS ONE			English	Article							PROSTAGLANDIN E-2; PROINFLAMMATORY CYTOKINE; EXPRESSION ANALYSIS; RESPIRATORY BURST; IL-1-BETA GENE; SALMO-SALAR; CYCLIC-AMP; MACROPHAGES; ACTIVATION; MECHANISMS	Prostaglandin E2 (PGE2) plays an important role in a broad spectrum of physiological and pathological processes by interacting with E-type prostanoid receptors (EPs). EP4 is one of four EP subtypes known to mediate the immune response in mammalian monocytes/macrophages. However, the precise function and characteristics of EP4 in fish remain unclear. In this study, we characterized a novel EP4-like (PaEP4L) gene from ayu, Plecoglossus altivelis. The cDNA sequence of PaEP4L is 2781 nucleotides (nts) in length, encoding a polypeptide of 459 amino acid residues with a calculated molecular weight of 51.17 kDa. Sequence comparison and phylogenetic tree analysis showed that PaEP4L shared 76% amino acid identity with that of the Atlantic salmon (Salmo salar). PaEP4L mRNA was detected by real-time quantitative PCR (QPCR) in all tested tissues and head kidney-derived monocytes/macrophages (MO/M Phi). It varied greatly in liver, spleen and MO/M. upon Vibrio anguillarum infection. Western blot analysis revealed a significant increase of PaEP4L in cell homogenates from ayu MO/M Phi upon V. anguillarum infection. Moreover, anti-PaEP4L IgG reversed the down-regulation of interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha) mRNA expression as well as phagocytosis in ayu MO/M Phi caused by PGE2. There were no significant differences in the respiratory burst response between PGE2 treated and untreated cells. We further found that cAMP mediated PGE2/PaEP4L signal in ayu MO/M Phi. In conclusion, our results indicate that PaEP4L mediates PGE2 effects on ayu MO/M Phi function, revealing that EP4 also plays a role in the modulation of cells of the fish's innate immune system.	[Rong, Ye-Jing; Lu, Xin-Jiang; Chen, Jiong] Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Jiong] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine Higheffici, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo 315211, Zhejiang, Peoples R China.; Chen, J (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine Higheffici, Ningbo 315211, Zhejiang, Peoples R China.	jchen1975@163.com		rong, yejing/0000-0002-9423-3002	Program for the National Natural Science Foundation of China [31372555, 31472300]; Zhejiang Provincial Natural Science Foundation of China [LZ13C190001]; Scientific Research Foundation of the Graduate School of Ningbo University [G15009]; KC Wong Magna Fund in Ningbo University	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Scientific Research Foundation of the Graduate School of Ningbo University; KC Wong Magna Fund in Ningbo University	This study was supported by the Program for the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (31372555, 31472300), Zhejiang Provincial Natural Science Foundation of China (http://www.zjnsf.gov.cn/) (LZ13C190001), the Scientific Research Foundation of the Graduate School of Ningbo University (http://www.nbu.edu.cn/) (G15009), and the KC Wong Magna Fund in Ningbo University (http://www.nbu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2008, MOL IMMUNOL, V45, P543, DOI 10.1016/j.molimm.2007.05.019; Beck-Speier I, 2001, ENVIRON HEALTH PERSP, V109, P613, DOI 10.2307/3454679; Bo YX, 2015, FISH SHELLFISH IMMUN, V46, P584, DOI 10.1016/j.fsi.2015.07.024; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Chadzinska M, 2014, DEV COMP IMMUNOL, V47, P68, DOI 10.1016/j.dci.2014.07.008; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; de Pablo MA, 2000, IMMUNOL CELL BIOL, V78, P31, DOI 10.1046/j.1440-1711.2000.00875.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gamil AAA, 2015, DEV COMP IMMUNOL, V48, P143, DOI 10.1016/j.dci.2014.09.013; Gonzalez-Stegmaier R, 2015, FISH SHELLFISH IMMUN, V47, P239, DOI 10.1016/j.fsi.2015.09.016; Guo TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120483; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; HUANG CF, 1995, BIOCHEM J, V307, P493, DOI 10.1042/bj3070493; HURME M, 1990, FEBS LETT, V263, P35, DOI 10.1016/0014-5793(90)80699-J; Jiang YS, 2015, MOL IMMUNOL, V66, P216, DOI 10.1016/j.molimm.2015.03.014; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Li Changhong, 2009, Weishengwu Xuebao, V49, P931; LIMAS C, 1984, ARCH BIOCHEM BIOPHYS, V233, P32, DOI 10.1016/0003-9861(84)90598-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XJ, 2013, FISH SHELLFISH IMMUN, V34, P1253, DOI 10.1016/j.fsi.2013.02.009; Lu XJ, 2013, FISH SHELLFISH IMMUN, V34, P497, DOI 10.1016/j.fsi.2012.11.047; Lu XJ, 2013, J EXP MED, V210, P5, DOI 10.1084/jem.20121466; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; McDonald PP, 1999, J IMMUNOL, V163, P6164; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ottonello L, 1996, CLIN EXP IMMUNOL, V106, P97, DOI 10.1046/j.1365-2249.1996.d01-804.x; Qu FF, 2015, FISH SHELLFISH IMMUN, V42, P316, DOI 10.1016/j.fsi.2014.11.023; Rieger AM, 2011, DEV COMP IMMUNOL, V35, P1238, DOI 10.1016/j.dci.2011.03.009; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Rogers LM, 2014, AM J REPROD IMMUNOL, V71, P34, DOI 10.1111/aji.12153; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SELDON PM, 1995, MOL PHARMACOL, V48, P747; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; SOTTILE A, 1995, IMMUNOPHARM IMMUNOT, V17, P311, DOI 10.3109/08923979509019753; Stillman BA, 1998, EUR J PHARMACOL, V357, P73, DOI 10.1016/S0014-2999(98)00522-6; Takahashi HK, 2002, J IMMUNOL, V168, P4446, DOI 10.4049/jimmunol.168.9.4446; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Tsuge K, 2013, BIOCHEM BIOPH RES CO, V436, P685, DOI 10.1016/j.bbrc.2013.06.017; Wu Jun, 2015, Zoological Research, V36, P133; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zhou QJ, 2014, J MICROBIOL METH, V104, P26, DOI 10.1016/j.mimet.2014.06.008	52	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147884	10.1371/journal.pone.0147884	http://dx.doi.org/10.1371/journal.pone.0147884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809077	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800237
J	Wang, Z; Ji, L; Hou, XY; Schellenberg, MP				Wang, Zhen; Ji, Lei; Hou, Xiangyang; Schellenberg, Michael P.			Soil Respiration in Semiarid Temperate Grasslands under Various Land Management	PLOS ONE			English	Article							CARBON-DIOXIDE FLUXES; PRECIPITATION PULSES; CO2 EFFLUX; INTERANNUAL VARIABILITY; NITROGEN-FERTILIZATION; HABITAT FRAGMENTATION; TALLGRASS PRAIRIE; RESPONSES; TOPOGRAPHY; BIOMASS	Soil respiration, a major component of the global carbon cycle, is significantly influenced by land management practices. Grasslands are potentially a major sink for carbon, but can also be a source. Here, we investigated the potential effect of land management (grazing, clipping, and ungrazed enclosures) on soil respiration in the semiarid grassland of northern China. Our results showed the mean soil respiration was significantly higher under enclosures (2.17 mu mol.m(-2).s(-1)) and clipping (2.06 mu mol.m(-2).s(-1)) than under grazing (1.65 mu mol.m(-2).s(-1)) over the three growing seasons. The high rates of soil respiration under enclosure and clipping were associated with the higher belowground net primary productivity (BNPP). Our analyses indicated that soil respiration was primarily related to BNPP under grazing, to soil water content under clipping. Using structural equation models, we found that soil water content, aboveground net primary productivity (ANPP) and BNPP regulated soil respiration, with soil water content as the predominant factor. Our findings highlight that management-induced changes in abiotic (soil temperature and soil water content) and biotic (ANPP and BNPP) factors regulate soil respiration in the semiarid temperate grassland of northern China.	[Wang, Zhen; Ji, Lei; Hou, Xiangyang] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot 010010, Peoples R China; [Schellenberg, Michael P.] AAFC AAC, SPARC, Box 1030, Swift Current, SK S9H 3X2, Canada	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Hou, XY (corresponding author), Chinese Acad Agr Sci, Grassland Res Inst, Hohhot 010010, Peoples R China.	Houxy16@126.com			National Key Basic Research Development Program of China [2014CB138806]; International Science and Technology Cooperation Project of China [2013DFR30760]; Natural Science Foundation Committee of Inner Mongolia [ZD201502]; National Science Foundation for Young Scientists of China [41401264]; Natural Science Foundation of Inner Mongolia [2015BS0330]; National Natural Science Foundation of China [D010503]	National Key Basic Research Development Program of China(National Basic Research Program of China); International Science and Technology Cooperation Project of China; Natural Science Foundation Committee of Inner Mongolia; National Science Foundation for Young Scientists of China; Natural Science Foundation of Inner Mongolia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Key Basic Research Development Program of China (2014CB138806), the International Science and Technology Cooperation Project of China (2013DFR30760), Natural Science Foundation Committee of Inner Mongolia (program no. ZD201502), National Science Foundation for Young Scientists of China (41401264), Natural Science Foundation of Inner Mongolia (2015BS0330), the Program of the National Natural Science Foundation of China (D010503).	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; Carbone F, 2008, P NATL ACAD SCI USA, V105, P20161, DOI 10.1073/pnas.0811335106; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Chen Z., 2000, TYPICAL STEPPE ECOSY; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2002, BIOGEOCHEMISTRY, V59, P303, DOI 10.1023/A:1016019728665; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Emmerich WE, 2003, AGR FOREST METEOROL, V116, P91, DOI 10.1016/S0168-1923(02)00231-9; Frank AB, 2002, SOIL BIOL BIOCHEM, V34, P1235, DOI 10.1016/S0038-0717(02)00062-7; Franzluebbers K, 2002, SOIL SCI SOC AM J, V66, P254, DOI 10.2136/sssaj2002.0254; Gallo ME, 2009, SOIL BIOL BIOCHEM, V41, P1433, DOI 10.1016/j.soilbio.2009.03.025; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hoffmann C, 2008, J ARID ENVIRON, V72, P792, DOI 10.1016/j.jaridenv.2007.09.004; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Inglima I, 2009, GLOBAL CHANGE BIOL, V15, P1289, DOI 10.1111/j.1365-2486.2008.01793.x; IUSS-Working-Group-WRB, 2006, WORLD REF BAS SOIL R; Jia BR, 2009, SOIL BIOL BIOCHEM, V41, P681, DOI 10.1016/j.soilbio.2008.12.030; Jia XX, 2012, AGR FOREST METEOROL, V166, P32, DOI 10.1016/j.agrformet.2012.05.022; Joshi J, 2006, OECOLOGIA, V148, P144, DOI 10.1007/s00442-005-0341-8; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Lal R, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P249; LeCain DR, 2002, AGR ECOSYST ENVIRON, V93, P421, DOI 10.1016/S0167-8809(01)00290-0; Li GY, 2011, ECOL RES, V26, P497, DOI 10.1007/s11284-011-0806-7; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Lin Y, 2010, AGR ECOSYST ENVIRON, V138, P282, DOI 10.1016/j.agee.2010.05.013; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; Lu XT, 2015, PLANT SOIL, V387, P69, DOI 10.1007/s11104-014-2282-7; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; Maestre FT, 2003, APPL SOIL ECOL, V23, P199, DOI 10.1016/S0929-1393(03)00050-7; Metcalfe DB, 2011, BIOGEOSCIENCES, V8, P2047, DOI 10.5194/bg-8-2047-2011; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Scholes RJ, 2009, TRENDS ECOL EVOL, V24, P427, DOI 10.1016/j.tree.2009.03.006; Steingrobe B, 2000, J PLANT NUTR SOIL SC, V163, P617, DOI 10.1002/1522-2624(200012)163:6<617::AID-JPLN617>3.0.CO;2-0; Thomas AD, 2011, GEODERMA, V167-68, P284, DOI 10.1016/j.geoderma.2011.07.034; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang W, 2009, GLOBAL PLANET CHANGE, V67, P20, DOI 10.1016/j.gloplacha.2008.12.011; Wilsey BJ, 2002, ECOL LETT, V5, P367, DOI 10.1046/j.1461-0248.2002.00322.x; Wu M.L, 2010, STRUCTURAL EQUATION; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Xu X, 2015, GLOBAL CHANGE BIOL, V21, P3846, DOI 10.1111/gcb.12940; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yang YS, 2007, PLANT ECOL, V193, P71, DOI 10.1007/s11258-006-9249-6; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	55	18	21	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147987	10.1371/journal.pone.0147987	http://dx.doi.org/10.1371/journal.pone.0147987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808376	Green Published, gold			2022-12-27	WOS:000369527800258
J	Berrondo, C; Flax, J; Kucherov, V; Siebert, A; Osinski, T; Rosenberg, A; Fucile, C; Richheimer, S; Beckham, CJ				Berrondo, Claudia; Flax, Jonathan; Kucherov, Victor; Siebert, Aisha; Osinski, Thomas; Rosenberg, Alex; Fucile, Christopher; Richheimer, Samuel; Beckham, Carla J.			Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLES; CELL-PROLIFERATION; DIAGNOSTIC MARKER; POOR-PROGNOSIS; UP-REGULATION; BIOMARKERS; TUMOR; INVASION; METASTASIS	Exosomes are 30-150nM membrane-bound secreted vesicles that are readily isolated from biological fluids such as urine (UEs). Exosomes contain proteins, micro RNA (miRNA), messenger RNA (mRNA), and long non-coding RNA (lncRNA) from their cells of origin. Although miRNA, protein and lncRNA have been isolated from serum as potential biomarkers for benign and malignant disease, it is unknown if lncRNAs in UEs from urothelial bladder cancer (UBC) patients can serve as biomarkers. lncRNAs are > 200 nucleotide long transcripts that do not encode protein and play critical roles in tumor biology. As the number of recognized tumor-associated lncRNAs continues to increase, there is a parallel need to include lncRNAs into biomarker discovery and therapeutic target algorithms. The lncRNA HOX transcript antisense RNA (HOTAIR) has been shown to facilitate tumor initiation and progression and is associated with poor prognosis in several cancers. The importance of HOTAIR in cancer biology has sparked interest in using HOTAIR as a biomarker and potential therapeutic target. Here we show HOTAIR and several tumor-associated lncRNAs are enriched in UEs from UBC patients with high-grade muscle-invasive disease (HGMI pT2pT4). Knockdown of HOTAIR in UBC cell lines reduces in vitro migration and invasion. Importantly, loss of HOTAIR expression in UBC cell lines alters expression of epithelial-to-mesenchyme transition (EMT) genes including SNAI1, TWIST1, ZEB1, ZO1, MMP1 LAMB3, and LAMC2. Finally, we used RNA-sequencing to identify four additional lncRNAs enriched in UBC patient UEs. These data, suggest that UE-derived lncRNA may potentially serve as biomarkers and therapeutic targets.	[Berrondo, Claudia; Flax, Jonathan; Richheimer, Samuel; Beckham, Carla J.] Univ Rochester, Dept Urol, Strong Mem Hosp Rochester, New York, NY USA; [Kucherov, Victor; Siebert, Aisha; Osinski, Thomas] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Rosenberg, Alex; Fucile, Christopher] Univ Rochester, Div Rheumatol & Immunol, Strong Mem Hosp Rochester, New York, NY USA	University of Rochester; University of Rochester; University of Rochester	Beckham, CJ (corresponding author), Univ Rochester, Dept Urol, Strong Mem Hosp Rochester, New York, NY USA.	carla_beckham@urmc.rochester.edu	Siebert, Aisha/AAI-7374-2021; Siebert, Aisha/AAF-3411-2020	Siebert, Aisha/0000-0001-6954-9163; 	CTSI at the University of Rochester [5UL1TR000042-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	CTSI at the University of Rochester; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CTSI at the University of Rochester 5UL1TR000042-09.	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Alvarez S, 2013, TRANSPL P, V45, P3719, DOI 10.1016/j.transproceed.2013.08.079; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Armstrong DA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0466-2; Arscott W Tristram, 2011, Biomark Med, V5, P822; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Batagov AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S18; Beckham CJ, 2014, J UROLOGY, V192, P583, DOI 10.1016/j.juro.2014.02.035; Borges FT, 2013, BRAZ J MED BIOL RES, V46, P824, DOI 10.1590/1414-431X20132964; Caivano A, 2015, TUMOR BIOL, V36, P9739, DOI 10.1007/s13277-015-3741-3; Cha DJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07197; Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dijkstra S, 2014, J UROLOGY, V191, P1132, DOI 10.1016/j.juro.2013.11.001; Doose G, 2015, P NATL ACAD SCI USA, V112, pE5261, DOI 10.1073/pnas.1505753112; Duan R, 2015, ONCOTARGET, V6, P27778, DOI 10.18632/oncotarget.4813; Duijvesz D, 2015, INT J CANCER, V137, P2869, DOI 10.1002/ijc.29664; Eissa S, 2015, TUMOR BIOL, V36, P9545, DOI 10.1007/s13277-015-3722-6; Eissa S, 2015, BIOMARKERS, V20, P212, DOI 10.3109/1354750X.2015.1062918; Erdbrugger U, 2016, J AM SOC NEPHROL, V27, P12, DOI 10.1681/ASN.2015010074; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Heubach J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0371-8; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Huebner AR, 2015, ADV EXP MED BIOL, V845, P43, DOI 10.1007/978-94-017-9523-4_5; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Kishikawa T, 2015, WORLD J GASTROENTERO, V21, P8527, DOI 10.3748/wjg.v21.i28.8527; Kladi-Skandali A, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/319861; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Lee H, 2012, PEDIATR NEPHROL, V27, P317, DOI 10.1007/s00467-011-2035-2; Lewis JM, 2015, EXPERT REV MOL DIAGN, V15, P1187, DOI 10.1586/14737159.2015.1069709; Li Q, 2015, TUMOR BIOL, V36, P2007, DOI 10.1007/s13277-014-2807-y; Li SJ, 2015, AM J TRANSL RES, V7, P1390; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu Y, 2015, TOXICOL APPL PHARM, V282, P9, DOI 10.1016/j.taap.2014.10.022; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Martinez-Fernandez M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0141-x; Matsui Y, 2012, INT J CANCER, V130, P521, DOI 10.1002/ijc.26008; Matullo G, 2016, INT J CANCER, V138, P2334, DOI 10.1002/ijc.29895; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ostenfeld MS, 2014, CANCER RES, V74, P5758, DOI 10.1158/0008-5472.CAN-13-3512; Peng P, 2011, ONCOL REP, V25, P749, DOI 10.3892/or.2010.1119; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Real FX, 2014, EUR UROL, V66, P4, DOI 10.1016/j.eururo.2014.03.028; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Sawek S, 2016, TUMOR BIOL, V37, P4241, DOI 10.1007/s13277-015-4407-x; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Street JM, 2014, J UROLOGY, V192, P297, DOI 10.1016/j.juro.2014.05.050; Sun M, 2016, HISTOL HISTOPATHOL, V31, P33, DOI 10.14670/HH-11-655; Sun X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.269; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang JT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0148-8; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Xu ZY, 2013, INT J BIOL SCI, V9, P587, DOI 10.7150/ijbs.6339; Yan TH, 2014, TUMOR BIOL, V35, P10249, DOI 10.1007/s13277-014-2344-8; Yang QQ, 2014, INT J CLIN EXP PATHO, V7, P1286; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Zhang L, 2015, BREAST CANCER RES TR, V152, P199, DOI 10.1007/s10549-015-3431-2; Zhang ZZ, 2015, MOL CANCER THER, V14, P1162, DOI 10.1158/1535-7163.MCT-14-0695; Zhao H, 2013, J CELL BIOCHEM, V114, P2375, DOI 10.1002/jcb.24586; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206; Zhou L, 2016, TUMOR BIOL, V37, P15583, DOI 10.1007/s13277-015-4138-z; Zhu HX, 2015, BIOCHEM BIOPH RES CO, V467, P223, DOI 10.1016/j.bbrc.2015.10.002	92	189	205	7	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147236	10.1371/journal.pone.0147236	http://dx.doi.org/10.1371/journal.pone.0147236			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800519	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300078
J	Lee, WY; Do, JT; Park, C; Kim, JH; Chung, HJ; Kim, KW; Gil, CH; Kim, NH; Song, H				Lee, Won-Young; Do, Jeong Tae; Park, Chankyu; Kim, Jin Hoi; Chung, Hak-Jae; Kim, Kyung-Woon; Gil, Chang-Hyun; Kim, Nam-Hyung; Song, Hyuk			Identification of Putative Biomarkers for the Early Stage of Porcine Spermatogonial Stem Cells Using Next-Generation Sequencing	PLOS ONE			English	Article							IN-VITRO CULTURE; LIPOPOLYSACCHARIDE LPS; UNDIFFERENTIATED SPERMATOGONIA; EXTRACELLULAR-MATRIX; GERM-CELLS; RNA-SEQ; RECEPTOR; MOUSE; INSULIN; TESTIS	To identify putative biomarkers of porcine spermatogonial stem cells (pSSCs), total RNA sequencing (RNA-seq) analysis was performed on 5- and 180-day-old porcine testes and on pSSC colonies that were established under low temperature culture conditions as reported previously. In total, 10,184 genes were selected using Cufflink software, followed by a logarithm and quantile normalization of the pairwise scatter plot. The correlation rates of pSSCs compared to 5- and 180-day-old testes were 0.869 and 0.529, respectively and that between 5-and 180-day-old testes was 0.580. Hierarchical clustering data revealed that gene expression patterns of pSSCs were similar to 5-day-old testis. By applying a differential expression filter of four fold or greater, 607 genes were identified between pSSCs and 5-day-old testis, and 2118 genes were identified between the 5-and 180-day-old testes. Among these differentially expressed genes, 293 genes were upregulated and 314 genes were downregulated in the 5-day-old testis compared to pSSCs, and 1106 genes were upregulated and 1012 genes were downregulated in the 180-day-old testis compared to the 5-day-old testis. The following genes upregulated in pSSCs compared to 5-day-old testes were selected for additional analysis: matrix metallopeptidase 9 (MMP9), matrix metallopeptidase 1 (MMP1), glutathione peroxidase 1 (GPX1), chemokine receptor 1 (CCR1), insulin-like growth factor binding protein 3 (IGFBP3), CD14, CD209, and Kruppel-like factor 9 (KLF9). Expression levels of these genes were evaluated in pSSCs and in 5- and 180-day-old porcine testes. In addition, immunohistochemistry analysis confirmed their germ cell-specific expression in 5-and 180-day-old testes. These finding may not only be useful in facilitating the enrichment and sorting of porcine spermatogonia, but may also be useful in the study of the early stages of spermatogenic meiosis.	[Lee, Won-Young] Konkuk Univ, Coll Biomed & Hlth Sci, Res Inst Biomed & Hlth Sci, Dept Food Biosci, Chungju 380701, South Korea; [Do, Jeong Tae; Park, Chankyu; Kim, Jin Hoi; Song, Hyuk] Konkuk Univ, Dept Anim Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea; [Chung, Hak-Jae; Kim, Kyung-Woon] RDA, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun 565851, South Korea; [Gil, Chang-Hyun] Konkuk Univ, Sch Med, 1 Hwayang Dong, Seoul 143701, South Korea; [Kim, Nam-Hyung] Chungbuk Natl Univ, Coll Agr, Dept Anim Sci, Choung Ju 361763, South Korea	Konkuk University; Konkuk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Konkuk University; Konkuk University Medical Center; Chungbuk National University	Song, H (corresponding author), Konkuk Univ, Dept Anim Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	songh@konkuk.ac.kr	Kim, Kyung-Woon/F-7287-2018; Park, Chankyu/D-8775-2011	Kim, Kyung-Woon/0000-0003-0225-9684; Park, Chankyu/0000-0003-4855-2210; Do, Jeong Tae/0000-0001-6721-1441; kim, jin-hoi/0000-0003-1232-5307	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea [PJ011076]	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea	This study was supported by grant PJ011076 from the Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea.	Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513; Bang P, 1997, ENDOCRINOLOGY, V138, P3912, DOI 10.1210/en.138.9.3912; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Goel S, 2007, BIOL REPROD, V77, P127, DOI 10.1095/biolreprod.106.056879; Hirai H, 2014, CLIN EXP METASTAS, V31, P977, DOI 10.1007/s10585-014-9684-z; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kempisty Bartosz, 2006, Ginekol Pol, V77, P238; Kim YH, 2013, J ANIM SCI, V91, P3143, DOI 10.2527/jas.2012-6139; Krishnan P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1899-0; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Lee KH, 2013, REPROD DOMEST ANIM, V48, P954, DOI 10.1111/rda.12193; Lee WY, 2014, ANIM REPROD SCI, V150, P115, DOI 10.1016/j.anireprosci.2014.09.010; Lee WY, 2013, STEM CELL RES, V11, P1234, DOI 10.1016/j.scr.2013.08.008; Longin J, 2001, J CELL SCI, V114, P2125; Luke L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3359; Luo JP, 2006, MOL REPROD DEV, V73, P1531, DOI 10.1002/mrd.20529; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neerincx M, 2015, ONCOGENESIS, V4, pe170; Ohta H, 2000, DEVELOPMENT, V127, P2125; Orwig KE, 2008, STEM CELLS, V26, P927, DOI 10.1634/stemcells.2007-0893; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Prensner JR, 2014, LANCET ONCOL, V15, P1469, DOI 10.1016/S1470-2045(14)71113-1; Rajah Roopa, 1995, Progress in Growth Factor Research, V6, P273, DOI 10.1016/0955-2235(95)00012-7; Robinson LLL, 2001, MOL HUM REPROD, V7, P641, DOI 10.1093/molehr/7.7.641; Rodrigues A, 2008, BIOL REPROD, V79, P1135, DOI 10.1095/biolreprod.108.069930; Ryser S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-29; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Siu MKY, 2008, ADV EXP MED BIOL, V636, P74, DOI 10.1007/978-0-387-09597-4_5; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; SODER O, 1992, ENDOCRINOLOGY, V131, P2344, DOI 10.1210/en.131.5.2344; Sykorova V, 2015, ANTICANCER RES, V35, P2029; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; VANNELLI BG, 1988, FERTIL STERIL, V49, P666; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang XY, 2015, INT J MOL SCI, V16, P26333, DOI 10.3390/ijms161125958; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yoon MJ, 2010, ANIM REPROD SCI, V122, P353, DOI 10.1016/j.anireprosci.2010.10.001; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	59	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147298	10.1371/journal.pone.0147298	http://dx.doi.org/10.1371/journal.pone.0147298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800048	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300089
J	Veltmann, M; Hollborn, M; Reichenbach, A; Wiedemann, P; Kohen, L; Bringmann, A				Veltmann, Moritz; Hollborn, Margrit; Reichenbach, Andreas; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas			Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							NACL-INDUCED ACTIVATION; VITREORETINAL PROLIFERATIVE DISEASE; TRANSCRIPTION FACTOR TONEBP/OREBP; OXYGEN SPECIES CONTRIBUTE; PATHOGENIC T(H)17 CELLS; MACULAR DEGENERATION; HB-EGF; GENE-EXPRESSION; RISK-FACTORS; AGE	Background Although systemic hypertension is a risk factor of age-related macular degeneration, antihypertensive medications do not affect the risk of the disease. One condition that induces hypertension is high intake of dietary salt resulting in increased blood osmolarity. In order to prove the assumption that, in addition to hypertension, high osmolarity may aggravate neovascular retinal diseases, we determined the effect of extracellular hyperosmolarity on the expression of angiogenic cytokines in cultured human retinal pigment epithelial (RPE) cells. Methodology/Principal Findings Hyperosmolarity was induced by the addition of 100 mM NaCI or sucrose to the culture medium. Hypoxia and oxidative stress were induced by the addition of the hypoxia mimetic CoCl2 and H2O2, respectively. Alterations in gene expression were determined with realtime RT-PCR. Secretion of bFGF was evaluated by ELISA. Cell viability was determined by trypan blue exclusion. Nuclear factor of activated T cell 5 (NFAT5) expression was knocked down with siRNA. Hyperosmolarity induced transcriptional activation of bFGF, HB-EGF, and VEGF genes, while the expression of other cytokines such as EGF, PDGF-A, TGF-01, HGF, and PEDF was not or moderately altered. Hypoxia induced increased expression of the HB-EGF, EGF, PDGF-A, TGF-01, and VEGF genes, but not of the bFGF gene. Oxidative stress induced gene expression of HB-EGF, but not of bFGF. The hyperosmotic expression of the bFGF gene was dependent on the activation of p38a/0 MAPK, JNK, P13K, and the transcriptional activity of NFAT5. The hyperosmotic expression of the HB-EGF gene was dependent on the activation of p38a/0 MAPK, ERK1/2, and JNK. The hyperosmotic expression of bFGF, HB-EGF, and VEGF genes was reduced by inhibitors of TGF-01 superfamily activin receptor-like kinase receptors and the FGF receptor kinase, respectively. Hyperosmolarity induced secretion of bFGF that was reduced by inhibition of autocrine/paracrine TGF-01 signaling and by NFAT5 siRNA, respectively. Hyperosmolarity decreased the viability of the cells; this effect was not altered by exogenous bFGF and HBEGF. Various vegetable polyphenols (luteolin, quercetin, apigenin) inhibited the hyperosmotic expression of bFGF, HB-EGF, and NFAT5 genes. Conclusion Hyperosmolarity induces transcription of bFGF and HB-EGF genes, and secretion of bFGF from RPE cells. This is in part mediated by autocrine/paracrine TGF-131 and FGF signaling. It is suggested that high intake of dietary salt resulting in osmotic stress may aggravate neovascular retinal diseases via stimulation of the production of angiogenic factors in RPE cells, independent of hypertension.	[Veltmann, Moritz; Hollborn, Margrit; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Veltmann, Moritz; Hollborn, Margrit; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany; [Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kohen, Leon] Helios Klinikum Aue, Aue, Germany	Leipzig University; Leipzig University; Leipzig University; Helios Kliniken	Hollborn, M (corresponding author), Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany.; Hollborn, M (corresponding author), Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany.	hollbm@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017		Deutsche Forschungsgemeinschaft [KO 1547/7-1, GRK 1097/1, RE 849/16-1]; Geschwister Freter Stiftung (Hannover, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Geschwister Freter Stiftung (Hannover, Germany)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 1547/7-1 to L.K.; GRK 1097/1, RE 849/16-1, to A.R.) and the Geschwister Freter Stiftung (Hannover, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Asakawa H, 1996, CELL BIOCHEM FUNCT, V14, P181; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chen R, 2014, MOL VIS, V20, P242; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Granner T, 2013, BRIT J OPHTHALMOL, V97, P371, DOI 10.1136/bjophthalmol-2012-302002; Guillonneau X, 1997, EXP CELL RES, V233, P198, DOI 10.1006/excr.1997.3542; Harnett ME, 1999, INVEST OPHTH VIS SCI, V40, P2945; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Hollborn M, 2005, MOL VIS, V11, P397; Hollborn M, 2004, GRAEF ARCH CLIN EXP, V242, P414, DOI 10.1007/s00417-004-0879-x; Hollborn M, 2006, CURR EYE RES, V31, P863, DOI 10.1080/02713680600888807; Hollborn M, 2015, MOL VIS, V21, P360; Hollborn M, 2009, INVEST OPHTH VIS SCI, V50, P4452, DOI 10.1167/iovs.08-3194; Hollborn MR, 2004, LAB INVEST, V84, P963, DOI 10.1038/labinvest.3700121; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Inoue Y, 2013, INVEST OPHTH VIS SCI, V54, P3815, DOI 10.1167/iovs.12-11236; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Izumi Y, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12000; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Kawasaka K, 1977, JPN J OPHTHALMOL, V31, P23; Kenney WL, 2001, MED SCI SPORT EXER, V33, P1524, DOI 10.1097/00005768-200109000-00016; KHAW KT, 1988, CIRCULATION, V77, P53, DOI 10.1161/01.CIR.77.1.53; Kippenberger S, 2005, FEBS LETT, V579, P207, DOI 10.1016/j.febslet.2004.11.077; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Koh YH, 2001, J BIOCHEM-TOKYO, V130, P351, DOI 10.1093/oxfordjournals.jbchem.a002993; Kuper C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00293; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Obika Lf O, 2013, Niger J Physiol Sci, V28, P83; Orgul S, 1993, Ger J Ophthalmol, V2, P436; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Park SW, 2012, INVEST OPHTH VIS SCI, V53, P7718, DOI 10.1167/iovs.11-8790; Peng PH, 2008, EXP EYE RES, V86, P637, DOI 10.1016/j.exer.2008.01.008; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Schlingemann RO, 2009, PROG BRAIN RES, V175, P253, DOI 10.1016/S0079-6123(09)17517-9; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SHIRAO Y, 1987, INVEST OPHTH VIS SCI, V28, P2015; Silva KC, 2013, INVEST OPHTH VIS SCI, V54, P1325, DOI 10.1167/iovs.12-10647; Sivakumar V, 2008, J NEUROSCI RES, V86, P702, DOI 10.1002/jnr.21519; SOUBRANE G, 1994, CURR EYE RES, V13, P183, DOI 10.3109/02713689408995776; Steinberg R. H., 1985, PROGR RETINAL RES, P33, DOI 10.1016/0278-4327(85)90004-5; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; Wang H, 2015, AM J PHYSIOL-RENAL, V308, pF140, DOI 10.1152/ajprenal.00471.2014; Weuste M, 2006, BIOCHEM BIOPH RES CO, V347, P310, DOI 10.1016/j.bbrc.2006.06.077; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yan Q, 2001, IN VITRO CELL DEV-AN, V37, P45; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	69	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147312	10.1371/journal.pone.0147312	http://dx.doi.org/10.1371/journal.pone.0147312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800359	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300092
J	Palmerini, CA; Mazzoni, M; Radicioni, G; Marzano, V; Granieri, L; Iavarone, F; Longhi, R; Messana, I; Cabras, T; Sanna, MT; Castagnola, M; Vitali, A				Palmerini, Carlo Alberto; Mazzoni, Michela; Radicioni, Giorgia; Marzano, Valeria; Granieri, Letizia; Iavarone, Federica; Longhi, Renato; Messana, Irene; Cabras, Tiziana; Sanna, Maria Teresa; Castagnola, Massimo; Vitali, Alberto			Antagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer Cells	PLOS ONE			English	Article							MEMBRANE COMPONENT 1; HUMAN BREAST-CANCER; ALPHA MPR-ALPHA; PGRMC1 PROTEIN; SH3 DOMAIN; RECEPTOR; EXPRESSION; BINDING; IDENTIFICATION; FAMILY	A salivary proline-rich peptide of 1932 Da showed a dose-dependent antagonistic effect on the cytosolic Ca2+ mobilization induced by progesterone in a tongue squamous carcinoma cell line. Structure-activity studies showed that the activity of the peptide resides in the C-terminal region characterized by a proline stretch flanked by basic residues. Furthermore, lack of activity of the retro-inverso peptide analogue suggested the involvement of stereospecific recognition. Mass spectrometry-based shotgun analysis, combined with Western blotting tests and biochemical data obtained with the Progesterone Receptor Membrane Component 1 (PGRMC1) inhibitor AG205, showed strong evidence that p1932 performs its modulatory action through an interaction with the progesterone receptor PGRMC1, which is predominantly expressed in this cell line and, clearly, plays a role in progesterone induced Ca2+ response. Thus, our results point to p1932 as a modulator of the transduction signal pathway mediated by this protein and, given a well-established involvement of PGRMC1 in tumorigenesis, highlight a possible therapeutic potential of p1932 for the treatment of oral cancer.	[Palmerini, Carlo Alberto; Mazzoni, Michela; Granieri, Letizia] Dipartimento Sci Agr Alimentari & Ambiental, Unit Ric Biochim & Biol Mol, Perugia, Italy; [Radicioni, Giorgia; Marzano, Valeria; Iavarone, Federica; Castagnola, Massimo] Catholic Univ, Fac Med, Ist Biochim & Biochim Clin, Rome, Italy; [Longhi, Renato] Italian Natl Res Council, Ist Chim Riconoscimento Mol, Milan, Italy; [Messana, Irene; Cabras, Tiziana; Sanna, Maria Teresa] Cittadella Univ, Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Castagnola, Massimo; Vitali, Alberto] Italian Natl Res Council, Ist Chim Riconoscimento Mol, Rome, Uos Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Vitali, A (corresponding author), Italian Natl Res Council, Ist Chim Riconoscimento Mol, Rome, Uos Rome, Italy.	alberto.vitali@icrm.cnr.it	Messana, Irene/L-2478-2019; Iavarone, Federica/K-6446-2016; Granieri, Letizia/AAC-2644-2019; Cabras, Tiziana/AAF-6231-2020; Vitali, Alberto/F-3667-2017; Castagnola, Massimo/AAB-2825-2019; Castagnola, Massimo/AAM-6355-2021; Marzano, Valeria/K-5770-2016	Messana, Irene/0000-0002-1436-6105; Iavarone, Federica/0000-0002-2074-5531; Vitali, Alberto/0000-0001-9828-4117; Castagnola, Massimo/0000-0002-0959-7259; Marzano, Valeria/0000-0001-6364-2121	Nando Peretti Foundation; Catholic University of Rome; Cagliari University; MIUR; FaReBio dQ CNR project; Regione Sardegna	Nando Peretti Foundation; Catholic University of Rome; Cagliari University; MIUR(Ministry of Education, Universities and Research (MIUR)); FaReBio dQ CNR project; Regione Sardegna(Regione Sardegna)	This work was supported by Nando Peretti Foundation, Catholic University of Rome, Cagliari University, MIUR and Regione Sardegna according to their programs of scientific diffusion. The work was also supported by FaReBio dQ 2012 CNR project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate C, 2015, EUR J PHARMACOL, V758, P16, DOI 10.1016/j.ejphar.2015.03.067; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Baron AC, 1999, ORAL DIS, V5, P234, DOI 10.1111/j.1601-0825.1999.tb00307.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Cao R, 2012, J PROTEOME RES, V11, P829, DOI 10.1021/pr200677z; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Falkenstein E, 1999, ENDOCRINOLOGY, V140, P5999, DOI 10.1210/en.140.12.5999; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fernandes MS, 2008, STEROIDS, V73, P942, DOI 10.1016/j.steroids.2007.12.004; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Franz M, 2006, HISTOCHEM CELL BIOL, V126, P125, DOI 10.1007/s00418-005-0126-5; Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Huang YS, 2014, MED RES REV, V34, P532, DOI 10.1002/med.21297; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kimura I, 2012, CURR PROTEIN PEPT SC, V13, P687, DOI 10.2174/138920312804142110; Koulen P, 2008, CELL PHYSIOL BIOCHEM, V21, P161, DOI 10.1159/000113758; Kulasekara KK, 2009, ARCH ORAL BIOL, V54, P924, DOI 10.1016/j.archoralbio.2009.07.004; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Losel RM, 2008, FRONT NEUROENDOCRIN, V29, P258, DOI 10.1016/j.yfrne.2007.09.002; Lukits J, 2007, INT J ONCOL, V30, P155; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Migliaccio A, 2012, STEROIDS, V77, P974, DOI 10.1016/j.steroids.2012.01.014; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Peluso JJ, 2011, STEROIDS, V76, P903, DOI 10.1016/j.steroids.2011.02.011; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Radicioni G, 2015, BBA-BIOMEMBRANES, V1848, P2868, DOI 10.1016/j.bbamem.2015.08.019; Riva A, 2000, EUR J MORPHOL, V38, P219, DOI 10.1076/0924-3860(200010)38:4;1-O;FT219; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Ruan X, 2012, CLIMACTERIC, V15, P467, DOI 10.3109/13697137.2011.648232; Sekine S, 2004, MICROBIOL-SGM, V150, P2373, DOI 10.1099/mic.0.27107-0; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomas P, 2014, ENDOCRINOLOGY, V155, P1107, DOI 10.1210/en.2013-1991; van Waarde A, 2015, BBA-BIOMEMBRANES, V1848, P2703, DOI 10.1016/j.bbamem.2014.08.022; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	54	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147925	10.1371/journal.pone.0147925	http://dx.doi.org/10.1371/journal.pone.0147925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814504	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200064
J	Cools, P; Jespers, V; Hardy, L; Crucitti, T; Delany-Moretlwe, S; Mwaura, M; Ndayisaba, GF; van de Wijgert, JHHM; Vaneechoutte, M				Cools, Piet; Jespers, Vicky; Hardy, Liselotte; Crucitti, Tania; Delany-Moretlwe, Sinead; Mwaura, Mary; Ndayisaba, Gilles F.; van de Wijgert, Janneke H. H. M.; Vaneechoutte, Mario			A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; MULTIPLEX PCR ASSAY; LOWER GENITAL-TRACT; PREGNANT-WOMEN; BACTERIAL VAGINOSIS; CERVICAL ECTOPY; AFRICAN WOMEN; ANTIMICROBIAL RESISTANCE; INTRAUTERINE-DEVICE; SAMPLING TECHNIQUES	Background One million neonates die each year in low- and middle-income countries because of neonatal sepsis; group B Streptococcus (GBS) and Escherichia coli are the leading causes. In sub-Saharan Africa, epidemiological data on vaginal GBS and E. coli carriage, a prerequisite for GBS and E. coli neonatal sepsis, respectively, are scarce but necessary to design and implement prevention strategies. Therefore, we assessed vaginal GBS and E. coli carriage rates and risk factors and the GBS serotype distribution in three sub-Saharan countries. Methods A total of 430 women from Kenya, Rwanda and South Africa were studied cross-sectionally. Vaginal carriage of GBS and E. coli, and GBS serotype were assessed using molecular techniques. Risk factors for carriage were identified using multivariable logistic regression analysis. Results Vaginal carriage rates in reference groups from Kenya and South Africa were 20.2% (95% CI, 13.7-28.7%) and 23.1%(95% CI, 16.2-31.9%), respectively for GBS; and 25.0% (95% CI, 17.8-33.9%) and 27.1%(95% CI, 19.6-36.2%), respectively for E. coli. GBS serotypes Ia (36.8%), V (26.3%) and III (14.0%) were most prevalent. Factors independently associated with GBS and E. coli carriage were Candida albicans, an intermediate vaginal microbiome, bacterial vaginosis, recent vaginal intercourse, vaginal washing, cervical ectopy and working as a sex worker. GBS and E. coli carriage were positively associated. Conclusions Reduced vaginal GBS carriage rates might be accomplished by advocating behavioral changes such as abstinence from sexual intercourse and by avoidance of vaginal washing during late pregnancy. It might be advisable to explore the inclusion of vaginal carriage of C. albicans, GBS, E. coli and of the presence of cervical ectopy in a risk- and/or screening-based administration of antibiotic prophylaxis. Current phase II GBS vaccines (a trivalent vaccine targeting serotypes Ia, Ib, and III, and a conjugate vaccine targeting serotype III) would not protect the majority of women against carriage in our study population.	[Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Dept Microbiol Immunol & Clin Chem, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Jespers, Vicky; Hardy, Liselotte] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Mwaura, Mary] ICRH Kenya, Mombasa, Kenya; [Ndayisaba, Gilles F.] Rinda Ubuzima, Kigali, Rwanda; [van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England	Ghent University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Witwatersrand; University of Liverpool	Vaneechoutte, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Microbiol Immunol & Clin Chem, Lab Bacteriol Res, B-9000 Ghent, Belgium.	mario.vaneechoutte@ugent.be	Crucitti, Tania/AAB-9967-2019; Hardy, Liselotte/AAF-3515-2019; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAH-1902-2021; Vaneechoutte, Mario/A-6189-2009	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Vaneechoutte, Mario/0000-0002-4586-203X; Cools, Piet/0000-0003-2980-5307; Hardy, Liselotte/0000-0002-8785-5081; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European & Developing Countries Clinical Trials Partnership [IP_2007_33070_001]	European & Developing Countries Clinical Trials Partnership	The project was funded by the European & Developing Countries Clinical Trials Partnership (IP_2007_33070_001, http://www.edctp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Afshar B, 2011, J CLIN MICROBIOL, V49, P1475, DOI 10.1128/JCM.02365-10; Anderson S, 2013, AM J OBSTET GYNECOL, V208, pS326, DOI 10.1016/j.ajog.2012.10.115; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; BAKER CJ, 1975, AM J OBSTET GYNECOL, V122, P820, DOI 10.1016/0002-9378(75)90721-8; BAKER CJ, 1977, J INFECT DIS, V135, P392, DOI 10.1093/infdis/135.3.392; Bayo M., 2002, International Microbiology, V5, P87, DOI 10.1007/s10123-002-0064-1; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Beigi RH, 2004, OBSTET GYNECOL, V104, P926, DOI 10.1097/01.AOG.0000140687.51048.73; Bergh K, 2004, INDIAN J MED RES, V119, P221; Brigtsen AK, 2015, J MICROBIOL METH, V108, P31, DOI 10.1016/j.mimet.2014.11.001; Capan M, 2012, WIEN KLIN WOCHENSCHR, V124, P14, DOI 10.1007/s00508-012-0239-5; Chase DJ, 2007, J CLIN MICROBIOL, V45, P1219, DOI 10.1128/JCM.02156-06; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Convert M, 2005, CLIN MICROBIOL INFEC, V11, P1022, DOI 10.1111/j.1469-0691.2005.01275.x; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DAVIDPRINCE M, 1991, B SOC PATHOL EXOT, V84, P522; Davies HD, 2004, CLIN INFECT DIS, V39, P1129, DOI 10.1086/424518; DAWODU AH, 1983, TROP GEOGR MED, V35, P145; De Luca Brunori I., 1994, Clinical and Experimental Obstetrics and Gynecology, V21, P105; de Steenwinkel FDO, 2008, TROP MED INT HEALTH, V13, P427, DOI 10.1111/j.1365-3156.2008.02018.x; Dzowela T, 2005, MALAWI MED J, V17, P97, DOI 10.4314/mmj.v17i3.10888; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; EKWEMPU CC, 1981, J CLIN PATHOL, V34, P82, DOI 10.1136/jcp.34.1.82; El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-285; El Aila NA, 2011, RES MICROBIOL, V162, P499, DOI 10.1016/j.resmic.2011.04.001; Eschenbach DA, 2001, J INFECT DIS, V183, P913, DOI 10.1086/319251; Foxman B, 2007, ANN EPIDEMIOL, V17, P854, DOI 10.1016/j.annepidem.2007.05.014; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; Foxman B, 2008, J INFECT DIS, V198, P1375, DOI 10.1086/592221; Gautam R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0831-1; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Ghartey JP, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.025; Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Guiver M, 2001, J CLIN PATHOL, V54, P362, DOI 10.1136/jcp.54.5.362; Gupta C, 2004, J CLIN MICROBIOL, V42, P3975, DOI 10.1128/JCM.42.9.3975-3977.2004; Hadavand Shahrzad, 2015, Iran J Pathol, V10, P120; HASTINGS MJG, 1986, J INFECTION, V12, P23, DOI 10.1016/S0163-4453(86)94775-4; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Honig E, 2002, EUR J OBSTET GYN R B, V105, P177; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Iavazzo C, 2008, MED SCI MONITOR, V14, pCR228; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Javanmanesh Forough, 2013, Med J Islam Repub Iran, V27, P7; Jespers V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0825-z; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Joubrel C, 2015, CLIN MICROBIOL INFEC, V21, P910, DOI 10.1016/j.cmi.2015.05.039; Kaliterna V, 2011, J OBSTET GYNAECOL RE, V37, P1035, DOI 10.1111/j.1447-0756.2010.01480.x; Karou Simplice D., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P294, DOI 10.1016/S2221-1691(12)60025-2; Kazi YF, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-22; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kim EJ, 2011, EPIDEMIOL HEALTH, V33, DOI 10.4178/epih/e2011010; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Lobos O, 2009, MICROBIOL-SGM, V155, P825, DOI 10.1099/mic.0.021733-0; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Macaluso M, 1999, CONTRACEPTION, V59, P195, DOI 10.1016/S0010-7824(99)00013-X; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; Mavenyengwa RT, 2010, ACTA OBSTET GYN SCAN, V89, P250, DOI 10.3109/00016340903398029; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Mitima KT, 2014, J INFECT DEV COUNTR, V8, P1195, DOI 10.3855/jidc.5030; Mobasheri M, 2014, TURK J MED SCI, V44, P232, DOI 10.3906/sag-1208-33; Moyo S. R., 2000, Central African Journal of Medicine, V46, P115; NATHOO KJ, 1990, CENT AFR J MED, V36, P150; Nikolaitchouk N, 2008, APMIS, V116, P263, DOI 10.1111/j.1600-0463.2008.00808.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; Ocak S, 2007, SAUDI MED J, V28, P727; Ohlsson A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007467.pub4; ONILE BA, 1980, T ROY SOC TROP MED H, V74, P367, DOI 10.1016/0035-9203(80)90102-9; PERCIVALSMITH R, 1983, CONTRACEPTION, V27, P497, DOI 10.1016/0010-7824(83)90046-X; Poyart C, 2007, J CLIN MICROBIOL, V45, P1985, DOI 10.1128/JCM.00159-07; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Rallu F, 2006, J CLIN MICROBIOL, V44, P725, DOI 10.1128/JCM.44.3.725-728.2006; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Razzak MSA, 2011, N AM J MED SCI, V3, P185, DOI 10.4297/najms.2011.3185; Regan JA, 1996, AM J OBSTET GYNECOL, V174, P1354, DOI 10.1016/S0002-9378(96)70684-1; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Rocchetti TT, 2011, ARCH GYNECOL OBSTET, V283, P717, DOI 10.1007/s00404-010-1439-8; Rocha-Zavaleta L, 2004, INT J GYNECOL OBSTET, V85, P259, DOI 10.1016/j.ijgo.2003.10.002; Sagna T, 2010, Pak J Biol Sci, V13, P951, DOI 10.3923/pjbs.2010.951.955; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 1998, PEDIATR INFECT DIS J, V17, P499, DOI 10.1097/00006454-199806000-00013; SUARA RO, 1994, J INFECT DIS, V170, P1316, DOI 10.1093/infdis/170.5.1316; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; Valkenburg-van den Berg AW, 2006, EUR J OBSTET GYN R B, V124, P178, DOI 10.1016/j.ejogrb.2005.06.007; van de Wijgert JHHM, 2000, J INFECT DIS, V181, P587, DOI 10.1086/315227; Veldhuijzen NJ, 2011, SEX HEALTH, V8, P251, DOI 10.1071/SH10047; Venkatesh KK, 2013, AM J REPROD IMMUNOL, V69, P68, DOI 10.1111/aji.12029; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wakkee M, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2014.132; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12	109	46	51	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148052	10.1371/journal.pone.0148052	http://dx.doi.org/10.1371/journal.pone.0148052			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811897	Green Published, gold			2022-12-27	WOS:000369528000074
J	Anan, M; Shinkoda, K; Suzuki, K; Yagi, M; Kito, N				Anan, Masaya; Shinkoda, Koichi; Suzuki, Kentaro; Yagi, Masahide; Kito, Nobuhiro			Dynamic Frequency Analyses of Lower Extremity Muscles during Sit-To-Stand Motion for the Patients with Knee Osteoarthritis	PLOS ONE			English	Article							QUADRICEPS STRENGTH; BIARTICULAR MUSCLES; FIBER TYPE; ELECTROMYOGRAM; WOMEN; STRATEGIES; MOVEMENT; SPECTRUM; FATIGUE; FORCE	Objective Muscle activities during the sit-to-stand motion (STS) are characterized by coordinated movements between hip extensors and knee extensors. However, previous reports regarding the STS and lower extremity muscle activities have focused on some quantitative assessment, but little qualitative research. This study aimed to examine the muscle activities of the lower extremity both quantitatively and qualitatively. Methods Study participants included 13 patients with knee osteoarthritis (knee OA) and 11 age-matched asymptomatic controls. The task was STS from a chair with a height-adjustable seat. EMG activities were acquired using surface electromyogram. The root mean square signals normalized as a percentage of maximum voluntary isometric contraction values (RMS% MVC) and the mean power frequency (MPF) were calculated. Results During STS, knee OA patients had increased RMS% MVC of the vastus medialis and raised MPF of the rectus femoris before buttocks-off. Conclusion These findings suggest that STS of knee OA patients not only increased relative muscle activity of the vastus medialis, but also enlisted the rectus femoris in knee extension to improve muscle contraction force by activating more type II fibers to accomplish buttocks-off.	[Anan, Masaya; Shinkoda, Koichi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Hiroshima Shi, Hiroshima, Japan; [Anan, Masaya; Shinkoda, Koichi] Hiroshima Univ, Ctr Adv Practice & Res Rehabil, Hiroshima Shi, Hiroshima, Japan; [Suzuki, Kentaro] Nagoya Univ Hosp, Nagoya Shi, Nagoya, Aichi, Japan; [Yagi, Masahide] Midorii Orthopaed Joint Reconstruct & Arthroscopy, Hiroshima Shi, Hiroshima, Japan; [Kito, Nobuhiro] Hiroshima Int Univ, Higashihiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University; Nagoya University	Anan, M (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Hiroshima Shi, Hiroshima, Japan.; Anan, M (corresponding author), Hiroshima Univ, Ctr Adv Practice & Res Rehabil, Hiroshima Shi, Hiroshima, Japan.	anan@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [21700532]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This is a part of the studies supported by grant-in-aid (21700532) by Japan Society for the Promotion of Science (JSPS). https://kaken.nii.ac.jp/d/p/21700532.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN RD, 1987, J RHEUMATOL, V14, P3; Anan M, 2015, GAIT POSTURE, V41, P488, DOI 10.1016/j.gaitpost.2014.11.015; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; Bouchouras G, 2015, CLIN BIOMECH, V30, P599, DOI 10.1016/j.clinbiomech.2015.03.025; Cruz-Martinez A, 2000, EUR NEUROL, V43, P110, DOI 10.1159/000008145; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hislop H., 2013, DANIELS WORTHINGHAMS; HODGE E, 1989, TRANSPL P, V21, P1609; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hortobagyi T, 2004, ARTHRITIS RHEUM, V51, P562, DOI [10.1002/art.20545, DOI 10.1002/ART.20545]; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Hunter DJ, 2009, J BONE JOINT SURG AM, V91A, P85, DOI 10.2106/JBJS.H.01409; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jones EJ, 2008, SPORTS MED, V38, P987, DOI 10.2165/00007256-200838120-00003; Kato H, 2009, MED BIOL, V152, P480; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; KUMAMOTO M, 1994, HUM MOVEMENT SCI, V13, P611, DOI 10.1016/0167-9457(94)90009-4; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LIPPOLD OCJ, 1952, J PHYSIOL-LONDON, V117, P492, DOI 10.1113/jphysiol.1952.sp004763; LUTZ GE, 1993, J BONE JOINT SURG AM, V75A, P732, DOI 10.2106/00004623-199305000-00014; McCartney N, 1986, HUMAN MUSCLE POWER; McHugh M, 2001, J ORTHOP SPORT PHYS, V31, P25, DOI 10.2519/jospt.2001.31.1.25; MILLINGTON PJ, 1992, ARCH PHYS MED REHAB, V73, P609; Miura H, 2009, KNEE, V16, P30, DOI 10.1016/j.knee.2008.09.003; MORITANI T, 1987, EUR J APPL PHYSIOL, V56, P260, DOI 10.1007/BF00690890; Muller W, 2012, SURG ARTHROSCOPY KNE, DOI [10.1007/978-3-642-72782-5, DOI 10.1007/978-3-642-72782-5]; NAGATA Akira, 1982, JAPANESE J ERGONOMIC, V18, P35, DOI [DOI 10.5100/JJE.18.35, 10.5100/jje.18.35]; OKADA Y, 1989, Hiroshima Journal of Medical Sciences, V38, P13; PAI YC, 1990, MED SCI SPORT EXER, V22, P378; Palmieri-Smith RM, 2010, AM J PHYS MED REHAB, V89, P541, DOI 10.1097/PHM.0b013e3181ddd5c3; Patsika G, 2011, J ELECTROMYOGR KINES, V21, P689, DOI 10.1016/j.jelekin.2011.05.006; Riley P O, 1997, IEEE Trans Rehabil Eng, V5, P353, DOI 10.1109/86.650289; Robertson GE., 2004, RES METHODS BIOMECHA; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; SCHENAU GJV, 1990, NETH J ZOOL, V40, P521; Schenkman M, 1996, J AM GERIATR SOC, V44, P1441, DOI 10.1111/j.1532-5415.1996.tb04068.x; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; SENIAM, 2011, REC SENS LOC HIP UPP; Sharma L, 2003, ANN INTERN MED, V138, P613, DOI 10.7326/0003-4819-138-8-200304150-00006; SOLOMONOW M, 1990, J APPL PHYSIOL, V68, P1177, DOI 10.1152/jappl.1990.68.3.1177; Westbury J R, 1987, Electromyogr Clin Neurophysiol, V27, P427	45	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147496	10.1371/journal.pone.0147496	http://dx.doi.org/10.1371/journal.pone.0147496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807578	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800112
J	Broucqsault-Dedrie, C; De Jonckheere, J; Jeanne, M; Nseir, S				Broucqsault-Dedrie, Celine; De Jonckheere, Julien; Jeanne, Mathieu; Nseir, Saad			Measurement of Heart Rate Variability to Assess Pain in Sedated Critically Ill Patients: A Prospective Observational Study	PLOS ONE			English	Article							ANALGESIA-NOCICEPTION INDEX; POSTOPERATIVE PAIN; AGITATION	Introduction The analgesia nociception index (ANI) assesses the relative parasympathetic tone as a surrogate for antinociception/nociception balance in sedated patients. The aim of this study is to determine the effectiveness of ANI in detecting pain in deeply sedated critically ill patients. Methods This prospective observational study was performed in two medical ICUs. All patients receiving invasive mechanical ventilation and deep sedation were eligible. In all patients, heart rate and ANI were continuously recorded using the Physiodoloris (R) device during 5 minutes at rest (T1), during a painful stimulus (T2), and during 5 minutes after the end of the painful stimulus (T3). The chosen painful stimulus was patient turning for washstand. Pain was evaluated at T2, using the behavioral pain scale (BPS). The primary objective was to determine the effectiveness of ANI in detecting pain. Secondary objectives included the impact of norepinephrine on the effectiveness of ANI in detecting pain, and the correlation between ANI and BPS. Results Forty-one patients were included. ANI was significantly lower at T2 (Med (IQR) 69(55-78)) compared with T1 (85(67-96), p<0.0001), or T3 (81(63-89), p<0.0001). Similar results were found in the subgroups of patients with (n = 21) or without (n = 20) norepinephrine. ANI values were significantly higher in patients with norepinephrine compared with those without norepinephrine at T1, and T2. No significant correlation was found between ANI and BPS at T2. Conclusions ANI is effective in detecting pain in deeply sedated critically ill patients, including those patients treated with norepinephrine. No significant correlation was found between ANI and BPS.	[Broucqsault-Dedrie, Celine] Hop Victor Provo, Intens Care Unit, CS 60359, 35 Rue Barbieux, F-59056 Roubaix, France; [De Jonckheere, Julien; Jeanne, Mathieu] CHU Lille, Clin Invest Ctr Innovat Technol, INSERM CIC IT 1403, F-59000 Lille, France; [Jeanne, Mathieu] CHU Lille, Anesthesia & Surg Crit Care Dept, F-59000 Lille, France; [Nseir, Saad] CHU Lille, Crit Care Ctr, F-59000 Lille, France; [Nseir, Saad] Univ Lille, Sch Med, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Nseir, S (corresponding author), CHU Lille, Crit Care Ctr, F-59000 Lille, France.; Nseir, S (corresponding author), Univ Lille, Sch Med, F-59000 Lille, France.	s-nseir@chru-lille.fr		Nseir, Saad/0000-0002-7618-0357				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Benarroch EE, 2006, NEUROL SCI, V27, pS130, DOI 10.1007/s10072-006-0587-x; Benchetrit G, 2003, REV MAL RESPIR, V20, P978; Boselli E, 2013, BRIT J ANAESTH, V111, P453, DOI 10.1093/bja/aet110; Camm AJ, 1996, CIRCULATION, V93, P1043; Chanques G, 2014, CRIT CARE, V18, DOI 10.1186/cc14000; De Jonghe B, 2003, CRIT CARE MED, V31, P2344, DOI 10.1097/01.CCM.0000084850.16444.94; Demaree HA, 2004, BRAIN COGNITION, V56, P14, DOI 10.1016/j.bandc.2004.05.001; Greisen J, 2001, ANESTHESIOLOGY, V95, P578, DOI 10.1097/00000542-200109000-00007; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; Jeanne M, 2012, J CLIN MONIT COMPUT, V26, P289, DOI 10.1007/s10877-012-9354-0; Jeanne M, 2014, CLIN J PAIN, V30, P1084, DOI 10.1097/AJP.0000000000000083; Jess G, 2016, EUR J ANAESTH, V33, P118, DOI 10.1097/EJA.0000000000000304; Le Guen M, 2012, INT J OBSTET ANESTH, V21, P146, DOI 10.1016/j.ijoa.2012.01.001; Logier R, 2004, P ANN INT IEEE EMBS, V26, P3937; Logier R, 2010, IEEE ENG MED BIO, P1194, DOI 10.1109/IEMBS.2010.5625971; Migeon A, 2013, PEDIATR ANESTH, V23, P1160, DOI 10.1111/pan.12243; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Parati G, 2006, J APPL PHYSIOL, V101, P690, DOI 10.1152/japplphysiol.00584.2006; Payen JF, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0554-5; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Puntillo KA, 2014, AM J RESP CRIT CARE, V189, P39, DOI 10.1164/rccm.201306-1174OC; Robleda G, 2016, INTENS CARE MED, V42, P183, DOI 10.1007/s00134-015-4112-7; Robleda G, 2015, J ADV NURS, V71, P441, DOI 10.1111/jan.12513; Sabourdin N, 2013, PEDIATR ANESTH, V23, P149, DOI 10.1111/pan.12071; Skrobik Y, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-9	30	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147720	10.1371/journal.pone.0147720	http://dx.doi.org/10.1371/journal.pone.0147720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808971	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800194
J	Gong, Z; Tang, MM; Wu, XL; Phillips, N; Galkowski, D; Jarvis, GA; Fan, HZ				Gong, Zheng; Tang, M. Matt; Wu, Xueliang; Phillips, Nancy; Galkowski, Dariusz; Jarvis, Gary A.; Fan, Huizhou			Arginine- and Polyamine-Induced Lactic Acid Resistance in Neisseria gonorrhoeae	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; CHLAMYDIA-TRACHOMATIS; INFECTION; DISEASE; SEMEN; COLONIZATION; LACTOBACILLI; ASSOCIATION; PROTEINS; DIAMINES	Microbe-derived lactic acid protects women from pathogens in their genital tract. The purpose of this study was to determine lactic acid susceptibility of Neisseria gonorrhoeae, and identify potential acid resistance mechanisms present in this pathogen. Tested in vitro, lactic acid killed all 10 gonococcal strains analyzed in a low pH-dependent manner. Full inactivation occurred at pH 4.5. At low pH, lactic acid treatment resulted in the entry of the DNA-binding fluorochrome propidium iodide into the microbial cells, suggesting that hydrogen ions from lactic acid compromise the integrity of the bacterial cell wall/membrane. Most likely, hydrogen ions also inactivate intracellular proteins since arginine rendered significant protection against lactic acid presumably through action of the gonococcal arginine decarboxylase, an enzyme located in the bacterial cytoplasm. Surprisingly, arginine also lessened lactic acid-mediated cell wall/membrane disruption. This effect is probably mediated by agmatine, a triamine product of arginine decarboxylase, since agmatine demonstrated a stronger protective effect on GC than arginine at equal molar concentration. In addition to agmatine, diamines cadaverine and putrescine, which are generated by bacterial vaginosis-associated microbes, also induced significant resistance to lactic acid-mediated GC killing and cell wall/membrane disruption. These findings suggest that the arginine-rich semen protects gonococci through both neutralization-dependent and independent mechanisms, whereas polyamine-induced acid resistance contributes to the increased risk of gonorrhea in women with bacterial vaginosis.	[Gong, Zheng; Tang, M. Matt; Wu, Xueliang; Fan, Huizhou] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Wu, Xueliang] Hunan Univ Tradit Chinese Med, Affiliated Ningxiang Peoples Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Phillips, Nancy] Rutgers State Univ, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08903 USA; [Phillips, Nancy] Rutgers State Univ, Womens Hlth Inst, New Brunswick, NJ 08903 USA; [Galkowski, Dariusz] New Jersey Dept Hlth, Publ Hlth & Environm Labs, Ewing, NJ USA; [Galkowski, Dariusz] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Hunan University of Chinese Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Fan, HZ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	fanhu@rwjms.rutgers.edu		FAN, HUIZHOU/0000-0002-4903-926X; Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health grant [AI071954]; New Jersey Health Foundation Grant [PC7-13]; Hunan University of Traditional Chinese Medicine-affiliated Hospital; Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071954, R33AI071954] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation Grant; Hunan University of Traditional Chinese Medicine-affiliated Hospital; Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grant (grant number AI071954) and a New Jersey Health Foundation Grant (grant number PC7-13) to HF. XW was a recipient of an oversea research scholarship awarded by the Hunan University of Traditional Chinese Medicine-affiliated Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ann E. Jerse for the kind supply of FA1090, Dr. Loren Runnels for giving us access to his fluorescence microscope equipped with an oil immersion objective, Drs. Theresa L. Chang, Gloria Bachmann and Lingli Tang for discussions and Mr. Malhar Desai for assistance in counting bacterial colonies. This work was supported by a National Institutes of Health grant (grant number AI071954) and a New Jersey Health Foundation Grant (grant number PC7-13) to HF. XW was a recipient of an oversea research scholarship awarded by the Hunan University of Traditional Chinese Medicine-affiliated Ningxiang People's Hospital.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Center for Disease Control and Prevention, 2013, MMWR SURVEILL SUMM, V62, P424; Center for Disease Control and Prevention, 2014, CDC FACT SHEET; Centers For Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; CHEN KCS, 1982, J INFECT DIS, V145, P337, DOI 10.1093/infdis/145.3.337; CHVAPIL M, 1978, OBSTET GYNECOL, V52, P88; Coconnier-Polter MH, 2005, APPL ENVIRON MICROB, V71, P6115, DOI 10.1128/AEM.71.10.6115-6120.2005; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; FAIR WR, 1972, FERTIL STERIL, V23, P38; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; Goytia M, 2010, INFECT IMMUN, V78, P3187, DOI 10.1128/IAI.01301-09; HILLIER SL, 1991, GENITOURIN MED, V67, P26; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MARTIUS J, 1988, OBSTET GYNECOL, V71, P89; Mendonca K, 2015, NEW MICROBIOL, V38, P267; MIETTINEN A, 1990, SEX TRANSM DIS, V17, P10; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Nelson TM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00253; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Pettit RK, 1996, INFECT IMMUN, V64, P1039, DOI 10.1128/IAI.64.3.1039-1042.1996; Pettit RK, 2001, CAN J MICROBIOL, V47, P871, DOI 10.1139/cjm-47-9-871; Pettit RK, 1999, J MED MICROBIOL, V48, P149, DOI 10.1099/00222615-48-2-149; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Ronnqvist PDJ, 2006, ACTA OBSTET GYN SCAN, V85, P726, DOI 10.1080/00016340600578357; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5893, DOI 10.1073/pnas.1301442110; WEIR SS, 1994, AIDS, V8, P1605, DOI 10.1097/00002030-199411000-00013; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WILLIAMSON JD, 1984, NATURE, V310, P103, DOI 10.1038/310103a0; Zini A, 2001, UROLOGY, V58, P85, DOI 10.1016/S0090-4295(01)01001-9	47	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147637	10.1371/journal.pone.0147637	http://dx.doi.org/10.1371/journal.pone.0147637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808268	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800159
J	Wang, CC; Wang, YC; Wang, GJ; Shen, MY; Chang, YL; Liou, SY; Chen, HC; Chang, CT				Wang, Chun-Cheng; Wang, Yao-Chang; Wang, Guei-Jane; Shen, Ming-Yi; Chang, Yen-Lin; Liou, Show-Yih; Chen, Hung-Chih; Chang, Chiz-Tzung			Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; BRACHIAL-ARTERY; PENTOSIDINE; DISEASE; COMPLICATIONS; GLYCOXIDATION; ACCUMULATION; PRAVASTATIN; MORTALITY	Background Elevated levels of advanced glycation end products (AGEs) within tissues may contribute to endothelial dysfunction, an early indicator of atherosclerosis. We aimed to investigate whether levels of skin AGEs could be a useful marker to predict endothelial dysfunction in uremic subjects on hemodialysis. Methods and Results One hundred and nineteen uremic patients on hemodialysis and 57 control subjects with moderate-to-high cardiovascular risk factors and without chronic kidney disease (CKD) were enrolled. We used ultrasound tomeasure flow-mediated vasodilation (FMD). An AGE reader measured skin autoflurorescence (AF). We then compared differences in FMD and skin AF values between the two groups. The uremic subjects had significantly higher levels of skin AF (3.47 +/- 0.76 AU vs. 2.21 +/- 0.45 arbitrary units; P<0.01) and significantly lower levels of FMD (4.79%+/- 1.88% vs. 7.19%+/- 2.17%; P<0.01) than the non-CKD subjects. After adjusting for all potential covariates, we found that skin AF level independently predicted FMD in both the hemodialysis and the non-CKD groups. In the hemodialysis group, skin AF >= +/- 3.05 arbitrary units predicted abnormal FMD at a sensitivity of 87.9% and a specificity of 78.6%(P<0.01). Conclusions Skin AF could be a useful marker to predict endothelial dysfunction in uremic subjects on hemodialysis.	[Wang, Chun-Cheng; Wang, Guei-Jane; Shen, Ming-Yi] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Chun-Cheng] Buddhist Tzuchi Med Fdn, Taichung Tzuchi Hosp, Dept Internal Med, Div Cardiol, Taichung, Taiwan; [Wang, Yao-Chang] Chang Gung Mem Hosp, Keelung Branch, Div Cardiothorac Surg, Keelung, Taiwan; [Wang, Guei-Jane] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Guei-Jane] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chang, Yen-Lin] Chung Yuan Christian Univ, Dept Biomed Engn, Taoyuan, Taiwan; [Liou, Show-Yih] Formosan Blood Purificat Fdn, Taipei, Taiwan; [Chen, Hung-Chih; Chang, Chiz-Tzung] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ, Coll Med, Taichung, Taiwan; [Wang, Chun-Cheng; Chang, Chiz-Tzung] China Med Univ Hosp, Cardiovas Res Lab, Taichung, Taiwan	China Medical University Taiwan; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Chung Yuan Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CT (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.; Chang, CT (corresponding author), China Med Univ Hosp, Cardiovas Res Lab, Taichung, Taiwan.	d19863@mail.cmuh.org.tw	Shen, Ming-Yi/L-6861-2019	Shen, Ming-Yi/0000-0002-9351-1912; Chen, Hung-Chih/0000-0001-7666-9729	Tzu-chi General Hospital [TTCRD 103-16]; China Medical University Hospital [DMR-104-014]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Tzu-chi General Hospital; China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by Taichung Tzu-chi General Hospital (grant number TTCRD 103-16), China Medical University Hospital (grant number DMR-104-014), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Contreras I, 1997, DIABETES CARE, V20, P832, DOI 10.2337/diacare.20.5.832; de Vos LC, 2013, ARTERIOSCL THROM VAS, V33, P131, DOI 10.1161/ATVBAHA.112.300016; Deng HF, 2005, ACTA PHARMACOL SIN, V26, P92, DOI 10.1111/j.1745-7254.2005.00013.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Iwamoto Y, 2012, ARTERIOSCL THROM VAS, V32, P2295, DOI 10.1161/ATVBAHA.112.249680; Jadoul M, 1999, KIDNEY INT, V55, P2487, DOI 10.1046/j.1523-1755.1999.00468.x; Kocak H, 2009, NEPHROLOGY, V14, P273, DOI 10.1111/j.1440-1797.2008.01062.x; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Miyata T, 2001, NEPHROL DIAL TRANSPL, V16, P8, DOI 10.1093/ndt/16.suppl_4.8; Miyazawa T, 2012, AMINO ACIDS, V42, P1163, DOI 10.1007/s00726-010-0772-3; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Nazratuna N, 2006, VASC MED, V11, P245, DOI 10.1177/1358863x06072202; Noordzij MJ, 2012, INT J CARDIOVAS IMAG, V28, P431, DOI 10.1007/s10554-011-9805-6; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Raitakari OT, 2000, BRIT J CLIN PHARMACO, V50, P397, DOI 10.1046/j.1365-2125.2000.00277.x; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Shechter M, 2009, INT J CARDIOL, V134, P52, DOI 10.1016/j.ijcard.2008.01.021; Soro-Paavonen A, 2010, J HYPERTENS, V28, P780, DOI 10.1097/HJH.0b013e328335043e; Suliman ME, 2003, J AM SOC NEPHROL, V14, P1614, DOI 10.1097/01.ASN.0000067413.32377.CF; Tanaka K, 2012, DIABETIC MED, V29, P492, DOI 10.1111/j.1464-5491.2011.03448.x; Teragawa H, 2001, AM J CARDIOL, V88, P1147, DOI 10.1016/S0002-9149(01)02051-3; U. S. Renal Data system, 2015, USRDS 2013 ANN DAT R, V4, P2; Ueno H, 2008, METABOLISM, V57, P1452, DOI 10.1016/j.metabol.2008.05.016; Uydes-Dogan BS, 2005, LIFE SCI, V76, P1771, DOI 10.1016/j.lfs.2004.11.002; Wagner Z, 2006, AM J KIDNEY DIS, V47, P294, DOI 10.1053/j.ajkd.2005.10.010; Weiss MF, 2000, KIDNEY INT, V57, P2571, DOI 10.1046/j.1523-1755.2000.00117.x; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Zhou YL, 2010, ARTIF ORGANS, V34, P193, DOI 10.1111/j.1525-1594.2009.00801.x	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147771	10.1371/journal.pone.0147771	http://dx.doi.org/10.1371/journal.pone.0147771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809145	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800209
J	Workneh, MH; Bjune, GA; Yimer, SA				Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe			Prevalence and Associated Factors of Diabetes Mellitus among Tuberculosis Patients in South-Eastern Amhara Region, Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHALLENGES	Background The association between diabetes mellitus (DM) and tuberculosis (TB) is re-emerging worldwide. Recently, the prevalence of DM is increasing in resource poor countries where TB is of high burden. The objective of the current study was to determine the prevalence and analyze associated factors of TB and DM comorbidity in South-Eastern Amhara Region, Ethiopia. Methods This was a facility based cross-sectional study. All newly diagnosed TB patients attending selected health facilities in the study area were consecutively screened for DM. DM was diagnosed based on the World Health Organization diagnostic criteria. A pre-tested semi-structured questionnaire was used to collect socio-demographic, lifestyles and clinical data. Logistic regression analysis was performed to identify factors associated with TB and DM comorbidity. Result Among a total of 1314 patients who participated in the study, the prevalence of DM was estimated at 109 (8.3%). Being female [odds ratio (OR) 1.70; 95% confidence interval (CI) (1.10-2.62)], patients age [41-64 years (OR 3.35; 95% CI (2.01-5.57), 65-89 years (OR 3.18; 95% CI (1.52-6.64)], being a pulmonary TB case [(OR 1.69; 95% CI 1.09-2.63)] and having a family history of DM [(OR 4.54; 95% CI (2.36-8.73)] were associated factors identified with TB and DM comorbidity. Conclusion The prevalence of DM among TB patients in South-Eastern Amahra Region is high. Routine screening of TB patients for DM is recommended in the study area.	[Workneh, Mahteme Haile; Bjune, Gunnar Aksel; Yimer, Solomon Abebe] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Workneh, Mahteme Haile; Yimer, Solomon Abebe] Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia; [Yimer, Solomon Abebe] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Yimer, Solomon Abebe] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Workneh, MH (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway.; Workneh, MH (corresponding author), Amhara Reg State Hlth Bur, Bahir Dar, Ethiopia.	maykm24@yahoo.com			University of Oslo	University of Oslo	Funding support for the research was provided by the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achanta S, 2013, PUBLIC HEALTH ACTION, V3, pS43, DOI 10.5588/pha.13.0033; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; Amhara Regional State Health Bureau, 2007, ANN HLTH SERV REP; Amin S, 2011, GOMAL J MED SCI, V9, P163; [Anonymous], 2013, DIABETES ATLAS; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Bukhary ZA, 2008, J TAIBAH UNIV MED SC, V3, P1; Castellanos-Joya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106961; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Damtew E, 2014, WORLD J MED SCI, V11, P389; Dave P, 2013, PUBLIC HEALTH ACTION, V3, pS29, DOI 10.5588/pha.13.0027; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Federal Democratic Republic of Ethiopia, 2012, GUID CLIN PROGR MAN, P1; Getachew A., 2014, British Journal of Medicine and Medical Research, V4, P862; Guptan A, 2000, IND J TUB, V47, P1; Harries AD, 2013, PUBLIC HEALTH ACTION, V3, pS3, DOI 10.5588/pha.13.0024; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kapur A, 2009, EUREOPEAN ENDOCRINOL, V5, P10; Kibirige D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-122; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Li L, 2012, TROP MED INT HEALTH, V17, P1294, DOI 10.1111/j.1365-3156.2012.03068.x; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Naik B, 2013, PUBLIC HEALTH ACTION, V3, pS34, DOI 10.5588/pha.13.0022; Nair S, 2013, PUBLIC HEALTH ACTION, V3, pS38, DOI 10.5588/pha.13.0037; Nandakumar KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076275; Ogbera Anthonia Okeoghene, 2014, Indian J Endocrinol Metab, V18, P475, DOI 10.4103/2230-8210.137488; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Reid MJA, 2013, JEMDSA, V18, P135, DOI 10.1080/22201009.2013.10844551; Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; ReyPineda G.D, 2014, MYCOBACTERIAL DIS, V4, P2, DOI [10.4172/2161-1068.1000144, DOI 10.4172/2161-1068.1000144]; Rimpi Sangral, 2012, JK Science, V14, P177; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang HT, 2014, THER CLIN RISK MANAG, V10, P45, DOI 10.2147/TCRM.S38872; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; World Health Organization, 2011, US GLYC HBA1C DIAGN, P1; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2014, GLOB TUB REP	43	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147621	10.1371/journal.pone.0147621	http://dx.doi.org/10.1371/journal.pone.0147621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808967	Green Published, gold			2022-12-27	WOS:000369527800152
J	Hu, Y; Zhao, JC; Wu, JJ				Hu, Yue; Zhao, Jichang; Wu, Junjie			Emoticon-Based Ambivalent Expression: A Hidden Indicator for Unusual Behaviors in Weibo	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKING; HAPPINESS; LIFE	Recent decades have witnessed online social media being a big-data window for testifying conventional social theories quantitatively and exploring much detailed human behavioral patterns. In this paper, by tracing the emoticon use in Weibo, a group of hidden "ambivalent users" are disclosed for frequently posting ambivalent tweets containing both positive and negative emotions. Further investigation reveals that this ambivalent expression could be a novel indicator of many unusual social behaviors. For instance, ambivalent users with the female as the majority like to make a sound in midnights and at weekends. They mention their close friends frequently in ambivalent tweets, which attract more replies and serve as a more private communication way. Ambivalent users also respond differently to public affairs from others and demonstrate more interests in entertainment and sports events. Moreover, the sentiment shift in ambivalent tweets is more evident than usual and exhibits a clear "negative to positive" pattern. The above observations, though being promiscuous seemingly, actually point to the self-regulation of negative mood in Weibo, which could find its basis from the traditional emotion management theories in sociology but makes an important extension to the online environment in this study. Finally, as an interesting corollary, ambivalent users are found connected with compulsive buyers and turn out to be perfect targets for online marketing.	[Hu, Yue; Zhao, Jichang; Wu, Junjie] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China	Beihang University	Wu, JJ (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.	wujj@buaa.edu.cn		Zhao, Jichang/0000-0002-5319-8060	National Natural Science Foundation of China [71322104, 71171007, 71471009, 71531001]; National Center for International Joint Research on E-Business Information Processing [2013B01035]; National High Technology Research and Development Program of China (863 Program) [SS2014AA012303]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201189]; Program for New Century Excellent Talents in University [NCET-11-0778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for International Joint Research on E-Business Information Processing; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was partially supported by National Natural Science Foundation of China (71322104, 71171007, 71471009 and 71531001), National Center for International Joint Research on E-Business Information Processing (2013B01035), National High Technology Research and Development Program of China (863 Program) (SS2014AA012303), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201189), and Program for New Century Excellent Talents in University (NCET-11-0778). JZ thanks NSF of China (71501005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON RP, 1983, PERS SOC PSYCHOL B, V9, P37, DOI 10.1177/0146167283091006; Apaolaza V, 2014, COMPUT HUM BEHAV, V41, P203, DOI 10.1016/j.chb.2014.09.029; Bagozzi RP, 1999, COGNITION EMOTION, V13, P641, DOI 10.1080/026999399379023; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; DANDOY AC, 1990, J SOC BEHAV PERS, V5, P275; Derks D, 2007, COMPUT HUM BEHAV, V23, P842, DOI 10.1016/j.chb.2004.11.013; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Faber RJ, 1996, PSYCHOL MARKET, V13, P803, DOI 10.1002/(SICI)1520-6793(199612)13:8<803::AID-MAR6>3.3.CO;2-2; Fan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110184; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Gallup JG, 1989, PEOPLES RELIG AM FAI; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Granovetter MS, 1974, STRENGTH WEAK TIES; Hormes JM, 2014, ADDICTION, V109, P2079, DOI 10.1111/add.12713; Hu X, 2013, PROCEEDING ACM INT C, P607, DOI DOI 10.1145/2488388.2488442; Liu B, 2010, CH CRC MACH LEARN PA, P627; Liu K. L., 2012, AAAI; Liu SH, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P2079, DOI 10.1145/2505515.2505569; Mathiesen J, 2013, P NATL ACAD SCI USA, V110, P17259, DOI 10.1073/pnas.1304179110; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Oh HJ, 2014, COMPUT HUM BEHAV, V30, P69, DOI 10.1016/j.chb.2013.07.053; Pantic I, 2012, PSYCHIAT DANUB, V24, P90; Park J., 2013, P 7 INT AAAI C WEBL; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Ptaszynski M., 2011, P 17 ANN M ASS NAT L, P1159; Purver M., 2012, P 13 C EUR CHAPT ASS, P482; Schnoebelen Tyler, 2012, U PENNSYLVANIA WORKI, V18, P117; Speriosu M, 2011, P 1 WORKSHOP UNSUPER, P53, DOI DOI 10.1017/CB09781107415324.004; Suvakov M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0819; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Tossell CC, 2012, COMPUT HUM BEHAV, V28, P659, DOI 10.1016/j.chb.2011.11.012; Valenza G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04998; Valkenburg PM, 2006, CYBERPSYCHOL BEHAV, V9, P584, DOI 10.1089/cpb.2006.9.584; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976; Yang J., 2011, P 4 ACM INT C WEB SE, P177; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772; Zhao ZD, 2015, CHAOS, V25, DOI 10.1063/1.4922302; Zhao ZD, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.050802; Zhao ZD, 2013, SCI REP-UK, V3, DOI 10.1038/srep03472	42	9	9	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147079	10.1371/journal.pone.0147079	http://dx.doi.org/10.1371/journal.pone.0147079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26800119	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300058
J	Lindensmith, CA; Rider, S; Bedrossian, M; Wallace, JK; Serabyn, E; Showalter, GM; Deming, JW; Nadeau, JL				Lindensmith, Christian A.; Rider, Stephanie; Bedrossian, Manuel; Wallace, J. Kent; Serabyn, Eugene; Showalter, G. Max; Deming, Jody W.; Nadeau, Jay L.			A Submersible, Off-Axis Holographic Microscope for Detection of Microbial Motility and Morphology in Aqueous and Icy Environments	PLOS ONE			English	Article							SEA-ICE; BACTERIAL MOTILITY; ARCTIC WINTER; PERMAFROST; GREENLAND; MICROORGANISMS; ECOLOGY; GLACIER; LIFE; BIODIVERSITY	Sea ice is an analog environment for several of astrobiology's near-term targets: Mars, Europa, Enceladus, and perhaps other Jovian or Saturnian moons. Microorganisms, both eukaryotic and prokaryotic, remain active within brine channels inside the ice, making it unnecessary to penetrate through to liquid water below in order to detect life. We have developed a submersible digital holographic microscope (DHM) that is capable of resolving individual bacterial cells, and demonstrated its utility for immediately imaging samples taken directly from sea ice at several locations near Nuuk, Greenland. In all samples, the appearance and motility of eukaryotes were conclusive signs of life. The appearance of prokaryotic cells alone was not sufficient to confirm life, but when prokaryotic motility occurred, it was rapid and conclusive. Warming the samples to above-freezing temperatures or supplementing with serine increased the number of motile cells and the speed of motility; supplementing with serine also stimulated chemotaxis. These results show that DHM is a useful technique for detection of active organisms in extreme environments, and that motility may be used as a biosignature in the liquid brines that persist in ice. These findings have important implications for the design of missions to icy environments and suggest ways in which DHM imaging may be integrated with chemical life-detection suites in order to create more conclusive life detection packages.	[Rider, Stephanie; Bedrossian, Manuel; Nadeau, Jay L.] CALTECH, Grad Aerosp Labs GALCIT, Pasadena, CA 91125 USA; [Lindensmith, Christian A.; Wallace, J. Kent; Serabyn, Eugene] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA; [Showalter, G. Max; Deming, Jody W.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Seattle	Nadeau, JL (corresponding author), CALTECH, Grad Aerosp Labs GALCIT, Pasadena, CA 91125 USA.	jnadeau@caltech.edu	Wallace, James/AAA-5741-2020	Nadeau, Jay/0000-0001-5258-0076	Gordon and Betty Moore Foundation (GBMF) [4037, 4038]	Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation)	This work was supported by the Gordon and Betty Moore Foundation (GBMF) grant numbers 4037 (McGill University, JN, subcontract to University of Washington, JWD, GMS) and 4038 (California Institute of Technology, CAL, SR, MB, JKW, ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SCIENCE, V347, P1294; Antkowiak M, 2008, OPT LETT, V33, P1626, DOI 10.1364/OL.33.001626; Bakermans C, 2011, ENVIRON MICROBIOL, V13, P2269, DOI 10.1111/j.1462-2920.2011.02485.x; Biele J, 2011, ADV SPACE RES, V48, P755, DOI 10.1016/j.asr.2010.02.029; Boetius A, 2015, NAT REV MICROBIOL, V13, P677, DOI 10.1038/nrmicro3522; Price PB, 2007, FEMS MICROBIOL ECOL, V59, P217, DOI 10.1111/j.1574-6941.2006.00234.x; Campen RK, 2003, GEOLOGY, V31, P231, DOI 10.1130/0091-7613(2003)031<0231:EOMCMW>2.0.CO;2; Colangelo-Lillis JR, 2016, FEMS MICROBIOLOGY EC; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Colomb T, 2010, OPT LETT, V35, P1840, DOI 10.1364/OL.35.001840; Committee on an Astrobiology Strategy for the Exploration of Mars, 2007, ASTR STRAT EXPL MARS; Deming J, 2007, PLANETS LIFE EMERGIN, P292; Deming JW, 2016, SEA ICE INT IN PRESS; Ewert Marcela, 2013, Biology (Basel), V2, P603, DOI 10.3390/biology2020603; Ferraro P, 2005, OPT EXPRESS, V13, P6738, DOI 10.1364/OPEX.13.006738; Gilichinsky D, 2005, FEMS MICROBIOL ECOL, V53, P117, DOI 10.1016/j.femsec.2005.02.003; Gilichinsky D, 2003, ASTROBIOLOGY, V3, P331, DOI 10.1089/153110703769016424; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Huston AL, 2003, BACTERIAL ADAPTATI H; Ikavalko J, 1997, POLAR BIOL, V17, P473, DOI 10.1007/s003000050145; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Junge K, 2004, APPL ENVIRON MICROB, V70, P550, DOI 10.1128/AEM.70.1.550-557.2004; Junge K, 2001, ANN GLACIOL, V33, P304, DOI 10.3189/172756401781818275; Junge K., 2002, BACTERIAL ABUNDANCE; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Kuhn J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904449; Mader HM, 2006, GEOLOGY, V34, P169, DOI 10.1130/G22096.1; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Martin-Torres FJ, 2015, TRANSIENT LIQUID WAT; McKay CP, 2013, ASTROBIOLOGY, V13, P334, DOI 10.1089/ast.2012.0878; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mikkelsen DM, 2008, MAR ECOL PROG SER, V368, P65, DOI 10.3354/meps07627; Mindl B, 2007, FEMS MICROBIOL ECOL, V59, P307, DOI 10.1111/j.1574-6941.2006.00262.x; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P877, DOI 10.1128/AEM.61.3.877-882.1995; Olson RJ, 2003, DEEP-SEA RES PT I, V50, P301, DOI 10.1016/S0967-0637(03)00003-7; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Pappalardo RT, 2013, ASTROBIOLOGY, V13, P740, DOI 10.1089/ast.2013.1003; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Saur J, 2015, J GEOPHYS RES-SPACE, V120, P1715, DOI 10.1002/2014JA020778; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976; Shcherbakova VA, 2009, MICROBIOLOGY+, V78, P84, DOI 10.1134/S0026261709010111; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheridan PP, 2003, APPL ENVIRON MICROB, V69, P2153, DOI 10.1128/AEM.69.4.2153-2160.2003; Skidmore ML, 2000, APPL ENVIRON MICROB, V66, P3214, DOI 10.1128/AEM.66.8.3214-3220.2000; Sogaard DH, 2010, MAR ECOL PROG SER, V419, P31, DOI 10.3354/meps08845; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Stibal M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00225; Stibal M, 2012, NAT GEOSCI, V5, P771, DOI 10.1038/ngeo1611; Tung HC, 2006, ASTROBIOLOGY, V6, P69, DOI 10.1089/ast.2006.6.69; von Quillfeldt CH, 2001, BOT MAR, V44, P375, DOI 10.1515/BOT.2001.048; Wallace JK, 2015, OPT EXPRESS, V23, P17367, DOI 10.1364/OE.23.017367	55	41	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147700	10.1371/journal.pone.0147700	http://dx.doi.org/10.1371/journal.pone.0147700			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812683	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000369528000049
J	Ramachandran, A; Radhapriya, P; Jayakumar, S; Dhanya, P; Geetha, R				Ramachandran, Andimuthu; Radhapriya, Parthasarathy; Jayakumar, Shanmuganathan; Dhanya, Praveen; Geetha, Rajadurai			Critical Analysis of Forest Degradation in the Southern Eastern Ghats of India: Comparison of Satellite Imagery and Soil Quality Index	PLOS ONE			English	Article							BIOCHEMICAL-PROPERTIES; MICROBIAL BIOMASS; TAMIL-NADU; INDICATORS; VEGETATION; ECOSYSTEM	India has one of the largest assemblages of tropical biodiversity, with its unique floristic composition of endemic species. However, current forest cover assessment is performed via satellite-based forest surveys, which havemany limitations. The present study, which was performed in the Eastern Ghats, analysed the satellite-based inventory provided by forest surveys and inferred from the results that this process no longer provides adequate information for quantifying forest degradation in an empirical manner. The study analysed 21 soil properties and generated a forest soil quality index of the Eastern Ghats, using principal component analysis. Using matrix modules and geospatial technology, we compared the forest degradation status calculated from satellite-based forest surveys with the degradation status calculated fromthe forest soil quality index. The Forest Survey of India classified about 1.8% of the Eastern Ghats' total area as degraded forests and the remainder (98.2%) as open, dense, and very dense forests, whereas the soil quality index results found that about 42.4% of the total area is degraded, with the remainder (57.6%) being non-degraded. Our ground truth verification analyses indicate that the forest soil quality index along with the forest cover density data from the Forest Survey of India are ideal tools for evaluating forest degradation.	[Ramachandran, Andimuthu; Radhapriya, Parthasarathy; Dhanya, Praveen; Geetha, Rajadurai] Anna Univ, Ctr Climate Change & Adaptat Res, Chennai 600025, Tamil Nadu, India; [Jayakumar, Shanmuganathan] Pondicherry Univ, Sch Life Sci, Dept Ecol & Environm Sci, Environm Informat & Spatial Modelling Lab, Pondicherry, India	Anna University; Anna University Chennai; Pondicherry University	Ramachandran, A; Radhapriya, P (corresponding author), Anna Univ, Ctr Climate Change & Adaptat Res, Chennai 600025, Tamil Nadu, India.	andimuthu.ramachandran@gmail.com; radhapriya.cc@gmail.com	/CAA-2711-2022; /AAP-2425-2020	/0000-0002-8157-3219; /0000-0002-8157-3219; Radhapriya, Parthasarathy/0000-0001-7568-0176; P, Dr. Dhanya/0000-0001-9957-8766; Dhanya, p/0000-0002-8443-269X	Anna University; Pondicherry University	Anna University; Pondicherry University(Pondicherry University)	This study received intramural funding from the Anna University and the Pondicherry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton DF, 1993, PROGRAM ASSESS MONIT; Adolphus WHW, 1932, CONSOLIDATED WORKING; Anderson JM., 1993, TROPICAL SOIL BIOL F, V2nd, DOI DOI 10.1017/S0014479700024832; Andrews SS, 2003, GEODERMA, V114, P187, DOI 10.1016/S0016-7061(03)00041-7; Andrews SS, 2002, AGR ECOSYST ENVIRON, V90, P25, DOI 10.1016/S0167-8809(01)00174-8; Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Balaguru B, 2006, IDENTIFYING CONSERVA, P469; Bastida F, 2008, GEODERMA, V147, P159, DOI 10.1016/j.geoderma.2008.08.007; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bhat D. M., 2001, Journal of Tropical Forest Science, V13, P601; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Blecker SW, 2012, ECOL INDIC, V20, P65, DOI 10.1016/j.ecolind.2012.02.010; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P2115, DOI 10.2136/sssaj2000.6462115x; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chen CR, 2003, FOREST ECOL MANAG, V186, P213, DOI 10.1016/S0378-1127(03)00275-5; Cleghorn H, 1861, FORESTS GARDENS S IN; Council of Europe, 1992, SOIL PROT REC COUNC; Doran J.W., 1996, METHODS ASSESSING SO, P25, DOI [10.2136/sssaspecpub49.c2, DOI 10.2136/SSSASPECPUB49.C2]; Erdas, 2011, ERD IM HEX G GEOSP I; Gil-Sotres F, 2005, SOIL BIOL BIOCHEM, V37, P877, DOI 10.1016/j.soilbio.2004.10.003; Goyal Neha, 2014, Environ Monit Assess, V186, P7941, DOI 10.1007/s10661-014-3978-0; Harikrishnan I., 1967, WORKING PLAN SALEM F; IBM Carp, 2013, IBM SPSS STAT WIND V; Jackson M.L, 1973, SOIL CHEM ANAL; Jayakumar S, 2007, KOREAN J REMOTE SENS, V23, P473; Jayakumar S, 2009, ENVIRON MANAGE, V43, P326, DOI 10.1007/s00267-008-9219-y; Joshi AA, 2015, TROP ECOL, V56, P233; Leiros MC, 2000, SOIL BIOL BIOCHEM, V32, P733, DOI 10.1016/S0038-0717(99)00195-9; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Lilburne L, 2002, P SOIL QUAL SUST LAN, P47; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Masto RE, 2007, AGR ECOSYST ENVIRON, V118, P130, DOI 10.1016/j.agee.2006.05.008; Menon S, 1998, AMBIO, V27, P576; Ministry of Environment and Forests, 2003, FOR SURV IND STAT FO; Miralles I, 2007, BIOL FERT SOILS, V43, P721, DOI 10.1007/s00374-006-0155-9; Moffat AJ, 2003, FORESTRY, V76, P1, DOI DOI 10.1093/forestry/76.5.547; Ndiaye E. L., 2000, American Journal of Alternative Agriculture, V15, P26, DOI 10.1017/S0889189300008432; NRCS/USDA (Natural Resources Conservation Service/United States Department of Agriculture), 2022, SOIL TEXT CALC; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Owen JS, 2003, FOREST ECOL MANAG, V176, P519, DOI 10.1016/S0378-1127(02)00225-6; Pratt PF, 1956, METHODS SOIL ANAL 2, P1022; Puri GS, 1960, FOREST ECOLOGY; Puyravaud JP, 2010, CONSERV LETT, V3, P390, DOI 10.1111/j.1755-263X.2010.00141.x; Puyravaud JP, 2010, SCIENCE, V329, P32, DOI 10.1126/science.329.5987.32-b; Raizada P, 2006, CURR SCI, V94, P180; Ram Prasad, 2000, RAP Publication, P27; Ramachandran A., 2008, Indian Journal of Forestry, V31, P175; Ramachandran A., 2007, Indian Forester, V133, P25; Ramachandran A., 2005, Indian Forester, V131, P3; Ramachandran A, 2007, CURR SCI INDIA, V92, P323; Ramaswami G, 2014, J BIOSCIENCES, V39, P717, DOI 10.1007/s12038-014-9465-5; Ramaswami G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076995; Royal Commission on Environmental Pollution, 1996, 19 ROYAL COMM ENV PO; Sagar R, 2004, ENVIRON CONSERV, V31, P55, DOI 10.1017/S0376892904001031; Satyam Verma, 2012, Proceedings of the International Academy of Ecology and Environmental Sciences, V2, P168; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; STANFORD G, 1949, AGRON J, V41, P446, DOI 10.2134/agronj1949.00021962004100090012x; Stebbing EP, 1922, THE FORESTS OF INDIA, VI; Subbiah B, 1956, CURR SCI, V25, P8; Tan SY, 2014, ISPRST TECHN COMM 2, VXL-2; Tandon HLS, 1995, METHODS ANAL SOILS P; TESFAHUNEGN GB, 2014, APPL ENV SOIL SCI 20, P1, DOI DOI 10.1016/j.geoderma.2011.04.005; Thankam K., 1959, WORKING PLAN CHENGAL; TOTH SJ, 1949, SOIL SCI, V67, P439, DOI 10.1097/00010694-194906000-00003; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Wang SQ, 2002, ENVIRON POLLUT, V116, pS157, DOI 10.1016/S0269-7491(01)00269-X	69	13	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147541	10.1371/journal.pone.0147541	http://dx.doi.org/10.1371/journal.pone.0147541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812397	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000038
J	Amarilyo, G; Furst, DE; Woo, JMP; Li, W; Bliddal, H; Christensen, R; Tarp, S				Amarilyo, Gil; Furst, Daniel E.; Woo, Jennifer M. P.; Li, Wen; Bliddal, Henning; Christensen, Robin; Tarp, Simon			Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project	PLOS ONE			English	Article								Background Sponsors that seek to commercialize new drugs apply to the Food and Drug Administration (FDA) which independently analyzes the raw data and reports the results on its website. Objectives This study sought to determine if there are differences between the FDA assessments and journal reports on biologic agents developed for the treatment of rheumatoid arthritis. Methods Available data on FDA-approved drugs were extracted from the website, and a systematic literature search was conducted to identify matching studies in peer-reviewed medical journals. Outcome measures were the American College of Rheumatology response criteria ACR20 (efficacy) and withdrawal due to adverse events (safety). As effect size odds ratios were estimated for each active trial arm vs. control arm (i.e. for both sources: FDA and journal report), followed by calculation of the ratios of the FDA and journal report odds ratios. A ratio of odds ratios not equal to 1 was categorized as a discrepancy. Results FDA reports were available for 8 of 9 FDA-approved biologic agents for rheumatoid arthritis; all identified trials (34) except one were published in peer-reviewed journals. Overall, discrepancies were noted for 20 of the 33 evaluated trials. Differences in the apparent benefit reporting were found in 39% (24/61) pairwise comparisons and in 11 cases these were statistically significant; the FDA report showed greater benefit than the journal publication in 15 comparisons and lesser benefit in 9. Differences in the reported harms were found in 51% (28/55) pairwise comparisons and were statistically significant in 5. The "signal" in FDA reports showed a less harmful effect than the journal publication in 17 comparisons whereas a more harmful effect in 11. The differences were attributed to differences in analytic approach, patient inclusion, rounding effect, and counting discrepancies. However, no differences were categorized as critical. Conclusion There was no empirical evidence to suggest biased estimates between the two sources. Increased and detailed transparency in publications would improve the understanding and credibility of published results. Further, the FDA report was found to be a useful source when data are missing in the published report (i.e. reporting bias).	[Amarilyo, Gil] Schneider Childrens Med Ctr Israel, Pediat Rheumatol Unit, Petah Tiqwa, Israel; [Amarilyo, Gil] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Furst, Daniel E.; Woo, Jennifer M. P.; Li, Wen] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bliddal, Henning; Christensen, Robin; Tarp, Simon] Copenhagen Univ Hosp, Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit,Dept Rheumatol, Copenhagen, Denmark	Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen; Bispebjerg Hospital	Tarp, S (corresponding author), Copenhagen Univ Hosp, Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit,Dept Rheumatol, Copenhagen, Denmark.	Simon.Tarp@regionh.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668; Woo, Jennifer/0000-0001-8455-3996; Christensen, Robin/0000-0002-6600-0631	Oak Foundation	Oak Foundation	The Parker Institute (HB, RC, and ST) is supported by grants from the Oak Foundation.	[Anonymous], 1998, Fed Regist, V63, P40858; Dwan K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001666; FDA's, 2003, FDAS REV PROC NEW DR; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Food and Drug Administration HHS, 2008, FED REGISTER, V73, P39588; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Ioannidis JPA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002264; Milne CP, 2012, CLIN PHARMACOL THER, V91, P393, DOI 10.1038/clpt.2011.338; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; Scherer RW, 2007, COCHRANE DB SYST REV, V2007; Seife C, 2015, JAMA INTERN MED 0209; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Zarin DA, 2015, NEW ENGL J MED, V372, P174, DOI 10.1056/NEJMsr1414226	15	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147556	10.1371/journal.pone.0147556	http://dx.doi.org/10.1371/journal.pone.0147556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808309	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800132
J	Angers-Loustau, A; Petrillo, M; Paracchini, V; Kagkli, DM; Rischitor, PE; Gallardo, AP; Patak, A; Querci, M; Kreysa, J				Angers-Loustau, Alexandre; Petrillo, Mauro; Paracchini, Valentina; Kagkli, Dafni M.; Rischitor, Patricia E.; Gallardo, Antonio Puertas; Patak, Alex; Querci, Maddalena; Kreysa, Joachim			Towards Plant Species Identification in Complex Samples: A Bioinformatics Pipeline for the Identification of Novel Nuclear Barcode Candidates	PLOS ONE			English	Article							DNA BARCODE; GENES; QUANTIFICATION; VALIDATION; GENERATION; MARKERS; PROTEIN	Monitoring of the food chain to fight fraud and protect consumer health relies on the availability of methods to correctly identify the species present in samples, for which DNA barcoding is a promising candidate. The nuclear genome is a rich potential source of barcode targets, but has been relatively unexploited until now. Here, we show the development and use of a bioinformatics pipeline that processes available genome sequences to automatically screen large numbers of input candidates, identifies novel nuclear barcode targets and designs associated primer pairs, according to a specific set of requirements. We applied this pipeline to identify novel barcodes for plant species, a kingdom for which the currently available solutions are known to be insufficient. We tested one of the identified primer pairs and show its capability to correctly identify the plant species in simple and complex samples, validating the output of our approach.	[Angers-Loustau, Alexandre; Petrillo, Mauro; Paracchini, Valentina; Kagkli, Dafni M.; Rischitor, Patricia E.; Gallardo, Antonio Puertas; Patak, Alex; Querci, Maddalena; Kreysa, Joachim] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Angers-Loustau, A (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Mol Biol & Genom Unit, I-21020 Ispra, Italy.	alexandre.angers@ec.europa.eu	paracchini, valentina/AAG-6302-2021; Kagkli, Dafni-Maria/C-5987-2008; Petrillo, Mauro/AAL-6533-2021; Patak, Alex/L-2882-2015	Kagkli, Dafni-Maria/0000-0002-7351-135X; Petrillo, Mauro/0000-0002-6782-4704; Patak, Alex/0000-0002-9282-188X; Querci, Maddalena/0000-0002-0788-1627; Angers-Loustau, Alexandre/0000-0003-1425-4143; Puertas Gallardo, Antonio/0000-0003-3457-4777; Paracchini, Valentina/0000-0002-4847-9992				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bruno F, 2015, METHODS MOL BIOL, V1269, P257, DOI 10.1007/978-1-4939-2291-8_16; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan Megan L, 2013, Investig Genet, V4, P27, DOI 10.1186/2041-2223-4-27; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gordon A, 2010, FASTX TOOLKIT FASTQ; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; International Organization for Standardization Geneva Switzerland, 2005, 215712005 ISO ISOIEC; Jacchia S, 2015, J AGR FOOD CHEM, V63, P1711, DOI 10.1021/jf505516y; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Little DP, 2014, GENOME, V57, P513, DOI 10.1139/gen-2014-0130; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Naeem A, 2014, GENET MOL RES, V13, P10341, DOI 10.4238/2014.December.4.29; Pillon Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-35; Poczai P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-6; Reneker J, 2012, P NATL ACAD SCI USA, V109, pE1183, DOI 10.1073/pnas.1121356109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonnante G, 2009, J AGR FOOD CHEM, V57, P10199, DOI 10.1021/jf902624z; Stoeckle MY, 2008, SCI AM, V299, P82	37	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147692	10.1371/journal.pone.0147692	http://dx.doi.org/10.1371/journal.pone.0147692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807711	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800183
J	Bello-Morales, R; Crespillo, AJ; Praena, B; Tabares, E; Revilla, Y; Garcia, E; Fraile-Ramos, A; Baron, W; Krummenacher, C; Lopez-Guerrero, JA				Bello-Morales, Raquel; Crespillo, Antonio Jesus; Praena, Beatriz; Tabares, Enrique; Revilla, Yolanda; Garcia, Elena; Fraile-Ramos, Alberto; Baron, Wia; Krummenacher, Claude; Lopez-Guerrero, Jose Antonio			Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; HEPARAN-SULFATE; LOW-PH; MYELIN; RECEPTOR; TYPE-1; HERPESVIRUSES; ENDOCYTOSIS; ADHESION	Herpes simplex virus type 1 (HSV-1) has the ability to enter many different hosts and cell types by several strategies. This highly prevalent alphaherpesvirus can enter target cells using different receptors and different pathways: fusion at a neutral pH, low-pH-dependent and low-pH-independent endocytosis. Several cell receptors for viral entry have been described, but several observations suggest that more receptors for HSV-1 might exist. In this work, we propose a novel role for the proteolipid protein (PLP) in HSV-1 entry into the human oligodendrocytic cell line HOG. Cells transfected with PLP-EGFP showed an increase in susceptibility to HSV-1. Furthermore, the infection of HOG and HOG-PLP transfected cells with the R120vGF virus-unable to replicate in ICP4-defficient cells-showed an increase in viral signal in HOG-PLP, suggesting a PLP involvement in viral entry. In addition, a mouse monoclonal antibody against PLP drastically inhibited HSV-1 entry into HOG cells. PLP and virions colocalized in confocal immunofluorescence images, and in electron microscopy images, which suggest that PLP acts at the site of entry into HOG cells. Taken together these results suggest that PLP may be involved in HSV-1 entry in human oligodendrocytic cells.	[Bello-Morales, Raquel; Crespillo, Antonio Jesus; Praena, Beatriz; Lopez-Guerrero, Jose Antonio] Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol,Darwin 2, E-28049 Madrid, Spain; [Tabares, Enrique] Univ Autonoma Madrid, Fac Med, Arzobispo Morcillo 4, Madrid 28029, Spain; [Revilla, Yolanda; Garcia, Elena] CSIC UAM, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 5, Madrid 28049, Spain; [Bello-Morales, Raquel; Fraile-Ramos, Alberto] Univ Complutense Madrid, Fac Med, Plaza Ramon & Cajal,S-N Ciudad Univ, E-28040 Madrid, Spain; [Baron, Wia] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Krummenacher, Claude] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Krummenacher, Claude] Rowan Univ, Dept Biomed & Translat Sci, Glassboro, NJ 08028 USA	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Complutense University of Madrid; University of Groningen; Rowan University; Rowan University	Lopez-Guerrero, JA (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol,Darwin 2, E-28049 Madrid, Spain.	ja.lopez@uam.es	LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Bello-Morales, Raquel/AHD-5028-2022; Tabares, Enrique/AAA-4492-2019; Fraile-Ramos, Alberto/M-2072-2017	LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Fraile-Ramos, Alberto/0000-0002-0701-5454; Garcia Sanchez, Elena/0000-0003-2379-8126; Krummenacher, Claude/0000-0002-3492-4987; Yolanda, Revilla/0000-0001-6555-6331; Baron, Wia/0000-0002-6673-4766; Bello-Morales, Raquel/0000-0002-4415-6483; Praena, Beatriz/0000-0002-4628-7575; Bello-Morales, Raquel/0000-0002-8526-6590	Plan Nacional de I+D+I Subprograma de Proyectos de Investigacion Fundamental [SAF2012-40023]; Ministerio de Economia y Competitividad; Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad [BIO2013-46605-R]; Ministerio de Economia y Competitividad [BFU2012-35067]	Plan Nacional de I+D+I Subprograma de Proyectos de Investigacion Fundamental; Ministerio de Economia y Competitividad(Spanish Government); Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad; Ministerio de Economia y Competitividad(Spanish Government)	Financial support for the study was provided by Plan Nacional de I+D+I SAF2012-40023 Subprograma de Proyectos de Investigacion Fundamental, Ministerio de Economia y Competitividad and BIO2013-46605-R Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad. A F-R and R B-M were supported by grant BFU2012-35067 (Ministerio de Economia y Competitividad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Bello-Morales R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089141; Bello-Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019388; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; BOISON D, 1995, J NEUROSCI, V15, P5502; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; DUNCAN ID, 1987, P NATL ACAD SCI USA, V84, P6287, DOI 10.1073/pnas.84.17.6287; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2015, P NATL ACAD SCI USA, V112, pE3901, DOI 10.1073/pnas.1506846112; Greer JM, 2002, INT J BIOCHEM CELL B, V34, P211, DOI 10.1016/S1357-2725(01)00136-4; Held K, 2011, J NEUROVIROL, V17, P518, DOI 10.1007/s13365-011-0063-0; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Knapp PE, 1996, DEV NEUROSCI-BASEL, V18, P297, DOI 10.1159/000111420; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; Mateo M, 2015, J CELL SCI, V128, P431, DOI 10.1242/jcs.159400; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mori Masahiro, 2014, Adv Neurobiol, V8, P91; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Roizman B, 2011, J NEUROVIROL, V17, P512, DOI 10.1007/s13365-011-0058-x; Sari TK, 2013, J VIROL, V87, P13922, DOI 10.1128/JVI.02500-13; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schweighardt B, 2001, J NEUROVIROL, V7, P187; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Soldan MMP, 2012, SEMIN NEUROL, V32, P9, DOI 10.1055/s-0032-1306381; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Yool DA, 2000, HUM MOL GENET, V9, P987, DOI 10.1093/hmg/9.6.987	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147885	10.1371/journal.pone.0147885	http://dx.doi.org/10.1371/journal.pone.0147885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807581	Green Published, gold			2022-12-27	WOS:000369527800238
J	Felice, MR; Gulati, M; Giuffre, L; Giosa, D; Di Bella, LM; Criseo, G; Nobile, CJ; Romeo, O; Scordino, F				Felice, Maria Rosa; Gulati, Megha; Giuffre, Letterio; Giosa, Domenico; Di Bella, Luca Marco; Criseo, Giuseppe; Nobile, Clarissa J.; Romeo, Orazio; Scordino, Fabio			Molecular Characterization of the N-Acetylglucosamine Catabolic Genes in Candida africana, a Natural N-Acetylglucosamine Kinase (HXK1) Mutant	PLOS ONE			English	Article							ALBICANS; DUBLINIENSIS; PATHOGEN; IDENTIFICATION; PHYLOGENETICS; EPIDEMIOLOGY; INDUCTION; STRAINS; YEASTS	Background In this study we report the genetic characterization, including expression analysis, of the genes involved in the uptake (NGT1) and catabolism (HXK1/NAG5, DAC1/NAG2, NAG1) of the aminosugar N-acetylglucosamine (GlcNAc) in Candida africana, a pathogenic biovariant of Candida albicans that is naturally unable to assimilate the GlcNAc. Results DNA sequence analysis of these genes revealed a number of characteristic nucleotide substitutions including a unique and distinctive guanine insertion that shifts the reading frame and generates a premature stop codon (TGA) 154 bp downstream of the ATG start codon of the HXK1 gene encoding the GlcNAc-kinase, a key enzyme of the GlcNAc catabolic pathway. However, all examined genes produced transcripts even though different levels of expression were observed among the Candida isolates examined. In particular, we found an HXK1-idependent relationship of the NGT1 gene and a considerable influence of the GlcNAc-kinase functionality on the transcription of the DAC1 and NAG1 genes. Additional phenotypic analysis revealed that C. africana isolates are hyperfilamentous in the first 2448h of growth on filament-inducing media and revert to the yeast morphological form after 72h of incubation on these media. Conclusions Our results show that C. africana is a natural HXK1 mutant, displaying a number of phenotypic characteristics distinct from typical C. albicans isolates.	[Felice, Maria Rosa; Giuffre, Letterio; Giosa, Domenico; Di Bella, Luca Marco; Criseo, Giuseppe; Romeo, Orazio] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Gulati, Megha; Nobile, Clarissa J.] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA USA; [Romeo, Orazio; Scordino, Fabio] Ctr Neurolesi Bonino Pulejo, Sci Inst Res Hospitalizat & Hlth Care IRCCS, Messina, Italy	University of Messina; University of California System; University of California Merced; IRCCS Bonino Pulejo	Romeo, O (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.; Romeo, O (corresponding author), Ctr Neurolesi Bonino Pulejo, Sci Inst Res Hospitalizat & Hlth Care IRCCS, Messina, Italy.	oromeo@unime.it	Giosa, Domenico/B-8102-2017; SCORDINO, FABIO/K-1980-2016; Romeo, Orazio/A-6829-2010; Giosa, Domenico/X-8541-2019; Giuffre', Letterio/AAB-9254-2019; Nobile, Clarissa/C-2407-2015	Giosa, Domenico/0000-0002-3893-5296; SCORDINO, FABIO/0000-0002-7776-8515; Romeo, Orazio/0000-0001-5093-2525; Giosa, Domenico/0000-0002-3893-5296; Giuffre', Letterio/0000-0001-5091-3017; Nobile, Clarissa/0000-0003-0799-6499; Di Bella, Luca Marco/0000-0002-9834-8448; felice, maria rosa/0000-0002-4224-2345				Alonso-Vargas R, 2008, MED MYCOL, V46, P167, DOI 10.1080/13693780701633101; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Borman AM, 2013, J CLIN MICROBIOL, V51, P967, DOI 10.1128/JCM.02816-12; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Criseo G, 2015, J MICROBIOL METH, V111, P50, DOI 10.1016/j.mimet.2015.02.004; Dieng Y, 2012, J MYCOL MED, V22, P335, DOI 10.1016/j.mycmed.2012.07.052; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2012, VIRULENCE, V3, P251, DOI 10.4161/viru.20010; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Konopka JB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/489208; Kurtzman C. P., 1998, YEASTS TAXONOMY STUD; Muller FMC, 1998, J CLIN MICROBIOL, V36, P1625; Naseem Shamoon, 2012, Commun Integr Biol, V5, P156, DOI 10.4161/cib.19034; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Ngouana TK, 2015, MYCOSES, V58, P33, DOI 10.1111/myc.12266; Nnadi NE, 2012, MED MYCOL, V50, P765, DOI 10.3109/13693786.2012.662598; Nobile Clarissa J., 2009, V499, P175, DOI 10.1007/978-1-60327-151-6_17; O'Connor L, 2010, EUKARYOT CELL, V9, P1383, DOI 10.1128/EC.00042-10; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pagniez F., 2015, J MYCOLOGIE M DICALE, V25, pe107, DOI DOI 10.1016/J.MYCMED.2015.02.028; Prediger E A, 2001, Methods Mol Biol, V160, P49; Rao KH, 2014, BIOCHEM BIOPH RES CO, V445, P138, DOI 10.1016/j.bbrc.2014.01.123; Rao KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053638; Romeo O, 2008, DIAGN MICR INFEC DIS, V62, P230, DOI 10.1016/j.diagmicrobio.2008.05.014; Romeo O, 2013, CURR FUNGAL INFECT R, V7, P192, DOI 10.1007/s12281-013-0142-1; Romeo O, 2011, MYCOSES, V54, P475, DOI 10.1111/j.1439-0507.2010.01939.x; Romeo O, 2011, MYCOSES, V54, pE57, DOI 10.1111/j.1439-0507.2009.01833.x; Romeo O, 2009, J CLIN MICROBIOL, V47, P212, DOI 10.1128/JCM.01540-08; Romeo O, 2009, MYCOSES, V52, P454, DOI 10.1111/j.1439-0507.2008.01630.x; Shan YY, 2014, MED MYCOL, V52, P636, DOI 10.1093/mmy/myu003; Sharma C, 2014, MYCOSES, V57, P544, DOI 10.1111/myc.12193; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tietz HJ, 2001, MYCOSES, V44, P437, DOI 10.1046/j.1439-0507.2001.00707.x; TIETZ HJ, 1995, J CLIN MICROBIOL, V33, P2462, DOI 10.1128/JCM.33.9.2462-2465.1995; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Yazdanparast SA, 2015, MYCOPATHOLOGIA, V180, P317, DOI 10.1007/s11046-015-9924-z	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147902	10.1371/journal.pone.0147902	http://dx.doi.org/10.1371/journal.pone.0147902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808192	Green Published, gold			2022-12-27	WOS:000369527800243
J	Jiang, JJ; Li, KL; Wang, FL; Yang, B; Fu, YQ; Zheng, JS; Li, D				Jiang, Jiajing; Li, Kelei; Wang, Fenglei; Yang, Bo; Fu, Yuanqing; Zheng, Jusheng; Li, Duo			Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on Major Eicosanoids: A Systematic Review and Meta-Analysis from 18 Randomized Controlled Trials	PLOS ONE			English	Review							FISH-OIL SUPPLEMENTATION; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; VEGETABLE-OIL; DOUBLE-BLIND; OMEGA-3-FATTY-ACIDS; AGGREGATION; THROMBOXANE; PLATELET; DISEASE	Background Marine-derived n-3 polyunsaturated fatty acids (PUFA) may have a beneficial effect on inflammation via lowering pro-inflammatory eicosanoid concentrations. We aimed to assess the effect of marine-derived n-3 PUFA on prostaglandin E-2 (PGE(2)), thromboxane B-2 (TXB2), and leukotriene B-4 (LTB4) through systematic review and meta-analysis of randomized controlled trials. Method and Findings A structured search strategy on PubMed, Web of Science and Cochrane up to November 2015 was undertaken in this meta-analysis. Standard mean difference was used to calculate the effect size of marine-derived n-3 PUFA on PGE(2), TXB2 and LTB4 in a random-effect model. A total of 18 RCTs with 826 subjects were included in this systematic review and meta-analysis. Supplementation of marine-derived n-3 PUFA significantly decreased concentrations of TXB2 in serum/plasma in subjects with high risk of cardiovascular diseases (SMD:-1.26; 95% CI: -1.65, -0.86) and LTB4 in neutrophils in unhealthy subjects (subjects with non-autoimmune chronic diseases or auto-immune diseases) (SMD:-0.59: 95% CI: -1.02, -0.16). Subgroup analyses showed a significant reduction of LTB4 in subjects with rheumatoid arthritis (SMD: -0.83; 95% CI: -1.37, -0.29), but not in non-autoimmune chronic disease patients (SMD: -0.33; 95% CI: -0.97, 0.31). No significant publication bias was shown in the meta-analysis. Conclusions Marine-derived n-3 PUFA had a beneficial effect on reducing the concentration of TXB2 in blood of subjects with high risk of CVD as well as LTB4 in neutrophils in unhealthy subjects, and that subjects with RA showed lower LTB4 content with supplementation of marinederived n-3 PUFA.	[Jiang, Jiajing; Li, Kelei; Wang, Fenglei; Yang, Bo; Fu, Yuanqing; Zheng, Jusheng; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Jiajing; Li, Kelei; Wang, Fenglei; Yang, Bo; Fu, Yuanqing; Zheng, Jusheng; Li, Duo] APCNS Ctr Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.; Li, D (corresponding author), APCNS Ctr Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China.	duoli@zju.edu.cn	Wang, Fenglei/GYE-0853-2022; Li, Duo/N-3682-2013	Fu, Yuanqing/0000-0002-3955-9376; Li, Duo/0000-0001-5227-5565	National Basic Research Program of China (973 Program) [2015CB553604]; National Natural Science Foundation of China [NSFC: 81273054]; Ph.D. Programs Foundation of Ministry of Education of China [20120101110107]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This study was funded by the National Basic Research Program of China (973 Program: 2015CB553604); by National Natural Science Foundation of China (NSFC: 81273054); and by the Ph.D. Programs Foundation of Ministry of Education of China (20120101110107).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andrade PMM, 2007, PROSTAG LEUKOTR ESS, V77, P139, DOI 10.1016/j.plefa.2007.08.010; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; BOUGHTONSMITH NK, 1983, GUT, V24, P1176, DOI 10.1136/gut.24.12.1176; Browning LM, 2003, P NUTR SOC, V62, P447, DOI 10.1079/PNS2003252; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Caughey GE, 1996, AM J CLIN NUTR, V63, P116, DOI 10.1093/ajcn/63.1.116; Dawczynski C, 2013, CLIN NUTR, V32, P686, DOI 10.1016/j.clnu.2012.12.010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; GOLDMAN DW, 1983, BIOCHEM BIOPH RES CO, V117, P282, DOI 10.1016/0006-291X(83)91572-3; HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hishinuma T, 2007, PROSTAG LEUKOTR ESS, V76, P321, DOI 10.1016/j.plefa.2007.04.005; HOLMAN RT, 1994, AM J KIDNEY DIS, V23, P648, DOI 10.1016/S0272-6386(12)70274-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; KREMER JM, 1987, ANN INTERN MED, V106, P497, DOI 10.7326/0003-4819-106-4-497; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Maalole T, 2011, PROSTAG LEUKOTR ESS, V85, P37, DOI 10.1016/j.plefa.2011.04.004; Mehta SP, 2008, AM J CLIN NUTR, V87, P949, DOI 10.1093/ajcn/87.4.949; MORI TA, 1992, METABOLISM, V41, P1059, DOI 10.1016/0026-0495(92)90286-J; Murphy KJ, 2006, ASIA PAC J CLIN NUTR, V15, P418; Park Y, 2013, J NUTR BIOCHEM, V24, P1367, DOI 10.1016/j.jnutbio.2012.11.004; Peck LW, 1996, AM J CLIN NUTR, V64, P210, DOI 10.1093/ajcn/64.2.210; Phang M, 2013, J NUTR, V143, P457, DOI 10.3945/jn.112.171249; Pilkington SM, 2014, MOL NUTR FOOD RES, V58, P580, DOI 10.1002/mnfr.201300405; Pirich C, 1999, THROMB RES, V96, P219, DOI 10.1016/S0049-3848(99)00103-6; Rees D, 2006, AM J CLIN NUTR, V83, P331; SCOTT WA, 1982, J EXP MED, V155, P535, DOI 10.1084/jem.155.2.535; Singer P, 2004, PROSTAG LEUKOTR ESS, V71, P153, DOI 10.1016/j.plefa.2004.03.003; SORENSEN JD, 1993, AM J OBSTET GYNECOL, V168, P915, DOI 10.1016/S0002-9378(12)90845-5; SPERLING RI, 1993, J CLIN INVEST, V91, P651, DOI 10.1172/JCI116245; Tartibian B, 2011, CLIN J SPORT MED, V21, P131, DOI 10.1097/JSM.0b013e31820f8c2f; Thusgaard M, 2009, SCAND J INFECT DIS, V41, P760, DOI 10.1080/00365540903168056; Trebble TM, 2003, AM J CLIN NUTR, V78, P376, DOI 10.1093/ajcn/78.3.376; TURINI ME, 1994, AM J CLIN NUTR, V60, P717, DOI 10.1093/ajcn/60.5.717; VANDERTEMPEL H, 1990, ANN RHEUM DIS, V49, P76, DOI 10.1136/ard.49.2.76; Veicel E, 1999, ATHEROSCLEROSIS, V147, P187, DOI 10.1016/S0021-9150(99)00171-9; VERSTRAETE M, 1983, BRIT J CLIN PHARMACO, V15, pS7, DOI 10.1111/j.1365-2125.1983.tb02100.x; Zulyniak MA, 2013, METABOLISM, V62, P1107, DOI 10.1016/j.metabol.2013.02.004	48	42	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147351	10.1371/journal.pone.0147351	http://dx.doi.org/10.1371/journal.pone.0147351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808318	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800076
J	Vazquez-Guillen, JM; Palacios-Saucedo, GC; Rivera-Morales, LG; Garcia-Campos, J; Ortiz-Lopez, R; Noguera-Julian, M; Paredes, R; Vielma-Ramirez, HJ; Ramirez, TJ; Chavez-Garcia, M; Lopez-Guillen, P; Briones-Lara, E; Sanchez-Sanchez, LM; Vazquez-Martinez, CA; Rodriguez-Padilla, C				Manuel Vazquez-Guillen, Jose; Palacios-Saucedo, Gerardo C.; Rivera-Morales, Lydia G.; Garcia-Campos, Jorge; Ortiz-Lopez, Rocio; Noguera-Julian, Marc; Paredes, Roger; Vielma-Ramirez, Herlinda J.; Ramirez, Teresa J.; Chavez-Garcia, Marcelino; Lopez-Guillen, Paulo; Briones-Lara, Evangelina; Sanchez-Sanchez, Luz M.; Vazquez-Martinez, Carlos A.; Rodriguez-Padilla, Cristina			Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; HIV-1; VIRUS; PROTEASE; POPULATIONS; THERAPY; FAILURE; NAIVE	Although Structured Treatment Interruptions (STI) are currently not considered an alternative strategy for antiretroviral treatment, their true benefits and limitations have not been fully established. Some studies suggest the possibility of improving the quality of life of patients with this strategy; however, the information that has been obtained corresponds mostly to studies conducted in adults, with a lack of knowledge about its impact on children. Furthermore, mutations associated with antiretroviral resistance could be selected due to sub-therapeutic levels of HAART at each interruption period. Genotyping methods to determine the resistance profiles of the infecting viruses have become increasingly important for the management of patients under STI, thus low-abundance antiretroviral drug-resistant mutations (DRM's) at levels under limit of detection of conventional genotyping (< 20% of quasispecies) could increase the risk of virologic failure. In this work, we analyzed the protease and reverse transcriptase regions of the pol gene by ultra-deep sequencing in pediatric patients under STI with the aim of determining the presence of high-and low-abundance DRM's in the viral rebounds generated by the STI. High-abundance mutations in protease and high- and low-abundance mutations in reverse transcriptase were detected but no one of these are directly associated with resistance to antiretroviral drugs. The results could suggest that the evaluated STI program is virologically safe, but strict and carefully planned studies, with greater numbers of patients and interruption/ restart cycles, are still needed to evaluate the selection of DRM's during STI.	[Manuel Vazquez-Guillen, Jose; Rivera-Morales, Lydia G.; Vielma-Ramirez, Herlinda J.; Rodriguez-Padilla, Cristina] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Inmunol & Virol, Monterrey, Nuevo Leon, Mexico; [Palacios-Saucedo, Gerardo C.; Garcia-Campos, Jorge; Chavez-Garcia, Marcelino; Briones-Lara, Evangelina; Sanchez-Sanchez, Luz M.; Vazquez-Martinez, Carlos A.] Hosp Especialidades 25, Unidad Med Alta Especialidad, Dept Pediat & Infectol Pediat, Inst Mexicano Seguro Social,Div Invest, Monterrey, Nuevo Leon, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Fac Med, Monterrey, Nuevo Leon, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Ctr Invest Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [Noguera-Julian, Marc; Paredes, Roger] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Recerca SIDA, IrsiCaixa, Badalona, Spain; [Noguera-Julian, Marc; Paredes, Roger] Univ Vic, Catedra SIDA, Vic, Spain; [Ramirez, Teresa J.] Lab Estatal Salud Publ Estado Nuevo Leon, Secretaria Salud, Nuevo Leon, Mexico; [Lopez-Guillen, Paulo] Hosp Gen Reg 45, Inst Mexicano Seguro Social, Unidad Infectol Dr Juan I Menchaca, Jalisco, Mexico	Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Instituto Mexicano del Seguro Social	Palacios-Saucedo, GC (corresponding author), Hosp Especialidades 25, Unidad Med Alta Especialidad, Dept Pediat & Infectol Pediat, Inst Mexicano Seguro Social,Div Invest, Monterrey, Nuevo Leon, Mexico.	palsaugc@gmail.com	Vazquez-Guillen, Jose Manuel/W-6886-2019; Ortiz-Lopez, Rocio/N-4827-2018; Noguera-Julian, Marc/F-8651-2016	Vazquez-Guillen, Jose Manuel/0000-0001-8256-4253; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Noguera-Julian, Marc/0000-0002-6194-1395; Sanchez-Sanchez, Luz Maria/0000-0001-5973-3530; Rivera-Morales, Lydia Guadalupe/0000-0001-7329-0449	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [44519]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the grant 44519 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. We thank to Ramses Medina-Gonzalez for his help and collaboration in the technical work of sequencing experiments, to the Laboratorio de Inmunologia y Virologia from Facultad de Ciencias Biologicas UANL for providing all the necessary facilities for the research, and to the Red Tematica de Inmunologia en Cancer y Enfermedades Infecciosas (INMUNOCANEI-CONACYT) for all its collaboration.	Alteri C, 2011, J ANTIMICROB CHEMOTH, V66, P2615, DOI 10.1093/jac/dkr354; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Borkowsky W, 2008, AIDS RES HUM RETROV, V24, P401, DOI 10.1089/aid.2007.0110; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Kalmar EMN, 2012, INT J STD AIDS, V23, P120, DOI 10.1258/ijsa.2011.011124; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lori F, 2000, LANCET, V355, P287, DOI 10.1016/S0140-6736(99)03515-1; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Monpoux F, 2004, AIDS, V18, P2401; O'Meara D, 2001, J CLIN MICROBIOL, V39, P464, DOI 10.1128/JCM.39.2.464-473.2001; Palacios GC, 2010, INT J INFECT DIS, V14, pE34, DOI 10.1016/j.ijid.2009.03.003; Palacios-Saucedo GC, 2011, CURR HIV RES, V9, P154, DOI 10.2174/157016211795945250; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Saitoh A, 2008, PEDIATRICS, V121, pE513, DOI 10.1542/peds.2007-1086; Valle-Bahena OM, 2006, ARCH MED RES, V37, P1022, DOI 10.1016/j.arcmed.2006.05.014; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642	24	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147591	10.1371/journal.pone.0147591	http://dx.doi.org/10.1371/journal.pone.0147591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807922	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800143
J	Pereira, RV; Lima, S; Siler, JD; Foditsch, C; Warnick, LD; Bicalho, RC				Pereira, Richard Van Vleck; Lima, Svetlana; Siler, Julie D.; Foditsch, Carla; Warnick, Lorin D.; Bicalho, Rodrigo Carvalho			Ingestion of Milk Containing Very Low Concentration of Antimicrobials: Longitudinal Effect on Fecal Microbiota Composition in Preweaned Calves	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GUT MICROBIOTA; CHILDHOOD; INFECTION; RESIDUES; BACTERIA; RISK; EXTRACTION; STABILITY; EXPOSURE	Although antimicrobial drugs are central to combat disease in modern medicine, the use of these drugs can have undesired consequences for human and animal health. One consequence is the post-therapy excretion of pharmacological agents, such as the elimination of drug residues at very low concentrations in the milk of lactating mammals. Limited information is currently available on the impact from the exposure of the gut microbiota to drug residues using in vivo natural models. The objective of our study was to address this knowledge gap and evaluate the effect on the fecal microbiota composition from feeding preweaned dairy calves raw milk with residual concentrations of ampicillin, ceftiofur, penicillin, and oxytetracycline from birth to weaning. At birth, thirty calves were randomly assigned to a controlled feeding trial where: 15 calves were fed raw milk with no drug residues (NR), and 15 calves were fed raw milk with drug residues (DR) by adding ceftiofur, penicillin, ampicillin, and oxytetracycline at final concentrations in the milk of 0.1, 0.005, 0.01, and 0.3 mu g/ml, respectively. Fecal samples were rectally collected from each calf once a week starting at birth, prior to the first feeding in the trial (pretreatment), until 6 weeks of age. Sequencing of the microbial 16S rRNA genes was conducted using the Illumina MiSeq, which provides a high resolution of the microbiota down to the genus level. Discriminant analysis showed that, except for pretreatment samples, calves fed milk with drug residues and calves fed milk without drug residues easily discriminated at the genus level on their weekly microbial profile. However, analysis comparing the abundance of taxon between NR and DR showed significant differences only at the genus levels, and not at the phylum, class, order or family levels. These results suggest that although drug residues can result in clear discriminate gut microbial communities, they do not result in disruption of taxonomic levels above the genus.	[Pereira, Richard Van Vleck; Lima, Svetlana; Siler, Julie D.; Foditsch, Carla; Warnick, Lorin D.; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Pereira, Richard Van Vleck] Univ Calif Davis, Coll Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Cornell University; University of California System; University of California Davis	Pereira, RV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.; Pereira, RV (corresponding author), Univ Calif Davis, Coll Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	rvpereira@UCDavis.edu	Pereira, Richard/L-2684-2019	Pereira, Richard/0000-0003-2028-8761	National Institute of Food and Agriculture (NIFA), USDA, under HATCH award [NYC-478400]; National Center for Research Resources, a component of the National Institutes of Health (NIH) [T32ODO011000]	National Institute of Food and Agriculture (NIFA), USDA, under HATCH award; National Center for Research Resources, a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this publication was supported by the National Institute of Food and Agriculture (NIFA), USDA, under HATCH award number NYC-478400. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Food and Agriculture (NIFA) or the USDA. Research reported in this publication was partially supported by National Center for Research Resources, a component of the National Institutes of Health (NIH), under Award Number T32ODO011000. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Akiho Hirotada, 2010, World J Gastrointest Pathophysiol, V1, P97, DOI 10.4291/wjgp.v1.i3.97; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Berlin CM, 2005, SEMIN FETAL NEONAT M, V10, P149, DOI 10.1016/j.siny.2004.09.016; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolder NM, 1999, POULTRY SCI, V78, P1681, DOI 10.1093/ps/78.12.1681; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CDC, 2015, BRIDG RAC POP EST US, P1; CLSI, 2012, M100D22 CLSI; Dantas G, 2014, AM SCI, V102, P42, DOI 10.1511/2014.106.42; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heinrichs A. J., 2005, Calf and heifer rearing: principles of rearing the modern dairy heifer from calf to calving. 60th University of Nottingham Easter School in Agricultural Science, Nottingham, UK. 23rd- 24th March, 2004, P53; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Johnson CC, 2005, J ALLERGY CLIN IMMUN, V115, P1218, DOI 10.1016/j.jaci.2005.04.020; Karageorgou EG, 2010, J SEP SCI, V33, P2862, DOI 10.1002/jssc.201000385; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Kruger M, 2014, ANAEROBE, V27, P100, DOI 10.1016/j.anaerobe.2014.03.013; Kusel MMH, 2008, CLIN EXP ALLERGY, V38, P1921, DOI 10.1111/j.1365-2222.2008.03138.x; Langford FM, 2003, J DAIRY SCI, V86, P3963, DOI 10.3168/jds.S0022-0302(03)74006-5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Niewold TA, 2007, POULTRY SCI, V86, P605, DOI 10.1093/ps/86.4.605; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pereira R. V., 2014, J DAIRY SCI; Pereira RV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115223; Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287; Riley Lee W, 2013, Front Public Health, V1, P69, DOI 10.3389/fpubh.2013.00069; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Schenck FJ, 2000, FOOD ADDIT CONTAM, V17, P675, DOI 10.1080/02652030050083196; Schneider MJ, 2005, J AOAC INT, V88, P1160; Schriks M, 2010, WATER RES, V44, P461, DOI 10.1016/j.watres.2009.08.023; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Smaill FM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub3; Smith DR, 2012, VET CLIN N AM-FOOD A, V28, P465, DOI 10.1016/j.cvfa.2012.07.010; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; USDA, 2008, REF DAIR CATTL HLT 1; Webster G, 2007, DERMATOL CLIN, V25, P133, DOI 10.1016/j.det.2007.01.012; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zwald AG, 2004, J DAIRY SCI, V87, P191, DOI 10.3168/jds.S0022-0302(04)73158-6	51	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147525	10.1371/journal.pone.0147525	http://dx.doi.org/10.1371/journal.pone.0147525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808865	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800121
J	Schulte, EC; Altmaier, E; Berger, HS; Do, KT; Kastenmuller, G; Wahl, S; Adamski, J; Peters, A; Krumsiek, J; Suhre, K; Haslinger, B; Ceballos-Baumann, A; Gieger, C; Winkelmann, J				Schulte, Eva C.; Altmaier, Elisabeth; Berger, Hannah S.; Kieu Trinh Do; Kastenmueller, Gabi; Wahl, Simone; Adamski, Jerzy; Peters, Annette; Krumsiek, Jan; Suhre, Karsten; Haslinger, Bernhard; Ceballos-Baumann, Andres; Gieger, Christian; Winkelmann, Juliane			Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders	PLOS ONE			English	Article							RESTLESS-LEGS-SYNDROME; POLYUNSATURATED FATTY-ACIDS; IDIOPATHIC PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; METABOLOMICS; POPULATION; BIOMARKERS; DIAGNOSIS	Background Serum metabolite profiling can be used to identify pathways involved in the pathogenesis of and potential biomarkers for a given disease. Both restless legs syndrome (RLS) and Parkinson's disease (PD) represent movement disorders for which currently no blood-based biomarkers are available and whose pathogenesis has not been uncovered conclusively. We performed unbiased serum metabolite profiling in search of signature metabolic changes for both diseases. Methods 456 metabolites were quantified in serum samples of 1272 general population controls belonging to the KORA cohort, 82 PD cases and 95 RLS cases by liquid-phase chromatography and gas chromatography separation coupled with tandem mass spectrometry. Genetically determined metabotypes were calculated using genome-wide genotyping data for the 1272 general population controls. Results After stringent quality control, we identified decreased levels of long-chain (polyunsaturated) fatty acids of individuals with PD compared to both RLS (PD vs. RLS: p = 0.0001 to 5.80x10(-9)) and general population controls (PD vs. KORA: p = 6.09x10(-5) to 3.45x10(-32)). In RLS, inositol metabolites were increased specifically (RLS vs. KORA: p = 1.35x10(-6) to 3.96x10(-7)). The impact of dopaminergic drugs was reflected in changes in the phenylalanine/tyrosine/dopamine metabolism observed in both individuals with RLS and PD. Conclusions A first discovery approach using serum metabolite profiling in two dopamine-related movement disorders compared to a large general population sample identified significant alterations in the polyunsaturated fatty acid metabolism in PD and implicated the inositol metabolism in RLS. These results provide a starting point for further studies investigating new perspectives on factors involved in the pathogenesis of the two diseases as well as possible points of therapeutic intervention.	[Schulte, Eva C.; Berger, Hannah S.; Haslinger, Bernhard; Ceballos-Baumann, Andres; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany; [Schulte, Eva C.; Berger, Hannah S.; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Altmaier, Elisabeth; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Altmaier, Elisabeth; Wahl, Simone; Gieger, Christian] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Kieu Trinh Do; Krumsiek, Jan] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Kastenmueller, Gabi] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Wahl, Simone; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Suhre, Karsten] Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, POB 24144, Doha, Qatar; [Ceballos-Baumann, Andres] Schon Klin Munchen Schwabing, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Winkelmann, Juliane] Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technical University of Munich; University of Munich; Stanford University	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany.; Winkelmann, J (corresponding author), Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Winkelmann, J (corresponding author), Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA.	winkelmann@lrz.tum.de	Kastenmüller, Gabi/ABF-5987-2020; Peters, Annette/A-6117-2011; Suhre, Karsten/AAF-1778-2020; Schulte, Eva C./AAT-2410-2021	Peters, Annette/0000-0001-6645-0985; Suhre, Karsten/0000-0001-9638-3912; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Winkelmann, Juliane/0000-0003-2667-9691; Schulte, Eva Christina/0000-0003-3105-5672	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH); German Federal Ministry of Education and Research (BMBF); State of Bavaria; European Union's Seventh Framework Programme (MIMOmics) [305280]; German Federal Ministry of Education and Research (BMBF) [01ZX1313C]; Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar; Technische Universitat Munchen, Munich, Germany; Xenoport; UCB; Biomedical Research Program funds at Weill Cornell Medical College in Qatar; Qatar Foundation; Pfizer Worldwide Research and Development	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH)(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union's Seventh Framework Programme (MIMOmics); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar; Technische Universitat Munchen, Munich, Germany; Xenoport; UCB(UCB Pharma SA); Biomedical Research Program funds at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Pfizer Worldwide Research and Development	The KORA research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education and Research (BMBF; http://www.bmbf.de/) and by the State of Bavaria. EA was supported from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement no 305280 (MIMOmics; http://www.mimomics.eu/). KTD was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:AtheroSysMed research and funding concept (grant no 01ZX1313C; http://www.sys-med.de/de/konsortien/eatherosysmed/). ECS and JW received funding from the Kommission fur Klinische Forschung (KKF) des Klinikums rechts der Isar, Technische Universitat Munchen, Munich, Germany (http://www.med.tum.de/en/node/427). JW received personal fees from Xenoport (http://www.xenoport.com/) and grant support from UCB (http://www.ucb.de/home) outside the submitted work. KS was supported in part by Biomedical Research Program funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). Serum metabolic profiles of KORA controls were partly financed by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.; http://www.dzd-ev.de/) and from Pfizer Worldwide Research and Development (http://www.pfizer.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; De Vito K, 2014, MOV DISORD; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fux M, 1996, AM J PSYCHIAT, V153, P1219; Gaut JP, 2014, CLIN CHEM, V60, P747, DOI 10.1373/clinchem.2013.212993; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hu XW, 2013, ACTA NEUROL SCAND, V128, P73, DOI 10.1111/ane.12106; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Meng QJ, 2010, EUR J PHARMACOL, V649, P127, DOI 10.1016/j.ejphar.2010.09.046; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schouwers S, 2012, CLIN CHIM ACTA, V413, P100, DOI 10.1016/j.cca.2011.08.037; Shchepinov MS, 2011, TOXICOL LETT, V207, P97, DOI 10.1016/j.toxlet.2011.07.020; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Trupp M, 2014, J PARKINSONS DIS; Whelan J, 2008, J NUTR, V138, P2521, DOI 10.3945/jn.108.095943; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Yakunin E, 2012, BRAIN PATHOL, V22, P280, DOI 10.1111/j.1750-3639.2011.00530.x; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	40	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147129	10.1371/journal.pone.0147129	http://dx.doi.org/10.1371/journal.pone.0147129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808974	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800054
J	Sothilingam, V; Michalakis, S; Garrido, MG; Biel, M; Tanimoto, N; Seeliger, MW				Sothilingam, Vithiyanjali; Michalakis, Stylianos; Garrido, Marina Garcia; Biel, Martin; Tanimoto, Naoyuki; Seeliger, Mathias W.			HCN1 Channels Enhance Rod System Responsivity in the Retina under Conditions of Light Exposure	PLOS ONE			English	Article							CONE BIPOLAR CELLS; MOUSE RETINA; MAMMALIAN RETINA; GAP-JUNCTIONS; ION CHANNELS; PATHWAYS; MICE; MODULATION; VISION; INPUT	Purpose Vision originates in rods and cones at the outer retina. Already at these early stages, diverse processing schemes shape and enhance image information to permit perception over a wide range of lighting conditions. In this work, we address the role of hyperpolarization-activated and cyclic nucleotide-gated channels 1 (HCN1) in rod photoreceptors for the enhancement of rod system responsivity under conditions of light exposure. Methods To isolate HCN1 channel actions in rod system responses, we generated double mutant mice by crossbreeding Hcn1(-/-) mice with Cnga3(-/-) mice in which cones are non-functional. Retinal function in the resulting Hcn1(-/-) Cnga3(-/-) animals was followed by means of electroretinography (ERG) up to the age of four month. Retinal imaging via scanning laser ophthalmoscopy (SLO) and optical coherence tomography (OCT) was also performed to exclude potential morphological alterations. Results This study on Hcn1(-/-) Cnga3(-/-) mutant mice complements our previous work on HCN1 channel function in the retina. We show here in a functional rod-only setting that rod responses following bright light exposure terminate without the counteraction of HCN channels much later than normal. The resulting sustained signal elevation does saturate the retinal network due to an intensity-dependent reduction in the dynamic range. In addition, the lack of rapid adaptational feedback modulation of rod photoreceptor output via HCN1 in this double mutant limits the ability to follow repetitive (flicker) stimuli, particularly under mesopic conditions. Conclusions This work corroborates the hypothesis that, in the absence of HCN1-mediated feedback, the amplitude of rod signals remains at high levels for a prolonged period of time, leading to saturation of the retinal pathways. Our results demonstrate the importance of HCN1 channels for regular vision.	[Sothilingam, Vithiyanjali; Garrido, Marina Garcia; Tanimoto, Naoyuki; Seeliger, Mathias W.] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Schleichstr 4-3, D-72076 Tubingen, Germany; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci Munich CIPSM, Ctr Drug Res, Butenandtstr 5-13, D-81377 Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Sothilingam, V (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Schleichstr 4-3, D-72076 Tubingen, Germany.	Vithiyanjali.Sothilingam@med.uni-tuebingen.de	Michalakis, Stylianos/M-4677-2019; Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018	Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238	Deutsche Forschungsgemeinschaft (DFG) [Se837/4-1, Se837/5-2, Se837/6-2]; University of Tuebingen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Tuebingen	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), grants Se837/4-1, 5-2, and 6-2 and Open Access Publishing Fund of University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Della Santina L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029812; Feigenspan A, 2004, J NEUROSCI, V24, P3325, DOI 10.1523/JNEUROSCI.5598-03.2004; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Haverkamp S, 2006, J NEUROSCI, V26, P5248, DOI 10.1523/JNEUROSCI.4483-05.2006; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; KOLB H, 1977, J NEUROCYTOL, V6, P131, DOI 10.1007/BF01261502; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Tanimoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10731; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2012, J NEUROSCI, V32, P4861, DOI 10.1523/JNEUROSCI.4654-11.2012; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147728	10.1371/journal.pone.0147728	http://dx.doi.org/10.1371/journal.pone.0147728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807953	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800199
J	Tan, CT; Xuan, LL; Cao, SH; Yu, GG; Hou, Q; Wang, HY				Tan, Chunting; Xuan, Lingling; Cao, Shuhua; Yu, Ganggang; Hou, Qi; Wang, Haoyan			Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients	PLOS ONE			English	Article							NF-KAPPA-B; LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; INFLAMMATION; SMOKING; TRANSCRIPTION; EPIGENETICS; EXPRESSION; RESPONSES	Background Histone deacetylase 2 (HDAC2) is a class I histone deacetylase family member that plays a critical role in suppressing inflammatory gene expression in the airways, lung parenchyma, and alveolar macrophages in patients with chronic obstructive pulmonary disease (COPD). However, the expression of HDAC2 in peripheral blood monocytes (PBMCs), nuclear factor kappa B (NF-kappa B) p65, and serum inflammatory cytokine levels in COPD patients, smokers, and non-smokers remains unclear. Methods PBMCs were obtained from COPD patients, healthy smokers, and healthy nonsmokers. The HDAC2 and NF-kappa B p65 expression were quantified byWestern Blot. HDAC activity was assessed by an HDAC fluorometric immunoprecipitation activity assay kit. Serum tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) levels were measured by ELISA. Results HDAC2 expression and HDAC activity were decreased in PBMCs in COPD patients compared with smokers and non-smokers. Increased NF-kappa B p65 expression, serum TNF-alpha and IL-8 levels were observed in COPD patients compared with nonsmokers. The FEV1% pred was positively correlated with HDAC2 expression and HDAC activity in COPD patients. Smokers had decreased HDAC activity, increased NF-kappa B p65 expression and serum TNF-alpha compared with nonsmokers. Conclusions HDAC2 expression was decreased in PBMCs of COPD patients and was correlated with disease severity. The reduction of HDAC2 expression not only directly enhances the expression of inflammatory genes, but may account for the activation of NF-kappa B mediated inflammation. Decreased HDAC2 may serve as a potential biomarker of COPD and predict the decline of lung function.	[Tan, Chunting; Yu, Ganggang; Wang, Haoyan] Capital Med Univ, Beijing Friendship Hosp, Dept Resp Med, Beijing, Peoples R China; [Xuan, Lingling; Cao, Shuhua; Hou, Qi] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Xuan, Lingling; Cao, Shuhua; Hou, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xuan, Lingling] Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Wang, HY (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Resp Med, Beijing, Peoples R China.	haoyanw@126.com	Tan, Chunting/AAC-5319-2019		Beijing Municipal Natural Science Foundation [7142046]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	Support was provided by the Beijing Municipal Natural Science Foundation (7142046).	Adcock Ian M, 2005, COPD, V2, P445; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Andreoli C, 2015, CLIN CHEM LAB MED, V53, P57, DOI 10.1515/cclm-2013-0290; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Caramori G, 2006, AM J RESP CRIT CARE, V174, P2, DOI 10.1164/rccm.2604001; Chen Y, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-10; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K., 2001, FASEB Journal, V15, P1110; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; Mittelstadt ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042152; Qu YQ, 2013, MOL BIOL REP, V40, P3995, DOI 10.1007/s11033-012-2477-z; Rahman I, 2002, BIOCHEM PHARMACOL, V64, P935, DOI 10.1016/S0006-2952(02)01153-X; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reddy NM, 2012, AM J PATHOL, V180, P562, DOI 10.1016/j.ajpath.2011.10.029; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Tatli U, 2013, IMPLANT DENT, V22, P519, DOI 10.1097/ID.0b013e31829a1718; Warburton David, 2006, Proc Am Thorac Soc, V3, P668, DOI 10.1513/pats.200605-122SF; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012	33	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147380	10.1371/journal.pone.0147380	http://dx.doi.org/10.1371/journal.pone.0147380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809128	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800083
J	Vos, AG; Idris, NS; Barth, RE; Klipstein-Grobusch, K; Grobbee, DE				Vos, Alinda G.; Idris, Nikmah S.; Barth, Roos E.; Klipstein-Grobusch, Kerstin; Grobbee, Diederick E.			Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review	PLOS ONE			English	Review							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL ACTIVATION MARKERS; SUBCLINICAL ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; ANTIRETROVIRAL THERAPY; UNINFECTED ADULTS; ARTERY-DISEASE	Background In the past years many inflammatory markers have been studied in association with clinically manifest cardiovascular disease (CVD) and carotid intima-media thickness (CIMT) in HIV-infected patients, to obtain insights in the increased cardiovascular risk observed in HIV infection. This systematic review provides an oversight of the current knowledge. Methods A search was performed in PubMed, Embase and Cochrane in July 2014, identifying all articles from 1996 onwards addressing the relation between inflammatory markers and CVD or CIMT in HIV-positive adults. Two authors, using predefined criteria, independently conducted the selection of articles, critical appraisal and extraction of the data. Analysis was focused on the immune markers that were most frequently assessed. The review protocol was registered in the PROSPERO database at 11 July 2014 (registration number CRD42014010516). This review was performed according to the PRISMA guideline. Findings Forty articles were selected; eight addressing cardiovascular disease (CVD) and thirty-two addressing CIMT. C-reactive protein (CRP), interleukin-6 (IL-6) and d-dimer were assessed most frequently in relation to the occurrence of CVD; in four out of eight studies. All three markers were positively related to CVD in three out of four studies. Studies addressing CIMT were too heterogeneous with respect to patient populations, inflammatory markers, CIMT measurement protocols and statistical methods to allow for a formal meta-analysis to obtain summary statistics. CRP, IL-6 and soluble vascular cell adhesion molecule (sVCAM-1) were the most studied markers in relation to CIMT. None of the inflammatory markers showed an association with CIMT. Interpretation This review showed a relation between some inflammatory markers and CVD, however, no consistent relation is observed for CIMT. Statistical approaches that yields effect estimates and standardized CIMT protocols should be chosen. Further research should focus on prospective studies and a selected set of inflammatory markers.	[Vos, Alinda G.; Idris, Nikmah S.; Klipstein-Grobusch, Kerstin; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Vos, Alinda G.; Barth, Roos E.] Univ Med Ctr Utrecht, Dept Infect Dis, Utrecht, Netherlands; [Idris, Nikmah S.] Univ Indonesia, Dept Child Hlth, Fac Med, Cipto Mangunkusumo Hosp, Jakarta, Indonesia	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Indonesia	Vos, AG (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Med Ctr Utrecht, Dept Infect Dis, Utrecht, Netherlands.	a.g.vos-8@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Vos, Alinda/0000-0002-9551-6223; Idris, Nikmah Salamia/0000-0001-5890-1934				Alonso-Villaverde C, 2004, CIRCULATION, V110, P2204, DOI 10.1161/01.CIR.0000143835.95029.7D; BadioU S, 2008, J INFECTION, V57, P47, DOI 10.1016/j.jinf.2008.05.007; Baker JV, 2011, AIDS, V25, P2133, DOI 10.1097/QAD.0b013e32834be088; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Bonilla H, 2013, INFECT DIS CLIN PRAC, V21, P177, DOI DOI 10.1097/IPC.0B013E31828262F3; Falcao MDBD, 2012, ARQ BRAS CARDIOL, V99, P971; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Luca A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-414; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Freitas P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-348; Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204; Hileman CO, 2014, JAIDS-J ACQ IMM DEF, V65, P340, DOI 10.1097/QAI.0000000000000063; Hileman CO, 2013, ANTIVIR THER, V18, P921, DOI 10.3851/IMP2651; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Jeong SJ, 2011, ATHEROSCLEROSIS, V219, P778, DOI 10.1016/j.atherosclerosis.2011.08.003; Joven J, 2006, CLIN CHIM ACTA, V368, P114, DOI 10.1016/j.cca.2005.12.014; Kaplan RC, 2012, JAIDS-J ACQ IMM DEF, V60, P359, DOI 10.1097/QAI.0b013e31825b03be; Kelesidis T, 2013, AIDS RES HUM RETROV, V29, P938, DOI [10.1089/AID.2012.0305, 10.1089/aid.2012.0305]; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Knudsen A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-230; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Longenecker CT, 2013, HIV MED, V14, P385, DOI 10.1111/hiv.12013; Longenecker CT, 2014, AIDS, V28, P969, DOI 10.1097/QAD.0000000000000158; Mangili A, 2007, CLIN INFECT DIS, V44, P1368, DOI 10.1086/516616; Mangili A, 2006, CLIN INFECT DIS, V43, P1482, DOI 10.1086/509575; Mangili A, 2014, CLIN INFECT DIS, V58, P893, DOI 10.1093/cid/cit815; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Miedema F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00298; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Parra S, 2010, HIV MED, V11, P225, DOI 10.1111/j.1468-1293.2009.00766.x; Piconi S, 2013, AIDS, V27, P381, DOI 10.1097/QAD.0b013e32835abcc9; Pirro M, 2014, EUR J PREV CARD 0606; Portilla J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18945; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Ross Eckard A, 2014, HIV MED; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sankatsing RR, 2009, ATHEROSCLEROSIS, V202, P589, DOI 10.1016/j.atherosclerosis.2008.05.028; Shah S, 2015, AIDS, V29, P1325, DOI 10.1097/QAD.0000000000000654; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Stein JH, 2013, AIDS, V27, P929, DOI 10.1097/QAD.0b013e32835ce27e; Su DF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/726178; Tenorio AR, 2014, J INFECT DIS; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Tungsiripat M, 2011, AIDS RES HUM RETROV, V27, P295, DOI 10.1089/aid.2010.0187; van Wijk JPH, 2006, J AM COLL CARDIOL, V47, P1117, DOI 10.1016/j.jacc.2005.09.073; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Willeit P, 2014, EUR J PREV CARD 1121; Willeit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055175; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	68	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147484	10.1371/journal.pone.0147484	http://dx.doi.org/10.1371/journal.pone.0147484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808540	Green Published, gold			2022-12-27	WOS:000369527800107
J	Wolf, A; Bauer, B; Abner, EL; Ashkenazy-Frolinger, T; Hartz, AMS				Wolf, Andrea; Bauer, Bjoern; Abner, Erin L.; Ashkenazy-Frolinger, Tal; Hartz, Anika M. S.			A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MOUSE MODEL; OBJECT RECOGNITION TASK; MORRIS WATER MAZE; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DEFICITS; SPONTANEOUS-ALTERNATION; SPATIAL MEMORY; RETINAL DEGENERATION	Transgenic Tg2576 mice overexpressing human amyloid precursor protein (hAPP) are a widely used Alzheimer's disease (AD) mouse model to evaluate treatment effects on amyloid beta (A beta) pathology and cognition. Tg2576 mice on a B6;SJL background strain carry a recessive rd1 mutation that leads to early retinal degeneration and visual impairment in homozygous carriers. This can impair performance in behavioral tests that rely on visual cues, and thus, affect study results. Therefore, B6;SJL/Tg2576 mice were systematically backcrossed with 129S6/SvEvTac mice resulting in 129S6/Tg2576 mice that lack the rd1 mutation. 129S6/Tg2576 mice do not develop retinal degeneration but still show A beta-accumulation in the brain that is comparable to the original B6;SJL/Tg2576 mouse. However, comprehensive studies on cognitive decline in 129S6/Tg2576 mice are limited. In this study, we used two dementia mouse models on a 129S6 background-scopolamine-treated 129S6/SvEvTac mice (3-5 month-old) and transgenic 129S6/Tg2576 mice (11-13 month-old)-to establish a behavioral test battery for assessing learning and memory. The test battery consisted of five tests to evaluate different aspects of cognitive impairment: a Y-Maze forced alternation task, a novel object recognition test, the Morris water maze, the radial arm water maze, and a Y-maze spontaneous alternation task. We first established this behavioral test battery with the scopolamine-induced dementia model using 129S6/SvEvTac mice and then evaluated 129S6/Tg2576 mice using the same testing protocol. Both models showed distinctive patterns of cognitive impairment. Together, the non-invasive behavioral test battery presented here allows detecting cognitive impairment in scopolamine-treated 129S6/SvEvTac mice and in transgenic 129S6/Tg2576 mice. Due to the modular nature of this test battery, more behavioral tests, e.g. invasive assays to gain additional cognitive information, can easily be added.	[Wolf, Andrea; Bauer, Bjoern; Hartz, Anika M. S.] Univ Minnesota, Dept Pharm Practice & Pharmaceut Sci, Coll Pharm, Duluth, MN 55812 USA; [Bauer, Bjoern] Univ Kentucky, Dept Pharmaceut Sci, Coll Pharm, Lexington, KY 40536 USA; [Abner, Erin L.; Ashkenazy-Frolinger, Tal; Hartz, Anika M. S.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Hartz, Anika M. S.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA	University of Minnesota System; University of Minnesota Duluth; University of Kentucky; University of Kentucky; University of Kentucky	Hartz, AMS (corresponding author), Univ Minnesota, Dept Pharm Practice & Pharmaceut Sci, Coll Pharm, Duluth, MN 55812 USA.; Hartz, AMS (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Hartz, AMS (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA.	anika.hartz@uky.edu			National Institute on Aging [1R01AG039621]; Sanders-Brown Center on Aging Biostatistics and Data Management Core [P30 AG028383]; NATIONAL INSTITUTE ON AGING [R01AG039621, P30AG028383] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sanders-Brown Center on Aging Biostatistics and Data Management Core; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by grant number 1R01AG039621 from the National Institute on Aging (to AMSH); statistical analysis was supported by the Sanders-Brown Center on Aging Biostatistics and Data Management Core (grant number: P30 AG028383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov U, 2008, NEUROSCI LETT, V443, P223, DOI 10.1016/j.neulet.2008.07.075; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alzheimer's Association, 2014, ALZHEIMERS DEMENT, P10; ANISMAN H, 1975, PHARMACOL BIOCHEM BE, V3, P613, DOI 10.1016/0091-3057(75)90182-3; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Bardgett ME, 2011, NEUROBIOL LEARN MEM, V95, P64, DOI 10.1016/j.nlm.2010.10.008; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bertaina-Anglade V., 2006, Journal of Pharmacological and Toxicological Methods, V54, P99, DOI 10.1016/j.vascn.2006.04.001; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Borchelt DR, 2008, HBK BEHAV NEUROSCI, V18, P553, DOI 10.1016/S1569-7339(08)00230-0; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brooks SP, 2005, GENES BRAIN BEHAV, V4, P307, DOI 10.1111/j.1601-183X.2004.00109.x; Brown RE, 2007, LEARN MEMORY, V14, P134, DOI 10.1101/lm.473907; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Clapcote SJ, 2005, COMPARATIVE MED, V55, P310; Clark RE, 2005, CURR OPIN NEUROBIOL, V15, P593, DOI 10.1016/j.conb.2005.08.014; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Deacon RMJ, 2008, BEHAV BRAIN RES, V189, P126, DOI 10.1016/j.bbr.2007.12.024; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fahlstrom A, 2012, AGE, V34, P1435, DOI 10.1007/s11357-011-9320-7; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Garcia MF, 2004, NEUROREPORT, V15, P73, DOI 10.1097/00001756-200401190-00015; Golub MS, 2008, NEUROBIOL AGING, V29, P1512, DOI 10.1016/j.neurobiolaging.2007.03.015; Goncalves MB, 2013, EUR J NEUROSCI, V37, P1182, DOI 10.1111/ejn.12142; GOWER AJ, 1993, BEHAV BRAIN RES, V57, P163, DOI 10.1016/0166-4328(93)90132-A; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Han RW, 2012, BRAIN RES, V1470, P59, DOI 10.1016/j.brainres.2012.06.015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; KOKKINIDIS L, 1976, PHARMACOL BIOCHEM BE, V5, P293, DOI 10.1016/0091-3057(76)90081-2; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laursen B, 2014, BRAIN RES, V1543, P253, DOI 10.1016/j.brainres.2013.10.055; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D, 2008, J ALZHEIMERS DIS, V15, P605; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Navarro-Frances CI, 2014, BEHAV PROCESS, V105, P6, DOI 10.1016/j.beproc.2014.02.009; Nichol KE, 2007, BEHAV BRAIN RES, V184, P124, DOI 10.1016/j.bbr.2007.06.027; NOMURA Y, 1994, BIOL PHARM BULL, V17, P490; Ohta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030007; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Rustay NR, 2010, BRAIN RES, V1311, P136, DOI 10.1016/j.brainres.2009.11.040; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Stavnezer AJ, 2002, BEHAV BRAIN RES, V133, P261, DOI 10.1016/S0166-4328(02)00021-9; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Sumien N, 2006, AGE, V28, P265, DOI 10.1007/s11357-006-9015-7; SWONGER AK, 1972, J COMP PHYSIOL PSYCH, V81, P509, DOI 10.1037/h0033690; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Wolff M, 2003, LEARN MEMORY, V10, P401, DOI 10.1101/lm.60103; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; Yassine N, 2013, NEUROBIOL AGING, V34, P716, DOI 10.1016/j.neurobiolaging.2012.06.016; Zhang WW, 2008, NEUROSCI LETT, V443, P241, DOI 10.1016/j.neulet.2008.07.048	83	132	133	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147733	10.1371/journal.pone.0147733	http://dx.doi.org/10.1371/journal.pone.0147733			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808326	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800201
J	Melin, AD; Kline, DW; Hiramatsu, C; Caro, T				Melin, Amanda D.; Kline, Donald W.; Hiramatsu, Chihiro; Caro, Tim			Zebra Stripes through the Eyes of Their Predators, Zebras, and Humans	PLOS ONE			English	Article							SPATIAL CONTRAST SENSITIVITY; COLOR-VISION; VISUAL RESOLUTION; ACUITY; PERCEPTION; SIZE; CAT	The century-old idea that stripes make zebras cryptic to large carnivores has never been examined systematically. We evaluated this hypothesis by passing digital images of zebras through species-specific spatial and colour filters to simulate their appearance for the visual systems of zebras' primary predators and zebras themselves. We also measured stripe widths and luminance contrast to estimate the maximum distances from which lions, spotted hyaenas, and zebras can resolve stripes. We found that beyond ca. 50 m (daylight) and 30 m (twilight) zebra stripes are difficult for the estimated visual systems of large carnivores to resolve, but not humans. On moonless nights, stripes are difficult for all species to resolve beyond ca. 9 m. In open treeless habitats where zebras spend most time, zebras are as clearly identified by the lion visual system as are similar-sized ungulates, suggesting that stripes cannot confer crypsis by disrupting the zebra's outline. Stripes confer a minor advantage over solid pelage in masking body shape in woodlands, but the effect is stronger for humans than for predators. Zebras appear to be less able than humans to resolve stripes although they are better than their chief predators. In conclusion, compared to the uniform pelage of other sympatric herbivores it appears highly unlikely that stripes are a form of anti-predator camouflage.	[Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Melin, Amanda D.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada; [Melin, Amanda D.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada; [Kline, Donald W.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Kline, Donald W.] Univ Calgary, Dept Surg Ophthalmol, Calgary, AB T2N 1N4, Canada; [Hiramatsu, Chihiro] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka 8158540, Japan; [Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	Washington University (WUSTL); University of Calgary; University of Calgary; University of Calgary; University of Calgary; Kyushu University; University of California System; University of California Davis	Melin, AD (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.; Melin, AD (corresponding author), Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB T2N 1N4, Canada.; Melin, AD (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada.	amanda.melin@ucalgary.ca		Melin, Amanda/0000-0002-0612-2514	Wenner Gren Foundation; National Sciences and Engineering Research Council of Canada; National Geographic Society; University of California Davis	Wenner Gren Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Society(National Geographic Society); University of California Davis(University of California System)	Funding was provided by the Wenner Gren Foundation (http://www.wennergren.org/) to ADM, the National Sciences and Engineering Research Council of Canada to ADM ( http://www.nserc-crsng.gc.ca/), the National Geographic Society (http://www.nationalgeographic.com/) to TC and University of California Davis to TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2006, VISUAL NEUROSCI, V23, P429, DOI 10.1017/S095252380623342X; Ahnelt PK, 2006, 6 SCI M EUR ASS ZER; BIRCH D, 1979, VISION RES, V19, P933, DOI 10.1016/0042-6989(79)90029-4; BISTI S, 1974, J PHYSIOL-LONDON, V241, P201, DOI 10.1113/jphysiol.1974.sp010649; BLAKE R, 1988, TRENDS NEUROSCI, V11, P78, DOI 10.1016/0166-2236(88)90169-5; BLAKE R, 1974, VISION RES, V14, P1211, DOI 10.1016/0042-6989(74)90218-1; Calderone JB, 2003, BRAIN BEHAV EVOLUT, V62, P182, DOI 10.1159/000073270; Caro T, ZEBRA STRIP IN PRESS; Caro T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150323; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro T, 2013, SEMIN CELL DEV BIOL, V24, P542, DOI 10.1016/j.semcdb.2013.03.016; Carroll J, 2001, J VISION, V1, P80, DOI 10.1167/1.2.2; Cronin TW, 2014, VISUAL ECOLOGY, P262; Darwin C., 1906, DESCENT MAN SELECTIO; DAUGMAN JG, 1986, BEHAV RES METH INSTR, V18, P559, DOI 10.3758/BF03201429; DeValois RL, 1988, SPATIAL VISION; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; EVANS DW, 1985, HUM FACTORS, V27, P637, DOI 10.1177/001872088502700602; GINSBURG AP, 1982, AM J OPTOM PHYS OPT, V59, P105; Ginsburg AP, 1978, VISUAL INFORM PROCES; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; Hanke FD, 2011, J COMP PHYSIOL A, V197, P203, DOI 10.1007/s00359-010-0600-y; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; JACOBSON SG, 1976, VISION RES, V16, P1141, DOI 10.1016/0042-6989(76)90254-6; Keller J, 2000, J NEUROSCI METH, V97, P103, DOI 10.1016/S0165-0270(00)00173-4; Kemp AD, 2014, ANAT REC, V297, P781, DOI 10.1002/ar.22892; Kingdon J., 1984, ENCY MAMMALS, P486; Kirk EC, 2006, FOLIA PRIMATOL, V77, P27, DOI 10.1159/000089694; Kruuk H., 1972, THE SPOTTED HYENA; Kwon M, 2012, VISION RES, V62, P139, DOI 10.1016/j.visres.2012.03.025; Matthews L, 1971, THE LIFE OF MAMMALS; Melin AD, 2013, VISION RES, V86, P87, DOI 10.1016/j.visres.2013.04.013; Melin AD, 2012, AM J PRIMATOL, V74, P185, DOI 10.1002/ajp.21996; Michael R, 2011, ACTA OPHTHALMOL, V89, P278, DOI 10.1111/j.1755-3768.2009.01665.x; Morris Animal Foundation, 2022, ANIMAL WATCHING FIEL; MUIR DW, 1973, SCIENCE, V180, P420, DOI 10.1126/science.180.4084.420; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; PASTERNAK T, 1981, VISION RES, V21, P1333, DOI 10.1016/0042-6989(81)90240-6; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Roth LSV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003711; Schaller G. B., 1972, SERENGETI LION; Schwartz S.H., 2010, VISUAL PERCEPTION CL; Selous FC, 1908, AFRICAN NATURE NOTES; Shapley R, 2009, VISION RES, V49, P907, DOI 10.1016/j.visres.2008.09.026; Souza Givago da Silva, 2011, Psychol. Neurosci., V4, P29, DOI 10.3922/j.psns.2011.1.005; Stevens M, 2008, P ROY SOC B-BIOL SCI, V275, P2639, DOI 10.1098/rspb.2008.0877; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; THAYER GH, 2009, CONCEALING COLOURATI; UHLRICH DJ, 1981, BEHAV BRAIN RES, V2, P291, DOI 10.1016/0166-4328(81)90013-9; Veilleux CC, 2014, BRAIN BEHAV EVOLUT, V83, P43, DOI 10.1159/000357830; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351; Wallace AR, 1896, DARWINISM EXPOSITION; Yokoyama S, 1999, GENETICS, V153, P919	58	21	21	9	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145679	10.1371/journal.pone.0145679	http://dx.doi.org/10.1371/journal.pone.0145679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799935	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300008
J	Mata-Pinzon, Z; Valladares, AA; Valladares, RM; Valladares, A				Mata-Pinzon, Zaahel; Valladares, Ariel A.; Valladares, Renela M.; Valladares, Alexander			Superconductivity in Bismuth. A New Look at an Old Problem	PLOS ONE			English	Article							AB-INITIO; ELECTRONIC-PROPERTIES; AMORPHOUS BISMUTH; PHONON SPECTRUM; LOW TEMPERATURE; DENSITY; LIQUID; DIFFRACTION; SI; MOLECULES	To investigate the relationship between atomic topology, vibrational and electronic properties and superconductivity of bismuth, a 216-atom amorphous structure (a-Bi216) was computer-generated using our undermelt-quench approach. Its pair distribution function compares well with experiment. The calculated electronic and vibrational densities of states (eDOS and vDOS, respectively) show that the amorphous eDOS is about 4 times the crystalline at the Fermi energy, whereas for the vDOS the energy range of the amorphous is roughly the same as the crystalline but the shapes are quite different. A simple BCS estimate of the possible crystalline superconducting transition temperature gives an upper limit of 1.3 mK. The e-ph coupling is more preponderant in a-Bi than in crystalline bismuth (x-Bi) as indicated by the lambda obtained via McMillan's formula, lambda(c) = 0.24 and experiment lambda(a) = 2.46. Therefore with respect to x-Bi, superconductivity in a-Bi is enhanced by the higher values of. and of eDOS at the Fermi energy.	[Mata-Pinzon, Zaahel; Valladares, Ariel A.] Univ Nacl Autonoma Mexico, Inst Invest & Mat, Dept Mat Condensada & Criogenia, Mexico City 04510, DF, Mexico; [Valladares, Renela M.; Valladares, Alexander] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Fis, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Valladares, AA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest & Mat, Dept Mat Condensada & Criogenia, Mexico City 04510, DF, Mexico.	valladar@unam.mx	VALLADARES, ARIEL A/G-1788-2017	Valladares, Ariel A./0000-0003-1505-2244; Mata-Pinzon, Zaahel/0000-0001-5307-5354	Direccion General de Asuntos del Personal Academico, UNAM; Proyecto "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas [IN110914]	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Proyecto "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas	This work was supported by Direccion General de Asuntos del Personal Academico, UNAM. Proyecto IN110914, "Simulando materiales metalicos amorfos. Su estructura y propiedades fisicas.	Alvarez F, 2002, J NON-CRYST SOLIDS, V299, P259, DOI 10.1016/S0022-3093(01)01005-5; [Anonymous], 2015, PHYSICA C, V514, piv, DOI [10.1016/S0921-4534(15)00168-9, DOI 10.1016/S0921-4534(15)00168-9]; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARYAM Y, 1986, PHYS REV LETT, V56, P2203, DOI 10.1103/PhysRevLett.56.2203; BEEBY JL, 1989, J NON-CRYST SOLIDS, V114, P253, DOI 10.1016/0022-3093(89)90128-2; BEEBY JL, 1985, PHYS REV B, V32, P6464, DOI 10.1103/PhysRevB.32.6464; CHAMBERLAIN O, 1950, PHYS REV, V77, P305, DOI 10.1103/PhysRev.77.305; CHEN JT, 1967, PHYS LETT A, VA 25, P679, DOI 10.1016/0375-9601(67)90471-9; CHEN TT, 1969, PHYS REV LETT, V22, P526, DOI 10.1103/PhysRevLett.22.526; Delley B, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155125; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DESORBO W, 1958, J PHYS CHEM-US, V62, P965, DOI 10.1021/j150566a017; Dijk V, 1981, LANDOLT BORNSTEIN, P53; FUJIME S, 1966, JPN J APPL PHYS, V5, P764, DOI 10.1143/JJAP.5.764; Galvan-Colin J, 2013, MRS P, P1517; GONZE X, 1988, PHYS SCRIPTA, V37, P785, DOI 10.1088/0031-8949/37/5/022; GONZE X, 1990, PHYS REV B, V41, P11827, DOI 10.1103/PhysRevB.41.11827; Grimvall G., 1981, ELECT PHONON INTERAC; Grimvall G., 1999, THERMOPHYSICAL PROPE; HARRIS J, 1985, PHYS REV B, V31, P1770, DOI 10.1103/PhysRevB.31.1770; Herrera WT, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40337-3; Ishimaru M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.055502; Jezequel G, 1997, PHYS REV B, V56, P6620, DOI 10.1103/PhysRevB.56.6620; KAKIZAKI A, 1988, J PHYS F MET PHYS, V18, P2617, DOI 10.1088/0305-4608/18/12/012; LEY L, 1973, PHYS REV B, V8, P641, DOI 10.1103/PhysRevB.8.641; Lifshits I. M., 1988, INTRO THEORY DISORDE; LIN ZJ, 1993, J PHYS-CONDENS MAT, V5, P1055, DOI 10.1088/0953-8984/5/8/008; Madelung O., 1998, NONTETRAHEDRALLY BON, V41C; Mata-Pinzon Z, 2013, MRS P, P1520; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; REYNOLDS JM, 1950, PHYS REV, V79, P405, DOI 10.1103/PhysRev.79.405; Richter H., 1969, J VAC SCI TECHNOL, P855; Romero C, 2010, MATERIALS, V3, P467, DOI 10.3390/ma3010467; Santiago-Cortes CU, 2011, THESIS U NACL AUTONO; TAKAGI M, 1956, J PHYS SOC JPN, V11, P396, DOI 10.1143/JPSJ.11.396; Tsuei CC, 2005, CONCISE ENCY MAGNETI, P43; Valladares A. A., 2008, ELECT VIBRATIONAL ST, P61; Valladares AA, 2001, EUR PHYS J B, V22, P443, DOI 10.1007/s100510170094; Valladares AA, 2011, MATERIALS, V4, P716, DOI 10.3390/ma4040716; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wyckoff R.W.G, 1963, CRYST STRUCT	43	21	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147645	10.1371/journal.pone.0147645	http://dx.doi.org/10.1371/journal.pone.0147645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815431	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200043
J	Seeger, B; Klawonn, F; Bekale, BN; Steinberg, P				Seeger, Bettina; Klawonn, Frank; Bekale, Boris Nguema; Steinberg, Pablo			Mixture Effects of Estrogenic Pesticides at the Human Estrogen Receptor alpha and beta	PLOS ONE			English	Article							IN-VITRO; XENOESTROGENS; DISRUPTION; ACTIVATION; MECHANISM; CHEMICALS; EXPOSURE; ASSAYS	Consumers of fruits and vegetables are frequently exposed to small amounts of hormonally active pesticides, some of them sharing a common mode of action such as the activation of the human estrogen receptor alpha (hER alpha) or beta (hER beta). Therefore, it is of particular importance to evaluate risks emanating from chemical mixtures, in which the individual pesticides are present at human-relevant concentrations, below their corresponding maximum residue levels. Binary and ternary iso-effective mixtures of estrogenic pesticides at effect concentrations eliciting a 1 or 10% effect in the presence or absence of 17 beta-estradiol were tested experimentally at the hER alpha in the yeast-based estrogen screen (YES) assay as well as in the human U2-OS cell-based ER alpha chemical-activated luciferase gene expression (ER alpha CALUX) assay and at the hER beta in the ER beta CALUX assay. The outcome was then compared to predictions calculated by means of concentration addition. In most cases, additive effects were observed with the tested combinations in all three test systems, an observation that supports the need to expand the risk assessment of pesticides and consider cumulative risk assessment. An additional testing of mixture effects at the hER beta showed that most test substances being active at the hER alpha could also elicit additive effects at the hER beta, but the hER beta was less sensitive. In conclusion, effects of the same ligands at the hER alpha and the hER beta could influence the estrogenic outcome under physiological conditions.	[Seeger, Bettina; Steinberg, Pablo] Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Bischofsholer Damm 15, D-30173 Hannover, Germany; [Klawonn, Frank] Helmholtz Ctr Infect Res, Biostat Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Klawonn, Frank; Bekale, Boris Nguema] Ostfalia Univ Appl Sci, Dept Comp Sci, Salzdahlumerstr 46-48, D-38302 Wolfenbuttel, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research	Seeger, B (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Bischofsholer Damm 15, D-30173 Hannover, Germany.	bettina.seeger@tiho-hannover.de	Seeger, Bettina/H-9072-2019; Klawonn, Frank/HFH-5887-2022	Seeger, Bettina/0000-0002-4653-2841; Klawonn, Frank/0000-0001-9613-182X	Federal Institute for Risk Assessment in Berlin, Germany [FK.3 1329-484 6433898]	Federal Institute for Risk Assessment in Berlin, Germany	This study was financially supported by the Federal Institute for Risk Assessment in Berlin, Germany (grant FK.3 1329-484 6433898). PS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Benford D, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3490; Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Bitsch Nikola, 2002, Umweltwissenschaften und Schadstoff-Forschung, V14, P76, DOI 10.1065/uwsf2002.04.016; Bottner M, 2014, J STEROID BIOCHEM, V139, P245, DOI 10.1016/j.jsbmb.2013.03.003; Bonefeld-Jorgensen EC, 2005, MOL CELL ENDOCRINOL, V244, P20, DOI 10.1016/j.mce.2005.01.017; Charles GD, 2002, TOXICOL SCI, V68, P349, DOI 10.1093/toxsci/68.2.349; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3694, 10.2903/j.efsa.2015.4038]; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360; Hass U, 2012, REPROD TOXICOL, V34, P261, DOI 10.1016/j.reprotox.2012.05.090; Kolle SN, 2010, TOXICOL IN VITRO, V24, P2030, DOI 10.1016/j.tiv.2010.08.008; Kortenkamp A, 1998, SCI TOTAL ENVIRON, V221, P59, DOI 10.1016/S0048-9697(98)00261-7; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Medjakovic S, 2014, ENVIRON TOXICOL, V29, P1201, DOI 10.1002/tox.21852; Mertl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100952; Montano M, 2010, TOXICOL SCI, V115, P462, DOI 10.1093/toxsci/kfq056; Niforou Katerina N., 2008, Cancer Genomics & Proteomics, V5, P63; OECD, 2015, TEST NO 455 DRAFT PE; Payne J, 2000, ENVIRON HEALTH PERSP, V108, P983, DOI 10.1289/ehp.00108983; Payne J, 2001, ENVIRON HEALTH PERSP, V109, P391, DOI 10.2307/3454899; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rajapakse N, 2004, ENVIRON SCI TECHNOL, V38, P6343, DOI 10.1021/es049681e; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228; Seeger B, 2016, TOXICOL LETT, V241, P193, DOI 10.1016/j.toxlet.2015.11.015; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; Sotoca AM, 2010, J STEROID BIOCHEM, V122, P204, DOI 10.1016/j.jsbmb.2010.06.010; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007; Vinggaard AM, 1999, FOOD ADDIT CONTAM, V16, P533, DOI 10.1080/026520399283678	34	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147490	10.1371/journal.pone.0147490	http://dx.doi.org/10.1371/journal.pone.0147490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812056	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000035
J	Cattel, J; Kaur, R; Gibert, P; Martinez, J; Fraimout, A; Jiggins, F; Andrieux, T; Siozios, S; Anfora, G; Miller, W; Rota-Stabelli, O; Mouton, L				Cattel, Julien; Kaur, Rupinder; Gibert, Patricia; Martinez, Julien; Fraimout, Antoine; Jiggins, Francis; Andrieux, Thibault; Siozios, Stefanos; Anfora, Gianfranco; Miller, Wolfgang; Rota-Stabelli, Omar; Mouton, Laurence			Wolbachia in European Populations of the Invasive Pest Drosophila suzukii: Regional Variation in Infection Frequencies	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; MATSUMURA DIPTERA DROSOPHILIDAE; RHAGOLETIS-CERASI DIPTERA; SPOTTED WING DROSOPHILA; CHERRY FRUIT-FLY; DYNAMICS; TEMPERATURE; EXPRESSION; DENSITY; MUSCLE	The invasive pest Drosophila suzukii is characterized by a specific fresh-fruit targeting behavior and has quickly become a menace for the fruit economy of newly infested North American and European regions. D. suzukii carries a strain of the endosymbiotic bacterium Wolbachia, named wSuz, which has a low infection frequency and no reproductive manipulation capabilities in American populations of D. suzukii. To further understand the nature of wSuz biology and assess its utility as a tool for controlling this pest's populations, we investigated the prevalence of Wolbachia in 23 European D. suzukii populations, and compared our results with those available in American populations. Our data showed a highly variable infection frequency with a mean prevalence of 46%, which is significantly higher than the 17% found in American populations. Based on Multilocus Sequence Typing analysis, a single wSuz strain was diagnosed in all European populations of D. suzukii. In agreement with American data, we found no evidence of cytoplasmic incompatibility induced by wSuz. These findings raise two questions: a) why Wolbachia is maintained in field populations of D. suzukii and b) what are the selective forces responsible for the variation in prevalence within populations, particularly between European and American continents? Our results provide new insights into the D. suzukii-Wolbachia association and highlight regional variations that await further investigation and that should be taken into account for using Wolbachia-based pest management programs.	[Cattel, Julien; Gibert, Patricia; Andrieux, Thibault; Mouton, Laurence] Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France; [Kaur, Rupinder; Siozios, Stefanos; Anfora, Gianfranco; Rota-Stabelli, Omar] Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, Chem Ecol Lab, San Michele All Adige, TN, Italy; [Kaur, Rupinder; Miller, Wolfgang] Med Univ Vienna, Ctr Anat & Cell Biol, Lab Genome Dynam, Dept Cell & Dev Biol, Vienna, Austria; [Martinez, Julien; Jiggins, Francis] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Fraimout, Antoine] Univ Paris 04, EPHE Museum Natl Hist Nat, Inst Systemat,Evolut,Biodiversite ISYEB, UMR CNRS 7205, 57 Rue Cuvier, Paris, France; [Siozios, Stefanos] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Fondazione Edmund Mach; Medical University of Vienna; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Liverpool	Cattel, J (corresponding author), Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.; Kaur, R (corresponding author), Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, Chem Ecol Lab, San Michele All Adige, TN, Italy.; Kaur, R (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Lab Genome Dynam, Dept Cell & Dev Biol, Vienna, Austria.	juliencattel@gmail.com; rupinderkaur@fmach.it	Miller, Wolfgang J/E-5716-2015; Martinez, Julien/AAW-6287-2020; Rota-Stabelli, Omar/G-8477-2011; Kaur, Rupinder/K-4709-2019	Miller, Wolfgang J/0000-0002-5044-6276; Martinez, Julien/0000-0001-8210-2921; Rota-Stabelli, Omar/0000-0002-0030-7788; Kaur, Rupinder/0000-0002-2132-8107; Gibert, Patricia/0000-0002-9461-6820; Mouton, Laurence/0000-0002-2718-9953; ANFORA, Gianfranco/0000-0003-2545-1409; Siozios, Stefanos/0000-0002-1104-7061; Jiggins, Francis Michael/0000-0001-7470-8157; Fraimout, Antoine/0000-0003-4552-3553	CNRS [IFR41-UMR5558]; Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France; FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling), Italy; Rhone-Alpes region ("ARC Program" Grant); FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy	CNRS(Centre National de la Recherche Scientifique (CNRS)); Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France; FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling), Italy; Rhone-Alpes region ("ARC Program" Grant)(Region Auvergne-Rhone-Alpes); FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy	This work was funded partly by CNRS (IFR41-UMR5558) and Office National de l'Eau est des Milieux Aquatiques (ONEMA) (Ecophyto project) for France, and FEM Accordo di Programma Provincia Autonoma di Trento and research funds for GrandiProgetti, Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu), Italy. Julien Cattel is the recipient of a PhD studentship from the Rhone-Alpes region ("ARC Program" Grant) and Rupinder Kaur has obtained a PhD fellowship from the FIRS>T (FEM International Research School-Trentino) programme at Fondazione Edmund Mach, Italy.	Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2007, INSECT MOL BIOL, V16, P799, DOI 10.1111/j.1365-2583.2007.00760.x; BOLLER EF, 1976, ENTOMOL EXP APPL, V20, P237, DOI 10.1007/BF00573829; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Chandler JA, 2014, PEERJ, V2, DOI 10.7717/peerj.474; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Cini A, 2012, B INSECTOL, V65, P149; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; Dobson SL, 2002, GENETICS, V160, P1087; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Dreves A, 2009, 899116 EM OR U, VEM 8991, P1; Dyck V.A., 2006, STERILE INSECT TECHN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Fry AJ, 2002, EVOLUTION, V56, P1976, DOI 10.1111/j.0014-3820.2002.tb00123.x; Gargani E, 2013, REDIA, V96, P85; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 1998, GENETICS, V148, P221; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Kanzawa T, 1936, REV APPL ENTOMOL, V24, P315; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; Mazzetto F, 2015, B INSECTOL, V68, P153; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Morrow JL, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0474-2; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pontier SM, 2015, CURR BIOL, V25, P2339, DOI 10.1016/j.cub.2015.07.052; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Schneider D, 2012, FRONT MICROBIOL SER, P149; SIOZIOS S., 2013, GENOME ANNOUNCEMENTS, V1, P1, DOI DOI 10.1128/GEN0MEA.00032-13; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; TURELLI M, 1995, GENETICS, V140, P1319; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Woltz JM, 2015, J APPL ENTOMOL, V139, P759, DOI 10.1111/jen.12200; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098	63	24	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147766	10.1371/journal.pone.0147766	http://dx.doi.org/10.1371/journal.pone.0147766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809119	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800208
J	Hardy, D; Besnard, A; Latil, M; Jouvion, G; Briand, D; Thepenier, C; Pascal, Q; Guguin, A; Gayraud-Morel, B; Cavaillon, JM; Tajbakhsh, S; Rocheteau, P; Chretien, F				Hardy, David; Besnard, Aurore; Latil, Mathilde; Jouvion, Gregory; Briand, David; Thepenier, Cedric; Pascal, Quentin; Guguin, Aurelie; Gayraud-Morel, Barbara; Cavaillon, Jean-Marc; Tajbakhsh, Shahragim; Rocheteau, Pierre; Chretien, Fabrice			Comparative Study of Injury Models for Studying Muscle Regeneration in Mice	PLOS ONE			English	Article							TEMPLATE DNA STRANDS; SATELLITE CELL; SELF-RENEWAL; STEM-CELLS; MACROPHAGES; PROLIFERATION; PHOSPHOLIPASE; MONOCYTES; EXPANSION; NOTEXIN	Background A longstanding goal in regenerative medicine is to reconstitute functional tissus or organs after injury or disease. Attention has focused on the identification and relative contribution of tissue specific stem cells to the regeneration process. Relatively little is known about how the physiological process is regulated by other tissue constituents. Numerous injury models are used to investigate tissue regeneration, however, these models are often poorly understood. Specifically, for skeletal muscle regeneration several models are reported in the literature, yet the relative impact on muscle physiology and the distinct cells types have not been extensively characterised. Methods We have used transgenic Tg:Pax7nGFP and Flk1(GFP/+) mouse models to respectively count the number of muscle stem (satellite) cells (SC) and number/shape of vessels by confocal microscopy. We performed histological and immunostainings to assess the differences in the key regeneration steps. Infiltration of immune cells, chemokines and cytokines production was assessed in vivo by Luminex (R). Results We compared the 4 most commonly used injury models i.e. freeze injury (FI), barium chloride (BaCl2), notexin (NTX) and cardiotoxin (CTX). The FI was the most damaging. In this model, up to 96% of the SCs are destroyed with their surrounding environment (basal lamina and vasculature) leaving a "dead zone" devoid of viable cells. The regeneration process itself is fulfilled in all 4 models with virtually no fibrosis 28 days post-injury, except in the FI model. Inflammatory cells return to basal levels in the CTX, BaCl2 but still significantly high 1-month post-injury in the FI and NTX models. Interestingly the number of SC returned to normal only in the FI, 1-month post-injury, with SCs that are still cycling up to 3-months after the induction of the injury in the other models. Conclusions Our studies show that the nature of the injury model should be chosen carefully depending on the experimental design and desired outcome. Although in all models the muscle regenerates completely, the trajectories of the regenerative process vary considerably. Furthermore, we show that histological parameters are not wholly sufficient to declare that regeneration is complete as molecular alterations (e.g. cycling SCs, cytokines) could have a major persistent impact.	[Hardy, David; Besnard, Aurore; Latil, Mathilde; Jouvion, Gregory; Briand, David; Thepenier, Cedric; Pascal, Quentin; Rocheteau, Pierre; Chretien, Fabrice] Inst Pasteur, Human Histopathol & Anim Models Unit, Infect & Epidemiol Dept, Paris, France; [Hardy, David] Paris Est Univ, Creteil, France; [Jouvion, Gregory; Chretien, Fabrice] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Thepenier, Cedric] IRBA, Inst Rech Biomed Armees, Unite Interact Hote Agents Pathogenes, Bretigny Sur Orge, France; [Guguin, Aurelie] INSERM, U955, Plateforme Cytometrie Flux, Creteil, France; [Gayraud-Morel, Barbara; Tajbakhsh, Shahragim] Inst Pasteur, Dept Dev & Stem Cell Biol, Stem Cells & Dev Unit, Paris, France; [Cavaillon, Jean-Marc] Inst Pasteur, Infect & Epidemiol Dept, Cytokines & Inflammat Unit, Paris, France; [Chretien, Fabrice] Ctr Hosp St Anne, Neuropathol Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Chretien, F (corresponding author), Inst Pasteur, Human Histopathol & Anim Models Unit, Infect & Epidemiol Dept, Paris, France.; Chretien, F (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Paris, France.; Chretien, F (corresponding author), Ctr Hosp St Anne, Neuropathol Lab, Paris, France.	fabrice.chretien@pasteur.fr	Jouvion, Grégory/AAL-2620-2021; Latil, Mathilde/E-2011-2017; Chretien, fabrice B/D-4035-2018	Chretien, fabrice B/0000-0002-2794-1383; PASCAL, Quentin/0000-0001-5842-7080; Gayraud-Morel, Barbara/0000-0002-1168-8504	AFM-vaincre les myopathies; Fondation Les gueules cassees; Institut Pasteur; agence-nationale-recherche; Region Ile de France	AFM-vaincre les myopathies(Association Francaise contre les Myopathies); Fondation Les gueules cassees; Institut Pasteur(European Commission); agence-nationale-recherche(French National Research Agency (ANR)); Region Ile de France(Region Ile-de-France)	This work was financially supported by AFM-vaincre les myopathies ([http://www.afmtelethon.fr/] Role: design, data collection and analysis), Fondation <SUP>3</SUP>Les gueules cassees<SUP>2</SUP>, Institut Pasteur and Region Ile de France. This work was also supported by the agence-nationale-recherche ([http://www.agence-nationale-recherche.fr/], Role: design, data collection and analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors also thank Patrick Ave, Patricia Flamant, Catherine Fitting, Huot Khun, Sabine Maurin for their excellent technical support. This work was financially supported by AFM-vaincre les myopathies, Fondation "Les gueules cassees", Institut Pasteur and Region Ile de France.	Abou-Khalil R, 2010, CELL CYCLE, V9, P892, DOI 10.4161/cc.9.5.10851; Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Brun CE, 2015, CELL METAB, V22, P54, DOI 10.1016/j.cmet.2015.05.009; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; CHANG CC, 1972, BRIT J PHARMACOL, V44, P752, DOI 10.1111/j.1476-5381.1972.tb07313.x; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Dixon RW, 1996, J NEUROPATH EXP NEUR, V55, P1230, DOI 10.1097/00005072-199612000-00006; Doles JD, 2014, NAT MED, V20, P1094, DOI 10.1038/nm.3720; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; GROUNDS MD, 1987, J PATHOL, V153, P71, DOI 10.1002/path.1711530110; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; HARRIS JB, 1974, BRIT J PHARMACOL, V52, pP152; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Latil M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1890; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McLennan IS, 1996, J ANAT, V188, P17; Morel BG, 2009, REGEN MED, V4, P293, DOI 10.2217/17460751.4.2.293; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Mounier R, 2011, CURR TOP DEV BIOL, V96, P121, DOI 10.1016/B978-0-12-385940-2.00005-X; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	47	221	223	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147198	10.1371/journal.pone.0147198	http://dx.doi.org/10.1371/journal.pone.0147198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807982	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800059
J	Quinonez-Calvache, EM; Rios-Chaparro, DI; Ramirez, JD; Soto-De Leon, SC; Camargo, M; Del Rio-Ospina, L; Sanchez, R; Patarroyo, ME; Patarroyo, MA				Margarita Quinonez-Calvache, Edith; Rios-Chaparro, Dora Ines; David Ramirez, Juan; Cecilia Soto-De Leon, Sara; Camargo, Milena; Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			Chlamydia trachomatis Frequency in a Cohort of HPV-Infected Colombian Women	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTION; MOLECULAR-DETECTION; CANCER; PERSISTENCE; LESIONS; RISK; ASSOCIATION; COINFECTION	Background Chlamydia trachomatis (C. trachomatis), an obligate intracellular bacterium, is the commonest infectious bacterial agent of sexual transmission throughout the world. It has been shown that the presence of this bacteria in the cervix represents a risk regarding HPV persistence and, thereafter, in developing cervical cancer (CC). Prevalence rates may vary from 2% to 17% in asymptomatic females, depending on the population being analysed. This study reports the identification of C. trachomatis in a cohort of 219 HPV-infected Colombian females. Methods C. trachomatis infection frequency was determined during each of the study's follow-up visits; it was detected by amplifying the cryptic plasmid sequence by polymerase chain reaction (PCR) using two sets of primers: KL5/KL6 and KL1/KL2. Infection was defined as a positive PCR result using either set of primers at any time during the study. Cox proportional risk models were used for evaluating the association between the appearance of infection and a group of independent variables. Results Base line C. trachomatis infection frequency was 28% (n = 61). Most females infected by C. trachomatis were infected by multiple types of HPV (77.42%), greater prevalence occurring in females infected with HPV-16 (19.18%), followed by HPV-58 (17.81%). It was observed that females having had the most sexual partners (HR = 6.44: 1.59-26.05 95% CI) or infection with multiple types of HPV (HR = 2.85: 1.22-6.63 95% CI) had the greatest risk of developing C. trachomatis. Conclusions The study provides data regarding the epidemiology of C. trachomatis /HPV coinfection in different population groups of Colombian females and contributes towards understanding the natural history of C. trachomatis infection.	[Margarita Quinonez-Calvache, Edith; Cecilia Soto-De Leon, Sara; Camargo, Milena; Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Margarita Quinonez-Calvache, Edith] Univ Nacl Colombia, Fac Sci, Inst Biotechnol, Bogota, Colombia; [Rios-Chaparro, Dora Ines; David Ramirez, Juan] Univ Rosario, Fac Nat & Math Sci, GIMUR, Bogota, Colombia; [Cecilia Soto-De Leon, Sara; Camargo, Milena; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario; Universidad del Rosario; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia.	mapatarr.fidic@gmail.com	De León, Sara Cecilia Soto/AAF-6301-2021; Leon, Sara Cecilia Soto-De/ABD-3186-2020; Rios-Chaparro, Dora-Ines/G-4795-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; Ramírez, Juan David/F-3524-2016; Sanchez, Ricardo/K-8254-2015	De León, Sara Cecilia Soto/0000-0003-4515-6749; Rios-Chaparro, Dora-Ines/0000-0002-7552-2677; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; Ramírez, Juan David/0000-0002-1344-9312; Sanchez, Ricardo/0000-0002-7540-4734; Camargo, Milena/0000-0003-0246-0716				BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bellaminutti S, 2014, J MED VIROL, V86, P1920, DOI 10.1002/jmv.24041; Calil LN, 2011, BRAZ J INFECT DIS, V15, P126, DOI [10.1590/S1413-86702011000200006, 10.1016/S1413-8670(11)70157-X]; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0551-y; Cribb P, 2002, MEM I OSWALDO CRUZ, V97, P897, DOI 10.1590/S0074-02762002000600027; Deluca GD, 2011, BRAZ J INFECT DIS, V15, P567, DOI 10.1016/S1413-8670(11)70252-5; de Abreu ALP, 2012, AM J TROP MED HYG, V87, P1149, DOI 10.4269/ajtmh.2012.12-0287; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; Deluca GD, 2005, EPIDEMIOLOGIA MOL CH; de Paula FDF, 2007, DIAGN CYTOPATHOL, V35, P198, DOI 10.1002/dc.20629; Finan R. R., 2002, Archives of Gynecology and Obstetrics, V266, P168, DOI 10.1007/s00404-001-0261-8; Fischer N, 2002, EUR J GYNAECOL ONCOL, V23, P247; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Girgis S. A., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P937; Golijow CD, 2005, GYNECOL ONCOL, V96, P181, DOI 10.1016/j.ygyno.2004.09.037; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Gravningen K, 2016, SEX TRANSM INFECT, V92, P97, DOI 10.1136/sextrans-2015-052152; Joyner JL, 2002, SEX TRANSM DIS, V29, P196, DOI 10.1097/00007435-200204000-00002; Kaushic C, 2000, INFECT IMMUN, V68, P4207, DOI 10.1128/IAI.68.7.4207-4216.2000; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; MAHONY JB, 1992, J CLIN MICROBIOL, V30, P2241, DOI 10.1128/JCM.30.9.2241-2245.1992; Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2; Ministerio-de-salud-Colombia, 2012, SIT INF TRANSM SEX D; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Molano M, 2003, SEX TRANSM INFECT, V79, P474, DOI 10.1136/sti.79.6.474; Paba P, 2008, INTERVIROLOGY, V51, P230, DOI 10.1159/000156481; Peuchant O, 2015, DIAGN MICR INFEC DIS, V82, P14, DOI 10.1016/j.diagmicrobio.2015.01.014; Pinto VM, 2011, SEX TRANSM DIS, V38, P957, DOI 10.1097/OLQ.0b013e31822037fc; Santos Cristina, 2003, Braz J Infect Dis, V7, P91, DOI 10.1590/S1413-86702003000200001; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Silins I, 2005, INT J CANCER, V116, P110, DOI 10.1002/ijc.20970; Silva J, 2014, ARCH GYNECOL OBSTET, V289, P715, DOI 10.1007/s00404-013-3122-3; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Soto-De Leon SC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-395; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; World Health Organization, 2011, PREV INC SEL SEX TRA	38	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147504	10.1371/journal.pone.0147504	http://dx.doi.org/10.1371/journal.pone.0147504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807957	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800115
J	Takarinda, KC; Madyira, LK; Mhangara, M; Makaza, V; Maphosa-Mutsaka, M; Rusakaniko, S; Kilmarx, PH; Mutasa-Apollo, T; Ncube, G; Harries, AD				Takarinda, Kudakwashe Collin; Madyira, Lydia Kudakwashe; Mhangara, Mutsa; Makaza, Victor; Maphosa-Mutsaka, Memory; Rusakaniko, Simbarashe; Kilmarx, Peter H.; Mutasa-Apollo, Tsitsi; Ncube, Getrude; Harries, Anthony David			Factors Associated with Ever Being HIV-Tested in Zimbabwe: An Extended Analysis of the Zimbabwe Demographic and Health Survey (2010-2011)	PLOS ONE			English	Article							TESTING OPT-OUT; SEXUAL-BEHAVIOR; MEDICAL-CARE; ACCEPTABILITY; TRANSMISSION; PREVENTION; BURDEN; STATES; WOMEN; MEN	Introduction Zimbabwe has a high human immunodeficiency virus (HIV) burden. It is therefore important to scale up HIV-testing and counseling (HTC) as a gateway to HIV prevention, treatment and care. Objective To determine factors associated with being HIV-tested among adult men and women in Zimbabwe. Methods Secondary analysis was done using data from 7,313 women and 6,584 men who completed interviewer-administered questionnaires and provided blood specimens for HIV testing during the Zimbabwe Demographic and Health Survey (ZDHS) 2010-11. Factors associated with ever being HIV-tested were determined using multivariate logistic regression. Results HIV-testing was higher among women compared to men (61% versus 39%). HIV-infected respondents were more likely to be tested compared to those who were HIV-negative for both men [adjusted odds ratio (AOR) = 1.53; 95% confidence interval (CI) (1.27-1.84)] and women [AOR = 1.42; 95% CI (1.20-1.69)]. However, only 55% and 74% of these HIV-infected men and women respectively had ever been tested. Among women, visiting antenatal care (ANC) [AOR = 5.48, 95% CI (4.08-7.36)] was the most significant predictor of being tested whilst a novel finding for men was higher odds of testing among those reporting a sexually transmitted infection (STI) in the past 12 months [AOR = 1.86, 95% CI (1.262.74)]. Among men, the odds of ever being tested increased with age >= 20 years, particularly those 45-49 years [AOR = 4.21; 95% CI (2.74-6.48)] whilst for women testing was highest among those aged 25-29 years [AOR = 2.01; 95% CI (1.63-2.48)]. Other significant factors for both sexes were increasing education level, higher wealth status and currently/formerly being in union. Conclusions There remains a high proportion of undiagnosed HIV-infected persons and hence there is a need for innovative strategies aimed at increasing HIV-testing, particularly for men and in lower-income and lower-educated populations. Promotion of STI services can be an important gateway for testing more men whilst ANC still remains an important option for HIV-testing among pregnant women.	[Takarinda, Kudakwashe Collin; Madyira, Lydia Kudakwashe; Mhangara, Mutsa; Mutasa-Apollo, Tsitsi; Ncube, Getrude] Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe; [Makaza, Victor; Maphosa-Mutsaka, Memory] Natl AIDS Council, Harare, Zimbabwe; [Rusakaniko, Simbarashe] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Harare, Zimbabwe; [Rusakaniko, Simbarashe] Univ Zimbabwe, Coll Hlth Sci, Ctr Res & Training Clin Epidemiol, Harare, Zimbabwe; [Kilmarx, Peter H.] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Harare, Zimbabwe; [Takarinda, Kudakwashe Collin; Harries, Anthony David] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of Zimbabwe; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine	Takarinda, KC (corresponding author), Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe.; Takarinda, KC (corresponding author), Int Union TB & Lung Dis, Paris, France.	ktakarinda@theunion.org		Kilmarx, Peter/0000-0001-6464-3345	United States Agency for International Development (USAID) through the MEASURE DHS project [GPO-C-00-08-00008-00]; Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief	United States Agency for International Development (USAID) through the MEASURE DHS project(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief	This paper is based on extended analysis of the Zimbabwe Demographic and Health Survey 2010-11. This research is carried out with support provided by the United States Agency for International Development (USAID) through the MEASURE DHS project (#GPO-C-00-08-00008-00) and the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cowan F.M., 2014, 20 INT AIDS C MELB; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Doherty T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3481; Fabiani M, 2007, AIDS CARE, V19, P733, DOI 10.1080/09540120601087731; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Hallfors DD, 2013, ETHNIC HEALTH, V18, P53, DOI 10.1080/13557858.2012.694068; Joint United Nations Programme on HIV/AIDS, 2014, THE GAP REP 2014; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kranzer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025244; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Maguranyanga B, 2015, P 19 INT AIDS C WASH; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Ministry of Health and Child Care, 2014, GLOB AIDS RESP COUNT; Ministry of Health and Child Care, 2011, NAT HIV TEST COUNS R; Ministry of Health and Child Care (Zimbabwe), 2021, TEEN NOW EL VACC 1 S; Mojumdar K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-416; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Mpofu E, 2011, ETHNIC HEALTH, V16, P551, DOI 10.1080/13557858.2011.583639; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; National AIDS Council, 2011, ZIMB NAT HIV AIDS ST; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; SAMET JH, 1994, AM J MED, V97, P347, DOI 10.1016/0002-9343(94)90301-8; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Staveteig S, 2013, DHS COMOPARATIVE REP, V30; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; United Nations in Zimbabwe, 2013, 1 UN ZIMB; Waters L, 2011, EXPERT REV ANTI-INFE, V9, P877, DOI [10.1586/eri.11.106, 10.1586/ERI.11.106]; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; World Health Organisation (WHO) regional office for Africa, 2011, HIV WHO AFR REG PROG; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	46	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147828	10.1371/journal.pone.0147828	http://dx.doi.org/10.1371/journal.pone.0147828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808547	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800219
J	Hawkes, AP; Weinberg, SL; Janusz, R; Demont-Heinrich, C; Vogt, RL				Hawkes, Allison P.; Weinberg, Stacy L.; Janusz, Ruth; Demont-Heinrich, Christine; Vogt, Richard L.			An Innovative Method of Measuring Changes in Access to Healthful Foods in School Lunch Programs: Findings from a Pilot Evaluation	PLOS ONE			English	Article								Introduction A large local health department in Colorado partnered with 15 school districts to develop an approach to evaluate changes in access to healthy foods in reimbursable school lunches and a la carte offerings. Materials and Methods School district nutrition managers were engaged at the start of this project. Health department dietitians developed criteria to classify food items as "Lower Fat and less added Sugar" (LFS) and "Higher Fat and more added Sugar" (HFS) based on the percentage of calories from fat and grams of added sugar. Lunch production sheets were obtained for two time periods, food items and the number of planned servings recorded. LFS and HFS planned servings were summed for each time period, and a LFS to HFS ratio calculated by dividing LFS planned servings by HFS planned servings. Additional analyses included calculating LFS: HFS ratios by school district, and for a la carte offerings. Results In 2009, the LFS: HFS ratio was 2.08, in 2011, 3.71 (P<0.0001). The method also detected changes in ratios at the school district level. For a la carte items, in 2009 the ratio of LFS: HFS was 0.53, and in 2011, 0.61 (not statistically significant). Conclusions This method detected an increase in the LFS: HFS ratio over time and demonstrated that the school districts improved access to healthful food/drink by changing the contents of reimbursable school lunches. The evaluation method discussed here can generate information that districts can use in helping sustain and expand their efforts to create healthier environments for children and adults. Although federal regulations now cover all food and beverages served during the school day, there are still opportunities to improve and measure changes in food served in other settings such as child care centers, youth correction facilities, or in schools not participating in the National School Lunch Program.	[Hawkes, Allison P.; Weinberg, Stacy L.; Janusz, Ruth; Demont-Heinrich, Christine; Vogt, Richard L.] Tricty Hlth Dept, Greenwood Village, CO USA; [Janusz, Ruth] Colorado Dept Publ Hlth & Environm, Hlth Facil & Emergency Med Serv Div, Denver, CO USA	Colorado Department of Public Health & Environment	Hawkes, AP (corresponding author), Tricty Hlth Dept, Greenwood Village, CO USA.	allisonphawkes@gmail.com			Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program [93.724]; CPPW grant; General Fund of the health department	Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program; CPPW grant; General Fund of the health department	Supported in part by a cooperative agreement from the Centers for Disease Control and Prevention's Communities Putting Prevention to Work (CPPW) program 93.724. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the US Department of Health and Human Services or the Centers for Disease Control and Prevention. APH, SW, RJ, CDH, and RLV received funding from the CPPW grant and from the General Fund of the health department for this evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NUTR BAS MAN PLANN A; [Anonymous], 2012, FED REG; [Anonymous], 2002, AD CATCH COORD APPR; [Anonymous], 2013, FED REG, V78, P78; [Anonymous], 2012, PROD REC IS OLD VERS; [Anonymous], 2015, CAT FED DOM ASS; Bartholomew JB, 2006, J AM DIET ASSOC, V106, P248, DOI 10.1016/j.jada.2005.10.030; Center for Research Strategies, 2007, WELLNESS POLICY IMPL; Comparison of previous and current regulatory requirements under Final Rule, COMP PREV CURR REG R; Condon EM, 2009, J AM DIET ASSOC, V109, pS67, DOI 10.1016/j.jada.2008.10.062; Cullen KW, 2009, AM J PUBLIC HEALTH, V99, P706, DOI 10.2105/AJPH.2007.129387; [Food and Nutrition Service U. S. Department of Agriculture], 2010, HLTH US SCH CHALL AP, P65; National Research Council, 2007, NUTR STAND FOODS SCH, P117; National Research Council, 2010, SCH MEALS BUILD BLOC, P115; Nutrition standards in the National School Lunch and School Breakfast programs, 2011, FED REGISTER, V76, P2494; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Agriculture (USDA) Food and Nutrition Service Office of Research and Analysis, 2012, SCH NUTR DIET ASS ST, VI	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146875	10.1371/journal.pone.0146875	http://dx.doi.org/10.1371/journal.pone.0146875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800523	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300046
J	Mickenautsch, S; Yengopal, V				Mickenautsch, Steffen; Yengopal, Veerasamy			Caries-Preventive Effect of High-Viscosity Glass Ionomer and Resin-Based Fissure Sealants on Permanent Teeth: A Systematic Review of Clinical Trials	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; COMPOSITE RESIN; SPLIT-MOUTH; DENTITION; BIAS; PIT	Background Glass-ionomers are traditionally regarded to be inferior to resin as fissure sealants in protecting teeth from dental caries, due to their comparatively lower retention rate. Unlike low-viscosity glass-ionomers, high-viscosity glass-ionomer cements (HVGIC) are placed as sealants by pressing the material into pits and fissures with a petroleum-jelly-coated index finger. Hence, HVGIC sealants are assumed to penetrate pits and fissures deeper, resulting in a higher material retention rate, which may increase its caries-preventive effect. Methods The aim of this review was to answer the question as to whether, in patients with fully erupted permanent molar teeth, HVGIC based fissure sealants are less effective to protect against dental carious lesions in occlusal pits and fissures than resin-based fissure sealants? A systematic literature search in eight databases was conducted. Heterogeneity of accepted trials and imprecision of the established evidence were assessed. Extracted sufficiently homogenous datasets were pooled by use of a random-effects meta-analysis. Internal trial validity was evaluated. The protocol of this systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO / Nr.: CRD42015016007). Results Seven clinical trials were provisionally included for further review. Of these, one was excluded. Seven trial reports reporting on six trials were accepted. From these, 11 datasets were extracted and pooled in four meta-analyses. The results suggest no statistically significant differences after up to 48 months and borderline significant differences in favour of HVGIC sealants after 60 months (RR 0.29; 95% CI: 0.09-0.95; p = 0.04 / RD -0.07; 95% CI: -0.14, -0.01). The point estimates and upper confidence levels after 24, 36, 48 and 60 months of RR 1.36; RR 0.90; RR 0.62; RR 0.29 and 2.78; 1.67; 1.21; 0.95, respectively, further suggest a chronological trend in favour of HVGIC above resin-based sealants. The internal trial validity was judged to be low and the bias risk high for all trials. Imprecision of results was considered too high for clinical guidance. Conclusion It can be concluded that: (i) Inferiority claims against HVGIC in comparison to resin-based sealants as current gold-standard are not supported by the clinical evidence; (ii) The clinical evidence suggests similar caries-preventive efficacy of HVGIC and resin-based sealants after a period of 48 months in permanent molar teeth but remains challenged by high bias risk; (iii) Evidence concerning a possible superiority of HVGIC above resin-based sealants after 60 months is poor (even if the high bias risk is disregarded) due to imprecision and requires corroboration through future research.	[Mickenautsch, Steffen; Yengopal, Veerasamy] Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa	University of Witwatersrand	Mickenautsch, S (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Community Dent, Systemat Review Initiat Evidence Based Minimum In, Johannesburg, South Africa.	neem@global.co.za	Mickenautsch, Steffen/D-1235-2013	Mickenautsch, Steffen/0000-0002-4994-2328				Adair Steven M, 2003, J Calif Dent Assoc, V31, P221; Ahovuo-Saloranta A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub4; Barja-Fidalgo F, 2009, J DENT CHILD, V76, P34; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Beiruti N, 2006, CARIES RES, V40, P52, DOI 10.1159/000088907; Cagetti MG, 2014, J DENT RES, V93, P59, DOI 10.1177/0022034514535808; Chen X, 2012, DENT MATER, V28, P554, DOI 10.1016/j.dental.2012.01.001; Feigal Robert J, 2002, Pediatr Dent, V24, P415; Frencken JE, 1996, J PUBLIC HEALTH DENT, V56, P135, DOI 10.1111/j.1752-7325.1996.tb02423.x; Frencken JE, 2004, J DENT RES, V83, P120, DOI 10.1177/154405910408300207; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hilgert LA, 2015, J DENT RES; Hujoel PP, 1998, COMMUNITY DENT ORAL, V26, P85, DOI 10.1111/j.1600-0528.1998.tb01932.x; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kitchens Dinah H, 2005, J Contemp Dent Pract, V6, P95; Kuhnisch J, 2012, DENT MATER, V28, P298, DOI 10.1016/j.dental.2011.11.002; Kuhnisch J, 2010, LEITLINIE FISSURENVE; Liu BY, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-54; Locker D, 2003, BRIT DENT J, V195, P375, DOI 10.1038/sj.bdj.4810556; Mickenautsch S, 2015, J MINIMUM INTERV DEN, V8, P1; Mickenautsch S, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-114; Mickenautsch S, 2013, J APPL ORAL SCI, V21, P482, DOI 10.1590/1679-775720130014; Mickenautsch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078397; Mickenautsch S, 2012, INT DENT J, V62, P175, DOI 10.1111/j.1875-595X.2011.00113.x; Mickenautsch S, 2012, CLIN ORAL INVEST, V16, P1, DOI 10.1007/s00784-011-0626-8; Mickenautsch Steffen, 2011, BMC Res Notes, V4, P58, DOI 10.1186/1756-0500-4-58; Mickenautsch Steffen, 2011, BMC Res Notes, V4, P22, DOI 10.1186/1756-0500-4-22; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Oba AA, 2009, J FORMOS MED ASSOC, V108, P844, DOI 10.1016/S0929-6646(09)60415-0; Pocock SJ, 1983, CLIN TRIALS PRACTICA, P125; Quinonez RB, 2005, J PUBLIC HEALTH DENT, V65, P82, DOI 10.1111/j.1752-7325.2005.tb02791.x; Simonsen Richard J, 2002, Pediatr Dent, V24, P393; Smail-Faugeron V, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-64; Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wendt LK, 2001, SWED DENT J, V25, P61; Yengopal Veerasamy, 2009, J Oral Sci, V51, P373; Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301; Zhang WW, 2014, DENT MATER, V30, P487, DOI 10.1016/j.dental.2014.01.016	40	32	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146512	10.1371/journal.pone.0146512	http://dx.doi.org/10.1371/journal.pone.0146512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799812	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300023
J	Takaschima, A; Marchioro, P; Sakae, TM; Porporatti, AL; Mezzomo, LA; Canto, GD				Takaschima, Augusto; Marchioro, Patricia; Sakae, Thiago M.; Porporatti, Andre L.; Mezzomo, Luis Andre; Canto, Graziela De Luca			Risk of Hemorrhage during Needle-Based Ophthalmic Regional Anesthesia in Patients Taking Antithrombotics: A Systematic Review	PLOS ONE			English	Article							ANTIPLATELET THERAPY; NONCARDIAC SURGERY; PERIOPERATIVE MANAGEMENT; CORONARY STENT; ANTICOAGULANT; PERIBULBAR; BLOCK; CONTINUATION; AGENTS; AUDIT	Background Patients undergoing ophthalmic surgery are usually elderly and, due to systemic disease, may be on long-term therapy, such as antithrombotic agents. Rates of hemorrhagic complications associated with invasive procedures may be increased by the use of anticoagulants and antiplatelet agents. Objective To compare the incidence of hemorrhagic complications in patients undergoing needle-based ophthalmic regional anesthesia between patients on antithrombotic therapy and those not on such therapy. Methods A systematic review was conducted by two independent reviewers based on searches of Cochrane, LILACS, PubMed, Scopus, Web of Science, and the "gray" literature (Google Scholar). The end search date was May 8, 2015, across all databases. Results Five studies met the eligibility criteria. In three studies, individual risk of bias was low, and in two of them, moderate. In all studies, no differences regarding mild to moderate incidence of hemorrhagic complications were found between patients using antithrombotics (aspirin, clopidogrel, and warfarin) and those not using them. Rates of severe hemorrhagic complication were very low (0.04%) in both groups, supporting the safety of needle blocks, even in patients using antithrombotics. High heterogeneity across studies prevented meta-analysis. Limitations to these results include low statistical power in three experimental studies and a large 95% confidence interval in the two retrospective cohorts. Conclusion In this review, none of the selected studies showed significant bleeding related to needle-based ophthalmic regional anesthesia in association with the use of aspirin, clopidogrel, or vitamin K inhibitors. Since the available data is not powerful enough to provide a reliable evaluation of the true effect of antithrombotics in this setting, new studies to address these limitations are necessary.	[Takaschima, Augusto; Marchioro, Patricia] Florianopolis Hosp, Florianopolis, SC, Brazil; [Takaschima, Augusto] Sianest Anesthesiol Serv, Florianopolis, SC, Brazil; [Takaschima, Augusto; Porporatti, Andre L.] Univ Fed Santa Catarina, Brazilian Ctr Evidence Based Res, Hlth Sci Ctr, Florianopolis, SC, Brazil; [Sakae, Thiago M.; Mezzomo, Luis Andre; Canto, Graziela De Luca] Unisul Univ Santa Catarina, Tubarao, Brazil; [Porporatti, Andre L.] Univ Sao Paulo, Bauru, Brazil; [Canto, Graziela De Luca] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada	Universidade Federal de Santa Catarina (UFSC); Universidade do Sul de Santa Catarina; Universidade de Sao Paulo; University of Alberta	Takaschima, A (corresponding author), Florianopolis Hosp, Florianopolis, SC, Brazil.; Takaschima, A (corresponding author), Sianest Anesthesiol Serv, Florianopolis, SC, Brazil.; Takaschima, A (corresponding author), Univ Fed Santa Catarina, Brazilian Ctr Evidence Based Res, Hlth Sci Ctr, Florianopolis, SC, Brazil.	takaschima@gmail.com	De Luca Canto, Graziela/AAW-5234-2021; Porporatti, Andre/D-5280-2012; Sakae, Thiago/AAN-5573-2020	Sakae, Thiago/0000-0002-0603-3685; De Luca Canto, Graziela/0000-0002-7986-8317; Porporatti, Andre/0000-0003-4379-9695				Alhassan MB, 2008, COCHRANE DB SYST REV, V3; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Benzimra JD, 2009, EYE, V23, P10, DOI 10.1038/sj.eye.6703069; Bonhomme F, 2013, EUR J ANAESTH, V30, P449, DOI 10.1097/EJA.0b013e328360c442; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Calenda E, 2014, INT J OPHTHALMOL-CHI, V7, P110, DOI 10.3980/j.issn.2222-3959.2014.01.20; Calenda E, 2012, J ANESTH, V26, P779, DOI 10.1007/s00540-012-1406-6; Calenda Emile, 2011, Acta Anaesthesiol Taiwan, V49, P141, DOI 10.1016/j.aat.2011.11.003; Darvish-Kazem S, 2013, CHEST, V144, P1848, DOI 10.1378/chest.13-0459; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Fleisher LA, 2015, J NUCL CARDIOL, V22, P162, DOI 10.1007/s12350-014-0025-z; Grzybowski A, 2015, CURR OPIN OPHTHALMOL, V26, P28, DOI 10.1097/ICU.0000000000000117; Kallio H, 2000, BRIT J ANAESTH, V85, P708, DOI 10.1093/bja/85.5.708; Katz J, 2003, OPHTHALMOLOGY, V110, P1784, DOI 10.1016/S0161-6420(03)00785-1; Kiire CA, 2014, BRIT J OPHTHALMOL, V98, P1320, DOI 10.1136/bjophthalmol-2014-304902; Kobayashi H, 2010, J CATARACT REFR SURG, V36, P1115, DOI 10.1016/j.jcrs.2010.01.017; Kong KL, 2015, BRIT J OPHTHALMOL, V99, P1025, DOI 10.1136/bjophthalmol-2014-306036; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Mason JO, 2011, OPHTHALMOLOGY, V118, P543, DOI 10.1016/j.ophtha.2010.07.005; Mather SJ, 2010, CURR ANAESTH CRIT CA, V21, P158; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nouvellon E, 2010, ANESTHESIOLOGY, V113, P1236, DOI 10.1097/ALN.0b013e3181f7a78e; Riad W, 2012, J CLIN ANESTH, V24, P193, DOI 10.1016/j.jclinane.2011.07.012; Rizk SN, 2014, EGYPT J ANAESTH, V30, P255, DOI 10.1016/j.egja.2014.01.002; Rossini R, 2015, THROMB HAEMOSTASIS, V113, P272, DOI 10.1160/TH14-05-0436; Saumier N, 2010, ANN FR ANESTH, V29, P878, DOI 10.1016/j.annfar.2010.08.009; Schouten O, 2007, J AM COLL CARDIOL, V49, P122, DOI 10.1016/j.jacc.2006.10.004; Smart S, 2007, BJA EDUC, V7, P157, DOI 10.1093/bjaceaccp/mkm030; The Joanna Briggs Institute, 2014, J BRIGGS I SYST REV; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	31	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147227	10.1371/journal.pone.0147227	http://dx.doi.org/10.1371/journal.pone.0147227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800356	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300076
J	Vigne, JD; Evin, A; Cucchi, T; Dai, LL; Yu, C; Hu, SM; Soulages, N; Wang, WL; Sun, ZY; Gao, JT; Dobney, K; Yuan, J				Vigne, Jean-Denis; Evin, Allowen; Cucchi, Thomas; Dai, Lingling; Yu, Chong; Hu, Songmei; Soulages, Nicolas; Wang, Weilin; Sun, Zhouyong; Gao, Jiangtao; Dobney, Keith; Yuan, Jing			Earliest "Domestic" Cats in China Identified as Leopard Cat (Prionailurus bengalensis)	PLOS ONE			English	Article							DIET; EVOLUTION; CYPRUS	The ancestor of all modern domestic cats is the wildcat, Felis silvestris lybica, with archaeological evidence indicating it was domesticated as early as 10,000 years ago in South-West Asia. A recent study, however, claims that cat domestication also occurred in China some 5,000 years ago and involved the same wildcat ancestor (F. silvestris). The application of geometric morphometric analyses to ancient small felid bones from China dating between 5,500 to 4,900 BP, instead reveal these and other remains to be that of the leopard cat (Prionailurus bengalensis). These data clearly indicate that the origins of a human-cat 'domestic' relationship in Neolithic China began independently from South-West Asia and involved a different wild felid species altogether. The leopard cat's 'domestic' status, however, appears to have been short-lived-its apparent subsequent replacement shown by the fact that today all domestic cats in China are genetically related to F. silvestris.	[Vigne, Jean-Denis; Evin, Allowen; Cucchi, Thomas; Dai, Lingling; Yu, Chong; Soulages, Nicolas] Univ Paris 04, Museum Natl Hist Nat, CNRS, UMR 7209,Archeozool,Archeobot Soc Prat & Environm, CP 56, Paris, France; [Evin, Allowen; Cucchi, Thomas; Yu, Chong; Dobney, Keith] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Dai, Lingling] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hu, Songmei; Wang, Weilin; Sun, Zhouyong] Shaanxi Prov Inst Archaeol, Xian, Peoples R China; [Gao, Jiangtao; Yuan, Jing] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Evin, Allowen] Univ Montpellier, CNRS, Inst Sci Evolut, IRD,EPHE, CC 61,Pl Eugene Bataillon, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Aberdeen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Social Sciences; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Vigne, JD (corresponding author), Univ Paris 04, Museum Natl Hist Nat, CNRS, UMR 7209,Archeozool,Archeobot Soc Prat & Environm, CP 56, Paris, France.	vigne@mnhn.fr	Cucchi, Thomas/Q-4014-2018	Cucchi, Thomas/0000-0001-6021-5001; Dobney, Keith/0000-0001-9036-4681; EVIN, Allowen/0000-0003-4515-1649; Yu, Chong/0000-0003-4171-2568	ERAnet Co-Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch) [137]; Chinese Academy of Social Science; Agence National pour la Recherche (ANR) through the LabEx [ANR-10-LABX-0003-BCDiv, ANR-11-IDEX-0004-02]; Natural Environment Research Council [NE/F003382/2, NE/K005243/2, NE/K003259/2, NE/H005552/1, NE/H005269/1, NE/K003259/1, NE/F003382/1, NE/K005243/1] Funding Source: researchfish; NERC [NE/K003259/1, NE/F003382/1, NE/F003382/2, NE/K005243/2, NE/K005243/1, NE/K003259/2, NE/H005552/1, NE/H005269/1] Funding Source: UKRI	ERAnet Co-Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch); Chinese Academy of Social Science; Agence National pour la Recherche (ANR) through the LabEx(French National Research Agency (ANR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ERAnet (https://ec.europa.eu) Co-Reach project no 137 (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch) led by K. Dobney, and the Chinese Academy of Social Science funded this research. This research was also granted by the Agence National pour la Recherche (ANR, http://www.agence-nationale-recherche.fr/), through the LabEx ANR-10-LABX-0003-BCDiv, in the framework of the Investissements d'avenir programme (ANR-11-IDEX-0004-02).	Bar-Oz G, 2014, P NATL ACAD SCI USA, V111, pE876, DOI 10.1073/pnas.1324177111; BAYLAC M, 2012, RMORPH R GEOMETRIC M; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; Cucchi T, 2002, C R PALEVOL, V1, P235, DOI 10.1016/S1631-0683(02)00033-7; Cucchi T, 2013, EVOLUTION OUR NEIGHB, P65; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; GOODALL C. R., 1995, CURRENT ISSUES STAT, P18; Grassman LI, 2005, J ZOOL, V266, P45, DOI 10.1017/S095283690500659X; Helgren JA., 2013, ENCY CAT BREEDS COMP; Hu S, 2005, ARCHAEOL CULT RELICS, V6, P72; Hu YW, 2014, P NATL ACAD SCI USA, V111, P116, DOI 10.1073/pnas.1311439110; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Le Brun A, 1984, FOUILLES RECENTES KH, P147; Malek J., 1993, CAT ANCIENT EGYPT; Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111; Pan QH, 2007, FIELD GUIDE MAMMALS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Rohlf F. J., 2010, TPSDIG V 2 16; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ross S., 2015, OTOCOLOBUS MANUL IUC; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sicuro FL, 2011, BIOL J LINN SOC, V103, P176, DOI 10.1111/j.1095-8312.2011.01636.x; Smith Andrew T., 2008, P1; Sunquist M., 2002, WILDCATS WORLD; Tamada T, 2008, ZOOL SCI, V25, P154, DOI 10.2108/zsj.25.154; Van Neer W, 2014, J ARCHAEOL SCI, V45, P103, DOI 10.1016/j.jas.2014.02.014; Vigne J.-D, 2014, ENCY GLOBAL ARCHAEOL, P1175; Vigne J-D, 2004, SCIENCE, V304, P259; Vigne Jean-Denis, 2004, Anthropozoologica, V39, P249; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; VILA E, 1998, EXPLOITATION ANIMAUX; Wang Z., 2010, ARCHAEOLOGY, V2, P91; Wang Z., 2006, HIST TAMING CAT; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Yamaguchi N, 2004, BIOL J LINN SOC, V83, P47, DOI 10.1111/j.1095-8312.2004.00372.x; ZEDER MA, 2012, AGR DOMESTICATION EV, P227	39	17	17	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147295	10.1371/journal.pone.0147295	http://dx.doi.org/10.1371/journal.pone.0147295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799955	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300088
J	Yoshida, CE; Kruczkiewicz, P; Laing, CR; Lingohr, EJ; Gannon, VPJ; Nash, JHE; Taboada, EN				Yoshida, Catherine E.; Kruczkiewicz, Peter; Laing, Chad R.; Lingohr, Erika J.; Gannon, Victor P. J.; Nash, John H. E.; Taboada, Eduardo N.			The Salmonella In Silico Typing Resource (SISTR): An Open Web-Accessible Tool for Rapidly Typing and Subtyping Draft Salmonella Genome Assemblies	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BY-GENE APPROACH; OLIGONUCLEOTIDE MICROARRAY; NEXT-GENERATION; PUBLIC-HEALTH; CD-HIT; IDENTIFICATION; MULTIPLEX; MLST; SURVEILLANCE	For nearly 100 years serotyping has been the gold standard for the identification of Salmonella serovars. Despite the increasing adoption of DNA-based subtyping approaches, serotype information remains a cornerstone in food safety and public health activities aimed at reducing the burden of salmonellosis. At the same time, recent advances in whole-genome sequencing (WGS) promise to revolutionize our ability to perform advanced pathogen characterization in support of improved source attribution and outbreak analysis. We present the Salmonella In Silico Typing Resource (SISTR), a bioinformatics platform for rapidly performing simultaneous in silico analyses for several leading subtyping methods on draft Salmonella genome assemblies. In addition to performing serovar prediction by genoserotyping, this resource integrates sequence-based typing analyses for: Multi-Locus Sequence Typing (MLST), ribosomal MLST (rMLST), and core genome MLST (cgMLST). We show how phylogenetic context from cgMLST analysis can supplement the genoserotyping analysis and increase the accuracy of in silico serovar prediction to over 94.6% on a dataset comprised of 4,188 finished genomes and WGS draft assemblies. In addition to allowing analysis of user-uploaded whole-genome assemblies, the SISTR platform incorporates a database comprising over 4,000 publicly available genomes, allowing users to place their isolates in a broader phylogenetic and epidemiological context. The resource incorporates several metadata driven visualizations to examine the phylogenetic, geospatial and temporal distribution of genome-sequenced isolates. As sequencing of Salmonella isolates at public health laboratories around the world becomes increasingly common, rapid in silico analysis of minimally processed draft genome assemblies provides a powerful approach for molecular epidemiology in support of public health investigations. Moreover, this type of integrated analysis using multiple sequence-based methods of sub-typing allows for continuity with historical serotyping data as we transition towards the increasing adoption of genomic analyses in epidemiology. The SISTR platform is freely available on the web at https://lfz.corefacility.ca/sistr-app/.	[Yoshida, Catherine E.; Lingohr, Erika J.; Nash, John H. E.] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada; [Kruczkiewicz, Peter; Laing, Chad R.; Gannon, Victor P. J.; Taboada, Eduardo N.] Publ Hlth Agcy Canada, Natl Microbiol Lab Lethbridge, Lethbridge, AB, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Taboada, EN (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab Lethbridge, Lethbridge, AB, Canada.	eduardo.taboada@phac-aspc.gc.ca	Taboada, Eduardo N/Y-4854-2018; Nash, John HE/P-2384-2017	Taboada, Eduardo N/0000-0001-8373-3653; Nash, John HE/0000-0003-2925-8710; Kruczkiewicz, Peter/0000-0002-0044-9460	Public Health Agency of Canada; Government of Canada's Genomics Research and Development Initiative	Public Health Agency of Canada; Government of Canada's Genomics Research and Development Initiative	This work was funded through the Public Health Agency of Canada (ENT, CEY and JHEN) and the Government of Canada's Genomics Research and Development Initiative (ENT, CEY and JHEN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Ballmer K, 2007, J CLIN MICROBIOL, V45, P370, DOI 10.1128/JCM.01361-06; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Fielding RT, 2001, THESIS U CALIFORNIA; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Franklin K, 2011, J CLIN MICROBIOL, V49, P2954, DOI 10.1128/JCM.02347-10; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gilmour MW, 2013, PUBLIC HEALTH GENOM, V16, P25, DOI 10.1159/000342709; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Kruczkiewicz P, 2013, BIOINFORMATICS 2013: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P316; Kumar S, 2006, LETT APPL MICROBIOL, V42, P149, DOI 10.1111/j.1472-765X.2005.01813.x; Laing CR, 2011, VET MICROBIOL, V153, P13, DOI 10.1016/j.vetmic.2011.06.014; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MASTEN BJ, 1993, J BACTERIOL, V175, P5359, DOI 10.1128/JB.175.17.5359-5365.1993; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; McQuiston JR, 2004, J CLIN MICROBIOL, V42, P1923, DOI 10.1128/JCM.42.5.1923-1932.2004; Mortimer CKB, 2007, INFECT GENET EVOL, V7, P411, DOI 10.1016/j.meegid.2006.12.001; Mullner D, 2013, J STAT SOFTW, V53; Munoz N, 2010, J MOL DIAGN, V12, P220, DOI 10.2353/jmoldx.2010.090036; SEGHETTI L, 1946, J AM VET MED ASSOC, V109, P134; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Struelens MJ, 2013, EUROSURVEILLANCE, V18, P3; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tankouo-Sandjong B, 2008, MICROB BIOTECHNOL, V1, P513, DOI 10.1111/j.1751-7915.2008.00053.x; Wattiau P, 2008, INT J FOOD MICROBIOL, V123, P293, DOI 10.1016/j.ijfoodmicro.2008.01.006; Wollin R., 2007, EUROSURVEILLANCE, V12; Yoshida C, 2007, J MICROBIOL METH, V70, P261, DOI 10.1016/j.mimet.2007.04.018; Yoshida C, 2014, DIAGN MICR INFEC DIS, V80, P185, DOI 10.1016/j.diagmicrobio.2014.08.006; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15	44	241	246	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147101	10.1371/journal.pone.0147101	http://dx.doi.org/10.1371/journal.pone.0147101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800248	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300059
J	Avila-Burgos, L; Cahuana-Hurtado, L; Montanez-Hernandez, J; Servan-Mori, E; Aracena-Genao, B; del Rio-Zolezzi, A				Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero; Montanez-Hernandez, Julio; Servan-Mori, Edson; Aracena-Genao, Belkis; del Rio-Zolezzi, Aurora			Financing Maternal Health and Family Planning: Are We on the Right Track? Evidence from the Reproductive Health Subaccounts in Mexico, 2003-2012	PLOS ONE			English	Article							PROTECTION; COVERAGE	Objective To analyze whether the changes observed in the level and distribution of resources for maternal health and family planning (MHFP) programs from 2003 to 2012 were consistent with the financial goals of the related policies. Materials and Methods A longitudinal descriptive analysis of the Mexican Reproductive Health Subaccounts 20032012 was performed by financing scheme and health function. Financing schemes included social security, government schemes, household out-of-pocket (OOP) payments, and private insurance plans. Functions were preventive care, including family planning, antenatal and puerperium health services, normal and cesarean deliveries, and treatment of complications. Changes in the financial imbalance indicators covered by MHFP policy were tracked: (a) public and OOP expenditures as percentages of total MHFP spending; (b) public expenditure per woman of reproductive age (WoRA, 15-49 years) by financing scheme; (c) public expenditure on treating complications as a percentage of preventive care; and (d) public expenditure on WoRA at state level. Statistical analyses of trends and distributions were performed. Results Public expenditure on government schemes grew by approximately 300%, and the financial imbalance between populations covered by social security and government schemes decreased. The financial burden on households declined, particularly among households without social security. Expenditure on preventive care grew by 16%, narrowing the financing gap between treatment of complications and preventive care. Finally, public expenditure per WoRA for government schemes nearly doubled at the state level, although considerable disparities persist. Conclusions Changes in the level and distribution of MHFP funding from 2003 to 2012 were consistent with the relevant policy goals. However, improving efficiency requires further analysis to ascertain the impact of investments on health outcomes. This, in turn, will require better financial data systems as a precondition for improving the monitoring and accountability functions in Mexico.	[Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero; Montanez-Hernandez, Julio; Servan-Mori, Edson] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Aracena-Genao, Belkis] Natl Inst Publ Hlth, Res Ctr Evaluat & Surveys, Cuernavaca, Morelos, Mexico; [del Rio-Zolezzi, Aurora] Minist Hlth, Natl Ctr Gender Equity & Reprod Hlth, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Cahuana-Hurtado, L (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	lucero.cahuana@insp.mx	Avila-Burgos, Leticia/AAR-1815-2021	Aracena-Genao, Belkis/0000-0001-5454-9531; Servan-Mori, Edson/0000-0001-9820-8325; Cahuana-Hurtado, Lucero/0000-0002-9438-1443	National Center for Gender Equity; Reproductive Health of the Mexican Ministry of Health	National Center for Gender Equity; Reproductive Health of the Mexican Ministry of Health	Funding for this study was provided by the National Center for Gender Equity and Reproductive Health of the Mexican Ministry of Health. The funder had no direct role in the study design or analysis, the decision to publish this work, or the preparation and drafting of this manuscript.	Allen-Leigh B, 2013, SALUD PUBLICA MEXICO, V55, pS235, DOI 10.21149/spm.v55s2.5120; Asociacion Mexicana de Instituciones de Seguros. Accidentes y enfermedades, 2003, EST AN SESA; Avila-Burgos L., 2006, DESAROLLO SUBANALISI; Avila- Burgos L., 2014, CUENTAS SALUD REPROD; Avila-Burgos L, 2013, SALUD PUBLICA MEXICO, V55, pS91; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Cahuana-Hurtado L, 2006, REV PANAM SALUD PUBL, V20, P287, DOI 10.1590/S1020-49892006001000001; Cuenca LC, 2013, GAC MED MEX, V149, P299; Diario Oficial de la Federacion, 1993, NOM007SSA21993 DIAR; Direccion General de Informacion en Salud (DGIS), BAS EGR EGR HOSP SEC; Dubovoy C., 1968, B INF SOC MEX MIC, V2, P15; Frenk J, 2007, SALUD PUBLICA MEXICO, V49, pS23, DOI 10.1590/S0036-36342007000700007; Gobierno de la Republica, 2014, SIST INF ODM MEXICO2; Dantes OG, 2011, SALUD PUBLICA MEXICO, V53, pS220; Gonzalez Block MA, 2007, EVALUACION SISTEMA P; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Heredia-Pi Ileana, 2013, Salud pública Méx, V55, pS282; Hubert C, 2013, MATERNAL MORTALITY T; INSP Secretaria de Salud, 2009, EV SIST PROT SOC SAL; Instituto Nacional de Estadistica y Geografia, CALC INFL 2014; Instituto Nacional de Estadistica y Geografia, ENC NAC INGR GAST HO; Lopez MJ, 2015, HEALTH SYST REFORM, V1, P181, DOI 10.1080/23288604.2015.1058999; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Lazcano-Ponce E G-DH, 2013, EVALUACION EXTERNA 2, P256; Lazcano-Ponce E, 2013, SALUD PUBLICA MEXICO, V55, pS214; Levine R BK, 2007, CGD REPORTS; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Nigenda G, 2015, HEALTH SYST REFORM, V1, P217, DOI 10.1080/23288604.2015.1031336; Organisation for Economic Co-operation and Development, 2011, SYST HLTH ACC; Organisation for Economic Co-operation and Development, PURCH POW PAR PPPS D; Organizacion de las Naciones Unidas, 2014, OBJ DES MIL; Orozco E, 2011, EVALUACION RETOS INN; Presidencia de la Republica, 2011, OBJ DES MIL MEX; Secretaria de Salud, 2004, FIN JUST PROT SOC UN; Secretaria de Salud, PROYECC POBL COND DE; Secretaria de Salud, 2010, EST POBL MEX 1990 20; Secretaria de Salud, 2003, SECR SAL B INF EST, VIV; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; StataCorp, 2013, STAT STAT SOFTW REL; The Partnership for Maternal Newborn and Child Health, 2014, CONS UPD GLOB STRAT; UN. United Nations, 2012, HLTH POST 2015 UN DE; United Nations, 2018, SUST DEV KNOWL PLATF; WHO, 2011, MANT PROM EV RES; WHO, 2009, GUID PROD REPR HLTH; World Health Organization, 2000, WORLD HLTH REP 2000	46	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147923	10.1371/journal.pone.0147923	http://dx.doi.org/10.1371/journal.pone.0147923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812646	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000064
J	Chessa, D; Ganau, G; Spiga, L; Bulla, A; Mazzarello, V; Campus, GV; Rubino, S				Chessa, Daniela; Ganau, Giulia; Spiga, Luisella; Bulla, Antonio; Mazzarello, Vittorio; Campus, Gian Vittorio; Rubino, Salvatore			Staphylococcus aureus and Staphylococcus epidermidis Virulence Strains as Causative Agents of Persistent Infections in Breast Implants	PLOS ONE			English	Article							IN-VIVO; MEDICAL DEVICES; MOLECULAR-BASIS; BIOFILM; ADHESION; INSERTION; IS256	Staphylococcus epidermidis and Staphylococcus aureus are currently considered two of the most important pathogens in nosocomial infections associated with catheters and other medical implants and are also the main contaminants of medical instruments. However because these species of Staphylococcus are part of the normal bacterial flora of human skin and mucosal surfaces, it is difficult to discern when a microbial isolate is the cause of infection or is detected on samples as a consequence of contamination. Rapid identification of invasive strains of Staphylococcus infections is crucial for correctly diagnosing and treating infections. The aim of the present study was to identify specific genes to distinguish between invasive and contaminating S. epidermidis and S. aureus strains isolated on medical devices; the majority of our samples were collected from breast prostheses. As a first step, we compared the adhesion ability of these samples with their efficacy in forming biofilms; second, we explored whether it is possible to determine if isolated pathogens were more virulent compared with international controls. In addition, this work may provide additional information on these pathogens, which are traditionally considered harmful bacteria in humans, and may increase our knowledge of virulence factors for these types of infections.	[Chessa, Daniela; Ganau, Giulia; Spiga, Luisella; Mazzarello, Vittorio; Rubino, Salvatore] Univ Sassari, Dept Biomed Sci, Microbiol & Immunol Unit, I-07100 Sassari, Italy; [Bulla, Antonio; Campus, Gian Vittorio] Univ Sassari, Dept Surg Microsurg & Med Sci, Plast Surg Unit, I-07100 Sassari, Italy; [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia	University of Sassari; University of Sassari; King Faisal Specialist Hospital & Research Center	Chessa, D (corresponding author), Univ Sassari, Dept Biomed Sci, Microbiol & Immunol Unit, I-07100 Sassari, Italy.	danielachessa@uniss.it	Barac, Aleksandra/W-9785-2019; Campus, Gian Vittorio/M-7428-2015; Rubino, Salvatore/AAC-5848-2022	Campus, Gian Vittorio/0000-0001-9448-3047; Mazzarello, Vittorio/0000-0002-9713-3306; Spiga, Luisella/0000-0002-4770-7156	Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy	Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy	The project was supported by Azienda Ospedaliera Univeritaria (AOU) Sassari, Italy and was founding by Fondazione Banco di Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660; Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017; Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28; Le KY, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00167; Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Rodrigues LR, 2011, ADV EXP MED BIOL, V715, P351, DOI 10.1007/978-94-007-0940-9_22; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rubino C, 2014, J INFECT DEV COUNTR, V8, P1089, DOI 10.3855/jidc.3898; Taj Y, 2012, J INFECT DEV COUNTR, V6, P403, DOI 10.3855/jidc.1743; Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	27	42	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146668	10.1371/journal.pone.0146668	http://dx.doi.org/10.1371/journal.pone.0146668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811915	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528000010
J	Dratva, J; Zemp, E; Dharmage, SC; Accordini, S; Burdet, L; Gislason, T; Heinrich, J; Janson, C; Jarvis, D; de Marco, R; Norback, D; Pons, M; Real, FG; Sunyer, J; Villani, S; Probst-Hensch, N; Svanes, C				Dratva, Julia; Zemp, Elisabeth; Dharmage, Shyamali C.; Accordini, Simone; Burdet, Luc; Gislason, Thorarinn; Heinrich, Joachim; Janson, Christer; Jarvis, Deborah; de Marco, Roberto; Norback, Dan; Pons, Marco; Real, Francisco Gomez; Sunyer, Jordi; Villani, Simona; Probst-Hensch, Nicole; Svanes, Cecilie			Early Life Origins of Lung Ageing: Early Life Exposures and Lung Function Decline in Adulthood in Two European Cohorts Aged 28-73 Years	PLOS ONE			English	Article							AIR-POLLUTION; RISK-FACTOR; HAY-FEVER; FOLLOW-UP; CHILDHOOD; ASTHMA; SMOKING; BIRTH; DISEASE; ASSOCIATIONS	Objectives Early life environment is essential for lung growth and maximally attained lung function. Whether early life exposures impact on lung function decline in adulthood, an indicator of lung ageing, has scarcely been studied. Methods Spirometry data from two time points (follow-up time 9-11 years) and information on early life exposures, health and life-style were available from 12862 persons aged 28-73 years participating in the European population-based cohorts SAPALDIA (n = 5705) and ECRHS (n = 7157). The associations of early life exposures with lung function (FEV1) decline were analysed using mixed-effects linear regression. Results Early life exposures were significantly associated with FEV1 decline, with estimates almost as large as personal smoking. FEV1 declined more rapidly among subjects born during the winter season (adjusted difference in FEV1/year of follow-up [95% CI] -2.04ml [-3.29;-0.80]), of older mothers, (-1.82 ml [-3.14;-0.49]) of smoking mothers (-1.82ml [-3.30;-0.34] or with younger siblings (-2.61ml [-3.85;-1.38]). Less rapid FEV1-decline was found in subjects who had attended daycare (3.98ml [2.78; 5.18]), and indicated in subjects with pets in childhood (0.97ml [-0.16; 2.09]). High maternal age and maternal smoking appeared to potentiate effects of personal smoking. The effects were independent of asthma at any age. Conclusion Early life factors predicted lung function decline decades later, suggesting that some mechanisms related lung ageing may be established early in life. Early life programming of susceptibility to adult insults could be a possible pathway that should be explored further.	[Dratva, Julia; Zemp, Elisabeth; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Dratva, Julia; Zemp, Elisabeth; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [Dharmage, Shyamali C.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Allergy & Lung Hlth Unit, Melbourne, Vic 3010, Australia; [Accordini, Simone; de Marco, Roberto] Univ Verona, Dept Publ Hlth & Community Med, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Burdet, Luc] Hop Intercantonal Broye, Payerne, Switzerland; [Gislason, Thorarinn] Landspitali Univ, Hosp Reykjavik, Dept Resp Med & Sleep, Reykjavik, Iceland; [Heinrich, Joachim] Helmholtz Ctr Munich, Natl Res Ctr Environm Hlth, Munich, Germany; [Heinrich, Joachim] Univ Munich, Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Heinrich, Joachim] German Ctr Lung Res DZ, Munich, Germany; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth Sci, London, England; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat Environm Med, Uppsala, Sweden; [Pons, Marco] Reg Hosp Lugano, Div Pulm Med, Lugano, Switzerland; [Real, Francisco Gomez] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Real, Francisco Gomez] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway; [Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Villani, Simona] Univ Pavia, Fac Med, Dept Publ Hlth Neurosci Expt & Legal Med, Via Palestro 3, I-27100 Pavia, Italy; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen Resp Res Grp, Bergen, Norway; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Melbourne; University of Verona; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Uppsala University; Imperial College London; Uppsala University; University of Bergen; University of Bergen; Haukeland University Hospital; Pompeu Fabra University; University of Pavia; University of Bergen; University of Bergen; Haukeland University Hospital	Dratva, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Dratva, J (corresponding author), Univ Basel, Basel, Switzerland.	julia.dratva@unibas.ch	Sunyer, Jordi/G-6909-2014; Heinrich, Joachim/N-1720-2013; Svanes, Cecilie/N-7556-2017	Sunyer, Jordi/0000-0002-2602-4110; Heinrich, Joachim/0000-0002-9620-1629; Svanes, Cecilie/0000-0001-8512-5192; Jarvis, Deborah/0000-0002-1753-3896; Gomez Real, Francisco/0000-0001-5407-3270; Dharmage, Shyamali/0000-0001-6063-1937; /0000-0003-2517-6515; Norback, Dan/0000-0002-5174-6668	Swiss National Science Foundation [PMPDP3_129021/1, PMPDP3_141671/1]; Lung league Beider Basel, Lung league Graubunden; Stiftung ehemals Bundner Heilstatten; COST action [BM1201]; SAPALDIA; ECRHS	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lung league Beider Basel, Lung league Graubunden; Stiftung ehemals Bundner Heilstatten; COST action(European Cooperation in Science and Technology (COST)); SAPALDIA; ECRHS	The first author was supported by a Marie Heim-Vogtlin grant from the Swiss National Science Foundation (grant # PMPDP3_129021/1; # PMPDP3_141671/1), the Lung league Beider Basel, Lung league Graubunden, the Stiftung ehemals Bundner Heilstatten and the COST action BM1201. Research support received by the SAPALDIA and ECRHS cohorts can be found in the online supplement (e-supplement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Apostol GG, 2002, AM J RESP CRIT CARE, V166, P166, DOI 10.1164/rccm.2007035; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Carlsen KH, 2008, PAEDIATR RESPIR REV, V9, P11, DOI 10.1016/j.prrv.2007.11.007; Carraro S, 2014, EUR RESPIR J, V44, P1682, DOI 10.1183/09031936.00084114; Caudri D, 2013, CLIN EXP ALLERGY, V43, P1395, DOI 10.1111/cea.12173; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Gazala E, 2006, PEDIATR PULM, V41, P1125, DOI 10.1002/ppul.20442; Ginde AA, 2010, J ALLERGY CLIN IMMUN, V126, P59, DOI 10.1016/j.jaci.2010.05.030; GOLD, GLOB STRAT DIAGN MAN; Gold DR, 2009, J ALLERGY CLIN IMMUN, V124, P1078, DOI 10.1016/j.jaci.2009.08.021; Grabenhenrich LB, 2014, J ALLERGY CLIN IMMUN, V133, P979, DOI 10.1016/j.jaci.2013.11.035; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Harding R, 2012, SEMIN FETAL NEONAT M, V17, P67, DOI 10.1016/j.siny.2012.01.005; Hayatbakhsh MR, 2009, THORAX, V64, P810, DOI 10.1136/thx.2009.116301; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jackson B, 2004, INT J EPIDEMIOL, V33, P271, DOI 10.1093/ije/dyh003; Kozyrskyj AL, 2011, CURR OPIN ALLERGY CL, V11, P400, DOI 10.1097/ACI.0b013e328349b166; Krauss-Etschmann S, 2013, THORAX, V68, P380, DOI 10.1136/thoraxjnl-2012-201902; Kunzli N, 2005, SWISS MED WKLY, V135, P503; London SJ, 2001, EPIDEMIOLOGY, V12, P577, DOI 10.1097/00001648-200109000-00019; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Marossy AE, 2007, AM J RESP CRIT CARE, V175, P355, DOI 10.1164/rccm.200607-1023OC; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Palmer DJ, 2014, IMMUNOL ALLERGY CLIN, V34, P825, DOI 10.1016/j.iac.2014.07.003; Petersen H, 2014, CHEST, V145, P695, DOI 10.1378/chest.13-0799; Pistelli F, 2008, RESP MED, V102, P674, DOI 10.1016/j.rmed.2007.12.022; Ramsay SE, 2011, THORAX, V66, P1058, DOI 10.1136/thoraxjnl-2011-200621; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Stocks J, 2013, THER ADV RESPIR DIS, V7, P161, DOI 10.1177/1753465813479428; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Svanes C, 2002, THORAX, V57, P945, DOI 10.1136/thorax.57.11.945; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Svanes O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131959; Tennant PWG, 2010, CHEST, V137, P146, DOI 10.1378/chest.09-0352; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; Upton MN, 2004, AM J RESP CRIT CARE, V169, P479, DOI 10.1164/rccm.200211-1357OC; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046	49	35	35	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0145127	10.1371/journal.pone.0145127	http://dx.doi.org/10.1371/journal.pone.0145127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26811913	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000369528000002
J	Luh, J; Cronk, R; Bartram, J				Luh, Jeanne; Cronk, Ryan; Bartram, Jamie			Assessing Progress towards Public Health, Human Rights, and International Development Goals Using Frontier Analysis	PLOS ONE			English	Article							OUTLIERS; INDEX	Indicators to measure progress towards achieving public health, human rights, and international development targets, such as 100% access to improved drinking water or zero maternal mortality ratio, generally focus on status (i.e., level of attainment or coverage) or trends in status (i.e., rates of change). However, these indicators do not account for different levels of development that countries experience, thus making it difficult to compare progress between countries. We describe a recently developed new use of frontier analysis and apply this method to calculate country performance indices in three areas: maternal mortality ratio, poverty headcount ratio, and primary school completion rate. Frontier analysis is used to identify the maximum achievable rates of change, defined by the historically best-performing countries, as a function of coverage level. Performance indices are calculated by comparing a country's rate of change against the maximum achievable rate at the same coverage level. A country's performance can be positive or negative, corresponding to progression or regression, respectively. The calculated performance indices allow countries to be compared against each other regardless of whether they have only begun to make progress or whether they have almost achieved the target. This paper is the first to use frontier analysis to determine the maximum achievable rates as a function of coverage level and to calculate performance indices for public health, human rights, and international development indicators. The method can be applied to multiple fields and settings, for example health targets such as cessation in smoking or specific vaccine immunizations, and offers both a new approach to analyze existing data and a new data source for consideration when assessing progress achieved.	[Luh, Jeanne; Cronk, Ryan; Bartram, Jamie] Univ N Carolina, Dept Environm Sci & Engn, Water Inst, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Luh, J; Bartram, J (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Water Inst, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.	jluh@email.unc.edu; jbartram@email.unc.edu		Bartram, Jamie/0000-0002-6542-6315	Conrad N. Hilton Foundation	Conrad N. Hilton Foundation	Funding for RC and JB was provided by the Conrad N. Hilton Foundation.	ANDREWS DF, 1978, J ROY STAT SOC B MET, V40, P85; [Anonymous], 2014, MIDWIFERY, V30; Cook WD, 2014, OMEGA-INT J MANAGE S, V44, P1, DOI 10.1016/j.omega.2013.09.004; Food and Agriculture Organization of the United Nations, 2003, APP D DAT ENV AN DEA; Fukuda-Parr S, 2009, J HUM RIGHTS, V8, P195, DOI 10.1080/14754830903110194; Luh J, 2013, INT J HYG ENVIR HEAL, V216, P662, DOI 10.1016/j.ijheh.2012.12.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SEIFORD LM, 1990, J ECONOMETRICS, V46, P7, DOI 10.1016/0304-4076(90)90045-U; UN Development Group, 2003, IND MON MILL DEV GOA; UN General Assembly, 2015, OUTC DOC UN IN PRESS; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; WHO & UNICEF Joint Monitoring Programme, 2014, COUNTR FIL; Wilson P., 2013, FEAR FRONTIER EFFICI; WILSON PW, 1993, J BUS ECON STAT, V11, P319, DOI 10.2307/1391956; World Bank, 2015, WORLD DEV INDICATORS	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147663	10.1371/journal.pone.0147663	http://dx.doi.org/10.1371/journal.pone.0147663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GB	26812524	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000047
J	Archidona-Yuste, A; Navas-Cortes, JA; Cantalapiedra-Navarrete, C; Palomares-Rius, JE; Castillo, P				Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo			Unravelling the Biodiversity and Molecular Phylogeny of Needle Nematodes of the Genus Longidorus (Nematoda: Longidoridae) in Olive and a Description of Six New Species	PLOS ONE			English	Article							N. SP NEMATODA; REVISED POLYTOMOUS KEY; HENANUS XU; XIPHINEMA; IDENTIFICATION; COMPLEX; REGION; DORYLAIMIDA; MICOLETZKY; DIVERSITY	The genus Longidorus includes a remarkable group of invertebrate animals of the phylum Nematoda comprising polyphagous root-ectoparasites of numerous plants including several agricultural crops and trees. Damage is caused by direct feeding on root cells as well as by transmitting nepoviruses that cause disease on those crops. Thus, correct identification of Longidorus species is essential to establish appropriate control measures. We provide the first detailed information on the diversity and distribution of Longidorus species infesting wild and cultivated olive soils in a wide-region in southern Spain that included 159 locations from which 449 sampling sites were analyzed. The present study doubles the known biodiversity of Longidorus species identified in olives by including six new species (Longidorus indalus sp. nov., Longidorus macrodorus sp. nov., Longidorus onubensis sp. nov., Longidorus silvestris sp. nov., Longidorus vallensis sp. nov., and Longidorus wicuolea sp. nov.), two new records for wild and cultivate olives (L. alvegus and L. vineacola), and two additional new records for wild olive (L. intermedius and L. lusitanicus). We also found evidence of some geographic species associations to western (viz. L. alvegus, L. intermedius, L. lusitanicus, L. onubensis sp. nov., L. vineacola, L. vinearum, L. wicuolea sp. nov.) and eastern distributions (viz. L. indalus sp. nov.), while only L. magnus was detected in both areas. We developed a comparative study by considering morphological and morphometrical features together with molecular data from nuclear ribosomal RNA genes (D2-D3 expansion segments of 28S, ITS1, and partial 18S). Results of molecular and phylogenetic analyses confirmed the morphological hypotheses and allowed the delimitation and discrimination of six new species of the genus described herein and four known species. Phylogenetic analyses of Longidorus spp. based on three molecular markers resulted in a general consensus of these species groups, since lineages were maintained for the majority of species. This study represents the most complete phylogenetic analysis for Longidorus species to date.	[Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo] CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Castillo, P (corresponding author), CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain.	p.castillo@csic.es	Castillo, Pablo/L-3397-2019; Navas-Cortes, Juan A./M-2060-2019; Palomares-Rius, Juan/K-8004-2015; Navas-Cortes, Juan A/H-3381-2014; Archidona-Yuste, Antonio/GRS-2729-2022; , Antonio/ABF-4935-2020; Archidona-Yuste, Antonio/C-2406-2018; Castillo, Pablo/A-1445-2011	Castillo, Pablo/0000-0001-6657-6385; Palomares-Rius, Juan/0000-0003-1776-8131; Navas-Cortes, Juan A/0000-0001-6480-1104; Archidona-Yuste, Antonio/0000-0003-4446-0642; , Antonio/0000-0003-4446-0642; Archidona-Yuste, Antonio/0000-0003-4446-0642; Castillo, Pablo/0000-0003-0256-876X	'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P12-AGR-1486]; FEDER - European Union; Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262 ArimNET_ERANET]	'Ministerio de Economia y Competitividad' of Spain; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; FEDER - European Union(European Commission); Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA))	Financial support was received by Projects AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain, Project P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, and FEDER financial support from the European Union is gratefully acknowledged. The grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), also provided partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD W., 1992, DORYLAIMIDA FREELIVI; Ali N, 2014, CR BIOL, V337, P423, DOI 10.1016/j.crvi.2014.05.006; Amrei SB, 2013, SYST PARASITOL, V85, P173, DOI 10.1007/s11230-013-9414-y; ARIAS M, 1986, Revue de Nematologie, V9, P101; Arias M, 1988, REV NEMATOL, V11, P415; Belaj A, 2007, ANN BOT-LONDON, V100, P449, DOI 10.1093/aob/mcm132; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boucher G, 1995, CONSERV BIOL, V9, P1594, DOI 10.1046/j.1523-1739.1995.09061594.x; Bravo M. A., 1998, Agronomia Lusitana, V46, P101; BRAVO MA, 1995, FUND APPL NEMATOL, V18, P81; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; Cantalapiedra-Navarrete C, 2013, ZOOL ANZ, V252, P246, DOI 10.1016/j.jcz.2012.08.002; CAP-JA, 2014, EST AGR; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; Chen QW, 1997, FUND APPL NEMATOL, V20, P15; Cherry T, 1997, J NEMATOL, V29, P23; Cooler W.A., 1979, P317; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Coomans A, 2001, ANN SCI ZOOLOGIQUES, V287, P1; Coomans A, 2012, NEMATOLOGY, V14, P285, DOI 10.1163/156854111X594974; Coomans August, 1996, Russian Journal of Nematology, V4, P51; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Luca F, 2004, J NEMATOL, V36, P147; De Luca F, 2009, NEMATOLOGY, V11, P155, DOI 10.1163/156854108X398534; Decraemer W, 2007, J NEMATOL, V39, P295; Decraemer W, 2013, NEMATOLOGY, V15, P57, DOI 10.1163/156854112X645598; FLEGG JJM, 1967, ANN APPL BIOL, V60, P429, DOI 10.1111/j.1744-7348.1967.tb04497.x; Guo K, 2011, RUSS J NEMATOL, V19, P83; Gutierrez-Gutierrez C, 2013, ZOOL J LINN SOC-LOND, V167, P473, DOI 10.1111/zoj.12019; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; Gutierrez-Gutierrez C, 2011, EUR J PLANT PATHOL, V129, P427, DOI 10.1007/s10658-010-9705-y; Gutierrez-Gutierrez C, 2010, ZOOL SCR, V39, P483, DOI 10.1111/j.1463-6409.2010.00437.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hashim Z., 1979, Nematologia Mediterranea, V7, P177; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; Hirata Kenji, 2002, Japanese Journal of Nematology, V32, P1, DOI 10.3725/jjn1993.32.1_1; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hooper D. J., 1961, Nematologica, V6, P237; Ibrahim IKA, 2010, NEMATROPICA, V40, P239; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KOZLOWSKA J, 1979, NEMATOLOGICA, V25, P42, DOI 10.1163/187529279X00361; Krnjaic Dj., 2000, Nematologia Mediterranea, V28, P235; Lamberti F., 1996, Nematologia Mediterranea, V24, P79; Lamberti F., 1983, Nematologia Mediterranea, V11, P49; Lamberti F., 1982, Nematologia Mediterranea, V10, P183; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Loof PAA, 1999, NEMATOLOGY, V1, P55, DOI 10.1163/156854199507974; MACARA AM, 1985, NEMATOLOGICA, V31, P410; Macfarlane SA, 2003, MOL PLANT PATHOL, V4, P211, DOI 10.1046/j.1364-3703.2003.00164.x; MacFarlane SA, 2002, ADV BOT RES, V36, P169, DOI 10.1016/S0065-2296(02)36063-4; MAGRAMA, 2014, EST AGR; MICOLETZKY H., 1922, Arch. Naturgesch., V87, P1; Navas A., 1993, Nematologia Mediterranea, V21, P71; Navas A., 1990, Nematologia Mediterranea, V18, P103; Neilson R, 2004, HELMINTHOLOGIA, V41, P209; Niknam G, 2010, RUSS J NEMATOL, V18, P127; Nunn G.B., 1992, NEMATODE MOL EVOLUTI; Oliveira CMG, 2006, J NEMATOL, V38, P418; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palomares-Rius JE, 2008, NEMATOLOGY, V10, P87, DOI 10.1163/156854108783360186; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Palomares-Rius JE, 2014, NEMATOLOGY, V16, P1105, DOI 10.1163/15685411-00002831; Palomares-Rius JE, 2013, NEMATOLOGY, V15, P363, DOI 10.1163/15685411-00002680; Palomares-Rius JE, 2010, NEMATOLOGY, V12, P631, DOI 10.1163/138855410X12628646276041; Pearse A.S., 1942, INTRO PARASITOLOGY; Pedram M, 2008, SYST PARASITOL, V71, P199, DOI 10.1007/s11230-008-9148-4; Pena Santiago R, 2003, COLLECTION MONOGRAPH, V1; PENA-SANTIAGO R, 1990, Revue de Nematologie, V13, P113; Peneva VK, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.330.5750; Robbins Robert T., 1996, Russian Journal of Nematology, V4, P163; ROBBINS RT, 1995, SYST PARASITOL, V32, P33, DOI 10.1007/BF00009466; Roca F., 1989, Nematologia Mediterranea, V17, P1; Roca F., 1984, Nematologia Mediterranea, V12, P187; Romanenko ND, 1998, RUSS J NEMATOL, V6, P185; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; SIDDIQI M. RAFIQ, 1962, NEMATOLOGICA, V8, P152; Sturhan D, 1954, NEMATOLOGICA, V10, P335; Subbotin SA, 2006, PLANT NEMATOLOGY, P33, DOI 10.1079/9781845930561.0033; Subbotin SA, 2014, EUR J PLANT PATHOL, V138, P377, DOI 10.1007/s10658-013-0338-9; Tarjan A. C., 1964, FAO PLANT PROTECTION, V12, P49; Taylor C.E., 1997, NEMATODE VECTORS PLA; THORNE GERALD, 1935, PROC HELMINTH SOC WASHINGTON, V2, P96; TOPHAM PB, 1985, J BIOGEOGR, V12, P165, DOI 10.2307/2844839; Tzortzakakis E. A., 2008, Nematologia Mediterranea, V36, P153; Tzortzakakis EA, 2014, EUR J PLANT PATHOL, V140, P563, DOI 10.1007/s10658-014-0488-4; VRAIN TC, 1992, FUND APPL NEMATOL, V15, P563; XU JH, 1992, FUND APPL NEMATOL, V15, P517; Ye WM, 2004, J NEMATOL, V36, P14; Zheng JW, 2001, NEMATOLOGY, V3, P219, DOI 10.1163/156854101750413298; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	94	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147689	10.1371/journal.pone.0147689	http://dx.doi.org/10.1371/journal.pone.0147689			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808994	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800180
J	Campbell, J; Sharma, A				Campbell, Julia; Sharma, Anu			Visual Cross-Modal Re-Organization in Children with Cochlear Implants	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; SPOKEN LANGUAGE-DEVELOPMENT; PRELINGUALLY DEAF-CHILDREN; EVENT-RELATED POTENTIALS; SPEECH-PERCEPTION; DEVELOPMENTAL-CHANGES; HEARING; PLASTICITY; MOTION; CORTEX	Background Visual cross-modal re-organization is a neurophysiological process that occurs in deafness. The intact sensory modality of vision recruits cortical areas from the deprived sensory modality of audition. Such compensatory plasticity is documented in deaf adults and animals, and is related to deficits in speech perception performance in cochlear-implanted adults. However, it is unclear whether visual cross-modal re-organization takes place in cochlear-implanted children and whether it may be a source of variability contributing to speech and language outcomes. Thus, the aim of this study was to determine if visual cross-modal re-organization occurs in cochlear-implanted children, and whether it is related to deficits in speech perception performance. Methods Visual evoked potentials (VEPs) were recorded via high-density EEG in 41 normal hearing children and 14 cochlear-implanted children, aged 5-15 years, in response to apparent motion and form change. Comparisons of VEP amplitude and latency, as well as source localization results, were conducted between the groups in order to view evidence of visual cross-modal re-organization. Finally, speech perception in background noise performance was correlated to the visual response in the implanted children. Results Distinct VEP morphological patterns were observed in both the normal hearing and cochlear-implanted children. However, the cochlear-implanted children demonstrated larger VEP amplitudes and earlier latency, concurrent with activation of right temporal cortex including auditory regions, suggestive of visual cross-modal re-organization. The VEP N1 latency was negatively related to speech perception in background noise for children with cochlear implants. Conclusion Our results are among the first to describe cross modal re-organization of auditory cortex by the visual modality in deaf children fitted with cochlear implants. Our findings suggest that, as a group, children with cochlear implants show evidence of visual cross-modal recruitment, which may be a contributing source of variability in speech perception outcomes with their implant.	[Campbell, Julia; Sharma, Anu] Univ Colorado, Brain & Behav Lab, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA; [Campbell, Julia; Sharma, Anu] Univ Colorado, Inst Cognit Sci, 344 UCB, Boulder, CO 80309 USA; [Campbell, Julia; Sharma, Anu] Univ Colorado, Dept Speech Language & Hearing Sci, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Sharma, A (corresponding author), Univ Colorado, Brain & Behav Lab, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA.; Sharma, A (corresponding author), Univ Colorado, Inst Cognit Sci, 344 UCB, Boulder, CO 80309 USA.; Sharma, A (corresponding author), Univ Colorado, Dept Speech Language & Hearing Sci, 409 UCB,2501 Kittredge Loop Rd, Boulder, CO 80309 USA.	anu.sharma@colorado.edu	Campbell, Julia/N-8425-2019	Campbell, Julia/0000-0003-3985-6204; SHARMA, ANU/0000-0001-8568-1420	National Institutes of Health National Institute on Deafness and Other Communication Disorders [F31DC011970]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011970] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	JC was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders F31DC011970. http://www.nidcd.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Bergeson TR, 2005, EAR HEARING, V26, P149, DOI 10.1097/00003446-200504000-00004; Bertrand JA, 2012, EXP BRAIN RES, V216, P145, DOI 10.1007/s00221-011-2920-8; Bucher K, 2006, NEUROIMAGE, V31, P1625, DOI 10.1016/j.neuroimage.2006.02.032; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Caldwell A, 2013, J SPEECH LANG HEAR R, V56, P13, DOI 10.1044/1092-4388(2012/11-0338); Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Chang DT, 2010, ARCH OTOLARYNGOL, V136, P648, DOI 10.1001/archoto.2010.90; Chen L, 2015, MED IMAGE ANAL, V23, P1, DOI 10.1016/j.media.2015.03.004; Chlubnova J, 2005, PHYSIOL RES, V54, P577, DOI 10.33549/physiolres.930649; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clemo HR, 2016, CEREB CORTEX, V26, P1365, DOI 10.1093/cercor/bhu225; De Raeve L, 2010, OTOL NEUROTOL, V31, P1261, DOI 10.1097/MAO.0b013e3181f1cde3; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dettman S, 2013, OTOL NEUROTOL, V34, P451, DOI 10.1097/MAO.0b013e3182839650; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Doucet ME, 2005, NEUROREPORT, V16, P1753, DOI 10.1097/01.wnr.0000185011.91197.58; Eggermont JJ, 1997, ACTA OTO-LARYNGOL, V117, P161, DOI 10.3109/00016489709117760; EGGERMONT JJ, 1988, ELECTROEN CLIN NEURO, V70, P293, DOI 10.1016/0013-4694(88)90048-X; Etymotic Research, 2005, BKB SIN SPEECH IN NO; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2006, Adv Otorhinolaryngol, V64, P50, DOI 10.1159/000094644; Geers AE, 2009, J DEAF STUD DEAF EDU, V14, P371, DOI 10.1093/deafed/enn046; Gifford RH, 2011, J AM ACAD AUDIOL, V22, P623, DOI 10.3766/jaaa.22.9.7; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Kok MA, 2014, J COMP NEUROL, V522, P654, DOI 10.1002/cne.23439; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kubova Z, 2014, DOC OPHTHALMOL, V128, P121, DOI 10.1007/s10633-014-9429-y; Lazard DS, 2014, HEARING RES, V307, P136, DOI 10.1016/j.heares.2013.08.006; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Lee HJ, 2005, HEARING RES, V203, P2, DOI 10.1016/j.heares.2004.11.005; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Letourneau SM, 2011, PERCEPTION, V40, P563, DOI 10.1068/p6858; Lin FR, 2014, NEUROIMAGE, V90, P84, DOI 10.1016/j.neuroimage.2013.12.059; Lin FR, 2008, OTOL NEUROTOL, V29, P208, DOI 10.1097/MAO.0b013e31812f6fa6; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; MOSKOWITZ A, 1983, ELECTROEN CLIN NEURO, V56, P1, DOI 10.1016/0013-4694(83)90002-0; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Passarotti AM, 2003, DEVELOPMENTAL SCI, V6, P100, DOI 10.1111/1467-7687.00259; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Peterson NR, 2010, RESTOR NEUROL NEUROS, V28, P237, DOI 10.3233/RNN-2010-0535; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Sarant J, 2014, EAR HEARING, V35, P396, DOI 10.1097/AUD.0000000000000022; Sarant JZ, 2001, EAR HEARING, V22, P18, DOI 10.1097/00003446-200102000-00003; Scott GD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00177; Sharma A, 2002, ANN OTO RHINOL LARYN, V111, P38, DOI 10.1177/00034894021110S508; Sharma A, 2002, NEUROREPORT, V13, P1365, DOI 10.1097/00001756-200207190-00030; Sharma A, 2015, INT J PSYCHOPHYSIOL, V95, P135, DOI 10.1016/j.ijpsycho.2014.04.007; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Stothart G, 2014, CLIN NEUROPHYSIOL, V125, P1471, DOI 10.1016/j.clinph.2013.11.029; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Tobey EA, 2003, EAR HEARING, V24, p36S, DOI 10.1097/01.AUD.0000051688.48224.A6; Tyler RS, 1997, OTOLARYNG HEAD NECK, V117, P180, DOI 10.1016/S0194-5998(97)70172-4; Vachon P, 2013, NEUROSCIENCE, V245, P50, DOI 10.1016/j.neuroscience.2013.04.004; Wang NY, 2008, OTOL NEUROTOL, V29, P240, DOI 10.1097/MAO.0b013e3181627a37; Whittingstall K, 2007, HUM BRAIN MAPP, V28, P134, DOI 10.1002/hbm.20265; Wilke M, 2007, EXP BRAIN RES, V178, P296, DOI 10.1007/s00221-006-0732-z; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059)	85	34	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147793	10.1371/journal.pone.0147793	http://dx.doi.org/10.1371/journal.pone.0147793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807850	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800212
J	de Gardelle, V; Le Corre, F; Mamassian, P				de Gardelle, Vincent; Le Corre, Francois; Mamassian, Pascal			Confidence as a Common Currency between Vision and Audition	PLOS ONE			English	Article							MEMORY	The idea of a common currency underlying our choice behaviour has played an important role in sciences of behaviour, from neurobiology to psychology and economics. However, while it has been mainly investigated in terms of values, with a common scale on which goods would be evaluated and compared, the question of a common scale for subjective probabilities and confidence in particular has received only little empirical investigation so far. The present study extends previous work addressing this question, by showing that confidence can be compared across visual and auditory decisions, with the same precision as for the comparison of two trials within the same task. We discuss the possibility that confidence could serve as a common currency when describing our choices to ourselves and to others.	[de Gardelle, Vincent] CNRS, UMR 8174, Ctr Econ Sorbonne, Paris, France; [de Gardelle, Vincent] Paris Sch Econ, Paris, France; [Le Corre, Francois; Mamassian, Pascal] CNRS, UMR 8248, Lab Syst Perceptifs, Paris, France; [Le Corre, Francois; Mamassian, Pascal] PSL Res Univ, Ecole Normale Super, Inst Etude Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Paris School of Economics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	de Gardelle, V (corresponding author), CNRS, UMR 8174, Ctr Econ Sorbonne, Paris, France.; de Gardelle, V (corresponding author), Paris Sch Econ, Paris, France.	vincent.gardelle@gmail.com	de Gardelle, Vincent/I-1226-2014; Mamassian, Pascal/F-4781-2012	de Gardelle, Vincent/0000-0001-5977-5597; Mamassian, Pascal/0000-0002-1605-4607	Agence Nationale de la Recherche [ANR-10-BLAN-1910]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an Agence Nationale de la Recherche grant to PM[ANR-10-BLAN-1910 "Visual Confidence"]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Bornstein BH, 1999, J EXP PSYCHOL-APPL, V5, P76, DOI 10.1037/1076-898X.5.1.76; CABANAC M, 1992, J THEOR BIOL, V155, P173, DOI 10.1016/S0022-5193(05)80594-6; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Hunt AR, 2004, BRAIN COGNITION, V55, P325, DOI 10.1016/j.bandc.2004.02.072; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Lebreton M, 2015, NAT NEUROSCI, V18, P1159, DOI 10.1038/nn.4064; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; Morey RD, 2014, STAT PROBABIL LETT, V92, P121, DOI 10.1016/j.spl.2014.05.010; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rose AK, 2005, J ECON SURV, V19, P347, DOI 10.1111/j.0950-0804.2005.00251.x; Savage L.J., 1954, FDN STAT; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; West RF, 1997, PSYCHON B REV, V4, P387, DOI 10.3758/BF03210798; Zarnoth P, 1997, J EXP SOC PSYCHOL, V33, P345, DOI 10.1006/jesp.1997.1326; Zhang H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00001	22	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147901	10.1371/journal.pone.0147901	http://dx.doi.org/10.1371/journal.pone.0147901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808061	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800242
J	Glenn, AE; Davis, CB; Gao, ML; Gold, SE; Mitchell, TR; Proctor, RH; Stewart, JE; Snook, ME				Glenn, Anthony E.; Davis, C. Britton; Gao, Minglu; Gold, Scott E.; Mitchell, Trevor R.; Proctor, Robert H.; Stewart, Jane E.; Snook, Maurice E.			Two Horizontally Transferred Xenobiotic Resistance Gene Clusters Associated with Detoxification of Benzoxazolinones by Fusarium Species	PLOS ONE			English	Article							ASPERGILLUS-KAWACHII; FUMONISIN PRODUCTION; FUNGAL ENDOPHYTES; BETA-LACTAMASES; VERTICILLIOIDES; ECOLOGY; BIOTRANSFORMATION; IDENTIFICATION; PHYTOALEXINS; DEGRADATION	Microbes encounter a broad spectrum of antimicrobial compounds in their environments and often possess metabolic strategies to detoxify such xenobiotics. We have previously shown that Fusarium verticillioides, a fungal pathogen of maize known for its production of fumonisin mycotoxins, possesses two unlinked loci, FDB1 and FDB2, necessary for detoxification of antimicrobial compounds produced by maize, including the gamma-lactam 2-benzoxazolinone ( BOA). In support of these earlier studies, microarray analysis of F. verticillioides exposed to BOA identified the induction of multiple genes at FDB1 and FDB2, indicating the loci consist of gene clusters. One of the FDB1 cluster genes encoded a protein having domain homology to the metallo-beta-lactamase (MBL) superfamily. Deletion of this gene ( MBL1) rendered F. verticillioides incapable of metabolizing BOA and thus unable to grow on BOA-amended media. Deletion of other FDB1 cluster genes, in particular AMD1 and DLH1, did not affect BOA degradation. Phylogenetic analyses and topology testing of the FDB1 and FDB2 cluster genes suggested two horizontal transfer events among fungi, one being transfer of FDB1 from Fusarium to Colletotrichum, and the second being transfer of the FDB2 cluster from Fusarium to Aspergillus. Together, the results suggest that plant-derived xenobiotics have exerted evolutionary pressure on these fungi, leading to horizontal transfer of genes that enhance fitness or virulence.	[Glenn, Anthony E.; Davis, C. Britton; Gold, Scott E.; Mitchell, Trevor R.; Snook, Maurice E.] USDA, ARS, Richard B Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA USA; [Gao, Minglu] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Proctor, Robert H.] USDA, ARS, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, Peoria, IL USA; [Stewart, Jane E.] Colorado State Univ, Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Davis, C. Britton] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Colorado State University; University System of Georgia; University of Georgia	Glenn, AE (corresponding author), USDA, ARS, Richard B Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA USA.	anthony.glenn@ars.usda.gov		Glenn, Anthony/0000-0001-8329-1306				Abbas HK, 2009, TOXIN REV, V28, P142, DOI 10.1080/15569540903081590; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Baldwin TT, 2014, J AGR FOOD CHEM, V62, P2118, DOI 10.1021/jf5001106; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; Bulder AS, 2012, P 74 M JOINT FAOWHO, P325; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Futagami T, 2015, APPL ENVIRON MICROB, V81, P1353, DOI 10.1128/AEM.03483-14; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Glenn AE, 2009, J APPL MICROBIOL, V107, P657, DOI 10.1111/j.1365-2672.2009.04246.x; Glenn AE, 2003, APPL ENVIRON MICROB, V69, P3165, DOI 10.1128/AEM.69.6.3165-3169.2003; Glenn AE, 2002, MOL PLANT MICROBE IN, V15, P91, DOI 10.1094/MPMI.2002.15.2.91; Glenn AE, 2001, APPL ENVIRON MICROB, V67, P2973, DOI 10.1128/AEM.67.7.2973-2981.2001; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Glenn AE, 2010, FEBS LETT, V584, P3158, DOI 10.1016/j.febslet.2010.05.063; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karagianni EP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12900; Kettle AJ, 2015, MOL PLANT PATHOL, V16, P946, DOI 10.1111/mpp.12250; Kettle AJ, 2015, FUNGAL GENET BIOL, V83, P1, DOI 10.1016/j.fgb.2015.08.005; Leslie JF, 2006, FUSARIUM LAB MANUAL; Lim FY, 2012, APPL ENVIRON MICROB, V78, P4117, DOI 10.1128/AEM.07710-11; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Nesme J, 2015, ENVIRON MICROBIOL, V17, P913, DOI 10.1111/1462-2920.12631; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Saunders M, 2008, APPL ENVIRON MICROB, V74, P136, DOI 10.1128/AEM.01538-07; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stone JK, 2000, BOOK SOIL P, P3; Sugimoto T, 2012, J IND MICROBIOL BIOT, V39, P605, DOI 10.1007/s10295-011-1053-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagena E, 2008, CURR DRUG METAB, V9, P628, DOI 10.2174/138920008785821729; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Vilich V, 1999, MYCOL RES, V103, P1529, DOI 10.1017/S0953756299008862; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Williams LD, 2007, J AGR FOOD CHEM, V55, P2937, DOI 10.1021/jf0635614; Williams LD, 2006, J AGR FOOD CHEM, V54, P5694, DOI 10.1021/jf0610209; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	46	23	49	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147486	10.1371/journal.pone.0147486	http://dx.doi.org/10.1371/journal.pone.0147486			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808652	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800108
J	Hayat, T; Rafiq, M; Ahmad, B				Hayat, Tasawar; Rafiq, Maimona; Ahmad, Bashir			Soret and Dufour Effects on MHD Peristaltic Flow of Jeffrey Fluid in a Rotating System with Porous Medium	PLOS ONE			English	Article							THERMAL-RADIATION; CARBON NANOTUBE; MAGNETIC-FIELD; GRADE FLUID; TRANSPORT; MOTION; SLIP	The objective of present paper is to examine the peristaltic flow of magnetohydrodynamic (MHD) Jeffrey fluid saturating porous space in a channel through rotating frame. Unlike the previous attempts, the flow formulation is based upon modified Darcy's law porous medium effect in Jeffrey fluid situation. In addition the impacts due to Soret and Dufour effects in the radiative peristaltic flow are accounted. Rosseland's approximation has been utilized for the thermal radiative heat flux. Lubrication approach is implemented for the simplification. Resulting problems are solved for the stream function, temperature and concentration. Graphical results are prepared and analyzed for different parameters of interest entering into the problems.	[Hayat, Tasawar; Rafiq, Maimona] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Ahmad, Bashir] King Abdulaziz Univ, Nonlinear & Appl Math NAAM Res Grp, Dept Math, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Rafiq, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	maimona_88@hotmail.com	Ahmad, Bashir/B-1977-2012; Hayat, Tasawar/Y-2524-2019; Rafiq, Maimona/AAM-7714-2020	Ahmad, Bashir/0000-0001-5350-2977; 				Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abbasi FM, 2014, APPL MATH INFORM SCI, V8, P211; Abbasi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105440; Abd-Alla AM, 2013, J MAGN MAGN MATER, V348, P33, DOI 10.1016/j.jmmm.2013.06.030; Abd-Alla AM, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074702; Abd-Alla AM, 2012, MECCANICA, V47, P1455, DOI 10.1007/s11012-011-9528-8; Ali N., 2012, SCI RES ESSAYS, V7, P2891; Awais M, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500235; BRASSEUR JG, 1987, J FLUID MECH, V174, P495, DOI 10.1017/S0022112087000211; Das K, 2012, IRAN J MATH SCI INFO, V7, P35, DOI 10.7508/ijmsi.2012.02.004; Dong RY, 2015, RSC ADV, V5, P88719, DOI 10.1039/c5ra18901b; Dong RY, 2015, MICROFLUID NANOFLUID, V19, P805, DOI 10.1007/s10404-015-1605-1; Dong RY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06120; Ellahi R, 2014, APPL NANOSCI, V4, P753, DOI 10.1007/s13204-013-0255-4; Fu HC, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3086320; FUNG YC, 1968, J APPL MECH, V35, P669, DOI 10.1115/1.3601290; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2012, NUMER METH PART D E, V28, P737, DOI 10.1002/num.20647; Hayat T., 2013, WALAILAK J SCI TECH, V10, P29; Hina S, 2014, APPL MATH MECH-ENGL, V35, P73, DOI 10.1007/s10483-014-1773-7; Jyothi B., 2013, J MATH COMPUT SCI, V3, P1306; Khan AA, 2014, J MAGN MAGN MATER, V372, P97, DOI 10.1016/j.jmmm.2014.07.051; Kothandapani M, 2015, IEEE T NANOBIOSCI, V14, P385, DOI 10.1109/TNB.2014.2363673; Kothandapani M, 2015, INT J HEAT MASS TRAN, V81, P234, DOI 10.1016/j.ijheatmasstransfer.2014.09.062; KUMAR Y.V.K.R, 2014, ADV APPL SCI RES, V5, P91; Lachiheb M, 2014, APPL MATH COMPUT, V244, P761, DOI 10.1016/j.amc.2014.07.062; Mahmoud SR, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/971456; Mekheimer KS, 2013, APPL BIONICS BIOMECH, V10, P19, DOI [10.3233/ABB-2012-0071, 10.1155/2013/902097]; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Ramesh K, 2015, J FLUIDS, V2015; Rathod V. P., 2014, J CHEM BIOL PHYS SCI, V4, P1452; Riaz A, 2014, ALEX ENG J, V53, P475, DOI 10.1016/j.aej.2014.01.005; Sadeghi K, 2014, J APPL MECH ENG, V3; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; Siller BM, 2013, J PHYS CHEM A, V117, P10034, DOI 10.1021/jp400570m; Thurston GB, 2006, BIORHEOLOGY, V43, P729; Tripathi D, 2011, J MECH MED BIOL, V11, P1045, DOI 10.1142/S0219519411004290; Vasudev C., 2011, INT J CURR SCI RES, V1, P105; Wang YQ, 2011, APPL MATH MODEL, V35, P3737, DOI 10.1016/j.apm.2011.02.030; Yazdanpanh-Ardakani K, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500528	41	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0145525	10.1371/journal.pone.0145525	http://dx.doi.org/10.1371/journal.pone.0145525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808387	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800007
J	Huang, C; Sachse, FB; Hitchcock, RW; Kaza, AK				Huang, Chao; Sachse, Frank B.; Hitchcock, Robert W.; Kaza, Aditya K.			Sensitivity and Specificity of Cardiac Tissue Discrimination Using Fiber-Optics Confocal Microscopy	PLOS ONE			English	Article							CONGENITALLY CORRECTED TRANSPOSITION; FLUORESCEIN ANGIOGRAPHY; LASER ENDOMICROSCOPY; GREAT-ARTERIES; HEART-DISEASE; PROBE; IDENTIFICATION; JUNCTION; BLOCK; NODE	Disturbances of the cardiac conduction system constitute a major risk after surgical repair of complex cases of congenital heart disease. Intraoperative identification of the conduction system may reduce the incidence of these disturbances. We previously developed an approach to identify cardiac tissue types using fiber-optics confocal microscopy and extracellular fluorophores. Here, we applied this approach to investigate sensitivity and specificity of human and automated classification in discriminating images of atrial working myocardium and specialized tissue of the conduction system. Two-dimensional image sequences from atrial working myocardium and nodal tissue of isolated perfused rodent hearts were acquired using a fiber-optics confocal microscope (Leica FCM1000). We compared two methods for local application of extracellular fluorophores: topical via pipette and with a dye carrier. Eight blinded examiners evaluated 162 randomly selected images of atrial working myocardium (n = 81) and nodal tissue (n = 81). In addition, we evaluated the images using automated classification. Blinded examiners achieved a sensitivity and specificity of 99.2 +/- 0.3% and 98.0 +/- 0.7%, respectively, with the dye carrier method of dye application. Sensitivity and specificity was similar for dye application via a pipette (99.2 +/- 0.3% and 94.0 +/- 2.4%, respectively). Sensitivity and specificity for automated methods of tissue discrimination were similarly high. Human and automated classification achieved high sensitivity and specificity in discriminating atrial working myocardium and nodal tissue. We suggest that our findings facilitate clinical translation of fiber-optics confocal microscopy as an intraoperative imaging modality to reduce the incidence of conduction disturbances during surgical correction of congenital heart disease.	[Huang, Chao; Sachse, Frank B.; Hitchcock, Robert W.; Kaza, Aditya K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Sachse, Frank B.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Traininng I, Salt Lake City, UT USA; [Kaza, Aditya K.] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA USA; [Kaza, Aditya K.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kaza, AK (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Kaza, AK (corresponding author), Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA USA.; Kaza, AK (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Aditya.Kaza@cardio.chboston.org	Kaza, Aditya/AAE-2116-2019	Kaza, Aditya/0000-0003-3450-4496; Sachse, Frank/0000-0003-4987-705X	US National Institutes of Health [R21 HL108099]; Nora Eccles Treadwell Foundation; Utah Science Technology and Research initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108099] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation; Utah Science Technology and Research initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the US National Institutes of Health (R21 HL108099), the Nora Eccles Treadwell Foundation, and the Utah Science Technology and Research initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; ANDERSON RH, 1983, THORAX, V38, P408, DOI 10.1136/thx.38.6.408; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; Bogers AJJC, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-74; Bonatti V, 1998, Pediatr Med Chir, V20, P181; Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Diaspro A, 2002, CONFOCAL 2 PHOTON MI; DICK M, 1979, CIRCULATION, V59, P150, DOI 10.1161/01.CIR.59.1.150; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Hoy CL, 2008, OPT EXPRESS, V16, P9996, DOI 10.1364/OE.16.009996; Huang C, 2014, FRONT PHYSIOL, V5; Huang C, 2013, CIRC-CARDIOVASC IMAG, V6, P739, DOI 10.1161/CIRCIMAGING.112.000121; Kwan ASL, 2006, CLIN EXP OPHTHALMOL, V34, P33, DOI 10.1111/j.1442-9071.2006.01136.x; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; Lackey DP, 2011, ANN BIOMED ENG, V39, P2683, DOI 10.1007/s10439-011-0369-3; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; LILLEHEI CW, 1963, J THORAC CARDIOV SUR, V46, P436, DOI 10.1016/S0022-5223(19)33647-5; LINCOLN C, 1979, BRIT HEART J, V42, P339; Liu GJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3555180; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Sharma P, 2011, GASTROINTEST ENDOSC, V74, P465, DOI 10.1016/j.gie.2011.04.004; SODERSTROM KO, 1987, HISTOCHEMISTRY, V87, P557, DOI 10.1007/BF00492470; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Wallace MB, 2010, ALIMENT PHARM THER, V31, P548, DOI 10.1111/j.1365-2036.2009.04207.x; Wallace SJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3027970; Weindling SN, 1998, AM J CARDIOL, V82, P525, DOI 10.1016/S0002-9149(98)00375-0; Wu K, 2011, UROLOGY, V78, P225, DOI 10.1016/j.urology.2011.02.057; Yicong W, 2010, ADV LASERS ELECTROOP; Yoo S, 2006, CIRCULATION, V114, P1360, DOI 10.1161/CIRCULATIONAHA.106.613182; Zhou H, 2010, STAT SCI, V25, P311, DOI 10.1214/10-STS336	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147667	10.1371/journal.pone.0147667	http://dx.doi.org/10.1371/journal.pone.0147667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808149	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800173
J	Jin, XH; Zhong, MT; Yao, SQ; Cao, XY; Tan, CL; Gan, J; Zhu, XZ; Yi, JY				Jin, Xinhu; Zhong, Mingtian; Yao, Shuqiao; Cao, Xiyu; Tan, Changlian; Gan, Jun; Zhu, Xiongzhao; Yi, Jinyao			A Voxel-Based Morphometric MRI Study in Young Adults with Borderline Personality Disorder	PLOS ONE			English	Article							STRUCTURAL BRAIN ABNORMALITIES; DEFAULT-MODE; SUICIDAL-BEHAVIOR; ATTACHMENT-STYLE; FEMALE-PATIENTS; CINGULATE; ABUSE; WOMEN; PSYCHOPATHOLOGY; COMORBIDITY	Background Increasing evidence has documented subtle changes in brain morphology and function in patients with borderline personality disorder (BPD). However, results of magnetic resonance imaging volumetry in patients with BPD are inconsistent. In addition, few researchers using voxel-based morphometry (VBM) have focused on attachment and childhood trauma in BPD. This preliminary study was performed to investigate structural brain changes and their relationships to attachment and childhood trauma in a homogenous sample of young adults with BPD. Method We examined 34 young adults with BPD and 34 healthy controls (HCs) to assess regionally specific differences in gray matter volume (GMV) and gray matter concentration (GMC). Multiple regressions between brain volumes measured by VBM and attachment style questionnaire (ASQ) and childhood trauma questionnaire (CTQ) scores were performed. Results Compared with HCs, subjects with BPD showed significant bilateral increases in GMV in the middle cingulate cortex (MCC)/posterior cingulate cortex (PCC)/precuneus. GMC did not differ significantly between groups. In multiple regression models, ASQ insecure attachment scores were correlated negatively with GMV in the precuneus/MCC and middle occipital gyrus in HCs, HCs with more severe insecure attachment showed smaller volumes in precuneus/MCC and middle occipital gyrus, whereas no negative correlations between insecure attachment and GMV in any region were found in BPD group. In addition, CTQ total scores were not correlated with GMV in any region in the two groups respectively. Conclusions Our findings fit with those of previous reports of larger precuneus GMV in patients with BPD, and suggest that GMV in the precuneus/MCC and middle occipital gyrus is associated inversely with insecure attachment style in HCs. Our finding of increased GMV in the MCC and PCC in patients with BPD compared with HCs has not been reported in previous VBM studies.	[Jin, Xinhu; Yao, Shuqiao; Cao, Xiyu; Gan, Jun; Zhu, Xiongzhao; Yi, Jinyao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China; [Zhong, Mingtian] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, 55 Zhongshan Rd, Guangzhou 510631, Guangdong, Peoples R China; [Yao, Shuqiao] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China; [Tan, Changlian] Cent S Univ, Xiangya Hosp 2, Dept Radiol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China; [Yi, Jinyao] Cent S Univ, Natl Technol Inst Psychiat, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China	Central South University; South China Normal University; Central South University; Central South University; Central South University	Yi, JY (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.; Yi, JY (corresponding author), Cent S Univ, Natl Technol Inst Psychiat, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	jinyaoyi@gmail.com	Zhong, Mingtian/AAA-3305-2022		National Natural Science Foundations of China [81370034, 81000590]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundations of China (grant nos. 81370034 and 81000590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal HR, 2004, HARVARD REV PSYCHIAT, V12, P94, DOI 10.1080/10673220490447218; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Brennan KA, 1998, J PERS, V66, P835, DOI 10.1111/1467-6494.00034; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; Feeney J. A., 1994, ATTACHMENT ADULTS CL, P128; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 1995, USERS GUIDE STRUCTUR; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Herwig U, 2007, PSYCHIAT RES-NEUROIM, V154, P1, DOI 10.1016/j.pscychresns.2006.02.007; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Irle E, 2007, PSYCHIAT RES-NEUROIM, V156, P139, DOI 10.1016/j.pscychresns.2007.01.007; Juengling FD, 2003, J PSYCHIAT RES, V37, P109, DOI 10.1016/S0022-3956(02)00084-5; Kluetsch RC, 2012, ARCH GEN PSYCHIAT, V69, P993, DOI 10.1001/archgenpsychiatry.2012.476; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Krause-Utz A, 2014, FRONT HUM NEUROSCI, V8, P1; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Kuo JR, 2015, CHILD ABUSE NEGLECT, V39, P147, DOI 10.1016/j.chiabu.2014.08.008; Labudda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083677; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Lenzenweger MF, 2010, J AM PSYCHOANAL ASS, V58, P741, DOI 10.1177/0003065110386111; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; Mickelson KD, 1997, J PERS SOC PSYCHOL, V73, P1092, DOI 10.1037/0022-3514.73.5.1092; Minzenberg MJ, 2008, DEV PSYCHOPATHOL, V20, P341, DOI 10.1017/S0954579408000163; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Bailey HN, 2007, ATTACH HUM DEV, V9, P139, DOI 10.1080/14616730701349721; Niedtfeld II, 2013, PLOS ONE, V8, P1; O'Neill A, 2013, PSYCHIAT RES-NEUROIM, V213, P1, DOI 10.1016/j.pscychresns.2013.02.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rossi R, 2013, PSYCHIAT RES-NEUROIM, V213, P83, DOI 10.1016/j.pscychresns.2012.07.002; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Scherpiet S, 2014, EUR ARCH PSY CLIN N, V264, P45, DOI 10.1007/s00406-013-0444-x; Schneider-Hassloff H, 2015, NEUROSCIENCE, V303, P462, DOI 10.1016/j.neuroscience.2015.06.062; Schulze L, 2015, BIOL PSYCHIAT, VS0006-3223, P00278; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2012, J PSYCHIATR RES, V46, P516, DOI 10.1016/j.jpsychires.2012.01.003; Soloff PH, 2002, J PERS DISORD, V16, P201, DOI 10.1521/pedi.16.3.201.22542; Spielberger C. D., 1983, MIND GARDEN; Steinberg M., 1994, STRUCTURED CLIN INTE; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Vollm Birgit, 2004, Crim Behav Ment Health, V14, P39, DOI 10.1002/cbm.559; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716; Wiltgen A, 2015, J AFFECT DISORDERS, V174, P411, DOI 10.1016/j.jad.2014.12.011; Wingenfeld K, 2010, PSYCHONEUROENDOCRINO, V35, P154, DOI 10.1016/j.psyneuen.2009.09.014; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Xiao J, 2014, STRESS HEALTH, P1; Yi JY, 2012, DEPRESS ANXIETY, V29, P789, DOI 10.1002/da.21953; Zanarini MC, 2006, AM J PSYCHIAT, V163, P827, DOI 10.1176/appi.ajp.163.5.827; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101	66	3	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147938	10.1371/journal.pone.0147938	http://dx.doi.org/10.1371/journal.pone.0147938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808504	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800246
J	Lee, LSU; Seng, KY; Wang, LZ; Yong, WP; Hee, KH; Soh, TI; Wong, A; Cheong, PF; Soong, R; Sapari, NS; Soo, R; Fan, L; Lee, SC; Goh, BC				Lee, Lawrence Soon-U; Seng, Kok-Yong; Wang, Ling-Zhi; Yong, Wei-Peng; Hee, Kim-Hor; Soh, Thomas I.; Wong, Andrea; Cheong, Pei F.; Soong, Richie; Sapari, Nur S.; Soo, Ross; Fan, Lu; Lee, Soo-Chin; Goh, Boon C.			Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI	PLOS ONE			English	Article							GENOTYPE; CANCER; MODEL; MIDAZOLAM; HUMANS	Background Irinotecan toxicity correlates with UGT1A1 activity. We explored whether phenotyping UGT1A1 using a probe approach works better than current genotyping methods. Methods Twenty-four Asian cancer patients received irinotecan as part of the FOLFIRI regimen. Subjects took raltegravir 400 mg orally and intravenous midazolam 1 mg. Pharmacokinetic analyses were performed using WinNonLin and NONMEM. Genomic DNA was isolated and screened for the known genetic variants in UGT1A1 and CYP3A4/5. Results SN-38G/SN-38 AUC ratio correlated well with Raltegravir glucuronide/Raltegravir AUC ratio (r = 0.784 p<0.01). Midazolam clearance correlated well with irinotecan clearance (r = 0.563 p<0.01). SN-38 AUC correlated well with Log10Nadir Absolute Neutrophil Count (ANC) (r = -0.397 p<0.05). Significant correlation was found between nadir ANC and formation rate constant of raltegravir glucuronide (r = 0.598, P<0.005), but not UGT1A1 genotype. Conclusion Raltegravir glucuronide formation is a good predictor of nadir ANC, and can predict neutropenia in East Asian patients. Prospective studies with dose adjustments should be done to develop raltegravir as a probe to optimize irinotecan therapy.	[Lee, Lawrence Soon-U; Soo, Ross] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Lee, Lawrence Soon-U; Hee, Kim-Hor] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Seng, Kok-Yong; Wang, Ling-Zhi; Soong, Richie; Sapari, Nur S.; Soo, Ross; Goh, Boon C.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Wang, Ling-Zhi; Fan, Lu; Lee, Soo-Chin; Goh, Boon C.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Yong, Wei-Peng; Soh, Thomas I.; Wong, Andrea; Cheong, Pei F.; Lee, Soo-Chin; Goh, Boon C.] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lee, LSU (corresponding author), Natl Univ Hlth Syst, Dept Med, Singapore, Singapore.; Lee, LSU (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	phcgbc@nus.edu.sg	Wang, Lingzhi/AAF-1851-2020; Lee, Soo Chin/S-9111-2016; Yong, Wei-Peng/Y-7260-2018	Wang, Lingzhi/0000-0001-5585-5426; Lee, Soo Chin/0000-0002-5835-6419; Yong, Wei-Peng/0000-0003-4404-3777; Goh, Boon Cher/0000-0002-4107-102X	National Medical Research Council, Singapore [NMRC/CSA/021/2010, NMRC/CSA/019/2010]	National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This study was supported by grants NMRC/CSA/021/2010 (GBC) and NMRC/CSA/019/2010 (LLSU). http://www.nmrc.gov.sg/ (National Medical Research Council, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charasson V, 2004, CLIN PHARMACOL THER, V76, P528, DOI 10.1016/j.clpt.2004.08.007; Gao J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0630-8; GUPTA E, 1994, CANCER RES, V54, P3723; Hee KH, 2013, J PHARM BIOMED ANAL, V88, P584; HEIZMANN P, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2220; Ichikawa R, 2014, ARCH GYNECOL OBSTET, V290, P979, DOI 10.1007/s00404-014-3268-7; Innocenti F, 2014, J CLIN ONCOL, V32, P2328, DOI 10.1200/JCO.2014.55.2307; Karlsson MO, 2007, CLIN PHARMACOL THER, V82, P17, DOI 10.1038/sj.clpt.6100241; Kweekel DM, 2008, BRIT J CANCER, V99, P275, DOI 10.1038/sj.bjc.6604461; Liu X, 2014, PHARMACOGENOMICS J, V14, P120, DOI 10.1038/tpj.2013.10; Marcuello E, 2011, BRIT J CANCER, V105, P53, DOI 10.1038/bjc.2011.206; Mould D, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.14; Pfizer Inc, 2006, CAMPT IR HYDR IN; Rosner GL, 2008, CLIN PHARMACOL THER, V84, P393, DOI 10.1038/clpt.2008.63; Savic RM, 2007, J PHARMACOKINET PHAR, V34, P711, DOI 10.1007/s10928-007-9066-0; Savic RM, 2009, AAPS J, V11, P558, DOI 10.1208/s12248-009-9133-0; Seng KY, 2015, ANTIMICROB AGENTS CH, V59, P6791, DOI 10.1128/AAC.01244-15; Seng KY, 2014, J CLIN PHARMACOL, V54, P215, DOI 10.1002/jcph.230; van der Bol JM, 2010, CLIN CANCER RES, V16, P736, DOI 10.1158/1078-0432.CCR-09-1526; Wang LZ, 2011, J MASS SPECTROM, V46, P202, DOI 10.1002/jms.1874; Wang LZ, 2011, ANTIMICROB AGENTS CH, V55, P4090, DOI 10.1128/AAC.00593-11; Xie RJ, 2002, CLIN PHARMACOL THER, V72, P265, DOI 10.1067/mcp.2002.126741	22	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147681	10.1371/journal.pone.0147681	http://dx.doi.org/10.1371/journal.pone.0147681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808671	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800178
J	Rezeanu, CI; Briciu, A; Briciu, V; Repanovici, A; Coman, C				Rezeanu, Catalina-Ionela; Briciu, Arabela; Briciu, Victor; Repanovici, Angela; Coman, Claudiu			The Influence of Urbanism and Information Consumption on Political Dimensions of Social Capital: Exploratory Study of the Localities Adjacent to the Core City from Brasov Metropolitan Area, Romania	PLOS ONE			English	Article							INTERNET USE; NEIGHBORHOOD; PARTICIPATION; COOPERATION; BUCHAREST; LATTICES; SIZE; AREA; NEWS; GAME	Background The last two decades have seen a growing trend towards the research of voting behavior in post-communist countries. Urban sociology theorists state that not only space structures influence political participation, but also space structures are changing under the influence of global, local, and individual factors. The growing role played by information in the globalised world has accelerated the paradigm shift in urban sociology: from central place model (based on urban-rural distinction and on monocentric metropolitan areas) to network society (based on space of flows and polycentric metropolitan areas). However, recent studies have mainly focused on countries with solid democracies, rather than on former communist countries. The present study aims to analyze the extent to which a new emerging spatial structure can be envisaged within a metropolitan area of Romania and its consequences for the political dimensions of social capital. Methods The Transilvania University Ethics Commission approved this study (S1 Aprouval). The research is based upon individual and aggregate empirical data, collected from the areas adjacent to the core city in Brasov metropolitan area. Individual data has been collected during October 2012, using the oral survey technique (S1 Survey), based on a standardized questionnaire (stratified simple random sample, N = 600). The National Institute of Statistics and the Electoral Register provided the aggregate data per locality. Unvaried and multivariate analyses (hierarchical regression method) were conducted based on these data. Results Some dimensions of urbanism, identified as predictors of the political dimensions of social capital, suggest that the area under analysis has a predominantly monocentric character, where the rural-urban distinction continues to remain relevant. There are also arguments favoring the dissolution of the rural-urban distinction and the emergence of polycentric spatial structures. The presence of some influences related to the information consumption on all six indicators of the political dimensions of social capital under analysis suggests the occurrence of emerging forms of a space of flows. The identified effects of social problems associated with transport infrastructure and of migration experience on the political dimensions of social capital, also support the emergence of space of flows. Conclusions We recommend that, in the urban studies in former communist countries, conceptualization of urbanism as predictor of the political dimensions of social capital should consider both the material dimensions of space, as well as the dimensions of information consumption and migration experience.	[Rezeanu, Catalina-Ionela] Univ Bucharest, Fac Sociol & Social Work, Dept Sociol, Bucharest, Romania; [Briciu, Arabela; Briciu, Victor; Coman, Claudiu] Transilvania Univ Brasov, Fac Sociol & Commun, Dept Social Sci & Commun, Brasov, Romania; [Repanovici, Angela] Transilvania Univ Brasov, Dept Fac Prod Design & Environm, Univ St,1 Corp D, Brasov 500068, Romania	University of Bucharest; Transylvania University of Brasov; Transylvania University of Brasov	Repanovici, A (corresponding author), Transilvania Univ Brasov, Dept Fac Prod Design & Environm, Univ St,1 Corp D, Brasov 500068, Romania.	arepanovici@unitbv.ro	REPANOVICI, Angela/C-8528-2009; Briciu, Victor-Alexandru/AAD-8238-2021; Repanovici, Angela/AAQ-4463-2020; Briciu, Victor-Alexandru/AAZ-8346-2021; Rezeanu, Cătălina-Ionela/W-3369-2018; Coman, Claudiu/AAL-3539-2021; Rezeanu, Catalina-Ionela/Y-9979-2018; Briciu, Victor-Alexandru/AAU-6658-2020; Briciu, Arabela/ABD-3189-2020	REPANOVICI, Angela/0000-0002-8748-5332; Briciu, Victor-Alexandru/0000-0002-7506-8099; Repanovici, Angela/0000-0002-8748-5332; Briciu, Victor-Alexandru/0000-0002-7506-8099; Rezeanu, Cătălina-Ionela/0000-0002-3085-5486; Coman, Claudiu/0000-0001-6272-7414; Rezeanu, Catalina-Ionela/0000-0002-3085-5486; Briciu, Victor-Alexandru/0000-0002-7506-8099; 				Agresti A., 2008, STAT METHODS SOCIAL; Amin A., 2002, CITIES REIMAGINING U; Anderson L, 2003, ELECT STUD, V22, P469, DOI 10.1016/S0261-3794(02)00009-4; [Anonymous], 2000, RISE NETWORK SOC; Australian Bureau of Statistics, 2000, MEAS SOC CAP CURR CO; Bakker TP, 2011, COMMUN RES, V38, P451, DOI 10.1177/0093650210381738; Balcerowicz L, 2013, LESSONS EC TRANSITIO, P153; Bartels L.M., 2010, OXFORD HDB AM ELECTI, P1; Berry WD, 1993, QUANTITATIVE APPL SO; Blanco H, 2014, STRUNGMANN FORUM REP, P275; Bourdieu PD, 1986, SOCIAL CRITIQUE JUDG, P148; Brenner N, 2013, PUBLIC CULTURE, V25, P85, DOI 10.1215/08992363-1890477; Cabrera JF, 2015, ENVIRON BEHAV, V47, P239, DOI 10.1177/0013916513500275; Cabrera JF, 2013, HOUS POLICY DEBATE, V23, P376, DOI 10.1080/10511482.2013.766626; Castells M., 1989, INFORM CITY; Cocheci M., 2014, URBAN ARCHIT CONSTR, V5, P21; Coleman J, 1988, FDN SOCIAL CAPITAL, P16; Constantin DL, 2013, ROMANIAN J REGIONAL, V7, P48; Croitoru A, 2014, EUROPEANISATION EVER, P8; de Zuniga HG, 2012, J COMPUT-MEDIAT COMM, V17, P319, DOI 10.1111/j.1083-6101.2012.01574.x; Duhr S, 2005, PLAN PRACT RES, V20, P235, DOI 10.1080/02697450500414728; European Commission. Public Opinion in the European Union, 2012, PUBL OP EUR UN NAT R; EUROSTAT, 2015, LEV INT ACC HOUS; EUROSTAT, 2015, IND WHO US INT FREQ; Firebaugh G., 2018, 7 RULES SOCIAL RES, DOI [10.1515/9780691190433, DOI 10.1515/9780691190433]; FISCHER CS, 1995, AM J SOCIOL, V101, P543, DOI 10.1086/230753; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Gans H. J., 1962, HUMAN BEHAVIOR SOCIA, P625; Gans H.J., 2002, CITY COMMUNITY, V1, P329, DOI [10.1111/1540-6040.00027, DOI 10.1111/1540-6040.00027]; Glock B, 2007, GEOJOURNAL LIB, V92, P191; Gottdiener M., 2011, NEW URBAN SOCIOLOGY; Gottdiener Mark, 2005, KEY CONCEPTS URBAN S; Grigorescu I., 2012, ROMANIAN J GEOGRAPHY, V56, P43; Growe A, 2012, ERDKUNDE, V66, P295, DOI 10.3112/erdkunde.2012.04.02; Hajdu Z, 2013, GEOGRAPHIA NAPOCENSI, V7, P19; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Harvey D, 2003, INT J URBAN REGIONAL, V27, P939, DOI 10.1111/j..2003.00492.x; Hubbard Phil, 2011, KEY THINKERS SPACE P; Ianos I, 2012, ENVIRON ENG MANAG J, V11, P1535, DOI 10.30638/eemj.2012.192; Ioja CL, 2014, ECOL INDIC, V42, P112, DOI 10.1016/j.ecolind.2013.09.029; Ionescu-Heroiu M., 2013, ENHANCED SPATIAL PLA; Johnson CA, 2010, LIBR INFORM SCI RES, V32, P147, DOI 10.1016/j.lisr.2009.12.006; Kideckel DA, 2010, GETTING POSTSOCIALIS; Kofman E, 1996, WRITINGS CITIES, P34; Kuechler M, 2000, ENCY SOCIOLOGY, P3231; kuOFN (Office for National Statistics), GUID SOC CAP; Lannoo S, 2012, J URBAN AFF, V34, P373, DOI 10.1111/j.1467-9906.2011.00592.x; Lefebvre Henri., 1996, WRITINGS CITIES; Lefebvre Henri, 1968, ANTHROPOS; Lewis-Beck M. S., 1980, QUANTITATIVE APPL SO; Metroplitan Agency for Sustainable Development of Brasov Brasov City Hall, 2010, INT URB DEV PLAN GRO; National Institute of Statistics, TEMP ONL DAT VAR POP; National Institute of Statistics, 2014, INT MIGR ROM; National Institute of Statistics, 2013, POP ACC INF COMM TEC; Neculau A, 2004, EVERYDAY LIFE COMMUN; Penard T, 2010, J ECON ISSUES, V44, P569, DOI 10.2753/JEI0021-3624440301; Permanent Electoral Authority, 2012, ROM PARL EL; Permanent Electoral Authority, 2012, LOC EL; Permanent Electoral Authority, 2012, REF DISM PRES ROM; Puscasu V, 2011, PUBLIC ADM REG STUD, V4, P50; PUTNAM RD, 1995, PS, V28, P664, DOI 10.2307/420517; Romanian Sociological Association, ROM SOC ASS COD ETH; S?rbu, 2012, HUMAN GEOGRAPHIES J, V6, P53, DOI [DOI 10.5719/HGEO.2012.61.53, 10.5719/hgeo.2012.61.53]; Sandu D., 2010, SOCIAL WORLDS ROMANI; Schoereder LD, 1986, QUANTITATIVE APPL SO; Siegler V., 2014, MEASURING SOCIAL CAP; Simmel G, 2002, BLACKWELL CITY READE, P324; Stern MJ, 2010, AM BEHAV SCI, V53, P1389, DOI 10.1177/0002764210361692; Suditu B., 2009, J STUDIES RES HUMAN, V3; Suditu B, 2012, HUMAN GEOGRAPHIES J, V4, P74, DOI [10.5719/hgeo.2012, DOI 10.5719/HGO0.2012]; Sztompka P, 1996, INT SOCIOL, V11, P37, DOI 10.1177/026858096011001004; Sztompka P., 1999, TRUST SOCIOLOGICAL T; The World Bank, MEAS DIM SOC CAP; TITTLE CR, 1989, SOC PROBL, V36, P270, DOI 10.1525/sp.1989.36.3.03a00050; Tlanga C., 2010, HUMAN GEOGRAPHIES J, V4, P47; Tufis CD, 2014, QUALITY LIFE, P281; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; WILSON TC, 1993, SOC FORCES, V71, P703, DOI 10.2307/2579891; Wirth L, 1938, AM J SOCIOLOGY   JUL, P1, DOI [DOI 10.1086/217913, 10.1086/217913]; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Zecchini S, 2013, LESSONS EC TRANSITIO; Zhang JC, 2012, ACTIVE CITIZEN PARTICIPATION IN E-GOVERNMENT: A GLOBAL PERSPECTIVE, P296, DOI 10.4018/978-1-4666-0116-1.ch015; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035; Zieleniec A. J. L., 2007, SPACE SOCIAL THEORY	84	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0144485	10.1371/journal.pone.0144485	http://dx.doi.org/10.1371/journal.pone.0144485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807882	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800003
J	Schulte, EM; Tuttle, HM; Gearhardt, AN				Schulte, Erica M.; Tuttle, Hannah M.; Gearhardt, Ashley N.			Belief in Food Addiction and Obesity-Related Policy Support	PLOS ONE			English	Article							PUBLIC-OPINION; STIGMA; DYSFUNCTION; PREJUDICE; IMPACT; MODEL; SUGAR; SIDE	Objectives This study examines whether belief in the food addiction construct is associated with support for obesity-related policies (e. g., restrictions on foods served in schools and workplace cafeterias, subsidies on fruits and vegetables), while simultaneously examining other factors associated with policy support (e. g., political party affiliation). Design Cross-sectional. Setting Online Community. Participants 200 individuals were recruited through Amazon Mechanical Turk. Measurements Participants (n = 193) responded to three questions about belief in food addiction and a measure evaluating support for 13 obesity-related policy initiatives. Individuals also completed the modified Yale Food Addiction Scale (mYFAS), self-reported height and weight, and provided demographic information (age, gender, race, political party affiliation). Results Belief in food addiction was significantly associated with greater support for obesity-related initiatives, even when accounting for the significant associations of age, gender, and political party. Belief in food addiction and political party both had moderate effect sizes for predicting support for obesity-related policy. There was an interaction between age and belief in food addiction, with significant associations with policy support for both younger and older individuals, though the effect was larger for younger participants. Conclusion The current study provides evidence that belief in food addiction is associated with increased obesity-related policy support, comparable to the influence of one's political party. Growing evidence for the role of an addictive process in obesity may have important implications for public support of obesity-related policy initiatives.	[Schulte, Erica M.; Gearhardt, Ashley N.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Tuttle, Hannah M.] Univ N Carolina, Ctr Dev Sci, Chapel Hill, NC USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Schulte, EM (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI USA.	eorenste@umich.edu		LaFata, Erica/0000-0002-8505-6366				Aiken L. S., 1991, MULTIPLE REGRESSION; Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena NM, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3212-c1; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barry CL, 2013, AM J PREV MED, V44, P158, DOI 10.1016/j.amepre.2012.09.065; Boseley S, 2014, GUARDIAN, P16; Buchman D, 2009, AM J BIOETHICS, V9, P18, DOI 10.1080/15265160903090066; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Control CfD Prevention, 2010, TOB SMOK CAUS DIS BI; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Crocq Marc-Antoine, 2007, Dialogues Clin Neurosci, V9, P355; Cummings KM, 2002, ONCOGENE, V21, P7349, DOI 10.1038/sj.onc.1205810; Davis Caroline, 2013, ISRN Obes, V2013, P435027, DOI 10.1155/2013/435027; Dingel MJ, 2011, SOC SCI QUART, V92, P1363, DOI 10.1111/j.1540-6237.2011.00822.x; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Ennis S. R., 2011, HISPANIC POPULATION; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Flint AJ, 2014, AM J CLIN NUTR, V99, P578, DOI 10.3945/ajcn.113.068965; Freeman S, 2001, PHILOS PUBLIC AFF, V30, P105, DOI 10.1111/j.1088-4963.2001.00105.x; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P201; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gonzalez JL, 2006, J NATL MED ASSOC, V98, P1483; Hardman CA, 2015, APPETITE, V91, P179, DOI 10.1016/j.appet.2015.04.052; Hinz A, 2007, GMS PSYCHOSOCIAL MED, V4; Howden L. M., 2010, AGE SEX COMPOSITION; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Latner JD, 2014, APPETITE, V77, P77, DOI 10.1016/j.appet.2014.03.004; Lee NM, 2014, NUTRIENTS, V6, P5312, DOI 10.3390/nu6115312; Lee NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074836; Malika NM, 2015, EAT BEHAV, V18, P25, DOI 10.1016/j.eatbeh.2015.03.005; Meule A., 2014, CURR ADDICT REP, V1, P193, DOI [10.1007/s40429-014-0021-z, DOI 10.1007/S40429-014-0021-Z]; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Rasmussen N, 2015, ADDICTION, V110, P217, DOI 10.1111/add.12774; Rastogi S., 2011, BLACK POPULATION 201; Schulte EM, 2015, FOODS MAY BE ADDICTI; Taber Katherine H, 2012, J Neuropsychiatry Clin Neurosci, V24, P1, DOI 10.1176/appi.neuropsych.24.1.1; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Warner KE, 2012, FOOD ADDICTION COMPR, P416; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147557	10.1371/journal.pone.0147557	http://dx.doi.org/10.1371/journal.pone.0147557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808427	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800133
J	Azevedo, LF; Perlingeiro, P; Hachul, DT; Gomes-Santos, IL; Tsutsui, JM; Negrao, CE; De Matos, LDNJ				Azevedo, Luciene Ferreira; Perlingeiro, Patricia; Hachul, Denise Tessariol; Gomes-Santos, Igor Lucas; Tsutsui, Jeane Mike; Negrao, Carlos Eduardo; De Matos, Luciana D. N. J.			Predominance of Intrinsic Mechanism of Resting Heart Rate Control and Preserved Baroreflex Sensitivity in Professional Cyclists after Competitive Training	PLOS ONE			English	Article							BLOOD-PRESSURE; SPECTRAL-ANALYSIS; VARIABILITY; BRADYCARDIA; DYSFUNCTION; EXERCISE; ADAPTATIONS; BLOCKADE; MARATHON; REFLEX	Different season trainings may influence autonomic and non-autonomic cardiac control of heart rate and provokes specific adaptations on heart's structure in athletes. We investigated the influence of transition training (TT) and competitive training (CT) on resting heart rate, its mechanisms of control, spontaneous baroreflex sensitivity (BRS) and relationships between heart rate mechanisms and cardiac structure in professional cyclists (N = 10). Heart rate (ECG) and arterial blood pressure (Pulse Tonometry) were recorded continuously. Autonomic blockade was performed (atropine-0.04 mg.kg(-1); esmolol-500 mu g.kg(-1) = 0.5 mg). Vagal effect, intrinsic heart rate, parasympathetic (n) and sympathetic (m) modulations, autonomic influence, autonomic balance and BRS were calculated. Plasma norepinephrine (high-pressure liquid chromatography) and cardiac structure (echocardiography) were evaluated. Resting heart rate was similar in TT and CT. However, vagal effect, intrinsic heart rate, autonomic influence and parasympathetic modulation (higher n value) decreased in CT (P <= 0.05). Sympathetic modulation was similar in both trainings. The autonomic balance increased in CT but still showed parasympathetic predominance. Cardiac diameter, septum and posterior wall thickness and left ventricular mass also increased in CT (P<0.05) as well as diastolic function. We observed an inverse correlation between left ventricular diastolic diameter, septum and posterior wall thickness and left ventricular mass with intrinsic heart rate. Blood pressure and BRS were similar in both trainings. Intrinsic heart rate mechanism is predominant over vagal effect during CT, despite similar resting heart rate. Preserved blood pressure levels and BRS during CT are probably due to similar sympathetic modulation in both trainings.	[Azevedo, Luciene Ferreira; Perlingeiro, Patricia; Gomes-Santos, Igor Lucas; Negrao, Carlos Eduardo; De Matos, Luciana D. N. J.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Rehabil & Exercise Physiol Unit, Sao Paulo, Brazil; [Hachul, Denise Tessariol] Univ Sao Paulo, Sch Med, Heart Inst InCor, Clin Arrhythmia Unit, Sao Paulo, Brazil; [Tsutsui, Jeane Mike] Univ Sao Paulo, Sch Med, Heart Inst InCor, Echocardiog Unit, Sao Paulo, Brazil; [Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Phys Educ & Sport, Biodynam Movement Human Body, Sao Paulo, Brazil; [De Matos, Luciana D. N. J.] Hosp Israelita Albert Einstein, Rehabil Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Azevedo, LF (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Rehabil & Exercise Physiol Unit, Sao Paulo, Brazil.	luciene.azevedo@usp.br	Negrao, Carlos E/C-4281-2012; Gomes dos Santos, Igor Lucas/H-3706-2013; De Matos, Luciana D.N.J/E-6723-2014; Azevedo, L F/A-9937-2010; Tsutsui, Jeane/C-6051-2013; Perlingeiro, Patricia/E-8646-2011	Gomes dos Santos, Igor Lucas/0000-0001-5946-8300; Diniz Nagem Janot de Matos, Luciana/0000-0002-9852-3293; Tessariol Hachul, Denise/0000-0001-5338-3242; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/08912-3, 2006/56613-7]; CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301867/2010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	LFA and LDNJM were supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/), # 2009/08912-3 and # 2006/56613-7, respectively), and CEN by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), # 301867/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LF, 2014, INT J SPORTS MED, V35, P954, DOI 10.1055/s-0033-1364024; BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; Bompa T., 2009, PERIODIZATION THEORY, V5th ed., P125; Bonaduce D, 1998, MED SCI SPORT EXER, V30, P691, DOI 10.1097/00005768-199805000-00008; Boyett MR, 2013, J APPL PHYSIOL, V114, P1351, DOI 10.1152/japplphysiol.01126.2012; Blasquez JCC, 2009, PSICOTHEMA, V21, P531; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Hug B, 2014, INT J SPORTS MED, V35, P676, DOI 10.1055/s-0033-1361184; Iellamo F, 2002, CIRCULATION, V105, P2719, DOI 10.1161/01.CIR.0000018124.01299.AE; Iellamo F, 1996, J HYPERTENS, V14, P1099; Iellamo F, 2001, J HYPERTENS, V19, P2231, DOI 10.1097/00004872-200112000-00017; JORDAN JL, 1978, CIRCULATION, V57, P217, DOI 10.1161/01.CIR.57.2.217; JOSE AD, 1969, J CLIN INVEST, V48, P2019, DOI 10.1172/JCI106167; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; KATONA PG, 1982, J APPL PHYSIOL, V52, P1652, DOI 10.1152/jappl.1982.52.6.1652; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEHMANN M, 1993, MED SCI SPORT EXER, V25, P854, DOI 10.1249/00005768-199307000-00015; LEWIS SF, 1980, ACTA PHYSIOL SCAND, V109, P297, DOI 10.1111/j.1748-1716.1980.tb06600.x; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Pagani M, 1997, CIRCULATION, V95, P1441; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Portier H, 2001, MED SCI SPORT EXER, V33, P1120; Raczak Grzegorz, 2006, Kardiol Pol, V64, P135; Rosenblueth A, 1934, AM J PHYSIOL, V110, P42, DOI 10.1152/ajplegacy.1934.110.1.42; Shin K, 1995, JPN J PHYSIOL, V45, P1053, DOI 10.2170/jjphysiol.45.1053; SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008; Stein R, 2000, EUR J APPL PHYSIOL, V82, P155, DOI 10.1007/s004210050666; Stein R, 2002, J AM COLL CARDIOL, V39, P1033, DOI 10.1016/S0735-1097(02)01722-9; VOLZZANG C, 1994, EUR J CLIN PHARMACOL, V46, P399; Zhang R, 2002, J PHYSIOL-LONDON, V543, P337, DOI 10.1113/jphysiol.2001.013398	35	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148036	10.1371/journal.pone.0148036	http://dx.doi.org/10.1371/journal.pone.0148036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812615	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528000072
J	Park, J; Yun, C; Kang, S				Park, Jinhee; Yun, Chul; Kang, Seungcheol			Physical Condition Does Not Affect Gravity-Induced Loss of Consciousness during Human Centrifuge Training in Well-Experienced Young Aviators	PLOS ONE			English	Article							RESPIRATORY MUSCLE FATIGUE; VALSALVA MANEUVER; GZ ACCELERATION; STRAINING MANEUVERS; BLOOD-PRESSURE; G-TOLERANCE; PERFORMANCE; PROTECTION; AIRCREW	Background Consensus on whether physical condition affects the risk of gravity-induced loss of consciousness (G-LOC) has not been reached, and most previous studies about the issue did not include well-experienced aviators. We compared the physical conditions of well-experienced young aviators according to the occurrence of G-LOC during human centrifuge training. Methods Among 361 young male aviators on active flight duty with experience in high performance aircrafts for at least 2 years, 350 had full data available and were reviewed in this study. We divided the aviators into the G-LOC group and the non-G-LOC group according to their human centrifuge training results. We then compared their basic characteristics, body composition, physical fitness level, and pulmonary function. Results Twenty nine aviators (8.3%) who experienced G-LOC during human centrifuge training in their first trials were classified into the G-LOC group. There was no difference in physical condition of aviators between the two groups. Conclusions Young aviators with experience in G-LOC showed no difference in physical condition such as muscle mass, strength, and general endurance from the aviators with no such experience. Although more studies are needed, physical condition does not seem to be a significant determinant of G-LOC among the experienced aviators.	[Park, Jinhee] Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 110744, South Korea; [Yun, Chul] Republ Korea Air Force, Aerosp Med Ctr, POB 18, Cheongju, Chungcheongbuk, South Korea; [Kang, Seungcheol] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, 88,Olymp Ro,43 Gil, Seoul 05505, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Ulsan	Kang, S (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, 88,Olymp Ro,43 Gil, Seoul 05505, South Korea.	ziozio79@daum.net						Bain B, 1997, AVIAT SPACE ENVIR MD, V68, P118; Bateman WA, 2006, AVIAT SPACE ENVIR MD, V77, P573; Rocha JSB, 2012, REV BRAS GINECOL OBS, V34, P414, DOI 10.1590/S0100-72032012000900005; BUICK F, 1992, AVIAT SPACE ENVIR MD, V63, P670; BULBULIAN R, 1994, AVIAT SPACE ENVIR MD, V65, P1097; Burns JW, 2001, AVIAT SPACE ENVIR MD, V72, P413; BURTON RR, 1974, AEROSPACE MED, V45, P1115; BURTON RR, 1988, AVIAT SPACE ENVIR MD, V59, P2; Cao XS, 2012, MIL MED, V177, P163, DOI 10.7205/MILMED-D-11-00003; Choi HS, 2010, EUR J APPL PHYSIOL, V109, P625, DOI 10.1007/s00421-010-1401-2; Eiken O, 2003, AVIAT SPACE ENVIR MD, V74, P822; EPPERSON WL, 1985, AVIAT SPACE ENVIR MD, V56, P534; Green NDC, 2006, AVIAT SPACE ENVIR MD, V77, P619; Johnson BD, 1996, MED SCI SPORT EXER, V28, P1129, DOI 10.1097/00005768-199609000-00008; Roman PAL, 2012, NUTR HOSP, V27, P1236, DOI 10.3305/nh.2012.27.4.5743; Looga R, 2005, RESP PHYSIOL NEUROBI, V147, P39, DOI 10.1016/j.resp.2005.01.003; LYONS TJ, 1992, AVIAT SPACE ENVIR MD, V63, P60; MACDOUGALL JD, 1992, J APPL PHYSIOL, V73, P1590, DOI 10.1152/jappl.1992.73.4.1590; Mateika JH, 2002, CLIN AUTON RES, V12, P24, DOI 10.1007/s102860200007; Ogawa H, 2011, HEPATO-GASTROENTEROL, V58, P42; SHUBROOK.SJ, 1973, J APPL PHYSIOL, V34, P460, DOI 10.1152/jappl.1973.34.4.460; SHUBROOKS SJ, 1973, J APPL PHYSIOL, V35, P294, DOI 10.1152/jappl.1973.35.2.294; TESCH PA, 1983, AVIAT SPACE ENVIR MD, V54, P691; Werchan PM, 1996, AVIAT SPACE ENVIR MD, V67, P751; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012; WOOD EH, 1987, AVIAT SPACE ENVIR MD, V58, P699; Yang P, 2007, AVIAT SPACE ENVIR MD, V78, P1035, DOI 10.3357/ASEM.2048.2007	27	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147921	10.1371/journal.pone.0147921	http://dx.doi.org/10.1371/journal.pone.0147921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812597	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528000063
J	Zhang, Q; Li, M; Zhang, TS; Chen, J				Zhang, Qian; Li, Ming; Zhang, Tiansong; Chen, Jing			Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							CHRONIC KIDNEY-DISEASE; MODERATE RENAL-FAILURE; LOW-DOSE CALCITRIOL; REDUCES BONE LOSS; SECONDARY HYPERPARATHYROIDISM; 1,25-DIHYDROXYVITAMIN D-3; PARICALCITOL; CALCIUM; ALFACALCIDOL; THERAPY	Background Vitamin D receptor activators (VDRAs) can protect against mineral bone disease, but they are reported to elevate serum creatinine (SCr) and may also reduce glomerular filtration rate (GFR). Methods We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) to evaluate the effect of VDRAs on kidney function and adverse events. MEDLINE, EMBASE, the Cochrane Controlled Trials Register were searched for RCTs that evaluate vitamin D receptor activators (alfacalcidol, calcitriol, doxercalciferol, falecalcitriol, maxacalcitol and paricalcitol) up to March 2015. Results We included 31 studies, all of which were performed between 1976 and 2015, which enrolled 2621 patients. Patients receiving VDRAs had lower eGFR (weighted mean difference WMD -1.29 mL/min /1.73 m(2), 95% CI -2.42 to -0.17) and elevated serum creatinine (WMD 7.03 mu mol/L, 95% CI 0.61 to 13.46) in sensitivity analysis excluding studies with dropout rate more than 30%. Subgroup analysis of the 5 studies that not use SCr-based measures did not indicated lower GFR in the VDRAs group(WMD -0.97 mL/min/1.73 m2, 95% CI -4.85 to 2.92). Compared with control groups, there was no difference in all-cause mortality (relative risk RR 1.41, 95% CI 0.58 to 3.80), cardiovascular disease (RR 0.84, 95% CI 0.42 to 1.71), and severe adverse events (RR 1.15, 95% CI 0.75 to 1.77) for the VDRAs groups. Episodes of hypercalcemia (RR 3.29, 95% CI 2.02 to 5.38) were more common in the VDRAs group than in the control group. Conclusions Administration of VDRAs increased serum creatinine levels. Subgroup analysis of studies that did not use SCr-based measures did not indicate a lower GFR in the VDRA group. Future studies with non-SCr-based measures are needed to assess whether the mild elevations of serum creatinine are of clinical significance.	[Zhang, Qian] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Zhang, Qian] Fudan Univ, Huashan Hosp North, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Li, Ming] Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Shanghai 200092, Peoples R China; [Zhang, Tiansong] Jingan Dist Ctr Hosp Shanghai, Dept TCM, Shanghai, Peoples R China; [Chen, Jing] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Tongji University; Fudan University	Chen, J (corresponding author), Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	chenjing1998@fudan.edu.cn	Chen, Jing/AAM-2184-2021		973 program of China [374 2012CB517700]; Specialized Research Fund for the Doctoral Program of Higher Education [20120071110068]; China Natural Science Foundation [81170684, 81400745]; Shanghai Sailing Program of Science and Technology Commission [14YF1400900]; Scientific Research Project; Huashan Hospital [2013QD24]	973 program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program of Science and Technology Commission; Scientific Research Project; Huashan Hospital	This work was supported by 973 program of China (374 2012CB517700), Specialized Research Fund for the Doctoral Program of Higher Education (20120071110068) and the China Natural Science Foundation (81170684) to Jing Chen. This work was also supported by Shanghai Sailing Program of Science and Technology Commission (14YF1400900), the China Natural Science Foundation (81400745), and Scientific Research Project supported by Huashan Hospital (2013QD24) to Qian Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, KIDNEY INT, V80, P1073, DOI 10.1038/ki.2011.207; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; ALOIA JF, 1988, AM J MED, V84, P401, DOI 10.1016/0002-9343(88)90259-8; Amer H, 2013, AM J TRANSPLANT, V13, P1576, DOI 10.1111/ajt.12227; BAKER LRI, 1989, KIDNEY INT, V35, P661, DOI 10.1038/ki.1989.36; BERTOLI M, 1990, CLIN NEPHROL, V33, P98; Cheng J, 2012, CLIN J AM SOC NEPHRO, V7, P391, DOI 10.2215/CJN.03000311; CHRISTIANSEN C, 1978, LANCET, V2, P700; Coburn JW, 2004, AM J KIDNEY DIS, V43, P877, DOI 10.1053/j.ajkd.2004.01.012; Coyne D, 2006, AM J KIDNEY DIS, V47, P263, DOI 10.1053/j.ajkd.2005.10.007; Cueto-Manzano AM, 2000, AM J KIDNEY DIS, V35, P227, DOI 10.1016/S0272-6386(00)70331-3; de Boer IH, 2008, CURR OPIN NEPHROL HY, V17, P566, DOI 10.1097/MNH.0b013e32830fe377; de Boer IH, 2013, KIDNEY INT, V83, P323, DOI 10.1038/ki.2012.311; de Borst MH, 2013, J AM SOC NEPHROL, V24, P1863, DOI 10.1681/ASN.2013030203; De Sevaux RGL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016082.70875.36; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Agroudy AE, 2005, KIDNEY INT, V67, P2039, DOI 10.1111/j.1523-1755.2005.00306.x; El-Agroudy AE, 2003, J AM SOC NEPHROL, V14, P2975, DOI 10.1097/01.ASN.0000093255.56474.B4; Fesler P, 2011, CURR HYPERTENS REP, V13, P116, DOI 10.1007/s11906-010-0176-5; Gallagher JC, 2007, J CLIN ENDOCR METAB, V92, P51, DOI 10.1210/jc.2006-1153; GALLAGHER JC, 1990, ANN INTERN MED, V113, P649, DOI 10.7326/0003-4819-113-9-649; HAMDY NAT, 1995, BRIT MED J, V310, P358, DOI 10.1136/bmj.310.6976.358; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; He Wengui, 2010, NW SEISMOLOGICAL J, V22, P90, DOI DOI 10.1681/ASN.2009121236; Heaney RP, 2008, CLIN J AM SOC NEPHRO, V3, P1535, DOI 10.2215/CJN.01160308; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ivarsen P, 2012, SCAND J UROL NEPHROL, V46, P381, DOI 10.3109/00365599.2012.693131; Krairittichai Udom, 2012, J Med Assoc Thai, V95 Suppl 3, pS41; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Liu LJ, 2012, AM J KIDNEY DIS, V59, P67, DOI 10.1053/j.ajkd.2011.09.014; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MENCZEL J, 1994, CLIN ORTHOP RELAT R, P241; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; NORDAL KP, 1988, J CLIN ENDOCR METAB, V67, P929, DOI 10.1210/jcem-67-5-929; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; Perez A, 1996, BRIT J DERMATOL, V134, P1070, DOI 10.1111/j.1365-2133.1996.tb07945.x; Perez V, 2010, TRANSPL P, V42, P2924, DOI 10.1016/j.transproceed.2010.07.077; PRZEDLACKI J, 1995, NEPHRON, V69, P433, DOI 10.1159/000188515; RIGGS BL, 1985, J CLIN ENDOCR METAB, V61, P457, DOI 10.1210/jcem-61-3-457; Ritz E, 1995, NEPHROL DIAL TRANSPL, V10, P2228, DOI 10.1093/ndt/10.12.2228; Rix M, 2004, NEPHROL DIAL TRANSPL, V19, P870, DOI 10.1093/ndt/gfg595; Sambrook P, 2000, J BONE MINER RES, V15, P1818, DOI 10.1359/jbmr.2000.15.9.1818; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Torres A, 2004, KIDNEY INT, V65, P705, DOI 10.1111/j.1523-1755.2004.00432.x; TOUGAARD L, 1976, LANCET, V1, P1044; Wang AYM, 2014, J AM SOC NEPHROL, V25, P175, DOI 10.1681/ASN.2013010103; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872; Zhang Z, 2008, P NATL ACAD SCI USA, V105, P15896, DOI 10.1073/pnas.0803751105	54	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147347	10.1371/journal.pone.0147347	http://dx.doi.org/10.1371/journal.pone.0147347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812502	gold, Green Published			2022-12-27	WOS:000369528000031
J	He, MX; Lv, LY; Li, HY; Meng, WQ; Zhao, N				He, Mengxuan; Lv, Lingyue; Li, Hongyuan; Meng, Weiqing; Zhao, Na			Analysis on Soil Seed Bank Diversity Characteristics and Its Relation with Soil Physical and Chemical Properties after Substrate Addition	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; VEGETATION; RESTORATION; PLANTATIONS; SUITABILITY; DYNAMICS; WETLAND; GROWTH; PLANT	Aims Considered as an essential measure in the application of soil seed bank (SSB) projects, the mixing of substrate and surface soil can effectively improve soil condition. This research is aimed at exploring the diversity characteristics of SSBs and the relationships between SSBs and soil properties. Methods Canonical correspondence analysis (CCA) was adopted to describe the ordination of SSBs on soil properties' gradients; multiple linear regressions were adopted to analyze the relationship between average growth height and soil properties, density and soil properties. Results Experimental groups of mixed substrate (the mixture of organic and inorganic substrates) had high diversity indexes, especially the Shannon-Wiener Index compared with those of single substrate. Meanwhile, a higher number of species and increased density were also noted in those of mixed substrate. The best test group, No. 16, had the highest diversity indexes with a Shannon-Wiener of 1.898, Simpson of 0.633 and Pielou of 0.717, and also showed the highest density of 14000 germinants / m(2) and 21 species. In addition, an improvement of the soil's chemical and physical properties was noted when the substrates were mixed. The mixed substrate of turfy soil and perlite could effectively enhance the soil moisture content, whilst a mixed substrate of rice husk carbon and vermiculite could improve the content of available potassium (AK) and phosphorus (AP) and strengthen soil fertility. The germinated plants also reflected obvious regularities of ordination on soil factor gradients. Three distinct cluster groups were presented, of which the first cluster was distributed in an area with a relatively higher content of AK and AP; the second cluster was distributed at places with relatively higher soil moisture content; and the third cluster of plants didn't show any obvious relationship with soil physical and chemical properties. Through CCA analysis, AK and AP were considered the most important soil factors to influence the SSB, which was illustrated in regression analysis with a high correlation coefficient when dependent values were growth height and density respectively. The linear regression equations with: growth height = 142.728 - 1.514TC + 30.218AP - 5.083TN + 10.839AK + 1.234mc; density = -68.216 - 4.609TC + 9.566AP - 35.492TN + 19.779AK - 1.591mc. were established by multiple linear regression. Conclusions (1) The mixed substrates showed a greater advantage for SSBs than single substrates, both in improving the number of species, density and diversity indexes. (2) The germinated plants reflected an obvious preference to different soil conditions, which different mixed substrates could improve accordingly. (3) AK, AP were important soil factors to influence SSBs, especially in the growth of plants and density.	[He, Mengxuan; Lv, Lingyue; Li, Hongyuan; Zhao, Na] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Meng, Weiqing] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Nankai University; Tianjin Normal University	Li, HY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	eialee@nankai.edu.cn	Meng, Weiqing/H-6005-2018	Meng, Weiqing/0000-0003-2848-0475	National Natural Science Foundation of China [31370700, 41301096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31370700 and 41301096).	Andreu MG, 2009, RESTOR ECOL, V17, P586, DOI 10.1111/j.1526-100X.2008.00457.x; Badwaik L. S., 2012, International Food Research Journal, V19, P341; [白文娟 Bai Wenjuan], 2012, [土壤, Soils], V44, P562; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bhosale MD, 2015, CURR SCI INDIA, V108, P2257; Bodaghabadi MB, 2011, CATENA, V86, P66, DOI 10.1016/j.catena.2011.02.009; Borji H, 2012, RES CROP, V13, P258; Borowiak K, 2011, FRESEN ENVIRON BULL, V20, P2264; Cao Jing, 2015, Chinese Journal of Plant Ecology, V39, P167, DOI 10.17521/cjpe.2015.0016; Carlile W. R., 1999, Acta Horticulturae, P587; Carmona E, 2012, SPAN J AGRIC RES, V10, P482, DOI 10.5424/sjar/2012102-320-11; Caron J., 1999, Acta Horticulturae, P545; Davies RJP, 2013, BIOL CONSERV, V158, P287, DOI 10.1016/j.biocon.2012.08.013; Fisher JL, 2009, BIOL CONSERV, V142, P256, DOI 10.1016/j.biocon.2008.10.019; Gruda N, 2004, SCI HORTIC-AMSTERDAM, V100, P333, DOI 10.1016/j.scienta.2003.09.004; Hager HA, 2015, BIOL INVASIONS, V17, P1833, DOI 10.1007/s10530-014-0839-2; Hanin N, 2013, J ARID ENVIRON, V91, P151, DOI 10.1016/j.jaridenv.2013.01.004; [郝翠 HAO Cui], 2009, [湿地科学, Wetland Science], V7, P266; [贺梦璇 He Mengxuan], 2015, [水土保持通报, Bulletin of Soil and Water Conservation], V35, P325; He MX, 2015, THESIS; Heydari Mehdi, 2013, Forest Science and Practice, V15, P286, DOI 10.1007/s11632-013-0413-5; Hill M. O., 1974, Applied Statistics, V23, P340, DOI 10.2307/2347127; Hong JM, 2012, ECOL ENG, V42, P192, DOI 10.1016/j.ecoleng.2012.01.004; Hosogi D, 2006, J JAPANESE SOC REVEG, V31, P385; Islam S, 2002, J HORTIC SCI BIOTECH, V77, P143, DOI 10.1080/14620316.2002.11511470; Jimmon T, 2000, J JAPANESE SOC REVEG, V25, P397; Jin ZJ, 2015, ENVIRON EARTH SCI, V73, P267, DOI 10.1007/s12665-014-3421-4; [康红梅 Kang Hongmei], 2005, [土壤通报, Journal of Soil Science], V36, P124; KEDDY PA, 1982, AM J BOT, V69, P13, DOI 10.2307/2442827; Koh J, 2006, J JAPANESE SOC REVEG, V32, P62; Landman GB, 2007, WETLANDS, V27, P211, DOI 10.1672/0277-5212(2007)27[211:SSBAOP]2.0.CO;2; Li H-Y, 2007, J LIAONING TU, V26, P140; [李洪远 Li Hongyuan], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P731; [李洪远 LI Hongyuan], 2006, [生态环境, Ecology and Environment], V15, P791; Li SX, 2009, ADV AGRON, V102, P223, DOI 10.1016/S0065-2113(09)01007-4; Liang J, 2015, ECOL ENG, V77, P119, DOI 10.1016/j.ecoleng.2015.01.016; Liang Yao-yuan, 2009, Yingyong Shengtai Xuebao, V20, P2832; Lyaruu HVM, 1999, APPL VEG SCI, V2, P209, DOI 10.2307/1478984; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Maranon T, 1998, J VEG SCI, V9, P371, DOI 10.2307/3237101; MARKS PL, 1985, B TORREY BOT CLUB, V112, P376, DOI 10.2307/2996038; Mo XQ, 2012, THESIS; Moreira DR, 1998, PESQUI AGROPECU BRAS, V33, P721; Nakamura K, 2006, J JAPANESE SOC REVEG, V32, P203; Nishihiro J., 2006, LANDSC ECOL ENG, V2, P171, DOI [10.1007/s11355-006-0005-9, DOI 10.1007/S11355-006-0005-9]; Page MJ, 2006, J ARID ENVIRON, V64, P323, DOI 10.1016/j.jaridenv.2005.05.003; Mesquita MLR, 2013, ACTA BOT BRAS, V27, P465, DOI 10.1590/S0102-33062013000300001; Shang ZH, 2013, PLANT SOIL, V364, P229, DOI 10.1007/s11104-012-1362-9; Shin JH, 2015, HORTIC ENVIRON BIOTE, V56, P178, DOI 10.1007/s13580-015-0154-6; Srivastava R, 2014, WEED BIOL MANAG, V14, P21, DOI 10.1111/wbm.12029; Sun ShouRu, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P41; Tai NH, 2010, KOREAN J HORTIC SCI, V28, P59; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Umehara T, 1997, JAPANESE J CONSERVAT, V2, P9; [王俊 WANG Jun], 2006, [生态环境, Ecology and Environment], V15, P1372; Whittle C. A., 1997, Environmental Reviews, V5, P79, DOI 10.1139/a97-003; Yamabe S, 2004, J JAPANESE SOC REVEG, V29, P393, DOI DOI 10.7211/JJSRT.29.393; Zhai FuQun, 2013, Research of Environmental Sciences, V26, P97; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhang ZM, 2014, REMOTE SENS-BASEL, V6, P1026, DOI 10.3390/rs6021026; Zhao ZH, 2014, ENVIRON SCI POLLUT R, V21, P3091, DOI 10.1007/s11356-013-2265-x	61	5	14	7	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147439	10.1371/journal.pone.0147439	http://dx.doi.org/10.1371/journal.pone.0147439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808785	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800095
J	Johnson, MJ; Allgar, V; Macleod, U; Jones, A; Oliver, S; Currow, D				Johnson, Miriam J.; Allgar, Victoria; Macleod, Una; Jones, Annie; Oliver, Steven; Currow, David			Family Caregivers Who Would Be Unwilling to Provide Care at the End of Life Again: Findings from the Health Survey for England Population Survey	PLOS ONE			English	Article							PALLIATIVE CARE; HEART-FAILURE; SERVICES; DEATH; PROFESSIONALS; MORTALITY; OUTCOMES; PEOPLE; TRENDS	Background Family caregivers provide significant care at the end of life. We aimed to describe caregiver characteristics, and of those unwilling to repeat this role under the same circumstances. Methods Observational study of adults in private households (Health Survey for England [HSE]). Caregiving questions included: whether someone close to them died within past 5 years; relationship to the deceased; provision, intensity and duration of care; supportive/palliative care services used; willingness to care again; able to carry on with life. Comparison between those willing to care again or not used univariable analyses and an exploratory multiple logistic regression. A descriptive comparison with Health Omnibus Survey (Australia) data was conducted. Findings HSE response was 64%. 2167/8861 (25%) respondents had someone close to them die in the previous 5 years. Some level of personal care was provided by 645/8861 (7.3%). 57/632 (9%) former caregivers would be unwilling to provide care again irrespective of time since the death, duration of care, education and income. Younger age (<= 65; odds ratio [OR] 2.79; 95% CI 136, 5.74) and use of palliative care services (odds ratio: 1.95, 95% CI: 1.09, 3.48) showed greater willingness to provide care again. Apart from use of palliative care services, findings were remarkably similar to the Australian data. Conclusions A significant group of caregivers would be unwilling to provide care again. Older people and those who had not used palliative care services were more likely to be unwilling to care again. Barriers preventing access for disadvantaged groups need to be overcome.	[Johnson, Miriam J.; Macleod, Una; Jones, Annie] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Allgar, Victoria; Oliver, Steven] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Currow, David] Flinders Univ S Australia, Discipline Palliat & Support Serv, Adelaide, SA 5001, Australia	University of Hull; University of York - UK; University of Hull; University of York - UK; Flinders University South Australia	Johnson, MJ (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	miriam.johnson@hyms.ac.uk		Allgar, Victoria/0000-0002-5228-2623; Currow, David/0000-0003-1988-1250; Johnson, Miriam/0000-0001-6204-9158	North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network	North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network	The work was funded by palliative care speciality group lead (MJ) general support funding provided by the North East Yorkshire, North Lincolnshire (NEYNL) Local Clinical Research Network who were independent of the study and the funding unrelated to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy A, 2009, PALLIATIVE MED, V23, P66, DOI 10.1177/0269216308098793; Abernethy AP, 2008, SUPPORT CARE CANCER, V16, P585, DOI 10.1007/s00520-007-0342-8; Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; [Anonymous], 2015, MDS FULL REP YEAR 20; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boodhna G, 2014, METHODS DOCUMENTATIO, V2; Boyd KJ, 2009, PALLIATIVE MED, V23, P767, DOI 10.1177/0269216309346541; Buckner L, 2011, VALUING CARERS 2011; Burns CM, 2013, PALLIATIVE MED, V27, P608, DOI 10.1177/0269216313483664; Candy B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007617.pub2; Cantwell P, 2000, J PALLIATIVE CARE, V16, P23, DOI 10.1177/082585970001600105; Carers UK tvoc, 2012, FACTS CAR 2012; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Currow DC, 2011, J PAIN SYMPTOM MANAG, V41, P661, DOI 10.1016/j.jpainsymman.2010.06.017; Davidson PM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-342; Department of Health, 2008, CAR HEART 21 CENT FA; Funk L, 2010, PALLIATIVE MED, V24, P594, DOI 10.1177/0269216310371411; Gadoud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113188; Gelfman LP, 2014, J PALLIAT MED, V17, P753, DOI 10.1089/jpm.2013.0675; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Gomes B, 2012, PALLIATIVE MED, V26, P102, DOI 10.1177/0269216311432329; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Grande G, 2008, PALLIATIVE MED, V22, P971, DOI 10.1177/0269216308098805; Grande GE, 2006, AGE AGEING, V35, P267, DOI 10.1093/ageing/afj071; Hauser JM, 2004, CLIN GERIATR MED, V20, P671, DOI 10.1016/j.cger.2004.07.003; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Morris SM, 2015, PALLIATIVE MED, V29, P487, DOI 10.1177/0269216314565706; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Institute of Cancer Research, 2010, RAP REV RES SURV CAN; NHS The Information Centre for Health and Social Care, 2010, SURV CAR HOUSEH 2009; Office for National Statistics, 2014, STAT B; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pinnock Hilary, 2011, BMJ Support Palliat Care, V1, P174, DOI 10.1136/bmjspcare.d142rep; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2008, GERIATRICS, V63, P20; Seaman JB, 2014, AM J HOSP PALLIAT CA; Simpson B, 2010, DOH CARERS PERSONALI; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476	41	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146960	10.1371/journal.pone.0146960	http://dx.doi.org/10.1371/journal.pone.0146960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809029	Green Published, gold, Green Accepted			2022-12-27	WOS:000369527800041
J	Sumida, K; Hoshino, J; Ueno, T; Mise, K; Hayami, N; Suwabe, T; Kawada, M; Imafuku, A; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Sawa, N; Fujii, T; Ohashi, K; Takaichi, K; Ubara, Y				Sumida, Keiichi; Hoshino, Junichi; Ueno, Toshiharu; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Sawa, Naoki; Fujii, Takeshi; Ohashi, Kenichi; Takaichi, Kenmei; Ubara, Yoshifumi			Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis	PLOS ONE			English	Article							CHRONIC HYPOXIA; KIDNEY-DISEASE; BLOOD-PRESSURE; HYPERTENSION; AUTOREGULATION; PROGRESSION; FIBROSIS	Background Reduced estimated glomerular filtration rate (eGFR) and proteinuria are risk factors for end-stage renal disease (ESRD), of which benign nephrosclerosis is a common cause. However, few biopsy-based studies have assessed these associations. Methods We performed retrospective cohort study of 182 Japanese patients who underwent renal biopsy from June 1985 through March 2014 and who were diagnosed with benign nephrosclerosis. Competing risk regression analyses were used to investigate the effect of eGFR and proteinuria levels at the time of renal biopsy on the risk for renal events (ESRD or a 50% decline in eGFR from baseline). Results During a median 5.8-year follow-up, 63 (34.6%) patients experienced renal events. The incidence of renal events increased with lower baseline eGFR and greater baseline proteinuria levels. After adjustment for baseline covariates, lower eGFR levels (subhazard ratios [SHRs], 1.30; 95% confidence interval [CI], 1.01-1.67, per 10 mL/min/1.73 m(2)) and higher proteinuria levels (SHR, 1.52; 95% CI, 1.23-1.87, per 1.0 g/day) at the time of renal biopsy were associated independently with higher risk for renal events. Lower levels of serum albumin (SHR, 2.07; 95% CI, 1.20-3.55 per 1.0 g/dL) were also associated with renal events. Patients with both eGFR <30 mL/min/1.73 m(2) and proteinuria >= 0.5 g/day had a 26.7-fold higher risk (95% CI, 3.97-179.4) of renal events than patients with both eGFR >= 60 mL/min/1.73 m(2) and proteinuria <0.5 g/day. Conclusions Reduced eGFR and increased proteinuria as well as lower serum albumin at the time of renal biopsy are independent risk factors for renal events among patients with biopsy-proven benign nephrosclerosis.	[Sumida, Keiichi; Hoshino, Junichi; Ueno, Toshiharu; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan; [Sumida, Keiichi; Hoshino, Junichi; Hayami, Noriko; Suwabe, Tatsuya; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Sawa, Naoki; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanagawa, Japan; [Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan	Toranomon Hospital; Toranomon Hospital; Yokohama City University; Toranomon Hospital	Sumida, K (corresponding author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kanagawa, Japan.; Sumida, K (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.	k-sumida@umin.ac.jp	Fujii, Takeshi/D-5877-2014	Fujii, Takeshi/0000-0001-7237-1183; Mise, Koki/0000-0003-0296-7429	Okinaka Memorial Institute for Medical Research	Okinaka Memorial Institute for Medical Research	This study was funded by the Okinaka Memorial Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; Churg J, 1982, RENAL DIS CLASSIFICA, P211; Crimi E, 2007, FREE RADICAL RES, V41, P1364, DOI 10.1080/10715760701732830; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dasgupta I, 2007, QJM-INT J MED, V100, P113, DOI 10.1093/qjmed/hcl139; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hill GS, 2006, KIDNEY INT, V69, P823, DOI 10.1038/sj.ki.5000163; Hill GS, 2003, KIDNEY INT, V63, P1027, DOI 10.1046/j.1523-1755.2003.00831.x; Kopp JB, 2013, CURR OPIN NEPHROL HY, V22, P266, DOI 10.1097/MNH.0b013e3283600f8c; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Marin Rafael, 2005, Kidney Int Suppl, pS52; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meyrier A., 2014, NEPHROL DIAL TRANSPL; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Olson JL, 2007, HEPTINSTALLS PATHOLO, P937; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Suzuki Hiromichi, 2015, Ther Adv Cardiovasc Dis, V9, P77, DOI 10.1177/1753944715578596; Takebayashi S, 2001, CLIN NEPHROL, V55, P349; TRACY RE, 1991, MODERN PATHOL, V4, P602; TRACY RE, 1992, VIRCHOWS ARCH A, V420, P479, DOI 10.1007/BF01600252; United States Renal Data System, 2014, 2014 ANN DAT REP EP; Veniant M, 1996, J CLIN INVEST, V98, P1966, DOI 10.1172/JCI119000; Vikse BE, 2003, NEPHROL DIAL TRANSPL, V18, P517, DOI 10.1093/ndt/18.3.517	30	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147690	10.1371/journal.pone.0147690	http://dx.doi.org/10.1371/journal.pone.0147690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26809068	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800181
J	Viviani, L; van der Es, M; Irvine, L; Tam, CC; Rodrigues, LC; Jackson, KA; O'Brien, SJ; Hunter, PR				Viviani, Laura; van der Es, Mike; Irvine, Lisa; Tam, Clarence C.; Rodrigues, Laura C.; Jackson, Kathryn A.; O'Brien, Sarah J.; Hunter, Paul R.		IID2 Study Executive Comm	Estimating the Incidence of Acute Infectious Intestinal Disease in the Community in the UK: A Retrospective Telephone Survey	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; NATIONAL SURVEILLANCE; ACUTE GASTROENTERITIS; GENERAL-PRACTICE; UNITED-STATES; POPULATION; BURDEN; DIARRHEA; IRELAND; CANADA	Objectives To estimate the burden of intestinal infectious disease (IID) in the UK and determine whether disease burden estimations using a retrospective study design differ from those using a prospective study design. Design/Setting A retrospective telephone survey undertaken in each of the four countries comprising the United Kingdom. Participants were randomly asked about illness either in the past 7 or 28 days. Participants 14,813 individuals for all of whom we had a legible recording of their agreement to participate Outcomes Self-reported IID, defined as loose stools or clinically significant vomiting lasting less than two weeks, in the absence of a known non-infectious cause. Results The rate of self-reported IID varied substantially depending on whether asked for illness in the previous 7 or 28 days. After standardising for age and sex, and adjusting for the number of interviews completed each month and the relative size of each UK country, the estimated rate of IID in the 7-day recall group was 1,530 cases per 1,000 person-years (95% CI: 1135-2113), while in the 28-day recall group it was 533 cases per 1,000 person-years (95% CI: 377-778). There was no significant variation in rates between the four countries. Rates in this study were also higher than in a related prospective study undertaken at the same time. Conclusions The estimated burden of disease from IID varied dramatically depending on study design. Retrospective studies of IID give higher estimates of disease burden than prospective studies. Of retrospective studies longer recall periods give lower estimated rates than studies with short recall periods. Caution needs to be exercised when comparing studies of self-reported IID as small changes in study design or case definition can markedly affect estimated rates.	[Viviani, Laura; Tam, Clarence C.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [van der Es, Mike; Irvine, Lisa; Hunter, Paul R.] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England; [Jackson, Kathryn A.; O'Brien, Sarah J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of East Anglia; University of Liverpool	Hunter, PR (corresponding author), Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Viviani, Laura/A-4787-2010; Hunter, Paul/A-7172-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Irvine, Lisa/ABH-5953-2020; Hunter, Paul/N-9021-2019	Viviani, Laura/0000-0003-2419-8472; Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; O'Brien, Sarah Jane/0000-0003-2896-8999; Tam, Clarence/0000-0003-1697-286X; Irvine, Lisa/0000-0003-1936-3584	UK Food standards agency; Medical Research Council [MC_U122785837] Funding Source: researchfish	UK Food standards agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the UK Food standards agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; Cantwell LB, 2010, FOODBORNE PATHOG DIS, V7, P1225, DOI 10.1089/fpd.2010.0567; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; FOX JP, 1972, AM J EPIDEMIOL, V96, P270, DOI 10.1093/oxfordjournals.aje.a121458; Hauri AM, 2011, GESUNDHEITSWESEN, V73, P78, DOI 10.1055/s-0030-1270492; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P1001, DOI 10.2307/2290792; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; McNulty CAM, 2014, BRIT J GEN PRACT, V64, pE24, DOI 10.3399/bjgp14X676429; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; O'Brien SJ, 2012, CURR OPIN INFECT DIS, V25, P537, DOI 10.1097/QCO.0b013e328356aeba; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; Roy Sharon L., 2006, Journal of Water and Health, V4, P31, DOI 10.2166/wh.2006.017; Scallan E, 2004, Commun Dis Public Health, V7, P61; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Sethi D, 1999, Commun Dis Public Health, V2, P101; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thomas MK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-307; Van Cauteren D, 2012, EPIDEMIOL INFECT, V140, P697, DOI 10.1017/S0950268811000999; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; World Health Organization, 2005, TREATM DIARRH MAN PH	23	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146171	10.1371/journal.pone.0146171	http://dx.doi.org/10.1371/journal.pone.0146171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807916	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800017
J	Wakagi, T; Nishimasu, H; Miyake, M; Fushinobu, S				Wakagi, Takayoshi; Nishimasu, Hiroshi; Miyake, Masayuki; Fushinobu, Shinya			Archaeal Mo-Containing Glyceraldehyde Oxidoreductase Isozymes Exhibit Diverse Substrate Specificities through Unique Subunit Assemblies	PLOS ONE			English	Article							THERMOACIDOPHILE SULFOLOBUS-ACIDOCALDARIUS; MONONUCLEAR MOLYBDENUM ENZYMES; CARBON-MONOXIDE DEHYDROGENASE; XANTHINE-OXIDASE FAMILY; ALDEHYDE OXIDOREDUCTASE; FERREDOXIN OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Archaea use glycolytic pathways distinct from those found in bacteria and eukaryotes, where unique enzymes catalyze each reaction step. In this study, we isolated three isozymes of glyceraldehyde oxidoreductase (GAOR1, GAOR2 and GAOR3) from the thermoacidophilic archaeon Sulfolobus tokodaii. GAOR1-3 belong to the xanthine oxidoreductase superfamily, and are composed of a molybdo-pyranopterin subunit (L), a flavin subunit (M), and an iron-sulfur subunit (S), forming an LMS hetero-trimer unit. We found that GAOR1 is a tetramer of the STK17810/STK17830/STK17820 hetero-trimer, GAOR2 is a dimer of the STK23390/STK05620/STK05610 hetero-trimer, and GAOR3 is the STK24840/STK05620/STK05610 hetero-trimer. GAOR1-3 exhibited diverse substrate specificities for their electron donors and acceptors, due to their different L-subunits, and probably participate in the non-phosphorylative Entner-Doudoroff glycolytic pathway. We determined the crystal structure of GAOR2, as the first three-dimensional structure of an archaeal molybdenum-containing hydroxylase, to obtain structural insights into their substrate specificities and subunit assemblies. The gene arrangement and the crystal structure suggested that the M/S-complex serves as a structural scaffold for the binding of the L-subunit, to construct the three enzymes with different specificities. Collectively, our findings illustrate a novel principle of a prokaryotic multicomponent isozyme system.	[Wakagi, Takayoshi; Miyake, Masayuki; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Nishimasu, Hiroshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Wakagi, T (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	t-wakagi@cb3.so-net.ne.jp	Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; 	Japan Society for the Promotion of Science [24580136]; Grants-in-Aid for Scientific Research [15H02443] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to T.W., No. 24580136).	BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Correia HD, 2015, J BIOL INORG CHEM, V20, P219, DOI 10.1007/s00775-014-1196-4; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; de Vos WM, 1998, EXTREMOPHILES, V2, P201, DOI 10.1007/s007920050061; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gremer L, 2000, J BIOL CHEM, V275, P1864, DOI 10.1074/jbc.275.3.1864; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hille R, 2013, DALTON T, V42, P3029, DOI 10.1039/c2dt32376a; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; Ito F, 2012, FEBS LETT, V586, P3097, DOI 10.1016/j.febslet.2012.07.059; Kardinahl S, 1999, EUR J BIOCHEM, V260, P540, DOI 10.1046/j.1432-1327.1999.00201.x; KARLSSON S, 1985, ANNU REV BIOCHEM, V54, P1071; Kletzin A, 1996, J BACTERIOL, V178, P248, DOI 10.1128/jb.178.1.248-257.1996; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MEYER W, 1995, ARCH BIOCHEM BIOPHYS, V319, P149, DOI 10.1006/abbi.1995.1277; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2006, J BACTERIOL, V188, P2014, DOI 10.1128/JB.188.5.2014-2019.2006; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; Reher M, 2006, FEBS LETT, V580, P1198, DOI 10.1016/j.febslet.2006.01.029; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; Rothery RA, 2015, J BIOL INORG CHEM, V20, P349, DOI 10.1007/s00775-014-1194-6; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Sato T, 2011, CURR OPIN MICROBIOL, V14, P307, DOI 10.1016/j.mib.2011.04.014; SCHRODER I, 1985, ARCH MICROBIOL, V140, P380, DOI 10.1007/BF00446982; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wakagi T, 2002, FEBS LETT, V510, P196, DOI 10.1016/S0014-5793(01)03259-8; Yan Z, 2014, EXTREMOPHILES, V18, P99, DOI 10.1007/s00792-013-0601-1	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147333	10.1371/journal.pone.0147333	http://dx.doi.org/10.1371/journal.pone.0147333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808202	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800075
J	Zeestraten, EA; Benjamin, P; Lambert, C; Lawrence, AJ; Williams, OA; Morris, RG; Barrick, TR; Markus, HS				Zeestraten, Eva Anna; Benjamin, Philip; Lambert, Christian; Lawrence, Andrew John; Williams, Owen Alan; Morris, Robin Guy; Barrick, Thomas Richard; Markus, Hugh Stephen			Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER; COGNITIVE IMPAIRMENT; SURROGATE MARKER; MRI; CADASIL; STROKE; BRAIN; ABNORMALITIES; LEUKOARAIOSIS; SEGMENTATION	Cerebral small vessel disease (SVD) is the major cause of vascular cognitive impairment, resulting in significant disability and reduced quality of life. Cognitive tests have been shown to be insensitive to change in longitudinal studies and, therefore, sensitive surrogate markers are needed to monitor disease progression and assess treatment effects in clinical trials. Diffusion tensor imaging (DTI) is thought to offer great potential in this regard. Sensitivity of the various parameters that can be derived from DTI is however unknown. We aimed to evaluate the differential sensitivity of DTI markers to detect SVD progression, and to estimate sample sizes required to assess therapeutic interventions aimed at halting decline based on DTI data. We investigated 99 patients with symptomatic SVD, defined as clinical lacunar syndrome with MRI confirmation of a corresponding infarct as well as confluent white matter hyperintensities over a 3 year follow-up period. We evaluated change in DTI histogram parameters using linear mixed effect models and calculated sample size estimates. Over a three-year follow-up period we observed a decline in fractional anisotropy and increase in diffusivity in white matter tissue and most parameters changed significantly. Mean diffusivity peak height was the most sensitive marker for SVD progression as it had the smallest sample size estimate. This suggests disease progression can be monitored sensitively using DTI histogram analysis and confirms DTI's potential as surrogate marker for SVD.	[Zeestraten, Eva Anna; Benjamin, Philip; Lambert, Christian; Williams, Owen Alan; Barrick, Thomas Richard] Univ London, Cardiovasc & Cell Sci Res Inst, Neurosci Res Ctr, London, England; [Benjamin, Philip] Imperial Coll NHS Trust, Dept Radiol, Charing Cross Hosp Campus, London, England; [Lawrence, Andrew John; Markus, Hugh Stephen] Univ Cambridge, Clin Neurosci, Stroke Res Grp, Cambridge, England; [Morris, Robin Guy] Kings Coll Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of London; King's College London; Imperial College London; University of Cambridge	Zeestraten, EA (corresponding author), Univ London, Cardiovasc & Cell Sci Res Inst, Neurosci Res Ctr, London, England.	p1207006@sgul.ac.uk		Williams, Owen/0000-0001-8252-6521; Barrick, Thomas/0000-0003-1783-3650; Lambert, Christian/0000-0001-8281-4611; Lawrence, Andrew/0000-0002-1420-3381	Wellcome Trust [081589]; English National Institute for Health Research Senior Investigator award; Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant; Alzheimer's Research UK [ARUK-PG2013-2]; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; Academy of Medical Sciences (AMS) [AMS-SGCL8-Lambert] Funding Source: researchfish; Alzheimers Research UK [ARUK-PG2013-2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019, CL-2012-16-501] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); English National Institute for Health Research Senior Investigator award; Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); English National Institute of Health Research (NIHR) Clinical Stroke Research Network; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR))	The SCANS study was supported by a Wellcome Trust grant #081589, awarded to HSM (http://www.wellcome.ac.uk). HSM is supported by an English National Institute for Health Research Senior Investigator award (http://www.nihr.ac.uk). CL is supported by an Academy of Medical Sciences (GB) Clinical Lecturer Start-Up Grant (http://www.acmedsci.ac.uk). AJL is supported by a research grant from Alzheimer's Research UK: ARUK-PG2013-2 (http://www.alzheimersresearchuk.org). Recruitment was supported by the English National Institute of Health Research (NIHR) Clinical Stroke Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benjamin P, 2015, J CEREB BLOOD FLOW M, P1; Benjamin P, 2014, NEUROIMAGE-CLIN, V4, P828, DOI 10.1016/j.nicl.2014.05.009; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Dunn JT, 2013, J CEREBR BLOOD F MET, V33, P1098, DOI 10.1038/jcbfm.2013.55; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fazekas F, 2002, J NEURAL TRANSM-SUPP, P61; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Gunda B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097173; Holtmannspotter M, 2005, STROKE, V36, P2559, DOI 10.1161/01.STR.0000189696.70989.a4; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; Lambert C, 2015, NEUROIMAGE-CLIN, V9, P194, DOI 10.1016/j.nicl.2015.07.002; Lambert C, 2013, NEUROIMAGE-CLIN, V2, P684, DOI 10.1016/j.nicl.2013.04.017; Lawrence AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135523; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liem MK, 2009, NEUROLOGY, V72, P143, DOI 10.1212/01.wnl.0000339038.65508.96; Liu GH, 1997, BIOMETRICS, V53, P937, DOI 10.2307/2533554; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Pearce LA, 2014, LANCET NEUROL, V13, P1177, DOI 10.1016/S1474-4422(14)70224-8; Rasbash J, 2009, MLWIN VERSION 21; Rovaris M, 1997, J NEUROL, V244, P266, DOI 10.1007/s004150050083; Schmidt R, 2012, STROKE, V43, P2643, DOI 10.1161/STROKEAHA.112.662593; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; van Norden AGW, 2012, BBA-MOL BASIS DIS, V1822, P401, DOI 10.1016/j.bbadis.2011.04.008; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	46	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147836	10.1371/journal.pone.0147836	http://dx.doi.org/10.1371/journal.pone.0147836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808982	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000369527800222
J	Ai, ZC; Jing, W; Fang, L				Ai, Zhichao; Jing, Wei; Fang, Li			Cytokine-Like Protein 1 (Cytl1): A Potential Molecular Mediator in Embryo Implantation	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; ENDOMETRIAL RECEPTIVITY; GROWTH; ANGIOGENESIS	Cytokine-like protein 1 (CytI1), originally described as a protein expressed in CD34+ cells, was recently identified as a functional secreted protein involved in chondrogenesis and cartilage development. However, our knowledge of CytI1 is still limited. Here, we determined the CytI1 expression pattern regulated by ovarian hormones at both the mRNA and protein levels. We found that the endometrial expression of CytI1 in mice was low before or on the first day of gestation, significantly increased during embryo implantation, and then decreased at the end of implantation. We investigated the effects of CytI1 on endometrial cell proliferation, and the effects on the secretion of leukemia inhibitory factor (LIF) and heparin -binding epidermal growth factor (HB-EGF). We also explored the effect of CytI1 on endometrial adhesion properties in cell-cell adhesion assays. Our findings demonstrated that CytI1 is an ovarian hormone-dependent protein expressed in the endometrium that enhances the proliferation of HEC-1-A and RL95-2 cells, stimulates endometrial secretion of LIF and HB-EGF, and enhances the adhesion of HEC-1-A and RL95-2 cells to JAR spheroids. This study suggests that CytI1 plays an active role in the regulation of embryo implantation.	[Ai, Zhichao; Jing, Wei; Fang, Li] Dalian Med Univ, Dept Immunol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Fang, L (corresponding author), Dalian Med Univ, Dept Immunol, Dalian, Liaoning, Peoples R China.	lifang16@hotmail.com			National Science Foundation of China [NSFC30772023]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Science Foundation of China (NSFC30772023). LF is the author who received the funding.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022256; d'Hauterive SP, 2005, NEUROIMMUNOMODULAT, V12, P157, DOI 10.1159/000084848; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Jeon J, 2011, J BIOL CHEM, V286, P27206, DOI 10.1074/jbc.M111.218065; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Steck T, 2004, EUR J OBSTET GYN R B, V112, P69, DOI 10.1016/S0301-2115(03)00315-4; Tomczak A, 2011, PROTEINS, V79, P1277, DOI 10.1002/prot.22963; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wen MJ, 2012, INT J ONCOL, V41, P1419, DOI 10.3892/ijo.2012.1552; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhou JH, 2014, CHEM-BIOL INTERACT, V219, P57, DOI 10.1016/j.cbi.2014.05.009	21	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147424	10.1371/journal.pone.0147424	http://dx.doi.org/10.1371/journal.pone.0147424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800213	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300106
J	Graham, NR; Fisher, BL; Girman, DJ				Graham, Natalie R.; Fisher, Brian L.; Girman, Derek J.			Phylogeography in Response to Reproductive Strategies and Ecogeographic Isolation in Ant Species on Madagascar: Genus Mystrium (Formicidae: Amblyoponinae)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; DEPENDENT COLONY FOUNDATION; EVOLUTION; HYMENOPTERA; PHYLOGENY; PATTERNS; DIVERSIFICATION; SYSTEMATICS; DIVERSITY; ENDEMISM	The bulk of models used to understand the species diversification on Madagascar have been constructed using vertebrate taxa. It is not clear how these models affect less vagile species that may interact at a variety of spatial scales. Several studies on vertebrates have divided Madagascar into east-west bioclimatic regions, suggesting there is a fundamental division between eastern wet-adapted and western dry-adapted taxa. An alternative model of ecogeographic constraints shows a north-south division. We test whether the diversification in a small arthropod with variable degrees of dispersal conform to either model of ecogeographic constraints proposed for vertebrate taxa. We employ a molecular taxonomic dataset using similar to 2 kilobases nuDNA (Wg, LW Rh, Abd-A, 28s) and 790 basepairs mtDNA (CO1), along with geographic and habitat data, to examine the diversification patterns of the ant genus Mystrium Roger, 1862, (Subfamily Amblyoponinae) from Madagascar. The nuclear and mitochondrial phylogenies were both congruent with morphospecies as indicated in a recent revision of the genus. Species of Mystrium practice different colony reproductive strategies (winged queens vs non-winged queens). Alternate reproductive strategies led to inequalities in female dispersal ability among species, providing an additional layer for examination of the impacts of vagility on divergence, especially when measured using a maternally inherited locus. Mystrium species distribution patterns support these models of ecogeographic constraints. Reproductive strategy effected how Mystrium mtDNA lineages were associated with large-scale habitat distinctions and various topographical features. Furthermore, in some cases we find microgeographic population structure which appears to have been impacted by localized habitat differences (tsingy limestone formations, littoral forest) on a scale much smaller than that found in vertebrates. The current system offers a finer scale look at species diversification on the island, and helps achieve a more universal understanding of the generation of biodiversity on Madagascar.	[Graham, Natalie R.; Girman, Derek J.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	California State University System; Sonoma State University; California Academy of Sciences	Graham, NR (corresponding author), Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA.	Natalie_Graham@outlook.com		Graham, Natalie/0000-0001-7704-1132; Fisher, Brian/0000-0002-4653-3270	National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395, DEB-9981667]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation under Grant No. DEB-0072713 (BLF), DEB-0344731 (BLF), DEB-0842395(BLF), and DEB-9981667 (BLF and DJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; [Anonymous], 1971, INSECT SOC; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown Jr WL, 1960, TRIBE AMBLYOPONINI M, V122, P145; Burney David A., 1997, P75; Clemencet J, 2005, MOL ECOL, V14, P3735, DOI 10.1111/j.1365-294X.2005.02706.x; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; CROZIER RH, 1993, GENETICS, V133, P97; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doums C, 2002, MOL ECOL, V11, P2251, DOI 10.1046/j.1365-294X.2002.01619.x; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Fisher Brian L., 2000, P331; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2003, NATURAL HIST MADAGAS; Graham Natalie, 2015, PHYLOGEOGRAPHY RESPO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holldobler B., 1990, pi; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaspari Michael, 2000, P89; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOECHLIN J, 1972, P145; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kuck P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021031; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; MASUKO K, 1986, BEHAV ECOL SOCIOBIOL, V19, P249, DOI 10.1007/BF00300639; Menozzi C., 1929, Zoologischer Anzeiger Leipzig, V82, P518; Miller M.A., 2010, P GAT COMP ENV WORKS; Moat J., 1998, CHOROLOGY TAXONOMY E, P97; Molet M, 2006, INT UN STUD SOC INS; Molet M, 2007, ETHOLOGY, V113, P721, DOI 10.1111/j.1439-0310.2007.01376.x; Molet M, 2007, NATURWISSENSCHAFTEN, V94, P280, DOI 10.1007/s00114-006-0190-2; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Molet M, 2009, BIOL J LINN SOC, V98, P198, DOI 10.1111/j.1095-8312.2009.01257.x; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Raselimanana AP, 2009, MOL PHYLOGENET EVOL, V50, P336, DOI 10.1016/j.ympev.2008.10.004; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Schatz GE., 2000, MEMOIRES SOC BIOGEOG, V1, P1, DOI DOI 10.1002/14356007; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Veress M, 2009, CARPATH J EARTH ENV, V4, P95; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Weiser MD, 2010, BIOL LETTERS, V6, P769, DOI 10.1098/rsbl.2010.0151; Wells N, 2003, NATURAL HIST MADAGAS, P16; WHEELER GC, 1988, ENTOMOL NEWS, V99, P23; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Yoshimura M, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.394.6446	79	0	0	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146170	10.1371/journal.pone.0146170	http://dx.doi.org/10.1371/journal.pone.0146170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800442	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300013
J	Ikeura, K; Kawakita, T; Tsunoda, K; Nakagawa, T; Tsubota, K				Ikeura, Kazuhiro; Kawakita, Tetsuya; Tsunoda, Kazuyuki; Nakagawa, Taneaki; Tsubota, Kazuo			Characterization of Long-Term Cultured Murine Submandibular Gland Epithelial Cells	PLOS ONE			English	Article							HUMAN SALIVARY-GLAND; FUNCTIONAL-PROPERTIES; MYOEPITHELIAL CELLS; PROGENITOR-CELL; ACINAR-CELLS; CYCLIC-AMP; LINE; ESTABLISHMENT; PROLIFERATION; GROWTH	Purpose Human and rat salivary gland cell lines derived from tumors or genetic modification are currently available for research. Here, we attempted to culture and characterize longterm cultured cells spontaneously derived from wild type murine submandibular glands (SGs). Methods SGs were removed from 3-week-old C57B/6J female mice and dissociated by collagenase type 1 and hyaluronidase digestion. Isolated SG epithelial cells were cultured in low calcium, serum-free growth media in the presence of cholera toxin (CT) during early passages. Single-cell colonies were isolated by limiting dilution culture after 25 passages. Early- and late-stage cell cultures were characterized for keratin 14, keratin 18, alpha-smooth muscle actin, and p63 by immunostaining and quantitative real-time PCR analysis. Results SG epithelial cells cultured in optimized media maintained their proliferative ability and morphology for over 80 passages. Long-term cultured cells expressed keratin 14, keratin 18, and p63, indicative of an epithelial phenotype. Conclusions Epithelial cells originating from wild type murine SGs could be cultured for longer periods of time and remain phenotypically similar to ductal basal epithelium.	[Ikeura, Kazuhiro; Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Ikeura, Kazuhiro; Tsunoda, Kazuyuki; Nakagawa, Taneaki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo, Japan	Keio University; Keio University	Kawakita, T (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	Kawakita@a2.keio.jp	tsunoda, kazuyuki/GLR-8745-2022					Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Almeida JL, 2014, CYTOTECHNOLOGY, V66, P133, DOI 10.1007/s10616-013-9545-7; Banh A, 2011, CLIN CANCER RES, V17, P7265, DOI 10.1158/1078-0432.CCR-11-0179; Bilal H, 2003, J HISTOCHEM CYTOCHEM, V51, P133, DOI 10.1177/002215540305100201; Castro-Munozledo F, 2008, EXP EYE RES, V86, P459, DOI 10.1016/j.exer.2007.11.017; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Gueiros LA, 2009, GERODONTOLOGY, V26, P297, DOI 10.1111/j.1741-2358.2009.00284.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Han P, 2015, J PROSTHODONT RES, V59, P6, DOI 10.1016/j.jpor.2014.11.001; Hiraki A, 2002, J CELL PHYSIOL, V193, P55, DOI 10.1002/jcp.10149; Hoffman MP, 1996, J CELL SCI, V109, P2013; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Jensen DH, 2014, OR SURG OR MED OR PA, V117, P335, DOI 10.1016/j.oooo.2013.11.496; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Kim JH, 2009, J PHARMACOL EXP THER, V330, P403, DOI 10.1124/jpet.109.153023; Kimoto M, 2008, J HISTOCHEM CYTOCHEM, V56, P15, DOI 10.1369/jhc.7A7269.2007; Kozlowski MR, 2015, CURR EYE RES, V40, P501, DOI 10.3109/02713683.2014.935440; Kwak M, 2015, STEM CELLS DEV, V24, P565, DOI 10.1089/scd.2014.0355; Laoide BM, 1996, J CELL SCI, V109, P2789; Liu JB, 2007, EXP EYE RES, V84, P599, DOI 10.1016/j.exer.2006.11.014; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Ma X, 2009, INVEST OPHTH VIS SCI, V50, P2716, DOI 10.1167/iovs.08-2139; Masamune A, 2003, WORLD J GASTROENTERO, V9, P2751; Mishima K, 2012, STEM CELLS, V30, P1925, DOI 10.1002/stem.1173; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Nelson J, 2013, ORAL DIS, V19, P236, DOI 10.1111/j.1601-0825.2012.01958.x; OKADA N, 1982, J INVEST DERMATOL, V79, P42, DOI 10.1111/1523-1747.ep12510580; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Wang Y, 2009, ARCH ORAL BIOL, V54, P986, DOI 10.1016/j.archoralbio.2009.07.011; WIGLEY CB, 1976, J CELL SCI, V20, P149; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yaniv A, 2011, TISSUE ENG PART C-ME, V17, P69, DOI [10.1089/ten.tec.2010.0228, 10.1089/ten.TEC.2010.0228]	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147407	10.1371/journal.pone.0147407	http://dx.doi.org/10.1371/journal.pone.0147407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800086	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300105
J	Shiwa, Y; Hachiya, T; Furukawa, R; Ohmomo, H; Ono, K; Kudo, H; Hata, J; Hozawa, A; Iwasaki, M; Matsuda, K; Minegishi, N; Satoh, M; Tanno, K; Yamaji, T; Wakai, K; Hitomi, J; Kiyohara, Y; Kubo, M; Tanaka, H; Tsugane, S; Yamamoto, M; Sobue, K; Shimizu, A				Shiwa, Yuh; Hachiya, Tsuyoshi; Furukawa, Ryohei; Ohmomo, Hideki; Ono, Kanako; Kudo, Hisaaki; Hata, Jun; Hozawa, Atsushi; Iwasaki, Motoki; Matsuda, Koichi; Minegishi, Naoko; Satoh, Mamoru; Tanno, Kozo; Yamaji, Taiki; Wakai, Kenji; Hitomi, Jiro; Kiyohara, Yutaka; Kubo, Michiaki; Tanaka, Hideo; Tsugane, Shoichiro; Yamamoto, Masayuki; Sobue, Kenji; Shimizu, Atsushi			Adjustment of Cell-Type Composition Minimizes Systematic Bias in Blood DNA Methylation Profiles Derived by DNA Collection Protocols	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; GENETIC RISK; CANCER; NORMALIZATION; PERFORMANCE; BIOBANKS; PACKAGE; STORAGE; SAMPLES; ARRAYS	Differences in DNA collection protocols may be a potential confounder in epigenome-wide association studies (EWAS) using a large number of blood specimens from multiple biobanks and/or cohorts. Here we show that pre -analytical procedures involved in DNA collection can induce systematic bias in the DNA methylation profiles of blood cells that can be adjusted by cell -type composition variables. In Experiment 1, whole blood from 16 volunteers was collected to examine the effect of a 24 h storage period at 4 C on DNA methylation profiles as measured using the Infinium HumanMethylation450 BeadChip array. Our statistical analysis showed that the P -value distribution of more than 450,000 CpG sites was similar to the theoretical distribution (in quantile-quantile plot, A = 1.03) when comparing two control replicates, which was remarkably deviated from the theoretical distribution (A = 1.50) when comparing control and storage conditions. We then considered cell -type composition as a possible cause of the observed bias in DNA methylation profiles and found that the bias associated with the cold storage condition was largely decreased (A adjusted = 1.14) by taking into account a cell -type composition variable. As such, we compared four respective sample collection protocols used in large-scale Japanese biobanks or cohorts as well as two control replicates. Systematic biases in DNA methylation profiles were observed between control and three of four protocols without adjustment of cell -type composition (A = 1.12-1.45) and no remarkable biases were seen after adjusting for cell -type composition in all four protocols (adjusted = 1.00-1.17). These results revealed important implications for comparing DNA methylation profiles between blood specimens from different sources and may lead to discovery of disease -associated DNA methylation markers and the development of DNA methylation profile -based predictive risk models.	[Shiwa, Yuh; Hachiya, Tsuyoshi; Satoh, Mamoru] Iwate Med Univ, Div Biobank & Data Management, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Shiwa, Yuh; Hachiya, Tsuyoshi; Furukawa, Ryohei; Ohmomo, Hideki; Ono, Kanako; Satoh, Mamoru; Shimizu, Atsushi] Iwate Med Univ, Div Biomed Informat Anal, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Kudo, Hisaaki; Minegishi, Naoko] Tohoku Univ, Dept Biobank, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Hata, Jun] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Hata, Jun] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Hozawa, Atsushi] Tohoku Univ, Prevent Med & Epidemiol, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Iwasaki, Motoki; Yamaji, Taiki; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Matsuda, Koichi] Univ Tokyo, Mol Med Lab, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Satoh, Mamoru] Iwate Med Univ, Community Med Supports & Hlth Record Informat, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Satoh, Mamoru] Iwate Med Univ, Div Biomed Informat Anal, Inst Biomed Sci, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Tanno, Kozo] Iwate Med Univ, Dept Hyg & Prevent Med, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Wakai, Kenji] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Hitomi, Jiro; Sobue, Kenji] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Hitomi, Jiro] Iwate Med Univ, Dept Anat, Sch Med, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan; [Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Sobue, Kenji] Iwate Med Univ, Dept Neurosci, Inst Biomed Sci, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan	Iwate Medical University; Iwate Medical University; Tohoku University; Kyushu University; Kyushu University; Tohoku University; National Cancer Center - Japan; University of Tokyo; Iwate Medical University; Iwate Medical University; Iwate Medical University; Nagoya University; Iwate Medical University; Iwate Medical University; Kyushu University; RIKEN; Aichi Cancer Center; Tohoku University; Tohoku University; Iwate Medical University	Shimizu, A (corresponding author), Iwate Med Univ, Div Biomed Informat Anal, Iwate Tohoku Med Megabank Org, Disaster Reconstruct Ctr, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan.	shimizu@iwate-med.ac.jp	Wakai, Kenji/I-7248-2014; Tsugane, Shoichiro/A-2424-2015; Yamamoto, Masayuki/A-4873-2010; Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Hachiya, Tsuyoshi/AAM-8691-2021; Matsuda, Koichi/D-4597-2011	Wakai, Kenji/0000-0001-7388-7157; Tsugane, Shoichiro/0000-0003-4105-2774; Yamamoto, Masayuki/0000-0002-9073-9436; Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Hachiya, Tsuyoshi/0000-0002-5274-3266; Ohmomo, Hideki/0000-0002-3524-6524; Matsuda, Koichi/0000-0001-7292-2686; xing zhi, shi zhi/0000-0003-3289-5681	Tohoku Medical Megabank Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [221S0001, 15K09464] Funding Source: KAKEN	Tohoku Medical Megabank Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Tohoku Medical Megabank Project (Special Account for reconstruction from the Great East Japan Earthquake) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Buhule OD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00354; Chen WA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-74; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Fiebig EW, 1997, CYTOMETRY, V29, P340, DOI 10.1002/(SICI)1097-0320(19971201)29:4<340::AID-CYTO11>3.0.CO;2-U; Harper KN, 2013, CANCER EPIDEM BIOMAR, V22, P1052, DOI 10.1158/1055-9965.EPI-13-0114; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Irvin MR, 2014, CIRCULATION, V130, P565, DOI 10.1161/CIRCULATIONAHA.114.009158; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Koestler DC, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-8; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; NICHOLSON JKA, 1984, J IMMUNOL METHODS, V73, P29, DOI 10.1016/0022-1759(84)90028-0; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Seow WJ, 2014, ENVIRON MOL MUTAGEN, V55, P449, DOI 10.1002/em.21860; Sun C, 2013, PEDIATR RES, V73, P523, DOI 10.1038/pr.2013.6; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; VANLAMBALGEN R, 1985, J IMMUNOL METHODS, V80, P39, DOI 10.1016/0022-1759(85)90162-0; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang T, 2015, EPIGENETICS-US, V10, P662, DOI 10.1080/15592294.2015.1057384; Watson RWG, 2010, NAT REV CANCER, V10, P646, DOI 10.1038/nrc2913; Xu ZL, 2013, JNCI-J NATL CANCER I, V105, P694, DOI 10.1093/jnci/djt045	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147519	10.1371/journal.pone.0147519	http://dx.doi.org/10.1371/journal.pone.0147519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799745	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300118
J	Takahashi, Y; Somta, P; Muto, C; Iseki, K; Naito, K; Pandiyan, M; Natesan, S; Tomooka, N				Takahashi, Yu; Somta, Prakit; Muto, Chiaki; Iseki, Kohtaro; Naito, Ken; Pandiyan, Muthaiyan; Natesan, Senthil; Tomooka, Norihiko			Novel Genetic Resources in the Genus Vigna Unveiled from Gene Bank Accessions	PLOS ONE			English	Article							L. A.-RICH.; SUBGENUS CERATOTROPIS; RIBOSOMAL-RNA; DIVERSITY; LEGUMINOSAE; PAPILIONOIDEAE; DOMESTICATION; HYBRIDIZATION; PHYLOGENY; TOLERANCE	The genus Vigna (Fabaceae) consists of five subgenera, and includes more than 100 wild species. In Vigna, 10 crops have been domesticated from three subgenera, Vigna, Plectrotropis, and Ceratotropis. The habitats of wild Vigna species are so diverse that their genomes could harbor various genes responsible for environmental stress adaptation, which could lead to innovations in agriculture. Since some of the gene bank Vigna accessions were unidentified and they seemed to be novel genetic resources, these accessions were identified based on morphological traits. The phylogenetic positions were estimated based on the DNA sequences of nuclear rDNA-ITS and chloroplast atpB-rbcL spacer regions. Based on the results, the potential usefulness of the recently described species V. indica and V. sahyadriana, and some wild Vigna species, i.e., V. aconitifolia, V. dalzelliana, V. khandalensis, V. marina var. oblonga, and V. vexillata, was discussed.	[Takahashi, Yu; Muto, Chiaki; Iseki, Kohtaro; Naito, Ken; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Somta, Prakit] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen, Nakhon Pathom, Thailand; [Pandiyan, Muthaiyan; Natesan, Senthil] Tamil Nadu Agr Univ, Coimbatore 641003, Tamil Nadu, India	National Institute of Agrobiological Sciences - Japan; Kasetsart University; Tamil Nadu Agricultural University	Tomooka, N (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan.	tomooka@affrc.go.jp	Muthaiyan, Pandiyan/AAS-6049-2020; Muthaiyan, Pandiyan/AAO-9610-2020; NATESAN, SENTHIL/AAH-2917-2019	Muthaiyan, Pandiyan/0000-0002-0510-0444; NATESAN, SENTHIL/0000-0002-2930-0715; Naito, Ken/0000-0002-0273-7837; Iseki, Kohtaro/0000-0001-8721-1553	JSPS KAKENHI [13J09808, 26850006]; Grants-in-Aid for Scientific Research [26850006] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 13J09808 and 26850006 to YT. Role of funders: data collection and analysis.	Aitawade M. M., 2012, Rheedea, V22, P20; Arora RK, 1984, NBPGR SCI MONOGRAPH, V7; BABU C R, 1985, Bulletin of the Botanical Survey of India, V27, P1; Baker J.G., 1871, FLORA TROPICAL AFRIC, V2, P1; Baker JG, 1879, FLORA BRIT INDIA, P204; Bhattacharyya P. K., 1984, Seeds & Farms, V10, P33; BIRCH ANE, 1986, PHYTOCHEMISTRY, V25, P2745, DOI 10.1016/S0031-9422(00)83733-4; Bisht IS, 2005, GENET RESOUR CROP EV, V52, P53, DOI 10.1007/s10722-005-0286-0; Chankaew S, 2014, THEOR APPL GENET, V127, P691, DOI 10.1007/s00122-013-2251-1; CHAVAN VM, 1966, INDIAN J GENET PL BR, VA 26, P152; Damayanti F, 2010, CROP PASTURE SCI, V61, P785, DOI 10.1071/CP10060; Delgado-Salinas A, 2011, AM J BOT, V98, P1694, DOI 10.3732/ajb.1100069; Dixit T. M., 2011, Rheedea, V21, P1; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; Fatokun CA, 1996, ADV COWPEA RES, P50; Gaikwad Sayajirao P, 2014, Biodivers Data J, pe4281, DOI 10.3897/BDJ.2.e4281; Garba M., 1998, Proceedings of 2nd International Symposium on Tuberous Legumes, Celaya, Guanajuato, Mexico, 5-8 August 1996., P61; Goel S, 2002, MOL PHYLOGENET EVOL, V22, P1, DOI 10.1006/mpev.2001.1037; Gomathinayagam P, 1998, EUPHYTICA, V102, P203, DOI 10.1023/A:1018381614098; IITA, 1988, ANN REP RES HIGHL 19; IRVINE F. R., 1952, ECON BOT, V6, P23, DOI 10.1007/BF02859192; Jain H. K., 1980, Advances in legume science, P459; John KJ., 2009, INDIAN J PLANT GENET, V22, P138; Karuniawan A, 2006, GENET RESOUR CROP EV, V53, P213, DOI 10.1007/s10722-005-1654-5; Latha M., 2014, Webbia, V69, P49, DOI 10.1080/00837792.2014.893951; LAWN RJ, 1988, BIOLOGIST, V35, P267; Lawn RJ, 2002, AUST J AGR RES, V53, P1305, DOI 10.1071/AR02065; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; MARECHAL R, 1978, Boissiera, V28, P1; Maxted N, 2004, AFRICAN VIGNA ECOGEO; MILLER IL, 1981, TROP GRASSLANDS, V15, P39; Ogundiwin EA, 2002, PLANT BREEDING, V121, P517, DOI 10.1046/j.1439-0523.2002.00769.x; Padulosi S., 1993, Bulletin du Jardin Botanique National de Belgique, V62, P119, DOI 10.2307/3668270; Palmer JL, 2002, AUST J BOT, V50, P331, DOI 10.1071/BT01086; Palmgren MG, 2015, TRENDS PLANT SCI, V20, P155, DOI 10.1016/j.tplants.2014.11.003; Pandiyan M., 2010, Electronic Journal of Plant Breeding, V1, P600; Pasquet R. S., 2001, Kew Bulletin, V56, P223, DOI 10.2307/4119438; PIENAAR BJ, 1991, S AFR J BOT, V57, P236, DOI 10.1016/S0254-6299(16)30924-3; Raghavan SR, 1972, CURRENT SCI, V41, P429; Schrire B. D., 2005, LEGUMES WORLD, P393, DOI DOI 10.1017/S0960428606190198; Schumacher CF, 1827, BESKRIVELSE GUINEISK, P338; Sebastin Raveendar, 2015, Plant Breeding and Biotechnology, V3, P153, DOI 10.9787/PBB.2015.3.2.153; SEN N. K., 1960, Cytologia, V25, P195, DOI 10.1508/cytologia.25.195; Smartt J., 1990, GRAIN LEGUMES, P160; Sonnante G, 1996, GENET RESOUR CROP EV, V43, P157, DOI 10.1007/BF00126759; Sonnante G, 1997, ANN BOT-LONDON, V80, P741, DOI 10.1006/anbo.1997.0511; Takahashi Y, 2014, ANN REPORT EXPLORATI, V30, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATEISHI Y, 1990, SERIES ENTOM, V46, P189; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuan NV, 1979, FLORE CAMBODGE LAOS, V17; Thulin M, 2004, SYST BOT, V29, P903, DOI 10.1600/0363644042451035; Tomooka N, 2010, P 14 NIAS INT WORKSH, P11; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Tomooka N, 2006, PL GE BI EV, V1, P87; Tomooka N, 2014, PLANT GENET RESOUR-C, V12, pS168, DOI 10.1017/S1479262114000483; Tomooka N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P291, DOI 10.1007/978-3-642-14387-8_15; VERDCOURT B, 1970, Kew Bulletin, V24, P507, DOI 10.2307/4102859; Vijaykumar A, 2010, J HERED, V101, P177, DOI 10.1093/jhered/esp084; Wong KC, 1997, PLANT RESOURCES SE A, P261; Yokoyama T, 2006, CAN J MICROBIOL, V52, P31, DOI 10.1139/W05-099; Yoon MS, 2000, J PLANT RES, V113, P375, DOI 10.1007/PL00013945; Zeven A. C., 1982, Dictionary of cultivated plants and their regions of diversity.	63	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147568	10.1371/journal.pone.0147568	http://dx.doi.org/10.1371/journal.pone.0147568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800459	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300125
J	Grosman, L; Munro, ND; Abadi, I; Boaretto, E; Shaham, D; Belfer-Cohen, A; Bar-Yosef, O				Grosman, Leore; Munro, Natalie D.; Abadi, Itay; Boaretto, Elisabetta; Shaham, Dana; Belfer-Cohen, Anna; Bar-Yosef, Ofer			Nahal Ein Gev II, a Late Natufian Community at the Sea of Galilee	PLOS ONE			English	Article							CAVE	The Natufian culture is of great importance as a starting point to investigate the dynamics of the transition to agriculture. Given its chronological position at the threshold of the Neolithic (ca. 12,000 years ago) and its geographic setting in the productive Jordan Valley, the site of Nahal Ein Gev II (NEG II) reveals aspects of the Late Natufian adaptations and its implications for the transition to agriculture. The size of the site, the thick archaeological deposits, invested architecture and multiple occupation sub-phases reveal a large, sedentary community at least on par with Early Natufian camps in the Mediterranean zone. Although the NEG II lithic tool kit completely lacks attributes typical of succeeding Pre Pottery Neolithic A (PPNA) assemblages, the artistic style is more closely related to the early PPNA world, despite clear roots in Early Natufian tradition. The site does not conform to current perceptions of the Late Natufians as a largely mobile population coping with reduced resource productivity caused by the Younger Dryas. Instead, the faunal and architectural data suggest that the sedentary populations of the Early Natufian did not revert back to a nomadic way of life in the Late Natufian in the Jordan Valley. NEG II encapsulates cultural characteristics typical of both Natufian and PPNA traditions and thus bridges the crossroads between Late Paleolithic foragers and Neolithic farmers.	[Grosman, Leore; Abadi, Itay; Shaham, Dana; Belfer-Cohen, Anna] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; [Munro, Natalie D.] Univ Connecticut, Dept Anthropol, Unit 1176, 354 Mansfield Rd, Storrs, CT 06269 USA; [Boaretto, Elisabetta] D REAMS Radiocarbon Lab, IL-76100 Rehovot, Israel; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; University of Connecticut; Harvard University	Grosman, L (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel.	leore.grosman@mail.huji.ac.il	Grosman, Leore/C-7010-2014; Grosman, Leore/GRJ-0792-2022	Grosman, Leore/0000-0002-6976-6202; Grosman, Leore/0000-0002-6976-6202; Munro, Natalie/0000-0003-1690-6133	American School of Prehistoric research (Peabody Museum, Harvard University); Israel Science Foundation [459/11]; National Science Foundation [BCS-1318381]; Division Of Behavioral and Cognitive Sci [1318381] Funding Source: National Science Foundation	American School of Prehistoric research (Peabody Museum, Harvard University); Israel Science Foundation(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	O. Bar-Yosef is grateful to the American School of Prehistoric research (Peabody Museum, Harvard University) for financial support to the project. In addition, this research was supported by the Israel Science Foundation (#459/11 to LG) and National Science Foundation (#BCS-1318381 to NDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2001, ARCHEOL PAPERS AM AN, DOI DOI 10.1525/AP3A.2001.10.1.80; Bar-Oz G., 2004, EPIPALAEOLITHIC SUBS; Bar-Yosef Mayer D.E., 2010, GILGAL EARLY NEOLITH, P223; Bar-Yosef Mayer D.E., 2005, PAL ORIENT, V31, P176, DOI DOI 10.3406/PALEO.2005.4796; Bar-Yosef O, 1999, ANTIQUITY, V73, P402, DOI 10.1017/S0003598X00088347; Bar-Yosef O, 1970, THESIS HEBREW U JERU; Bar-Yosef O., 2000, J ISRAEL PREHIST SOC, V30, P49; Bar-Yosef O., 1973, PALEORIENT, V1, P49; Bar-Yosef O, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P57; BarYosef O, 1995, SCH AM RES, V354, P39; BARYOSEF O, 1979, PALEORIENT, V5, P145; Belfer-Cohen, 1997, PALEORIENT, V23, P71, DOI 10.3406/paleo.1997.4653; Belfer-Cohen A., 2002, ARCHEOLOGICAL PAPERS, V12, P57; Belfer-Cohen A., 1989, INT SERIES, V497, P297; Belfer-Cohen A., 1996, NEOLITHIC CHIPPED LI, P217; BELFERCOHEN A, 1991, ANNU REV ANTHROPOL, V20, P167, DOI 10.1146/annurev.an.20.100191.001123; BELFERCOHEN A, 1988, THESIS HEBREW U JERU; Bocquentin F., 2013, INT MONOGRAPHS PREHI, P185; Bocquentin F., 2003, PRATIQUES FUNERAIRES; Cappers, 2002, DAWN FARMING NEAR E, P49; Caughley G., 1977, ANAL VERTEBRATE POPU; Dag D., 2010, GILGAL EXCAVATIONS E, P121; DAVIS SJ, 1980, ZOOL J LINN SOC-LOND, V70, P289, DOI 10.1111/j.1096-3642.1980.tb00854.x; Edwards PC, 2007, CONTEXT PRODUCTION I, V39, P27; Garrod DAE, 1932, J R ANTHROPOL INST G, V62, P257, DOI 10.2307/2843957; Goring-Morris A.N., 1991, NATUFIAN CULTURE LEV, P173; Goring-Morris AN, 2005, ARCHAEOLOGICAL PERSP, P89; Groman-Yaroslavski I., 2013, STONE TOOLS TRANSITI, P165; Grosman L, 2003, CURR ANTHROPOL, V44, P571, DOI 10.1086/377650; Grosman L, 1999, J ISRAEL PREHISTORIC, V29, P17; Grosman L., 2005, THESIS HEBREW U JERU; Grosman L., 2013, ANN ARBOR MI ARCHAEO, P622; Grosman L, 2014, J EAST MEDITERR ARCH, V2, P48; Grosman Leore, 2005, PALEORIENT, V31, P5; Hartman G, HUNTED GAZELLE EVIDE; Kuijt I, 2000, J ANTHROPOL ARCHAEOL, V19, P75, DOI 10.1006/jaar.1999.0352; Kuijt I., 2000, LIFE NEOLITHIC FARMI, P19, DOI DOI 10.1007/0-306-47166-3_2; Kuijt I., 1994, J MEDITERR ARCHAEOL, V7, P165, DOI [10.1558/jmea.v7i2.165, DOI 10.1558/JMEA.V7I2.165]; Marder O., 2002, THESIS HEBREW U; Martin L, 2000, J ZOOL, V250, P13; Mayer DEBY, 2008, P NATL ACAD SCI USA, V105, P8548, DOI 10.1073/pnas.0709931105; Mayer DEB, 2013, J FIELD ARCHAEOL, V38, P129, DOI 10.1179/0093469013Z.00000000043; Mithen SJ, 2011, ANTIQUITY, V85, P350, DOI 10.1017/S0003598X00067806; Munro ND, 2004, CURR ANTHROPOL, V45, pS5, DOI 10.1086/422084; Munro ND, 2009, FARMING, V2009, p4/1; Nadel D, 2006, DOMESTICATING SPACE, P25; Olszewski DI, 1989, PALEORIENT, V15, P29; Ozkaya V., 2011, NEOLITHIC TURKEY TIG, P89; Perrot J., 1966, ANTHROPOLOGIE, V70, P437; Rabinovich R, 2004, INT J OSTEOARCHAEOL, V14, P287, DOI 10.1002/oa.762; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; RODRIGO A. J., 2013, ANUARIO ESPANOL DERE, P61; Rosenberg D., 2010, PALEORIENT, V36, P189, DOI [DOI 10.3406/PALEO.2010.5395, 10.3406/paleo.2010.5395]; Speth J.D., 2006, FARMING, V3, P1, DOI [10.3828/bfarm.2006.3.1, DOI 10.3828/BFARM.2006.3.1]; Stein M, 2014, QUATERNARY SCI REV; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Stiner MC, 2005, 200000 YEAR RECORD P; STORDEUR D, 1999, HABITAT SOC, P131; Stordeur D., 2000, PALE ORIENT, V26, P29, DOI DOI 10.3406/paleo.2000.4696; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tchernov E., 1984, BAR INT SERIES, P91; Tixier J, 1963, TYPOLOGIE EPIPALEOLI; Torfstein A, 2013, QUATERNARY SCI REV, V69, P1, DOI 10.1016/j.quascirev.2013.02.015; Valla F.R., 2004, J ISR PREHIST SOC, V34, P49; Valla F.R., 2007, J ISRAEL PREHISTORIC, V37, P132; Valla FR., 1995, ARCHAEOLOGY SOC HOLY, P170; Winter H, 2005, MANASSE HILL COUNTRY, P576; Yartah Th., 2013, THESIS U LYON 2, VI; Yeshurun R, 2014, J HUM EVOL, V70, P16, DOI 10.1016/j.jhevol.2014.02.011; Zohar, 2010, EURASIAN PREHIST, V7, P31	74	35	35	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146647	10.1371/journal.pone.0146647	http://dx.doi.org/10.1371/journal.pone.0146647			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DC9GD	26815363	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200018
J	Singh, AR; Sivadas, A; Sabharwal, A; Vellarikal, SK; Jayarajan, R; Verma, A; Kapoor, S; Joshi, A; Scaria, V; Sivasubbu, S				Singh, Angom Ramcharan; Sivadas, Ambily; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Jayarajan, Rijith; Verma, Ankit; Kapoor, Shruti; Joshi, Adita; Scaria, Vinod; Sivasubbu, Sridhar			Chamber Specific Gene Expression Landscape of the Zebrafish Heart	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; IN-SITU HYBRIDIZATION; RNA-SEQ; CARDIAC DEVELOPMENT; NONCODING RNAS; MUTATIONS; REVEALS; CARDIOMYOPATHY; IDENTIFICATION; TRANSCRIPTOME	The organization of structure and function of cardiac chambers in vertebrates is defined by chamber-specific distinct gene expression. This peculiarity and uniqueness of the genetic signatures demonstrates functional resolution attributed to the different chambers of the heart. Altered expression of the cardiac chamber genes can lead to individual chamber related dysfunctions and disease patho-physiologies. Information on transcriptional repertoire of cardiac compartments is important to understand the spectrum of chamber specific anomalies. We have carried out a genome wide transcriptome profiling study of the three cardiac chambers in the zebrafish heart using RNA sequencing. We have captured the gene expression patterns of 13,396 protein coding genes in the three cardiac chambers-atrium, ventricle and bulbus arteriosus. Of these, 7,260 known protein coding genes are highly expressed (>= 10 FPKM) in the zebrafish heart. Thus, this study represents nearly an all-inclusive information on the zebrafish cardiac transcriptome. In this study, a total of 96 differentially expressed genes across the three cardiac chambers in zebrafish were identified. The atrium, ventricle and bulbus arteriosus displayed 20, 32 and 44 uniquely expressing genes respectively. We validated the expression of predicted chamber-restricted genes using independent semi-quantitative and qualitative experimental techniques. In addition, we identified 23 putative novel protein coding genes that are specifically restricted to the ventricle and not in the atrium or bulbus arteriosus. In our knowledge, these 23 novel genes have either not been investigated in detail or are sparsely studied. The transcriptome identified in this study includes 68 differentially expressing zebrafish cardiac chamber genes that have a human ortholog. We also carried out spatiotemporal gene expression profiling of the 96 differentially expressed genes throughout the three cardiac chambers in 11 developmental stages and 6 tissue types of zebrafish. We hypothesize that clustering the differentially expressed genes with both known and unknown functions will deliver detailed insights on fundamental gene networks that are important for the development and specification of the cardiac chambers. It is also postulated that this transcriptome atlas will help utilize zebrafish in a better way as a model for studying cardiac development and to explore functional role of gene networks in cardiac disease pathogenesis.	[Singh, Angom Ramcharan; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Jayarajan, Rijith; Verma, Ankit; Kapoor, Shruti; Joshi, Adita; Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Mathura Rd, Delhi 110025, India; [Sivadas, Ambily; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Mathura Rd, Delhi 110025, India; [Sivadas, Ambily; Sabharwal, Ankit; Vellarikal, Shamsudheen Karuthedath; Kapoor, Shruti; Scaria, Vinod; Sivasubbu, Sridhar] Acad Sci & Innovat Res, CSIR IGIB South Campus,Mathura Rd, Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Sivasubbu, S (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med, Mathura Rd, Delhi 110025, India.; Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Mathura Rd, Delhi 110025, India.; Scaria, V; Sivasubbu, S (corresponding author), Acad Sci & Innovat Res, CSIR IGIB South Campus,Mathura Rd, Delhi 110025, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Sabharwal, Ankit/AAH-4776-2019; Verma, Ankit/ABB-9786-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Scaria, Vinod/AAS-3151-2021; KAPOOR, SHRUTI/GLS-3871-2022	Sabharwal, Ankit/0000-0003-4355-0355; Verma, Ankit/0000-0002-9791-4997; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Sivadas, Ambily/0000-0001-5694-3866; Scaria, Vinod/0000-0001-7644-7181; KAPOOR, SHRUTI/0000-0003-4216-8488	Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR) India [BSC0122]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	ARS acknowledges a Senior Research Fellowship from the Indian Council of Medical Research (ICMR). Authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR) India through Grant BSC0122. The funders had no role in preparation of the manuscript or decision to publish.	Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen J, 2013, GENET MOL RES, V12, P4687, DOI 10.4238/2013.October.18.7; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dang MQ, 2015, CELL PHYSIOL BIOCHEM, V35, P467, DOI 10.1159/000369712; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; EVERETT AW, 1986, FASEB J, V45, P2568; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Geng J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1127; Gong WM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0460-0; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Iruretagoyena JI, 2014, MOL HUM REPROD, V20, P690, DOI 10.1093/molehr/gau026; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KLEIN SC, 1991, J BIOL CHEM, V266, P18058; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077938; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu HL, 2014, CELL BIOCHEM BIOPHYS, V70, P635, DOI 10.1007/s12013-014-9967-7; Liu H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-10; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Liu YB, 2014, GENE, V543, P15, DOI 10.1016/j.gene.2014.04.016; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2315, DOI 10.1016/j.jacc.2004.05.088; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patowary A, 2013, ZEBRAFISH, V10, P15, DOI 10.1089/zeb.2012.0848; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipkin W, 2003, CIRCULATION, V107, P469, DOI 10.1161/01.CIR.0000044386.27444.5A; Posch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028872; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodius S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-852; Ruzicka L, 2015, GENESIS, V53, P498, DOI 10.1002/dvg.22868; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Sogah VM, 2010, DEV DYNAM, V239, P3115, DOI 10.1002/dvdy.22445; Somi S, 2003, ANAT REC PART A, V273A, P603, DOI 10.1002/ar.a.10070; Song GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077492; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Tessier DJ, 2003, J SURG RES, V111, P152, DOI 10.1016/S0022-4804(03)00113-6; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006; Zhang RL, 2009, DEV DYNAM, V238, P1564, DOI 10.1002/dvdy.21929; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002; Zhou J, 2014, INT HEART J, V55, P71, DOI 10.1536/ihj.13-196; Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561	92	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147823	10.1371/journal.pone.0147823	http://dx.doi.org/10.1371/journal.pone.0147823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815362	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200056
J	Do, TN; Seah, TET; Yu, HK; Phee, SJ				Thanh Nho Do; Seah, Tian En Timothy; Yu, Ho Khek; Phee, Soo Jay			Development and Testing of a Magnetically Actuated Capsule Endoscopy for Obesity Treatment	PLOS ONE			English	Article							BIOENTERICS INTRAGASTRIC BALLOON; SYSTEMS; SAFETY; TIME; DIET	Intra-gastric balloons (IGB) have become an efficient and less invasive method for obesity treatment. The use of traditional IGBs require complex insertion tools and flexible endoscopes to place and remove the balloon inside the patient's stomach, which may cause discomfort and complications to the patient. This paper introduces a new ingestible weightloss capsule with a magnetically remote-controlled inflatable and deflatable balloon. To inflate the balloon, biocompatible effervescent chemicals are used. As the source of the actuation is provided via external magnetic fields, the magnetic capsule size can be significantly reduced compared to current weight-loss capsules in the literature. In addition, there are no limitations on the power supply. To lose weight, the obese subject needs only to swallow the magnetic capsule with a glass of water. Once the magnetic capsule has reached the patient's stomach, the balloon will be wirelessly inflated to occupy gastric space and give the feeling of satiety. The balloon can be wirelessly deflated at any time to allow the magnetic capsule to travel down the intestine and exit the body via normal peristalsis. The optimal ratio between the acid and base to provide the desired gas volume is experimentally evaluated and presented. A prototype capsule (9.6mm x 27mm) is developed and experimentally validated in ex-vivo experiments. The unique ease of delivery and expulsion of the proposed magnetic capsule is slated to make this development a good treatment option for people seeking to lose excess weight.	[Thanh Nho Do; Seah, Tian En Timothy; Phee, Soo Jay] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore; [Yu, Ho Khek] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119260, Singapore; [Yu, Ho Khek] Natl Univ Hlth Syst, Singapore 119260, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Do, TN (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.	thanh4@e.ntu.edu.sg	Nho, Thanh/M-7952-2013; Nho, Thanh/AAQ-1759-2021	Nho, Thanh/0000-0002-4980-5251; Nho, Thanh/0000-0002-4980-5251	STARTUP GRANT from Nanyang Technological University, Singapore [M4081419.050]	STARTUP GRANT from Nanyang Technological University, Singapore	This work was supported by the STARTUP GRANT, M4081419.050, from Nanyang Technological University, Singapore.	[Anonymous], CITR AC MON PROD INF; BURNMURDOCH R, 1980, J PHYSIOL-LONDON, V302, P395; Carbonelli MG, 2003, ACTA DIABETOL, V40, pS261, DOI 10.1007/s00592-003-0081-3; Chisaka H, 2006, DYSPHAGIA, V21, P275, DOI 10.1007/s00455-006-9054-3; Direct Food Substances Affirmed as Generally Recognized as Safe: U.S. Government Publishing Office, DIRECT FOOD SUBSTANC; Do TN, 2015, MECH MACH THEORY, V85, P14, DOI 10.1016/j.mechmachtheory.2014.11.003; Do T. N., 2014, Proceedings of the 11th International Conference on Informatics in Control, Automation and Robotics ICINCO 2014, P110; Dogan UB, 2013, OBES SURG, V23, P892, DOI 10.1007/s11695-013-0876-4; Dumonceau JM, 2008, OBES SURG, V18, P1611, DOI 10.1007/s11695-008-9593-9; Forestieri P, 2006, OBES SURG, V16, P635, DOI 10.1381/096089206776945156; Genco A, 2010, OBES SURG, V20, P1496, DOI 10.1007/s11695-010-0231-y; Giardiello C, 2012, OBES SURG, V22, P1916, DOI 10.1007/s11695-012-0786-x; Gorlewicz JL, 2013, IEEE T BIO-MED ENG, V60, P1225, DOI 10.1109/TBME.2012.2230631; Gou JH, 2014, CLIN ENDOSC, V47, P266, DOI 10.5946/ce.2014.47.3.266; Hu C, 2010, IEEE SENS J, V10, P903, DOI 10.1109/JSEN.2009.2035711; Imaz I, 2008, OBES SURG, V18, P841, DOI 10.1007/s11695-007-9331-8; Kannan RY, 2013, INT J SURG CASE REP, V4, P936, DOI 10.1016/j.ijscr.2013.07.025; Kencana AP, 2010, IEEE ENG MED BIO, P963, DOI 10.1109/IEMBS.2010.5627585; Kong K, 2012, J MED DEVICES, V6, DOI 10.1115/1.4007100; Lien GS, 2012, IEEE T BIO-MED ENG, V59, P2068, DOI 10.1109/TBME.2012.2198061; Lopez-Nava G, 2011, OBES SURG, V21, P5, DOI 10.1007/s11695-010-0093-3; Machytka E, 2011, OBES SURG, V21, P1499, DOI 10.1007/s11695-011-0424-z; Mahoney AW, 2013, IEEE INTERNATIONAL C; Manning EP, 2014, ANN EMERG MED, V64, P330, DOI 10.1016/j.annemergmed.2013.12.022; Martin Corby K, 2007, J Diabetes Sci Technol, V1, P574; Mathus-Vliegen EMH, 2005, GASTROINTEST ENDOSC, V61, P19, DOI 10.1016/S0016-5107(04)02406-X; Morita E, 2010, GASTROINTEST ENDOSC, V72, P836, DOI 10.1016/j.gie.2010.06.016; Munk JF, 1978, GASTROINTESTINAL MOT, P349; Neff KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-8; NIEBEN OG, 1982, LANCET, V1, P198; Noori N, 2010, AM J KIDNEY DIS, V56, P338, DOI 10.1053/j.ajkd.2010.03.022; O'Donoghue K, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2304271; Occupational Safety and Health Guideline for Acetic Acid: Centres for Disease Control and Prevention, OCC SAF HLTH GUID AC; Podczeck F, 2007, J PHARM PHARMACOL, V59, P23, DOI 10.1211/jpp.59.1.0004; Pryor R.W., 2011, MULTIPHYSICS MODELIN; SALESSIOTIS N, 1972, AM J SURG, V124, P331, DOI 10.1016/0002-9610(72)90036-0; Simi M, 2013, J MED DEVICES, V7, DOI 10.1115/1.4025185; Sioulas AD, 2012, OBESITY FACTS, V5, P436, DOI 10.1159/000341134; Solmaz A., 2015, Journal of Obesity & Weight Loss Therapy, V5, P265; Toennies JL, 2010, IEEE ENG MED BIO, P1946, DOI 10.1109/IEMBS.2010.5627793; Than TD, 2012, IEEE T BIO-MED ENG, V59, P2387, DOI 10.1109/TBME.2012.2201715; University CS, 2006, PATH DIG SYST 2006; Vasavid P, 2014, J NEUROGASTROENTEROL, V20, P371, DOI 10.5056/jnm13114; WADE JB, 1988, GROUP, V12, P172, DOI 10.1007/BF01456566; Wahlen CH, 2001, OBES SURG, V11, P524, DOI 10.1381/096089201321209468; Yan L, 2015, IEEE T IND ELECTRON, V62, P1125, DOI 10.1109/TIE.2014.2352216; Yim S, 2014, IEEE T BIO-MED ENG, V61, P513, DOI 10.1109/TBME.2013.2283369; Yim S, 2012, IEEE T ROBOT, V28, P1198, DOI 10.1109/TRO.2012.2197309	48	19	23	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148035	10.1371/journal.pone.0148035	http://dx.doi.org/10.1371/journal.pone.0148035			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815309	Green Published, gold			2022-12-27	WOS:000369528200069
J	Wu, YJ; Chen, WS; Chen, HS; Zhang, LL; Chang, Y; Yan, SX; Dai, X; Ma, Y; Huang, Q; Wei, W				Wu, Yujing; Chen, Wensheng; Chen, Hengshi; Zhang, Lingling; Chang, Yan; Yan, Shangxue; Dai, Xing; Ma, Yang; Huang, Qiong; Wei, Wei			The Elevated Secreted Immunoglobulin D Enhanced the Activation of Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis	PLOS ONE			English	Article							ADJUVANT-INDUCED ARTHRITIS; B-CELLS; T-CELLS; TACI-IG; EXPRESSION; RECEPTORS; LYMPHOCYTES; RESPONSES; SIGNALS; TARGETS	Immunoglobulin D (IgD) is a surface immunoglobulin that is expressed as either membrane IgD (mIgD) or secreted IgD (sIgD). Researchers have shown that sIgD is often elevated in patients with autoimmune diseases. The possible roles of sIgD on the function of peripheral blood mononuclear cells (PBMCs) in rheumatoid arthritis (RA) are still unclear. In this study, we compared the expression of sIgD, mIgD and IgD receptor (IgDR) in RA patients and healthy controls, and investigated the effect of sIgD on the function of PBMCs. We found that the levels of sIgD, mIgD and IgDR were significantly higher in RA patients compared with healthy controls. The concentrations of sIgD were positively correlated with soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), rheumatoid factor (RF) and C-reactive protein (CRP) in RA patients. Strikingly, IgD could enhance the proliferation of PBMCs and induce IL-1 alpha, IL-1 beta, TNF-alpha, IL-6 and IL-10 production from PBMCs. Moreover, the percentage of activated T cell subsets (CD4(+) CD69(+), CD4(+) CD154(+)) and activated B cell subsets (CD19(+) CD23(+), CD19(+) CD21(+), CD19(+) IgD(+) and CD19(-)CD138(+)) were increased by IgD. The percentage of unactivated T cell subset (CD4(+) CD62L(+)) and immature B cell subset (CD19(+) IgM(+) IgD(-)) were decreased by IgD in PBMCs. Furthermore, the expressions of IgDR on T and B cells were significantly increased by treatment with IgD. Our results demonstrate that IgD enhanced the activation of PBMCs, which may contribute to RA pathogenesis. Therefore, IgD could be a potential novel immunotherapeutic target for the management of RA.	[Wu, Yujing; Chen, Wensheng; Chen, Hengshi; Zhang, Lingling; Chang, Yan; Yan, Shangxue; Dai, Xing; Ma, Yang; Huang, Qiong; Wei, Wei] Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Anhui Collaborat Innovat Ctr Antiinflammatory & I, Inst Clin Pharmacol,Minist Educ, Hefei 230032, Peoples R China	Anhui Medical University	Huang, Q; Wei, W (corresponding author), Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Anhui Collaborat Innovat Ctr Antiinflammatory & I, Inst Clin Pharmacol,Minist Educ, Hefei 230032, Peoples R China.	qionghuang@126.com; wwei@ahmu.edu.cn	wei, wei/HHR-8613-2022; Huang, Qiong/HGC-7895-2022; zhang, lingling/HDM-2189-2022	Huang, Qiong/0000-0002-0570-5961; 	National Natural Science Foundation of China [81173075, 81330081, 81202596, 81473223, 31200675]; Specialized Research Fund for the Doctoral Program of Higher Education [20113420120006, 20123420110003]; Anhui provincial Natural Science Foundation [1408085QH173]; Program for tackling key problems in science and technology by Anhui Province [1301042098]; China Postdoctoral Science Foundation [2013M540508, 2013M540509]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Program for tackling key problems in science and technology by Anhui Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (No. 81173075; 81330081; 81202596; 81473223; 31200675), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20113420120006; 20123420110003), Anhui provincial Natural Science Foundation (No. 1408085QH173), Program for tackling key problems in science and technology by Anhui Province (No. 1301042098) and China Postdoctoral Science Foundation (No. 2013M540508; 2013M540509).	Alghasham A, 2014, AUTOIMMUNITY, V47, P77, DOI 10.3109/08916934.2013.873413; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bluml S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3906; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chang Y, 2011, RHEUMATOLOGY, V50, P862, DOI 10.1093/rheumatology/keq404; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; COICO RF, 1988, IMMUNOL REV, V105, P45, DOI 10.1111/j.1600-065X.1988.tb00765.x; COICO RF, 1985, NATURE, V316, P744, DOI 10.1038/316744a0; COICO RF, 1990, J IMMUNOL, V145, P3556; Dai X, 2016, IMMUNOL RES, V64, P978, DOI 10.1007/s12026-015-8777-3; Enders A, 2014, P NATL ACAD SCI USA, V111, P4513, DOI 10.1073/pnas.1402739111; Furst DE, 2014, RHEUMATOLOGY, V53, P1560, DOI 10.1093/rheumatology/ket414; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Kim KW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0563-z; Kloesch B, 2013, INT IMMUNOPHARMACOL, V15, P400, DOI 10.1016/j.intimp.2013.01.003; Nguyen TG, 2014, IMMUNOL LETT, V161, P157, DOI 10.1016/j.imlet.2014.06.007; Nguyen TG, 2010, J AUTOIMMUN, V35, P86, DOI 10.1016/j.jaut.2010.03.003; Norvell A, 1996, J IMMUNOL, V156, P1328; Raza K, 2006, BEST PRACT RES CL RH, V20, P849, DOI 10.1016/j.berh.2006.05.005; Rogers KA, 2006, IMMUNOLOGY, V118, P88, DOI 10.1111/j.1365-2567.2006.02345.x; ROSTENBERG I, 1978, CLIN CHIM ACTA, V85, P319, DOI 10.1016/0009-8981(78)90310-8; SCHMIDT K, 1973, Z IMMUNITATSFORSCH, V145, P385; SJOBERG O, 1980, SCAND J IMMUNOL, V11, P377, DOI 10.1111/j.1365-3083.1980.tb00003.x; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Tamma SML, 2001, CELL IMMUNOL, V207, P110, DOI 10.1006/cimm.2000.1747; Tanaka H, 2013, CLIN EXP IMMUNOL, V174, P364, DOI 10.1111/cei.12193; Trujillo MA, 2003, DNA CELL BIOL, V22, P525, DOI 10.1089/10445490360708937; VANVOLLENHOVEN RF, 1989, J AUTOIMMUN, V2, P259, DOI 10.1016/0896-8411(89)90268-0; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Wang D, 2013, J CELL MOL MED, V17, P1577, DOI 10.1111/jcmm.12128; Wang P, 2012, SCI CHINA LIFE SCI, V55, P219, DOI 10.1007/s11427-012-4301-3; Wu Y, 1999, CELL IMMUNOL, V192, P194, DOI 10.1006/cimm.1998.1453; Xie X, 2014, EXPERT OPIN BIOL TH, V14, P157, DOI 10.1517/14712598.2014.859672; Xu BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044719; Zhang LL, 2013, EUR J PHARMACOL, V708, P113, DOI 10.1016/j.ejphar.2013.02.025	36	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147788	10.1371/journal.pone.0147788	http://dx.doi.org/10.1371/journal.pone.0147788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26814717	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200052
J	Gutierrez-Zapata, DM; Galeano-Vasco, LF; Ceron-Munoz, MF				Maria Gutierrez-Zapata, Diana; Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario			Semiparametric Modeling of Daily Ammonia Levels in Naturally Ventilated Caged-Egg Facilities	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; ATMOSPHERIC AMMONIA; AIR-POLLUTION; BROILER PRODUCTION; DAILY MORTALITY; EMISSIONS; PERFORMANCE; NITROGEN; GASES; DUST	Ammonia concentration (AMC) in poultry facilities varies depending on different environmental conditions and management; however, this is a relatively unexplored subject in Colombia (South America). The objective of this study was to model daily AMC variations in a naturally ventilated caged-egg facility using generalized additive models. Four sensor nodes were used to record AMC, temperature, relative humidity and wind speed on a daily basis, with 10 minute intervals for 12 weeks. The following variables were included in the model: Heat index, Wind, Hour, Location, Height of the sensor to the ground level, and Period of manure accumulation. All effects included in the model were highly significant (p<0.001). The AMC was higher during the night and early morning when the wind was not blowing (0.0 m/s) and the heat index was extreme. The average and maximum AMC were 5.94 +/- 3.83 and 31.70 ppm, respectively. Temperatures above 25 degrees C and humidity greater than 80% increased AMC levels. In naturally ventilated caged-egg facilities the daily variations observed in AMC primarily depend on cyclic variations of the environmental conditions and are also affected by litter handling (i.e., removal of the bedding material).	[Maria Gutierrez-Zapata, Diana] Univ Antioquia, Fac Ciencias Exactas & Nat, Medellin, Antioquia, Colombia; [Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia; [Maria Gutierrez-Zapata, Diana; Fernando Galeano-Vasco, Luis; Fernando Ceron-Munoz, Mario] Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Gutierrez-Zapata, DM (corresponding author), Univ Antioquia, Fac Ciencias Exactas & Nat, Medellin, Antioquia, Colombia.; Gutierrez-Zapata, DM (corresponding author), Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia.	grupogamma@udea.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625	Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia [E01533]; Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA projects	Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia; Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA projects	The authors acknowledge the support of the Comite para el Desarrollo de la Investigacion (Committee for Research Development) CODI of Universidad de Antioquia through the E01533 "Design and validation of decision support systems for commercial-egg poultry farms" and the Estrategia de Sostenibilidad (Sustainability Strategy) CODI-UdeA 2016 projects granted to GaMMA research group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrin M, 2005, ATMOS ENVIRON, V39, P2145, DOI 10.1016/j.atmosenv.2004.12.020; Alencar M do CB de, 2004, Rev. Bras. Cienc. Avic., V6, P23, DOI 10.1590/S1516-635X2004000100004; Osorio JA, 2009, DYNA-COLOMBIA, V76, P89; Alloui N., 2013, J WORLDS POULT RES, V3, P54; ALMASHHADANI EH, 1985, POULTRY SCI, V64, P2056, DOI 10.3382/ps.0642056; ANDERSON DP, 1964, AVIAN DIS, V8, P369, DOI 10.2307/1587967; [Anonymous], 1992, OCCUPATIONAL SAFETY, P1; Atapattu NSBM, 2008, POULTRY SCI, V87, P2436, DOI 10.3382/ps.2007-00320; Beker A, 2004, J APPL POULTRY RES, V13, P5, DOI 10.1093/japr/13.1.5; Calvet S, 2011, POULTRY SCI, V90, P534, DOI 10.3382/ps.2010-01037; Carey JB, 2004, J APPL POULTRY RES, V13, P509, DOI 10.1093/japr/13.3.509; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Cheng WH, 2011, ENVIRON ENG SCI, V28, P283, DOI 10.1089/ees.2010.0205; Clark M., 2013, GEN ADDITIVE MODELS; DEATON JW, 1982, POULTRY SCI, V61, P1815, DOI 10.3382/ps.0611815; DEATON JW, 1984, POULTRY SCI, V63, P384, DOI 10.3382/ps.0630384; Diaz Z, 2013, MODELOS ADITIVOS GEN; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Donham Kelley J, 2002, J Agromedicine, V8, P57, DOI 10.1300/J096v08n02_09; Estelles F, 2010, BIOSYST ENG, V107, P16, DOI 10.1016/j.biosystemseng.2010.06.007; Fairley D, 1999, ENVIRON HEALTH PERSP, V107, P637, DOI 10.2307/3434455; Fidanci UR, 2010, J ANIM VET ADV, V9, P346; Fiedler AM, 2011, METEOROL Z, V20, P59, DOI 10.1127/0941-2948/2011/0490; Fiedler M, 2014, ENVIRON ENG MANAG J, V13, P2193, DOI 10.30638/eemj.2014.244; Food and Agriculture Organization of the United Nations (FAO), 2011, RUR STRUCT TROP DES; Green AR, 2009, T ASABE, V52, P2027, DOI 10.13031/2013.29204; Green AR, 2009, J APPL POULTRY RES, V18, P605, DOI 10.3382/japr.2007-00086; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gyldenkaerne S, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005459; Harper LA, 2010, POULTRY SCI, V89, P1802, DOI 10.3382/ps.2010-00718; Harper LA, 2005, AMMONIA MEASUREMENT; Hastie T., 1986, STAT SCI, V1, P297; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Kilic I, 2013, J ANIM VET ADV, V12, P42; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Li LF, 2013, ENVIRON SCI TECHNOL, V47, P9291, DOI 10.1021/es401281r; Liang Y, 2004, 2004 ASAE CSAE ANN I; Mendes LB, 2015, BIOSYST ENG, V129, P360, DOI 10.1016/j.biosystemseng.2014.11.011; Miles DM, 2011, POULTRY SCI, V90, P1162, DOI 10.3382/ps.2010-01113; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; National Research Council (NRC), 2003, AIR EM AN FEED OP CU, P225; Neijat M, 2011, POULTRY SCI, V90, P543, DOI 10.3382/ps.2010-01069; Nimmermark S, 2009, ANN AGR ENV MED, V16, P103; O'Shaughnessy P T, 2002, J Agric Saf Health, V8, P349; Patterson PH, 2005, J APPL POULTRY RES, V14, P638, DOI 10.1093/japr/14.3.638; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay TO, 2003, EPIDEMIOLOGY, V14, P18, DOI 10.1097/00001648-200301000-00009; Reina Jhovana, 2012, Rev.EIA.Esc.Ing.Antioq, P19; Richards R, 2014, J COASTAL RES, V30, P1321, DOI 10.2112/JCOASTRES-D-12-00190.1; Ritz CW, 2004, J APPL POULTRY RES, V13, P684, DOI 10.1093/japr/13.4.684; Rumburg BP, 2006, DIFFERENTIAL OPTICAL; Schoen C, 2005, J APPL METEOROL, V44, P1413, DOI 10.1175/JAM2285.1; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Seedorf J, 1999, J AGR SCI, V133, P433, DOI 10.1017/S0021859699007170; Singh A, 2009, J APPL POULTRY RES, V18, P34, DOI 10.3382/japr.2008-00046; Staelens J, 2012, ATMOS ENVIRON, V49, P186, DOI 10.1016/j.atmosenv.2011.11.065; Terzi Y, 2009, SCI RES ESSAYS, V4, P867; The National Chicken Council (NCC), 2014, NAT CHICK COUNC AN W; Tinoco IFF, 2001, REV BRAS CIENC AVIC, V3; Tobias A., 2004, TIME SERIES REGRESSI; U. S. Department of Health and Human Services (DHHS), 2004, TOX PROF AMM; United Egg Producers (UEP), 2010, AN HUSB GUID US EGG; United States Environmental Protection Agency (EPA), 2004, NAT EM INV IN PRESS, P131; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wang YM, 2010, J ANIM VET ADV, V9, P2802, DOI 10.3923/javaa.2010.2802.2806; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Xin H, 2011, EMERGING ISSUES SOCI, P1; Xin H, 2004, P MIDW POULTR FED CO; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Yang P, 2000, T ASAE, V43, P1771, DOI 10.13031/2013.3080; Yang P, 2002, ASAE ANN M AM SOC AG; Zhang G, 2005, BIOSYST ENG, V92, P355, DOI 10.1016/j.biosystemseng.2005.08.002; Zhang K, 2010, ATMOS ENVIRON, V44, P1740, DOI 10.1016/j.atmosenv.2010.02.008; Zhao Y, 2015, POULTRY SCI, V94, P518, DOI 10.3382/ps/peu076; Zhao Y, 2013, T ASABE, V56, P1145; Zhu Z, 2011, T ASABE, V54, P1085, DOI 10.13031/2013.37100	77	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147135	10.1371/journal.pone.0147135	http://dx.doi.org/10.1371/journal.pone.0147135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812150	gold, Green Published			2022-12-27	WOS:000369528000020
J	Blanco-Heredia, J; Lecanda, A; Valenzuela-Ponce, H; Brander, C; Avila-Rios, S; Reyes-Teran, G				Blanco-Heredia, Juan; Lecanda, Aaron; Valenzuela-Ponce, Humberto; Brander, Christian; Avila-Rios, Santiago; Reyes-Teran, Gustavo			Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naive HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESTRICTED IMMUNE-RESPONSES; ORIGINAL ANTIGENIC SIN; I ALLELE PROMISCUITY; SELECTIVE PRESSURES; VARIANT EPITOPES; THERAPY; PERSISTENCE	Background Therapeutic HIV vaccines may prove helpful to intensify antiretroviral treatment (ART) efficacy and may be an integral part of future cure strategies. Methods We examined IFN-gamma ELISpot responses to a panel of 218 HIV clade B consensus-based HIV protease-reverse transcriptase peptides, designed to mimic previously described and predicted cytotoxic T lymphocyte epitopes overlapping drug resistance (DR) positions, that either included the consensus sequence or the DR variant sequence, in 49 ART-naive HIV-infected individuals. Next generation sequencing was used to assess the presence of minority DR variants in circulating viral populations. Results Although a wide spectrum of differential magnitudes of response to DR vs. WT peptide pairs was observed, responses to DR peptides were frequent and strong in the study cohort. No difference between the median magnitudes of response to DR vs. WT peptides was observed. Interestingly, of the 22 peptides that were recognized by > 15% of the participants, two-thirds (64%) corresponded to DR peptides. When analysing responses per peptide pair per individual, responses to only WT (median 4 pairs/individual) or DR (median 6 pairs/individual) were more common than responses to both WT and DR (median 2 pairs/individual; p< 0.001). While the presence of ELISpot responses to WT peptides was frequently associated with the presence of the corresponding peptide sequence in the patient's virus (mean 68% of cases), responses to DR peptides were generally not associated with the presence of DR mutations in the viral population, even at low frequencies (mean 1.4% of cases; p = 0.0002). Conclusions Our data suggests that DR peptides are frequently immunogenic and raises the potential benefit of broadening the antigens included in a therapeutic vaccine approach to immunogenic epitopes containing common DR sequences. Further studies are needed to assess the quality of responses elicited by DR peptides.	[Blanco-Heredia, Juan; Lecanda, Aaron; Valenzuela-Ponce, Humberto; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Infect Dis Res, Mexico City, DF, Mexico; [Lecanda, Aaron] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona, Spain; [Brander, Christian] Inst Catalana Recerca & Estudis Avancats ICREA UA, Barcelona, Spain; [Brander, Christian] Univ Vic & Cent Catalonia, Vic, Spain	Max Planck Society; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Avila-Rios, S; Reyes-Teran, G (corresponding author), Natl Inst Resp Dis, Ctr Infect Dis Res, Mexico City, DF, Mexico.	santiago.avila@cieni.org.mx; gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020	Reyes-Teran, Gustavo/0000-0002-4115-4888	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT [SALUD-2013-01-202475]; National Council of Science and Technology (CONACyT) [229424]; National Autonomous University of Mexico (UNAM); ICREA Funding Source: Custom	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Autonomous University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); ICREA(ICREA)	This work was supported by grants by the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI and Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana), CONACYT (SALUD-2013-01-202475). JBH received a scholarship by the National Council of Science and Technology (CONACyT; Scholarship No. 229424) and the National Autonomous University of Mexico (UNAM).	Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Avila-Rios S, 2007, MED HYPOTHESES, V69, P422, DOI 10.1016/j.mehy.2006.12.012; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Avila-Rios S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-72; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Chakradhar S, 2015, NAT MED, V21, P540, DOI 10.1038/nm0615-540; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harrer T, 2014, VACCINE, V32, P2657, DOI 10.1016/j.vaccine.2013.10.030; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Ji H, 2013, CAN J INFECT DIS MED; John M, 2005, ANTIVIR THER, V10, P551; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; LANL, 2015, LOS AL HIV IMM DAT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019; Mothe B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0392-5; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Nixon DF, 1999, IMMUNOL LETT, V66, P219, DOI 10.1016/S0165-2478(98)00162-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Stnford University, 2015, HIV DRUG RES DAT; Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147571	10.1371/journal.pone.0147571	http://dx.doi.org/10.1371/journal.pone.0147571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808823	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800137
J	Chiou, SY; Gottardi, SEA; Hodges, PW; Strutton, PH				Chiou, Shin-Yi; Gottardi, Sam E. A.; Hodges, Paul W.; Strutton, Paul H.			Corticospinal Excitability of Trunk Muscles during Different Postural Tasks	PLOS ONE			English	Article							LOW-BACK-PAIN; ERECTOR SPINAE MUSCLES; MOTOR-EVOKED-POTENTIALS; VOLUNTARY ARM MOVEMENTS; TRANSCRANIAL MAGNETIC STIMULATION; TRANSVERSUS ABDOMINIS; FLEXION MOVEMENTS; BALANCE-RECOVERY; CORTICAL CONTROL; REACTION-TIME	Evidence suggests that the primary motor cortex (M1) is involved in both voluntary, goal-directed movements and in postural control. Trunk muscles are involved in both tasks, however, the extent to which M1 controls these muscles in trunk flexion/extension (voluntary movement) and in rapid shoulder flexion (postural control) remains unclear. The purpose of this study was to investigate this question by examining excitability of corticospinal inputs to trunk muscles during voluntary and postural tasks. Twenty healthy adults participated. Transcranial magnetic stimulation was delivered to the M1 to examine motor evoked potentials (MEPs) in the trunk muscles (erector spinae (ES) and rectus abdominis (RA)) during dynamic shoulder flexion (DSF), static shoulder flexion (SSF), and static trunk extension (STE). The level of background muscle activity in the ES muscles was matched across tasks. MEP amplitudes in ES were significantly larger in DSF than in SSF or in STE; however, this was not observed for RA. Further, there were no differences in levels of muscle activity in RA between tasks. Our findings reveal that corticospinal excitability of the ES muscles appears greater during dynamic anticipatory posture-related adjustments than during static tasks requiring postural (SSF) and goal-directed voluntary (STE) activity. These results suggest that task-oriented rehabilitation of trunk muscles should be considered for optimal transfer of therapeutic effect to function.	[Chiou, Shin-Yi; Gottardi, Sam E. A.; Strutton, Paul H.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Fac Med,Nick Davy Lab, Dept Surg & Canc,Div Surg,Human Performance Grp, London, England; [Hodges, Paul W.] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Imperial College London; University of Queensland	Strutton, PH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Fac Med,Nick Davy Lab, Dept Surg & Canc,Div Surg,Human Performance Grp, London, England.	p.strutton@imperial.ac.uk	Hodges, Paul W/B-6578-2008	Hodges, Paul W/0000-0002-1206-9107	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	PH is funded by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia.	Aranyi Z, 1998, MUSCLE NERVE, V21, P1309, DOI 10.1002/(SICI)1097-4598(199810)21:10<1309::AID-MUS10>3.0.CO;2-X; Aruin AS, 1998, ELECTROMYOGR MOTOR C, V109, P350, DOI 10.1016/S0924-980X(98)00029-0; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Aruin AS, 1996, ELECTROMYOGR MOTOR C, V101, P497, DOI 10.1016/S0013-4694(96)95219-4; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Bard P, 1933, ARCH NEUROL PSYCHIAT, V30, P35; BELEN'KII V. E., 1967, BIOFIZIKA, V12, P135; Benvenuti F, 1997, BRAIN RES, V761, P59, DOI 10.1016/S0006-8993(97)00260-6; CHAN CWY, 1979, ELECTROEN CLIN NEURO, V46, P173, DOI 10.1016/0013-4694(79)90066-X; Chen R, 1999, CAN J NEUROL SCI, V26, P163, DOI 10.1017/S0317167100000196; Chiou SY, 2014, EUR J PAIN, V18, P794, DOI 10.1002/j.1532-2149.2013.00428.x; CLAUS D, 1990, MUSCLE NERVE, V13, P1125, DOI 10.1002/mus.880131207; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; COTTINGHAM SL, 1988, EXP BRAIN RES, V73, P198, DOI 10.1007/BF00279673; D'hooge R, 2013, J ELECTROMYOGR KINES, V23, P173, DOI 10.1016/j.jelekin.2012.09.003; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Davey NJ, 2002, SPINE, V27, P1355, DOI 10.1097/00007632-200206150-00019; Deliagina TG, 2008, BRAIN RES REV, V57, P212, DOI 10.1016/j.brainresrev.2007.06.017; Dettmers C, 1996, NEUROREPORT, V7, P2103, DOI 10.1097/00001756-199609020-00008; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; FERBERT A, 1992, ELECTROEN CLIN NEURO, V85, P382, DOI 10.1016/0168-5597(92)90051-C; FRIEDLI WG, 1984, J NEUROL NEUROSUR PS, V47, P611, DOI 10.1136/jnnp.47.6.611; FRIEDLI WG, 1988, J NEUROL NEUROSUR PS, V51, P232, DOI 10.1136/jnnp.51.2.232; GAHERY Y, 1978, BRAIN RES, V149, P25, DOI 10.1016/0006-8993(78)90585-1; Galea MP, 2010, J NEUROSCI, V30, P858, DOI 10.1523/JNEUROSCI.4859-09.2010; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hodges P, 1999, EXP BRAIN RES, V124, P69, DOI 10.1007/s002210050601; Hodges PW, 1997, EXP BRAIN RES, V114, P362, DOI 10.1007/PL00005644; Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; Hodges PW, 2001, EXP BRAIN RES, V138, P243, DOI 10.1007/s002210100693; Jacobs JV, 2010, CLIN NEUROPHYSIOL, V121, P431, DOI 10.1016/j.clinph.2009.11.076; Kouchtir-Devanne N, 2012, J NEUROPHYSIOL, V107, P1522, DOI 10.1152/jn.00786.2011; Kuppuswamy A, 2008, GAIT POSTURE, V27, P478, DOI 10.1016/j.gaitpost.2007.06.001; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; Luu B, 2007, IBRO WORLD C NEUR SA; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; Masakado Y, 2008, Electromyogr Clin Neurophysiol, V48, P27; Masakado Yoshihisa, 2008, Keio Journal of Medicine, V57, P50, DOI 10.2302/kjm.57.50; Masse-Alarie H, 2012, EXP BRAIN RES, V218, P99, DOI 10.1007/s00221-012-3008-9; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Metman Leo Verhagen, 1993, Brain Topography, V6, P13, DOI 10.1007/BF01234122; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Nowicky AV, 2001, MOTOR CONTROL, V5, P270, DOI 10.1123/mcj.5.3.270; ODDSSON L, 1986, ACTA PHYSIOL SCAND, V128, P341, DOI 10.1111/j.1748-1716.1986.tb07987.x; Penfield W, 1937, BRAIN, V60, P55; Petersen TH, 2009, EXP BRAIN RES, V193, P161, DOI 10.1007/s00221-008-1603-6; Poortvliet PC, 2015, EXP BRAIN RES, V233, P3447, DOI 10.1007/s00221-015-4404-8; Quant S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-18; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Schieppati M, 1996, J PHYSIOL-LONDON, V491, P551, DOI 10.1113/jphysiol.1996.sp021239; Schneider C, 2004, J APPL PHYSIOL, V97, P2220, DOI 10.1152/japplphysiol.00542.2004; Soto O, 2006, J NEUROPHYSIOL, V96, P1711, DOI 10.1152/jn.00133.2006; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Tani T, 1997, ELECTROMYOGR MOTOR C, V105, P194, DOI 10.1016/S0924-980X(97)00017-9; Taniguchi S, 1999, SPINE, V24, P154, DOI 10.1097/00007632-199901150-00014; THORSTENSSON A, 1985, ACTA PHYSIOL SCAND, V125, P309, DOI 10.1111/j.1748-1716.1985.tb07721.x; TRAUB MM, 1980, BRAIN, V103, P393, DOI 10.1093/brain/103.2.393; Tsao H, 2011, NEUROSCIENCE, V181, P127, DOI 10.1016/j.neuroscience.2011.02.033; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; Tsao H, 2011, CLIN NEUROPHYSIOL, V122, P1580, DOI 10.1016/j.clinph.2011.01.048; Tunstill SA, 2001, EXP PHYSIOL, V86, P131, DOI 10.1113/eph8602071; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; VIALLET F, 1992, EXP BRAIN RES, V88, P674; Zedka M, 1999, J PHYSIOL-LONDON, V520, P591, DOI 10.1111/j.1469-7793.1999.00591.x	73	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147650	10.1371/journal.pone.0147650	http://dx.doi.org/10.1371/journal.pone.0147650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807583	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800168
J	Dawson-Hahn, EE; Pak-Gorstein, S; Hoopes, AJ; Matheson, J				Dawson-Hahn, Elizabeth E.; Pak-Gorstein, Suzinne; Hoopes, Andrea J.; Matheson, Jasmine			Comparison of the Nutritional Status of Overseas Refugee Children with Low Income Children in Washington State	PLOS ONE			English	Article							UNITED-STATES; OVERWEIGHT; UNDERNUTRITION; COUNTRIES	Introduction The extent that the dual burden of undernutrition and overnutrition affects refugee children before resettlement in the US is not well described. Objective To describe the prevalence of wasting, stunting, overweight, and obesity among refugee children ages 0-10 years at their overseas medical screening examination prior to resettlement in Washington State (WA), and to compare the nutritional status of refugee children with that of low-income children in WA. Methods We analyzed anthropometric measurements of 1047 refugee children ages 0-10 years old to assess their nutritional status at the overseas medical screening examination prior to resettlement in WA from July 2012-June 2014. The prevalence estimates of the nutritional status categories were compared by country of origin. In addition, the nutritional status of refugee children age 0-5 years old were compared to that of low-income children in WA from the Center for Disease Control and Prevention's Pediatric Nutrition Surveillance System. Results A total of 982 children were eligible for the study, with the majority (65%) from Somalia, Iraq and Burma. Overall, nearly one-half of all refugee children had at least one form of malnutrition (44.9%). Refugee children ages 0-10 years were affected by wasting (17.3%), stunting 20.1%), overweight (7.6%) and obesity (5.9%). Among children 0-5 years old, refugee children had a significantly higher prevalence of wasting (14.3% versus 1.9%, p<0.001) and stunting (21.3% versus 5.5%, p<0.001), and a lower prevalence of obesity (6.2% versus 12.9%, p<0.001) than low-income children in WA. Conclusion The dual burden of under-and over-nutrition among incoming refugee children as well as their overall difference in prevalence of nutritional status categories compared to low-income children in WA provides evidence for the importance of tailored interventions to address the nutritional needs of refugee children.	[Dawson-Hahn, Elizabeth E.; Pak-Gorstein, Suzinne] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dawson-Hahn, Elizabeth E.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Pak-Gorstein, Suzinne] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hoopes, Andrea J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Matheson, Jasmine] Washington State Dept Hlth, Off Communicable Dis Epidemiol, Refugee Hlth Program, Shoreline, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Dawson-Hahn, EE (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Dawson-Hahn, EE (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA.	eedh@uw.edu		Dawson-Hahn, Elizabeth/0000-0003-3176-8461; Pak-Gorstein, Suzinne/0000-0002-6194-895X	National Institutes of Health Ruth L. Kirschstein National Research Service award [T32HP10002]; Center for Diversity and Health Equity at Seattle Children's Hospital; Biostatistics, Epidemiology, Econometrics and Programming Core stimulus funding of the Center for Child Health, Behavior and Development at the Seattle Children's Research Institute	National Institutes of Health Ruth L. Kirschstein National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Diversity and Health Equity at Seattle Children's Hospital; Biostatistics, Epidemiology, Econometrics and Programming Core stimulus funding of the Center for Child Health, Behavior and Development at the Seattle Children's Research Institute	Dr. Dawson-Hahn is supported by the National Institutes of Health Ruth L. Kirschstein National Research Service award, T32HP10002 (https:// researchtraining.nih.gov/programs/training-grants/T32), a grant from the Center for Diversity and Health Equity at Seattle Children's Hospital (http://www.seattlechildrens.org/about/diversity/), and the Biostatistics, Epidemiology, Econometrics and Programming Core stimulus funding of the Center for Child Health, Behavior and Development at the Seattle Children's Research Institute (http://www.seattlechildrens.org/research/). The Seattle Children's Research Institute received an honorarium from the Migration Policy Institute to develop and disseminate this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilukha OO, 2014, NUTR STATUS WOMEN CH; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Centers for Disease Control and Prevention, 2012, TECHN INSTR PAN PHYS; Centers for Disease Control and Prevention, 2014, GUID US DOM MED EX N; Centers for Disease Control and Prevention, 2012, PED NUTR SURV SYST 2; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Guam Police Department, 2013, CITIZEN CENTRIC REPO; Gushulak BD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-3; Helfrecht C, 2016, AM J HUM BIOL, V28, P159, DOI 10.1002/ajhb.22763; Heney JH, 2013, R I MED J, V98, P43; Hervey K, 2009, J HEALTH CARE POOR U, V20, P246, DOI 10.1353/hpu.0.0118; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; International Organization for Migration, 2013, NUTR SUV REP; Kelsey MM, 2014, GERONTOLOGY, V60, P222, DOI 10.1159/000356023; Kuczmarski R J, 2000, Adv Data, P1; Lutfy C, 2014, J IMMIGR MINOR HEALT, V16, P1016, DOI 10.1007/s10903-013-9796-6; Martin D. C., 2014, REFUGEES ASYLEES 201; Martin DC, 2013, REFUGEES ASYLEES 201; Mei ZG, 2008, J PEDIATR-US, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Mitchell T, 2012, PEDIATRICS, V129, pE392, DOI 10.1542/peds.2011-1218; Olson CK, 2013, HLTH CONSIDERATIONS; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Renzaho AMN, 2006, ASIA PAC J CLIN NUTR, V15, P482; Shah AY, 2014, J IMMIGR MINOR HEALT, V16, P959, DOI 10.1007/s10903-013-9867-8; Shuangyan Qiu, 2015, INV HLTH CAR CHILDR; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; United Nations High Commissioner for Refugees, 2015, UNHCR GLOB TRENDS FO; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2010, WHO ANTHR PERS COMP; World Health Organization, 2012, POP BAS APPR CHILDH; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Yanni EA, 2013, J IMMIGR MINOR HEALT, V15, P1, DOI 10.1007/s10903-012-9578-6; Yun K, 2016, AM J PUBLIC HEALTH, V106, P128, DOI 10.2105/AJPH.2015.302873	35	20	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147854	10.1371/journal.pone.0147854	http://dx.doi.org/10.1371/journal.pone.0147854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808275	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800230
J	Hong, AR; Kim, JH; Song, YS; Lee, KE; Seo, SH; Seong, MW; Shin, CS; Kim, SW; Kim, SY				Hong, A. Ram; Kim, Jung Hee; Song, Young Shin; Lee, Kyu Eun; Seo, Soo Hyun; Seong, Moon-Woo; Shin, Chan Soo; Kim, Sang Wan; Kim, Seong Yeon			Genetics of Aldosterone-Producing Adenoma in Korean Patients	PLOS ONE			English	Article							K+ CHANNEL MUTATIONS; SOMATIC MUTATIONS; KCNJ5 MUTATIONS; HYPERTENSION; PREVALENCE; EXPRESSION; POTASSIUM; DIAGNOSIS; ATP1A1; ATP2B3	Objectives Recently, somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes were found to be associated with the pathogenesis of aldosterone-producing adenoma (APA). This study aimed to investigate the prevalence of somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D and examine the correlations between these mutations and the clinical and biochemical characteristics in Korean patients with APA. Methods We performed targeted gene sequencing in 66 patients with APA to detect somatic mutations in these genes. Results Somatic KCNJ5 mutations were found in 47 (71.2%) of the 66 patients with APA (31 cases of p. G151R and 16 cases of p. L168R); these two mutations were mutually exclusive. Somatic mutations in the ATP1A1, ATP2B3, and CACNA1D genes were not observed. Somatic KCNJ5 mutations were more prevalent in female patients (66% versus 36.8%, respectively; P = 0.030). Moreover, patients with KCNJ5 mutations comprised a significantly higher proportion of patients younger than 35 years of age (19.1% versus 0%, respectively; P = 0.040). There were no significant differences in pre-operative blood pressure, plasma aldosterone, serum potassium, lateralization index, and adenoma size according to mutational status. Patients with KCNJ5 mutations were less likely to need antihypertensive medications after adrenalectomy compared with those without mutation (36.2% versus 63.2%; P = 0.045). Conclusions The present study demonstrated the high prevalence of somatic KCNJ5 mutations in Korean patients with APA. Carriers of somatic KCNJ5 mutations were more likely to be female. Early diagnosis and better therapeutic outcomes were associated with somatic KCNJ5 mutations in APA.	[Hong, A. Ram; Kim, Jung Hee; Song, Young Shin; Shin, Chan Soo; Kim, Sang Wan; Kim, Seong Yeon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Kyu Eun] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Seo, Soo Hyun; Seong, Moon-Woo] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Sang Wan] Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SW; Kim, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Kim, SW (corresponding author), Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	seongyk@plaza.snu.ac.kr; swkimmd@snu.ac.kr	Kim, Jung Hee/AAG-1191-2019; Kim, Sang Wan/J-5399-2012	Kim, Jung Hee/0000-0003-1932-0234; Kim, Sang Wan/0000-0001-9561-9110; Seong, Moon-Woo/0000-0003-2954-3677	Seoul National University Hospital [3020140290]; Seoul Metropolitan Government Boramae Medical Center [26-2015-18]	Seoul National University Hospital; Seoul Metropolitan Government Boramae Medical Center	This study was supported by grant 3020140290 (2014-3283) to SYK from Seoul National University Hospital (http://www.snuh.org) and grant 26-2015-18 to SWK from Seoul Metropolitan Government Boramae Medical Center(http://www.brmh.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Fernandes-Rosa FL, 2014, HYPERTENSION, V64, P354, DOI 10.1161/HYPERTENSIONAHA.114.03419; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Gomez-Sanchez CE, 2014, ENDOCRINOLOGY, V155, P47, DOI 10.1210/en.2013-1733; Han JY, 2014, LUNG CANCER, V85, P161, DOI 10.1016/j.lungcan.2014.04.009; Kitamoto T, 2015, J ATHEROSCLER THROMB, V22, P191, DOI 10.5551/jat.24455; Kuppusamy M, 2014, J CLIN ENDOCR METAB, V99, pE1765, DOI 10.1210/jc.2014-1927; Lenzini L, 2015, J CLIN ENDOCR METAB, V100, pE1089, DOI 10.1210/jc.2015-2149; Monticone S, 2012, J CLIN ENDOCR METAB, V97, pE1567, DOI 10.1210/jc.2011-3132; Mulatero P, 2013, NAT REV ENDOCRINOL, V9, P104, DOI 10.1038/nrendo.2012.230; Mulatero P, 2009, CURR HYPERTENS REP, V11, P217, DOI 10.1007/s11906-009-0038-1; Oki K, 2012, ENDOCRINOLOGY, V153, P1774, DOI 10.1210/en.2011-1733; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Seccia TM, 2012, J CLIN ENDOCR METAB, V97, pE2307, DOI 10.1210/jc.2012-2342; Taguchi R, 2012, J CLIN ENDOCR METAB, V97, P1311, DOI 10.1210/jc.2011-2885; Wang BJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000708; Williams TA, 2015, HYPERTENSION, V65, P507, DOI 10.1161/HYPERTENSIONAHA.114.04636; Williams TA, 2014, HYPERTENSION, V63, P188, DOI 10.1161/HYPERTENSIONAHA.113.01733; Wu VC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11396; Zhang WQ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S11-S6; Zheng FF, 2015, HYPERTENSION, V65, P622, DOI 10.1161/HYPERTENSIONAHA.114.03346	26	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147590	10.1371/journal.pone.0147590	http://dx.doi.org/10.1371/journal.pone.0147590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807823	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800142
J	Hong, T; Mitchell, P; Burlutsky, G; Liew, G; Wang, JJ				Hong, Thomas; Mitchell, Paul; Burlutsky, George; Liew, Gerald; Wang, Jie Jin			Visual Impairment, Hearing Loss and Cognitive Function in an Older Population: Longitudinal Findings from the Blue Mountains Eye Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; VISION IMPAIRMENT; DECLINE; DEMENTIA; ADULTS; ACUITY; RISK; MMSE; AGE	The presence of visual impairment (VI) and hearing loss (HL) with may be a marker for subsequent cognitive decline over time in older people. A prospective, longitudinal population-based study of the 3654 participants of the Blue Mountains Eye Study were assessed for the associations between VI and HL and a decline in mini-mental state examination (MMSE) scores over a duration of 10 years from the 5-year (baseline of this report) to the 15-year follow-up visits. MMSE was assessed at the 5-, 10-and 15-year follow-up visits. A decline >= 3 scores from 5-year to 10- or 15-year visits indicated possible cognitive decline. VI was defined as best-corrected visual acuity <6/12 in the worse-eye, HL was defined as pure-tone average >40 decibels in the worse-ear and dual sensory impairment (DSI) was defined by the co-presence of VI and HL, detected at 5-year followup (baseline of this report). Participants with no VI and HL over the same 5- or 10-year corresponding period were controls. Associations of VI, HL and DSI with possible cognitive decline were assessed using logistic regression models adjusting for age and sex after excluding subjects with a stroke history. The presence of VI, HL or DSI was not associated with possible cognitive decline over 5 years (odds ratio (OR) 0.84, 95% confidence-intervals (CI) 0.40-1.79, OR 1.02, 95% CI 0.61-1.70 and 1.41, 95% CI 0.54-3.72, respectively) or 10 years (OR 1.09, 95% CI 0.52-2.30, OR 1.09, 95% CI 0.65-1.82 and 1.15, 95% CI 0.28-4.73, respectively). There were no changes to these findings after adjustment for other potential confounders. Age was significantly associated with possible cognitive decline (OR 1.07, 95% CI 1.04-1.10 for both periods). Neither visual impairment, hearing loss nor dual sensory impairment was independently associated with subsequent decline in cognition.	[Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research	Wang, JJ (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.; Wang, JJ (corresponding author), Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jiejin.wang@sydney.edu.au	Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; Liew, Gerald/AAB-6870-2022; wang, jie/GRS-0942-2022	Wang, Jie Jin/0000-0001-9491-4898; 	National Health and Medical Research Council, Australia [974159, 211069, 457349]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	PM was supported by National Health and Medical Research Council, Australia (grant nos. 974159, 211069, 457349) https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Busse A, 2002, J CLIN EPIDEMIOL, V55, P909, DOI 10.1016/S0895-4356(02)00449-3; Clemons TE, 2006, ARCH OPHTHALMOL-CHIC, V124, P537; Diaz M, 2011, BRIT J OPHTHALMOL, V95, P24, DOI 10.1136/bjo.2010.183459; Dregan A, 2013, AGE AGEING, V42, P338, DOI 10.1093/ageing/afs166; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENNIS V, 1991, ARCH INTERN MED, V151, P2259, DOI 10.1001/archinte.151.11.2259; Gopinath B, 2012, AGE AGEING, V41, P618, DOI 10.1093/ageing/afs058; Hensel A, 2007, J NEUROL NEUROSUR PS, V78, P1298, DOI 10.1136/jnnp.2006.109074; Hong T, 2013, OPHTHALMOLOGY, V120, P2091, DOI 10.1016/j.ophtha.2013.03.032; Jefferis JM, 2012, AGE AGEING, V41, P565, DOI 10.1093/ageing/afs042; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Ong SY, 2012, ARCH OPHTHALMOL; Rait G, 2005, AGE AGEING, V34, P242, DOI 10.1093/ageing/afi039; Reischies FM, 1997, BRIT J PSYCHIAT, V171, P449, DOI 10.1192/bjp.171.5.449; Reyes-Ortiz CA, 2005, J AM GERIATR SOC, V53, P681, DOI 10.1111/j.1532-5415.2005.53219.x; Sachdev PS, 2014, J NEUROL NEUROSUR PS, V63, P1618; Schultz-Larsen K, 2007, J CLIN EPIDEMIOL, V60, P268, DOI 10.1016/j.jclinepi.2006.06.007; Stein J, 2012, ACTA PSYCHIAT SCAND, V126, P208, DOI 10.1111/j.1600-0447.2012.01850.x; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van Boxtel MPJ, 2000, J CLIN EXP NEUROPSYC, V22, P147, DOI 10.1076/1380-3395(200002)22:1;1-8;FT147	27	80	81	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147646	10.1371/journal.pone.0147646	http://dx.doi.org/10.1371/journal.pone.0147646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808979	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800166
J	Michael, BD; Griffiths, MJ; Granerod, J; Brown, D; Davies, NWS; Borrow, R; Solomon, T				Michael, Benedict D.; Griffiths, Michael J.; Granerod, Julia; Brown, David; Davies, Nicholas W. S.; Borrow, Ray; Solomon, Tom			Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HERPES-SIMPLEX ENCEPHALITIS; ACUTE LIMBIC ENCEPHALITIS; CEREBROSPINAL-FLUID; MANIFESTATIONS; MACROPHAGES; MECHANISMS; EXPRESSION; CHILDREN; MARKERS	Background Encephalitis is parenchymal brain inflammation due to infectious or immune-mediated processes. However, in 15-60% the cause remains unknown. This study aimed to determine if the cytokine/chemokine-mediated host response can distinguish infectious from immune-mediated cases, and whether this may give a clue to aetiology in those of unknown cause. Methods We measured 38 mediators in serum and cerebrospinal fluid (CSF) of patients from the Health Protection Agency Encephalitis Study. Of serum from 78 patients, 38 had infectious, 20 immune-mediated, and 20 unknown aetiology. Of CSF from 37 patients, 20 had infectious, nine immune-mediated and eight unknown aetiology. Results Heat-map analysis of CSF mediator interactions was different for infectious and immune-mediated cases, and that of the unknown aetiology group was similar to the infectious pattern. Higher myeloperoxidase (MPO) concentrations were found in infectious than immune-mediated cases, in serum and CSF (p = 0.01 and p = 0.006). Serum MPO was also higher in unknown than immune-mediated cases (p = 0.03). Multivariate analysis selected serum MPO; classifying 31 (91%) as infectious (p = 0.008) and 17 (85%) as unknown (p = 0.009) as opposed to immune-mediated. CSF data also selected MPO classifying 11 (85%) as infectious as opposed to immune-mediated (p = 0.036). CSF neutrophils were detected in eight (62%) infective and one (14%) immune-mediated cases (p = 0.004); CSF MPO correlated with neutrophils (p < 0.0001). Conclusions Mediator profiles of infectious aetiology differed from immune-mediated encephalitis; and those of unknown cause were similar to infectious cases, raising the hypothesis of a possible undiagnosed infectious cause. Particularly, neutrophils and MPO merit further investigation.	[Michael, Benedict D.; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Michael, Benedict D.; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Michael, Benedict D.; Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3BX, Merseyside, England; [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Granerod, Julia; Brown, David] Publ Hlth England, London, England; [Brown, David] Fiocruz MS, Influenza & Measles Lab, IOC, BR-21045900 Rio De Janeiro, Brazil; [Davies, Nicholas W. S.] Chelsea & Westminster NHS Fdn Trust, London, England; [Borrow, Ray] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England	Walton Centre; University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Public Health England; Fundacao Oswaldo Cruz; Imperial College London; Public Health England	Michael, BD (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.; Michael, BD (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.; Michael, BD (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3BX, Merseyside, England.	benmic@liv.ac.uk		Michael, Benedict/0000-0002-8693-8926; Solomon, Tom/0000-0001-7266-6547	NIHR Doctoral Research Fellowship [NIHR-DRF2010-03-97]; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool; MRC; Vaccine Evaluation Unit; Public Health England, Manchester, UK; MRC [G116/194] Funding Source: UKRI; Academy of Medical Sciences (AMS) [SGL015\\1016] Funding Source: researchfish; Medical Research Council [G116/194] Funding Source: researchfish; National Institute for Health Research [IS-HPU-1112-10117, CL-2014-07-002, 12/205/28, 3546, RP-PG-0108-10048, NF-SI-0514-10177, DRF-2010-03-97, ACF-2008-07-001] Funding Source: researchfish	NIHR Doctoral Research Fellowship; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vaccine Evaluation Unit; Public Health England, Manchester, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BDM is an NIHR Academic Clinical Lecturer and this work received support as part of an NIHR Doctoral Research Fellowship (NIHR-DRF2010-03-97). TS received support from the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at Liverpool. TS was also supported by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the laboratory team at the Vaccine Evaluation Unit, Public Health England, Manchester, UK. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	Ambrose HE, 2011, J CLIN MICROBIOL, V49, P3576, DOI 10.1128/JCM.00862-11; Armangue T, 2015, NEUROLOGY, V85, P1736, DOI 10.1212/WNL.0000000000002125; Asaoka K, 2004, INTERNAL MED, V43, P42, DOI 10.2169/internalmedicine.43.42; Baggiolini M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00285; Benjamin LA, 2011, EMERG INFECT DIS, V17, P1484, DOI 10.3201/eid1708.110165; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Boutin H, 2003, MOL NEUROBIOL, V27, P239, DOI 10.1385/MN:27:3:239; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Davies NWS, 2005, J NEUROL NEUROSUR PS, V76, P82, DOI 10.1136/jnnp.2004.045336; Ellermann-Eriksen S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-59; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fraisier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093637; Goenka A, 2014, CLIN INFECT DIS, V58, P775, DOI 10.1093/cid/cit922; Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Griffiths MJ, 2012, J INFECT DIS, V206, P881, DOI 10.1093/infdis/jis446; Hamed SA, 2009, NEUROPEDIATRICS, V40, P66, DOI 10.1055/s-0029-1231054; Hsu J, 2015, PHARM RES-DORDR, V32, P1264, DOI 10.1007/s11095-014-1531-z; Ichiyama T, 2008, CYTOKINE, V44, P149, DOI 10.1016/j.cyto.2008.07.002; Irani SR, 2014, ANN NEUROL, V76, P168, DOI 10.1002/ana.24200; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kaluza J, 1997, FOLIA NEUROPATHOL, V35, P24; Kamei S, 2004, INTERNAL MED, V43, P796, DOI 10.2169/internalmedicine.43.796; Kamei S, 2009, CYTOKINE, V46, P187, DOI 10.1016/j.cyto.2009.01.004; Kang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077427; Kaunisto A, 2015, MOL ONCOL, V9, P1140, DOI 10.1016/j.molonc.2015.02.004; Kimura A, 2015, J NEUROL SCI, V352, P79, DOI 10.1016/j.jns.2015.03.036; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kothur K, 2015, CYTOKINE, pS1043; Leypoldt F, 2015, JAMA NEUROL, V72, P180, DOI 10.1001/jamaneurol.2014.2956; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Love S, 2008, GREENFIELDS NEUROPAT, P1293; Majwala A, 2013, AM J TROP MED HYG, V88, P127, DOI 10.4269/ajtmh.2012.12-0447; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143; Melchjorsen J, 2002, J VIROL, V76, P2780, DOI 10.1128/JVI.76.6.2780-2788.2002; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Moscato EH, 2010, EUR J NEUROSCI, V32, P298, DOI 10.1111/j.1460-9568.2010.07349.x; Palus M, 2015, J MED VIROL, V87, P885, DOI 10.1002/jmv.24140; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Schrier RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116526; Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Szodoray P, 2007, RHEUMATOLOGY, V46, P417, DOI 10.1093/rheumatology/kel306; Tuzun E, 2009, ACTA NEUROPATHOL, V118, P737, DOI 10.1007/s00401-009-0582-4; Vilela MC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-19; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; WHITLEY RJ, 1987, INFECTION, V15, pS3, DOI 10.1007/BF01650104; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Zou J, 2015, CLIN RHEUMATOL	56	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146288	10.1371/journal.pone.0146288	http://dx.doi.org/10.1371/journal.pone.0146288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808276	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800020
J	Tiwary, S; Xu, L				Tiwary, Shweta; Xu, Lei			FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells	PLOS ONE			English	Article							STEM-CELLS; WNT RECEPTOR; BRAF INHIBITORS; BETA-CATENIN; ACTIVATION; KINASE; RESISTANCE; GPR56; PROLIFERATION; MECHANISMS	Metastases are thought to arise from cancer stem cells and their tumor initiating abilities are required for the establishment of metastases. Nevertheless, in metastatic melanoma, the nature of cancer stem cells is under debate and their contribution to metastasis formation remains unknown. Using an experimental metastasis model, we discovered that high levels of the WNT receptor, FZD7, correlated with enhanced metastatic potentials of melanoma cell lines. Knocking down of FZD7 in a panel of four melanoma cell lines led to a significant reduction in lung metastases in animal models, arguing that FZD7 plays a causal role during metastasis formation. Notably, limiting dilution analyses revealed that FZD7 is essential for the tumor initiation of melanoma cells and FZD7 knockdown impeded the early expansion of metastatic melanoma cells shortly after seeding, in accordance with the view that tumor initiating ability of cancer cells is required for metastasis formation. FZD7 activated JNK in melanoma cell lines in vitro and the expression of a dominant negative JNK suppressed metastasis formation in vivo, suggesting that FZD7 may promote metastatic growth of melanoma cells via activation of JNK. Taken together, our findings uncovered a signaling pathway that regulates the tumor initiation of melanoma cells and contributes to metastasis formation in melanoma.	[Tiwary, Shweta; Xu, Lei] Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA; [Tiwary, Shweta] Univ Texas Houston, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Rochester; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Xu, L (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	lei_xu@urmc.rochester.edu	Tiwary, Shweta/I-8076-2019	Tiwary, Shweta/0000-0002-2635-2560	James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center; IDEA Award from New York State Department of Health [N08G-480]; University of Rochester; JWCC/RPCI Collaborative Pilot Grant; NYSTEM IDEA AWARD [N08G-480]	James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center; IDEA Award from New York State Department of Health; University of Rochester; JWCC/RPCI Collaborative Pilot Grant; NYSTEM IDEA AWARD	This work was funded by the James Wilmot Cancer Center Pilot Grant, University of Rochester Medical Center, (to LX; https://www.urmc.rochester.edu/cancer-institute/researchers/fundingopportunities.aspx), and the IDEA Award for Stem Cell Research from the New York State Department of Health (#N08G-480, to LX; http://stemcell.ny.gov/grants-and-contracts-awarded). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nancy Corson and Morgan Preziosi for technical assistance and Dr. Glynis Scott for reading the manuscript. This work was supported by the start-up fund from University of Rochester (L.X.), the JWCC/RPCI Collaborative Pilot Grant (L.X.) and the NYSTEM IDEA AWARD (#N08G-480; L.X.).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anastas JN, 2014, J CLIN INVEST, V124, P2877, DOI 10.1172/JCI70156; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Fernandez A, 2014, P NATL ACAD SCI USA, V111, P1409, DOI 10.1073/pnas.1323697111; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Flanagan DJ, 2015, STEM CELL REP, V4, P759, DOI 10.1016/j.stemcr.2015.03.003; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gao YJ, 2009, EXP NEUROL, V219, P146, DOI 10.1016/j.expneurol.2009.05.006; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; HERLYN M, 1985, J NATL CANCER I, V74, P283; Hersey P, 2010, PIGM CELL MELANOMA R, V24, pe1, DOI 10.1111/j.1755-148X.2010.00811.x; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jorgensen K, 2006, MODERN PATHOL, V19, P1446, DOI 10.1038/modpathol.3800662; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kolben T, 2012, BIOL CHEM, V393, P1433, DOI 10.1515/hsz-2012-0186; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mei H, 2014, STEM CELLS, V32, P938, DOI 10.1002/stem.1582; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tiwary S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.23; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Yang LQ, 2014, CANCER RES, V74, P1022, DOI 10.1158/0008-5472.CAN-13-1268; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	53	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147638	10.1371/journal.pone.0147638	http://dx.doi.org/10.1371/journal.pone.0147638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808375	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800160
J	Chuang, PS; Hung, TC; Chang, HA; Huang, CK; Shiao, JC				Chuang, Po-Shun; Hung, Tzu-Chiao; Chang, Hung-An; Huang, Chien-Kang; Shiao, Jen-Chieh			The Species and Origin of Shark Fins in Taiwan's Fishing Ports, Markets, and Customs Detention: A DNA Barcoding Analysis	PLOS ONE			English	Article							HAMMERHEAD SHARKS; IDENTIFICATION; CONSERVATION; TRADE; MANAGEMENT; CATCHES; RAYS	The increasing consumption of shark products, along with the shark's fishing vulnerabilities, has led to the decrease in certain shark populations. In this study we used a DNA barcoding method to identify the species of shark landings at fishing ports, shark fin products in retail stores, and shark fins detained by Taiwan customs. In total we identified 23, 24, and 14 species from 231 fishing landings, 316 fin products, and 113 detained shark fins, respectively. All the three sample sources were dominated by Prionace glauca, which accounted for more than 30% of the collected samples. Over 60% of the species identified in the fin products also appeared in the port landings, suggesting the domestic-dominance of shark fin products in Taiwan. However, international trade also contributes a certain proportion of the fin product markets, as four species identified from the shark fin products are not found in Taiwan's waters, and some domestic-available species were also found in the customs-detained sample. In addition to the species identification, we also found geographical differentiation in the cox1 gene of the common thresher sharks (Alopias vulpinus), the pelagic thresher shark (A. pelagicus), the smooth hammerhead shark (Sphyrna zygaena), and the scalloped hammerhead shark (S. lewini). This result might allow fishing authorities to more effectively trace the origins as well as enforce the management and conservation of these sharks.	[Chuang, Po-Shun; Hung, Tzu-Chiao; Chang, Hung-An; Huang, Chien-Kang; Shiao, Jen-Chieh] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Taiwan University	Shiao, JC (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	jcshiao@ntu.edu.tw		Chuang, Po-Shun/0000-0003-3792-5421; SHIAO, JEN-CHIEH/0000-0002-3824-5738	Council of Agriculture, Executive Yuan (Taiwan, ROC) [101AS-11.2.1-FA-F6]; Ministry of Science and Technology of Taiwan; Fishery Agency	Council of Agriculture, Executive Yuan (Taiwan, ROC); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Fishery Agency	This study was financially supported by the Fishery Agency, Council of Agriculture, Executive Yuan (Taiwan, ROC) in the grant number: 101AS-11.2.1-FA-F6, and the Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beerkircher L, 2003, FISH B-NOAA, V101, P168; Beerkircher LR, 2002, MAR FISH REV, V64, P40; Bonfil R., 1994, OVERVIEW OF WORLD EL; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Clarke S, 2008, AQUAT LIVING RESOUR, V21, P373, DOI 10.1051/alr:2008060; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Fong QSW, 2002, ECOL ECON, V40, P117, DOI 10.1016/S0921-8009(01)00273-7; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Garrick JAF, 1982, SHARKS OF THE GENUS; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Liu SYV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079373; Molina JM, 2012, REV FISH BIOL FISHER, V22, P719, DOI 10.1007/s11160-012-9269-3; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Naylor GJP, 2012, B AM MUS NAT HIST, P1; NAYLOR GJP, 1992, CLADISTICS, V8, P295, DOI 10.1111/j.1096-0031.1992.tb00073.x; Pank M, 2001, MAR BIOTECHNOL, V3, P231, DOI 10.1007/s101260000071; Pinhal D, 2012, MAR BIOL, V159, P829, DOI 10.1007/s00227-011-1858-5; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Shotton R., 1999, CASE STUDIES MANAGEM; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2002, FISH RES, V55, P175; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; White WT, 2012, J FISH BIOL, V80, P897, DOI 10.1111/j.1095-8649.2012.03268.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	36	24	25	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147290	10.1371/journal.pone.0147290	http://dx.doi.org/10.1371/journal.pone.0147290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799827	gold, Green Published			2022-12-27	WOS:000368655300087
J	Rocha, FAD; Gomes, BD; Silveira, LCD; Martins, SL; Aguiar, RG; de Souza, JM; Ventura, DF				de Farias Rocha, Fernando Allan; Gomes, Bruno Duarte; de Lima Silveira, Luiz Carlos; Martins, Sonia Limara; Aguiar, Renata Genaro; de Souza, John Manuel; Ventura, Dora Fix			Spectral Sensitivity Measured with Electroretinogram Using a Constant Response Method	PLOS ONE			English	Article							GERBIL MERIONES-UNGUICULATUS; COLOR-VISION; VISUAL PIGMENTS; ELECTROPHYSIOLOGICAL MEASUREMENTS; FLICKER PHOTOMETRY; MONGOLIAN GERBIL; LIGHT ADAPTATION; SCRIPTA-ELEGANS; TURTLE RETINA; RAT RETINA	A new method is presented to determine the retinal spectral sensitivity function S(A) using the electroretinogram (ERG). S(A)s were assessed in three different species of myomorph rodents, Gerbils (Meriones unguiculatus), Wistar rats (Ratus norvegicus), and mice (Mus musculus). The method, called AC Constant Method, is based on a computerized automatic feedback system that adjusts light intensity to maintain a constant-response amplitude to a flickering stimulus throughout the spectrum, as it is scanned from 300 to 700 nm, and back. The results are presented as the reciprocal of the intensity at each wavelength required to maintain a constant peak to peak response amplitude. The resulting S(A) had two peaks in all three rodent species, corresponding to ultraviolet and M cones, respectively: 359 nm and 511 nm for mice, 362 nm and 493 nm for gerbils, and 362 nm and 502 nm for rats. Results for mouse and gerbil were similar to literature reports of S(A) functions obtained with other methods, confirming that the ERG associated to the AC Constant-Response Method was effective to obtain reliable S(A) functions. In addition, due to its fast data collection time, the AC Constant Response Method has the advantage of keeping the eye in a constant light adapted state.	[de Farias Rocha, Fernando Allan; Gomes, Bruno Duarte; de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Martins, Sonia Limara; Aguiar, Renata Genaro; de Souza, John Manuel; Ventura, Dora Fix] Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil; [Gomes, Bruno Duarte; de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos] Univ Ceuma, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Ceuma	Rocha, FAD (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	rochaf@ufpa.br	Ventura, Dora F/B-9071-2012; Gomes, Bruno Duarte/I-4499-2013; de Farias Rocha, Fernando Allan/T-7868-2019	Ventura, Dora F/0000-0002-7616-4031; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [02/12733-8]; Brazilian funding agencies Financiadora de Estudos e Projetos (FINEP); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): FINEP IBN-Net [1723]; CAPES-PROCAD [182/2007]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian funding agencies Financiadora de Estudos e Projetos (FINEP); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): FINEP IBN-Net; CAPES-PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Thematic Project 02/12733-8 (DFV), Brazilian funding agencies Financiadora de Estudos e Projetos (FINEP), Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): FINEP IBN-Net #1723 (LCLS and DFV); CAPES-PROCAD #182/2007 (DFV and LCLS); LCLS and DFV are CNPq research fellows; FAFR received CAPES fellowship for graduate students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; BOWMAKER JK, 1991, VISION RES, V31, P349, DOI 10.1016/0042-6989(91)90087-L; Bowmaker JK, 2005, J COMP PHYSIOL A, V191, P925, DOI 10.1007/s00359-005-0014-4; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; deSouza JM, 1996, J NEUROSCI METH, V68, P203, DOI 10.1016/0165-0270(96)00076-3; DeVoe RD, 1997, BRAZ J MED BIOL RES, V30, P169, DOI 10.1590/S0100-879X1997000200003; DODT E, 1961, J NEUROPHYSIOL, V24, P427, DOI 10.1152/jn.1961.24.4.427; Dogan ON, 2012, J ALLOY COMPD, V528, P10, DOI 10.1016/j.jallcom.2012.02.120; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GOVARDOVSKII VI, 1992, VISION RES, V32, P19, DOI 10.1016/0042-6989(92)90108-U; GREEN DG, 1971, SCIENCE, V174, P598, DOI 10.1126/science.174.4009.598; Hemmi JM, 2000, VISION RES, V40, P591, DOI 10.1016/S0042-6989(99)00210-2; Huang QX, 2012, ANAL BIOANAL CHEM, V403, P1751, DOI 10.1007/s00216-012-5976-9; Jacobs GH, 2007, DOC OPHTHALMOL, V115, P137, DOI 10.1007/s10633-007-9055-z; Jacobs GH, 2010, J COMP PHYSIOL A, V196, P379, DOI 10.1007/s00359-010-0519-3; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1994, VISION RES, V34, P1433, DOI 10.1016/0042-6989(94)90144-9; Jacobs GH, 1996, VISION RES, V36, P2587, DOI 10.1016/0042-6989(95)00335-5; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; Jacobs GH, 2003, VISION RES, V43, P227, DOI 10.1016/S0042-6989(02)00565-5; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; JACOBS GH, 1986, VISION RES, V26, P291, DOI 10.1016/0042-6989(86)90026-X; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; Jacobson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070562; KALTENRIEDER M, 1989, J COMP PHYSIOL A, V165, P155, DOI 10.1007/BF00619190; LEWIS DM, 1957, J PHYSIOL-LONDON, V136, P615, DOI 10.1113/jphysiol.1957.sp005786; LOEW ER, 1994, VISION RES, V34, P1427, DOI 10.1016/0042-6989(94)90143-0; Loew ER, 2001, VISUAL NEUROSCI, V18, P753, DOI 10.1017/S0952523801185081; Loew ER, 1996, VISUAL NEUROSCI, V13, P247, DOI 10.1017/S0952523800007483; MASSOF RW, 1972, PSYCHON SCI, V26, P175, DOI 10.3758/BF03335473; Matsumoto T, 2009, BIOL BULL-US, V217, P142, DOI 10.1086/BBLv217n2p142; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; NEUMEYER C, 1985, VISION RES, V25, P833, DOI 10.1016/0042-6989(85)90191-9; NEUMEYER C, 1989, VISION RES, V29, P1719, DOI 10.1016/0042-6989(89)90154-5; Parry JWL, 2002, INVEST OPHTH VIS SCI, V43, P1662; PARTRIDGE JC, 1992, VISUAL NEUROSCI, V9, P137, DOI 10.1017/S0952523800009597; Rocha FAF, 2008, VISUAL NEUROSCI, V25, P307, DOI 10.1017/S0952523808080516; Schleich CE, 2010, J COMP NEUROL, V518, P4001, DOI 10.1002/cne.22440; SILVER PH, 1967, VISION RES, V7, P377, DOI 10.1016/0042-6989(67)90046-6; Singh TB, 2011, INDIAN J PURE AP PHY, V49, P297; SZEL A, 1992, EXP EYE RES, V55, P47; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Ventura DF, 2001, J EXP BIOL, V204, P2527; Yang SY, 2015, NEUROSCI LETT, V589, P7, DOI 10.1016/j.neulet.2015.01.018; Zana Y, 2001, VISUAL NEUROSCI, V18, P759, DOI 10.1017/S0952523801185093	46	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147318	10.1371/journal.pone.0147318	http://dx.doi.org/10.1371/journal.pone.0147318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800521	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300094
J	Hafner, P; Bonati, U; Erne, B; Schmid, M; Rubino, D; Pohlman, U; Peters, T; Rutz, E; Frank, S; Neuhaus, C; Deuster, S; Gloor, M; Bieri, O; Fischmann, A; Sinnreich, M; Gueven, N; Fischer, D				Hafner, Patricia; Bonati, Ulrike; Erne, Beat; Schmid, Maurice; Rubino, Daniela; Pohlman, Urs; Peters, Thomas; Rutz, Erich; Frank, Stephan; Neuhaus, Cornelia; Deuster, Stefanie; Gloor, Monika; Bieri, Oliver; Fischmann, Arne; Sinnreich, Michael; Gueven, Nuri; Fischer, Dirk			Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; NITRIC-OXIDE; ASYMMETRIC DIMETHYLARGININE; MITOCHONDRIA; HOMOARGININE; SILDENAFIL; CHILDREN; ADMA	Altered neuronal nitric oxide synthase function in Duchenne muscular dystrophy leads to impaired mitochondrial function which is thought to be one cause of muscle damage in this disease. The study tested if increased intramuscular nitric oxide concentration can improve mitochondrial energy metabolism in Duchenne muscular dystrophy using a novel therapeutic approach through the combination of L-arginine with metformin. Five ambulatory, genetically confirmed Duchenne muscular dystrophy patients aged between 7-10 years were treated with L-arginine (3 x 2.5 g/d) and metformin (2 x 250 mg/d) for 16 weeks. Treatment effects were assessed using mitochondrial protein expression analysis in muscular biopsies, indirect calorimetry, Dual-Energy X-Ray Absorptiometry, quantitative thigh muscle MRI, and clinical scores of muscle performance. There were no serious side effects and no patient dropped out. Muscle biopsy results showed pre-treatment a significantly reduced mitochondrial protein expression and increased oxidative stress in Duchenne muscular dystrophy patients compared to controls. Post-treatment a significant elevation of proteins of the mitochondrial electron transport chain was observed as well as a reduction in oxidative stress. Treatment also decreased resting energy expenditure rates and energy substrate use shifted from carbohydrates to fatty acids. These changes were associated with improved clinical scores. In conclusion pharmacological stimulation of the nitric oxide pathway leads to improved mitochondria function and clinically a slowing of disease progression in Duchenne muscular dystrophy. This study shall lead to further development of this novel therapeutic approach into a real alternative for Duchenne muscular dystrophy patients.	[Hafner, Patricia; Bonati, Ulrike; Schmid, Maurice; Rubino, Daniela; Pohlman, Urs; Fischer, Dirk] Univ Basel Childrens Hosp, Div Neuropediat, Basel, Switzerland; [Hafner, Patricia; Sinnreich, Michael; Fischer, Dirk] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Erne, Beat; Sinnreich, Michael] Univ Basel, Dept Biomed, Basel, Switzerland; [Peters, Thomas] St Clara Hosp, Interdisciplinary Ctr Nutr & Metab Dis, Basel, Switzerland; [Rutz, Erich] Univ Basel Childrens Hosp, Paediat Orthopaed Dept, Basel, Switzerland; [Frank, Stephan] Univ Basel Hosp, Inst Pathol, Div Neuropathol, CH-4031 Basel, Switzerland; [Neuhaus, Cornelia] Univ Basel Childrens Hosp, Therapy Dept, Basel, Switzerland; [Deuster, Stefanie] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; [Gloor, Monika; Bieri, Oliver] Univ Basel Hosp, Dept Radiol, Div Radiol Phys, CH-4031 Basel, Switzerland; [Fischmann, Arne] Univ Basel Hosp, Div Neuroradiol, CH-4031 Basel, Switzerland; [Gueven, Nuri] Univ Tasmania, Sch Med, Pharm, Hobart, Tas, Australia	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Tasmania	Hafner, P (corresponding author), Univ Basel Childrens Hosp, Div Neuropediat, Basel, Switzerland.; Hafner, P (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	patricia.hafner@ukbb.ch	Bonati, Ulrike/P-4093-2017; Fischmann, Arne/AAM-9771-2020; Bonati, Leo/G-4058-2012	Fischmann, Arne/0000-0001-7561-0098; Bonati, Leo/0000-0003-1163-8133; Sinnreich, Michael/0000-0002-9835-1276; Rutz, Erich/0000-0002-2292-0946; Guven, Nuri/0000-0003-3782-767X	University of Basel; Lorenzo-Piaggio Foundation, Switzerland; Thomi-Hopf-Stiftung, Switzerland; Neuromuscular Research Association Basel, Switzerland; University of Basel Children's Hospital; Department of Neurology, University Hospital Basel; Bracco Suisse SA	University of Basel; Lorenzo-Piaggio Foundation, Switzerland; Thomi-Hopf-Stiftung, Switzerland; Neuromuscular Research Association Basel, Switzerland; University of Basel Children's Hospital; Department of Neurology, University Hospital Basel; Bracco Suisse SA	PH and UB were supported by grants of the University of Basel (https://medizin.unibas.ch/lehre/nachwuchsfoerderung.html) DF was supported by the Lorenzo-Piaggio Foundation, Switzerland; the Thomi-Hopf-Stiftung, Switzerland (www.thomi-hopf-stiftung.ch); the Neuromuscular Research Association Basel, Switzerland (http://www.nerab.org/); the University of Basel Children's Hospital, and the Department of Neurology, University Hospital Basel. The Department of Diagnostic and Interventional Radiology (AF) is supported by a grant from Bracco Suisse SA (http://imaging.bracco.com/ch-en/bracco-suisse-sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TD, 2013, METABOLISM, V62, P79, DOI 10.1016/j.metabol.2012.06.011; Bennett-Richards KJ, 2002, KIDNEY INT, V62, P1372, DOI 10.1046/j.1523-1755.2002.00555.x; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Bestermann WH, 2011, CARDIORENAL MED, V1, P211, DOI 10.1159/000332382; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Braun U, 2001, BBA-BIOENERGETICS, V1505, P258, DOI 10.1016/S0005-2728(01)00172-4; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; D'Angelo MG, 2012, PHARMACOL RES, V65, P472, DOI 10.1016/j.phrs.2012.01.006; da Silva EC, 2012, ARQ NEURO-PSIQUIAT, V70, P191, DOI 10.1590/S0004-282X2012000300007; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Dudley RWR, 2006, AM J PATHOL, V168, P1276, DOI 10.2353/ajpath.2006.050683; Elliott SA, 2012, EUR J PAEDIATR NEURO, V16, P631, DOI 10.1016/j.ejpn.2012.02.011; Fischmann A, 2013, J NEUROL, V260, P969, DOI 10.1007/s00415-012-6733-x; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; Garbincius JF, 2015, P NATL ACAD SCI USA, V112, P13663, DOI 10.1073/pnas.1512991112; Hall DT, 2011, AGING-US, V3, P702, DOI 10.18632/aging.100358; Hankard R, 1996, PEDIATR RES, V40, P29, DOI 10.1203/00006450-199607000-00006; Horster I, 2015, AMINO ACIDS, V47, P1853, DOI 10.1007/s00726-015-2018-x; Hollingsworth KG, 2013, MUSCLE NERVE, V48, P586, DOI 10.1002/mus.23879; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Kayacelebi A, 2015, AMINO ACIDS, V47, P1893, DOI 10.1007/s00726-015-2012-3; KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T; Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01; Kruszelnicka O, 2015, AMINO ACIDS, V47, P1951, DOI 10.1007/s00726-015-1976-3; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Langone F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114018; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Ljubicic V, 2015, MUSCLE NERVE, V52, P139, DOI 10.1002/mus.24692; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; MACALLISTER RJ, 1994, KIDNEY INT, V45, P737, DOI 10.1038/ki.1994.98; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Percival JM, 2012, J PATHOL, V228, P77, DOI 10.1002/path.4054; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; SCHOLTE HR, 1985, NEUROLOGY, V35, P1396, DOI 10.1212/WNL.35.9.1396; Sciorati C, 2013, PHARMACOL RES, V73, P35, DOI 10.1016/j.phrs.2013.04.009; Skalsky AJ, 2009, MUSCLE NERVE, V39, P647, DOI 10.1002/mus.21212; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195; Suhr F, 2013, INT J MOL SCI, V14, P7109, DOI 10.3390/ijms14047109; Vuillerot C, 2010, DEV MED CHILD NEUROL, V52, P60, DOI 10.1111/j.1469-8749.2009.03316.x; Witting N, 2014, ANN NEUROL, V76, P550, DOI 10.1002/ana.24216; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	50	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147634	10.1371/journal.pone.0147634	http://dx.doi.org/10.1371/journal.pone.0147634			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799743	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300134
J	Sakaie, K; Takahashi, M; Remington, G; Wang, XF; Conger, A; Conger, D; Dimitrov, I; Jones, S; Frohman, A; Frohman, T; Sagiyama, K; Togao, O; Fox, RJ; Frohman, E				Sakaie, Ken; Takahashi, Masaya; Remington, Gina; Wang, Xiaofeng; Conger, Amy; Conger, Darrel; Dimitrov, Ivan; Jones, Stephen; Frohman, Ashley; Frohman, Teresa; Sagiyama, Koji; Togao, Osamu; Fox, Robert J.; Frohman, Elliot			Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus	PLOS ONE			English	Article							BRAIN-STEM; MULTIPLE-SCLEROSIS; DIFFUSION; SYSTEM; MRI; REGISTRATION; VALIDATION; ATLAS; INO; MS	Objective To test the validity of diffusion tensor imaging (DTI) measures of tissue injury by examining such measures in a white matter structure with well-defined function, the medial longitudinal fasciculus (MLF). Injury to the MLF underlies internuclear ophthalmoparesis (INO). Methods 40 MS patients with chronic INO and 15 healthy controls were examined under an IRB-approved protocol. Tissue integrity of the MLF was characterized by DTI parameters: longitudinal diffusivity (LD), transverse diffusivity (TD), mean diffusivity (MD) and fractional anisotropy (FA). Severity of INO was quantified by infrared oculography to measure versional disconjugacy index (VDI). Results LD was significantly lower in patients than in controls in the medulla-pons region of the MLF (p < 0.03). FA was also lower in patients in the same region (p < 0.0004). LD of the medullapons region correlated with VDI (R = -0.28, p < 0.05) as did FA in the midbrain section (R = 0.31, p < 0.02). Conclusions This study demonstrates that DTI measures of brain tissue injury can detect injury to a functionally relevant white matter pathway, and that such measures correlate with clinically accepted evaluation indices for INO. The results validate DTI as a useful imaging measure of tissue integrity.	[Sakaie, Ken; Jones, Stephen] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Takahashi, Masaya; Dimitrov, Ivan; Sagiyama, Koji; Togao, Osamu] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Remington, Gina; Conger, Amy; Conger, Darrel; Frohman, Ashley; Frohman, Teresa; Frohman, Elliot] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Wang, Xiaofeng] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Dimitrov, Ivan] Philips Med Syst, Cleveland, OH USA; [Fox, Robert J.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; Philips; Philips Healthcare; Cleveland Clinic Foundation	Sakaie, K (corresponding author), Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA.	sakaiek@ccf.org	Togao, Osamu/AAE-4702-2022	Sagiyama, Koji/0000-0001-7253-0703; Dimitrov, Ivan/0000-0003-2686-6884	National Multiple Sclerosis Society [RG 4091 A3/1]; DADs Foundation	National Multiple Sclerosis Society(National Multiple Sclerosis Society); DADs Foundation	We gratefully acknowledge support from the National Multiple Sclerosis Society (RG 4091 A3/1) and from the DADs Foundation.	Aggarwal M, 2013, NEUROIMAGE, V74, P117, DOI 10.1016/j.neuroimage.2013.01.061; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Fox RJ, 2005, MULT SCLER J, V11, P140, DOI 10.1191/1352458505ms1142oa; Fox RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1179, DOI 10.1001/archneur.65.9.1179; Frohman EM, 2002, J NEUROL NEUROSUR PS, V73, P51, DOI 10.1136/jnnp.73.1.51; Frohman EM, 2001, NEUROLOGY, V57, P762, DOI 10.1212/WNL.57.5.762; Frohman TC, 2008, NEUROLOGY, V70, pE57, DOI 10.1212/01.wnl.0000310640.37810.b3; Frohman TC, 2003, NEUROLOGY, V61, P848, DOI 10.1212/01.WNL.0000085863.54218.72; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; Niemann K, 1999, J NEUROSURG, V90, P891, DOI 10.3171/jns.1999.90.5.0891; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Sakaie K, 2014, NEUROLOGY, V82, P182, DOI 10.1212/WNL.0000000000000016; Sakaie K, 2011, ANN NY ACAD SCI, V1233, P307, DOI 10.1111/j.1749-6632.2011.06156.x; Sakaie KE, 2010, MAGN RESON IMAGING, V28, P290, DOI 10.1016/j.mri.2009.07.004; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wang XF, 2009, J NEUROSCI METH, V177, P232, DOI 10.1016/j.jneumeth.2008.09.030; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wood SN, 2006, GEN ADDITIVE MODELS, pxvii	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147863	10.1371/journal.pone.0147863	http://dx.doi.org/10.1371/journal.pone.0147863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800522	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300142
J	Kasai, T; Tokuda, T; Ohmichi, T; Ishii, R; Tatebe, H; Nakagawa, M; Mizuno, T				Kasai, Takashi; Tokuda, Takahiko; Ohmichi, Takuma; Ishii, Ryotaro; Tatebe, Harutsugu; Nakagawa, Masanori; Mizuno, Toshiki			Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy	PLOS ONE			English	Article							Q(10); FIBROBLASTS; DEFICIENCY; UBIQUINONE; PHENOTYPE; DIAGNOSIS; SPECTRUM; MUSCLE	The COQ2 gene encodes an essential enzyme for biogenesis, coenzyme Q10 (CoQ10). Recessive mutations in this gene have recently been identified in families with multiple system atrophy (MSA). Moreover, specific heterozygous variants in the COQ2 gene have also been reported to confer susceptibility to sporadic MSA in Japanese cohorts. These findings have suggested the potential usefulness of CoQ10 as a blood-based biomarker for diagnosing MSA. This study measured serum levels of CoQ10 in 18 patients with MSA, 20 patients with Parkinson's disease and 18 control participants. Although differences in total CoQ10 (i.e., total levels of serum CoQ10 and its reduced form) among the three groups were not significant, total CoQ10 level corrected by serum cholesterol was significantly lower in the MSA group than in the Control group. Our findings suggest that serum CoQ10 can be used as a biomarker in the diagnosis of MSA and to provide supportive evidence for the hypothesis that decreased levels of CoQ10 in brain tissue lead to an increased risk of MSA.	[Kasai, Takashi; Tokuda, Takahiko; Ohmichi, Takuma; Ishii, Ryotaro; Tatebe, Harutsugu; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Neurol, Kyoto 6020841, Japan; [Kasai, Takashi; Tokuda, Takahiko] Japan Agcy Med Res & Dev, AMED CREST, Kyoto 6020841, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Mol Pathobiol Brain Dis, Kyoto 6020841, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare Med, Kyoto 6020841, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, Med Ctr N, Kyoto 6292261, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Res Inst Geriatr, Dept Neurol, Kyoto 6020841, Japan.; Kasai, T (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Kyoto 6020841, Japan.	kasaita@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020; Ishii, Ryotaro/K-4595-2019		AMED; AMED-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09319]	AMED; AMED-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by AMED, AMED-CREST and by a Grant-in-Aid (No. 15K09319) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Coppadoro A, 2013, J CRIT CARE, V28, P571, DOI 10.1016/j.jcrc.2013.02.009; Del Pozo-Cruz J, 2014, EXP GERONTOL, V52, P46, DOI 10.1016/j.exger.2014.01.026; FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kaikkonen J, 1999, FEBS LETT, V443, P163, DOI 10.1016/S0014-5793(98)01712-8; LAAKSONEN R, 1995, J LAB CLIN MED, V125, P517; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; Molina JA, 2000, J NEURAL TRANSM, V107, P1021, DOI 10.1007/s007020070050; Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007; Naini A, 2003, BIOFACTORS, V18, P145, DOI 10.1002/biof.5520180217; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Ozawa T, 2010, J NEUROL NEUROSUR PS, V81, P1253, DOI 10.1136/jnnp.2009.182576; Steele Paul E, 2004, Am J Clin Pathol, V121 Suppl, pS113; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064	16	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147574	10.1371/journal.pone.0147574	http://dx.doi.org/10.1371/journal.pone.0147574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812605	Green Published, gold			2022-12-27	WOS:000369528000040
J	Ouldamer, L; Goupille, C; Vilde, A; Arbion, F; Body, G; Chevalier, S; Cottier, JP; Bougnoux, P				Ouldamer, Lobna; Goupille, Caroline; Vilde, Anne; Arbion, Flavie; Body, Gilles; Chevalier, Stephan; Cottier, Jean Philippe; Bougnoux, Philippe			N-3 Polyunsaturated Fatty Acids of Marine Origin and Multifocality in Human Breast Cancer	PLOS ONE			English	Article							ADIPOSE-TISSUE; MAMMARY-TUMOR; EXPRESSION; RISK; OMEGA-3-FATTY-ACIDS; MULTICENTRICITY; INHIBITION; MODULATION; PREVENTION; GROWTH	Objective The microenvironment of breast epithelial tissue may contribute to the clinical expression of breast cancer. Breast epithelial tissue, whether healthy or tumoral, is directly in contact with fat cells, which in turn could influence tumor multifocality. In this pilot study we investigated whether the fatty acid composition of breast adipose tissue differed according to breast cancer focality. Methods Twenty-three consecutive women presenting with non-metastatic breast cancer underwent breast-imaging procedures including Magnetic Resonance Imaging prior to treatment. Breast adipose tissue specimens were collected during breast surgery. We established a biochemical profile of adipose tissue fatty acids by gas chromatography. We assessed whether there were differences according to breast cancer focality. Results We found that decreased levels in breast adipose tissue of docosahexaenoic and eicosapentaenoic acids, the two main polyunsaturated n-3 fatty acids of marine origin, were associated with multifocality. Discussion These differences in lipid content may contribute to mechanisms through which peritumoral adipose tissue fuels breast cancer multifocality.	[Ouldamer, Lobna; Body, Gilles] CHU Tours, Hop Bretonneau, Dept Gynecol, 2 Blvd Tonnelle, F-37044 Tours, France; [Ouldamer, Lobna; Goupille, Caroline; Chevalier, Stephan; Bougnoux, Philippe] INSERM, UMR1069, 10 Blvd Tonnelle, F-37044 Tours, France; [Ouldamer, Lobna; Goupille, Caroline; Body, Gilles; Chevalier, Stephan; Cottier, Jean Philippe; Bougnoux, Philippe] Univ Tours, 10 Blvd Tonnelle, F-37044 Tours, France; [Vilde, Anne; Cottier, Jean Philippe] Ctr Hosp Reg Univ Tours, Dept Radiol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France; [Arbion, Flavie] Ctr Hosp Reg Univ Tours, Dept Pathol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France; [Cottier, Jean Philippe] INSERM, UMR930, 10 Blvd Tonnelle, F-37044 Tours, France; [Bougnoux, Philippe] Ctr Hosp Reg Univ Tours, Dept Oncol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours	Ouldamer, L (corresponding author), CHU Tours, Hop Bretonneau, Dept Gynecol, 2 Blvd Tonnelle, F-37044 Tours, France.; Ouldamer, L (corresponding author), INSERM, UMR1069, 10 Blvd Tonnelle, F-37044 Tours, France.; Ouldamer, L (corresponding author), Univ Tours, 10 Blvd Tonnelle, F-37044 Tours, France.	l.ouldamer@chu-tours.fr	Goupille, Caroline/AAC-3339-2022; Ouldamer, Lobna/I-2062-2016; Cottier, Jean-Philippe/AAZ-6005-2021	Goupille, Caroline/0000-0002-0177-0926; Chevalier, Stephan/0000-0001-5689-2034; Cottier, Jean-Philippe/0000-0001-9166-212X; Bougnoux, Philippe/0000-0002-8717-055X	Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire)	Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire)	We thank Dr Iris Kellal and Dr Aymeric Saint Hilaire for their contributions to the clinical study, Violetta Guerin for technical help and Region Centre (Lipid project of ARD 2020, biomedicaments) and the Ligue nationale contre le cancer (Comite Departemental d'Indre et Loire) for their support.	Aberg UWN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025720; Anderson BM, 2014, APPL PHYSIOL NUTR ME, V39, P699, DOI 10.1139/apnm-2013-0365; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Barascu A, 2006, INT J BIOCHEM CELL B, V38, P196, DOI 10.1016/j.biocel.2005.08.015; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; BOUGNOUX P, 1994, BRIT J CANCER, V70, P330, DOI 10.1038/bjc.1994.302; Chen Z, 2014, ONCOGENE, V33, P4548, DOI 10.1038/onc.2013.402; Chenais B, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/712536; Delort L, 2015, LIFE SCI; Djuric Z, 2012, BREAST, V21, P608, DOI 10.1016/j.breast.2012.02.003; Duraker N, 2014, BREAST J, V20, P61, DOI 10.1111/tbj.12205; Erickson KL, 2010, PROSTAG LEUKOTR ESS, V82, P237, DOI 10.1016/j.plefa.2010.02.019; Fabian CJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0571-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; Kanumuri P, 2015, ANN SURG ONCOL, V22, P2475, DOI 10.1245/s10434-015-4430-6; LHUILLERY C, 1995, NUTR CANCER, V24, P299, DOI 10.1080/01635589509514419; Lynch SP, 2013, ONCOLOGIST, V18, P1167, DOI 10.1634/theoncologist.2013-0167; Merendino N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/310186; Nicol CJ, 2004, CARCINOGENESIS, V25, P1747, DOI 10.1093/carcin/bgh160; Panis C, 2012, BREAST CANCER RES TR, V133, P881, DOI 10.1007/s10549-011-1851-1; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Touvier M, 2012, AM J CLIN NUTR, V95, P944, DOI 10.3945/ajcn.111.027805; Vaughan VC, 2013, BRIT J CANCER, V108, P486, DOI 10.1038/bjc.2012.586; Vera-Badillo FE, 2014, BREAST CANCER RES TR, V146, P235, DOI 10.1007/s10549-014-3018-3; Wannous R, 2013, BBA-MOL CELL BIOL L, V1831, P1618, DOI 10.1016/j.bbalip.2013.07.010; Wei N, 2008, NUTR CANCER, V60, P810, DOI 10.1080/01635580802192858; Witte TR, 2015, LIPIDS, V50, P437, DOI 10.1007/s11745-015-4011-2; Wojcik C, 2014, J CELL MOL MED, V18, P590, DOI 10.1111/jcmm.12194; Yee LD, 2010, AM J CLIN NUTR, V91, P1185, DOI 10.3945/ajcn.2009.29036	31	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0147148	10.1371/journal.pone.0147148	http://dx.doi.org/10.1371/journal.pone.0147148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812254	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000021
J	Tomas-Gamisans, M; Ferrer, P; Albiol, J				Tomas-Gamisans, Marius; Ferrer, Pau; Albiol, Joan			Integration and Validation of the Genome-Scale Metabolic Models of Pichia pastoris: A Comprehensive Update of Protein Glycosylation Pathways, Lipid and Energy Metabolism	PLOS ONE			English	Article							CYANIDE-RESISTANT RESPIRATION; FATTY-ACID SYNTHESIS; YEAST SACCHAROMYCES-CEREVISIAE; N-LINKED OLIGOSACCHARIDES; ACYL-COA SYNTHETASE; METHYLOTROPHIC YEAST; KLUYVEROMYCES-LACTIS; FLUX ANALYSIS; HETEROLOGOUS PROTEINS; PRODUCTION HOST	Motivation Genome-scale metabolic models (GEMs) are tools that allow predicting a phenotype from a genotype under certain environmental conditions. GEMs have been developed in the last ten years for a broad range of organisms, and are used for multiple purposes such as discovering new properties of metabolic networks, predicting new targets for metabolic engineering, as well as optimizing the cultivation conditions for biochemicals or recombinant protein production. Pichia pastoris is one of the most widely used organisms for heterologous protein expression. There are different GEMs for this methylotrophic yeast of which the most relevant and complete in the published literature are iPP668, PpaMBEL1254 and iLC915. However, these three models differ regarding certain pathways, terminology for metabolites and reactions and annotations. Moreover, GEMs for some species are typically built based on the reconstructed models of related model organisms. In these cases, some organism-specific pathways could be missing or misrepresented. Results In order to provide an updated and more comprehensive GEM for P. pastoris, we have reconstructed and validated a consensus model integrating and merging all three existing models. In this step a comprehensive review and integration of the metabolic pathways included in each one of these three versions was performed. In addition, the resulting iMT1026 model includes a new description of some metabolic processes. Particularly new information described in recently published literature is included, mainly related to fatty acid and sphingolipid metabolism, glycosylation and cell energetics. Finally the reconstructed model was tested and validated, by comparing the results of the simulations with available empirical physiological datasets results obtained from a wide range of experimental conditions, such as different carbon sources, distinct oxygen availability conditions, as well as producing of two different recombinant proteins. In these simulations, the iMT1026 model has shown a better performance than the previous existing models.	[Tomas-Gamisans, Marius; Ferrer, Pau; Albiol, Joan] Univ Autonoma Barcelona, Dept Engn Quim Biol & Ambiental, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Albiol, J (corresponding author), Univ Autonoma Barcelona, Dept Engn Quim Biol & Ambiental, E-08193 Barcelona, Spain.	joan.albiol@uab.cat	Tomàs-Gamisans, Màrius/B-4136-2016; Sala, Joan Albiol/A-8280-2008; Tomàs-Gamisans, Màrius/AAG-8539-2020; Ferrer, Pau/A-4147-2009; Albiol, Joan/Z-5173-2019	Tomàs-Gamisans, Màrius/0000-0002-6076-6716; Sala, Joan Albiol/0000-0001-5626-429X; Tomàs-Gamisans, Màrius/0000-0002-6076-6716; Ferrer, Pau/0000-0002-5287-4127; Albiol, Joan/0000-0001-5626-429X	Spanish Ministry of Economy and Competitiveness [CTQ2013-42391-R]; Spanish Ministry of Education, Culture and Sport [FPU12/06185]; ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government); ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology)	This work was supported by the project CTQ2013-42391-R of the Spanish Ministry of Economy and Competitiveness and the grant FPU12/06185 (M.T.) of the Spanish Ministry of Education, Culture and Sport. Also the authors would like to acknowledge partial support from the ERA-IB IPCRES network (Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology - http://www.era-ib.net/ipcres). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Balagurunathan B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-27; Baumann K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-141; Bernard T, 2014, BRIEF BIOINFORM, V15, P123, DOI 10.1093/bib/bbs058; Borgel D, 2012, METAB ENG, V14, P412, DOI 10.1016/j.ymben.2012.03.003; Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Bridges HR, 2009, BIOCHEM J, V422, P151, DOI 10.1042/BJ20090492; Buchel F, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-116; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Carnicer M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-83; Carnicer M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-65; Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24; Caspeta L, 2013, BIOTECHNOL J, V8, P534, DOI 10.1002/biot.201200345; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Chen Y, 2013, CURR OPIN BIOTECH, V24, P965, DOI 10.1016/j.copbio.2013.03.008; Cheng HR, 2014, APPL MICROBIOL BIOT, V98, P3539, DOI 10.1007/s00253-013-5501-x; Cheon SA, 2012, MOL MICROBIOL, V83, P728, DOI 10.1111/j.1365-2958.2011.07961.x; Cheung CYM, 2013, PLANT J, V75, P1050, DOI 10.1111/tpj.12252; Chung BKS, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-50; Chung BKS, 2013, APPL MICROBIOL BIOT, V97, P1865, DOI 10.1007/s00253-013-4702-7; Chung BK-S, 2012, THESIS NATL U SINGAP; Cos O, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-17; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dias O, 2014, BIOTECHNOL J, V9, P776, DOI 10.1002/biot.201300242; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dikicioglu D, 2014, TRENDS BIOTECHNOL, V32, P397, DOI 10.1016/j.tibtech.2014.05.003; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fonseca C, 2008, APPL ENVIRON MICROB, V74, P1845, DOI 10.1128/AEM.02453-07; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; Gasser B, 2013, FUTURE MICROBIOL, V8, P191, DOI [10.2217/fmb.12.133, 10.2217/FMB.12.133]; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Gonzalez-Barroso MM, 2006, YEAST, V23, P307, DOI 10.1002/yea.1355; Gopalakrishnan S, 2015, METAB ENG, V32, P12, DOI 10.1016/j.ymben.2015.08.006; Govindappa N, 2013, PROTEIN EXPRES PURIF, V88, P164, DOI 10.1016/j.pep.2012.12.009; Grillitsch K, 2014, BBA-BIOMEMBRANES, V1838, P1889, DOI 10.1016/j.bbamem.2014.03.012; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Guerra G, 2002, BIOCHEM MOL BIOL EDU, V30, P363, DOI 10.1002/bmb.2002.494030060133; Gurvitz A, 2001, J BIOL CHEM, V276, P895, DOI 10.1074/jbc.M003305200; Heavner BD, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat059; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Heyland J, 2010, BIOTECHNOL BIOENG, V107, P357, DOI 10.1002/bit.22836; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hirose M, 2002, YEAST, V19, P1191, DOI 10.1002/yea.914; Gonzalez-Siso MI, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-46; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Jorda J, 2014, NEW BIOTECHNOL, V31, P120, DOI 10.1016/j.nbt.2013.06.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kannan V, 2009, RAPID COMMUN MASS SP, V23, P1035, DOI 10.1002/rcm.3965; Kern A, 2007, MICROBIOL-SGM, V153, P1250, DOI 10.1099/mic.0.2006/001404-0; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Klug L, 2014, BBA-MOL CELL BIOL L, V1841, P215, DOI 10.1016/j.bbalip.2013.11.005; Koivistoinen OM, 2012, GENE, V492, P177, DOI 10.1016/j.gene.2011.10.031; Koury MJ, 2003, TRENDS BIOTECHNOL, V21, P459, DOI 10.1016/j.tibtech.2003.09.005; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Kurtzman CP, 2009, J IND MICROBIOL BIOT, V36, P1435, DOI 10.1007/s10295-009-0638-4; Kurtzman CP, 2005, INT J SYST EVOL MICR, V55, P973, DOI 10.1099/ijs.0.63491-0; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Li PF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0206-8; Lin-Cereghino Joan, 2007, V389, P11; Liu YF, 2015, APPL MICROBIOL BIOT, V99, P1109, DOI 10.1007/s00253-014-6298-y; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Corchero JL, 2013, BIOTECHNOL ADV, V31, P140, DOI 10.1016/j.biotechadv.2012.09.001; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Mazat JP, 2013, IUBMB LIFE, V65, P171, DOI 10.1002/iub.1138; Minning S, 1998, J BIOTECHNOL, V66, P147, DOI 10.1016/S0168-1656(98)00142-4; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Montesino R, 1998, PROTEIN EXPRES PURIF, V14, P197, DOI 10.1006/prep.1998.0933; Nakagawa T, 2000, J BIOL CHEM, V275, P3455, DOI 10.1074/jbc.275.5.3455; Naumov GI, 2013, ANTON LEEUW INT J G, V104, P339, DOI 10.1007/s10482-013-9956-7; Nett JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068325; Nicholls DG, 2003, BIOENERGETICS, P89, DOI [10.1016/B978-012518121-1/50007-5, DOI 10.1016/B978-012518121-1/50007-5]; Nocon J, 2014, METAB ENG, V24, P129, DOI 10.1016/j.ymben.2014.05.011; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Petersen J, 2012, P NATL ACAD SCI USA, V109, P11150, DOI 10.1073/pnas.1202799109; PIRT SJ, 1982, ARCH MICROBIOL, V133, P300, DOI 10.1007/BF00521294; Pitkanen E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003465; Potvin G, 2012, BIOCHEM ENG J, V64, P91, DOI 10.1016/j.bej.2010.07.017; Prielhofer R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1393-8; Rebnegger C, 2014, BIOTECHNOL J, V9, P511, DOI 10.1002/biot.201300334; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Roca C, 2012, PROCESS BIOCHEM, V47, P1670, DOI 10.1016/j.procbio.2012.04.004; Nicolas R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-79; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Sauls JT, 2014, BIOINFORMATICS, V30, P1036, DOI 10.1093/bioinformatics/btt747; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SCORER CA, 1993, GENE, V136, P111, DOI 10.1016/0378-1119(93)90454-B; Sohn SB, 2010, BIOTECHNOL J, V5, P705, DOI 10.1002/biot.201000078; Sola A, 2004, EUR J BIOCHEM, V271, P2462, DOI 10.1111/j.1432-1033.2004.04176.x; Sola A, 2007, MICROBIOL-SGM, V153, P281, DOI 10.1099/mic.0.29263-0; Stadlmayr G, 2010, J BIOTECHNOL, V150, P519, DOI 10.1016/j.jbiotec.2010.09.957; Stephanopoulos G, 1998, REV CELLULAR METABOL, P21, DOI [10.1016/B978-012666260-3/50003-0, DOI 10.1016/B978-012666260-3/50003-0]; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Tarrio N, 2006, FEMS YEAST RES, V6, P371, DOI 10.1111/j.1567-1364.2005.00021.x; Tarrio N, 2005, BBA-BIOENERGETICS, V1707, P199, DOI 10.1016/j.bbabio.2004.12.008; Tarrio N, 2006, BBA-BIOENERGETICS, V1757, P1476, DOI 10.1016/j.bbabio.2006.09.002; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2011, J BIOL CHEM, V286, P11401, DOI 10.1074/jbc.M110.193094; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; Veiga A, 2003, FEMS YEAST RES, V3, P141, DOI 10.1016/S1567-1356(02)00189-7; Veiga A, 2003, FEMS YEAST RES, V3, P239, DOI 10.1016/S1567-1356(03)00036-9; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1991, ANTON LEEUW INT J G, V59, P49, DOI 10.1007/BF00582119; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Watanabe S, 2008, J BIOL CHEM, V283, P20372, DOI 10.1074/jbc.M801065200; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; WONG B, 1993, J BACTERIOL, V175, P6314, DOI 10.1128/JB.175.19.6314-6320.1993; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	148	36	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0148031	10.1371/journal.pone.0148031	http://dx.doi.org/10.1371/journal.pone.0148031			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812499	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528000071
J	Adler, PH; Kudelova, T; Kudela, M; Seitz, G; Ignjatovic-Cupina, A				Adler, Peter H.; Kudelova, Tatiana; Kudela, Matus; Seitz, Gunther; Ignjatovic-Cupina, Aleksandra			Cryptic Biodiversity and the Origins of Pest Status Revealed in the Macrogenome of Simulium colombaschense (Diptera: Simuliidae), History's Most Destructive Black Fly	PLOS ONE			English	Article							SPECIES GROUP DIPTERA; CYTOLOGICAL DESCRIPTION; FLIES DIPTERA; HABITAT; SYSTEMATICS; FEEDERS; LARVAE; GENES; RIVER	The European black fly Simulium (Simulium) colombaschense (Scopoli), once responsible for as many as 22,000 livestock deaths per year, is chromosomally mapped, permitting its evolutionary relationships and pest drivers to be inferred. The species is 12 fixed inversions removed from the standard sequence of the subgenus Simulium. Three of these fixed inversions, 38 autosomal polymorphisms, and a complex set of 12 X and 6 Y chromosomes in 29 zygotic combinations uniquely characterize S. colombaschense and reveal 5 cytoforms: 'A' in the Danube watershed, 'B' in Italy's Adige River, 'C' in the Aliakmonas River of Greece, 'D' in the Aoos drainage in Greece, and 'E' in the Bela River of Slovakia. 'C' and 'D' are reproductively isolated from one another, and 'B' is considered a cytotype of 'A,' the probable name bearer of colombaschense. The species status of 'E' cannot be determined without additional collections. Three derived polytene sequences, based on outgroup comparisons, place S. colombaschense in a clade of species composed of the S. jenningsi, S. malyschevi, and S. reptans species groups. Only cytoforms 'A' and 'B' are pests. Within the Simuliidae, pest status is reached through one of two principal pathways, both of which promote the production of large populations of blood-seeking flies: (1) colonization of the world's largest rivers (habitat specialization) or (2) colonization of multiple habitat types (habitat generalization). Evolutionary acquisition of the ability to colonize large rivers by an ancestor of the S. jenningsi-malyschevi-reptans clade set the scene for the pest status of S. colombaschense and other big-river members of the clade. In an ironic twist, the macrogenome of S. colombaschense reveals that the name associated with history's worst simuliid pest represents a complex of species, two or more of which are nonpests potentially vulnerable to loss of their limited habitat.	[Adler, Peter H.] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA; [Kudelova, Tatiana; Kudela, Matus] Comenius Univ, Dept Zool, Bratislava, Slovakia; [Seitz, Gunther] Dist Govt Lower Bavaria, Landshut, Germany; [Ignjatovic-Cupina, Aleksandra] Univ Novi Sad, Fac Agr, Dept Environm & Plant Protect, Novi Sad 21000, Serbia	Clemson University; Comenius University Bratislava; University of Novi Sad	Adler, PH (corresponding author), Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA.	padler@clemson.edu		Ignjatovic Cupina, Aleksandra/0000-0001-7045-6896	National Science Foundation [DEB-0841636]; VEGA of the Ministry of Education of the Slovak Republic [1/0561/14]; Slovak Research and Development Agency [APVV-0436-12]; Ministry of Science, Education and Technological Development, Republic of Serbia [TR31084, III43007]; National Institute of Food and Agriculture/United States Department of Agriculture [SC-1700433]; EurNegVec COST Action [TD1303]; Clemson University Experiment Station [SC-1700433, 6348]	National Science Foundation(National Science Foundation (NSF)); VEGA of the Ministry of Education of the Slovak Republic; Slovak Research and Development Agency(Slovak Research and Development Agency); Ministry of Science, Education and Technological Development, Republic of Serbia; National Institute of Food and Agriculture/United States Department of Agriculture(United States Department of Agriculture (USDA)); EurNegVec COST Action(European Cooperation in Science and Technology (COST)); Clemson University Experiment Station	This work was funded, in part, by National Science Foundation (http://www.nsf.gov/) award DEB-0841636 to PHA under the American Recovery and Reinvestment Act of 2009; VEGA grant no. 1/0561/14 of the Ministry of Education of the Slovak Republic (http://www.minedu.sk/) to MK; Slovak Research and Development Agency (http://www.apvv.sk/) under contract No. APVV-0436-12 to MK; and the Ministry of Science, Education and Technological Development, Republic of Serbia (http://www.mpn.gov.rs/) under Project Nos. TR31084 and III43007 to AIC. The work of PHA also was supported in part by the National Institute of Food and Agriculture/United States Department of Agriculture (http://nifa.usda.gov/) linked to project number SC-1700433, and the work of AIC also was supported in part by EurNegVec COST Action TD1303 (http://www.cost.eu/COST_Actions/bmbs/TD1303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sasa Nestorovic, guardian of the Iron Gate National Park, for assistance in interpretation of the Serbian and Walachian legends of the Golubatz fly, including the tale of St. George and the dragon. We thank C. E. Beard for scanning the photographic negatives of the chromosomes and A. G. Wheeler for helpful comments on the manuscript. This is Technical Contribution No. 6348 of the Clemson University Experiment Station, linked to project number SC-1700433.	Adler P. H., 2015, WORLD BLACKFLIES DIP; Adler Peter H., 2005, P127; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler Peter H., 2009, P189; Adler PH, 2001, CAN J ZOOL, V79, P1972, DOI 10.1139/cjz-79-11-1972; Adler PH, 2004, BLACK FLIES SIMULIID; AMRINE JW, 1982, W V U AGR FOR EXP ST, V678, P1; ANDERSON JR, 1987, CAN ENTOMOL, V119, P29, DOI 10.4039/Ent11929-1; BEDO DG, 1975, CAN J ZOOL, V53, P1147, DOI 10.1139/z75-134; BOOBAR LR, 1980, ENVIRON ENTOMOL, V9, P412, DOI 10.1093/ee/9.4.412; Bruderova T, 2012, 5 INT SIM S 3 7 SEPT, P7; Bruderova Tatiana, 2012, Folia Faunistica Slovaca, V17, P133; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; Cheke RA, 2008, MED VET ENTOMOL, V22, P172, DOI 10.1111/j.1365-2915.2008.00725.x; CIADAMIDARO S, 2013, BR SIMULIID GROU JUL, P4; Cianchi R, 1986, Ann Ist Super Sanita, V22, P365; CIUREA T., 1924, Annals of Tropical Medicine and Parasitology, V18, P323; Conflitti IM, 2012, SYST ENTOMOL, V37, P571, DOI 10.1111/j.1365-3113.2012.00629.x; CROSSKEY R.W., 1990, NEW TAXONOMIC GEOGRA; Crosskey R.W., 1990, NATURAL HIST BLACKFL; FREDEEN F J H, 1985, Quaestiones Entomologicae, V21, P175; FREDEEN F J H, 1977, Quaestiones Entomologicae, V13, P219; FREDEEN F J H, 1969, Quaestiones Entomologicae, V5, P341; Fredeen F.J.H., 1958, P 10 INT C ENT MONTR, V3, P819; Garms R, 1988, BLACK FLIES ECOLOGY, P201; Hamada N, 1999, SYST ENTOMOL, V24, P273, DOI 10.1046/j.1365-3113.1999.00080.x; Hunter FF, 2000, J INSECT BEHAV, V13, P585, DOI 10.1023/A:1007871820796; Ignjatovic-Cupina A, 2010, BILJNI LEKAR NOVISAD, VXXXVIII, P208; Ignjatovic-Cupinai A., 2006, Acta Entomologica Serbica, P97; Jedlicka L., 1982, Acta Entomologica Bohemoslovaca, V79, P396; Jedlicka Ladislav, 2008, Lauterbornia, V62, P93; Karadzic VS, 1867, ZIVOT OBICAJI NARODA; Kirk H, 2013, EVOL APPL, V6, P842, DOI 10.1111/eva.12071; LANDAU R, 1962, CAN J ZOOLOG, V40, P921, DOI 10.1139/z62-082; Malmqvist B, 1999, AQUAT INSECT, V21, P89, DOI 10.1076/aqin.21.2.89.4534; Malmqvist B, 2004, P ROY SOC B-BIOL SCI, V271, pS152, DOI 10.1098/rsbl.2003.0120; Malmqvist B, 2001, OIKOS, V92, P35, DOI 10.1034/j.1600-0706.2001.920105.x; MASON GF, 1982, CAN J ZOOL, V60, P292, DOI 10.1139/z82-039; MULLA M S, 1976, Proceedings and Papers of the Annual Conference of the California Mosquito Control Association, V44, P130; Papanicolaou A, 2013, INSECT BIOCHEM MOLEC, V43, P1181, DOI 10.1016/j.ibmb.2013.09.008; PASTERNAK J, 1964, CAN J ZOOLOG, V42, P135, DOI 10.1139/z64-013; POST RJ, 1982, HEREDITY, V48, P85, DOI 10.1038/hdy.1982.9; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; RICHARDSON JS, 1991, OIKOS, V62, P370, DOI 10.2307/3545503; Rios-Velasquez C, 2002, INSECT SYST EVOL, V33, P113, DOI 10.1163/187631202X00082; Rivosecchi L, 1984, Ann Ist Super Sanita, V20, P377; Rivosecchi L., 1978, Fauna d'Italia, V13, P1; Rivosecchi L., 1965, Rivista di Parassitologia Roma, V26, P31; Rivosecchi L., 1961, Parassitologia, V3, P199; Rivosecchi L, 2007, QUAD MUS TRIDENTINO, V2, P1; Rivosecchi Leo, 2005, Annali dell'Istituto Superiore di Sanita, V41, P415; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K. H., 1953, CANADIAN JOUR ZOOL, V31, P226, DOI 10.1139/z53-020; Rothfels K.H., 1980, Symposia of the Royal Entomological Society of London, P207; Rothfels K.H., 1981, APPL GENETICS CYTOLO, P67; Rubtsov IA, 1956, FAUNA USSR NEW SERIE, V6; Ruiz-Arrondo I, 2014, SEA, V54, P193; Sariozkan Savas, 2014, Turkiye Parazitoloji Dergisi, V38, P116, DOI 10.5152/tpd.2014.3446; Schonbauer JA, 1795, GESCH SCHADLICHEN KO; Senatore GL, 2014, MOL PHYLOGENET EVOL, V75, P138, DOI 10.1016/j.ympev.2014.02.018; SHELLEY AJ, 2010, AQUATIC BIODIVERSITY, V6; Sherban EN, 1960, REV BIOL ACAD REPUB, V5, P145; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Thompson FC, 2001, ENTOMOL NEWS, V112, P125; Werner D, 2005, ABHANDLUNGEN BERICHT, V27, P205; Zanin E, 1983, ATTI SOC ITAL BUIATR, V15, P513; Zhang YX, 1996, BIOL J LINN SOC, V59, P261; Zhang YX, 1998, J APPL ECOL, V35, P673, DOI 10.1046/j.1365-2664.1998.355345.x; ZIVKOVIC V, 1975, Acta Veterinaria (Belgrade), V25, P279; Zivkovic V, 1955, ACAD SERBE SCI MONOG, V245, P1	73	24	24	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147673	10.1371/journal.pone.0147673	http://dx.doi.org/10.1371/journal.pone.0147673			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808274	Green Submitted, gold, Green Published			2022-12-27	WOS:000369527800174
J	Ahnaou, A; Biermans, R; Drinkenburg, WH				Ahnaou, Abdallah; Biermans, Ria; Drinkenburg, Wilhelmus H.			Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats	PLOS ONE			English	Article							PHOSPHODIESTERASE 10A INHIBITORS; EVENT-RELATED POTENTIALS; PREPULSE INHIBITION; ACOUSTIC STARTLE; GATING DEFICITS; SCHIZOPHRENIA; P50; GLUTAMATE; DOPAMINE; AGONIST	Improvement of cognitive impairments represents a high medical need in the development of new antipsychotics. Aberrant EEG gamma oscillations and reductions in the P1/N1 complex peak amplitude of the auditory evoked potential (AEP) are neurophysiological biomarkers for schizophrenia that indicate disruption in sensory information processing. Inhibition of phosphodiesterase (i.e. PDE10A) and activation of metabotropic glutamate receptor (mGluR2) signaling are believed to provide antipsychotic efficacy in schizophrenia, but it is unclear whether this occurs with cognition-enhancing potential. The present study used the auditory paired click paradigm in passive awake Sprague Dawley rats to 1) model disruption of AEP waveforms and oscillations as observed in schizophrenia by peripheral administration of amphetamine and the N-methyl-D-aspartate (NMDA) antagonist phencyclidine (PCP); 2) confirm the potential of the antipsychotics risperidone and olanzapine to attenuate these disruptions; 3) evaluate the potential of mGluR2 agonist LY404039 and PDE10 inhibitor PQ-10 to improve AEP deficits in both the amphetamine and PCP models. PCP and amphetamine disrupted auditory information processing to the first click, associated with suppression of the P1/N1 complex peak amplitude, and increased cortical gamma oscillations. Risperidone and olanzapine normalized PCP and amphetamine-induced abnormalities in AEP waveforms and aberrant gamma/alpha oscillations, respectively. LY404039 increased P1/N1 complex peak amplitudes and potently attenuated the disruptive effects of both PCP and amphetamine on AEPs amplitudes and oscillations. However, PQ-10 failed to show such effect in either models. These outcomes indicate that modulation of the mGluR2 results in effective restoration of abnormalities in AEP components in two widely used animal models of psychosis, whereas PDE10A inhibition does not.	[Ahnaou, Abdallah; Biermans, Ria; Drinkenburg, Wilhelmus H.] Dept Neurosci Janssen Res & Dev, Div Janssen Pharmaceut NV A, Turnhoutseweg 30, B-2340 Beerse, Belgium	Johnson & Johnson; Janssen Pharmaceuticals	Ahnaou, A (corresponding author), Dept Neurosci Janssen Res & Dev, Div Janssen Pharmaceut NV A, Turnhoutseweg 30, B-2340 Beerse, Belgium.	aahnaou@its.jnj.com			Janssen Research Development	Janssen Research Development	The authors received no specific funding for this work. All authors are employed by Janssen Research & Development. Janssen Research & Development provided support in the form of salaries for authors [AA, RB and WD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1986, BIOL PSYCHIAT, V21, P787, DOI 10.1016/0006-3223(86)90244-1; Adler LE, 2004, AM J PSYCHIAT, V161, P1822, DOI 10.1176/appi.ajp.161.10.1822; Baldeweg T, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79575-1; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Blumenfeld LD, 2001, CLIN NEUROPHYSIOL, V112, P1650, DOI 10.1016/S1388-2457(01)00604-6; Boutros NN, 2009, SCHIZOPHR RES, V113, P339, DOI 10.1016/j.schres.2009.05.019; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Cadenhead KS, 2002, PSYCHIAT CLIN N AM, V25, P837, DOI 10.1016/S0193-953X(02)00021-7; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P55, DOI 10.1176/ajp.157.1.55; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Cartmell J, 2000, PSYCHOPHARMACOLOGY, V148, P423, DOI 10.1007/s002130050072; Clementz BA, 2003, EUR J NEUROSCI, V18, P2853, DOI 10.1111/j.1460-9568.2003.03027.x; Clementz BA, 1997, BIOL PSYCHIAT, V41, P1035, DOI 10.1016/S0006-3223(96)00208-9; Connolly PM, 2003, BRAIN RES, V992, P85, DOI 10.1016/j.brainres.2003.08.035; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Cromwell HC, 2008, CLIN EEG NEUROSCI, V39, P69, DOI 10.1177/155005940803900209; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; DAVIS M, 1982, J NEUROSCI, V2, P791; de Bruin NMWJ, 1999, PSYCHOPHARMACOLOGY, V142, P9, DOI 10.1007/s002130050856; Dimpfel W, 2007, BRIT J PHARMACOL, V152, P538, DOI 10.1038/sj.bjp.0707427; DIMPFEL W, 1989, PSYCHOPHARMACOLOGY, V98, P297, DOI 10.1007/BF00451678; Ellenbroek BA, 2004, PSYCHOPHARMACOLOGY, V174, P65, DOI 10.1007/s00213-003-1684-7; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Grauer SM, 2009, J PHARMACOL EXP THER, V331, P574, DOI 10.1124/jpet.109.155994; Gresack JE, 2014, PSYCHOPHARMACOLOGY, V231, P2189, DOI 10.1007/s00213-013-3371-7; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Halene TB, 2008, J PHARMACOL EXP THER, V326, P230, DOI 10.1124/jpet.108.138586; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hiyoshi T, 2014, J PHARMACOL EXP THER, V351, P642, DOI 10.1124/jpet.114.218651; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Johannesen JK, 2005, SCHIZOPHR RES, V78, P269, DOI 10.1016/j.schres.2005.05.022; JOHNSON MR, 1993, BIOL PSYCHIAT, V33, P380, DOI 10.1016/0006-3223(93)90328-B; Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Joy B, 2004, PSYCHOPHARMACOLOGY, V174, P274, DOI 10.1007/s00213-003-1731-4; Kittelberger K, 2012, BRAIN STRUCT FUNCT, V217, P395, DOI 10.1007/s00429-011-0351-8; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; LACROIX D, 1995, PROG NEURO-PSYCHOPH, V19, P861, DOI 10.1016/0278-5846(95)00116-D; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Light GA, 2000, BIOL PSYCHIAT, V47, P463, DOI 10.1016/S0006-3223(99)00280-2; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Maxwell CR, 2004, NEUROPSYCHOPHARMACOL, V29, P739, DOI 10.1038/sj.npp.1300376; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Mazhari S, 2011, PSYCHIAT RES, V187, P317, DOI 10.1016/j.psychres.2011.01.003; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Oranje B, 2006, PSYCHIAT RES, V143, P147, DOI 10.1016/j.psychres.2005.11.002; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Reneerkens OAH, 2013, BEHAV BRAIN RES, V250, P251, DOI 10.1016/j.bbr.2013.05.014; Reneerkens OAH, 2013, BEHAV BRAIN RES, V236, P16, DOI 10.1016/j.bbr.2012.08.019; Rorick-Kehn LM, 2007, J PHARMACOL EXP THER, V321, P308, DOI 10.1124/jpet.106.110809; SALETU B, 1987, PHARMACOPSYCHIATRY, V20, P12, DOI 10.1055/s-2007-1017125; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SCHWARZKOPF SB, 1993, BIOL PSYCHIAT, V33, P815, DOI 10.1016/0006-3223(93)90023-7; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Seeman P, 2013, NEUROPHARMACOLOGY, V66, P87, DOI 10.1016/j.neuropharm.2012.07.001; Siegel SJ, 2005, NEUROSCIENCE, V133, P729, DOI 10.1016/j.neuroscience.2005.03.027; Simosky JK, 2003, PSYCHOPHARMACOLOGY, V165, P386, DOI 10.1007/s00213-002-1285-x; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00190; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stevens KE, 1997, PHARMACOL BIOCHEM BE, V57, P869, DOI 10.1016/S0091-3057(96)00466-2; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tallon-Baudry C, 2004, TRENDS COGN SCI, V8, P523, DOI 10.1016/j.tics.2004.10.008; Tregellas JR, 2009, AM J PSYCHIAT, V166, P354, DOI 10.1176/appi.ajp.2008.08030411; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2004, BRAIN RES, V1019, P189, DOI 10.1016/j.brainres.2004.05.097; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042	91	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147365	10.1371/journal.pone.0147365	http://dx.doi.org/10.1371/journal.pone.0147365			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808689	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800080
J	Bacev-Giles, C; Peetz, J				Bacev-Giles, Chantal; Peetz, Johanna			Thinking Big or Small: Does Mental Abstraction Affect Social Network Organization?	PLOS ONE			English	Article							CONSTRUAL-LEVEL THEORY; LOVE; DISTANCE; SIZE; LUST	Four studies examined howmental abstraction affects how people perceive their relationships with other people, specifically, how these relationships may be categorized in social groups. We expected that individuals induced to think abstractly would report fewer more global social groups, compared to those induced to think concretely, who would reportmore specific groups. However, induced abstract mindset did not affect how people structured their social groups (Study 2-4), despite evidence that the mindset manipulation changed the level of abstraction in their thoughts (Study 3) and evidence that it changed how people structured groups for a control condition (household objects, Study 4). Together, these studies suggest that while the way people organize their relationships into groups is malleable; cognitive abstraction does not seem to affect how people categorize their relationships into social groups.	[Bacev-Giles, Chantal; Peetz, Johanna] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Carleton University	Bacev-Giles, C (corresponding author), Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada.	chantal.bacevgiles@carleton.ca			Social Sciences and Humanities Research Council Canada [435-2012-1211]	Social Sciences and Humanities Research Council Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Funder Name: Social Sciences and Humanities Research Council Canada. URL: http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx. Fund number: 435-2012-1211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDENDERFER MS, 1978, AM ANTIQUITY, V43, P502, DOI 10.2307/279415; Asendorpf JB, 1998, J PERS SOC PSYCHOL, V74, P1531, DOI 10.1037/0022-3514.74.6.1531; Dhar R, 2007, J CONSUM PSYCHOL, V17, P96, DOI 10.1016/S1057-7408(07)70014-1; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; Epstude K, 2011, J EXP SOC PSYCHOL, V47, P1017, DOI 10.1016/j.jesp.2011.03.019; Forster J, 2010, EUR J SOC PSYCHOL, V40, P524, DOI 10.1002/ejsp.656; Forster J, 2010, J EXP SOC PSYCHOL, V46, P237, DOI 10.1016/j.jesp.2009.08.009; Freitas AL, 2004, J EXP SOC PSYCHOL, V40, P739, DOI 10.1016/j.jesp.2004.04.003; Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x; Galliot MT, 2010, EFFORTFUL ENERGY DEM, P169; Kalish Y, 2006, SOC NETWORKS, V28, P56, DOI 10.1016/j.socnet.2005.04.004; Knee CR, 2008, J PERS SOC PSYCHOL, V95, P608, DOI 10.1037/0022-3514.95.3.608; Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Matthews RA, 2010, J OCCUP HEALTH PSYCH, V15, P330, DOI 10.1037/a0019302; McCrea SM, 2008, PSYCHOL SCI, V19, P1308, DOI 10.1111/j.1467-9280.2008.02240.x; MCPHERSON JM, 1992, AM SOCIOL REV, V57, P153, DOI 10.2307/2096202; Mihailidis P, 2014, INFORM COMMUN SOC, V17, P1059, DOI 10.1080/1369118X.2013.877054; Milardo R.M., 1988, NEW PERSPECTIVES FAM, P13; MILARDO RM, 1989, J MARRIAGE FAM, V51, P165, DOI 10.2307/352377; MILARDO RM, 1983, J PERS SOC PSYCHOL, V44, P964; MILARDO RM, 1992, J SOC PERS RELAT, V9, P447, DOI 10.1177/0265407592093007; MILLER J, 1991, Q J EXP PSYCHOL-A, V43, P907, DOI 10.1080/14640749108400962; Miller S., 1986, GENERATIONS, V10, P6; Pollet TV, 2011, J INDIVID DIFFER, V32, P161, DOI 10.1027/1614-0001/a000048; Rands M., 1988, FAMILIES SOCIAL NETW, P127; Roberts SGB, 2008, PERS INDIV DIFFER, V44, P954, DOI 10.1016/j.paid.2007.10.033; SALZINGER LL, 1982, SOC NETWORKS, V4, P117, DOI 10.1016/0378-8733(82)90029-6; Schmeichel BJ, 2011, SOC PSYCHOL PERS SCI, V2, P182, DOI 10.1177/1948550610385955; Spencer L., 2006, RETHINKING FRIENDSHI; Strauss A., 1978, STUDIES SYMBOLIC INT, V1, P119; SUDMAN S, 1985, SOC NETWORKS, V7, P127, DOI 10.1016/0378-8733(85)90002-4; SURRA CA, 1985, J PERS SOC PSYCHOL, V49, P357, DOI 10.1037/0022-3514.49.2.357; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2000, J PERS SOC PSYCHOL, V79, P876, DOI 10.1037//0022-3514.79.6.876; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; VALLACHER RR, 1989, J PERS SOC PSYCHOL, V57, P660, DOI 10.1037/0022-3514.57.4.660	38	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147325	10.1371/journal.pone.0147325	http://dx.doi.org/10.1371/journal.pone.0147325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808086	Green Published, gold			2022-12-27	WOS:000369527800074
J	Boisrame-Helms, J; Meyer, G; Degirmenci, SE; Burban, M; Schini-Kerth, V; Cynober, L; De Bandt, JP; Hasselmann, M; Meziani, F				Boisrame-Helms, Julie; Meyer, Gregory; Degirmenci, Su Emmanuelle; Burban, Melanie; Schini-Kerth, Valerie; Cynober, Luc; De Bandt, Jean-Pascal; Hasselmann, Michel; Meziani, Ferhat			"Immunonutrition" Has Failed to Improve Peritonitis-Induced Septic Shock in Rodents	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; NITRIC-OXIDE PRODUCTION; CRITICALLY-ILL PATIENT; GAMMA-LINOLENIC ACID; CARE-UNIT PATIENTS; PARENTERAL-NUTRITION; SEVERE SEPSIS; L-ARGININE; FISH-OIL; OMEGA-3-FATTY-ACIDS IMPROVE	Background Immunonutrition in sepsis, including n-3 poly-unsaturated fatty acids (PUFAs) or L-arginine supplementation, is a controversial issue that has yielded a great number of studies for the last thirty-five years, and the conclusions regarding the quantity and quality of this support in patients are deceiving. The aim of the present experimental study is to investigate the effects of a pretreatment with enteral nutrition enriched with n-3 PUFAs or L-arginine on vascular dysfunctions, inflammation and oxidative stress during septic shock in rats. Design Rats were fed with enteral Peptamen (R) HN (HN group), Peptamen (R) AF containing n-3 PUFAs (AF group) or Peptamen (R) AF enriched with L-arginine (AFA group). On day 4, peritonitis by cecal ligation and puncture (CLP) was performed. Rats were resuscitated (H18) once septic shock was established. After a 4-hour resuscitation, vessels and organs were harvested to assess inflammation, superoxide anion, nitric oxide and prostacyclin levels. Ex-vivo vascular reactivity was also performed. Results Compared to CLP-AF or CLP-HN groups, 47.6% of CLP-AFA rats died before the beginning of hemodynamic measurements (vs. 8.0% and 20.0% respectively, p<0.05). AF and AFA rats required significantly increased norepinephrine infusion rates to reach the mean arterial pressure objective, compared to CLP-HN rats. Both CLP-AF and CLP-AFA reduced mesenteric resistance arterial contractility, decreased vascular oxidative stress, but increased NF-kappa B (0.40 +/- 0.15 in CLP-AF and 0.69 +/- 0.06 in CLP-AFA vs. 0.09 +/- 0.03 in SHAM rats and 0.30 +/- 0.06 in CLP-HN, beta-actin ratio, p<0.05) and pI kappa B expression (0.60 +/- 0.03 in CLP-AF and 0.94 +/- 0.15 in CLP-AFA vs. 0.04 +/- 0.01 in SHAM rats and 0.56 +/- 0.07 in CLP-HN, beta-actin ratio, p<0.05), nitric oxide and prostacyclin production in septic rats. Conclusions Although n-3 PUFAs or L-arginine supplementation exhibited an antioxidant effect, it worsened the septic shock-induced vascular dysfunction. Furthermore, mortality was higher after L-arginine supplementation.	[Boisrame-Helms, Julie; Meziani, Ferhat] Univ Strasbourg, Fac Med, FMTS, EA 7293, Strasbourg, France; [Boisrame-Helms, Julie; Hasselmann, Michel; Meziani, Ferhat] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France; [Meyer, Gregory] Univ Avignon, EA 4278, F-84000 Avignon, France; [Degirmenci, Su Emmanuelle; Burban, Melanie; Schini-Kerth, Valerie] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Cynober, Luc; De Bandt, Jean-Pascal] Hop Cochin, AP HP, Hop Univ Paris Ctr, Dept Chim Clin, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Cynober, Luc; De Bandt, Jean-Pascal] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm, Lab Biol Nutr,EA 4466, Paris, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Meziani, F (corresponding author), Univ Strasbourg, Fac Med, FMTS, EA 7293, Strasbourg, France.; Meziani, F (corresponding author), Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France.	ferhat.meziani@chru-strasbourg.fr	De Bandt, Jean-Pascal/ABA-4382-2020; De BANDT, Jean Pascal/C-4822-2013; Cynober, Luc/ABB-2368-2020	Helms, Julie/0000-0003-0895-6800	Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER); Nestle; Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL)	Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER); Nestle(Nestle SA); Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL)	Funding source: this work has been in part supported by the Association for Research Development in Intensive Care (Association pour le Developpement de la Recherche En Reanimation, ADRER) and grant from Nestle. The authors also thank the Alsacian Association for Respiratory Failure Help at Home (Association Des Insuffisants Respiratoires Alsace Lorraine, ADIRAL) for its financial and material support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Achard F, 1997, BIOCHEM BIOPH RES CO, V241, P513, DOI 10.1006/bbrc.1997.7848; Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844; BARBUL A, 1984, J SURG RES, V36, P620, DOI 10.1016/0022-4804(84)90149-5; Barbul A, 2007, CRIT CARE MED, V35, pS564, DOI 10.1097/01.CCM.0000279188.97421.FE; Bertolini G, 2003, INTENS CARE MED, V29, P834, DOI 10.1007/s00134-003-1711-5; Boisrame-Helms J, 2015, PROG LIPID RES; Boisrame-Helms J, 2015, PROG LIPID RES, V60, P1, DOI 10.1016/j.plipres.2015.08.002; Boisrame-Helms J, 2014, SHOCK, V42, P548, DOI 10.1097/SHK.0000000000000255; Boisrame-Helms J, 2014, LIPIDS, V49, P1091, DOI 10.1007/s11745-014-3930-7; Boisrame-Helms J, 2014, THROMB HAEMOSTASIS, V111, P154, DOI 10.1160/TH13-04-0313; Boisrame-Helms J, 2013, CURR VASC PHARMACOL, V11, P150; Bruins MJ, 2002, CRIT CARE MED, V30, P508, DOI 10.1097/00003246-200203000-00003; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Cynober L, 2012, CRIT CARE MED, V40, P2540, DOI 10.1097/CCM.0b013e318256b800; Das UN, 2013, CRIT CARE, V17, DOI 10.1186/cc12574; Davis JS, 2011, CRIT CARE MED, V39, P380, DOI 10.1097/CCM.0b013e3181ffd9f7; Desai SV, 2014, CHEST, V145, P1148, DOI 10.1378/chest.13-1158; Elwafi F, 2012, EUR J CLIN INVEST, V42, P282, DOI 10.1111/j.1365-2362.2011.02581.x; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Fremont RD, 2015, NUTR CLIN PRACT, V30, P344, DOI 10.1177/0884533615578457; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Friesecke S, 2008, INTENS CARE MED, V34, P1411, DOI 10.1007/s00134-008-1072-1; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Gultekin G, 2014, PAK J MED SCI, V30, P299; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; Hamani D, 2010, CLIN NUTR, V29, P654, DOI 10.1016/j.clnu.2010.02.011; Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860; Heller AR, 2006, CRIT CARE MED, V34, P972, DOI 10.1097/01.CCM.0000206309.83570.45; Heller AR, 2015, WORLD REV NUTR DIET, V112, P127, DOI 10.1159/000365607; Heyland DK, 2001, JPEN-PARENTER ENTER, V25, pS51, DOI 10.1177/014860710102500211; Iapichino G, 2010, MINERVA ANESTESIOL, V76, P325; Jain AP, 2015, EUR REV MED PHARMACO, V19, P441; Kalil AC, 2006, CRIT CARE MED, V34, P2719, DOI 10.1097/01.CCM.0000242757.26245.03; Kao CC, 2009, CLIN SCI, V117, P23, DOI 10.1042/CS20080444; Leclerc J, 2000, CRIT CARE MED, V28, P3672, DOI 10.1097/00003246-200011000-00023; Lorente JA, 1999, CRIT CARE MED, V27, P2474, DOI 10.1097/00003246-199911000-00025; Luiking YC, 2015, CLIN SCI, V128, P57, DOI 10.1042/CS20140343; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; Meziani F, 2007, AM J PATHOL, V171, P1753, DOI 10.2353/ajpath.2007.070316; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARKER JL, 1993, CIRC RES, V72, P539, DOI 10.1161/01.RES.72.3.539; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; SEIFTER E, 1978, SURGERY, V84, P224; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; SITREN HS, 1977, BRIT J NUTR, V37, P195, DOI 10.1079/BJN19770021; Stoclet JC, 1999, CIRCULATION, V100, P107, DOI 10.1161/01.CIR.100.2.107; Tadie JM, 2013, INTENS CARE MED, V39, P1663, DOI 10.1007/s00134-013-2984-y; UMANS JG, 1993, AM REV RESPIR DIS, V148, P1638, DOI 10.1164/ajrccm/148.6_Pt_1.1638; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Visser M, 2011, BR J NUTR, P1; Wijnands KAP, 2015, NUTRIENTS, V7, P1426, DOI 10.3390/nu7031426	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147644	10.1371/journal.pone.0147644	http://dx.doi.org/10.1371/journal.pone.0147644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808822	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800165
J	Chochinov, HM; Johnston, W; McClement, SE; Hack, TF; Dufault, B; Enns, M; Thompson, G; Harlos, M; Damant, RW; Ramsey, CD; Davison, S; Zacharias, J; Milke, D; Strang, D; Campbell-Enns, HJ; Kredentser, MS				Chochinov, Harvey Max; Johnston, Wendy; McClement, Susan E.; Hack, Thomas F.; Dufault, Brenden; Enns, Murray; Thompson, Genevieve; Harlos, Mike; Damant, Ronald W.; Ramsey, Clare D.; Davison, Sara; Zacharias, James; Milke, Doris; Strang, David; Campbell-Enns, Heather J.; Kredentser, Maia S.			Dignity and Distress towards the End of Life across Four Non-Cancer Populations	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PALLIATIVE CARE NEEDS; ADVANCED CANCER; SYMPTOM BURDEN; TERMINALLY-ILL; OF-LIFE; PERSPECTIVE; INVENTORY; DYSPNEA; HOPE	Objective The purpose of this study was to identify four non-cancer populations that might benefit from a palliative approach; and describe and compare the prevalence and patterns of dignity related distress across these diverse clinical populations. Design A prospective, multi-site approach was used. Setting Outpatient clinics, inpatient facilities or personal care homes, located in Winnipeg, Manitoba and Edmonton, Alberta, Canada. Participants Patients with advanced Amyotrophic Lateral Sclerosis (ALS), Chronic Obstructive Pulmonary Disease (COPD), End Stage Renal Disease (ESRD); and the institutionalized alert frail elderly. Main Outcome Measure In addition to standardized measures of physical, psychological and spiritual aspects of patient experience, the Patient Dignity Inventory (PDI). Results Between February 2009 and December 2012, 404 participants were recruited (ALS, 101; COPD, 100; ESRD, 101; and frail elderly, 102). Depending on group designation, 35% to 58% died within one year of taking part in the study. While moderate to severe loss of sense of dignity did not differ significantly across the four study populations (4-11%), the number of PDI items reported as problematic was significantly different i.e. ALS 6.2 (5.2), COPD 5.6 (5.9), frail elderly 3.0 (4.4) and ESRD 2.3 (3.9) [p < .0001]. Each of the study populations also revealed unique and distinct patterns of physical, psychological and existential distress. Conclusion People with ALS, COPD, ESRD and the frail elderly face unique challenges as they move towards the end of life. Knowing the intricacies of distress and how they differ across these groups broadens our understanding of end-of-life experience within non-cancer populations and how best to meet their palliative care needs.	[Chochinov, Harvey Max; Enns, Murray] Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Psychiat, Winnipeg, MB, Canada; [Chochinov, Harvey Max; McClement, Susan E.; Thompson, Genevieve; Campbell-Enns, Heather J.; Kredentser, Maia S.] CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada; [Johnston, Wendy] Univ Alberta, Fac Med, Dept Med, Neurol, Edmonton, AB, Canada; [McClement, Susan E.; Hack, Thomas F.; Thompson, Genevieve] Univ Manitoba, Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada; [Dufault, Brenden] Univ Manitoba, Dept Community Hlth Sci, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB R3T 2N2, Canada; [Harlos, Mike] Winnipeg Reg Hlth Author, Palliat Care Program, Winnipeg, MB, Canada; [Damant, Ronald W.] Univ Alberta, Div Pulm Med, Edmonton, AB, Canada; [Ramsey, Clare D.] Univ Manitoba, Fac Hlth Sci, Coll Med, Dept Internal Med, Winnipeg, MB, Canada; [Ramsey, Clare D.; Zacharias, James] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada; [Davison, Sara] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Zacharias, James] Univ Manitoba, Fac Hlth Sci, Coll Med, Nephrol Sect, Winnipeg, MB, Canada; [Milke, Doris] CapitalCare, Edmonton, AB, Canada; [Milke, Doris] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Milke, Doris] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Strang, David] Univ Manitoba, Geriatr Med, Winnipeg, MB, Canada; [Strang, David] Winnipeg Reg Hlth Author, Geriatr Program, Winnipeg, MB, Canada; [Campbell-Enns, Heather J.] Univ Manitoba, Fac Grad Studies, Fac Hlth Sci, Interdisciplinary Canc Control, Winnipeg, MB, Canada; [Kredentser, Maia S.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; CancerCare Manitoba Foundation; University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Manitoba; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba; University of Manitoba	Chochinov, HM (corresponding author), Univ Manitoba, Coll Med, Fac Hlth Sci, Dept Psychiat, Winnipeg, MB, Canada.; Chochinov, HM (corresponding author), CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada.	hchochinov@cancercare.mb.ca	McClement, Susan E/H-7031-2016; Johnston, Wendy S/E-2491-2013	McClement, Susan E/0000-0002-9537-9900; Johnston, Wendy S/0000-0002-4330-5563; Campbell-Enns, Heather J./0000-0002-9920-5254; Chochinov, Harvey/0000-0003-2656-4704; Zacharias, James/0000-0002-4887-5338; Enns, Murray/0000-0002-8375-0151; Thompson, Genevieve/0000-0003-2558-9926	Canadian Institutes for Health Research [93640]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Funding provided by Canadian Institutes for Health Research, http://www.cihr-irsc.gc.ca, Grant # 93640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers G, 2013, J PALLIAT MED, V16, P1108, DOI 10.1089/jpm.2012.0307; BENGTSON VL, 1977, J GERONTOL, V32, P76, DOI 10.1093/geronj/32.1.76; Benzein E, 2001, PALLIATIVE MED, V15, P117, DOI 10.1191/026921601675617254; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chochinov HM, 2012, J PALLIAT MED, V15, P998, DOI 10.1089/jpm.2012.0066; Chochinov HM, 2009, J PAIN SYMPTOM MANAG, V38, P641, DOI 10.1016/j.jpainsymman.2009.04.021; Chochinov HM, 2008, J PAIN SYMPTOM MANAG, V36, P559, DOI 10.1016/j.jpainsymman.2007.12.018; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2004, J CLIN ONCOL, V22, P1336, DOI 10.1200/JCO.2004.12.095; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen LM, 2007, J PALLIAT MED, V10, P1262, DOI 10.1089/jpm.2007.0054; Cohen LM, 2003, JAMA-J AM MED ASSOC, V289, P2113, DOI 10.1001/jama.289.16.2113; Cohen LM, 2002, PSYCHOSOM MED, V64, P889, DOI 10.1097/01.PSY.0000028828.64279.84; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; Davison SN, 2014, BMJ SUPPORT PALLIAT; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; Elkington H, 2005, PALLIATIVE MED, V19, P485, DOI 10.1191/0269216305pm1056oa; Fitzsimons D, 2007, PALLIATIVE MED, V21, P313, DOI 10.1177/0269216307077711; Gesser G., 1988, OMEGA, V18, P113, DOI DOI 10.2190/0DQB-7Q1E-2BER-H6YC; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Hall S, 2013, PSYCHO-ONCOLOGY, V22, P1748, DOI 10.1002/pon.3206; Hall S, 2012, PALLIATIVE MED, V26, P703, DOI 10.1177/0269216311418145; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Johnston B, 2012, INT J PALLIAT NURS, V18, P483, DOI 10.12968/ijpn.2012.18.10.483; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Kimmel PL, 2003, AM J KIDNEY DIS, V42, P713, DOI 10.1016/S0272-6386(03)00907-7; Luddington L, 2001, Int J Palliat Nurs, V7, P221; Maessen M, 2010, J NEUROL, V257, P1192, DOI 10.1007/s00415-010-5474-y; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; McIlfatrick S, 2007, J ADV NURS, V57, P77, DOI 10.1111/j.1365-2648.2006.04062.x; McVey P, 2014, HEALTH SOC CARE COMM, V22, P197, DOI 10.1111/hsc.12077; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Murray AM, 2006, CLIN J AM SOC NEPHRO, V1, P1248, DOI 10.2215/CJN.00970306; Neimeyer RA, 1995, DYING FACING FACTS; Neuman A, 2006, RESP MED, V100, P1843, DOI 10.1016/j.rmed.2006.01.016; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; Oechsle K, 2014, J PAIN SYMPTOM MANAG, V48, P313, DOI 10.1016/j.jpainsymman.2013.10.022; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Reynolds Kimberly, 2002, J Palliat Med, V5, P895, DOI 10.1089/10966210260499087; Sautier LP, 2014, J PAIN SYMPTOM MANAG, V47, P181, DOI 10.1016/j.jpainsymman.2013.02.023; Skilbeck JK, 2005, J ADV NURS, V51, P325, DOI 10.1111/j.1365-2648.2005.03503.x; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Tamura Keiko, 2006, Palliat Support Care, V4, P189; Thompson Genevieve N, 2008, Curr Opin Support Palliat Care, V2, P49, DOI 10.1097/SPC.0b013e3282f4cb15; Thorson J.A., 2000, DEATH ATTITUDES OLDE, P123, DOI DOI 10.1108/09534810210449550; Vehling S, 2014, PSYCHO-ONCOLOGY, V23, P283, DOI 10.1002/pon.3417; von Leupoldt A, 2013, CURR OPIN PSYCHIATR, V26, P458, DOI 10.1097/YCO.0b013e328363c1fc; Watanabe SM, 2011, J PAIN SYMPTOM MANAG, V41, P456, DOI 10.1016/j.jpainsymman.2010.04.020; Wilson KG, 2004, CAN J PSYCHIAT, V49, P350, DOI 10.1177/070674370404900603; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	54	57	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147607	10.1371/journal.pone.0147607	http://dx.doi.org/10.1371/journal.pone.0147607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26808530	Green Published, gold			2022-12-27	WOS:000369527800148
J	Khalfaoui, S; Eichhorn, V; Karagiannidis, C; Bayh, I; Brockmann, M; Pieper, M; Windisch, W; Schildgen, O; Schildgen, V				Khalfaoui, Soumaya; Eichhorn, Vivien; Karagiannidis, Christian; Bayh, Inga; Brockmann, Michael; Pieper, Monika; Windisch, Wolfram; Schildgen, Oliver; Schildgen, Verena			Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; TNF-ALPHA; PULMONARY-FIBROSIS; LIVER FIBROSIS; POOR-PROGNOSIS; COMMON COLD; IFN-GAMMA; GM-CSF; CANCER; DNA	Human Bocavirus subtype 1 (HBoV1) is associated with respiratory diseases and may contribute to chronic lung diseases by persisting in the infected host. Here the question was addressed if HBoV infections could contribute to fibrogenesis processes as suggested by previously published clinical observations. Cytokine profiles induced by HBoV infection in CuFi-8 air-liquid interphase cell cultures and in bronchoalveolar lavage fluid (BALF) of 20 HBoV-positive and 12 HBoV-negative patients were analysed by semi-quantitative Western spot blot analyses. Although lots of cytokines were regulated independently of HBoV status, several cytokines associated with lung fibrosis and tumour development, e.g., EGF, VEGF, TARC (CCL17), TNF-alpha, TNF-beta, TIMP-1, were clearly upregulated in the HBoV-positive cohort. These findings suggest that the development of lung fibrosis might be triggered by HBoV induced cytokine expression.	[Khalfaoui, Soumaya; Eichhorn, Vivien; Brockmann, Michael; Pieper, Monika; Schildgen, Oliver; Schildgen, Verena] Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Inst Pathol, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Karagiannidis, Christian; Windisch, Wolfram] Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Dept Pneumol & Crit Care Med, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Bayh, Inga] Univ Witten Herdecke, Inst Med Biometry & Epidemiol, Fac Hlth, Alfred Herrhausen Str 50, Witten, Germany	University of Cologne; Witten Herdecke University	Schildgen, V (corresponding author), Kliniken Stadt Koln gGmbH, Univ Hosp Witten Herdecke, Inst Pathol, Ostmerheimer Str 200, D-51109 Cologne, Germany.	schildgenv@kliniken-koeln.de	Windisch, Wolfram/AFV-2171-2022; Windisch, Wolfram/ABI-7381-2020; Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	Else Kroner-Fresenius Stiftung (Germany) [A100_2013]; Beatrix-Lichtken-Stifung (Germany); Private University of Witten/Herdecke	Else Kroner-Fresenius Stiftung (Germany); Beatrix-Lichtken-Stifung (Germany); Private University of Witten/Herdecke	This study was supported by research grants from the Else Kroner-Fresenius Stiftung (Germany) (grant number A100_2013 to VS), the Beatrix-Lichtken-Stifung (Germany) (grant for HBoV Research to OS), and the Private University of Witten/Herdecke (internal grant to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LA, 2011, THYROID, V21, P411, DOI 10.1089/thy.2010.0307; Adamson-Small LA, 2014, ENDOCR PATHOL, V25, P339, DOI 10.1007/s12022-014-9305-z; Alevizakos M, 2013, CANCER CHEMOTH PHARM, V72, P1169, DOI 10.1007/s00280-013-2298-3; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Cheadle EJ, 2007, CLIN CANCER RES, V13, P5719, DOI 10.1158/1078-0432.CCR-07-1145; CHEUNG AKM, 1980, J VIROL, V33, P739, DOI 10.1128/JVI.33.2.739-748.1980; Chou DHI, 1996, J IMMUNOL, V156, P4354; Coe BR, 2005, GENE CHROMOSOME CANC, V42, P308, DOI 10.1002/gcc.20137; Corsini J, 2001, VIROLOGY, V288, P154, DOI 10.1006/viro.2001.1076; De Vos N, 2009, EUR J CLIN MICROBIOL, V28, P1305, DOI 10.1007/s10096-009-0780-y; Di Stefano A, 2009, THORAX, V64, P968, DOI 10.1136/thx.2009.113647; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Don M, 2011, J INFECT DIS, V203, P1031, DOI 10.1093/infdis/jiq157; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fisgin T, 2002, LEUKEMIA LYMPHOMA, V43, P2059, DOI 10.1080/1042819021000016168; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; GAULDIE J, 1993, THORAX, V48, P931, DOI 10.1136/thx.48.9.931; HART PH, 1989, IMMUNOLOGY, V66, P376; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929; Hobbs JA, 2015, SEMIN ONCOL, V42, P304, DOI 10.1053/j.seminoncol.2014.12.022; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Huguenin A, 2012, J MED VIROL, V84, P979, DOI 10.1002/jmv.23272; Ibrahem WN, 2014, J PAK MED ASSOC, V64, P9; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Jartti Laura, 2011, Open Respir Med J, V5, P61, DOI 10.2174/1874306401105010061; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kaur J, 2014, FUTURE VIROL, V9, P715, DOI 10.2217/FVL.14.59; Keane MP, 2008, EUR RESPIR REV, V17, P151, DOI 10.1183/09059180.00010908; Kishi M, 2008, THORAX, V63, P810, DOI 10.1136/thx.2007.086074; Korppi M, 2010, PEDIATR INFECT DIS J, V29, P387, DOI 10.1097/INF.0b013e3181ce8e81; Kuusniemi AM, 2005, KIDNEY INT, V68, P121, DOI 10.1111/j.1523-1755.2005.00386.x; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Li YS, 2012, ONCOL LETT, V3, P635, DOI 10.3892/ol.2012.548; Lin HJ, 2015, J THORAC DIS, V7, P767, DOI 10.3978/j.issn.2072-1439.2015.04.17; Lloyd CM, 1997, J LEUKOCYTE BIOL, V62, P676, DOI 10.1002/jlb.62.5.676; Longtin J, 2010, J INFECT DIS, V202, P1617, DOI 10.1086/656786; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Mangieri D, 2012, NEPHROL DIAL TRANSPL, V27, P3875, DOI 10.1093/ndt/gfs408; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Munthe-Kaas MC, 2015, J PEDIAT HEMATOL ONC, V37, pE67, DOI 10.1097/MPH.0000000000000093; Ohgino K, 2014, LUNG CANCER, V83, P90, DOI 10.1016/j.lungcan.2013.10.016; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Pesta M, 2011, ANTICANCER RES, V31, P4031; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Ribeiro R, 2006, EUR J CANCER, V42, P1188, DOI 10.1016/j.ejca.2006.02.004; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Ricci A, 2007, SARCOIDOSIS VASC DIF, V24, P13; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Safranek J, 2009, ANTICANCER RES, V29, P2513; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen V, 2014, MBIO, V5, DOI 10.1128/mBio.01186-14; Schildgen V, 2014, REV MED MICROBIOL, V25, P113, DOI 10.1097/MRM.0000000000000010; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Seeger C., 2013, FIELDS VIROLOGY, V7th ed., P2185; Stoll P, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-116; Streiter M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-417; Uemura Y, 2006, INT J MOL MED, V18, P365; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang JH, 2008, BRIT J CANCER, V98, P611, DOI 10.1038/sj.bjc.6604196; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Weseslindtner L, 2011, AM J TRANSPLANT, V11, P542, DOI 10.1111/j.1600-6143.2010.03404.x; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Windisch W, 2013, J CLIN VIROL, V58, P325, DOI 10.1016/j.jcv.2013.05.020; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943; Zhang K, 1997, J IMMUNOL, V158, P954; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	83	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147010	10.1371/journal.pone.0147010	http://dx.doi.org/10.1371/journal.pone.0147010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807786	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800044
J	Kshatriya, GK; Acharya, SK				Kshatriya, Gautam K.; Acharya, Subhendu K.			Triple Burden of Obesity, Undernutrition, and Cardiovascular Disease Risk among Indian Tribes	PLOS ONE			English	Article							BODY-MASS-INDEX; SOCIOECONOMIC-STATUS; PRESCHOOL-CHILDREN; METABOLIC SYNDROME; DIETARY DIVERSITY; FAT PERCENTAGE; BLOOD-PRESSURE; HEIGHT RATIO; HEALTH-RISKS; HYPERTENSION	Background Socio-cultural transitions among individuals from vulnerable groups introduce epidemiological transition, with a concomitant increase in the prevalence of undernutrition, obesity, and cardiovascular disease risks. An accepted conventional wisdom exists for Indian tribes that they are undernourished and away from lifestyle-related diseases. However, the extent of this triple burden affecting them is unknown. In this study, we assessed this triple burden among the 9 major tribes of India. Methods and Findings During January 2011 to December 2013, we conducted a cross-sectional study among 1066 men and 1090 women constituting a total of 2156 adults belonging to the 9 major tribal groups: Santals, Oraons, and Koras (West Bengal); Santals, Bhumijs, and Bathudis (Odisha); and Dhodias, Kuknas, and Chaudharis (Gujarat) to estimate the prevalence of the triple burden (undernutrition, overweight or obesity, and hypertension). A high prevalence of undernutrition and hypertension was observed among the Koras (51.9% and 10.6%, respectively), Bathudis (51.3% and 12.1%, respectively), and Oraons (49.6% and 16.5%, respectively). However, the prevalence of overweight and hypertension among the Bhumijs (17.7% and 14.7%, respectively), Dhodias (23.8% and 12.9%, respectively), Kuknas (15.8% and 11.3%, respectively), and Santals of West Bengal (12.2% and 11.8%, respectively) and Odisha (15% and 9.6%, respectively) was most alarming. The prevalence of overweight or obesity among the women was 10.9% and 1.5%, respectively, with 14.0% hypertensive women. The prevalence of overweight and obesity among the men was 14.8% and 1.7%, respectively, with 9.2% hypertensive men. Undernutrition was highly prevalent among men and women. However, data from the past 30 years on systolic blood pressure (SBP) and body mass index (BMI) revealed that the studied tribes were at a higher risk than the general Indian population. In addition, a vast gender disparity with relation to the disease and risk prevalence was observed. Conclusion The alarming trend of an increasing prevalence of overweight/obesity, undernutrition, and hypertension is observed among indigenous populations of India, emphasizing the incorporation of a specific health management policy.	[Kshatriya, Gautam K.; Acharya, Subhendu K.] Univ Delhi, Dept Anthropol, Delhi 110007, India	University of Delhi	Kshatriya, GK (corresponding author), Univ Delhi, Dept Anthropol, Delhi 110007, India.	g26_51@yahoo.co.in			Indian Council of Medical Research (ICMR), Government of India [5/4/8-2/2010 NCD-II]	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This study was funded to GKK by the Indian Council of Medical Research (ICMR), Government of India, bearing project reference number 5/4/8-2/2010 NCD-II.	Allen LH, 2006, J PEDIATR GASTR NUTR, V43, pS8, DOI 10.1097/01.mpg.0000255845.99905.20; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2010, STAT ED AM SCHED TRI; [Anonymous], 2010, STAT PROF SCHED TRIB; [Anonymous], 1998, WHONUTNCD981; Arnold F, 2009, NUTR INDIA NATL FAMI; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2009, OBESITY FACTS, V2, P97, DOI 10.1159/000203363; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Basu S., 1990, GENETIC SOCIOCULTURA; Benyshek DC, 2007, COLLEGIUM ANTROPOL, V31, P11; Bisai S, 2010, EJBS, V3, P43; Bisai S, 2014, INT J PEDIATR-MASSHA, V2, P347; Cassels S, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-10; Chandramouli C., 2011, RURAL URBAN DISTRIBU; Cheema A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010404; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Das S, 2013, HUM BIO REV, V2, P359; DAS S, 2012, ANTHROPOL NOTEB, V18, P5; Deurenberg P, 2001, EUR J CLIN NUTR, V55, P973, DOI 10.1038/sj.ejcn.1601254; Diaz ME, 2002, J HUM HYPERTENS, V16, pS18, DOI 10.1038/sj.jhh.1001335; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Gautam Mohan K., 1977, SEARCH IDENTITY CASE; Gautam RK, 2006, TRIBAL HLTH; Ghosh A, 2004, J R SOC PROMO HEALTH, V124, P86, DOI 10.1177/146642400412400213; Ghurye GS, 1963, ANATOMY RURAL URBAN; Gopalan C, 1992, 21 SEARO WHO REG OFF; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Hackenberg R, 1983, HDB N AM INDIANS, V10; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HALL JE, 1994, HYPERTENSION, V23, P381, DOI 10.1161/01.HYP.23.3.381; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; HE J, 1994, AM J EPIDEMIOL, V139, P380, DOI 10.1093/oxfordjournals.aje.a117010; Height Haque M., 1990, CULTURAL ENV DIMENSI, P192; Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hsieh SD, 2000, INT J OBESITY, V24, P358, DOI 10.1038/sj.ijo.0801157; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; JONES DW, 1994, J HYPERTENS, V12, P1433, DOI 10.1097/00004872-199412000-00018; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; Kar GC, 2007, STUDY FOOD RELATED N; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Kesavachandran CN, 2012, INDIAN J MED RES, V135, P72, DOI 10.4103/0971-5916.93427; Kotchen TA, 2008, HYPERTENSION, V52, P801, DOI 10.1161/HYPERTENSIONAHA.108.120915; Kshatriya GK, 2008, ANTHROPOL ANZ, V66, P355, DOI 10.1127/aa/66/2008/355; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Lohman T. G., 1998, ANTROPOMETRIC STANDA; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810; Mahapatra D, 1990, CULTURAL ENV DIMENSI; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2007, INDIAN J MED RES, V125, P345; Misra R, 2011, INT J DIABETES DEV C, V31, P82, DOI 10.1007/s13410-011-0017-3; Mohan V, 2003, J Assoc Physicians India, V51, P771; Mohapatra G, 2012, TRANSCIENCE J GLOBAL, V3, P51; Muth ND., 2009, ACE BLOG        1202; [National Institute of Nutrition Indian Council of Medical Research], 2004, ANN REPORT; National Institute of Nutrition. Indian Council of Medical Research, 2000, SPEC REP ELD AD DIET; National Institute of Nutrition. Indian Council of Medical Research, 1971, ANN REPORT; National Institutes of Health, 1994, BIOEL IMP AN BOD COM, V12, P12; National Nutrition Monitoring Bureau, 2009, 25 NNMB NAT I NUTR I; Padhi S, 2011, 51 CRPC IIPA; Patel RC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001223; Peng Ya-guang, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P607; Radhakrishna R, 2004, ECON POLIT WEEKLY, V39, P14; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Rizwan SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095896; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Sayeed M A, 2003, Bangladesh Med Res Counc Bull, V29, P1; van der Sande MAB, 2001, AM J PUBLIC HEALTH, V91, P1641, DOI 10.2105/AJPH.91.10.1641; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Welthungerhilfe IFPRI Concern Worldwide, 2014, GLOB HUNG IND CHALL; World Health Organization, 2000, INT ASS STUD OB INT; World Health Organization Western Pacific Region International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PAC RED OB IT; Yajnik CS, 2004, P NUTR SOC, V63, P387, DOI 10.1079/PNS2004365	80	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147934	10.1371/journal.pone.0147934	http://dx.doi.org/10.1371/journal.pone.0147934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808418	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800245
J	Lundeen, EA; Norris, SA; Martorell, R; Suchdev, PS; Mehta, NK; Richter, LM; Stein, AD				Lundeen, Elizabeth A.; Norris, Shane A.; Martorell, Reynaldo; Suchdev, Parminder S.; Mehta, Neil K.; Richter, Linda M.; Stein, Aryeh D.			Adolescent Pregnancy and Attained Height among Black South African Girls: Matched-Pair Prospective Study	PLOS ONE			English	Article							FINAL ADULT HEIGHT; MATERNAL GROWTH; NUTRITIONAL-STATUS; BIRTH-WEIGHT; OUTCOMES; AGE; CHILDREN; FATNESS; MOTHERS; SCHOOL	Importance The impact of adolescent pregnancy on offspring birth outcomes has been widely studied, but less is known about its impact on the growth of the young mother herself. Objective To determine the association between adolescent pregnancy and attained height. Design Prospective birth cohort study. Setting Cohort members followed from birth to age 20 y in Soweto, South Africa. Participant From among 840 Black females with sufficient data, we identified 54 matched pairs, in which a girl who became pregnant before the age of 17 years was matched with a girl who did not have a pregnancy by age 20 y. Pairs were matched on age at menarche and height-for-age z scores in the year before the case became pregnant (mean 15.0 y). Main Outcome Measures The two groups were compared with respect to attained height, measured at mean age 18.5 y. Results Mean age at conception was 15.9 years (range: 13.7 to 16.9 y). Mean height at matching was 159.4 cm in the adolescent pregnancy group and 159.3 cm in the comparison group (p = 0.3). Mean attained height was 160.4 cm in the adolescent pregnancy group and 160.3 cm in the comparison group (p = 0.7). Conclusions Among Black females in Soweto, South Africa, adolescent pregnancy was not associated with attained height.	[Lundeen, Elizabeth A.] Emory Univ, Laney Grad Sch, Div Biol & Biomed Sci, Nutr & Hlth Sci Program, Atlanta, GA 30322 USA; [Lundeen, Elizabeth A.; Norris, Shane A.; Richter, Linda M.; Stein, Aryeh D.] Univ Witwatersrand, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Martorell, Reynaldo; Suchdev, Parminder S.; Mehta, Neil K.; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa	Emory University; University of Witwatersrand; Emory University; Rollins School Public Health; University of Witwatersrand	Stein, AD (corresponding author), Univ Witwatersrand, MRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa.; Stein, AD (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Suchdev, Parmi S/K-4851-2012; Norris, Shane/C-4664-2014; Martorell, Reynaldo/I-2539-2012	Norris, Shane/0000-0001-7124-3788; Stein, Aryeh/0000-0003-1138-6458	Bill and Melinda Gates Foundation; Laney Graduate School at Emory University; Wellcome Trust (UK); Medical Research Council of South Africa; Anglo-American Chairman's Fund; University of the Witwatersrand; Human Sciences Research Council of South Africa; South African National Research Foundation; Medical Research Council [G1001333] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Laney Graduate School at Emory University; Wellcome Trust (UK)(Wellcome Trust); Medical Research Council of South Africa(South African Medical Research Council); Anglo-American Chairman's Fund; University of the Witwatersrand; Human Sciences Research Council of South Africa; South African National Research Foundation(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Bill and Melinda Gates Foundation and the Laney Graduate School at Emory University. The Birth-to-Twenty study has received financial and logistic support from the Wellcome Trust (UK), the Medical Research Council of South Africa, the Anglo-American Chairman's Fund, the University of the Witwatersrand, the Human Sciences Research Council of South Africa, and the South African National Research Foundation. The funders had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.	BACCI A, 1993, INT J GYNECOL OBSTET, V40, P19, DOI 10.1016/0020-7292(93)90767-Q; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Brennan L, 2005, J BIOSOC SCI, V37, P185, DOI 10.1017/S0021932003006515; Cameron N., 1984, MEASUREMENT HUMAN GR; Casanueva E, 2006, J NUTR, V136, P2498, DOI 10.1093/jn/136.10.2498; de Almeida MDC, 2011, CAD SAUDE PUBLICA, V27, P2386, DOI 10.1590/S0102-311X2011001200010; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Frisancho AR, 1997, ANN NY ACAD SCI, V817, P272, DOI 10.1111/j.1749-6632.1997.tb48213.x; FRISCH RE, 1976, HUM BIOL, V48, P353; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; Gigante DP, 2005, J NUTR, V135, P74, DOI 10.1093/jn/135.1.74; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Gortzak-Uzan L, 2001, J Matern Fetal Med, V10, P393; Gunderson EP, 2009, ARCH PEDIAT ADOL MED, V163, P349, DOI 10.1001/archpediatrics.2009.9; Hediger ML, 1997, ANN NY ACAD SCI, V817, P281, DOI 10.1111/j.1749-6632.1997.tb48214.x; Igwegbe A O, 2001, J Obstet Gynaecol, V21, P478, DOI 10.1080/01443610120072027; Jolly MC, 2000, OBSTET GYNECOL, V96, P962, DOI 10.1016/S0029-7844(00)01075-9; Klein JD, 2005, PEDIATRICS, V116, P281, DOI 10.1542/peds.2005-0999; Koniak-Griffin D, 2001, J PERINAT NEONAT NUR, V15, P1; Lundeen EA, J NUTR IN PRESS; Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Pauli JM, 2013, ARCH GYNECOL OBSTET, V288, P679, DOI 10.1007/s00404-013-2781-4; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Roche, 1989, GROWTH GENETICS HORM, V5, P4; ROCHE AF, 1972, PEDIATRICS, V50, P874; SATIN AJ, 1994, AM J OBSTET GYNECOL, V171, P184, DOI 10.1016/0002-9378(94)90467-7; SCHOLL TO, 1990, AM J CLIN NUTR, V51, P790, DOI 10.1093/ajcn/51.5.790; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; WHO, 2006, WHO CHILD GROWTH STA	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147861	10.1371/journal.pone.0147861	http://dx.doi.org/10.1371/journal.pone.0147861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808552	Green Submitted, Green Published, gold			2022-12-27	WOS:000369527800233
J	Roura, E; Travier, N; Waterboer, T; de Sanjose, S; Bosch, FX; Pawlita, M; Pala, V; Weiderpass, E; Margall, N; Dillner, J; Gram, IT; Tjonneland, A; Munk, C; Palli, D; Khaw, KT; Overvad, K; Clavel-Chapelon, F; Mesrine, S; Fournier, A; Fortner, RT; Ose, J; Steffen, A; Trichopoulou, A; Lagiou, P; Orfanos, P; Masala, G; Tumino, R; Sacerdote, C; Polidoro, S; Mattiello, A; Lund, E; Peeters, PH; Bueno-de-Mesquita, HB; Quiros, JR; Sanchez, MJ; Navarro, C; Barricarte, A; Larranaga, N; Ekstrom, J; Lindquist, D; Idahl, A; Travis, RC; Merritt, MA; Gunter, MJ; Rinaldi, S; Tommasino, M; Franceschi, S; Riboli, E; Castellsague, X				Roura, Esther; Travier, Noemie; Waterboer, Tim; de Sanjose, Silvia; Bosch, F. Xavier; Pawlita, Michael; Pala, Valeria; Weiderpass, Elisabete; Margall, Nuria; Dillner, Joakim; Gram, Inger T.; Tjonneland, Anne; Munk, Christian; Palli, Domenico; Khaw, Kay-Tee; Overvad, Kim; Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes; Fortner, Renee T.; Ose, Jennifer; Steffen, Annika; Trichopoulou, Antonia; Lagiou, Pagona; Orfanos, Philippos; Masala, Giovanna; Tumino, Rosario; Sacerdote, Carlotta; Polidoro, Silvia; Mattiello, Amalia; Lund, Eiliv; Peeters, Petra H.; Bueno-de-Mesquita, H. B(as).; Quiros, J. Ramon; Sanchez, Maria-Jose; Navarro, Carmen; Barricarte, Aurelio; Larranaga, Nerea; Ekstrom, Johanna; Lindquist, David; Idahl, Annika; Travis, Ruth C.; Merritt, Melissa A.; Gunter, Marc J.; Rinaldi, Sabina; Tommasino, Massimo; Franceschi, Silvia; Riboli, Elio; Castellsague, Xavier			The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ORAL-CONTRACEPTIVES; INTRAEPITHELIAL NEOPLASIA; REPRODUCTIVE FACTORS; REPLACEMENT THERAPY; WOMEN; HPV; SMOKING; PARITY; CARCINOGENESIS	Background In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). Methods and Findings We followed a cohort of 308,036 women recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. At enrollment, participants completed a questionnaire and provided serum. After a 9-year median follow-up, 261 ICC and 804 CIN3/CIS cases were reported. In a nested case-control study, the sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11,16,18,31,33,35,45, 52,58, and antibodies against Chlamydia trachomatis and Human herpesvirus 2. Multivariate analyses were performed to estimate hazard ratios (HR), odds ratios (OR) and corresponding 95% confidence intervals (CI). The cohort analysis showed that number of fullterm pregnancies was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated with a significantly increased risk of both CIN3/CIS and ICC (HR = 1.6 and HR = 1.8 respectively for >= 15 years versus never use). Ever use of menopausal hormone therapy was associated with a reduced risk of ICC (HR = 0.5, 95% CI: 0.4-0.8). A non-significant reduced risk of ICC with ever use of intrauterine devices (IUD) was found in the nested case-control analysis (OR = 0.6). Analyses restricted to all cases and HPV seropositive controls yielded similar results, revealing a significant inverse association with IUD for combined CIN3/CIS and ICC (OR = 0.7). Conclusions Even though HPV is the necessary cause of CC, our results suggest that several hormonal factors are risk factors for cervical carcinogenesis. Adherence to current cervical cancer screening guidelines should minimize the increased risk of CC associated with these hormonal risk factors.	[Roura, Esther; de Sanjose, Silvia; Bosch, F. Xavier; Castellsague, Xavier] Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Infect & Canc, Barcelona, Catalonia, Spain; [Roura, Esther; de Sanjose, Silvia; Sanchez, Maria-Jose; Navarro, Carmen; Barricarte, Aurelio; Larranaga, Nerea; Castellsague, Xavier] CIBERESP, Madrid, Spain; [Travier, Noemie] Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Catalonia, Spain; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Res Program Infect Inflammat & Canc, Div Mol Diagnost Oncogen Infect F020, Heidelberg, Germany; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Weiderpass, Elisabete; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete; Gram, Inger T.; Lund, Eiliv] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Margall, Nuria] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Microbiol, E-08193 Barcelona, Catalonia, Spain; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Diet Genes & Environm, Copenhagen, Denmark; [Munk, Christian] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Palli, Domenico; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Cambridge, England; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Nutr Hormones & Womens Hlth Team, Ctr Res Epidemiol & Populat Hlth CESP, INSERM, U318, F-94705 Villejuif, France; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Univ Paris Sud, UMRS 318, F-94705 Villejuif, France; [Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes] Inst Gustave Roussy, F-94705 Villejuif, France; [Fortner, Renee T.; Ose, Jennifer] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Steffen, Annika] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia; Orfanos, Philippos] Hellen Hlth Fdn, Athens, Greece; [Lagiou, Pagona; Orfanos, Philippos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA; [Tumino, Rosario] Civic MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta] Ctr Canc Epidemiol & Prevent CPO Piemonte, Turin, Italy; [Polidoro, Silvia] Human Genet Fdn HuGeF, Turin, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Peeters, Petra H.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. B(as).] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. B(as).] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. B(as).; Merritt, Melissa A.; Gunter, Marc J.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Bueno-de-Mesquita, H. B(as).] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Quiros, J. Ramon] Publ Hlth Directorate, Asturias, Spain; [Sanchez, Maria-Jose] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain; [Navarro, Carmen] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain; [Barricarte, Aurelio] Navarra Publ Hlth Inst, Pamplona, Spain; [Barricarte, Aurelio] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Larranaga, Nerea] BIODonostia Res Inst, Basque Hlth Dept, Publ Hlth Div Gipuzkoa, Bilbao, Spain; [Ekstrom, Johanna] Lund Univ, BBMRI Se Serv Ctr Southern Sweden, Lund, Sweden; [Lindquist, David] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Idahl, Annika] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden; [Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Rinaldi, Sabina; Tommasino, Massimo; Franceschi, Silvia] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Helmholtz Association; German Cancer Research Center (DKFZ); Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; UiT The Arctic University of Tromso; University of Oslo; Folkhalsan Research Center; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Karolinska Institutet; Danish Cancer Society; Danish Cancer Society; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Cambridge; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Civile M.P. Arezzo Hospital; University of Turin; University of Naples Federico II; Imperial College London; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Imperial College London; Universiti Malaya; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; University of Murcia; Public Health Institute of Navarra; Lund University; Umea University; Umea University; University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC)	Roura, E (corresponding author), Hosp Llobregat, Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Infect & Canc, Barcelona, Catalonia, Spain.; Roura, E (corresponding author), CIBERESP, Madrid, Spain.	eroura@iconcologia.net	Mattiello, Amalia AM/K-5112-2016; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Weiderpass, Elisabete/AAP-2747-2021; Masala, Giovanna/AAC-5474-2022; de Sanjosé Llongueras, Silvia/H-6339-2014; Steffen, Annika/H-7709-2018; Polidoro, Silvia/GYJ-3517-2022; Waterboer, Tim/G-1252-2010; Khaw, Kay-Tee/AAZ-3209-2021; Pala, Valeria/K-4738-2016; Steffen, Annika/E-8540-2016; franceschi, silvia/M-2452-2014; Lindquist, David/AAM-3662-2020; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Gunter, Marc/AAP-8621-2020; Weiderpass, Elisabete/M-4029-2016; Fournier, Agnès/H-4615-2018; Sánchez, Maria-José/D-1087-2011; Pique, Xavier Castellsagué/N-5795-2014; Orfanos, Philippos/AAL-2606-2021	Mattiello, Amalia AM/0000-0003-3676-7353; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Weiderpass, Elisabete/0000-0003-2237-0128; Masala, Giovanna/0000-0002-5758-9069; Steffen, Annika/0000-0003-4072-9245; Pala, Valeria/0000-0001-5438-970X; Steffen, Annika/0000-0003-4072-9245; franceschi, silvia/0000-0003-4181-8071; Lindquist, David/0000-0002-7507-937X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Weiderpass, Elisabete/0000-0003-2237-0128; Fournier, Agnès/0000-0001-8380-3439; Sánchez, Maria-José/0000-0003-4817-0757; Pique, Xavier Castellsagué/0000-0002-0802-3595; Rasul, holem/0000-0003-0579-9029; Navarro, Carmen/0000-0001-8896-7483; Pawlita, Michael/0000-0002-4720-8306; Riboli, Elio/0000-0001-6795-6080; Polidoro, Silvia/0000-0003-2968-0575; Orfanos, Philippos/0000-0002-9949-3137; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Fortner, Renee/0000-0002-1426-8505; Larranaga, Nerea/0000-0002-9993-9880; Tjonneland, Anne/0000-0003-4385-2097; Gunter, Marc/0000-0001-5472-6761; Lund, Eiliv/0000-0002-8071-8711; Travier, Noemie/0000-0001-5228-7769; Tommasino, Massimo/0000-0002-0890-8596	Instituto de Salud Carlos III (Spanish Government) [FIS PI08/1308, PI13/00053, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, RD12/0036/0018, CIBERESP]; Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government) [AGAUR 2005SGR00695, 2009SGR939, 2009SGR126, 2014SGR1077, 2014SGR2016]; European Commission (DG-SANCO); International Agency for Research on Cancer; Health Research Fund (FIS) of the Spanish Ministry of Health [P10710130]; Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra and the Catalan Institute of Oncology, La Caixa (Spain) [BM 06-130, RTICC-RD06/10091]; Danish Cancer Society (Denmark); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council (United Kingdom); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway); Cancer Research UK [16491, 14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	Instituto de Salud Carlos III (Spanish Government)(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government); European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Health Research Fund (FIS) of the Spanish Ministry of Health(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra and the Catalan Institute of Oncology, La Caixa (Spain); Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany)(Deutsche Krebshilfe); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy)(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden)(Swedish Cancer Society); Cancer Research UK, Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was partially supported by grants from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI08/1308, PI13/00053, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, RD12/0036/0018, and CIBERESP) and from the Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695, 2009SGR939 and 2009SGR126, 2014SGR1077, 2014SGR2016). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the Health Research Fund (FIS) of the Spanish Ministry of Health (Exp P10710130), Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236), Navarra and the Catalan Institute of Oncology, La Caixa (BM 06-130), RTICC-RD06/10091 (Spain); Danish Cancer Society (Denmark); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) and Statistics Netherlands (The Netherlands); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council (United Kingdom); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Berrington A, 2002, LANCET, V360, P410, DOI 10.1016/S0140-6736(02)09578-8; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castellsague X, 2014, INT J CANCER, V135, P440, DOI 10.1002/ijc.28665; Castellsague X, 2011, LANCET ONCOL, V12, P1023, DOI 10.1016/S1470-2045(11)70223-6; Castle PE, 2005, INT J CANCER, V117, P1007, DOI 10.1002/ijc.21279; Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Daling JR, 1996, CANCER EPIDEM BIOMAR, V5, P541; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gadducci A, 2011, GYNECOL ENDOCRINOL, V27, P597, DOI 10.3109/09513590.2011.558953; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V91, P1; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Lacey JV, 2000, GYNECOL ONCOL, V77, P149, DOI 10.1006/gyno.2000.5731; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; Moodley M, 2003, INT J GYNECOL CANCER, V13, P103, DOI 10.1136/ijgc-00009577-200303000-00001; Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Parazzini F, 1997, BRIT MED J, V315, P85, DOI 10.1136/bmj.315.7100.85; PARAZZINI F, 1989, BRIT J CANCER, V59, P805, DOI 10.1038/bjc.1989.168; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2011, CANCER EPIDEM BIOMAR, V20, P2532, DOI 10.1158/1055-9965.EPI-11-0753; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Russo E, 2011, J LOW GENIT TRACT DI, V15, P195, DOI 10.1097/LGT.0b013e31820918ea; Schneider C, 2009, CLIMACTERIC, V12, P514, DOI 10.3109/13697130903075352; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Shields TS, 2004, CANCER EPIDEM BIOMAR, V13, P1574; Syrjanen K, 2006, ANTICANCER RES, V26, P4729; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Yoo YA, 2013, AM J PATHOL, V183, P1679, DOI 10.1016/j.ajpath.2013.07.026; Zondervan KT, 1996, BRIT J CANCER, V73, P1291, DOI 10.1038/bjc.1996.247	41	69	77	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147029	10.1371/journal.pone.0147029	http://dx.doi.org/10.1371/journal.pone.0147029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808155	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800047
J	Sharma, S; Sapkota, D; Xue, Y; Sun, Y; Finne-Wistrand, A; Bruland, O; Mustafa, K				Sharma, Sunita; Sapkota, Dipak; Xue, Ying; Sun, Yang; Finne-Wistrand, Anna; Bruland, Ove; Mustafa, Kamal			Adenoviral Mediated Expression of BMP2 by Bone Marrow Stromal Cells Cultured in 3D Copolymer Scaffolds Enhances Bone Formation	PLOS ONE			English	Article							BIODEGRADABLE POLYMER SCAFFOLDS; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VIVO; OSTEOGENIC DIFFERENTIATION; UP-REGULATION; GENE-THERAPY; II COLLAGEN; REGENERATION	Selection of appropriate osteoinductive growth factors, suitable delivery method and proper supportive scaffold are critical for a successful outcome in bone tissue engineering using bone marrow stromal cells (BMSC). This study examined the molecular and functional effect of a combination of adenoviral mediated expression of bone morphogenetic protein-2 (BMP2) in BMSC and recently developed and characterized, biodegradable Poly(L-lactideco-epsilon-caprolactone){poly(LLA-co-CL)} scaffolds in osteogenic molecular changes and ectopic bone formation by using in vitro and in vivo approaches. Pathway-focused custom PCR array, validation using TaqMan based quantitative RT-PCR (qRT-PCR) and ALP staining showed significant up-regulation of several osteogenic and angiogenic molecules, including ALPL and RUNX2 in ad-BMP2 BMSC group grown in poly(LLA-co-CL) scaffolds both at 3 and 14 days. Micro CT and histological analyses of the subcutaneously implanted scaffolds in NOD/SCID mice revealed significantly increased radiopaque areas, percentage bone volume and formation of vital bone in ad-BMP2 scaffolds as compared to the control groups both at 2 and 8 weeks. The increased bone formation in the ad-BMP2 group in vivo was paralleled at the molecular level with concomitant over-expression of a number of osteogenic and angiogenic genes including ALPL, RUNX2, SPP1, ANGPT1. The increased bone formation in ad-BMP2 explants was not found to be associated with enhanced endochondral activity as evidenced by qRT-PCR (SOX9 and FGF2) and Safranin O staining. Taken together, combination of adenoviral mediated BMP-2 expression in BMSC grown in the newly developed poly(LLA-co-CL) scaffolds induced expression of osteogenic markers and enhanced bone formation in vivo.	[Sharma, Sunita; Xue, Ying; Sun, Yang; Mustafa, Kamal] Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway; [Sapkota, Dipak] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Sun, Yang; Finne-Wistrand, Anna] Royal Inst Technol, Dept Fibre & Polymer Technol, Stockholm, Sweden; [Bruland, Ove] Haukeland Hosp, Dept Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Royal Institute of Technology; University of Bergen; Haukeland University Hospital	Mustafa, K (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway.	kamal.mustafa@uib.no	Mustafa, Kamal/ABD-4458-2020	Sapkota, Dipak/0000-0003-0061-825X	Meltzer Research Fund; European Union FP7, VascuBone [242175]; European Union [242175]	Meltzer Research Fund; European Union FP7, VascuBone; European Union(European Commission)	We acknowledge the financial support by Meltzer Research Fund and The European Union FP7, VascuBone, (Project number 242175).; This work was supported by the European Union 7th Frame Program, VascuBone (Project number 242175) to KM, and the Meltzer Research Fund to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeel S, 2012, ARCH ORAL BIOL, V57, P445, DOI 10.1016/j.archoralbio.2011.10.002; Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]; Calori GM, 2009, INJURY, V40, P67; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang SCN, 2010, J BIOMED MATER RES A, V94A, P433, DOI 10.1002/jbm.a.32685; Chiu LH, 2014, BIOMATERIALS, V35, P2680, DOI 10.1016/j.biomaterials.2013.12.005; Danmark S, 2011, ACTA BIOMATER, V7, P2035, DOI 10.1016/j.actbio.2011.02.011; Danmark S, 2010, J BIOACT COMPAT POL, V25, P207, DOI 10.1177/0883911509358812; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Idris SB, 2010, J BIOACT COMPAT POL, V25, P567, DOI 10.1177/0883911510381368; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74; Odelius K, 2005, BIOMACROMOLECULES, V6, P2718, DOI 10.1021/bm050190b; Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.02.009; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; Suliman S, 2015, J CONTROL RELEASE, V197, P148, DOI 10.1016/j.jconrel.2014.11.003; Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; Xing Z, 2013, TISSUE ENG PT A, V19, P1783, DOI [10.1089/ten.TEA.2012.0336, 10.1089/ten.tea.2012.0336]; Xing Z, 2011, J BIOMED MATER RES A, V96A, P349, DOI 10.1002/jbm.a.32989; Xue Y, 2010, J BIOMED MATER RES A, V95A, P1244, DOI 10.1002/jbm.a.32945; Yang L, 2010, J PERIODONTAL RES, V45, P532, DOI 10.1111/j.1600-0765.2009.01268.x; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411	37	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147507	10.1371/journal.pone.0147507	http://dx.doi.org/10.1371/journal.pone.0147507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808122	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800116
J	Shi, L; Li, NW; Wang, SQ; Zhou, YB; Huang, WJ; Yang, YC; Ma, YP; Zhou, RC				Shi, Lin; Li, Naiwei; Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Ma, Yongpeng; Zhou, Renchao			Molecular Evidence for the Hybrid Origin of Ilex dabieshanensis (Aquifoliaceae)	PLOS ONE			English	Article							SUNFLOWER HELIANTHUS-ANNUUS; SPECIES AQUIFOLIACEAE; ADAPTIVE INTROGRESSION; L. AQUIFOLIACEAE; SEQUENCE DATA; HYBRIDIZATION; HISTORY; BIOLOGY; MARKERS; TRAITS	Ilex, the largest genus of dioecious woody plants, is a good study system to assess the role of hybridization in speciation and evolution. Ilex dabieshanensis, a tree endemic to Dabieshan Mountains region, was initially described as a new species. Based on morphological intermediacy and sympatric distribution with its putative parental species, I. cornuta and I. latifolia, we proposed it as a natural hybrid between them. In this study, we sequenced one chloroplast intergenic spacer (trnH-psbA) and two nuclear genes (gapC and nepGS) in I. dabieshanensis and its putative parental species to test the hybrid origin hypothesis. Our results showed that there were one to two differentially fixed sequence differences between I. cornuta and I. latifolia at the two nuclear genes. Twelve of the 14 individuals of I. dabieshanensis exhibited additivity in chromatograms on these differentially fixed sites at both nuclear genes, and the remaining two exhibited additivity in chromatograms on the fixed site at only the nepGS gene. Except one haplotype of I. cornuta at the nepGS gene, all of the haplotypes of I. cornuta at the two nuclear genes were well separated from those of I. latifolia, and most haplotypes of I. dabieshanensis were shared with those of I. cornuta and I. latifolia. Phylogenetic analysis of these haplotypes was largely consistent with haplotype network analysis. I. cornuta and I. latifolia differed by two nucleotide substitutions in the chloroplast intergenic spacer, and 12 individuals of I. dabieshanensis had the same sequences as I. latifolia, while the remaining two were identical with I. cornuta. The molecular data provide convincing evidence for the hybrid origin of I. dabieshanensis and asymmetrical direction of hybridization. One haplotype of I. cornuta at the nepGS gene was nested with those of I. latifolia, indicating introgression to I. cornuta.	[Shi, Lin] Shunde Polytech, Foshan 528333, Peoples R China; [Li, Naiwei] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing 210014, Jiangsu, Peoples R China; [Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Zhou, Renchao] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Shuqiong; Zhou, Yubing; Huang, Weijie; Yang, Yuchen; Zhou, Renchao] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Yongpeng] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China	Shunde Polytechnic; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhou, RC (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, RC (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China.; Ma, YP (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China.	mayongpeng@mail.kib.ac.cn; zhrench@mail.sysu.edu.cn	Yang, Yuchen/GZK-6062-2022		National Natural Science Foundation of China [31170213, 91231106]; Fundamental Research Funds for the Central Universities [15lgjc23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170213 and 91231106) and the Fundamental Research Funds for the Central Universities (15lgjc23) to RZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; BAAS P, 1978, BOT J LINN SOC, V77, P41, DOI 10.1111/j.1095-8339.1978.tb01371.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Chen S.K., 2008, FLORA CHINA, V11, P359; Chen S.-K., 1999, FLORA REIPUBLICAE PO, V45, P1; Cuenoud P, 2000, ANN BOT-LONDON, V85, P111, DOI 10.1006/anbo.1999.1003; Doyle J. J., 1987, PHYTOCHEM B, P11; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Galle F.C., 1997, HOLLIES GENUS ILEX; GARGIULLO MB, 1991, J CHEM ECOL, V17, P1091, DOI 10.1007/BF01402936; Gottlieb AM, 2005, AM J BOT, V92, P352, DOI 10.3732/ajb.92.2.352; Hamilton MB, 1999, MOL ECOL, V8, P521; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Lee NS, 2006, J PLANT BIOL, V49, P491, DOI 10.1007/BF03031131; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loesener T., 1942, NATURLICHEN PFLANZ B, V20b, P36; Loizeau PA, 2004, FLOWERING PLANTS NEO, P26; Lu X, 2007, J JIANGSU FORESTRY S, V34, P32; Manen JF, 2010, MOL PHYLOGENET EVOL, V57, P961, DOI 10.1016/j.ympev.2010.09.006; Manen JF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-46; Manen JF, 2002, PLANT SYST EVOL, V235, P79, DOI 10.1007/s00606-002-0225-x; Martinez MAD, 1997, BIOCHEM SYST ECOL, V25, P619, DOI 10.1016/S0305-1978(97)00054-9; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Powell M., 2000, KEW B, V55, P341; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; Snow B. K., 1988, BIRDS BERRIES STUDY; Son SW, 2009, GENES GENOM, V31, P53, DOI 10.1007/BF03191138; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strand AE, 1997, MOL ECOL, V6, P113, DOI 10.1046/j.1365-294X.1997.00153.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsang ACW, 2005, CAN J BOT, V83, P1645, DOI 10.1139/b05-131; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, NEW PHYTOL, V187, P230, DOI 10.1111/j.1469-8137.2010.03234.x; Yao K., 1987, ACTA PHYTOTAXONOMICA, V25, P324	39	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147825	10.1371/journal.pone.0147825	http://dx.doi.org/10.1371/journal.pone.0147825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808531	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800218
J	Shokoohi, M; Karamouzian, M; Khajekazemi, R; Osooli, M; Sharifi, H; Haghdoost, AA; Kamali, K; Mirzazadeh, A				Shokoohi, Mostafa; Karamouzian, Mohammad; Khajekazemi, Razieh; Osooli, Mehdi; Sharifi, Hamid; Haghdoost, Ali Akbar; Kamali, Kianoush; Mirzazadeh, Ali			Correlates of HIV Testing among Female Sex Workers in Iran: Findings of a National Bio-Behavioural Surveillance Survey	PLOS ONE			English	Article							RISK BEHAVIORS; HIV/AIDS; PEOPLE	Introduction Female sex workers (FSWs) are the second most affected population by HIV in Iran. However, their HIV testing practices are poorly understood. The aim of this study was to investigate testing and its associated factors among HIV negative FSWs. Materials and Methods Using facility based sampling, 1005 FSWs were recruited in 14 cities of Iran in 2010. Biological and survey data were collected through dried blood spot testing and standardized risk assessment questionnaire, respectively. In this paper, the prevalence of HIV testing and its correlates were explored among 714 HIV-negative FSWs using descriptive statistics and logistic regression models. Results Overall 65.4% had not tested in the past year. Only 27.5% had tested in the past year and received their results. FSWs who perceived themselves at risk of HIV (Adjusted Odds Ratio (AOR) = 8.35, 95% CI: 1.46, 47.6), had received free condom during past year (AOR = 3.90, 95% CI: 1.67, 9.14), started sex work at an older age (AOR18-24 = 2.83, 95% CI: 1.14, 7.0; AOR (>24) = 2.76, 95% CI: 1.11, 6.84), and knew an HIV testing site (AOR = 5.67, 95% CI: 2.60, 12.4) had a significantly higher chance of having a recent HIV test result. Conclusions Less than one third of FSWs in Iran knew their recent HIV status. Interventions to help FSWs evaluate their potential risk for HIV and integrate HIV testing services in condom distribution programs, could be viable strategies in increasing HIV testing uptake among FSWs. Health policy makers should also try to de-stigmatize HIV testing, identify the barriers to HIV testing, and make HIV testing sites more visible to FSWs.	[Shokoohi, Mostafa; Karamouzian, Mohammad; Sharifi, Hamid; Mirzazadeh, Ali] Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran; [Shokoohi, Mostafa; Karamouzian, Mohammad; Sharifi, Hamid; Mirzazadeh, Ali] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Khajekazemi, Razieh; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Osooli, Mehdi] Lund Univ, Dept Translat Med, Ctr Haemostasis & Thrombosis, Skane Univ Hosp, Lund, Sweden; [Kamali, Kianoush] Minist Hlth & Med Educ, Ctr Dis Control, Tehran, Iran; [Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Lund University; Skane University Hospital; Ministry of Health & Medical Education (MOHME); University of California System; University of California San Francisco	Karamouzian, M (corresponding author), Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran.; Karamouzian, M (corresponding author), Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran.	Karamouzian.m@gmail.com	Karamouzian, Mohammad/C-9277-2018; Osooli, Mehdi/A-6457-2009; Mirzazadeh, Ali/AAJ-5907-2021; Haghdoost, Ali Akbar/C-2823-2009; Sharifi, Hamid/B-5493-2019	Karamouzian, Mohammad/0000-0002-5631-4469; Osooli, Mehdi/0000-0002-9862-3665; Haghdoost, Ali Akbar/0000-0003-4628-4849; Sharifi, Hamid/0000-0002-9008-7618	HIV/STI office at the Ministry of Health; Ministry of Health of Iran	HIV/STI office at the Ministry of Health; Ministry of Health of Iran	The authors are thankful to the HIV/STI office at the Ministry of Health for their technical and financial support of the study. We would also like to acknowledge the provincial university supervisors and staff who assisted us in data collection. Our gratitude also goes to the FSWs who took part in the study.; The survey was financially supported by the Ministry of Health of Iran in 2010. However, the authors received no funding for this specific paper.	[Anonymous], 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120595, DOI 10.1371/JOURNAL.PONE.0120595]; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Chow EP, RISK BEHAV FEMALE SE; Deering KN, 2015, AIDS CARE, V27, P499, DOI 10.1080/09540121.2014.978730; Donoghoe M, 2009, WHO UNODC UNAIDS TEC; Dugas M, 2015, JAIDS-J ACQ IMM DEF, V68, pS198, DOI 10.1097/QAI.0000000000000463; Elhadi M, 2013, SEXUALLY TRANSMITTED; Fahimfar N, 2013, IRAN J PUBLIC HEALTH, V42, P98; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Karamouzian M, 2015, J ASSOC NURSE AIDS C, V26, P46, DOI 10.1016/j.jana.2014.04.005; Karamouzian M, 2014, J ADOLESCENT HEALTH, V55, P149, DOI 10.1016/j.jadohealth.2014.04.009; Karamouzian M, 2014, INT J HEALTH POLICY, V2, P81, DOI 10.15171/ijhpm.2014.19; Kazerooni PA., 2014, J HLTH SCI SURVEILLA, V2, P99; Khajehkazemi R, 2014, SEX HEALTH, V11, P568, DOI 10.1071/SH14165; Kolahi A, 2012, QOM U MED SCI J, V6; Mirzazadeh A, 2014, AIDS BEHAV, V18, pS19, DOI 10.1007/s10461-013-0548-3; Mirzazadeh A, 2013, AIDS BEHAV, V17, P623, DOI 10.1007/s10461-012-0285-z; Mohebbi M, 2015, SEXUALLY TRANSMITTED, V81, P180; MOHME National AIDS Committee Secretariat, 2010, ISL REP IR AIDS PROG; Nasirian M, 2012, J RES HEALTH SCI, V12, P81; National ACS, 2015, ISLAMIC REPUBLIC IRA, P73; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2015, ISL REP IR AIDS PROG; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Sajadi L, 2013, SEX TRANSM INFECT, V89, P37, DOI 10.1136/sextrans-2013-051028; Uddin SM, 2014, JPN J INFECT DIS, V67, P191, DOI 10.7883/yoken.67.191; UNAIDS, GLOB AIDS RESP PROGR; *UNAIDS, 2011, MIDDL E N AFR REG RE; UNAIDS, 2014, THE GAP REP; Valadez JJ, 2013, FILLING KNOWLEDGE GA; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e	32	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147587	10.1371/journal.pone.0147587	http://dx.doi.org/10.1371/journal.pone.0147587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9FZ	26807584	gold, Green Published, Green Submitted			2022-12-27	WOS:000369527800140
J	Simanski, M; Rademacher, F; Schroder, L; Glaser, R; Harder, J				Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Glaeser, Regine; Harder, Juergen			The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes	PLOS ONE			English	Article							INTERLEUKIN-1-ALPHA SECRETION; HUMAN BETA-DEFENSIN-2; KAPPA-B; RNASE 7; SKIN; IL-1-BETA; ACTIVATION; EXPRESSION; PRECURSOR; ADAM17	Staphylococcus (S.) aureus is an important pathogen causing various infections including those of the skin. Keratinocytes are able to sense invading S. aureus and to initiate a fast defense reaction by the rapid release of innate defense mediators such as antimicrobial peptides and cytokines. There is increasing evidence that the cytokines IL-1alpha and IL-1beta, which both signal through the IL-1 receptor, play an important role in cutaneous defense against S. aureus. The aim of this study was to gain more insight into the underlying mechanisms leading to the S. aureus-induced IL-1alpha and IL-1beta expression in keratinocytes. Infection of human primary keratinocytes with S. aureus led to the induction of gene expression and protein secretion of IL-1alpha and IL-1beta. Full S. aureus-induced IL-1 protein release required the inflammasome components caspase-1 and ASC (apoptosis-associated speck-like protein containing a CARD) whereas gene induction of IL-1alpha and IL-1beta by S. aureus was not dependent on caspase-1 and ASC. Since patients receiving anti-cancer therapy by inhibition of the epidermal growth factor receptor (EGFR) often suffer from skin infections caused by S. aureus we additionally evaluated whether the EGFR pathway may be involved in the IL-1alpha and IL-1beta induction by S. aureus. Inactivation of the EGFR with a blocking antibody decreased the S. aureus-mediated IL-1alpha and IL-1beta induction in primary keratinocytes. Moreover, the use of siRNA experiments revealed that ADAM17 (A Disintegrin and A Metalloprotease 17), a metalloproteinase known to mediate the shedding and release of EGFR ligands, was required for full induction of IL-1alpha and IL-1beta in keratinocytes infected with S. aureus. A failure of keratinocytes to adequately upregulate IL-1alpha and IL-1beta may promote S. aureus skin infections.	[Simanski, Maren; Rademacher, Franziska; Schroeder, Lena; Glaeser, Regine; Harder, Juergen] Univ Kiel, Dept Dermatol, Schittenhelmstr 7, Kiel, Germany	University of Kiel	Harder, J (corresponding author), Univ Kiel, Dept Dermatol, Schittenhelmstr 7, Kiel, Germany.	jharder@dermatology.uni-kiel.de		Harder, Jurgen/0000-0002-4075-4603	German Research Foundation [HA 3386/5-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by a grant of the German Research Foundation given to JH (HA 3386/5-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Breshears LM, 2012, J BIOL CHEM, V287, P32578, DOI 10.1074/jbc.M112.352534; COOPER KD, 1990, J INVEST DERMATOL, V95, pS24, DOI 10.1111/1523-1747.ep12505698; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Glaser R, 2014, J INVEST DERMATOL, V134, P2347, DOI 10.1038/jid.2014.176; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Grimstad O, 2013, J DERMATOL SCI, V72, P45, DOI 10.1016/j.jdermsci.2013.05.006; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kisich KO, 2007, J INVEST DERMATOL, V127, P2368, DOI 10.1038/sj.jid.5700861; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LG, 2009, INFECT DIS CLIN N AM, V23, P35, DOI 10.1016/j.idc.2008.10.002; Milora KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6230; Mistry RD, 2013, PEDIATR CLIN N AM, V60, P1063, DOI 10.1016/j.pcl.2013.06.011; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Olaru F, 2010, J INVEST DERMATOL, V130, P1866, DOI 10.1038/jid.2010.37; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Roth SA, 2014, J INVEST DERMATOL, V134, P374, DOI 10.1038/jid.2013.313; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Simanski M, 2010, J INVEST DERMATOL, V130, P2836, DOI 10.1038/jid.2010.217; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10; Zanger P, 2009, J INFECT DIS, V200, P1907, DOI 10.1086/648408	47	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147118	10.1371/journal.pone.0147118	http://dx.doi.org/10.1371/journal.pone.0147118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808616	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800052
J	Ullrich, SR; Poehlein, A; Tischler, JS; Gonzalez, C; Ossandon, FJ; Daniel, R; Holmes, DS; Schlomann, M; Muhling, M				Ullrich, Sophie R.; Poehlein, Anja; Tischler, Judith S.; Gonzalez, Carolina; Ossandon, Francisco J.; Daniel, Rolf; Holmes, David S.; Schloemann, Michael; Muehling, Martin			Genome Analysis of the Biotechnologically Relevant Acidophilic Iron Oxidising Strain JA12 Indicates Phylogenetic and Metabolic Diversity within the Novel Genus "Ferrovum"	PLOS ONE			English	Article							PHOTOTROPHIC FE(II) OXIDATION; FORE-SUDETIC MONOCLINE; DNA-DNA HYBRIDIZATION; TRANSFER-RNA GENES; THIOBACILLUS-FERROOXIDANS; ACIDITHIOBACILLUS-FERROOXIDANS; RHODOBACTER-CAPSULATUS; MICROBIAL GENOMES; METAL RESISTANCE; DRAFT GENOME	Background Members of the genus "Ferrovum" are ubiquitously distributed in acid mine drainage (AMD) waters which are characterised by their high metal and sulfate loads. So far isolation and microbiological characterisation have only been successful for the designated type strain "Ferrovum myxofaciens" P3G. Thus, knowledge about physiological characteristics and the phylogeny of the genus "Ferrovum" is extremely scarce. Objective In order to access the wider genetic pool of the genus "Ferrovum" we sequenced the genome of a "Ferrovum"-containing mixed culture and successfully assembled the almost complete genome sequence of the novel "Ferrovum" strain JA12. Phylogeny and Lifestyle The genome-based phylogenetic analysis indicates that strain JA12 and the type strain represent two distinct "Ferrovum" species. "Ferrovum" strain JA12 is characterised by an unusually small genome in comparison to the type strain and other iron oxidising bacteria. The prediction of nutrient assimilation pathways suggests that "Ferrovum" strain JA12 maintains a chemolithoautotrophic lifestyle utilising carbon dioxide and bicarbonate, ammonium and urea, sulfate, phosphate and ferrous iron as carbon, nitrogen, sulfur, phosphorous and energy sources, respectively. Unique Metabolic Features The potential utilisation of urea by "Ferrovum" strain JA12 is moreover remarkable since it may furthermore represent a strategy among extreme acidophiles to cope with the acidic environment. Unlike other acidophilic chemolithoautotrophs "Ferrovum" strain JA12 exhibits a complete tricarboxylic acid cycle, a metabolic feature shared with the closer related neutrophilic iron oxidisers among the Betaproteobacteria including Sideroxydans lithotrophicus and Thiobacillus denitrificans. Furthermore, the absence of characteristic redox proteins involved in iron oxidation in the well-studied acidophiles Acidithiobacillus ferrooxidans (rusticyanin) and Acidithiobacillus ferrivorans (iron oxidase) indicates the existence of a modified pathway in "Ferrovum" strain JA12. Therefore, the results of the present study extend our understanding of the genus "Ferrovum" and provide a comprehensive framework for future comparative genome and metagenome studies.	[Ullrich, Sophie R.; Tischler, Judith S.; Schloemann, Michael; Muehling, Martin] TU Bergakad Freiberg, Inst Biol Sci, Leipziger Str 29, Freiberg, Germany; [Poehlein, Anja; Daniel, Rolf] Univ Gottingen, Genom & Appl Microbiol & Gottingen Genom Lab, Grisebachstr 8, D-37073 Gottingen, Germany; [Gonzalez, Carolina] Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Biocomp Div, Ave Mariano Sanchez Fontecilla 310, Santiago, Chile; [Gonzalez, Carolina] Fraunhofer Chile Res Fdn, Appl Genet Div, Ave Mariano Sanchez Fontecilla 310, Santiago, Chile; [Gonzalez, Carolina; Ossandon, Francisco J.; Holmes, David S.] Fnd Ciencia & Vida, Ctr Bioinformat & Genome Biol, Zanartu 1482, Chile; [Gonzalez, Carolina; Ossandon, Francisco J.; Holmes, David S.] Univ Andres Bello, Fac Ciencias Biol, Ave Los Leones 745, Santiago, Chile	Technical University Freiberg; University of Gottingen; Universidad Andres Bello	Ullrich, SR; Muhling, M (corresponding author), TU Bergakad Freiberg, Inst Biol Sci, Leipziger Str 29, Freiberg, Germany.	sophie.ullrich@ioez.tu-freiberg.de; martin.muehling@ioez.tu-freiberg.de	Tischler, Judith/I-4433-2019; Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Holmes, David/0000-0001-9555-138X; Poehlein, Anja/0000-0002-2473-6202; Gonzalez Rosales, Carolina/0000-0003-3566-4758	ESF junior research group GETGEOWEB [100101363]; German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II [03G0821B]; Basal Program of CONICYT [PFB16];  [FONDECYT 1130683];  [FONDECYT 3140005]	ESF junior research group GETGEOWEB; German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II(Federal Ministry of Education & Research (BMBF)); Basal Program of CONICYT; ; 	This project was funded by the ESF junior research group GETGEOWEB (project nr. 100101363) awarded to MS and MM, with additional support from the German Federal Ministry of Education and Research (BMBF) through project SURFTRAP-II (03G0821B) awarded to MS and through grants FONDECYT 1130683, FONDECYT 3140005, and the Basal Program of CONICYT PFB16 which were awarded to DSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amouric A, 2011, MICROBIOL-SGM, V157, P111, DOI 10.1099/mic.0.044537-0; Andrews S., 2010, FASTQC QUALITY CONTR; Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Appia-Ayme C, 2006, HYDROMETALLURGY, V83, P273, DOI 10.1016/j.hydromet.2006.03.029; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Banks D, 1997, ENVIRON GEOL, V32, P157, DOI 10.1007/s002540050204; Barreto M, 2005, APPL ENVIRON MICROB, V71, P2902, DOI 10.1128/AEM.71.6.2902-2909.2005; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Boyd ES, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00349; Brown JF, 2011, APPL ENVIRON MICROB, V77, P545, DOI 10.1128/AEM.01550-10; Bruscella P, 2007, MICROBIOL-SGM, V153, P102, DOI 10.1099/mic.0.2006/000067-0; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Byrne-Bailey KG, 2012, J BACTERIOL, V194, P2400, DOI 10.1128/JB.00214-12; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chevreux B, 1999, GENOME RES, V14, P1147; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Darbari VC, 2015, ANNU REV BIOCHEM, V84, P603, DOI 10.1146/annurev-biochem-062911-102821; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Dopson M, 2005, MICROBIOL-SGM, V151, P4127, DOI 10.1099/mic.0.28362-0; Dopson M, 2003, MICROBIOL-SGM, V149, P1959, DOI 10.1099/mic.0.26296-0; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Esparza M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-229; Fabisch M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00390; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujimura R, 2012, J BACTERIOL, V194, P4122, DOI 10.1128/JB.00696-12; Futterer O, 2004, P NATL ACAD SCI USA, V101, P9091, DOI 10.1073/pnas.0401356101; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Gonzalez-Toril E, 2011, APPL ENVIRON MICROB, V77, P2685, DOI 10.1128/AEM.02459-10; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hallberg KB, 2006, APPL ENVIRON MICROB, V72, P2022, DOI 10.1128/AEM.72.3.2022-2030.2006; HARRISON AP, 1980, J BACTERIOL, V143, P448, DOI 10.1128/JB.143.1.448-454.1980; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Hedrich S, 2012, BIORESOURCE TECHNOL, V106, P44, DOI 10.1016/j.biortech.2011.11.130; Hedrich S, 2011, ENVIRON SCI TECHNOL, V45, P7685, DOI 10.1021/es201564g; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Heijerick DG, 2002, COMP BIOCHEM PHYS C, V133, P207, DOI 10.1016/S1532-0456(02)00077-7; Heinzel E, 2009, ENVIRON SCI TECHNOL, V43, P6138, DOI 10.1021/es900067d; Heinzel E, 2009, APPL ENVIRON MICROB, V75, P858, DOI 10.1128/AEM.01045-08; Holmes D.S., 2007, BIOMINING, P281, DOI 10.1007/978-3-540-34911-2_14; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hua ZS, 2015, ISME J, V9, P1280, DOI 10.1038/ismej.2014.212; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Johnson DB, 2014, APPL ENVIRON MICROB, V80, P672, DOI 10.1128/AEM.03230-13; JOHNSON DB, 1991, J MICROBIOL METH, V13, P113, DOI 10.1016/0167-7012(91)90011-E; JOHNSON DB, 1995, INT BIODETER BIODEGR, V35, P41, DOI 10.1016/0964-8305(95)00065-D; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; JOHNSON DB, 1983, J GEN MICROBIOL, V129, P2969; Jones DS, 2015, APPL ENVIRON MICROB, V81, P1242, DOI 10.1128/AEM.02919-14; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Jormakka M, 2003, CURR OPIN STRUC BIOL, V13, P418, DOI 10.1016/S0959-440X(03)00098-8; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kay CM, 2014, RES MICROBIOL, V165, P705, DOI 10.1016/j.resmic.2014.07.007; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kimura S, 2011, ENVIRON MICROBIOL, V13, P2092, DOI 10.1111/j.1462-2920.2011.02434.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Mangold S, 2013, EXTREMOPHILES, V17, P75, DOI 10.1007/s00792-012-0495-3; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martinez-Cano DJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00742; Masepohl B, 2001, J BACTERIOL, V183, P637, DOI 10.1128/JB.183.2.637-643.2001; Matlakowska R, 2012, FEMS MICROBIOL ECOL, V81, P99, DOI 10.1111/j.1574-6941.2012.01326.x; Matlakowska R, 2011, CHEMOSPHERE, V83, P1255, DOI 10.1016/j.chemosphere.2011.03.003; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mendez-Garcia C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00475; Merrick JM., 1978, PHOTOSYNTHETIC BACTE, P199; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Moriarty TF, 2006, LETT APPL MICROBIOL, V42, P617, DOI 10.1111/j.1472-765X.2006.01930.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Mosler S, 2013, ADV MATER RES-SWITZ, V825, P153, DOI 10.4028/www.scientific.net/AMR.825.153; Mossey P, 2010, J BACTERIOL, V192, P2830, DOI 10.1128/JB.01331-09; Moya-Beltran A, 2014, GENOME ANNOUNC, DOI [10.1128/genomeA.00834-14, DOI 10.1128/GEN0MEA.00834-14]; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nicolle JLC, 2009, MICROBIOL-SGM, V155, P1302, DOI 10.1099/mic.0.023192-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Osorio H, 2013, APPL ENVIRON MICROB, V79, P2172, DOI 10.1128/AEM.03057-12; Cardenas JP, 2012, HYDROMETALLURGY, V127, P162, DOI 10.1016/j.hydromet.2012.07.014; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Quatrini R, 2006, HYDROMETALLURGY, V83, P263, DOI 10.1016/j.hydromet.2006.03.030; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Riadi G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/678761; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rowe OF, 2008, SYST APPL MICROBIOL, V31, P68, DOI 10.1016/j.syapm.2007.09.001; Santofimia E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066746; Schippers A., 2004, 379 GEOL SOC AM, V379, P49, DOI DOI 10.1130/0-8137-2379-5.49; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Soboh B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-173; Stolz JF, 2002, CHEMBIOCHEM, V3, P198, DOI 10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; The GAP Group, 2012, GAP GROUPS ALG PROGR; Tischler JS, 2014, WATER RES, V48, P345, DOI 10.1016/j.watres.2013.09.049; Tischler JS, 2013, J MICROBIOL METH, V95, P138, DOI 10.1016/j.mimet.2013.07.027; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Ullrich SR, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0040-y; Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Van Driessche G, 2003, J MOL EVOL, V57, P181, DOI 10.1007/s00239-003-2465-y; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; WALTON KC, 1992, ENVIRON POLLUT, V76, P169, DOI 10.1016/0269-7491(92)90105-J; Wang Y, 2014, BIOSCI BIOTECH BIOCH, V78, P1274, DOI 10.1080/09168451.2014.915735; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wong KKY, 2001, J BACTERIOL, V183, P367, DOI 10.1128/JB.183.1.367-374.2001; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; Young GM, 1996, J BACTERIOL, V178, P6487, DOI 10.1128/jb.178.22.6487-6495.1996; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	157	30	31	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0146832	10.1371/journal.pone.0146832	http://dx.doi.org/10.1371/journal.pone.0146832			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808278	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800034
J	Verma, SK; Garikipati, VNS; Krishnamurthy, P; Khan, M; Thorne, T; Qin, GJ; Losordo, DW; Kishore, R				Verma, Suresh K.; Garikipati, Venkata Naga Srikanth; Krishnamurthy, Prasanna; Khan, Mohsin; Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.; Kishore, Raj			IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRUG-ELUTING STENT; MUSCLE-CELL-PROLIFERATION; VASCULAR INJURY; CYCLIN-A; TRANSCRIPTIONAL REPRESSION; INFLAMMATORY RESPONSE; NEOINTIMAL FORMATION; INTERLEUKIN-10; REENDOTHELIALIZATION	The role of inflammation on atherosclerosis and restenosis is well established. Restenosis is thought to be a complex response to injury, which includes early thrombus formation, acute inflammation and neo-intimal growth. Inflammatory cells are likely contributors in the host response to vascular injury, via cytokines and chemokines secretion, including TNFalpha (TNF). We have previously shown that IL-10 inhibits TNF and other inflammatory mediators produced in response to cardiovascular injuries. The specific effect of IL-10 on endothelial cell (ECs) biology is not well elucidated. Here we report that in a mouse model of carotid denudation, IL-10 knock-out mice (IL-10KO) displayed significantly delayed Re-endothelialization and enhanced neo-intimal growth compared to their WT counterparts. Exogenous recombinant IL-10 treatment dramatically blunted the neo-intimal thickening while significantly accelerating the recovery of the injured endothelium in WT mice. In vitro, IL-10 inhibited negative effects of TNF on ECs proliferation, ECs cell cycle, ECs-monocyte adhesion and ECs apoptosis. Furthermore, IL-10 treatment attenuated TNF-induced smooth muscle cells proliferation. Our data suggest that IL-10 differentially regulate endothelial and vascular smooth cells proliferation and function and thus inhibits neo-intimal hyperplasia. Thus, these results may provide insights necessary to develop new therapeutic strategies to limit vascular restenosis during percutaneous coronary intervention (PCI) in the clinics.	[Verma, Suresh K.; Garikipati, Venkata Naga Srikanth; Khan, Mohsin; Kishore, Raj] Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA; [Kishore, Raj] Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA; [Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Methodist Hospital System; The Methodist Hospital - Houston; Northwestern University; Feinberg School of Medicine	Kishore, R (corresponding author), Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA.; Kishore, R (corresponding author), Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA.	raj.kishore@temple.edu	Verma, Suresh/AAU-9979-2020	Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Losordo, Douglas/0000-0002-6857-7506	National Institutes of Health [HL091983, HL105597, HL126186, HL053354, HL108795]; American Heart Association-Scientist Development [14SDG20480104]; American Heart Association-Postdoctoral grant [15POST22720022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL091983, R01HL126186, R01HL116729, R01HL105597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Scientist Development(American Heart Association); American Heart Association-Postdoctoral grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All the work described in this manuscript was supported in part by National Institutes of Health grant numbers HL091983, HL105597, HL126186, HL053354, and HL108795 to R.K.; American Heart Association-Scientist Development Grant 14SDG20480104 to S.K.V.; American Heart Association-Postdoctoral grant 15POST22720022 to V.N.S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chen JP, 2008, SOUTH MED J, V101, P174, DOI 10.1097/01.smj.0000286752.67205.e0; Colombo A, 2004, J AM COLL CARDIOL, V43, P24, DOI 10.1016/j.jacc.2003.10.015; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; De Haro J, 2014, J VASC SURG; Donato AJ, 2015, J MOL CELL CARDIOL; Douglas G, 2013, EUR HEART J, V34, P3378, DOI 10.1093/eurheartj/ehs240; Feldman LJ, 2000, CIRCULATION, V101, P908, DOI 10.1161/01.CIR.101.8.908; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Kibos A, 2007, Acute Card Care, V9, P111, DOI 10.1080/17482940701263285; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kishore R, 1999, J IMMUNOL, V162, P2457; Kishore R, 2002, CIRC RES, V91, P307, DOI 10.1161/01.RES.0000031744.06353.D3; Krasinski K, 2001, CIRCULATION, V104, P1754, DOI 10.1161/hc4001.098046; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Luedemann C, 2005, ALCOHOL CLIN EXP RES, V29, P930, DOI 10.1097/01.ALC.0000171037.90100.6B; Maffia P, 2006, CIRCULATION, V114, P430, DOI 10.1161/CIRCULATIONAHA.105.602714; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; McDonald RA, 2015, J AM COLL CARDIOL, V65, P2314, DOI 10.1016/j.jacc.2015.03.549; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Murayama H, 2008, CARDIOVASC RES, V80, P175, DOI 10.1093/cvr/cvn250; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Roubille F, 2014, ATHEROSCLEROSIS, V236, P277, DOI 10.1016/j.atherosclerosis.2014.07.012; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Shah N, 2012, CURR ALLERGY ASTHM R, V12, P373, DOI 10.1007/s11882-012-0286-z; Slottow TLP, 2007, AM J CARDIOL, V100, p10M, DOI 10.1016/j.amjcard.2007.08.017; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec; Zymek P, 2007, CARDIOVASC RES, V74, P313, DOI 10.1016/j.cardiores.2006.11.028	36	17	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147615	10.1371/journal.pone.0147615	http://dx.doi.org/10.1371/journal.pone.0147615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26808574	Green Published, gold, Green Submitted			2022-12-27	WOS:000369527800149
J	Agafonov, O; Selsto, CH; Thorsen, K; Xu, XM; Drengstig, T; Ruoff, P				Agafonov, Oleg; Selsto, Christina Helen; Thorsen, Kristian; Xu, Xiang Ming; Drengstig, Tormod; Ruoff, Peter			The Organization of Controller Motifs Leading to Robust Plant Iron Homeostasis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FIT; ARABIDOPSIS-THALIANA; METAL TRANSPORTER; REGULATED TRANSPORTER1; PERFECT ADAPTATION; VACUOLAR SYMPLAST; UPTAKE SYSTEM; IRT1; PROTEIN; EXPRESSION	Iron is an essential element needed by all organisms for growth and development. Because iron becomes toxic at higher concentrations iron is under homeostatic control. Plants face also the problem that iron in the soil is tightly bound to oxygen and difficult to access. Plants have therefore developed special mechanisms for iron uptake and regulation. During the last years key components of plant iron regulation have been identified. How these components integrate and maintain robust iron homeostasis is presently not well understood. Here we use a computational approach to identify mechanisms for robust iron homeostasis in non-graminaceous plants. In comparison with experimental results certain control arrangements can be eliminated, among them that iron homeostasis is solely based on an iron-dependent degradation of the transporter IRT1. Recent IRT1 overexpression experiments suggested that IRT1-degradation is iron-independent. This suggestion appears to be misleading. We show that iron signaling pathways under IRT1 overexpression conditions become saturated, leading to a breakdown in iron regulation and to the observed iron-independent degradation of IRT1. A model, which complies with experimental data places the regulation of cytosolic iron at the transcript level of the transcription factor FIT. Including the experimental observation that FIT induces inhibition of IRT1 turnover we found a significant improvement in the system's response time, suggesting a functional role for the FIT-mediated inhibition of IRT1 degradation. By combining iron uptake with storage and remobilization mechanisms a model is obtained which in a concerted manner integrates iron uptake, storage and remobilization. In agreement with experiments the model does not store iron during its high-affinity uptake. As an iron biofortification approach we discuss the possibility how iron can be accumulated even during high-affinity uptake.	[Agafonov, Oleg; Selsto, Christina Helen; Xu, Xiang Ming; Ruoff, Peter] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway; [Thorsen, Kristian; Drengstig, Tormod] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway	Universitetet i Stavanger; Universitetet i Stavanger	Ruoff, P (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	peter.ruoff@uis.no		Ruoff, Peter/0000-0003-4430-0382	Program Area Fund "Organelle Biology" from the Faculty of Science and Technology, University of Stavanger; Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger; University of Stavanger	Program Area Fund "Organelle Biology" from the Faculty of Science and Technology, University of Stavanger; Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger; University of Stavanger	This research was funded by Program Area Fund "Organelle Biology" and the Program Area Fund "Biomedical data analysis group" from the Faculty of Science and Technology, University of Stavanger (https://www.uis.no/fakulteter-institutter-og-sentre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financed in part by Program Area Funds from the University of Stavanger to TD and PR.	Alon U., 2006, INTRO SYSTEMS BIOL D; Andreev IM, 2008, RUSS J PLANT PHYSL+, V55, P843, DOI 10.1134/S1021443708060150; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Ang J, 2010, J THEOR BIOL, V266, P723, DOI 10.1016/j.jtbi.2010.07.034; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Bauer P, 2007, PLANT PHYSIOL BIOCH, V45, P260, DOI 10.1016/j.plaphy.2007.03.006; BECKER R, 1995, PLANT PHYSIOL, V108, P269, DOI 10.1104/pp.108.1.269; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Claus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037193; Cloutier M, 2009, J ROYAL SOC INTERFAC; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; De-Regil L, 2011, INTERMITTENT IRON SU; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; Duc C, 2009, J BIOL CHEM, V284, P36271, DOI 10.1074/jbc.M109.059873; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Gollhofer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110468; Grossoehme NE, 2006, INORG CHEM, V45, P8500, DOI 10.1021/ic0606431; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Huang YS, 2012, PLANT CELL ENVIRON, V35, P917, DOI 10.1111/j.1365-3040.2011.02462.x; Hughes GM, 1964, HOMEOSTASIS FEEDBACK; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; Jain A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00100; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Katebi, 2002, CONTROL ENG INTRO CO; Kerkeb L, 2008, PLANT PHYSIOL, V146, P1964, DOI 10.1104/pp.107.113282; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Langley L. L., 1973, HOMEOSTASIS ORIGINS; Ling HQ, 1999, P NATL ACAD SCI USA, V96, P7098, DOI 10.1073/pnas.96.12.7098; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Louie AH, 2010, FORESIGHT, V12, P18, DOI 10.1108/14636681011049848; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Moore-Ede MC., 1982, CLOCKS TIME US; MOOREEDE MC, 1986, AM J PHYSIOL, V250, pR737, DOI 10.1152/ajpregu.1986.250.5.R737; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Radhakrishnan K., 1993, NASA REFERENCE PUBLI; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Rellan-Alvarez R, 2008, RAPID COMMUN MASS SP, V22, P1553, DOI 10.1002/rcm.3523; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Rosen R, 2012, IFSR INT SER SYST SC, V1, P1, DOI 10.1007/978-1-4614-1269-4; Schmidt W, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P229, DOI 10.1007/1-4020-4743-6_11; Schulkin J., 2004, ALLOSTASIS HOMEOSTAS; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Thomine S, 2013, CURR OPIN PLANT BIOL, V16, P322, DOI 10.1016/j.pbi.2013.01.003; Thorsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107766; Velikanov GA, 2007, RUSS J PLANT PHYSL+, V54, P683, DOI 10.1134/S1021443707050172; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Vigani G, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00316; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Walker EL, 2008, CURR OPIN PLANT BIOL, V11, P530, DOI 10.1016/j.pbi.2008.06.013; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	76	4	4	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147120	10.1371/journal.pone.0147120	http://dx.doi.org/10.1371/journal.pone.0147120			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800438	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000368655300061
J	Pereira, AL; Malcher, SM; Nagamachi, CY; O'Brien, PCM; Ferguson-Smith, MA; Mendes-Oliveira, AC; Pieczarka, JC				Pereira, Adenilson Leao; Malcher, Stella Miranda; Nagamachi, Cleusa Yoshiko; Mary O'Brien, Patricia Caroline; Ferguson-Smith, Malcolm Andrew; Mendes-Oliveira, Ana Cristina; Pieczarka, Julio Cesar			Extensive Chromosomal Reorganization in the Evolution of New World Muroid Rodents (Cricetidae, Sigmodontinae): Searching for Ancestral Phylogenetic Traits	PLOS ONE			English	Article							ARVICOLINAE CRICETIDAE; WHOLE CHROMOSOME; LABORATORY MOUSE; GENOME HOMOLOGY; MUS-MUSCULUS; FIELD VOLE; MURIDAE; FISH; RAT; KARYOTYPE	Sigmodontinae rodents show great diversity and complexity in morphology and ecology. This diversity is accompanied by extensive chromosome variation challenging attempts to reconstruct their ancestral genome. The species Hylaeamys megacephalus-HME (Oryzomyini, 2n = 54), Necromys lasiurus-NLA (Akodontini, 2n = 34) and Akodon sp.-ASP (Akodontini, 2n = 10) have extreme diploid numbers that make it difficult to understand the rearrangements that are responsible for such differences. In this study we analyzed these changes using whole chromosome probes of HME in cross-species painting of NLA and ASP to construct chromosome homology maps that reveal the rearrangements between species. We include data from the literature for other Sigmodontinae previously studied with probes from HME and Mus musculus (MMU) probes. We also use the HME probes on MMU chromosomes for the comparative analysis of NLA with other species already mapped by MMU probes. Our results show that NLA and ASP have highly rearranged karyotypes when compared to HME. Eleven HME syntenic blocks are shared among the species studied here. Four syntenies may be ancestral to Akodontini (HME2/18, 3/25, 18/25 and 4/11/16) and eight to Sigmodontinae (HME26, 1/12, 6/21, 7/9, 5/17, 11/16, 20/13 and 19/14/19). Using MMU data we identified six associations shared among rodents from seven subfamilies, where MMU3/18 and MMU8/13 are phylogenetic signatures of Sigmodontinae. We suggest that the associations MMU2entire, MMU6proximal/12entire, MMU3/18, MMU8/13, MMU1/17, MMU10/17, MMU12/17, MMU5/16, MMU5/6 and MMU7/19 are part of the ancestral Sigmodontinae genome.	[Pereira, Adenilson Leao; Malcher, Stella Miranda; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] Fed Univ Para, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, BR-66059 Belem, Para, Brazil; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] CNPq, Brasilia, DF, Brazil; [Mary O'Brien, Patricia Caroline; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Mendes-Oliveira, Ana Cristina] Fed Univ Para, ICB, Lab Zool & Ecol Vertebrados, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; University of Cambridge; Universidade Federal do Para	Pieczarka, JC (corresponding author), Fed Univ Para, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, BR-66059 Belem, Para, Brazil.; Pieczarka, JC (corresponding author), CNPq, Brasilia, DF, Brazil.	juliopieczarka@gmail.com	Pereira, Adenilson Leão/C-9820-2018; Pieczarka, Julio C/E-7585-2016; de Oliveira, Ana Cristina Mendes/I-2680-2012; Nagamachi, Cleusa/AAV-8985-2021	Pereira, Adenilson Leão/0000-0003-2687-5297; Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552032/2010-7]; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) [2010/110447]; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA); CAPES Doctor Scholarship inNeuroscience and Cell Biology; CAPES Doctor Scholarship in Genetics and Molecular Biology	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES Doctor Scholarship inNeuroscience and Cell Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Doctor Scholarship in Genetics and Molecular Biology(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Proc 552032/2010-7, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br; ICAAF 007/2011); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (http://www.fapespa.pa.gov.br); Proc 2010/110447, Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (http://www.fapespa.pa.gov.br). S. M. Malcher is the recipient of a CAPES Doctor Scholarship inNeuroscience and Cell Biology, and A. L. Pereira is the recipient of a CAPES Doctor Scholarship in Genetics and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MC, 2009, IHERINGIA SER ZOOL, V99, P373, DOI 10.1590/S0073-47212009000400006; Basheva EA, 2014, CHROMOSOME RES, V22, P351, DOI 10.1007/s10577-014-9429-5; Cavagna P, 2002, MAMM GENOME, V13, P157, DOI [10.1007/BF02684021, 10.1007/s0033501-1020-7]; Chaves R, 2012, CHROMOSOME RES, V20, P673, DOI 10.1007/s10577-012-9304-1; Cursino MS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-40; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; de Silva MJ, 1998, CYTOGENET CELL GENET, V81, P46; DELIA G, 2015, MAMMALS S AM, V2, P63; Di-Nizo CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117579; EISENBERG JF, 1999, MAMMALS NEOTROPICS, V3, P527; Engelbrecht A, 2006, CYTOGENET GENOME RES, V112, P126, DOI 10.1159/000087524; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; Graphodatsky AS, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-22; Guilly MN, 1999, CHROMOSOME RES, V7, P213, DOI 10.1023/A:1009251416856; Hass I, 2011, CYTOGENET GENOME RES, V135, P42, DOI 10.1159/000330259; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; King M., 1995, SPECIES EVOLUTION RO; Leite RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100687; Lessa EP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00039; Matsubara K, 2004, CHROMOSOME RES, V12, P383, DOI 10.1023/B:CHRO.0000034103.05528.83; Matsubara K, 2003, CHROMOSOME RES, V11, P57, DOI 10.1023/A:1022010116287; Mlynarski EE, 2010, MAMM GENOME, V21, P77, DOI 10.1007/s00335-009-9242-1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Nakamura T, 2007, CHROMOSOME RES, V15, P1023, DOI 10.1007/s10577-007-1177-3; Nakamura T, 2007, CHROMOSOME RES, V15, P799, DOI 10.1007/s10577-007-1163-9; Parada A, 2013, MOL PHYLOGENET EVOL, V66, P960, DOI 10.1016/j.ympev.2012.12.001; Pardiñas Ulyses F. J, 2015, Mastozool. neotrop., V22, P171; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Percequillo AR, 2005, J MAMMAL, V86, P873, DOI 10.1644/1545-1542(2005)86[873:ANSONI]2.0.CO;2; Rambau RV, 2003, CHROMOSOME RES, V11, P91, DOI 10.1023/A:1022887629707; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2007, CHROMOSOME RES, V15, P891, DOI 10.1007/s10577-007-1171-9; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; SCHMID M, 1988, CYTOGENET CELL GENET, V49, P305, DOI 10.1159/000132683; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Stanyon R, 1999, CYTOGENET CELL GENET, V84, P150, DOI 10.1159/000015244; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suarez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143482; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swier VJ, 2009, CYTOGENET GENOME RES, V125, P54, DOI 10.1159/000218747; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Verma RS., 1995, HUMAN CHROMOSOMES PR, V2; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Vieira-da-Silva A, 2015, CYTOGENET GENOME RES, V145, P59, DOI 10.1159/000381840; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang F, 2000, CHROMOSOME RES, V8, P219, DOI 10.1023/A:1009200912436	53	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146179	10.1371/journal.pone.0146179	http://dx.doi.org/10.1371/journal.pone.0146179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26800516	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300014
J	Cho, Y; Chang, JS; Rha, KH; Hong, SJ; Choi, YD; Ham, WS; Kim, JW; Cho, J				Cho, Yeona; Chang, Jee Suk; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik; Kim, Jun Won; Cho, Jaeho			Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; RADIATION-THERAPY; BREAST-CANCER; SURVIVAL; DISEASE; IMMUNOTHERAPY	Purpose/Objectives Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. Materials/Methods The study cohort included 140 men with metastatic prostate cancer at initial diagnosis. Metastatic sites were divided into 4 groups as follows: solitary bone, 2-4 bones, >= 5 bones, and visceral organs. Patient, tumor, and treatment characteristics, and clinical outcomes were compared between patients treated with (prostate radiotherapy [PRT] group) or without radiotherapy to the primary tumor. Results Patients in PRT group presented with a statistically significantly younger age (p = .02), whereas other characteristics showed no significant difference. Overall survival (OS) and biochemical failure-free survival (BCFFS) were improved in PRT patients (3-year OS: 69% vs. 43%, p = 0.004; 3-year BCFFS: 52% vs. 16%, p = 0.002). Multivariate analysis identified PRT as a significant predictor of both OS (hazard ratio [HR] = 0.43, p = 0.015). None of the 38 PRT patients experienced severe (grade >= 3) genitourinary or gastrointestinal toxicity. Conclusions Our data suggest that radiotherapy to the primary tumor was associated with improved OS and BCFFS in metastatic prostate cancer. The results of this study warrant prospective controlled clinical trials of this approach in stage IV prostate cancer patients with limited extent of bone metastasis and good performance status.	[Cho, Yeona; Chang, Jee Suk; Kim, Jun Won; Cho, Jaeho] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea; [Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik] Yonsei Univ, Coll Med, Dept Urol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120749, South Korea.	jjhmd@yuhs.ac	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	Yonsei University College of Medicine [6-2014-0031]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	Yonsei University College of Medicine(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a faculty research grant from Yonsei University College of Medicine in 2014 (6-2014-0031).	Adli M, 2006, J NATL CANCER I, V98, P364, DOI 10.1093/jnci/djj077; Boehmer D, 2006, RADIOTHER ONCOL, V79, P259, DOI 10.1016/j.radonc.2006.05.012; Camphausen K, 2001, CANCER RES, V61, P2207; Coen JJ, 2002, J CLIN ONCOL, V20, P3199, DOI 10.1200/JCO.2002.01.086; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Lee IJ, 2009, INT J RADIAT ONCOL, V73, P1517, DOI 10.1016/j.ijrobp.2008.07.035; McGrath SD, 2010, BRACHYTHERAPY, V9, P137, DOI 10.1016/j.brachy.2009.07.005; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081, DOI 10.6004/jnccn.2012.0114; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Nguyen DHA, 2012, ANN SURG ONCOL, V19, P3028, DOI 10.1245/s10434-012-2333-3; Nguyen DHA, 2012, INT J RADIAT ONCOL, V84, P39, DOI 10.1016/j.ijrobp.2011.11.046; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Parker CC, 2013, BJU INT, V111, P697, DOI 10.1111/bju.12087; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; Staehler MD, 2010, WORLD J UROL, V28, P543, DOI 10.1007/s00345-010-0560-4; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Temple LKF, 2004, J CLIN ONCOL, V22, P3475, DOI 10.1200/JCO.2004.10.218; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2	32	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0147191	10.1371/journal.pone.0147191	http://dx.doi.org/10.1371/journal.pone.0147191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	26807740	Green Published, Green Submitted, gold			2022-12-27	WOS:000369527800057
J	Cho, YJ; Thrasher, JF; Swayampakala, K; Yong, HH; McKeever, R; Hammond, D; Anshari, D; Cummings, KM; Borland, R				Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Yong, Hua-Hie; McKeever, Robert; Hammond, David; Anshari, Dien; Cummings, K. Michael; Borland, Ron			Does Reactance against Cigarette Warning Labels Matter? Warning Label Responses and Downstream Smoking Cessation amongst Adult Smokers in Australia, Canada, Mexico and the United States	PLOS ONE			English	Article							PSYCHOLOGICAL REACTANCE; HEALTH WARNINGS; SENSATION SEEKING; TRAIT REACTANCE; IMPACT; MESSAGES	Objective Some researchers have raised concerns that pictorial health warning labels (HWLs) on cigarette packages may lead to message rejection and reduced effectiveness of HWL messages. This study aimed to determine how state reactance (i.e., negative affect due to perceived manipulation) in response to both pictorial and text-only HWLs is associated with other types of HWL responses and with subsequent cessation attempts. Methods Survey data were collected every 4 months between September 2013 and 2014 from online panels of adult smokers in Australia, Canada, Mexico, and the US were analyzed. Participants with at least one wave of follow-up were included in the analysis (n = 4,072 smokers; 7,459 observations). Surveys assessed psychological and behavioral responses to HWLs (i.e., attention to HWLs, cognitive elaboration of risks due to HWLs, avoiding HWLs, and forgoing cigarettes because of HWLs) and cessation attempts. Participants then viewed specific HWLs from their countries and were queried about affective state reactance. Logistic and linear Generalized Estimating Equation (GEE) models regressed each of the psychological and behavioral HWL responses on reactance, while controlling for socio-demographic and smoking-related variables. Logistic GEE models also regressed having attempted to quit by the subsequent survey on reactance, each of the psychological and behavioral HWL responses (analyzed separately), adjustment variables. Data from all countries were initially pooled, with interactions between country and reactance assessed; when interactions were statistically significant, country-stratified models were estimated. Results Interactions between country and reactance were found in all models that regressed psychological and behavioral HWL responses on study variables. In the US, stronger reactance was associated with more frequent reading of HWLs and thinking about health risks. Smokers from all four countries with stronger reactance reported greater likelihood of avoiding warnings and forgoing cigarettes due to warnings, although the association appeared stronger in the US. Both stronger HWLs responses and reactance were positively associated with subsequent cessation attempts, with no significant interaction between country and reactance. Conclusions Reactance towards HWLs does not appear to interfere with quitting, which is consistent with its being an indicator of concern, not a systematic effort to avoid HWL message engagement.	[Cho, Yoo Jin; Thrasher, James F.; Swayampakala, Kamala; Anshari, Dien] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Thrasher, James F.] Natl Inst Publ Hlth, Dept Tobacco Res, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Yong, Hua-Hie; Borland, Ron] Canc Council Victoria, Melbourne, Vic, Australia; [McKeever, Robert] Univ South Carolina, Sch Journalism & Mass Commun, Columbia, SC 29208 USA; [Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Anshari, Dien] Univ Indonesia, Fac Publ Hlth, Dept Hlth Educ & Behav Sci, Depok, Indonesia; [Cummings, K. Michael] Med Univ South Carolina, Dept Psychiat & Behav Sci, 171 Ashley Ave, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Instituto Nacional de Salud Publica; Cancer Council Victoria; University of South Carolina System; University of South Carolina Columbia; University of Waterloo; University of Indonesia; Medical University of South Carolina	Cho, YJ (corresponding author), Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	ycho@email.sc.edu	Anshari, Dien/B-9544-2018; Cho, Yeona/AAT-3257-2021; Cho, Yoo Jin/I-8291-2018	Anshari, Dien/0000-0002-7984-0111; Cho, Yoo Jin/0000-0001-9590-9206; Borland, Ron/0000-0003-0059-178X; McKeever, Robert/0000-0002-5924-0514; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; cho, Yeona/0000-0002-1202-0880; Hong, Sung Joon/0000-0001-9869-065X; Choi, Young Deuk/0000-0002-8545-5797; Chang, Jee Suk/0000-0001-7685-3382; Kim, Jun Won/0000-0003-1358-364X; Cho, Jaeho/0000-0001-9966-5157	U.S. National Cancer Institute [R01 CA167067]; NATIONAL CANCER INSTITUTE [R01CA167067] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Data collection and analyses for the study were funded by a grant from the U.S. National Cancer Institute (R01 CA167067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanton H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096315; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Borland R, 2014, UNDERSTANDING HARD T; Brehm SS, 1981, PSYCHOLOGICAL REACTA; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Emery LF, 2014, NICOTINE TOB RES, V16, P263, DOI 10.1093/ntr/ntt124; Erceg-Hurn DM, 2011, J APPL SOC PSYCHOL, V41, P219, DOI 10.1111/j.1559-1816.2010.00710.x; Fathelrahman AI, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-20; Gibson L, 2015, NICOTINE TOB RES, V17, P898, DOI 10.1093/ntr/ntv082; Grandpre J, 2003, HEALTH COMMUN, V15, P349, DOI 10.1207/S15327027HC1503_6; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; International Agency for Research on Cancer, 2008, METH EV TOB CONTR PO, V12; International Telecommunication Union, 2015, PERCENTAGE OF INDIVI; Kees J, 2006, J PUBLIC POLICY MARK, V25, P212, DOI 10.1509/jppm.25.2.212; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; LaVoie NR, 2015, COMMUN RES; Maynard OM, 2014, DRUG ALCOHOL DEPEN, V136, P170, DOI 10.1016/j.drugalcdep.2014.01.001; Miller CH, 2010, HEALTH COMMUN, V25, P266, DOI 10.1080/10410231003698945; Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978; O'Keefe DJ, 2003, COMMUN THEOR, V13, P251, DOI 10.1111/j.1468-2885.2003.tb00292.x; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527; Petty R. E., 1986, COMMUN PERSUATION; Quick BL, 2008, HUM COMMUN RES, V34, P448, DOI 10.1111/j.1468-2958.2008.00328.x; Quick BL, 2012, HEALTH COMMUN, V27, P1, DOI 10.1080/10410236.2011.567446; Quick BL, 2011, J HEALTH COMMUN, V16, P660, DOI 10.1080/10810730.2011.551989; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; Ruiter RAC, 2005, EUR J PUBLIC HEALTH, V15, P329, DOI 10.1093/eurpub/cki095; Shanahan P., 2001, EVALUATION OF THE HE; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Swayampakala K, 2015, HEALTH EDUC RES, V30, P35, DOI 10.1093/her/cyu022; Thrasher JF, 2015, NICOTINE TOB RES, V17, P870, DOI 10.1093/ntr/ntu246; Thrasher JF, 2010, SALUD PUBLICA MEXICO, V52, pS206, DOI 10.1590/S0036-36342010000800016; Thrasher JF, HLTH COMMUNICATION; Thrasher JF S K, CIGARETTE PACKAGE IN; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wiium N, 2009, J APPL SOC PSYCHOL, V39, P1718, DOI 10.1111/j.1559-1816.2009.00501.x; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; World Health Organization, 2008, THIRD SESSION OF THE; Xu J, 2015, PSYCHOL HEALTH, V30, P423, DOI 10.1080/08870446.2014.977280; Yong HH, 2014, HEALTH PSYCHOL, V33, P1410, DOI 10.1037/hea0000056	48	74	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159245	10.1371/journal.pone.0159245	http://dx.doi.org/10.1371/journal.pone.0159245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	26807740	Green Published, gold			2022-12-27	WOS:000379508300070
J	Snow, NJ; Mang, CS; Roig, M; McDonnell, MN; Campbell, KL; Boyd, LA				Snow, Nicholas J.; Mang, Cameron S.; Roig, Marc; McDonnell, Michelle N.; Campbell, Kristin L.; Boyd, Lara A.			The Effect of an Acute Bout of Moderate-Intensity Aerobic Exercise on Motor Learning of a Continuous Tracking Task	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; SINGLE BOUT; CARDIOVASCULAR EXERCISE; MEMORY CONSOLIDATION; PERFORMANCE; ACCURACY; RELIABILITY; PLASTICITY; INCREASES; AROUSAL	Introduction There is evidence for beneficial effects of acute and long-term exercise interventions on several forms of memory, including procedural motor learning. In the present study we examined how performing a single bout of continuous moderate intensity aerobic exercise would impact motor skill acquisition and retention in young healthy adults, compared to a period of rest. We hypothesized that exercise would improve motor skill acquisition and retention, compared to motor practice alone. Materials and Methods Sixteen healthy adults completed sessions of aerobic exercise or seated rest that were immediately followed by practice of a novel motor task (practice). Exercise consisted of 30 minutes of continuous cycling at 60% peak O-2 uptake. Twenty-four hours after practice, we assessed motor learning with a no-exercise retention test (retention). We also quantified changes in offline motor memory consolidation, which occurred between practice and retention (offline). Tracking error was separated into indices of temporal precision and spatial accuracy. Results There were no differences between conditions in the timing of movements during practice (p = 0.066), at retention (p = 0.761), or offline (p = 0.966). However, the exercise condition enabled participants to maintain spatial accuracy during practice (p = 0.477); whereas, following rest performance diminished (p = 0.050). There were no significant differences between conditions at retention (p = 0.532) or offline (p = 0.246). Discussion An acute bout of moderate-intensity aerobic exercise facilitated the maintenance of motor performance during skill acquisition, but did not influence motor learning. Given past work showing that pairing high intensity exercise with skilled motor practice benefits learning, it seems plausible that intensity is a key modulator of the effects of acute aerobic exercise on changes in complex motor behavior. Further work is necessary to establish a dose-response relationship between aerobic exercise and motor learning.	[Snow, Nicholas J.; Mang, Cameron S.; Campbell, Kristin L.; Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada; [Roig, Marc] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Roig, Marc] Montreal Ctr Interdisciplinary Res Rehabil CRIR, Memory & Motor Rehabil Lab MEMORY LAB, Feil & Oberfeld Res Ctr, Jewish Rehabil Hosp, Laval, PQ, Canada; [McDonnell, Michelle N.] Univ S Australia, Int Ctr Allied Hlth Evidence & Alliance Res Exerc, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada	University of British Columbia; McGill University; McGill University; University of South Australia; University of British Columbia	Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada.; Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada.	lara.boyd@ubc.ca	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	Natural Sciences and Engineering Research Council of Canada [RGPIN 401890-11]; Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Canada Research Chairs; Michael Smith Foundation for Health Research; Canada Foundation for Innovation; Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	This work was funded by awards from the Natural Sciences and Engineering Research Council of Canada (RGPIN 401890-11 to LAB; http://www.nserc-crsng.gc.ca/) and the Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia (award to LAB; http://pwias.ubc.ca/). NJS and CSM are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the University of British Columbia (https://www.ubc.ca/). LAB receives salary support from the Canada Research Chairs (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Michael Smith Foundation for Health Research (http://www.msfhr.org/). MR was supported with funds from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant; http://www.nserc-crsng.gc.ca/), Canada Foundation for Innovation (John R. Evans Leaders Fund; http://www.innovation.ca/), Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique; http://www.repar.ca/FR/000/default.asp), and the Montreal Centre for Interdisciplinary Research in Rehabilitation (http:// www.crir.ca/?lang=EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine [ACSM], 2013, ACSMS GUIDELINES EXE; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Bakken RC, 2001, PHYS THER, V81, P1870, DOI 10.1093/ptj/81.12.1870; Borg G, 1978, PSYCHOL RES PRACTICE, P333; Boyd LA, 2004, NEUROREHAB NEURAL RE, V18, P134, DOI 10.1177/0888439004269072; Boyd LA, 2004, LEARN MEMORY, V11, P388, DOI 10.1101/lm.80104; Boyd LA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-72; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Canadian Society for Exercise Physiology (CSEP), 2002, PHYS ACT READ QUEST; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Coco M, 2010, SOMATOSENS MOT RES, V27, P1, DOI 10.3109/08990220903471765; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P139, DOI 10.1007/s00421-006-0255-0; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McClernon FJ, 2016, ADDICT BIOL, V21, P954, DOI 10.1111/adb.12253; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Potter D, 2005, J SPORT EXERCISE PSY, V27, P117, DOI 10.1123/jsep.27.1.117; Powers ME, 2015, J ATHL TRAINING, V50, P453, DOI 10.4085/1062-6050-50.1.07; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rhee J, 2016, PSYCHOL RES-PSYCH FO, V80, P518, DOI 10.1007/s00426-015-0682-9; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roig M, 2014, NEUROBIOL AGING, V35, P1892, DOI 10.1016/j.neurobiolaging.2014.02.022; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Saunders AC, 2005, J INHERIT METAB DIS, V28, P695, DOI 10.1007/s10545-005-0090-1; Segal SK, 2012, J ALZHEIMERS DIS, V32, P1011, DOI 10.3233/JAD-2012-121078; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Singh AM, 2016, BEHAV BRAIN RES, V301, P19, DOI 10.1016/j.bbr.2015.12.020; Singh AM, 2015, J MOTOR BEHAV, V47, P328, DOI 10.1080/00222895.2014.983450; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Taubert M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00692; Wadden K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00169; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	59	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150039	10.1371/journal.pone.0150039	http://dx.doi.org/10.1371/journal.pone.0150039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26812148	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371276100203
J	Snow, NP; Halseth, JM; Lavelle, MJ; Hanson, TE; Blass, CR; Foster, JA; Humphrys, ST; Staples, LD; Hewitt, DG; VerCauteren, KC				Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; Foster, Justin A.; Humphrys, Simon T.; Staples, Linton D.; Hewitt, David G.; VerCauteren, Kurt C.			Bait Preference of Free-Ranging Feral Swine for Delivery of a Novel Toxicant	PLOS ONE			English	Article							BOAR SUS-SCROFA; BIRDS; PIGS; PHARMACEUTICALS; CONSUMPTION; BEHAVIOR; COLOR; HOGS	Invasive feral swine (Sus scrofa) cause extensive damage to agricultural and wildlife resources throughout the United States. Development of sodium nitrite as a new, orally delivered toxicant is underway to provide an additional tool to curtail growth and expansion of feral swine populations. A micro-encapsulation coating around sodium nitrite is used to minimize detection by feral swine and maximize stability for the reactive molecule. To maximize uptake of this toxicant by feral swine, development a bait matrix is needed to 1) protect the micro-encapsulation coating so that sodium nitrite remains undetectable to feral swine, 2) achieve a high degree of acceptance by feral swine, and 3) be minimally appealing to non-target species. With these purposes, a field evaluation at 88 sites in south-central Texas was conducted using remote cameras to evaluate preferences by feral swine for several oil-based bait matrices including uncolored peanut paste, black-colored peanut paste, and peanut-based slurry mixed onto whole-kernel corn. These placebo baits were compared to a reference food, whole-kernel corn, known to be readily taken by feral swine (i.e., control). The amount of bait consumed by feral swine was also estimated using remote cameras and grid boards at 5 additional sites. On initial exposure, feral swine showed reduced visitations to the uncolored peanut paste and peanut slurry treatments. This reduced visitation subsided by the end of the treatment period, suggesting that feral swine needed time to accept these bait types. The black-colored peanut paste was visited equally to the control throughout the study, and enough of this matrix was consumed to deliver lethal doses of micro-encapsulated sodium nitrite to most feral swine during 1-2 feeding events. None of the treatment matrices reduced visitations by nontarget species, but feral swine dominated visitations for all matrices. It was concluded that black-colored peanut paste achieved satisfactory preference and consumption by feral swine, and no discernable preference by non-target species, compared to the other treatments.	[Snow, Nathan P.; Hewitt, David G.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA; [Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; VerCauteren, Kurt C.] US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA; [Foster, Justin A.] Texas Parks & Wildlife Dept, Kerr Wildlife Management Area, 2625 FM 1340, Hunt, TX 78024 USA; [Humphrys, Simon T.; Staples, Linton D.] Invas Anim CRC, 33 Flemington St, Glenside, SA 5062, Australia; [Staples, Linton D.] Anim Control Technol Australia Pty Ltd, 46-50 Freight Dr, Somerton, Vic 3062, Australia	Texas A&M University System; Texas A&M University Kingsville; United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Snow, NP (corresponding author), Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA.; Snow, NP (corresponding author), US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA.	Nathan.P.Snow@aphis.usda.gov	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	Funding was provided by the USDA National Feral Swine Damage Management Program and the Invasive Animals Cooperative Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author (LS) of this manuscript was commercially affiliated with Animal Control Technologies Australia Pty Ltd. This author played a role in the study by providing the test materials and preparation of the manuscript.	Adams CE., 2006, URBAN WILDLIFE MANAG; Bailey RG., 1980, DESCRIPTION ECOREGIO; Bailey RG, 1998, ECOREGIONS; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Baubet E, 2003, WILDLIFE RES, V30, P179, DOI 10.1071/WR00113; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; BRYANT H, 1984, AUST WILDLIFE RES, V11, P509; CAITHNES.TA, 1971, NEW ZEAL J AGR, V122, P38; Campbell TA, 2012, P 25 VERT PEST C; Campbell TA, 2007, J WILDLIFE DIS, V43, P485, DOI 10.7589/0090-3558-43.3.485; Campbell TA, 2006, WILDLIFE SOC B, V34, P1184, DOI 10.2193/0091-7648(2006)34[1184:UBTDPT]2.0.CO;2; Campbell TA, 2013, INT J PEST MANAGE, V59, P197, DOI 10.1080/09670874.2013.815830; Campbell TA, 2011, PREV VET MED, V98, P243, DOI 10.1016/j.prevetmed.2010.11.018; Campbell TA, 2010, J WILDLIFE MANAGE, V74, P337, DOI 10.2193/2009-131; Campbell TA, 2009, J WILDLIFE MANAGE, V73, P615, DOI 10.2193/2008-326; Chapman J., 2003, WILD MAMMALS N AM, P1164; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; COBLENTZ BE, 1987, J APPL ECOL, V24, P403, DOI 10.2307/2403883; Cowled BD, 2008, WILDLIFE RES, V35, P651, DOI 10.1071/WR07072; Cushman JH, 2004, ECOL APPL, V14, P1746, DOI 10.1890/03-5142; Day TD, 1999, NEW ZEAL J ECOL, V23, P261; Deligeorgis SG, 2006, APPL ANIM BEHAV SCI, V96, P233, DOI 10.1016/j.applanim.2005.06.006; DICKSON JG, 2001, WILDLIFE SO FORESTS, P191; Figueroa J, 2013, APPL ANIM BEHAV SCI, V148, P120, DOI 10.1016/j.applanim.2013.06.002; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; ILSE LM, 1995, J MAMMAL, V76, P784, DOI 10.2307/1382747; Jolley DB, 2010, J MAMMAL, V91, P519, DOI 10.1644/09-MAMM-A-129.1; Kittawornrat Apisit, 2011, Animal Health Research Reviews, V12, P25, DOI 10.1017/S1466252310000174; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lapidge S, 2012, USDA NATL WILDLIFE C, P1158; Massei G, 2010, J WILDLIFE MANAGE, V74, P333, DOI 10.2193/2008-489; MAYER J, 2009, WILD PIGS BIOL DAMAG; Mayer J. J., 2014, SRNLSTI201400292; Newkirk ES, 2014, CPW PHOTO DATABASE; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pimentel David, 2007, P2; SMITH JE, 1966, AM J PHYSIOL, V210, P347, DOI 10.1152/ajplegacy.1966.210.2.347; Snow N, 2015, BAIT PREFERENCE FREE; Tanida H, 1996, APPL ANIM BEHAV SCI, V49, P173, DOI 10.1016/0168-1591(96)01039-8; Taylor RB, 1997, SOUTHWEST NAT, V42, P33; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; Weser C, 2013, NEW ZEAL J ZOOL, V40, P137, DOI 10.1080/03014223.2012.710639; West B.C., 2009, MANAGING WILD PIGS T; Williams BL, 2011, J WILDLIFE MANAGE, V75, P655, DOI 10.1002/jwmg.75; Zhang YW, 2013, STAT COMPUT, V23, P743, DOI 10.1007/s11222-012-9343-7	48	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146712	10.1371/journal.pone.0146712	http://dx.doi.org/10.1371/journal.pone.0146712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812148	gold, Green Published			2022-12-27	WOS:000369528000012
